sampleID	AJCC_Stage_nature2012	Age_at_Initial_Pathologic_Diagnosis_nature2012	CN_Clusters_nature2012	Converted_Stage_nature2012	Days_to_Date_of_Last_Contact_nature2012	Days_to_date_of_Death_nature2012	ER_Status_nature2012	Gender_nature2012	HER2_Final_Status_nature2012	Integrated_Clusters_no_exp__nature2012	Integrated_Clusters_unsup_exp__nature2012	Integrated_Clusters_with_PAM50__nature2012	Metastasis_Coded_nature2012	Metastasis_nature2012	Node_Coded_nature2012	Node_nature2012	OS_Time_nature2012	OS_event_nature2012	PAM50Call_RNAseq	PAM50_mRNA_nature2012	PR_Status_nature2012	RPPA_Clusters_nature2012	SigClust_Intrinsic_mRNA_nature2012	SigClust_Unsupervised_mRNA_nature2012	Survival_Data_Form_nature2012	Tumor_T1_Coded_nature2012	Tumor_nature2012	Vital_Status_nature2012	_EVENT	_INTEGRATION	_OS	_OS_IND	_OS_UNIT	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_BRCA	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_BRCA	_PANCAN_mutation_PANCAN	_PATIENT	_RFS	_RFS_IND	_RFS_UNIT	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr	days_to_additional_surgery_locoregional_procedure	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	disease_code	distant_metastasis_present_ind2	er_detection_method_text	er_level_cell_percentage_category	fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng	followup_case_report_form_submission_reason	form_completion_date	gender	her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr	histological_type	histological_type_other	history_of_neoadjuvant_treatment	hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lost_follow_up	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt	metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts	metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt	metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt	metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl	metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr	metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ	metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt	metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt	metastatic_breast_carcinoma_progesterone_receptor_status	metastatic_site_at_diagnosis	metastatic_site_at_diagnosis_other	methylation_Clusters_nature2012	miRNA_Clusters_nature2012	mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn	mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn	mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	oct_embedded	other_dx	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	progesterone_receptor_level_cell_percent_category	project_code	radiation_therapy	sample_type	sample_type_id	surgical_procedure_purpose_other_text	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_BRCA_GSNP6noCNV	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_BRCA_GSNP6raw	_GENOMIC_ID_TCGA_BRCA_RPPA_RBN	_GENOMIC_ID_TCGA_BRCA_mutation	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_totalRNA_exon	_GENOMIC_ID_TCGA_BRCA_PDMRNAseq	_GENOMIC_ID_TCGA_BRCA_hMethyl450	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_totalRNA	_GENOMIC_ID_TCGA_BRCA_RPPA	_GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV	_GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene	_GENOMIC_ID_TCGA_BRCA_hMethyl27	_GENOMIC_ID_TCGA_BRCA_PDMarrayCNV	_GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq	_GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene	_GENOMIC_ID_TCGA_BRCA_miRNA_GA	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile	_GENOMIC_ID_data/public/TCGA/BRCA/miRNA_GA_gene	_GENOMIC_ID_TCGA_BRCA_gistic2thd	_GENOMIC_ID_data/public/TCGA/BRCA/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_BRCA_G4502A_07_3	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2	_GENOMIC_ID_TCGA_BRCA_gistic2	_GENOMIC_ID_TCGA_BRCA_PDMarray
TCGA-3C-AAAU-01																													0	TCGA-3C-AAAU-01	4047	0	days										TCGA-3C-AAAU	4047	0	days	4047	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-3C-AAAU-F68069	TCGA-3C-AAAU	TCGA-3C-AAAU-01A		Positive					Positive	Modified Radical Mastectomy		YES			-20211	3599		0	4047			1808				50-59%			2015-3-24	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			60	NO	Negative		NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																									Lung	Distant Metastasis			NO	4		true	No	MX	NX	TX	Stage X	TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf	AAAU	WITH TUMOR						NO	YES	50-59%		NO	Primary Tumor	01		6th		NO	YES	3C	Breast	A	LIVING	2004	6ef883fc-81f3-4089-95e0-86904ffc0d38	d247c6c5-a429-41ae-83d9-bf8307ab76e5	6ef883fc-81f3-4089-95e0-86904ffc0d38	d247c6c5-a429-41ae-83d9-bf8307ab76e5				TCGA-3C-AAAU-01	TCGA-3C-AAAU-01A-11D-A41Q-05			TCGA-3C-AAAU-01				TCGA-3C-AAAU-01			6ef883fc-81f3-4089-95e0-86904ffc0d38		TCGA-3C-AAAU-01A-11D-A41E-01	TCGA-3C-AAAU-01		6ef883fc-81f3-4089-95e0-86904ffc0d38	TCGA-3C-AAAU-01A-11D-A41E-01	
TCGA-3C-AALI-01																													0	TCGA-3C-AALI-01	4005	0	days										TCGA-3C-AALI	4005	0	days	4005	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-3C-AALI-F68057	TCGA-3C-AALI	TCGA-3C-AALI-01A		Positive					Positive	Lumpectomy					-18538	3772		0	4005							<10%			2014-11-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive		NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf	AALI	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	3C	Breast	A	LIVING	2003	dd8d3665-ec9d-45be-b7b9-a85dac3585e2	0fa8d96d-b739-4da6-b525-c62cdabee68c	dd8d3665-ec9d-45be-b7b9-a85dac3585e2	0fa8d96d-b739-4da6-b525-c62cdabee68c				TCGA-3C-AALI-01	TCGA-3C-AALI-01A-11D-A41Q-05		1B37DE89-DEB6-4049-A2D4-450A4A1DE5D3	TCGA-3C-AALI-01				TCGA-3C-AALI-01			dd8d3665-ec9d-45be-b7b9-a85dac3585e2		TCGA-3C-AALI-01A-11D-A41E-01	TCGA-3C-AALI-01		dd8d3665-ec9d-45be-b7b9-a85dac3585e2	TCGA-3C-AALI-01A-11D-A41E-01	
TCGA-3C-AALJ-01																													0	TCGA-3C-AALJ-01	1474	0	days										TCGA-3C-AALJ	1474	0	days	1474	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right			TCGA-3C-AALJ-F71675	TCGA-3C-AALJ	TCGA-3C-AALJ-01A		Positive					Positive	Modified Radical Mastectomy					-22848	1026		0	1474							90-99%			2015-3-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Indeterminate		NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-3C-AALJ.265E5A9A-64FD-4B86-89BC-5E89F253C118.pdf	AALJ	TUMOR FREE						NO	YES	30-39%		NO	Primary Tumor	01		7th		NO	YES	3C	Breast	A	LIVING	2011	c924c2a8-ab41-4499-bb30-79705cc17d45	6cb7dc53-ea35-431b-9bd9-4f13f5ec40fd	c924c2a8-ab41-4499-bb30-79705cc17d45	6cb7dc53-ea35-431b-9bd9-4f13f5ec40fd				TCGA-3C-AALJ-01	TCGA-3C-AALJ-01A-31D-A41Q-05			TCGA-3C-AALJ-01				TCGA-3C-AALJ-01			c924c2a8-ab41-4499-bb30-79705cc17d45		TCGA-3C-AALJ-01A-31D-A41E-01	TCGA-3C-AALJ-01		c924c2a8-ab41-4499-bb30-79705cc17d45	TCGA-3C-AALJ-01A-31D-A41E-01	
TCGA-3C-AALK-01																													0	TCGA-3C-AALK-01	1448	0	days										TCGA-3C-AALK	1448	0	days	1448	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right	Sentinel node biopsy alone		TCGA-3C-AALK-F71676	TCGA-3C-AALK	TCGA-3C-AALK-01A		Positive					Positive	Simple Mastectomy		YES			-19074	1022		0	1448							70-79%			2015-3-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Positive		NO	2	Close																														NO	0	1	true	No	M0	N0 (i+)	T1c	Stage IA	TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A.pdf	AALK	TUMOR FREE						NO	YES	80-89%		NO	Primary Tumor	01		7th		NO	YES	3C	Breast	A	LIVING	2011	1a19e068-d213-41ef-aebb-104017a883cc	52dbb525-a0ad-4dce-bb51-650f97510c6e	1a19e068-d213-41ef-aebb-104017a883cc	52dbb525-a0ad-4dce-bb51-650f97510c6e				TCGA-3C-AALK-01	TCGA-3C-AALK-01A-11D-A41Q-05		4B79D851-B233-49F8-95B1-B4AA057D7FD2	TCGA-3C-AALK-01				TCGA-3C-AALK-01			1a19e068-d213-41ef-aebb-104017a883cc		TCGA-3C-AALK-01A-11D-A41E-01	TCGA-3C-AALK-01		1a19e068-d213-41ef-aebb-104017a883cc	TCGA-3C-AALK-01A-11D-A41E-01	
TCGA-4H-AAAK-01																													0	TCGA-4H-AAAK-01	348	0	days										TCGA-4H-AAAK	348	0	days	348	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-4H-AAAK-F67414	TCGA-4H-AAAK	TCGA-4H-AAAK-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-18371	35		0	348							60-69%			2014-11-13	FEMALE			10-19%		2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	770	NO	Equivocal		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	4		true	No	M0	N2a	T2	Stage IIIA	TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf	AAAK	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	01		7th		YES	NO	4H	Breast	A	LIVING	2013	2ea9e472-a408-4ae0-975d-50a566f22b2a	1d102fff-6466-491d-9727-9f059aad616f	2ea9e472-a408-4ae0-975d-50a566f22b2a	1d102fff-6466-491d-9727-9f059aad616f				TCGA-4H-AAAK-01	TCGA-4H-AAAK-01A-12D-A41Q-05		C1C10723-C328-4CAB-9959-E98025E4CD71	TCGA-4H-AAAK-01				TCGA-4H-AAAK-01			2ea9e472-a408-4ae0-975d-50a566f22b2a		TCGA-4H-AAAK-01A-12D-A41E-01	TCGA-4H-AAAK-01		2ea9e472-a408-4ae0-975d-50a566f22b2a	TCGA-4H-AAAK-01A-12D-A41E-01	
TCGA-5L-AAT0-01																													0	TCGA-5L-AAT0-01	1477	0	days										TCGA-5L-AAT0	1477	0	days	1477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right|Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-5L-AAT0	TCGA-5L-AAT0-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15393	1320		0	1477							70-79%			2014-8-15	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	80	NO	Negative			8	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	Yes	M0	N0	T2	Stage IIA	TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE.pdf	AAT0	TUMOR FREE						YES	YES	50-59%		YES	Primary Tumor	01		7th		NO	YES	5L	Breast	A	LIVING	2010	32e61645-eb89-49f7-9876-85b1497c7e42	615b2826-7f9f-498b-8309-d4d54d598c50	32e61645-eb89-49f7-9876-85b1497c7e42	615b2826-7f9f-498b-8309-d4d54d598c50				TCGA-5L-AAT0-01	TCGA-5L-AAT0-01A-12D-A41Q-05			TCGA-5L-AAT0-01				TCGA-5L-AAT0-01			32e61645-eb89-49f7-9876-85b1497c7e42		TCGA-5L-AAT0-01A-12D-A41E-01	TCGA-5L-AAT0-01		32e61645-eb89-49f7-9876-85b1497c7e42	TCGA-5L-AAT0-01A-12D-A41E-01	
TCGA-5L-AAT1-01																													0	TCGA-5L-AAT1-01	1471	0	days										TCGA-5L-AAT1	1471	0	days	1471	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left	Other (specify)	Level 1 clearance		TCGA-5L-AAT1	TCGA-5L-AAT1-01A		Positive					Positive	Simple Mastectomy		NO			-23225	1259		0	1471							80-89%			2014-8-15	FEMALE		CISH			2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	130	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Bone											NO	0		false	Yes	M1	N0	T2	Stage IV	TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A.pdf	AAT1	WITH TUMOR		CISH				YES	YES	10-19%		NO	Primary Tumor	01		7th		NO	YES	5L	Breast	A	LIVING	2010	34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	4d7ffa3e-0218-4fc4-b3da-691d56a7df1a	34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	4d7ffa3e-0218-4fc4-b3da-691d56a7df1a				TCGA-5L-AAT1-01	TCGA-5L-AAT1-01A-12D-A41Q-05		047431B7-6180-49AB-9DD0-D23D794F2953	TCGA-5L-AAT1-01							34dfa8c6-6445-4ef8-bc3b-b2ba600b5808		TCGA-5L-AAT1-01A-12D-A41E-01			34dfa8c6-6445-4ef8-bc3b-b2ba600b5808	TCGA-5L-AAT1-01A-12D-A41E-01	
TCGA-5T-A9QA-01																													0	TCGA-5T-A9QA-01	303	0	days										TCGA-5T-A9QA	303	0	days	303	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left	No axillary staging		TCGA-5T-A9QA-F66889	TCGA-5T-A9QA	TCGA-5T-A9QA-01A		Positive	3 Point Scale				Negative			NO			-19031	31		0	303							70-79%			2014-10-25	FEMALE			10-19%		2+					Other, specify		No		C50.9	8523/3	C50.9	2+	YES		Excisional Biopsy	650	NO	Equivocal	Negative	NO																																NO			true	No	MX	NX	T2	Stage IIA	TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf	A9QA							YES	NO			YES	Primary Tumor	01		7th		YES	NO	5T	Breast	A	LIVING	2013	41ab76d7-fae0-490c-9545-be576b64b827	74d626f8-5b32-4cc9-b86a-2ddd8fd46651	41ab76d7-fae0-490c-9545-be576b64b827	74d626f8-5b32-4cc9-b86a-2ddd8fd46651				TCGA-5T-A9QA-01	TCGA-5T-A9QA-01A-11D-A41Q-05		9E71A150-8FD7-466C-96AF-AAB29520BCDC	TCGA-5T-A9QA-01				TCGA-5T-A9QA-01			41ab76d7-fae0-490c-9545-be576b64b827		TCGA-5T-A9QA-01A-11D-A41E-01	TCGA-5T-A9QA-01		41ab76d7-fae0-490c-9545-be576b64b827	TCGA-5T-A9QA-01A-11D-A41E-01	
TCGA-A1-A0SB-01	Stage I	70	1	Stage I	259		Positive	FEMALE	Negative				Negative	M0	Negative	N0	259	0	Normal		Negative				enrollment	T1	T1	LIVING	0	TCGA-A1-A0SB-01	259	0	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A1-A0SB			days	259	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left	Sentinel node biopsy alone			TCGA-A1-A0SB			Positive					Negative	Lumpectomy					-25833			0	259					NO		70-79%			2011-6-30	FEMALE										Other, specify		No		C50.9	8200/3	C50.9		YES		Fine needle aspiration biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3									0			No	M0	N0	T1c	Stage I		A0SB	TUMOR FREE							YES				Primary Tumor	01		6th		NO	YES	A1	Breast		LIVING	2008	a2405d64-34eb-4915-abf7-8530151d5cb0	d4c2fab5-8fbd-4ab5-b18c-37f9b4b576a8	a2405d64-34eb-4915-abf7-8530151d5cb0	d4c2fab5-8fbd-4ab5-b18c-37f9b4b576a8		TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01	TCGA-A1-A0SB-01A-11D-A145-05			TCGA-A1-A0SB-01	TCGA-A1-A0SB-01A-11D-A142-09			TCGA-A1-A0SB-01	TCGA-A1-A0SB-01A-11D-A142-09		a2405d64-34eb-4915-abf7-8530151d5cb0		TCGA-A1-A0SB-01A-11D-A141-01	TCGA-A1-A0SB-01		a2405d64-34eb-4915-abf7-8530151d5cb0	TCGA-A1-A0SB-01A-11D-A141-01	
TCGA-A1-A0SD-01	Stage IIA	59	2	Stage IIA	437		Positive	FEMALE	Negative				Negative	M0	Negative	N0	437	0	LumA	Luminal A	Positive		-9	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SD-01	437	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-A1-A0SD			days	437	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SD	TCGA-A1-A0SD-01A	Negative	Positive				Lumpectomy	Positive	Lumpectomy					-21793	1697		0	437							90-99%			2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			3	Positive																					1	6									0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B.pdf	A0SD								YES	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2005	15bad71d-3031-413b-9e8d-6426ae5dfbea	07321363-1d47-430a-a3ce-ec16f9b52d3a	15bad71d-3031-413b-9e8d-6426ae5dfbea	07321363-1d47-430a-a3ce-ec16f9b52d3a		TCGA-A1-A0SD-01A-11D-A10Y-09		TCGA-A1-A0SD-01				TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11D-A10Y-09	TCGA-A1-A0SD-01A-11D-A112-05	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11D-A10Y-09		15bad71d-3031-413b-9e8d-6426ae5dfbea		TCGA-A1-A0SD-01A-11D-A111-01	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11R-A115-07	15bad71d-3031-413b-9e8d-6426ae5dfbea	TCGA-A1-A0SD-01A-11D-A111-01	TCGA-A1-A0SD-01
TCGA-A1-A0SE-01	Stage I	56	2	Stage I	1320		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1320	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-A1-A0SE-01	1321	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A1-A0SE			days	1321	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SE	TCGA-A1-A0SE-01A		Positive		3+			Positive	Modified Radical Mastectomy					-20717	1672		0	1321							80-89%	2		2010-12-6	FEMALE					1+		2	1		Mixed Histology (please specify)	invasive ductal and lobular carcinoma	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	90	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6									0		true	No	M0	N0 (i-)	T1c	Stage I	TCGA-A1-A0SE.CFF567FC-8867-4CA4-85AE-81A7D30095E7.pdf	A0SE	TUMOR FREE								90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2005	a998e0ce-9248-460f-aabc-2dad452a1ff9	401a4b1d-1f1d-4d3c-b330-02fb9ba433d3	a998e0ce-9248-460f-aabc-2dad452a1ff9	401a4b1d-1f1d-4d3c-b330-02fb9ba433d3		TCGA-A1-A0SE-01A-11D-A099-09		TCGA-A1-A0SE-01	TCGA-A1-A0SE-01A-11D-A10P-05			TCGA-A1-A0SE-01	TCGA-A1-A0SE-01A-11D-A099-09		TCGA-A1-A0SE-01		TCGA-A1-A0SE-01A-11D-A099-09	TCGA-A1-A0SE-01	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01	TCGA-A1-A0SE-01A-11D-A087-01		TCGA-A1-A0SE-01A-11R-A084-07	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01A-11D-A087-01	TCGA-A1-A0SE-01
TCGA-A1-A0SF-01	Stage IIA	54	3	Stage IIA	1463		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1463	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SF-01	1463	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-A1-A0SF			days	1463	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SF	TCGA-A1-A0SF-01A		Positive					Positive	Modified Radical Mastectomy					-19731	1648		0	1463					NO		90-99%			2011-5-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6									0		true	No	M0	N0	T2	Stage IIA	TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf	A0SF	TUMOR FREE							YES	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	28089e15-5e2c-4e83-ba6c-62b3cb40e431	ea71ebc6-d742-4a38-8b9a-1e8b63f43b38	28089e15-5e2c-4e83-ba6c-62b3cb40e431	ea71ebc6-d742-4a38-8b9a-1e8b63f43b38	TCGA-A1-A0SF-01A-21-A17I-20	TCGA-A1-A0SF-01A-11D-A142-09		TCGA-A1-A0SF-01	TCGA-A1-A0SF-01A-11D-A145-05		f0b3d871-c0aa-4ef8-ab74-c3e812393ed5	TCGA-A1-A0SF-01	TCGA-A1-A0SF-01A-11D-A142-09			TCGA-A1-A0SF-01	TCGA-A1-A0SF-01A-11D-A142-09		28089e15-5e2c-4e83-ba6c-62b3cb40e431		TCGA-A1-A0SF-01A-11D-A141-01	TCGA-A1-A0SF-01		28089e15-5e2c-4e83-ba6c-62b3cb40e431	TCGA-A1-A0SF-01A-11D-A141-01	
TCGA-A1-A0SG-01	Stage IIB	61	4	Stage IIB	433		Positive	FEMALE	Negative				Negative	M0	Positive	N1	433	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SG-01	434	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 5	mutation c1uster 9	TCGA-A1-A0SG			days	434	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SG	TCGA-A1-A0SG-01A		Positive					Positive	Lumpectomy					-22380	1581		0	434							90-99%			2011-5-31	FEMALE										Other, specify		No		C50.9	8507/3	C50.9		YES		Core needle biopsy	120	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	5									1		true	No	M0	N1a	T2	Stage IIB	TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf	A0SG								YES	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	0df6b948-367d-4951-9d98-d3bebabff63e	75937dba-a780-42c5-91db-c7ae7a4b8c41	0df6b948-367d-4951-9d98-d3bebabff63e	75937dba-a780-42c5-91db-c7ae7a4b8c41		TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01	TCGA-A1-A0SG-01A-11D-A145-05			TCGA-A1-A0SG-01	TCGA-A1-A0SG-01A-11D-A142-09			TCGA-A1-A0SG-01	TCGA-A1-A0SG-01A-11D-A142-09		0df6b948-367d-4951-9d98-d3bebabff63e		TCGA-A1-A0SG-01A-11D-A141-01	TCGA-A1-A0SG-01		0df6b948-367d-4951-9d98-d3bebabff63e	TCGA-A1-A0SG-01A-11D-A141-01	
TCGA-A1-A0SH-01	Stage IIA	39	5	Stage IIA	1437		Negative	FEMALE	Negative	1	1	1	Negative	M0	Negative	N0	1437	0	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SH-01	1437	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4	mutation c1uster 10	TCGA-A1-A0SH			days	1437	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A1-A0SH	TCGA-A1-A0SH-01A		Negative					Positive	Lumpectomy					-14595	1305		0	1437								1.8		2010-12-6	FEMALE					2+		2.5	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4									0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6.pdf	A0SH	TUMOR FREE								90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	dce3de3e-f851-4859-a208-72e65d36ab3d	43ba3339-996b-4477-878f-4a62c471ab5f	dce3de3e-f851-4859-a208-72e65d36ab3d	43ba3339-996b-4477-878f-4a62c471ab5f	TCGA-A1-A0SH-01A-21-A13A-20	TCGA-A1-A0SH-01A-11D-A099-09		TCGA-A1-A0SH-01	TCGA-A1-A0SH-01A-11D-A10P-05		4760c029-9150-4384-b036-263684155c89	TCGA-A1-A0SH-01	TCGA-A1-A0SH-01A-11D-A099-09		TCGA-A1-A0SH-01		TCGA-A1-A0SH-01A-11D-A099-09	TCGA-A1-A0SH-01	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01	TCGA-A1-A0SH-01A-11D-A087-01		TCGA-A1-A0SH-01A-11R-A084-07	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01A-11D-A087-01	TCGA-A1-A0SH-01
TCGA-A1-A0SI-01	Stage IIB	52	3	Stage IIB	634		Positive	FEMALE	Negative				Negative	M0	Positive	N1	634	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SI-01	635	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 3	TCGA-A1-A0SI			days	635	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SI	TCGA-A1-A0SI-01A		Positive					Positive	Lumpectomy					-19250	1267		0	635					NO		50-59%			2011-6-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	40	NO	Negative			23	Negative																					5	7									1		true	No	M0	N1a	T2	Stage IIB	TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf	A0SI	TUMOR FREE							YES	10-19%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	44d93b9f-95d6-4382-9590-f6e7bdda65c5	35d22d6b-6b95-48bc-bc2f-fe4495ff188e	44d93b9f-95d6-4382-9590-f6e7bdda65c5	35d22d6b-6b95-48bc-bc2f-fe4495ff188e		TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01	TCGA-A1-A0SI-01A-11D-A145-05			TCGA-A1-A0SI-01	TCGA-A1-A0SI-01A-11D-A142-09			TCGA-A1-A0SI-01	TCGA-A1-A0SI-01A-11D-A142-09		44d93b9f-95d6-4382-9590-f6e7bdda65c5		TCGA-A1-A0SI-01A-11D-A141-01	TCGA-A1-A0SI-01		44d93b9f-95d6-4382-9590-f6e7bdda65c5	TCGA-A1-A0SI-01A-11D-A141-01	
TCGA-A1-A0SJ-01	Stage IIIA	39	3	Stage IIIA	426		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	426	0	LumA	Luminal A	Positive	ReacI	-3	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A1-A0SJ-01	416	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SJ			days	416	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SJ	TCGA-A1-A0SJ-01A		Positive					Positive	Modified Radical Mastectomy					-14383	1399		0	416							70-79%	4		2010-12-6	FEMALE					2+		5	1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative		19	Negative																					4	4									3		true	No	M0	N1a	T3	Stage IIIA	TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3.pdf	A0SJ	TUMOR FREE								10-19%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2006	61017170-a36a-4ce9-9b8e-324755b88dd7	c9020c2b-9c08-45c6-b13d-1bcb9f9d451f	61017170-a36a-4ce9-9b8e-324755b88dd7	c9020c2b-9c08-45c6-b13d-1bcb9f9d451f	TCGA-A1-A0SJ-01A-21-A13A-20	TCGA-A1-A0SJ-01A-11D-A099-09		TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01A-11D-A10P-05		33773418-77f8-4219-9b75-04d5ba09bb97	TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01A-11D-A099-09		TCGA-A1-A0SJ-01		TCGA-A1-A0SJ-01A-11D-A099-09	TCGA-A1-A0SJ-01	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01A-11D-A087-01		TCGA-A1-A0SJ-01A-11R-A084-07	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01A-11D-A087-01	TCGA-A1-A0SJ-01
TCGA-A1-A0SK-01	Stage IIA	54	1	Stage IIA	594	967	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	967	1	Basal	Basal-like	Negative	Basal	-13	-6	followup	T_Other	T2	DECEASED	1	TCGA-A1-A0SK-01	967	1	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	GBM-like c6	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SK			days	967	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A1-A0SK-F15926	TCGA-A1-A0SK	TCGA-A1-A0SK-01A	Negative	Negative				Other	Negative	Lumpectomy	surgical resection				-20048	1164	967	0										Scheduled Follow-up Submission	2011-9-7	FEMALE					0					Other, specify		No		C50.9	8013/3	C50.9		YES		Excisional Biopsy	160	NO	Negative			4	Positive	Indeterminate (neither Pre or Postmenopausal)																				5	5									0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE.pdf	A0SK	WITH TUMOR											Primary Tumor	01		6th		NO	YES	A1	Breast	A	DECEASED	2007	a63583ca-0ef2-4417-b435-5f3a6951d0c2	c76440c7-2213-4933-b79d-d832910334ea	a63583ca-0ef2-4417-b435-5f3a6951d0c2	c76440c7-2213-4933-b79d-d832910334ea	TCGA-A1-A0SK-01A-21-A13A-20	TCGA-A1-A0SK-01A-12D-A099-09		TCGA-A1-A0SK-01	TCGA-A1-A0SK-01A-12D-A10P-05		8d8099ba-c207-473b-8ffc-e9610494386c	TCGA-A1-A0SK-01	TCGA-A1-A0SK-01A-12D-A099-09		TCGA-A1-A0SK-01		TCGA-A1-A0SK-01A-12D-A099-09	TCGA-A1-A0SK-01	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01	TCGA-A1-A0SK-01A-12D-A087-01		TCGA-A1-A0SK-01A-12R-A084-07	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01A-12D-A087-01	TCGA-A1-A0SK-01
TCGA-A1-A0SM-01	Stage IIA	77	2	Stage IIA	242		Positive	MALE	Positive				Negative	M0	Negative	N0	242	0	LumA	Luminal B	Negative		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SM-01	242	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SM			days	242	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SM	TCGA-A1-A0SM-01A		Positive					Negative	Modified Radical Mastectomy					-28198	1115		0	242							20-29%	2		2010-12-6	MALE					3+		21	11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive	Positive		3	Negative																					4	4									0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A1-A0SM.4F047F5B-EF3A-4590-8E7A-D90A52860324.pdf	A0SM	TUMOR FREE											Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	e637db43-508a-4a37-92e4-eea96b35b65b	17bd1937-b31e-46af-8334-49b86f7a1922	e637db43-508a-4a37-92e4-eea96b35b65b	17bd1937-b31e-46af-8334-49b86f7a1922		TCGA-A1-A0SM-01A-11D-A099-09		TCGA-A1-A0SM-01	TCGA-A1-A0SM-01A-11D-A10P-05			TCGA-A1-A0SM-01	TCGA-A1-A0SM-01A-11D-A099-09		TCGA-A1-A0SM-01		TCGA-A1-A0SM-01A-11D-A099-09	TCGA-A1-A0SM-01	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01	TCGA-A1-A0SM-01A-11D-A087-01		TCGA-A1-A0SM-01A-11R-A084-07	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01A-11D-A087-01	TCGA-A1-A0SM-01
TCGA-A1-A0SN-01	Stage IIIA	50	5	Stage IIA	1196		Positive	FEMALE	Positive				Negative	M0	Positive	N1	1196	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-A1-A0SN-01	1196	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SN			days	1196	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SN	TCGA-A1-A0SN-01A		Positive					Positive	Lumpectomy					-18401	1091		0	1196							90-99%			2011-5-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4									4		true	No	MX	N1	T1c	Stage IIA	TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf	A0SN	TUMOR FREE							YES	60-69%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	2e5d28ee-b288-466f-9d14-0ed674e0c6b0	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	2e5d28ee-b288-466f-9d14-0ed674e0c6b0		TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01	TCGA-A1-A0SN-01A-11D-A145-05			TCGA-A1-A0SN-01	TCGA-A1-A0SN-01A-11D-A142-09			TCGA-A1-A0SN-01	TCGA-A1-A0SN-01A-11D-A142-09		7fdf1ebf-149a-43d5-bae7-6e01beb647dd		TCGA-A1-A0SN-01A-11D-A141-01	TCGA-A1-A0SN-01		7fdf1ebf-149a-43d5-bae7-6e01beb647dd	TCGA-A1-A0SN-01A-11D-A141-01	
TCGA-A1-A0SO-01	Stage IIB	67	1	Stage IIB	852		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	852	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SO-01	852	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SO			days	852	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SO	TCGA-A1-A0SO-01A		Negative					Negative	Modified Radical Mastectomy					-24826	1057		0	852								3.2		2010-12-6	FEMALE							5	1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5									1		true	No	M0	N1	T2	Stage IIB	TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3.pdf	A0SO	TUMOR FREE											Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b21b55-af53-4b23-97ef-5be59a3495d8	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b21b55-af53-4b23-97ef-5be59a3495d8	TCGA-A1-A0SO-01A-11-A13A-20	TCGA-A1-A0SO-01A-22D-A099-09		TCGA-A1-A0SO-01	TCGA-A1-A0SO-01A-22D-A10P-05		3c86150e-49f3-4303-bd6e-3d4bcc4aad50	TCGA-A1-A0SO-01			TCGA-A1-A0SO-01		TCGA-A1-A0SO-01A-22D-A099-09	TCGA-A1-A0SO-01	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01	TCGA-A1-A0SO-01A-22D-A087-01		TCGA-A1-A0SO-01A-22R-A084-07	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01A-22D-A087-01	TCGA-A1-A0SO-01
TCGA-A1-A0SP-01	Stage IIA	40		Stage IIA	583		Negative	FEMALE	Negative				Negative	M0	Negative	N0	583	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SP-01	584	0	days	High	C4-BRCA/Basal		BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-A1-A0SP			days	584	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Axillary lymph node dissection alone			TCGA-A1-A0SP			Negative					Negative	Lumpectomy					-14954			0	584										2010-12-6	FEMALE					0					Infiltrating Ductal Carcinoma				C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			3	Negative																															0			Yes	M0	N0 (i-)	T2	Stage IIA		A0SP	TUMOR FREE											Primary Tumor	01		6th		NO	YES	A1	Breast		LIVING	2007	f091d050-4847-4d4d-b94c-1efacecdef6b	fda83c5d-bec0-427d-8c6e-e8c06953e58a	f091d050-4847-4d4d-b94c-1efacecdef6b	fda83c5d-bec0-427d-8c6e-e8c06953e58a		TCGA-A1-A0SP-01A-11D-A099-09		TCGA-A1-A0SP-01	TCGA-A1-A0SP-01A-11D-A10P-05			TCGA-A1-A0SP-01	TCGA-A1-A0SP-01A-11D-A099-09		TCGA-A1-A0SP-01		TCGA-A1-A0SP-01A-11D-A099-09	TCGA-A1-A0SP-01	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01	TCGA-A1-A0SP-01A-11D-A087-01		TCGA-A1-A0SP-01A-11R-A084-07	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01A-11D-A087-01	TCGA-A1-A0SP-01
TCGA-A1-A0SQ-01	Stage IIB	45	3	Stage IIB	553		Positive	FEMALE	Negative				Negative	M0	Positive	N1	553	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SQ-01	554	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-A1-A0SQ			days	554	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SQ	TCGA-A1-A0SQ-01A		Positive					Positive	Modified Radical Mastectomy					-16458	967		0	554					NO		90-99%			2011-6-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	2									1		true	No	MX	N1	T2	Stage IIB	TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf	A0SQ	TUMOR FREE							YES	90-99%			Primary Tumor	01		6th		NO	YES	A1	Breast	A	LIVING	2007	9efdba02-2752-4c89-bb53-e8018f5aa7bf	e4c6cf2d-7eac-44e0-b338-a8dbeffc212e	9efdba02-2752-4c89-bb53-e8018f5aa7bf	e4c6cf2d-7eac-44e0-b338-a8dbeffc212e	TCGA-A1-A0SQ-01A-11-A17I-20	TCGA-A1-A0SQ-01A-21D-A142-09		TCGA-A1-A0SQ-01	TCGA-A1-A0SQ-01A-21D-A145-05		5f624f7e-a0d0-454e-ba7a-6ca212ec4fda	TCGA-A1-A0SQ-01	TCGA-A1-A0SQ-01A-21D-A142-09			TCGA-A1-A0SQ-01	TCGA-A1-A0SQ-01A-21D-A142-09		9efdba02-2752-4c89-bb53-e8018f5aa7bf		TCGA-A1-A0SQ-01A-21D-A141-01	TCGA-A1-A0SQ-01		9efdba02-2752-4c89-bb53-e8018f5aa7bf	TCGA-A1-A0SQ-01A-21D-A141-01	
TCGA-A2-A04N-01	Stage IA	66	4	Stage I	3188		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	3188	0	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	LIVING	0	TCGA-A2-A04N-01	4354	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A04N	4354	0	days	4354	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right	Other (specify)	Sentinel lymph node biopsy plus non-sentinel lymph node biopsy	TCGA-A2-A04N-F59311	TCGA-A2-A04N	TCGA-A2-A04N-01A		Positive					Positive	Lumpectomy		YES			-24155	2850		0	4354										2014-5-8	FEMALE								1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	130	NO		Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A.pdf	A04N	TUMOR FREE						YES				YES	Primary Tumor	01		5th	YES	NO	YES	A2	Breast	A	LIVING	2002	71b60d53-513c-4da5-b095-39f913bd4f11	5ed8c239-3f5f-409e-9d46-8995ca7fa57d	71b60d53-513c-4da5-b095-39f913bd4f11	5ed8c239-3f5f-409e-9d46-8995ca7fa57d	TCGA-A2-A04N-01A-21-A13A-20	TCGA-A2-A04N-01A-11D-A10Y-09		TCGA-A2-A04N-01			2ef34d44-4aa3-4b06-8029-f92c4b3a49a7	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11D-A10Y-09	TCGA-A2-A04N-01A-11D-A112-05	TCGA-A2-A04N-01	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11D-A10Y-09		71b60d53-513c-4da5-b095-39f913bd4f11		TCGA-A2-A04N-01A-11D-A111-01	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11R-A115-07	71b60d53-513c-4da5-b095-39f913bd4f11	TCGA-A2-A04N-01A-11D-A111-01	TCGA-A2-A04N-01
TCGA-A2-A04P-01	Stage IIIC	36	1	No_Conversion	547	547	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N3	547	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	DECEASED	1	TCGA-A2-A04P-01	548	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-A2-A04P	179	1	days	548	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO	NO	36	Left	Axillary lymph node dissection alone		TCGA-A2-A04P-F71021	TCGA-A2-A04P	TCGA-A2-A04P-01A	Positive	Negative				Mastectomy NOS	Negative	Lumpectomy		NO			-13238	2623	548	0			179	179				<10%			2015-3-13	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	250	NO		Negative	NO	20	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Negative				1.0				Negative				Negative			5	5				Other, specify	Locoregional Recurrence	Axilla	YES	YES	18	0	true	No	M0	N3c	T2	Stage IIIC	TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5.pdf	A04P	WITH TUMOR						YES		<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003	357ba9f6-716c-4ef0-8ac8-41977397dbf5	514e30c9-fe93-4d52-a31f-9e771c71d300	357ba9f6-716c-4ef0-8ac8-41977397dbf5	514e30c9-fe93-4d52-a31f-9e771c71d300	TCGA-A2-A04P-01A-41-A13A-20	TCGA-A2-A04P-01A-31D-A128-09		TCGA-A2-A04P-01			15a1aee0-d9cf-4122-9290-0d4bfaee159a	TCGA-A2-A04P-01	TCGA-A2-A04P-01A-31D-A128-09	TCGA-A2-A04P-01A-31D-A032-05	TCGA-A2-A04P-01		TCGA-A2-A04P-01A-31D-A128-09	TCGA-A2-A04P-01	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA-A2-A04P-01	TCGA-A2-A04P-01A-31D-A036-01		TCGA-A2-A04P-01A-31R-A034-07	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA-A2-A04P-01A-31D-A036-01	TCGA-A2-A04P-01
TCGA-A2-A04Q-01	Stage IA	48	3	Stage I	1275		Negative	FEMALE	Negative	1	2	3	Negative	M0	Negative	N0	1275	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA-A2-A04Q-01	2385	0	days	High	C4-BRCA/Basal	cluster 1	BRCA CIMP c7	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A04Q			days	2385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant|Right	Other (specify)	SLN AND NON-SLN BX	TCGA-A2-A04Q-F59314	TCGA-A2-A04Q	TCGA-A2-A04Q-01A		Negative					Negative	Simple Mastectomy		YES			-17660	2260		0	2385							<10%			2014-5-8	FEMALE					2+			1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	SKIN BIOPSY	Other method, specify:	230	NO	Equivocal	Negative	YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4									0	0	true	No	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484.pdf	A04Q	TUMOR FREE						YES		<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	e69d3fc4-7639-471d-9a76-41e20afd4b62	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	e69d3fc4-7639-471d-9a76-41e20afd4b62	TCGA-A2-A04Q-01A-11-A13A-20	TCGA-A2-A04Q-01A-21W-A050-09		TCGA-A2-A04Q-01			9e43165b-f93c-4a25-a1c8-7bdad54cee95	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01A-21W-A050-09	TCGA-A2-A04Q-01A-21D-A032-05	TCGA-A2-A04Q-01		TCGA-A2-A04Q-01A-21W-A050-09	TCGA-A2-A04Q-01	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01A-21D-A036-01		TCGA-A2-A04Q-01A-21R-A034-07	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	TCGA-A2-A04Q-01A-21D-A036-01	TCGA-A2-A04Q-01
TCGA-A2-A04R-01	Stage IA	36	5	Stage I	2499		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2499	0	LumB	Luminal B	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A04R-01	3709	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 10	TCGA-A2-A04R	3709	0	days	3709	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A04R-F59315	TCGA-A2-A04R	TCGA-A2-A04R-01A		Positive					Positive	Lumpectomy		YES			-13483	2233		0	3709							60-69%			2014-5-8	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Negative	NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	0	0	true	No	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35.pdf	A04R	TUMOR FREE						YES		80-89%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	8801f107-f5d5-4ad5-877d-a5acb12596b3	ca39b4e5-b1ee-4f4f-a78c-5aaf90044663	8801f107-f5d5-4ad5-877d-a5acb12596b3	ca39b4e5-b1ee-4f4f-a78c-5aaf90044663		TCGA-A2-A04R-01A-41D-A117-09		TCGA-A2-A04R-01	TCGA-A2-A04R-01A-41D-A10A-05			TCGA-A2-A04R-01	TCGA-A2-A04R-01A-41D-A117-09		TCGA-A2-A04R-01		TCGA-A2-A04R-01A-41D-A117-09	TCGA-A2-A04R-01	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01	TCGA-A2-A04R-01A-41D-A107-01		TCGA-A2-A04R-01A-41R-A109-07	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01A-41D-A107-01	TCGA-A2-A04R-01
TCGA-A2-A04T-01	Stage IIA	62	1	Stage IIA	2246		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2246	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A04T-01	2246	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-A2-A04T			days	2246	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A04T-F9343	TCGA-A2-A04T	TCGA-A2-A04T-01A		Negative					Negative	Lumpectomy		YES			-22707	1979		0	2246							<10%			2011-3-17	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5									0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf	A04T	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	79d7a589-60bd-4b4a-89c1-d557fe24c733	9f5d61da-fe30-4975-a3d5-3ba4eab06683	79d7a589-60bd-4b4a-89c1-d557fe24c733	9f5d61da-fe30-4975-a3d5-3ba4eab06683	TCGA-A2-A04T-01A-31-A13A-20			TCGA-A2-A04T-01			2724de89-78e5-4da5-b2d9-350a986a8abb	TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21W-A050-09	TCGA-A2-A04T-01A-21D-A032-05	TCGA-A2-A04T-01			TCGA-A2-A04T-01	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21D-A036-01		TCGA-A2-A04T-01A-21R-A034-07	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01A-21D-A036-01	TCGA-A2-A04T-01
TCGA-A2-A04U-01	Stage IIA	47		Stage IIA	670		Negative	FEMALE	Negative				Negative	M0	Negative	N0	670	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A04U-01	2654	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A2-A04U			days	2654	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right	Sentinel node biopsy alone		TCGA-A2-A04U-F59317	TCGA-A2-A04U	TCGA-A2-A04U-01A		Negative					Negative	Simple Mastectomy		YES			-17474	1924		0	2654							<10%			2014-5-8	FEMALE					1+			2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Positive	YES	3	Negative	Peri (6-12 months since last menstrual period)																				5	5									0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf	A04U	TUMOR FREE						YES		<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	4d12d021-3673-4e14-9fd9-033f811f87da	544dd94e-abd8-4cca-98cf-d1c2c646f23a	4d12d021-3673-4e14-9fd9-033f811f87da	544dd94e-abd8-4cca-98cf-d1c2c646f23a	TCGA-A2-A04U-01A-21-A13A-20	TCGA-A2-A04U-01A-11D-A10Y-09		TCGA-A2-A04U-01			485e1504-dfe0-43a4-83a1-f4376e8e687b	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11D-A10Y-09	TCGA-A2-A04U-01A-11D-A112-05	TCGA-A2-A04U-01	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11D-A10Y-09		4d12d021-3673-4e14-9fd9-033f811f87da		TCGA-A2-A04U-01A-11D-A111-01	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11R-A115-07	4d12d021-3673-4e14-9fd9-033f811f87da	TCGA-A2-A04U-01A-11D-A111-01	TCGA-A2-A04U-01
TCGA-A2-A04V-01	Stage IIA	39	2	Stage IIA	1920	1920	Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	1920	1	LumA	Luminal A	Positive	LumA/B	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-A2-A04V-01	1920	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A04V			days	1920	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO	NO	39	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-A2-A04V-F10273	TCGA-A2-A04V	TCGA-A2-A04V-01A		Positive					Positive	Simple Mastectomy		YES			-14250	1812	1920	0				1470				90-99%			2011-3-18	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	2									0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26.pdf	A04V	WITH TUMOR				MODERATE	STRONG			10-19%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2005	72d79574-45e1-453a-bc95-a2dca1d3e251	48d99272-3117-4309-9800-25900f7c695a	72d79574-45e1-453a-bc95-a2dca1d3e251	48d99272-3117-4309-9800-25900f7c695a	TCGA-A2-A04V-01A-11-A13A-20	TCGA-A2-A04V-01A-21W-A050-09		TCGA-A2-A04V-01			676bd916-c1a1-4b1f-b406-0c3bae66640e	TCGA-A2-A04V-01	TCGA-A2-A04V-01A-21W-A050-09	TCGA-A2-A04V-01A-21D-A032-05	TCGA-A2-A04V-01		TCGA-A2-A04V-01A-21W-A050-09,TCGA-A2-A04V-01A-21D-A045-09	TCGA-A2-A04V-01	72d79574-45e1-453a-bc95-a2dca1d3e251	TCGA-A2-A04V-01	TCGA-A2-A04V-01A-21D-A036-01		TCGA-A2-A04V-01A-21R-A034-07	72d79574-45e1-453a-bc95-a2dca1d3e251	TCGA-A2-A04V-01A-21D-A036-01	TCGA-A2-A04V-01
TCGA-A2-A04W-01	Stage IIB	50	3	No_Conversion	1948		Negative	FEMALE	Positive				Negative	M0	Positive	N1	1948	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A04W-01	3102	0	days	Squamous	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4	mutation cluster 3	TCGA-A2-A04W	3102	0	days	3102	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A04W-F59320	TCGA-A2-A04W	TCGA-A2-A04W-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18345	1630		0	3102							<10%			2014-5-8	FEMALE								3.2		Other, specify		No		C50.9	8401/3	C50.9		YES		Core needle biopsy	420	NO	Positive	Positive	NO	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	1		true	No	M0	N1mi	T2	Stage IIB	TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4.pdf	A04W	TUMOR FREE						YES		<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2005	ddb62dc3-293b-4021-905a-83ae10aa0f8e	e22edca1-493b-4d79-a311-3d5027d1e509	ddb62dc3-293b-4021-905a-83ae10aa0f8e	e22edca1-493b-4d79-a311-3d5027d1e509	TCGA-A2-A04W-01A-21-A13A-20	TCGA-A2-A04W-01A-31D-A10Y-09		TCGA-A2-A04W-01			469913c6-08bb-4c19-8a68-2735f5c4f981	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31D-A10Y-09	TCGA-A2-A04W-01A-31D-A112-05	TCGA-A2-A04W-01	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31D-A10Y-09		ddb62dc3-293b-4021-905a-83ae10aa0f8e		TCGA-A2-A04W-01A-31D-A111-01	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31R-A115-07	ddb62dc3-293b-4021-905a-83ae10aa0f8e	TCGA-A2-A04W-01A-31D-A111-01	TCGA-A2-A04W-01
TCGA-A2-A04X-01	Stage IIA	34	3	Stage IIA	1686		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1686	0	Her2	HER2-enriched	Positive		-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A04X-01	1686	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A04X			days	1686	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Left	Sentinel node biopsy alone		TCGA-A2-A04X-F9335	TCGA-A2-A04X	TCGA-A2-A04X-01A		Positive					Positive	Simple Mastectomy		YES			-12642	1390		0	1686							80-89%			2011-3-18	FEMALE					3+			3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Positive	Positive		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4									0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31.pdf	A04X	TUMOR FREE				MODERATE	STRONG			50-59%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2006	08c54c9c-195c-4754-83af-a97544d0eb12	456b1e0c-72a4-4850-b52b-8eecf5ecabd8	08c54c9c-195c-4754-83af-a97544d0eb12	456b1e0c-72a4-4850-b52b-8eecf5ecabd8		TCGA-A2-A04X-01A-21W-A050-09		TCGA-A2-A04X-01				TCGA-A2-A04X-01	TCGA-A2-A04X-01A-21W-A050-09	TCGA-A2-A04X-01A-21D-A032-05	TCGA-A2-A04X-01		TCGA-A2-A04X-01A-21W-A050-09	TCGA-A2-A04X-01	08c54c9c-195c-4754-83af-a97544d0eb12	TCGA-A2-A04X-01	TCGA-A2-A04X-01A-21D-A036-01		TCGA-A2-A04X-01A-21R-A034-07	08c54c9c-195c-4754-83af-a97544d0eb12	TCGA-A2-A04X-01A-21D-A036-01	TCGA-A2-A04X-01
TCGA-A2-A04Y-01	Stage IIB	53	5	No_Conversion	1099		Positive	FEMALE	Negative	2	3	3	Negative	M0	Positive	N1	1099	0	LumB	Luminal A	Positive	LumA	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A04Y-01	1099	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A2-A04Y			days	1099	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A04Y-F9330	TCGA-A2-A04Y	TCGA-A2-A04Y-01A		Positive					Positive	Simple Mastectomy		YES			-19533	756		0	1099							90-99%			2011-3-18	FEMALE					1+			1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	5									1	0	true	No	M0	N1mi	T2	Stage IIB	TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E.pdf	A04Y	TUMOR FREE					Strong			10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	7002615e-435b-4631-bb5b-e4b7532a143a	93a1aed5-c6cc-4e07-9060-fd6cead060b2	7002615e-435b-4631-bb5b-e4b7532a143a	93a1aed5-c6cc-4e07-9060-fd6cead060b2	TCGA-A2-A04Y-01A-11-A13A-20	TCGA-A2-A04Y-01A-21W-A050-09		TCGA-A2-A04Y-01			b850ebdc-d177-4c59-8c71-9cf8dd589307	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01A-21W-A050-09	TCGA-A2-A04Y-01A-21D-A032-05	TCGA-A2-A04Y-01		TCGA-A2-A04Y-01A-21W-A050-09	TCGA-A2-A04Y-01	7002615e-435b-4631-bb5b-e4b7532a143a	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01A-21D-A036-01		TCGA-A2-A04Y-01A-21R-A034-07	7002615e-435b-4631-bb5b-e4b7532a143a	TCGA-A2-A04Y-01A-21D-A036-01	TCGA-A2-A04Y-01
TCGA-A2-A0CK-01																													0	TCGA-A2-A0CK-01	4159	0	days	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14			TCGA-A2-A0CK	1364	1	days	4159	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			60	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0CK-F42396	TCGA-A2-A0CK	TCGA-A2-A0CK-01A	Negative	Positive	3 Point Scale	3+	3 Point Scale	Modified radical mastectomy	Positive	Lumpectomy		NO			-22094	3080		0	4159		1409	1364		NO		40-49%			2013-4-18	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Excisional Biopsy	230	NO	Negative	Negative	NO	20	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive	50-59%			1.2	3 Point Scale	2+	1+	Negative		10-19%		Positive							3 Point Scale	Other, specify	New Primary Tumor	LEFT BREAST	YES	YES	4		true	No	M0	N2a	T3	Stage IIIA	TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf	A0CK	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		5th		NO	YES	A2	Breast	A	LIVING	2001	fe5e8cb8-45e2-4321-ad32-a776f79bfcac	da561a17-8bdc-4bbb-b6be-c4fe38e5b1b9	fe5e8cb8-45e2-4321-ad32-a776f79bfcac	da561a17-8bdc-4bbb-b6be-c4fe38e5b1b9	TCGA-A2-A0CK-01A-21-A24A-20			TCGA-A2-A0CK-01	TCGA-A2-A0CK-01A-11D-A22B-05		9c5f525e-a62e-4bfd-aed9-96603a95f72b	TCGA-A2-A0CK-01	TCGA-A2-A0CK-01A-11D-A228-09			TCGA-A2-A0CK-01			fe5e8cb8-45e2-4321-ad32-a776f79bfcac		TCGA-A2-A0CK-01A-11D-A227-01	TCGA-A2-A0CK-01		fe5e8cb8-45e2-4321-ad32-a776f79bfcac	TCGA-A2-A0CK-01A-11D-A227-01	
TCGA-A2-A0CL-01	Stage IIIA	37	3	No_Conversion	1963		Positive	FEMALE	Negative	1	1	1	Negative	M0	Positive	N2	1963	0	Normal	HER2-enriched	Positive	Basal	-2	-5	followup	T_Other	T3	LIVING	0	TCGA-A2-A0CL-01	3015	0	days	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A0CL	3015	0	days	3015	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CL-F59313	TCGA-A2-A0CL			Positive					Positive	Modified Radical Mastectomy		NO			-13556			0	3015							20-29%		Scheduled Follow-up Submission	2014-5-8	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative	Negative	NO	14	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	9	0		No	M0	N2a	T3	Stage IIIA		A0CL	TUMOR FREE						YES		<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast		LIVING	2006	ee92fcd7-4be2-47c2-9725-1ec425d212cf	ffc153c8-b303-4bf6-aa6a-9db6f698a9fb	ee92fcd7-4be2-47c2-9725-1ec425d212cf	ffc153c8-b303-4bf6-aa6a-9db6f698a9fb	TCGA-A2-A0CL-01A-21-A13C-20	TCGA-A2-A0CL-01A-11D-A10Y-09		TCGA-A2-A0CL-01			f660575f-37ae-427d-acf6-767799017d6d	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11D-A10Y-09	TCGA-A2-A0CL-01A-11D-A112-05	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11D-A10Y-09		ee92fcd7-4be2-47c2-9725-1ec425d212cf		TCGA-A2-A0CL-01A-11D-A111-01	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11R-A115-07	ee92fcd7-4be2-47c2-9725-1ec425d212cf	TCGA-A2-A0CL-01A-11D-A111-01	TCGA-A2-A0CL-01
TCGA-A2-A0CM-01	Stage IIA	40	4	Stage IIA	754	754	Negative	FEMALE	Negative	1	1	2	Negative	M0	Negative	N0	754	1	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0CM-01	754	1	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0CM			days	754	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		40	Left	Sentinel node biopsy alone		TCGA-A2-A0CM-F2013	TCGA-A2-A0CM	TCGA-A2-A0CM-01A		Negative		0			Negative	Simple Mastectomy		YES			-14969	2546	754	0				382				<10%			2010-9-6	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Excisional Biopsy	300	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4									0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf	A0CM	WITH TUMOR								<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003	62dd11c2-2271-45e7-b753-d0f0d79fdf23	34e39e63-405b-4eae-a326-163ea06baa81	62dd11c2-2271-45e7-b753-d0f0d79fdf23	34e39e63-405b-4eae-a326-163ea06baa81	TCGA-A2-A0CM-01A-21-A13C-20	TCGA-A2-A0CM-01A-31W-A050-09		TCGA-A2-A0CM-01			bd38e599-aa6d-4349-b7de-630514cc1220	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01A-31W-A050-09	TCGA-A2-A0CM-01A-31D-A032-05	TCGA-A2-A0CM-01		TCGA-A2-A0CM-01A-31W-A050-09	TCGA-A2-A0CM-01	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01A-31D-A036-01		TCGA-A2-A0CM-01A-31R-A034-07	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA-A2-A0CM-01A-31D-A036-01	TCGA-A2-A0CM-01
TCGA-A2-A0CO-01																													1	TCGA-A2-A0CO-01	3492	1	days	Iq			BRCA non-CIMP c9			miRNA cluster 3			TCGA-A2-A0CO	3492	0	days	3492	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					85	Right	Axillary lymph node dissection alone		TCGA-A2-A0CO-F42395	TCGA-A2-A0CO	TCGA-A2-A0CO-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-31404	2709	3492	0	3409					NO		40-49%			2013-4-18	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	260	NO	Negative	Negative	NO	11	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T3	Stage IIB	TCGA-A2-A0CO.8C440009-E05E-4046-96AB-BAB211CB7D02.pdf	A0CO	TUMOR FREE						YES	YES	20-29%		YES	Primary Tumor	01		7th		NO	YES	A2	Breast	A	DECEASED	2002	cb2d5668-d44b-49dc-8941-79615d2fb6c2	04dc714b-e905-4d74-a53a-f41ecfbbbe7c	cb2d5668-d44b-49dc-8941-79615d2fb6c2	04dc714b-e905-4d74-a53a-f41ecfbbbe7c				TCGA-A2-A0CO-01	TCGA-A2-A0CO-01A-13D-A22B-05			TCGA-A2-A0CO-01	TCGA-A2-A0CO-01A-13D-A228-09			TCGA-A2-A0CO-01			cb2d5668-d44b-49dc-8941-79615d2fb6c2		TCGA-A2-A0CO-01A-13D-A227-01	TCGA-A2-A0CO-01		cb2d5668-d44b-49dc-8941-79615d2fb6c2	TCGA-A2-A0CO-01A-13D-A227-01	
TCGA-A2-A0CP-01	Stage IA	60	4	Stage I	2813		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	2813	0	LumA	Luminal A	Positive	X	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0CP-01	2813	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0CP	2813	0	days	2813	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right	Sentinel node biopsy alone		TCGA-A2-A0CP-F13741	TCGA-A2-A0CP	TCGA-A2-A0CP-01A		Positive					Positive	Lumpectomy		YES			-22133	2445		0	2813							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO		Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B.pdf	A0CP	TUMOR FREE								90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	a7998037-e713-46a6-adc2-8c22aa0cd362	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	a7998037-e713-46a6-adc2-8c22aa0cd362	TCGA-A2-A0CP-01A-21-A13B-20	TCGA-A2-A0CP-01A-11W-A050-09		TCGA-A2-A0CP-01			901a41bd-d57b-46b6-afec-bfc93e5d2c93	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01A-11W-A050-09	TCGA-A2-A0CP-01A-11D-A032-05	TCGA-A2-A0CP-01		TCGA-A2-A0CP-01A-11W-A050-09	TCGA-A2-A0CP-01	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01A-11D-A036-01		TCGA-A2-A0CP-01A-11R-A034-07	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	TCGA-A2-A0CP-01A-11D-A036-01	TCGA-A2-A0CP-01
TCGA-A2-A0CQ-01	Stage IA	62	2	Stage I	2694		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	2694	0	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0CQ-01	2695	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0CQ	2695	0	days	2695	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right	Sentinel node biopsy alone		TCGA-A2-A0CQ-F13723	TCGA-A2-A0CQ	TCGA-A2-A0CQ-01A	Negative	Positive				Lumpectomy	Positive	Lumpectomy		YES			-22810	2310		0	2695							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0	0	true	No	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096.pdf	A0CQ	TUMOR FREE								90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	31ff1045-fdc1-4b02-ae0e-880f652adb31	28486246-1a3f-463d-87e4-a70d1eed0c88	31ff1045-fdc1-4b02-ae0e-880f652adb31	28486246-1a3f-463d-87e4-a70d1eed0c88	TCGA-A2-A0CQ-01A-11-A13B-20	TCGA-A2-A0CQ-01A-21W-A050-09		TCGA-A2-A0CQ-01			deba1bb0-c1bf-4018-8c35-1376661c7d01	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01A-21W-A050-09	TCGA-A2-A0CQ-01A-21D-A032-05	TCGA-A2-A0CQ-01		TCGA-A2-A0CQ-01A-21W-A050-09	TCGA-A2-A0CQ-01	31ff1045-fdc1-4b02-ae0e-880f652adb31	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01A-21D-A036-01		TCGA-A2-A0CQ-01A-21R-A034-07	31ff1045-fdc1-4b02-ae0e-880f652adb31	TCGA-A2-A0CQ-01A-21D-A036-01	TCGA-A2-A0CQ-01
TCGA-A2-A0CR-01																													0	TCGA-A2-A0CR-01	3283	0	days	Quiet			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 13			TCGA-A2-A0CR	3283	0	days	3283	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CR-F42400	TCGA-A2-A0CR	TCGA-A2-A0CR-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-20075	2191		0	3283					NO		60-69%			2013-4-18	FEMALE								1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	280	NO	Negative	Negative	NO	16	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T3	Stage IIB	TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf	A0CR	TUMOR FREE						YES	YES	80-89%		NO	Primary Tumor	01		7th		NO	YES	A2	Breast	A	LIVING	2004	00e597fa-72b4-4e92-9428-7ec686e4cc0b	e98fb773-897b-48bb-9b3d-387079e5e5db	00e597fa-72b4-4e92-9428-7ec686e4cc0b	e98fb773-897b-48bb-9b3d-387079e5e5db	TCGA-A2-A0CR-01A-22-A24A-20			TCGA-A2-A0CR-01	TCGA-A2-A0CR-01A-11D-A22B-05		3ed7fa0f-b208-4493-aac0-71cb01860ac9	TCGA-A2-A0CR-01	TCGA-A2-A0CR-01A-11D-A228-09			TCGA-A2-A0CR-01			00e597fa-72b4-4e92-9428-7ec686e4cc0b		TCGA-A2-A0CR-01A-11D-A227-01	TCGA-A2-A0CR-01		00e597fa-72b4-4e92-9428-7ec686e4cc0b	TCGA-A2-A0CR-01A-11D-A227-01	
TCGA-A2-A0CS-01	Stage IV	73	2	No_Conversion	2298		Positive	FEMALE	Negative	3	3	3	Positive	M1	Positive	N3	2298	0	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T4	LIVING	1	TCGA-A2-A0CS-01	2348	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0CS	2348	0	days	2348	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left	Axillary lymph node dissection alone		TCGA-A2-A0CS-F59316	TCGA-A2-A0CS	TCGA-A2-A0CS-01A		Positive					Positive	Modified Radical Mastectomy		NO			-26817	2030	2348	0	2298							80-89%		Scheduled Follow-up Submission	2014-5-8	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Skin biopsy	Other method, specify:	220	NO	Equivocal	Negative	NO	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive				1.09				Negative				Positive	Other, specify	Ovary	2	4								NO	12	0	true	No	M1	N3a	T4b	Stage IV	TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D.pdf	A0CS	TUMOR FREE						YES		80-89%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2004	560ab6aa-cbfe-42ac-9446-9d3df720bc81	f00b3a1a-5336-4540-a8e6-d731947f9ee5	560ab6aa-cbfe-42ac-9446-9d3df720bc81	f00b3a1a-5336-4540-a8e6-d731947f9ee5	TCGA-A2-A0CS-01A-21-A13B-20	TCGA-A2-A0CS-01A-11D-A10Y-09		TCGA-A2-A0CS-01			b49a2c08-435f-4790-818a-267a2ce6499c	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11D-A10Y-09	TCGA-A2-A0CS-01A-11D-A112-05	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11D-A10Y-09		560ab6aa-cbfe-42ac-9446-9d3df720bc81		TCGA-A2-A0CS-01A-11D-A111-01	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11R-A115-07	560ab6aa-cbfe-42ac-9446-9d3df720bc81	TCGA-A2-A0CS-01A-11D-A111-01	TCGA-A2-A0CS-01
TCGA-A2-A0CT-01	Stage IIA	71	5	Stage IIA	2288		Positive	FEMALE	Negative	4	3	4	Negative	M0	Negative	N0	2288	0	LumA	Luminal B	Negative	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CT-01	2289	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CT	2289	0	days	2289	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0CT-F13730	TCGA-A2-A0CT	TCGA-A2-A0CT-01A		Positive		0			Negative	Simple Mastectomy		YES			-25959	1931		0	2289							90-99%		Scheduled Follow-up Submission	2011-6-9	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CT.FDF38AA6-DC65-4043-8277-71BAE47902B1.pdf	A0CT	TUMOR FREE								<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2005	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	548f7871-ac2a-469a-8f4a-4bda2aaae71a	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	548f7871-ac2a-469a-8f4a-4bda2aaae71a	TCGA-A2-A0CT-01A-11-A13B-20	TCGA-A2-A0CT-01A-31W-A071-09		TCGA-A2-A0CT-01	TCGA-A2-A0CT-01A-31D-A10P-05		cfc7cb7e-3c46-41d6-9b19-ee2652b2c3e9	TCGA-A2-A0CT-01	TCGA-A2-A0CT-01A-31W-A071-09		TCGA-A2-A0CT-01		TCGA-A2-A0CT-01A-31W-A071-09	TCGA-A2-A0CT-01	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01	TCGA-A2-A0CT-01A-31D-A059-01		TCGA-A2-A0CT-01A-31R-A056-07	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01A-31D-A059-01	TCGA-A2-A0CT-01
TCGA-A2-A0CU-01	Stage IIA	73	5	Stage IIA	139	157	Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	157	1	LumA	Luminal A	Positive	LumA/B	0	-3	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0CU-01	158	1	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CU	158	0	days	158	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0CU-F13735	TCGA-A2-A0CU	TCGA-A2-A0CU-01A		Positive					Positive	Simple Mastectomy		YES			-26823	1911	158	0								90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D.pdf	A0CU	TUMOR FREE								<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2005	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	846ab0bd-1c82-48a3-a25a-8a3af1f2bfa0	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	846ab0bd-1c82-48a3-a25a-8a3af1f2bfa0	TCGA-A2-A0CU-01A-21-A13B-20	TCGA-A2-A0CU-01A-12W-A050-09		TCGA-A2-A0CU-01			74d7ee07-2eba-4552-a888-c29010bbc5ea	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01A-12W-A050-09	TCGA-A2-A0CU-01A-12D-A032-05	TCGA-A2-A0CU-01		TCGA-A2-A0CU-01A-12W-A050-09	TCGA-A2-A0CU-01	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01A-12D-A036-01		TCGA-A2-A0CU-01A-12R-A034-07	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	TCGA-A2-A0CU-01A-12D-A036-01	TCGA-A2-A0CU-01
TCGA-A2-A0CV-01	Stage IIB	41	2	No_Conversion	1929		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1929	0	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CV-01	3011	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-A2-A0CV	3011	0	days	3011	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0CV-F59321	TCGA-A2-A0CV	TCGA-A2-A0CV-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15289	1574		0	3011							90-99%		Scheduled Follow-up Submission	2014-5-8	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative	Negative	NO	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	4	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A0CV.FBDDD9EE-0A5C-4CAB-9EB3-48B6431A9A84.pdf	A0CV	TUMOR FREE						YES		90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2005	a8154f60-e391-44b5-b378-c944c5e8621d	8c3a83e9-071e-429b-88c7-21d4b2748ba3	a8154f60-e391-44b5-b378-c944c5e8621d	8c3a83e9-071e-429b-88c7-21d4b2748ba3	TCGA-A2-A0CV-01A-21-A13B-20	TCGA-A2-A0CV-01A-31D-A10Y-09		TCGA-A2-A0CV-01			b595e1e2-77fa-4ebd-b2d4-054e8b9ca3ae	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01A-31D-A112-05	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A10Y-09		a8154f60-e391-44b5-b378-c944c5e8621d		TCGA-A2-A0CV-01A-31D-A111-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31R-A115-07	a8154f60-e391-44b5-b378-c944c5e8621d	TCGA-A2-A0CV-01A-31D-A111-01	TCGA-A2-A0CV-01
TCGA-A2-A0CW-01	Stage IIB	67	1	No_Conversion	1947		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1947	0	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CW-01	3283	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 3	TCGA-A2-A0CW	3283	0	days	3283	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0CW-F70690	TCGA-A2-A0CW	TCGA-A2-A0CW-01A		Positive					Positive	Lumpectomy		YES			-24541	1533		0	3283							90-99%		Scheduled Follow-up Submission	2015-3-2	FEMALE					2+			0.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	2	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D.pdf	A0CW	TUMOR FREE						YES		10-19%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2006	1c1560f6-62bf-4185-912f-25c234ebd71f	6f1627be-b4c7-4b99-874b-f1313bc2f284	1c1560f6-62bf-4185-912f-25c234ebd71f	6f1627be-b4c7-4b99-874b-f1313bc2f284	TCGA-A2-A0CW-01A-11-A13B-20	TCGA-A2-A0CW-01A-21D-A10Y-09		TCGA-A2-A0CW-01			6d65d556-9be9-4491-bd22-85cee7a0ee7c	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21D-A10Y-09	TCGA-A2-A0CW-01A-21D-A112-05	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21D-A10Y-09		1c1560f6-62bf-4185-912f-25c234ebd71f		TCGA-A2-A0CW-01A-21D-A111-01	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21R-A115-07	1c1560f6-62bf-4185-912f-25c234ebd71f	TCGA-A2-A0CW-01A-21D-A111-01	TCGA-A2-A0CW-01
TCGA-A2-A0CX-01	Stage IIA	52	3	Stage IIA	1728		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1728	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CX-01	1728	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7			mutation cluster 5	TCGA-A2-A0CX	1728	0	days	1728	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left	Sentinel node biopsy alone		TCGA-A2-A0CX-F13721	TCGA-A2-A0CX	TCGA-A2-A0CX-01A		Positive					Negative	Lumpectomy		YES			-19152	1316		0	1728									Scheduled Follow-up Submission	2011-6-10	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	560	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06.pdf	A0CX	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2006	b1ecc303-eb55-436f-9629-cdac63bde297	17076dfd-f38a-4894-b39e-f732f4a0823a	b1ecc303-eb55-436f-9629-cdac63bde297	17076dfd-f38a-4894-b39e-f732f4a0823a	TCGA-A2-A0CX-01A-11-A13B-20	TCGA-A2-A0CX-01A-21W-A019-09		TCGA-A2-A0CX-01			1f7a4605-1972-4f36-b0e7-543ce95a3d0f	TCGA-A2-A0CX-01	TCGA-A2-A0CX-01A-21W-A019-09	TCGA-A2-A0CX-01A-21D-A00Y-05	TCGA-A2-A0CX-01		TCGA-A2-A0CX-01A-21W-A019-09		b1ecc303-eb55-436f-9629-cdac63bde297		TCGA-A2-A0CX-01A-21D-A011-01		TCGA-A2-A0CX-01A-21R-A00Z-07	b1ecc303-eb55-436f-9629-cdac63bde297	TCGA-A2-A0CX-01A-21D-A011-01	TCGA-A2-A0CX-01
TCGA-A2-A0CY-01	Stage IIB	63	1	No_Conversion	1673		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1673	0		HER2-enriched	Positive	LumA/B	0	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CY-01	1673	0	days	Kirc+		cluster 5	Cluster 5	BRCA nonbasal-like c8		miRNA c1uster 10	cluster 7		TCGA-A2-A0CY	1673	0	days	1673	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0CY-F13731	TCGA-A2-A0CY	TCGA-A2-A0CY-01A		Positive					Positive	Simple Mastectomy		YES			-23229	1274		0	1673							90-99%		Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			0.89		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	7								NO	1	0	true	No	M0	N1	T2	Stage IIB	TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21.pdf	A0CY	TUMOR FREE								10-19%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2006	c7d2b685-5f11-4879-82d5-e983b5dbb07d		c7d2b685-5f11-4879-82d5-e983b5dbb07d		TCGA-A2-A0CY-01A-21-A13C-20			TCGA-A2-A0CY-01			3dc93dcc-2b14-4725-b40e-23be7cdbbb9d			TCGA-A2-A0CY-01A-12D-A032-05				TCGA-A2-A0CY-01	c7d2b685-5f11-4879-82d5-e983b5dbb07d	TCGA-A2-A0CY-01			TCGA-A2-A0CY-01A-12R-A034-07	c7d2b685-5f11-4879-82d5-e983b5dbb07d		TCGA-A2-A0CY-01
TCGA-A2-A0CZ-01	Stage IIA	46	4	Stage IIA	1615		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1615	0	Normal	Luminal A	Positive	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CZ-01	1616	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CZ	1616	0	days	1616	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0CZ-F13728	TCGA-A2-A0CZ	TCGA-A2-A0CZ-01A		Positive					Positive	Simple Mastectomy		YES			-17026	1204		0	1616							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative	Negative		2	Positive	Peri (6-12 months since last menstrual period)																				1	2								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0CZ.57153075-9055-4D7E-9CD6-9167D165E860.pdf	A0CZ	TUMOR FREE								20-29%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2007	229ebbe9-4dc8-434f-998c-fc0660cd2b00		229ebbe9-4dc8-434f-998c-fc0660cd2b00		TCGA-A2-A0CZ-01A-21-A13C-20	TCGA-A2-A0CZ-01A-11W-A050-09		TCGA-A2-A0CZ-01			af5345d8-db03-4d37-b327-5a62c1fe1285		TCGA-A2-A0CZ-01A-11W-A050-09	TCGA-A2-A0CZ-01A-11D-A032-05			TCGA-A2-A0CZ-01A-11W-A050-09	TCGA-A2-A0CZ-01	229ebbe9-4dc8-434f-998c-fc0660cd2b00	TCGA-A2-A0CZ-01			TCGA-A2-A0CZ-01A-11R-A034-07	229ebbe9-4dc8-434f-998c-fc0660cd2b00		TCGA-A2-A0CZ-01
TCGA-A2-A0D0-01	Stage IIA	60	1	Stage IIA	643		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	643	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D0-01	2048	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-A2-A0D0	2048	0	days	2048	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0D0-F59399	TCGA-A2-A0D0	TCGA-A2-A0D0-01A		Negative		0			Negative	Simple Mastectomy		NO			-22115	720		0	2048							<10%		Scheduled Follow-up Submission	2014-5-12	FEMALE					0			1.17		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	500	NO	Negative	Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf	A0D0	TUMOR FREE						YES		<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	TCGA-A2-A0D0-01A-21-A13C-20	TCGA-A2-A0D0-01A-11W-A019-09		TCGA-A2-A0D0-01			980c774a-c662-489e-82a3-212d0a45f759	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01A-11W-A019-09	TCGA-A2-A0D0-01A-11D-A00Y-05	TCGA-A2-A0D0-01		TCGA-A2-A0D0-01A-11W-A019-09	TCGA-A2-A0D0-01	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01A-11D-A011-01		TCGA-A2-A0D0-01A-11R-A00Z-07	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA-A2-A0D0-01A-11D-A011-01	TCGA-A2-A0D0-01
TCGA-A2-A0D1-01	Stage IIA	76	1	Stage IIA	1051		Negative	FEMALE	Positive	2	2	1	Negative	M0	Negative	N0	1051	0	Her2	HER2-enriched	Negative	Basal	-2	-6	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D1-01	1051	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-A2-A0D1	1051	0	days	1051	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0D1-F13733	TCGA-A2-A0D1	TCGA-A2-A0D1-01A		Negative					Negative	Lumpectomy		YES			-28084	637		0	1051							<10%		Scheduled Follow-up Submission	2011-6-9	FEMALE					3+			5.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive	Positive		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3.pdf	A0D1	TUMOR FREE				Intensity=Weak	Intensity=Weak			<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	01370d42-f75c-4532-9b9c-24ff7302b033	bca3ec5f-f504-4f47-9359-6576d0ca164a	01370d42-f75c-4532-9b9c-24ff7302b033	bca3ec5f-f504-4f47-9359-6576d0ca164a	TCGA-A2-A0D1-01A-21-A13C-20	TCGA-A2-A0D1-01A-11W-A050-09		TCGA-A2-A0D1-01			aa90ba5a-1a36-46e9-a3f5-21ba48c5f29a	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01A-11W-A050-09	TCGA-A2-A0D1-01A-11D-A032-05	TCGA-A2-A0D1-01		TCGA-A2-A0D1-01A-11W-A050-09	TCGA-A2-A0D1-01	01370d42-f75c-4532-9b9c-24ff7302b033	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01A-11D-A036-01		TCGA-A2-A0D1-01A-11R-A034-07	01370d42-f75c-4532-9b9c-24ff7302b033	TCGA-A2-A0D1-01A-11D-A036-01	TCGA-A2-A0D1-01
TCGA-A2-A0D2-01	Stage IIB	45	3	Stage IIA	1027		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1027	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D2-01	1027	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0D2	1027	0	days	1027	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0D2-F14458	TCGA-A2-A0D2	TCGA-A2-A0D2-01A		Negative		0			Negative	Simple Mastectomy		YES			-16623	614		0	1027							<10%		Scheduled Follow-up Submission	2011-6-9	FEMALE					0			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	330	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0	4	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf	A0D2	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	2ad8d416-08a4-4e6f-947e-d74269d02ab1	3da4a808-275c-45fd-b9e4-81183ebeb0c9	2ad8d416-08a4-4e6f-947e-d74269d02ab1	3da4a808-275c-45fd-b9e4-81183ebeb0c9	TCGA-A2-A0D2-01A-11-A13C-20	TCGA-A2-A0D2-01A-21W-A050-09		TCGA-A2-A0D2-01			74c3c43d-b3f1-4846-be03-3b65098774c7	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01A-21W-A050-09	TCGA-A2-A0D2-01A-21D-A032-05	TCGA-A2-A0D2-01		TCGA-A2-A0D2-01A-21W-A050-09	TCGA-A2-A0D2-01	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01A-21D-A036-01		TCGA-A2-A0D2-01A-21R-A034-07	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA-A2-A0D2-01A-21D-A036-01	TCGA-A2-A0D2-01
TCGA-A2-A0D3-01	Stage IA	42	2	Stage I	875		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	875	0	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0D3-01	1873	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-A2-A0D3	1873	0	days	1873	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0D3-F59451	TCGA-A2-A0D3	TCGA-A2-A0D3-01A		Positive					Positive	Simple Mastectomy		YES			-15524	545		0	1873							90-99%		Scheduled Follow-up Submission	2014-5-13	FEMALE					1+			1.41		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592.pdf	A0D3	TUMOR FREE						YES		90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	eefe67c9-48a1-4381-a3ef-81b51e46c6df	34a4a64c-d8a5-44c8-ae5e-3ef0258179d6	eefe67c9-48a1-4381-a3ef-81b51e46c6df	34a4a64c-d8a5-44c8-ae5e-3ef0258179d6	TCGA-A2-A0D3-01A-21-A13A-20	TCGA-A2-A0D3-01A-11D-A10Y-09		TCGA-A2-A0D3-01			068b3d7e-b3b4-4fd1-89c5-2019253806b2	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11D-A10Y-09	TCGA-A2-A0D3-01A-11D-A112-05	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11D-A10Y-09		eefe67c9-48a1-4381-a3ef-81b51e46c6df		TCGA-A2-A0D3-01A-11D-A111-01	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11R-A115-07	eefe67c9-48a1-4381-a3ef-81b51e46c6df	TCGA-A2-A0D3-01A-11D-A111-01	TCGA-A2-A0D3-01
TCGA-A2-A0D4-01	Stage IIB	37	5	No_Conversion	767		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	767	0	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D4-01	767	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A2-A0D4	767	0	days	767	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Left	Axillary lymph node dissection alone		TCGA-A2-A0D4-F13726	TCGA-A2-A0D4	TCGA-A2-A0D4-01A		Positive					Positive	Lumpectomy		NO			-13805	384		0	767							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.14		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	5								NO	1	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1.pdf	A0D4	TUMOR FREE				Intensity=weak	Intensity=moderate			10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	2522bd3d-f6b3-45df-b68f-577ffbf3a819	a1b53759-99b5-4470-bb22-242ab09561dd	2522bd3d-f6b3-45df-b68f-577ffbf3a819	a1b53759-99b5-4470-bb22-242ab09561dd	TCGA-A2-A0D4-01A-21-A13C-20	TCGA-A2-A0D4-01A-11W-A019-09		TCGA-A2-A0D4-01			33556a57-3d4b-4d1d-ac6f-bf0974c4ca36	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01A-11W-A019-09	TCGA-A2-A0D4-01A-11D-A00Y-05	TCGA-A2-A0D4-01		TCGA-A2-A0D4-01A-11W-A019-09	TCGA-A2-A0D4-01	2522bd3d-f6b3-45df-b68f-577ffbf3a819	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01A-11D-A011-01		TCGA-A2-A0D4-01A-11R-A00Z-07	2522bd3d-f6b3-45df-b68f-577ffbf3a819	TCGA-A2-A0D4-01A-11D-A011-01	TCGA-A2-A0D4-01
TCGA-A2-A0EM-01	Stage IA	73	2	Stage I	3093		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3093	0	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0EM-01	3094	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EM	3094	0	days	3094	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EM-F13714	TCGA-A2-A0EM	TCGA-A2-A0EM-01A		Positive					Positive	Lumpectomy		YES			-26845	2696		0	3094									Scheduled Follow-up Submission	2011-6-9	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	20	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0	0	true	No	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615.pdf	A0EM	TUMOR FREE										YES	Primary Tumor	01		5th	YES	NO	YES	A2	Breast	A	LIVING	2002	8d30a0ab-a41f-40ef-bd59-f738f4b39941	3b12a9e9-a268-4469-b63e-2a735e164803	8d30a0ab-a41f-40ef-bd59-f738f4b39941	3b12a9e9-a268-4469-b63e-2a735e164803		TCGA-A2-A0EM-01A-11W-A050-09		TCGA-A2-A0EM-01				TCGA-A2-A0EM-01	TCGA-A2-A0EM-01A-11W-A050-09	TCGA-A2-A0EM-01A-11D-A032-05	TCGA-A2-A0EM-01		TCGA-A2-A0EM-01A-11W-A050-09	TCGA-A2-A0EM-01	8d30a0ab-a41f-40ef-bd59-f738f4b39941	TCGA-A2-A0EM-01	TCGA-A2-A0EM-01A-11D-A036-01		TCGA-A2-A0EM-01A-11R-A034-07	8d30a0ab-a41f-40ef-bd59-f738f4b39941	TCGA-A2-A0EM-01A-11D-A036-01	TCGA-A2-A0EM-01
TCGA-A2-A0EN-01	Stage IIA	70	2	Stage IIA	2717		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2717	0	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EN-01	2718	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EN	2718	0	days	2718	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right	Sentinel node biopsy alone		TCGA-A2-A0EN-F13725	TCGA-A2-A0EN	TCGA-A2-A0EN-01A		Positive					Positive	Lumpectomy		YES			-25771	2348		0	2718									Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.4		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	110	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	2								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E.pdf	A0EN	TUMOR FREE								50-59%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	38decb88-ca75-4a0c-bdd2-917ccdd60851	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	38decb88-ca75-4a0c-bdd2-917ccdd60851		TCGA-A2-A0EN-01A-13D-A099-09		TCGA-A2-A0EN-01	TCGA-A2-A0EN-01A-13D-A10P-05			TCGA-A2-A0EN-01	TCGA-A2-A0EN-01A-13D-A099-09		TCGA-A2-A0EN-01		TCGA-A2-A0EN-01A-13D-A099-09	TCGA-A2-A0EN-01	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01	TCGA-A2-A0EN-01A-13D-A087-01		TCGA-A2-A0EN-01A-13R-A084-07	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01A-13D-A087-01	TCGA-A2-A0EN-01
TCGA-A2-A0EO-01	Stage IA	54	2	Stage I	2441		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	2441	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0EO-01	2442	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EO	2442	0	days	2442	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Sentinel node biopsy alone		TCGA-A2-A0EO-F13732	TCGA-A2-A0EO	TCGA-A2-A0EO-01A		Positive					Positive	Lumpectomy		YES			-19880	2331		0	2442									Scheduled Follow-up Submission	2011-6-13	FEMALE					1+			1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative	Negative		3	Close	Peri (6-12 months since last menstrual period)																				4	2								NO	0	0	true	No	M0	N0 (i-)	T1	Stage IA	TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610.pdf	A0EO	TUMOR FREE										YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	cdeceaf0-beb6-4374-8aea-83bd35318892	8aba442b-9f10-4d63-8780-b3462cfc2945	cdeceaf0-beb6-4374-8aea-83bd35318892	8aba442b-9f10-4d63-8780-b3462cfc2945	TCGA-A2-A0EO-01A-21-A13B-20	TCGA-A2-A0EO-01A-11W-A050-09		TCGA-A2-A0EO-01			368ae06c-f56e-4ba9-af38-0cc01e900f70	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01A-11W-A050-09	TCGA-A2-A0EO-01A-11D-A032-05	TCGA-A2-A0EO-01		TCGA-A2-A0EO-01A-11W-A050-09	TCGA-A2-A0EO-01	cdeceaf0-beb6-4374-8aea-83bd35318892	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01A-11D-A036-01		TCGA-A2-A0EO-01A-11R-A034-07	cdeceaf0-beb6-4374-8aea-83bd35318892	TCGA-A2-A0EO-01A-11D-A036-01	TCGA-A2-A0EO-01
TCGA-A2-A0EP-01																													0	TCGA-A2-A0EP-01	3603	0	days					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-A2-A0EP	3603	0	days	3603	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EP-F58499	TCGA-A2-A0EP			Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-20585			0	3603							80-89%			2014-4-11	FEMALE								1.3		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	1		No	M0	N0 (i+)	T1	Stage I		A0EP	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	A2	Breast		LIVING	2004	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	fd6c7c33-de06-4766-9e4f-6f40b761008e	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	fd6c7c33-de06-4766-9e4f-6f40b761008e	TCGA-A2-A0EP-01A-61-A24A-20			TCGA-A2-A0EP-01	TCGA-A2-A0EP-01A-52D-A230-05		be62a150-20f9-449e-8992-796d4640879a	TCGA-A2-A0EP-01	TCGA-A2-A0EP-01A-52D-A22X-09			TCGA-A2-A0EP-01			b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c		TCGA-A2-A0EP-01A-52D-A22W-01	TCGA-A2-A0EP-01		b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	TCGA-A2-A0EP-01A-52D-A22W-01	
TCGA-A2-A0EQ-01	Stage IIA	64	4	Stage IIA	2426		Negative	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	2426	0	Her2	HER2-enriched	Negative	Basal	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EQ-01	2426	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-A2-A0EQ	2426	0	days	2426	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left	Other (specify)	Sentinel lymph node and non-sentinel lymph node biopsy	TCGA-A2-A0EQ-F13720	TCGA-A2-A0EQ	TCGA-A2-A0EQ-01A	Negative	Negative		0		Lumpectomy	Negative	Lumpectomy		YES			-23543	2038		0	2426							<10%		Scheduled Follow-up Submission	2011-6-13	FEMALE					3+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	600	NO	Positive	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0EQ.60569C8B-7209-4A3F-A177-F337085E9146.pdf	A0EQ	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	7b6fada0-555f-4234-9436-a498d03e7413	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	7b6fada0-555f-4234-9436-a498d03e7413	TCGA-A2-A0EQ-01A-21-A13C-20	TCGA-A2-A0EQ-01A-11W-A050-09		TCGA-A2-A0EQ-01			cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01A-11D-A032-05	TCGA-A2-A0EQ-01		TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11D-A036-01		TCGA-A2-A0EQ-01A-11R-A034-07	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01A-11D-A036-01	TCGA-A2-A0EQ-01
TCGA-A2-A0ER-01	Stage IB	63	5	No_Conversion	2262		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2262	0	LumA	Luminal B	Positive	ReacII	-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0ER-01	2263	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0ER	2263	0	days	2263	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0ER-F13719	TCGA-A2-A0ER	TCGA-A2-A0ER-01A	Negative	Positive				Lumpectomy	Positive	Lumpectomy		YES			-23021	1862		0	2263							90-99%		Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Equivocal	Negative		14	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	1	0	true	No	M0	N1mi	T1c	Stage IB	TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02.pdf	A0ER	TUMOR FREE								80-89%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2005	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	49f8fe03-b923-4bb7-b042-6cb4d6f6e2b0	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	49f8fe03-b923-4bb7-b042-6cb4d6f6e2b0	TCGA-A2-A0ER-01A-11-A13C-20	TCGA-A2-A0ER-01A-21W-A050-09		TCGA-A2-A0ER-01			7b71576b-d077-4e99-ae77-0c061517a5f9	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01A-21W-A050-09	TCGA-A2-A0ER-01A-21D-A032-05	TCGA-A2-A0ER-01		TCGA-A2-A0ER-01A-21W-A050-09	TCGA-A2-A0ER-01	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01A-21D-A036-01		TCGA-A2-A0ER-01A-21R-A034-07	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	TCGA-A2-A0ER-01A-21D-A036-01	TCGA-A2-A0ER-01
TCGA-A2-A0ES-01	Stage IIA	52	4	Stage IIA	1127		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1127	0	LumA	Luminal A	Positive	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0ES-01	2190	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A0ES	2190	0	days	2190	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0ES-F59395	TCGA-A2-A0ES	TCGA-A2-A0ES-01A		Positive					Positive	Simple Mastectomy		YES			-19160	756		0	2190							60-69%		Scheduled Follow-up Submission	2014-5-12	FEMALE					1+			1.32		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	460	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05.pdf	A0ES	TUMOR FREE						YES		10-19%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	698c9928-1aa8-4b48-9048-5675e5943c22	3dc8a0fe-341f-4f09-af43-1e142208caba	698c9928-1aa8-4b48-9048-5675e5943c22	3dc8a0fe-341f-4f09-af43-1e142208caba	TCGA-A2-A0ES-01A-21-A13B-20	TCGA-A2-A0ES-01A-11D-A10Y-09		TCGA-A2-A0ES-01			8d841c4a-d6b2-4d89-8d26-b415bce6c25d	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11D-A10Y-09	TCGA-A2-A0ES-01A-11D-A112-05	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11D-A10Y-09		698c9928-1aa8-4b48-9048-5675e5943c22		TCGA-A2-A0ES-01A-11D-A111-01	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11R-A115-07	698c9928-1aa8-4b48-9048-5675e5943c22	TCGA-A2-A0ES-01A-11D-A111-01	TCGA-A2-A0ES-01
TCGA-A2-A0ET-01	Stage IIIA	58	3	No_Conversion	1066		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1066	0	LumA	Luminal A	Positive		-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0ET-01	1066	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0ET	1066	0	days	1066	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0ET-F13713	TCGA-A2-A0ET	TCGA-A2-A0ET-01A		Positive					Positive	Lumpectomy		NO			-21464	674		0	1066							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.09		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	890	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO	5	0	true	No	M0	N2a	T2	Stage IIIA	TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf	A0ET	TUMOR FREE				Intensity=Strong	Intensity=Strong			70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	4eb0c00d-595c-47ee-bcad-818c7723656d	fec7f250-896a-40c3-a6ed-82607bf7af4d	4eb0c00d-595c-47ee-bcad-818c7723656d	fec7f250-896a-40c3-a6ed-82607bf7af4d		TCGA-A2-A0ET-01A-31D-A045-09		TCGA-A2-A0ET-01				TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01A-31D-A032-05	TCGA-A2-A0ET-01		TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A036-01		TCGA-A2-A0ET-01A-31R-A034-07	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01A-31D-A036-01	TCGA-A2-A0ET-01
TCGA-A2-A0EU-01	Stage IA	79	4	Stage I	1043		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	1043	0	LumA	Luminal A	Positive	ReacI	-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0EU-01	1043	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0EU	1043	0	days	1043	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EU-F13717	TCGA-A2-A0EU	TCGA-A2-A0EU-01A	Negative	Positive				Lumpectomy	Positive	Lumpectomy		YES			-29144	644		0	1043							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE					0			0.97		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	610	NO	Negative	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB.pdf	A0EU	TUMOR FREE				Intensity=Strong	Intensity=Strong			90-99%		YES	Primary Tumor	01		6th	NO	NO	YES	A2	Breast	A	LIVING	2008	70633069-e9df-4fce-84df-6849f4b2693c	d30e36ac-0c71-4210-bf07-334f2b5ba904	70633069-e9df-4fce-84df-6849f4b2693c	d30e36ac-0c71-4210-bf07-334f2b5ba904	TCGA-A2-A0EU-01A-11-A13B-20	TCGA-A2-A0EU-01A-22W-A071-09		TCGA-A2-A0EU-01	TCGA-A2-A0EU-01A-22D-A10P-05		616af0e6-b37f-48aa-aa61-2e5b5a72b749	TCGA-A2-A0EU-01	TCGA-A2-A0EU-01A-22W-A071-09		TCGA-A2-A0EU-01		TCGA-A2-A0EU-01A-22W-A071-09	TCGA-A2-A0EU-01	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01	TCGA-A2-A0EU-01A-22D-A059-01		TCGA-A2-A0EU-01A-22R-A056-07	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01A-22D-A059-01	TCGA-A2-A0EU-01
TCGA-A2-A0EV-01	Stage IA	80	3	Stage I	968		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	968	0	LumA	Luminal A	Positive	ReacI	0	-4	followup	T1	T1	LIVING	0	TCGA-A2-A0EV-01	968	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0EV	968	0	days	968	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left	Sentinel node biopsy alone		TCGA-A2-A0EV-F13712	TCGA-A2-A0EV	TCGA-A2-A0EV-01A		Positive					Positive	Lumpectomy		YES			-29285	590		0	968							90-99%		Scheduled Follow-up Submission	2011-6-10	FEMALE			<10%		0			1.40		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960	NO	Negative	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A.pdf	A0EV	TUMOR FREE								90-99%		NO	Primary Tumor	01		6th	NO	NO	YES	A2	Breast	A	LIVING	2008	75cd6423-52b8-4d29-97de-1fe2583dbac1	2ee9b4c3-15a5-4766-b762-ad8a96dc08f8	75cd6423-52b8-4d29-97de-1fe2583dbac1	2ee9b4c3-15a5-4766-b762-ad8a96dc08f8	TCGA-A2-A0EV-01A-21-A13C-20	TCGA-A2-A0EV-01A-11W-A050-09		TCGA-A2-A0EV-01			19683ba7-695c-484a-95ba-39a8dd02a6a3	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01A-11W-A050-09	TCGA-A2-A0EV-01A-11D-A032-05	TCGA-A2-A0EV-01		TCGA-A2-A0EV-01A-11W-A050-09	TCGA-A2-A0EV-01	75cd6423-52b8-4d29-97de-1fe2583dbac1	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01A-11D-A036-01		TCGA-A2-A0EV-01A-11R-A034-07	75cd6423-52b8-4d29-97de-1fe2583dbac1	TCGA-A2-A0EV-01A-11D-A036-01	TCGA-A2-A0EV-01
TCGA-A2-A0EW-01	Stage IIIC	53	2	No_Conversion	904		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N3	904	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	1	TCGA-A2-A0EW-01	1884	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0EW	1353	1	days	1884	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			53	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0EW-F59511	TCGA-A2-A0EW	TCGA-A2-A0EW-01A		Positive					Positive	Simple Mastectomy		YES			-19413	542	1884	0	905			1353				90-99%		Scheduled Follow-up Submission	2014-5-14	FEMALE					0			1.33		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1710	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6				Bone	Distant Metastasis		NO	YES	26	0	true	No	M0	N3a	T1b	Stage IIIC	TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A.pdf	A0EW	WITH TUMOR						YES		10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2008	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	581771be-7430-4032-8cec-55b339d22c49	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	581771be-7430-4032-8cec-55b339d22c49	TCGA-A2-A0EW-01A-31-A13B-20	TCGA-A2-A0EW-01A-21D-A10Y-09		TCGA-A2-A0EW-01			e365a292-15b3-4e28-bf58-3ecdde392c22	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21D-A10Y-09	TCGA-A2-A0EW-01A-21D-A112-05	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21D-A10Y-09		5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9		TCGA-A2-A0EW-01A-21D-A111-01	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21R-A115-07	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	TCGA-A2-A0EW-01A-21D-A111-01	TCGA-A2-A0EW-01
TCGA-A2-A0EX-01	Stage IIB	46	4	Stage IIB	549		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	549	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	LIVING	0	TCGA-A2-A0EX-01	752	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0EX	752	0	days	752	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			46	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0EX-F13742	TCGA-A2-A0EX	TCGA-A2-A0EX-01A	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy		YES			-16858	468		0	752							60-69%		Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.22		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	650	NO	Negative	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0	1	true	No	M0	N0 (i+)	T3	Stage IIB	TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF.pdf	A0EX	TUMOR FREE								90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	6fc8b7da-3de6-4111-b685-bb03c032466a	5382306d-84ce-4839-acb5-ba11a8f8cea5	6fc8b7da-3de6-4111-b685-bb03c032466a	5382306d-84ce-4839-acb5-ba11a8f8cea5	TCGA-A2-A0EX-01A-11-A13C-20	TCGA-A2-A0EX-01A-21W-A050-09		TCGA-A2-A0EX-01			83a37012-5a0c-4263-a361-3aaff03b0429	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01A-21W-A050-09	TCGA-A2-A0EX-01A-21D-A032-05	TCGA-A2-A0EX-01		TCGA-A2-A0EX-01A-21W-A050-09	TCGA-A2-A0EX-01	6fc8b7da-3de6-4111-b685-bb03c032466a	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01A-21D-A036-01		TCGA-A2-A0EX-01A-21R-A034-07	6fc8b7da-3de6-4111-b685-bb03c032466a	TCGA-A2-A0EX-01A-21D-A036-01	TCGA-A2-A0EX-01
TCGA-A2-A0EY-01	Stage IIB	62	3	No_Conversion	735		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N1	735	0	LumB	Luminal B	Negative	Her2	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EY-01	1925	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-A2-A0EY	1925	0	days	1925	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0EY-F13716	TCGA-A2-A0EY	TCGA-A2-A0EY-01A		Positive					Negative	Lumpectomy		YES			-22872	358		0	1925							60-69%		Scheduled Follow-up Submission	2011-6-10	FEMALE					3+			7.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	580	NO	Positive	Positive		23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO	1	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD.pdf	A0EY	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	93f09df2-f3c1-43d6-9c79-4751740bfa45	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	93f09df2-f3c1-43d6-9c79-4751740bfa45	TCGA-A2-A0EY-01A-21-A13C-20	TCGA-A2-A0EY-01A-11W-A050-09		TCGA-A2-A0EY-01			b4fefb35-16bd-4db4-aa7a-805703f36514	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01A-11W-A050-09	TCGA-A2-A0EY-01A-11D-A032-05	TCGA-A2-A0EY-01		TCGA-A2-A0EY-01A-11W-A050-09	TCGA-A2-A0EY-01	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01A-11D-A036-01		TCGA-A2-A0EY-01A-11R-A034-07	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	TCGA-A2-A0EY-01A-11D-A036-01	TCGA-A2-A0EY-01
TCGA-A2-A0ST-01	Stage IIA	62	1	No_Conversion	1643		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1643	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-A2-A0ST-01	3017	0	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A2-A0ST			days	3017	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0ST-F14035	TCGA-A2-A0ST	TCGA-A2-A0ST-01A		Negative					Negative	Lumpectomy		YES			-22922	2597		0	3017									Scheduled Follow-up Submission	2011-7-14	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	210	NO		Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								YES	3	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf	A0ST	WITH TUMOR										YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	920e47c0-1b19-46e6-b1db-b5fd95e44df0	db464b40-f99f-4427-9d17-edd9af51b2c8	920e47c0-1b19-46e6-b1db-b5fd95e44df0	db464b40-f99f-4427-9d17-edd9af51b2c8	TCGA-A2-A0ST-01A-21-A13A-20	TCGA-A2-A0ST-01A-12D-A099-09		TCGA-A2-A0ST-01	TCGA-A2-A0ST-01A-12D-A10P-05		d662c746-aeee-4b37-b811-a236222583b8	TCGA-A2-A0ST-01	TCGA-A2-A0ST-01A-12D-A099-09		TCGA-A2-A0ST-01		TCGA-A2-A0ST-01A-12D-A099-09	TCGA-A2-A0ST-01	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01	TCGA-A2-A0ST-01A-12D-A087-01		TCGA-A2-A0ST-01A-12R-A084-07	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01A-12D-A087-01	TCGA-A2-A0ST-01
TCGA-A2-A0SU-01	Stage IIA	66	2	Stage IIA	1661		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	1661	0	LumA	Luminal A	Positive	LumA/B	0	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0SU-01	1662	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0SU	1662	0	days	1662	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left	Sentinel node biopsy alone		TCGA-A2-A0SU-F13954	TCGA-A2-A0SU	TCGA-A2-A0SU-01A		Positive					Positive	Simple Mastectomy		YES			-24219	1317		0	1662							90-99%		Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740.pdf	A0SU	TUMOR FREE								<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2006	05aa0960-505b-4b04-be9f-7b54940f5b27	8d301711-4802-4905-ac86-8b13a545e414	05aa0960-505b-4b04-be9f-7b54940f5b27	8d301711-4802-4905-ac86-8b13a545e414	TCGA-A2-A0SU-01A-21-A13C-20	TCGA-A2-A0SU-01A-11D-A099-09		TCGA-A2-A0SU-01	TCGA-A2-A0SU-01A-11D-A10P-05		4fbcc317-6f56-4227-a6ef-304afa8880eb	TCGA-A2-A0SU-01	TCGA-A2-A0SU-01A-11D-A099-09		TCGA-A2-A0SU-01		TCGA-A2-A0SU-01A-11D-A099-09	TCGA-A2-A0SU-01	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01	TCGA-A2-A0SU-01A-11D-A087-01		TCGA-A2-A0SU-01A-11R-A084-07	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01A-11D-A087-01	TCGA-A2-A0SU-01
TCGA-A2-A0SV-01	Stage IV	63	5	No_Conversion	825	825	Positive	FEMALE	Negative	3	3	4	Positive	M1	Positive	N2	825	1	LumB	Luminal B	Positive	Basal	-2	-3	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0SV-01	825	1	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-A2-A0SV			days	825	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO		NO	63	Right	Axillary lymph node dissection alone		TCGA-A2-A0SV-F3755	TCGA-A2-A0SV	TCGA-A2-A0SV-01A		Positive					Positive	Simple Mastectomy		NO			-23126	1513	825	0								90-99%			2010-11-22	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Equivocal	Negative		9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Bone		2	6									8		true	No	M1	N2a	T2	Stage IV	TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633.pdf	A0SV	WITH TUMOR								10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2006	783d861d-ba0c-4b0d-9922-06ac23d3fc85	438bf0f6-af07-42dd-8121-fce6c1163e97	783d861d-ba0c-4b0d-9922-06ac23d3fc85	438bf0f6-af07-42dd-8121-fce6c1163e97	TCGA-A2-A0SV-01A-21-A13A-20	TCGA-A2-A0SV-01A-11D-A099-09		TCGA-A2-A0SV-01	TCGA-A2-A0SV-01A-11D-A10P-05		fc3b7efa-17e1-4f22-82f6-46b9eb25ab83	TCGA-A2-A0SV-01	TCGA-A2-A0SV-01A-11D-A099-09		TCGA-A2-A0SV-01		TCGA-A2-A0SV-01A-11D-A099-09	TCGA-A2-A0SV-01	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01	TCGA-A2-A0SV-01A-11D-A087-01		TCGA-A2-A0SV-01A-11R-A084-07	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01A-11D-A087-01	TCGA-A2-A0SV-01
TCGA-A2-A0SW-01	Stage IV	82	4	No_Conversion	1364	1364	Positive	FEMALE	Negative	1	1	4	Positive	M1	Positive	N2	1364	1	LumB	Luminal B	Negative	Basal	-2	-5	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0SW-01	1365	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A2-A0SW			days	1365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		82	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0SW-F3701	TCGA-A2-A0SW			Positive					Negative	Lumpectomy		NO			-30085		1365	0				653				40-49%			2010-11-8	FEMALE				Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified		60		1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Liver		4	3									4			No	M1	N2	T2	Stage IV		A0SW	WITH TUMOR								<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast		DECEASED	2006	d17676ea-d64e-49d0-9737-3b852879ce52	e06babf2-ca3c-4bde-9c36-9799e305c520	d17676ea-d64e-49d0-9737-3b852879ce52	e06babf2-ca3c-4bde-9c36-9799e305c520	TCGA-A2-A0SW-01A-21-A13A-20	TCGA-A2-A0SW-01A-11D-A099-09		TCGA-A2-A0SW-01	TCGA-A2-A0SW-01A-11D-A10P-05		dc3609ce-4a40-4456-b26f-f366770af706	TCGA-A2-A0SW-01	TCGA-A2-A0SW-01A-11D-A099-09		TCGA-A2-A0SW-01		TCGA-A2-A0SW-01A-11D-A099-09	TCGA-A2-A0SW-01	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01	TCGA-A2-A0SW-01A-11D-A087-01		TCGA-A2-A0SW-01A-11R-A084-07	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01A-11D-A087-01	TCGA-A2-A0SW-01
TCGA-A2-A0SX-01	Stage IA	48	1	Stage I	1288		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1288	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA-A2-A0SX-01	1534	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0SX	1534	0	days	1534	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		48	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0SX-F14037	TCGA-A2-A0SX	TCGA-A2-A0SX-01A	Negative	Negative				Lumpectomy	Negative	Lumpectomy		YES	1239		-17774	1177		0	1534			1239						Scheduled Follow-up Submission	2011-7-14	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	910	NO	Negative			1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf	A0SX	WITH TUMOR										YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2007	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	aa2d584e-9a6b-418e-a401-c8a17d669cb8	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	aa2d584e-9a6b-418e-a401-c8a17d669cb8	TCGA-A2-A0SX-01A-21-A13A-20	TCGA-A2-A0SX-01A-12D-A099-09		TCGA-A2-A0SX-01	TCGA-A2-A0SX-01A-12D-A10P-05		13ef422e-b0f0-4c0a-bbe4-3d38bb2a2532	TCGA-A2-A0SX-01	TCGA-A2-A0SX-01A-12D-A099-09		TCGA-A2-A0SX-01		TCGA-A2-A0SX-01A-12D-A099-09	TCGA-A2-A0SX-01	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01	TCGA-A2-A0SX-01A-12D-A087-01		TCGA-A2-A0SX-01A-12R-A084-07	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01A-12D-A087-01	TCGA-A2-A0SX-01
TCGA-A2-A0SY-01	Stage IIIA	62	2	No_Conversion	1347		Positive	FEMALE	Positive				Negative	M0	Positive	N1	1347	0	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0SY-01	1347	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0SY	1347	0	days	1347	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0SY-F13943	TCGA-A2-A0SY	TCGA-A2-A0SY-01A		Positive					Positive	Modified Radical Mastectomy		YES			-22928	1083		0	1347							80-89%		Scheduled Follow-up Submission	2011-7-18	FEMALE				Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified		60		4.8		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO		Positive		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	1	0	true	No	M0	N1	T3	Stage IIIA	TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F.pdf	A0SY	TUMOR FREE								40-49%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2007	30fad3cd-09a5-4867-9d18-a940041a2b60	b322940e-f03c-46f9-9dd4-f027089d5b40	30fad3cd-09a5-4867-9d18-a940041a2b60	b322940e-f03c-46f9-9dd4-f027089d5b40		TCGA-A2-A0SY-01A-31D-A099-09		TCGA-A2-A0SY-01	TCGA-A2-A0SY-01A-31D-A10P-05			TCGA-A2-A0SY-01	TCGA-A2-A0SY-01A-31D-A099-09		TCGA-A2-A0SY-01		TCGA-A2-A0SY-01A-31D-A099-09	TCGA-A2-A0SY-01	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01	TCGA-A2-A0SY-01A-31D-A087-01		TCGA-A2-A0SY-01A-31R-A084-07	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01A-31D-A087-01	TCGA-A2-A0SY-01
TCGA-A2-A0T0-01	Stage IIB	59	1	No_Conversion	533		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	533	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T0-01	533	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 12	TCGA-A2-A0T0	533	0	days	533	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0T0-F13944	TCGA-A2-A0T0	TCGA-A2-A0T0-01A		Negative					Negative	Lumpectomy		NO			-21575	268		0	533							<10%		Scheduled Follow-up Submission	2011-7-18	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf	A0T0	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	7e073ecd-452a-4cba-9dfd-8601f3245721	07d13cdb-332c-4bd8-82f6-8655881cea74	7e073ecd-452a-4cba-9dfd-8601f3245721	07d13cdb-332c-4bd8-82f6-8655881cea74	TCGA-A2-A0T0-01A-11-A13D-20	TCGA-A2-A0T0-01A-22D-A099-09		TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A10P-05		87565b35-30bd-4e31-bb26-404baf053cdc	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A099-09		TCGA-A2-A0T0-01		TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A087-01		TCGA-A2-A0T0-01A-22R-A084-07	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-22D-A087-01	TCGA-A2-A0T0-01
TCGA-A2-A0T1-01	Stage IIIC	55	4	No_Conversion	520		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N3	520	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T3	LIVING	0	TCGA-A2-A0T1-01	521	0	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0T1	521	0	days	521	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0T1-F13946	TCGA-A2-A0T1	TCGA-A2-A0T1-01A		Negative					Negative	Lumpectomy		NO			-20227	233		0	521							<10%		Scheduled Follow-up Submission	2011-7-18	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	10		true	No	M0	N3	T3	Stage IIIC	TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7.pdf	A0T1	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	8a19b992-4173-400d-8aec-d156525eedd6	e8889068-b216-4662-816f-b8e712b61ec7	8a19b992-4173-400d-8aec-d156525eedd6	e8889068-b216-4662-816f-b8e712b61ec7	TCGA-A2-A0T1-01A-11-A13D-20	TCGA-A2-A0T1-01A-21D-A099-09		TCGA-A2-A0T1-01	TCGA-A2-A0T1-01A-21D-A10P-05		84b6d9cc-201e-421d-b7af-77156e50c627	TCGA-A2-A0T1-01	TCGA-A2-A0T1-01A-21D-A099-09		TCGA-A2-A0T1-01		TCGA-A2-A0T1-01A-21D-A099-09	TCGA-A2-A0T1-01	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01	TCGA-A2-A0T1-01A-21D-A087-01		TCGA-A2-A0T1-01A-21R-A084-07	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01A-21D-A087-01	TCGA-A2-A0T1-01
TCGA-A2-A0T2-01	Stage IV	66	3	No_Conversion	240	240	Negative	FEMALE	Negative	2	2	2	Positive	M1	Positive	N3	240	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	DECEASED	1	TCGA-A2-A0T2-01	255	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A2-A0T2			days	255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO		NO	66	Right	Axillary lymph node dissection alone		TCGA-A2-A0T2-F3706	TCGA-A2-A0T2	TCGA-A2-A0T2-01A		Negative					Negative	Modified Radical Mastectomy		NO			-24235	261	255	0								<10%			2010-11-12	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	270	NO	Negative			14	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Liver	Abdomen	5	3									10		true	No	M1	N3	T3	Stage IV	TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313.pdf	A0T2	WITH TUMOR								<10%		NO	Primary Tumor	01			NO	NO	YES	A2	Breast	A	DECEASED	2009	491c6c41-d1c5-4be7-bb7c-9df7275aa388	eaf1eb18-1568-459d-be40-71e5e92df673	491c6c41-d1c5-4be7-bb7c-9df7275aa388	eaf1eb18-1568-459d-be40-71e5e92df673	TCGA-A2-A0T2-01A-21-A13D-20	TCGA-A2-A0T2-01A-11W-A097-09		TCGA-A2-A0T2-01	TCGA-A2-A0T2-01A-11D-A10P-05		73634c23-d25e-4268-a1bb-f8270a5d1d00	TCGA-A2-A0T2-01	TCGA-A2-A0T2-01A-11W-A097-09		TCGA-A2-A0T2-01		TCGA-A2-A0T2-01A-11W-A097-09	TCGA-A2-A0T2-01	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01	TCGA-A2-A0T2-01A-11D-A087-01		TCGA-A2-A0T2-01A-11R-A084-07	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01A-11D-A087-01	TCGA-A2-A0T2-01
TCGA-A2-A0T3-01	Stage IA	37	3	Stage IIA	569		Positive	FEMALE	Negative	4	5	4	Negative	M0	Positive	N1	569	0	LumB	Luminal B	Positive	ReacII	0	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0T3-01	1516	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 5	TCGA-A2-A0T3	1516	0	days	1516	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0T3-F59384	TCGA-A2-A0T3		Negative	Positive	3 Point Scale	3+	3 Point Scale	Other	Positive	Lumpectomy	Margin resection	YES			-13680			0	1516					NO		90-99%	2.3	Scheduled Follow-up Submission	2014-5-12	FEMALE					2+	556	3.2	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Negative	NO	13	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	7								NO	2	0		No	M0	N1mi	T1c	Stage IB		A0T3	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	A2	Breast		LIVING	2009	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	e4aa08a3-8089-4ed2-a6f3-8778934936d9	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	e4aa08a3-8089-4ed2-a6f3-8778934936d9	TCGA-A2-A0T3-01A-11-A13D-20	TCGA-A2-A0T3-01A-21D-A10Y-09		TCGA-A2-A0T3-01			c6a1647b-f6fb-4d3d-a67e-07719db0a308	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21D-A10Y-09	TCGA-A2-A0T3-01A-21D-A112-05	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21D-A10Y-09		d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32		TCGA-A2-A0T3-01A-21D-A111-01	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21R-A115-07	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	TCGA-A2-A0T3-01A-21D-A111-01	TCGA-A2-A0T3-01
TCGA-A2-A0T4-01	Stage IIA	62	2	Stage IIA	624		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	624	0	LumA	Luminal B	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T4-01	624	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0T4	624	0	days	624	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Inner Quadrant	Other (specify)	SLN and non-SLN biopsy	TCGA-A2-A0T4-F13948	TCGA-A2-A0T4	TCGA-A2-A0T4-01A		Positive		2+			Positive	Simple Mastectomy		YES			-22849	303		0	624							90-99%		Scheduled Follow-up Submission	2011-7-12	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	1500	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5.pdf	A0T4	TUMOR FREE								60-69%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	09787ddc-336f-4a53-a687-339d90457085	504fc7b4-3097-420e-b9e0-8981e934c2b6	09787ddc-336f-4a53-a687-339d90457085	504fc7b4-3097-420e-b9e0-8981e934c2b6	TCGA-A2-A0T4-01A-21-A13D-20	TCGA-A2-A0T4-01A-31D-A099-09		TCGA-A2-A0T4-01	TCGA-A2-A0T4-01A-31D-A10P-05		a5869d20-d1ff-42f3-979d-797d1ed7a9e2	TCGA-A2-A0T4-01	TCGA-A2-A0T4-01A-31D-A099-09		TCGA-A2-A0T4-01		TCGA-A2-A0T4-01A-31D-A099-09	TCGA-A2-A0T4-01	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01	TCGA-A2-A0T4-01A-31D-A087-01		TCGA-A2-A0T4-01A-31R-A084-07	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01A-31D-A087-01	TCGA-A2-A0T4-01
TCGA-A2-A0T5-01	Stage IIB	39	2	Stage IIA	531		Positive	FEMALE	Negative				Negative	M0	Negative	N0	531	0	LumA	Luminal A	Positive	LumA	-5	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T5-01	531	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6		TCGA-A2-A0T5	531	0	days	531	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left	Sentinel node biopsy alone		TCGA-A2-A0T5-F13949	TCGA-A2-A0T5	TCGA-A2-A0T5-01A		Positive					Positive	Simple Mastectomy		YES			-14503	263		0	531							90-99%		Scheduled Follow-up Submission	2011-7-12	FEMALE					1+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1740	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F.pdf	A0T5	TUMOR FREE								90-99%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	4c15b588-6017-4f0c-9b66-4f18122acc83	05cc8716-27bb-48f1-8bf7-563a728a1873	4c15b588-6017-4f0c-9b66-4f18122acc83	05cc8716-27bb-48f1-8bf7-563a728a1873	TCGA-A2-A0T5-01A-11-A13D-20			TCGA-A2-A0T5-01	TCGA-A2-A0T5-01A-21D-A10P-05		c7933393-6f03-4495-9e54-53e3e72d81e7	TCGA-A2-A0T5-01	TCGA-A2-A0T5-01A-21D-A099-09		TCGA-A2-A0T5-01			TCGA-A2-A0T5-01	4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01	TCGA-A2-A0T5-01A-21D-A087-01		TCGA-A2-A0T5-01A-21R-A084-07	4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01A-21D-A087-01	TCGA-A2-A0T5-01
TCGA-A2-A0T6-01	Stage IIB	50	2	Stage IIB	575		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	575	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0T6-01	575	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0T6	575	0	days	575	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left	Sentinel node biopsy alone		TCGA-A2-A0T6-F13950	TCGA-A2-A0T6			Positive		3+			Positive	Simple Mastectomy		YES			-18334			0	575							90-99%		Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	2								NO	0	0		No	M0	N0 (i-)	T3	Stage IIB		A0T6	TUMOR FREE								90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast		LIVING	2009	e3639f71-cfe7-46c7-8390-73f8043ac6b0	c6bd807e-dcb7-4f05-bba1-5caf20e43415	e3639f71-cfe7-46c7-8390-73f8043ac6b0	c6bd807e-dcb7-4f05-bba1-5caf20e43415	TCGA-A2-A0T6-01A-21-A13C-20	TCGA-A2-A0T6-01A-11D-A099-09		TCGA-A2-A0T6-01	TCGA-A2-A0T6-01A-11D-A10P-05		dcf310c3-9f6b-492b-b733-ece45d60089a	TCGA-A2-A0T6-01	TCGA-A2-A0T6-01A-11D-A099-09		TCGA-A2-A0T6-01		TCGA-A2-A0T6-01A-11D-A099-09	TCGA-A2-A0T6-01	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01	TCGA-A2-A0T6-01A-11D-A087-01		TCGA-A2-A0T6-01A-11R-A084-07	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01A-11D-A087-01	TCGA-A2-A0T6-01
TCGA-A2-A0T7-01	Stage IIA	51	2	Stage IIA	631		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	631	0	LumA	Luminal A	Positive	ReacI	-3	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T7-01	631	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0T7	631	0	days	631	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-A2-A0T7-F13953	TCGA-A2-A0T7	TCGA-A2-A0T7-01A	Negative	Positive		2+		Other	Positive	Modified Radical Mastectomy	Skin excision	YES			-18756	280		0	631							90-99%		Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	990	NO	Negative			2	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E.pdf	A0T7	TUMOR FREE								70-79%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	b5de3654-8983-45ab-a83a-d15284740d39	1dafc3c4-349e-4af4-871c-566f44080b09	b5de3654-8983-45ab-a83a-d15284740d39	1dafc3c4-349e-4af4-871c-566f44080b09	TCGA-A2-A0T7-01A-11-A13A-20	TCGA-A2-A0T7-01A-21D-A099-09		TCGA-A2-A0T7-01	TCGA-A2-A0T7-01A-21D-A10P-05		7a10bda1-1af5-4641-91bd-9a5174a68ff9	TCGA-A2-A0T7-01	TCGA-A2-A0T7-01A-21D-A099-09		TCGA-A2-A0T7-01		TCGA-A2-A0T7-01A-21D-A099-09	TCGA-A2-A0T7-01	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01	TCGA-A2-A0T7-01A-21D-A087-01		TCGA-A2-A0T7-01A-21R-A084-07	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01A-21D-A087-01	TCGA-A2-A0T7-01
TCGA-A2-A0YC-01	Stage IIB	59	2	No_Conversion	989		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	989	0	LumA	Luminal A	Positive	ReacII	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YC-01	990	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0YC	798	1	days	990	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		59	Right Upper Inner Quadrant	Other (specify)	Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy	TCGA-A2-A0YC-F15846	TCGA-A2-A0YC	TCGA-A2-A0YC-01A		Positive					Positive	Lumpectomy		YES		798	-21685	673		0	990			798				90-99%		Additional New Tumor Event	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified		60		1.18		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1170	NO		Negative		3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal			Positive												Positive			4	4				Bone	Distant Metastasis			YES	1	0	true	No	M0	N1mi	T2	Stage IIB	TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1.pdf	A0YC	WITH TUMOR								90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2008	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	bac34a30-d37a-4bd6-a196-ff72ecd07e65	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	bac34a30-d37a-4bd6-a196-ff72ecd07e65	TCGA-A2-A0YC-01A-21-A13D-20	TCGA-A2-A0YC-01A-11D-A117-09		TCGA-A2-A0YC-01	TCGA-A2-A0YC-01A-11D-A10A-05		ca761204-8a14-4297-afa7-f200bc37d53a	TCGA-A2-A0YC-01	TCGA-A2-A0YC-01A-11D-A117-09		TCGA-A2-A0YC-01		TCGA-A2-A0YC-01A-11D-A117-09	TCGA-A2-A0YC-01	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01	TCGA-A2-A0YC-01A-11D-A107-01		TCGA-A2-A0YC-01A-11R-A109-07	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01A-11D-A107-01	TCGA-A2-A0YC-01
TCGA-A2-A0YD-01	Stage IIB	63	2	Stage IIB	769		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	769	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YD-01	769	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A0YD	769	0	days	769	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0YD-F15770	TCGA-A2-A0YD			Positive					Positive	Simple Mastectomy		YES			-23021			0	769							90-99%		Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified		60		1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy				Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0	1		No	M0	N0 (i+)	T3	Stage IIB		A0YD	TUMOR FREE								80-89%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast		LIVING	2009	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	ed834fb2-f108-4b4c-b543-57f8dc0520c1	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	ed834fb2-f108-4b4c-b543-57f8dc0520c1	TCGA-A2-A0YD-01A-21-A13D-20	TCGA-A2-A0YD-01A-11D-A10G-09		TCGA-A2-A0YD-01	TCGA-A2-A0YD-01A-11D-A10A-05		b3a0423a-0d47-45f2-aa7c-1ae650ab5dd0	TCGA-A2-A0YD-01	TCGA-A2-A0YD-01A-11D-A10G-09		TCGA-A2-A0YD-01		TCGA-A2-A0YD-01A-11D-A10G-09	TCGA-A2-A0YD-01	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01	TCGA-A2-A0YD-01A-11D-A107-01		TCGA-A2-A0YD-01A-11R-A109-07	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01A-11D-A107-01	TCGA-A2-A0YD-01
TCGA-A2-A0YE-01	Stage IIB	48	3	No_Conversion	553		Negative	FEMALE	Negative				Negative	M0	Positive	N1	553	0	Basal	Basal-like	Negative	X	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YE-01	554	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8				TCGA-A2-A0YE	554	0	days	554	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0YE-F15771	TCGA-A2-A0YE	TCGA-A2-A0YE-01A		Negative					Negative	Lumpectomy		NO			-17727	238		0	554							<10%		Scheduled Follow-up Submission	2011-8-30	FEMALE		No membrane staining or incomplete membrane staining in <10% of tumor cells is negative	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8.pdf	A0YE	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2010	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	c5387233-2168-406d-aa69-9e92df136d0d	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	c5387233-2168-406d-aa69-9e92df136d0d	TCGA-A2-A0YE-01A-21-A13D-20			TCGA-A2-A0YE-01	TCGA-A2-A0YE-01A-11D-A10A-05		510563aa-4a19-4dd1-82c8-ac67f8a77a55	TCGA-A2-A0YE-01	TCGA-A2-A0YE-01A-11D-A10G-09		TCGA-A2-A0YE-01				7f57b9e7-1b1b-4e07-beb4-b877b7651f7b		TCGA-A2-A0YE-01A-11D-A107-01		TCGA-A2-A0YE-01A-11R-A109-07	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA-A2-A0YE-01A-11D-A107-01	TCGA-A2-A0YE-01
TCGA-A2-A0YF-01	Stage IA	67	2	Stage I	469		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	469	0	LumA	Luminal A	Negative	ReacII	-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0YF-01	1535	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0YF	1535	0	days	1535	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Sentinel node biopsy alone		TCGA-A2-A0YF-F59385	TCGA-A2-A0YF	TCGA-A2-A0YF-01A		Positive		0			Negative	Simple Mastectomy		YES			-24660	343		0	1535							90-99%		Scheduled Follow-up Submission	2014-5-12	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	600	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO	0	1	true	No	M0	N0 (i+)	T1b	Stage I	TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217.pdf	A0YF	TUMOR FREE						YES		<10%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	b3ac6331-6c8f-4165-add7-482aadf7fa68	fb2d1af2-81a7-4eb7-8a49-e6448c76e44e	b3ac6331-6c8f-4165-add7-482aadf7fa68	fb2d1af2-81a7-4eb7-8a49-e6448c76e44e	TCGA-A2-A0YF-01A-11-A13D-20	TCGA-A2-A0YF-01A-21D-A10G-09		TCGA-A2-A0YF-01	TCGA-A2-A0YF-01A-21D-A10A-05		85fd3e18-e927-47b3-9e06-b73de5edd740	TCGA-A2-A0YF-01	TCGA-A2-A0YF-01A-21D-A10G-09		TCGA-A2-A0YF-01		TCGA-A2-A0YF-01A-21D-A10G-09	TCGA-A2-A0YF-01	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01	TCGA-A2-A0YF-01A-21D-A107-01		TCGA-A2-A0YF-01A-21R-A109-07	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01A-21D-A107-01	TCGA-A2-A0YF-01
TCGA-A2-A0YG-01	Stage IIIC	63	5	No_Conversion	665		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N3	665	0	LumB	Luminal B	Positive	Her2	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YG-01	666	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0YG	666	0	days	666	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YG-F16753	TCGA-A2-A0YG	TCGA-A2-A0YG-01A		Positive		2+			Positive	Lumpectomy		NO			-23058	329		0	666							90-99%		Scheduled Follow-up Submission	2011-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	1530	NO	Positive			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	14		true	No	M0	N3a	T2	Stage IIIC	TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf	A0YG	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	c539f561-93db-41f3-8d9f-71cd77a096a7	2c4bb4d1-3f75-4aa5-aec3-c402ba52579e	c539f561-93db-41f3-8d9f-71cd77a096a7	2c4bb4d1-3f75-4aa5-aec3-c402ba52579e	TCGA-A2-A0YG-01A-31-A13D-20	TCGA-A2-A0YG-01A-21D-A10G-09		TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A10A-05		2d2789e0-0933-496a-a29b-63c0b05cfa19	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A10G-09		TCGA-A2-A0YG-01		TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A107-01		TCGA-A2-A0YG-01A-21R-A109-07	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-21D-A107-01	TCGA-A2-A0YG-01
TCGA-A2-A0YH-01	Stage IIIA	53	4	No_Conversion	658		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N2	658	0	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YH-01	659	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A2-A0YH	659	0	days	659	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YH-F16752	TCGA-A2-A0YH	TCGA-A2-A0YH-01A		Positive		3+			Positive	Lumpectomy		NO			-19596	321		0	659							80-89%		Scheduled Follow-up Submission	2011-9-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	480	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	5		true	No	M0	N2a	T2	Stage IIIA	TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626.pdf	A0YH	TUMOR FREE								70-79%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	5275bc42-18a3-43d1-9dee-dfb80c39ba20	2d4e7bff-a4ec-4bf0-9925-6b21b231f4b8	5275bc42-18a3-43d1-9dee-dfb80c39ba20	2d4e7bff-a4ec-4bf0-9925-6b21b231f4b8	TCGA-A2-A0YH-01A-21-A13D-20	TCGA-A2-A0YH-01A-11D-A10G-09		TCGA-A2-A0YH-01	TCGA-A2-A0YH-01A-11D-A10A-05		1682b578-8f05-4a4c-b98c-4ffe7ef3346e	TCGA-A2-A0YH-01	TCGA-A2-A0YH-01A-11D-A10G-09		TCGA-A2-A0YH-01		TCGA-A2-A0YH-01A-11D-A10G-09	TCGA-A2-A0YH-01	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01	TCGA-A2-A0YH-01A-11D-A107-01		TCGA-A2-A0YH-01A-11R-A109-07	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01A-11D-A107-01	TCGA-A2-A0YH-01
TCGA-A2-A0YI-01	Stage IA	62	3	Stage I	441		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	441	0	LumA	Luminal A	Positive	ReacI	-12	-4	followup	T1	T1	LIVING	0	TCGA-A2-A0YI-01	1505	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0YI	1505	0	days	1505	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Other (specify)	Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy	TCGA-A2-A0YI-F59386	TCGA-A2-A0YI	TCGA-A2-A0YI-01A		Positive		2+			Positive	Lumpectomy		YES			-22961	303		0	1505							90-99%		Scheduled Follow-up Submission	2014-5-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	340	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0	1	true	No	M0	N0 (i+)	T1c	Stage I	TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5.pdf	A0YI	TUMOR FREE						YES		60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2009	4de3ad78-68e4-4ab9-b1f6-eb0666140761	9758cc40-6f04-4297-b933-dd2d0a938930	4de3ad78-68e4-4ab9-b1f6-eb0666140761	9758cc40-6f04-4297-b933-dd2d0a938930	TCGA-A2-A0YI-01A-21-A13D-20	TCGA-A2-A0YI-01A-31D-A10M-09		TCGA-A2-A0YI-01	TCGA-A2-A0YI-01A-31D-A10N-05		0dca7119-3230-47a7-89e3-93c4bd405f4d	TCGA-A2-A0YI-01	TCGA-A2-A0YI-01A-31D-A10M-09		TCGA-A2-A0YI-01		TCGA-A2-A0YI-01A-31D-A10M-09	TCGA-A2-A0YI-01	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01	TCGA-A2-A0YI-01A-31D-A10L-01		TCGA-A2-A0YI-01A-31R-A10J-07	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01A-31D-A10L-01	TCGA-A2-A0YI-01
TCGA-A2-A0YJ-01	Stage IIIA	39	3	No_Conversion	565		Positive	FEMALE	Negative				Negative	M0	Positive	N2	565	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YJ-01	566	0	days	COAD-READ	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 5	TCGA-A2-A0YJ	559	1	days	566	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		39	Left	Axillary lymph node dissection alone		TCGA-A2-A0YJ-F16756	TCGA-A2-A0YJ	TCGA-A2-A0YJ-01A		Positive		0			Negative	Modified Radical Mastectomy		NO		559	-14448	264		0	566			559				<10%		Scheduled Follow-up Submission	2011-9-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	1080	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Negative			<10%									Negative			5					Other, specify	Distant Metastasis	Left Cervical Lymph Node		YES	5		true	No	M0	N2a	T3	Stage IIIA	TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514.pdf	A0YJ	WITH TUMOR								<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2010	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	98c00874-2525-47b6-b555-ebd259cbbcd1	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	98c00874-2525-47b6-b555-ebd259cbbcd1	TCGA-A2-A0YJ-01A-21-A13D-20	TCGA-A2-A0YJ-01A-11D-A10G-09		TCGA-A2-A0YJ-01	TCGA-A2-A0YJ-01A-11D-A10A-05		d6e27bfa-0efe-457b-8628-38958d21268b	TCGA-A2-A0YJ-01	TCGA-A2-A0YJ-01A-11D-A10G-09		TCGA-A2-A0YJ-01		TCGA-A2-A0YJ-01A-11D-A10G-09		330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19		TCGA-A2-A0YJ-01A-11D-A107-01		TCGA-A2-A0YJ-01A-11R-A109-07	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	TCGA-A2-A0YJ-01A-11D-A107-01	TCGA-A2-A0YJ-01
TCGA-A2-A0YK-01	Stage IIA	61	5	Stage IIA	587		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	587	0	Normal	Normal-like	Negative	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YK-01	588	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A0YK	588	0	days	588	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A0YK-F16750	TCGA-A2-A0YK	TCGA-A2-A0YK-01A		Positive					Negative	Simple Mastectomy		YES			-22625	280		0	588							90-99%		Scheduled Follow-up Submission	2011-9-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	620	NO	Negative			3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F.pdf	A0YK	TUMOR FREE								<10%		NO	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2009	ae614f7b-b310-4c60-bd50-9e02be984943	8536ff4e-4027-4673-96b9-43f4f61a5376	ae614f7b-b310-4c60-bd50-9e02be984943	8536ff4e-4027-4673-96b9-43f4f61a5376	TCGA-A2-A0YK-01A-31-A13D-20	TCGA-A2-A0YK-01A-22D-A117-09		TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A10A-05		07e19b85-cee6-4ea4-8588-5df93bf33053	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A117-09		TCGA-A2-A0YK-01		TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A107-01		TCGA-A2-A0YK-01A-22R-A109-07	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-22D-A107-01	TCGA-A2-A0YK-01
TCGA-A2-A0YL-01	Stage IIIA	48	2	No_Conversion	445		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	445	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YL-01	1474	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0YL	1474	0	days	1474	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A0YL-F59387	TCGA-A2-A0YL	TCGA-A2-A0YL-01A		Positive		3+			Positive	Simple Mastectomy		YES			-17702	205		0	1474							70-79%		Scheduled Follow-up Submission	2014-5-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	730	NO	Negative		NO	29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6								NO	4	0	true	No	M0	N2a	T3	Stage IIIA	TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE.pdf	A0YL	TUMOR FREE						YES		90-99%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	LIVING	2010	32cfb4f4-1de9-4937-8cfa-dc6c37081583	d1740289-b374-4298-a155-88bbb5f1a87d	32cfb4f4-1de9-4937-8cfa-dc6c37081583	d1740289-b374-4298-a155-88bbb5f1a87d	TCGA-A2-A0YL-01A-11-A13D-20	TCGA-A2-A0YL-01A-21D-A10G-09		TCGA-A2-A0YL-01	TCGA-A2-A0YL-01A-21D-A10A-05		2f4ab3d7-e280-4c21-9b13-e1c240627337	TCGA-A2-A0YL-01	TCGA-A2-A0YL-01A-21D-A10G-09		TCGA-A2-A0YL-01		TCGA-A2-A0YL-01A-21D-A10G-09	TCGA-A2-A0YL-01	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01	TCGA-A2-A0YL-01A-21D-A107-01		TCGA-A2-A0YL-01A-21R-A109-07	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01A-21D-A107-01	TCGA-A2-A0YL-01
TCGA-A2-A0YM-01	Stage IIA	67	3	Stage IIA	964		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	964	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YM-01	965	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	OV-like c4	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-A2-A0YM	965	0	days	965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node biopsy and non-sentinel lymph node biopsy	TCGA-A2-A0YM-F15767	TCGA-A2-A0YM	TCGA-A2-A0YM-01A		Negative					Negative	Lumpectomy		YES			-24831	691		0	965							<10%		Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified		60		1.08		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf	A0YM	TUMOR FREE								<10%		YES	Primary Tumor	01			NO	NO	YES	A2	Breast	A	LIVING	2008	1e59ea3f-36fa-4860-8c28-87b4b09075ec	356ec0ad-a065-44db-8a4d-218efff4c3b4	1e59ea3f-36fa-4860-8c28-87b4b09075ec	356ec0ad-a065-44db-8a4d-218efff4c3b4	TCGA-A2-A0YM-01A-21-A13D-20	TCGA-A2-A0YM-01A-11D-A10G-09		TCGA-A2-A0YM-01	TCGA-A2-A0YM-01A-11D-A10A-05		a55195f2-8c4d-40ab-a452-8424a0403d03	TCGA-A2-A0YM-01	TCGA-A2-A0YM-01A-11D-A10G-09		TCGA-A2-A0YM-01		TCGA-A2-A0YM-01A-11D-A10G-09	TCGA-A2-A0YM-01	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01	TCGA-A2-A0YM-01A-11D-A107-01		TCGA-A2-A0YM-01A-11R-A109-07	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01A-11D-A107-01	TCGA-A2-A0YM-01
TCGA-A2-A0YT-01	Stage IIIB	56		No_Conversion	669	723	Positive	FEMALE	Negative				Negative	M0	Positive	N2	723	1	LumB		Negative				followup	T_Other	T4	DECEASED	1	TCGA-A2-A0YT-01	723	1	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 3	TCGA-A2-A0YT	723	0	days	723	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A0YT-F15768	TCGA-A2-A0YT	TCGA-A2-A0YT-01A		Positive					Negative	Modified Radical Mastectomy		NO			-20482	884	723	0								90-99%		Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified		60		1.3		Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Core needle biopsy	950	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5		true	No	M0	N2a	T4b	Stage IIIB	TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD.pdf	A0YT	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	A2	Breast	A	DECEASED	2008	451099b0-f348-4aec-bf9f-2982601f013c	0b6fed27-b3fc-4078-a9d3-e766d718c19b	451099b0-f348-4aec-bf9f-2982601f013c	0b6fed27-b3fc-4078-a9d3-e766d718c19b	TCGA-A2-A0YT-01A-21-A13D-20	TCGA-A2-A0YT-01A-11D-A10G-09		TCGA-A2-A0YT-01	TCGA-A2-A0YT-01A-11D-A10A-05		cea5a1de-f9e8-406b-a6ac-08e3d9869c5b	TCGA-A2-A0YT-01	TCGA-A2-A0YT-01A-11D-A10G-09		TCGA-A2-A0YT-01		TCGA-A2-A0YT-01A-11D-A10G-09	TCGA-A2-A0YT-01	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01	TCGA-A2-A0YT-01A-11D-A107-01		TCGA-A2-A0YT-01A-11R-A109-07	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01A-11D-A107-01	TCGA-A2-A0YT-01
TCGA-A2-A1FV-01	Stage IIB	74	4	Stage IIB	460		Positive	FEMALE	Negative				Negative	M0	Negative	N0	460	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FV-01	714	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-A2-A1FV	714	0	days	714	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left	Sentinel node biopsy alone		TCGA-A2-A1FV-F20238	TCGA-A2-A1FV	TCGA-A2-A1FV-01A		Positive					Positive	Simple Mastectomy		YES			-27287	372		0	714					NO		90-99%		Scheduled Follow-up Submission	2012-1-9	FEMALE					1+			0.92		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Negative	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	6								NO	0	1	true	No	M0	N0 (i+)	T3	Stage IIB	TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf	A1FV	TUMOR FREE				Strong	Strong		YES	<10%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	ee12f85b-64f8-4052-9477-392c4bd99257	9deea0fe-12ed-4cd6-8d76-11d857b03607	ee12f85b-64f8-4052-9477-392c4bd99257	9deea0fe-12ed-4cd6-8d76-11d857b03607	TCGA-A2-A1FV-01A-21-A17I-20	TCGA-A2-A1FV-01A-11D-A13L-09		TCGA-A2-A1FV-01	TCGA-A2-A1FV-01A-11D-A13K-05		5d85b493-8ea7-46e2-a2f1-f21b8ccc46c8	TCGA-A2-A1FV-01	TCGA-A2-A1FV-01A-11D-A13L-09			TCGA-A2-A1FV-01	TCGA-A2-A1FV-01A-11D-A13L-09		ee12f85b-64f8-4052-9477-392c4bd99257		TCGA-A2-A1FV-01A-11D-A13J-01	TCGA-A2-A1FV-01		ee12f85b-64f8-4052-9477-392c4bd99257	TCGA-A2-A1FV-01A-11D-A13J-01	
TCGA-A2-A1FW-01	Stage IIIA	62	3	Stage IIIA	221		Positive	FEMALE	Negative				Negative	M0	Positive	N2	221	0	LumB		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FW-01	528	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-A2-A1FW	528	0	days	528	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1FW-F20810	TCGA-A2-A1FW	TCGA-A2-A1FW-01A		Positive					Negative	Modified Radical Mastectomy		NO			-22779	198		0	528					NO		90-99%		Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	640	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	5		true	No	M0	N2a	T3	Stage IIIA	TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf	A1FW	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	b8ee56ee-5cac-45d1-af7d-d89eb8fa3360	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	b8ee56ee-5cac-45d1-af7d-d89eb8fa3360	TCGA-A2-A1FW-01A-21-A17I-20	TCGA-A2-A1FW-01A-11D-A13L-09		TCGA-A2-A1FW-01	TCGA-A2-A1FW-01A-11D-A13K-05		fdc673b1-add6-4078-8f96-0ed4f6985240	TCGA-A2-A1FW-01	TCGA-A2-A1FW-01A-11D-A13L-09			TCGA-A2-A1FW-01	TCGA-A2-A1FW-01A-11D-A13L-09		2f1af8cf-ded3-45b6-88cd-2c154c66ab8c		TCGA-A2-A1FW-01A-11D-A13J-01	TCGA-A2-A1FW-01		2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	TCGA-A2-A1FW-01A-11D-A13J-01	
TCGA-A2-A1FX-01	Stage IIIA	61	4	Stage IIIA	935		Positive	FEMALE	Negative				Negative	M0	Positive	N2	935	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FX-01	1847	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A1FX	1847	0	days	1847	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1FX-F59654	TCGA-A2-A1FX	TCGA-A2-A1FX-01A	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy		NO			-22344	937		0	1847					NO		70-79%	160	Scheduled Follow-up Submission	2014-5-19	FEMALE						60	185	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative	NO	24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	6		true	No	M0	N2a	T3	Stage IIIA	TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf	A1FX	TUMOR FREE						YES	YES	60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2008	60f078d7-d594-48a2-9011-f0f926243a42	a3f4ad97-3d59-4568-84e8-674280b1f04a	60f078d7-d594-48a2-9011-f0f926243a42	a3f4ad97-3d59-4568-84e8-674280b1f04a	TCGA-A2-A1FX-01A-21-A17I-20	TCGA-A2-A1FX-01A-11D-A13L-09		TCGA-A2-A1FX-01	TCGA-A2-A1FX-01A-11D-A13K-05		0b991416-2ca1-4582-b119-e95e4e8ca5e8	TCGA-A2-A1FX-01	TCGA-A2-A1FX-01A-11D-A13L-09			TCGA-A2-A1FX-01	TCGA-A2-A1FX-01A-11D-A13L-09		60f078d7-d594-48a2-9011-f0f926243a42		TCGA-A2-A1FX-01A-11D-A13J-01	TCGA-A2-A1FX-01		60f078d7-d594-48a2-9011-f0f926243a42	TCGA-A2-A1FX-01A-11D-A13J-01	
TCGA-A2-A1FZ-01	Stage IIA	63	3	Stage IIA	409		Positive	FEMALE	Negative				Negative	M0	Negative	N0	409	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1FZ-01	683	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-A2-A1FZ	683	0	days	683	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Sentinel node biopsy alone		TCGA-A2-A1FZ-F20803	TCGA-A2-A1FZ	TCGA-A2-A1FZ-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-23055	335		0	683					NO		90-99%		Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	740	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf	A1FZ	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	2324a415-fc47-477f-8842-822a48b120a6	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	2324a415-fc47-477f-8842-822a48b120a6	TCGA-A2-A1FZ-01A-11-A17I-20	TCGA-A2-A1FZ-01A-51D-A17G-09		TCGA-A2-A1FZ-01	TCGA-A2-A1FZ-01A-51D-A14H-05		5157205e-da8c-4890-9df3-02f40831c268	TCGA-A2-A1FZ-01	TCGA-A2-A1FZ-01A-51D-A17G-09			TCGA-A2-A1FZ-01	TCGA-A2-A1FZ-01A-51D-A17G-09		27e70f84-80c5-4f6c-9d22-83c5a6e66eb5		TCGA-A2-A1FZ-01A-51D-A14F-01	TCGA-A2-A1FZ-01		27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	TCGA-A2-A1FZ-01A-51D-A14F-01	
TCGA-A2-A1G0-01	Stage IIB	49	3	Stage IIB	380		Positive	FEMALE	Negative				Negative	M0	Positive	N1	380	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G0-01	616	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A1G0	616	0	days	616	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1G0-F20802	TCGA-A2-A1G0	TCGA-A2-A1G0-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-18002	315		0	616					NO		90-99%		Scheduled Follow-up Submission	2012-1-9	FEMALE					2+			1.2		Other, specify		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	730	NO	Equivocal	Negative		19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf	A1G0	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	753e77c2-6175-49d8-afd4-3a87d1dc2404	454e0016-63ac-4727-a1bd-0319b09d17a0	753e77c2-6175-49d8-afd4-3a87d1dc2404	454e0016-63ac-4727-a1bd-0319b09d17a0	TCGA-A2-A1G0-01A-21-A17I-20	TCGA-A2-A1G0-01A-11D-A13L-09		TCGA-A2-A1G0-01	TCGA-A2-A1G0-01A-11D-A13K-05		5875ba8b-aa27-4573-b1c7-30878613288e	TCGA-A2-A1G0-01	TCGA-A2-A1G0-01A-11D-A13L-09			TCGA-A2-A1G0-01	TCGA-A2-A1G0-01A-11D-A13L-09		753e77c2-6175-49d8-afd4-3a87d1dc2404		TCGA-A2-A1G0-01A-11D-A13J-01	TCGA-A2-A1G0-01		753e77c2-6175-49d8-afd4-3a87d1dc2404	TCGA-A2-A1G0-01A-11D-A13J-01	
TCGA-A2-A1G1-01	Stage IIB	85	4	Stage IIB	371		Negative	FEMALE	Positive				Negative	M0	Positive	N1	371	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G1-01	584	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 14	cluster 6	mutation cluster 5	TCGA-A2-A1G1	584	0	days	584	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					85	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A1G1-F20808	TCGA-A2-A1G1	TCGA-A2-A1G1-01A		Negative					Negative	Lumpectomy		NO			-31223	338		0	584					NO			51	Scheduled Follow-up Submission	2012-1-12	FEMALE					2+	30	816	16.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal	Positive		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf	A1G1	TUMOR FREE							YES			YES	Primary Tumor	01		7th	NO	YES	NO	A2	Breast	A	LIVING	2010	122a1ed2-9757-4cac-9656-149da6d872f4	b71535be-881b-4ea5-888a-1f2afbdec4d1	122a1ed2-9757-4cac-9656-149da6d872f4	b71535be-881b-4ea5-888a-1f2afbdec4d1	TCGA-A2-A1G1-01A-11-A17I-20	TCGA-A2-A1G1-01A-21D-A13L-09		TCGA-A2-A1G1-01	TCGA-A2-A1G1-01A-21D-A13K-05		cd315ed6-e7af-4f4e-9990-348e464d5738	TCGA-A2-A1G1-01	TCGA-A2-A1G1-01A-21D-A13L-09			TCGA-A2-A1G1-01	TCGA-A2-A1G1-01A-21D-A13L-09		122a1ed2-9757-4cac-9656-149da6d872f4		TCGA-A2-A1G1-01A-21D-A13J-01	TCGA-A2-A1G1-01		122a1ed2-9757-4cac-9656-149da6d872f4	TCGA-A2-A1G1-01A-21D-A13J-01	
TCGA-A2-A1G4-01	Stage IIIA	71	4	Stage IIIA	372		Positive	FEMALE	Negative				Negative	M0	Positive	N1	372	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1G4-01	595	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-A2-A1G4	595	0	days	595	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A1G4-F20805	TCGA-A2-A1G4	TCGA-A2-A1G4-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-25966	310		0	595					NO		90-99%		Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	710	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	2		true	Yes	M0	N1a	T3	Stage IIIA	TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf	A1G4	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	6b688e59-a222-4068-8b2b-71494fdfde17	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	6b688e59-a222-4068-8b2b-71494fdfde17	TCGA-A2-A1G4-01A-21-A17I-20	TCGA-A2-A1G4-01A-11D-A13L-09		TCGA-A2-A1G4-01	TCGA-A2-A1G4-01A-11D-A13K-05		d573b843-5656-47aa-958a-c295311876f0	TCGA-A2-A1G4-01	TCGA-A2-A1G4-01A-11D-A13L-09			TCGA-A2-A1G4-01	TCGA-A2-A1G4-01A-11D-A13L-09		2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2		TCGA-A2-A1G4-01A-11D-A13J-01	TCGA-A2-A1G4-01		2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	TCGA-A2-A1G4-01A-11D-A13J-01	
TCGA-A2-A1G6-01	Stage IIIA	50	1	Stage IIIA	132		Negative	FEMALE	Negative				Negative	M0	Positive	N2	132	0	Normal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G6-01	501	0	days	Quiet	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A1G6	501	0	days	501	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Axillary lymph node dissection alone		TCGA-A2-A1G6-F20947	TCGA-A2-A1G6	TCGA-A2-A1G6-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18514	229		0	501					NO				Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	6								NO	4		true	No	M0	N2a	T2	Stage IIIA	TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf	A1G6	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	8b216b0f-1881-45de-a4ae-78dfd87764fe	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	8b216b0f-1881-45de-a4ae-78dfd87764fe	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	TCGA-A2-A1G6-01A-21-A17I-20	TCGA-A2-A1G6-01A-11D-A13L-09		TCGA-A2-A1G6-01	TCGA-A2-A1G6-01A-11D-A13K-05		02e55cff-87a6-4719-b988-4b8f46f079a5	TCGA-A2-A1G6-01	TCGA-A2-A1G6-01A-11D-A13L-09			TCGA-A2-A1G6-01	TCGA-A2-A1G6-01A-11D-A13L-09		8b216b0f-1881-45de-a4ae-78dfd87764fe		TCGA-A2-A1G6-01A-11D-A13J-01	TCGA-A2-A1G6-01		8b216b0f-1881-45de-a4ae-78dfd87764fe	TCGA-A2-A1G6-01A-11D-A13J-01	
TCGA-A2-A259-01	Stage IA	70	4	Stage I	1285		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1285	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-A2-A259-01	1596	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-A2-A259	1596	0	days	1596	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left	Sentinel node biopsy alone		TCGA-A2-A259-F31034	TCGA-A2-A259	TCGA-A2-A259-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		YES			-25666	1238		0	1596					NO		90-99%	125	Scheduled Follow-up Submission	2012-4-23	FEMALE						60	132	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf	A259	TUMOR FREE				Strong using Weak, Moderate and Strong	Strong using Weak, Moderate and Strong		YES	80-89%		NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2007	7157ccb4-b4f6-41ba-9f9c-da862b749a57	ec4242c5-4c16-43d6-9fe3-0fc2766928a1	7157ccb4-b4f6-41ba-9f9c-da862b749a57	ec4242c5-4c16-43d6-9fe3-0fc2766928a1	TCGA-A2-A259-01A-21-A17I-20	TCGA-A2-A259-01A-11D-A16D-09		TCGA-A2-A259-01	TCGA-A2-A259-01A-11D-A16G-05		f49215ab-aaf7-4a3a-bf77-196395a8cae7	TCGA-A2-A259-01	TCGA-A2-A259-01A-11D-A16D-09			TCGA-A2-A259-01	TCGA-A2-A259-01A-11D-A16D-09		7157ccb4-b4f6-41ba-9f9c-da862b749a57		TCGA-A2-A259-01A-11D-A16C-01	TCGA-A2-A259-01		7157ccb4-b4f6-41ba-9f9c-da862b749a57	TCGA-A2-A259-01A-11D-A16C-01	
TCGA-A2-A25A-01	Stage IIA	44	2	Stage IIA	2968		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2968	0	Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25A-01	3276	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 4	TCGA-A2-A25A	3276	0	days	3276	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25A-F30927	TCGA-A2-A25A	TCGA-A2-A25A-01A		Positive					Positive	Simple Mastectomy		YES			-16084	2927		0	3276					NO		<10%		Scheduled Follow-up Submission	2012-4-19	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Negative		14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	0	0	true	Yes	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf	A25A	TUMOR FREE							YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2003	50c720f4-dbcb-4b8b-9808-d130f5197d27	3e0fb875-1681-4fb4-a955-924eba446e9b	50c720f4-dbcb-4b8b-9808-d130f5197d27	3e0fb875-1681-4fb4-a955-924eba446e9b	TCGA-A2-A25A-01A-21-A17I-20	TCGA-A2-A25A-01A-12D-A16D-09		TCGA-A2-A25A-01	TCGA-A2-A25A-01A-12D-A16G-05		bf3c63c7-643e-43b2-b5ea-3c2185ba9238	TCGA-A2-A25A-01	TCGA-A2-A25A-01A-12D-A16D-09			TCGA-A2-A25A-01	TCGA-A2-A25A-01A-12D-A16D-09		50c720f4-dbcb-4b8b-9808-d130f5197d27		TCGA-A2-A25A-01A-12D-A16C-01	TCGA-A2-A25A-01		50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-12D-A16C-01	
TCGA-A2-A25B-01	Stage IIB	39	5	Stage IIB	258		Positive	FEMALE	Negative				Negative	M0	Positive	N1	258	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25B-01	1291	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-A2-A25B	1290	1	days	1291	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A25B-F70679	TCGA-A2-A25B	TCGA-A2-A25B-01A		Positive					Positive	Simple Mastectomy		NO			-14454	183		0	1291			1290		NO		90-99%		Scheduled Follow-up Submission	2015-3-2	FEMALE					2+			0.93		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	840	NO	Equivocal	Negative	NO	8	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Positive															4	5				Bone	Distant Metastasis		NO	YES	2		true	No	M0	N1	T2	Stage IIB	TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf	A25B	WITH TUMOR						YES	YES	10-19%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	716578b3-e202-483b-b15c-784f5a0c60f3	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	716578b3-e202-483b-b15c-784f5a0c60f3	TCGA-A2-A25B-01A-21-A17I-20	TCGA-A2-A25B-01A-11D-A167-09		TCGA-A2-A25B-01	TCGA-A2-A25B-01A-11D-A16A-05		b5b0794f-7149-4056-8687-98a9a1401d2c	TCGA-A2-A25B-01	TCGA-A2-A25B-01A-11D-A167-09			TCGA-A2-A25B-01	TCGA-A2-A25B-01A-11D-A167-09		3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b		TCGA-A2-A25B-01A-11D-A166-01	TCGA-A2-A25B-01		3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	TCGA-A2-A25B-01A-11D-A166-01	
TCGA-A2-A25C-01	Stage IIB	50	3	Stage IIB	285		Positive	FEMALE	Negative				Negative	M0	Positive	N1	285	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25C-01	523	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 4	TCGA-A2-A25C	523	0	days	523	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A25C-F31282	TCGA-A2-A25C			Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		NO			-18508			0	523					NO		90-99%		Scheduled Follow-up Submission	2012-4-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	5								NO	3			No	M0	N1a	T2	Stage IIB		A25C	TUMOR FREE							YES	20-29%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast		LIVING	2010	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	bd2557ec-ce5b-4e98-aed0-2ca6ad51742e	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	bd2557ec-ce5b-4e98-aed0-2ca6ad51742e	TCGA-A2-A25C-01A-21-A17I-20	TCGA-A2-A25C-01A-11D-A167-09		TCGA-A2-A25C-01	TCGA-A2-A25C-01A-11D-A16A-05		dbc23df1-b14d-4f24-81ef-fc12e2cdda21	TCGA-A2-A25C-01	TCGA-A2-A25C-01A-11D-A167-09			TCGA-A2-A25C-01	TCGA-A2-A25C-01A-11D-A167-09		f5b16ba5-0fd1-4ca4-865f-fdff0af65901		TCGA-A2-A25C-01A-11D-A166-01	TCGA-A2-A25C-01		f5b16ba5-0fd1-4ca4-865f-fdff0af65901	TCGA-A2-A25C-01A-11D-A166-01	
TCGA-A2-A25D-01	Stage IIIC	90	4	Stage IIIC	243		Positive	FEMALE	Negative				Negative	M0	Positive	N3	243	0	LumA		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25D-01	552	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-A2-A25D	552	0	days	552	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25D-F30931	TCGA-A2-A25D	TCGA-A2-A25D-01A		Positive					Negative	Lumpectomy		NO			-32872	224		0	552					NO		70-79%	118	Scheduled Follow-up Submission	2012-4-19	FEMALE					1+	60	145	1.22		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	430	NO	Negative	Negative		24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	22		true	No	M0	N3a	T2	Stage IIIC	TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf	A25D	TUMOR FREE					Moderate using the scale of Weak, Moderate, Strong		YES			YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2010	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	91bb8c75-008a-4c32-84bd-fb55524a39aa	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	91bb8c75-008a-4c32-84bd-fb55524a39aa	TCGA-A2-A25D-01A-21-A17I-20	TCGA-A2-A25D-01A-12D-A16D-09		TCGA-A2-A25D-01	TCGA-A2-A25D-01A-12D-A16G-05		6ff66f90-93c3-4c1e-84c6-9db89ca701c2	TCGA-A2-A25D-01	TCGA-A2-A25D-01A-12D-A16D-09			TCGA-A2-A25D-01	TCGA-A2-A25D-01A-12D-A16D-09		d6b5cec3-edeb-46c5-839b-e62a1e850e0e		TCGA-A2-A25D-01A-12D-A16C-01	TCGA-A2-A25D-01		d6b5cec3-edeb-46c5-839b-e62a1e850e0e	TCGA-A2-A25D-01A-12D-A16C-01	
TCGA-A2-A25E-01	Stage IIIA	34	5	Stage IIIA	2511		Positive	FEMALE	Equivocal				Negative	M0	Positive	N2	2511	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25E-01	3204	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-A2-A25E	2989	1	days	3204	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			34	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A25E-F44982	TCGA-A2-A25E	TCGA-A2-A25E-01A		Positive					Positive	Modified Radical Mastectomy		NO			-12601	2441		0	3204		3024	2989		NO		80-89%		Scheduled Follow-up Submission	2013-7-2	FEMALE					2+			2.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO	Equivocal	Equivocal	NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Positive	90-99%				3 Point Scale	3+	2+			<10%		Positive			4	5			3 Point Scale	Other, specify	Locoregional Recurrence	Left Chest Wall	YES	YES	6		true	No	M0	N2a	T2	Stage IIIA	TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf	A25E	TUMOR FREE				Strong, using scale of Weak, Moderate and Strong	Moderate using scale of Weak, Moderate, Strong	YES	YES	60-69%		YES	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	LIVING	2004	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	d8bafd3e-45a4-4392-b06d-554c5d2eb95a	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	d8bafd3e-45a4-4392-b06d-554c5d2eb95a	TCGA-A2-A25E-01A-21-A17I-20	TCGA-A2-A25E-01A-11D-A167-09		TCGA-A2-A25E-01	TCGA-A2-A25E-01A-11D-A16A-05		6a6f4c33-d59e-462a-9fa7-aed32a35ff44	TCGA-A2-A25E-01	TCGA-A2-A25E-01A-11D-A167-09			TCGA-A2-A25E-01	TCGA-A2-A25E-01A-11D-A167-09		7265c93b-7138-4bc8-bc9c-22ce1abf0ef2		TCGA-A2-A25E-01A-11D-A166-01	TCGA-A2-A25E-01		7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	TCGA-A2-A25E-01A-11D-A166-01	
TCGA-A2-A25F-01	Stage IIA	66	1	Stage IIA	113		Negative	FEMALE	Negative				Negative	M0	Negative	N0	113	0	Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25F-01	322	0	days	Kirc+	C4-BRCA/Basal	cluster 1	Low purity c2	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-A2-A25F	322	0	days	322	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A25F-F31197	TCGA-A2-A25F	TCGA-A2-A25F-01A		Negative					Positive	Lumpectomy		YES			-24319	86		0	322					NO				Scheduled Follow-up Submission	2012-4-23	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	390	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf	A25F	TUMOR FREE							YES	<10%		YES	Primary Tumor	01		7th	YES	YES	NO	A2	Breast	A	LIVING	2011	acd59617-770c-4653-891f-71ea87d67c41	c4d15095-d0bf-4fe0-a2b9-52e0119a7a26	acd59617-770c-4653-891f-71ea87d67c41	c4d15095-d0bf-4fe0-a2b9-52e0119a7a26	TCGA-A2-A25F-01A-21-A17I-20	TCGA-A2-A25F-01A-11D-A167-09		TCGA-A2-A25F-01	TCGA-A2-A25F-01A-11D-A16A-05		04f35825-e128-4a77-b58e-7b98019dad24	TCGA-A2-A25F-01	TCGA-A2-A25F-01A-11D-A167-09			TCGA-A2-A25F-01	TCGA-A2-A25F-01A-11D-A167-09		acd59617-770c-4653-891f-71ea87d67c41		TCGA-A2-A25F-01A-11D-A166-01	TCGA-A2-A25F-01		acd59617-770c-4653-891f-71ea87d67c41	TCGA-A2-A25F-01A-11D-A166-01	
TCGA-A2-A3KC-01																			LumA										0	TCGA-A2-A3KC-01	1102	0	days	Iq	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A2-A3KC	1102	0	days	1102	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3KC-F59210	TCGA-A2-A3KC	TCGA-A2-A3KC-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-20401	299		0	1102					NO		90-99%	1.9		2014-5-5	FEMALE					2+	20	1.8	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	780	NO	Equivocal	Negative	NO	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	2	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf	A3KC	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2011	7bbe4637-394e-42c0-af7d-6184c3f48916	add405f0-8223-4e7d-b1aa-7cdf9432a16f	7bbe4637-394e-42c0-af7d-6184c3f48916	add405f0-8223-4e7d-b1aa-7cdf9432a16f	TCGA-A2-A3KC-01A-21-A24A-20			TCGA-A2-A3KC-01	TCGA-A2-A3KC-01A-11D-A212-05		aa78b6ce-fccf-478e-b4b0-9cebaeeb99fb	TCGA-A2-A3KC-01	TCGA-A2-A3KC-01A-11D-A20S-09			TCGA-A2-A3KC-01			7bbe4637-394e-42c0-af7d-6184c3f48916		TCGA-A2-A3KC-01A-11D-A20R-01	TCGA-A2-A3KC-01		7bbe4637-394e-42c0-af7d-6184c3f48916	TCGA-A2-A3KC-01A-11D-A20R-01	
TCGA-A2-A3KD-01																			LumA										0	TCGA-A2-A3KD-01	1206	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A2-A3KD	1206	0	days	1206	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3KD-F37343	TCGA-A2-A3KD	TCGA-A2-A3KD-01A	Close	Positive	3 Point Scale		3 Point Scale	Mastectomy NOS	Positive	Lumpectomy		YES			-17372	700		0	1206					NO		90-99%			2012-12-3	FEMALE					1+			1.2		Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	770	NO	Negative	Negative	NO	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1	1	true	No	M0	N1mi	T3	Stage IIIA	TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf	A3KD	TUMOR FREE				Strong	Strong	YES	YES	70-79%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2010	8a224dc6-632b-418b-bd5e-bcefc8ad049e	b9d3e65d-b417-4611-b340-e9d8365e9fd9	8a224dc6-632b-418b-bd5e-bcefc8ad049e	b9d3e65d-b417-4611-b340-e9d8365e9fd9	TCGA-A2-A3KD-01A-21-A24A-20			TCGA-A2-A3KD-01	TCGA-A2-A3KD-01A-12D-A212-05		981593f7-f9eb-44af-a697-624af03e6bbf	TCGA-A2-A3KD-01	TCGA-A2-A3KD-01A-12D-A20S-09			TCGA-A2-A3KD-01			8a224dc6-632b-418b-bd5e-bcefc8ad049e		TCGA-A2-A3KD-01A-12D-A20R-01	TCGA-A2-A3KD-01		8a224dc6-632b-418b-bd5e-bcefc8ad049e	TCGA-A2-A3KD-01A-12D-A20R-01	
TCGA-A2-A3XS-01																													1	TCGA-A2-A3XS-01	1032	1	days							miRNA cluster 4			TCGA-A2-A3XS	682	1	days	1032	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3XS-F34446	TCGA-A2-A3XS	TCGA-A2-A3XS-01A	Negative	Negative				Mastectomy NOS	Negative	Lumpectomy		YES			-23000	3355	1032	0				682		YES				Additional New Tumor Event	2012-8-15	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO		Negative		19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis			YES	9	0	true	No	M0	N2a	T1	Stage IIIA	TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf	A3XS	WITH TUMOR							YES			NO	Primary Tumor	01		6th	YES	NO	YES	A2	Breast	A	DECEASED	2003	799df122-75f1-46bf-8b5e-ca557cd38d53	b53f403a-449d-4a77-891e-562a0ce6ff75	799df122-75f1-46bf-8b5e-ca557cd38d53	b53f403a-449d-4a77-891e-562a0ce6ff75				TCGA-A2-A3XS-01	TCGA-A2-A3XS-01A-11D-A230-05			TCGA-A2-A3XS-01	TCGA-A2-A3XS-01A-11D-A22X-09			TCGA-A2-A3XS-01			799df122-75f1-46bf-8b5e-ca557cd38d53		TCGA-A2-A3XS-01A-11D-A22W-01	TCGA-A2-A3XS-01		799df122-75f1-46bf-8b5e-ca557cd38d53	TCGA-A2-A3XS-01A-11D-A22W-01	
TCGA-A2-A3XT-01																													0	TCGA-A2-A3XT-01	2770	0	days					BRCA basal-like c6		miRNA cluster 4			TCGA-A2-A3XT	2770	0	days	2770	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left	Other (specify)	F plus axillary lymph node dissection	TCGA-A2-A3XT-F55841	TCGA-A2-A3XT	TCGA-A2-A3XT-01A		Negative					Negative	Modified Radical Mastectomy		NO			-16649	2164		0	2770										2014-1-16	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	340	NO	Negative	Negative	NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf	A3XT	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	A2	Breast	A	LIVING	2006	e0a10445-6266-4f41-a747-fb19d7182652	bbbed4e0-9f0b-4312-999a-dcd592b8e383	e0a10445-6266-4f41-a747-fb19d7182652	bbbed4e0-9f0b-4312-999a-dcd592b8e383	TCGA-A2-A3XT-01A-21-A24A-20			TCGA-A2-A3XT-01	TCGA-A2-A3XT-01A-11D-A230-05		904a9035-e5e9-4a07-99dd-3a74f66c9145	TCGA-A2-A3XT-01	TCGA-A2-A3XT-01A-11D-A22X-09			TCGA-A2-A3XT-01			e0a10445-6266-4f41-a747-fb19d7182652		TCGA-A2-A3XT-01A-11D-A22W-01	TCGA-A2-A3XT-01		e0a10445-6266-4f41-a747-fb19d7182652	TCGA-A2-A3XT-01A-11D-A22W-01	
TCGA-A2-A3XU-01																													1	TCGA-A2-A3XU-01	912	1	days					BRCA basal-like c6		miRNA cluster 4			TCGA-A2-A3XU	596	1	days	912	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			35	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3XU-F34704	TCGA-A2-A3XU	TCGA-A2-A3XU-01A		Negative					Negative	Lumpectomy		NO			-13046	2089	912	0				596					1.5		2012-8-30	FEMALE						60	1.66	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	350	NO		Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Positive								Other, specify	Locoregional Recurrence	Breast	NO	YES	3	0	true	No	M0	N1mi	T2	Stage IIB	TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf	A3XU	WITH TUMOR						YES	YES			YES	Primary Tumor	01		6th		NO	YES	A2	Breast	A	DECEASED	2006	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	TCGA-A2-A3XU-01A-21-A24A-20			TCGA-A2-A3XU-01	TCGA-A2-A3XU-01A-12D-A230-05		2233e116-6f58-4bf5-bcb7-528fc4ff8d30	TCGA-A2-A3XU-01	TCGA-A2-A3XU-01A-12D-A22X-09			TCGA-A2-A3XU-01			2ec1df5c-7272-44f4-922c-cdd6ba37f6b6		TCGA-A2-A3XU-01A-12D-A22W-01	TCGA-A2-A3XU-01		2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	TCGA-A2-A3XU-01A-12D-A22W-01	
TCGA-A2-A3XV-01																													0	TCGA-A2-A3XV-01	996	0	days					BRCA basal-like c6					TCGA-A2-A3XV	996	0	days	996	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right	Sentinel node biopsy alone		TCGA-A2-A3XV-F59117	TCGA-A2-A3XV	TCGA-A2-A3XV-01A		Positive	3 Point Scale				Negative	Lumpectomy		YES			-16971	344		0	996							<10%	1.7		2014-5-1	FEMALE					2+	60	4.5	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	360	NO	Equivocal	Positive	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A2-A3XV.405B9D03-6200-4DFA-A7D1-C622D3A48AEA.pdf	A3XV	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2011	fc2aa9aa-3df5-4723-9892-95edcc92bb6f	5018e45a-c0ab-462d-8c8b-9fe67b472002	fc2aa9aa-3df5-4723-9892-95edcc92bb6f	5018e45a-c0ab-462d-8c8b-9fe67b472002	TCGA-A2-A3XV-01A-41-A24A-20			TCGA-A2-A3XV-01	TCGA-A2-A3XV-01A-21D-A23D-05		bcfc3c93-8457-45c3-bace-45fb134af40e	TCGA-A2-A3XV-01	TCGA-A2-A3XV-01A-21D-A23C-09			TCGA-A2-A3XV-01			fc2aa9aa-3df5-4723-9892-95edcc92bb6f		TCGA-A2-A3XV-01A-21D-A238-01	TCGA-A2-A3XV-01		fc2aa9aa-3df5-4723-9892-95edcc92bb6f	TCGA-A2-A3XV-01A-21D-A238-01	
TCGA-A2-A3XW-01																													0	TCGA-A2-A3XW-01	1712	0	days					BRCA nonbasal-like c8					TCGA-A2-A3XW	1712	0	days	1712	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A2-A3XW-F55843	TCGA-A2-A3XW			Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-15670			0	1712					NO		90-99%			2014-1-16	FEMALE			<10%					1.31		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy			Negative	Negative	NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3	0		No	M0	N1a	T2	Stage IIB		A3XW	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A2	Breast		LIVING	2009	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	ec923957-81ba-44b9-8e2c-15305f8829a5	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	ec923957-81ba-44b9-8e2c-15305f8829a5	TCGA-A2-A3XW-01A-21-A24A-20			TCGA-A2-A3XW-01	TCGA-A2-A3XW-01A-11D-A23D-05		d9ca1e39-2191-444f-b17f-f5f57f73aa0c	TCGA-A2-A3XW-01	TCGA-A2-A3XW-01A-11D-A23C-09			TCGA-A2-A3XW-01			f6cbfa5a-7d10-4efb-ae74-195e1a1e9774		TCGA-A2-A3XW-01A-11D-A238-01	TCGA-A2-A3XW-01		f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	TCGA-A2-A3XW-01A-11D-A238-01	
TCGA-A2-A3XX-01																													1	TCGA-A2-A3XX-01	1439	1	days					KIRC-like c1					TCGA-A2-A3XX	1439	0	days	1439	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A3XX-F43310	TCGA-A2-A3XX	TCGA-A2-A3XX-01A		Negative					Negative	Simple Mastectomy		YES			-17981	1143	1439	0	1168					NO					2013-5-16	FEMALE					1+			1.25		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	780	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf	A3XX	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	A2	Breast	A	DECEASED	2009	043d5dcd-1524-402b-939c-984a1dc916a0	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	043d5dcd-1524-402b-939c-984a1dc916a0	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	TCGA-A2-A3XX-01A-41-A24A-20			TCGA-A2-A3XX-01	TCGA-A2-A3XX-01A-21D-A23D-05		c4757b28-bb38-49bb-bb06-70fa40ad8298	TCGA-A2-A3XX-01	TCGA-A2-A3XX-01A-21D-A23C-09			TCGA-A2-A3XX-01			043d5dcd-1524-402b-939c-984a1dc916a0		TCGA-A2-A3XX-01A-21D-A238-01	TCGA-A2-A3XX-01		043d5dcd-1524-402b-939c-984a1dc916a0	TCGA-A2-A3XX-01A-21D-A238-01	
TCGA-A2-A3XY-01																													1	TCGA-A2-A3XY-01	1093	1	days										TCGA-A2-A3XY	1072	1	days	1093	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A3XY-F55836	TCGA-A2-A3XY	TCGA-A2-A3XY-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18059	703	1093	0	786			1072		NO					2014-1-16	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	950	NO	Negative	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Brain	Distant Metastasis		NO	YES	3		true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf	A3XY	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	DECEASED	2010	42c88ed3-de96-487d-8b03-e1d4269d0505	43446fc2-82dd-4759-af34-b0db537143f2	42c88ed3-de96-487d-8b03-e1d4269d0505	43446fc2-82dd-4759-af34-b0db537143f2				TCGA-A2-A3XY-01	TCGA-A2-A3XY-01A-11D-A23D-05			TCGA-A2-A3XY-01	TCGA-A2-A3XY-01A-11D-A23C-09			TCGA-A2-A3XY-01			42c88ed3-de96-487d-8b03-e1d4269d0505		TCGA-A2-A3XY-01A-11D-A238-01	TCGA-A2-A3XY-01		42c88ed3-de96-487d-8b03-e1d4269d0505	TCGA-A2-A3XY-01A-11D-A238-01	
TCGA-A2-A3XZ-01																													0	TCGA-A2-A3XZ-01	1532	0	days					BRCA basal-like c6					TCGA-A2-A3XZ	1532	0	days	1532	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A3XZ-F58924	TCGA-A2-A3XZ	TCGA-A2-A3XZ-01A		Negative					Negative	Simple Mastectomy		YES			-16978	909		0	1532										2014-4-28	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1100	NO	Positive		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	true	No	M0	N0	T1c	Stage I	TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf	A3XZ	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	A2	Breast	A	LIVING	2009	176b2422-3599-41c5-be62-ae6e28d60b90	7a55f6a3-a438-418f-a5a8-dcea12c977d9	176b2422-3599-41c5-be62-ae6e28d60b90	7a55f6a3-a438-418f-a5a8-dcea12c977d9	TCGA-A2-A3XZ-01A-51-A24A-20			TCGA-A2-A3XZ-01	TCGA-A2-A3XZ-01A-42D-A23D-05		78747541-53ed-4037-af62-694fc6f00433	TCGA-A2-A3XZ-01	TCGA-A2-A3XZ-01A-42D-A23C-09			TCGA-A2-A3XZ-01			176b2422-3599-41c5-be62-ae6e28d60b90		TCGA-A2-A3XZ-01A-42D-A238-01	TCGA-A2-A3XZ-01		176b2422-3599-41c5-be62-ae6e28d60b90	TCGA-A2-A3XZ-01A-42D-A238-01	
TCGA-A2-A3Y0-01																													0	TCGA-A2-A3Y0-01	1546	0	days										TCGA-A2-A3Y0	1546	0	days	1546	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A3Y0-F59118	TCGA-A2-A3Y0	TCGA-A2-A3Y0-01A		Positive	3 Point Scale				Negative	Modified Radical Mastectomy		NO			-21024	845		0	1546							90-99%			2014-5-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	850	NO	Negative		NO	39	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf	A3Y0	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		NO	YES	A2	Breast	A	LIVING	2010	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	7eda3bc1-76cc-4eff-ad0a-7f855ec2d7f3	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	7eda3bc1-76cc-4eff-ad0a-7f855ec2d7f3				TCGA-A2-A3Y0-01	TCGA-A2-A3Y0-01A-11D-A23D-05			TCGA-A2-A3Y0-01	TCGA-A2-A3Y0-01A-11D-A23C-09			TCGA-A2-A3Y0-01			9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5		TCGA-A2-A3Y0-01A-11D-A238-01	TCGA-A2-A3Y0-01		9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	TCGA-A2-A3Y0-01A-11D-A238-01	
TCGA-A2-A4RW-01																													0	TCGA-A2-A4RW-01	222	0	days										TCGA-A2-A4RW	222	0	days	222	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A4RW-F59123	TCGA-A2-A4RW	TCGA-A2-A4RW-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-18060	567		0	222							80-89%			2014-5-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	1550	NO	Negative		YES	27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	27	0	true	No	M0	N3a	T2	Stage IIIC	TCGA-A2-A4RW.C1D4D6BB-AF86-4208-A729-C61365941217.pdf	A4RW	TUMOR FREE							YES	90-99%			Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2011	f8bfd67a-1d78-44b0-9715-712dee01b008	82aeac9e-e169-41dc-8580-4165d4ea0ac9	f8bfd67a-1d78-44b0-9715-712dee01b008	82aeac9e-e169-41dc-8580-4165d4ea0ac9				TCGA-A2-A4RW-01	TCGA-A2-A4RW-01A-21D-A268-05		cee2c148-efa3-45e2-8b28-f65e56a5d2b9	TCGA-A2-A4RW-01	TCGA-A2-A4RW-01A-21D-A25Q-09			TCGA-A2-A4RW-01			f8bfd67a-1d78-44b0-9715-712dee01b008		TCGA-A2-A4RW-01A-21D-A25N-01	TCGA-A2-A4RW-01		f8bfd67a-1d78-44b0-9715-712dee01b008	TCGA-A2-A4RW-01A-21D-A25N-01	
TCGA-A2-A4RX-01																													0	TCGA-A2-A4RX-01	742	0	days										TCGA-A2-A4RX	742	0	days	742	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A4RX-F58491	TCGA-A2-A4RX	TCGA-A2-A4RX-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-24779	210		0	742							<10%			2014-4-11	FEMALE					1+					Metaplastic Carcinoma		No		C50.9	8575/3	C50.9	1+	YES		Core needle biopsy	920	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A2-A4RX.CA88491F-5572-4B0D-8E3D-D536E3CE5069.pdf	A4RX	TUMOR FREE							YES	<10%			Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012	cbef9672-38ba-4873-b232-9a656b7428ce	73cfbf43-5452-47f9-9a59-6b985e15d66c	cbef9672-38ba-4873-b232-9a656b7428ce	73cfbf43-5452-47f9-9a59-6b985e15d66c				TCGA-A2-A4RX-01	TCGA-A2-A4RX-01A-11D-A268-05		d980ca91-4ae1-4fc2-a4d1-052051aa7d41	TCGA-A2-A4RX-01	TCGA-A2-A4RX-01A-11D-A25Q-09			TCGA-A2-A4RX-01			cbef9672-38ba-4873-b232-9a656b7428ce		TCGA-A2-A4RX-01A-11D-A25N-01	TCGA-A2-A4RX-01		cbef9672-38ba-4873-b232-9a656b7428ce	TCGA-A2-A4RX-01A-11D-A25N-01	
TCGA-A2-A4RY-01																													0	TCGA-A2-A4RY-01	648	0	days										TCGA-A2-A4RY	648	0	days	648	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right	Axillary lymph node dissection alone		TCGA-A2-A4RY-F59208	TCGA-A2-A4RY	TCGA-A2-A4RY-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-17157	149		0	648							90-99%			2014-5-5	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	1180	NO	Negative		NO	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	18	0	true	No	M0	N3a	T3	Stage IIIC	TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf	A4RY	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012	51d9b960-276a-4c7b-b135-f2f8c05f3bd6	fa655127-d3c8-4a16-a5cb-b1b4853a6adb	51d9b960-276a-4c7b-b135-f2f8c05f3bd6	fa655127-d3c8-4a16-a5cb-b1b4853a6adb				TCGA-A2-A4RY-01	TCGA-A2-A4RY-01A-31D-A268-05		e40037c5-5570-43d6-ad24-cd4ceea41828	TCGA-A2-A4RY-01	TCGA-A2-A4RY-01A-31D-A25Q-09			TCGA-A2-A4RY-01			51d9b960-276a-4c7b-b135-f2f8c05f3bd6		TCGA-A2-A4RY-01A-31D-A25N-01	TCGA-A2-A4RY-01		51d9b960-276a-4c7b-b135-f2f8c05f3bd6	TCGA-A2-A4RY-01A-31D-A25N-01	
TCGA-A2-A4S0-01																													0	TCGA-A2-A4S0-01	706	0	days										TCGA-A2-A4S0	706	0	days	706	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A4S0-F59120	TCGA-A2-A4S0	TCGA-A2-A4S0-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-28416	159		0	706							90-99%			2014-5-1	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Core needle biopsy	960	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf	A4S0	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012	81e350d9-7e2f-4650-9871-54ed2d5a5ab3	e3fdbf1e-1a63-4a7d-9f84-e36e40ffd4f3	81e350d9-7e2f-4650-9871-54ed2d5a5ab3	e3fdbf1e-1a63-4a7d-9f84-e36e40ffd4f3				TCGA-A2-A4S0-01	TCGA-A2-A4S0-01A-21D-A268-05		b37a030f-c2f7-4690-8503-78a2af066cdf	TCGA-A2-A4S0-01	TCGA-A2-A4S0-01A-21D-A25Q-09			TCGA-A2-A4S0-01			81e350d9-7e2f-4650-9871-54ed2d5a5ab3		TCGA-A2-A4S0-01A-21D-A25N-01	TCGA-A2-A4S0-01		81e350d9-7e2f-4650-9871-54ed2d5a5ab3	TCGA-A2-A4S0-01A-21D-A25N-01	
TCGA-A2-A4S1-01																													0	TCGA-A2-A4S1-01	820	0	days										TCGA-A2-A4S1	820	0	days	820	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A2-A4S1-F58925	TCGA-A2-A4S1	TCGA-A2-A4S1-01A		Positive	3 Point Scale				Negative	Lumpectomy		YES			-24353	282		0	820							<10%			2014-4-28	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9	1+	YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf	A4S1	TUMOR FREE						NO	YES			YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012	3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	fbe3afb5-4dcf-488b-b118-6c8adae6e740	3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	fbe3afb5-4dcf-488b-b118-6c8adae6e740				TCGA-A2-A4S1-01	TCGA-A2-A4S1-01A-21D-A268-05		ae7e510a-5cda-4520-b879-ec7685609a2e	TCGA-A2-A4S1-01	TCGA-A2-A4S1-01A-21D-A25Q-09			TCGA-A2-A4S1-01			3d9d61f1-ad25-45a5-b0be-8698dc4b8c68		TCGA-A2-A4S1-01A-21D-A25N-01	TCGA-A2-A4S1-01		3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	TCGA-A2-A4S1-01A-21D-A25N-01	
TCGA-A2-A4S2-01																													0	TCGA-A2-A4S2-01	643	0	days										TCGA-A2-A4S2	643	0	days	643	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right	Axillary lymph node dissection alone		TCGA-A2-A4S2-F59085	TCGA-A2-A4S2	TCGA-A2-A4S2-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-22936	112		0	643							90-99%			2014-4-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.9	2+	YES		Core needle biopsy	1390	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5	0	true	No	M0	N2	T3	Stage IIIA	TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf	A4S2	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012	2c6af71f-b876-4475-a94a-61e99075123f	8c74f209-9286-4af4-8c65-61801d2aa47e	2c6af71f-b876-4475-a94a-61e99075123f	8c74f209-9286-4af4-8c65-61801d2aa47e				TCGA-A2-A4S2-01	TCGA-A2-A4S2-01A-12D-A268-05		e2a6282d-a3b4-42be-b034-d1203d078044	TCGA-A2-A4S2-01	TCGA-A2-A4S2-01A-12D-A25Q-09			TCGA-A2-A4S2-01			2c6af71f-b876-4475-a94a-61e99075123f		TCGA-A2-A4S2-01A-12D-A25N-01	TCGA-A2-A4S2-01		2c6af71f-b876-4475-a94a-61e99075123f	TCGA-A2-A4S2-01A-12D-A25N-01	
TCGA-A2-A4S3-01																													0	TCGA-A2-A4S3-01	666	0	days										TCGA-A2-A4S3	666	0	days	666	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-A2-A4S3-F59128	TCGA-A2-A4S3	TCGA-A2-A4S3-01A		Positive					Positive	Modified Radical Mastectomy		NO			-21762	147		0	666							90-99%			2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1500	NO	Negative		NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2	0	true	No	M0	N1a	T2	Stage IIB	TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf	A4S3	TUMOR FREE							YES	90-99%			Primary Tumor	01		7th		YES	NO	A2	Breast	A	LIVING	2012	a26b4751-91a2-420c-9ff3-7df7361939fd	c3744133-3c3e-4f65-b3cc-3ddadc486384	a26b4751-91a2-420c-9ff3-7df7361939fd	c3744133-3c3e-4f65-b3cc-3ddadc486384				TCGA-A2-A4S3-01	TCGA-A2-A4S3-01A-21D-A268-05		18c0493c-af12-4d29-9e41-e4debdf3e0b1	TCGA-A2-A4S3-01	TCGA-A2-A4S3-01A-21D-A25Q-09			TCGA-A2-A4S3-01			a26b4751-91a2-420c-9ff3-7df7361939fd		TCGA-A2-A4S3-01A-21D-A25N-01	TCGA-A2-A4S3-01		a26b4751-91a2-420c-9ff3-7df7361939fd	TCGA-A2-A4S3-01A-21D-A25N-01	
TCGA-A7-A0CD-01	Stage IA	66	3	Stage I	372		Positive	FEMALE	Negative	4	3	3	Negative	M0	Negative	N0	372	0	LumA	Luminal A	Positive	LumA	-10	-3	followup	T1	T1	LIVING	0	TCGA-A7-A0CD-01	1165	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A7-A0CD	1165	0	days	1165	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left	Sentinel node biopsy alone		TCGA-A7-A0CD-F39827	TCGA-A7-A0CD	TCGA-A7-A0CD-01A		Positive					Positive	Lumpectomy		NO			-24242	157		0	1165							90-99%	4.0		2013-2-4	FEMALE				PathVysion HER-2 D Probe Kit	2+	279	4.6	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Equivocal	Negative	NO	2	Negative	Indeterminate (neither Pre or Postmenopausal)																				3	2								NO	0		false	Yes	M0	N0	T1	Stage I	TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C.pdf	A0CD	TUMOR FREE						YES		70-79%		YES	Primary Tumor	01		6th	YES	YES	NO	A7	Breast	A	LIVING	2009	1edf44b5-61ba-47cd-81ed-b586ae81cb32	a82e297d-8342-44f1-b7e8-e42872c834fa	1edf44b5-61ba-47cd-81ed-b586ae81cb32	a82e297d-8342-44f1-b7e8-e42872c834fa	TCGA-A7-A0CD-01A-21-A13A-20	TCGA-A7-A0CD-01A-11W-A019-09		TCGA-A7-A0CD-01			0466e496-e1c2-4cd0-ab1d-34babdbfc80f	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01A-11W-A019-09	TCGA-A7-A0CD-01A-11D-A00Y-05	TCGA-A7-A0CD-01		TCGA-A7-A0CD-01A-11W-A019-09	TCGA-A7-A0CD-01	1edf44b5-61ba-47cd-81ed-b586ae81cb32	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01A-11D-A011-01		TCGA-A7-A0CD-01A-11R-A00Z-07	1edf44b5-61ba-47cd-81ed-b586ae81cb32	TCGA-A7-A0CD-01A-11D-A011-01	TCGA-A7-A0CD-01
TCGA-A7-A0CE-01	Stage IIA	57	1	Stage IIA	309		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	309	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CE-01	1074	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A7-A0CE	1074	0	days	1074	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CE-F39153	TCGA-A7-A0CE	TCGA-A7-A0CE-01A		Negative					Negative	Lumpectomy		YES			-20863	129		0	1074							<10%	2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	330	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	5								NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf	A0CE	TUMOR FREE						YES		<10%		YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	f79ed0dc-7704-4967-b62c-0112de377fc3	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	f79ed0dc-7704-4967-b62c-0112de377fc3	TCGA-A7-A0CE-01A-21-A13A-20	TCGA-A7-A0CE-01A-11W-A019-09		TCGA-A7-A0CE-01			7a0dcaa3-a8ab-4437-b642-11872fbf6456	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01A-11W-A019-09	TCGA-A7-A0CE-01A-11D-A00Y-05	TCGA-A7-A0CE-01		TCGA-A7-A0CE-01A-11W-A019-09	TCGA-A7-A0CE-01	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01A-11D-A011-01		TCGA-A7-A0CE-01A-11R-A00Z-07	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA-A7-A0CE-01A-11D-A011-01	TCGA-A7-A0CE-01
TCGA-A7-A0CE-11		57			309			FEMALE									309	0							followup			LIVING	0	TCGA-A7-A0CE-11	1074	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-A7-A0CE	1074	0	days	1074	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CE-F39153	TCGA-A7-A0CE	TCGA-A7-A0CE-11A		Negative					Negative	Lumpectomy		YES			-20863	129		0	1074							<10%	2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA		A0CE	TUMOR FREE						YES		<10%		YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009	2d5351f1-e9d7-44a3-ae43-f595a0151516		2d5351f1-e9d7-44a3-ae43-f595a0151516						TCGA-A7-A0CE-11A-21D-A10Q-05									TCGA-A7-A0CE-11	2d5351f1-e9d7-44a3-ae43-f595a0151516	TCGA-A7-A0CE-11			TCGA-A7-A0CE-11A-21R-A089-07	2d5351f1-e9d7-44a3-ae43-f595a0151516		
TCGA-A7-A0CG-01	Stage IIA	78	2	Stage IIA	230		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	230	0	LumA	Luminal A	Negative	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CG-01	1043	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 4	TCGA-A7-A0CG	1043	0	days	1043	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CG-F39202	TCGA-A7-A0CG	TCGA-A7-A0CG-01A		Positive					Negative	Lumpectomy		YES			-28596	93		0	1043							90-99%			2013-1-15	FEMALE					1+					Mixed Histology (please specify)	Mixed infiltrating lobular and grade 1 ductal carcinoma	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	5	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	7								NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CG.2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE.pdf	A0CG	TUMOR FREE						NO		<10%		YES	Primary Tumor	01			NO	YES	NO	A7	Breast	A	LIVING	2010	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	5c6ed3a7-7ba7-44e2-b33f-dc104789b0eb	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	5c6ed3a7-7ba7-44e2-b33f-dc104789b0eb	TCGA-A7-A0CG-01A-21-A13A-20	TCGA-A7-A0CG-01A-11W-A019-09		TCGA-A7-A0CG-01			0b26254d-1199-487f-8cc1-e99d2dc58737	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01A-11W-A019-09	TCGA-A7-A0CG-01A-11D-A00Y-05	TCGA-A7-A0CG-01		TCGA-A7-A0CG-01A-11W-A019-09	TCGA-A7-A0CG-01	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01A-11D-A011-01		TCGA-A7-A0CG-01A-12R-A056-07	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	TCGA-A7-A0CG-01A-11D-A011-01	TCGA-A7-A0CG-01
TCGA-A7-A0CH-01	Stage IIA	79	2	Stage IIA	232			FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	232	0	LumA	Luminal A		LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CH-01	1079	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A7-A0CH	1079	0	days	1079	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-A7-A0CH-F39148	TCGA-A7-A0CH	TCGA-A7-A0CH-01A								Simple Mastectomy		YES			-29104	121		0	1079										2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0.pdf	A0CH	TUMOR FREE						YES				NO	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	0b225e38-d4c8-4cb5-a668-316894ab858f	05ee789e-dc0f-4f44-a238-84ec5a8207ab	0b225e38-d4c8-4cb5-a668-316894ab858f	05ee789e-dc0f-4f44-a238-84ec5a8207ab	TCGA-A7-A0CH-01A-11-A13A-20	TCGA-A7-A0CH-01A-21W-A019-09		TCGA-A7-A0CH-01			d44c8f0f-090f-417f-b80e-ff5da42138d0	TCGA-A7-A0CH-01	TCGA-A7-A0CH-01A-21W-A019-09	TCGA-A7-A0CH-01A-21D-A00Y-05	TCGA-A7-A0CH-01		TCGA-A7-A0CH-01A-21W-A019-09	TCGA-A7-A0CH-01	0b225e38-d4c8-4cb5-a668-316894ab858f	TCGA-A7-A0CH-01	TCGA-A7-A0CH-01A-21D-A011-01		TCGA-A7-A0CH-01A-21R-A00Z-07	0b225e38-d4c8-4cb5-a668-316894ab858f	TCGA-A7-A0CH-01A-21D-A011-01	TCGA-A7-A0CH-01
TCGA-A7-A0CH-11		79			232			FEMALE									232	0							followup			LIVING	0	TCGA-A7-A0CH-11	1079	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0CH	1079	0	days	1079	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-A7-A0CH-F39148	TCGA-A7-A0CH	TCGA-A7-A0CH-11A								Simple Mastectomy		YES			-29104	121		0	1079										2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	390	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA		A0CH	TUMOR FREE						YES				NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009	a4b19504-8f04-48db-b88b-d76b8b3c3881		a4b19504-8f04-48db-b88b-d76b8b3c3881						TCGA-A7-A0CH-11A-32D-A10Q-05										a4b19504-8f04-48db-b88b-d76b8b3c3881				TCGA-A7-A0CH-11A-32R-A089-07	a4b19504-8f04-48db-b88b-d76b8b3c3881		
TCGA-A7-A0CJ-01	Stage IIA	57	1	Stage IIA	409		Positive	FEMALE	Negative	4	3	4	Negative	M0	Negative	N0	409	0	LumB	Luminal B	Positive	LumA/B	-6	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CJ-01	931	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-A7-A0CJ	931	0	days	931	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0CJ-F39740	TCGA-A7-A0CJ	TCGA-A7-A0CJ-01A		Positive				Other	Positive	Lumpectomy	Re-excision of the inferior margin	YES			-21014	36		0	931							90-99%			2013-1-31	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative		NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2								NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0CJ.019F390D-7479-4CDC-8C82-45A27910E782.pdf	A0CJ	TUMOR FREE						YES		70-79%		YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2010	62de6863-5d60-473c-8e13-e300b0640ed7	363b439f-0335-48f6-838b-e603c24ff1e3	62de6863-5d60-473c-8e13-e300b0640ed7	363b439f-0335-48f6-838b-e603c24ff1e3	TCGA-A7-A0CJ-01A-11-A13A-20	TCGA-A7-A0CJ-01A-21W-A019-09		TCGA-A7-A0CJ-01			d9f09beb-2d34-4507-a3bf-039786bba9a9	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01A-21W-A019-09	TCGA-A7-A0CJ-01A-21D-A00Y-05	TCGA-A7-A0CJ-01		TCGA-A7-A0CJ-01A-21W-A019-09	TCGA-A7-A0CJ-01	62de6863-5d60-473c-8e13-e300b0640ed7	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01A-21D-A011-01		TCGA-A7-A0CJ-01A-21R-A00Z-07	62de6863-5d60-473c-8e13-e300b0640ed7	TCGA-A7-A0CJ-01A-21D-A011-01	TCGA-A7-A0CJ-01
TCGA-A7-A0D9-01	Stage IIA	37	4	Stage IIA	272		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	272	0	LumA	Luminal A	Negative	ReacII	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0D9-01	1139	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-A7-A0D9	1139	0	days	1139	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-A7-A0D9-F39771	TCGA-A7-A0D9	TCGA-A7-A0D9-01A		Positive					Negative	Simple Mastectomy		YES			-13836	173		0	1139							90-99%			2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1760	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	5								NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495.pdf	A0D9	TUMOR FREE						YES		<10%		NO	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	755912f4-6725-4b7b-84b1-518c7529a176	3338d4d6-755c-446a-ae7f-7da3bfaf68af	755912f4-6725-4b7b-84b1-518c7529a176	3338d4d6-755c-446a-ae7f-7da3bfaf68af	TCGA-A7-A0D9-01A-21-A13C-20	TCGA-A7-A0D9-01A-31W-A071-09		TCGA-A7-A0D9-01	TCGA-A7-A0D9-01A-31D-A10P-05		8cbc03f3-4f0a-4a76-99cd-3a8479558cb1	TCGA-A7-A0D9-01	TCGA-A7-A0D9-01A-31W-A071-09		TCGA-A7-A0D9-01		TCGA-A7-A0D9-01A-31W-A071-09	TCGA-A7-A0D9-01	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01	TCGA-A7-A0D9-01A-31D-A059-01		TCGA-A7-A0D9-01A-31R-A056-07	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01A-31D-A059-01	TCGA-A7-A0D9-01
TCGA-A7-A0D9-11		37			272			FEMALE									272	0	Normal						followup			LIVING	0	TCGA-A7-A0D9-11	1139	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0D9	1139	0	days	1139	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-A7-A0D9-F39771	TCGA-A7-A0D9	TCGA-A7-A0D9-11A		Positive					Negative	Simple Mastectomy		YES			-13836	173		0	1139							90-99%			2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1830	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA		A0D9	TUMOR FREE						YES		<10%		NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009	fc5bb351-c5f7-4d8c-850c-13e69e13e04d		fc5bb351-c5f7-4d8c-850c-13e69e13e04d						TCGA-A7-A0D9-11A-53D-A10Q-05										fc5bb351-c5f7-4d8c-850c-13e69e13e04d				TCGA-A7-A0D9-11A-53R-A089-07	fc5bb351-c5f7-4d8c-850c-13e69e13e04d		
TCGA-A7-A0DA-01	Stage IIA	62	1	Stage IIA	373		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	373	0	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A0DA-01	1085	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 13	TCGA-A7-A0DA	1085	0	days	1085	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DA-F38487	TCGA-A7-A0DA	TCGA-A7-A0DA-01A		Negative					Negative	Lumpectomy					-22708	177		0	1085										2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	0		false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf	A0DA	TUMOR FREE						YES				YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	9d04c180-7c23-490e-92cf-c018629b8b7f	91c8c373-e923-4e7f-b8b3-2417e92760c7	9d04c180-7c23-490e-92cf-c018629b8b7f	91c8c373-e923-4e7f-b8b3-2417e92760c7	TCGA-A7-A0DA-01A-11-A13C-20	TCGA-A7-A0DA-01A-31D-A10Y-09		TCGA-A7-A0DA-01			190fcd17-0d7a-4d28-9958-492d56360678	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01A-31D-A112-05	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A10Y-09		9d04c180-7c23-490e-92cf-c018629b8b7f		TCGA-A7-A0DA-01A-31D-A111-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31R-A115-07	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA-A7-A0DA-01A-31D-A111-01	TCGA-A7-A0DA-01
TCGA-A7-A0DB-01	Stage IIA	56	2	Stage IIA	266		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	266	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A7-A0DB-01	1007	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-A7-A0DB	1007	0	days	1007	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DB-F38479	TCGA-A7-A0DB	TCGA-A7-A0DB-01A		Positive					Positive	Simple Mastectomy		YES			-20570	167		0	1007				FPPP			90-99%			2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A0DB.511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3.pdf	A0DB	TUMOR FREE						YES		60-69%	TCGA	YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2009	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	8428a325-211e-4a7d-99df-ef5cf6e57c77	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	8428a325-211e-4a7d-99df-ef5cf6e57c77	TCGA-A7-A0DB-01A-21-A13C-20	TCGA-A7-A0DB-01A-11W-A019-09	b629190c-9d4b-4cb4-8b3d-c0137774cc72,5e9f382b-467c-450b-9921-828e39759a44	TCGA-A7-A0DB-01		b629190c-9d4b-4cb4-8b3d-c0137774cc72,5e9f382b-467c-450b-9921-828e39759a44	74072dd9-7503-4152-9734-65dcb4bca217	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11W-A019-09,TCGA-A7-A0DB-01A-11D-A272-09	TCGA-A7-A0DB-01A-11D-A00Y-05	TCGA-A7-A0DB-01		TCGA-A7-A0DB-01A-11W-A019-09	TCGA-A7-A0DB-01	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11D-A011-01		TCGA-A7-A0DB-01A-11R-A00Z-07	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	TCGA-A7-A0DB-01A-11D-A011-01	TCGA-A7-A0DB-01
TCGA-A7-A0DB-11		56			266			FEMALE									266	0	Normal						followup			LIVING	0	TCGA-A7-A0DB-11	1007	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-A7-A0DB	1007	0	days	1007	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DB-F38479	TCGA-A7-A0DB	TCGA-A7-A0DB-11A		Positive					Positive	Simple Mastectomy		YES			-20570	167		0	1007				FPPP			90-99%			2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA		A0DB	TUMOR FREE						YES		60-69%	TCGA	YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009	3f3bdfbb-3490-42e4-9511-9df4b8a126a3		3f3bdfbb-3490-42e4-9511-9df4b8a126a3						TCGA-A7-A0DB-11A-33D-A093-05										3f3bdfbb-3490-42e4-9511-9df4b8a126a3				TCGA-A7-A0DB-11A-33R-A089-07	3f3bdfbb-3490-42e4-9511-9df4b8a126a3		
TCGA-A7-A0DC-01	Stage IA	63		Stage I	386		Positive	FEMALE	Negative				Negative	M0	Negative	N0	386	0	LumA		Negative				followup	T1	T1	LIVING	0	TCGA-A7-A0DC-01	906	0	days					BRCA nonbasal-like c8					TCGA-A7-A0DC	906	0	days	906	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DC-F40607	TCGA-A7-A0DC	TCGA-A7-A0DC-01B		Positive					Negative	Simple Mastectomy		YES			-23294	818		0	906							90-99%			2013-2-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection		YES	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T1c	Stage IA	TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2.pdf	A0DC	TUMOR FREE						YES		<10%		YES	Primary Tumor	01			YES	YES	NO	A7	Breast	B	LIVING	2009	43bbd0f7-87d7-472f-ad3e-e016df3d5d89	5bfd4ac0-78fb-4ee5-ac75-7e20a268685c,e781547e-415c-4656-b656-c1df8cc22fc3	43bbd0f7-87d7-472f-ad3e-e016df3d5d89	5bfd4ac0-78fb-4ee5-ac75-7e20a268685c,e781547e-415c-4656-b656-c1df8cc22fc3	TCGA-A7-A0DC-01A-21-A13C-20		22fe5cac-0623-4d0a-a158-f15fb5477d8f,43bbd0f7-87d7-472f-ad3e-e016df3d5d89		TCGA-A7-A0DC-01B-04D-A22R-05	22fe5cac-0623-4d0a-a158-f15fb5477d8f,43bbd0f7-87d7-472f-ad3e-e016df3d5d89	31b94bd4-e63e-4e52-b366-3bafe08524e7		TCGA-A7-A0DC-01B-04D-A22N-09	TCGA-A7-A0DC-01A-11D-A00Y-05					43bbd0f7-87d7-472f-ad3e-e016df3d5d89		TCGA-A7-A0DC-01A-11D-A011-01		TCGA-A7-A0DC-01A-11R-A00Z-07	43bbd0f7-87d7-472f-ad3e-e016df3d5d89	TCGA-A7-A0DC-01A-11D-A011-01	
TCGA-A7-A0DC-11		63			386			FEMALE									386	0	Normal						followup			LIVING	0	TCGA-A7-A0DC-11	906	0	days										TCGA-A7-A0DC	906	0	days	906	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A0DC-F40607	TCGA-A7-A0DC	TCGA-A7-A0DC-11A		Positive					Negative	Simple Mastectomy		YES			-23294	238		0	906							90-99%			2013-2-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	470	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T1c	Stage IA		A0DC	TUMOR FREE						YES		<10%		YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2009	cb3f974e-6bce-4757-a350-aef8e7925086		cb3f974e-6bce-4757-a350-aef8e7925086						TCGA-A7-A0DC-11A-41D-A10Q-05										cb3f974e-6bce-4757-a350-aef8e7925086				TCGA-A7-A0DC-11A-41R-A089-07	cb3f974e-6bce-4757-a350-aef8e7925086		
TCGA-A7-A13D-01	Stage IIA	46	3	Stage IIA	267		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	267	0	Basal	Basal-like	Positive	ReacII	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A13D-01	965	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-A7-A13D	965	0	days	965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A13D-F39794	TCGA-A7-A13D	TCGA-A7-A13D-01A	Negative	Negative				Lumpectomy	Positive	Lumpectomy		NO			-17070	240		0	965				FPPP			<10%	1.8		2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	197	1.9	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Equivocal	Negative	NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	0		false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf	A13D	TUMOR FREE						YES		<10%	TCGA	YES	Primary Tumor	01			YES	YES	NO	A7	Breast	A	LIVING	2010	3af60b03-66c3-48a1-a42b-1e05fdb529c4	498cc80a-ec3c-4d05-839a-b3ea73ebc774	3af60b03-66c3-48a1-a42b-1e05fdb529c4	498cc80a-ec3c-4d05-839a-b3ea73ebc774	TCGA-A7-A13D-01A-21-A13E-20	TCGA-A7-A13D-01A-13D-A12Q-09	24664b94-f5b5-4a99-a09b-66e23edf5916,3a13becc-9a26-496c-b028-5a72315d2cfe	TCGA-A7-A13D-01	TCGA-A7-A13D-01A-13D-A12R-05	24664b94-f5b5-4a99-a09b-66e23edf5916,3a13becc-9a26-496c-b028-5a72315d2cfe	bf4b9dc3-df06-4735-b9b6-4cc8240c93b7	TCGA-A7-A13D-01	TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01A-13D-A272-09		TCGA-A7-A13D-01	TCGA-A7-A13D-01	TCGA-A7-A13D-01A-13D-A12Q-09		3af60b03-66c3-48a1-a42b-1e05fdb529c4		TCGA-A7-A13D-01A-13D-A12N-01	TCGA-A7-A13D-01	TCGA-A7-A13D-01A-13R-A12P-07	3af60b03-66c3-48a1-a42b-1e05fdb529c4	TCGA-A7-A13D-01A-13D-A12N-01	TCGA-A7-A13D-01
TCGA-A7-A13E-01	Stage IIB	62	1	No_Conversion	326		Positive	FEMALE	Negative				Negative	M0	Positive	N1	326	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	1	TCGA-A7-A13E-01	614	1	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5		TCGA-A7-A13E	556	1	days	614	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13E-F30405	TCGA-A7-A13E	TCGA-A7-A13E-01A		Positive					Negative	Lumpectomy		NO			-22690	220	614	0	326			556	FPPP			20-29%	3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	730	NO	Equivocal	Negative		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative			4	5				Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2		false	No	MX	N1	T2	Stage IIB	TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf	A13E	WITH TUMOR								<10%	TCGA	NO	Primary Tumor	01			YES	YES	NO	A7	Breast	A	DECEASED	2010	b7f491a9-eddf-43b1-9baf-862db2d50383	2518f7da-afba-4a61-9ff1-41bc919e10af	b7f491a9-eddf-43b1-9baf-862db2d50383	2518f7da-afba-4a61-9ff1-41bc919e10af	TCGA-A7-A13E-01A-21-A13E-20		d3c9cc63-ca20-47de-b635-f843c7d3a824,ca9882fa-7f02-4277-9786-b9394f451f7b	TCGA-A7-A13E-01	TCGA-A7-A13E-01A-11D-A12R-05	d3c9cc63-ca20-47de-b635-f843c7d3a824,ca9882fa-7f02-4277-9786-b9394f451f7b	724b7cef-9bb6-4c6b-8c78-b632f910fe85	TCGA-A7-A13E-01	TCGA-A7-A13E-01A-11D-A12Q-09,TCGA-A7-A13E-01A-11D-A272-09		TCGA-A7-A13E-01	TCGA-A7-A13E-01			b7f491a9-eddf-43b1-9baf-862db2d50383		TCGA-A7-A13E-01A-11D-A12N-01	TCGA-A7-A13E-01	TCGA-A7-A13E-01A-11R-A12P-07	b7f491a9-eddf-43b1-9baf-862db2d50383	TCGA-A7-A13E-01A-11D-A12N-01	TCGA-A7-A13E-01
TCGA-A7-A13E-11		62			326			FEMALE									326	0	Normal						followup			LIVING	1	TCGA-A7-A13E-11	614	1	days		C4-BRCA/Basal								TCGA-A7-A13E	556	1	days	614	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13E-F30405	TCGA-A7-A13E	TCGA-A7-A13E-11A		Positive					Negative	Lumpectomy		NO			-22690	220	614	0	326			556	FPPP			20-29%	3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Equivocal	Negative		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative								Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2		false	No	MX	N1	T2	Stage IIB		A13E	WITH TUMOR								<10%	TCGA	NO	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	DECEASED	2010	80efdbaa-067b-4018-89b2-b8869bfb9163		80efdbaa-067b-4018-89b2-b8869bfb9163						TCGA-A7-A13E-11A-61D-A12R-05		E408026E-6C07-4F2E-A609-29F21E997938					TCGA-A7-A13E-11			80efdbaa-067b-4018-89b2-b8869bfb9163			TCGA-A7-A13E-11	TCGA-A7-A13E-11A-61R-A12P-07	80efdbaa-067b-4018-89b2-b8869bfb9163		
TCGA-A7-A13F-01	Stage IIIA	44	3	No_Conversion	387		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	387	0	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-A7-A13F-01	765	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A7-A13F	765	0	days	765	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13F-F39779	TCGA-A7-A13F			Positive					Positive	Modified Radical Mastectomy		NO			-16363			0	765								2.8	Scheduled Follow-up Submission	2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	403	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	3			No	M0	N1a	T3	Stage IIIA		A13F	TUMOR FREE						YES				YES	Primary Tumor	01			YES	YES	NO	A7	Breast		LIVING	2010	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	b2b8924a-2ad1-4463-9b5d-c6c5609318ef	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	b2b8924a-2ad1-4463-9b5d-c6c5609318ef	TCGA-A7-A13F-01A-21-A13E-20	TCGA-A7-A13F-01A-11D-A12Q-09		TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11D-A12R-05		ad57bf3d-f283-4c26-95ad-86a116794296	TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11D-A12Q-09		TCGA-A7-A13F-01	TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11D-A12Q-09		fc4f35dd-9924-4e5d-ba71-0d7a79752b6a		TCGA-A7-A13F-01A-11D-A12N-01	TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11R-A12P-07	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	TCGA-A7-A13F-01A-11D-A12N-01	TCGA-A7-A13F-01
TCGA-A7-A13F-11		44			387			FEMALE									387	0	Normal						followup			LIVING	0	TCGA-A7-A13F-11	765	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-A7-A13F	765	0	days	765	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13F-F39779	TCGA-A7-A13F	TCGA-A7-A13F-11A		Positive					Positive	Modified Radical Mastectomy		NO			-16363	121		0	765								2.8	Scheduled Follow-up Submission	2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	403	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960	NO	Equivocal	Negative	NO	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3		false	No	M0	N1a	T3	Stage IIIA		A13F	TUMOR FREE						YES				YES	Solid Tissue Normal	11			YES	YES	NO	A7	Breast	A	LIVING	2010	82f3157c-09cc-40d7-872e-59f82f5f31f4		82f3157c-09cc-40d7-872e-59f82f5f31f4						TCGA-A7-A13F-11A-42D-A12R-05		2F10F1D9-54A0-42EB-B9B7-C9733D431824					TCGA-A7-A13F-11			82f3157c-09cc-40d7-872e-59f82f5f31f4			TCGA-A7-A13F-11	TCGA-A7-A13F-11A-42R-A12P-07	82f3157c-09cc-40d7-872e-59f82f5f31f4		
TCGA-A7-A13G-01	Stage IIA	79	2	Stage IIA	348		Positive	FEMALE	Negative				Negative	M0	Negative	N0	348	0	LumA		Positive				followup	T_Other	T2	LIVING	0	TCGA-A7-A13G-01	718	0	days	Iq		cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 3	mutation cluster 4	TCGA-A7-A13G	586	1	days	718	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			79	Left	Sentinel node biopsy alone		TCGA-A7-A13G-F35039	TCGA-A7-A13G	TCGA-A7-A13G-01B		Positive					Positive	Simple Mastectomy		NO			-28969	445		0	718		586	586		NO		90-99%		Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy		YES	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	3				Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0		false	Yes	MX	N0	T2	Stage IIA	TCGA-A7-A13G.50782829-35B6-4A61-A3CE-F105A31EDB42.pdf	A13G	TUMOR FREE						YES	YES	50-59%		NO	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	B	LIVING	2010	ac567288-88cc-4a65-937e-086655c038df	defdce72-fa52-4bbc-8f34-b3e9e1c3f12d,df947eb4-659d-46a6-95e1-fcc0d471a17c	ac567288-88cc-4a65-937e-086655c038df	defdce72-fa52-4bbc-8f34-b3e9e1c3f12d,df947eb4-659d-46a6-95e1-fcc0d471a17c		TCGA-A7-A13G-01A-11D-A13L-09	ac567288-88cc-4a65-937e-086655c038df,95817802-63d7-4dd4-902f-3c61332e017c	TCGA-A7-A13G-01	TCGA-A7-A13G-01B-04D-A22R-05,TCGA-A7-A13G-01A-11D-A13K-05	ac567288-88cc-4a65-937e-086655c038df,95817802-63d7-4dd4-902f-3c61332e017c		TCGA-A7-A13G-01	TCGA-A7-A13G-01A-11D-A13L-09			TCGA-A7-A13G-01	TCGA-A7-A13G-01A-11D-A13L-09		ac567288-88cc-4a65-937e-086655c038df		TCGA-A7-A13G-01A-11D-A13J-01	TCGA-A7-A13G-01		ac567288-88cc-4a65-937e-086655c038df	TCGA-A7-A13G-01A-11D-A13J-01	
TCGA-A7-A13G-11		79			348			FEMALE									348	0	LumA						followup			LIVING	0	TCGA-A7-A13G-11	718	0	days									mutation cluster 4	TCGA-A7-A13G	586	1	days	718	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			79	Left	Sentinel node biopsy alone		TCGA-A7-A13G-F35039	TCGA-A7-A13G	TCGA-A7-A13G-11A		Positive					Positive	Simple Mastectomy		NO			-28969	69		0	718		586	586		NO		90-99%		Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	880	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0		false	Yes	MX	N0	T2	Stage IIA		A13G	TUMOR FREE						YES	YES	50-59%		NO	Solid Tissue Normal	11		7th	YES	YES	NO	A7	Breast	A	LIVING	2010	76f30f56-7b80-4938-b514-1e1c2d24ff66		76f30f56-7b80-4938-b514-1e1c2d24ff66						TCGA-A7-A13G-11A-51D-A13T-05										76f30f56-7b80-4938-b514-1e1c2d24ff66					76f30f56-7b80-4938-b514-1e1c2d24ff66		
TCGA-A7-A13H-01																													0	TCGA-A7-A13H-01	899	0	days	Iq			BRCA non-CIMP c9			miRNA cluster 4			TCGA-A7-A13H	795	1	days	899	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			61	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A13H-F41651	TCGA-A7-A13H	TCGA-A7-A13H-01A		Positive					Positive	Simple Mastectomy		YES			-22643	62		0	899		840	795		NO		80-89%	2.7		2013-3-25	FEMALE				Pathvysion HER2 D Probe Kit	2+	371	3.2	2.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	New Primary Tumor	Skin lesion-Basal Cell Left Lower Lateral Back	YES	YES	2	2	false	No	MX	N1a	T2	Stage IIB	TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf	A13H	TUMOR FREE						NO	YES	30-39%		NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2010	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	812b77aa-63c6-47ef-9ad4-5938ae3661d4	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	812b77aa-63c6-47ef-9ad4-5938ae3661d4				TCGA-A7-A13H-01	TCGA-A7-A13H-01A-11D-A22B-05			TCGA-A7-A13H-01	TCGA-A7-A13H-01A-11D-A228-09			TCGA-A7-A13H-01			4f0fdfc6-6578-4d9a-92ae-6d82291a3785		TCGA-A7-A13H-01A-11D-A227-01	TCGA-A7-A13H-01		4f0fdfc6-6578-4d9a-92ae-6d82291a3785	TCGA-A7-A13H-01A-11D-A227-01	
TCGA-A7-A26E-01	Stage IIIA	71	2	Stage IIIA	421		Positive	FEMALE	Negative				Negative	M0	Positive	N1	421	0	LumA		Positive				followup	T_Other	T3	LIVING	0	TCGA-A7-A26E-01	954	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-A7-A26E	954	0	days	954	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26E-F39792	TCGA-A7-A26E	TCGA-A7-A26E-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-26274	372		0	954				FPPP	NO		90-99%		Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	230	NO	Negative		NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	0		false	Yes	MX	N1a	T3	Stage IIIA	TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf	A26E	TUMOR FREE						YES	YES	20-29%	TCGA	YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2010	6130b450-8b88-4a9a-b462-a34ec94183c9	2b8ab526-01bc-4c93-b019-273a04d94c8c,a1eac6e1-39d3-4e29-a381-1bd7848b7bc2,ba887b57-a7ae-4bb7-b7fb-8e37f5e0cc20	6130b450-8b88-4a9a-b462-a34ec94183c9	2b8ab526-01bc-4c93-b019-273a04d94c8c,a1eac6e1-39d3-4e29-a381-1bd7848b7bc2,ba887b57-a7ae-4bb7-b7fb-8e37f5e0cc20	TCGA-A7-A26E-01A-21-A17I-20	TCGA-A7-A26E-01A-11D-A167-09	f992d081-e919-4f45-9c43-70a3de5d51f9,44be9bd3-c7ab-4310-898d-c462a88926d2	TCGA-A7-A26E-01	TCGA-A7-A26E-01A-11D-A27B-05,TCGA-A7-A26E-01A-11D-A16A-05,TCGA-A7-A26E-01B-06D-A27B-05	f992d081-e919-4f45-9c43-70a3de5d51f9,44be9bd3-c7ab-4310-898d-c462a88926d2	1c700207-2bd3-421f-8c10-5365a680df72	TCGA-A7-A26E-01	TCGA-A7-A26E-01B-06D-A272-09,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01A-11D-A272-09			TCGA-A7-A26E-01	TCGA-A7-A26E-01A-11D-A167-09		6130b450-8b88-4a9a-b462-a34ec94183c9		TCGA-A7-A26E-01A-11D-A275-01	TCGA-A7-A26E-01		6130b450-8b88-4a9a-b462-a34ec94183c9	TCGA-A7-A26E-01A-11D-A275-01	
TCGA-A7-A26F-01	Stage IA	55	3	Stage I	257		Negative	FEMALE	Negative				Negative	M0	Negative	N0	257	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-A7-A26F-01	738	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-A7-A26F	738	0	days	738	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left	Sentinel node biopsy alone		TCGA-A7-A26F-F38499	TCGA-A7-A26F	TCGA-A7-A26F-01B	Negative	Negative					Negative	Lumpectomy		NO			-20210	389		0	738					NO			1.8	Scheduled Follow-up Submission	2012-12-14	FEMALE				PathVysion HER-2 D probe kit.	2+	330	1.9	1.1		Other, specify		No		C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy		YES	Equivocal	Negative	NO	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	0		false	Yes	M0	N0	T1	Stage IA	TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf	A26F	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	B	LIVING	2010	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2d32a4ba-d5da-4f17-915c-ac1c1bceac01,5676cfeb-171d-493a-bd7f-902315494da7	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2d32a4ba-d5da-4f17-915c-ac1c1bceac01,5676cfeb-171d-493a-bd7f-902315494da7	TCGA-A7-A26F-01A-11-A17I-20	TCGA-A7-A26F-01A-21D-A167-09	1b907925-b33c-4e4a-96e0-65f15b4712b9,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA-A7-A26F-01	TCGA-A7-A26F-01A-21D-A16A-05,TCGA-A7-A26F-01B-04D-A22R-05	1b907925-b33c-4e4a-96e0-65f15b4712b9,2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	6bda0261-6c33-4c86-8cf9-c9dce2bcadec	TCGA-A7-A26F-01	TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01B-04D-A22N-09			TCGA-A7-A26F-01	TCGA-A7-A26F-01A-21D-A167-09		2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b		TCGA-A7-A26F-01A-21D-A166-01	TCGA-A7-A26F-01		2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA-A7-A26F-01A-21D-A166-01	
TCGA-A7-A26G-01	Stage IIA	50	3	Stage IIA	209		Negative	FEMALE	Negative				Negative	M0	Negative	N0	209	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26G-01	722	0	days	COAD-READ	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A7-A26G	722	0	days	722	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26G-F39047	TCGA-A7-A26G	TCGA-A7-A26G-01A		Negative					Negative	Other		NO			-18362	161		0	722					NO				Scheduled Follow-up Submission	2013-1-9	FEMALE										Other, specify		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	410	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0		false	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf	A26G	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Total Mastectomy	7th	YES	YES	NO	A7	Breast	A	LIVING	2010	8cf1853a-55b2-4fb9-9a65-a46243304d54	766041d3-8592-405b-8fec-225c17bcfa96	8cf1853a-55b2-4fb9-9a65-a46243304d54	766041d3-8592-405b-8fec-225c17bcfa96	TCGA-A7-A26G-01A-11-A17I-20	TCGA-A7-A26G-01A-21D-A167-09		TCGA-A7-A26G-01	TCGA-A7-A26G-01A-21D-A16A-05		1c0d3d0a-579d-4cfc-bea5-cd7ecb74dd88	TCGA-A7-A26G-01	TCGA-A7-A26G-01A-21D-A167-09			TCGA-A7-A26G-01	TCGA-A7-A26G-01A-21D-A167-09		8cf1853a-55b2-4fb9-9a65-a46243304d54		TCGA-A7-A26G-01A-21D-A166-01	TCGA-A7-A26G-01		8cf1853a-55b2-4fb9-9a65-a46243304d54	TCGA-A7-A26G-01A-21D-A166-01	
TCGA-A7-A26H-01	Stage IIA	72	3	Stage IIA	64		Positive	FEMALE	Positive				Negative	M0	Positive	N1	64	0	LumA		Negative				enrollment	T1	T1	LIVING	0	TCGA-A7-A26H-01	724	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-A7-A26H	311	1	days	724	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		72	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26H-F39890	TCGA-A7-A26H	TCGA-A7-A26H-01A		Positive					Negative	Other		NO			-26423	79		0	724			311		NO		90-99%	2.2	Scheduled Follow-up Submission	2013-2-5	FEMALE				PathVysion Her-2 D	2+	20	5.8	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal	Positive	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive	10-19%											Negative			4					Liver	Distant Metastasis			YES	0	1	false	Yes	M0	N1a	T1	Stage IIA	TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf	A26H	WITH TUMOR						YES	YES			NO	Primary Tumor	01	Bilateral Mastectomy	7th	YES	YES	NO	A7	Breast	A	LIVING	2011	d1810175-47a5-4409-b1b8-f5ba78ed1c30	3b70861d-2c7b-4139-a282-6cfdd8aa4386	d1810175-47a5-4409-b1b8-f5ba78ed1c30	3b70861d-2c7b-4139-a282-6cfdd8aa4386	TCGA-A7-A26H-01A-21-A17I-20	TCGA-A7-A26H-01A-11D-A167-09		TCGA-A7-A26H-01	TCGA-A7-A26H-01A-11D-A16A-05		24bf1453-2154-4eb2-a417-274489d22753	TCGA-A7-A26H-01	TCGA-A7-A26H-01A-11D-A167-09			TCGA-A7-A26H-01	TCGA-A7-A26H-01A-11D-A167-09		d1810175-47a5-4409-b1b8-f5ba78ed1c30		TCGA-A7-A26H-01A-11D-A166-01	TCGA-A7-A26H-01		d1810175-47a5-4409-b1b8-f5ba78ed1c30	TCGA-A7-A26H-01A-11D-A166-01	
TCGA-A7-A26I-01	Stage IIA	65	1	Stage IIA	122		Negative	FEMALE	Negative				Negative	M0	Negative	N0	122	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26I-01	661	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4		mutation cluster 5	TCGA-A7-A26I	661	0	days	661	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left	Axillary lymph node dissection alone		TCGA-A7-A26I-F39791	TCGA-A7-A26I	TCGA-A7-A26I-01A	Negative	Negative				Other	Negative	Lumpectomy	Re-Excision of Superior Margin	NO			-23948	40		0	661					NO			2.0	Scheduled Follow-up Submission	2013-2-1	FEMALE				Path Vysion HER-2 D probe kit	2+	229	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	120	NO	Equivocal	Negative	NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	0		false	Yes	M0	N0	T2	Stage IIA	TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf	A26I	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011	5610fa97-eac4-4306-aead-983ee6570baf	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	5610fa97-eac4-4306-aead-983ee6570baf	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	TCGA-A7-A26I-01A-21-A17I-20	TCGA-A7-A26I-01A-11D-A167-09	e5949631-ebaf-4ec2-aac8-b0a6fd51d946,5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01	TCGA-A7-A26I-01A-11D-A16A-05	e5949631-ebaf-4ec2-aac8-b0a6fd51d946,5610fa97-eac4-4306-aead-983ee6570baf	c74b933c-9dd5-42a6-a906-4951a21e8bc2	TCGA-A7-A26I-01	TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09			TCGA-A7-A26I-01	TCGA-A7-A26I-01A-11D-A167-09		5610fa97-eac4-4306-aead-983ee6570baf		TCGA-A7-A26I-01A-11D-A166-01	TCGA-A7-A26I-01		5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-11D-A166-01	
TCGA-A7-A26J-01	Stage IIA	49	3	Stage IIA	67		Positive	FEMALE	Negative				Negative	M0	Negative	N0	67	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26J-01	627	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A7-A26J	627	0	days	627	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A26J-F39793	TCGA-A7-A26J	TCGA-A7-A26J-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-17930	54		0	627				FPPP	NO		90-99%		Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74.pdf	A26J	TUMOR FREE						YES	YES	70-79%	TCGA	NO	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011	ed40061b-ad15-4f91-94ae-ae276394f42d	be8500f8-6446-4f52-aa16-2ac597e6eb68,f373fd2d-5d41-4ade-ba39-f290ef8482ce,fa523b14-e71e-4e6f-a1f3-b445af1ff788	ed40061b-ad15-4f91-94ae-ae276394f42d	be8500f8-6446-4f52-aa16-2ac597e6eb68,f373fd2d-5d41-4ade-ba39-f290ef8482ce,fa523b14-e71e-4e6f-a1f3-b445af1ff788		TCGA-A7-A26J-01A-11D-A167-09	00683b30-d386-48a8-ad29-4f4698864c66,c7e03f4d-910e-4913-aac6-de1b70a47479	TCGA-A7-A26J-01	TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05,TCGA-A7-A26J-01A-11D-A16A-05	00683b30-d386-48a8-ad29-4f4698864c66,c7e03f4d-910e-4913-aac6-de1b70a47479		TCGA-A7-A26J-01	TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09			TCGA-A7-A26J-01	TCGA-A7-A26J-01A-11D-A167-09		ed40061b-ad15-4f91-94ae-ae276394f42d		TCGA-A7-A26J-01A-11D-A275-01	TCGA-A7-A26J-01		ed40061b-ad15-4f91-94ae-ae276394f42d	TCGA-A7-A26J-01A-11D-A275-01	
TCGA-A7-A2KD-01																			LumB										0	TCGA-A7-A2KD-01	679	0	days	Squamous	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A7-A2KD	679	0	days	679	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right	No axillary staging		TCGA-A7-A2KD-F39783	TCGA-A7-A2KD	TCGA-A7-A2KD-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-19563	141		0	679							90-99%		Scheduled Follow-up Submission	2013-2-1	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	260	NO	Positive		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	8	0	false	Yes	MX	N2a	T2	Stage IIIA	TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf	A2KD	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011	5e04619f-0fa5-45fa-a30b-31b062600047	647c33ff-55fa-43b7-91ef-eb63ab47a549	5e04619f-0fa5-45fa-a30b-31b062600047	647c33ff-55fa-43b7-91ef-eb63ab47a549	TCGA-A7-A2KD-01A-41-A24A-20			TCGA-A7-A2KD-01	TCGA-A7-A2KD-01A-31D-A21R-05		58fcf58b-b94c-4605-a0fc-7ddc5e269879	TCGA-A7-A2KD-01	TCGA-A7-A2KD-01A-31D-A21Q-09			TCGA-A7-A2KD-01			5e04619f-0fa5-45fa-a30b-31b062600047		TCGA-A7-A2KD-01A-31D-A21P-01	TCGA-A7-A2KD-01		5e04619f-0fa5-45fa-a30b-31b062600047	TCGA-A7-A2KD-01A-31D-A21P-01	
TCGA-A7-A3IY-01																			LumA										0	TCGA-A7-A3IY-01	345	0	days	Kirc+			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A7-A3IY	345	0	days	345	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A3IY-F33856	TCGA-A7-A3IY	TCGA-A7-A3IY-01A	Negative	Positive				Lumpectomy	Positive	Lumpectomy		NO			-26042	143		0	345					NO		90-99%		Scheduled Follow-up Submission	2012-7-20	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	130	NO	Negative			1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T1c	Stage I	TCGA-A7-A3IY.63F5F3D8-6393-4DA7-BB74-7D587199D7FD.pdf	A3IY	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	YES	NO	A7	Breast	A	LIVING	2011	c4149cf6-980f-4da1-b749-c24aae86f351	6b3ed6de-3485-430e-aeda-024874161978	c4149cf6-980f-4da1-b749-c24aae86f351	6b3ed6de-3485-430e-aeda-024874161978				TCGA-A7-A3IY-01	TCGA-A7-A3IY-01A-21D-A21R-05			TCGA-A7-A3IY-01	TCGA-A7-A3IY-01A-21D-A21Q-09			TCGA-A7-A3IY-01			c4149cf6-980f-4da1-b749-c24aae86f351		TCGA-A7-A3IY-01A-21D-A21P-01	TCGA-A7-A3IY-01		c4149cf6-980f-4da1-b749-c24aae86f351	TCGA-A7-A3IY-01A-21D-A21P-01	
TCGA-A7-A3IZ-01																			LumA										0	TCGA-A7-A3IZ-01	322	0	days	Kirc+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14			TCGA-A7-A3IZ	322	0	days	322	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A3IZ-F34491	TCGA-A7-A3IZ	TCGA-A7-A3IZ-01A	Negative	Positive				Other	Negative	Lumpectomy	Reexcision	YES			-22997	86		0	322					NO		90-99%	3.0		2012-8-16	FEMALE				PathVysion HER-2 D probe kit.	2+	569	3.0	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO		1	false	No	M0	N0 (i+)	T2	Stage IIA	TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf	A3IZ	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011	e4400dbf-b871-48ab-b571-4f883bb3c24e	a5acf8e3-4062-4ee9-a31f-5ab07d991230	e4400dbf-b871-48ab-b571-4f883bb3c24e	a5acf8e3-4062-4ee9-a31f-5ab07d991230	TCGA-A7-A3IZ-01A-21-A24A-20			TCGA-A7-A3IZ-01	TCGA-A7-A3IZ-01A-11D-A212-05		0d5491ae-73ff-44ad-9aba-cde4b61fbf78	TCGA-A7-A3IZ-01	TCGA-A7-A3IZ-01A-11D-A20S-09			TCGA-A7-A3IZ-01			e4400dbf-b871-48ab-b571-4f883bb3c24e		TCGA-A7-A3IZ-01A-11D-A20R-01	TCGA-A7-A3IZ-01		e4400dbf-b871-48ab-b571-4f883bb3c24e	TCGA-A7-A3IZ-01A-11D-A20R-01	
TCGA-A7-A3J0-01																			LumA										0	TCGA-A7-A3J0-01	313	0	days	BRCA-LUAD+	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-A7-A3J0	313	0	days	313	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right	Sentinel node biopsy alone		TCGA-A7-A3J0-F35965	TCGA-A7-A3J0	TCGA-A7-A3J0-01A		Positive					Positive	Lumpectomy		NO			-22672	78		0	313					NO		90-99%			2012-10-12	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf	A3J0	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011	1fbf8004-0091-4eb0-9042-d2f1a5174abe	23d1f5b1-6b5f-45f3-b30a-b6b04692ba68	1fbf8004-0091-4eb0-9042-d2f1a5174abe	23d1f5b1-6b5f-45f3-b30a-b6b04692ba68	TCGA-A7-A3J0-01A-21-A24A-20			TCGA-A7-A3J0-01	TCGA-A7-A3J0-01A-11D-A212-05		d601836e-e95a-41eb-ad27-e72deada49b6	TCGA-A7-A3J0-01	TCGA-A7-A3J0-01A-11D-A20S-09			TCGA-A7-A3J0-01			1fbf8004-0091-4eb0-9042-d2f1a5174abe		TCGA-A7-A3J0-01A-11D-A20R-01	TCGA-A7-A3J0-01		1fbf8004-0091-4eb0-9042-d2f1a5174abe	TCGA-A7-A3J0-01A-11D-A20R-01	
TCGA-A7-A3J1-01																			LumA										0	TCGA-A7-A3J1-01	343	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-A7-A3J1	343	0	days	343	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A3J1-F36693	TCGA-A7-A3J1	TCGA-A7-A3J1-01A		Positive					Positive	Lumpectomy					-23209	49		0	343					NO		90-99%			2012-11-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	100	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	Yes	MX	N0	T1c	Stage IA	TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf	A3J1	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011	3b042185-867f-492b-a448-7c51e05f9b42	bcc81b67-ecd6-442f-abc4-dd5b916bea85	3b042185-867f-492b-a448-7c51e05f9b42	bcc81b67-ecd6-442f-abc4-dd5b916bea85	TCGA-A7-A3J1-01A-21-A24A-20			TCGA-A7-A3J1-01	TCGA-A7-A3J1-01A-11D-A212-05		88ae23a8-e617-43a4-85be-d4b1f25847ec	TCGA-A7-A3J1-01	TCGA-A7-A3J1-01A-11D-A20S-09			TCGA-A7-A3J1-01			3b042185-867f-492b-a448-7c51e05f9b42		TCGA-A7-A3J1-01A-11D-A20R-01	TCGA-A7-A3J1-01		3b042185-867f-492b-a448-7c51e05f9b42	TCGA-A7-A3J1-01A-11D-A20R-01	
TCGA-A7-A3RF-01																													0	TCGA-A7-A3RF-01	408	0	days	Quiet			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA c1uster 10			TCGA-A7-A3RF	174	1	days	408	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			79	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A3RF-F40413	TCGA-A7-A3RF	TCGA-A7-A3RF-01A	Negative	Positive				Other	Positive	Lumpectomy	Left breast reexcision	NO			-29184	61		0	408			174				90-99%			2013-2-19	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	190	NO	Negative		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Distant Metastasis		NO	YES	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf	A3RF	WITH TUMOR						YES	YES	30-39%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	de0a584e-117e-4cf6-8c4a-6fb040270eda	2e06544e-c9e6-4f9b-a1d9-804c7051ddd5	de0a584e-117e-4cf6-8c4a-6fb040270eda	2e06544e-c9e6-4f9b-a1d9-804c7051ddd5	TCGA-A7-A3RF-01A-21-A24A-20			TCGA-A7-A3RF-01	TCGA-A7-A3RF-01A-11D-A22B-05		1ecde81b-56db-4c3f-981d-6f1c4baa4a32	TCGA-A7-A3RF-01	TCGA-A7-A3RF-01A-11D-A228-09			TCGA-A7-A3RF-01			de0a584e-117e-4cf6-8c4a-6fb040270eda		TCGA-A7-A3RF-01A-11D-A227-01	TCGA-A7-A3RF-01		de0a584e-117e-4cf6-8c4a-6fb040270eda	TCGA-A7-A3RF-01A-11D-A227-01	
TCGA-A7-A425-01																													0	TCGA-A7-A425-01	447	0	days										TCGA-A7-A425	419	1	days	447	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A425-F41648	TCGA-A7-A425	TCGA-A7-A425-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-25678	198		0	447		419	419				90-99%	2.5		2013-3-25	FEMALE			30-39%	Pathvysion HER-2 D Probe Kit	3+	228	2.8	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	400	NO	Indeterminate	Negative	NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%				3 Point Scale					<10%		Negative							3 Point Scale	Other, specify	Locoregional Recurrence	Left Breast	YES	YES	12		false	No	MX	N3a	T3	Stage IIIC	TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf	A425	WITH TUMOR						YES	YES	70-79%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	0a423f86-ffa5-4c16-97ab-2d262c34fd41	d0a1e510-1f13-4153-ab54-e813217d5704	0a423f86-ffa5-4c16-97ab-2d262c34fd41	d0a1e510-1f13-4153-ab54-e813217d5704				TCGA-A7-A425-01	TCGA-A7-A425-01A-11D-A244-05		45d1596a-0b23-41ad-87c5-b1acc92619d2	TCGA-A7-A425-01	TCGA-A7-A425-01A-11D-A243-09			TCGA-A7-A425-01			0a423f86-ffa5-4c16-97ab-2d262c34fd41		TCGA-A7-A425-01A-11D-A242-01	TCGA-A7-A425-01		0a423f86-ffa5-4c16-97ab-2d262c34fd41	TCGA-A7-A425-01A-11D-A242-01	
TCGA-A7-A426-01																													0	TCGA-A7-A426-01	364	0	days										TCGA-A7-A426	364	0	days	364	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A426-F41743	TCGA-A7-A426	TCGA-A7-A426-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-18296	132		0	364							70-79%			2013-3-26	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	180	NO	Negative		NO	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	13		false	Yes	MX	N3a	T3	Stage IIIC	TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf	A426	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	185d3410-2daa-4d28-ab60-a7c13ae9d4fb	e134fc8d-f999-402a-9414-864b0a1e660d	185d3410-2daa-4d28-ab60-a7c13ae9d4fb	e134fc8d-f999-402a-9414-864b0a1e660d				TCGA-A7-A426-01	TCGA-A7-A426-01A-22D-A244-05			TCGA-A7-A426-01	TCGA-A7-A426-01A-22D-A243-09			TCGA-A7-A426-01			185d3410-2daa-4d28-ab60-a7c13ae9d4fb		TCGA-A7-A426-01A-22D-A242-01	TCGA-A7-A426-01		185d3410-2daa-4d28-ab60-a7c13ae9d4fb	TCGA-A7-A426-01A-22D-A242-01	
TCGA-A7-A4SA-01																													0	TCGA-A7-A4SA-01	454	0	days										TCGA-A7-A4SA	454	0	days	454	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A4SA-F49560	TCGA-A7-A4SA	TCGA-A7-A4SA-01A		Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-14906	127		0	454							80-89%			2013-10-3	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1	0	false	No	M0	N1a	T2	Stage IIB	TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf	A4SA	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	781945fb-6d9e-4b45-8082-57675f21dc4a	1d92f9a9-b47a-4a3d-821c-99b7538ac5a9	781945fb-6d9e-4b45-8082-57675f21dc4a	1d92f9a9-b47a-4a3d-821c-99b7538ac5a9				TCGA-A7-A4SA-01	TCGA-A7-A4SA-01A-11D-A268-05		95bdb84b-c36a-4c64-8059-445ebf7adbb4	TCGA-A7-A4SA-01	TCGA-A7-A4SA-01A-11D-A25Q-09			TCGA-A7-A4SA-01			781945fb-6d9e-4b45-8082-57675f21dc4a		TCGA-A7-A4SA-01A-11D-A25N-01	TCGA-A7-A4SA-01		781945fb-6d9e-4b45-8082-57675f21dc4a	TCGA-A7-A4SA-01A-11D-A25N-01	
TCGA-A7-A4SA-11																													0	TCGA-A7-A4SA-11	454	0	days										TCGA-A7-A4SA	454	0	days	454	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A4SA-F49560	TCGA-A7-A4SA	TCGA-A7-A4SA-11A		Positive	3 Point Scale				Negative	Simple Mastectomy		YES			-14906	127		0	454							80-89%			2013-10-3	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1430	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1	0	false	No	M0	N1a	T2	Stage IIB		A4SA	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th		YES	NO	A7	Breast	A	LIVING	2012											BF5A86FA-5213-494A-852B-C0782A9A0A56															
TCGA-A7-A4SB-01																													0	TCGA-A7-A4SB-01	418	0	days										TCGA-A7-A4SB	418	0	days	418	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A4SB-F49625	TCGA-A7-A4SB	TCGA-A7-A4SB-01A	Negative	Positive	3 Point Scale		3 Point Scale	Other	Positive	Lumpectomy	Right Breast reexcision	YES			-20539	75		0	418							70-79%			2013-10-4	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	1	false	No	M0	N1mi	T3	Stage IIIA	TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf	A4SB	TUMOR FREE						YES	YES	50-59%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	352dc94a-fc74-4292-890c-4ed9c22dcfbc	58f16a99-4220-411d-be80-c354c3dde02f	352dc94a-fc74-4292-890c-4ed9c22dcfbc	58f16a99-4220-411d-be80-c354c3dde02f				TCGA-A7-A4SB-01	TCGA-A7-A4SB-01A-21D-A268-05			TCGA-A7-A4SB-01	TCGA-A7-A4SB-01A-21D-A25Q-09			TCGA-A7-A4SB-01			352dc94a-fc74-4292-890c-4ed9c22dcfbc		TCGA-A7-A4SB-01A-21D-A25N-01	TCGA-A7-A4SB-01		352dc94a-fc74-4292-890c-4ed9c22dcfbc	TCGA-A7-A4SB-01A-21D-A25N-01	
TCGA-A7-A4SC-01																													0	TCGA-A7-A4SC-01	446	0	days										TCGA-A7-A4SC	446	0	days	446	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant			TCGA-A7-A4SC-F49714	TCGA-A7-A4SC	TCGA-A7-A4SC-01A		Positive					Negative	Simple Mastectomy		YES			-23008	110		0	446							90-99%	2.2		2013-10-8	FEMALE				PathVysion HER-2 D Probe kit	3+	303	2.4	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T3	Stage IIB	TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf	A4SC	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	84633979-56dd-4244-90bc-fa4652718880		84633979-56dd-4244-90bc-fa4652718880					TCGA-A7-A4SC-01	TCGA-A7-A4SC-01A-12D-A268-05		3d087331-9673-4816-97ac-741f364cccae		TCGA-A7-A4SC-01A-12D-A25Q-09			TCGA-A7-A4SC-01			84633979-56dd-4244-90bc-fa4652718880			TCGA-A7-A4SC-01		84633979-56dd-4244-90bc-fa4652718880		
TCGA-A7-A4SC-11																													0	TCGA-A7-A4SC-11	446	0	days										TCGA-A7-A4SC	446	0	days	446	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant			TCGA-A7-A4SC-F49714	TCGA-A7-A4SC	TCGA-A7-A4SC-11A		Positive					Negative	Simple Mastectomy		YES			-23008	110		0	446							90-99%	2.2		2013-10-8	FEMALE				PathVysion HER-2 D Probe kit	3+	303	2.4	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	610	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T3	Stage IIB		A4SC	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th		YES	NO	A7	Breast	A	LIVING	2012											325798E1-709A-4A61-AF20-E1E85844CF20															
TCGA-A7-A4SD-01																													0	TCGA-A7-A4SD-01	441	0	days										TCGA-A7-A4SD	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right	Sentinel node biopsy alone		TCGA-A7-A4SD-F52732	TCGA-A7-A4SD	TCGA-A7-A4SD-01A		Negative					Negative	Simple Mastectomy		YES			-19131	63		0	441								5		2013-12-5	FEMALE				PathVysion HER-2 D Probe Kit	2+	20	6.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf	A4SD	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	cb0d669b-658a-4a41-9904-f838ddb12db2	cf272587-883b-4844-a81e-46fca956cc66	cb0d669b-658a-4a41-9904-f838ddb12db2	cf272587-883b-4844-a81e-46fca956cc66				TCGA-A7-A4SD-01	TCGA-A7-A4SD-01A-11D-A268-05		148f42bd-6aee-4dc7-bf8b-d5e8580c1b4d	TCGA-A7-A4SD-01	TCGA-A7-A4SD-01A-11D-A25Q-09			TCGA-A7-A4SD-01			cb0d669b-658a-4a41-9904-f838ddb12db2		TCGA-A7-A4SD-01A-11D-A25N-01	TCGA-A7-A4SD-01		cb0d669b-658a-4a41-9904-f838ddb12db2	TCGA-A7-A4SD-01A-11D-A25N-01	
TCGA-A7-A4SD-11																													0	TCGA-A7-A4SD-11	441	0	days										TCGA-A7-A4SD	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right	Sentinel node biopsy alone		TCGA-A7-A4SD-F52732	TCGA-A7-A4SD	TCGA-A7-A4SD-11A		Negative					Negative	Simple Mastectomy		YES			-19131	63		0	441								5		2013-12-5	FEMALE				PathVysion HER-2 D Probe Kit	2+	20	6.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	980	NO	Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA		A4SD	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th		YES	NO	A7	Breast	A	LIVING	2012											3EB15608-D3BE-4E35-89F9-BEF3DFEB60EC															
TCGA-A7-A4SE-01																													0	TCGA-A7-A4SE-01	644	0	days										TCGA-A7-A4SE	644	0	days	644	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Sentinel node biopsy alone		TCGA-A7-A4SE-F50162	TCGA-A7-A4SE	TCGA-A7-A4SE-01A		Negative					Negative	Lumpectomy		YES			-20080	306		0	644										2013-10-16	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf	A4SE	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2011	6bb217e7-3fd4-477f-87bf-b55e50a33e45	7b527732-597f-49af-bf0c-69b485bbe511	6bb217e7-3fd4-477f-87bf-b55e50a33e45	7b527732-597f-49af-bf0c-69b485bbe511				TCGA-A7-A4SE-01	TCGA-A7-A4SE-01A-11D-A268-05		7309fdea-a4df-4081-adac-88e2966c8642	TCGA-A7-A4SE-01	TCGA-A7-A4SE-01A-11D-A25Q-09			TCGA-A7-A4SE-01			6bb217e7-3fd4-477f-87bf-b55e50a33e45		TCGA-A7-A4SE-01A-11D-A25N-01	TCGA-A7-A4SE-01		6bb217e7-3fd4-477f-87bf-b55e50a33e45	TCGA-A7-A4SE-01A-11D-A25N-01	
TCGA-A7-A4SE-11																													0	TCGA-A7-A4SE-11	644	0	days										TCGA-A7-A4SE	644	0	days	644	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Sentinel node biopsy alone		TCGA-A7-A4SE-F50162	TCGA-A7-A4SE	TCGA-A7-A4SE-11A		Negative					Negative	Lumpectomy		YES			-20080	306		0	644										2013-10-16	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	650	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA		A4SE	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th		YES	NO	A7	Breast	A	LIVING	2011											715C8450-EEA3-4C5C-8B9B-D30D994FB08D															
TCGA-A7-A4SF-01																													0	TCGA-A7-A4SF-01	545	0	days										TCGA-A7-A4SF	545	0	days	545	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right	Sentinel node biopsy alone		TCGA-A7-A4SF-F49721	TCGA-A7-A4SF	TCGA-A7-A4SF-01A	Positive	Positive	3 Point Scale			Other	Negative	Lumpectomy	Right Breast Reexcision	YES			-19985	245		0	545							90-99%			2013-10-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Positive		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A4SF.C1B1FAA6-EB15-43BB-B3A3-D11511C76060.pdf	A4SF	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	2080f468-6807-4c8d-a9d8-99775effd6ba	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	2080f468-6807-4c8d-a9d8-99775effd6ba				TCGA-A7-A4SF-01	TCGA-A7-A4SF-01A-11D-A268-05		e04e9fb6-be99-430f-8f5b-fd4aaba872dc	TCGA-A7-A4SF-01	TCGA-A7-A4SF-01A-11D-A25Q-09			TCGA-A7-A4SF-01			f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8		TCGA-A7-A4SF-01A-11D-A25N-01	TCGA-A7-A4SF-01		f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	TCGA-A7-A4SF-01A-11D-A25N-01	
TCGA-A7-A56D-01																													0	TCGA-A7-A56D-01	448	0	days										TCGA-A7-A56D	448	0	days	448	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A56D-F50426	TCGA-A7-A56D	TCGA-A7-A56D-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Lumpectomy		YES			-30783	140		0	448							90-99%			2013-10-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	80	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf	A56D	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	71bafb6d-c0cd-499e-98cb-12bca4360593	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	71bafb6d-c0cd-499e-98cb-12bca4360593				TCGA-A7-A56D-01	TCGA-A7-A56D-01A-11D-A27Y-05			TCGA-A7-A56D-01	TCGA-A7-A56D-01A-11D-A27P-09			TCGA-A7-A56D-01			3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4		TCGA-A7-A56D-01A-11D-A27O-01	TCGA-A7-A56D-01		3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	TCGA-A7-A56D-01A-11D-A27O-01	
TCGA-A7-A5ZV-01																													0	TCGA-A7-A5ZV-01	368	0	days										TCGA-A7-A5ZV	368	0	days	368	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left	Sentinel node biopsy alone		TCGA-A7-A5ZV-F51143	TCGA-A7-A5ZV	TCGA-A7-A5ZV-01A		Negative					Negative	Lumpectomy		NO			-22966	154		0	368								2.5		2013-11-8	FEMALE				PathVysion HER-2 D Probe Kit	2+	40	3.8	1.5		Infiltrating Carcinoma NOS		No		C50.9	8010/3	C50.9		YES		Core needle biopsy	940	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A5ZV.FA5CF5A2-F44A-4303-9200-32250FAEF374.pdf	A5ZV	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	e121ae32-63c2-4b13-b135-d1837fc10999	37f156e4-c11a-4934-b0d2-c860222f68d6	e121ae32-63c2-4b13-b135-d1837fc10999	37f156e4-c11a-4934-b0d2-c860222f68d6				TCGA-A7-A5ZV-01	TCGA-A7-A5ZV-01A-11D-A28C-05		cc46932d-0799-42ae-8a92-5bf65e381969	TCGA-A7-A5ZV-01	TCGA-A7-A5ZV-01A-11D-A28B-09			TCGA-A7-A5ZV-01			e121ae32-63c2-4b13-b135-d1837fc10999		TCGA-A7-A5ZV-01A-11D-A28A-01	TCGA-A7-A5ZV-01		e121ae32-63c2-4b13-b135-d1837fc10999	TCGA-A7-A5ZV-01A-11D-A28A-01	
TCGA-A7-A5ZW-01																													0	TCGA-A7-A5ZW-01	326	0	days										TCGA-A7-A5ZW	326	0	days	326	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A5ZW-F51509	TCGA-A7-A5ZW	TCGA-A7-A5ZW-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-17529	77		0	326							90-99%			2013-11-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	1	Negative	Peri (6-12 months since last menstrual period)																													NO	1		false	No	M0	N1a	T1c	Stage IIA	TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf	A5ZW	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2012	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	1fe5b258-cd2d-401f-b119-75f183b44711	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	1fe5b258-cd2d-401f-b119-75f183b44711				TCGA-A7-A5ZW-01	TCGA-A7-A5ZW-01A-12D-A29O-05			TCGA-A7-A5ZW-01	TCGA-A7-A5ZW-01A-12D-A29N-09			TCGA-A7-A5ZW-01			8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f		TCGA-A7-A5ZW-01A-12D-A29M-01	TCGA-A7-A5ZW-01		8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	TCGA-A7-A5ZW-01A-12D-A29M-01	
TCGA-A7-A5ZX-01																													0	TCGA-A7-A5ZX-01	336	0	days										TCGA-A7-A5ZX	336	0	days	336	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A5ZX-F52721	TCGA-A7-A5ZX			Positive	3 Point Scale		3 Point Scale		Positive	Other		YES			-17683			0	336										2013-12-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative		NO	24		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	21			Yes	M0	N3a	T2	Stage IIIC		A5ZX	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.	7th		YES	NO	A7	Breast		LIVING	2012	e3c70f4d-4a23-486b-b221-3058b13a1c69	e1e56aa2-5327-450f-ab74-b1472d75e5df	e3c70f4d-4a23-486b-b221-3058b13a1c69	e1e56aa2-5327-450f-ab74-b1472d75e5df				TCGA-A7-A5ZX-01	TCGA-A7-A5ZX-01A-12D-A29O-05			TCGA-A7-A5ZX-01	TCGA-A7-A5ZX-01A-12D-A29N-09			TCGA-A7-A5ZX-01			e3c70f4d-4a23-486b-b221-3058b13a1c69		TCGA-A7-A5ZX-01A-12D-A29M-01	TCGA-A7-A5ZX-01		e3c70f4d-4a23-486b-b221-3058b13a1c69	TCGA-A7-A5ZX-01A-12D-A29M-01	
TCGA-A7-A6VV-01																													0	TCGA-A7-A6VV-01	313	0	days										TCGA-A7-A6VV	313	0	days	313	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A6VV-F57249	TCGA-A7-A6VV	TCGA-A7-A6VV-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18695	85		0	313										2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1100	NO	Negative		NO	5	Negative	Peri (6-12 months since last menstrual period)																													NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf	A6VV	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013	c02ec36d-9e79-4e2f-a46c-f898838766df	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85	c02ec36d-9e79-4e2f-a46c-f898838766df	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85				TCGA-A7-A6VV-01	TCGA-A7-A6VV-01A-22D-A33F-05		66E3766B-46AB-4A9B-8B6E-1EECA04D9B62	TCGA-A7-A6VV-01				TCGA-A7-A6VV-01			c02ec36d-9e79-4e2f-a46c-f898838766df		TCGA-A7-A6VV-01A-22D-A33D-01	TCGA-A7-A6VV-01		c02ec36d-9e79-4e2f-a46c-f898838766df	TCGA-A7-A6VV-01A-22D-A33D-01	
TCGA-A7-A6VW-01																													0	TCGA-A7-A6VW-01	285	0	days										TCGA-A7-A6VW	285	0	days	285	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left	Sentinel node biopsy alone		TCGA-A7-A6VW-F57227	TCGA-A7-A6VW	TCGA-A7-A6VW-01A		Negative					Negative	Lumpectomy		NO			-17539	71		0	285										2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative		NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A6VW.BE19CEFA-7A66-480C-BEC0-AF52F4C8A04C.pdf	A6VW	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	8a5f6839-507d-4288-91e9-22badf54b089	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	8a5f6839-507d-4288-91e9-22badf54b089				TCGA-A7-A6VW-01	TCGA-A7-A6VW-01A-21D-A33F-05			TCGA-A7-A6VW-01				TCGA-A7-A6VW-01			f572c953-e1aa-4dd2-a8f8-e292ab7bd139		TCGA-A7-A6VW-01A-21D-A33D-01	TCGA-A7-A6VW-01		f572c953-e1aa-4dd2-a8f8-e292ab7bd139	TCGA-A7-A6VW-01A-21D-A33D-01	
TCGA-A7-A6VX-01																													0	TCGA-A7-A6VX-01	317	0	days										TCGA-A7-A6VX	317	0	days	317	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-A7-A6VX-F57518	TCGA-A7-A6VX	TCGA-A7-A6VX-01A		Positive					Positive	Lumpectomy		NO			-25066	73		0	317						Immune Stain by GenPath	90-99%			2014-3-13	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf	A6VX	TUMOR FREE	Immune stain by GenPath					YES	YES			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013	aed86155-1d12-4447-bdf6-3aaba9938a71	5856d23e-c230-4122-abf1-fa304bdceee9	aed86155-1d12-4447-bdf6-3aaba9938a71	5856d23e-c230-4122-abf1-fa304bdceee9				TCGA-A7-A6VX-01	TCGA-A7-A6VX-01A-12D-A33F-05		8C0E2DD9-D3B3-4AF6-A450-4B7F1DBA5CE7	TCGA-A7-A6VX-01				TCGA-A7-A6VX-01			aed86155-1d12-4447-bdf6-3aaba9938a71		TCGA-A7-A6VX-01A-12D-A33D-01	TCGA-A7-A6VX-01		aed86155-1d12-4447-bdf6-3aaba9938a71	TCGA-A7-A6VX-01A-12D-A33D-01	
TCGA-A7-A6VY-01																													0	TCGA-A7-A6VY-01	266	0	days										TCGA-A7-A6VY	266	0	days	266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-A7-A6VY-F57257	TCGA-A7-A6VY	TCGA-A7-A6VY-01A		Negative					Negative	Lumpectomy		NO			-17640	29		0	266										2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	No	M0	N1	T2	Stage IIB	TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf	A6VY	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	A7	Breast	A	LIVING	2013	2fb506f2-4b76-4c20-ae45-8939f2e14753	317d4bae-a933-41ef-ab8a-d4fbb6de5285	2fb506f2-4b76-4c20-ae45-8939f2e14753	317d4bae-a933-41ef-ab8a-d4fbb6de5285				TCGA-A7-A6VY-01	TCGA-A7-A6VY-01A-12D-A33F-05			TCGA-A7-A6VY-01				TCGA-A7-A6VY-01			2fb506f2-4b76-4c20-ae45-8939f2e14753		TCGA-A7-A6VY-01A-12D-A33D-01	TCGA-A7-A6VY-01		2fb506f2-4b76-4c20-ae45-8939f2e14753	TCGA-A7-A6VY-01A-12D-A33D-01	
TCGA-A8-A06N-01	Stage IIIB	66	3	Stage IIIB	0		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	0	0	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T4	LIVING		TCGA-A8-A06N-01			days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A06N			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left				TCGA-A8-A06N	TCGA-A8-A06N-01A		Positive					Negative	Other					-24288	241		0	0										2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			510	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2											false	No	M0	N0	T4b	Stage IIIB	TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84.pdf	A06N	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	0a28c663-7cc6-466c-b64d-f9d8d6d6b4c8	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	0a28c663-7cc6-466c-b64d-f9d8d6d6b4c8	TCGA-A8-A06N-01A-21-A13B-20	TCGA-A8-A06N-01A-11W-A019-09		TCGA-A8-A06N-01			99692232-7d23-4ea5-847e-17064bac010d	TCGA-A8-A06N-01	TCGA-A8-A06N-01A-11W-A019-09	TCGA-A8-A06N-01A-11D-A00Y-05	TCGA-A8-A06N-01		TCGA-A8-A06N-01A-11W-A019-09	TCGA-A8-A06N-01	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	TCGA-A8-A06N-01	TCGA-A8-A06N-01A-11D-A011-01		TCGA-A8-A06N-01A-12R-A056-07	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	TCGA-A8-A06N-01A-11D-A011-01	TCGA-A8-A06N-01
TCGA-A8-A06O-01	Stage I	60	5	Stage I	396		Positive	FEMALE	Negative				Negative	M0	Negative	N0	396	0	LumB	Luminal B	Positive		-2	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A06O-01	396	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A06O	396	0	days	396	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left			TCGA-A8-A06O-F40806	TCGA-A8-A06O	TCGA-A8-A06O-01A		Positive					Positive	Other					-22157	272		0	396										2013-3-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO			false	No	M0	N0	T1c	Stage I	TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3.pdf	A06O	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	7dbd8795-b264-4f68-bdea-4cfe39884864	dc99456b-c429-4e33-8ceb-26dd8d43b78a	7dbd8795-b264-4f68-bdea-4cfe39884864	dc99456b-c429-4e33-8ceb-26dd8d43b78a		TCGA-A8-A06O-01A-11W-A019-09		TCGA-A8-A06O-01				TCGA-A8-A06O-01	TCGA-A8-A06O-01A-11W-A019-09	TCGA-A8-A06O-01A-11D-A00Y-05	TCGA-A8-A06O-01		TCGA-A8-A06O-01A-11W-A019-09	TCGA-A8-A06O-01	7dbd8795-b264-4f68-bdea-4cfe39884864	TCGA-A8-A06O-01	TCGA-A8-A06O-01A-11D-A011-01		TCGA-A8-A06O-01A-11R-A00Z-07	7dbd8795-b264-4f68-bdea-4cfe39884864	TCGA-A8-A06O-01A-11D-A011-01	TCGA-A8-A06O-01
TCGA-A8-A06P-01	Stage IIIA	63	4	Stage IIIA	396		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	396	0	LumA	Luminal A	Positive	ReacI	-5	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A06P-01	396	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06P			days	396	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right			TCGA-A8-A06P-F40814	TCGA-A8-A06P	TCGA-A8-A06P-01A		Positive					Positive	Other					-23011	241		0	396										2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4											false	No	M0	N2a	T1c	Stage IIIA	TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31.pdf	A06P	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	9d8f2b85-f203-47ac-8217-987640f89b26	90ef86f0-9b29-4f97-b8c8-128a5771ed75	9d8f2b85-f203-47ac-8217-987640f89b26	90ef86f0-9b29-4f97-b8c8-128a5771ed75	TCGA-A8-A06P-01A-21-A13B-20	TCGA-A8-A06P-01A-11W-A019-09		TCGA-A8-A06P-01			9d804a48-aeb9-4785-af7c-2b8a4763c148	TCGA-A8-A06P-01	TCGA-A8-A06P-01A-11W-A019-09	TCGA-A8-A06P-01A-11D-A00Y-05	TCGA-A8-A06P-01		TCGA-A8-A06P-01A-11W-A019-09	TCGA-A8-A06P-01	9d8f2b85-f203-47ac-8217-987640f89b26	TCGA-A8-A06P-01	TCGA-A8-A06P-01A-11D-A011-01		TCGA-A8-A06P-01A-11R-A00Z-07	9d8f2b85-f203-47ac-8217-987640f89b26	TCGA-A8-A06P-01A-11D-A011-01	TCGA-A8-A06P-01
TCGA-A8-A06Q-01	Stage IIIA	63	3	No_Conversion	31		Positive	FEMALE	Negative				Negative	M0	Positive	N2	31	0	LumB	Luminal B	Positive		-2	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06Q-01	31	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 3	TCGA-A8-A06Q			days	31	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant				TCGA-A8-A06Q	TCGA-A8-A06Q-01A		Positive					Positive	Other					-23164	1184		0	31										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			50	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7											false	No	M0	N2	T3	Stage IIIA	TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF.pdf	A06Q	TUMOR FREE											Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	ac9a0bec-1011-41da-b5b4-774fed87b5b0	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	ac9a0bec-1011-41da-b5b4-774fed87b5b0		TCGA-A8-A06Q-01A-11W-A050-09		TCGA-A8-A06Q-01				TCGA-A8-A06Q-01	TCGA-A8-A06Q-01A-11W-A050-09	TCGA-A8-A06Q-01A-11D-A032-05	TCGA-A8-A06Q-01		TCGA-A8-A06Q-01A-11W-A050-09	TCGA-A8-A06Q-01	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	TCGA-A8-A06Q-01	TCGA-A8-A06Q-01A-11D-A036-01		TCGA-A8-A06Q-01A-11R-A034-07	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	TCGA-A8-A06Q-01A-11D-A036-01	TCGA-A8-A06Q-01
TCGA-A8-A06R-01	Stage IIB	69		No_Conversion	546		Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	546	0	LumB	Luminal B	Negative	ReacI	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A06R-01	547	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06R	547	0	days	547	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant			TCGA-A8-A06R-F40815	TCGA-A8-A06R	TCGA-A8-A06R-01A		Positive					Negative	Other					-25477	1184		0	547										2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			220	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO			false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871.pdf	A06R	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	e2d7656c-0d06-427c-998c-c26ba4a1def4	aa0e910d-28fb-41f0-b545-601feb989ee1	e2d7656c-0d06-427c-998c-c26ba4a1def4	aa0e910d-28fb-41f0-b545-601feb989ee1	TCGA-A8-A06R-01A-21-A13A-20	TCGA-A8-A06R-01A-11D-A015-09		TCGA-A8-A06R-01			7bcd06e7-a4de-4c5b-9337-4d7d3b8014b9	TCGA-A8-A06R-01	TCGA-A8-A06R-01A-11D-A015-09	TCGA-A8-A06R-01A-11D-A00Y-05	TCGA-A8-A06R-01		TCGA-A8-A06R-01A-11D-A015-09	TCGA-A8-A06R-01	e2d7656c-0d06-427c-998c-c26ba4a1def4	TCGA-A8-A06R-01	TCGA-A8-A06R-01A-11D-A011-01		TCGA-A8-A06R-01A-11R-A00Z-07	e2d7656c-0d06-427c-998c-c26ba4a1def4	TCGA-A8-A06R-01A-11D-A011-01	TCGA-A8-A06R-01
TCGA-A8-A06T-01	Stage IIIA	75	4	Stage IIIA	1249		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1249	0	LumA	Luminal A	Positive		-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06T-01	1614	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 14	TCGA-A8-A06T			days	1614	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left Upper Outer Quadrant			TCGA-A8-A06T-F40816	TCGA-A8-A06T	TCGA-A8-A06T-01A		Positive					Positive	Other					-27393	941		0	1614										2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2											false	Yes	M0	N1a	T3	Stage IIIA	TCGA-A8-A06T.5D888D65-685F-4598-884F-AD057DE5FD1D.pdf	A06T	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	de1cdf25-62e6-41c0-b1c8-257175519041	768075b7-62ca-4f16-b1a6-7700c94a146b	de1cdf25-62e6-41c0-b1c8-257175519041	768075b7-62ca-4f16-b1a6-7700c94a146b		TCGA-A8-A06T-01A-11W-A019-09		TCGA-A8-A06T-01				TCGA-A8-A06T-01	TCGA-A8-A06T-01A-11W-A019-09	TCGA-A8-A06T-01A-11D-A00Y-05	TCGA-A8-A06T-01		TCGA-A8-A06T-01A-11W-A019-09	TCGA-A8-A06T-01	de1cdf25-62e6-41c0-b1c8-257175519041	TCGA-A8-A06T-01	TCGA-A8-A06T-01A-11D-A011-01		TCGA-A8-A06T-01A-11R-A00Z-07	de1cdf25-62e6-41c0-b1c8-257175519041	TCGA-A8-A06T-01A-11D-A011-01	TCGA-A8-A06T-01
TCGA-A8-A06U-01	Stage IIB	80		Stage IIB	882	882	Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	882	1	LumA	Luminal A	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-A8-A06U-01	883	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06U			days	883	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Upper Outer Quadrant			TCGA-A8-A06U-F40817	TCGA-A8-A06U	TCGA-A8-A06U-01A		Positive					Positive	Other					-29525	759	883	0											2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			250	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4											false	Yes	M0	N1a	T2	Stage IIB	TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf	A06U	TUMOR FREE										NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2008	89f9e509-5f4c-439b-b610-860f209332d2	714b3b2b-ad91-483d-8754-2afc96067e5e	89f9e509-5f4c-439b-b610-860f209332d2	714b3b2b-ad91-483d-8754-2afc96067e5e	TCGA-A8-A06U-01A-21-A13A-20	TCGA-A8-A06U-01A-11W-A019-09		TCGA-A8-A06U-01			f47ef5b8-45ae-4cd2-915a-ba5f790465bd	TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01A-11D-A00Y-05	TCGA-A8-A06U-01		TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11D-A011-01		TCGA-A8-A06U-01A-11R-A00Z-07	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01A-11D-A011-01	TCGA-A8-A06U-01
TCGA-A8-A06X-01	Stage IIB	77	1	Stage IIB	943	943	Positive	FEMALE	Positive				Negative	M0	Negative	N0	943	1	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T3	DECEASED	1	TCGA-A8-A06X-01	943	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 10	TCGA-A8-A06X			days	943	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant			TCGA-A8-A06X-F40818	TCGA-A8-A06X	TCGA-A8-A06X-01A		Positive					Negative	Other					-28338	1276	943	0											2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			760	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3												false	No	M0	N0	T3	Stage IIB	TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070.pdf	A06X	TUMOR FREE										YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2006	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	b8726c73-a8fe-4444-b034-a3100bd3d02b	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	b8726c73-a8fe-4444-b034-a3100bd3d02b	TCGA-A8-A06X-01A-11-A13A-20	TCGA-A8-A06X-01A-21W-A019-09		TCGA-A8-A06X-01			1896a8eb-415e-4b05-aad1-dec8b4a5c473	TCGA-A8-A06X-01	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01A-21D-A00Y-05	TCGA-A8-A06X-01		TCGA-A8-A06X-01A-21W-A019-09		3ea9e7f1-39af-4089-b1c0-3c62db4e3102		TCGA-A8-A06X-01A-21D-A011-01		TCGA-A8-A06X-01A-21R-A00Z-07	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	TCGA-A8-A06X-01A-21D-A011-01	TCGA-A8-A06X-01
TCGA-A8-A06Y-01	Stage IIA	66	4	Stage IIA	791		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	791	0	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A06Y-01	791	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A06Y	791	1	days	791	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Outer Quadrant			TCGA-A8-A06Y-F40819	TCGA-A8-A06Y	TCGA-A8-A06Y-01A		Positive					Positive	Other					-24442	667		0	791			791							2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								YES			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26.pdf	A06Y	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	14f20743-35f3-4e68-a2e5-e03edfe31a97	2e6c87bb-1fb1-4c26-9081-8848b022d900	14f20743-35f3-4e68-a2e5-e03edfe31a97	2e6c87bb-1fb1-4c26-9081-8848b022d900	TCGA-A8-A06Y-01A-11-A13A-20	TCGA-A8-A06Y-01A-21W-A019-09		TCGA-A8-A06Y-01			71251016-7304-4492-8278-a1718ecdb97a	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01A-21W-A019-09	TCGA-A8-A06Y-01A-21D-A00Y-05	TCGA-A8-A06Y-01		TCGA-A8-A06Y-01A-21W-A019-09	TCGA-A8-A06Y-01	14f20743-35f3-4e68-a2e5-e03edfe31a97	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01A-21D-A011-01		TCGA-A8-A06Y-01A-21R-A00Z-07	14f20743-35f3-4e68-a2e5-e03edfe31a97	TCGA-A8-A06Y-01A-21D-A011-01	TCGA-A8-A06Y-01
TCGA-A8-A06Z-01	Stage IIB	84	5	Stage IIB	31		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	31	0	LumB	Luminal B	Positive	Her2	-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06Z-01	31	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A8-A06Z			days	31	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Right Upper Outer Quadrant				TCGA-A8-A06Z	TCGA-A8-A06Z-01A		Positive					Positive	Other					-30984	1003		0	31										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			330	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	1											false	No	M0	N0	T3	Stage IIB	TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584.pdf	A06Z												Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	42b99ee7-a1ae-4383-b343-adf468cb8b51	0cea4cc3-5997-4ab3-8528-2e13e1e0fade	42b99ee7-a1ae-4383-b343-adf468cb8b51	0cea4cc3-5997-4ab3-8528-2e13e1e0fade	TCGA-A8-A06Z-01A-21-A13A-20	TCGA-A8-A06Z-01A-11W-A019-09		TCGA-A8-A06Z-01			afd9a962-46e2-4b42-bc6e-eb091d7f9b5b	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01A-11W-A019-09	TCGA-A8-A06Z-01A-11D-A00Y-05	TCGA-A8-A06Z-01		TCGA-A8-A06Z-01A-11W-A019-09	TCGA-A8-A06Z-01	42b99ee7-a1ae-4383-b343-adf468cb8b51	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01A-11D-A011-01		TCGA-A8-A06Z-01A-11R-A00Z-07	42b99ee7-a1ae-4383-b343-adf468cb8b51	TCGA-A8-A06Z-01A-11D-A011-01	TCGA-A8-A06Z-01
TCGA-A8-A075-01	Stage IIB	42	2	Stage IIB	517		Positive	FEMALE	Negative	5	2	1	Negative	M0	Positive	N1	517	0	LumB	HER2-enriched	Positive	X	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A075-01	518	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-A8-A075	518	0	days	518	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Left Upper Outer Quadrant			TCGA-A8-A075-F40820	TCGA-A8-A075	TCGA-A8-A075-01A		Positive					Positive	Other					-15369	394		0	518										2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			120	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	1								NO			false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31.pdf	A075	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	1ccf908a-7620-4af8-b83f-0e287f3655c5	a213bd41-34bd-4bf5-b8af-096156c79b8d	1ccf908a-7620-4af8-b83f-0e287f3655c5	a213bd41-34bd-4bf5-b8af-096156c79b8d	TCGA-A8-A075-01A-21-A13A-20	TCGA-A8-A075-01A-11D-A099-09		TCGA-A8-A075-01	TCGA-A8-A075-01A-11D-A10P-05		a84864ab-5eba-4a64-aa65-883deca0c967	TCGA-A8-A075-01	TCGA-A8-A075-01A-11D-A099-09		TCGA-A8-A075-01		TCGA-A8-A075-01A-11D-A099-09	TCGA-A8-A075-01	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01	TCGA-A8-A075-01A-11D-A087-01		TCGA-A8-A075-01A-11R-A084-07	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01A-11D-A087-01	TCGA-A8-A075-01
TCGA-A8-A076-01	Stage IIA	66	4	Stage IIA	1641		Positive	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	1641	0	LumB	HER2-enriched	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A076-01	1642	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation c1uster 9	TCGA-A8-A076	1642	0	days	1642	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Outer Quadrant			TCGA-A8-A076-F40821	TCGA-A8-A076	TCGA-A8-A076-01A		Positive					Positive	Other					-24230	1518		0	1642										2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9.pdf	A076	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2006	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	4f7e5b63-0735-4b62-82c8-0def83906d4c	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	4f7e5b63-0735-4b62-82c8-0def83906d4c	TCGA-A8-A076-01A-11-A13A-20	TCGA-A8-A076-01A-21W-A019-09		TCGA-A8-A076-01			9d5a9ed1-b633-4e0d-8006-826e20c62538	TCGA-A8-A076-01	TCGA-A8-A076-01A-21W-A019-09	TCGA-A8-A076-01A-21D-A00Y-05	TCGA-A8-A076-01		TCGA-A8-A076-01A-21W-A019-09	TCGA-A8-A076-01	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	TCGA-A8-A076-01	TCGA-A8-A076-01A-21D-A011-01		TCGA-A8-A076-01A-21R-A00Z-07	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	TCGA-A8-A076-01A-21D-A011-01	TCGA-A8-A076-01
TCGA-A8-A079-01	Stage IIIB	69	5	Stage IIIC	274		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N3	274	0	LumB	Luminal B	Positive	LumA/B	-6	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A079-01	274	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A8-A079			days	274	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Outer Quadrant			TCGA-A8-A079-F40822	TCGA-A8-A079	TCGA-A8-A079-01A		Positive					Positive	Other					-25294	1033		0	274										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			380	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5											false	No	M0	N3	T4b	Stage IIIB	TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42.pdf	A079	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	105f3c7d-547d-45d9-b722-5c9fa04ee8d0	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	105f3c7d-547d-45d9-b722-5c9fa04ee8d0	TCGA-A8-A079-01A-11-A13A-20	TCGA-A8-A079-01A-21W-A019-09		TCGA-A8-A079-01			b22ff43f-3646-49dd-ba2e-3cc1a82eb7bd	TCGA-A8-A079-01	TCGA-A8-A079-01A-21W-A019-09	TCGA-A8-A079-01A-21D-A00Y-05	TCGA-A8-A079-01		TCGA-A8-A079-01A-21W-A019-09	TCGA-A8-A079-01	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	TCGA-A8-A079-01	TCGA-A8-A079-01A-21D-A011-01		TCGA-A8-A079-01A-21R-A00Z-07	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	TCGA-A8-A079-01A-21D-A011-01	TCGA-A8-A079-01
TCGA-A8-A07B-01	Stage IIA	69	5	Stage IIA	1004		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1004	0	LumA	HER2-enriched	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07B-01	1308	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 2	TCGA-A8-A07B			days	1308	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Lower Outer Quadrant			TCGA-A8-A07B-F40823	TCGA-A8-A07B	TCGA-A8-A07B-01A		Positive					Positive	Other					-25475	880		0	1308										2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			90	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA.pdf	A07B	TUMOR FREE						NO				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	0c9fe532-3920-4a59-b348-65b184c0eff4	46ca210a-0284-4e84-9a0b-4648b337ed02	0c9fe532-3920-4a59-b348-65b184c0eff4	46ca210a-0284-4e84-9a0b-4648b337ed02		TCGA-A8-A07B-01A-11W-A019-09		TCGA-A8-A07B-01				TCGA-A8-A07B-01	TCGA-A8-A07B-01A-11W-A019-09	TCGA-A8-A07B-01A-11D-A00Y-05	TCGA-A8-A07B-01		TCGA-A8-A07B-01A-11W-A019-09	TCGA-A8-A07B-01	0c9fe532-3920-4a59-b348-65b184c0eff4	TCGA-A8-A07B-01	TCGA-A8-A07B-01A-11D-A011-01		TCGA-A8-A07B-01A-11R-A00Z-07	0c9fe532-3920-4a59-b348-65b184c0eff4	TCGA-A8-A07B-01A-11D-A011-01	TCGA-A8-A07B-01
TCGA-A8-A07C-01	Stage IIA	57	2	Stage IIA	580		Negative	FEMALE	Negative				Negative	M0	Negative	N0	580	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07C-01	1034	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 14	TCGA-A8-A07C	1034	0	days	1034	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Outer Quadrant			TCGA-A8-A07C-F40824	TCGA-A8-A07C	TCGA-A8-A07C-01A		Negative					Negative	Other					-20820	637		0	1034										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71.pdf	A07C	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	19d713e8-e754-44a4-9b23-0ef70f5d6b44		19d713e8-e754-44a4-9b23-0ef70f5d6b44			TCGA-A8-A07C-01A-11D-A045-09		TCGA-A8-A07C-01					TCGA-A8-A07C-01A-11D-A045-09	TCGA-A8-A07C-01A-11D-A032-05			TCGA-A8-A07C-01A-11D-A045-09	TCGA-A8-A07C-01	19d713e8-e754-44a4-9b23-0ef70f5d6b44	TCGA-A8-A07C-01			TCGA-A8-A07C-01A-11R-A034-07	19d713e8-e754-44a4-9b23-0ef70f5d6b44		TCGA-A8-A07C-01
TCGA-A8-A07E-01	Stage X	81	2	Stage IIIC	608		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N3	608	0	LumA	Luminal A	Positive	ReacII	-4	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A07E-01	608	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A07E	608	0	days	608	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Left Upper Outer Quadrant			TCGA-A8-A07E-F40825	TCGA-A8-A07E	TCGA-A8-A07E-01A		Positive					Positive	Other					-29800	545		0	608										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			260	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO			false	Yes	MX	N3a	T4b	Stage X	TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7.pdf	A07E	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	3510559d-33b7-423a-88c9-d8c42270d546	16f17633-0917-4fe4-bea8-a1301a37bcc9	3510559d-33b7-423a-88c9-d8c42270d546	16f17633-0917-4fe4-bea8-a1301a37bcc9	TCGA-A8-A07E-01A-21-A13B-20	TCGA-A8-A07E-01A-11W-A050-09		TCGA-A8-A07E-01			857d3ad8-e3a8-4366-8f34-2b89be3dd24c	TCGA-A8-A07E-01	TCGA-A8-A07E-01A-11W-A050-09	TCGA-A8-A07E-01A-11D-A032-05	TCGA-A8-A07E-01		TCGA-A8-A07E-01A-11W-A050-09	TCGA-A8-A07E-01	3510559d-33b7-423a-88c9-d8c42270d546	TCGA-A8-A07E-01	TCGA-A8-A07E-01A-11D-A036-01		TCGA-A8-A07E-01A-11R-A034-07	3510559d-33b7-423a-88c9-d8c42270d546	TCGA-A8-A07E-01A-11D-A036-01	TCGA-A8-A07E-01
TCGA-A8-A07F-01	Stage IIB	65	2	Stage IIB	576		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N1	576	0	LumA	Luminal A	Positive	ReacI	-1	-1	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07F-01	577	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-A8-A07F	577	0	days	577	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Outer Quadrant			TCGA-A8-A07F-F40826	TCGA-A8-A07F	TCGA-A8-A07F-01A		Positive					Positive	Other					-23742	453		0	577										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			150	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO			false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156.pdf	A07F	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	f6fd41e3-c597-4c5d-8f47-a315be0330f8	1609caae-f341-4227-ac2a-a76a6c253e95	f6fd41e3-c597-4c5d-8f47-a315be0330f8	1609caae-f341-4227-ac2a-a76a6c253e95	TCGA-A8-A07F-01A-21-A13B-20	TCGA-A8-A07F-01A-11W-A019-09		TCGA-A8-A07F-01			4d97ec15-8bf1-4bc7-9bc9-4ef5c58f1fbc	TCGA-A8-A07F-01	TCGA-A8-A07F-01A-11W-A019-09	TCGA-A8-A07F-01A-11D-A00Y-05	TCGA-A8-A07F-01		TCGA-A8-A07F-01A-11W-A019-09	TCGA-A8-A07F-01	f6fd41e3-c597-4c5d-8f47-a315be0330f8	TCGA-A8-A07F-01	TCGA-A8-A07F-01A-11D-A011-01		TCGA-A8-A07F-01A-11R-A00Z-07	f6fd41e3-c597-4c5d-8f47-a315be0330f8	TCGA-A8-A07F-01A-11D-A011-01	TCGA-A8-A07F-01
TCGA-A8-A07G-01	Stage IIA	65	3	Stage IIA	576		Positive	FEMALE	Negative				Negative	M0	Positive	N1	576	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-A8-A07G-01	577	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A07G	577	0	days	577	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Upper Outer Quadrant			TCGA-A8-A07G-F40827	TCGA-A8-A07G			Positive					Positive	Other					-23926			0	577										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO				No	M0	N1a	T1c	Stage IIA		A07G	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	aad6a297-72fe-4483-8c81-b7bef2522437	acf17ee7-c238-4602-9ec3-855c8d334089	aad6a297-72fe-4483-8c81-b7bef2522437	acf17ee7-c238-4602-9ec3-855c8d334089		TCGA-A8-A07G-01A-11W-A050-09		TCGA-A8-A07G-01				TCGA-A8-A07G-01	TCGA-A8-A07G-01A-11W-A050-09	TCGA-A8-A07G-01A-11D-A032-05	TCGA-A8-A07G-01		TCGA-A8-A07G-01A-11W-A050-09	TCGA-A8-A07G-01	aad6a297-72fe-4483-8c81-b7bef2522437	TCGA-A8-A07G-01	TCGA-A8-A07G-01A-11D-A036-01		TCGA-A8-A07G-01A-11R-A034-07	aad6a297-72fe-4483-8c81-b7bef2522437	TCGA-A8-A07G-01A-11D-A036-01	TCGA-A8-A07G-01
TCGA-A8-A07I-01	Stage IIIA	69	3	Stage IIIA	426		Positive	FEMALE	Positive	1	1	1	Negative	M0	Positive	N2	426	0	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07I-01	426	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A07I	426	0	days	426	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Outer Quadrant			TCGA-A8-A07I-F40828	TCGA-A8-A07I	TCGA-A8-A07I-01A		Positive					Negative	Other					-25263	302		0	426										2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO			false	No	M0	N2a	T2	Stage IIIA	TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B.pdf	A07I	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	670eab31-e873-4404-bbff-1b427e7b80c1	8c976a66-2f34-4441-8f79-a13136e1dbe7	670eab31-e873-4404-bbff-1b427e7b80c1	8c976a66-2f34-4441-8f79-a13136e1dbe7	TCGA-A8-A07I-01A-21-A13B-20	TCGA-A8-A07I-01A-11W-A019-09		TCGA-A8-A07I-01			f8e3aadc-06b2-43d4-9cdb-a3c285bedaee	TCGA-A8-A07I-01	TCGA-A8-A07I-01A-11W-A019-09	TCGA-A8-A07I-01A-11D-A00Y-05	TCGA-A8-A07I-01		TCGA-A8-A07I-01A-11W-A019-09	TCGA-A8-A07I-01	670eab31-e873-4404-bbff-1b427e7b80c1	TCGA-A8-A07I-01	TCGA-A8-A07I-01A-11D-A011-01		TCGA-A8-A07I-01A-11R-A00Z-07	670eab31-e873-4404-bbff-1b427e7b80c1	TCGA-A8-A07I-01A-11D-A011-01	TCGA-A8-A07I-01
TCGA-A8-A07J-01	Stage IIB	35	2	Stage IIB	365		Positive	FEMALE	Negative				Negative	M0	Positive	N1	365	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07J-01	365	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A07J	365	0	days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Outer Quadrant			TCGA-A8-A07J-F40829	TCGA-A8-A07J	TCGA-A8-A07J-01A		Positive					Positive	Other					-12965	241		0	365										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO			false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A07J.2243F29C-191C-4D33-8483-09BB3AD36598.pdf	A07J	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	8990de9b-eee2-4d3c-9711-87bdf6019586	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	8990de9b-eee2-4d3c-9711-87bdf6019586		TCGA-A8-A07J-01A-11W-A019-09		TCGA-A8-A07J-01				TCGA-A8-A07J-01	TCGA-A8-A07J-01A-11W-A019-09	TCGA-A8-A07J-01A-11D-A00Y-05	TCGA-A8-A07J-01		TCGA-A8-A07J-01A-11W-A019-09	TCGA-A8-A07J-01	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	TCGA-A8-A07J-01	TCGA-A8-A07J-01A-11D-A011-01		TCGA-A8-A07J-01A-11R-A00Z-07	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	TCGA-A8-A07J-01A-11D-A011-01	TCGA-A8-A07J-01
TCGA-A8-A07L-01	Stage IIIA	58	4	Stage IIIA	517		Positive	FEMALE	Negative				Negative	M0	Positive	N1	517	0	LumB	Luminal B	Positive		-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A07L-01	975	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 12	TCGA-A8-A07L	975	0	days	975	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant			TCGA-A8-A07L-F40830	TCGA-A8-A07L	TCGA-A8-A07L-01A		Positive					Positive	Other					-21428	394		0	975										2013-3-2	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO			false	No	M0	N1a	T3	Stage IIIA	TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851.pdf	A07L	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	76cbecbe-22ef-479a-9306-2f09e1d87757	11e4ced1-680d-482e-85fc-0a518c4f3e81	76cbecbe-22ef-479a-9306-2f09e1d87757	11e4ced1-680d-482e-85fc-0a518c4f3e81		TCGA-A8-A07L-01A-11W-A019-09		TCGA-A8-A07L-01				TCGA-A8-A07L-01	TCGA-A8-A07L-01A-11W-A019-09	TCGA-A8-A07L-01A-11D-A00Y-05	TCGA-A8-A07L-01		TCGA-A8-A07L-01A-11W-A019-09	TCGA-A8-A07L-01	76cbecbe-22ef-479a-9306-2f09e1d87757	TCGA-A8-A07L-01	TCGA-A8-A07L-01A-11D-A011-01		TCGA-A8-A07L-01A-11R-A040-07	76cbecbe-22ef-479a-9306-2f09e1d87757	TCGA-A8-A07L-01A-11D-A011-01	TCGA-A8-A07L-01
TCGA-A8-A07O-01	Stage IIA	51	1	Stage IIA	304		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	304	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07O-01	304	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07O	304	0	days	304	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Outer Quadrant			TCGA-A8-A07O-F40831	TCGA-A8-A07O	TCGA-A8-A07O-01A		Negative					Negative	Other					-18870	180		0	304										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			220	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf	A07O	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	TCGA-A8-A07O-01A-21-A13B-20	TCGA-A8-A07O-01A-11W-A019-09		TCGA-A8-A07O-01			d7dd9819-8523-4dff-8ffb-689d37a73368	TCGA-A8-A07O-01	TCGA-A8-A07O-01A-11W-A019-09	TCGA-A8-A07O-01A-11D-A00Y-05	TCGA-A8-A07O-01		TCGA-A8-A07O-01A-11W-A019-09	TCGA-A8-A07O-01	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA-A8-A07O-01	TCGA-A8-A07O-01A-11D-A011-01		TCGA-A8-A07O-01A-11R-A00Z-07	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA-A8-A07O-01A-11D-A011-01	TCGA-A8-A07O-01
TCGA-A8-A07P-01	Stage IIB	68	4	Stage IIB	334		Positive	FEMALE	Positive	4	3	3	Negative	M0	Positive	N1	334	0	LumA	Luminal A	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07P-01	334	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A07P			days	334	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Upper Outer Quadrant			TCGA-A8-A07P-F40832	TCGA-A8-A07P	TCGA-A8-A07P-01A		Positive					Positive	Other					-24929	210		0	334										2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			120	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2											false	No	M0	N1	T2	Stage IIB	TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959.pdf	A07P	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	5a7e3234-ced9-46cb-ac95-cbf4c9ef1d85	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	5a7e3234-ced9-46cb-ac95-cbf4c9ef1d85	TCGA-A8-A07P-01A-21-A13B-20	TCGA-A8-A07P-01A-11W-A019-09		TCGA-A8-A07P-01			00703e0f-8964-4b44-a5f3-d1246e5358ff	TCGA-A8-A07P-01	TCGA-A8-A07P-01A-11W-A019-09	TCGA-A8-A07P-01A-11D-A00Y-05	TCGA-A8-A07P-01		TCGA-A8-A07P-01A-11W-A019-09	TCGA-A8-A07P-01	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	TCGA-A8-A07P-01	TCGA-A8-A07P-01A-11D-A011-01		TCGA-A8-A07P-01A-11R-A00Z-07	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	TCGA-A8-A07P-01A-11D-A011-01	TCGA-A8-A07P-01
TCGA-A8-A07R-01	Stage IIIC	80	3	Stage IIIC	273		Negative	FEMALE	Equivocal	2	2	2	Negative	M0	Positive	N3	273	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07R-01	273	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07R			days	273	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left Upper Outer Quadrant				TCGA-A8-A07R			Negative					Negative	Other					-29251			0	273										2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Positive				Positive																					5	4												No	M0	N3a	T2	Stage IIIC		A07R												Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	b5e9e344-a813-442e-8bd4-504111e98c0b	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	b5e9e344-a813-442e-8bd4-504111e98c0b	TCGA-A8-A07R-01A-12-A13B-20	TCGA-A8-A07R-01A-21W-A050-09		TCGA-A8-A07R-01			f547b351-f375-4f31-970f-40e006020b01	TCGA-A8-A07R-01	TCGA-A8-A07R-01A-21W-A050-09	TCGA-A8-A07R-01A-21D-A032-05	TCGA-A8-A07R-01		TCGA-A8-A07R-01A-21W-A050-09	TCGA-A8-A07R-01	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA-A8-A07R-01	TCGA-A8-A07R-01A-21D-A036-01		TCGA-A8-A07R-01A-21R-A034-07	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA-A8-A07R-01A-21D-A036-01	TCGA-A8-A07R-01
TCGA-A8-A07S-01	Stage IIA	73	2	Stage IIA	242		Positive	FEMALE	Negative				Negative	M0	Negative	N0	242	0	LumB	Luminal B	Negative	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07S-01	243	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7		TCGA-A8-A07S	243	0	days	243	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Upper Outer Quadrant			TCGA-A8-A07S-F40833	TCGA-A8-A07S	TCGA-A8-A07S-01A		Positive					Negative	Other					-26998	119		0	243										2013-3-2	FEMALE										Mixed Histology (please specify)	lobular/ductal	No		C50.9	8522/3	C50.9		YES			220	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A.pdf	A07S	WITH TUMOR						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	15acd388-f958-4f43-bc38-39bab4cb830e	3d19e369-66d9-425c-b692-b82da1c5455a	15acd388-f958-4f43-bc38-39bab4cb830e	3d19e369-66d9-425c-b692-b82da1c5455a	TCGA-A8-A07S-01A-22-A13B-20			TCGA-A8-A07S-01			a86ad293-8480-4f2f-b3d2-6f59fa709d03	TCGA-A8-A07S-01		TCGA-A8-A07S-01A-11D-A032-05	TCGA-A8-A07S-01			TCGA-A8-A07S-01	15acd388-f958-4f43-bc38-39bab4cb830e	TCGA-A8-A07S-01	TCGA-A8-A07S-01A-11D-A036-01		TCGA-A8-A07S-01A-11R-A034-07	15acd388-f958-4f43-bc38-39bab4cb830e	TCGA-A8-A07S-01A-11D-A036-01	TCGA-A8-A07S-01
TCGA-A8-A07U-01	Stage IIIA	66	3	Stage IIIA	303		Negative	FEMALE	Negative				Negative	M0	Positive	N2	303	0	Basal	Basal-like	Positive		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07U-01	760	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-A8-A07U	760	0	days	760	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant			TCGA-A8-A07U-F40834	TCGA-A8-A07U	TCGA-A8-A07U-01A		Negative					Positive	Other					-24411	210		0	760										2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO			false	No	M0	N2a	T2	Stage IIIA	TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A.pdf	A07U	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	77daa4a6-93c2-4455-a173-ead372d92010	b010bf66-762b-4080-9427-130a56fe2760	77daa4a6-93c2-4455-a173-ead372d92010	b010bf66-762b-4080-9427-130a56fe2760		TCGA-A8-A07U-01A-11W-A050-09		TCGA-A8-A07U-01				TCGA-A8-A07U-01	TCGA-A8-A07U-01A-11W-A050-09	TCGA-A8-A07U-01A-11D-A032-05	TCGA-A8-A07U-01		TCGA-A8-A07U-01A-11W-A050-09	TCGA-A8-A07U-01	77daa4a6-93c2-4455-a173-ead372d92010	TCGA-A8-A07U-01	TCGA-A8-A07U-01A-11D-A036-01		TCGA-A8-A07U-01A-11R-A034-07	77daa4a6-93c2-4455-a173-ead372d92010	TCGA-A8-A07U-01A-11D-A036-01	TCGA-A8-A07U-01
TCGA-A8-A07W-01	Stage IV	76	3	Stage IV	304		Positive	FEMALE	Negative	1	1	4	Positive	M1	Negative	N0	304	0	LumB	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07W-01	304	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07W			days	304	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant			TCGA-A8-A07W-F40835	TCGA-A8-A07W	TCGA-A8-A07W-01A		Positive					Positive	Other					-27942	180		0	304										2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4											false	No	M1	NX	T2	Stage IV	TCGA-A8-A07W.C39563FD-CD7F-47C6-A257-5CB70A01C67C.pdf	A07W	WITH TUMOR						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	03403807-a06f-4d79-ac2d-2d494d4fabee	3e06faf7-1e08-4c15-9aee-8891de8cad5c	03403807-a06f-4d79-ac2d-2d494d4fabee	3e06faf7-1e08-4c15-9aee-8891de8cad5c	TCGA-A8-A07W-01A-21-A13A-20	TCGA-A8-A07W-01A-11W-A019-09		TCGA-A8-A07W-01			e407dd09-754f-4167-b2cf-391893051541	TCGA-A8-A07W-01	TCGA-A8-A07W-01A-11W-A019-09	TCGA-A8-A07W-01A-11D-A00Y-05	TCGA-A8-A07W-01		TCGA-A8-A07W-01A-11W-A019-09	TCGA-A8-A07W-01	03403807-a06f-4d79-ac2d-2d494d4fabee	TCGA-A8-A07W-01	TCGA-A8-A07W-01A-11D-A011-01		TCGA-A8-A07W-01A-11R-A00Z-07	03403807-a06f-4d79-ac2d-2d494d4fabee	TCGA-A8-A07W-01A-11D-A011-01	TCGA-A8-A07W-01
TCGA-A8-A07Z-01	Stage IIA	85	3	Stage IIA	853		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	853	0		Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07Z-01	1371	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A07Z	1371	0	days	1371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					85	Left			TCGA-A8-A07Z-F40836	TCGA-A8-A07Z	TCGA-A8-A07Z-01A		Positive					Positive	Other					-31351	698		0	1371										2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A07Z.DD558354-3BF1-4037-881E-011E6BFC0987.pdf	A07Z	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	5ea9f45c-2863-4516-a5a2-057ff494b14e	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	5ea9f45c-2863-4516-a5a2-057ff494b14e	TCGA-A8-A07Z-01A-21-A13A-20	TCGA-A8-A07Z-01A-11W-A019-09		TCGA-A8-A07Z-01			a0ca1a15-ed13-4ba7-9565-604073ec88a3	TCGA-A8-A07Z-01	TCGA-A8-A07Z-01A-11W-A019-09	TCGA-A8-A07Z-01A-11D-A00Y-05	TCGA-A8-A07Z-01		TCGA-A8-A07Z-01A-11W-A019-09	TCGA-A8-A07Z-01	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	TCGA-A8-A07Z-01	TCGA-A8-A07Z-01A-11D-A011-01		TCGA-A8-A07Z-01A-11R-A00Z-07	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	TCGA-A8-A07Z-01A-11D-A011-01	TCGA-A8-A07Z-01
TCGA-A8-A081-01	Stage IIA	80	5	Stage IIA	0		Positive	FEMALE	Negative	1	1	1	Negative	M0	Negative	N0	0	0	LumB	HER2-enriched	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING		TCGA-A8-A081-01			days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A8-A081			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right				TCGA-A8-A081	TCGA-A8-A081-01A		Positive					Positive	Other					-29555	637		0	0										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			150	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62.pdf	A081	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	c88b614b-811e-42f9-86e3-10909ced98e7	fe041229-97be-4bac-9294-04b42df07890	c88b614b-811e-42f9-86e3-10909ced98e7	fe041229-97be-4bac-9294-04b42df07890	TCGA-A8-A081-01A-21-A13A-20	TCGA-A8-A081-01A-11W-A019-09		TCGA-A8-A081-01			8392c9cd-b36d-4cb2-887b-8fa3c219d843	TCGA-A8-A081-01	TCGA-A8-A081-01A-11W-A019-09	TCGA-A8-A081-01A-11D-A00Y-05	TCGA-A8-A081-01		TCGA-A8-A081-01A-11W-A019-09	TCGA-A8-A081-01	c88b614b-811e-42f9-86e3-10909ced98e7	TCGA-A8-A081-01	TCGA-A8-A081-01A-11D-A011-01		TCGA-A8-A081-01A-11R-A00Z-07	c88b614b-811e-42f9-86e3-10909ced98e7	TCGA-A8-A081-01A-11D-A011-01	TCGA-A8-A081-01
TCGA-A8-A082-01	Stage IIB	58	4	Stage IIB	549		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	549	0	LumB	Luminal B	Positive	LumA	-9	-3	enrollment	T_Other	T2	LIVING		TCGA-A8-A082-01			days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A8-A082			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right			TCGA-A8-A082-F40837	TCGA-A8-A082	TCGA-A8-A082-01A		Positive					Positive	Other					-21338	606		0	-31										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO			false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C.pdf	A082	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	2fd81438-46a2-42f5-910e-728faea3872a	4b289590-8f98-4153-a0e8-1d59e7d3260c	2fd81438-46a2-42f5-910e-728faea3872a	4b289590-8f98-4153-a0e8-1d59e7d3260c	TCGA-A8-A082-01A-21-A13A-20	TCGA-A8-A082-01A-11W-A019-09		TCGA-A8-A082-01			a9d13722-7419-4250-a943-ccb78a486228	TCGA-A8-A082-01	TCGA-A8-A082-01A-11W-A019-09	TCGA-A8-A082-01A-11D-A00Y-05	TCGA-A8-A082-01		TCGA-A8-A082-01A-11W-A019-09	TCGA-A8-A082-01	2fd81438-46a2-42f5-910e-728faea3872a	TCGA-A8-A082-01	TCGA-A8-A082-01A-11D-A011-01		TCGA-A8-A082-01A-11R-A00Z-07	2fd81438-46a2-42f5-910e-728faea3872a	TCGA-A8-A082-01A-11D-A011-01	TCGA-A8-A082-01
TCGA-A8-A083-01	Stage IIB	67	2	Stage IIB	0		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T3	LIVING		TCGA-A8-A083-01			days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A083			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left				TCGA-A8-A083	TCGA-A8-A083-01A		Positive					Positive	Other					-24746	575		0	0										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			300	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2											false	No	M0	N0	T3	Stage IIB	TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517.pdf	A083	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	72b7ab0e-81e0-4385-8125-5146243e21ac	0d197013-8a77-4839-a2ad-bc70650613eb	72b7ab0e-81e0-4385-8125-5146243e21ac	0d197013-8a77-4839-a2ad-bc70650613eb	TCGA-A8-A083-01A-11-A13A-20	TCGA-A8-A083-01A-21W-A019-09		TCGA-A8-A083-01			503f0e18-bc85-4950-bba1-b55d4c29760a	TCGA-A8-A083-01	TCGA-A8-A083-01A-21W-A019-09	TCGA-A8-A083-01A-21D-A00Y-05	TCGA-A8-A083-01		TCGA-A8-A083-01A-21W-A019-09	TCGA-A8-A083-01	72b7ab0e-81e0-4385-8125-5146243e21ac	TCGA-A8-A083-01	TCGA-A8-A083-01A-21D-A011-01		TCGA-A8-A083-01A-21R-A00Z-07	72b7ab0e-81e0-4385-8125-5146243e21ac	TCGA-A8-A083-01A-21D-A011-01	TCGA-A8-A083-01
TCGA-A8-A084-01	Stage IIB	81	1	No_Conversion	458		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	458	0	LumB	Luminal B	Negative	X	-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A084-01	458	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A8-A084			days	458	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Left			TCGA-A8-A084-F40838	TCGA-A8-A084	TCGA-A8-A084-01A		Positive					Negative	Other					-29858	1033		0	458										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			270	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	3											false	Yes	M0	N1a	T2	Stage IIB	TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B.pdf	A084	WITH TUMOR						NO				YES	Primary Tumor	01	Surgical resection	5th		NO	YES	A8	Breast	A	LIVING	2007	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	5b2d8ac0-cdb6-486f-bbad-3555c216ab0a	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	5b2d8ac0-cdb6-486f-bbad-3555c216ab0a	TCGA-A8-A084-01A-11-A13A-20	TCGA-A8-A084-01A-21W-A019-09		TCGA-A8-A084-01			adfcebcc-edf7-4351-ba59-e1fea8580893	TCGA-A8-A084-01	TCGA-A8-A084-01A-21W-A019-09	TCGA-A8-A084-01A-21D-A00Y-05	TCGA-A8-A084-01		TCGA-A8-A084-01A-21W-A019-09		2f2fe990-f8f6-4904-b3d5-083e17a7a29d		TCGA-A8-A084-01A-21D-A011-01		TCGA-A8-A084-01A-21R-A00Z-07	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	TCGA-A8-A084-01A-21D-A011-01	TCGA-A8-A084-01
TCGA-A8-A085-01	Stage IIB	44	5	Stage IIB	1124		Positive	MALE	Negative	1	3	4	Negative	M0	Positive	N1	1124	0	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A085-01	1124	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A085	1124	0	days	1124	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left			TCGA-A8-A085-F40839	TCGA-A8-A085	TCGA-A8-A085-01A		Positive					Positive	Other					-16377	788		0	1124										2013-3-2	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Negative																					4	2								NO			false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E.pdf	A085	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	4be8001c-c6a2-420c-8761-93469a6a7904	03b447b0-d92c-4d78-a496-fcf20be55ce5	4be8001c-c6a2-420c-8761-93469a6a7904	03b447b0-d92c-4d78-a496-fcf20be55ce5	TCGA-A8-A085-01A-21-A13B-20	TCGA-A8-A085-01A-11W-A019-09		TCGA-A8-A085-01			96e8bae5-7cde-475e-b1ba-ec2ac2efeb6e	TCGA-A8-A085-01	TCGA-A8-A085-01A-11W-A019-09	TCGA-A8-A085-01A-11D-A00Y-05	TCGA-A8-A085-01		TCGA-A8-A085-01A-11W-A019-09	TCGA-A8-A085-01	4be8001c-c6a2-420c-8761-93469a6a7904	TCGA-A8-A085-01	TCGA-A8-A085-01A-11D-A011-01		TCGA-A8-A085-01A-11R-A00Z-07	4be8001c-c6a2-420c-8761-93469a6a7904	TCGA-A8-A085-01A-11D-A011-01	TCGA-A8-A085-01
TCGA-A8-A086-01	Stage IIA	59	5	Stage IIA	396		Positive	FEMALE	Negative	2	3	3	Negative	M0	Positive	N1	396	0	LumA	Luminal A	Positive	LumA	-9	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A086-01	396	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A8-A086	396	0	days	396	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right			TCGA-A8-A086-F40840	TCGA-A8-A086	TCGA-A8-A086-01A		Positive					Positive	Other					-21731	272		0	396										2013-3-2	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			150	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	5								NO			false	No	M0	N1a	T1c	Stage IIA	TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8.pdf	A086	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	7347a336-6248-47be-817b-88543164d564	064b8a58-45eb-4abe-8627-5b4a8c69e6c7	7347a336-6248-47be-817b-88543164d564	064b8a58-45eb-4abe-8627-5b4a8c69e6c7	TCGA-A8-A086-01A-21-A13B-20	TCGA-A8-A086-01A-11W-A019-09		TCGA-A8-A086-01			faed055f-e054-4c59-953f-c118dd531f04	TCGA-A8-A086-01	TCGA-A8-A086-01A-11W-A019-09	TCGA-A8-A086-01A-11D-A00Y-05	TCGA-A8-A086-01		TCGA-A8-A086-01A-11W-A019-09	TCGA-A8-A086-01	7347a336-6248-47be-817b-88543164d564	TCGA-A8-A086-01	TCGA-A8-A086-01A-11D-A011-01		TCGA-A8-A086-01A-11R-A00Z-07	7347a336-6248-47be-817b-88543164d564	TCGA-A8-A086-01A-11D-A011-01	TCGA-A8-A086-01
TCGA-A8-A08A-01	Stage I	89	2	Stage I	30		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	30	0		Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A08A-01	30	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A08A			days	30	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					89	Left Upper Inner Quadrant				TCGA-A8-A08A	TCGA-A8-A08A-01A		Positive					Positive	Other					-32750	1033		0	30										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			160	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2											false	No	M0	N0	T1c	Stage I	TCGA-A8-A08A.6D2212CE-C80F-4545-A895-3F1B6E4C6DB6.pdf	A08A	TUMOR FREE											Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	46a7082e-19e7-4f1a-806b-31c2db120c34	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	46a7082e-19e7-4f1a-806b-31c2db120c34	TCGA-A8-A08A-01A-21-A13A-20	TCGA-A8-A08A-01A-11W-A019-09		TCGA-A8-A08A-01			80af2202-8a16-4cb7-8556-5ff94a042038	TCGA-A8-A08A-01	TCGA-A8-A08A-01A-11W-A019-09	TCGA-A8-A08A-01A-11D-A00Y-05	TCGA-A8-A08A-01		TCGA-A8-A08A-01A-11W-A019-09	TCGA-A8-A08A-01	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	TCGA-A8-A08A-01	TCGA-A8-A08A-01A-11D-A011-01		TCGA-A8-A08A-01A-11R-A00Z-07	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	TCGA-A8-A08A-01A-11D-A011-01	TCGA-A8-A08A-01
TCGA-A8-A08B-01	Stage IIA	52	3	Stage IIA	702		Positive	FEMALE	Positive				Negative	M0	Negative	N0	702	0	Her2	HER2-enriched	Negative		-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08B-01	1156	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 7	mutation cluster 4	TCGA-A8-A08B	1156	0	days	1156	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Inner Quadrant			TCGA-A8-A08B-F40841	TCGA-A8-A08B	TCGA-A8-A08B-01A		Positive					Negative	Other					-19114	759		0	1156										2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	7								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80.pdf	A08B	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	0307bd0b-b59a-4996-b89d-612e72652890	95a462db-8ab9-4a3e-8463-0927b77a9a93	0307bd0b-b59a-4996-b89d-612e72652890	95a462db-8ab9-4a3e-8463-0927b77a9a93		TCGA-A8-A08B-01A-11W-A019-09		TCGA-A8-A08B-01				TCGA-A8-A08B-01	TCGA-A8-A08B-01A-11W-A019-09	TCGA-A8-A08B-01A-11D-A00Y-05	TCGA-A8-A08B-01		TCGA-A8-A08B-01A-11W-A019-09	TCGA-A8-A08B-01	0307bd0b-b59a-4996-b89d-612e72652890	TCGA-A8-A08B-01	TCGA-A8-A08B-01A-11D-A011-01		TCGA-A8-A08B-01A-11R-A00Z-07	0307bd0b-b59a-4996-b89d-612e72652890	TCGA-A8-A08B-01A-11D-A011-01	TCGA-A8-A08B-01
TCGA-A8-A08C-01	Stage IIA	65	2	Stage IIA	607		Positive	FEMALE	Negative				Negative	M0	Negative	N0	607	0	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08C-01	881	0	days	BRCA-LUAD+		cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7				TCGA-A8-A08C	881	0	days	881	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Inner Quadrant			TCGA-A8-A08C-F40842	TCGA-A8-A08C	TCGA-A8-A08C-01A		Positive					Positive	Other					-24017	484		0	881										2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2									NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06.pdf	A08C	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	22c2050e-587d-4dc3-8955-9578bdd050d9	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	22c2050e-587d-4dc3-8955-9578bdd050d9				TCGA-A8-A08C-01				TCGA-A8-A08C-01	TCGA-A8-A08C-01A-11W-A019-09	TCGA-A8-A08C-01A-11D-A00Y-05	TCGA-A8-A08C-01		TCGA-A8-A08C-01A-11W-A019-09		7c8b9d9a-653a-4dc7-8c53-b196fbd0482a		TCGA-A8-A08C-01A-11D-A011-01		TCGA-A8-A08C-01A-11R-A00Z-07	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	TCGA-A8-A08C-01A-11D-A011-01	TCGA-A8-A08C-01
TCGA-A8-A08F-01	Stage IIIC	59	4	Stage IIIC	549		Positive	FEMALE	Negative				Negative	M0	Positive	N3	549	0	LumB	Luminal B	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08F-01	1004	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A08F	1004	0	days	1004	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right Upper Inner Quadrant			TCGA-A8-A08F-F40843	TCGA-A8-A08F	TCGA-A8-A08F-01A		Positive					Positive	Other					-21641	637		0	1004										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2									NO			false	Yes	M0	N3a	T2	Stage IIIC	TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647.pdf	A08F	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	523e45c2-4f98-4010-b48e-bdbda62865cf	91094862-5aee-4304-b503-12a163a52532	523e45c2-4f98-4010-b48e-bdbda62865cf	91094862-5aee-4304-b503-12a163a52532		TCGA-A8-A08F-01A-11W-A019-09		TCGA-A8-A08F-01				TCGA-A8-A08F-01	TCGA-A8-A08F-01A-11W-A019-09	TCGA-A8-A08F-01A-11D-A00Y-05	TCGA-A8-A08F-01		TCGA-A8-A08F-01A-11W-A019-09		523e45c2-4f98-4010-b48e-bdbda62865cf		TCGA-A8-A08F-01A-11D-A011-01		TCGA-A8-A08F-01A-11R-A00Z-07	523e45c2-4f98-4010-b48e-bdbda62865cf	TCGA-A8-A08F-01A-11D-A011-01	TCGA-A8-A08F-01
TCGA-A8-A08G-01	Stage IIA	41	3	Stage IIA	606		Positive	FEMALE	Positive	3	3	4	Negative	M0	Negative	N0	606	0	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08G-01	607	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A08G	607	0	days	607	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Inner Quadrant			TCGA-A8-A08G-F40844	TCGA-A8-A08G	TCGA-A8-A08G-01A		Positive					Positive	Other					-14976	422		0	607										2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7.pdf	A08G	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	0584b467-a0f7-45fd-9948-9a01318d34bd	d46db8e4-b4f2-4a38-b4f1-57bb62d5c989	0584b467-a0f7-45fd-9948-9a01318d34bd	d46db8e4-b4f2-4a38-b4f1-57bb62d5c989	TCGA-A8-A08G-01A-21-A13B-20	TCGA-A8-A08G-01A-11W-A019-09		TCGA-A8-A08G-01			df81dd47-6e43-495c-ad4a-e3347a9d233e	TCGA-A8-A08G-01	TCGA-A8-A08G-01A-11W-A019-09	TCGA-A8-A08G-01A-11D-A00Y-05	TCGA-A8-A08G-01		TCGA-A8-A08G-01A-11W-A019-09	TCGA-A8-A08G-01	0584b467-a0f7-45fd-9948-9a01318d34bd	TCGA-A8-A08G-01	TCGA-A8-A08G-01A-11D-A011-01		TCGA-A8-A08G-01A-11R-A00Z-07	0584b467-a0f7-45fd-9948-9a01318d34bd	TCGA-A8-A08G-01A-11D-A011-01	TCGA-A8-A08G-01
TCGA-A8-A08H-01	Stage IIA	66	1	Stage IIA	0		Positive	FEMALE	Positive	1	4	3	Negative	M0	Negative	N0	0	0	Normal	Basal-like	Positive	ReacI	-5	-8	enrollment	T_Other	T2	LIVING		TCGA-A8-A08H-01			days	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A08H			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Inner Quadrant				TCGA-A8-A08H	TCGA-A8-A08H-01A		Positive					Positive	Other					-24137	1184		0	0										2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			250	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7.pdf	A08H	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	9c5eb452-caec-4a9a-9ced-215be92c91d2	b091515b-e33a-4f0b-bc81-72dad7fb5414	9c5eb452-caec-4a9a-9ced-215be92c91d2	b091515b-e33a-4f0b-bc81-72dad7fb5414	TCGA-A8-A08H-01A-11-A13B-20	TCGA-A8-A08H-01A-21W-A019-09		TCGA-A8-A08H-01			1ff81e2a-4af2-471e-805a-073a952b5b0e	TCGA-A8-A08H-01	TCGA-A8-A08H-01A-21W-A019-09	TCGA-A8-A08H-01A-21D-A00Y-05	TCGA-A8-A08H-01		TCGA-A8-A08H-01A-21W-A019-09	TCGA-A8-A08H-01	9c5eb452-caec-4a9a-9ced-215be92c91d2	TCGA-A8-A08H-01	TCGA-A8-A08H-01A-21D-A011-01		TCGA-A8-A08H-01A-21R-A00Z-07	9c5eb452-caec-4a9a-9ced-215be92c91d2	TCGA-A8-A08H-01A-21D-A011-01	TCGA-A8-A08H-01
TCGA-A8-A08I-01	Stage IIA	53	4	Stage IIA	365		Positive	FEMALE	Negative				Negative	M0	Negative	N0	365	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08I-01	365	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08I	365	0	days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Inner Quadrant			TCGA-A8-A08I-F40845	TCGA-A8-A08I	TCGA-A8-A08I-01A		Positive					Positive	Other					-19389	241		0	365										2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	3								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6.pdf	A08I	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	3e853cb1-4747-4f98-be64-d5de7fba801e	6527b4d3-3706-41e5-8106-55ed4981f593	3e853cb1-4747-4f98-be64-d5de7fba801e	6527b4d3-3706-41e5-8106-55ed4981f593		TCGA-A8-A08I-01A-11W-A019-09		TCGA-A8-A08I-01				TCGA-A8-A08I-01	TCGA-A8-A08I-01A-11W-A019-09	TCGA-A8-A08I-01A-11D-A00Y-05	TCGA-A8-A08I-01		TCGA-A8-A08I-01A-11W-A019-09	TCGA-A8-A08I-01	3e853cb1-4747-4f98-be64-d5de7fba801e	TCGA-A8-A08I-01	TCGA-A8-A08I-01A-11D-A011-01		TCGA-A8-A08I-01A-11R-A00Z-07	3e853cb1-4747-4f98-be64-d5de7fba801e	TCGA-A8-A08I-01A-11D-A011-01	TCGA-A8-A08I-01
TCGA-A8-A08J-01	Stage IV	52	5	Stage IV	1127	1127	Positive	FEMALE	Negative	1	1	1	Positive	M1	Positive	N3	1127	1	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T4	DECEASED	1	TCGA-A8-A08J-01	1127	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-A8-A08J			days	1127	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right			TCGA-A8-A08J-F40846	TCGA-A8-A08J	TCGA-A8-A08J-01A		Positive					Negative	Other					-19266	1733	1127	0											2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES			630	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4											false	No	M1	N3	T4b	Stage IV	TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0.pdf	A08J	WITH TUMOR										NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2005	67e019fc-65c4-4274-a0f7-5a92f0f87bba	d3063866-3dfe-4bb7-a0ae-e59b059dc816	67e019fc-65c4-4274-a0f7-5a92f0f87bba	d3063866-3dfe-4bb7-a0ae-e59b059dc816	TCGA-A8-A08J-01A-21-A13A-20	TCGA-A8-A08J-01A-11W-A019-09		TCGA-A8-A08J-01			c8144900-30dc-4081-882a-4dc863120a39	TCGA-A8-A08J-01	TCGA-A8-A08J-01A-11W-A019-09	TCGA-A8-A08J-01A-11D-A00Y-05	TCGA-A8-A08J-01		TCGA-A8-A08J-01A-11W-A019-09	TCGA-A8-A08J-01	67e019fc-65c4-4274-a0f7-5a92f0f87bba	TCGA-A8-A08J-01	TCGA-A8-A08J-01A-11D-A011-01		TCGA-A8-A08J-01A-11R-A00Z-07	67e019fc-65c4-4274-a0f7-5a92f0f87bba	TCGA-A8-A08J-01A-11D-A011-01	TCGA-A8-A08J-01
TCGA-A8-A08L-01	Stage IIIA	89	1	Stage IIIA	304	304	Positive	FEMALE	Negative	5	2	1	Negative	M0	Positive	N2	304	1	Her2	HER2-enriched	Negative	X	-2	-6	enrollment	T_Other	T3	DECEASED	1	TCGA-A8-A08L-01	304	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 1	TCGA-A8-A08L			days	304	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					89	Left			TCGA-A8-A08L-F40847	TCGA-A8-A08L	TCGA-A8-A08L-01A		Positive					Negative	Other					-32842	698	304	0											2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			200	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1											false	No	M0	N2a	T3	Stage IIIA	TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf	A08L	TUMOR FREE										YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2008	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	35d16368-1462-4c9b-952a-b81b4e08d33c	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	35d16368-1462-4c9b-952a-b81b4e08d33c	TCGA-A8-A08L-01A-21-A13A-20	TCGA-A8-A08L-01A-11W-A019-09		TCGA-A8-A08L-01			7a837782-6edf-48bb-83db-40548ddd2b69	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01A-11D-A00Y-05	TCGA-A8-A08L-01		TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11D-A011-01		TCGA-A8-A08L-01A-11R-A00Z-07	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01A-11D-A011-01	TCGA-A8-A08L-01
TCGA-A8-A08O-01	Stage IV	45	2	Stage IV	942		Positive	FEMALE	Negative	3	4	3	Positive	M1	Positive	N3	942	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08O-01	943	0	days	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-A8-A08O	762	1	days	943	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right			TCGA-A8-A08O-F40848	TCGA-A8-A08O	TCGA-A8-A08O-01A		Positive					Positive	Other					-16681	819		0	943			762							2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative	NO		Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								YES			false	No	M1	N3a	T2	Stage IV	TCGA-A8-A08O.2F102533-4B6B-4411-9080-3697ED3099EA.pdf	A08O	WITH TUMOR						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	f71db767-ac59-49c8-b6a9-50bf20767ddc	84e50324-d98b-4fa7-b6df-27714ed34a48	f71db767-ac59-49c8-b6a9-50bf20767ddc	84e50324-d98b-4fa7-b6df-27714ed34a48	TCGA-A8-A08O-01A-11-A13A-20	TCGA-A8-A08O-01A-21W-A071-09		TCGA-A8-A08O-01	TCGA-A8-A08O-01A-21D-A10P-05		b661ea2e-2f24-44b9-b8ed-30f38223b85c	TCGA-A8-A08O-01	TCGA-A8-A08O-01A-21W-A071-09		TCGA-A8-A08O-01		TCGA-A8-A08O-01A-21W-A071-09	TCGA-A8-A08O-01	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01	TCGA-A8-A08O-01A-21D-A059-01		TCGA-A8-A08O-01A-21R-A056-07	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01A-21D-A059-01	TCGA-A8-A08O-01
TCGA-A8-A08P-01	Stage IIIA	70	3	Stage IIIA	942		Positive	FEMALE	Positive				Negative	M0	Positive	N2	942	0	LumB	Luminal B	Positive	ReacII	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08P-01	943	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 3	TCGA-A8-A08P	943	0	days	943	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right			TCGA-A8-A08P-F40561	TCGA-A8-A08P	TCGA-A8-A08P-01A		Positive					Positive	Other					-25598	819		0	943										2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO			false	No	M0	N2a	T2	Stage IIIA	TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1.pdf	A08P	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	f8dbf3ce-7c30-4e62-a25f-d98843794672	0a972399-22e7-41f5-af02-e2cbc04c72f3	f8dbf3ce-7c30-4e62-a25f-d98843794672	0a972399-22e7-41f5-af02-e2cbc04c72f3	TCGA-A8-A08P-01A-21-A13A-20	TCGA-A8-A08P-01A-11W-A019-09		TCGA-A8-A08P-01			4e6516f3-1962-4f3e-99a4-e086891381c1	TCGA-A8-A08P-01	TCGA-A8-A08P-01A-11W-A019-09	TCGA-A8-A08P-01A-11D-A00Y-05	TCGA-A8-A08P-01		TCGA-A8-A08P-01A-11W-A019-09		f8dbf3ce-7c30-4e62-a25f-d98843794672		TCGA-A8-A08P-01A-11D-A011-01		TCGA-A8-A08P-01A-11R-A00Z-07	f8dbf3ce-7c30-4e62-a25f-d98843794672	TCGA-A8-A08P-01A-11D-A011-01	TCGA-A8-A08P-01
TCGA-A8-A08R-01	Stage IIB	52	4	Stage IIB	30		Negative	FEMALE	Negative				Negative	M0	Positive	N1	30	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08R-01	30	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A08R			days	30	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left				TCGA-A8-A08R	TCGA-A8-A08R-01A		Negative					Negative	Other					-19298	728		0	30										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4											false	No	M0	N1a	T2	Stage IIB	TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf	A08R	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	3a1d8959-f829-4b8a-a65f-70a51845f118	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4	3a1d8959-f829-4b8a-a65f-70a51845f118	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4		TCGA-A8-A08R-01A-11W-A050-09		TCGA-A8-A08R-01				TCGA-A8-A08R-01	TCGA-A8-A08R-01A-11W-A050-09	TCGA-A8-A08R-01A-11D-A032-05	TCGA-A8-A08R-01		TCGA-A8-A08R-01A-11W-A050-09	TCGA-A8-A08R-01	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA-A8-A08R-01	TCGA-A8-A08R-01A-11D-A036-01		TCGA-A8-A08R-01A-11R-A034-07	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA-A8-A08R-01A-11D-A036-01	TCGA-A8-A08R-01
TCGA-A8-A08S-01	Stage IIA	71		Stage IIA	580		Positive	FEMALE	Positive				Negative	M0	Positive	N1	580	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-A8-A08S-01	1004	0	days	Squamous	C3-BRCA/Luminal		BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-A8-A08S	1004	0	days	1004	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left			TCGA-A8-A08S-F40560	TCGA-A8-A08S	TCGA-A8-A08S-01A		Positive					Positive	Other					-25994	637		0	1004										2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			80	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	Yes	M0	N1	T1c	Stage IIA	TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25.pdf	A08S	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2008	667c209e-9b4a-474d-8f69-102cfaffddf2	3ab709a7-87e2-44e5-bce1-ca2a0fc0286e	667c209e-9b4a-474d-8f69-102cfaffddf2	3ab709a7-87e2-44e5-bce1-ca2a0fc0286e		TCGA-A8-A08S-01A-11W-A050-09		TCGA-A8-A08S-01				TCGA-A8-A08S-01	TCGA-A8-A08S-01A-11W-A050-09	TCGA-A8-A08S-01A-11D-A032-05	TCGA-A8-A08S-01		TCGA-A8-A08S-01A-11W-A050-09		667c209e-9b4a-474d-8f69-102cfaffddf2		TCGA-A8-A08S-01A-11D-A036-01		TCGA-A8-A08S-01A-11R-A034-07	667c209e-9b4a-474d-8f69-102cfaffddf2	TCGA-A8-A08S-01A-11D-A036-01	TCGA-A8-A08S-01
TCGA-A8-A08T-01	Stage IV	64	4	Stage IV	2830		Positive	FEMALE	Negative	1	3	3	Positive	M1	Positive	N1	2830	0	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T2	LIVING	1	TCGA-A8-A08T-01	3409	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A08T	2557	1	days	3409	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right			TCGA-A8-A08T-F40559	TCGA-A8-A08T	TCGA-A8-A08T-01A		Positive					Positive	Other					-23560	2767	3409	0	2830			2557							2013-2-24	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			190	NO	Positive	Positive	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								YES			false	No	M1	N1a	T2	Stage IV	TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A.pdf	A08T	WITH TUMOR										NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2002	ed6ebb15-1401-49e0-be9a-e1391e84b374	dfe66ee6-0535-42b6-b6b1-b961604d8a27	ed6ebb15-1401-49e0-be9a-e1391e84b374	dfe66ee6-0535-42b6-b6b1-b961604d8a27	TCGA-A8-A08T-01A-11-A13A-20	TCGA-A8-A08T-01A-21W-A019-09		TCGA-A8-A08T-01			68cba786-7b1c-4e7c-863b-19a037b1d07e	TCGA-A8-A08T-01	TCGA-A8-A08T-01A-21W-A019-09	TCGA-A8-A08T-01A-21D-A00Y-05	TCGA-A8-A08T-01		TCGA-A8-A08T-01A-21W-A019-09	TCGA-A8-A08T-01	ed6ebb15-1401-49e0-be9a-e1391e84b374	TCGA-A8-A08T-01	TCGA-A8-A08T-01A-21D-A011-01		TCGA-A8-A08T-01A-21R-A00Z-07	ed6ebb15-1401-49e0-be9a-e1391e84b374	TCGA-A8-A08T-01A-21D-A011-01	TCGA-A8-A08T-01
TCGA-A8-A08X-01	Stage IIIC	43	3	Stage IIIC	1034		Negative	FEMALE	Positive	2	2	1	Negative	M0	Positive	N3	1034	0	Her2	HER2-enriched	Negative	Her2	-13	-10	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A08X-01	1308	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08X	366	1	days	1308	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left			TCGA-A8-A08X-F40558	TCGA-A8-A08X	TCGA-A8-A08X-01A		Negative					Negative	Other					-15705	941		0	1308			366							2013-2-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	3								YES			false	No	M0	N3a	T4d	Stage IIIC	TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf	A08X	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	354adce5-6ca4-4d6d-a519-4eabc01c6b36	04174e2d-2241-4ac5-a0b1-653b8fd41db9	354adce5-6ca4-4d6d-a519-4eabc01c6b36	04174e2d-2241-4ac5-a0b1-653b8fd41db9	TCGA-A8-A08X-01A-11-A13B-20	TCGA-A8-A08X-01A-21W-A019-09		TCGA-A8-A08X-01			3fd8c428-08bb-4598-b3cb-0c4a33fc4eab	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01A-21D-A00Y-05	TCGA-A8-A08X-01		TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21D-A011-01		TCGA-A8-A08X-01A-21R-A00Z-07	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01A-21D-A011-01	TCGA-A8-A08X-01
TCGA-A8-A08Z-01	Stage IIIB	76	2	Stage IIIC	1217		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N3	1217	0	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A08Z-01	1217	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A08Z			days	1217	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left				TCGA-A8-A08Z	TCGA-A8-A08Z-01A		Positive					Positive	Other					-28003	2036		0	1217										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			350	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4											false	No	M0	N3a	T4b	[Discrepancy]	TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696.pdf	A08Z	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2004	1462b0a9-6467-4977-aea7-006ea3f5109e	2b58ea3d-2a6b-4acb-9db2-526ad07551bb	1462b0a9-6467-4977-aea7-006ea3f5109e	2b58ea3d-2a6b-4acb-9db2-526ad07551bb	TCGA-A8-A08Z-01A-11-A13B-20	TCGA-A8-A08Z-01A-21W-A019-09		TCGA-A8-A08Z-01			8f5042d5-cb01-4d32-a80e-f1e3c161ab78	TCGA-A8-A08Z-01	TCGA-A8-A08Z-01A-21W-A019-09	TCGA-A8-A08Z-01A-21D-A00Y-05	TCGA-A8-A08Z-01		TCGA-A8-A08Z-01A-21W-A019-09	TCGA-A8-A08Z-01	1462b0a9-6467-4977-aea7-006ea3f5109e	TCGA-A8-A08Z-01	TCGA-A8-A08Z-01A-21D-A011-01		TCGA-A8-A08Z-01A-21R-A00Z-07	1462b0a9-6467-4977-aea7-006ea3f5109e	TCGA-A8-A08Z-01A-21D-A011-01	TCGA-A8-A08Z-01
TCGA-A8-A090-01	Stage IIA	74	4	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING		TCGA-A8-A090-01			days	COAD-READ	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A090			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Right				TCGA-A8-A090	TCGA-A8-A090-01A		Positive					Positive	Other					-27121	667		0	0										2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831.pdf	A090	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	752efa27-8d87-4007-9dc5-baef53b37a87	145a4a31-347b-418f-a5ad-4e77ca35e3ca	752efa27-8d87-4007-9dc5-baef53b37a87	145a4a31-347b-418f-a5ad-4e77ca35e3ca		TCGA-A8-A090-01A-11W-A019-09		TCGA-A8-A090-01				TCGA-A8-A090-01	TCGA-A8-A090-01A-11W-A019-09	TCGA-A8-A090-01A-11D-A00Y-05	TCGA-A8-A090-01		TCGA-A8-A090-01A-11W-A019-09	TCGA-A8-A090-01	752efa27-8d87-4007-9dc5-baef53b37a87	TCGA-A8-A090-01	TCGA-A8-A090-01A-11D-A011-01		TCGA-A8-A090-01A-11R-A00Z-07	752efa27-8d87-4007-9dc5-baef53b37a87	TCGA-A8-A090-01A-11D-A011-01	TCGA-A8-A090-01
TCGA-A8-A091-01	Stage IIA	61	4	Stage IIA	580		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	580	0	LumA	Luminal A	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A091-01	1004	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A091	243	1	days	1004	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right			TCGA-A8-A091-F40557	TCGA-A8-A091	TCGA-A8-A091-01A		Positive					Negative	Other					-22554	637		0	1004			243							2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								YES			false	Yes	M0	N0	T2	Stage IIA	TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf	A091	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	7cd3f9f8-20a8-468e-aaca-9a49a32d250f	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	7cd3f9f8-20a8-468e-aaca-9a49a32d250f	TCGA-A8-A091-01A-21-A13B-20	TCGA-A8-A091-01A-11W-A019-09		TCGA-A8-A091-01			30426ea5-f884-4216-9435-4ba810f8687e	TCGA-A8-A091-01	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01A-11D-A00Y-05	TCGA-A8-A091-01		TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01	TCGA-A8-A091-01A-11D-A011-01		TCGA-A8-A091-01A-11R-A00Z-07	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01A-11D-A011-01	TCGA-A8-A091-01
TCGA-A8-A092-01	Stage IIIA	48	2	Stage IIIA	518		Positive	FEMALE	Negative				Negative	M0	Positive	N2	518	0	LumB	HER2-enriched	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A092-01	942	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A092	942	0	days	942	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left			TCGA-A8-A092-F40556	TCGA-A8-A092	TCGA-A8-A092-01A		Positive					Positive	Other					-17807	575		0	942										2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO			false	No	M0	N2a	T2	Stage IIIA	TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9.pdf	A092	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	98b2b18a-004d-459c-8aba-499d06897910	d03b22fa-5bae-4247-a7fa-e8f77e38d8fd	98b2b18a-004d-459c-8aba-499d06897910	d03b22fa-5bae-4247-a7fa-e8f77e38d8fd		TCGA-A8-A092-01A-11W-A019-09		TCGA-A8-A092-01				TCGA-A8-A092-01	TCGA-A8-A092-01A-11W-A019-09	TCGA-A8-A092-01A-11D-A00Y-05	TCGA-A8-A092-01		TCGA-A8-A092-01A-11W-A019-09	TCGA-A8-A092-01	98b2b18a-004d-459c-8aba-499d06897910	TCGA-A8-A092-01	TCGA-A8-A092-01A-11D-A011-01		TCGA-A8-A092-01A-11R-A00Z-07	98b2b18a-004d-459c-8aba-499d06897910	TCGA-A8-A092-01A-11D-A011-01	TCGA-A8-A092-01
TCGA-A8-A093-01	Stage IIA	61	3	Stage IIA	545		Positive	FEMALE	Negative				Negative	M0	Negative	N0	545	0	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A093-01	546	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 2	mutation cluster 4	TCGA-A8-A093	546	0	days	546	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right			TCGA-A8-A093-F40555	TCGA-A8-A093	TCGA-A8-A093-01A		Positive					Positive	Other					-22373	422		0	546										2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO			false	Yes	M0	N0	T2	Stage IIA	TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7.pdf	A093	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2009	54d372bf-07c8-4525-a081-ff26c28aff39	66c6efd3-406c-4b96-ac62-b570d161c825	54d372bf-07c8-4525-a081-ff26c28aff39	66c6efd3-406c-4b96-ac62-b570d161c825		TCGA-A8-A093-01A-11W-A019-09		TCGA-A8-A093-01				TCGA-A8-A093-01	TCGA-A8-A093-01A-11W-A019-09	TCGA-A8-A093-01A-11D-A00Y-05	TCGA-A8-A093-01		TCGA-A8-A093-01A-11W-A019-09	TCGA-A8-A093-01	54d372bf-07c8-4525-a081-ff26c28aff39	TCGA-A8-A093-01	TCGA-A8-A093-01A-11D-A011-01		TCGA-A8-A093-01A-11R-A00Z-07	54d372bf-07c8-4525-a081-ff26c28aff39	TCGA-A8-A093-01A-11D-A011-01	TCGA-A8-A093-01
TCGA-A8-A094-01	Stage IIA	75	1	Stage IIA	0		Positive	FEMALE	Negative	2	2	1	Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Negative	Basal	-11	-5	enrollment	T_Other	T2	LIVING		TCGA-A8-A094-01			days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 6	TCGA-A8-A094			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left				TCGA-A8-A094	TCGA-A8-A094-01A		Positive					Negative	Other					-27729	363		0	0										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			400	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	3											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235.pdf	A094	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	877adc79-0651-4140-bb6a-876162733bf3	deedcd96-88fd-445e-bc6c-085c79a431ab	877adc79-0651-4140-bb6a-876162733bf3	deedcd96-88fd-445e-bc6c-085c79a431ab	TCGA-A8-A094-01A-21-A13B-20	TCGA-A8-A094-01A-11W-A019-09		TCGA-A8-A094-01			c7af042d-07e1-40fd-878d-a91d31397bb6	TCGA-A8-A094-01	TCGA-A8-A094-01A-11W-A019-09	TCGA-A8-A094-01A-11D-A00Y-05	TCGA-A8-A094-01		TCGA-A8-A094-01A-11W-A019-09	TCGA-A8-A094-01	877adc79-0651-4140-bb6a-876162733bf3	TCGA-A8-A094-01	TCGA-A8-A094-01A-11D-A011-01		TCGA-A8-A094-01A-11R-A00Z-07	877adc79-0651-4140-bb6a-876162733bf3	TCGA-A8-A094-01A-11D-A011-01	TCGA-A8-A094-01
TCGA-A8-A095-01	Stage I	45	3	Stage I	1276		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1276	0	LumB	Luminal B	Positive	ReacII	-7	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A095-01	1277	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A095	1277	0	days	1277	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left			TCGA-A8-A095-F40554	TCGA-A8-A095	TCGA-A8-A095-01A		Positive					Positive	Other					-16742	1153		0	1277										2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			160	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO			false	No	M0	N0	T1c	Stage I	TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1.pdf	A095	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2007	c943873c-e153-42bc-a8de-e1080b252e81	8bb0471f-9d25-4c27-9a4c-ecc00090a7da	c943873c-e153-42bc-a8de-e1080b252e81	8bb0471f-9d25-4c27-9a4c-ecc00090a7da	TCGA-A8-A095-01A-21-A13B-20	TCGA-A8-A095-01A-11W-A019-09		TCGA-A8-A095-01			61dbc912-9edf-4635-926c-e9ae57c40b67	TCGA-A8-A095-01	TCGA-A8-A095-01A-11W-A019-09	TCGA-A8-A095-01A-11D-A00Y-05	TCGA-A8-A095-01		TCGA-A8-A095-01A-11W-A019-09	TCGA-A8-A095-01	c943873c-e153-42bc-a8de-e1080b252e81	TCGA-A8-A095-01	TCGA-A8-A095-01A-11D-A011-01		TCGA-A8-A095-01A-11R-A00Z-07	c943873c-e153-42bc-a8de-e1080b252e81	TCGA-A8-A095-01A-11D-A011-01	TCGA-A8-A095-01
TCGA-A8-A096-01	Stage IIA	73	2	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB	Luminal B	Positive		-12	-4	enrollment	T_Other	T2	LIVING		TCGA-A8-A096-01			days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A096			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Right				TCGA-A8-A096	TCGA-A8-A096-01A		Positive					Positive	Other					-26723	394		0	0										2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf	A096	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	7bf79330-52fa-4111-88fe-b3ea62bcc63a	b9f519b1-a3ef-48a2-8a66-fe83096ef611	7bf79330-52fa-4111-88fe-b3ea62bcc63a	b9f519b1-a3ef-48a2-8a66-fe83096ef611		TCGA-A8-A096-01A-11W-A019-09		TCGA-A8-A096-01				TCGA-A8-A096-01	TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01A-11D-A00Y-05	TCGA-A8-A096-01		TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01	TCGA-A8-A096-01A-11D-A011-01		TCGA-A8-A096-01A-11R-A00Z-07	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01A-11D-A011-01	TCGA-A8-A096-01
TCGA-A8-A097-01	Stage IIB	65	5	Stage IIB	365		Positive	FEMALE	Positive				Negative	M0	Positive	N1	365	0	LumA	Luminal B	Positive		0	-2	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A097-01	365	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A097	365	0	days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left			TCGA-A8-A097-F40553	TCGA-A8-A097	TCGA-A8-A097-01A		Positive					Positive	Other					-23741	241		0	365										2013-2-23	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO			false	No	M0	N1	T2	Stage IIB	TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077.pdf	A097	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	1873a785-0f15-40ef-a7c9-1799ab482338	efbe880f-55bf-4c85-b30c-902c44578821	1873a785-0f15-40ef-a7c9-1799ab482338	efbe880f-55bf-4c85-b30c-902c44578821		TCGA-A8-A097-01A-11W-A050-09		TCGA-A8-A097-01				TCGA-A8-A097-01	TCGA-A8-A097-01A-11W-A050-09	TCGA-A8-A097-01A-11D-A032-05	TCGA-A8-A097-01		TCGA-A8-A097-01A-11W-A050-09	TCGA-A8-A097-01	1873a785-0f15-40ef-a7c9-1799ab482338	TCGA-A8-A097-01	TCGA-A8-A097-01A-11D-A036-01		TCGA-A8-A097-01A-11R-A034-07	1873a785-0f15-40ef-a7c9-1799ab482338	TCGA-A8-A097-01A-11D-A036-01	TCGA-A8-A097-01
TCGA-A8-A099-01	Stage X	76	2	Stage IIIC	304		Positive	FEMALE	Positive	4	3	3	Negative	M0	Positive	N3	304	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A099-01	304	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A099	304	0	days	304	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Right			TCGA-A8-A099-F40552	TCGA-A8-A099	TCGA-A8-A099-01A		Positive					Positive	Other					-28063	180		0	304										2013-2-23	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive	NO			Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO			false	No	MX	N3a	T4b	Stage X	TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07.pdf	A099							YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	e7d3f302-d068-487a-b1cf-89cf4d9f6f60	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	e7d3f302-d068-487a-b1cf-89cf4d9f6f60	TCGA-A8-A099-01A-21-A13B-20	TCGA-A8-A099-01A-11W-A019-09		TCGA-A8-A099-01			6e221e0d-416e-420d-a798-9afde72b03fb	TCGA-A8-A099-01	TCGA-A8-A099-01A-11W-A019-09	TCGA-A8-A099-01A-11D-A00Y-05	TCGA-A8-A099-01		TCGA-A8-A099-01A-11W-A019-09	TCGA-A8-A099-01	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	TCGA-A8-A099-01	TCGA-A8-A099-01A-11D-A011-01		TCGA-A8-A099-01A-11R-A00Z-07	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	TCGA-A8-A099-01A-11D-A011-01	TCGA-A8-A099-01
TCGA-A8-A09A-01	Stage X	40	4	Stage IIA	304		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	304	0	LumA	Luminal A	Positive	LumA	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09A-01	304	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation c1uster 10	TCGA-A8-A09A			days	304	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left			TCGA-A8-A09A-F40551	TCGA-A8-A09A	TCGA-A8-A09A-01A		Positive					Positive	Other					-14883	180		0	304										2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Negative	Negative	NO		Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4											false	No	M0	NX	T2	Stage X	TCGA-A8-A09A.5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF.pdf	A09A	WITH TUMOR						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	7b1992b8-781d-49cc-a600-4bee56bcf1b5	14c07825-f4cc-4d62-ad12-6a0bcc00e4b9	7b1992b8-781d-49cc-a600-4bee56bcf1b5	14c07825-f4cc-4d62-ad12-6a0bcc00e4b9	TCGA-A8-A09A-01A-21-A13B-20	TCGA-A8-A09A-01A-11W-A019-09		TCGA-A8-A09A-01			5e5a89f5-a778-4893-9d17-38c946016d53	TCGA-A8-A09A-01	TCGA-A8-A09A-01A-11W-A019-09	TCGA-A8-A09A-01A-11D-A00Y-05	TCGA-A8-A09A-01		TCGA-A8-A09A-01A-11W-A019-09	TCGA-A8-A09A-01	7b1992b8-781d-49cc-a600-4bee56bcf1b5	TCGA-A8-A09A-01	TCGA-A8-A09A-01A-11D-A011-01		TCGA-A8-A09A-01A-11R-A00Z-07	7b1992b8-781d-49cc-a600-4bee56bcf1b5	TCGA-A8-A09A-01A-11D-A011-01	TCGA-A8-A09A-01
TCGA-A8-A09B-01	Stage IIIB	58	4	Stage IIIB	365		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	365	0	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09B-01	365	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A09B			days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left			TCGA-A8-A09B-F40550	TCGA-A8-A09B			Positive					Positive	Other					-21520			0	365										2013-2-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4												No	M0	N1a	T4b	Stage IIIB		A09B	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	df95b9f5-437f-438d-89b4-7c556e79b616	f7d6ee92-7add-46f0-9de5-17f1bea1842d	df95b9f5-437f-438d-89b4-7c556e79b616	f7d6ee92-7add-46f0-9de5-17f1bea1842d	TCGA-A8-A09B-01A-21-A13B-20	TCGA-A8-A09B-01A-11W-A019-09		TCGA-A8-A09B-01			cc046686-7a84-4a71-8b94-70b2ec82c616	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01A-11D-A00Y-05	TCGA-A8-A09B-01		TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11D-A011-01		TCGA-A8-A09B-01A-11R-A00Z-07	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01A-11D-A011-01	TCGA-A8-A09B-01
TCGA-A8-A09C-01	Stage X	69	4	Stage IIA	31		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	31	0	LumB	Luminal B	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09C-01	31	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A09C			days	31	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right				TCGA-A8-A09C	TCGA-A8-A09C-01A		Positive					Positive	Other					-25355	180		0	31										2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			120	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2											false	Yes	MX	N0	T2	Stage X	TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66.pdf	A09C												Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2009	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	967323eb-3ae6-4b35-bab3-35abf8b80299	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	967323eb-3ae6-4b35-bab3-35abf8b80299	TCGA-A8-A09C-01A-21-A13A-20	TCGA-A8-A09C-01A-11W-A019-09		TCGA-A8-A09C-01			9012f763-2482-415b-9d86-fdabde299719	TCGA-A8-A09C-01	TCGA-A8-A09C-01A-11W-A019-09	TCGA-A8-A09C-01A-11D-A00Y-05	TCGA-A8-A09C-01		TCGA-A8-A09C-01A-11W-A019-09	TCGA-A8-A09C-01	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	TCGA-A8-A09C-01	TCGA-A8-A09C-01A-11D-A011-01		TCGA-A8-A09C-01A-11R-A00Z-07	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	TCGA-A8-A09C-01A-11D-A011-01	TCGA-A8-A09C-01
TCGA-A8-A09D-01	Stage IIB	47	5	No_Conversion	396		Positive	FEMALE	Negative				Negative	M0	Positive	N1	396	0	LumA	Luminal B	Positive		-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09D-01	1522	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A09D	1522	0	days	1522	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right Lower Outer Quadrant			TCGA-A8-A09D-F40549	TCGA-A8-A09D			Positive					Positive	Other					-17440			0	1522										2013-2-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	1								NO				No	M0	N1	T2	Stage IIB		A09D	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast		LIVING	2007	f2563687-e055-41a8-8436-614fbad762d4	ccbe901d-210e-402f-92b3-875c51074ef3	f2563687-e055-41a8-8436-614fbad762d4	ccbe901d-210e-402f-92b3-875c51074ef3		TCGA-A8-A09D-01A-11W-A019-09		TCGA-A8-A09D-01				TCGA-A8-A09D-01	TCGA-A8-A09D-01A-11W-A019-09	TCGA-A8-A09D-01A-11D-A00Y-05	TCGA-A8-A09D-01		TCGA-A8-A09D-01A-11W-A019-09	TCGA-A8-A09D-01	f2563687-e055-41a8-8436-614fbad762d4	TCGA-A8-A09D-01	TCGA-A8-A09D-01A-11D-A011-01		TCGA-A8-A09D-01A-11R-A00Z-07	f2563687-e055-41a8-8436-614fbad762d4	TCGA-A8-A09D-01A-11D-A011-01	TCGA-A8-A09D-01
TCGA-A8-A09E-01	Stage IIIB	73		Stage IIIB	942		Positive	FEMALE	Equivocal				Negative	M0	Positive	N1	942	0			Positive				enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09E-01	1492	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 14		mutation c1uster 9	TCGA-A8-A09E	1492	0	days	1492	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Lower Outer Quadrant			TCGA-A8-A09E-F40334	TCGA-A8-A09E	TCGA-A8-A09E-01A		Positive					Positive	Other					-26724	819		0	1492										2013-2-17	FEMALE					2+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			220	NO	Positive	Positive	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	Yes	M0	N1a	T4b	Stage IIIB	TCGA-A8-A09E.C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03.pdf	A09E	WITH TUMOR						YES				YES	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2008	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	70b9ece6-dedc-44c7-8f35-b78d9bac626e	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	70b9ece6-dedc-44c7-8f35-b78d9bac626e	TCGA-A8-A09E-01A-21-A13A-20	TCGA-A8-A09E-01A-11W-A019-09		TCGA-A8-A09E-01			f0bc5acd-5e59-47c9-b2a6-8f47508a9ec6	TCGA-A8-A09E-01	TCGA-A8-A09E-01A-11W-A019-09	TCGA-A8-A09E-01A-11D-A00Y-05	TCGA-A8-A09E-01		TCGA-A8-A09E-01A-11W-A019-09		1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd		TCGA-A8-A09E-01A-11D-A011-01		TCGA-A8-A09E-01A-11R-A00Z-07	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	TCGA-A8-A09E-01A-11D-A011-01	TCGA-A8-A09E-01
TCGA-A8-A09G-01	Stage IIIC	79	2	Stage IIIC	0		Positive	FEMALE	Positive	3	2	1	Negative	M0	Positive	N3	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T3	LIVING		TCGA-A8-A09G-01			days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A8-A09G			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right Lower Outer Quadrant				TCGA-A8-A09G	TCGA-A8-A09G-01A		Positive					Negative	Other					-29006	759		0	0										2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			270	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	3											false	No	M0	N3a	T3	Stage IIIC	TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C.pdf	A09G	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	31757dda-12d6-4f35-87f1-d00464f2815b	3cd925e9-93f6-4810-87c6-f3c7ecaf6e77	31757dda-12d6-4f35-87f1-d00464f2815b	3cd925e9-93f6-4810-87c6-f3c7ecaf6e77	TCGA-A8-A09G-01A-11-A13A-20	TCGA-A8-A09G-01A-21W-A019-09		TCGA-A8-A09G-01			8390a7e5-0373-43e2-adc0-8f6fbdc665d1	TCGA-A8-A09G-01	TCGA-A8-A09G-01A-21W-A019-09	TCGA-A8-A09G-01A-21D-A00Y-05	TCGA-A8-A09G-01		TCGA-A8-A09G-01A-21W-A019-09	TCGA-A8-A09G-01	31757dda-12d6-4f35-87f1-d00464f2815b	TCGA-A8-A09G-01	TCGA-A8-A09G-01A-21D-A011-01		TCGA-A8-A09G-01A-21R-A00Z-07	31757dda-12d6-4f35-87f1-d00464f2815b	TCGA-A8-A09G-01A-21D-A011-01	TCGA-A8-A09G-01
TCGA-A8-A09I-01	Stage IIA	84	5	Stage IIA	1006		Positive	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	1006	0	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09I-01	1371	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09I	1371	0	days	1371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Right Lower Outer Quadrant			TCGA-A8-A09I-F40333	TCGA-A8-A09I	TCGA-A8-A09I-01A		Positive					Positive	Other					-30711	698		0	1371										2013-2-17	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			430	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO			false	Yes	M0	N0	T2	Stage IIA	TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf	A09I	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	433b49ba-949b-4914-985a-be19b3b32502	bd4d930e-0848-48c1-8b03-c04a986f22d8	433b49ba-949b-4914-985a-be19b3b32502	bd4d930e-0848-48c1-8b03-c04a986f22d8	TCGA-A8-A09I-01A-11-A13A-20	TCGA-A8-A09I-01A-22W-A050-09		TCGA-A8-A09I-01			93a8128c-9314-44b7-8737-0c5b08c057f4	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01A-22D-A032-05	TCGA-A8-A09I-01		TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22D-A036-01		TCGA-A8-A09I-01A-22R-A034-07	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01A-22D-A036-01	TCGA-A8-A09I-01
TCGA-A8-A09K-01	Stage IIA	68		Stage IIA	911		Positive	FEMALE	Negative				Negative	M0	Positive	N1	911	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-A8-A09K-01	912	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-A8-A09K	912	0	days	912	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Lower Outer Quadrant			TCGA-A8-A09K-F40332	TCGA-A8-A09K	TCGA-A8-A09K-01A		Positive					Positive	Other					-24960	788		0	912										2013-2-17	FEMALE					0					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			240	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	Yes	M0	N1	T1c	Stage IIA	TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566.pdf	A09K	TUMOR FREE						NO				NO	Primary Tumor	01	Surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2008	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	b412fc52-5776-4ff9-b9c4-829efabfb377	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	b412fc52-5776-4ff9-b9c4-829efabfb377	TCGA-A8-A09K-01A-21-A13A-20	TCGA-A8-A09K-01A-11W-A019-09		TCGA-A8-A09K-01			795da071-d853-421e-85e3-902a7e1af1eb	TCGA-A8-A09K-01	TCGA-A8-A09K-01A-11W-A019-09	TCGA-A8-A09K-01A-11D-A00Y-05	TCGA-A8-A09K-01		TCGA-A8-A09K-01A-11W-A019-09		9b54f75f-80eb-441d-83ca-5ae1d00bdfa9		TCGA-A8-A09K-01A-11D-A011-01		TCGA-A8-A09K-01A-11R-A00Z-07	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	TCGA-A8-A09K-01A-11D-A011-01	TCGA-A8-A09K-01
TCGA-A8-A09M-01	Stage IIIC	75	5	Stage IIIC	457		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N3	457	0	LumB	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09M-01	1006	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 5	mutation c1uster 10	TCGA-A8-A09M	1006	0	days	1006	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right Lower Outer Quadrant			TCGA-A8-A09M-F40331	TCGA-A8-A09M	TCGA-A8-A09M-01A		Positive					Positive	Other					-27455	333		0	1006										2013-2-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO			false	No	M0	N3a	T2	Stage IIIC	TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591.pdf	A09M	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	3e08280c-f748-43c7-928b-007b322917b2	9240c87f-41fc-4576-aedb-2c8010079920	3e08280c-f748-43c7-928b-007b322917b2	9240c87f-41fc-4576-aedb-2c8010079920	TCGA-A8-A09M-01A-21-A13B-20	TCGA-A8-A09M-01A-11W-A019-09		TCGA-A8-A09M-01			fcc864a9-3f22-4717-a5e1-2c034b9ae7f5	TCGA-A8-A09M-01	TCGA-A8-A09M-01A-11W-A019-09	TCGA-A8-A09M-01A-11D-A00Y-05	TCGA-A8-A09M-01		TCGA-A8-A09M-01A-11W-A019-09	TCGA-A8-A09M-01	3e08280c-f748-43c7-928b-007b322917b2	TCGA-A8-A09M-01	TCGA-A8-A09M-01A-11D-A011-01		TCGA-A8-A09M-01A-11R-A00Z-07	3e08280c-f748-43c7-928b-007b322917b2	TCGA-A8-A09M-01A-11D-A011-01	TCGA-A8-A09M-01
TCGA-A8-A09N-01	Stage IIIC	57	1	Stage IIIC	31		Positive	FEMALE	Positive				Negative	M0	Positive	N3	31	0	LumB	Luminal B	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09N-01	31	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 5	TCGA-A8-A09N			days	31	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Lower Outer Quadrant				TCGA-A8-A09N	TCGA-A8-A09N-01A		Positive					Positive	Other					-21002	1276		0	31										2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			70	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7											false	No	M0	N3a	T2	Stage IIIC	TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF.pdf	A09N	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2006	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	bdf230f7-71c7-4ee8-b1ed-b29015b40f57	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	bdf230f7-71c7-4ee8-b1ed-b29015b40f57		TCGA-A8-A09N-01A-11W-A019-09		TCGA-A8-A09N-01				TCGA-A8-A09N-01	TCGA-A8-A09N-01A-11W-A019-09	TCGA-A8-A09N-01A-11D-A00Y-05	TCGA-A8-A09N-01		TCGA-A8-A09N-01A-11W-A019-09	TCGA-A8-A09N-01	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	TCGA-A8-A09N-01	TCGA-A8-A09N-01A-11D-A011-01		TCGA-A8-A09N-01A-11R-A00Z-07	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	TCGA-A8-A09N-01A-11D-A011-01	TCGA-A8-A09N-01
TCGA-A8-A09Q-01	Stage IIIB	83	2	Stage IIIB	761		Positive	FEMALE	Negative				Negative	M0	Positive	N2	761	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09Q-01	761	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A09Q			days	761	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Left Lower Inner Quadrant			TCGA-A8-A09Q-F41022	TCGA-A8-A09Q	TCGA-A8-A09Q-01A		Positive					Positive	Other					-30528	637		0	761										2013-3-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4											false	No	M0	N2a	T4b	Stage IIIB	TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7.pdf	A09Q	WITH TUMOR						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	9560e482-cb14-4456-b9a6-d2ac12f96a4f	f2824bc4-e4fd-4416-83ce-f9ab555cd208	9560e482-cb14-4456-b9a6-d2ac12f96a4f	f2824bc4-e4fd-4416-83ce-f9ab555cd208		TCGA-A8-A09Q-01A-11W-A019-09		TCGA-A8-A09Q-01				TCGA-A8-A09Q-01	TCGA-A8-A09Q-01A-11W-A019-09	TCGA-A8-A09Q-01A-11D-A00Y-05	TCGA-A8-A09Q-01		TCGA-A8-A09Q-01A-11W-A019-09	TCGA-A8-A09Q-01	9560e482-cb14-4456-b9a6-d2ac12f96a4f	TCGA-A8-A09Q-01	TCGA-A8-A09Q-01A-11D-A011-01		TCGA-A8-A09Q-01A-11R-A00Z-07	9560e482-cb14-4456-b9a6-d2ac12f96a4f	TCGA-A8-A09Q-01A-11D-A011-01	TCGA-A8-A09Q-01
TCGA-A8-A09R-01	Stage IIB	82	5	Stage IIB	273		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	273	0	LumB	Luminal B	Positive	Her2	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09R-01	273	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09R	273	0	days	273	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Left Lower Inner Quadrant			TCGA-A8-A09R-F40330	TCGA-A8-A09R	TCGA-A8-A09R-01A		Positive					Positive	Other					-30196	149		0	273										2013-2-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO			false	No	M0	N1	T2	Stage IIB	TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf	A09R	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	c7064fcd-f96a-4977-8782-9131dfdf843e	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	c7064fcd-f96a-4977-8782-9131dfdf843e	TCGA-A8-A09R-01A-21-A13B-20	TCGA-A8-A09R-01A-11W-A019-09		TCGA-A8-A09R-01			7c1073e9-1995-4dfa-a9aa-e260e8999d54	TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01A-11D-A00Y-05	TCGA-A8-A09R-01		TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11D-A011-01		TCGA-A8-A09R-01A-11R-A00Z-07	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01A-11D-A011-01	TCGA-A8-A09R-01
TCGA-A8-A09T-01	Stage X	68	4	Stage I	578		Positive	FEMALE	Negative				Negative	M0	Negative	N0	578	0	LumA	Luminal A	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A09T-01	579	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A09T	579	0	days	579	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left			TCGA-A8-A09T-F40329	TCGA-A8-A09T	TCGA-A8-A09T-01A		Positive					Positive	Other					-25110	394		0	579										2013-2-17	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO			false	No	MX	N0	T1c	Stage X	TCGA-A8-A09T.C616E97C-8352-4FED-9E83-558318216FB6.pdf	A09T	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	63eeed5c-ee46-43e0-8886-3ad9b50634e3	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	63eeed5c-ee46-43e0-8886-3ad9b50634e3		TCGA-A8-A09T-01A-11W-A019-09		TCGA-A8-A09T-01				TCGA-A8-A09T-01	TCGA-A8-A09T-01A-11W-A019-09	TCGA-A8-A09T-01A-11D-A00Y-05	TCGA-A8-A09T-01		TCGA-A8-A09T-01A-11W-A019-09	TCGA-A8-A09T-01	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	TCGA-A8-A09T-01	TCGA-A8-A09T-01A-11D-A011-01		TCGA-A8-A09T-01A-11R-A00Z-07	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	TCGA-A8-A09T-01A-11D-A011-01	TCGA-A8-A09T-01
TCGA-A8-A09V-01	Stage IIA	51	2	Stage IIA	457		Positive	FEMALE	Negative				Negative	M0	Negative	N0	457	0	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09V-01	457	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A09V	457	0	days	457	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Inner Quadrant			TCGA-A8-A09V-F40328	TCGA-A8-A09V	TCGA-A8-A09V-01A		Positive					Positive	Other					-18628	333		0	457										2013-2-17	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			60	NO	Negative	Negative	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2									NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090.pdf	A09V	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	416041ff-f179-4c72-a281-f39d32c595c1	72d21cce-e233-49e4-8277-aa1b0be0a160	416041ff-f179-4c72-a281-f39d32c595c1	72d21cce-e233-49e4-8277-aa1b0be0a160		TCGA-A8-A09V-01A-11D-A045-09		TCGA-A8-A09V-01				TCGA-A8-A09V-01	TCGA-A8-A09V-01A-11D-A045-09	TCGA-A8-A09V-01A-11D-A032-05	TCGA-A8-A09V-01		TCGA-A8-A09V-01A-11D-A045-09		416041ff-f179-4c72-a281-f39d32c595c1		TCGA-A8-A09V-01A-11D-A036-01		TCGA-A8-A09V-01A-11R-A034-07	416041ff-f179-4c72-a281-f39d32c595c1	TCGA-A8-A09V-01A-11D-A036-01	TCGA-A8-A09V-01
TCGA-A8-A09W-01	Stage IIIB	70	2	Stage IIIC	30		Positive	FEMALE	Negative				Negative	M0	Positive	N3	30	0	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09W-01	30	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-A8-A09W			days	30	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Inner Quadrant				TCGA-A8-A09W	TCGA-A8-A09W-01A		Positive					Positive	Other					-25659	1033		0	30										2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			180	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4												false	No	M0	N3	T2	Stage IIIB	TCGA-A8-A09W.B73AF7B0-EED3-413C-B249-C97F27E4EA1C.pdf	A09W												Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	Breast	A	LIVING	2007	aaec0cbc-a493-48f4-9cc7-32629880ee24	51f01aa5-6fd7-4f74-ba41-603e338b3ed1	aaec0cbc-a493-48f4-9cc7-32629880ee24	51f01aa5-6fd7-4f74-ba41-603e338b3ed1	TCGA-A8-A09W-01A-21-A13A-20	TCGA-A8-A09W-01A-11W-A019-09		TCGA-A8-A09W-01			074231b9-2438-4e1e-9965-6ae7e02ae660	TCGA-A8-A09W-01	TCGA-A8-A09W-01A-11W-A019-09	TCGA-A8-A09W-01A-11D-A00Y-05	TCGA-A8-A09W-01		TCGA-A8-A09W-01A-11W-A019-09		aaec0cbc-a493-48f4-9cc7-32629880ee24		TCGA-A8-A09W-01A-11D-A011-01		TCGA-A8-A09W-01A-11R-A00Z-07	aaec0cbc-a493-48f4-9cc7-32629880ee24	TCGA-A8-A09W-01A-11D-A011-01	TCGA-A8-A09W-01
TCGA-A8-A09X-01	Stage IIIC	62	3	Stage IIIC	426	426	Negative	FEMALE	Negative	2	1	1	Negative	M0	Positive	N3	426	1	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-A8-A09X-01	426	1	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A09X			days	426	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Inner Quadrant				TCGA-A8-A09X	TCGA-A8-A09X-01A		Negative					Negative	Other					-22858	302	426	0											2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			150	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3											false	No	M0	N3a	T2	Stage IIIC	TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491.pdf	A09X												Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	DECEASED	2009	f97f68be-6838-455c-91bf-7549543a82c3	aff06258-5ee9-4f2b-8947-f296ca0b34f3	f97f68be-6838-455c-91bf-7549543a82c3	aff06258-5ee9-4f2b-8947-f296ca0b34f3	TCGA-A8-A09X-01A-21-A13A-20	TCGA-A8-A09X-01A-11W-A019-09		TCGA-A8-A09X-01			62752717-e2ef-42c9-b0c2-282f66bc0096	TCGA-A8-A09X-01	TCGA-A8-A09X-01A-11W-A019-09	TCGA-A8-A09X-01A-11D-A00Y-05	TCGA-A8-A09X-01		TCGA-A8-A09X-01A-11W-A019-09	TCGA-A8-A09X-01	f97f68be-6838-455c-91bf-7549543a82c3	TCGA-A8-A09X-01	TCGA-A8-A09X-01A-11D-A011-01		TCGA-A8-A09X-01A-11R-A00Z-07	f97f68be-6838-455c-91bf-7549543a82c3	TCGA-A8-A09X-01A-11D-A011-01	TCGA-A8-A09X-01
TCGA-A8-A09Z-01	Stage IIB	83	2	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0		Luminal B	Negative	Basal	0	-5	enrollment	T_Other	T3	LIVING		TCGA-A8-A09Z-01			days	Iq		cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2		TCGA-A8-A09Z			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Right				TCGA-A8-A09Z	TCGA-A8-A09Z-01A		Positive					Negative	Other					-30590	728		0	0										2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			320	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2											false	No	M0	N0	T3	Stage IIB	TCGA-A8-A09Z.DF890966-D14E-4EDF-B6E3-E10E40BA5B5D.pdf	A09Z	WITH TUMOR											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2008	2c3ad15f-0d26-441e-8139-85194b3389f2	6696111b-ca51-4c58-806d-2d5faa3a9456	2c3ad15f-0d26-441e-8139-85194b3389f2	6696111b-ca51-4c58-806d-2d5faa3a9456	TCGA-A8-A09Z-01A-21-A13A-20			TCGA-A8-A09Z-01			c8b43014-8e13-462a-90c5-c38032e02d7a	TCGA-A8-A09Z-01	TCGA-A8-A09Z-01A-11W-A019-09	TCGA-A8-A09Z-01A-11D-A00Y-05	TCGA-A8-A09Z-01			TCGA-A8-A09Z-01	2c3ad15f-0d26-441e-8139-85194b3389f2	TCGA-A8-A09Z-01	TCGA-A8-A09Z-01A-11D-A011-01		TCGA-A8-A09Z-01A-11R-A00Z-07	2c3ad15f-0d26-441e-8139-85194b3389f2	TCGA-A8-A09Z-01A-11D-A011-01	TCGA-A8-A09Z-01
TCGA-A8-A0A1-01	Stage IIA	84	2	Stage IIA	365		Positive	FEMALE	Negative				Negative	M0	Negative	N0	365	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A1-01	365	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-A8-A0A1			days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Right				TCGA-A8-A0A1	TCGA-A8-A0A1-01A		Positive					Positive	Other					-30742	241		0	365										2011-5-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf	A0A1	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	8522865b-457c-4199-a870-bf8353f2b0a5	ebcb8722-05fc-441d-a13a-1fb5c8f1228f	8522865b-457c-4199-a870-bf8353f2b0a5	ebcb8722-05fc-441d-a13a-1fb5c8f1228f		TCGA-A8-A0A1-01A-11W-A019-09		TCGA-A8-A0A1-01				TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01A-11D-A00Y-05	TCGA-A8-A0A1-01		TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11D-A011-01		TCGA-A8-A0A1-01A-11R-A00Z-07	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01A-11D-A011-01	TCGA-A8-A0A1-01
TCGA-A8-A0A2-01	Stage IIA	66	2	Stage IIA	578		Positive	FEMALE	Negative				Negative	M0	Negative	N0	578	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A2-01	579	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A0A2			days	579	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Lower Outer Quadrant				TCGA-A8-A0A2	TCGA-A8-A0A2-01A		Positive					Positive	Other					-24380	394		0	579										2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			70	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2											false	No	M0	N0	T2	Stage IIA	TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE.pdf	A0A2	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	6330ab59-db9d-4b22-a96b-1024c9b4908d	2c01b1ef-d826-4183-b79d-903d4fe5ef5e	6330ab59-db9d-4b22-a96b-1024c9b4908d	2c01b1ef-d826-4183-b79d-903d4fe5ef5e		TCGA-A8-A0A2-01A-11W-A050-09		TCGA-A8-A0A2-01				TCGA-A8-A0A2-01	TCGA-A8-A0A2-01A-11W-A050-09	TCGA-A8-A0A2-01A-11D-A032-05	TCGA-A8-A0A2-01		TCGA-A8-A0A2-01A-11W-A050-09	TCGA-A8-A0A2-01	6330ab59-db9d-4b22-a96b-1024c9b4908d	TCGA-A8-A0A2-01	TCGA-A8-A0A2-01A-11D-A036-01		TCGA-A8-A0A2-01A-11R-A034-07	6330ab59-db9d-4b22-a96b-1024c9b4908d	TCGA-A8-A0A2-01A-11D-A036-01	TCGA-A8-A0A2-01
TCGA-A8-A0A4-01	Stage IIA	73	2	Stage IIA	396		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	396	0	LumA	Luminal A	Positive	ReacII	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A4-01	396	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A8-A0A4	396	0	days	396	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left			TCGA-A8-A0A4-F40326	TCGA-A8-A0A4	TCGA-A8-A0A4-01A		Positive					Positive	Other					-26693	272		0	396										2013-2-16	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			160	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9.pdf	A0A4	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	a4acb159-6b4b-431f-9ae3-1352299bc461	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	a4acb159-6b4b-431f-9ae3-1352299bc461	TCGA-A8-A0A4-01A-21-A13A-20	TCGA-A8-A0A4-01A-11W-A019-09		TCGA-A8-A0A4-01			9748e726-7d5e-4e3c-ad24-ab078118010c	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01A-11W-A019-09	TCGA-A8-A0A4-01A-11D-A00Y-05	TCGA-A8-A0A4-01		TCGA-A8-A0A4-01A-11W-A019-09	TCGA-A8-A0A4-01	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01A-11D-A011-01		TCGA-A8-A0A4-01A-11R-A00Z-07	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	TCGA-A8-A0A4-01A-11D-A011-01	TCGA-A8-A0A4-01
TCGA-A8-A0A6-01	Stage IIIC	64	2	Stage IIIC	640		Positive	FEMALE	Negative				Negative	M0	Positive	N3	640	0	LumA	Luminal A	Positive		-5	-4	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A6-01	640	0	days	BRCA-LUAD+		cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1		TCGA-A8-A0A6	640	0	days	640	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left Upper Outer Quadrant			TCGA-A8-A0A6-F40325	TCGA-A8-A0A6	TCGA-A8-A0A6-01A		Positive					Positive	Other					-23404	394		0	640										2013-2-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			90	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO			false	No	M0	N3a	T2	Stage IIIC	TCGA-A8-A0A6.161A2735-C3CF-466D-AE21-C6A2C987BB1E.pdf	A0A6	TUMOR FREE						YES				YES	Primary Tumor	01	surgical resection	6th		NO	YES	A8	Breast	A	LIVING	2009	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	0f68f8f1-514a-41b6-bf5a-87792ef5a50f	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	0f68f8f1-514a-41b6-bf5a-87792ef5a50f				TCGA-A8-A0A6-01	TCGA-A8-A0A6-01A-12D-A10P-05			TCGA-A8-A0A6-01	TCGA-A8-A0A6-01A-12W-A071-09		TCGA-A8-A0A6-01			TCGA-A8-A0A6-01	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01	TCGA-A8-A0A6-01A-12D-A059-01		TCGA-A8-A0A6-01A-12R-A056-07	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01A-12D-A059-01	TCGA-A8-A0A6-01
TCGA-A8-A0A7-01	Stage IIB	57	3	Stage IIB	30		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	30	0	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A7-01	30	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A0A7			days	30	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Outer Quadrant				TCGA-A8-A0A7			Negative					Negative	Other					-20940			0	30										2011-5-27	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES					Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4												No	M0	N1a	T2	Stage IIB		A0A7	TUMOR FREE											Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2009	bae23acf-5981-4071-a7e1-6363ab128561	ea568589-43f0-4539-acdf-c626aeb20446	bae23acf-5981-4071-a7e1-6363ab128561	ea568589-43f0-4539-acdf-c626aeb20446	TCGA-A8-A0A7-01A-21-A13A-20	TCGA-A8-A0A7-01A-11W-A019-09		TCGA-A8-A0A7-01			d459629a-8ef9-4556-adfb-a3105e460556	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01A-11W-A019-09	TCGA-A8-A0A7-01A-11D-A00Y-05	TCGA-A8-A0A7-01		TCGA-A8-A0A7-01A-11W-A019-09	TCGA-A8-A0A7-01	bae23acf-5981-4071-a7e1-6363ab128561	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01A-11D-A011-01		TCGA-A8-A0A7-01A-11R-A040-07	bae23acf-5981-4071-a7e1-6363ab128561	TCGA-A8-A0A7-01A-11D-A011-01	TCGA-A8-A0A7-01
TCGA-A8-A0A9-01	Stage IIA	80	3	Stage IIA	396		Positive	FEMALE	Negative				Negative	M0	Negative	N0	396	0	LumA	Luminal B	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A9-01	822	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A0A9	822	0	days	822	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left Upper Outer Quadrant			TCGA-A8-A0A9-F40323	TCGA-A8-A0A9	TCGA-A8-A0A9-01A		Positive					Positive	Other					-29370	272		0	822										2013-2-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf	A0A9	TUMOR FREE						YES				YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	1766e42e-f8cf-447d-a694-3999a1fec43a	e58bcf4e-94ae-47b3-9148-43a76567841d	1766e42e-f8cf-447d-a694-3999a1fec43a	e58bcf4e-94ae-47b3-9148-43a76567841d		TCGA-A8-A0A9-01A-11W-A019-09		TCGA-A8-A0A9-01				TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01A-11D-A00Y-05	TCGA-A8-A0A9-01		TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11D-A011-01		TCGA-A8-A0A9-01A-11R-A00Z-07	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01A-11D-A011-01	TCGA-A8-A0A9-01
TCGA-A8-A0AB-01	Stage IIA	54	2	Stage IIA	517		Positive	FEMALE	Negative				Negative	M0	Negative	N0	517	0	LumA	Luminal B	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0AB-01	518	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A0AB	518	0	days	518	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant			TCGA-A8-A0AB-F40322	TCGA-A8-A0AB	TCGA-A8-A0AB-01A		Positive					Positive	Other					-19814	394		0	518										2013-2-16	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO			false	No	M0	N0	T2	Stage IIA	TCGA-A8-A0AB.E4D30B42-383A-40BF-BB91-511A90227655.pdf	A0AB	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast	A	LIVING	2009	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	bffa483f-5c3a-4945-be72-4b868b1c10fb	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	bffa483f-5c3a-4945-be72-4b868b1c10fb		TCGA-A8-A0AB-01A-11W-A050-09		TCGA-A8-A0AB-01				TCGA-A8-A0AB-01	TCGA-A8-A0AB-01A-11W-A050-09	TCGA-A8-A0AB-01A-11D-A032-05	TCGA-A8-A0AB-01		TCGA-A8-A0AB-01A-11W-A050-09	TCGA-A8-A0AB-01	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	TCGA-A8-A0AB-01	TCGA-A8-A0AB-01A-11D-A036-01		TCGA-A8-A0AB-01A-11R-A034-07	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	TCGA-A8-A0AB-01A-11D-A036-01	TCGA-A8-A0AB-01
TCGA-A8-A0AD-01	Stage I	83	2	Stage I	1157		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1157	0	LumA	Luminal A	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A0AD-01	1157	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-A8-A0AD	1157	0	days	1157	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Right Upper Outer Quadrant			TCGA-A8-A0AD-F40321	TCGA-A8-A0AD			Positive					Positive	Other					-30407			0	1157										2013-2-16	FEMALE					1+					Mixed Histology (please specify)	lobular/ductal	No		C50.9	8522/3	C50.9		YES					Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO				No	M0	N0	T1c	Stage I		A0AD	TUMOR FREE						YES				NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	Breast		LIVING	2007	b62f3825-9634-4252-b841-4c455a007353	f9e62dfe-3037-4306-be92-dfbeae90283e	b62f3825-9634-4252-b841-4c455a007353	f9e62dfe-3037-4306-be92-dfbeae90283e		TCGA-A8-A0AD-01A-11W-A071-09		TCGA-A8-A0AD-01	TCGA-A8-A0AD-01A-11D-A10P-05			TCGA-A8-A0AD-01	TCGA-A8-A0AD-01A-11W-A071-09		TCGA-A8-A0AD-01		TCGA-A8-A0AD-01A-11W-A071-09	TCGA-A8-A0AD-01	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01	TCGA-A8-A0AD-01A-11D-A059-01		TCGA-A8-A0AD-01A-11R-A056-07	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01A-11D-A059-01	TCGA-A8-A0AD-01
TCGA-AC-A23C-01		62	3	Stage IIB	29		Positive	FEMALE	Positive				Negative	M0	Positive	N1	29	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AC-A23C-01	585	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 4	TCGA-AC-A23C	585	0	days	585	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left			TCGA-AC-A23C-F43235	TCGA-AC-A23C	TCGA-AC-A23C-01A		Positive					Positive	Modified Radical Mastectomy					-22751	198		0	585					NO		90-99%			2013-5-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Positive	Positive	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	1		false	No	MX	N1	T2	Stage IIB	TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf	A23C	TUMOR FREE						YES	YES	50-59%		NO	Primary Tumor	01		7th		NO	YES	AC	Breast	A	LIVING	2010	052b565f-1955-4c4e-8b1f-dd48743ba944	2036be70-c64b-4ef4-82c6-822c5afae946	052b565f-1955-4c4e-8b1f-dd48743ba944	2036be70-c64b-4ef4-82c6-822c5afae946	TCGA-AC-A23C-01A-21-A17I-20	TCGA-AC-A23C-01A-12D-A167-09		TCGA-AC-A23C-01	TCGA-AC-A23C-01A-12D-A16A-05		53968cee-b8a9-43d6-b9cd-d4b9cd39baf0	TCGA-AC-A23C-01	TCGA-AC-A23C-01A-12D-A167-09			TCGA-AC-A23C-01	TCGA-AC-A23C-01A-12D-A167-09		052b565f-1955-4c4e-8b1f-dd48743ba944		TCGA-AC-A23C-01A-12D-A166-01	TCGA-AC-A23C-01		052b565f-1955-4c4e-8b1f-dd48743ba944	TCGA-AC-A23C-01A-12D-A166-01	
TCGA-AC-A23E-01		50	2	Stage IIB	72		Positive	FEMALE	Negative				Negative	M0	Positive	N1	72	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AC-A23E-01	698	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-AC-A23E	698	0	days	698	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Sentinel node biopsy alone		TCGA-AC-A23E-F43240	TCGA-AC-A23E	TCGA-AC-A23E-01A		Positive					Positive	Modified Radical Mastectomy					-18500	158		0	698					NO		30-39%			2013-5-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO			NO	2	Negative																					2									NO	1		false	No	MX	N1	T2	Stage IIB	TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf	A23E	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		7th				AC	Breast	A	LIVING	2010	25be50e7-7705-492d-a44a-0e40180d10c8	f875e50e-fc0f-4421-8ffb-4fec24d3340c	25be50e7-7705-492d-a44a-0e40180d10c8	f875e50e-fc0f-4421-8ffb-4fec24d3340c	TCGA-AC-A23E-01A-21-A17I-20	TCGA-AC-A23E-01A-11D-A159-09		TCGA-AC-A23E-01	TCGA-AC-A23E-01A-11D-A161-05		f5ca4ea4-d35a-456e-aabb-0aec9f48a7be	TCGA-AC-A23E-01	TCGA-AC-A23E-01A-11D-A159-09			TCGA-AC-A23E-01	TCGA-AC-A23E-01A-11D-A159-09		25be50e7-7705-492d-a44a-0e40180d10c8		TCGA-AC-A23E-01A-11D-A160-01	TCGA-AC-A23E-01		25be50e7-7705-492d-a44a-0e40180d10c8	TCGA-AC-A23E-01A-11D-A160-01	
TCGA-AC-A23G-01																			LumA										0	TCGA-AC-A23G-01	2248	0	days	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A23G	2248	0	days	2248	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Right Upper Inner Quadrant			TCGA-AC-A23G-F43241	TCGA-AC-A23G	TCGA-AC-A23G-01A		Positive					Positive	Other					-27934	1590		0	2248					NO		90-99%			2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO	Positive	Positive	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	No	MX	N1	T1c	Stage IIA	TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf	A23G	TUMOR FREE						YES	YES	80-89%		NO	Primary Tumor	01	Right Total Mastectomy and Sentinel Node Biopsy	6th		NO	YES	AC	Breast	A	LIVING	2006	3cd0b704-99b5-401b-8f52-daead9359692	02bde32b-37e9-4768-9222-aba698b4ef49	3cd0b704-99b5-401b-8f52-daead9359692	02bde32b-37e9-4768-9222-aba698b4ef49				TCGA-AC-A23G-01	TCGA-AC-A23G-01A-11D-A212-05			TCGA-AC-A23G-01	TCGA-AC-A23G-01A-11D-A20S-09			TCGA-AC-A23G-01			3cd0b704-99b5-401b-8f52-daead9359692		TCGA-AC-A23G-01A-11D-A20R-01	TCGA-AC-A23G-01		3cd0b704-99b5-401b-8f52-daead9359692	TCGA-AC-A23G-01A-11D-A20R-01	
TCGA-AC-A23H-01		90	3	Stage IIA	81		Positive	FEMALE	Positive				Negative	M0	Negative	N0	81	0	Her2		Negative				enrollment	T_Other	T2	LIVING	1	TCGA-AC-A23H-01	174	1	days	High		cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A23H	174	0	days	174	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right Upper Inner Quadrant|Right Lower Inner Quadrant			TCGA-AC-A23H-F45572	TCGA-AC-A23H	TCGA-AC-A23H-01A		Positive					Negative	Simple Mastectomy					-32873	478	174	0	81					NO		10-19%			2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO			false	No	M0	NX	T2	Stage IIA	TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf	A23H	WITH TUMOR						NO	NO			NO	Primary Tumor	01		7th		NO	YES	AC	Breast	A	DECEASED	2009	28199d71-9111-4763-a07f-66734769bb98	f8597ba1-42d8-4506-a306-3e443b82018d	28199d71-9111-4763-a07f-66734769bb98	f8597ba1-42d8-4506-a306-3e443b82018d				TCGA-AC-A23H-01	TCGA-AC-A23H-01A-11D-A161-05			TCGA-AC-A23H-01	TCGA-AC-A23H-01A-11D-A159-09			TCGA-AC-A23H-01			28199d71-9111-4763-a07f-66734769bb98		TCGA-AC-A23H-01A-11D-A160-01	TCGA-AC-A23H-01		28199d71-9111-4763-a07f-66734769bb98	TCGA-AC-A23H-01A-11D-A160-01	
TCGA-AC-A23H-11		90			81			FEMALE									81	0	Normal						enrollment			LIVING	1	TCGA-AC-A23H-11	174	1	days										TCGA-AC-A23H	174	0	days	174	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right Upper Inner Quadrant|Right Lower Inner Quadrant			TCGA-AC-A23H-F45572	TCGA-AC-A23H	TCGA-AC-A23H-11A		Positive					Negative	Simple Mastectomy					-32873	478	174	0	81					NO		10-19%			2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	No	M0	NX	T2	Stage IIA		A23H	WITH TUMOR						NO	NO			NO	Solid Tissue Normal	11		7th		NO	YES	AC	Breast	A	DECEASED	2009	93108690-ccc2-4ae4-89e0-042a654a0228		93108690-ccc2-4ae4-89e0-042a654a0228						TCGA-AC-A23H-11A-12D-A161-05							TCGA-AC-A23H-11			93108690-ccc2-4ae4-89e0-042a654a0228			TCGA-AC-A23H-11		93108690-ccc2-4ae4-89e0-042a654a0228		
TCGA-AC-A2B8-01			2																LumA										0	TCGA-AC-A2B8-01	677	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2B8	654	1	days	677	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			84	Right	Axillary lymph node dissection alone		TCGA-AC-A2B8-F43210	TCGA-AC-A2B8	TCGA-AC-A2B8-01A		Positive					Positive	Simple Mastectomy					-31003	101		0	677		672	654		NO		90-99%			2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1					Other, specify	New Primary Tumor	Rectum	YES	YES	0	0	false	No	M0	N0 (i-)	T3	Stage IIB	TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf	A2B8	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	ed74a7e1-90de-4943-9ca2-e7f94a5540e4	abfdddc2-b118-4b4e-a283-f8cbc56730b4	ed74a7e1-90de-4943-9ca2-e7f94a5540e4	abfdddc2-b118-4b4e-a283-f8cbc56730b4	TCGA-AC-A2B8-01A-21-A24A-20			TCGA-AC-A2B8-01	TCGA-AC-A2B8-01A-11D-A17F-05		7365ebda-a4f6-4d52-bed9-220059dc5e5e	TCGA-AC-A2B8-01	TCGA-AC-A2B8-01A-11D-A17D-09			TCGA-AC-A2B8-01			ed74a7e1-90de-4943-9ca2-e7f94a5540e4		TCGA-AC-A2B8-01A-11D-A17C-01	TCGA-AC-A2B8-01		ed74a7e1-90de-4943-9ca2-e7f94a5540e4	TCGA-AC-A2B8-01A-11D-A17C-01	
TCGA-AC-A2BK-01																			Basal										0	TCGA-AC-A2BK-01	2222	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4			TCGA-AC-A2BK	2222	0	days	2222	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A2BK-F43987	TCGA-AC-A2BK	TCGA-AC-A2BK-01A		Negative					Negative	Modified Radical Mastectomy		NO			-28625	1717		0	2222					NO					2013-6-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	6		false	No	MX	N2a	T2	Stage IIIA	TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf	A2BK	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2006	08893743-829b-4594-ab67-d5eb5e80a4f3	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	08893743-829b-4594-ab67-d5eb5e80a4f3	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	TCGA-AC-A2BK-01A-21-A24A-20			TCGA-AC-A2BK-01	TCGA-AC-A2BK-01A-11D-A21R-05		1392fc51-37de-493d-a7e9-01269e73c9c5	TCGA-AC-A2BK-01	TCGA-AC-A2BK-01A-11D-A21Q-09			TCGA-AC-A2BK-01			08893743-829b-4594-ab67-d5eb5e80a4f3		TCGA-AC-A2BK-01A-11D-A21P-01	TCGA-AC-A2BK-01		08893743-829b-4594-ab67-d5eb5e80a4f3	TCGA-AC-A2BK-01A-11D-A21P-01	
TCGA-AC-A2BM-01																			LumB										0	TCGA-AC-A2BM-01	3022	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2BM	3022	0	days	3022	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2BM-F66202	TCGA-AC-A2BM	TCGA-AC-A2BM-01A		Positive					Positive	Modified Radical Mastectomy		YES			-15212	2164		0	3022					NO		60-69%			2014-10-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO		Negative	NO	13	Negative																														NO	1	1	false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf	A2BM	TUMOR FREE						NO	YES	10-19%		NO	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2005	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	af345a5e-3793-4751-b412-333cf037cda8	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	af345a5e-3793-4751-b412-333cf037cda8	TCGA-AC-A2BM-01A-21-A24A-20			TCGA-AC-A2BM-01	TCGA-AC-A2BM-01A-11D-A21R-05		2222f10b-39fd-4aa4-8021-7f320c835f88	TCGA-AC-A2BM-01	TCGA-AC-A2BM-01A-11D-A21Q-09			TCGA-AC-A2BM-01			54f1981b-9d8f-48cc-9586-d2e9a8d468f5		TCGA-AC-A2BM-01A-11D-A21P-01	TCGA-AC-A2BM-01		54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-11D-A21P-01	
TCGA-AC-A2FB-01			3																LumA										0	TCGA-AC-A2FB-01	1234	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2FB	1234	0	days	1234	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FB-F45574	TCGA-AC-A2FB	TCGA-AC-A2FB-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-23851	576		0	1234					NO		90-99%			2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	140	NO	Positive		NO	1	Negative																					1									NO	0		false	No	MX	N0	T2	Stage IIA	TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf	A2FB	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2009	fce0d59e-78a5-4d7b-8136-b8421f5116b0	ebef629e-e465-4ef3-84db-81ff8522b7f9	fce0d59e-78a5-4d7b-8136-b8421f5116b0	ebef629e-e465-4ef3-84db-81ff8522b7f9	TCGA-AC-A2FB-01A-21-A24A-20			TCGA-AC-A2FB-01	TCGA-AC-A2FB-01A-11D-A17F-05		6bde7ec5-1170-4bdf-afa6-bff4642ef9e3	TCGA-AC-A2FB-01	TCGA-AC-A2FB-01A-11D-A17D-09			TCGA-AC-A2FB-01			fce0d59e-78a5-4d7b-8136-b8421f5116b0		TCGA-AC-A2FB-01A-11D-A17C-01	TCGA-AC-A2FB-01		fce0d59e-78a5-4d7b-8136-b8421f5116b0	TCGA-AC-A2FB-01A-11D-A17C-01	
TCGA-AC-A2FB-11																			Normal										0	TCGA-AC-A2FB-11	1234	0	days		C3-BRCA/Luminal								TCGA-AC-A2FB	1234	0	days	1234	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FB-F45574	TCGA-AC-A2FB			Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		NO			-23851			0	1234					NO		90-99%			2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy			Positive		NO	1	Negative																														NO	0			No	MX	N0	T2	Stage IIA		A2FB	TUMOR FREE						YES	YES	<10%		NO	Solid Tissue Normal	11		6th		NO	YES	AC	Breast		LIVING	2009	f18b2ff7-eddb-40b5-9bbe-7ef09787ddef		f18b2ff7-eddb-40b5-9bbe-7ef09787ddef						TCGA-AC-A2FB-11A-13D-A17F-05							TCGA-AC-A2FB-11			f18b2ff7-eddb-40b5-9bbe-7ef09787ddef			TCGA-AC-A2FB-11		f18b2ff7-eddb-40b5-9bbe-7ef09787ddef		
TCGA-AC-A2FE-01																													1	TCGA-AC-A2FE-01	2636	1	days	BRCA-LUAD+			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 5			TCGA-AC-A2FE	2496	1	days	2636	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2FE-F47725	TCGA-AC-A2FE	TCGA-AC-A2FE-01A		Positive					Positive	Modified Radical Mastectomy		NO			-22746	2228	2636	0	791			2496				60-69%			2013-8-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	120	NO			NO	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Liver	Distant Metastasis		NO	YES	18		false	No	MX	N3a	T3	Stage IIIC	TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf	A2FE	WITH TUMOR						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	AC	Breast	A	DECEASED	2005	22e03b77-aa0f-4348-98c1-9b0914e8af8b	dfc59958-404b-4e0e-9950-9c120f6956c0	22e03b77-aa0f-4348-98c1-9b0914e8af8b	dfc59958-404b-4e0e-9950-9c120f6956c0	TCGA-AC-A2FE-01A-21-A24A-20			TCGA-AC-A2FE-01	TCGA-AC-A2FE-01A-11D-A19Z-05		419206c6-a1d6-4541-b154-10aae75b04a2	TCGA-AC-A2FE-01	TCGA-AC-A2FE-01A-11D-A19Y-09			TCGA-AC-A2FE-01			22e03b77-aa0f-4348-98c1-9b0914e8af8b		TCGA-AC-A2FE-01A-11D-A19X-01	TCGA-AC-A2FE-01		22e03b77-aa0f-4348-98c1-9b0914e8af8b	TCGA-AC-A2FE-01A-11D-A19X-01	
TCGA-AC-A2FF-01			1																LumA										0	TCGA-AC-A2FF-01	2759	0	days	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A2FF	2759	0	days	2759	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2FF-F58655	TCGA-AC-A2FF	TCGA-AC-A2FF-01A		Positive					Positive	Lumpectomy		YES				1904		0	2759					NO		30-39%			2014-4-17	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO		Negative	NO	7	Negative																					1									NO	3	0	false	No	MX	N1	T2	Stage IIB	TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf	A2FF	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2006	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	aabd1bd8-a5fc-44fd-8a1c-300fbab3032f	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	aabd1bd8-a5fc-44fd-8a1c-300fbab3032f	TCGA-AC-A2FF-01A-21-A24A-20			TCGA-AC-A2FF-01	TCGA-AC-A2FF-01A-11D-A17F-05		588f1cc2-09a3-4ffa-b934-a8b7c4c8524c	TCGA-AC-A2FF-01	TCGA-AC-A2FF-01A-11D-A17D-09			TCGA-AC-A2FF-01			f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8		TCGA-AC-A2FF-01A-11D-A17C-01	TCGA-AC-A2FF-01		f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	TCGA-AC-A2FF-01A-11D-A17C-01	
TCGA-AC-A2FF-11																			Normal										0	TCGA-AC-A2FF-11	2759	0	days		C3-BRCA/Luminal								TCGA-AC-A2FF	2759	0	days	2759	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2FF-F58655	TCGA-AC-A2FF	TCGA-AC-A2FF-11A		Positive					Positive	Lumpectomy		YES				1904		0	2759					NO		30-39%			2014-4-17	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative	NO	7	Negative																														NO	3	0	false	No	MX	N1	T2	Stage IIB		A2FF	TUMOR FREE						YES	YES	70-79%		YES	Solid Tissue Normal	11		6th		NO	YES	AC	Breast	A	LIVING	2006	3610639e-d947-446f-8483-86be65c80ed3		3610639e-d947-446f-8483-86be65c80ed3						TCGA-AC-A2FF-11A-13D-A17F-05										3610639e-d947-446f-8483-86be65c80ed3					3610639e-d947-446f-8483-86be65c80ed3		
TCGA-AC-A2FG-01			2																LumA										0	TCGA-AC-A2FG-01	1853	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-AC-A2FG	1853	0	days	1853	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2FG-F43221	TCGA-AC-A2FG	TCGA-AC-A2FG-01A		Positive					Negative	Modified Radical Mastectomy		YES			-29211	1517		0	1853					NO		90-99%			2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO		Negative	NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	1	1	false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf	A2FG	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2007	c4cc228f-ab41-4779-b405-175618e5f77c	709f0022-50be-49df-839c-9e716e3e0869	c4cc228f-ab41-4779-b405-175618e5f77c	709f0022-50be-49df-839c-9e716e3e0869	TCGA-AC-A2FG-01A-21-A24A-20			TCGA-AC-A2FG-01	TCGA-AC-A2FG-01A-11D-A17F-05		4be4e39c-7061-4ef0-8347-75622194af98	TCGA-AC-A2FG-01	TCGA-AC-A2FG-01A-11D-A17D-09			TCGA-AC-A2FG-01			c4cc228f-ab41-4779-b405-175618e5f77c		TCGA-AC-A2FG-01A-11D-A17C-01	TCGA-AC-A2FG-01		c4cc228f-ab41-4779-b405-175618e5f77c	TCGA-AC-A2FG-01A-11D-A17C-01	
TCGA-AC-A2FG-11																													0	TCGA-AC-A2FG-11	1853	0	days		C3-BRCA/Luminal								TCGA-AC-A2FG	1853	0	days	1853	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A2FG-F43221	TCGA-AC-A2FG	TCGA-AC-A2FG-11A		Positive					Negative	Modified Radical Mastectomy		YES			-29211	1517		0	1853					NO		90-99%			2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO		Negative	NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	1	false	No	MX	N1a	T2	Stage IIB		A2FG	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		6th		NO	YES	AC	Breast	A	LIVING	2007									TCGA-AC-A2FG-11A-22D-A17F-05																	
TCGA-AC-A2FK-01																			Normal										0	TCGA-AC-A2FK-01	2650	0	days	Quiet			Low purity c2		BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AC-A2FK	2650	0	days	2650	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant			TCGA-AC-A2FK-F66196	TCGA-AC-A2FK	TCGA-AC-A2FK-01A		Positive					Positive	Modified Radical Mastectomy					-16627	1833		0	2650					NO		90-99%			2014-10-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative	NO	3	Negative																														NO	3		false	No	M0	N3a	T2	Stage IIIC	TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf	A2FK	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2006	1fff796f-626b-4408-9fd1-4fea54e153a6	643d3847-9b4e-44c3-ae8e-965a14b19a55	1fff796f-626b-4408-9fd1-4fea54e153a6	643d3847-9b4e-44c3-ae8e-965a14b19a55				TCGA-AC-A2FK-01	TCGA-AC-A2FK-01A-12D-A17Z-05			TCGA-AC-A2FK-01	TCGA-AC-A2FK-01A-12D-A17W-09			TCGA-AC-A2FK-01			1fff796f-626b-4408-9fd1-4fea54e153a6		TCGA-AC-A2FK-01A-12D-A17U-01	TCGA-AC-A2FK-01		1fff796f-626b-4408-9fd1-4fea54e153a6	TCGA-AC-A2FK-01A-12D-A17U-01	
TCGA-AC-A2FM-01																													1	TCGA-AC-A2FM-01	792	1	days	High			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 5			TCGA-AC-A2FM	780	1	days	792	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			87	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FM-F43237	TCGA-AC-A2FM	TCGA-AC-A2FM-01A								Modified Radical Mastectomy		YES			-31805	2606	792	0				780		YES					2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	Distant Metastasis	Bone Marrow	NO	YES	0	0	false	No	M0	N1mi	T2	Stage IIB	TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf	A2FM	WITH TUMOR						NO	YES			NO	Primary Tumor	01		6th		NO	YES	AC	Breast	A	DECEASED	2004	c1280be2-b926-4632-975a-fe52bb04c65d	92864651-156a-44ab-a442-f17567476e0f	c1280be2-b926-4632-975a-fe52bb04c65d	92864651-156a-44ab-a442-f17567476e0f	TCGA-AC-A2FM-01A-21-A24A-20			TCGA-AC-A2FM-01	TCGA-AC-A2FM-01A-11D-A19Z-05		26f52e65-dac7-4cd4-9d02-7d01c2c6f0b7	TCGA-AC-A2FM-01	TCGA-AC-A2FM-01A-11D-A19Y-09			TCGA-AC-A2FM-01			c1280be2-b926-4632-975a-fe52bb04c65d		TCGA-AC-A2FM-01A-11D-A19X-01	TCGA-AC-A2FM-01		c1280be2-b926-4632-975a-fe52bb04c65d	TCGA-AC-A2FM-01A-11D-A19X-01	
TCGA-AC-A2FM-11																													1	TCGA-AC-A2FM-11	792	1	days										TCGA-AC-A2FM	780	1	days	792	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			87	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A2FM-F43237	TCGA-AC-A2FM	TCGA-AC-A2FM-11B								Modified Radical Mastectomy		YES			-31805	2733	792	0				780		YES					2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	Distant Metastasis	Bone Marrow	NO	YES	0	0	false	No	M0	N1mi	T2	Stage IIB		A2FM	WITH TUMOR						NO	YES			NO	Solid Tissue Normal	11		6th		NO	YES	AC	Breast	B	DECEASED	2004	68ec8441-f60a-4c80-8a9f-7609a0f81430		68ec8441-f60a-4c80-8a9f-7609a0f81430						TCGA-AC-A2FM-11B-32D-A19Z-05							TCGA-AC-A2FM-11			68ec8441-f60a-4c80-8a9f-7609a0f81430			TCGA-AC-A2FM-11		68ec8441-f60a-4c80-8a9f-7609a0f81430		
TCGA-AC-A2FO-01																			LumA										0	TCGA-AC-A2FO-01	2255	0	days	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AC-A2FO	2255	0	days	2255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node plus Level I and Level II lymph nodes	TCGA-AC-A2FO-F43223	TCGA-AC-A2FO	TCGA-AC-A2FO-01A		Positive					Negative	Simple Mastectomy		NO			-23928	2051		0	2255					NO		90-99%			2013-5-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Negative	Indeterminate	NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	No	MX	N1	T2	Stage IIB	TCGA-AC-A2FO.5A7EB73F-E681-46CC-B2D6-C87EEAB0AC99.pdf	A2FO	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	AC	Breast	A	LIVING	2005	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	51d21451-3c81-475b-bcd8-02e23e44cbd0	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	51d21451-3c81-475b-bcd8-02e23e44cbd0				TCGA-AC-A2FO-01	TCGA-AC-A2FO-01A-11D-A17Z-05			TCGA-AC-A2FO-01	TCGA-AC-A2FO-01A-11D-A17W-09			TCGA-AC-A2FO-01			bd07aa68-708b-4bd3-88b9-78a8b9e298f5		TCGA-AC-A2FO-01A-11D-A17U-01	TCGA-AC-A2FO-01		bd07aa68-708b-4bd3-88b9-78a8b9e298f5	TCGA-AC-A2FO-01A-11D-A17U-01	
TCGA-AC-A2QH-01																			Basal										0	TCGA-AC-A2QH-01	1005	0	days	Squamous			Cluster 5		GBM-like c6	miRNA cluster 13			TCGA-AC-A2QH	1005	0	days	1005	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A2QH-F64100	TCGA-AC-A2QH	TCGA-AC-A2QH-01A		Negative					Negative	Modified Radical Mastectomy		YES			-21488	108		0	1005					NO					2014-8-26	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T3	Stage IIB	TCGA-AC-A2QH.C2A0E948-2B9E-4E49-90C4-57CE4C4A95B3.pdf	A2QH	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	d848ad65-9261-4854-a6bd-e76484c6a337	116845a5-2178-44ff-8cac-58b95dd85081,86c22622-a7fb-4c73-8d6a-40be9a307dbe	d848ad65-9261-4854-a6bd-e76484c6a337	116845a5-2178-44ff-8cac-58b95dd85081,86c22622-a7fb-4c73-8d6a-40be9a307dbe			d848ad65-9261-4854-a6bd-e76484c6a337,eeef0334-de2a-4206-84ad-cd18e349635e	TCGA-AC-A2QH-01	TCGA-AC-A2QH-01A-11D-A18O-05,TCGA-AC-A2QH-01B-04D-A22R-05	d848ad65-9261-4854-a6bd-e76484c6a337,eeef0334-de2a-4206-84ad-cd18e349635e		TCGA-AC-A2QH-01	TCGA-AC-A2QH-01B-04D-A22N-09,TCGA-AC-A2QH-01A-11D-A18P-09			TCGA-AC-A2QH-01			d848ad65-9261-4854-a6bd-e76484c6a337		TCGA-AC-A2QH-01A-11D-A18N-01	TCGA-AC-A2QH-01		d848ad65-9261-4854-a6bd-e76484c6a337	TCGA-AC-A2QH-01A-11D-A18N-01	
TCGA-AC-A2QI-01																													0	TCGA-AC-A2QI-01	588	0	days	BRCA-LUAD+			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 3			TCGA-AC-A2QI	588	0	days	588	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Right	Sentinel node biopsy alone		TCGA-AC-A2QI-F57047	TCGA-AC-A2QI	TCGA-AC-A2QI-01A		Positive					Negative	Other					-27865	91		0	588					NO		90-99%			2014-2-28	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	No	MX	N1a	T3	Stage IIIA	TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf	A2QI	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Total Mastectomy	7th		YES	NO	AC	Breast	A	LIVING	2011	d620baa1-c329-46c6-a56a-dc08dfa23470	daf25698-598f-4efb-b1b5-6083d673b63f	d620baa1-c329-46c6-a56a-dc08dfa23470	daf25698-598f-4efb-b1b5-6083d673b63f	TCGA-AC-A2QI-01A-21-A24A-20			TCGA-AC-A2QI-01	TCGA-AC-A2QI-01A-12D-A19Z-05		3d65de31-a929-4c60-af58-5c24b7e3d6a5	TCGA-AC-A2QI-01	TCGA-AC-A2QI-01A-12D-A19Y-09			TCGA-AC-A2QI-01			d620baa1-c329-46c6-a56a-dc08dfa23470		TCGA-AC-A2QI-01A-12D-A19X-01	TCGA-AC-A2QI-01		d620baa1-c329-46c6-a56a-dc08dfa23470	TCGA-AC-A2QI-01A-12D-A19X-01	
TCGA-AC-A2QJ-01																													1	TCGA-AC-A2QJ-01	446	1	days	BRCA-LUAD+			BRCA non-CIMP c9	KIRC-like c1		miRNA cluster 5			TCGA-AC-A2QJ	237	1	days	446	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			48	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Other (specify)	Sentinel lymph node and axillary lymph node biopsy	TCGA-AC-A2QJ-F44021	TCGA-AC-A2QJ	TCGA-AC-A2QJ-01A		Negative					Negative	Other		NO			-17569	160	446	0	69			237		NO					2013-6-28	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)																									Bone	Distant Metastasis		NO	YES	0		false	No	M0	N0	T4b	Stage IIIB	TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf	A2QJ	WITH TUMOR						YES	YES			YES	Primary Tumor	01	Mastectomy	7th		YES	NO	AC	Breast	A	DECEASED	2011	49a0f1eb-6ece-48fc-970f-3922263fd20b	52daa11e-014a-4418-8d86-f8c405bd9cc5	49a0f1eb-6ece-48fc-970f-3922263fd20b	52daa11e-014a-4418-8d86-f8c405bd9cc5	TCGA-AC-A2QJ-01A-21-A24A-20			TCGA-AC-A2QJ-01	TCGA-AC-A2QJ-01A-12D-A19Z-05		5755434d-e797-4963-b728-caefc7bd49d5	TCGA-AC-A2QJ-01	TCGA-AC-A2QJ-01A-12D-A19Y-09			TCGA-AC-A2QJ-01			49a0f1eb-6ece-48fc-970f-3922263fd20b		TCGA-AC-A2QJ-01A-12D-A19X-01	TCGA-AC-A2QJ-01		49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-12D-A19X-01	
TCGA-AC-A3BB-01																													0	TCGA-AC-A3BB-01	987	0	days	BRCA-LUAD+			BRCA non-CIMP c9			miRNA cluster 5			TCGA-AC-A3BB	987	0	days	987	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A3BB-F58953	TCGA-AC-A3BB	TCGA-AC-A3BB-01A		Positive					Positive	Modified Radical Mastectomy					-16983	106		0	987					NO		90-99%			2014-4-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Negative		NO	14	Negative																														NO	5		false	No	MX	N2a	T3	Stage IIIA	TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf	A3BB	TUMOR FREE						YES		90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	325333bd-a1cc-43d2-bb16-420130c6ebf9	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	325333bd-a1cc-43d2-bb16-420130c6ebf9				TCGA-AC-A3BB-01	TCGA-AC-A3BB-01A-21D-A19Z-05			TCGA-AC-A3BB-01	TCGA-AC-A3BB-01A-21D-A19Y-09			TCGA-AC-A3BB-01			5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa		TCGA-AC-A3BB-01A-21D-A19X-01	TCGA-AC-A3BB-01		5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	TCGA-AC-A3BB-01A-21D-A19X-01	
TCGA-AC-A3EH-01																													1	TCGA-AC-A3EH-01	197	1	days	BRCA-LUAD+			BRCA CIMP c7			miRNA c1uster 9			TCGA-AC-A3EH	197	0	days	197	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right	Axillary lymph node dissection alone		TCGA-AC-A3EH-F65834	TCGA-AC-A3EH	TCGA-AC-A3EH-01A		Positive					Negative	Modified Radical Mastectomy		NO			-29014	67	197	0	17										2014-9-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8022/3	C50.9		YES		Excisional Biopsy	150	NO	Negative	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	12		false	No	M0	N3	T3	Stage IIIC	TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf	A3EH	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	DECEASED	2011	616255fe-88b3-4567-ae8d-bd68dd8380a3	0efe66fb-f938-47f8-8f5e-25f519faa2fc	616255fe-88b3-4567-ae8d-bd68dd8380a3	0efe66fb-f938-47f8-8f5e-25f519faa2fc				TCGA-AC-A3EH-01	TCGA-AC-A3EH-01A-22D-A22B-05			TCGA-AC-A3EH-01	TCGA-AC-A3EH-01A-22D-A228-09			TCGA-AC-A3EH-01			616255fe-88b3-4567-ae8d-bd68dd8380a3		TCGA-AC-A3EH-01A-22D-A227-01	TCGA-AC-A3EH-01		616255fe-88b3-4567-ae8d-bd68dd8380a3	TCGA-AC-A3EH-01A-22D-A227-01	
TCGA-AC-A3HN-01																			LumA										0	TCGA-AC-A3HN-01	496	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AC-A3HN	496	0	days	496	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					87	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A3HN-F65835	TCGA-AC-A3HN	TCGA-AC-A3HN-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		YES			-32061	97		0	496					NO		90-99%			2014-9-30	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2	0	false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf	A3HN	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	79a14838-69d2-4c73-83a7-b57ff6ecdd79	a7973daa-ca19-42a9-bf7c-a4dfc2359ba3	79a14838-69d2-4c73-83a7-b57ff6ecdd79	a7973daa-ca19-42a9-bf7c-a4dfc2359ba3	TCGA-AC-A3HN-01A-21-A24A-20			TCGA-AC-A3HN-01	TCGA-AC-A3HN-01A-11D-A212-05		b7044729-14de-486e-932a-ed425ff476f0	TCGA-AC-A3HN-01	TCGA-AC-A3HN-01A-11D-A20S-09			TCGA-AC-A3HN-01			79a14838-69d2-4c73-83a7-b57ff6ecdd79		TCGA-AC-A3HN-01A-11D-A20R-01	TCGA-AC-A3HN-01		79a14838-69d2-4c73-83a7-b57ff6ecdd79	TCGA-AC-A3HN-01A-11D-A20R-01	
TCGA-AC-A3OD-01																			LumA										0	TCGA-AC-A3OD-01	451	0	days	High			BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AC-A3OD	451	0	days	451	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A3OD-F45582	TCGA-AC-A3OD	TCGA-AC-A3OD-01A		Positive					Positive	Modified Radical Mastectomy		YES			-25186	63		0	451					NO		90-99%			2013-7-17	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	30	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	No	MX	N1mi	T2	Stage IIB	TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf	A3OD	TUMOR FREE						NO	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	7c521ef7-4adf-46ef-ade0-088cbe02223d	1a425572-ceb5-4f65-89c4-8fb8bc4c648e,339d0eca-df55-41e8-8415-9017c03018df	7c521ef7-4adf-46ef-ade0-088cbe02223d	1a425572-ceb5-4f65-89c4-8fb8bc4c648e,339d0eca-df55-41e8-8415-9017c03018df			7c521ef7-4adf-46ef-ade0-088cbe02223d,89a6d94d-59fc-45aa-859a-3b24e6691fe8	TCGA-AC-A3OD-01	TCGA-AC-A3OD-01B-06D-A22R-05,TCGA-AC-A3OD-01A-11D-A21R-05	89a6d94d-59fc-45aa-859a-3b24e6691fe8,7c521ef7-4adf-46ef-ade0-088cbe02223d		TCGA-AC-A3OD-01	TCGA-AC-A3OD-01B-06D-A22N-09,TCGA-AC-A3OD-01A-11D-A21Q-09			TCGA-AC-A3OD-01			7c521ef7-4adf-46ef-ade0-088cbe02223d		TCGA-AC-A3OD-01A-11D-A21P-01	TCGA-AC-A3OD-01		7c521ef7-4adf-46ef-ade0-088cbe02223d	TCGA-AC-A3OD-01A-11D-A21P-01	
TCGA-AC-A3QP-01																													0	TCGA-AC-A3QP-01	675	0	days					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3QP	675	0	days	675	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right	Sentinel node biopsy alone		TCGA-AC-A3QP-F56161	TCGA-AC-A3QP	TCGA-AC-A3QP-01A		Positive					Positive	Lumpectomy					-29113	184		0	675					NO		70-79%	2.2		2014-1-29	FEMALE					2+	30	2.6	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	1	true	No	MX	N1mi	T2	Stage IIB	TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf	A3QP	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	4545ed8f-a83b-4049-9504-ba673ecd6d1d	19b4b554-9f45-46e8-b92d-65ee32331cb4	4545ed8f-a83b-4049-9504-ba673ecd6d1d	19b4b554-9f45-46e8-b92d-65ee32331cb4	TCGA-AC-A3QP-01A-21-A24A-20			TCGA-AC-A3QP-01	TCGA-AC-A3QP-01A-11D-A230-05		334363b1-b6e4-4135-a42d-4d49e62ce2c5	TCGA-AC-A3QP-01	TCGA-AC-A3QP-01A-11D-A22X-09			TCGA-AC-A3QP-01			4545ed8f-a83b-4049-9504-ba673ecd6d1d		TCGA-AC-A3QP-01A-11D-A22W-01	TCGA-AC-A3QP-01		4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-11D-A22W-01	
TCGA-AC-A3QQ-01																													0	TCGA-AC-A3QQ-01	734	0	days	Iq			BRCA non-CIMP c9			miRNA c1uster 10			TCGA-AC-A3QQ	734	0	days	734	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right	Sentinel node biopsy alone		TCGA-AC-A3QQ-F66024	TCGA-AC-A3QQ	TCGA-AC-A3QQ-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-19723	77		0	734							90-99%			2014-10-1	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	30	NO	Positive		NO	5	Close	Peri (6-12 months since last menstrual period)																													NO	0	0	true	No	MX	N0 (i-)	T1c	Stage IA	TCGA-AC-A3QQ.07833A91-F827-4708-AECC-728C708F8E2D.pdf	A3QQ	TUMOR FREE						NO	YES	70-79%		NO	Primary Tumor	01	Nipple Sparing Total Mastectomy	7th		YES	NO	AC	Breast	A	LIVING	2011	bf9ca847-f30f-4dcf-bb91-a483be8db666	25dbaee9-17b6-4279-94ec-99b5b97e14e9	bf9ca847-f30f-4dcf-bb91-a483be8db666	25dbaee9-17b6-4279-94ec-99b5b97e14e9			bf9ca847-f30f-4dcf-bb91-a483be8db666,40263202-5826-4059-b7f4-56b1be17b65e	TCGA-AC-A3QQ-01	TCGA-AC-A3QQ-01A-11D-A22B-05	40263202-5826-4059-b7f4-56b1be17b65e,bf9ca847-f30f-4dcf-bb91-a483be8db666		TCGA-AC-A3QQ-01				TCGA-AC-A3QQ-01			bf9ca847-f30f-4dcf-bb91-a483be8db666		TCGA-AC-A3QQ-01A-11D-A227-01	TCGA-AC-A3QQ-01		bf9ca847-f30f-4dcf-bb91-a483be8db666	TCGA-AC-A3QQ-01A-11D-A227-01	
TCGA-AC-A3TM-01																													0	TCGA-AC-A3TM-01	762	0	days	Iq			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3TM	762	0	days	762	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Sentinel node biopsy alone		TCGA-AC-A3TM-F60193	TCGA-AC-A3TM	TCGA-AC-A3TM-01A		Positive					Positive	Simple Mastectomy		YES			-18535	136		0	762					NO		90-99%	1.9		2014-5-31	FEMALE					2+	60	3.3	1.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Equivocal	NO	4	Negative	Peri (6-12 months since last menstrual period)																													NO	0	2	false	No	M0	N1mi	T3	Stage IIIA	TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf	A3TM	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	902592e6-c7c5-46b8-b70b-5520df79a8a3	af766e9d-ade5-4aed-bf45-52f1804d0850	902592e6-c7c5-46b8-b70b-5520df79a8a3	af766e9d-ade5-4aed-bf45-52f1804d0850	TCGA-AC-A3TM-01A-21-A24A-20			TCGA-AC-A3TM-01	TCGA-AC-A3TM-01A-11D-A22B-05		c53769a6-b6af-4346-9a88-ffa6ffc19bfe	TCGA-AC-A3TM-01	TCGA-AC-A3TM-01A-11D-A228-09			TCGA-AC-A3TM-01			902592e6-c7c5-46b8-b70b-5520df79a8a3		TCGA-AC-A3TM-01A-11D-A227-01	TCGA-AC-A3TM-01		902592e6-c7c5-46b8-b70b-5520df79a8a3	TCGA-AC-A3TM-01A-11D-A227-01	
TCGA-AC-A3TN-01																													0	TCGA-AC-A3TN-01	456	0	days	Iq			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3TN	456	0	days	456	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A3TN-F60190	TCGA-AC-A3TN	TCGA-AC-A3TN-01A		Positive					Positive	Simple Mastectomy					-27421	78		0	456					NO		90-99%			2014-5-31	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Other method, specify:	140	NO	Positive	Indeterminate	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	MX	N0	T3	Stage IIB	TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf	A3TN	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	032db552-7828-4ed4-a1d7-b01b7fa89e29	0016bb20-f9ab-42ad-9d22-154bc12dfc14	032db552-7828-4ed4-a1d7-b01b7fa89e29	0016bb20-f9ab-42ad-9d22-154bc12dfc14	TCGA-AC-A3TN-01A-21-A24A-20			TCGA-AC-A3TN-01	TCGA-AC-A3TN-01A-11D-A22B-05		c619a2c9-fbfd-4c44-b40c-3a12259b24c2	TCGA-AC-A3TN-01	TCGA-AC-A3TN-01A-11D-A228-09			TCGA-AC-A3TN-01			032db552-7828-4ed4-a1d7-b01b7fa89e29		TCGA-AC-A3TN-01A-11D-A227-01	TCGA-AC-A3TN-01		032db552-7828-4ed4-a1d7-b01b7fa89e29	TCGA-AC-A3TN-01A-11D-A227-01	
TCGA-AC-A3W5-01																													0	TCGA-AC-A3W5-01	504	0	days	High			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3W5	504	0	days	504	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right	Sentinel node biopsy alone		TCGA-AC-A3W5-F56177	TCGA-AC-A3W5	TCGA-AC-A3W5-01A		Positive					Positive	Lumpectomy		YES			-24029	120		0	504							50-59%			2014-1-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO		Positive	NO	3	Close																														NO	0	0	false	Yes	MX	N0	T2	Stage IIA	TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf	A3W5	TUMOR FREE						YES	YES	30-39%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	3e775d6c-3845-49a7-80e0-82c5c68a473c	28b8f0a3-764b-4156-aea9-dc97f06fac1f	3e775d6c-3845-49a7-80e0-82c5c68a473c	28b8f0a3-764b-4156-aea9-dc97f06fac1f	TCGA-AC-A3W5-01A-21-A24A-20			TCGA-AC-A3W5-01	TCGA-AC-A3W5-01A-11D-A22B-05		795bf55f-c58c-45f4-9443-7f9fd1ef4c3e	TCGA-AC-A3W5-01	TCGA-AC-A3W5-01A-11D-A228-09			TCGA-AC-A3W5-01			3e775d6c-3845-49a7-80e0-82c5c68a473c		TCGA-AC-A3W5-01A-11D-A227-01	TCGA-AC-A3W5-01		3e775d6c-3845-49a7-80e0-82c5c68a473c	TCGA-AC-A3W5-01A-11D-A227-01	
TCGA-AC-A3W6-01																													0	TCGA-AC-A3W6-01	602	0	days	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3W6	602	0	days	602	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right	Sentinel node biopsy alone		TCGA-AC-A3W6-F57046	TCGA-AC-A3W6	TCGA-AC-A3W6-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-32872	101		0	602							90-99%			2014-2-28	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	140	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3	3	false	Yes	MX	N1	T3	Stage IIIA	TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf	A3W6	TUMOR FREE						NO	YES	20-29%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	bfedc051-75dd-44f8-add4-40ec7eabf0b0	077a366b-98ed-4fea-a525-9405f7aa4dea	bfedc051-75dd-44f8-add4-40ec7eabf0b0	077a366b-98ed-4fea-a525-9405f7aa4dea	TCGA-AC-A3W6-01A-21-A24A-20			TCGA-AC-A3W6-01	TCGA-AC-A3W6-01A-12D-A22B-05		37b78d3f-d378-49c8-970c-8b83f7372aeb	TCGA-AC-A3W6-01	TCGA-AC-A3W6-01A-12D-A228-09			TCGA-AC-A3W6-01			bfedc051-75dd-44f8-add4-40ec7eabf0b0		TCGA-AC-A3W6-01A-12D-A227-01	TCGA-AC-A3W6-01		bfedc051-75dd-44f8-add4-40ec7eabf0b0	TCGA-AC-A3W6-01A-12D-A227-01	
TCGA-AC-A3W7-01																													0	TCGA-AC-A3W7-01	471	0	days	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AC-A3W7	471	0	days	471	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AC-A3W7-F57847	TCGA-AC-A3W7	TCGA-AC-A3W7-01A		Positive					Negative	Simple Mastectomy		NO			-24327	65		0	471							90-99%			2014-3-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf	A3W7	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	e5636c48-9d0d-42d5-9ac2-31ad566bd168	4925e901-5ffb-4a14-93dd-d89bd32b09af	e5636c48-9d0d-42d5-9ac2-31ad566bd168	4925e901-5ffb-4a14-93dd-d89bd32b09af	TCGA-AC-A3W7-01A-21-A24A-20			TCGA-AC-A3W7-01	TCGA-AC-A3W7-01A-11D-A22B-05		1a6ceae8-c0e6-48fe-8ebc-1897613040c1	TCGA-AC-A3W7-01	TCGA-AC-A3W7-01A-11D-A228-09			TCGA-AC-A3W7-01			e5636c48-9d0d-42d5-9ac2-31ad566bd168		TCGA-AC-A3W7-01A-11D-A227-01	TCGA-AC-A3W7-01		e5636c48-9d0d-42d5-9ac2-31ad566bd168	TCGA-AC-A3W7-01A-11D-A227-01	
TCGA-AC-A3YI-01																													0	TCGA-AC-A3YI-01	707	0	days										TCGA-AC-A3YI	707	0	days	707	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A3YI-F61513	TCGA-AC-A3YI	TCGA-AC-A3YI-01A		Positive					Positive	Lumpectomy		NO			-27143	87		0	707							90-99%			2014-6-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Positive		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	12		false	No	MX	N3a	T1c	Stage IIIC	TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf	A3YI	TUMOR FREE						YES	YES	20-29%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	3207d7c9-bfaa-4b09-a86b-6bbc22280e8c	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	3207d7c9-bfaa-4b09-a86b-6bbc22280e8c				TCGA-AC-A3YI-01	TCGA-AC-A3YI-01A-21D-A23D-05			TCGA-AC-A3YI-01	TCGA-AC-A3YI-01A-21D-A23C-09			TCGA-AC-A3YI-01			20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26		TCGA-AC-A3YI-01A-21D-A238-01	TCGA-AC-A3YI-01		20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	TCGA-AC-A3YI-01A-21D-A238-01	
TCGA-AC-A3YJ-01																													0	TCGA-AC-A3YJ-01	754	0	days					BRCA nonbasal-like c8					TCGA-AC-A3YJ	754	0	days	754	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right	Sentinel node biopsy alone		TCGA-AC-A3YJ-F60187	TCGA-AC-A3YJ	TCGA-AC-A3YJ-01A		Positive					Positive	Modified Radical Mastectomy		YES			-24439	114		0	754										2014-5-31	FEMALE										Other, specify		No		C50.9	8050/3	C50.9		YES		Core needle biopsy	220	NO			NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf	A3YJ	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	5d5982c0-530f-4b2b-b1fb-d70c8168c793	72908a86-8eb9-4a84-af76-cea3e9eed064	5d5982c0-530f-4b2b-b1fb-d70c8168c793	72908a86-8eb9-4a84-af76-cea3e9eed064	TCGA-AC-A3YJ-01A-21-A24A-20			TCGA-AC-A3YJ-01	TCGA-AC-A3YJ-01A-11D-A230-05		7de47993-6f31-4dd7-8219-b5734464922f	TCGA-AC-A3YJ-01	TCGA-AC-A3YJ-01A-11D-A22X-09			TCGA-AC-A3YJ-01			5d5982c0-530f-4b2b-b1fb-d70c8168c793		TCGA-AC-A3YJ-01A-11D-A22W-01	TCGA-AC-A3YJ-01		5d5982c0-530f-4b2b-b1fb-d70c8168c793	TCGA-AC-A3YJ-01A-11D-A22W-01	
TCGA-AC-A4ZE-01																													0	TCGA-AC-A4ZE-01	890	0	days										TCGA-AC-A4ZE	890	0	days	890	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-AC-A4ZE-F72379	TCGA-AC-A4ZE	TCGA-AC-A4ZE-01A		Positive					Positive	Simple Mastectomy		NO			-23284	169		0	890										2015-6-9	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	180	NO	Positive		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T3	Stage IIB	TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf	A4ZE	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	089da1d2-bdac-4ef2-9d59-2d144f77d5da	09a78982-3fe5-4dd0-be97-03b03a6bf683	089da1d2-bdac-4ef2-9d59-2d144f77d5da	09a78982-3fe5-4dd0-be97-03b03a6bf683				TCGA-AC-A4ZE-01	TCGA-AC-A4ZE-01A-11D-A41Q-05		77F57ED3-C635-4292-9D39-987F74C22793	TCGA-AC-A4ZE-01				TCGA-AC-A4ZE-01			089da1d2-bdac-4ef2-9d59-2d144f77d5da		TCGA-AC-A4ZE-01A-11D-A41E-01	TCGA-AC-A4ZE-01		089da1d2-bdac-4ef2-9d59-2d144f77d5da	TCGA-AC-A4ZE-01A-11D-A41E-01	
TCGA-AC-A5EH-01																													0	TCGA-AC-A5EH-01	511	0	days										TCGA-AC-A5EH	511	0	days	511	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A5EH-F60185	TCGA-AC-A5EH			Positive					Negative	Modified Radical Mastectomy		NO			-27964			0	511							20-29%			2014-5-31	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	14	Negative																														NO	1			No	MX	N1mi	T2	Stage IIB		A5EH	TUMOR FREE						NO	YES			YES	Primary Tumor	01		7th		YES	NO	AC	Breast		LIVING	2012	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	cbcffc05-aa0d-493e-a5e3-47bbb833af4c	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	cbcffc05-aa0d-493e-a5e3-47bbb833af4c				TCGA-AC-A5EH-01	TCGA-AC-A5EH-01A-11D-A28C-05			TCGA-AC-A5EH-01	TCGA-AC-A5EH-01A-11D-A28B-09			TCGA-AC-A5EH-01			eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7		TCGA-AC-A5EH-01A-11D-A28A-01	TCGA-AC-A5EH-01		eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	TCGA-AC-A5EH-01A-11D-A28A-01	
TCGA-AC-A5EI-01																													0	TCGA-AC-A5EI-01	442	0	days										TCGA-AC-A5EI	442	0	days	442	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AC-A5EI-F60184	TCGA-AC-A5EI	TCGA-AC-A5EI-01A		Positive					Positive	Simple Mastectomy		NO			-32375	36		0	442							90-99%			2014-5-31	FEMALE										Other, specify		No		C50.9	9020/3	C50.9		YES		Tumor resection	120	NO	Negative		NO	2	Negative																														NO	1		false	Yes	MX	N1mi	T1c	Stage IB	TCGA-AC-A5EI.C0F7848A-DD0B-47B2-956F-A24D597D70BC.pdf	A5EI	TUMOR FREE						NO	YES	60-69%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012		92324d49-edbe-410b-9613-47089246d8a1		92324d49-edbe-410b-9613-47089246d8a1					TCGA-AC-A5EI-01A-11D-A27Y-05		d26ea3b4-9e10-4e5e-8922-0d4070605764		TCGA-AC-A5EI-01A-11D-A27P-09			TCGA-AC-A5EI-01					TCGA-AC-A5EI-01A-11D-A27O-01	TCGA-AC-A5EI-01			TCGA-AC-A5EI-01A-11D-A27O-01	
TCGA-AC-A5XS-01																													0	TCGA-AC-A5XS-01	588	0	days										TCGA-AC-A5XS	588	0	days	588	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A5XS-F64108	TCGA-AC-A5XS	TCGA-AC-A5XS-01A		Positive					Positive	Simple Mastectomy		NO			-27160	127		0	588										2014-8-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	8	Negative																														NO	0		false	Yes	MX	N0	T2	Stage IIA	TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf	A5XS	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	b713b36d-44c7-41ed-82a5-762322472a56	afe43453-1c7a-45fc-9db5-e2ff478c5077	b713b36d-44c7-41ed-82a5-762322472a56	afe43453-1c7a-45fc-9db5-e2ff478c5077				TCGA-AC-A5XS-01	TCGA-AC-A5XS-01A-11D-A29O-05		5bb0d7f3-6b33-4d61-95e4-1a9006c4b4c3	TCGA-AC-A5XS-01	TCGA-AC-A5XS-01A-11D-A29N-09			TCGA-AC-A5XS-01			b713b36d-44c7-41ed-82a5-762322472a56		TCGA-AC-A5XS-01A-11D-A29M-01	TCGA-AC-A5XS-01		b713b36d-44c7-41ed-82a5-762322472a56	TCGA-AC-A5XS-01A-11D-A29M-01	
TCGA-AC-A5XU-01																													0	TCGA-AC-A5XU-01	455	0	days										TCGA-AC-A5XU	455	0	days	455	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AC-A5XU-F60181	TCGA-AC-A5XU	TCGA-AC-A5XU-01A		Positive					Positive	Lumpectomy					-27191	44		0	455							90-99%			2014-5-31	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	2	Negative																														NO	0		false	No	MX	N0 (i-)	T3	Stage IIB	TCGA-AC-A5XU.D61D4CCC-2AB5-4268-AEB7-C8928E0AF964.pdf	A5XU	TUMOR FREE						YES	YES	60-69%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	513f5d19-3ff2-436a-adeb-817f9ac828d6	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	513f5d19-3ff2-436a-adeb-817f9ac828d6				TCGA-AC-A5XU-01	TCGA-AC-A5XU-01A-11D-A28C-05		e6e4ace7-7888-4b68-9662-0b7caa3c68c5	TCGA-AC-A5XU-01	TCGA-AC-A5XU-01A-11D-A28B-09			TCGA-AC-A5XU-01			f48e8432-bcb7-4aa9-9c8f-6de4a96179b2		TCGA-AC-A5XU-01A-11D-A28A-01	TCGA-AC-A5XU-01		f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	TCGA-AC-A5XU-01A-11D-A28A-01	
TCGA-AC-A62V-01																													1	TCGA-AC-A62V-01	348	1	days										TCGA-AC-A62V	348	0	days	348	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A62V-F60177	TCGA-AC-A62V	TCGA-AC-A62V-01A		Positive					Positive	Modified Radical Mastectomy		NO			-21389	38	348	0	2							90-99%			2014-5-31	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO			NO	17	Negative																			Bone											NO	3		false	No	M1	N1a	T2	Stage IV	TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C.pdf	A62V	WITH TUMOR						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	DECEASED	2013	7a356940-c460-4714-a949-42afe6ea5d86	938700b3-a62c-4bb7-886f-7b01dc98e33b	7a356940-c460-4714-a949-42afe6ea5d86	938700b3-a62c-4bb7-886f-7b01dc98e33b				TCGA-AC-A62V-01	TCGA-AC-A62V-01A-11D-A31V-05			TCGA-AC-A62V-01				TCGA-AC-A62V-01			7a356940-c460-4714-a949-42afe6ea5d86		TCGA-AC-A62V-01A-11D-A31T-01	TCGA-AC-A62V-01		7a356940-c460-4714-a949-42afe6ea5d86	TCGA-AC-A62V-01A-11D-A31T-01	
TCGA-AC-A62X-01																													0	TCGA-AC-A62X-01	417	0	days										TCGA-AC-A62X	417	0	days	417	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AC-A62X-F64105	TCGA-AC-A62X	TCGA-AC-A62X-01A		Positive					Negative	Modified Radical Mastectomy		NO			-26627	70		0	417							<10%			2014-8-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	Yes	MX	N0	T2	Stage IIA	TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905.pdf	A62X	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	cdc523d2-da82-4a3d-a97e-9745c8a802d1	cdd09ef8-5842-49ac-a579-f71cd06ae41c	cdc523d2-da82-4a3d-a97e-9745c8a802d1	cdd09ef8-5842-49ac-a579-f71cd06ae41c				TCGA-AC-A62X-01	TCGA-AC-A62X-01A-11D-A29O-05		4956c5cb-1ab4-46c2-8df0-1d71a2a73f15	TCGA-AC-A62X-01	TCGA-AC-A62X-01A-11D-A29N-09			TCGA-AC-A62X-01			cdc523d2-da82-4a3d-a97e-9745c8a802d1		TCGA-AC-A62X-01A-11D-A29M-01	TCGA-AC-A62X-01		cdc523d2-da82-4a3d-a97e-9745c8a802d1	TCGA-AC-A62X-01A-11D-A29M-01	
TCGA-AC-A62Y-01																													0	TCGA-AC-A62Y-01	530	0	days										TCGA-AC-A62Y	530	0	days	530	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right	Sentinel node biopsy alone		TCGA-AC-A62Y-F65833	TCGA-AC-A62Y	TCGA-AC-A62Y-01A		Positive	3 Point Scale		3 Point Scale		Positive	Modified Radical Mastectomy		NO			-28876	112		0	530							90-99%			2014-9-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	50	NO	Negative		NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	No	MX	N1	T2	Stage IIB	TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf	A62Y	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	02d9d59b-de6f-41c7-b529-142116debfd9	67091f0b-d37a-45b7-9b30-9254fdf898a5	02d9d59b-de6f-41c7-b529-142116debfd9	67091f0b-d37a-45b7-9b30-9254fdf898a5				TCGA-AC-A62Y-01	TCGA-AC-A62Y-01A-11D-A29O-05			TCGA-AC-A62Y-01	TCGA-AC-A62Y-01A-11D-A29N-09			TCGA-AC-A62Y-01			02d9d59b-de6f-41c7-b529-142116debfd9		TCGA-AC-A62Y-01A-11D-A29M-01	TCGA-AC-A62Y-01		02d9d59b-de6f-41c7-b529-142116debfd9	TCGA-AC-A62Y-01A-11D-A29M-01	
TCGA-AC-A6IV-01																													0	TCGA-AC-A6IV-01	568	0	days										TCGA-AC-A6IV	568	0	days	568	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right	Sentinel node biopsy alone		TCGA-AC-A6IV-F66023	TCGA-AC-A6IV	TCGA-AC-A6IV-01A		Positive					Positive	Modified Radical Mastectomy		YES			-17521	289		0	568							90-99%			2014-10-1	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.9		YES		Core needle biopsy	110	NO	Equivocal		NO	1	Negative																														NO	1	1	false	No	MX	N1	T2	Stage IIB	TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf	A6IV	TUMOR FREE						YES	YES	60-69%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2012	253e692f-71db-4a5a-b2f4-9e640ef831a2	52fad299-e76e-48e7-a770-c7737f5cd89c	253e692f-71db-4a5a-b2f4-9e640ef831a2	52fad299-e76e-48e7-a770-c7737f5cd89c				TCGA-AC-A6IV-01	TCGA-AC-A6IV-01A-12D-A33F-05			TCGA-AC-A6IV-01				TCGA-AC-A6IV-01			253e692f-71db-4a5a-b2f4-9e640ef831a2		TCGA-AC-A6IV-01A-12D-A33D-01	TCGA-AC-A6IV-01		253e692f-71db-4a5a-b2f4-9e640ef831a2	TCGA-AC-A6IV-01A-12D-A33D-01	
TCGA-AC-A6IW-01																													0	TCGA-AC-A6IW-01	413	0	days										TCGA-AC-A6IW	413	0	days	413	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AC-A6IW-F64106	TCGA-AC-A6IW	TCGA-AC-A6IW-01A		Negative					Negative	Simple Mastectomy		YES			-26896	74		0	413							<10%			2014-8-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf	A6IW	TUMOR FREE						NO	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	fceb1551-4b16-45de-8ba0-7906aa3fe841	fd183f1b-305a-48f9-a42b-a0d2711bcadb	fceb1551-4b16-45de-8ba0-7906aa3fe841	fd183f1b-305a-48f9-a42b-a0d2711bcadb				TCGA-AC-A6IW-01	TCGA-AC-A6IW-01A-12D-A33F-05		7FE7ED52-C8B0-4C86-BE4E-BF31EFBEA9BB	TCGA-AC-A6IW-01				TCGA-AC-A6IW-01			fceb1551-4b16-45de-8ba0-7906aa3fe841		TCGA-AC-A6IW-01A-12D-A33D-01	TCGA-AC-A6IW-01		fceb1551-4b16-45de-8ba0-7906aa3fe841	TCGA-AC-A6IW-01A-12D-A33D-01	
TCGA-AC-A6IX-01																													0	TCGA-AC-A6IX-01	373	0	days										TCGA-AC-A6IX	373	0	days	373	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A6IX-F66025	TCGA-AC-A6IX	TCGA-AC-A6IX-01A		Positive					Positive	Modified Radical Mastectomy		NO			-17969	107		0	373							90-99%			2014-10-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO			NO	21	Negative	Peri (6-12 months since last menstrual period)																													NO	19		false	No	MX	N3a	T2	Stage IIIC	TCGA-AC-A6IX.3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1.pdf	A6IX	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	a96dcbf3-d86b-4747-810d-f6d9751d273e	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	a96dcbf3-d86b-4747-810d-f6d9751d273e				TCGA-AC-A6IX-01	TCGA-AC-A6IX-01A-12D-A32T-05		A01C3771-F0E8-4514-AE2A-927E852F47D8	TCGA-AC-A6IX-01				TCGA-AC-A6IX-01			ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182		TCGA-AC-A6IX-01A-12D-A32H-01	TCGA-AC-A6IX-01		ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	TCGA-AC-A6IX-01A-12D-A32H-01	
TCGA-AC-A6IX-06																													0	TCGA-AC-A6IX-06	373	0	days										TCGA-AC-A6IX	373	0	days	373	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AC-A6IX-F66025	TCGA-AC-A6IX	TCGA-AC-A6IX-06A		Positive					Positive	Modified Radical Mastectomy		NO			-17969	107		0	373							90-99%			2014-10-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO			NO	21	Negative	Peri (6-12 months since last menstrual period)																													NO	19		false	No	MX	N3a	T2	Stage IIIC	TCGA-AC-A6IX.A92859DA-41AD-4CF9-86AF-E4073E6276ED.pdf	A6IX	TUMOR FREE						YES	YES	<10%		YES	Metastatic	06		7th		YES	NO	AC	Breast	A	LIVING	2013	9d5cd723-da40-47ce-a413-20057593905d	98022470-8d33-46c2-b162-78626a3eb4b7	9d5cd723-da40-47ce-a413-20057593905d	98022470-8d33-46c2-b162-78626a3eb4b7					TCGA-AC-A6IX-06A-11D-A32T-05							TCGA-AC-A6IX-06			9d5cd723-da40-47ce-a413-20057593905d			TCGA-AC-A6IX-06		9d5cd723-da40-47ce-a413-20057593905d		
TCGA-AC-A6NO-01																													0	TCGA-AC-A6NO-01	51	0	days										TCGA-AC-A6NO	51	0	days	51	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right	Axillary lymph node dissection alone			TCGA-AC-A6NO	TCGA-AC-A6NO-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15996	605		0	51										2014-4-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	150	NO	Negative			16	Negative																														NO	2		false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf	A6NO	TUMOR FREE							YES				Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	5055b564-b80d-4003-b1c1-3fe080c99fc1	1806385b-a8a3-45e4-980f-638292039978	5055b564-b80d-4003-b1c1-3fe080c99fc1	1806385b-a8a3-45e4-980f-638292039978				TCGA-AC-A6NO-01	TCGA-AC-A6NO-01A-12D-A33F-05		EE1327D4-4700-49EF-84B1-292DE21BB827	TCGA-AC-A6NO-01				TCGA-AC-A6NO-01			5055b564-b80d-4003-b1c1-3fe080c99fc1		TCGA-AC-A6NO-01A-12D-A33D-01	TCGA-AC-A6NO-01		5055b564-b80d-4003-b1c1-3fe080c99fc1	TCGA-AC-A6NO-01A-12D-A33D-01	
TCGA-AC-A7VB-01																													0	TCGA-AC-A7VB-01	250	0	days										TCGA-AC-A7VB	250	0	days	250	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AC-A7VB-F66026	TCGA-AC-A7VB	TCGA-AC-A7VB-01A		Positive					Negative	Modified Radical Mastectomy		NO			-18806	131		0	250							80-89%			2014-10-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO			NO	15	Negative																														NO	3		false	No	MX	N1a	T1c	Stage IIA	TCGA-AC-A7VB.53881871-C36B-4622-BFC6-4DA3635D7B26.pdf	A7VB	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	a0059fcb-6adc-47f4-8601-b7eed9e12576	3285e0c3-243c-41ac-b930-880af2f6ab87	a0059fcb-6adc-47f4-8601-b7eed9e12576	3285e0c3-243c-41ac-b930-880af2f6ab87				TCGA-AC-A7VB-01	TCGA-AC-A7VB-01A-11D-A357-05			TCGA-AC-A7VB-01				TCGA-AC-A7VB-01			a0059fcb-6adc-47f4-8601-b7eed9e12576		TCGA-AC-A7VB-01A-11D-A350-01	TCGA-AC-A7VB-01		a0059fcb-6adc-47f4-8601-b7eed9e12576	TCGA-AC-A7VB-01A-11D-A350-01	
TCGA-AC-A7VC-01																													0	TCGA-AC-A7VC-01	1	0	days										TCGA-AC-A7VC	1	0	days	1	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Sentinel node biopsy alone			TCGA-AC-A7VC	TCGA-AC-A7VC-01A		Negative					Negative	Simple Mastectomy		YES			-20479	63		0	1										2014-3-29	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Tumor resection	80	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T3	Stage IIB	TCGA-AC-A7VC.A1681334-684E-41E0-B3FA-EFFE1E5A8B7F.pdf	A7VC	TUMOR FREE							YES				Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	f88a5259-4413-4d0c-9083-600d74caffbc	1a7b4ca8-2987-4327-a79d-9a54531434e8	f88a5259-4413-4d0c-9083-600d74caffbc	1a7b4ca8-2987-4327-a79d-9a54531434e8				TCGA-AC-A7VC-01	TCGA-AC-A7VC-01A-11D-A357-05			TCGA-AC-A7VC-01				TCGA-AC-A7VC-01			f88a5259-4413-4d0c-9083-600d74caffbc		TCGA-AC-A7VC-01A-11D-A350-01	TCGA-AC-A7VC-01		f88a5259-4413-4d0c-9083-600d74caffbc	TCGA-AC-A7VC-01A-11D-A350-01	
TCGA-AC-A8OP-01																													0	TCGA-AC-A8OP-01	614	0	days										TCGA-AC-A8OP	614	0	days	614	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-AC-A8OP-F66027	TCGA-AC-A8OP	TCGA-AC-A8OP-01A		Positive					Positive	Simple Mastectomy		YES			-26550	921		0	614							90-99%			2014-10-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Indeterminate		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T1c	Stage IA	TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf	A8OP	TUMOR FREE						YES	YES	10-19%		NO	Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	001773a6-9cf3-48a1-8ea1-1f0da4991bc5	0a7bfa84-8239-4d2b-8320-3d8a9db2a3ef	001773a6-9cf3-48a1-8ea1-1f0da4991bc5	0a7bfa84-8239-4d2b-8320-3d8a9db2a3ef				TCGA-AC-A8OP-01	TCGA-AC-A8OP-01A-11D-A36K-05			TCGA-AC-A8OP-01				TCGA-AC-A8OP-01			001773a6-9cf3-48a1-8ea1-1f0da4991bc5		TCGA-AC-A8OP-01A-11D-A36I-01	TCGA-AC-A8OP-01		001773a6-9cf3-48a1-8ea1-1f0da4991bc5	TCGA-AC-A8OP-01A-11D-A36I-01	
TCGA-AC-A8OQ-01																													0	TCGA-AC-A8OQ-01	34	0	days										TCGA-AC-A8OQ	34	0	days	34	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-AC-A8OQ	TCGA-AC-A8OQ-01A		Negative					Negative	Lumpectomy		NO			-26535	742		0	34										2014-2-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Indeterminate			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	No	MX	N1a	T2	Stage IIB	TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf	A8OQ	TUMOR FREE							YES				Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2011	cca6f765-44ff-4540-a961-0a2be4e41f93	9e0a88d5-c42a-4094-a44d-f638243a23f9	cca6f765-44ff-4540-a961-0a2be4e41f93	9e0a88d5-c42a-4094-a44d-f638243a23f9				TCGA-AC-A8OQ-01	TCGA-AC-A8OQ-01A-11D-A41Q-05		4B47C521-A9C2-4CF0-91BB-27DD99200EC7	TCGA-AC-A8OQ-01				TCGA-AC-A8OQ-01			cca6f765-44ff-4540-a961-0a2be4e41f93		TCGA-AC-A8OQ-01A-11D-A41E-01	TCGA-AC-A8OQ-01		cca6f765-44ff-4540-a961-0a2be4e41f93	TCGA-AC-A8OQ-01A-11D-A41E-01	
TCGA-AC-A8OR-01																													0	TCGA-AC-A8OR-01	40	0	days										TCGA-AC-A8OR	40	0	days	40	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left	Sentinel node biopsy alone			TCGA-AC-A8OR	TCGA-AC-A8OR-01A		Positive					Positive	Simple Mastectomy		YES			-27605	98		0	40							90-99%			2014-2-26	FEMALE			<10%							Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	120	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T1c	Stage IA	TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf	A8OR	TUMOR FREE							YES	90-99%			Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	15c73666-b316-4108-97e9-9d0e40540a2c	963b652a-9415-435b-ab29-0fdb15de3305	15c73666-b316-4108-97e9-9d0e40540a2c	963b652a-9415-435b-ab29-0fdb15de3305				TCGA-AC-A8OR-01	TCGA-AC-A8OR-01A-21D-A41Q-05			TCGA-AC-A8OR-01				TCGA-AC-A8OR-01			15c73666-b316-4108-97e9-9d0e40540a2c		TCGA-AC-A8OR-01A-21D-A41E-01	TCGA-AC-A8OR-01		15c73666-b316-4108-97e9-9d0e40540a2c	TCGA-AC-A8OR-01A-21D-A41E-01	
TCGA-AC-A8OS-01																													0	TCGA-AC-A8OS-01	70	0	days										TCGA-AC-A8OS	70	0	days	70	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-AC-A8OS	TCGA-AC-A8OS-01A		Positive					Positive	Simple Mastectomy		YES			-26248	106		0	70							90-99%			2014-2-26	FEMALE			10-19%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	70	NO	Positive			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-AC-A8OS.EEF4E8C6-6D80-4C6A-BFC6-E529692088C1.pdf	A8OS	TUMOR FREE							YES	<10%			Primary Tumor	01		7th		YES	NO	AC	Breast	A	LIVING	2013	c119a170-e1ba-4965-a9c6-5c0b41ceefba	4f6bea16-ba0c-4c4f-a7b6-188e5b9c58a5	c119a170-e1ba-4965-a9c6-5c0b41ceefba	4f6bea16-ba0c-4c4f-a7b6-188e5b9c58a5				TCGA-AC-A8OS-01	TCGA-AC-A8OS-01A-12D-A41Q-05			TCGA-AC-A8OS-01				TCGA-AC-A8OS-01			c119a170-e1ba-4965-a9c6-5c0b41ceefba		TCGA-AC-A8OS-01A-12D-A41E-01	TCGA-AC-A8OS-01		c119a170-e1ba-4965-a9c6-5c0b41ceefba	TCGA-AC-A8OS-01A-12D-A41E-01	
TCGA-AN-A03X-01	Stage IIA	74	4	No_Conversion	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A03X-01	10	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A03X			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A03X-F68976	TCGA-AN-A03X			Positive					Positive	Modified Radical Mastectomy		NO			-27163			0	10										2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive		YES	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4									0	0		No	M0	N0	T2	Stage IIA		A03X	TUMOR FREE				200	200	NO				NO	Primary Tumor	01				NO	YES	AN	Breast		LIVING	2010	ae97b841-ddef-4bed-81ac-0b91627c4ef3	eb8bc681-2b7a-4100-a3cc-b8b90e1f017f	ae97b841-ddef-4bed-81ac-0b91627c4ef3	eb8bc681-2b7a-4100-a3cc-b8b90e1f017f		TCGA-AN-A03X-01A-21W-A019-09		TCGA-AN-A03X-01				TCGA-AN-A03X-01	TCGA-AN-A03X-01A-21W-A019-09	TCGA-AN-A03X-01A-21D-A00Y-05	TCGA-AN-A03X-01		TCGA-AN-A03X-01A-21W-A019-09	TCGA-AN-A03X-01	ae97b841-ddef-4bed-81ac-0b91627c4ef3	TCGA-AN-A03X-01	TCGA-AN-A03X-01A-21D-A011-01		TCGA-AN-A03X-01A-21R-A00Z-07	ae97b841-ddef-4bed-81ac-0b91627c4ef3	TCGA-AN-A03X-01A-21D-A011-01	TCGA-AN-A03X-01
TCGA-AN-A03Y-01	Stage IIA	66	3	No_Conversion	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumB	Luminal B	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A03Y-01	10	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 5	mutation cluster 4	TCGA-AN-A03Y			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A03Y-F68977	TCGA-AN-A03Y	TCGA-AN-A03Y-01A		Positive					Positive	Modified Radical Mastectomy		NO			-24232	36		0	10										2014-12-24	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Negative		YES	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5									0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AN-A03Y.76734A82-9137-4DA4-871E-D4EC1BC33831.pdf	A03Y	TUMOR FREE				210	210	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	7509b7dc-18cc-4430-ad93-fa598fc97330	da97f597-b09e-40b2-8517-e98c3e643ce3	7509b7dc-18cc-4430-ad93-fa598fc97330	da97f597-b09e-40b2-8517-e98c3e643ce3		TCGA-AN-A03Y-01A-21W-A019-09		TCGA-AN-A03Y-01				TCGA-AN-A03Y-01	TCGA-AN-A03Y-01A-21W-A019-09	TCGA-AN-A03Y-01A-21D-A00Y-05	TCGA-AN-A03Y-01		TCGA-AN-A03Y-01A-21W-A019-09	TCGA-AN-A03Y-01	7509b7dc-18cc-4430-ad93-fa598fc97330	TCGA-AN-A03Y-01	TCGA-AN-A03Y-01A-21D-A011-01		TCGA-AN-A03Y-01A-21R-A00Z-07	7509b7dc-18cc-4430-ad93-fa598fc97330	TCGA-AN-A03Y-01A-21D-A011-01	TCGA-AN-A03Y-01
TCGA-AN-A041-01	Stage IIB	29	5	Stage IIB	7		Positive	FEMALE	Equivocal	1	3	4	Negative	M0	Positive	N1	7	0	LumA	Luminal B	Negative	LumA	-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A041-01	7	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A041			days	7	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left Upper Outer Quadrant			TCGA-AN-A041-F68971	TCGA-AN-A041			Positive					Negative						-10812			0	7					NO					2014-12-24	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive		YES	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4									1			No	M0	N1a	T2	Stage IIB		A041	TUMOR FREE				0	170	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast		LIVING	2010	dc131436-aa38-4601-a42e-e3ad746d5be3	e9846666-467e-4ae9-b9c3-c749fb7cc6c3	dc131436-aa38-4601-a42e-e3ad746d5be3	e9846666-467e-4ae9-b9c3-c749fb7cc6c3	TCGA-AN-A041-01A-31-A13A-20	TCGA-AN-A041-01A-11W-A050-09		TCGA-AN-A041-01			a64d4ca5-a6f8-4e09-9278-c8f7e2d88e86	TCGA-AN-A041-01	TCGA-AN-A041-01A-11W-A050-09	TCGA-AN-A041-01A-11D-A032-05	TCGA-AN-A041-01		TCGA-AN-A041-01A-11W-A050-09	TCGA-AN-A041-01	dc131436-aa38-4601-a42e-e3ad746d5be3	TCGA-AN-A041-01	TCGA-AN-A041-01A-11D-A036-01		TCGA-AN-A041-01A-11R-A034-07	dc131436-aa38-4601-a42e-e3ad746d5be3	TCGA-AN-A041-01A-11D-A036-01	TCGA-AN-A041-01
TCGA-AN-A046-01	Stage IIA	68	2	No_Conversion	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A046-01	10	0	days	Iq		cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4		TCGA-AN-A046			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right Lower Inner Quadrant	No axillary staging		TCGA-AN-A046-F68972	TCGA-AN-A046	TCGA-AN-A046-01A		Positive					Positive	Modified Radical Mastectomy		NO			-25158	27		0	10										2014-12-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	150	NO	Negative		NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6.pdf	A046	TUMOR FREE		0		108	205	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	20eb1da4-ef70-49dd-956f-18d65725ba27	c62fa764-5d48-4bbc-ad18-6e0aff57fa4f	20eb1da4-ef70-49dd-956f-18d65725ba27	c62fa764-5d48-4bbc-ad18-6e0aff57fa4f				TCGA-AN-A046-01				TCGA-AN-A046-01	TCGA-AN-A046-01A-21W-A050-09	TCGA-AN-A046-01A-21D-A032-05	TCGA-AN-A046-01			TCGA-AN-A046-01	20eb1da4-ef70-49dd-956f-18d65725ba27	TCGA-AN-A046-01	TCGA-AN-A046-01A-21D-A036-01		TCGA-AN-A046-01A-21R-A034-07	20eb1da4-ef70-49dd-956f-18d65725ba27	TCGA-AN-A046-01A-21D-A036-01	TCGA-AN-A046-01
TCGA-AN-A049-01	Stage IIA	62	5	No_Conversion	19		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	19	0	LumA	Luminal B	Positive	ReacI	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A049-01	19	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AN-A049			days	19	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A049-F68978	TCGA-AN-A049	TCGA-AN-A049-01A		Positive		2+		Modified radical mastectomy	Positive	Simple Mastectomy		NO			-22710	769		0	19						Allred (Biocare)				2014-12-24	FEMALE		Dako Hercept test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Negative		YES	9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3									0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AN-A049.8C2B719A-D45A-4DF3-BA61-908A2E1F6D1D.pdf	A049	TUMOR FREE	Allred (Biocare)			100	80						Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	4b29c2ad-b966-4f56-b97b-35f5d4aea434	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	4b29c2ad-b966-4f56-b97b-35f5d4aea434	TCGA-AN-A049-01A-31-A13A-20	TCGA-AN-A049-01A-21W-A019-09		TCGA-AN-A049-01			e292a5df-0dcf-4760-92cf-7bb2c8f69e1e	TCGA-AN-A049-01	TCGA-AN-A049-01A-21W-A019-09	TCGA-AN-A049-01A-21D-A00Y-05	TCGA-AN-A049-01		TCGA-AN-A049-01A-21W-A019-09	TCGA-AN-A049-01	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	TCGA-AN-A049-01	TCGA-AN-A049-01A-21D-A011-01		TCGA-AN-A049-01A-21R-A00Z-07	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	TCGA-AN-A049-01A-21D-A011-01	TCGA-AN-A049-01
TCGA-AN-A04A-01	Stage IIIA	36	5	No_Conversion	89		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	89	0	LumA	Luminal A	Positive	LumA/B	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04A-01	90	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A04A			days	90	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Left Lower Inner Quadrant|Left Lower Outer Quadrant	No axillary staging		TCGA-AN-A04A-F68973	TCGA-AN-A04A	TCGA-AN-A04A-01A		Positive		1+		Modified radical mastectomy	Positive	Simple Mastectomy		NO			-13445	743		0	90						Allred (Biocare)				2014-12-24	FEMALE		Dako Hercept test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Tumor resection	370	NO	Negative		YES	7	Positive	Peri (6-12 months since last menstrual period)																				2	4									4	0	true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A04A.6FB7A794-C3E7-4501-A844-CF65B9C3D32C.pdf	A04A	TUMOR FREE	Allred (Biocare)	0		87	112						Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2008	7e09faf6-137d-4d33-98dd-80c48af7ebab	928be25e-9343-4042-a5c0-851465def55b	7e09faf6-137d-4d33-98dd-80c48af7ebab	928be25e-9343-4042-a5c0-851465def55b	TCGA-AN-A04A-01A-11-A13A-20	TCGA-AN-A04A-01A-21W-A050-09		TCGA-AN-A04A-01			08c6c9ec-04e4-4ce9-8b57-b35f8e562e32	TCGA-AN-A04A-01	TCGA-AN-A04A-01A-21W-A050-09	TCGA-AN-A04A-01A-21D-A032-05	TCGA-AN-A04A-01		TCGA-AN-A04A-01A-21W-A050-09	TCGA-AN-A04A-01	7e09faf6-137d-4d33-98dd-80c48af7ebab	TCGA-AN-A04A-01	TCGA-AN-A04A-01A-21D-A036-01		TCGA-AN-A04A-01A-21R-A034-07	7e09faf6-137d-4d33-98dd-80c48af7ebab	TCGA-AN-A04A-01A-21D-A036-01	TCGA-AN-A04A-01
TCGA-AN-A04C-01	Stage IIB	51	3	No_Conversion	54		Negative	FEMALE	Positive				Negative	M0	Positive	N1	54	0	Her2	HER2-enriched	Negative		-11	-9	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04C-01	54	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 5	mutation cluster 3	TCGA-AN-A04C			days	54	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A04C-F68974	TCGA-AN-A04C	TCGA-AN-A04C-01A		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		NO			-18851	656		0	54						Allred (Biocare)				2014-12-24	FEMALE		Dako Hecept Test			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	190	NO	Positive		YES	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5									2	0	true	No	M0	N1	T2	Stage IIB	TCGA-AN-A04C.045B2852-E1FF-4376-8F39-60FC940224D0.pdf	A04C	TUMOR FREE	Allred (Biocare)			0	0						Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	87d149dc-fcf5-4c2b-8c3e-f866ed274cee	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	87d149dc-fcf5-4c2b-8c3e-f866ed274cee		TCGA-AN-A04C-01A-21W-A050-09		TCGA-AN-A04C-01				TCGA-AN-A04C-01	TCGA-AN-A04C-01A-21W-A050-09	TCGA-AN-A04C-01A-21D-A032-05	TCGA-AN-A04C-01		TCGA-AN-A04C-01A-21W-A050-09	TCGA-AN-A04C-01	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	TCGA-AN-A04C-01	TCGA-AN-A04C-01A-21D-A036-01		TCGA-AN-A04C-01A-21R-A034-07	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	TCGA-AN-A04C-01A-21D-A036-01	TCGA-AN-A04C-01
TCGA-AN-A04D-01	Stage IIB	58	1	No_Conversion	52		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	52	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04D-01	52	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AN-A04D			days	52	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A04D-F68975	TCGA-AN-A04D	TCGA-AN-A04D-01A		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		NO			-21426	676		0	52						Allred (Biocare)				2014-12-24	FEMALE		Dako Hercept Test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	260	NO	Negative		YES	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5									2	0	true	No	M0	N1	T2	Stage IIB	TCGA-AN-A04D.A3CB59DE-5893-4FA2-B4D5-EDA612480E76.pdf	A04D	TUMOR FREE	Allred (Biocare)			0	0						Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2008	a09baab9-3eac-4271-9c12-2684642f8869	336a5a76-3373-47ac-85ea-c78ba65cd902	a09baab9-3eac-4271-9c12-2684642f8869	336a5a76-3373-47ac-85ea-c78ba65cd902	TCGA-AN-A04D-01A-31-A13A-20	TCGA-AN-A04D-01A-21W-A050-09		TCGA-AN-A04D-01			e48b250c-b634-4bfb-90e4-c2e1c0069400	TCGA-AN-A04D-01	TCGA-AN-A04D-01A-21W-A050-09	TCGA-AN-A04D-01A-21D-A032-05	TCGA-AN-A04D-01		TCGA-AN-A04D-01A-21W-A050-09	TCGA-AN-A04D-01	a09baab9-3eac-4271-9c12-2684642f8869	TCGA-AN-A04D-01	TCGA-AN-A04D-01A-21D-A036-01		TCGA-AN-A04D-01A-21R-A034-07	a09baab9-3eac-4271-9c12-2684642f8869	TCGA-AN-A04D-01A-21D-A036-01	TCGA-AN-A04D-01
TCGA-AN-A0AJ-01	Stage IIB	79	5	No_Conversion	243		Positive	FEMALE	Positive	1	1	4	Negative	M0	Negative	N0	243	0	LumB	Luminal B	Positive	LumA	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AN-A0AJ-01	303	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AN-A0AJ	303	0	days	303	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0AJ-F68941	TCGA-AN-A0AJ	TCGA-AN-A0AJ-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-29131	63		0	303						dextran coated charcoal	80-89%			2014-12-23	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Tumor resection	310	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	0	0	false	No	M0	N0	T3	Stage IIB	TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700.pdf	A0AJ	TUMOR FREE	dextran coated charcoal			120	230	NO		40-49%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	cc92e983-2367-4353-ac01-88851fd0f71e	48548c7f-466f-419b-b9c1-e600adc7c2fa	cc92e983-2367-4353-ac01-88851fd0f71e	48548c7f-466f-419b-b9c1-e600adc7c2fa	TCGA-AN-A0AJ-01A-21-A13B-20	TCGA-AN-A0AJ-01A-11W-A019-09		TCGA-AN-A0AJ-01			69d158b2-9c07-471c-a594-36551fb6f7f3	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01A-11W-A019-09	TCGA-AN-A0AJ-01A-11D-A00Y-05	TCGA-AN-A0AJ-01		TCGA-AN-A0AJ-01A-11W-A019-09	TCGA-AN-A0AJ-01	cc92e983-2367-4353-ac01-88851fd0f71e	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01A-11D-A011-01		TCGA-AN-A0AJ-01A-11R-A00Z-07	cc92e983-2367-4353-ac01-88851fd0f71e	TCGA-AN-A0AJ-01A-11D-A011-01	TCGA-AN-A0AJ-01
TCGA-AN-A0AK-01	Stage IIA	76	1	No_Conversion	223		Positive	FEMALE	Negative				Negative	M0	Negative	N0	223	0	LumB	Luminal B	Negative	Basal	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AK-01	224	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1		TCGA-AN-A0AK	224	0	days	224	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0AK-F68942	TCGA-AN-A0AK	TCGA-AN-A0AK-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-27977	58		0	224						dextran coated charcoal	80-89%			2014-12-23	FEMALE			70-79%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	290	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417.pdf	A0AK	TUMOR FREE	dextran coated charcoal				230	NO		<10%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	05afee4e-9acd-44f1-8a0c-ffa34d772b9c	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	05afee4e-9acd-44f1-8a0c-ffa34d772b9c	TCGA-AN-A0AK-01A-11-A13B-20			TCGA-AN-A0AK-01			d4158db7-366b-400e-af77-9a6db7eec59c	TCGA-AN-A0AK-01	TCGA-AN-A0AK-01A-21W-A019-09	TCGA-AN-A0AK-01A-21D-A00Y-05	TCGA-AN-A0AK-01			TCGA-AN-A0AK-01	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	TCGA-AN-A0AK-01	TCGA-AN-A0AK-01A-21D-A011-01		TCGA-AN-A0AK-01A-21R-A00Z-07	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	TCGA-AN-A0AK-01A-21D-A011-01	TCGA-AN-A0AK-01
TCGA-AN-A0AL-01	Stage IIIB	41	1	No_Conversion	197		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	197	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T4	LIVING	0	TCGA-AN-A0AL-01	227	0	days	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0AL	227	0	days	227	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0AL-F68944	TCGA-AN-A0AL	TCGA-AN-A0AL-01A		Negative		0			Negative	Modified Radical Mastectomy		NO			-15286	49		0	227						dextran coated charcoal	<10%			2014-12-23	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	300	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	0	0	false	No	M0	N0	T4	Stage IIIB	TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf	A0AL	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	467314d6-f946-447f-920a-d33b60f66eb2	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	467314d6-f946-447f-920a-d33b60f66eb2	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	TCGA-AN-A0AL-01A-21-A13B-20	TCGA-AN-A0AL-01A-11W-A019-09		TCGA-AN-A0AL-01			b689bc66-7909-4edc-a0e1-701ffcd1a602	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01A-11D-A00Y-05	TCGA-AN-A0AL-01		TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11D-A011-01		TCGA-AN-A0AL-01A-11R-A00Z-07	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01A-11D-A011-01	TCGA-AN-A0AL-01
TCGA-AN-A0AM-01	Stage IIA	56	3	No_Conversion	5		Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	5	0	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AM-01	5	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0AM			days	5	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0AM-F68945	TCGA-AN-A0AM	TCGA-AN-A0AM-01A		Positive					Negative	Modified Radical Mastectomy		NO			-20713	47		0	5										2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	350	NO	Negative		YES	20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7.pdf	A0AM	TUMOR FREE		0		0	205	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	6050d8b9-2d10-4a03-ae57-979cba25bb70	e444884d-d4ee-4ffb-a429-558fd4c1dd5a	6050d8b9-2d10-4a03-ae57-979cba25bb70	e444884d-d4ee-4ffb-a429-558fd4c1dd5a	TCGA-AN-A0AM-01A-21-A13B-20	TCGA-AN-A0AM-01A-11W-A050-09		TCGA-AN-A0AM-01			a2edc1b2-9932-44f8-9135-cf6ec465f84d	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01A-11W-A050-09	TCGA-AN-A0AM-01A-11D-A032-05	TCGA-AN-A0AM-01		TCGA-AN-A0AM-01A-11W-A050-09	TCGA-AN-A0AM-01	6050d8b9-2d10-4a03-ae57-979cba25bb70	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01A-11D-A036-01		TCGA-AN-A0AM-01A-11R-A034-07	6050d8b9-2d10-4a03-ae57-979cba25bb70	TCGA-AN-A0AM-01A-11D-A036-01	TCGA-AN-A0AM-01
TCGA-AN-A0AR-01	Stage IIA	55	1	No_Conversion	9		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	9	0		Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AR-01	10	0	days	Squamous	C8-BLCA	cluster 5	Cluster 5	BRCA basal-like c6		miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0AR			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0AR-F68946	TCGA-AN-A0AR	TCGA-AN-A0AR-01A		Negative		0			Negative	Modified Radical Mastectomy		NO			-20152	34		0	10										2014-12-23	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	150	NO	Negative		YES	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38.pdf	A0AR	TUMOR FREE						NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	12c36b7c-f302-4cea-bb4f-5a01211e00e9	f6743da4-ebb2-4223-ba29-2b1a0859181f	12c36b7c-f302-4cea-bb4f-5a01211e00e9	f6743da4-ebb2-4223-ba29-2b1a0859181f	TCGA-AN-A0AR-01A-21-A13B-20	TCGA-AN-A0AR-01A-11W-A019-09		TCGA-AN-A0AR-01			a18bbbc7-9c94-4fe9-a927-5c07be69428c	TCGA-AN-A0AR-01	TCGA-AN-A0AR-01A-11W-A019-09	TCGA-AN-A0AR-01A-11D-A00Y-05	TCGA-AN-A0AR-01		TCGA-AN-A0AR-01A-11W-A019-09	TCGA-AN-A0AR-01	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA-AN-A0AR-01	TCGA-AN-A0AR-01A-11D-A011-01		TCGA-AN-A0AR-01A-11R-A00Z-07	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA-AN-A0AR-01A-11D-A011-01	TCGA-AN-A0AR-01
TCGA-AN-A0AS-01	Stage IIIA	70	3	No_Conversion	9		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N2	9	0	LumA	Luminal B	Negative	Basal	-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AS-01	10	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AN-A0AS			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0AS-F68947	TCGA-AN-A0AS	TCGA-AN-A0AS-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-25658	33		0	10										2014-12-23	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Negative		YES	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2									4	0	false	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A.pdf	A0AS	TUMOR FREE				0	190	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	e866475d-4919-4bf6-920e-5390720d15bf	47150649-c6a6-48fc-a65c-bc621cbaec41	e866475d-4919-4bf6-920e-5390720d15bf	47150649-c6a6-48fc-a65c-bc621cbaec41	TCGA-AN-A0AS-01A-21-A13B-20	TCGA-AN-A0AS-01A-11W-A019-09		TCGA-AN-A0AS-01			52341dad-b2bf-4985-bb60-4921675983de	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01A-11W-A019-09	TCGA-AN-A0AS-01A-11D-A00Y-05	TCGA-AN-A0AS-01		TCGA-AN-A0AS-01A-11W-A019-09	TCGA-AN-A0AS-01	e866475d-4919-4bf6-920e-5390720d15bf	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01A-11D-A011-01		TCGA-AN-A0AS-01A-11R-A00Z-07	e866475d-4919-4bf6-920e-5390720d15bf	TCGA-AN-A0AS-01A-11D-A011-01	TCGA-AN-A0AS-01
TCGA-AN-A0AT-01	Stage IIA	62	1	No_Conversion	10		Negative	FEMALE	Negative				Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AT-01	10	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AN-A0AT			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0AT-F68948	TCGA-AN-A0AT	TCGA-AN-A0AT-01A		Negative					Negative	Modified Radical Mastectomy		NO			-22798	28		0	10										2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5										0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0AT.3E8F2012-A457-4358-9C8B-23292374A743.pdf	A0AT	TUMOR FREE		0		0	0	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	edda9023-a8d9-45dc-af21-5bba663967e4	170030ae-72f3-46cc-b82a-d23c7f3ad70d	edda9023-a8d9-45dc-af21-5bba663967e4	170030ae-72f3-46cc-b82a-d23c7f3ad70d	TCGA-AN-A0AT-01A-21-A13C-20	TCGA-AN-A0AT-01A-11D-A045-09		TCGA-AN-A0AT-01			d29e84ac-dc3b-4139-950c-fd197d9ca11f	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01A-11D-A032-05	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A045-09		edda9023-a8d9-45dc-af21-5bba663967e4		TCGA-AN-A0AT-01A-11D-A036-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11R-A034-07	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA-AN-A0AT-01A-11D-A036-01	TCGA-AN-A0AT-01
TCGA-AN-A0FD-01	Stage IIA	71	1	No_Conversion	195		Positive	FEMALE	Positive	3	3	3	Negative	M0	Negative	N0	195	0	LumA	Luminal A	Positive	LumA/B	-8	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FD-01	196	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FD			days	196	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FD-F68949	TCGA-AN-A0FD	TCGA-AN-A0FD-01A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-26007	84		0	196						dextran coated charcoal	80-89%			2014-12-23	FEMALE		dextran coated charcoal	60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	260	NO	Positive	Positive	YES	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3.pdf	A0FD	TUMOR FREE	dextran coated charcoal					NO		10-19%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	3264f809-4bbf-48e6-bbfd-77eaca9e602e	ba8ff683-777a-4d41-9261-014c89e17791	3264f809-4bbf-48e6-bbfd-77eaca9e602e	ba8ff683-777a-4d41-9261-014c89e17791	TCGA-AN-A0FD-01A-21-A13C-20	TCGA-AN-A0FD-01A-11W-A050-09		TCGA-AN-A0FD-01			aecc7da7-67e1-41cb-b17f-5be1e6c55e34	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01A-11W-A050-09	TCGA-AN-A0FD-01A-11D-A032-05	TCGA-AN-A0FD-01		TCGA-AN-A0FD-01A-11W-A050-09	TCGA-AN-A0FD-01	3264f809-4bbf-48e6-bbfd-77eaca9e602e	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01A-11D-A036-01		TCGA-AN-A0FD-01A-11R-A034-07	3264f809-4bbf-48e6-bbfd-77eaca9e602e	TCGA-AN-A0FD-01A-11D-A036-01	TCGA-AN-A0FD-01
TCGA-AN-A0FE-01																														TCGA-AN-A0FE-01			days										TCGA-AN-A0FE			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast											TCGA-AN-A0FE-01A																																																	330	NO																																						false																			Primary Tumor	01								A				97bf6a26-512f-493e-b7fe-53d309f1159a		97bf6a26-512f-493e-b7fe-53d309f1159a										TCGA-AN-A0FE-01A-11D-A00Y-05									TCGA-AN-A0FE-01A-11R-A00Z-07			
TCGA-AN-A0FF-01	Stage IA	32	3	No_Conversion	140		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	140	0	LumB	Luminal B	Positive	LumA	0	-3	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FF-01	172	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AN-A0FF	172	0	days	172	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					32	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FF-F68943	TCGA-AN-A0FF	TCGA-AN-A0FF-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-11929	75		0	172						dextran coated charcoal	90-99%			2014-12-23	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	300	NO	Negative		NO	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	1								NO	0	0	false	No	M0	N0	T1b	Stage IA	TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf	A0FF	TUMOR FREE	dextran coated charcoal					NO		90-99%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	7a5bc56e-e787-4798-8c4d-ee792f9e3149	9add77c5-e24a-4c2f-9e79-fa09dc8697cd	7a5bc56e-e787-4798-8c4d-ee792f9e3149	9add77c5-e24a-4c2f-9e79-fa09dc8697cd	TCGA-AN-A0FF-01A-21-A13C-20	TCGA-AN-A0FF-01A-11W-A050-09		TCGA-AN-A0FF-01			87bf53e1-aab3-44d0-a641-3464095b9a51	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01A-11D-A032-05	TCGA-AN-A0FF-01		TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11D-A036-01		TCGA-AN-A0FF-01A-11R-A034-07	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01A-11D-A036-01	TCGA-AN-A0FF-01
TCGA-AN-A0FG-01																														TCGA-AN-A0FG-01			days										TCGA-AN-A0FG			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast											TCGA-AN-A0FG-01A																																																	400	NO																																						false																			Primary Tumor	01								A				0e82163d-bfb2-4b39-9f36-4672b12040ed		0e82163d-bfb2-4b39-9f36-4672b12040ed										TCGA-AN-A0FG-01A-11D-A00Y-05									TCGA-AN-A0FG-01A-11R-A00Z-07			
TCGA-AN-A0FJ-01	Stage IV	59	1	No_Conversion	241		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	241	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FJ-01	242	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FJ			days	242	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FJ-F68950	TCGA-AN-A0FJ	TCGA-AN-A0FJ-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-21910	70		0	242						dextran coated charcoal	10-19%			2014-12-23	FEMALE		dextran coated charcoal	40-49%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	280	NO	Positive		YES	14	Negative	Peri (6-12 months since last menstrual period)																				5	5									8	0	false	No	M1	N2	T2	Stage IV	TCGA-AN-A0FJ.59163BD6-41E8-4489-81F0-036484447886.pdf	A0FJ	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	d6b8993f-e850-47a9-842d-ef6173866780	84412819-5a7d-4d8c-a834-7170777e94e6	d6b8993f-e850-47a9-842d-ef6173866780	84412819-5a7d-4d8c-a834-7170777e94e6	TCGA-AN-A0FJ-01A-21-A13A-20	TCGA-AN-A0FJ-01A-11W-A019-09		TCGA-AN-A0FJ-01			d2876882-dd7e-43af-b066-d578da1f8f3d	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01A-11W-A019-09	TCGA-AN-A0FJ-01A-11D-A00Y-05	TCGA-AN-A0FJ-01		TCGA-AN-A0FJ-01A-11W-A019-09	TCGA-AN-A0FJ-01	d6b8993f-e850-47a9-842d-ef6173866780	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01A-11D-A011-01		TCGA-AN-A0FJ-01A-11R-A00Z-07	d6b8993f-e850-47a9-842d-ef6173866780	TCGA-AN-A0FJ-01A-11D-A011-01	TCGA-AN-A0FJ-01
TCGA-AN-A0FK-01	Stage IIIB	88	2	No_Conversion	212		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	212	0	LumA	Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T4	LIVING	0	TCGA-AN-A0FK-01	213	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FK			days	213	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FK-F68951	TCGA-AN-A0FK	TCGA-AN-A0FK-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-32462	69		0	213						dextran coated charcoal	90-99%			2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	340	NO	Positive		YES	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4									0	0	false	No	M0	N0	T4	Stage IIIB	TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB.pdf	A0FK	TUMOR FREE	dextran coated charcoal			230	230	NO		90-99%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	570ee0fd-7003-45ce-9c42-8f6145604186	4da6e060-d771-42fd-9d1b-2310848775d7	570ee0fd-7003-45ce-9c42-8f6145604186	4da6e060-d771-42fd-9d1b-2310848775d7	TCGA-AN-A0FK-01A-21-A13A-20	TCGA-AN-A0FK-01A-11W-A050-09		TCGA-AN-A0FK-01			2030c965-6cfa-4164-b5c9-222e1d522f58	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01A-11W-A050-09	TCGA-AN-A0FK-01A-11D-A032-05	TCGA-AN-A0FK-01		TCGA-AN-A0FK-01A-11W-A050-09	TCGA-AN-A0FK-01	570ee0fd-7003-45ce-9c42-8f6145604186	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01A-11D-A036-01		TCGA-AN-A0FK-01A-11R-A034-07	570ee0fd-7003-45ce-9c42-8f6145604186	TCGA-AN-A0FK-01A-11D-A036-01	TCGA-AN-A0FK-01
TCGA-AN-A0FL-01	Stage IIA	62	1	No_Conversion	230		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	230	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FL-01	231	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FL			days	231	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FL-F68952	TCGA-AN-A0FL	TCGA-AN-A0FL-01A		Negative		1+			Negative	Modified Radical Mastectomy		NO			-22805	69		0	231						dextran coated charcoal	<10%			2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	310	NO	Positive		YES	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf	A0FL	TUMOR FREE	dextran coated charcoal					NO		<10%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	299add94-3b97-41a6-9fd4-c572f88982d5	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	299add94-3b97-41a6-9fd4-c572f88982d5	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	TCGA-AN-A0FL-01A-21-A13A-20	TCGA-AN-A0FL-01A-11W-A050-09		TCGA-AN-A0FL-01			ef3ba9e1-e1ca-477a-8700-37e88c048655	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01A-11W-A050-09	TCGA-AN-A0FL-01A-11D-A032-05	TCGA-AN-A0FL-01		TCGA-AN-A0FL-01A-11W-A050-09	TCGA-AN-A0FL-01	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01A-11D-A036-01		TCGA-AN-A0FL-01A-11R-A034-07	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA-AN-A0FL-01A-11D-A036-01	TCGA-AN-A0FL-01
TCGA-AN-A0FN-01	Stage IB	61	1	No_Conversion	218		Positive	FEMALE	Negative				Negative	M0	Negative	N0	218	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FN-01	218	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FN			days	218	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FN-F68953	TCGA-AN-A0FN	TCGA-AN-A0FN-01A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-22629	57		0	218						dextran coated charcoal	90-99%			2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	110	NO	Positive		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4									0	0	false	No	M0	N0	T1c	Stage IA	TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4.pdf	A0FN	TUMOR FREE	dextran coated charcoal				250	NO		10-19%		NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	4aac7c40-db6b-4648-a82a-7bf397de913a	ce822227-cbde-4263-9264-71ef718916ea	4aac7c40-db6b-4648-a82a-7bf397de913a	ce822227-cbde-4263-9264-71ef718916ea		TCGA-AN-A0FN-01A-11W-A050-09		TCGA-AN-A0FN-01				TCGA-AN-A0FN-01	TCGA-AN-A0FN-01A-11W-A050-09	TCGA-AN-A0FN-01A-11D-A032-05	TCGA-AN-A0FN-01		TCGA-AN-A0FN-01A-11W-A050-09	TCGA-AN-A0FN-01	4aac7c40-db6b-4648-a82a-7bf397de913a	TCGA-AN-A0FN-01	TCGA-AN-A0FN-01A-11D-A036-01		TCGA-AN-A0FN-01A-11R-A034-07	4aac7c40-db6b-4648-a82a-7bf397de913a	TCGA-AN-A0FN-01A-11D-A036-01	TCGA-AN-A0FN-01
TCGA-AN-A0FS-01	Stage IB	55	2	No_Conversion	191		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	191	0	LumA	Luminal A	Negative	ReacII	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FS-01	210	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AN-A0FS			days	210	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FS-F68954	TCGA-AN-A0FS	TCGA-AN-A0FS-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-20352	44		0	210						dextran coated charcoal	90-99%			2014-12-23	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	170	NO	Positive		YES	14	Negative	Peri (6-12 months since last menstrual period)																				2	2									0	0	false	No	M0	N0	T1c	Stage IA	TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf	A0FS	TUMOR FREE	dextran coated charcoal				230	NO		<10%		NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	29ac13ea-a350-42e9-a3eb-024c537ead94	5ed36cde-08a1-439e-8b03-7ed3fbddbacf	29ac13ea-a350-42e9-a3eb-024c537ead94	5ed36cde-08a1-439e-8b03-7ed3fbddbacf	TCGA-AN-A0FS-01A-21-A13C-20	TCGA-AN-A0FS-01A-11W-A050-09		TCGA-AN-A0FS-01			9cc29dc5-b324-4ee3-b94b-42a1f5927ae9	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01A-11D-A032-05	TCGA-AN-A0FS-01		TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11D-A036-01		TCGA-AN-A0FS-01A-11R-A034-07	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01A-11D-A036-01	TCGA-AN-A0FS-01
TCGA-AN-A0FT-01	Stage IIB	63	3	No_Conversion	183		Positive	FEMALE	Positive	4	5	3	Negative	M0	Positive	N1	183	0	LumA	Luminal A	Positive	Her2	-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FT-01	214	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 5	mutation cluster 5	TCGA-AN-A0FT			days	214	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0FT-F68964	TCGA-AN-A0FT	TCGA-AN-A0FT-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-23300	44		0	214						dextran coated charcoal	90-99%			2014-12-24	FEMALE		dextran coated charcoal	90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Positive		YES	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5									1	0	false	No	M0	N1	T2	Stage IIB	TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769.pdf	A0FT	TUMOR FREE	dextran coated charcoal				230	NO		90-99%		NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	ae592879-5689-4818-8ac3-23a00c5d3934	8f41eb88-b15f-4b04-934a-0a110a544fbc	ae592879-5689-4818-8ac3-23a00c5d3934	8f41eb88-b15f-4b04-934a-0a110a544fbc	TCGA-AN-A0FT-01A-21-A13C-20	TCGA-AN-A0FT-01A-11W-A050-09		TCGA-AN-A0FT-01			3953f300-15f9-4c43-a4a2-cc7d1c056d59	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01A-11W-A050-09	TCGA-AN-A0FT-01A-11D-A032-05	TCGA-AN-A0FT-01		TCGA-AN-A0FT-01A-11W-A050-09	TCGA-AN-A0FT-01	ae592879-5689-4818-8ac3-23a00c5d3934	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01A-11D-A036-01		TCGA-AN-A0FT-01A-11R-A034-07	ae592879-5689-4818-8ac3-23a00c5d3934	TCGA-AN-A0FT-01A-11D-A036-01	TCGA-AN-A0FT-01
TCGA-AN-A0FV-01	Stage IIA	58	1	No_Conversion	10		Negative	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	10	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FV-01	10	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-AN-A0FV			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FV-F68965	TCGA-AN-A0FV	TCGA-AN-A0FV-01A		Negative					Negative	Modified Radical Mastectomy		NO			-21479	42		0	10										2014-12-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Positive		YES	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D.pdf	A0FV	TUMOR FREE				0	0	NO				NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	600db536-d7c5-4cfa-bb80-fcc269b96b8c	1df1f52c-ac80-480a-af35-772bd79ad3d0	600db536-d7c5-4cfa-bb80-fcc269b96b8c	1df1f52c-ac80-480a-af35-772bd79ad3d0	TCGA-AN-A0FV-01A-21-A13A-20	TCGA-AN-A0FV-01A-11W-A019-09		TCGA-AN-A0FV-01			db678c4c-245c-4438-9e57-6daad3be0250	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01A-11W-A019-09	TCGA-AN-A0FV-01A-11D-A00Y-05	TCGA-AN-A0FV-01		TCGA-AN-A0FV-01A-11W-A019-09	TCGA-AN-A0FV-01	600db536-d7c5-4cfa-bb80-fcc269b96b8c	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01A-11D-A011-01		TCGA-AN-A0FV-01A-11R-A00Z-07	600db536-d7c5-4cfa-bb80-fcc269b96b8c	TCGA-AN-A0FV-01A-11D-A011-01	TCGA-AN-A0FV-01
TCGA-AN-A0FW-01	Stage IIIA	67	3	No_Conversion	11		Positive	FEMALE	Negative	4	3	3	Negative	M0	Positive	N2	11	0	LumA	Luminal A	Indeterminate	LumA/B	-4	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FW-01	11	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AN-A0FW	11	0	days	11	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FW-F68966	TCGA-AN-A0FW	TCGA-AN-A0FW-01A		Positive					Indeterminate	Modified Radical Mastectomy		NO			-24692	41		0	11										2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		YES	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO	2	0	false	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908.pdf	A0FW	TUMOR FREE				10	180	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	34b7764e-748a-415c-84b5-c45d0932e642	9450b2d6-de1d-4c14-8d56-21cc3363d9ab	34b7764e-748a-415c-84b5-c45d0932e642	9450b2d6-de1d-4c14-8d56-21cc3363d9ab	TCGA-AN-A0FW-01A-21-A13C-20	TCGA-AN-A0FW-01A-11W-A050-09		TCGA-AN-A0FW-01			3eec78cf-bead-4279-b0b3-60b9dea9496f	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01A-11W-A050-09	TCGA-AN-A0FW-01A-11D-A032-05	TCGA-AN-A0FW-01		TCGA-AN-A0FW-01A-11W-A050-09	TCGA-AN-A0FW-01	34b7764e-748a-415c-84b5-c45d0932e642	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01A-11D-A036-01		TCGA-AN-A0FW-01A-11R-A034-07	34b7764e-748a-415c-84b5-c45d0932e642	TCGA-AN-A0FW-01A-11D-A036-01	TCGA-AN-A0FW-01
TCGA-AN-A0FX-01	Stage IIA	52	1	No_Conversion	10		Negative	FEMALE	Negative	1	1	2	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	ReacII	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FX-01	10	0	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0FX			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FX-F68967	TCGA-AN-A0FX	TCGA-AN-A0FX-01A		Negative					Negative	Modified Radical Mastectomy		NO			-19309	34		0	10										2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive		YES	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf	A0FX	TUMOR FREE				0	0	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	de299c77-a9d8-4acf-97ae-337427f27132	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	de299c77-a9d8-4acf-97ae-337427f27132	TCGA-AN-A0FX-01A-21-A13C-20	TCGA-AN-A0FX-01A-11W-A050-09		TCGA-AN-A0FX-01			14bd231c-c5f5-4e4a-a2e3-4ee4a17248af	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01A-11W-A050-09	TCGA-AN-A0FX-01A-11D-A032-05	TCGA-AN-A0FX-01		TCGA-AN-A0FX-01A-11W-A050-09	TCGA-AN-A0FX-01	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01A-11D-A036-01		TCGA-AN-A0FX-01A-11R-A034-07	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA-AN-A0FX-01A-11D-A036-01	TCGA-AN-A0FX-01
TCGA-AN-A0FY-01	Stage IB	55	3	No_Conversion	10		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	10	0	LumB	Luminal B	Positive	LumA	-2	-3	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FY-01	10	0	days	High	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-AN-A0FY			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FY-F68968	TCGA-AN-A0FY	TCGA-AN-A0FY-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20347	34		0	10										2014-12-24	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	5									0	0	false	No	M0	N0	T1c	Stage IA	TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2.pdf	A0FY	TUMOR FREE				110	80	NO				NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	52ebb933-775a-448c-82ba-42fd1da8cf2e	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	52ebb933-775a-448c-82ba-42fd1da8cf2e	TCGA-AN-A0FY-01A-21-A13C-20	TCGA-AN-A0FY-01A-11W-A050-09		TCGA-AN-A0FY-01			22b79545-b004-46b6-a9dc-02285b1e2988	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01A-11W-A050-09	TCGA-AN-A0FY-01A-11D-A032-05	TCGA-AN-A0FY-01		TCGA-AN-A0FY-01A-11W-A050-09	TCGA-AN-A0FY-01	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01A-11D-A036-01		TCGA-AN-A0FY-01A-11R-A034-07	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	TCGA-AN-A0FY-01A-11D-A036-01	TCGA-AN-A0FY-01
TCGA-AN-A0FZ-01	Stage IIIA	45	3	No_Conversion	10		Positive	FEMALE	Equivocal	3	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Negative	LumA/B	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FZ-01	10	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-AN-A0FZ			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant	No axillary staging		TCGA-AN-A0FZ-F68969	TCGA-AN-A0FZ	TCGA-AN-A0FZ-01A		Positive					Negative	Modified Radical Mastectomy		NO			-16533	34		0	10										2014-12-24	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive		YES	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4									1	0	false	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE.pdf	A0FZ	TUMOR FREE				0	120	NO				NO	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	1fc2800f-3427-4134-8a02-fea3ecbd2656	522b6d2e-b8b1-46d0-b0cb-3823d574e549	1fc2800f-3427-4134-8a02-fea3ecbd2656	522b6d2e-b8b1-46d0-b0cb-3823d574e549	TCGA-AN-A0FZ-01A-21-A13C-20	TCGA-AN-A0FZ-01A-11W-A050-09		TCGA-AN-A0FZ-01			e91f0195-b30d-4641-b90c-5f5b2082c391	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01A-11W-A050-09	TCGA-AN-A0FZ-01A-11D-A032-05	TCGA-AN-A0FZ-01		TCGA-AN-A0FZ-01A-11W-A050-09	TCGA-AN-A0FZ-01	1fc2800f-3427-4134-8a02-fea3ecbd2656	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01A-11D-A036-01		TCGA-AN-A0FZ-01A-11R-A034-07	1fc2800f-3427-4134-8a02-fea3ecbd2656	TCGA-AN-A0FZ-01A-11D-A036-01	TCGA-AN-A0FZ-01
TCGA-AN-A0G0-01	Stage IIA	56		No_Conversion	16		Negative	FEMALE	Negative				Negative	M0	Negative	N0	16	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0G0-01	16	0	days		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0G0			days	16	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Inner Quadrant	No axillary staging		TCGA-AN-A0G0-F68970	TCGA-AN-A0G0	TCGA-AN-A0G0-01A		Negative					Negative	Modified Radical Mastectomy		NO			-20504	34		0	16										2014-12-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative		YES	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3									0	0	false	No	M0	N0	T2	Stage IIA	TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4.pdf	A0G0	TUMOR FREE				0	0	YES				YES	Primary Tumor	01				NO	YES	AN	Breast	A	LIVING	2010	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	TCGA-AN-A0G0-01A-21-A13C-20	TCGA-AN-A0G0-01A-11W-A050-09		TCGA-AN-A0G0-01			8675dc8b-b185-4aa8-9c1c-60505e502215		TCGA-AN-A0G0-01A-11W-A050-09	TCGA-AN-A0G0-01A-11D-A032-05			TCGA-AN-A0G0-01A-11W-A050-09	TCGA-AN-A0G0-01	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	TCGA-AN-A0G0-01			TCGA-AN-A0G0-01A-11R-A034-07	c09e8a88-5a82-4fd6-8d03-ef3ecb988003		TCGA-AN-A0G0-01
TCGA-AN-A0XL-01	Stage IIA	61	5	Stage IIA	10		Positive	FEMALE	Negative				Negative	M0	Negative	N0	10	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XL-01	163	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-AN-A0XL			days	163	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Upper Outer Quadrant			TCGA-AN-A0XL-F68955	TCGA-AN-A0XL	TCGA-AN-A0XL-01A		Positive					Positive						-22341	169		0	163					NO					2014-12-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative		YES	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6									0		true	No	M0	N0	T2	Stage IIA	TCGA-AN-A0XL.A85A959B-F18C-43D3-8BBF-770DA2189462.pdf	A0XL	TUMOR FREE				60	130	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	0cde4246-2dcb-478b-ace9-df557f71e4cd	c73ed584-52f7-4eda-ba8d-cbe2ac0867b7	0cde4246-2dcb-478b-ace9-df557f71e4cd	c73ed584-52f7-4eda-ba8d-cbe2ac0867b7		TCGA-AN-A0XL-01A-11D-A10M-09		TCGA-AN-A0XL-01	TCGA-AN-A0XL-01A-11D-A10N-05			TCGA-AN-A0XL-01	TCGA-AN-A0XL-01A-11D-A10M-09		TCGA-AN-A0XL-01		TCGA-AN-A0XL-01A-11D-A10M-09	TCGA-AN-A0XL-01	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01	TCGA-AN-A0XL-01A-11D-A10L-01		TCGA-AN-A0XL-01A-11R-A10J-07	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01A-11D-A10L-01	TCGA-AN-A0XL-01
TCGA-AN-A0XN-01	Stage IIIA	68	4	Stage IIIA	10		Negative	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Positive	ReacI	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XN-01	10	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AN-A0XN			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right Upper Inner Quadrant			TCGA-AN-A0XN-F68956	TCGA-AN-A0XN	TCGA-AN-A0XN-01A		Negative					Positive						-25029	163		0	10					NO					2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		YES	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4									1		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2.pdf	A0XN	TUMOR FREE		0		170	0	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	5a269a43-59a4-4718-878e-1086a07b13ee	109817fb-aa2e-4ac8-8bac-a8c6f0d93551	5a269a43-59a4-4718-878e-1086a07b13ee	109817fb-aa2e-4ac8-8bac-a8c6f0d93551	TCGA-AN-A0XN-01A-11-A13D-20	TCGA-AN-A0XN-01A-21D-A10G-09		TCGA-AN-A0XN-01	TCGA-AN-A0XN-01A-21D-A10A-05		20ec155a-e210-4e70-8de0-236318167eff	TCGA-AN-A0XN-01	TCGA-AN-A0XN-01A-21D-A10G-09		TCGA-AN-A0XN-01		TCGA-AN-A0XN-01A-21D-A10G-09	TCGA-AN-A0XN-01	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01	TCGA-AN-A0XN-01A-21D-A107-01		TCGA-AN-A0XN-01A-21R-A109-07	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01A-21D-A107-01	TCGA-AN-A0XN-01
TCGA-AN-A0XO-01	Stage IIIA	59	2	Stage IIIA	375		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	375	0	LumA	Luminal A	Negative	LumA/B	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XO-01	375	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XO			days	375	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant			TCGA-AN-A0XO-F68957	TCGA-AN-A0XO	TCGA-AN-A0XO-01A		Positive					Negative						-21640	163		0	375					NO					2014-12-23	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative		YES	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									2		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D.pdf	A0XO	TUMOR FREE				0	180	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	508f0932-673f-48b4-ac71-845ed9eb7c52	20e3c431-7416-49c3-88a0-b59801f6b05d	508f0932-673f-48b4-ac71-845ed9eb7c52	20e3c431-7416-49c3-88a0-b59801f6b05d	TCGA-AN-A0XO-01A-21-A13D-20	TCGA-AN-A0XO-01A-11D-A10G-09		TCGA-AN-A0XO-01	TCGA-AN-A0XO-01A-11D-A10A-05		591208e6-48b0-4a0a-b925-255e07225396	TCGA-AN-A0XO-01	TCGA-AN-A0XO-01A-11D-A10G-09		TCGA-AN-A0XO-01		TCGA-AN-A0XO-01A-11D-A10G-09	TCGA-AN-A0XO-01	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01	TCGA-AN-A0XO-01A-11D-A107-01		TCGA-AN-A0XO-01A-11R-A109-07	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01A-11D-A107-01	TCGA-AN-A0XO-01
TCGA-AN-A0XP-01	Stage IIIA	69	2	Stage IIIA	9		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	9	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XP-01	9	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XP			days	9	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Inner Quadrant			TCGA-AN-A0XP-F68958	TCGA-AN-A0XP	TCGA-AN-A0XP-01A		Positive					Positive						-25305	162		0	9					NO					2014-12-23	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Positive		YES	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4									1		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XP.80E9B7CE-0D5D-4C01-A8E3-E6345BE145EC.pdf	A0XP	TUMOR FREE				140	260	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	14fb9342-c11d-460d-af84-f31f7753beeb	dd464f65-b905-44a2-8e45-018d58c112c7	14fb9342-c11d-460d-af84-f31f7753beeb	dd464f65-b905-44a2-8e45-018d58c112c7	TCGA-AN-A0XP-01A-21-A13D-20	TCGA-AN-A0XP-01A-11D-A117-09		TCGA-AN-A0XP-01	TCGA-AN-A0XP-01A-11D-A10A-05		a4ce1a58-da4d-4beb-9785-856f1d1a72e5	TCGA-AN-A0XP-01	TCGA-AN-A0XP-01A-11D-A117-09		TCGA-AN-A0XP-01		TCGA-AN-A0XP-01A-11D-A117-09	TCGA-AN-A0XP-01	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01	TCGA-AN-A0XP-01A-11D-A107-01		TCGA-AN-A0XP-01A-11R-A109-07	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01A-11D-A107-01	TCGA-AN-A0XP-01
TCGA-AN-A0XR-01	Stage IIIA	55	2	Stage IIIA	10		Positive	FEMALE	Negative				Negative	M0	Positive	N2	10	0	LumB	Luminal B	Negative		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XR-01	10	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XR			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left Upper Outer Quadrant			TCGA-AN-A0XR-F56951	TCGA-AN-A0XR	TCGA-AN-A0XR-01A		Positive					Negative						-20381	155		0	10					NO					2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative		YES	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4									7		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6.pdf	A0XR	TUMOR FREE				0	160	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	2738d02e-ac2a-4d26-beb6-794f3e11cf88	73792381-9fcb-4a9f-b192-9eb30f94a4fa	2738d02e-ac2a-4d26-beb6-794f3e11cf88	73792381-9fcb-4a9f-b192-9eb30f94a4fa		TCGA-AN-A0XR-01A-11D-A10G-09		TCGA-AN-A0XR-01	TCGA-AN-A0XR-01A-11D-A10A-05			TCGA-AN-A0XR-01	TCGA-AN-A0XR-01A-11D-A10G-09		TCGA-AN-A0XR-01		TCGA-AN-A0XR-01A-11D-A10G-09	TCGA-AN-A0XR-01	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01	TCGA-AN-A0XR-01A-11D-A107-01		TCGA-AN-A0XR-01A-11R-A109-07	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01A-11D-A107-01	TCGA-AN-A0XR-01
TCGA-AN-A0XS-01	Stage IIIA	63	4	Stage IIIA	10		Negative	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Positive	LumA	-5	-4	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XS-01	10	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-AN-A0XS	10	0	days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant			TCGA-AN-A0XS-F68959	TCGA-AN-A0XS	TCGA-AN-A0XS-01A		Negative					Positive						-23358	120		0	10					NO					2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative		YES	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	1		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8.pdf	A0XS	TUMOR FREE				160	0	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	b77f4222-9000-4485-8728-8864780ebcb8	b90d3cc1-678c-414a-b57f-864f8b6951eb	b77f4222-9000-4485-8728-8864780ebcb8	b90d3cc1-678c-414a-b57f-864f8b6951eb	TCGA-AN-A0XS-01A-11-A13D-20	TCGA-AN-A0XS-01A-22D-A10G-09		TCGA-AN-A0XS-01	TCGA-AN-A0XS-01A-22D-A10A-05		7ca812ab-5eb8-4ae0-8da0-8a53020c32ef	TCGA-AN-A0XS-01	TCGA-AN-A0XS-01A-22D-A10G-09		TCGA-AN-A0XS-01		TCGA-AN-A0XS-01A-22D-A10G-09	TCGA-AN-A0XS-01	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01	TCGA-AN-A0XS-01A-22D-A107-01		TCGA-AN-A0XS-01A-22R-A109-07	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01A-22D-A107-01	TCGA-AN-A0XS-01
TCGA-AN-A0XT-01	Stage IIIA	54	2	Stage IIIA	10		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	10	0	LumA	Luminal A	Negative	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XT-01	10	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 7	mutation cluster 5	TCGA-AN-A0XT			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant			TCGA-AN-A0XT-F68960	TCGA-AN-A0XT	TCGA-AN-A0XT-01A		Positive					Negative						-19794	114		0	10					NO					2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Negative		YES	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	7									1		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05.pdf	A0XT	TUMOR FREE				0	120	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	21f22460-fac7-4dbc-8ab2-75738331cb5c	98d18655-65da-47d9-982e-de5ab600a3a0	21f22460-fac7-4dbc-8ab2-75738331cb5c	98d18655-65da-47d9-982e-de5ab600a3a0	TCGA-AN-A0XT-01A-21-A13D-20	TCGA-AN-A0XT-01A-11D-A10G-09		TCGA-AN-A0XT-01	TCGA-AN-A0XT-01A-11D-A10A-05		95d4260a-5886-44ff-824f-6c2c76c9c1bc	TCGA-AN-A0XT-01	TCGA-AN-A0XT-01A-11D-A10G-09		TCGA-AN-A0XT-01		TCGA-AN-A0XT-01A-11D-A10G-09	TCGA-AN-A0XT-01	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01	TCGA-AN-A0XT-01A-11D-A107-01		TCGA-AN-A0XT-01A-11R-A109-07	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01A-11D-A107-01	TCGA-AN-A0XT-01
TCGA-AN-A0XU-01	Stage IIA	54	1	Stage IIA	10		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	10	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XU-01	10	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0XU			days	10	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant			TCGA-AN-A0XU-F68961	TCGA-AN-A0XU	TCGA-AN-A0XU-01A		Negative					Negative						-20052	106		0	10					NO					2014-12-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		YES	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4									0		true	No	M0	N0	T2	Stage IIA	TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf	A0XU	TUMOR FREE				0	0	NO	YES			NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	74cba80b-7677-41d6-ab22-10f1a962ba2f	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	74cba80b-7677-41d6-ab22-10f1a962ba2f	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	TCGA-AN-A0XU-01A-21-A13D-20	TCGA-AN-A0XU-01A-11D-A10G-09		TCGA-AN-A0XU-01	TCGA-AN-A0XU-01A-11D-A10A-05		fa8604b6-7128-4db4-bfaf-6f1000fb4017	TCGA-AN-A0XU-01	TCGA-AN-A0XU-01A-11D-A10G-09		TCGA-AN-A0XU-01		TCGA-AN-A0XU-01A-11D-A10G-09	TCGA-AN-A0XU-01	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01	TCGA-AN-A0XU-01A-11D-A107-01		TCGA-AN-A0XU-01A-11R-A109-07	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01A-11D-A107-01	TCGA-AN-A0XU-01
TCGA-AN-A0XV-01	Stage IIIA	67	4	Stage IIIA	162		Positive	FEMALE	Negative				Negative	M0	Positive	N2	162	0	LumA	Luminal A	Positive		0	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XV-01	162	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AN-A0XV	162	0	days	162	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AN-A0XV-F68962	TCGA-AN-A0XV	TCGA-AN-A0XV-01A		Positive		1+	3 Point Scale		Positive			NO			-24779	121		0	162					NO	dextran coated charcoal	90-99%			2014-12-23	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Positive	Negative	YES	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	7		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XV.5F626AB6-EEB5-4005-97C5-9E48D9FA7730.pdf	A0XV	TUMOR FREE	dextran coated charcoal			90 H	270 H	NO	YES	30-39%		NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	7b33b321-fe4b-4296-91bc-53bac35828e5	7754e179-0e81-431d-926e-c24be0e6b4e1	7b33b321-fe4b-4296-91bc-53bac35828e5	7754e179-0e81-431d-926e-c24be0e6b4e1		TCGA-AN-A0XV-01A-11D-A10G-09		TCGA-AN-A0XV-01	TCGA-AN-A0XV-01A-11D-A10A-05			TCGA-AN-A0XV-01	TCGA-AN-A0XV-01A-11D-A10G-09		TCGA-AN-A0XV-01		TCGA-AN-A0XV-01A-11D-A10G-09	TCGA-AN-A0XV-01	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01	TCGA-AN-A0XV-01A-11D-A107-01		TCGA-AN-A0XV-01A-11R-A109-07	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01A-11D-A107-01	TCGA-AN-A0XV-01
TCGA-AN-A0XW-01	Stage IIIA	36	5	Stage IIIA	170		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N2	170	0	LumA	Luminal B	Positive	Her2	-2	-4	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XW-01	170	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0XW	170	0	days	170	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-AN-A0XW-F68963	TCGA-AN-A0XW	TCGA-AN-A0XW-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive			NO			-13208	121		0	170					NO	dextran coated charcoal	90-99%			2014-12-23	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	270	NO	Positive	Negative	YES	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO	1		true	No	M0	N2	T2	Stage IIIA	TCGA-AN-A0XW.5CBC6417-4E3D-4E9C-AE93-A56B777EF2F4.pdf	A0XW	TUMOR FREE	dextran coated charcoal			240 H	240 H	NO	YES	90-99%		NO	Primary Tumor	01		7th		NO	YES	AN	Breast	A	LIVING	2010	52033f64-1e6f-4657-a4fb-7cfeffc61951	742b1f3f-a199-4dac-8d56-82db36855633	52033f64-1e6f-4657-a4fb-7cfeffc61951	742b1f3f-a199-4dac-8d56-82db36855633	TCGA-AN-A0XW-01A-21-A13D-20	TCGA-AN-A0XW-01A-11D-A10G-09		TCGA-AN-A0XW-01	TCGA-AN-A0XW-01A-11D-A10A-05		a8db4abd-7071-4135-96f6-dfcd0f003f02	TCGA-AN-A0XW-01	TCGA-AN-A0XW-01A-11D-A10G-09		TCGA-AN-A0XW-01		TCGA-AN-A0XW-01A-11D-A10G-09	TCGA-AN-A0XW-01	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01	TCGA-AN-A0XW-01A-11D-A107-01		TCGA-AN-A0XW-01A-11R-A109-07	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01A-11D-A107-01	TCGA-AN-A0XW-01
TCGA-AO-A03L-01	Stage IIIA	34	5	No_Conversion	2442		Positive	FEMALE	Negative	1	3	1	Negative	M0	Positive	N2	2442	0	LumA	HER2-enriched	Positive	Basal	-2	-4	followup	T_Other	T3	LIVING	0	TCGA-AO-A03L-01	2442	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-AO-A03L	2442	0	days	2442	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03L-F19390	TCGA-AO-A03L	TCGA-AO-A03L-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-12443	2456		0	2442							70-79%	63	Scheduled Follow-up Submission	2011-12-12	FEMALE			10-19%	>= 2.0 Positive	2+	30	47	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	680	NO	Positive	Negative		17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	1								NO	4		true	No	M0	N2	T3	Stage IIIA	TCGA-AO-A03L.FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D.pdf	A03L	TUMOR FREE								10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2003	34980e1d-956b-4d89-8bf2-dcc008dbaad7	c5f3f2c3-0c41-4b3d-91d5-767a54746db9	34980e1d-956b-4d89-8bf2-dcc008dbaad7	c5f3f2c3-0c41-4b3d-91d5-767a54746db9	TCGA-AO-A03L-01A-31-A13A-20	TCGA-AO-A03L-01A-41W-A071-09		TCGA-AO-A03L-01	TCGA-AO-A03L-01A-41D-A10P-05		f54048ea-ae8d-4786-b466-a9f4604507e0	TCGA-AO-A03L-01	TCGA-AO-A03L-01A-41W-A071-09		TCGA-AO-A03L-01		TCGA-AO-A03L-01A-41W-A071-09	TCGA-AO-A03L-01	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01	TCGA-AO-A03L-01A-41D-A059-01		TCGA-AO-A03L-01A-41R-A056-07	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01A-41D-A059-01	TCGA-AO-A03L-01
TCGA-AO-A03M-01	Stage IA	29	1	Stage I	1455		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1455	0	LumA	Luminal A	Positive	ReacII	-2	-5	followup	T1	T1	LIVING	0	TCGA-AO-A03M-01	1866	0	days	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7		TCGA-AO-A03M	1866	0	days	1866	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A03M-F30186	TCGA-AO-A03M	TCGA-AO-A03M-01B		Positive		3+			Positive	Simple Mastectomy		YES			-10616	1414		0	1866							70-79%		Scheduled Follow-up Submission	2012-4-4	FEMALE		3+ Positive	30-39%	>= 2.0 Positive	2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	310	NO	Negative	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	7								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-AO-A03M.967287FE-7751-4A90-9465-0A1AD007061D.pdf	A03M	TUMOR FREE								60-69%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	B	LIVING	2006	f65936bc-02d6-4954-9068-0fb7c930d685	1d26df40-c4fd-4609-8f7d-a7ad6c39ea1e	f65936bc-02d6-4954-9068-0fb7c930d685	1d26df40-c4fd-4609-8f7d-a7ad6c39ea1e	TCGA-AO-A03M-01B-21-A13E-20			TCGA-AO-A03M-01	TCGA-AO-A03M-01B-11D-A10N-05		dbfbb734-f8c7-46df-b27b-0320a0372428	TCGA-AO-A03M-01	TCGA-AO-A03M-01B-11D-A10M-09		TCGA-AO-A03M-01			TCGA-AO-A03M-01	f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01	TCGA-AO-A03M-01B-11D-A10L-01		TCGA-AO-A03M-01B-11R-A10J-07	f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01B-11D-A10L-01	TCGA-AO-A03M-01
TCGA-AO-A03N-01	Stage IIB	59	3	No_Conversion	1645		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N1	1645	0	LumB	HER2-enriched	Positive	Her2	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A03N-01	2031	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation cluster 2	TCGA-AO-A03N	1645	1	days	2031	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		59	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03N-F20915	TCGA-AO-A03N	TCGA-AO-A03N-01B		Positive		1+			Positive	Modified Radical Mastectomy		NO			-21816	1596		0	2031			1645				70-79%		Scheduled Follow-up Submission	2012-1-24	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative					4 Point Scale							Negative			2	6			4 Point Scale		Locoregional Disease			YES	2		true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A03N.44527CD3-6EC3-4861-8394-CEA005A17A9E.pdf	A03N	WITH TUMOR								<10%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	B	LIVING	2006	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	b721638f-668e-4118-b704-04e85f308aa3	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	b721638f-668e-4118-b704-04e85f308aa3	TCGA-AO-A03N-01B-21-A13E-20	TCGA-AO-A03N-01B-11D-A10M-09		TCGA-AO-A03N-01	TCGA-AO-A03N-01B-11D-A10N-05		0a7af48e-5b73-42e8-acf6-a0bca1372cc4	TCGA-AO-A03N-01	TCGA-AO-A03N-01B-11D-A10M-09		TCGA-AO-A03N-01		TCGA-AO-A03N-01B-11D-A10M-09	TCGA-AO-A03N-01	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01	TCGA-AO-A03N-01B-11D-A10L-01		TCGA-AO-A03N-01B-11R-A10J-07	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01B-11D-A10L-01	TCGA-AO-A03N-01
TCGA-AO-A03O-01	Stage IIA	69	3	Stage IIA	993	2483	Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	2483	1	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	DECEASED	1	TCGA-AO-A03O-01	2483	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-AO-A03O			days	2483	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03O-F3141	TCGA-AO-A03O	TCGA-AO-A03O-01A		Positive					Positive	Modified Radical Mastectomy		YES			-25362	2694	2483	0							>10% STAINING = POSITIVE		68		2010-9-19	FEMALE		3+ POSITIVE	<10%	> = 2.0	1+	29	73	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	690	NO	Negative	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1									0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A03O.FE9C56C4-B6D4-4054-A58C-13642370052E.pdf	A03O	TUMOR FREE				>10% STAINING = POSITIVE						NO	Primary Tumor	01			YES	NO	YES	AO	Breast	A	DECEASED	2002	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	e866c189-b2f5-4948-afcf-adfc6ff323eb	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	e866c189-b2f5-4948-afcf-adfc6ff323eb	TCGA-AO-A03O-01A-31-A13A-20	TCGA-AO-A03O-01A-11W-A019-09		TCGA-AO-A03O-01			191dae29-7228-4645-9efe-8c80596a5e50	TCGA-AO-A03O-01	TCGA-AO-A03O-01A-11W-A019-09	TCGA-AO-A03O-01A-11D-A00Y-05	TCGA-AO-A03O-01		TCGA-AO-A03O-01A-11W-A019-09	TCGA-AO-A03O-01	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	TCGA-AO-A03O-01	TCGA-AO-A03O-01A-11D-A011-01		TCGA-AO-A03O-01A-11R-A00Z-07	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	TCGA-AO-A03O-01A-11D-A011-01	TCGA-AO-A03O-01
TCGA-AO-A03P-01	Stage IIA	54	3	No_Conversion	2576		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2576	0	LumB	Luminal B	Positive	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	1	TCGA-AO-A03P-01	2911	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-AO-A03P	1922	1	days	2911	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		54	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03P-F15452	TCGA-AO-A03P	TCGA-AO-A03P-01A		Positive		2+			Positive	Lumpectomy		YES		1922	-19724	2414	2911	0	2576	2576		1922				90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0				4.0	Infiltrating Ductal Carcinoma		No	40	C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	370	NO	Negative			26	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	2+		Positive	90-99%	3 Point Scale	20-29%	1.7	4 Point Scale	4+	2+	Negative		80-89%		Positive			2		2.4	RATIO >2.2	4 Point Scale	Liver	Distant Metastasis			YES	0	2	true	No	M0	N1	T2	Stage IIB	TCGA-AO-A03P.0BFAB667-8B40-46AE-A224-535573E268C7.pdf	A03P	WITH TUMOR								40-49%		YES	Primary Tumor	01		6th	NO	NO	YES	AO	Breast	A	DECEASED	2003	9543095d-b05b-43e0-8b8d-74bd916b510b	1ec0101f-dc3b-4d2e-b182-b70350f92562	9543095d-b05b-43e0-8b8d-74bd916b510b	1ec0101f-dc3b-4d2e-b182-b70350f92562	TCGA-AO-A03P-01A-31-A13A-20	TCGA-AO-A03P-01A-11W-A019-09		TCGA-AO-A03P-01			dafdae39-54bf-4a1a-a15b-3538e36ed42c	TCGA-AO-A03P-01	TCGA-AO-A03P-01A-11W-A019-09	TCGA-AO-A03P-01A-11D-A00Y-05	TCGA-AO-A03P-01		TCGA-AO-A03P-01A-11W-A019-09		9543095d-b05b-43e0-8b8d-74bd916b510b		TCGA-AO-A03P-01A-11D-A011-01		TCGA-AO-A03P-01A-11R-A00Z-07	9543095d-b05b-43e0-8b8d-74bd916b510b	TCGA-AO-A03P-01A-11D-A011-01	TCGA-AO-A03P-01
TCGA-AO-A03R-01	Stage IIB	57	4	No_Conversion	1707		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1707	0	Normal	Normal-like	Positive		0	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A03R-01	2091	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation cluster 5	TCGA-AO-A03R	2091	0	days	2091	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03R-F15469	TCGA-AO-A03R	TCGA-AO-A03R-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-20930	1608		0	2091							90-99%	70	Scheduled Follow-up Submission	2011-8-22	FEMALE			<10%	Ratio >=2.0	0	28	105	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative	Negative		26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	3	0	true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE.pdf	A03R	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	6722de75-5d6d-4b1d-a961-856ec5bd12f1	cd00934b-6df0-467f-ae7d-ea7f4632e77c	6722de75-5d6d-4b1d-a961-856ec5bd12f1	cd00934b-6df0-467f-ae7d-ea7f4632e77c		TCGA-AO-A03R-01A-21W-A050-09		TCGA-AO-A03R-01				TCGA-AO-A03R-01	TCGA-AO-A03R-01A-21W-A050-09	TCGA-AO-A03R-01A-21D-A032-05	TCGA-AO-A03R-01		TCGA-AO-A03R-01A-21W-A050-09	TCGA-AO-A03R-01	6722de75-5d6d-4b1d-a961-856ec5bd12f1	TCGA-AO-A03R-01	TCGA-AO-A03R-01A-21D-A036-01		TCGA-AO-A03R-01A-21R-A034-07	6722de75-5d6d-4b1d-a961-856ec5bd12f1	TCGA-AO-A03R-01A-21D-A036-01	TCGA-AO-A03R-01
TCGA-AO-A03T-01	Stage IIB	42	5	No_Conversion	1187		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1187	0	Normal	Normal-like	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AO-A03T-01	2124	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-AO-A03T	2124	0	days	2124	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A03T-F43476	TCGA-AO-A03T	TCGA-AO-A03T-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-15540	1031		0	2124							90-99%		Scheduled Follow-up Submission	2013-5-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative		NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A03T.D5EF8C37-811E-42B7-84E5-E6ED71217971.pdf	A03T	TUMOR FREE						YES		60-69%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2007	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	fb504c0c-2c3c-4b5d-8836-dc9bbf30ff98	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	fb504c0c-2c3c-4b5d-8836-dc9bbf30ff98		TCGA-AO-A03T-01A-21W-A050-09		TCGA-AO-A03T-01				TCGA-AO-A03T-01	TCGA-AO-A03T-01A-21W-A050-09	TCGA-AO-A03T-01A-21D-A032-05	TCGA-AO-A03T-01		TCGA-AO-A03T-01A-21W-A050-09	TCGA-AO-A03T-01	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	TCGA-AO-A03T-01	TCGA-AO-A03T-01A-21D-A036-01		TCGA-AO-A03T-01A-21R-A034-07	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	TCGA-AO-A03T-01A-21D-A036-01	TCGA-AO-A03T-01
TCGA-AO-A03U-01	Stage IA	31	1	Stage I	1727	1796	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1796	1	Normal	Normal-like	Negative	Basal	-5	0	followup	T1	T1	DECEASED	1	TCGA-AO-A03U-01	1793	1	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A03U	1614	1	days	1793	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		31	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A03U-F20907	TCGA-AO-A03U	TCGA-AO-A03U-01B		Negative					Negative	Simple Mastectomy		YES			-11354	3254	1793	0				1614				<10%		Scheduled Follow-up Submission	2012-1-24	FEMALE		3+ Positive	<10%		0					Other, specify		No		C50.9	8502/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative			Negative												Negative			5	4				Lung	New Primary Tumor			YES	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-AO-A03U.A8AF94A0-F3C2-4AB0-AB0C-22BDA51AF546.pdf	A03U	TUMOR FREE								<10%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	B	DECEASED	2001	bbca4523-28a7-416c-98a8-02c3350705fc	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	bbca4523-28a7-416c-98a8-02c3350705fc	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	TCGA-AO-A03U-01B-11-A13E-20	TCGA-AO-A03U-01B-21D-A10M-09		TCGA-AO-A03U-01	TCGA-AO-A03U-01B-21D-A10N-05		93635795-8741-4a0d-b538-48fb08377942	TCGA-AO-A03U-01	TCGA-AO-A03U-01B-21D-A10M-09		TCGA-AO-A03U-01		TCGA-AO-A03U-01B-21D-A10M-09	TCGA-AO-A03U-01	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01	TCGA-AO-A03U-01B-21D-A10L-01		TCGA-AO-A03U-01B-21R-A10J-07	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01B-21D-A10L-01	TCGA-AO-A03U-01
TCGA-AO-A03V-01	Stage IA	41	1	Stage I	886		Positive	FEMALE	Negative				Negative	M0	Negative	N0	886	0	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-AO-A03V-01	1351	0	days	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 5	TCGA-AO-A03V	1351	0	days	1351	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Inner Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A03V-F20912	TCGA-AO-A03V	TCGA-AO-A03V-01A		Positive		2+			Positive	Simple Mastectomy		YES			-15284	670		0	1351							90-99%		Scheduled Follow-up Submission	2012-1-24	FEMALE		3+ Positive	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	70	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																				2	7								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-AO-A03V.63E34973-F630-4295-AC1B-94F81BBEBE41.pdf	A03V	TUMOR FREE								80-89%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2008	35a76121-7e58-4e28-a39c-6301a4cc0e2e	6c95b250-69e7-444d-8087-731383aaff4f	35a76121-7e58-4e28-a39c-6301a4cc0e2e	6c95b250-69e7-444d-8087-731383aaff4f		TCGA-AO-A03V-01A-11D-A10Y-09		TCGA-AO-A03V-01				TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11D-A10Y-09	TCGA-AO-A03V-01A-11D-A112-05	TCGA-AO-A03V-01	TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11D-A10Y-09		35a76121-7e58-4e28-a39c-6301a4cc0e2e		TCGA-AO-A03V-01A-11D-A111-01	TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11R-A115-07	35a76121-7e58-4e28-a39c-6301a4cc0e2e	TCGA-AO-A03V-01A-11D-A111-01	TCGA-AO-A03V-01
TCGA-AO-A0J2-01	Stage IA	41	3	Stage I	585		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	585	0	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T1	T1	LIVING	0	TCGA-AO-A0J2-01	997	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J2	997	0	days	997	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Lower Inner Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A0J2-F15481	TCGA-AO-A0J2	TCGA-AO-A0J2-01A		Negative					Negative	Simple Mastectomy		YES			-15324	668		0	997							<10%	2.4	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	30-39%	RATIO > 2.2	2+	40	3.5	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD.pdf	A0J2	TUMOR FREE								<10%		NO	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2008	81689324-2986-49f6-bef6-f5a525ca36c2	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	81689324-2986-49f6-bef6-f5a525ca36c2	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	TCGA-AO-A0J2-01A-21-A13A-20	TCGA-AO-A0J2-01A-11W-A050-09		TCGA-AO-A0J2-01			c8e29a9a-2a2c-49ad-8101-2f74df959c0c	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01A-11W-A050-09	TCGA-AO-A0J2-01A-11D-A032-05	TCGA-AO-A0J2-01		TCGA-AO-A0J2-01A-11W-A050-09	TCGA-AO-A0J2-01	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01A-11D-A036-01		TCGA-AO-A0J2-01A-11R-A034-07	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA-AO-A0J2-01A-11D-A036-01	TCGA-AO-A0J2-01
TCGA-AO-A0J3-01	Stage IIB	67	5	No_Conversion	302		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	302	0	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J3-01	651	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 1	mutation c1uster 9	TCGA-AO-A0J3	651	0	days	651	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A0J3-F15477	TCGA-AO-A0J3	TCGA-AO-A0J3-01A		Positive		4+			Positive	Modified Radical Mastectomy		YES			-24519	220		0	651							<10%	2.6	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ Positive	10-19%	Ratio >=2.2	2+	40	2.4	0.9		Other, specify		No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	1180	NO	Equivocal	Negative		36	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO	1	0	true	No	M0	N1b	T2	Stage IIB	TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8.pdf	A0J3	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	7455cc98-aceb-4adc-932b-4fddd979c522	40c683dc-6337-4e19-9a9d-bad8fcfaa026	7455cc98-aceb-4adc-932b-4fddd979c522	40c683dc-6337-4e19-9a9d-bad8fcfaa026	TCGA-AO-A0J3-01A-21-A13B-20	TCGA-AO-A0J3-01A-11W-A050-09		TCGA-AO-A0J3-01			67394de8-86f3-40e0-b897-52e23c163647	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01A-11W-A050-09	TCGA-AO-A0J3-01A-11D-A032-05	TCGA-AO-A0J3-01		TCGA-AO-A0J3-01A-11W-A050-09	TCGA-AO-A0J3-01	7455cc98-aceb-4adc-932b-4fddd979c522	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01A-11D-A036-01		TCGA-AO-A0J3-01A-11R-A034-07	7455cc98-aceb-4adc-932b-4fddd979c522	TCGA-AO-A0J3-01A-11D-A036-01	TCGA-AO-A0J3-01
TCGA-AO-A0J4-01	Stage IA	41	1	Stage I	294		Negative	FEMALE	Negative				Negative	M0	Negative	N0	294	0	Basal	Basal-like	Negative		-13	-12	followup	T1	T1	LIVING	0	TCGA-AO-A0J4-01	1587	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J4	1587	0	days	1587	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A0J4-F15478	TCGA-AO-A0J4	TCGA-AO-A0J4-01A		Negative					Negative	Lumpectomy		YES			-15052	224		0	1587							<10%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62.pdf	A0J4	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	4808bc63-000a-4a49-a25b-4b817ca5ea54	4883e039-c3b8-4777-a0fa-765f06006523	4808bc63-000a-4a49-a25b-4b817ca5ea54	4883e039-c3b8-4777-a0fa-765f06006523		TCGA-AO-A0J4-01A-11W-A050-09		TCGA-AO-A0J4-01				TCGA-AO-A0J4-01	TCGA-AO-A0J4-01A-11W-A050-09	TCGA-AO-A0J4-01A-11D-A032-05	TCGA-AO-A0J4-01		TCGA-AO-A0J4-01A-11W-A050-09	TCGA-AO-A0J4-01	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA-AO-A0J4-01	TCGA-AO-A0J4-01A-11D-A036-01		TCGA-AO-A0J4-01A-11R-A034-07	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA-AO-A0J4-01A-11D-A036-01	TCGA-AO-A0J4-01
TCGA-AO-A0J5-01	Stage IV	48		No_Conversion	704		Positive	FEMALE	Negative				Positive	M1	Positive	N1	704	0	LumA		Negative				followup	T_Other	T4	LIVING	1	TCGA-AO-A0J5-01	792	1	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-AO-A0J5	792	0	days	792	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A0J5-F19407	TCGA-AO-A0J5	TCGA-AO-A0J5-01A		Positive					Negative	Modified Radical Mastectomy		NO			-17815	554	792	0	705	735						90-99%	64	Scheduled Follow-up Submission	2011-12-12	FEMALE	>2.2 Positive	3+ Positive	10-19%		2+	25	71	1.1		Other, specify		Yes		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	500	NO	Equivocal	Negative		2	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		Lung|Bone|Liver											NO	2		true	No	M1	N1a	T4	Stage IV	TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22.pdf	A0J5	WITH TUMOR								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	DECEASED	2008	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	7a2353f9-e0cf-4231-8c96-1799f9547328	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	7a2353f9-e0cf-4231-8c96-1799f9547328	TCGA-AO-A0J5-01A-21-A13A-20	TCGA-AO-A0J5-01A-11W-A050-09		TCGA-AO-A0J5-01			42dea565-bb3c-4c5f-badc-b1615a3482e4	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01A-11W-A050-09	TCGA-AO-A0J5-01A-11D-A032-05	TCGA-AO-A0J5-01		TCGA-AO-A0J5-01A-11W-A050-09	TCGA-AO-A0J5-01	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01A-11D-A036-01		TCGA-AO-A0J5-01A-11R-A034-07	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	TCGA-AO-A0J5-01A-11D-A036-01	TCGA-AO-A0J5-01
TCGA-AO-A0J6-01	Stage IIA	61	1	Stage IIA	775		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	775	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J6-01	1140	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0J6	1140	0	days	1140	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A0J6-F15479	TCGA-AO-A0J6	TCGA-AO-A0J6-01A		Negative					Negative	Lumpectomy		YES			-22462	748		0	1140							<10%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	2								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271.pdf	A0J6	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2008	1fe98b05-6803-4803-83cd-a59e794b956e	6fc05d70-1569-4bfa-bab2-5947d36fd71b	1fe98b05-6803-4803-83cd-a59e794b956e	6fc05d70-1569-4bfa-bab2-5947d36fd71b	TCGA-AO-A0J6-01A-21-A13A-20	TCGA-AO-A0J6-01A-11W-A050-09		TCGA-AO-A0J6-01			13c00c4c-d6c9-4d3f-b63d-780757d0e5e1	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01A-11W-A050-09	TCGA-AO-A0J6-01A-11D-A032-05	TCGA-AO-A0J6-01		TCGA-AO-A0J6-01A-11W-A050-09	TCGA-AO-A0J6-01	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01A-11D-A036-01		TCGA-AO-A0J6-01A-11R-A034-07	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA-AO-A0J6-01A-11D-A036-01	TCGA-AO-A0J6-01
TCGA-AO-A0J7-01	Stage IIB	71	2	No_Conversion	260		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	260	0	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J7-01	618	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AO-A0J7	618	0	days	618	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0J7-F15480	TCGA-AO-A0J7	TCGA-AO-A0J7-01A		Positive					Positive	Modified Radical Mastectomy		NO			-26281	177		0	618							90-99%			2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Other, specify		No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	300	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	3	0	true	No	M0	N1	T2	Stage IIB	TCGA-AO-A0J7.4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE.pdf	A0J7	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	542bb107-1b0c-4ace-834d-9e32ed82429c	1dcce010-051a-42dc-a569-f669660fe99a	542bb107-1b0c-4ace-834d-9e32ed82429c	1dcce010-051a-42dc-a569-f669660fe99a	TCGA-AO-A0J7-01A-21-A13B-20	TCGA-AO-A0J7-01A-11W-A050-09		TCGA-AO-A0J7-01			dd6cd205-238d-4ba8-88db-6f0028931ca7	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01A-11W-A050-09	TCGA-AO-A0J7-01A-11D-A032-05	TCGA-AO-A0J7-01		TCGA-AO-A0J7-01A-11W-A050-09	TCGA-AO-A0J7-01	542bb107-1b0c-4ace-834d-9e32ed82429c	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01A-11D-A036-01		TCGA-AO-A0J7-01A-11R-A034-07	542bb107-1b0c-4ace-834d-9e32ed82429c	TCGA-AO-A0J7-01A-11D-A036-01	TCGA-AO-A0J7-01
TCGA-AO-A0J8-01	Stage IIA	61	2	Stage IIA	277		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	277	0	LumA	Luminal A	Positive	ReacI	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J8-01	680	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J8	680	0	days	680	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A0J8-F15482	TCGA-AO-A0J8	TCGA-AO-A0J8-01A		Positive		3+			Positive	Lumpectomy		YES			-22284	241		0	680							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	670	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	2								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08.pdf	A0J8	TUMOR FREE								70-79%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	70109263-1d2b-4abe-a582-2b28e87cde67	962ff806-5a8d-44ff-ac8b-9f158d65d014	70109263-1d2b-4abe-a582-2b28e87cde67	962ff806-5a8d-44ff-ac8b-9f158d65d014	TCGA-AO-A0J8-01A-11-A13A-20	TCGA-AO-A0J8-01A-21D-A045-09		TCGA-AO-A0J8-01			287094b7-2cf5-415d-81f7-5ef0196d181c	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01A-21D-A032-05	TCGA-AO-A0J8-01		TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A036-01		TCGA-AO-A0J8-01A-21R-A034-07	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01A-21D-A036-01	TCGA-AO-A0J8-01
TCGA-AO-A0J9-01	Stage IIIC	61	2	No_Conversion	1255		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N3	1255	0	LumA	Luminal A	Positive	ReacI	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J9-01	1613	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J9	1066	1	days	1613	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		61	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0J9-F15483	TCGA-AO-A0J9	TCGA-AO-A0J9-01A	Negative	Positive		4+		Mastectomy NOS	Positive	Lumpectomy		NO		1066	-22642	1207		0	1613			1066				90-99%	127	Scheduled Follow-up Submission	2011-8-22	FEMALE				RATIO >EQUAL 2.0		33	149	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	430	NO		Negative		32	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%	3+ POSITIVE	<10%		4 Point Scale	4+	1+		3 Point Scale	10-19%		Positive			4	2			4 Point Scale	Bone	Distant Metastasis			YES	15	0	true	No	M0	N3	T2	Stage IIIC	TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD.pdf	A0J9	WITH TUMOR								30-39%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2007	2d4b31ad-8790-426a-965b-25b74293156c	556981d5-78ea-4e3e-ad02-4d9f71729caa	2d4b31ad-8790-426a-965b-25b74293156c	556981d5-78ea-4e3e-ad02-4d9f71729caa	TCGA-AO-A0J9-01A-21-A13B-20	TCGA-AO-A0J9-01A-11W-A050-09		TCGA-AO-A0J9-01			5141cf13-4997-4411-b0d5-9d2ecb048cdb	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01A-11W-A050-09	TCGA-AO-A0J9-01A-11D-A032-05	TCGA-AO-A0J9-01		TCGA-AO-A0J9-01A-11W-A050-09	TCGA-AO-A0J9-01	2d4b31ad-8790-426a-965b-25b74293156c	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01A-11D-A036-01		TCGA-AO-A0J9-01A-11R-A034-07	2d4b31ad-8790-426a-965b-25b74293156c	TCGA-AO-A0J9-01A-11D-A036-01	TCGA-AO-A0J9-01
TCGA-AO-A0JA-01	Stage IIIC	36	2	No_Conversion	346		Positive	FEMALE	Negative				Negative	M0	Positive	N3	346	0	LumA	Luminal A	Positive		-4	-4	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JA-01	655	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AO-A0JA	143	1	days	655	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		36	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JA-F15484	TCGA-AO-A0JA	TCGA-AO-A0JA-01A		Positive		1+			Positive	Modified Radical Mastectomy		NO		143	-13307	258		0	655			143				90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	100	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Negative	<10%	3+ POSITIVE	<10%		4 Point Scale		2+		3 Point Scale	70-79%		Positive			4	1			4 Point Scale	Bone	Distant Metastasis			YES	11		true	No	M0	N3	T2	Stage IIIC	TCGA-AO-A0JA.2E8A1816-E963-4063-B2F0-6289514084A5.pdf	A0JA	WITH TUMOR								<10%		NO	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	d38a839f-06dc-40d2-81e9-3b7822e258c7	25822371-680d-4663-98ef-ebf79e6dff4d	d38a839f-06dc-40d2-81e9-3b7822e258c7	25822371-680d-4663-98ef-ebf79e6dff4d		TCGA-AO-A0JA-01A-11W-A071-09		TCGA-AO-A0JA-01	TCGA-AO-A0JA-01A-11D-A10P-05			TCGA-AO-A0JA-01	TCGA-AO-A0JA-01A-11W-A071-09		TCGA-AO-A0JA-01		TCGA-AO-A0JA-01A-11W-A071-09	TCGA-AO-A0JA-01	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01	TCGA-AO-A0JA-01A-11D-A059-01		TCGA-AO-A0JA-01A-11R-A056-07	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01A-11D-A059-01	TCGA-AO-A0JA-01
TCGA-AO-A0JB-01	Stage IIIA	50	1	No_Conversion	1150		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1150	0		Normal-like	Positive	Basal	-2	-3	followup	T_Other	T3	LIVING	0	TCGA-AO-A0JB-01	1542	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0JB	1542	0	days	1542	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-AO-A0JB-F15485	TCGA-AO-A0JB	TCGA-AO-A0JB-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-18561	1178		0	1542							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	510	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	2								NO	1	0	true	No	M0	N1a	T3	Stage IIIA	TCGA-AO-A0JB.6C202D3E-5670-4B63-82A2-9EE7AC385089.pdf	A0JB	TUMOR FREE								60-69%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2007	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	747d51ed-f576-421b-8e92-868a35b01cdb	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	747d51ed-f576-421b-8e92-868a35b01cdb	TCGA-AO-A0JB-01A-21-A13A-20	TCGA-AO-A0JB-01A-11W-A071-09		TCGA-AO-A0JB-01	TCGA-AO-A0JB-01A-11D-A10P-05		a9a1fd2e-401f-4469-87fd-a42b3680c32b	TCGA-AO-A0JB-01	TCGA-AO-A0JB-01A-11W-A071-09		TCGA-AO-A0JB-01		TCGA-AO-A0JB-01A-11W-A071-09	TCGA-AO-A0JB-01	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01	TCGA-AO-A0JB-01A-11D-A059-01		TCGA-AO-A0JB-01A-11R-A056-07	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01A-11D-A059-01	TCGA-AO-A0JB-01
TCGA-AO-A0JC-01	Stage IIA	64	1	Stage IIA	1547		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1547	0	LumA	Luminal B	Positive	LumA	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JC-01	1547	0	days	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0JC	1547	0	days	1547	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JC-F15486	TCGA-AO-A0JC	TCGA-AO-A0JC-01A		Positive		3+			Positive	Modified Radical Mastectomy		YES			-23404	1522		0	1547							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	550	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	2								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A0JC.A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B.pdf	A0JC	TUMOR FREE								50-59%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2006	0f578102-ede7-46ad-ae1f-3c7351edb491	6ef9047c-f0c6-4414-8025-2ea0dc914014	0f578102-ede7-46ad-ae1f-3c7351edb491	6ef9047c-f0c6-4414-8025-2ea0dc914014	TCGA-AO-A0JC-01A-21-A13A-20	TCGA-AO-A0JC-01A-11W-A071-09		TCGA-AO-A0JC-01	TCGA-AO-A0JC-01A-11D-A10P-05		020a471c-8f4c-40c5-b4e2-6181b5499a0a	TCGA-AO-A0JC-01	TCGA-AO-A0JC-01A-11W-A071-09		TCGA-AO-A0JC-01		TCGA-AO-A0JC-01A-11W-A071-09	TCGA-AO-A0JC-01	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01	TCGA-AO-A0JC-01A-11D-A059-01		TCGA-AO-A0JC-01A-11R-A056-07	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01A-11D-A059-01	TCGA-AO-A0JC-01
TCGA-AO-A0JD-01	Stage IIIA	59	2	No_Conversion	1813		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N1	1813	0	LumB	Luminal B	Positive	Basal	-2	-2	followup	T_Other	T3	LIVING	0	TCGA-AO-A0JD-01	2190	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 5	mutation cluster 8	TCGA-AO-A0JD	2190	0	days	2190	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JD-F15487	TCGA-AO-A0JD	TCGA-AO-A0JD-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-21831	1863		0	2190							90-99%	49	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%	RATIO > = 2.0	1+	20	68	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	230	NO	Negative	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	5								NO	3	0	true	No	M0	N1a	T3	Stage IIIA	TCGA-AO-A0JD.E8A43FF3-3D98-45EE-9567-6EED4DA38274.pdf	A0JD	TUMOR FREE								40-49%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	ce2e1bd2-6d7a-45d2-92ca-e2550974cfc8	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	ce2e1bd2-6d7a-45d2-92ca-e2550974cfc8	TCGA-AO-A0JD-01A-21-A13B-20	TCGA-AO-A0JD-01A-11W-A071-09		TCGA-AO-A0JD-01	TCGA-AO-A0JD-01A-11D-A10P-05		ac0bdea2-ebe1-454a-8425-960820b9a1ad	TCGA-AO-A0JD-01	TCGA-AO-A0JD-01A-11W-A071-09		TCGA-AO-A0JD-01		TCGA-AO-A0JD-01A-11W-A071-09	TCGA-AO-A0JD-01	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01	TCGA-AO-A0JD-01A-11D-A059-01		TCGA-AO-A0JD-01A-11R-A056-07	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01A-11D-A059-01	TCGA-AO-A0JD-01
TCGA-AO-A0JE-01	Stage IIIA	53	5	No_Conversion	1965		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N2	1965	0	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JE-01	2335	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 4	mutation cluster 3	TCGA-AO-A0JE	2335	0	days	2335	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JE-F15488	TCGA-AO-A0JE	TCGA-AO-A0JE-01A		Negative					Negative	Lumpectomy		NO			-19516	1910		0	2335							<10%	71	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	50-59%	RATIO > = 2.0	3+	33	269	3.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Positive	Positive		29	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	8	0	true	No	M0	N2a	T2	Stage IIIA	TCGA-AO-A0JE.15CAD156-1E40-4C83-B3ED-484964FE407F.pdf	A0JE	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	d73174ef-182c-48b9-af79-dfb457d5b7be	3110bb7f-d80d-4f08-9758-d90368f07cf0	d73174ef-182c-48b9-af79-dfb457d5b7be	3110bb7f-d80d-4f08-9758-d90368f07cf0	TCGA-AO-A0JE-01A-21-A13B-20	TCGA-AO-A0JE-01A-11W-A071-09		TCGA-AO-A0JE-01	TCGA-AO-A0JE-01A-11D-A10P-05		d9cdfaa4-a07d-4172-9ffd-67fb62cc8d9a	TCGA-AO-A0JE-01	TCGA-AO-A0JE-01A-11W-A071-09		TCGA-AO-A0JE-01		TCGA-AO-A0JE-01A-11W-A071-09	TCGA-AO-A0JE-01	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01	TCGA-AO-A0JE-01A-11D-A059-01		TCGA-AO-A0JE-01A-11R-A056-07	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01A-11D-A059-01	TCGA-AO-A0JE-01
TCGA-AO-A0JF-01	Stage IIA	68	2	No_Conversion	354		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	354	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-AO-A0JF-01	1980	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 4	TCGA-AO-A0JF	1980	0	days	1980	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JF-F72115	TCGA-AO-A0JF	TCGA-AO-A0JF-01A		Positive		2+			Positive	Lumpectomy		NO			-24923	273		0	1980							90-99%		Scheduled Follow-up Submission	2015-4-15	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	410	NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7								NO	2	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-AO-A0JF.D58E5D64-B5B9-4487-8E46-225AE3617C14.pdf	A0JF	TUMOR FREE						YES		70-79%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	3389d4b9-0190-4a69-a647-a6d53e3c96be	d075dd35-f392-4092-8e32-3f4fb622ccb1	3389d4b9-0190-4a69-a647-a6d53e3c96be	d075dd35-f392-4092-8e32-3f4fb622ccb1	TCGA-AO-A0JF-01A-21-A13B-20	TCGA-AO-A0JF-01A-11W-A071-09		TCGA-AO-A0JF-01	TCGA-AO-A0JF-01A-11D-A10P-05		c730759a-51df-45f0-94f3-c9054b9f40ff	TCGA-AO-A0JF-01	TCGA-AO-A0JF-01A-11W-A071-09		TCGA-AO-A0JF-01		TCGA-AO-A0JF-01A-11W-A071-09	TCGA-AO-A0JF-01	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01	TCGA-AO-A0JF-01A-11D-A059-01		TCGA-AO-A0JF-01A-11R-A056-07	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01A-11D-A059-01	TCGA-AO-A0JF-01
TCGA-AO-A0JG-01	Stage IIIA	49	5	No_Conversion	449		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	449	0	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JG-01	798	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AO-A0JG	798	0	days	798	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A0JG-F15492	TCGA-AO-A0JG	TCGA-AO-A0JG-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-18021	395		0	798							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Other, specify		No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	410	NO	Negative			19	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO	4	0	true	No	M0	N2a	T2	Stage IIIA	TCGA-AO-A0JG.3671D46F-6D69-42DA-9830-24F67EB8B0B6.pdf	A0JG	TUMOR FREE								10-19%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2009	97b5ef6f-d621-4093-ab77-d60dcf706173	fda181a5-c1fa-4e2a-8df5-57b5cd18b0e0	97b5ef6f-d621-4093-ab77-d60dcf706173	fda181a5-c1fa-4e2a-8df5-57b5cd18b0e0	TCGA-AO-A0JG-01A-21-A13C-20	TCGA-AO-A0JG-01A-31D-A099-09		TCGA-AO-A0JG-01	TCGA-AO-A0JG-01A-31D-A10P-05		a9d2c3f6-0a53-4e38-8a3c-93bf0748df8f	TCGA-AO-A0JG-01			TCGA-AO-A0JG-01		TCGA-AO-A0JG-01A-31D-A099-09	TCGA-AO-A0JG-01	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01	TCGA-AO-A0JG-01A-31D-A087-01		TCGA-AO-A0JG-01A-31R-A084-07	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01A-31D-A087-01	TCGA-AO-A0JG-01
TCGA-AO-A0JI-01	Stage IIA	56	4	No_Conversion	1172		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	1172	0	LumA	Luminal B	Negative	LumA/B	-10	-3	followup	T1	T1	LIVING	0	TCGA-AO-A0JI-01	1528	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0JI	1528	0	days	1528	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JI-F19410	TCGA-AO-A0JI			Positive					Negative	Modified Radical Mastectomy		YES			-20694			0	1528							90-99%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy			Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2								NO	0	1		No	M0	N1	T1c	Stage IIA		A0JI	TUMOR FREE								<10%		NO	Primary Tumor	01			YES	NO	YES	AO	Breast		LIVING	2007	fb0cd718-5300-4447-9740-a63308f65d92	fdc086da-5ae1-4600-9039-4ea5c1fb7655	fb0cd718-5300-4447-9740-a63308f65d92	fdc086da-5ae1-4600-9039-4ea5c1fb7655	TCGA-AO-A0JI-01A-11-A13A-20	TCGA-AO-A0JI-01A-21W-A100-09		TCGA-AO-A0JI-01	TCGA-AO-A0JI-01A-21D-A10P-05		ff238c04-e4ff-43e6-8ee6-38828939ed9f	TCGA-AO-A0JI-01	TCGA-AO-A0JI-01A-21W-A100-09		TCGA-AO-A0JI-01		TCGA-AO-A0JI-01A-21W-A100-09	TCGA-AO-A0JI-01	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01	TCGA-AO-A0JI-01A-21D-A059-01		TCGA-AO-A0JI-01A-21R-A056-07	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01A-21D-A059-01	TCGA-AO-A0JI-01
TCGA-AO-A0JJ-01	Stage IIB	54	2	No_Conversion	1512		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1512	0	LumA	Luminal A	Positive	LumA/B	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AO-A0JJ-01	1887	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 7	mutation c1uster 9	TCGA-AO-A0JJ	1887	0	days	1887	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JJ-F15493	TCGA-AO-A0JJ	TCGA-AO-A0JJ-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-19758	1477		0	1887							90-99%		Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	260	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	7								NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A0JJ.EB9B6625-6674-4665-9BEE-D4DFD9366A02.pdf	A0JJ	TUMOR FREE								70-79%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2006	b5eeba4f-8e46-4084-9054-961ea524cf72	8429bc9e-7bf1-44b1-8e7f-a3ee2d8c2b43	b5eeba4f-8e46-4084-9054-961ea524cf72	8429bc9e-7bf1-44b1-8e7f-a3ee2d8c2b43	TCGA-AO-A0JJ-01A-21-A13A-20	TCGA-AO-A0JJ-01A-11W-A071-09		TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11D-A10P-05		c4fcf63c-a35e-451c-bf06-64b36bc30ba0	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11W-A071-09		TCGA-AO-A0JJ-01		TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11D-A059-01		TCGA-AO-A0JJ-01A-11R-A056-07	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-11D-A059-01	TCGA-AO-A0JJ-01
TCGA-AO-A0JL-01	Stage IIIA	59	3	No_Conversion	1319		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	1319	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JL-01	1683	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AO-A0JL	1683	0	days	1683	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-AO-A0JL-F15495	TCGA-AO-A0JL	TCGA-AO-A0JL-01A		Negative					Negative	Modified Radical Mastectomy		NO			-21895	1332		0	1683							<10%	50	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%	RATIO > = 2.0	1+	21	131	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative	Positive		26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	7		true	No	M0	N2a	T2	Stage IIIA	TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722.pdf	A0JL	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2006	7953e62d-4871-4928-a2ba-a38c740134e1	cb51709b-1103-435b-b9da-eb362eae58fe	7953e62d-4871-4928-a2ba-a38c740134e1	cb51709b-1103-435b-b9da-eb362eae58fe	TCGA-AO-A0JL-01A-21-A13A-20	TCGA-AO-A0JL-01A-11W-A071-09		TCGA-AO-A0JL-01	TCGA-AO-A0JL-01A-11D-A10P-05		8299edee-f043-4cf2-8dc5-501df636be7d	TCGA-AO-A0JL-01	TCGA-AO-A0JL-01A-11W-A071-09		TCGA-AO-A0JL-01		TCGA-AO-A0JL-01A-11W-A071-09	TCGA-AO-A0JL-01	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01	TCGA-AO-A0JL-01A-11D-A059-01		TCGA-AO-A0JL-01A-11R-A056-07	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01A-11D-A059-01	TCGA-AO-A0JL-01
TCGA-AO-A0JM-01	Stage IIB	40	3	No_Conversion	1826		Positive	FEMALE	Positive	4	5	4	Negative	M0	Positive	N1	1826	0	LumB	Luminal B	Positive	ReacII	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JM-01	2184	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A0JM	2184	0	days	2184	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A0JM-F15496	TCGA-AO-A0JM	TCGA-AO-A0JM-01A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-14653	1828		0	2184							90-99%	74		2011-8-22	FEMALE		3+ POSITIVE	70-79%		3+	30	366	5.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	710	NO	Positive	Positive		23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	5								NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05.pdf	A0JM	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2005	7b53ba9f-506e-4af7-9752-ae50e4445880	34401e18-8273-4fbb-bbf6-4830e1d7cc96	7b53ba9f-506e-4af7-9752-ae50e4445880	34401e18-8273-4fbb-bbf6-4830e1d7cc96	TCGA-AO-A0JM-01A-11-A13A-20	TCGA-AO-A0JM-01A-21W-A071-09		TCGA-AO-A0JM-01	TCGA-AO-A0JM-01A-21D-A10P-05		f53d3976-6b25-4a6d-9969-89f363a1b810	TCGA-AO-A0JM-01	TCGA-AO-A0JM-01A-21W-A071-09		TCGA-AO-A0JM-01		TCGA-AO-A0JM-01A-21W-A071-09	TCGA-AO-A0JM-01	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01	TCGA-AO-A0JM-01A-21D-A059-01		TCGA-AO-A0JM-01A-21R-A056-07	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01A-21D-A059-01	TCGA-AO-A0JM-01
TCGA-AO-A124-01	Stage IIA	38	3	Stage IIA	3119		Negative	FEMALE	Negative				Negative	M0	Negative	N0	3119	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A124-01	3506	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A124	3506	0	days	3506	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A124-F19395	TCGA-AO-A124	TCGA-AO-A124-01A		Negative					Negative	Modified Radical Mastectomy		YES			-14174	3213		0	3506							<10%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		0					Other, specify		No		C50.9	8523/3	C50.9		YES		Core needle biopsy	730	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A.pdf	A124	TUMOR FREE								<10%		NO	Primary Tumor	01		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	5cd42d4a-5971-4a01-8c10-99321105a864	cea1bfb5-fe63-4515-8f2b-66696afa23b2	5cd42d4a-5971-4a01-8c10-99321105a864	cea1bfb5-fe63-4515-8f2b-66696afa23b2	TCGA-AO-A124-01A-21-A13E-20	TCGA-AO-A124-01A-11D-A10M-09		TCGA-AO-A124-01	TCGA-AO-A124-01A-11D-A10N-05		184cfad8-a50d-4212-b808-dd5a0275cc32	TCGA-AO-A124-01	TCGA-AO-A124-01A-11D-A10M-09		TCGA-AO-A124-01		TCGA-AO-A124-01A-11D-A10M-09	TCGA-AO-A124-01	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01	TCGA-AO-A124-01A-11D-A10L-01		TCGA-AO-A124-01A-11R-A10J-07	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01A-11D-A10L-01	TCGA-AO-A124-01
TCGA-AO-A125-01	Stage IIA	72	2	Stage IIA	3018		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3018	0	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A125-01	3456	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A125	3456	0	days	3456	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A125-F19398	TCGA-AO-A125	TCGA-AO-A125-01A		Positive		4+			Positive	Simple Mastectomy		YES			-26466	3193		0	3456							50-59%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0			1.0		Other, specify		No		C50.9	8050/3	C50.9	3+	YES		Core needle biopsy	90	NO	Negative	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872.pdf	A125	TUMOR FREE								90-99%		NO	Primary Tumor	01		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	6c8cb6ae-99bb-4878-b6f5-9da28be98588	dbda4063-8216-488e-b84f-65847e980fe5	6c8cb6ae-99bb-4878-b6f5-9da28be98588	dbda4063-8216-488e-b84f-65847e980fe5		TCGA-AO-A125-01A-11D-A10M-09		TCGA-AO-A125-01	TCGA-AO-A125-01A-11D-A10N-05			TCGA-AO-A125-01	TCGA-AO-A125-01A-11D-A10M-09		TCGA-AO-A125-01		TCGA-AO-A125-01A-11D-A10M-09	TCGA-AO-A125-01	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01	TCGA-AO-A125-01A-11D-A10L-01		TCGA-AO-A125-01A-11R-A10J-07	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01A-11D-A10L-01	TCGA-AO-A125-01
TCGA-AO-A126-01	Stage IIA	39	5	Stage IIA	2850		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	2850	0	LumA	Luminal A	Positive	Her2	0	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A126-01	3307	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-AO-A126	267	1	days	3307	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES	YES	NO	39	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A126-F19402	TCGA-AO-A126	TCGA-AO-A126-01A		Positive		2+			Positive	Simple Mastectomy		YES	295	295	-14264	3033		0	3307			267				20-29%	49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	62	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	450	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	0		Positive	20-29%		<10%	1.3	4 Point Scale			Negative		60-69%		Positive			4	6			4 Point Scale		Locoregional Disease			YES	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A126.A4BFA94D-166F-43D4-90B5-3C547F4026A0.pdf	A126	TUMOR FREE								60-69%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2002	690cf196-9b2c-4886-a0e2-ce3a49cb4389	b232d272-6cc0-43ec-92e6-f854213a4b19	690cf196-9b2c-4886-a0e2-ce3a49cb4389	b232d272-6cc0-43ec-92e6-f854213a4b19	TCGA-AO-A126-01A-21-A13E-20	TCGA-AO-A126-01A-11D-A10M-09		TCGA-AO-A126-01	TCGA-AO-A126-01A-11D-A10N-05		da59b9c1-ff1d-4949-ac71-087257291201	TCGA-AO-A126-01	TCGA-AO-A126-01A-11D-A10M-09		TCGA-AO-A126-01		TCGA-AO-A126-01A-11D-A10M-09	TCGA-AO-A126-01	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01	TCGA-AO-A126-01A-11D-A10L-01		TCGA-AO-A126-01A-11R-A10J-07	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01A-11D-A10L-01	TCGA-AO-A126-01
TCGA-AO-A128-01	Stage IIA	61	3	Stage IIA	2877		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2877	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A128-01	3248	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 6		TCGA-AO-A128	3248	0	days	3248	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A128-F19405	TCGA-AO-A128	TCGA-AO-A128-01A		Negative					Negative	Lumpectomy		YES			-22340	2960		0	3248							<10%	49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	30	52	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf	A128	TUMOR FREE								<10%		YES	Primary Tumor	01			YES	NO	YES	AO	Breast	A	LIVING	2002	4a93eaee-d821-4640-a441-255008aaf3b4	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	4a93eaee-d821-4640-a441-255008aaf3b4	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	TCGA-AO-A128-01A-21-A13E-20			TCGA-AO-A128-01	TCGA-AO-A128-01A-11D-A10N-05		b629bd13-8d7f-4bff-aa80-08dec4b64d8e	TCGA-AO-A128-01	TCGA-AO-A128-01A-11D-A10M-09		TCGA-AO-A128-01			TCGA-AO-A128-01	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01	TCGA-AO-A128-01A-11D-A10L-01		TCGA-AO-A128-01A-11R-A10J-07	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01A-11D-A10L-01	TCGA-AO-A128-01
TCGA-AO-A129-01	Stage IIB	29	1	No_Conversion	2923		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2923	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A129-01	3286	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 3	mutation cluster 5	TCGA-AO-A129	3286	0	days	3286	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-AO-A129-F19415	TCGA-AO-A129	TCGA-AO-A129-01A		Negative					Negative	Modified Radical Mastectomy		NO			-10898	2915		0	3286							<10%	49	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	52	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative	Negative		21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B.pdf	A129	TUMOR FREE								<10%		YES	Primary Tumor	01		5th	YES	NO	YES	AO	Breast	A	LIVING	2002	15b9736e-eafc-465e-9ddd-b1b498e8b701	4cd8277c-8a70-44e6-b491-cd35c63408db	15b9736e-eafc-465e-9ddd-b1b498e8b701	4cd8277c-8a70-44e6-b491-cd35c63408db	TCGA-AO-A129-01A-11-A13E-20	TCGA-AO-A129-01A-21D-A10M-09		TCGA-AO-A129-01	TCGA-AO-A129-01A-21D-A10N-05		480c68cf-c569-476a-86eb-cd14d5ba6b54	TCGA-AO-A129-01	TCGA-AO-A129-01A-21D-A10M-09		TCGA-AO-A129-01		TCGA-AO-A129-01A-21D-A10M-09	TCGA-AO-A129-01	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01	TCGA-AO-A129-01A-21D-A10L-01		TCGA-AO-A129-01A-21R-A10J-07	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01A-21D-A10L-01	TCGA-AO-A129-01
TCGA-AO-A12A-01	Stage IIA	47	2	Stage IIA	2754		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	2754	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A12A-01	3112	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-AO-A12A	3112	0	days	3112	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A12A-F19418	TCGA-AO-A12A	TCGA-AO-A12A-01A		Positive		4+			Positive	Modified Radical Mastectomy		YES			-17420	2793		0	3112							90-99%	58	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%	>=2.0 Positive	1+	30	61	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	220	NO	Negative	Negative		27	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A12A.A54E82A4-D7C2-4A5C-A69C-C66976F0282F.pdf	A12A	TUMOR FREE								90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2003	3f4c6d17-a971-4ba0-83ad-3addc24f1298	2cbacdf7-951b-4e62-b703-909aaae769ae	3f4c6d17-a971-4ba0-83ad-3addc24f1298	2cbacdf7-951b-4e62-b703-909aaae769ae	TCGA-AO-A12A-01A-11-A13E-20	TCGA-AO-A12A-01A-21D-A10Y-09		TCGA-AO-A12A-01			e6f501dd-64cd-404e-92f3-56c0de08d987	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21D-A10Y-09	TCGA-AO-A12A-01A-21D-A112-05	TCGA-AO-A12A-01	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21D-A10Y-09		3f4c6d17-a971-4ba0-83ad-3addc24f1298		TCGA-AO-A12A-01A-21D-A111-01	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21R-A115-07	3f4c6d17-a971-4ba0-83ad-3addc24f1298	TCGA-AO-A12A-01A-21D-A111-01	TCGA-AO-A12A-01
TCGA-AO-A12B-01	Stage IIA	63	3	Stage IIA	2359		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	2359	0	LumA	Luminal B	Positive	LumA/B	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A12B-01	2989	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-AO-A12B	2989	0	days	2989	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12B-F43473	TCGA-AO-A12B	TCGA-AO-A12B-01A		Positive		4+			Positive	Simple Mastectomy		YES			-23150	2365		0	2989							90-99%		Scheduled Follow-up Submission	2013-5-22	FEMALE		3+ Positive	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	570	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	3								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F.pdf	A12B	TUMOR FREE						YES		90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2004	44225bb7-92c6-4a6d-b136-bc51666ba84a	9c9304d2-57bc-42b3-91ae-e4671165e030	44225bb7-92c6-4a6d-b136-bc51666ba84a	9c9304d2-57bc-42b3-91ae-e4671165e030	TCGA-AO-A12B-01A-21-A13E-20	TCGA-AO-A12B-01A-11D-A10M-09		TCGA-AO-A12B-01	TCGA-AO-A12B-01A-11D-A10N-05		1ecefd90-2eeb-48bb-9f53-3c5ccdfa465c	TCGA-AO-A12B-01	TCGA-AO-A12B-01A-11D-A10M-09		TCGA-AO-A12B-01	TCGA-AO-A12B-01	TCGA-AO-A12B-01A-11D-A10M-09		44225bb7-92c6-4a6d-b136-bc51666ba84a		TCGA-AO-A12B-01A-11D-A10L-01	TCGA-AO-A12B-01	TCGA-AO-A12B-01A-11R-A10J-07	44225bb7-92c6-4a6d-b136-bc51666ba84a	TCGA-AO-A12B-01A-11D-A10L-01	TCGA-AO-A12B-01
TCGA-AO-A12C-01	Stage IIB	42	2	No_Conversion	1993		Positive	FEMALE	Positive				Negative	M0	Positive	N1	1993	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A12C-01	2372	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6		TCGA-AO-A12C	2372	0	days	2372	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A12C-F19425	TCGA-AO-A12C	TCGA-AO-A12C-01A	Negative	Positive		2+		Modified radical mastectomy	Positive	Lumpectomy		NO			-15469	2086		0	2372							90-99%	78	Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	90-99%	>=2.0 Positive	3+	30	125	1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	350	NO	Positive	Negative		31	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6								NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-AO-A12C.7E9202F6-F2DB-4CC0-A10F-3D9A82E84242.pdf	A12C	TUMOR FREE								40-49%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3		3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3		TCGA-AO-A12C-01A-21-A13E-20			TCGA-AO-A12C-01	TCGA-AO-A12C-01A-11D-A10N-05		6b20b15d-4ebc-4169-a36c-e9abab1dd6f0							TCGA-AO-A12C-01	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3	TCGA-AO-A12C-01			TCGA-AO-A12C-01A-11R-A10J-07	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3		TCGA-AO-A12C-01
TCGA-AO-A12D-01	Stage IIA	43	3	No_Conversion	1948		Negative	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	1948	0	Her2	HER2-enriched	Negative	Her2	-11	-10	followup	T1	T1	LIVING	0	TCGA-AO-A12D-01	2515	0	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A12D	2515	0	days	2515	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A12D-F43438	TCGA-AO-A12D	TCGA-AO-A12D-01A		Negative					Negative	Modified Radical Mastectomy		YES			-15774	1948		0	2515							<10%	66	Scheduled Follow-up Submission	2013-5-21	FEMALE		3+ Positive	90-99%	>=2.0 Positive	3+	32	441	6.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Positive	Positive	NO	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	1	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-AO-A12D.9363D53D-BC3B-4AC0-8185-536C6DB3A6AE.pdf	A12D	TUMOR FREE						YES		<10%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	4adf4439-3d60-44ac-a6f0-9f42cc081a93	83122683-8f67-481a-92f2-f60687a83ba3	4adf4439-3d60-44ac-a6f0-9f42cc081a93	83122683-8f67-481a-92f2-f60687a83ba3	TCGA-AO-A12D-01A-21-A13E-20	TCGA-AO-A12D-01A-11D-A10Y-09		TCGA-AO-A12D-01			1dd0fa5e-8122-4008-a89b-025ed17a3dd9	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11D-A10Y-09	TCGA-AO-A12D-01A-11D-A112-05	TCGA-AO-A12D-01	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11D-A10Y-09		4adf4439-3d60-44ac-a6f0-9f42cc081a93		TCGA-AO-A12D-01A-11D-A111-01	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11R-A115-07	4adf4439-3d60-44ac-a6f0-9f42cc081a93	TCGA-AO-A12D-01A-11D-A111-01	TCGA-AO-A12D-01
TCGA-AO-A12E-01	Stage IIB	51	3	Stage IIB	1742		Positive	FEMALE	Negative	4	3	3	Negative	M0	Negative	N0	1742	0	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-AO-A12E-01	2142	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AO-A12E	2142	0	days	2142	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-AO-A12E-F19431	TCGA-AO-A12E	TCGA-AO-A12E-01A		Positive		2+			Positive	Modified Radical Mastectomy		YES			-18721	1822		0	2142							80-89%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	630	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	1								NO	0	1	true	No	M0	N0 (i+)	T3	Stage IIB	TCGA-AO-A12E.332675C9-53CB-4244-8480-82E1546DA7F2.pdf	A12E	TUMOR FREE								40-49%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	222c7e4d-f6ed-4db0-ba36-1670159cee1b	ecb453b9-9594-424f-9a73-be8f90737a6a	222c7e4d-f6ed-4db0-ba36-1670159cee1b	ecb453b9-9594-424f-9a73-be8f90737a6a	TCGA-AO-A12E-01A-21-A13E-20	TCGA-AO-A12E-01A-11D-A10M-09		TCGA-AO-A12E-01	TCGA-AO-A12E-01A-11D-A10N-05		b6ec964a-db35-4120-aaaf-f3018a330490	TCGA-AO-A12E-01	TCGA-AO-A12E-01A-11D-A10M-09		TCGA-AO-A12E-01		TCGA-AO-A12E-01A-11D-A10M-09	TCGA-AO-A12E-01	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01	TCGA-AO-A12E-01A-11D-A10L-01		TCGA-AO-A12E-01A-11R-A10J-07	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01A-11D-A10L-01	TCGA-AO-A12E-01
TCGA-AO-A12F-01	Stage IIA	36	1	Stage IIA	1471		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1471	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A12F-01	1842	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A12F	1842	0	days	1842	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12F-F19434	TCGA-AO-A12F	TCGA-AO-A12F-01A		Negative					Negative	Simple Mastectomy		YES			-13409	1578		0	1842							<10%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51.pdf	A12F	TUMOR FREE								<10%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2006	05610046-ec77-4592-892a-464a81d55c45	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	05610046-ec77-4592-892a-464a81d55c45	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	TCGA-AO-A12F-01A-21-A13D-20	TCGA-AO-A12F-01A-11D-A10Y-09		TCGA-AO-A12F-01			8f64c41b-17ee-40d2-98d6-4c483e5d5384	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11D-A10Y-09	TCGA-AO-A12F-01A-11D-A112-05	TCGA-AO-A12F-01	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11D-A10Y-09		05610046-ec77-4592-892a-464a81d55c45		TCGA-AO-A12F-01A-11D-A111-01	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11R-A115-07	05610046-ec77-4592-892a-464a81d55c45	TCGA-AO-A12F-01A-11D-A111-01	TCGA-AO-A12F-01
TCGA-AO-A12G-01	Stage IIA	75	2	Stage IIA	1265		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	1265	0	LumA	Luminal A	Positive	LumA/B	-1	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A12G-01	1639	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AO-A12G	1639	0	days	1639	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12G-F19448	TCGA-AO-A12G	TCGA-AO-A12G-01A		Positive		2+			Positive	Simple Mastectomy		YES			-27705	1415		0	1639							90-99%	67	Scheduled Follow-up Submission	2011-6-16	FEMALE				>=2.0 Positive	2+	23	66	1.0		Other, specify		No		C50.9	8022/3	C50.9	4+	YES		Core needle biopsy	280	NO	Positive	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0	1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F.pdf	A12G	TUMOR FREE								30-39%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2006	348a0fd6-eb6b-4550-a26a-3896c4963b3a	4a2c3e4c-941a-4d08-9d30-386ac70cd657	348a0fd6-eb6b-4550-a26a-3896c4963b3a	4a2c3e4c-941a-4d08-9d30-386ac70cd657	TCGA-AO-A12G-01A-21-A13D-20	TCGA-AO-A12G-01A-11D-A10M-09		TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11D-A10N-05		e5214399-e1f0-42f1-be38-366c47e438fa	TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11D-A10M-09		TCGA-AO-A12G-01		TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01	TCGA-AO-A12G-01A-11D-A10L-01		TCGA-AO-A12G-01A-11R-A10J-07	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-11D-A10L-01	TCGA-AO-A12G-01
TCGA-AO-A12H-01	Stage IIA	69	1	Stage IIA	862		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	862	0	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A12H-01	1234	0	days	Quiet	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 2	mutation cluster 4	TCGA-AO-A12H	1234	0	days	1234	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-AO-A12H-F19451	TCGA-AO-A12H	TCGA-AO-A12H-01A		Positive		2+			Positive	Simple Mastectomy		YES			-25515	1017		0	1234							90-99%		Scheduled Follow-up Submission	2011-12-12	FEMALE		3+ Positive	<10%		0					Other, specify		No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	290	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	2								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B.pdf	A12H	TUMOR FREE								<10%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2008	71b58051-3bf8-4dfb-a431-c8aceab7c799	099a5aae-f24a-47e6-b40d-a0db5c009c27	71b58051-3bf8-4dfb-a431-c8aceab7c799	099a5aae-f24a-47e6-b40d-a0db5c009c27	TCGA-AO-A12H-01A-21-A13D-20	TCGA-AO-A12H-01A-11D-A10Y-09		TCGA-AO-A12H-01			6988badd-172f-4880-9ad6-75f7896112bb	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11D-A10Y-09	TCGA-AO-A12H-01A-11D-A112-05	TCGA-AO-A12H-01	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11D-A10Y-09		71b58051-3bf8-4dfb-a431-c8aceab7c799		TCGA-AO-A12H-01A-11D-A111-01	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11R-A115-07	71b58051-3bf8-4dfb-a431-c8aceab7c799	TCGA-AO-A12H-01A-11D-A111-01	TCGA-AO-A12H-01
TCGA-AO-A1KO-01	Stage IIB	46	1	Stage IIB	448		Positive	FEMALE	Negative				Negative	M0	Negative	N0	448	0	Normal		Positive				followup	T_Other	T3	LIVING	0	TCGA-AO-A1KO-01	622	0	days	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-AO-A1KO	622	0	days	622	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A1KO-F20630	TCGA-AO-A1KO	TCGA-AO-A1KO-01A		Positive	4 Point Scale	4+	4 Point Scale		Positive	Simple Mastectomy		YES			-16817	832		0	622					NO		90-99%		Scheduled Follow-up Submission	2012-2-20	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Excisional Biopsy	580	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	6								NO	0	1	true	No	M0	N0 (i+)	T3	Stage IIB	TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf	A1KO	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2008	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	5152cac8-5c7e-419c-a4da-46a1607db2e8	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	5152cac8-5c7e-419c-a4da-46a1607db2e8	TCGA-AO-A1KO-01A-41-A17I-20	TCGA-AO-A1KO-01A-31D-A188-09		TCGA-AO-A1KO-01	TCGA-AO-A1KO-01A-31D-A13K-05		a17c27f3-818b-4fbb-aa5d-ab86494f4456	TCGA-AO-A1KO-01	TCGA-AO-A1KO-01A-31D-A188-09			TCGA-AO-A1KO-01	TCGA-AO-A1KO-01A-31D-A188-09		62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34		TCGA-AO-A1KO-01A-31D-A13J-01	TCGA-AO-A1KO-01		62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	TCGA-AO-A1KO-01A-31D-A13J-01	
TCGA-AO-A1KP-01	Stage IIA	77	2	Stage IIA	2513		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2513	0	LumB		Positive				followup	T1	T1	LIVING	0	TCGA-AO-A1KP-01	2953	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-AO-A1KP	2953	0	days	2953	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A1KP-F21774	TCGA-AO-A1KP	TCGA-AO-A1KP-01A		Positive	4 Point Scale	4+	4 Point Scale		Positive	Simple Mastectomy		YES			-28247	2604		0	2953					NO		80-89%		Scheduled Follow-up Submission	2012-2-20	FEMALE			<10%	>=2.0 Positive	1+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	360	NO	Negative	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0	1	true	No	M0	N1	T1	Stage IIA	TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf	A1KP	TUMOR FREE							YES	40-49%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2003	773a2357-99b8-40df-b657-f237d9735db9	a22ae2e3-fd36-4ec5-a76d-a34a3961060b	773a2357-99b8-40df-b657-f237d9735db9	a22ae2e3-fd36-4ec5-a76d-a34a3961060b	TCGA-AO-A1KP-01A-21-A17I-20	TCGA-AO-A1KP-01A-11D-A13L-09		TCGA-AO-A1KP-01	TCGA-AO-A1KP-01A-11D-A13K-05		a69b3e33-9fa5-47f1-931d-d100136d9d80	TCGA-AO-A1KP-01	TCGA-AO-A1KP-01A-11D-A13L-09			TCGA-AO-A1KP-01	TCGA-AO-A1KP-01A-11D-A13L-09		773a2357-99b8-40df-b657-f237d9735db9		TCGA-AO-A1KP-01A-11D-A13J-01	TCGA-AO-A1KP-01		773a2357-99b8-40df-b657-f237d9735db9	TCGA-AO-A1KP-01A-11D-A13J-01	
TCGA-AO-A1KQ-01	Stage IIIB	84	4	Stage IIIB	1519		Positive	MALE	Negative				Negative	M0	Positive	N1	1519	0	LumB		Positive				followup	T_Other	T4	LIVING	0	TCGA-AO-A1KQ-01	1882	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-AO-A1KQ	1882	0	days	1882	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AO-A1KQ-F21775	TCGA-AO-A1KQ	TCGA-AO-A1KQ-01A		Positive	4 Point Scale	3+	4 Point Scale		Positive	Modified Radical Mastectomy		NO			-30859	1553		0	1882					NO		90-99%		Scheduled Follow-up Submission	2012-2-20	MALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	540	NO	Negative			9	Negative																					2	4								NO	2	0	true	No	M0	N1	T4	Stage IIIB	TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf	A1KQ	TUMOR FREE							YES	80-89%		NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2006	204a78d9-67aa-4e49-b285-bbb25c6ed142	ebc2cde9-7556-4c6d-94d4-b61e14efb0f3	204a78d9-67aa-4e49-b285-bbb25c6ed142	ebc2cde9-7556-4c6d-94d4-b61e14efb0f3	TCGA-AO-A1KQ-01A-21-A17I-20			TCGA-AO-A1KQ-01	TCGA-AO-A1KQ-01A-11D-A13K-05		ccdaef5f-d816-426d-8e4f-b1bc561a11c5	TCGA-AO-A1KQ-01				TCGA-AO-A1KQ-01			204a78d9-67aa-4e49-b285-bbb25c6ed142		TCGA-AO-A1KQ-01A-11D-A13J-01	TCGA-AO-A1KQ-01		204a78d9-67aa-4e49-b285-bbb25c6ed142	TCGA-AO-A1KQ-01A-11D-A13J-01	
TCGA-AO-A1KR-01		51	1		2140		Negative	FEMALE									2140	0	Basal		Negative				enrollment			LIVING	0	TCGA-AO-A1KR-01	2513	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A1KR	2513	0	days	2513	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-AO-A1KR-F21768	TCGA-AO-A1KR	TCGA-AO-A1KR-01A		Negative	4 Point Scale		3 Point Scale		Negative	Simple Mastectomy		YES			-18900	1932		0	2513					NO				Scheduled Follow-up Submission	2013-5-21	FEMALE					1+		1			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf	A1KR	TUMOR FREE							YES			NO	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2005	6d22f538-114f-48b6-94ba-fb60151ed567	0d7cde44-ec86-415a-8667-0ea894d1c344	6d22f538-114f-48b6-94ba-fb60151ed567	0d7cde44-ec86-415a-8667-0ea894d1c344	TCGA-AO-A1KR-01A-21-A17I-20	TCGA-AO-A1KR-01A-12D-A142-09		TCGA-AO-A1KR-01	TCGA-AO-A1KR-01A-12D-A145-05		209b9ca9-04fe-441d-915a-b8f4ef9e4b74	TCGA-AO-A1KR-01	TCGA-AO-A1KR-01A-12D-A142-09			TCGA-AO-A1KR-01	TCGA-AO-A1KR-01A-12D-A142-09		6d22f538-114f-48b6-94ba-fb60151ed567		TCGA-AO-A1KR-01A-12D-A141-01	TCGA-AO-A1KR-01		6d22f538-114f-48b6-94ba-fb60151ed567	TCGA-AO-A1KR-01A-12D-A141-01	
TCGA-AO-A1KS-01	Stage IIA	69	5	Stage IIA	16		Positive	FEMALE	Negative				Negative	M0	Negative	N0	16	0	LumB		Positive				followup	T_Other	T2	LIVING	0	TCGA-AO-A1KS-01	350	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A1KS	350	0	days	350	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A1KS-F21777	TCGA-AO-A1KS	TCGA-AO-A1KS-01A		Positive	4 Point Scale	2+	4 Point Scale		Positive	Lumpectomy		YES			-25230	147		0	350					NO		90-99%	3.2	Scheduled Follow-up Submission	2012-2-20	FEMALE			10-19%	Positive >2.2	2+	40	3.2	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	420	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf	A1KS	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	AO	Breast	A	LIVING	2010	9eab0553-20cc-41bb-bcdb-9ade0578da82	4f393818-bf59-495d-85cf-6ddf1571e717	9eab0553-20cc-41bb-bcdb-9ade0578da82	4f393818-bf59-495d-85cf-6ddf1571e717	TCGA-AO-A1KS-01A-21-A17I-20	TCGA-AO-A1KS-01A-11D-A13L-09		TCGA-AO-A1KS-01	TCGA-AO-A1KS-01A-11D-A13K-05		6022e4a0-4bd2-4d51-ac93-56f6b54dfa39	TCGA-AO-A1KS-01	TCGA-AO-A1KS-01A-11D-A13L-09			TCGA-AO-A1KS-01	TCGA-AO-A1KS-01A-11D-A13L-09		9eab0553-20cc-41bb-bcdb-9ade0578da82		TCGA-AO-A1KS-01A-11D-A13J-01	TCGA-AO-A1KS-01		9eab0553-20cc-41bb-bcdb-9ade0578da82	TCGA-AO-A1KS-01A-11D-A13J-01	
TCGA-AO-A1KT-01	Stage IIA	78	2	Stage IIA	541		Positive	FEMALE	Negative				Negative	M0	Positive	N1	541	0	LumB		Positive				followup	T1	T1	LIVING	0	TCGA-AO-A1KT-01	541	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A1KT			days	541	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-AO-A1KT-F9905	TCGA-AO-A1KT	TCGA-AO-A1KT-01A		Positive	4 Point Scale	4+	4 Point Scale		Positive	Lumpectomy		YES			-28660	617		0	541					NO		90-99%	1.7		2011-4-1	FEMALE			10-19%	>2.2 Positive	2+	40	2.4	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	200	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4									1	1	true	[Discrepancy]	M0	N1	T1	Stage IIA	TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf	A1KT	TUMOR FREE							YES	40-49%		YES	Primary Tumor	01		6th	YES	NO	YES	AO	Breast	A	LIVING	2009	82140d3a-0787-4e1e-993d-1b222c073cf8	b93dd87f-11db-4cd2-8051-32251eace393	82140d3a-0787-4e1e-993d-1b222c073cf8	b93dd87f-11db-4cd2-8051-32251eace393	TCGA-AO-A1KT-01A-21-A17I-20	TCGA-AO-A1KT-01A-11D-A13L-09		TCGA-AO-A1KT-01	TCGA-AO-A1KT-01A-11D-A13K-05		c440c6d0-6b35-4764-be41-cd4ca2d3c713	TCGA-AO-A1KT-01	TCGA-AO-A1KT-01A-11D-A13L-09			TCGA-AO-A1KT-01	TCGA-AO-A1KT-01A-11D-A13L-09		82140d3a-0787-4e1e-993d-1b222c073cf8		TCGA-AO-A1KT-01A-11D-A13J-01	TCGA-AO-A1KT-01		82140d3a-0787-4e1e-993d-1b222c073cf8	TCGA-AO-A1KT-01A-11D-A13J-01	
TCGA-AQ-A04H-01	Stage IIIA	61	5	No_Conversion	439		Positive	FEMALE	Positive						Positive	N2	439	0	LumB	Luminal B	Positive		-10	-3	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04H-01	754	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 5	TCGA-AQ-A04H	754	0	days	754	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-AQ-A04H-F35322	TCGA-AQ-A04H	TCGA-AQ-A04H-01B		Positive					Positive	Modified Radical Mastectomy		NO			-22539	365		0	754							90-99%			2012-9-24	FEMALE					2+	30		3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Indeterminate	Positive	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	7								NO	4		false	No	MX	N2a	T2	Stage IIIA	TCGA-AQ-A04H.D40D0424-E1DA-4AEF-AD00-126038E80218.pdf	A04H	TUMOR FREE				>10%	>10%	YES		20-29%		YES	Primary Tumor	01		6th	YES	NO	YES	AQ	Breast	B	LIVING	2009	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	965e2ec0-0a64-4ad1-a201-97cdf65dcb39	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	965e2ec0-0a64-4ad1-a201-97cdf65dcb39		TCGA-AQ-A04H-01B-11D-A10M-09		TCGA-AQ-A04H-01	TCGA-AQ-A04H-01B-11D-A10N-05			TCGA-AQ-A04H-01	TCGA-AQ-A04H-01B-11D-A10M-09		TCGA-AQ-A04H-01		TCGA-AQ-A04H-01B-11D-A10M-09	TCGA-AQ-A04H-01	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01	TCGA-AQ-A04H-01B-11D-A10L-01		TCGA-AQ-A04H-01B-11R-A10J-07	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01B-11D-A10L-01	TCGA-AQ-A04H-01
TCGA-AQ-A04J-01	Stage IIA	45	1	Stage IIA	499		Negative	FEMALE	Negative				Negative	M0	Negative	N0	499	0	Basal	Basal-like	Negative		-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04J-01	819	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AQ-A04J	819	0	days	819	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AQ-A04J-F21740	TCGA-AQ-A04J	TCGA-AQ-A04J-01A		Negative		0			Negative	Simple Mastectomy		NO			-16615	118		0	819							<10%		Scheduled Follow-up Submission	2012-2-20	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	160	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0	0	false	No	M0	N0 (i+)	T2	Stage IIA	TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf	A04J	TUMOR FREE								<10%		NO	Primary Tumor	01			YES	NO	YES	AQ	Breast	A	LIVING	2009	97168a1f-abf8-414b-af10-b63f5daa7023	57b92480-0f4d-436d-b6f0-1d01a2d6ce21	97168a1f-abf8-414b-af10-b63f5daa7023	57b92480-0f4d-436d-b6f0-1d01a2d6ce21		TCGA-AQ-A04J-01A-02W-A050-09		TCGA-AQ-A04J-01				TCGA-AQ-A04J-01	TCGA-AQ-A04J-01A-02W-A050-09	TCGA-AQ-A04J-01A-02D-A032-05	TCGA-AQ-A04J-01		TCGA-AQ-A04J-01A-02W-A050-09	TCGA-AQ-A04J-01	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA-AQ-A04J-01	TCGA-AQ-A04J-01A-02D-A036-01		TCGA-AQ-A04J-01A-02R-A034-07	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA-AQ-A04J-01A-02D-A036-01	TCGA-AQ-A04J-01
TCGA-AQ-A04L-01	Stage IIA	48	1	Stage IIA	3344		Positive	FEMALE	Positive	2	2	2	Negative	M0	Negative	N0	3344	0	LumA	Luminal A	Negative	ReacI	-1	-5	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04L-01	3957	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 13	TCGA-AQ-A04L	3957	0	days	3957	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right	Sentinel node biopsy alone		TCGA-AQ-A04L-F35324	TCGA-AQ-A04L	TCGA-AQ-A04L-01B		Positive					Negative	Modified Radical Mastectomy		NO			-17759	3403		0	3957							60-69%			2012-9-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Fine needle aspiration biopsy	160	NO	Positive		NO	2	Negative	Peri (6-12 months since last menstrual period)																				3	3								NO	0		false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-AQ-A04L.40B58A7A-2A05-4AAF-B1D4-B418E4A56115.pdf	A04L	TUMOR FREE						YES				NO	Primary Tumor	01		5th	YES	NO	YES	AQ	Breast	B	LIVING	2001	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	f77f1d25-be2a-4a1e-a262-f01482406c10	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	f77f1d25-be2a-4a1e-a262-f01482406c10	TCGA-AQ-A04L-01B-11-A13D-20	TCGA-AQ-A04L-01B-21D-A10M-09		TCGA-AQ-A04L-01	TCGA-AQ-A04L-01B-21D-A10N-05		16b9cd57-86e9-4409-8ad3-02d5a4540f0f	TCGA-AQ-A04L-01	TCGA-AQ-A04L-01B-21D-A10M-09		TCGA-AQ-A04L-01		TCGA-AQ-A04L-01B-21D-A10M-09	TCGA-AQ-A04L-01	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01	TCGA-AQ-A04L-01B-21D-A10L-01		TCGA-AQ-A04L-01B-21R-A10J-07	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01B-21D-A10L-01	TCGA-AQ-A04L-01
TCGA-AQ-A0Y5-01	Stage IIIA	70	3	Stage IIIA		161	Positive	FEMALE	Positive				Negative	M0	Positive	N2	161	1	LumA		Positive				followup	T_Other	T2	DECEASED	1	TCGA-AQ-A0Y5-01	172	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AQ-A0Y5			days	172	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A0Y5-F10119	TCGA-AQ-A0Y5	TCGA-AQ-A0Y5-01A		Positive					Positive	Modified Radical Mastectomy		NO			-25793	212	172	0						NO		70-79%			2011-4-7	FEMALE					2+			3.8		Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Positive	Positive		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									5		false	Yes	MX	N2a	T2	Stage IIIA	TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf	A0Y5	TUMOR FREE							YES	40-49%		NO	Primary Tumor	01		7th	YES	YES	NO	AQ	Breast	A	DECEASED	2010	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	80ffdd30-9845-4ee5-8f68-f272c0b0b1f5	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	80ffdd30-9845-4ee5-8f68-f272c0b0b1f5		TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01	TCGA-AQ-A0Y5-01A-11D-A14N-05			TCGA-AQ-A0Y5-01	TCGA-AQ-A0Y5-01A-11D-A14K-09			TCGA-AQ-A0Y5-01	TCGA-AQ-A0Y5-01A-11D-A14K-09		9bb258a4-dd26-4c43-bd29-04b68ea3c7ca		TCGA-AQ-A0Y5-01A-11D-A14J-01	TCGA-AQ-A0Y5-01		9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	TCGA-AQ-A0Y5-01A-11D-A14J-01	
TCGA-AQ-A1H2-01	Stage IIIA	84	5	Stage IIIA	197		Positive	FEMALE	Positive				Negative	M0	Positive	N2	197	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AQ-A1H2-01	475	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AQ-A1H2	475	0	days	475	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AQ-A1H2-F19896	TCGA-AQ-A1H2	TCGA-AQ-A1H2-01A		Positive					Positive	Modified Radical Mastectomy		NO			-30958	156		0	475					NO		90-99%		Scheduled Follow-up Submission	2012-1-3	FEMALE					2+			2.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Indeterminate	Positive		19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO	13		false	No	MX	N2a	T2	Stage IIIA	TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf	A1H2	TUMOR FREE							YES	10-19%		YES	Primary Tumor	01		7th	YES	YES	NO	AQ	Breast	A	LIVING	2010	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	fd45dc6f-bce7-4005-b1e7-be2b2b7dbbca	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	fd45dc6f-bce7-4005-b1e7-be2b2b7dbbca	TCGA-AQ-A1H2-01A-21-A17I-20	TCGA-AQ-A1H2-01A-11D-A13L-09		TCGA-AQ-A1H2-01	TCGA-AQ-A1H2-01A-11D-A13K-05		8191dc7a-6508-44aa-beb6-397c035c8052	TCGA-AQ-A1H2-01	TCGA-AQ-A1H2-01A-11D-A13L-09			TCGA-AQ-A1H2-01	TCGA-AQ-A1H2-01A-11D-A13L-09		8b954cec-cf3e-4b0d-a4e8-cfbc9575a732		TCGA-AQ-A1H2-01A-11D-A13J-01	TCGA-AQ-A1H2-01		8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	TCGA-AQ-A1H2-01A-11D-A13J-01	
TCGA-AQ-A1H3-01	Stage IIIC	49	2	Stage IIIC	138		Positive	FEMALE	Negative				Negative	M0	Positive	N3	138	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AQ-A1H3-01	989	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5	cluster 6	mutation c1uster 9	TCGA-AQ-A1H3	989	0	days	989	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A1H3-F50661	TCGA-AQ-A1H3	TCGA-AQ-A1H3-01A		Positive					Positive	Modified Radical Mastectomy		NO			-18177	94		0	989					NO		90-99%		Scheduled Follow-up Submission	2013-10-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6								NO	14		false	No	MX	N3a	T2	Stage IIIC	TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf	A1H3	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		7th	YES	YES	NO	AQ	Breast	A	LIVING	2010	554df3b0-e305-4dab-a268-47ad7c1dcffc	3ca91d58-5838-480a-8708-61a9a6b40447	554df3b0-e305-4dab-a268-47ad7c1dcffc	3ca91d58-5838-480a-8708-61a9a6b40447	TCGA-AQ-A1H3-01A-41-A17I-20	TCGA-AQ-A1H3-01A-31D-A13L-09		TCGA-AQ-A1H3-01	TCGA-AQ-A1H3-01A-31D-A13K-05		ba38e345-7c27-4ab0-a8e9-57b727fec06c	TCGA-AQ-A1H3-01	TCGA-AQ-A1H3-01A-31D-A13L-09			TCGA-AQ-A1H3-01	TCGA-AQ-A1H3-01A-31D-A13L-09		554df3b0-e305-4dab-a268-47ad7c1dcffc		TCGA-AQ-A1H3-01A-31D-A13J-01	TCGA-AQ-A1H3-01		554df3b0-e305-4dab-a268-47ad7c1dcffc	TCGA-AQ-A1H3-01A-31D-A13J-01	
TCGA-AQ-A54N-01																													0	TCGA-AQ-A54N-01	78	0	days										TCGA-AQ-A54N	78	0	days	78	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-AQ-A54N-F55736	TCGA-AQ-A54N	TCGA-AQ-A54N-01A		Negative					Negative	Lumpectomy		YES			-18741	639		0	78										2014-1-14	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative	YES	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	Yes	M0	N0	T2	Stage IIA	TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf	A54N	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	AQ	Breast	A	LIVING	2011	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	1ba42f73-8bc1-44c5-87ca-251e2691764d	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	1ba42f73-8bc1-44c5-87ca-251e2691764d				TCGA-AQ-A54N-01	TCGA-AQ-A54N-01A-11D-A268-05		3b93ce2c-bc79-48ef-910d-9d1e7c070008	TCGA-AQ-A54N-01	TCGA-AQ-A54N-01A-11D-A25Q-09			TCGA-AQ-A54N-01			ed3e6c57-a0ec-4441-a1a1-794f3f15e112		TCGA-AQ-A54N-01A-11D-A25N-01	TCGA-AQ-A54N-01		ed3e6c57-a0ec-4441-a1a1-794f3f15e112	TCGA-AQ-A54N-01A-11D-A25N-01	
TCGA-AQ-A54O-01																													0	TCGA-AQ-A54O-01	1001	0	days										TCGA-AQ-A54O	1001	0	days	1001	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A54O-F55731	TCGA-AQ-A54O	TCGA-AQ-A54O-01A		Positive					Positive	Simple Mastectomy		YES			-18694	617		0	1001							90-99%			2014-1-14	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	360	NO	Negative		NO	14	Negative																														NO	0	0	false	Yes	M0	N0	T2	Stage IIA	TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf	A54O	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	01		7th		YES	NO	AQ	Breast	A	LIVING	2011	3c1b6647-26bb-4110-aaea-f542024e8bf3	f9396883-7828-4aaf-b487-9deec4e199fb	3c1b6647-26bb-4110-aaea-f542024e8bf3	f9396883-7828-4aaf-b487-9deec4e199fb				TCGA-AQ-A54O-01	TCGA-AQ-A54O-01A-11D-A268-05		e546ea71-dcab-49bf-b972-d6b6dbe57b8f	TCGA-AQ-A54O-01	TCGA-AQ-A54O-01A-11D-A25Q-09			TCGA-AQ-A54O-01			3c1b6647-26bb-4110-aaea-f542024e8bf3		TCGA-AQ-A54O-01A-11D-A25N-01	TCGA-AQ-A54O-01		3c1b6647-26bb-4110-aaea-f542024e8bf3	TCGA-AQ-A54O-01A-11D-A25N-01	
TCGA-AQ-A7U7-01																													1	TCGA-AQ-A7U7-01	584	1	days										TCGA-AQ-A7U7	584	0	days	584	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AQ-A7U7-F68763	TCGA-AQ-A7U7	TCGA-AQ-A7U7-01A		Positive					Positive	Other		YES			-20239	223	584	0	304							80-89%			2014-12-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy		NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	4	0	false	Yes	M0	N2a	T2	Stage IIIA	TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf	A7U7	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01	L Total Mastectomy	7th		YES	NO	AQ	Breast	A	DECEASED	2013	0f3672e4-ab71-4cb6-9d46-3ae57b58e249	8b2ac658-78b4-40dc-8151-fb5296ecc828	0f3672e4-ab71-4cb6-9d46-3ae57b58e249	8b2ac658-78b4-40dc-8151-fb5296ecc828				TCGA-AQ-A7U7-01	TCGA-AQ-A7U7-01A-22D-A357-05		3956ACBB-F98A-4510-95FF-E9A7FFF1AEF7	TCGA-AQ-A7U7-01				TCGA-AQ-A7U7-01			0f3672e4-ab71-4cb6-9d46-3ae57b58e249		TCGA-AQ-A7U7-01A-22D-A350-01	TCGA-AQ-A7U7-01		0f3672e4-ab71-4cb6-9d46-3ae57b58e249	TCGA-AQ-A7U7-01A-22D-A350-01	
TCGA-AR-A0TP-01	Stage II	43	1	No_Conversion	2392		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	2392	0	Basal	Basal-like	Negative	Basal	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TP-01	4275	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A0TP	4275	0	days	4275	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TP-F71715	TCGA-AR-A0TP	TCGA-AR-A0TP-01A		Positive					Negative	Other		YES			-15812	2512		0	4275							<10%		Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	650	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0TP.E1A92F92-1DD2-4E33-9C16-3FD0371D1431.pdf	A0TP	TUMOR FREE						YES				YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2003	f9739b94-ac64-40d5-bfdd-041a412976c4	17e54aa6-f5d6-437a-8345-d40805c86430	f9739b94-ac64-40d5-bfdd-041a412976c4	17e54aa6-f5d6-437a-8345-d40805c86430	TCGA-AR-A0TP-01A-21-A13C-20	TCGA-AR-A0TP-01A-11D-A099-09		TCGA-AR-A0TP-01	TCGA-AR-A0TP-01A-11D-A10P-05		c8173431-25a0-4853-a0ca-7df5c5cf40e8	TCGA-AR-A0TP-01			TCGA-AR-A0TP-01		TCGA-AR-A0TP-01A-11D-A099-09	TCGA-AR-A0TP-01	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01	TCGA-AR-A0TP-01A-11D-A087-01		TCGA-AR-A0TP-01A-11R-A084-07	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01A-11D-A087-01	TCGA-AR-A0TP-01
TCGA-AR-A0TQ-01	Stage III	27	3	No_Conversion	1500		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N1	1500	0	LumB	Luminal B	Negative	Her2	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A0TQ-01	2991	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AR-A0TQ	2991	0	days	2991	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					27	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AR-A0TQ-F71717	TCGA-AR-A0TQ	TCGA-AR-A0TQ-01A		Positive					Negative	Simple Mastectomy		NO			-9873	1512		0	2991							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Equivocal	Positive	NO	15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	2		true	No	M0	N1	T3	Stage IIIA	TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E.pdf	A0TQ	TUMOR FREE						YES				YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	5d48d86f-703e-4390-a86f-c48426aa290f	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	5d48d86f-703e-4390-a86f-c48426aa290f	TCGA-AR-A0TQ-01A-21-A13C-20	TCGA-AR-A0TQ-01A-11D-A099-09		TCGA-AR-A0TQ-01	TCGA-AR-A0TQ-01A-11D-A10P-05		e214f5bd-2ee3-4f27-b1e4-2895df122c9f	TCGA-AR-A0TQ-01			TCGA-AR-A0TQ-01		TCGA-AR-A0TQ-01A-11D-A099-09	TCGA-AR-A0TQ-01	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01	TCGA-AR-A0TQ-01A-11D-A087-01		TCGA-AR-A0TQ-01A-11R-A084-07	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01A-11D-A087-01	TCGA-AR-A0TQ-01
TCGA-AR-A0TR-01	Stage II	68	1	No_Conversion	21	160	Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	160	1	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0TR-01	160	1	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 7	mutation cluster 4	TCGA-AR-A0TR	160	0	days	160	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TR-F18771	TCGA-AR-A0TR	TCGA-AR-A0TR-01A		Positive					Positive	Modified Radical Mastectomy		NO			-25190	1535	160	0										Scheduled Follow-up Submission	2011-12-12	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy not specified	Other method, specify:	520	NO	Equivocal	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF.pdf	A0TR											NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2006	b31bf328-6ead-4ee4-b8c7-4407372dc683	0d98d3ff-375a-4f82-ba8e-734a8a8fc17e	b31bf328-6ead-4ee4-b8c7-4407372dc683	0d98d3ff-375a-4f82-ba8e-734a8a8fc17e	TCGA-AR-A0TR-01A-21-A13C-20	TCGA-AR-A0TR-01A-11D-A099-09		TCGA-AR-A0TR-01	TCGA-AR-A0TR-01A-11D-A10P-05		64d25a8c-e5fc-42f2-8d71-7cf2afb1d9ff	TCGA-AR-A0TR-01			TCGA-AR-A0TR-01		TCGA-AR-A0TR-01A-11D-A099-09	TCGA-AR-A0TR-01	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01	TCGA-AR-A0TR-01A-11D-A087-01		TCGA-AR-A0TR-01A-11R-A084-07	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01A-11D-A087-01	TCGA-AR-A0TR-01
TCGA-AR-A0TS-01	Stage II	46	4	No_Conversion	1138		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1138	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TS-01	2558	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 5	mutation cluster 5	TCGA-AR-A0TS	2558	0	days	2558	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TS-F71730	TCGA-AR-A0TS	TCGA-AR-A0TS-01A		Negative		0			Negative	Lumpectomy		YES			-17141	1549		0	2558									Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative		NO	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5								NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf	A0TS	TUMOR FREE						YES				YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	3e57b40c-7079-4f05-bf37-f560304966c1	51577886-4016-4714-8b35-c7a61a85baa2	3e57b40c-7079-4f05-bf37-f560304966c1	51577886-4016-4714-8b35-c7a61a85baa2	TCGA-AR-A0TS-01A-21-A13C-20	TCGA-AR-A0TS-01A-11D-A10Y-09		TCGA-AR-A0TS-01			3dd4ebe5-1445-46c9-8815-f9a3dc659585	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11D-A10Y-09	TCGA-AR-A0TS-01A-11D-A112-05	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11D-A10Y-09		3e57b40c-7079-4f05-bf37-f560304966c1		TCGA-AR-A0TS-01A-11D-A111-01	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11R-A115-07	3e57b40c-7079-4f05-bf37-f560304966c1	TCGA-AR-A0TS-01A-11D-A111-01	TCGA-AR-A0TS-01
TCGA-AR-A0TT-01	Stage III	53	3	No_Conversion	1679		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N2	1679	0	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TT-01	3316	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A0TT	3316	0	days	3316	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TT-F71737	TCGA-AR-A0TT	TCGA-AR-A0TT-01A		Positive		0			Negative	Other					-19679	1567		0	3316							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative		NO	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	5		true	No	M0	N2	T2	Stage IIIA	TCGA-AR-A0TT.E9231B33-E1CE-4396-9F9E-03DBF049919A.pdf	A0TT	TUMOR FREE						YES				YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	2b2697ab-f5e8-476f-b043-62ecdf1ca8b0	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	2b2697ab-f5e8-476f-b043-62ecdf1ca8b0	TCGA-AR-A0TT-01A-21-A13C-20	TCGA-AR-A0TT-01A-31D-A099-09		TCGA-AR-A0TT-01	TCGA-AR-A0TT-01A-31D-A10P-05		5f13706f-5c4d-421f-9b16-eaeec34f283b	TCGA-AR-A0TT-01			TCGA-AR-A0TT-01		TCGA-AR-A0TT-01A-31D-A099-09	TCGA-AR-A0TT-01	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01	TCGA-AR-A0TT-01A-31D-A087-01		TCGA-AR-A0TT-01A-31R-A084-07	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01A-31D-A087-01	TCGA-AR-A0TT-01
TCGA-AR-A0TU-01	Stage II	35	4	No_Conversion	360		Negative	FEMALE	Negative				Negative	M0	Negative	N0	360	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TU-01	709	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-AR-A0TU	709	0	days	709	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TU-F71735	TCGA-AR-A0TU	TCGA-AR-A0TU-01A		Negative		0			Negative	Simple Mastectomy		YES			-13039	1633		0	709									Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	830	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5									NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3.pdf	A0TU	TUMOR FREE						YES				NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	2877059f-b560-413b-b8be-40d9fde8fbcf		2877059f-b560-413b-b8be-40d9fde8fbcf		TCGA-AR-A0TU-01A-21-A13C-20	TCGA-AR-A0TU-01A-31D-A10G-09		TCGA-AR-A0TU-01	TCGA-AR-A0TU-01A-31D-A10A-05		3c72159d-4ac6-4f06-89f5-4e7bc6a4e134		TCGA-AR-A0TU-01A-31D-A10G-09				TCGA-AR-A0TU-01A-31D-A10G-09		2877059f-b560-413b-b8be-40d9fde8fbcf				TCGA-AR-A0TU-01A-31R-A109-07	2877059f-b560-413b-b8be-40d9fde8fbcf		TCGA-AR-A0TU-01
TCGA-AR-A0TV-01	Stage II	66	1	No_Conversion	904		Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	904	0	LumB	Luminal B	Positive	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TV-01	2288	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AR-A0TV	2288	0	days	2288	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TV-F71734	TCGA-AR-A0TV	TCGA-AR-A0TV-01A		Positive					Positive	Simple Mastectomy		YES			-24279	1716		0	2288							90-99%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Equivocal	Negative	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0TV.7594A7F8-1806-4B74-99EF-4E4C889E7BEA.pdf	A0TV	TUMOR FREE						NO				NO	Primary Tumor	01		6th	NO	NO	YES	AR	Breast	A	LIVING	2005	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	5f623237-b478-4bca-8647-d633e9e63d7c	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	5f623237-b478-4bca-8647-d633e9e63d7c	TCGA-AR-A0TV-01A-11-A13D-20	TCGA-AR-A0TV-01A-21D-A099-09		TCGA-AR-A0TV-01	TCGA-AR-A0TV-01A-21D-A10P-05		457d54a9-a2c9-4747-928c-4c428e187548	TCGA-AR-A0TV-01			TCGA-AR-A0TV-01		TCGA-AR-A0TV-01A-21D-A099-09	TCGA-AR-A0TV-01	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01	TCGA-AR-A0TV-01A-21D-A087-01		TCGA-AR-A0TV-01A-21R-A084-07	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01A-21D-A087-01	TCGA-AR-A0TV-01
TCGA-AR-A0TW-01	Stage III	50	4	No_Conversion	739		Positive	FEMALE	Negative				Negative	M0	Positive	N1	739	0	LumA	Luminal A	Positive	Basal	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A0TW-01	3009	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-AR-A0TW	3009	0	days	3009	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Outer Quadrant|Right Lower Outer Quadrant			TCGA-AR-A0TW-F49464	TCGA-AR-A0TW	TCGA-AR-A0TW-01A		Positive					Positive	Modified Radical Mastectomy					-18263	1888		0	3009			739						Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	760	NO	Equivocal	Negative		27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	3		true	No	M0	N1	T3	Stage IIIA	TCGA-AR-A0TW.F832C787-3668-475F-8F67-6342DA3777F4.pdf	A0TW	TUMOR FREE						YES				NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	LIVING	2005	f8fd0762-44b8-41ff-9c1a-ff688497e312	18466ec8-1c12-4047-b792-9693e00fe15b	f8fd0762-44b8-41ff-9c1a-ff688497e312	18466ec8-1c12-4047-b792-9693e00fe15b	TCGA-AR-A0TW-01A-21-A13D-20	TCGA-AR-A0TW-01A-11D-A099-09		TCGA-AR-A0TW-01	TCGA-AR-A0TW-01A-11D-A10P-05		d09f498e-9952-4926-b6e2-56e774b0bdcf	TCGA-AR-A0TW-01			TCGA-AR-A0TW-01		TCGA-AR-A0TW-01A-11D-A099-09		f8fd0762-44b8-41ff-9c1a-ff688497e312		TCGA-AR-A0TW-01A-11D-A087-01		TCGA-AR-A0TW-01A-11R-A084-07	f8fd0762-44b8-41ff-9c1a-ff688497e312	TCGA-AR-A0TW-01A-11D-A087-01	TCGA-AR-A0TW-01
TCGA-AR-A0TX-01	Stage II	64	1	No_Conversion	15		Positive	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	15	0	Her2	HER2-enriched	Positive	ReacII	-11	-5	enrollment	T1	T1	LIVING	0	TCGA-AR-A0TX-01	1972	0	days	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-AR-A0TX	1972	0	days	1972	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-AR-A0TX-F63939	TCGA-AR-A0TX	TCGA-AR-A0TX-01A		Positive					Positive	Other		NO			-23653	1976		0	1972							<10%		Scheduled Follow-up Submission	2014-8-21	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470	NO	Positive		NO	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	1								NO	3		true	No	M0	N1	T1	Stage IIA	TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8.pdf	A0TX	TUMOR FREE										YES	Primary Tumor	01	Wide local excision			NO	YES	AR	Breast	A	LIVING	2005	08d85849-cda7-4709-a934-fdc586418d7f	ffb216a3-2131-42ce-97ba-9a4fb4ad0a69	08d85849-cda7-4709-a934-fdc586418d7f	ffb216a3-2131-42ce-97ba-9a4fb4ad0a69	TCGA-AR-A0TX-01A-21-A13D-20	TCGA-AR-A0TX-01A-11D-A099-09		TCGA-AR-A0TX-01	TCGA-AR-A0TX-01A-11D-A10P-05		82828084-520c-4384-aa18-0d668bfa5ed6	TCGA-AR-A0TX-01	TCGA-AR-A0TX-01A-11D-A099-09		TCGA-AR-A0TX-01		TCGA-AR-A0TX-01A-11D-A099-09	TCGA-AR-A0TX-01	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01	TCGA-AR-A0TX-01A-11D-A087-01		TCGA-AR-A0TX-01A-11R-A084-07	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01A-11D-A087-01	TCGA-AR-A0TX-01
TCGA-AR-A0TY-01	Stage II	54	1	No_Conversion	544	1699	Positive	FEMALE	Negative	1	1	4	Negative	M0	Negative	N0	1699	1	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0TY-01	1699	1	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-AR-A0TY	544	1	days	1699	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0TY-F18561	TCGA-AR-A0TY	TCGA-AR-A0TY-01A		Positive		0			Negative	Simple Mastectomy		YES			-19836	2141	1699	0				544				10-19%		Scheduled Follow-up Submission	2011-12-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)			1+		Positive												Negative			4	4				Bone	Distant Metastasis			YES	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3.pdf	A0TY	WITH TUMOR										NO	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2004	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	1614a21e-1cc6-430a-a5da-c2a15e4542b2	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	1614a21e-1cc6-430a-a5da-c2a15e4542b2	TCGA-AR-A0TY-01A-21-A13D-20	TCGA-AR-A0TY-01A-12W-A12T-09		TCGA-AR-A0TY-01			8a76d3b0-5e1c-48d9-a325-71be8a93a093	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12W-A12T-09	TCGA-AR-A0TY-01A-12D-A112-05	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12W-A12T-09		7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920		TCGA-AR-A0TY-01A-12D-A111-01	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12R-A115-07	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	TCGA-AR-A0TY-01A-12D-A111-01	TCGA-AR-A0TY-01
TCGA-AR-A0TZ-01	Stage III	43	5	No_Conversion	1313		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N2	1313	0	LumA	Luminal B	Positive	ReacII	-10	-3	enrollment	T_Other	T2	LIVING	1	TCGA-AR-A0TZ-01	3262	1	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A0TZ	1313	1	days	3262	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant			TCGA-AR-A0TZ-F49471	TCGA-AR-A0TZ	TCGA-AR-A0TZ-01A		Positive					Positive	Modified Radical Mastectomy					-15720	2239	3262	0	2316			1313						Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Positive	70-79%									<10%		Positive	Bone		3	2				Bone	Distant Metastasis			YES	6		true	No	M1	N2	T2	Stage IIIA	TCGA-AR-A0TZ.48F86416-8304-479E-B477-7C37A2F951A2.pdf	A0TZ							YES				YES	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2004	1d6480da-a470-4726-8bc4-57fa30799a15	0509eaa2-2671-4c59-b98b-200a6132cede	1d6480da-a470-4726-8bc4-57fa30799a15	0509eaa2-2671-4c59-b98b-200a6132cede	TCGA-AR-A0TZ-01A-21-A13D-20	TCGA-AR-A0TZ-01A-12D-A099-09		TCGA-AR-A0TZ-01	TCGA-AR-A0TZ-01A-12D-A10P-05		5afd9456-59f9-44d4-ac7c-b086ef899105	TCGA-AR-A0TZ-01			TCGA-AR-A0TZ-01		TCGA-AR-A0TZ-01A-12D-A099-09	TCGA-AR-A0TZ-01	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01	TCGA-AR-A0TZ-01A-12D-A087-01		TCGA-AR-A0TZ-01A-12R-A084-07	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01A-12D-A087-01	TCGA-AR-A0TZ-01
TCGA-AR-A0U0-01	Stage II	73	1	No_Conversion	8		Negative	FEMALE	Negative				Negative	M0	Positive	N1	8	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U0-01	1988	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 3	TCGA-AR-A0U0	1988	0	days	1988	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U0-F65068	TCGA-AR-A0U0	TCGA-AR-A0U0-01A		Negative		0			Negative	Simple Mastectomy		YES			-26993	2289		0	1988									Scheduled Follow-up Submission	2014-9-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO			NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	0	2	true	No	M0	N1	T2	Stage IIB	TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A.pdf	A0U0	TUMOR FREE										YES	Primary Tumor	01				NO	YES	AR	Breast	A	LIVING	2004	dea20128-b180-4da1-9da5-0f00bea3b1ab	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	dea20128-b180-4da1-9da5-0f00bea3b1ab	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	TCGA-AR-A0U0-01A-21-A13D-20	TCGA-AR-A0U0-01A-11D-A10G-09		TCGA-AR-A0U0-01	TCGA-AR-A0U0-01A-11D-A10A-05		4c67c3c8-cc93-4bb4-a8c6-76232335c00f	TCGA-AR-A0U0-01	TCGA-AR-A0U0-01A-11D-A10G-09		TCGA-AR-A0U0-01		TCGA-AR-A0U0-01A-11D-A10G-09		dea20128-b180-4da1-9da5-0f00bea3b1ab		TCGA-AR-A0U0-01A-11D-A107-01		TCGA-AR-A0U0-01A-11R-A109-07	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA-AR-A0U0-01A-11D-A107-01	TCGA-AR-A0U0-01
TCGA-AR-A0U1-01	Stage II	36	1	No_Conversion	185		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	185	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U1-01	4052	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6		miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-AR-A0U1	4052	0	days	4052	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U1-F71729	TCGA-AR-A0U1	TCGA-AR-A0U1-01A		Negative		0			Negative	Other		NO			-13467	2301		0	4052									Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	300	NO	Negative		NO	31	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	6								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A0U1.007C609A-7874-4E39-BC4D-1EA81F4722EA.pdf	A0U1	TUMOR FREE						YES				YES	Primary Tumor	01	wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2004	3450eaab-777a-46ab-9d13-8e0783c4a686	aee2ca13-3b6a-4459-b42a-b6a3c3496927	3450eaab-777a-46ab-9d13-8e0783c4a686	aee2ca13-3b6a-4459-b42a-b6a3c3496927	TCGA-AR-A0U1-01A-21-A13C-20	TCGA-AR-A0U1-01A-11D-A10Y-09					9b542860-aebc-49d8-a1a3-3f693c8b119a		TCGA-AR-A0U1-01A-11D-A10Y-09	TCGA-AR-A0U1-01A-11D-A112-05			TCGA-AR-A0U1-01A-11D-A10Y-09		3450eaab-777a-46ab-9d13-8e0783c4a686		TCGA-AR-A0U1-01A-11D-A111-01		TCGA-AR-A0U1-01A-11R-A115-07	3450eaab-777a-46ab-9d13-8e0783c4a686	TCGA-AR-A0U1-01A-11D-A111-01	
TCGA-AR-A0U2-01	Stage III	47	5	No_Conversion	1608	2551	Positive	FEMALE	Negative				Negative	M0	Positive	N2	2551	1	LumB	Luminal B	Positive	ReacII	-10	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0U2-01	2551	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A0U2	1609	1	days	2551	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-AR-A0U2-F18483	TCGA-AR-A0U2	TCGA-AR-A0U2-01A	Negative	Positive					Positive	Modified Radical Mastectomy		NO			-17390	2395	2551	0				1609				10-19%		Scheduled Follow-up Submission	2011-12-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	150	NO	Negative			16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	2+		Positive	70-79%			2.47				Negative				Negative	Bone|Liver		2	5				Bone	Distant Metastasis	Liver		YES	4	0	true	No	M0	N2	T2	Stage IIIA	TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F.pdf	A0U2	WITH TUMOR										YES	Primary Tumor	01			YES	NO	YES	AR	Breast	A	DECEASED	2004	45f011a1-cc58-47f8-9545-66c313441650	90cc0bf8-5e04-4c34-bc2d-7d9d3b98569c	45f011a1-cc58-47f8-9545-66c313441650	90cc0bf8-5e04-4c34-bc2d-7d9d3b98569c	TCGA-AR-A0U2-01A-21-A13D-20	TCGA-AR-A0U2-01A-11D-A10G-09		TCGA-AR-A0U2-01	TCGA-AR-A0U2-01A-11D-A10A-05		bb541d0b-a4ba-482a-b4ff-427185e70239	TCGA-AR-A0U2-01	TCGA-AR-A0U2-01A-11D-A10G-09		TCGA-AR-A0U2-01		TCGA-AR-A0U2-01A-11D-A10G-09	TCGA-AR-A0U2-01	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01	TCGA-AR-A0U2-01A-11D-A107-01		TCGA-AR-A0U2-01A-11R-A109-07	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01A-11D-A107-01	TCGA-AR-A0U2-01
TCGA-AR-A0U3-01	Stage II	59	4	No_Conversion	2263		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	2263	0	LumA	Luminal B	Positive	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U3-01	4080	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 5	TCGA-AR-A0U3	4080	0	days	4080	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U3-F71712	TCGA-AR-A0U3			Positive					Positive	Other		NO			-21755			0	4080							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	7								NO	1			No	M0	N1	T2	Stage IIB		A0U3	TUMOR FREE						YES				YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast		LIVING	2004	b36b5a17-972f-442a-84a0-469099a619ec	c64f2c9b-e2e4-4a48-94e8-7f76569c8b7b	b36b5a17-972f-442a-84a0-469099a619ec	c64f2c9b-e2e4-4a48-94e8-7f76569c8b7b	TCGA-AR-A0U3-01A-21-A13C-20	TCGA-AR-A0U3-01A-11D-A10G-09		TCGA-AR-A0U3-01	TCGA-AR-A0U3-01A-11D-A10A-05		c5be7166-dd6f-422d-b420-ee73dc2675f4	TCGA-AR-A0U3-01	TCGA-AR-A0U3-01A-11D-A10G-09		TCGA-AR-A0U3-01		TCGA-AR-A0U3-01A-11D-A10G-09	TCGA-AR-A0U3-01	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01	TCGA-AR-A0U3-01A-11D-A107-01		TCGA-AR-A0U3-01A-11R-A109-07	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01A-11D-A107-01	TCGA-AR-A0U3-01
TCGA-AR-A0U4-01	Stage II	54	1	No_Conversion	1627		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1627	0	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U4-01	3261	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-AR-A0U4	3261	0	days	3261	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A0U4-F71739	TCGA-AR-A0U4	TCGA-AR-A0U4-01A		Negative		0			Negative	Simple Mastectomy		NO			-19729	1517		0	3261									Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A0U4.6424BA69-DA2B-4CCD-ADDF-DB1BEDA11EBF.pdf	A0U4	TUMOR FREE						YES				NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	ee7156b6-f469-402c-8f63-f4c2f6913db1	753d28b1-7ff1-4211-beaf-6966e9ce0d18	ee7156b6-f469-402c-8f63-f4c2f6913db1	753d28b1-7ff1-4211-beaf-6966e9ce0d18	TCGA-AR-A0U4-01A-21-A13D-20	TCGA-AR-A0U4-01A-11D-A117-09		TCGA-AR-A0U4-01	TCGA-AR-A0U4-01A-11D-A10A-05		e4120a7f-41ff-4928-a173-0cb5f7fb8674	TCGA-AR-A0U4-01			TCGA-AR-A0U4-01		TCGA-AR-A0U4-01A-11D-A117-09	TCGA-AR-A0U4-01	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01	TCGA-AR-A0U4-01A-11D-A107-01		TCGA-AR-A0U4-01A-11R-A109-07	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01A-11D-A107-01	TCGA-AR-A0U4-01
TCGA-AR-A1AH-01	Stage II	51	1	Stage IIB	2298		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2298	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AH-01	3807	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AH	3807	0	days	3807	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AH-F69267	TCGA-AR-A1AH	TCGA-AR-A1AH-01A		Positive					Negative	Other					-18991	2368		0	3807			1136				10-19%		Scheduled Follow-up Submission	2014-12-31	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5				Other, specify	New Primary Tumor	Renal		NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf	A1AH	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2004	ff0d7627-cec2-42e7-891b-cba5f42e3272	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	ff0d7627-cec2-42e7-891b-cba5f42e3272	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	TCGA-AR-A1AH-01A-21-A13E-20	TCGA-AR-A1AH-01A-11D-A12B-09		TCGA-AR-A1AH-01			180cde2e-13d3-462d-bba2-ae37bdee0f3f	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11D-A12B-09	TCGA-AR-A1AH-01A-11D-A12E-05	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11D-A12B-09		ff0d7627-cec2-42e7-891b-cba5f42e3272		TCGA-AR-A1AH-01A-11D-A12A-01	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11R-A12D-07	ff0d7627-cec2-42e7-891b-cba5f42e3272	TCGA-AR-A1AH-01A-11D-A12A-01	TCGA-AR-A1AH-01
TCGA-AR-A1AI-01	Stage II	47	1	Stage IIA	1881		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1881	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AI-01	3296	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AI	3296	0	days	3296	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AI-F69268	TCGA-AR-A1AI	TCGA-AR-A1AI-01A		Negative					Negative	Simple Mastectomy		YES			-17229	1939		0	3296			588						Scheduled Follow-up Submission	2014-12-31	FEMALE					2+					Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	1050	NO	Equivocal	Negative	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3				Other, specify	New Primary Tumor	Contralateral Breast		NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf	A1AI	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2005	52ff562f-6a13-435a-acab-16a064633b1d	68564280-daf0-4bbb-9aa0-79493b39231b	52ff562f-6a13-435a-acab-16a064633b1d	68564280-daf0-4bbb-9aa0-79493b39231b	TCGA-AR-A1AI-01A-21-A13E-20	TCGA-AR-A1AI-01A-11D-A12Q-09		TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11D-A12R-05		d872badb-8c24-48fe-b482-6b3c262a4259	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11D-A12Q-09		TCGA-AR-A1AI-01	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11D-A12Q-09		52ff562f-6a13-435a-acab-16a064633b1d		TCGA-AR-A1AI-01A-11D-A12N-01	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11R-A12P-07	52ff562f-6a13-435a-acab-16a064633b1d	TCGA-AR-A1AI-01A-11D-A12N-01	TCGA-AR-A1AI-01
TCGA-AR-A1AJ-01	Stage I	83	3	Stage I	1604		Positive	FEMALE	Negative	1	2	2	Negative	M0	Negative	N0	1604	0	Basal	Basal-like	Negative	ReacI	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AJ-01	3072	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AJ	3072	0	days	3072	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AJ-F69269	TCGA-AR-A1AJ	TCGA-AR-A1AJ-01A		Positive					Negative	Other		YES			-30489	1828		0	3072							10-19%		Scheduled Follow-up Submission	2014-12-31	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf	A1AJ	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Wide local excision	6th	NO	NO	YES	AR	Breast	A	LIVING	2005	98703904-572d-4220-b959-a1293a2e1c33	146bbf8b-4047-4e89-9463-abba54e8d992	98703904-572d-4220-b959-a1293a2e1c33	146bbf8b-4047-4e89-9463-abba54e8d992	TCGA-AR-A1AJ-01A-31-A13E-20	TCGA-AR-A1AJ-01A-21D-A12Q-09		TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21D-A12R-05		26cb824a-251d-4b4c-a00c-19de6d7e2562	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21D-A12Q-09		TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21D-A12Q-09		98703904-572d-4220-b959-a1293a2e1c33		TCGA-AR-A1AJ-01A-21D-A12N-01	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21R-A12P-07	98703904-572d-4220-b959-a1293a2e1c33	TCGA-AR-A1AJ-01A-21D-A12N-01	TCGA-AR-A1AJ-01
TCGA-AR-A1AK-01	Stage I	70	3	Stage I	1558		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	1558	0	LumA	Luminal A	Positive	ReacI	-5	0	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AK-01	3159	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AK	3159	0	days	3159	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AK-F69271	TCGA-AR-A1AK			Positive					Positive	Simple Mastectomy		YES			-25825			0	3159							10-19%		Scheduled Follow-up Submission	2014-12-31	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0			No	M0	N0	T1	Stage I		A1AK	TUMOR FREE						YES	YES	10-19%		NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast		LIVING	2006	a3568fd6-4b6d-4507-9c59-1788834d3a75	a972d2c7-e885-4dfe-b56c-d0468d154419	a3568fd6-4b6d-4507-9c59-1788834d3a75	a972d2c7-e885-4dfe-b56c-d0468d154419	TCGA-AR-A1AK-01A-31-A13E-20	TCGA-AR-A1AK-01A-21D-A12Q-09		TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21D-A12R-05		f0e4daf7-c2e8-40e8-826e-1cb9df14327e	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21D-A12Q-09		TCGA-AR-A1AK-01	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21D-A12Q-09		a3568fd6-4b6d-4507-9c59-1788834d3a75		TCGA-AR-A1AK-01A-21D-A12N-01	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21R-A12P-07	a3568fd6-4b6d-4507-9c59-1788834d3a75	TCGA-AR-A1AK-01A-21D-A12N-01	TCGA-AR-A1AK-01
TCGA-AR-A1AL-01	Stage III	60	2	Stage IIIA	1485		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1485	0	LumA	Luminal A	Positive	ReacI	-4	0	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A1AL-01	2971	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 1	TCGA-AR-A1AL	2971	0	days	2971	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AL-F69272	TCGA-AR-A1AL	TCGA-AR-A1AL-01A		Positive					Positive	Simple Mastectomy		YES			-22023	1528		0	2971							70-79%		Scheduled Follow-up Submission	2014-12-31	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	630	NO	Negative		NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	3		true	No	M0	N1	T3	Stage IIIA	TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf	A1AL	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	9c918c56-fd45-443d-8137-00685de9f0c3	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	9c918c56-fd45-443d-8137-00685de9f0c3	TCGA-AR-A1AL-01A-31-A13E-20	TCGA-AR-A1AL-01A-21D-A12Q-09		TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21D-A12R-05		12c1530b-8aaf-4eb5-bda4-5d3225242d79	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21D-A12Q-09		TCGA-AR-A1AL-01	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21D-A12Q-09		ad602633-fdd7-4bf1-b3ac-e1c8e0a02934		TCGA-AR-A1AL-01A-21D-A12N-01	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21R-A12P-07	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	TCGA-AR-A1AL-01A-21D-A12N-01	TCGA-AR-A1AL-01
TCGA-AR-A1AM-01																													0	TCGA-AR-A1AM-01	2991	0	days	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AR-A1AM	2991	0	days	2991	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant			TCGA-AR-A1AM-F71733	TCGA-AR-A1AM			Positive					Positive	Simple Mastectomy					-19123			0	2991										2015-3-30	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1			No	M0	N1	T3	Stage IIIA		A1AM	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	AR	Breast		LIVING	2006	a58de230-f177-4c58-95ec-55b6edb08452	e08e1eac-89df-42a3-b202-2280c39146d5	a58de230-f177-4c58-95ec-55b6edb08452	e08e1eac-89df-42a3-b202-2280c39146d5	TCGA-AR-A1AM-01A-31-A24A-20			TCGA-AR-A1AM-01	TCGA-AR-A1AM-01A-41D-A22B-05		d30acc0b-b6b7-4134-96f5-4b76004ca893	TCGA-AR-A1AM-01	TCGA-AR-A1AM-01A-41D-A228-09			TCGA-AR-A1AM-01			a58de230-f177-4c58-95ec-55b6edb08452		TCGA-AR-A1AM-01A-41D-A227-01	TCGA-AR-A1AM-01		a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-41D-A227-01	
TCGA-AR-A1AN-01	Stage II	46	1	Stage IIA	1329		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1329	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AN-01	2920	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation cluster 5	TCGA-AR-A1AN	2920	0	days	2920	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AN-F69273	TCGA-AR-A1AN	TCGA-AR-A1AN-01A		Positive					Positive	Other		YES			-16974	1463		0	2920							70-79%		Scheduled Follow-up Submission	2014-12-31	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf	A1AN	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01	Wide Local Excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	9046caf3-bbfe-4554-b9d2-11b333ad7704	cc0c2c46-bf0a-4a5d-b441-55037838b7d5	9046caf3-bbfe-4554-b9d2-11b333ad7704	cc0c2c46-bf0a-4a5d-b441-55037838b7d5		TCGA-AR-A1AN-01A-11D-A12Q-09		TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11D-A12R-05			TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11D-A12Q-09		TCGA-AR-A1AN-01	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11D-A12Q-09		9046caf3-bbfe-4554-b9d2-11b333ad7704		TCGA-AR-A1AN-01A-11D-A12N-01	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11R-A12P-07	9046caf3-bbfe-4554-b9d2-11b333ad7704	TCGA-AR-A1AN-01A-11D-A12N-01	TCGA-AR-A1AN-01
TCGA-AR-A1AO-01	Stage II	47	1	Stage IIA	1324		Positive	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1324	0	Normal	Normal-like	Negative	Basal	-5	-8	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AO-01	2618	0	days	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AO	2618	0	days	2618	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AO-F69274	TCGA-AR-A1AO	TCGA-AR-A1AO-01A		Positive					Negative	Other		YES			-17332	1471		0	2618									Scheduled Follow-up Submission	2014-12-31	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	39	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	2		true	No	M0	N1	T1	Stage IIA	TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf	A1AO	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	56183330-0700-46d7-b45f-6d915ae587fa	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	56183330-0700-46d7-b45f-6d915ae587fa	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	TCGA-AR-A1AO-01A-21-A13E-20	TCGA-AR-A1AO-01A-11D-A12Q-09		TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11D-A12R-05		310b6320-7ad9-4977-9c23-e80e0500e94c	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11D-A12Q-09		TCGA-AR-A1AO-01	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11D-A12Q-09		56183330-0700-46d7-b45f-6d915ae587fa		TCGA-AR-A1AO-01A-11D-A12N-01	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11R-A12P-07	56183330-0700-46d7-b45f-6d915ae587fa	TCGA-AR-A1AO-01A-11D-A12N-01	TCGA-AR-A1AO-01
TCGA-AR-A1AP-01	Stage I	80	2	Stage I	1215		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	1215	0	LumA	Luminal A	Positive	LumA/B	0	0	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AP-01	2856	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AP	2856	0	days	2856	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AP-F69275	TCGA-AR-A1AP	TCGA-AR-A1AP-01A	Negative	Positive				Mastectomy NOS	Positive	Other		YES			-29406	1450		0	2856							70-79%		Scheduled Follow-up Submission	2014-12-31	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Equivocal	Negative	NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf	A1AP	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	8b0f1897-20d8-492d-9ea9-22f771bbae9d	81e9397d-c246-4d14-a6e9-f3e068e8c43f	8b0f1897-20d8-492d-9ea9-22f771bbae9d	81e9397d-c246-4d14-a6e9-f3e068e8c43f	TCGA-AR-A1AP-01A-21-A13E-20	TCGA-AR-A1AP-01A-11D-A12Q-09		TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11D-A12R-05		07e57b56-5370-4a69-86e4-cdd0955d371b	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11D-A12Q-09		TCGA-AR-A1AP-01	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11D-A12Q-09		8b0f1897-20d8-492d-9ea9-22f771bbae9d		TCGA-AR-A1AP-01A-11D-A12N-01	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11R-A12P-07	8b0f1897-20d8-492d-9ea9-22f771bbae9d	TCGA-AR-A1AP-01A-11D-A12N-01	TCGA-AR-A1AP-01
TCGA-AR-A1AQ-01	Stage II	49	1	Stage IIA	1309		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1309	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AQ-01	3021	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AQ	3021	0	days	3021	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AQ-F69276	TCGA-AR-A1AQ	TCGA-AR-A1AQ-01A		Negative					Negative	Other		YES			-18109	1424		0	3021									Scheduled Follow-up Submission	2014-12-31	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf	A1AQ	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	747f56be-2fdd-4eb8-99a7-34afd923d8e1	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	747f56be-2fdd-4eb8-99a7-34afd923d8e1	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	TCGA-AR-A1AQ-01A-21-A13E-20	TCGA-AR-A1AQ-01A-11D-A12Q-09		TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11D-A12R-05		23358473-9909-47ff-b683-d046e292d504	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11D-A12Q-09		TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11D-A12Q-09		747f56be-2fdd-4eb8-99a7-34afd923d8e1		TCGA-AR-A1AQ-01A-11D-A12N-01	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11R-A12P-07	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA-AR-A1AQ-01A-11D-A12N-01	TCGA-AR-A1AQ-01
TCGA-AR-A1AR-01	Stage III	50	1	Stage IIIA		523	Negative	FEMALE	Negative				Negative	M0	Positive	N2	523	1	Basal	Basal-like	Negative		-13	0	enrollment	T1	T1	DECEASED	1	TCGA-AR-A1AR-01	524	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A1AR	387	1	days	524	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AR-F21825	TCGA-AR-A1AR	TCGA-AR-A1AR-01A		Negative					Negative	Lumpectomy					-18482	1416	524	0				387						Additional New Tumor Event	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5				Other, specify	New Primary Tumor	Breast		YES	5		true	Yes	M0	N2	T1	Stage IIIA	TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf	A1AR	WITH TUMOR										YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	DECEASED	2007	6d066a72-f59f-45a8-ab90-216000b36da4	c7976361-e689-44f1-9e5a-2a07064f2f95	6d066a72-f59f-45a8-ab90-216000b36da4	c7976361-e689-44f1-9e5a-2a07064f2f95		TCGA-AR-A1AR-01A-31D-A135-09		TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31D-A138-05			TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31D-A135-09		TCGA-AR-A1AR-01	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31D-A135-09		6d066a72-f59f-45a8-ab90-216000b36da4		TCGA-AR-A1AR-01A-31D-A134-01	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31R-A137-07	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA-AR-A1AR-01A-31D-A134-01	TCGA-AR-A1AR-01
TCGA-AR-A1AS-01	Stage II	54	3	Stage IIB	1242		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1242	0	LumA	Luminal A	Positive	LumA	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AS-01	1150	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A1AS	1150	0	days	1150	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-AR-A1AS-F49470	TCGA-AR-A1AS	TCGA-AR-A1AS-01A		Positive					Positive	Other					-20028	1331		0	1150							70-79%		Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf	A1AS	TUMOR FREE						NO	YES	70-79%		YES	Primary Tumor	01	Wide local excision	6th	NO	NO	YES	AR	Breast	A	LIVING	2007	e7b64cc3-9b2b-4938-9896-84b640d1586f	8fcff679-66ba-4348-93ed-eb7166302c3e	e7b64cc3-9b2b-4938-9896-84b640d1586f	8fcff679-66ba-4348-93ed-eb7166302c3e	TCGA-AR-A1AS-01A-21-A13E-20	TCGA-AR-A1AS-01A-11D-A12Q-09		TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12R-05		0db7dee4-ca2e-4f47-a9bc-5e55ca0df269	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12Q-09		TCGA-AR-A1AS-01	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12Q-09		e7b64cc3-9b2b-4938-9896-84b640d1586f		TCGA-AR-A1AS-01A-11D-A12N-01	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11R-A12P-07	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-11D-A12N-01	TCGA-AR-A1AS-01
TCGA-AR-A1AT-01	Stage II	62		Stage IIA		1272	Positive	FEMALE	Positive				Negative	M0	Negative	N0	1272	1		HER2-enriched	Positive	Her2	-11	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A1AT-01	1272	1	days			cluster 1	BRCA CIMP c7	BRCA basal-like c6		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AT	1272	0	days	1272	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AT-F22148	TCGA-AR-A1AT	TCGA-AR-A1AT-01A		Positive					Positive	Other		YES			-22942	1339	1272	0								<10%		Scheduled Follow-up Submission	2012-3-1	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	1		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67.pdf	A1AT								YES	<10%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	DECEASED	2007	e70e1882-b4be-4ed6-9c2d-4e8c84fde633		e70e1882-b4be-4ed6-9c2d-4e8c84fde633		TCGA-AR-A1AT-01A-21-A13E-20	TCGA-AR-A1AT-01A-11D-A12Q-09		TCGA-AR-A1AT-01	TCGA-AR-A1AT-01A-11D-A12R-05		6605222f-3dc9-4a93-987e-a8720dc38b32		TCGA-AR-A1AT-01A-11D-A12Q-09			TCGA-AR-A1AT-01	TCGA-AR-A1AT-01A-11D-A12Q-09		e70e1882-b4be-4ed6-9c2d-4e8c84fde633			TCGA-AR-A1AT-01	TCGA-AR-A1AT-01A-11R-A12P-07	e70e1882-b4be-4ed6-9c2d-4e8c84fde633		TCGA-AR-A1AT-01
TCGA-AR-A1AU-01	Stage III	39	4	Stage IIIA	1409		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	1409	0	LumA	Luminal A	Positive	ReacI	-3	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AU-01	2868	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-AR-A1AU	2868	0	days	2868	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AU-F71744	TCGA-AR-A1AU	TCGA-AR-A1AU-01A		Positive					Positive	Other					-14564	1317		0	2868							70-79%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative	NO	37	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	4		true	No	M0	N2	T2	Stage IIIA	TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf	A1AU	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	bb07b646-1dcc-4cf5-9aae-1df150e84a84	3830d91c-48eb-4f67-9db9-1a4ff4b28c92	bb07b646-1dcc-4cf5-9aae-1df150e84a84	3830d91c-48eb-4f67-9db9-1a4ff4b28c92	TCGA-AR-A1AU-01A-21-A13E-20	TCGA-AR-A1AU-01A-11D-A12Q-09		TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11D-A12R-05		48cc7955-160a-4e19-aafc-4fad203a9082	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11D-A12Q-09		TCGA-AR-A1AU-01	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11D-A12Q-09		bb07b646-1dcc-4cf5-9aae-1df150e84a84		TCGA-AR-A1AU-01A-11D-A12N-01	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11R-A12P-07	bb07b646-1dcc-4cf5-9aae-1df150e84a84	TCGA-AR-A1AU-01A-11D-A12N-01	TCGA-AR-A1AU-01
TCGA-AR-A1AV-01	Stage II	68	3	Stage IIB	1295		Positive	MALE	Negative	4	5	4	Negative	M0	Positive	N1	1295	0	LumA	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AV-01	1864	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A1AV	1864	0	days	1864	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left	Axillary lymph node dissection alone		TCGA-AR-A1AV-F49475	TCGA-AR-A1AV	TCGA-AR-A1AV-01A		Positive					Positive	Modified Radical Mastectomy					-24875	1233		0	1864							70-79%		Scheduled Follow-up Submission	2013-10-2	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative		NO	25	Negative																					3	7								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf	A1AV	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2007	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	135f0af7-da27-4a64-b7a5-16c0eaa1df7a	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	135f0af7-da27-4a64-b7a5-16c0eaa1df7a	TCGA-AR-A1AV-01A-31-A13E-20	TCGA-AR-A1AV-01A-21D-A12Q-09		TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21D-A12R-05		9432773f-696b-4104-9232-c6e6a6a379c2	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21D-A12Q-09		TCGA-AR-A1AV-01	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21D-A12Q-09		dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a		TCGA-AR-A1AV-01A-21D-A12N-01	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21R-A12P-07	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	TCGA-AR-A1AV-01A-21D-A12N-01	TCGA-AR-A1AV-01
TCGA-AR-A1AW-01	Stage II	65	3	Stage IIA	1072		Positive	FEMALE	Negative	2	2	3	Negative	M0	Negative	N0	1072	0	LumB	Luminal A	Positive	ReacII	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AW-01	2632	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-AR-A1AW	2632	0	days	2632	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AW-F71714	TCGA-AR-A1AW	TCGA-AR-A1AW-01A		Positive					Positive	Lumpectomy		YES			-23855	1157		0	2632							70-79%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	800	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	3								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf	A1AW	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2007	cff4a5bc-ba2b-47d6-8d36-6277ae991606	4fe5e02e-c89b-445d-8b84-8db10e210c86	cff4a5bc-ba2b-47d6-8d36-6277ae991606	4fe5e02e-c89b-445d-8b84-8db10e210c86	TCGA-AR-A1AW-01A-11-A13E-20	TCGA-AR-A1AW-01A-21D-A12Q-09		TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21D-A12R-05		15e9c25c-1736-4fed-9c7f-5a2f86ee7248	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21D-A12Q-09		TCGA-AR-A1AW-01	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21D-A12Q-09		cff4a5bc-ba2b-47d6-8d36-6277ae991606		TCGA-AR-A1AW-01A-21D-A12N-01	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21R-A12P-07	cff4a5bc-ba2b-47d6-8d36-6277ae991606	TCGA-AR-A1AW-01A-21D-A12N-01	TCGA-AR-A1AW-01
TCGA-AR-A1AX-01	Stage I	64	4	Stage I	1103		Positive	FEMALE	Positive	3	1	3	Negative	M0	Negative	N0	1103	0	LumA	Luminal A	Positive	ReacII	0	-5	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AX-01	2629	0	days	Squamous	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-AR-A1AX	2629	0	days	2629	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AX-F71720	TCGA-AR-A1AX	TCGA-AR-A1AX-01A		Positive					Positive	Other		YES			-23507	1140		0	2629									Scheduled Follow-up Submission	2015-3-30	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf	A1AX	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	66626142-7c5c-4ed0-8ef0-f4133423f275	e79dcb48-5228-42e7-8b67-1e51a68796e6	66626142-7c5c-4ed0-8ef0-f4133423f275	e79dcb48-5228-42e7-8b67-1e51a68796e6	TCGA-AR-A1AX-01A-21-A13E-20	TCGA-AR-A1AX-01A-11D-A12Q-09		TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11D-A12R-05		f30b231a-6dd9-4ae5-a0d4-34056bcbd5f8	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11D-A12Q-09		TCGA-AR-A1AX-01	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11D-A12Q-09		66626142-7c5c-4ed0-8ef0-f4133423f275		TCGA-AR-A1AX-01A-11D-A12N-01	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11R-A12P-07	66626142-7c5c-4ed0-8ef0-f4133423f275	TCGA-AR-A1AX-01A-11D-A12N-01	TCGA-AR-A1AX-01
TCGA-AR-A1AY-01	Stage I	65	1	Stage I	614		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	614	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AY-01	1026	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AY	1026	0	days	1026	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A1AY-F49482	TCGA-AR-A1AY	TCGA-AR-A1AY-01A		Negative					Negative	Other		YES			-23927	1085		0	1026									Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf	A1AY	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide Local Excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2008	49c4166c-701a-4f53-8968-99aec3347214	dab4207f-5e33-4cbb-81af-b3f005c74c16	49c4166c-701a-4f53-8968-99aec3347214	dab4207f-5e33-4cbb-81af-b3f005c74c16	TCGA-AR-A1AY-01A-11-A13E-20	TCGA-AR-A1AY-01A-21D-A12Q-09		TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21D-A12R-05		1815b916-4da0-4ada-9774-7231a10c6862	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21D-A12Q-09		TCGA-AR-A1AY-01	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21D-A12Q-09		49c4166c-701a-4f53-8968-99aec3347214		TCGA-AR-A1AY-01A-21D-A12N-01	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21R-A12P-07	49c4166c-701a-4f53-8968-99aec3347214	TCGA-AR-A1AY-01A-21D-A12N-01	TCGA-AR-A1AY-01
TCGA-AR-A24H-01	Stage II	65	2	Stage IIA	3333		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3333	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24H-01	4894	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 13		mutation c1uster 9	TCGA-AR-A24H	4894	0	days	4894	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24H-F65797	TCGA-AR-A24H	TCGA-AR-A24H-01A		Positive					Positive	Other					-24046	3641		0	4894									Scheduled Follow-up Submission	2014-9-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A24H.C373F2EE-C601-4E17-8E2D-D9BC6AC0301A.pdf	A24H	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Excision	5th	YES	NO	YES	AR	Breast	A	LIVING	2001	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	95021181-8971-4d62-acf9-9a7bd1b960f2	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	95021181-8971-4d62-acf9-9a7bd1b960f2		TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01	TCGA-AR-A24H-01A-11D-A16A-05			TCGA-AR-A24H-01	TCGA-AR-A24H-01A-11D-A167-09			TCGA-AR-A24H-01	TCGA-AR-A24H-01A-11D-A167-09		a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c		TCGA-AR-A24H-01A-11D-A166-01	TCGA-AR-A24H-01		a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	TCGA-AR-A24H-01A-11D-A166-01	
TCGA-AR-A24K-01	Stage II	46	3	Stage IIA	1548		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1548	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24K-01	1548	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 3	TCGA-AR-A24K	1548	0	days	1548	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24K-F49485	TCGA-AR-A24K	TCGA-AR-A24K-01A		Positive					Positive	Other		YES			-16961	2325		0	1548						No value Given	10-19%		Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative	NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf	A24K	TUMOR FREE						YES	YES	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2004	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	51797bbf-7ed7-49ef-b23f-d3ba37a31ae6	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	51797bbf-7ed7-49ef-b23f-d3ba37a31ae6	TCGA-AR-A24K-01A-21-A17I-20	TCGA-AR-A24K-01A-11D-A167-09		TCGA-AR-A24K-01	TCGA-AR-A24K-01A-11D-A16A-05		6308773f-3789-47c1-8254-eaf5f9801868	TCGA-AR-A24K-01	TCGA-AR-A24K-01A-11D-A167-09			TCGA-AR-A24K-01	TCGA-AR-A24K-01A-11D-A167-09		e3008c10-aa31-40ef-ad50-77fd8ec7a1a9		TCGA-AR-A24K-01A-11D-A166-01	TCGA-AR-A24K-01		e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	TCGA-AR-A24K-01A-11D-A166-01	
TCGA-AR-A24L-01	Stage II	26	5	Stage IIB	2221		Positive	FEMALE	Negative				Negative	M0	Positive	N1	2221	0	LumA		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-AR-A24L-01	2866	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24L	1414	1	days	2866	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					26	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24L-F49488	TCGA-AR-A24L	TCGA-AR-A24L-01A		Positive					Positive	Other					-9706	2275	2866	0	2221			1414				10-19%		Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1250	NO	Equivocal	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4					Locoregional Disease			YES	2		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A24L.BF82AD23-B40E-459F-83EC-590D392664FD.pdf	A24L	WITH TUMOR						YES	YES	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	DECEASED	2005	bfa78a45-16bf-410a-816d-bd369ded91e5	0d02b005-05e4-4287-b451-40a4424d1a54	bfa78a45-16bf-410a-816d-bd369ded91e5	0d02b005-05e4-4287-b451-40a4424d1a54	TCGA-AR-A24L-01A-21-A17I-20	TCGA-AR-A24L-01A-11D-A167-09		TCGA-AR-A24L-01	TCGA-AR-A24L-01A-11D-A16A-05		e1bd54aa-7e28-47ce-98fb-95593ee07f96	TCGA-AR-A24L-01	TCGA-AR-A24L-01A-11D-A167-09			TCGA-AR-A24L-01	TCGA-AR-A24L-01A-11D-A167-09		bfa78a45-16bf-410a-816d-bd369ded91e5		TCGA-AR-A24L-01A-11D-A166-01	TCGA-AR-A24L-01		bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-11D-A166-01	
TCGA-AR-A24M-01	Stage III	38	3	Stage IIIA	1990		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1990	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24M-01	3660	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A24M	3660	0	days	3660	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24M-F71732	TCGA-AR-A24M	TCGA-AR-A24M-01A		Positive					Positive	Other					-14119	2245		0	3660							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	7								NO	4		true	No	M0	N2	T2	Stage IIIA	TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf	A24M	TUMOR FREE						YES	YES	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2005	4977200c-765d-475f-8df4-bf8d9a3b0aa9	071b569b-3b44-4a6b-ac2c-bbda7d13c501	4977200c-765d-475f-8df4-bf8d9a3b0aa9	071b569b-3b44-4a6b-ac2c-bbda7d13c501	TCGA-AR-A24M-01A-21-A17I-20	TCGA-AR-A24M-01A-11D-A167-09		TCGA-AR-A24M-01	TCGA-AR-A24M-01A-11D-A16A-05		8728cab4-4860-4753-aa84-05f91f245005	TCGA-AR-A24M-01	TCGA-AR-A24M-01A-11D-A167-09			TCGA-AR-A24M-01	TCGA-AR-A24M-01A-11D-A167-09		4977200c-765d-475f-8df4-bf8d9a3b0aa9		TCGA-AR-A24M-01A-11D-A166-01	TCGA-AR-A24M-01		4977200c-765d-475f-8df4-bf8d9a3b0aa9	TCGA-AR-A24M-01A-11D-A166-01	
TCGA-AR-A24N-01	Stage I	54	2	Stage I	2074		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2074	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24N-01	3035	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 3	mutation c1uster 9	TCGA-AR-A24N	3035	0	days	3035	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24N-F71723	TCGA-AR-A24N	TCGA-AR-A24N-01A		Positive					Positive	Simple Mastectomy		YES			-19989	2219		0	3035							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Equivocal	Negative	NO	4	Negative	Peri (6-12 months since last menstrual period)																				3	3								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf	A24N	TUMOR FREE						NO	YES	10-19%		NO	Primary Tumor	01		6th	NO	NO	YES	AR	Breast	A	LIVING	2005	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	27715ff1-8709-46a3-84c3-41b1ae9dbbc4	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	27715ff1-8709-46a3-84c3-41b1ae9dbbc4	TCGA-AR-A24N-01A-21-A17I-20	TCGA-AR-A24N-01A-11D-A167-09		TCGA-AR-A24N-01	TCGA-AR-A24N-01A-11D-A16A-05		90813751-60f8-4e79-bfd3-1f363203a029	TCGA-AR-A24N-01	TCGA-AR-A24N-01A-11D-A167-09			TCGA-AR-A24N-01	TCGA-AR-A24N-01A-11D-A167-09		48bf0fa5-66c2-495d-93ef-943bc7ff31ac		TCGA-AR-A24N-01A-11D-A166-01	TCGA-AR-A24N-01		48bf0fa5-66c2-495d-93ef-943bc7ff31ac	TCGA-AR-A24N-01A-11D-A166-01	
TCGA-AR-A24O-01	Stage III	43	2	Stage IIIA	1997		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1997	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24O-01	3607	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A24O	2561	1	days	3607	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left			TCGA-AR-A24O-F71713	TCGA-AR-A24O	TCGA-AR-A24O-01A	Negative	Positive				Mastectomy NOS	Positive	Modified Radical Mastectomy					-15977	2213		0	3607			2561						Scheduled Follow-up Submission	2015-3-30	FEMALE										Mixed Histology (please specify)	Lobular carcinoma with ductal features	No		C50.9	8522/3	C50.9		YES		Incisional Biopsy	700	NO	Negative		NO	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	7								YES	7		true	No	M0	N2	T3	Stage IIIA	TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf	A24O	WITH TUMOR						YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2005	2cd8167d-d35f-43e8-927f-cd7decebd9cf	f4558e75-6fb7-4042-8b8b-589aacc8ff47	2cd8167d-d35f-43e8-927f-cd7decebd9cf	f4558e75-6fb7-4042-8b8b-589aacc8ff47	TCGA-AR-A24O-01A-21-A17I-20	TCGA-AR-A24O-01A-11D-A167-09		TCGA-AR-A24O-01	TCGA-AR-A24O-01A-11D-A16A-05		c364acc4-6658-4deb-97ff-a367022c6958	TCGA-AR-A24O-01	TCGA-AR-A24O-01A-11D-A167-09			TCGA-AR-A24O-01	TCGA-AR-A24O-01A-11D-A167-09		2cd8167d-d35f-43e8-927f-cd7decebd9cf		TCGA-AR-A24O-01A-11D-A166-01	TCGA-AR-A24O-01		2cd8167d-d35f-43e8-927f-cd7decebd9cf	TCGA-AR-A24O-01A-11D-A166-01	
TCGA-AR-A24P-01	Stage I	47	2	Stage I	26		Positive	FEMALE	Negative				Negative	M0	Negative	N0	26	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24P-01	84	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AR-A24P	84	0	days	84	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24P-F31403	TCGA-AR-A24P	TCGA-AR-A24P-01A		Positive					Positive	Other		YES			-17490	2161		0	84							10-19%		Scheduled Follow-up Submission	2012-5-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf	A24P								YES	10-19%			Primary Tumor	01	Wide local excision	6th		NO	YES	AR	Breast	A	LIVING	2005	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	28b9b7dd-f419-4894-a629-eee1891015e1	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	28b9b7dd-f419-4894-a629-eee1891015e1	TCGA-AR-A24P-01A-21-A17I-20	TCGA-AR-A24P-01A-11D-A167-09		TCGA-AR-A24P-01	TCGA-AR-A24P-01A-11D-A16A-05		085b7387-61df-4f55-a320-72c165bf8647	TCGA-AR-A24P-01	TCGA-AR-A24P-01A-11D-A167-09			TCGA-AR-A24P-01	TCGA-AR-A24P-01A-11D-A167-09		49bdbb64-75a8-4a30-bde6-57f3c2a38f9b		TCGA-AR-A24P-01A-11D-A166-01	TCGA-AR-A24P-01		49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	TCGA-AR-A24P-01A-11D-A166-01	
TCGA-AR-A24Q-01	Stage II	49	1	Stage IIB	2008		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2008	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24Q-01	3172	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA c1uster 9	cluster 6	mutation cluster 2	TCGA-AR-A24Q	3172	0	days	3172	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24Q-F65802	TCGA-AR-A24Q	TCGA-AR-A24Q-01A		Positive					Negative	Simple Mastectomy					-18084	1932		0	3172							<10%		Scheduled Follow-up Submission	2014-9-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	590	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO	0		true	No	M0	N0	T3	Stage IIB	TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf	A24Q	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	72c34d2c-f255-492b-9249-e9e9c506ece2	f4a87897-7b1c-4783-ac66-b99a74b8eec6	72c34d2c-f255-492b-9249-e9e9c506ece2	f4a87897-7b1c-4783-ac66-b99a74b8eec6	TCGA-AR-A24Q-01A-21-A17I-20	TCGA-AR-A24Q-01A-12D-A167-09		TCGA-AR-A24Q-01	TCGA-AR-A24Q-01A-12D-A16A-05		f39fe8fb-2c5e-403b-aceb-bd9604f1a25e	TCGA-AR-A24Q-01	TCGA-AR-A24Q-01A-12D-A167-09			TCGA-AR-A24Q-01	TCGA-AR-A24Q-01A-12D-A167-09		72c34d2c-f255-492b-9249-e9e9c506ece2		TCGA-AR-A24Q-01A-12D-A166-01	TCGA-AR-A24Q-01		72c34d2c-f255-492b-9249-e9e9c506ece2	TCGA-AR-A24Q-01A-12D-A166-01	
TCGA-AR-A24R-01	Stage III	45	5	Stage IIIA	1745		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1745	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24R-01	3430	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A24R	3430	0	days	3430	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24R-F71731	TCGA-AR-A24R	TCGA-AR-A24R-01A		Positive					Positive	Other					-16642	1913		0	3430							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative	Negative	NO	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	5								NO	6		true	No	M0	N2	T1	Stage IIIA	TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf	A24R	TUMOR FREE						YES	YES	10-19%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	401721b2-a1d1-46d3-b73c-ec06df30d61e	17f5d685-ed80-4953-b02e-b069e529faa6	401721b2-a1d1-46d3-b73c-ec06df30d61e	17f5d685-ed80-4953-b02e-b069e529faa6	TCGA-AR-A24R-01A-21-A17I-20	TCGA-AR-A24R-01A-11D-A167-09		TCGA-AR-A24R-01	TCGA-AR-A24R-01A-11D-A16A-05		1734096f-0942-4abe-acb4-cd6e183080c0	TCGA-AR-A24R-01	TCGA-AR-A24R-01A-11D-A167-09			TCGA-AR-A24R-01	TCGA-AR-A24R-01A-11D-A167-09		401721b2-a1d1-46d3-b73c-ec06df30d61e		TCGA-AR-A24R-01A-11D-A166-01	TCGA-AR-A24R-01		401721b2-a1d1-46d3-b73c-ec06df30d61e	TCGA-AR-A24R-01A-11D-A166-01	
TCGA-AR-A24S-01	Stage I	61	1	Stage I	1888		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1888	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24S-01	2976	0	days	Squamous	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A24S	2976	0	days	2976	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24S-F31496	TCGA-AR-A24S	TCGA-AR-A24S-01A		Positive					Positive	Other		YES			-22587	1812		0	2976							70-79%		Scheduled Follow-up Submission	2012-5-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf	A24S								YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	ce2bf11c-61cb-49c7-8135-906719050d28	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	ce2bf11c-61cb-49c7-8135-906719050d28	TCGA-AR-A24S-01A-21-A17I-20	TCGA-AR-A24S-01A-11D-A167-09		TCGA-AR-A24S-01	TCGA-AR-A24S-01A-11D-A16A-05		9e00e8b9-5977-4a9c-aef4-c9f3e8007475	TCGA-AR-A24S-01	TCGA-AR-A24S-01A-11D-A167-09			TCGA-AR-A24S-01	TCGA-AR-A24S-01A-11D-A167-09		3795f6d6-3a1d-4b41-8a4b-e832078e9d48		TCGA-AR-A24S-01A-11D-A166-01	TCGA-AR-A24S-01		3795f6d6-3a1d-4b41-8a4b-e832078e9d48	TCGA-AR-A24S-01A-11D-A166-01	
TCGA-AR-A24T-01	Stage III	46	2	Stage IIIC	1620		Positive	FEMALE	Negative				Negative	M0	Positive	N3	1620	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24T-01	3202	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24T	3202	0	days	3202	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24T-F71728	TCGA-AR-A24T	TCGA-AR-A24T-01A		Positive					Positive	Simple Mastectomy					-17135	1786		0	3202							10-19%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative	NO	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	2								NO	15		true	No	M0	N3	T3	Stage IIIC	TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf	A24T	TUMOR FREE						YES	YES	10-19%		YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	101abe3f-d317-4f8b-9b20-042da3d22457	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	101abe3f-d317-4f8b-9b20-042da3d22457	TCGA-AR-A24T-01A-21-A17I-20	TCGA-AR-A24T-01A-11D-A167-09		TCGA-AR-A24T-01	TCGA-AR-A24T-01A-11D-A16A-05		7c08cdc2-f620-4ba3-9a66-37bd23d75d3e	TCGA-AR-A24T-01	TCGA-AR-A24T-01A-11D-A167-09			TCGA-AR-A24T-01	TCGA-AR-A24T-01A-11D-A167-09		d2e1fdf7-1ac9-49e9-a611-b15c90772bf6		TCGA-AR-A24T-01A-11D-A166-01	TCGA-AR-A24T-01		d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-11D-A166-01	
TCGA-AR-A24U-01	Stage II	47	4	Stage IIA	1623		Negative	FEMALE	Positive				Negative	M0	Positive	N1	1623	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-AR-A24U-01	3128	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation c1uster 9	TCGA-AR-A24U	3128	0	days	3128	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24U-F71738	TCGA-AR-A24U	TCGA-AR-A24U-01A	Negative	Negative				Mastectomy NOS	Negative	Simple Mastectomy					-17523	1763		0	3128									Scheduled Follow-up Submission	2015-3-30	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Positive		NO	25	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	7								NO	2		true	No	M0	N1	T1	Stage IIA	TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf	A24U	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	296c69de-2b77-4b3a-a228-9552a8a9836e	6c84f85f-2dd5-452e-8658-a7844f7143ed	296c69de-2b77-4b3a-a228-9552a8a9836e	6c84f85f-2dd5-452e-8658-a7844f7143ed	TCGA-AR-A24U-01A-21-A17I-20	TCGA-AR-A24U-01A-11D-A167-09		TCGA-AR-A24U-01	TCGA-AR-A24U-01A-11D-A16A-05		c0592373-1465-46d8-984a-2c02e0c53cfc	TCGA-AR-A24U-01	TCGA-AR-A24U-01A-11D-A167-09			TCGA-AR-A24U-01	TCGA-AR-A24U-01A-11D-A167-09		296c69de-2b77-4b3a-a228-9552a8a9836e		TCGA-AR-A24U-01A-11D-A166-01	TCGA-AR-A24U-01		296c69de-2b77-4b3a-a228-9552a8a9836e	TCGA-AR-A24U-01A-11D-A166-01	
TCGA-AR-A24V-01	Stage II	52	5	Stage IIB	1648		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1648	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24V-01	3203	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24V	3203	0	days	3203	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24V-F71740	TCGA-AR-A24V	TCGA-AR-A24V-01A		Positive					Positive	Other		YES			-19027	1720		0	3203							80-89%		Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)																				4	4								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf	A24V	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	2623f99f-9e60-476b-b522-50e7fc6fef5a	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	2623f99f-9e60-476b-b522-50e7fc6fef5a	TCGA-AR-A24V-01A-11-A17I-20	TCGA-AR-A24V-01A-21D-A167-09		TCGA-AR-A24V-01	TCGA-AR-A24V-01A-21D-A16A-05		38c6af12-c50f-4dbe-8130-0b737b29390a	TCGA-AR-A24V-01	TCGA-AR-A24V-01A-21D-A167-09			TCGA-AR-A24V-01	TCGA-AR-A24V-01A-21D-A167-09		29b04717-c5f2-4d4c-b006-e5c5f0aade7a		TCGA-AR-A24V-01A-21D-A166-01	TCGA-AR-A24V-01		29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-21D-A166-01	
TCGA-AR-A24W-01			3																LumA										0	TCGA-AR-A24W-01	991	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-AR-A24W	991	0	days	991	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24W-F49476	TCGA-AR-A24W	TCGA-AR-A24W-01A		Positive					Positive	Other					-20123	1720		0	991									Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	3		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A24W.0F2464F7-4108-4700-B2EC-17BC6C432D42.pdf	A24W	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	10a3bfcd-1650-480e-a3eb-f72d6ae052fe	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	10a3bfcd-1650-480e-a3eb-f72d6ae052fe	TCGA-AR-A24W-01A-21-A17I-20	TCGA-AR-A24W-01A-11D-A17G-09		TCGA-AR-A24W-01	TCGA-AR-A24W-01A-11D-A16A-05		bb6402d2-2bc7-461a-8143-4e6939bb6813	TCGA-AR-A24W-01	TCGA-AR-A24W-01A-11D-A17G-09			TCGA-AR-A24W-01	TCGA-AR-A24W-01A-11D-A17G-09		a2f3fd7f-9a5d-44aa-8810-4978abad6e12		TCGA-AR-A24W-01A-11D-A166-01	TCGA-AR-A24W-01		a2f3fd7f-9a5d-44aa-8810-4978abad6e12	TCGA-AR-A24W-01A-11D-A166-01	
TCGA-AR-A24X-01	Stage II	52	2	Stage IIA	1465		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1465	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24X-01	3004	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24X	3004	0	days	3004	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24X-F71741	TCGA-AR-A24X	TCGA-AR-A24X-01A		Positive					Positive	Simple Mastectomy		YES			-19030	1717		0	3004							80-89%		Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative	NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	2								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf	A24X	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	AR	Breast	A	LIVING	2006	42a7e579-365d-4393-8b98-e4516863299e	2f68651c-31bc-4e28-af88-ae2c22c34d5c	42a7e579-365d-4393-8b98-e4516863299e	2f68651c-31bc-4e28-af88-ae2c22c34d5c	TCGA-AR-A24X-01A-21-A17I-20	TCGA-AR-A24X-01A-11D-A167-09		TCGA-AR-A24X-01	TCGA-AR-A24X-01A-11D-A16A-05		44e1a92c-dabb-4fdb-936c-bd1dfb2719ac	TCGA-AR-A24X-01	TCGA-AR-A24X-01A-11D-A167-09			TCGA-AR-A24X-01	TCGA-AR-A24X-01A-11D-A167-09		42a7e579-365d-4393-8b98-e4516863299e		TCGA-AR-A24X-01A-11D-A166-01	TCGA-AR-A24X-01		42a7e579-365d-4393-8b98-e4516863299e	TCGA-AR-A24X-01A-11D-A166-01	
TCGA-AR-A24Z-01	Stage II	57	3	Stage IIA	1574		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1574	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24Z-01	3001	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-AR-A24Z	3001	0	days	3001	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A24Z-F71743	TCGA-AR-A24Z	TCGA-AR-A24Z-01A		Positive					Positive	Other		YES			-20900	1673		0	3001									Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf	A24Z	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Total mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	712486dc-9fc5-4e76-85ae-34a1e35120b5	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	712486dc-9fc5-4e76-85ae-34a1e35120b5	TCGA-AR-A24Z-01A-21-A17I-20	TCGA-AR-A24Z-01A-11D-A167-09		TCGA-AR-A24Z-01	TCGA-AR-A24Z-01A-11D-A16A-05		93fa3c81-01ce-4073-811d-146d1ef739ac	TCGA-AR-A24Z-01	TCGA-AR-A24Z-01A-11D-A167-09			TCGA-AR-A24Z-01	TCGA-AR-A24Z-01A-11D-A167-09		8d0d1eea-9e60-4507-8cfa-1fac66edc8a4		TCGA-AR-A24Z-01A-11D-A166-01	TCGA-AR-A24Z-01		8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	TCGA-AR-A24Z-01A-11D-A166-01	
TCGA-AR-A250-01	Stage II	58	3	Stage IIA	1707		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1707	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A250-01	2707	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A250	2707	0	days	2707	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A250-F65794	TCGA-AR-A250	TCGA-AR-A250-01A	Negative	Positive				Mastectomy NOS	Negative	Other					-21309	1629		0	2707							70-79%			2014-9-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Equivocal	Positive	NO	4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf	A250	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Wide local excision and simple mastectomy	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	86373f83-264a-4875-8672-749ea434422f	66b51ec8-15d1-4d1e-9edf-28f2a6b037d9	86373f83-264a-4875-8672-749ea434422f	66b51ec8-15d1-4d1e-9edf-28f2a6b037d9	TCGA-AR-A250-01A-41-A17I-20	TCGA-AR-A250-01A-31D-A167-09		TCGA-AR-A250-01	TCGA-AR-A250-01A-31D-A16A-05		1c3c4e67-cd5b-42b6-9cd8-5f18356a8e80	TCGA-AR-A250-01	TCGA-AR-A250-01A-31D-A167-09			TCGA-AR-A250-01	TCGA-AR-A250-01A-31D-A167-09		86373f83-264a-4875-8672-749ea434422f		TCGA-AR-A250-01A-31D-A166-01	TCGA-AR-A250-01		86373f83-264a-4875-8672-749ea434422f	TCGA-AR-A250-01A-31D-A166-01	
TCGA-AR-A251-01	Stage III	51	1	Stage IIIA	1373		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1373	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A251-01	3030	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7		mutation c1uster 9	TCGA-AR-A251	3030	0	days	3030	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A251-F71716	TCGA-AR-A251	TCGA-AR-A251-01A	Negative	Positive				Mastectomy NOS	Negative	Other					-18771	1611		0	3030									Scheduled Follow-up Submission	2015-3-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Equivocal	Negative	NO	7	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5									NO	4		true	No	M0	N2	T2	Stage IIIA	TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf	A251	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2006	06760907-c6ec-4b72-bfd4-87811823b8ba	a36f9f16-a240-419b-b230-17e2eb03eb73	06760907-c6ec-4b72-bfd4-87811823b8ba	a36f9f16-a240-419b-b230-17e2eb03eb73	TCGA-AR-A251-01A-21-A17I-20	TCGA-AR-A251-01A-12D-A167-09		TCGA-AR-A251-01	TCGA-AR-A251-01A-12D-A16A-05		4378eaf7-993d-40b3-ab7f-1a909c768a47	TCGA-AR-A251-01	TCGA-AR-A251-01A-12D-A167-09			TCGA-AR-A251-01	TCGA-AR-A251-01A-12D-A167-09		06760907-c6ec-4b72-bfd4-87811823b8ba		TCGA-AR-A251-01A-12D-A166-01	TCGA-AR-A251-01		06760907-c6ec-4b72-bfd4-87811823b8ba	TCGA-AR-A251-01A-12D-A166-01	
TCGA-AR-A252-01	Stage I	50	3	Stage I	1236		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1236	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A252-01	2838	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AR-A252	2838	0	days	2838	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A252-F71727	TCGA-AR-A252	TCGA-AR-A252-01A		Positive					Positive	Other		YES			-18611	1405		0	2838							70-79%		Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	480	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	1								NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf	A252	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	f325c7a8-46b0-4d75-9228-db391c270c71	4100914c-192f-4cac-ac05-56f707463196	f325c7a8-46b0-4d75-9228-db391c270c71	4100914c-192f-4cac-ac05-56f707463196	TCGA-AR-A252-01A-21-A17I-20	TCGA-AR-A252-01A-11D-A167-09		TCGA-AR-A252-01	TCGA-AR-A252-01A-11D-A16A-05		8fd7447f-07c3-4bd3-a877-7bf96db17d03	TCGA-AR-A252-01	TCGA-AR-A252-01A-11D-A167-09			TCGA-AR-A252-01	TCGA-AR-A252-01A-11D-A167-09		f325c7a8-46b0-4d75-9228-db391c270c71		TCGA-AR-A252-01A-11D-A166-01	TCGA-AR-A252-01		f325c7a8-46b0-4d75-9228-db391c270c71	TCGA-AR-A252-01A-11D-A166-01	
TCGA-AR-A254-01	Stage III	50	3	Stage IIIA	1212		Positive	FEMALE	Positive				Negative	M0	Positive	N2	1212	0	Her2		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A254-01	2605	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-AR-A254	2605	0	days	2605	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A254-F71726	TCGA-AR-A254	TCGA-AR-A254-01A		Positive					Positive	Other					-18270	1381		0	2605									Scheduled Follow-up Submission	2015-3-30	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Wide local incision	Other method, specify:	990	NO	Positive		NO	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	9		true	No	M0	N2	T2	Stage IIIA	TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf	A254	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	5741e1ce-5d4c-40dc-aa01-e71a45341884	7385c5f6-5fb1-4d45-a17d-93636a161c7c	5741e1ce-5d4c-40dc-aa01-e71a45341884	7385c5f6-5fb1-4d45-a17d-93636a161c7c	TCGA-AR-A254-01A-11-A17I-20	TCGA-AR-A254-01A-21D-A167-09		TCGA-AR-A254-01	TCGA-AR-A254-01A-21D-A16A-05		a7ba4821-8817-4411-a013-904b5c771b9e	TCGA-AR-A254-01	TCGA-AR-A254-01A-21D-A167-09			TCGA-AR-A254-01	TCGA-AR-A254-01A-21D-A167-09		5741e1ce-5d4c-40dc-aa01-e71a45341884		TCGA-AR-A254-01A-21D-A166-01	TCGA-AR-A254-01		5741e1ce-5d4c-40dc-aa01-e71a45341884	TCGA-AR-A254-01A-21D-A166-01	
TCGA-AR-A255-01	Stage I	62	5	Stage I	1058		Positive	FEMALE	Positive				Negative	M0	Negative	N0	1058	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A255-01	2161	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-AR-A255	2161	0	days	2161	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A255-F71745	TCGA-AR-A255	TCGA-AR-A255-01A		Positive					Positive	Other		YES			-22809	1225		0	2161									Scheduled Follow-up Submission	2015-3-30	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Positive		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf	A255	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	Breast	A	LIVING	2007	5f714b76-1ed1-4828-8b66-3627c5d78189	5845be86-bd10-4bf5-ade3-71674a1eecca	5f714b76-1ed1-4828-8b66-3627c5d78189	5845be86-bd10-4bf5-ade3-71674a1eecca	TCGA-AR-A255-01A-21-A17I-20	TCGA-AR-A255-01A-11D-A167-09		TCGA-AR-A255-01	TCGA-AR-A255-01A-11D-A16A-05		1f885532-b89a-406c-af84-bcfc9441ae2a	TCGA-AR-A255-01	TCGA-AR-A255-01A-11D-A167-09			TCGA-AR-A255-01	TCGA-AR-A255-01A-11D-A167-09		5f714b76-1ed1-4828-8b66-3627c5d78189		TCGA-AR-A255-01A-11D-A166-01	TCGA-AR-A255-01		5f714b76-1ed1-4828-8b66-3627c5d78189	TCGA-AR-A255-01A-11D-A166-01	
TCGA-AR-A256-01	Stage II	45	1	Stage IIA	2854	2854	Negative	FEMALE	Negative				Negative	M0	Negative	N0	2854	1	Basal		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A256-01	2854	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-AR-A256	1640	1	days	2854	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A256-F31923	TCGA-AR-A256	TCGA-AR-A256-01A		Negative					Negative	Other		YES			-16642	3740	2854	0				1640						Scheduled Follow-up Submission	2012-5-11	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5						Locoregional Disease			YES	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf	A256								YES			NO	Primary Tumor	01	Mastectomy	5th	YES	NO	YES	AR	Breast	A	DECEASED	2001	60534f8f-970a-4308-9844-a3a41dd6c187	4b23b5e1-813b-4975-8594-627aadcd3f92	60534f8f-970a-4308-9844-a3a41dd6c187	4b23b5e1-813b-4975-8594-627aadcd3f92	TCGA-AR-A256-01A-21-A17I-20	TCGA-AR-A256-01A-11D-A167-09		TCGA-AR-A256-01	TCGA-AR-A256-01A-11D-A16A-05		c98c88ee-f8ed-444b-a51c-67e6d942a8b5	TCGA-AR-A256-01	TCGA-AR-A256-01A-11D-A167-09			TCGA-AR-A256-01	TCGA-AR-A256-01A-11D-A167-09		60534f8f-970a-4308-9844-a3a41dd6c187		TCGA-AR-A256-01A-11D-A166-01	TCGA-AR-A256-01		60534f8f-970a-4308-9844-a3a41dd6c187	TCGA-AR-A256-01A-11D-A166-01	
TCGA-AR-A2LE-01																			LumA										0	TCGA-AR-A2LE-01	5062	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-AR-A2LE	5062	0	days	5062	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right	Sentinel node biopsy alone		TCGA-AR-A2LE-F35164	TCGA-AR-A2LE	TCGA-AR-A2LE-01A		Positive					Negative	Other		YES			-25499	3755		0	5062			4203		NO					2015-3-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	320	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	New Primary Tumor	Endometrium		NO	0		true	No	M0	N0	T1	Stage I	TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf	A2LE	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Excision	5th		NO	YES	AR	Breast	A	LIVING	2001	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	8689ec70-41c0-43fb-9d1d-723c0ef60a16	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	8689ec70-41c0-43fb-9d1d-723c0ef60a16	TCGA-AR-A2LE-01A-21-A24A-20			TCGA-AR-A2LE-01	TCGA-AR-A2LE-01A-11D-A17Z-05		642d23a8-3c0c-4004-9d50-3787178cb070	TCGA-AR-A2LE-01	TCGA-AR-A2LE-01A-11D-A17W-09			TCGA-AR-A2LE-01			5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74		TCGA-AR-A2LE-01A-11D-A17U-01	TCGA-AR-A2LE-01		5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	TCGA-AR-A2LE-01A-11D-A17U-01	
TCGA-AR-A2LH-01																			Normal										1	TCGA-AR-A2LH-01	616	1	days	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LH	434	1	days	616	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LH-F35165	TCGA-AR-A2LH	TCGA-AR-A2LH-01A		Negative					Negative	Modified Radical Mastectomy					-20288	1661	616	0				434		YES					2012-12-6	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1100	NO	Equivocal	Negative	NO	39	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Bone|Liver							Bone	Distant Metastasis			YES	29		true	No	M0	N3	T3	Stage III	TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf	A2LH							YES	YES			YES	Primary Tumor	01		6th		NO	YES	AR	Breast	A	DECEASED	2007	6aa1a643-013f-43d4-a3e6-a4a946ac3678	b99a1cb6-1b23-4d66-8865-ab265a85b41b	6aa1a643-013f-43d4-a3e6-a4a946ac3678	b99a1cb6-1b23-4d66-8865-ab265a85b41b	TCGA-AR-A2LH-01A-41-A24A-20			TCGA-AR-A2LH-01	TCGA-AR-A2LH-01A-31D-A18O-05		eca21066-45f1-49c3-b6ac-d594ed529c0e	TCGA-AR-A2LH-01	TCGA-AR-A2LH-01A-31D-A18P-09			TCGA-AR-A2LH-01			6aa1a643-013f-43d4-a3e6-a4a946ac3678		TCGA-AR-A2LH-01A-31D-A18N-01	TCGA-AR-A2LH-01		6aa1a643-013f-43d4-a3e6-a4a946ac3678	TCGA-AR-A2LH-01A-31D-A18N-01	
TCGA-AR-A2LJ-01																													0	TCGA-AR-A2LJ-01	2632	0	days	Iq			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4			TCGA-AR-A2LJ	2632	0	days	2632	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LJ-F71721	TCGA-AR-A2LJ	TCGA-AR-A2LJ-01A		Positive					Positive	Other		YES			-14723	1382		0	2632					NO		70-79%			2015-3-30	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	540	NO	Positive	Positive	NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	MX	N1	T3	Stage IIIA	TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf	A2LJ	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01	Total Mastectomy	6th		NO	YES	AR	Breast	A	LIVING	2007	52cca577-c5d1-4dff-9e3a-4007beb120db	18114439-8780-438d-a7cc-50b73533b619	52cca577-c5d1-4dff-9e3a-4007beb120db	18114439-8780-438d-a7cc-50b73533b619	TCGA-AR-A2LJ-01A-21-A24B-20			TCGA-AR-A2LJ-01	TCGA-AR-A2LJ-01A-12D-A19Z-05		c7155c5f-8110-4eb1-9c42-a959435f5f88	TCGA-AR-A2LJ-01	TCGA-AR-A2LJ-01A-12D-A19Y-09			TCGA-AR-A2LJ-01			52cca577-c5d1-4dff-9e3a-4007beb120db		TCGA-AR-A2LJ-01A-12D-A19X-01	TCGA-AR-A2LJ-01		52cca577-c5d1-4dff-9e3a-4007beb120db	TCGA-AR-A2LJ-01A-12D-A19X-01	
TCGA-AR-A2LK-01																			LumB										1	TCGA-AR-A2LK-01	1649	1	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AR-A2LK	1304	1	days	1649	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LK-F35203	TCGA-AR-A2LK	TCGA-AR-A2LK-01A	Negative	Positive				Mastectomy NOS	Positive	Other					-22800	1340	1649	0	1304			1304		NO		70-79%			2012-12-6	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	650	NO	Equivocal	Negative	NO	18	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive												Positive								Bone	Distant Metastasis			YES	5		true	No	M0	N2	T3	Stage III	TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf	A2LK							YES	YES			YES	Primary Tumor	01	Wide local excision	6th		NO	YES	AR	Breast	A	DECEASED	2007	047160f7-3727-4915-b02d-61557350d88b	263be494-445c-469b-8b53-d27860d73f8d	047160f7-3727-4915-b02d-61557350d88b	263be494-445c-469b-8b53-d27860d73f8d	TCGA-AR-A2LK-01A-21-A24A-20			TCGA-AR-A2LK-01	TCGA-AR-A2LK-01A-11D-A17Z-05		bcdf5107-7ac1-4f83-8b7e-30173b7d4760	TCGA-AR-A2LK-01	TCGA-AR-A2LK-01A-11D-A17W-09			TCGA-AR-A2LK-01			047160f7-3727-4915-b02d-61557350d88b		TCGA-AR-A2LK-01A-11D-A17U-01	TCGA-AR-A2LK-01		047160f7-3727-4915-b02d-61557350d88b	TCGA-AR-A2LK-01A-11D-A17U-01	
TCGA-AR-A2LL-01																			LumB										0	TCGA-AR-A2LL-01	2012	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14			TCGA-AR-A2LL	2012	0	days	2012	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LL-F49493	TCGA-AR-A2LL	TCGA-AR-A2LL-01A		Positive					Positive	Simple Mastectomy		YES			-25747	1315		0	2012					NO		70-79%			2013-10-2	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1300	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	Yes	M0	N0	T3	Stage IIB	TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf	A2LL	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	01		6th		NO	YES	AR	Breast	A	LIVING	2007	2c08d3bc-c5f6-4077-86b5-633ed85818ec	1e086721-663c-47b9-9753-a468d2b1df1b	2c08d3bc-c5f6-4077-86b5-633ed85818ec	1e086721-663c-47b9-9753-a468d2b1df1b	TCGA-AR-A2LL-01A-21-A24A-20			TCGA-AR-A2LL-01	TCGA-AR-A2LL-01A-11D-A17Z-05		6aee5a1d-a53e-4c02-90f5-fdb8e7765573	TCGA-AR-A2LL-01	TCGA-AR-A2LL-01A-11D-A17W-09						2c08d3bc-c5f6-4077-86b5-633ed85818ec		TCGA-AR-A2LL-01A-11D-A17U-01			2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-11D-A17U-01	
TCGA-AR-A2LM-01																			LumA										0	TCGA-AR-A2LM-01	1935	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12			TCGA-AR-A2LM	1935	0	days	1935	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LM-F71746	TCGA-AR-A2LM	TCGA-AR-A2LM-01A		Positive					Positive	Simple Mastectomy		YES			-18053	1339		0	1935					NO		70-79%			2015-3-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490	NO		Negative	NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1	T1	Stage II	TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf	A2LM	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	01		6th		NO	YES	AR	Breast	A	LIVING	2007	461cbf67-a11d-4411-95b5-cf83ecf05d02	27925a3c-9258-4c9e-9674-34c744a31eb3	461cbf67-a11d-4411-95b5-cf83ecf05d02	27925a3c-9258-4c9e-9674-34c744a31eb3	TCGA-AR-A2LM-01A-21-A24A-20			TCGA-AR-A2LM-01	TCGA-AR-A2LM-01A-11D-A17Z-05		02ae8e2a-6a69-4de2-b23c-f4e6a3b8ef7d	TCGA-AR-A2LM-01	TCGA-AR-A2LM-01A-11D-A17W-09			TCGA-AR-A2LM-01			461cbf67-a11d-4411-95b5-cf83ecf05d02		TCGA-AR-A2LM-01A-11D-A17U-01	TCGA-AR-A2LM-01		461cbf67-a11d-4411-95b5-cf83ecf05d02	TCGA-AR-A2LM-01A-11D-A17U-01	
TCGA-AR-A2LN-01																			LumA										0	TCGA-AR-A2LN-01	1161	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LN	1161	0	days	1161	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LN-F49496	TCGA-AR-A2LN	TCGA-AR-A2LN-01A		Positive					Positive	Other					-23992	513		0	1161					NO		70-79%			2013-10-2	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1460	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf	A2LN	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	01	Mastectomy	7th		NO	YES	AR	Breast	A	LIVING	2010	8a23348d-3371-431e-a6c8-b031cde82279	e0e62b44-bcb1-4776-843d-a9493b115324	8a23348d-3371-431e-a6c8-b031cde82279	e0e62b44-bcb1-4776-843d-a9493b115324	TCGA-AR-A2LN-01A-31-A24A-20			TCGA-AR-A2LN-01	TCGA-AR-A2LN-01A-21D-A18O-05		bbf9a555-e910-4604-bffd-d7e76c024c46	TCGA-AR-A2LN-01	TCGA-AR-A2LN-01A-21D-A18P-09			TCGA-AR-A2LN-01			8a23348d-3371-431e-a6c8-b031cde82279		TCGA-AR-A2LN-01A-21D-A18N-01	TCGA-AR-A2LN-01		8a23348d-3371-431e-a6c8-b031cde82279	TCGA-AR-A2LN-01A-21D-A18N-01	
TCGA-AR-A2LO-01																			LumA										0	TCGA-AR-A2LO-01	1198	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-AR-A2LO	1198	0	days	1198	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LO-F49498	TCGA-AR-A2LO	TCGA-AR-A2LO-01A		Positive					Positive	Simple Mastectomy					-17080	486		0	1198					NO		70-79%			2013-10-2	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1650	NO	Equivocal	Negative		16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf	A2LO	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2010	3e71718b-3ab9-4b0d-a92b-52c46e6f1670	491e98e5-27e9-4e1e-809b-09a3715fc609	3e71718b-3ab9-4b0d-a92b-52c46e6f1670	491e98e5-27e9-4e1e-809b-09a3715fc609	TCGA-AR-A2LO-01A-41-A24A-20			TCGA-AR-A2LO-01	TCGA-AR-A2LO-01A-31D-A18O-05		d9a30b5c-ba93-4cee-8ad7-937a95df1679	TCGA-AR-A2LO-01	TCGA-AR-A2LO-01A-31D-A18P-09			TCGA-AR-A2LO-01			3e71718b-3ab9-4b0d-a92b-52c46e6f1670		TCGA-AR-A2LO-01A-31D-A19G-01	TCGA-AR-A2LO-01		3e71718b-3ab9-4b0d-a92b-52c46e6f1670	TCGA-AR-A2LO-01A-31D-A19G-01	
TCGA-AR-A2LQ-01																			Normal										0	TCGA-AR-A2LQ-01	1233	0	days	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-AR-A2LQ	1233	0	days	1233	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LQ-F49500	TCGA-AR-A2LQ	TCGA-AR-A2LQ-01A		Positive					Positive	Simple Mastectomy					-21865	449		0	1233					NO		70-79%			2013-10-2	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1270	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T3	Stage IIB	TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf	A2LQ	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2010	7a72bd47-7504-4a59-ae95-096c32f70965	895c4a2a-2c43-4e3a-ab26-694f80b7ca70	7a72bd47-7504-4a59-ae95-096c32f70965	895c4a2a-2c43-4e3a-ab26-694f80b7ca70	TCGA-AR-A2LQ-01A-11-A24A-20			TCGA-AR-A2LQ-01	TCGA-AR-A2LQ-01A-22D-A18O-05		a4b9430f-9ede-4e82-8d92-b7483d029609	TCGA-AR-A2LQ-01	TCGA-AR-A2LQ-01A-22D-A18P-09			TCGA-AR-A2LQ-01			7a72bd47-7504-4a59-ae95-096c32f70965		TCGA-AR-A2LQ-01A-22D-A18N-01	TCGA-AR-A2LQ-01		7a72bd47-7504-4a59-ae95-096c32f70965	TCGA-AR-A2LQ-01A-22D-A18N-01	
TCGA-AR-A2LR-01																			Basal										0	TCGA-AR-A2LR-01	1742	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 5			TCGA-AR-A2LR	1742	0	days	1742	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A2LR-F71747	TCGA-AR-A2LR	TCGA-AR-A2LR-01A		Negative					Negative	Simple Mastectomy					-18214	447		0	1742					NO					2015-3-30	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	800	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	Yes	M0	N0	T1	Stage I	TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf	A2LR	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2010	9f693816-6957-413c-a100-54f7bc0eddf9	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	9f693816-6957-413c-a100-54f7bc0eddf9	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	TCGA-AR-A2LR-01A-21-A24A-20			TCGA-AR-A2LR-01	TCGA-AR-A2LR-01A-12D-A18O-05		1504ffd3-5ca4-4858-a554-120455f8d456	TCGA-AR-A2LR-01	TCGA-AR-A2LR-01A-12D-A18P-09						9f693816-6957-413c-a100-54f7bc0eddf9		TCGA-AR-A2LR-01A-12D-A18N-01			9f693816-6957-413c-a100-54f7bc0eddf9	TCGA-AR-A2LR-01A-12D-A18N-01	
TCGA-AR-A5QM-01																													0	TCGA-AR-A5QM-01	2231	0	days										TCGA-AR-A5QM	2231	0	days	2231	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A5QM-F43848	TCGA-AR-A5QM	TCGA-AR-A5QM-01A		Positive					Positive	Other					-22780	1541		0	2231			968							2014-12-31	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	350	NO	Equivocal		NO	9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	New Primary Tumor	Malignant melanoma		NO	0		true	Yes	M0	N0	T2	Stage IIA	TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F.pdf	A5QM	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Wide Excision	6th		NO	YES	AR	Breast	A	LIVING	2008	6bbb74ed-93be-4cbe-a854-4ea6aaec0615	2bb73e92-de96-408c-a239-ed6999006c6f	6bbb74ed-93be-4cbe-a854-4ea6aaec0615	2bb73e92-de96-408c-a239-ed6999006c6f				TCGA-AR-A5QM-01	TCGA-AR-A5QM-01A-11D-A27Y-05		049c6f4f-37ba-4507-b37b-0686a3b7bf19	TCGA-AR-A5QM-01	TCGA-AR-A5QM-01A-11D-A27P-09			TCGA-AR-A5QM-01			6bbb74ed-93be-4cbe-a854-4ea6aaec0615		TCGA-AR-A5QM-01A-11D-A27O-01	TCGA-AR-A5QM-01		6bbb74ed-93be-4cbe-a854-4ea6aaec0615	TCGA-AR-A5QM-01A-11D-A27O-01	
TCGA-AR-A5QN-01																													0	TCGA-AR-A5QN-01	1013	0	days										TCGA-AR-A5QN	1013	0	days	1013	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left	Axillary lymph node dissection alone		TCGA-AR-A5QN-F69265	TCGA-AR-A5QN	TCGA-AR-A5QN-01A		Positive					Positive	Modified Radical Mastectomy					-25089	328		0	1013										2014-12-31	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO	Positive		NO	19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	10		true	No	M0	N3	T2	Stage IIIC	TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf	A5QN	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2012	76353751-a05c-432e-a35b-12f2bf62a494	c5bb2a65-d71d-4a5b-bc29-afc97e38b8c1	76353751-a05c-432e-a35b-12f2bf62a494	c5bb2a65-d71d-4a5b-bc29-afc97e38b8c1				TCGA-AR-A5QN-01	TCGA-AR-A5QN-01A-12D-A28C-05		29dda56e-2d14-4864-97a2-03bc1a97e7fd	TCGA-AR-A5QN-01	TCGA-AR-A5QN-01A-12D-A28B-09			TCGA-AR-A5QN-01			76353751-a05c-432e-a35b-12f2bf62a494		TCGA-AR-A5QN-01A-12D-A28A-01	TCGA-AR-A5QN-01		76353751-a05c-432e-a35b-12f2bf62a494	TCGA-AR-A5QN-01A-12D-A28A-01	
TCGA-AR-A5QP-01																													0	TCGA-AR-A5QP-01	1185	0	days										TCGA-AR-A5QP	1185	0	days	1185	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-AR-A5QP-F69266	TCGA-AR-A5QP	TCGA-AR-A5QP-01A		Positive					Positive	Lumpectomy					-19805	498		0	1185										2014-12-31	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			230	NO	Equivocal		NO	40		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf	A5QP	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	LIVING	2011	b2d0c724-40ae-44ca-90eb-ce86a9546c05	62f32fa7-690a-4896-980a-831208a3c6ae	b2d0c724-40ae-44ca-90eb-ce86a9546c05	62f32fa7-690a-4896-980a-831208a3c6ae				TCGA-AR-A5QP-01	TCGA-AR-A5QP-01A-11D-A28C-05		160070ff-2113-459e-b1ab-ffe2167da75d	TCGA-AR-A5QP-01	TCGA-AR-A5QP-01A-11D-A28B-09			TCGA-AR-A5QP-01			b2d0c724-40ae-44ca-90eb-ce86a9546c05		TCGA-AR-A5QP-01A-11D-A28A-01	TCGA-AR-A5QP-01		b2d0c724-40ae-44ca-90eb-ce86a9546c05	TCGA-AR-A5QP-01A-11D-A28A-01	
TCGA-AR-A5QQ-01																													1	TCGA-AR-A5QQ-01	322	1	days										TCGA-AR-A5QQ	301	1	days	322	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right	Axillary lymph node dissection alone		TCGA-AR-A5QQ-F42734	TCGA-AR-A5QQ	TCGA-AR-A5QQ-01A		Negative					Negative	Modified Radical Mastectomy					-24841	576	322	0				301							2013-6-10	FEMALE					1+					Other, specify		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	800	NO	Negative		NO	24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis	Liver, bone, chest wall, adrenal glands		YES	1		true	No	M0	N1	T3	Stage IIIA	TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf	A5QQ	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th		NO	YES	AR	Breast	A	DECEASED	2011	16f90247-c9a5-40d5-a3a1-08bba2d1d266	d871dcd8-1cb2-4c05-8ecf-4e30837267ff	16f90247-c9a5-40d5-a3a1-08bba2d1d266	d871dcd8-1cb2-4c05-8ecf-4e30837267ff				TCGA-AR-A5QQ-01	TCGA-AR-A5QQ-01A-11D-A28C-05		23195a90-ef03-4655-9b11-4668986a94c3	TCGA-AR-A5QQ-01	TCGA-AR-A5QQ-01A-11D-A28B-09			TCGA-AR-A5QQ-01			16f90247-c9a5-40d5-a3a1-08bba2d1d266		TCGA-AR-A5QQ-01A-11D-A28A-01	TCGA-AR-A5QQ-01		16f90247-c9a5-40d5-a3a1-08bba2d1d266	TCGA-AR-A5QQ-01A-11D-A28A-01	
TCGA-B6-A0I1-01																			Basal										1	TCGA-B6-A0I1-01	2361	1	days	High			BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4			TCGA-B6-A0I1	1120	1	days	2361	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			73	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0I1-F38909	TCGA-B6-A0I1	TCGA-B6-A0I1-01A		Negative					Negative	Modified Radical Mastectomy		NO			-26902	4248	2361	0			1120	1120			image cytometry				2013-1-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	100	NO			NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Negative												Negative								Lung	Distant Metastasis		YES	YES	0		true	No	M0	N0	T2	Stage IIA	TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf	A0I1	TUMOR FREE	image cytometry					NO	YES			NO	Primary Tumor	01		5th		NO	YES	B6	Breast	A	DECEASED	1998	785856fc-d042-4b7f-a137-95b17c59b876	42f8da15-4b82-4660-8f91-7bf874fbe35c	785856fc-d042-4b7f-a137-95b17c59b876	42f8da15-4b82-4660-8f91-7bf874fbe35c				TCGA-B6-A0I1-01	TCGA-B6-A0I1-01A-11D-A21R-05			TCGA-B6-A0I1-01	TCGA-B6-A0I1-01A-11D-A21Q-09			TCGA-B6-A0I1-01			785856fc-d042-4b7f-a137-95b17c59b876		TCGA-B6-A0I1-01A-11D-A21P-01	TCGA-B6-A0I1-01		785856fc-d042-4b7f-a137-95b17c59b876	TCGA-B6-A0I1-01A-11D-A21P-01	
TCGA-B6-A0I2-01	Stage IA	45	3	Stage I	4360			FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	4360	0	Basal	Basal-like		ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA-B6-A0I2-01	4361	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-B6-A0I2	4361	0	days	4361	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0I2-F12630	TCGA-B6-A0I2	TCGA-B6-A0I2-01A										NO			-16702	5305		0	4361									Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO				8		Indeterminate (neither Pre or Postmenopausal)																				5	3								NO	0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E.pdf	A0I2	TUMOR FREE										YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1995	7175b3eb-5198-4d7f-b205-91ae8df344b4	aa5e3733-d47a-4371-99ab-34d98aec9bf6	7175b3eb-5198-4d7f-b205-91ae8df344b4	aa5e3733-d47a-4371-99ab-34d98aec9bf6	TCGA-B6-A0I2-01A-21-A13C-20	TCGA-B6-A0I2-01A-11W-A050-09		TCGA-B6-A0I2-01			3c520911-0d5d-4a69-bef5-f2666b99544c	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01A-11W-A050-09	TCGA-B6-A0I2-01A-11D-A032-05	TCGA-B6-A0I2-01		TCGA-B6-A0I2-01A-11W-A050-09	TCGA-B6-A0I2-01	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01A-11D-A036-01		TCGA-B6-A0I2-01A-11R-A034-07	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA-B6-A0I2-01A-11D-A036-01	TCGA-B6-A0I2-01
TCGA-B6-A0I5-01	Stage IIB	49	2	No_Conversion	4549		Positive	FEMALE	Negative				Negative	M0	Positive	N1	4549	0	LumA	Luminal A	Positive		-5	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0I5-01	8556	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation cluster 4	TCGA-B6-A0I5	8556	0	days	8556	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0I5-F71505	TCGA-B6-A0I5	TCGA-B6-A0I5-01A		Positive					Positive	Other		NO			-18038	7820		0	8556									Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	biopsy, NOS	Other method, specify:	50	NO			NO	13	Negative	Indeterminate (neither Pre or Postmenopausal)																				1	6								NO	5		true	No	M0	N1b	T2	Stage IIB	TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D.pdf	A0I5	TUMOR FREE						YES				NO	Primary Tumor	01	biopsy	3rd	YES	NO	YES	B6	Breast	A	LIVING	1988	2448118f-9664-4b9e-b67f-c019cf5b8d35	2ecbf2ad-e0d5-4197-a4a1-90014bdcc615	2448118f-9664-4b9e-b67f-c019cf5b8d35	2ecbf2ad-e0d5-4197-a4a1-90014bdcc615		TCGA-B6-A0I5-01A-11W-A100-09		TCGA-B6-A0I5-01				TCGA-B6-A0I5-01	TCGA-B6-A0I5-01A-11W-A100-09	TCGA-B6-A0I5-01A-11D-A032-05	TCGA-B6-A0I5-01		TCGA-B6-A0I5-01A-11W-A100-09	TCGA-B6-A0I5-01	2448118f-9664-4b9e-b67f-c019cf5b8d35	TCGA-B6-A0I5-01	TCGA-B6-A0I5-01A-11D-A036-01		TCGA-B6-A0I5-01A-11R-A034-07	2448118f-9664-4b9e-b67f-c019cf5b8d35	TCGA-B6-A0I5-01A-11D-A036-01	TCGA-B6-A0I5-01
TCGA-B6-A0I6-01	Stage IIA	49		No_Conversion	991	997	Negative	FEMALE					Negative	M0	Positive	N1	997	1	Basal	Basal-like	Negative	Basal	-13	0	followup	T1	T1	DECEASED	1	TCGA-B6-A0I6-01	991	1	days		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I6	859	1	days	991	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		49	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0I6-F12605	TCGA-B6-A0I6	TCGA-B6-A0I6-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18014	7362	991	0				859						Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	200	NO				32	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	4				Other, specify	Distant Metastasis	Skin and bone		YES	6		true	No	M0	N1	T1c	Stage IIA	TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9.pdf	A0I6	WITH TUMOR										NO	Primary Tumor	01		3rd	YES	NO	YES	B6	Breast	A	DECEASED	1990	09c248f8-cdd7-4c13-9085-26c56544bcf7	ba92130c-fd4f-492f-b4c8-8420a9d017f9	09c248f8-cdd7-4c13-9085-26c56544bcf7	ba92130c-fd4f-492f-b4c8-8420a9d017f9	TCGA-B6-A0I6-01A-21-A13B-20	TCGA-B6-A0I6-01A-11D-A128-09		TCGA-B6-A0I6-01			4b55651d-88f5-411e-9986-702e8173a3d9		TCGA-B6-A0I6-01A-11D-A128-09	TCGA-B6-A0I6-01A-11D-A032-05			TCGA-B6-A0I6-01A-11D-A128-09	TCGA-B6-A0I6-01	09c248f8-cdd7-4c13-9085-26c56544bcf7	TCGA-B6-A0I6-01			TCGA-B6-A0I6-01A-11R-A034-07	09c248f8-cdd7-4c13-9085-26c56544bcf7		TCGA-B6-A0I6-01
TCGA-B6-A0I8-01		46		No_Conversion	749	749		FEMALE					Negative	M0	Negative	N0	749	1	LumA	Luminal A		Her2	0	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0I8-01	749	1	days		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I8	746	1	days	749	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	YES		46	Right Upper Inner Quadrant|Right	No axillary staging		TCGA-B6-A0I8-F12607	TCGA-B6-A0I8	TCGA-B6-A0I8-01A										NO		746	-17073	6372	749	0				746						Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	190	NO				0		Indeterminate (neither Pre or Postmenopausal)																				2	4				Other, specify	Locoregional Disease	Pectoral muscle		YES			true	Yes	M0	NX	T1	Stage X	TCGA-B6-A0I8.E958CD3C-EE14-4CE1-B55C-7830E320F6AE.pdf	A0I8	WITH TUMOR										NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1992	c71ca9f7-248f-460c-b5d3-afb2c648fef2	20605d45-0b1d-4c98-a2fe-8ad7e9f81b22	c71ca9f7-248f-460c-b5d3-afb2c648fef2	20605d45-0b1d-4c98-a2fe-8ad7e9f81b22	TCGA-B6-A0I8-01A-21-A13B-20	TCGA-B6-A0I8-01A-11W-A050-09		TCGA-B6-A0I8-01			b8370b84-548e-42c1-8cf5-435502ae0050		TCGA-B6-A0I8-01A-11W-A050-09	TCGA-B6-A0I8-01A-11D-A032-05			TCGA-B6-A0I8-01A-11W-A050-09	TCGA-B6-A0I8-01	c71ca9f7-248f-460c-b5d3-afb2c648fef2	TCGA-B6-A0I8-01			TCGA-B6-A0I8-01A-11R-A034-07	c71ca9f7-248f-460c-b5d3-afb2c648fef2		TCGA-B6-A0I8-01
TCGA-B6-A0I9-01	Stage IV	62	5	No_Conversion	369	369	Indeterminate	FEMALE	Positive	1	1	1	Positive	M1	Negative	N0	369	1	Her2	HER2-enriched	Positive	Her2	-2	-5	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0I9-01	362	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0I9	362	0	days	362	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Outer Quadrant|Left	No axillary staging		TCGA-B6-A0I9-F12609	TCGA-B6-A0I9	TCGA-B6-A0I9-01A		Indeterminate					Positive			NO			-22798	6687	362	0							IHC			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	180	NO						Indeterminate (neither Pre or Postmenopausal)																		Bone		4	4								NO			true	No	M1	NX	T3	Stage IV	TCGA-B6-A0I9.291884D2-FDFD-4C98-BA19-1A0824ABB68F.pdf	A0I9	WITH TUMOR	IHC									YES	Primary Tumor	01		3rd	YES	NO	YES	B6	Breast	A	DECEASED	1992	1a99c4ba-6948-4054-96cd-62164ff4a6f0	947bb0f4-c580-43da-967d-1026abbd4e32	1a99c4ba-6948-4054-96cd-62164ff4a6f0	947bb0f4-c580-43da-967d-1026abbd4e32	TCGA-B6-A0I9-01A-21-A13B-20	TCGA-B6-A0I9-01A-11W-A050-09		TCGA-B6-A0I9-01			be91388f-7261-4e1a-94a0-29215be9bb4d	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01A-11W-A050-09	TCGA-B6-A0I9-01A-11D-A032-05	TCGA-B6-A0I9-01		TCGA-B6-A0I9-01A-11W-A050-09	TCGA-B6-A0I9-01	1a99c4ba-6948-4054-96cd-62164ff4a6f0	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01A-11D-A036-01		TCGA-B6-A0I9-01A-11R-A034-07	1a99c4ba-6948-4054-96cd-62164ff4a6f0	TCGA-B6-A0I9-01A-11D-A036-01	TCGA-B6-A0I9-01
TCGA-B6-A0IA-01	Stage IIA	51	4	Stage IIA	6718		Positive	FEMALE	Negative				Negative	M0	Negative	N0	6718	0	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0IA-01	8391	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-B6-A0IA	8391	0	days	8391	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right	Axillary lymph node dissection alone		TCGA-B6-A0IA-F71513	TCGA-B6-A0IA	TCGA-B6-A0IA-01A		Positive					Positive	Other		NO			-18748	6664		0	8391						IHC			Scheduled Follow-up Submission	2015-3-26	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES	Biopsy, NOS	Other method, specify:	70	NO			NO	15	Negative	Indeterminate (neither Pre or Postmenopausal)																				2	4								NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf	A0IA	TUMOR FREE	IHC					YES				NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	Breast	A	LIVING	1992	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	8b4314b3-0f2a-4451-87ff-ad498c7a1ab9	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	8b4314b3-0f2a-4451-87ff-ad498c7a1ab9		TCGA-B6-A0IA-01A-11W-A050-09		TCGA-B6-A0IA-01				TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01A-11D-A032-05	TCGA-B6-A0IA-01		TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11D-A036-01		TCGA-B6-A0IA-01A-11R-A034-07	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01A-11D-A036-01	TCGA-B6-A0IA-01
TCGA-B6-A0IB-01	Stage IV	64	4	No_Conversion	3941	3941	Positive	FEMALE	Negative	1	3	4	Positive	M1	Positive	N3	3941	1	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0IB-01	3941	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IB	2717	1	days	3941	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		64	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0IB-F12612	TCGA-B6-A0IB	TCGA-B6-A0IB-01A		Positive					Positive	Modified Radical Mastectomy		NO			-23646	6660	3941	0				2717			IHC			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	150	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)	fmol/mg			image cytometry	Positive											image cytometry	Positive	Other, specify	Skin	4	1				Other, specify	Distant Metastasis	lung, bone, liver		YES	8		true	No	M1	N3	T3	Stage IV	TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49.pdf	A0IB	WITH TUMOR	IHC		fmol/mg							NO	Primary Tumor	01		3rd	YES	NO	YES	B6	Breast	A	DECEASED	1992	9857acef-08eb-43d6-b086-4b513e23753a	b7d03467-5de2-47e1-9f1b-2ab9e2a968f4	9857acef-08eb-43d6-b086-4b513e23753a	b7d03467-5de2-47e1-9f1b-2ab9e2a968f4	TCGA-B6-A0IB-01A-21-A13B-20	TCGA-B6-A0IB-01A-11W-A050-09		TCGA-B6-A0IB-01			5e4f32df-eccb-4283-b97e-41addb397f4b	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01A-11W-A050-09	TCGA-B6-A0IB-01A-11D-A032-05	TCGA-B6-A0IB-01		TCGA-B6-A0IB-01A-11W-A050-09	TCGA-B6-A0IB-01	9857acef-08eb-43d6-b086-4b513e23753a	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01A-11D-A036-01		TCGA-B6-A0IB-01A-11R-A034-07	9857acef-08eb-43d6-b086-4b513e23753a	TCGA-B6-A0IB-01A-11D-A036-01	TCGA-B6-A0IB-01
TCGA-B6-A0IC-01		90	2	No_Conversion	1542	1542	Positive	FEMALE	Negative						Negative	N0	1542	1	LumA	Luminal B	Positive		-12	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0IC-01	1542	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0IC	1542	0	days	1542	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right	No axillary staging		TCGA-B6-A0IC-F12613	TCGA-B6-A0IC	TCGA-B6-A0IC-01A		Positive					Positive	Other		NO			-32872	6475	1542	0							IHC			Scheduled Follow-up Submission	2011-6-1	FEMALE										Other, specify		No		C50.9	8503/3	C50.9		YES		Fine needle aspiration biopsy	100	NO					Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO			true	No	MX	NX	T2	Stage X	TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B.pdf	A0IC	TUMOR FREE	IHC									NO	Primary Tumor	01	Excisional biopsy	3rd	NO	NO	YES	B6	Breast	A	DECEASED	1992	718599d7-723a-4121-ac07-51120cde9af1	3f92a9cb-5bd0-44b4-bc75-efe4b8c29b92	718599d7-723a-4121-ac07-51120cde9af1	3f92a9cb-5bd0-44b4-bc75-efe4b8c29b92		TCGA-B6-A0IC-01A-11W-A050-09		TCGA-B6-A0IC-01				TCGA-B6-A0IC-01	TCGA-B6-A0IC-01A-11W-A050-09	TCGA-B6-A0IC-01A-11D-A032-05	TCGA-B6-A0IC-01		TCGA-B6-A0IC-01A-11W-A050-09	TCGA-B6-A0IC-01	718599d7-723a-4121-ac07-51120cde9af1	TCGA-B6-A0IC-01	TCGA-B6-A0IC-01A-11D-A036-01		TCGA-B6-A0IC-01A-11R-A034-07	718599d7-723a-4121-ac07-51120cde9af1	TCGA-B6-A0IC-01A-11D-A036-01	TCGA-B6-A0IC-01
TCGA-B6-A0IE-01		38	3	No_Conversion	1998	1998	Negative	FEMALE	Negative				Negative	M0	Positive	N1	1998	1	LumA	Normal-like	Negative		-2	-3	followup		TX	DECEASED	1	TCGA-B6-A0IE-01	1993	1	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IE	834	1	days	1993	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		38	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IE-F12614	TCGA-B6-A0IE	TCGA-B6-A0IE-01A	Negative	Negative					Negative	Other		NO			-13982	5557	1993	0				834			Image Analysis			Scheduled Follow-up Submission	2011-6-1	FEMALE										Mixed Histology (please specify)	Lobular/Ductal	No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	90	NO				24	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4				Bone	Distant Metastasis			YES	6		true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IE.DFCA9C6E-710E-4645-9CFC-A908AAD583F3.pdf	A0IE	WITH TUMOR	Image Analysis									YES	Primary Tumor	01	Wide re-excisional biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1995	f40b4aa3-b474-4c2e-a197-0347e46d3309	0716b4fb-1209-4a73-b14f-245d7277c7f3	f40b4aa3-b474-4c2e-a197-0347e46d3309	0716b4fb-1209-4a73-b14f-245d7277c7f3		TCGA-B6-A0IE-01A-11W-A050-09		TCGA-B6-A0IE-01				TCGA-B6-A0IE-01	TCGA-B6-A0IE-01A-11W-A050-09	TCGA-B6-A0IE-01A-11D-A032-05	TCGA-B6-A0IE-01		TCGA-B6-A0IE-01A-11W-A050-09	TCGA-B6-A0IE-01	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA-B6-A0IE-01	TCGA-B6-A0IE-01A-11D-A036-01		TCGA-B6-A0IE-01A-11R-A034-07	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA-B6-A0IE-01A-11D-A036-01	TCGA-B6-A0IE-01
TCGA-B6-A0IG-01	Stage IIB	50		No_Conversion	4456	4456	Positive	FEMALE					Negative	M0	Positive	N1	4456	1	LumA	Luminal A	Positive	Her2	-2	0	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0IG-01	4456	1	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 12	TCGA-B6-A0IG			days	4456	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left	Axillary lymph node dissection alone		TCGA-B6-A0IG-F12616	TCGA-B6-A0IG	TCGA-B6-A0IG-01A		Positive					Positive	Modified Radical Mastectomy		NO			-18433	5836	4456	0							Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	200	NO				16	Negative	Indeterminate (neither Pre or Postmenopausal)																				4	7									4		true	No	M0	N1b	T2	Stage IIB	TCGA-B6-A0IG.4379DEE0-F7CB-4A73-8828-21EA0AA830F5.pdf	A0IG	WITH TUMOR	Image Analysis									YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1994	463d3f12-16bb-456a-8fb1-f200c7996406	9c3fcdbc-c563-416e-8cd4-b95d15b9bee9	463d3f12-16bb-456a-8fb1-f200c7996406	9c3fcdbc-c563-416e-8cd4-b95d15b9bee9	TCGA-B6-A0IG-01A-21-A13B-20	TCGA-B6-A0IG-01A-11W-A050-09		TCGA-B6-A0IG-01			439c88c2-8efe-4981-96b8-015a9360ec6a	TCGA-B6-A0IG-01	TCGA-B6-A0IG-01A-11W-A050-09	TCGA-B6-A0IG-01A-11D-A032-05	TCGA-B6-A0IG-01		TCGA-B6-A0IG-01A-11W-A050-09	TCGA-B6-A0IG-01	463d3f12-16bb-456a-8fb1-f200c7996406	TCGA-B6-A0IG-01	TCGA-B6-A0IG-01A-11D-A036-01		TCGA-B6-A0IG-01A-11R-A034-07	463d3f12-16bb-456a-8fb1-f200c7996406	TCGA-B6-A0IG-01A-11D-A036-01	TCGA-B6-A0IG-01
TCGA-B6-A0IH-01	Stage IIIA	81	2	Stage IIIA		3418	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3418	1	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0IH-01	3418	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-B6-A0IH			days	3418	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IH-F12617	TCGA-B6-A0IH	TCGA-B6-A0IH-01A	Negative	Positive				Modified radical mastectomy	Positive	Other		NO			-29907	5388	3418	0							Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	110	NO				27	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6									25		true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530.pdf	A0IH		Image Analysis						YES			YES	Primary Tumor	01	Excisional biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1995	76fabc98-ad85-4315-8653-4028e24cd2ff	79e2c7cc-5875-41c6-9586-301a4aea7597	76fabc98-ad85-4315-8653-4028e24cd2ff	79e2c7cc-5875-41c6-9586-301a4aea7597		TCGA-B6-A0IH-01A-11D-A10Y-09		TCGA-B6-A0IH-01				TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11D-A10Y-09	TCGA-B6-A0IH-01A-11D-A112-05	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11D-A10Y-09		76fabc98-ad85-4315-8653-4028e24cd2ff		TCGA-B6-A0IH-01A-11D-A111-01	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11R-A115-07	76fabc98-ad85-4315-8653-4028e24cd2ff	TCGA-B6-A0IH-01A-11D-A111-01	TCGA-B6-A0IH-01
TCGA-B6-A0IJ-01	Stage IIB	42	3	Stage IIB	5383		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	5383	0	Basal	Basal-like	Positive	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IJ-01	7106	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-B6-A0IJ	7106	0	days	7106	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0IJ-F71500	TCGA-B6-A0IJ	TCGA-B6-A0IJ-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15625	5350		0	7106						Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	170	NO			NO	27	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	5								NO	0		true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD.pdf	A0IJ	TUMOR FREE	Image Analysis					YES				NO	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1995	f77e9ef0-0a62-426b-98d9-6813edeb63a5	6c71c171-be2a-4eac-bae9-841c1192ab61	f77e9ef0-0a62-426b-98d9-6813edeb63a5	6c71c171-be2a-4eac-bae9-841c1192ab61	TCGA-B6-A0IJ-01A-21-A13B-20	TCGA-B6-A0IJ-01A-11W-A050-09		TCGA-B6-A0IJ-01			25933fc4-60a0-4223-af5f-c8eed92f0f02	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01A-11W-A050-09	TCGA-B6-A0IJ-01A-11D-A032-05	TCGA-B6-A0IJ-01		TCGA-B6-A0IJ-01A-11W-A050-09	TCGA-B6-A0IJ-01	f77e9ef0-0a62-426b-98d9-6813edeb63a5	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01A-11D-A036-01		TCGA-B6-A0IJ-01A-11R-A034-07	f77e9ef0-0a62-426b-98d9-6813edeb63a5	TCGA-B6-A0IJ-01A-11D-A036-01	TCGA-B6-A0IJ-01
TCGA-B6-A0IK-01	Stage IIIB	63	5	No_Conversion	571	571	Negative	FEMALE	Negative	1	1	1	Negative	M0	Positive	N1	571	1	Her2	HER2-enriched	Negative	ReacII	-11	-5	followup	T_Other	T4	DECEASED	1	TCGA-B6-A0IK-01	571	1	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IK	489	1	days	571	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	YES		63	Left			TCGA-B6-A0IK-F12621	TCGA-B6-A0IK	TCGA-B6-A0IK-01A	Negative	Negative				Modified radical mastectomy	Negative	Lumpectomy		NO		489	-23150	5724	571	0				489			Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	140	NO				14	Positive	Indeterminate (neither Pre or Postmenopausal)																				4	4				Brain	Distant Metastasis			YES	1		true	No	M0	N1	T4	Stage IIIB	TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A.pdf	A0IK	WITH TUMOR	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1994	8fb338fe-ffa8-45c2-857b-f713d1935330	e0a41bf9-0af4-4a94-9b08-724a938ae4ae	8fb338fe-ffa8-45c2-857b-f713d1935330	e0a41bf9-0af4-4a94-9b08-724a938ae4ae	TCGA-B6-A0IK-01A-21-A13B-20	TCGA-B6-A0IK-01A-12W-A071-09		TCGA-B6-A0IK-01	TCGA-B6-A0IK-01A-12D-A10P-05		3d6a2ce9-3d70-4bec-80f1-bd5035ae2b3d	TCGA-B6-A0IK-01	TCGA-B6-A0IK-01A-12W-A071-09		TCGA-B6-A0IK-01		TCGA-B6-A0IK-01A-12W-A071-09	TCGA-B6-A0IK-01	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01	TCGA-B6-A0IK-01A-12D-A059-01		TCGA-B6-A0IK-01A-12R-A056-07	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01A-12D-A059-01	TCGA-B6-A0IK-01
TCGA-B6-A0IM-01	Stage IIB	75	4	Stage IIB	3836		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3836	0	LumA	Luminal B	Positive		-10	-3	followup	T_Other	T3	LIVING	1	TCGA-B6-A0IM-01	3873	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0IM	3873	0	days	3873	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0IM-F12623	TCGA-B6-A0IM	TCGA-B6-A0IM-01A	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		NO			-27557	4754	3873	0	3836						Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	110	NO				9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734.pdf	A0IM	TUMOR FREE	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1997	53f4d557-cad7-4367-9546-c10752cc6189	a12ef456-3010-4ec9-a428-0259be208606	53f4d557-cad7-4367-9546-c10752cc6189	a12ef456-3010-4ec9-a428-0259be208606		TCGA-B6-A0IM-01A-11W-A050-09		TCGA-B6-A0IM-01				TCGA-B6-A0IM-01	TCGA-B6-A0IM-01A-11W-A050-09	TCGA-B6-A0IM-01A-11D-A032-05	TCGA-B6-A0IM-01		TCGA-B6-A0IM-01A-11W-A050-09	TCGA-B6-A0IM-01	53f4d557-cad7-4367-9546-c10752cc6189	TCGA-B6-A0IM-01	TCGA-B6-A0IM-01A-11D-A036-01		TCGA-B6-A0IM-01A-11R-A034-07	53f4d557-cad7-4367-9546-c10752cc6189	TCGA-B6-A0IM-01A-11D-A036-01	TCGA-B6-A0IM-01
TCGA-B6-A0IN-01		45	3	No_Conversion	2573	2573	Positive	FEMALE							Negative	N0	2573	1	LumB	Luminal A	Negative		-2	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0IN-01	2573	1	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IN	1412	1	days	2573	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES		NO		45	Right Upper Outer Quadrant|Right	No axillary staging		TCGA-B6-A0IN-F12625	TCGA-B6-A0IN	TCGA-B6-A0IN-01A	Negative	Positive				Modified radical mastectomy	Negative	Other		NO			-16705	5073	2573	0				1412			Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	20	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																				4	1				Other, specify	Distant Metastasis	bone, brain		YES			true	No	MX	NX	T1c	Stage X	TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf	A0IN	WITH TUMOR	Image Analysis									NO	Primary Tumor	01	Excisional biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1996	4eaae575-d631-4e2e-8e70-4b4e0a429d74	83dfa7a2-901f-40ed-ab73-fa8f0a938566	4eaae575-d631-4e2e-8e70-4b4e0a429d74	83dfa7a2-901f-40ed-ab73-fa8f0a938566		TCGA-B6-A0IN-01A-11W-A050-09		TCGA-B6-A0IN-01				TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01A-11D-A032-05	TCGA-B6-A0IN-01		TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11D-A036-01		TCGA-B6-A0IN-01A-11R-A034-07	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01A-11D-A036-01	TCGA-B6-A0IN-01
TCGA-B6-A0IO-01	Stage IIA	66	3	Stage IIA	3350		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	3350	0	LumA	Luminal A	Indeterminate	X	0	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0IO-01	5042	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IO	5042	0	days	5042	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left	Axillary lymph node dissection alone		TCGA-B6-A0IO-F71503	TCGA-B6-A0IO			Positive					Indeterminate	Modified Radical Mastectomy		NO			-24322			0	5042						Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy					NO	17	Negative	Indeterminate (neither Pre or Postmenopausal)																				2	1								NO	0			No	M0	N0 (i-)	T2	Stage IIA		A0IO	TUMOR FREE	Image Analysis					YES				NO	Primary Tumor	01			YES	NO	YES	B6	Breast		LIVING	2001	e7a1527b-dbaf-48ae-a322-e54efd36985d	e9f6dacc-c812-45f5-8ec1-d70866537325	e7a1527b-dbaf-48ae-a322-e54efd36985d	e9f6dacc-c812-45f5-8ec1-d70866537325	TCGA-B6-A0IO-01A-21-A13B-20	TCGA-B6-A0IO-01A-11W-A050-09		TCGA-B6-A0IO-01			f7075f2f-6892-4338-b042-1c48529275bd	TCGA-B6-A0IO-01	TCGA-B6-A0IO-01A-11W-A050-09	TCGA-B6-A0IO-01A-11D-A032-05	TCGA-B6-A0IO-01		TCGA-B6-A0IO-01A-11W-A050-09	TCGA-B6-A0IO-01	e7a1527b-dbaf-48ae-a322-e54efd36985d	TCGA-B6-A0IO-01	TCGA-B6-A0IO-01A-11D-A036-01		TCGA-B6-A0IO-01A-11R-A034-07	e7a1527b-dbaf-48ae-a322-e54efd36985d	TCGA-B6-A0IO-01A-11D-A036-01	TCGA-B6-A0IO-01
TCGA-B6-A0IP-01	Stage IA	74	2	Stage I	3374		Positive	FEMALE	Negative				Negative	M0	Negative	N0	3374	0	LumA	Luminal A	Positive		-5	0	followup	T1	T1	LIVING	1	TCGA-B6-A0IP-01	3926	1	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0IP	3926	0	days	3926	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0IP-F71501	TCGA-B6-A0IP	TCGA-B6-A0IP-01A		Positive					Positive	Modified Radical Mastectomy		NO			-27047	4565	3926	0	3374						IMAGE ALYSIS			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO			NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268.pdf	A0IP	TUMOR FREE	IMAGE ALYSIS						YES			NO	Primary Tumor	01			NO	NO	YES	B6	Breast	A	DECEASED	1997	9384eb09-5787-49e8-b07e-bd9f71997771	12dff233-d164-4560-8045-1712fd973416	9384eb09-5787-49e8-b07e-bd9f71997771	12dff233-d164-4560-8045-1712fd973416		TCGA-B6-A0IP-01A-11D-A045-09		TCGA-B6-A0IP-01				TCGA-B6-A0IP-01	TCGA-B6-A0IP-01A-11D-A045-09	TCGA-B6-A0IP-01A-11D-A032-05	TCGA-B6-A0IP-01		TCGA-B6-A0IP-01A-11D-A045-09	TCGA-B6-A0IP-01	9384eb09-5787-49e8-b07e-bd9f71997771	TCGA-B6-A0IP-01	TCGA-B6-A0IP-01A-11D-A036-01		TCGA-B6-A0IP-01A-11R-A034-07	9384eb09-5787-49e8-b07e-bd9f71997771	TCGA-B6-A0IP-01A-11D-A036-01	TCGA-B6-A0IP-01
TCGA-B6-A0IQ-01	Stage IIIA	40	1	No_Conversion	4284		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	4284	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IQ-01	4285	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 5	TCGA-B6-A0IQ	4285	0	days	4285	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0IQ-F12629	TCGA-B6-A0IQ	TCGA-B6-A0IQ-01A		Negative					Negative	Modified Radical Mastectomy		NO			-14669	5238		0	4285						Image Analysis			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	210	NO				26	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	5								NO	1		true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf	A0IQ	TUMOR FREE	Image Analysis									YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1996	2e9c893c-1d72-49a7-8755-1ede20b26fcf	758e3752-e267-4bb3-be83-a88b6eb7e9fc	2e9c893c-1d72-49a7-8755-1ede20b26fcf	758e3752-e267-4bb3-be83-a88b6eb7e9fc	TCGA-B6-A0IQ-01A-21-A13B-20	TCGA-B6-A0IQ-01A-11W-A050-09		TCGA-B6-A0IQ-01			940d8074-3223-49f6-8d86-d50e9ae69c9b	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01A-11D-A032-05	TCGA-B6-A0IQ-01		TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11D-A036-01		TCGA-B6-A0IQ-01A-11R-A034-07	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01A-11D-A036-01	TCGA-B6-A0IQ-01
TCGA-B6-A0RE-01		61	1	No_Conversion	6434		Negative	FEMALE	Negative				Negative	M0	Negative	N0	6434	0	Basal	Basal-like	Negative		-13	-12	followup		TX	LIVING	0	TCGA-B6-A0RE-01	7777	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RE	7777	0	days	7777	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RE-F71507	TCGA-B6-A0RE	TCGA-B6-A0RE-01A		Negative					Negative	Modified Radical Mastectomy		NO			-22449	7492		0	7777									Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Other method, specify:	90	NO			NO	14	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	4								NO	0		true	No	M0	N0 (i-)	TX	Stage X	TCGA-B6-A0RE.5607C6CE-21D5-495E-9174-85F1E2E0CB9D.pdf	A0RE	TUMOR FREE						NO				YES	Primary Tumor	01			NO	NO	YES	B6	Breast	A	LIVING	1989	ad46ed65-3cc2-4956-9d90-3e1edca24417	268d0a2b-cd03-425f-8775-4202f6a2e339	ad46ed65-3cc2-4956-9d90-3e1edca24417	268d0a2b-cd03-425f-8775-4202f6a2e339		TCGA-B6-A0RE-01A-11W-A071-09		TCGA-B6-A0RE-01	TCGA-B6-A0RE-01A-11D-A10P-05			TCGA-B6-A0RE-01	TCGA-B6-A0RE-01A-11W-A071-09		TCGA-B6-A0RE-01		TCGA-B6-A0RE-01A-11W-A071-09	TCGA-B6-A0RE-01	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01	TCGA-B6-A0RE-01A-11D-A059-01		TCGA-B6-A0RE-01A-11R-A056-07	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01A-11D-A059-01	TCGA-B6-A0RE-01
TCGA-B6-A0RG-01	Stage IIB	26	2	Stage IIB	2082		Negative	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	2082	0	LumA	Luminal A	Negative	ReacII	0	-3	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RG-01	2082	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 4	mutation cluster 4	TCGA-B6-A0RG	2082	0	days	2082	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					26	Left	Axillary lymph node dissection alone		TCGA-B6-A0RG-F13793	TCGA-B6-A0RG	TCGA-B6-A0RG-01A		Negative					Negative	Lumpectomy		NO			-9840	6869		0	2082						IHC			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	160	NO				19	Negative	Indeterminate (neither Pre or Postmenopausal)																				2	4								NO	0		true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559.pdf	A0RG	TUMOR FREE	IHC									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1991	006e88ce-ad31-45bf-8da5-802f0e387b3a	64c61d5d-6be8-48e4-a111-3eb9a72f9efc	006e88ce-ad31-45bf-8da5-802f0e387b3a	64c61d5d-6be8-48e4-a111-3eb9a72f9efc	TCGA-B6-A0RG-01A-21-A13C-20	TCGA-B6-A0RG-01A-11W-A071-09		TCGA-B6-A0RG-01	TCGA-B6-A0RG-01A-11D-A10P-05		5da7a020-3d19-499b-9941-2028de5c5a3e	TCGA-B6-A0RG-01	TCGA-B6-A0RG-01A-11W-A071-09		TCGA-B6-A0RG-01		TCGA-B6-A0RG-01A-11W-A071-09	TCGA-B6-A0RG-01	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01	TCGA-B6-A0RG-01A-11D-A059-01		TCGA-B6-A0RG-01A-11R-A056-07	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01A-11D-A059-01	TCGA-B6-A0RG-01
TCGA-B6-A0RH-01	Stage IIA	51	2	Stage IIA	5748		Positive	FEMALE	Positive	3	3	3	Negative	M0	Negative	N0	5748	0	Her2	HER2-enriched	Positive	ReacII	-1	-5	followup	T_Other	T2	LIVING	1	TCGA-B6-A0RH-01	6456	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-B6-A0RH	6456	0	days	6456	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	YES		51	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A0RH-F71512	TCGA-B6-A0RH	TCGA-B6-A0RH-01A	Negative	Positive					Positive	Modified Radical Mastectomy		NO		2268	-18759	6821	6456	0	5749			2165			Immunohistochemistry			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	130	NO			NO	23	Positive	Indeterminate (neither Pre or Postmenopausal)																				2	6				Other, specify	Locoregional Disease	Chest Wall		NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf	A0RH	TUMOR FREE	Immunohistochemistry					YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	B6	Breast	A	DECEASED	1991	d40f62c9-c134-4477-98d7-11d343b5e867	5994c06d-ee9b-4ead-b3d1-2e1f286f7d6d	d40f62c9-c134-4477-98d7-11d343b5e867	5994c06d-ee9b-4ead-b3d1-2e1f286f7d6d	TCGA-B6-A0RH-01A-11-A13C-20	TCGA-B6-A0RH-01A-21D-A10Y-09		TCGA-B6-A0RH-01			90975b3f-f130-4032-804a-88f06b0d3147	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01A-21D-A112-05	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A10Y-09		d40f62c9-c134-4477-98d7-11d343b5e867		TCGA-B6-A0RH-01A-21D-A111-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21R-A115-07	d40f62c9-c134-4477-98d7-11d343b5e867	TCGA-B6-A0RH-01A-21D-A111-01	TCGA-B6-A0RH-01
TCGA-B6-A0RI-01	Stage IIIB	44	2	No_Conversion	7125		Positive	FEMALE	Negative				Negative	M0	Positive	N1	7125	0	LumA	Luminal A	Positive		-7	-3	followup	T_Other	T4	LIVING	0	TCGA-B6-A0RI-01	7126	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0RI	1100	1	days	7126	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	YES		44	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RI-F13795	TCGA-B6-A0RI	TCGA-B6-A0RI-01A		Positive					Positive	Modified Radical Mastectomy		NO		1100	-16138	6755		0	7126			1100			IHC			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	50	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)	105 fmol/mg			image cytometry	Positive					Other Reporting Scale						image cytometry	Positive			2	4			Other Reporting Scale	Other, specify	Locoregional Disease	Chest Wall		YES	6		true	No	M0	N1b	T4b	Stage IIIB	TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6.pdf	A0RI	WITH TUMOR	IHC		133 fmol/mg							YES	Primary Tumor	01		3rd	YES	NO	YES	B6	Breast	A	LIVING	1992	6f5986b6-28b9-4213-97a9-899190ea36dd	83cdf265-ec7f-40cf-ae0c-b1f28c791d7f	6f5986b6-28b9-4213-97a9-899190ea36dd	83cdf265-ec7f-40cf-ae0c-b1f28c791d7f		TCGA-B6-A0RI-01A-11W-A071-09		TCGA-B6-A0RI-01	TCGA-B6-A0RI-01A-11D-A10P-05			TCGA-B6-A0RI-01	TCGA-B6-A0RI-01A-11W-A071-09		TCGA-B6-A0RI-01		TCGA-B6-A0RI-01A-11W-A071-09	TCGA-B6-A0RI-01	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01	TCGA-B6-A0RI-01A-11D-A059-01		TCGA-B6-A0RI-01A-11R-A056-07	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01A-11D-A059-01	TCGA-B6-A0RI-01
TCGA-B6-A0RL-01	Stage IIA	60	2	Stage IIA	2469	2469	Positive	FEMALE	Negative	4	3	4	Negative	M0	Negative	N0	2469	1	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RL-01	2469	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 10	TCGA-B6-A0RL	2469	0	days	2469	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left	Axillary lymph node dissection alone		TCGA-B6-A0RL-F13796	TCGA-B6-A0RL	TCGA-B6-A0RL-01A		Positive					Positive	Modified Radical Mastectomy		NO			-22238	6336	2469	0							Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	170	NO				16	Negative																					3	5								NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-B6-A0RL.6C50D456-A828-4514-92D2-01A5900B74F1.pdf	A0RL	TUMOR FREE	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1993	0e704d8f-c0c0-4165-83c4-a1fa93014894	6217eb8d-0841-471a-aaba-b21023267625	0e704d8f-c0c0-4165-83c4-a1fa93014894	6217eb8d-0841-471a-aaba-b21023267625	TCGA-B6-A0RL-01A-21-A13C-20	TCGA-B6-A0RL-01A-11D-A099-09		TCGA-B6-A0RL-01	TCGA-B6-A0RL-01A-11D-A10P-05		0ca6a866-1fd5-4144-80a9-01cc7f7caa9c	TCGA-B6-A0RL-01			TCGA-B6-A0RL-01		TCGA-B6-A0RL-01A-11D-A099-09	TCGA-B6-A0RL-01	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01	TCGA-B6-A0RL-01A-11D-A087-01		TCGA-B6-A0RL-01A-11R-A084-07	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01A-11D-A087-01	TCGA-B6-A0RL-01
TCGA-B6-A0RM-01		57	4	No_Conversion	2373	2373	Positive	FEMALE	Negative	3	3	3			Negative	N0	2373	1	LumA	Luminal A	Positive	LumA	-10	-3	followup		TX	DECEASED	1	TCGA-B6-A0RM-01	2373	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-B6-A0RM	2373	0	days	2373	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left	No axillary staging		TCGA-B6-A0RM-F13797	TCGA-B6-A0RM	TCGA-B6-A0RM-01A		Positive					Positive			NO			-21047	6279	2373	0							Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	160	NO				0		Indeterminate (neither Pre or Postmenopausal)																				2	2								NO			true	No	MX	NX	TX	Stage X	TCGA-B6-A0RM.EC8093CD-66E7-4466-99AD-B2A6B93526FD.pdf	A0RM	TUMOR FREE	Image Analysis									NO	Primary Tumor	01		4th	NO	NO	YES	B6	Breast	A	DECEASED	1993	17fdb26d-d808-4b0d-a794-6b664dae8b2b	4a733db9-a92f-457b-b0ef-25a0722e9d44	17fdb26d-d808-4b0d-a794-6b664dae8b2b	4a733db9-a92f-457b-b0ef-25a0722e9d44	TCGA-B6-A0RM-01A-21-A13C-20	TCGA-B6-A0RM-01A-11D-A099-09		TCGA-B6-A0RM-01	TCGA-B6-A0RM-01A-11D-A10P-05		10cf7b61-7523-4c17-a786-618537217cff	TCGA-B6-A0RM-01			TCGA-B6-A0RM-01		TCGA-B6-A0RM-01A-11D-A099-09	TCGA-B6-A0RM-01	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01	TCGA-B6-A0RM-01A-11D-A087-01		TCGA-B6-A0RM-01A-11R-A084-07	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01A-11D-A087-01	TCGA-B6-A0RM-01
TCGA-B6-A0RN-01	Stage IA	60	2	Stage I	5261		Negative	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	5261	0	LumA	Luminal A	Negative	ReacI	-5	-3	followup	T1	T1	LIVING	0	TCGA-B6-A0RN-01	8008	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0RN	8008	0	days	8008	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RN-F71514	TCGA-B6-A0RN	TCGA-B6-A0RN-01A		Negative					Negative	Modified Radical Mastectomy		NO			-22077	6286		0	8008						Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	130	NO			NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF.pdf	A0RN	TUMOR FREE	Image Analysis					YES				YES	Primary Tumor	01			YES	NO	YES	B6	Breast	A	LIVING	1993	c417152a-d278-4aeb-951e-a7b6ae5654c1	ff2a4301-de9c-46b1-9b37-4c5c20935883	c417152a-d278-4aeb-951e-a7b6ae5654c1	ff2a4301-de9c-46b1-9b37-4c5c20935883	TCGA-B6-A0RN-01A-21-A13C-20	TCGA-B6-A0RN-01A-12D-A099-09		TCGA-B6-A0RN-01	TCGA-B6-A0RN-01A-12D-A10P-05		734fdc04-4666-4ae2-898f-d375c47eb33b	TCGA-B6-A0RN-01	TCGA-B6-A0RN-01A-12D-A099-09		TCGA-B6-A0RN-01		TCGA-B6-A0RN-01A-12D-A099-09	TCGA-B6-A0RN-01	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01	TCGA-B6-A0RN-01A-12D-A087-01		TCGA-B6-A0RN-01A-12R-A084-07	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01A-12D-A087-01	TCGA-B6-A0RN-01
TCGA-B6-A0RO-01	Stage IIIB	71	3	No_Conversion	4928		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	4928	0	LumA	Luminal A	Positive	ReacI	0	-3	followup	T_Other	T4	LIVING	0	TCGA-B6-A0RO-01	4929	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-B6-A0RO	4929	0	days	4929	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right	Axillary lymph node dissection alone		TCGA-B6-A0RO-F13799	TCGA-B6-A0RO	TCGA-B6-A0RO-01A		Positive					Positive	Modified Radical Mastectomy		NO			-26269	6035		0	4929						Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	140	NO				17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO	2		true	No	M0	N1a	T4	Stage IIIB	TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF.pdf	A0RO	TUMOR FREE	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1993	d99fef01-1eb5-4300-8031-d5a157fd5b28	c42276ca-218e-44c7-9ac3-b8fd17937399	d99fef01-1eb5-4300-8031-d5a157fd5b28	c42276ca-218e-44c7-9ac3-b8fd17937399	TCGA-B6-A0RO-01A-11-A13C-20	TCGA-B6-A0RO-01A-22D-A099-09		TCGA-B6-A0RO-01	TCGA-B6-A0RO-01A-22D-A10P-05		02857059-5b3e-4a7a-a0e0-93ee7f90cfff	TCGA-B6-A0RO-01	TCGA-B6-A0RO-01A-22D-A099-09		TCGA-B6-A0RO-01		TCGA-B6-A0RO-01A-22D-A099-09	TCGA-B6-A0RO-01	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01	TCGA-B6-A0RO-01A-22D-A087-01		TCGA-B6-A0RO-01A-22R-A084-07	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01A-22D-A087-01	TCGA-B6-A0RO-01
TCGA-B6-A0RP-01	Stage IIIB	73	4	No_Conversion	3126	3126	Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	3126	1	LumA	Luminal A	Positive	LumA	-12	-4	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RP-01	3126	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-B6-A0RP	2787	1	days	3126	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		73	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0RP-F13786	TCGA-B6-A0RP		Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		NO			-26941		3126	0				2787			Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Mixed Histology (please specify)	ductal/lobular	No		C50.9	8522/3	C50.9		YES	Biopsy, NOS	Other method, specify:						15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4				Bone	Distant Metastasis			YES	2			No	M0	N1b	T2	[Discrepancy]		A0RP	WITH TUMOR	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast		DECEASED	1994	a77173cb-3e81-4957-a76f-18824d5e06dd	b4881758-2563-45d9-8ad6-1121335492a8	a77173cb-3e81-4957-a76f-18824d5e06dd	b4881758-2563-45d9-8ad6-1121335492a8	TCGA-B6-A0RP-01A-11-A13C-20	TCGA-B6-A0RP-01A-21D-A099-09		TCGA-B6-A0RP-01	TCGA-B6-A0RP-01A-21D-A10P-05		ac2921f3-13fa-457b-b436-1da8977a163c	TCGA-B6-A0RP-01	TCGA-B6-A0RP-01A-21D-A099-09		TCGA-B6-A0RP-01		TCGA-B6-A0RP-01A-21D-A099-09	TCGA-B6-A0RP-01	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01	TCGA-B6-A0RP-01A-21D-A087-01		TCGA-B6-A0RP-01A-21R-A084-07	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01A-21D-A087-01	TCGA-B6-A0RP-01
TCGA-B6-A0RQ-01	Stage IIB	68	1	Stage IIB		4273	Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	4273	1	Normal	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0RQ-01	4267	1	days	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-B6-A0RQ	4267	0	days	4267	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RQ-F13787	TCGA-B6-A0RQ	TCGA-B6-A0RQ-01A	Negative	Positive					Positive	Other		NO			-25010	5890	4267	0							Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	160	NO				14		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0		true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A.pdf	A0RQ	TUMOR FREE	Image Analysis						YES			NO	Primary Tumor	01	excisional biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1994	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	76bd56f0-661c-4165-8818-b564fe6d8b56	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	76bd56f0-661c-4165-8818-b564fe6d8b56	TCGA-B6-A0RQ-01A-21-A13C-20	TCGA-B6-A0RQ-01A-11D-A10Y-09		TCGA-B6-A0RQ-01			23aabbc3-fe66-44d8-8640-5c153f409754	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11D-A10Y-09	TCGA-B6-A0RQ-01A-11D-A112-05	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11D-A10Y-09		184fe3c4-58bb-45c5-a9a5-9a8a56985f9f		TCGA-B6-A0RQ-01A-11D-A111-01	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11R-A115-07	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	TCGA-B6-A0RQ-01A-11D-A111-01	TCGA-B6-A0RQ-01
TCGA-B6-A0RS-01	Stage IIA	38	1	Stage IIA	3062	3062	Negative	FEMALE	Negative				Negative	M0	Negative	N0	3062	1	Her2	HER2-enriched	Negative		0	0	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RS-01	3063	1	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RS	2041	1	days	3063	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		38	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0RS-F13788	TCGA-B6-A0RS			Negative					Negative	Modified Radical Mastectomy		NO		2041	-14134		3063	0				2041						Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:						15	Negative	Indeterminate (neither Pre or Postmenopausal)					Negative												Negative			5	4				Other, specify	New Primary Tumor	Breast		YES	0			No	M0	N0 (i-)	T2	Stage IIA		A0RS	WITH TUMOR										NO	Primary Tumor	01		3rd	YES	NO	YES	B6	Breast		DECEASED	1988	be1f09ae-deec-45d7-8504-fea3f6e7feb4	e191f444-0987-42d9-baed-ceb74591810f	be1f09ae-deec-45d7-8504-fea3f6e7feb4	e191f444-0987-42d9-baed-ceb74591810f		TCGA-B6-A0RS-01A-11D-A099-09		TCGA-B6-A0RS-01	TCGA-B6-A0RS-01A-11D-A10P-05			TCGA-B6-A0RS-01			TCGA-B6-A0RS-01		TCGA-B6-A0RS-01A-11D-A099-09	TCGA-B6-A0RS-01	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01	TCGA-B6-A0RS-01A-11D-A087-01		TCGA-B6-A0RS-01A-11R-A084-07	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01A-11D-A087-01	TCGA-B6-A0RS-01
TCGA-B6-A0RT-01	Stage IIIA	39	1	No_Conversion	2721		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	2721	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RT-01	2721	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-B6-A0RT	2721	0	days	2721	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0RT-F13789	TCGA-B6-A0RT	TCGA-B6-A0RT-01A		Negative					Negative	Modified Radical Mastectomy		NO			-14374	5047		0	2721						Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO				23	Close	Indeterminate (neither Pre or Postmenopausal)																				5	3								NO	1		true	No	M0	N1	T3	Stage IIIA	TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB.pdf	A0RT	TUMOR FREE	Image Analysis									YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1996	2b721e04-5452-4b34-b3df-c6cdd04e87b1	ee1a99fc-1434-4d2f-a989-02edc2d64dba	2b721e04-5452-4b34-b3df-c6cdd04e87b1	ee1a99fc-1434-4d2f-a989-02edc2d64dba	TCGA-B6-A0RT-01A-11-A13C-20	TCGA-B6-A0RT-01A-21D-A099-09		TCGA-B6-A0RT-01	TCGA-B6-A0RT-01A-21D-A10P-05		f4b94eba-e9e8-4f06-812e-7f68eefa407b	TCGA-B6-A0RT-01	TCGA-B6-A0RT-01A-21D-A099-09		TCGA-B6-A0RT-01		TCGA-B6-A0RT-01A-21D-A099-09	TCGA-B6-A0RT-01	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01	TCGA-B6-A0RT-01A-21D-A087-01		TCGA-B6-A0RT-01A-21R-A084-07	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01A-21D-A087-01	TCGA-B6-A0RT-01
TCGA-B6-A0RU-01	Stage IA	49	1	Stage I	3991		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	3991	0	Basal	Basal-like	Negative	Basal	-13	-11	followup	T1	T1	LIVING	0	TCGA-B6-A0RU-01	8605	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-B6-A0RU	8605	0	days	8605	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			YES		40	Right	Axillary lymph node dissection alone		TCGA-B6-A0RU-F71565	TCGA-B6-A0RU	TCGA-B6-A0RU-01A		Negative					Negative	Other		NO		3076	-14920	7290		0	8605			3076			Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Tumor resection	170	NO			NO	15	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	6				Other, specify	New Primary Tumor	Right Breast		NO	0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf	A0RU	TUMOR FREE	Image Analysis					YES				YES	Primary Tumor	01	Excisional biopsy	3rd	YES	NO	YES	B6	Breast	A	LIVING	1990	7abad802-817a-4d95-b022-f21cc4b1d9bc	39df545d-dade-4342-8ac3-312fd5664692	7abad802-817a-4d95-b022-f21cc4b1d9bc	39df545d-dade-4342-8ac3-312fd5664692	TCGA-B6-A0RU-01A-21-A13C-20	TCGA-B6-A0RU-01A-11D-A099-09		TCGA-B6-A0RU-01	TCGA-B6-A0RU-01A-11D-A10P-05		608bb166-ceaa-49d5-ae7d-d4060e8c6dc2	TCGA-B6-A0RU-01	TCGA-B6-A0RU-01A-11D-A099-09		TCGA-B6-A0RU-01		TCGA-B6-A0RU-01A-11D-A099-09	TCGA-B6-A0RU-01	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01	TCGA-B6-A0RU-01A-11D-A087-01		TCGA-B6-A0RU-01A-11R-A084-07	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01A-11D-A087-01	TCGA-B6-A0RU-01
TCGA-B6-A0RV-01	Stage IIIA	42	4	No_Conversion	4788		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	4788	0	LumA	Luminal A	Positive	ReacII	-5	0	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RV-01	5156	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-B6-A0RV	5156	0	days	5156	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right	Axillary lymph node dissection alone		TCGA-B6-A0RV-F13791	TCGA-B6-A0RV	TCGA-B6-A0RV-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15507	5165		0	5156						Image Analysis			Scheduled Follow-up Submission	2011-7-12	FEMALE										Mixed Histology (please specify)	Lobular/Ductal	No		C50.9	8522/3	C50.9		YES		Incisional Biopsy	480	NO				10	Negative	Indeterminate (neither Pre or Postmenopausal)																				1	6								NO	5		true	No	M0	N2	T3	Stage IIIA	TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6.pdf	A0RV	TUMOR FREE	Image Analysis									YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1996	25068ef3-d87f-45e2-a15f-152b87e9dedb	671267f1-3fef-4709-8df2-97b8cb9cf052	25068ef3-d87f-45e2-a15f-152b87e9dedb	671267f1-3fef-4709-8df2-97b8cb9cf052	TCGA-B6-A0RV-01A-21-A13C-20	TCGA-B6-A0RV-01A-11D-A099-09		TCGA-B6-A0RV-01	TCGA-B6-A0RV-01A-11D-A10P-05		f132d6af-68eb-4b00-8a2d-84322ac5758b	TCGA-B6-A0RV-01	TCGA-B6-A0RV-01A-11D-A099-09		TCGA-B6-A0RV-01		TCGA-B6-A0RV-01A-11D-A099-09	TCGA-B6-A0RV-01	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01	TCGA-B6-A0RV-01A-11D-A087-01		TCGA-B6-A0RV-01A-11R-A084-07	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01A-11D-A087-01	TCGA-B6-A0RV-01
TCGA-B6-A0WS-01		58	4	Stage I		2965	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2965	1	LumA	Luminal A	Positive		0	-4	followup	T1	T1	DECEASED	1	TCGA-B6-A0WS-01	2965	1	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-B6-A0WS	2965	0	days	2965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant|Left	No axillary staging		TCGA-B6-A0WS-F15707	TCGA-B6-A0WS	TCGA-B6-A0WS-01A		Positive					Positive	Lumpectomy		NO			-21230	5113	2965	0							Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																				1	7								NO			true	No	MX	NX	T1c	Stage X	TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF.pdf	A0WS	TUMOR FREE	Image Analysis						NO			NO	Primary Tumor	01		4th	NO	NO	YES	B6	Breast	A	DECEASED	1996	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	e217bf80-4072-44c6-9675-d1a1c3029977	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	e217bf80-4072-44c6-9675-d1a1c3029977		TCGA-B6-A0WS-01A-11D-A10Y-09		TCGA-B6-A0WS-01				TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A10Y-09	TCGA-B6-A0WS-01A-11D-A112-05	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A10Y-09		44bd10a8-c4c0-466c-8cd8-31a5da70ba0b		TCGA-B6-A0WS-01A-11D-A111-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11R-A115-07	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	TCGA-B6-A0WS-01A-11D-A111-01	TCGA-B6-A0WS-01
TCGA-B6-A0WT-01	Stage IIB	61	3	No_Conversion	5739		Positive	FEMALE	Negative				Negative	M0	Positive	N1	5739	0	LumA	Luminal A	Positive		-2	-4	followup	T_Other	T2	LIVING	0	TCGA-B6-A0WT-01	5739	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0WT	3862	1	days	5739	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		61	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0WT-F15728	TCGA-B6-A0WT	TCGA-B6-A0WT-01A		Positive					Positive	Modified Radical Mastectomy		NO		3862	-22362	5606		0	5739			3862			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	90	NO				15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	fmol/mg	Equivocal	2+	image cytometry	Positive					Other Reporting Scale			Negative			image cytometry	Positive			2	4			Other Reporting Scale	Other, specify	New Primary Tumor	right breast cancer contralateral		YES	1		true	No	M0	N1	T2	Stage IIB	TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F.pdf	A0WT	TUMOR FREE	Image Analysis		fmol/mg							NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	LIVING	1995	0507f62d-e776-4efb-bd51-dba9d74090bd	5b9509ca-fb9c-4e51-b7d4-9c04f5cc141f	0507f62d-e776-4efb-bd51-dba9d74090bd	5b9509ca-fb9c-4e51-b7d4-9c04f5cc141f		TCGA-B6-A0WT-01A-11D-A10G-09		TCGA-B6-A0WT-01	TCGA-B6-A0WT-01A-11D-A10A-05			TCGA-B6-A0WT-01	TCGA-B6-A0WT-01A-11D-A10G-09		TCGA-B6-A0WT-01		TCGA-B6-A0WT-01A-11D-A10G-09	TCGA-B6-A0WT-01	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01	TCGA-B6-A0WT-01A-11D-A107-01		TCGA-B6-A0WT-01A-11R-A109-07	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01A-11D-A107-01	TCGA-B6-A0WT-01
TCGA-B6-A0WV-01	Stage IIB	67	5	No_Conversion	2422	2422	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2422	1	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0WV-01	2417	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0WV	2417	0	days	2417	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Axillary lymph node dissection alone		TCGA-B6-A0WV-F15732	TCGA-B6-A0WV	TCGA-B6-A0WV-01A		Positive					Positive	Modified Radical Mastectomy		NO			-24803	5531	2417	0							Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	30	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	4		true	No	M0	N1b	T2	Stage IIB	TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72.pdf	A0WV	TUMOR FREE	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1995	87bdfb78-8690-4569-ba85-592cd2390c24	b4ebf80f-787e-4a3f-b0a1-63ad56d36aa2	87bdfb78-8690-4569-ba85-592cd2390c24	b4ebf80f-787e-4a3f-b0a1-63ad56d36aa2		TCGA-B6-A0WV-01A-11D-A10G-09		TCGA-B6-A0WV-01	TCGA-B6-A0WV-01A-11D-A10A-05			TCGA-B6-A0WV-01	TCGA-B6-A0WV-01A-11D-A10G-09		TCGA-B6-A0WV-01		TCGA-B6-A0WV-01A-11D-A10G-09	TCGA-B6-A0WV-01	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01	TCGA-B6-A0WV-01A-11D-A107-01		TCGA-B6-A0WV-01A-11R-A109-07	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01A-11D-A107-01	TCGA-B6-A0WV-01
TCGA-B6-A0WW-01		58	4	No_Conversion	546	557	Positive	FEMALE	Negative						Positive	N1	557	1	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0WW-01	558	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0WW	447	1	days	558	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		58	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0WW-F15734	TCGA-B6-A0WW	TCGA-B6-A0WW-01A		Positive					Positive	Modified Radical Mastectomy		NO			-21479	4664	558	0				447			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	30	NO				18	Negative	Indeterminate (neither Pre or Postmenopausal)																				4	2				Liver	Distant Metastasis			YES	5		true	No	MX	N1b	T2	Stage X	TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9.pdf	A0WW	WITH TUMOR	Image Analysis									YES	Primary Tumor	01		4th	NO	NO	YES	B6	Breast	A	DECEASED	1997	3bdcdadf-67da-4a50-b311-81196c0c8362	5494421e-ace6-4315-8337-edbd09f2e30e	3bdcdadf-67da-4a50-b311-81196c0c8362	5494421e-ace6-4315-8337-edbd09f2e30e		TCGA-B6-A0WW-01A-11D-A10G-09		TCGA-B6-A0WW-01	TCGA-B6-A0WW-01A-11D-A10A-05			TCGA-B6-A0WW-01	TCGA-B6-A0WW-01A-11D-A10G-09		TCGA-B6-A0WW-01		TCGA-B6-A0WW-01A-11D-A10G-09	TCGA-B6-A0WW-01	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01	TCGA-B6-A0WW-01A-11D-A107-01		TCGA-B6-A0WW-01A-11R-A109-07	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01A-11D-A107-01	TCGA-B6-A0WW-01
TCGA-B6-A0WX-01	Stage IIIA	40	1	No_Conversion	653	653	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	653	1	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0WX-01	639	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0WX	563	1	days	639	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		40	Left	Axillary lymph node dissection alone		TCGA-B6-A0WX-F15729	TCGA-B6-A0WX	TCGA-B6-A0WX-01A		Negative					Negative	Modified Radical Mastectomy		NO			-14784	4476	639	0				563			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Other, specify		No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	300	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4				Bone	Distant Metastasis			YES	9		true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf	A0WX	WITH TUMOR	Image Analysis									NO	Primary Tumor	01		5th	YES	NO	YES	B6	Breast	A	DECEASED	1998	8dc04505-fae5-4185-b3f8-53882fbbb4fd	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	8dc04505-fae5-4185-b3f8-53882fbbb4fd	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	TCGA-B6-A0WX-01A-21-A13D-20	TCGA-B6-A0WX-01A-11D-A10G-09		TCGA-B6-A0WX-01	TCGA-B6-A0WX-01A-11D-A10A-05		f484ca3b-7c40-42fe-b5aa-a73453b45b0b	TCGA-B6-A0WX-01	TCGA-B6-A0WX-01A-11D-A10G-09		TCGA-B6-A0WX-01		TCGA-B6-A0WX-01A-11D-A10G-09	TCGA-B6-A0WX-01	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01	TCGA-B6-A0WX-01A-11D-A107-01		TCGA-B6-A0WX-01A-11R-A109-07	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01A-11D-A107-01	TCGA-B6-A0WX-01
TCGA-B6-A0WY-01	Stage IIIA	40	4	No_Conversion	3410	3460	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3460	1	LumA	Luminal A	Negative		-5	-3	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0WY-01	3461	1	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-B6-A0WY	2011	1	days	3461	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		40	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone		TCGA-B6-A0WY-F15730	TCGA-B6-A0WY	TCGA-B6-A0WY-01A		Positive					Negative	Lumpectomy		NO			-14778	5294	3461	0				2011			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	30	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)													Negative							1	4				Bone	Distant Metastasis			YES	3		true	No	M0	N1b	T3	Stage IIIA	TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F.pdf	A0WY	WITH TUMOR	Image Analysis									YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1996	90a60ebe-ce7e-4b64-af2a-1676f46e6601	2e1d7b07-9e79-47b6-98c2-d5966f1760d2	90a60ebe-ce7e-4b64-af2a-1676f46e6601	2e1d7b07-9e79-47b6-98c2-d5966f1760d2		TCGA-B6-A0WY-01A-11D-A10G-09		TCGA-B6-A0WY-01	TCGA-B6-A0WY-01A-11D-A10A-05			TCGA-B6-A0WY-01	TCGA-B6-A0WY-01A-11D-A10G-09		TCGA-B6-A0WY-01		TCGA-B6-A0WY-01A-11D-A10G-09	TCGA-B6-A0WY-01	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01	TCGA-B6-A0WY-01A-11D-A107-01		TCGA-B6-A0WY-01A-11R-A109-07	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01A-11D-A107-01	TCGA-B6-A0WY-01
TCGA-B6-A0WZ-01	Stage IIB	50	2	No_Conversion	3941		Positive	FEMALE	Negative				Negative	M0	Positive	N1	3941	0	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0WZ-01	6292	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-B6-A0WZ	5117	1	days	6292	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0WZ-F71575	TCGA-B6-A0WZ			Positive					Positive	Other		NO			-18584			0	6292		5117	5117			Image Analysis			Scheduled Follow-up Submission	2015-3-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy					NO	21	Negative	Indeterminate (neither Pre or Postmenopausal)																				4	4				Bone	New Primary Tumor		YES	YES	11			No	M0	N1b	T2	Stage II		A0WZ	TUMOR FREE	Image Analysis					YES				YES	Primary Tumor	01	Fine Needle aspiration biopsy	4th	YES	NO	YES	B6	Breast		LIVING	1996	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	f9bccbe0-28c1-4d60-b656-432527eaf911	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	f9bccbe0-28c1-4d60-b656-432527eaf911		TCGA-B6-A0WZ-01A-11D-A10G-09		TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01A-11D-A10A-05			TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01A-11D-A10G-09		TCGA-B6-A0WZ-01		TCGA-B6-A0WZ-01A-11D-A10G-09	TCGA-B6-A0WZ-01	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01A-11D-A107-01		TCGA-B6-A0WZ-01A-11R-A109-07	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01A-11D-A107-01	TCGA-B6-A0WZ-01
TCGA-B6-A0X0-01	Stage IA	54	2	Stage I		3945	Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	3945	1	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0X0-01	3945	1	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-B6-A0X0	3945	0	days	3945	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-B6-A0X0-F15710	TCGA-B6-A0X0	TCGA-B6-A0X0-01A		Positive					Positive	Modified Radical Mastectomy		NO			-19802	5243	3945	0							Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Other, specify		No		C50.919	8201/3	C50.9		YES		Fine needle aspiration biopsy	150	NO				31	Negative	Indeterminate (neither Pre or Postmenopausal)																				2	7								NO	0		true	No	M0	N0 (i-)	T1c	Stage I	TCGA-B6-A0X0.84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8.pdf	A0X0		Image Analysis						YES			NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1996	222a566c-2bad-4b47-97dc-ca1f60a9a981	c9d3c5ea-400a-47dd-82e1-7b2d3d0f9fa6	222a566c-2bad-4b47-97dc-ca1f60a9a981	c9d3c5ea-400a-47dd-82e1-7b2d3d0f9fa6	TCGA-B6-A0X0-01A-11-A13D-20	TCGA-B6-A0X0-01A-21D-A10Y-09		TCGA-B6-A0X0-01			1831ec43-6958-4950-8b0f-dd822fc81f17	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21D-A10Y-09	TCGA-B6-A0X0-01A-21D-A112-05	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21D-A10Y-09		222a566c-2bad-4b47-97dc-ca1f60a9a981		TCGA-B6-A0X0-01A-21D-A111-01	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21R-A115-07	222a566c-2bad-4b47-97dc-ca1f60a9a981	TCGA-B6-A0X0-01A-21D-A111-01	TCGA-B6-A0X0-01
TCGA-B6-A0X1-01	Stage IV	48	3	No_Conversion	5671		Negative	FEMALE					Positive	M1	Positive	N2	5671	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	1	TCGA-B6-A0X1-01	7455	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation cluster 5	TCGA-B6-A0X1	7455	0	days	7455	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		48	Left	Axillary lymph node dissection alone		TCGA-B6-A0X1-F71498	TCGA-B6-A0X1	TCGA-B6-A0X1-01A		Negative					Negative	Other		NO			-17624	6035	7455	0	5677			490			Image Analysis			Scheduled Follow-up Submission	2015-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO			NO	21	Negative	Indeterminate (neither Pre or Postmenopausal)																				5					Brain	Distant Metastasis			NO	16		true	No	M1	N1	T2	Stage IIB	TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B.pdf	A0X1	TUMOR FREE	Image Analysis					NO				NO	Primary Tumor	01	Fine needle aspiration biopsy	4th	YES	NO	YES	B6	Breast	A	DECEASED	1994	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	66665c22-d495-4ae1-a6fe-378d96c05c1a	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	66665c22-d495-4ae1-a6fe-378d96c05c1a	TCGA-B6-A0X1-01A-21-A13D-20	TCGA-B6-A0X1-01A-11D-A10G-09		TCGA-B6-A0X1-01	TCGA-B6-A0X1-01A-11D-A10A-05		03c36239-f261-44e4-829b-01e679a414ad	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01A-11D-A10G-09		TCGA-B6-A0X1-01		TCGA-B6-A0X1-01A-11D-A10G-09		897b769d-f66a-4baf-b5fa-fe92ed49a8b4		TCGA-B6-A0X1-01A-11D-A107-01		TCGA-B6-A0X1-01A-11R-A109-07	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-11D-A107-01	TCGA-B6-A0X1-01
TCGA-B6-A0X4-01	Stage IIB	62	3	No_Conversion	776	859	Positive	FEMALE	Negative				Negative	M0	Positive	N1	859	1	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0X4-01	860	1	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0X4	716	1	days	860	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		62	Left	Axillary lymph node dissection alone		TCGA-B6-A0X4-F15723	TCGA-B6-A0X4	TCGA-B6-A0X4-01A		Positive					Positive	Modified Radical Mastectomy		NO			-22688	5323	860	0				716			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	110	NO				21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1				Bone	Distant Metastasis			YES	2		true	No	M0	N1b	T2	Stage IIB	TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5.pdf	A0X4	WITH TUMOR	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1996	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	90a0edb3-d939-4c43-bbc5-0ed30023e35b	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	90a0edb3-d939-4c43-bbc5-0ed30023e35b		TCGA-B6-A0X4-01A-11D-A10G-09		TCGA-B6-A0X4-01	TCGA-B6-A0X4-01A-11D-A10A-05			TCGA-B6-A0X4-01	TCGA-B6-A0X4-01A-11D-A10G-09		TCGA-B6-A0X4-01		TCGA-B6-A0X4-01A-11D-A10G-09	TCGA-B6-A0X4-01	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01	TCGA-B6-A0X4-01A-11D-A107-01		TCGA-B6-A0X4-01A-11R-A109-07	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01A-11D-A107-01	TCGA-B6-A0X4-01
TCGA-B6-A0X5-01	Stage IIB	61	4	No_Conversion	2097	2097	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2097	1	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0X5-01	2097	1	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-B6-A0X5	1343	1	days	2097	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		61	Left	Axillary lymph node dissection alone		TCGA-B6-A0X5-F15726	TCGA-B6-A0X5			Positive					Positive	Modified Radical Mastectomy		NO			-22380		2097	0				1343			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES								14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1				Other, specify	Distant Metastasis	Liver and Pleura and Bone		YES	3			No	M0	N1b	T2	Stage IIB		A0X5	WITH TUMOR	Image Analysis									NO	Primary Tumor	01		4th	YES	NO	YES	B6	Breast		DECEASED	1995	d4d04af8-9c60-4d14-90a2-c2b211e20092	b8269119-af11-4653-bab9-fb56da542fab	d4d04af8-9c60-4d14-90a2-c2b211e20092	b8269119-af11-4653-bab9-fb56da542fab		TCGA-B6-A0X5-01A-21D-A10G-09		TCGA-B6-A0X5-01	TCGA-B6-A0X5-01A-21D-A10A-05			TCGA-B6-A0X5-01	TCGA-B6-A0X5-01A-21D-A10G-09		TCGA-B6-A0X5-01		TCGA-B6-A0X5-01A-21D-A10G-09	TCGA-B6-A0X5-01	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01	TCGA-B6-A0X5-01A-21D-A107-01		TCGA-B6-A0X5-01A-21R-A109-07	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01A-21D-A107-01	TCGA-B6-A0X5-01
TCGA-B6-A0X7-01		62	2	No_Conversion	1791	1791	Positive	FEMALE	Negative						Negative	N0	1791	1	LumA	Luminal A	Positive		-5	-3	enrollment	T1	T1	DECEASED	1	TCGA-B6-A0X7-01	1781	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-B6-A0X7	1104	1	days	1781	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		62	Right	No axillary staging		TCGA-B6-A0X7-F15714	TCGA-B6-A0X7	TCGA-B6-A0X7-01A		Positive					Positive			NO		1104	-22723	6002	1781	0				1104			Image Analysis			Scheduled Follow-up Submission	2011-8-29	FEMALE										Mixed Histology (please specify)	Ductal/Lobular	No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	40	NO				0		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	3				Other, specify	New Primary Tumor	colon		YES			true	No	MX	NX	T1c	Stage X	TCGA-B6-A0X7.0FB6BB0F-C3F9-43E6-8BDE-90D1DBA298CA.pdf	A0X7	TUMOR FREE	Image Analysis									YES	Primary Tumor	01		4th	YES	NO	YES	B6	Breast	A	DECEASED	1994	b5ec5184-90d6-4b74-b08c-e39af59bc807	8e7476bd-4f16-472b-9368-23096042b16c	b5ec5184-90d6-4b74-b08c-e39af59bc807	8e7476bd-4f16-472b-9368-23096042b16c		TCGA-B6-A0X7-01A-11D-A10M-09		TCGA-B6-A0X7-01	TCGA-B6-A0X7-01A-11D-A10N-05			TCGA-B6-A0X7-01	TCGA-B6-A0X7-01A-11D-A10M-09		TCGA-B6-A0X7-01		TCGA-B6-A0X7-01A-11D-A10M-09	TCGA-B6-A0X7-01	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01	TCGA-B6-A0X7-01A-11D-A10L-01		TCGA-B6-A0X7-01A-11R-A10J-07	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01A-11D-A10L-01	TCGA-B6-A0X7-01
TCGA-B6-A1KC-01	Stage IIA	67	4	Stage IIB	1326		Positive	FEMALE					Negative	M0	Positive	N1	1326	0	LumB		Negative				followup	T_Other	T2	LIVING	0	TCGA-B6-A1KC-01	1326	0	days	BRCA-LUAD+		cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA c1uster 9	cluster 5	mutation c1uster 9	TCGA-B6-A1KC	1326	0	days	1326	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A1KC-F15740	TCGA-B6-A1KC	TCGA-B6-A1KC-01B		Positive					Negative	Lumpectomy		NO			-24791	2781		0	1326					NO	image cytometry			Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-B6-A1KC.E1FDF8EB-9D75-4629-9C78-6019DAF8190E.pdf	A1KC	TUMOR FREE	image cytometry				49 fmol/mg protein		YES			YES	Primary Tumor	01		6th	YES	NO	YES	B6	Breast	B	LIVING	2003	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	63c1bf52-78e7-48aa-ba7c-acf89b20b1e0,89a93ef7-73a7-451f-9c83-251b827f02c6	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	63c1bf52-78e7-48aa-ba7c-acf89b20b1e0,89a93ef7-73a7-451f-9c83-251b827f02c6		TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01	TCGA-B6-A1KC-01B-11D-A161-05,TCGA-B6-A1KC-01A-11D-A13K-05			TCGA-B6-A1KC-01	TCGA-B6-A1KC-01B-11D-A159-09			TCGA-B6-A1KC-01	TCGA-B6-A1KC-01B-11D-A159-09		fe5e5b08-d5c0-4165-ae92-bec6a1d98e60		TCGA-B6-A1KC-01B-11D-A160-01	TCGA-B6-A1KC-01		fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	TCGA-B6-A1KC-01B-11D-A160-01	
TCGA-B6-A1KF-01	Stage IIB	68	1	Stage IIB	3088		Negative	FEMALE	Positive				Negative	M0	Positive	N1	3088	0	Basal		Negative				followup	T_Other	T2	LIVING	0	TCGA-B6-A1KF-01	3088	0	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-B6-A1KF	3088	0	days	3088	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-B6-A1KF-F15739	TCGA-B6-A1KF	TCGA-B6-A1KF-01A		Negative					Negative	Other		NO			-24891	4536		0	3088					NO				Scheduled Follow-up Submission	2011-8-29	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	20	NO	Equivocal			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-B6-A1KF.40EE8416-9DD8-457D-94AC-A871B5C62873.pdf	A1KF	TUMOR FREE							YES			YES	Primary Tumor	01	Excisional biopsy	5th	YES	NO	YES	B6	Breast	A	LIVING	1998	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	2b07b60b-de7c-4b22-a292-8a30c10dab05	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	2b07b60b-de7c-4b22-a292-8a30c10dab05		TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01	TCGA-B6-A1KF-01A-11D-A13K-05			TCGA-B6-A1KF-01	TCGA-B6-A1KF-01A-11D-A13L-09			TCGA-B6-A1KF-01	TCGA-B6-A1KF-01A-11D-A13L-09		e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66		TCGA-B6-A1KF-01A-11D-A13J-01	TCGA-B6-A1KF-01		e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	TCGA-B6-A1KF-01A-11D-A13J-01	
TCGA-B6-A1KI-01	Stage I	63	2	Stage I	2236		Positive	FEMALE	Negative				Negative	M0	Negative	N0	2236	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-B6-A1KI-01	2236	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A1KI	2236	0	days	2236	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-B6-A1KI-F15737	TCGA-B6-A1KI	TCGA-B6-A1KI-01A		Positive					Positive	Other		NO			-23031	2634		0	2236					NO	image cytometry		3.1	Scheduled Follow-up Submission	2011-8-29	FEMALE			90-99%		2+	60	3.8	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	2								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf	A1KI	TUMOR FREE	image cytometry			70 fmol/mg	288 fmol/mg		YES			YES	Primary Tumor	01	Excisional biospy	6th	YES	NO	YES	B6	Breast	A	LIVING	2003	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	82bfe88a-541f-4187-be75-b05bec1ce60c	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	82bfe88a-541f-4187-be75-b05bec1ce60c		TCGA-B6-A1KI-01A-11D-A14K-09		TCGA-B6-A1KI-01	TCGA-B6-A1KI-01A-11D-A14N-05			TCGA-B6-A1KI-01	TCGA-B6-A1KI-01A-11D-A14K-09			TCGA-B6-A1KI-01	TCGA-B6-A1KI-01A-11D-A14K-09		7d34b1bc-ac5a-4365-8dae-75b3f2ea5055		TCGA-B6-A1KI-01A-11D-A14J-01	TCGA-B6-A1KI-01		7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	TCGA-B6-A1KI-01A-11D-A14J-01	
TCGA-B6-A1KN-01	Stage IIIB	57	5	Stage IIIC	4233		Negative	FEMALE	Positive				Negative	M0	Positive	N1	4233	0	LumB		Negative				followup	T_Other	T4	LIVING	0	TCGA-B6-A1KN-01	4233	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-B6-A1KN	4233	0	days	4233	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A1KN-F15738	TCGA-B6-A1KN	TCGA-B6-A1KN-01A		Negative					Negative	Modified Radical Mastectomy		NO			-21183	4537		0	4233					NO				Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO				30	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	6								NO	24		true	No	M0	N1	T4b	Stage IIIB	TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf	A1KN	TUMOR FREE							YES			YES	Primary Tumor	01		5th	YES	NO	YES	B6	Breast	A	LIVING	1998	71b773fb-1efb-4d0f-9499-110ba937ade6	c5a9ae9d-9331-48b7-a5c9-a37102897313	71b773fb-1efb-4d0f-9499-110ba937ade6	c5a9ae9d-9331-48b7-a5c9-a37102897313		TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01	TCGA-B6-A1KN-01A-11D-A13K-05			TCGA-B6-A1KN-01	TCGA-B6-A1KN-01A-11D-A13L-09			TCGA-B6-A1KN-01	TCGA-B6-A1KN-01A-11D-A13L-09		71b773fb-1efb-4d0f-9499-110ba937ade6		TCGA-B6-A1KN-01A-11D-A13J-01	TCGA-B6-A1KN-01		71b773fb-1efb-4d0f-9499-110ba937ade6	TCGA-B6-A1KN-01A-11D-A13J-01	
TCGA-B6-A2IU-01																			LumA										0	TCGA-B6-A2IU-01	5176	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-B6-A2IU	4224	1	days	5176	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			62	Right	Axillary lymph node dissection alone		TCGA-B6-A2IU-F38907	TCGA-B6-A2IU	TCGA-B6-A2IU-01A		Positive					Positive	Modified Radical Mastectomy		NO			-22905	4665		0	5176			4224			image cytometry				2013-1-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO			NO	28	Negative	Indeterminate (neither Pre or Postmenopausal)																									Other, specify	New Primary Tumor	Lung	NO	YES	0		true	No	M0	N0	T2	Stage IIA	TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf	A2IU	WITH TUMOR	image cytometry					YES	YES			YES	Primary Tumor	01		5th		NO	YES	B6	Breast	A	LIVING	1998	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	568de015-d66d-4731-83ce-8f8439ffa6b2	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	568de015-d66d-4731-83ce-8f8439ffa6b2	TCGA-B6-A2IU-01A-21-A24A-20			TCGA-B6-A2IU-01	TCGA-B6-A2IU-01A-32D-A18O-05		fe9fb778-16b4-47ef-84a1-e5f74c25ae59	TCGA-B6-A2IU-01	TCGA-B6-A2IU-01A-32D-A19T-09			TCGA-B6-A2IU-01			71a6367e-a876-4f1e-b80c-0e2d7d02e7cd		TCGA-B6-A2IU-01A-32D-A18N-01	TCGA-B6-A2IU-01		71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	TCGA-B6-A2IU-01A-32D-A18N-01	
TCGA-B6-A3ZX-01																													1	TCGA-B6-A3ZX-01	1152	1	days										TCGA-B6-A3ZX	994	1	days	1152	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			50	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-B6-A3ZX-F59573	TCGA-B6-A3ZX	TCGA-B6-A3ZX-01A	Negative	Negative	4 Point Scale	1+	4 Point Scale	Lumpectomy	Negative	Lumpectomy		NO			-18434	1954	1152	0	1132		1096	994				<10%			2014-6-3	FEMALE			<10%		1+					Mixed Histology (please specify)	ductal and lobular	No		C50.9	8522/3	C50.9	1+	YES		Core needle biopsy	5	NO	Negative		NO	7	Close																			Bone							Bone	Distant Metastasis		YES	YES	1		true	No	M1	N1	T3	Stage IV	TCGA-B6-A3ZX.B3CFFF02-89AA-43AE-B19B-BEE6817AA997.pdf	A3ZX	WITH TUMOR						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	DECEASED	2007	e89806d3-1cd5-4bc0-8e8a-edf823d8f110	4104df00-1af0-40be-867d-ba794e075ae7	e89806d3-1cd5-4bc0-8e8a-edf823d8f110	4104df00-1af0-40be-867d-ba794e075ae7				TCGA-B6-A3ZX-01	TCGA-B6-A3ZX-01A-11D-A23D-05			TCGA-B6-A3ZX-01	TCGA-B6-A3ZX-01A-11D-A23C-09			TCGA-B6-A3ZX-01			e89806d3-1cd5-4bc0-8e8a-edf823d8f110		TCGA-B6-A3ZX-01A-11D-A238-01	TCGA-B6-A3ZX-01		e89806d3-1cd5-4bc0-8e8a-edf823d8f110	TCGA-B6-A3ZX-01A-11D-A238-01	
TCGA-B6-A400-01																													0	TCGA-B6-A400-01	215	0	days										TCGA-B6-A400	215	0	days	215	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-B6-A400-F59655	TCGA-B6-A400	TCGA-B6-A400-01A		Negative	4 Point Scale	1+	4 Point Scale		Negative	Lumpectomy		NO			-16022	1610		0	215							<10%			2014-6-3	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	20	NO	Negative		YES	5	Negative																														NO	4		true	No	M0	N2a	T2	Stage IIIA	TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf	A400	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2008	6b70d210-9cbd-44bc-a770-a075fd0d4672	42d878a6-160a-40a3-a72b-f5e9a4270b2d	6b70d210-9cbd-44bc-a770-a075fd0d4672	42d878a6-160a-40a3-a72b-f5e9a4270b2d				TCGA-B6-A400-01	TCGA-B6-A400-01A-11D-A23D-05			TCGA-B6-A400-01	TCGA-B6-A400-01A-11D-A23C-09			TCGA-B6-A400-01			6b70d210-9cbd-44bc-a770-a075fd0d4672		TCGA-B6-A400-01A-11D-A238-01	TCGA-B6-A400-01		6b70d210-9cbd-44bc-a770-a075fd0d4672	TCGA-B6-A400-01A-11D-A238-01	
TCGA-B6-A401-01																													0	TCGA-B6-A401-01	2596	0	days										TCGA-B6-A401	2596	0	days	2596	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-B6-A401-F59658	TCGA-B6-A401	TCGA-B6-A401-01A		Positive	4 Point Scale	3+	4 Point Scale		Positive	Lumpectomy		NO			-17438	1935		0	2596							80-89%			2014-6-3	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	30	NO	Negative		NO	4	Negative																														NO	1		true	No	M0	N1a	T1c	Stage IIA	TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf	A401	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2007	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	2221013e-55d1-4eeb-99db-c150f39432bb	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	2221013e-55d1-4eeb-99db-c150f39432bb				TCGA-B6-A401-01	TCGA-B6-A401-01A-11D-A23D-05			TCGA-B6-A401-01	TCGA-B6-A401-01A-11D-A23C-09			TCGA-B6-A401-01			2a591fdd-c9e5-4c6e-90f8-8f993450a8d7		TCGA-B6-A401-01A-11D-A238-01	TCGA-B6-A401-01		2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	TCGA-B6-A401-01A-11D-A238-01	
TCGA-B6-A402-01																													0	TCGA-B6-A402-01	2134	0	days										TCGA-B6-A402	2330	1	days	2134	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			47	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A402-F60751	TCGA-B6-A402	TCGA-B6-A402-01A		Negative	4 Point Scale	1+	4 Point Scale		Negative	Lumpectomy		YES			-17314	1563		0	2134			2330				<10%			2014-7-8	FEMALE			<10%		1+				4.4	Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	10	NO	Negative		NO	3	Negative			Positive	2+		Positive	<10%		<10%	4.1	3 Point Scale	2+	2+	Negative		70-79%		Negative					3.1		3 Point Scale	Other, specify	Locoregional Recurrence	Lymph Node	NO	YES	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf	A402	WITH TUMOR						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2008	976a1b88-ed7a-493a-8ac9-3d504edfbc76	1adbdc80-ec5b-4c24-8198-6e6166be39c1	976a1b88-ed7a-493a-8ac9-3d504edfbc76	1adbdc80-ec5b-4c24-8198-6e6166be39c1				TCGA-B6-A402-01	TCGA-B6-A402-01A-11D-A23D-05			TCGA-B6-A402-01	TCGA-B6-A402-01A-11D-A23C-09			TCGA-B6-A402-01			976a1b88-ed7a-493a-8ac9-3d504edfbc76		TCGA-B6-A402-01A-11D-A238-01	TCGA-B6-A402-01		976a1b88-ed7a-493a-8ac9-3d504edfbc76	TCGA-B6-A402-01A-11D-A238-01	
TCGA-B6-A408-01																													0	TCGA-B6-A408-01	2072	0	days										TCGA-B6-A408	2072	0	days	2072	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left	Axillary lymph node dissection alone		TCGA-B6-A408-F59666	TCGA-B6-A408	TCGA-B6-A408-01A		Positive	4 Point Scale	3+	4 Point Scale		Positive	Simple Mastectomy		NO			-20102	1500		0	2072							90-99%	2.6		2014-6-3	FEMALE			20-29%		2+	60	2.9	1.2		Mixed Histology (please specify)	ductal and lobular	No		C50.9	8522/3	C50.9	3+	YES		Tumor resection	50	NO	Equivocal	Negative	NO	23	Negative																														NO	10		true	No	M0	N3a	T2	Stage IIIC	TCGA-B6-A408.F5A14797-6676-4331-9424-D8B820008924.pdf	A408	TUMOR FREE						YES	YES	60-69%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2008	bbb7f769-ac55-4e7f-b0bf-acc36294bb05	2d33342b-a41f-4bb1-9226-1b5058209488	bbb7f769-ac55-4e7f-b0bf-acc36294bb05	2d33342b-a41f-4bb1-9226-1b5058209488				TCGA-B6-A408-01	TCGA-B6-A408-01A-12D-A244-05			TCGA-B6-A408-01	TCGA-B6-A408-01A-12D-A243-09			TCGA-B6-A408-01			bbb7f769-ac55-4e7f-b0bf-acc36294bb05		TCGA-B6-A408-01A-12D-A242-01	TCGA-B6-A408-01		bbb7f769-ac55-4e7f-b0bf-acc36294bb05	TCGA-B6-A408-01A-12D-A242-01	
TCGA-B6-A409-01																													1	TCGA-B6-A409-01	573	1	days										TCGA-B6-A409			days	573	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-B6-A409	TCGA-B6-A409-01A		Negative	4 Point Scale	1+	4 Point Scale		Negative	Simple Mastectomy		NO			-16178	1480	573	0								<10%	1.8		2012-9-20	FEMALE			10-19%		1+	60	2	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Fine needle aspiration biopsy	20	NO	Equivocal	Negative		22	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													YES	6		true	No	M0	N2a	T1c	Stage IIIA	TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf	A409	WITH TUMOR						YES	YES	<10%		NO	Primary Tumor	01		6th		NO	YES	B6	Breast	A	DECEASED	2008	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	97bcb0a5-f1c7-4277-bce3-763473b3ff4f	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	97bcb0a5-f1c7-4277-bce3-763473b3ff4f				TCGA-B6-A409-01	TCGA-B6-A409-01A-11D-A244-05			TCGA-B6-A409-01	TCGA-B6-A409-01A-11D-A243-09			TCGA-B6-A409-01			4d9bb08c-d954-4e14-aff2-3bec55cdf1c1		TCGA-B6-A409-01A-11D-A242-01	TCGA-B6-A409-01		4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	TCGA-B6-A409-01A-11D-A242-01	
TCGA-B6-A40B-01																													0	TCGA-B6-A40B-01	3152	0	days										TCGA-B6-A40B	3152	0	days	3152	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A40B-F59661	TCGA-B6-A40B	TCGA-B6-A40B-01A		Positive	4 Point Scale	3+	4 Point Scale		Positive	Lumpectomy		YES			-27811	2467		0	3152							90-99%			2014-6-3	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	10	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0 (i-)	T1b	Stage I	TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf	A40B	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2005	40c7e862-e1f6-4425-af9d-c9d07161a2ed	2da6a5d4-1759-4d0b-b023-cf9e2dabb8a7	40c7e862-e1f6-4425-af9d-c9d07161a2ed	2da6a5d4-1759-4d0b-b023-cf9e2dabb8a7				TCGA-B6-A40B-01	TCGA-B6-A40B-01A-11D-A23D-05			TCGA-B6-A40B-01	TCGA-B6-A40B-01A-11D-A23C-09			TCGA-B6-A40B-01			40c7e862-e1f6-4425-af9d-c9d07161a2ed		TCGA-B6-A40B-01A-11D-A238-01	TCGA-B6-A40B-01		40c7e862-e1f6-4425-af9d-c9d07161a2ed	TCGA-B6-A40B-01A-11D-A238-01	
TCGA-B6-A40C-01																													0	TCGA-B6-A40C-01	2164	0	days										TCGA-B6-A40C	2164	0	days	2164	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-B6-A40C-F59660	TCGA-B6-A40C	TCGA-B6-A40C-01A		Positive	4 Point Scale	3+	4 Point Scale		Positive	Simple Mastectomy		YES			-18852	2677		0	2164							50-59%			2014-6-3	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative		NO	3	Negative																														NO	0	0	true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-B6-A40C.87B150CC-1C5D-42D5-9951-9157A81316D5.pdf	A40C	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	B6	Breast	A	LIVING	2005	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	7fc82e40-6a59-4650-8eb3-6924a7572e83	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	7fc82e40-6a59-4650-8eb3-6924a7572e83				TCGA-B6-A40C-01	TCGA-B6-A40C-01A-11D-A23D-05			TCGA-B6-A40C-01	TCGA-B6-A40C-01A-11D-A23C-09			TCGA-B6-A40C-01			e04bddbb-224b-4c6c-a8c8-88fd42a52ac5		TCGA-B6-A40C-01A-11D-A238-01	TCGA-B6-A40C-01		e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	TCGA-B6-A40C-01A-11D-A238-01	
TCGA-BH-A0AU-01	Stage IIA	45	1	Stage IIA	746		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	746	0	LumB	Luminal B	Positive	ReacI	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0AU-01	1914	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0AU	1914	0	days	1914	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Inner Quadrant			TCGA-BH-A0AU-F60769	TCGA-BH-A0AU	TCGA-BH-A0AU-01A		Positive					Positive	Other					-16688	583		0	1914					NO					2014-6-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative	NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf	A0AU	TUMOR FREE						NO	YES			YES	Primary Tumor	01	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	d448433c-3c4b-4371-b749-f96af8da2237	9687f34c-0460-4fef-b5ba-d7ec23013f4d	d448433c-3c4b-4371-b749-f96af8da2237	9687f34c-0460-4fef-b5ba-d7ec23013f4d	TCGA-BH-A0AU-01A-21-A13C-20	TCGA-BH-A0AU-01A-11D-A12Q-09		TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11D-A12R-05		6b8a5434-3207-46f0-836b-542e427d22d5	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11D-A12Q-09		TCGA-BH-A0AU-01	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11D-A12Q-09		d448433c-3c4b-4371-b749-f96af8da2237		TCGA-BH-A0AU-01A-11D-A12N-01	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11R-A12P-07	d448433c-3c4b-4371-b749-f96af8da2237	TCGA-BH-A0AU-01A-11D-A12N-01	TCGA-BH-A0AU-01
TCGA-BH-A0AU-11		45			746			FEMALE									746	0	Normal						enrollment			LIVING	0	TCGA-BH-A0AU-11	1914	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AU	1914	0	days	1914	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Inner Quadrant			TCGA-BH-A0AU-F60769	TCGA-BH-A0AU			Positive					Positive	Other					-16688			0	1914					NO					2014-6-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Positive	Negative	NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0			No	M0	N0	T2	Stage IIA		A0AU	TUMOR FREE						NO	YES			YES	Solid Tissue Normal	11	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	Breast		LIVING	2008	eb7e6bfc-79ad-4674-9d58-2cbad8c65658		eb7e6bfc-79ad-4674-9d58-2cbad8c65658						TCGA-BH-A0AU-11A-11D-A12R-05							TCGA-BH-A0AU-11			eb7e6bfc-79ad-4674-9d58-2cbad8c65658			TCGA-BH-A0AU-11	TCGA-BH-A0AU-11A-11R-A12P-07	eb7e6bfc-79ad-4674-9d58-2cbad8c65658		
TCGA-BH-A0AV-01	Stage I	52	1	Stage I	1180		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1180	0	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A0AV-01	1820	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0AV	1820	0	days	1820	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant			TCGA-BH-A0AV-F59174	TCGA-BH-A0AV	TCGA-BH-A0AV-01A		Negative					Negative	Other					-19314	761		0	1820					NO					2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO		Negative	NO	2	Negative																					5	4								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf	A0AV	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Segmental mastectomy with left axillary lymph node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	fe110a00-ddf8-468a-966e-4823df9cbe40	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	fe110a00-ddf8-468a-966e-4823df9cbe40	TCGA-BH-A0AV-01A-21-A13C-20	TCGA-BH-A0AV-01A-31D-A10Y-09		TCGA-BH-A0AV-01			9a298279-0097-4dfc-bfb0-b119b92d1fd7	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31D-A10Y-09	TCGA-BH-A0AV-01A-31D-A112-05	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31D-A10Y-09		afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93		TCGA-BH-A0AV-01A-31D-A111-01	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31R-A115-07	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	TCGA-BH-A0AV-01A-31D-A111-01	TCGA-BH-A0AV-01
TCGA-BH-A0AW-01	Stage IIA	56	3	No_Conversion	622		Positive	FEMALE	Positive				Negative	M0	Positive	N1	622	0	Her2	HER2-enriched	Negative		-11	-5	followup	T1	T1	LIVING	0	TCGA-BH-A0AW-01	622	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-BH-A0AW	622	0	days	622	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0AW-F15445	TCGA-BH-A0AW	TCGA-BH-A0AW-01A		Positive					Negative	Lumpectomy		NO			-20468	545		0	622						ER Positive H-Score 95			Scheduled Follow-up Submission	2010-11-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Positive			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	5								NO	2	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72.pdf	A0AW	TUMOR FREE	PR Negative H-Score 0			H-Score	H-Score					YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	8b615995-6210-4dd5-bf58-cf8a109d7648	34c5238e-d4ee-424c-976c-0f9bbfb1e0bc	8b615995-6210-4dd5-bf58-cf8a109d7648	34c5238e-d4ee-424c-976c-0f9bbfb1e0bc		TCGA-BH-A0AW-01A-11W-A071-09		TCGA-BH-A0AW-01	TCGA-BH-A0AW-01A-11D-A10P-05			TCGA-BH-A0AW-01	TCGA-BH-A0AW-01A-11W-A071-09		TCGA-BH-A0AW-01		TCGA-BH-A0AW-01A-11W-A071-09	TCGA-BH-A0AW-01	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01	TCGA-BH-A0AW-01A-11D-A059-01		TCGA-BH-A0AW-01A-11R-A056-07	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01A-11D-A059-01	TCGA-BH-A0AW-01
TCGA-BH-A0AY-01	Stage IIA	62	3	Stage IIA	777		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	777	0	LumA	Luminal B	Positive	ReacI	-1	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0AY-01	777	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0AY	777	0	days	777	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0AY-F15456	TCGA-BH-A0AY	TCGA-BH-A0AY-01A		Positive					Positive	Simple Mastectomy		NO			-22703	587		0	777									Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B.pdf	A0AY	TUMOR FREE										NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	80817359-b0f0-4bea-ada4-b48bea37f5d2	4fd27ab7-1bec-4d0c-a8e2-9ab804d0a5eb	80817359-b0f0-4bea-ada4-b48bea37f5d2	4fd27ab7-1bec-4d0c-a8e2-9ab804d0a5eb	TCGA-BH-A0AY-01A-11-A13B-20	TCGA-BH-A0AY-01A-21W-A019-09		TCGA-BH-A0AY-01			71b12add-c266-433f-b842-86be8893fb06	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01A-21W-A019-09	TCGA-BH-A0AY-01A-21D-A00Y-05	TCGA-BH-A0AY-01		TCGA-BH-A0AY-01A-21W-A019-09	TCGA-BH-A0AY-01	80817359-b0f0-4bea-ada4-b48bea37f5d2	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01A-21D-A011-01		TCGA-BH-A0AY-01A-21R-A00Z-07	80817359-b0f0-4bea-ada4-b48bea37f5d2	TCGA-BH-A0AY-01A-21D-A011-01	TCGA-BH-A0AY-01
TCGA-BH-A0AY-11		62			777			FEMALE									777	0	Normal						followup			LIVING	0	TCGA-BH-A0AY-11	777	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AY	777	0	days	777	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0AY-F15456	TCGA-BH-A0AY	TCGA-BH-A0AY-11A		Positive					Positive	Simple Mastectomy		NO			-22703	587		0	777									Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0 (i-)	T2	Stage IIA		A0AY	TUMOR FREE										NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008	d9c8ecc3-0e92-49e9-99e4-9976785c73a6		d9c8ecc3-0e92-49e9-99e4-9976785c73a6						TCGA-BH-A0AY-11A-23D-A10Q-05		80042D05-76C1-40BE-90E4-5391A86314E9							TCGA-BH-A0AY-11	d9c8ecc3-0e92-49e9-99e4-9976785c73a6	TCGA-BH-A0AY-11			TCGA-BH-A0AY-11A-23R-A089-07	d9c8ecc3-0e92-49e9-99e4-9976785c73a6		
TCGA-BH-A0AZ-01	Stage IIIA	47	2	Stage IIIA	867		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	867	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0AZ-01	1919	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0AZ	1919	0	days	1919	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right			TCGA-BH-A0AZ-F58602	TCGA-BH-A0AZ	TCGA-BH-A0AZ-01A		Positive					Positive	Other					-17465	575		0	1919					NO					2014-4-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Negative		NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO	1		true	No	cM0 (i+)	N1a	T3	Stage IIIA	TCGA-BH-A0AZ.6721193F-FE9D-4573-BF2A-ABAECF57DFD9.pdf	A0AZ	TUMOR FREE						YES	YES			NO	Primary Tumor	01	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH	Breast	A	LIVING	2008	cb9d4717-15a8-4499-ae3b-e047e5c2926a	55a8c247-5d96-4f48-9fd6-a18f75e9dc32	cb9d4717-15a8-4499-ae3b-e047e5c2926a	55a8c247-5d96-4f48-9fd6-a18f75e9dc32	TCGA-BH-A0AZ-01A-11-A13A-20	TCGA-BH-A0AZ-01A-21D-A12Q-09		TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21D-A12R-05		e7b4dae9-ba72-4281-a84c-9207120cfd65	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21D-A12Q-09		TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21D-A12Q-09		cb9d4717-15a8-4499-ae3b-e047e5c2926a		TCGA-BH-A0AZ-01A-21D-A12N-01	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21R-A12P-07	cb9d4717-15a8-4499-ae3b-e047e5c2926a	TCGA-BH-A0AZ-01A-21D-A12N-01	TCGA-BH-A0AZ-01
TCGA-BH-A0AZ-11		47			867			FEMALE									867	0	Normal						enrollment			LIVING	0	TCGA-BH-A0AZ-11	1919	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0AZ	1919	0	days	1919	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right			TCGA-BH-A0AZ-F58602	TCGA-BH-A0AZ			Positive					Positive	Other					-17465			0	1919					NO					2014-4-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1			No	cM0 (i+)	N1a	T3	Stage IIIA		A0AZ	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH	Breast		LIVING	2008	ec31d946-74b0-4984-b3d8-cb1bf58e4d20		ec31d946-74b0-4984-b3d8-cb1bf58e4d20						TCGA-BH-A0AZ-11A-22D-A12R-05							TCGA-BH-A0AZ-11			ec31d946-74b0-4984-b3d8-cb1bf58e4d20			TCGA-BH-A0AZ-11		ec31d946-74b0-4984-b3d8-cb1bf58e4d20		
TCGA-BH-A0B0-01	Stage I	56	2	Stage I	1427		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1427	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0B0-01	2477	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 3	TCGA-BH-A0B0	2477	0	days	2477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant			TCGA-BH-A0B0-F59204	TCGA-BH-A0B0	TCGA-BH-A0B0-01A		Positive					Positive	Other					-20776	1223		0	2477					NO					2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	320	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)																				1	6								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE.pdf	A0B0	TUMOR FREE						YES	YES			YES	Primary Tumor	01	left segmental mastectomy with axillary sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006	059c8834-efd5-447c-97c6-49fd68c09c0d	a41f4ff0-3452-497b-a05f-952d79da82ba	059c8834-efd5-447c-97c6-49fd68c09c0d	a41f4ff0-3452-497b-a05f-952d79da82ba	TCGA-BH-A0B0-01A-11-A13C-20	TCGA-BH-A0B0-01A-21D-A10Y-09		TCGA-BH-A0B0-01			3e408dd6-0e42-4310-909b-95a91fe6cd3c	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21D-A10Y-09	TCGA-BH-A0B0-01A-21D-A112-05	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21D-A10Y-09		059c8834-efd5-447c-97c6-49fd68c09c0d		TCGA-BH-A0B0-01A-21D-A111-01	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21R-A115-07	059c8834-efd5-447c-97c6-49fd68c09c0d	TCGA-BH-A0B0-01A-21D-A111-01	TCGA-BH-A0B0-01
TCGA-BH-A0B1-01	Stage IIB	66		No_Conversion	1148		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1148	0	LumA	Luminal A	Positive	LumA/B	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B1-01	1148	0	days					BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0B1	1148	0	days	1148	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B1-F15429	TCGA-BH-A0B1	TCGA-BH-A0B1-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-24315	1071		0	1148							90-99%		Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	740	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					6								NO	1	0	true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0B1.BAEB6705-FCDC-4B40-B1CB-D926B8287F92.pdf	A0B1	TUMOR FREE								40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	0042b857-502f-4d8e-baac-845c1a9bb64b	4e237dc0-b785-4eb0-9948-a946b41dab8f	0042b857-502f-4d8e-baac-845c1a9bb64b	4e237dc0-b785-4eb0-9948-a946b41dab8f	TCGA-BH-A0B1-01A-21-A13C-20	TCGA-BH-A0B1-01A-12W-A071-09		TCGA-BH-A0B1-01			cb0ffa62-bbfe-481a-9eda-099f9381319e		TCGA-BH-A0B1-01A-12W-A071-09				TCGA-BH-A0B1-01A-12W-A071-09	TCGA-BH-A0B1-01	0042b857-502f-4d8e-baac-845c1a9bb64b	TCGA-BH-A0B1-01			TCGA-BH-A0B1-01A-12R-A056-07	0042b857-502f-4d8e-baac-845c1a9bb64b		TCGA-BH-A0B1-01
TCGA-BH-A0B2-01	Stage I	43		Stage I	1242		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1242	0	LumA		Positive				enrollment	T1	T1	LIVING		TCGA-BH-A0B2-01			days					BRCA nonbasal-like c8					TCGA-BH-A0B2			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast											TCGA-BH-A0B2-01A														1031																																			220	NO																																						true						TCGA-BH-A0B2.81FABA8A-1F6A-43DD-80F2-2466A7E8664E.pdf													Primary Tumor	01								A			a27c5907-1ad2-4414-a9c9-448f1b484946	ae2856f4-dafc-45b6-96af-6c6615cf9475	a27c5907-1ad2-4414-a9c9-448f1b484946	ae2856f4-dafc-45b6-96af-6c6615cf9475	TCGA-BH-A0B2-01A-21-A13C-20				TCGA-BH-A0B2-01A-11D-A10N-05		2cdcaddf-2dd3-492b-a08f-71adc1065fec							TCGA-BH-A0B2-01	a27c5907-1ad2-4414-a9c9-448f1b484946	TCGA-BH-A0B2-01	TCGA-BH-A0B2-01A-11D-A10L-01		TCGA-BH-A0B2-01A-11R-A10J-07	a27c5907-1ad2-4414-a9c9-448f1b484946	TCGA-BH-A0B2-01A-11D-A10L-01	
TCGA-BH-A0B2-11		43			1242			FEMALE									1242	0	Normal						enrollment			LIVING		TCGA-BH-A0B2-11			days										TCGA-BH-A0B2			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast											TCGA-BH-A0B2-11A														1031																																			130	NO																																						true																			Solid Tissue Normal	11								A			83b0bb89-66a7-4c70-87e1-78a0cc7de9e6		83b0bb89-66a7-4c70-87e1-78a0cc7de9e6						TCGA-BH-A0B2-11A-11D-A10N-05										83b0bb89-66a7-4c70-87e1-78a0cc7de9e6				TCGA-BH-A0B2-11A-11R-A10J-07	83b0bb89-66a7-4c70-87e1-78a0cc7de9e6		
TCGA-BH-A0B3-01	Stage IIB	53	1	No_Conversion	1203		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1203	0	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B3-01	1203	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0B3	1203	0	days	1203	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B3-F15418	TCGA-BH-A0B3	TCGA-BH-A0B3-01A		Negative		0			Negative	Other		NO			-19479	1030		0	1203									Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	280	NO	Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf	A0B3	TUMOR FREE										YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	6d2744ba-4817-482b-ad46-2e4e0897ad88	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	6d2744ba-4817-482b-ad46-2e4e0897ad88	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	TCGA-BH-A0B3-01A-21-A13A-20	TCGA-BH-A0B3-01A-11W-A071-09		TCGA-BH-A0B3-01	TCGA-BH-A0B3-01A-11D-A10P-05		971d0c2f-844b-45a2-a541-05189e0278d4	TCGA-BH-A0B3-01	TCGA-BH-A0B3-01A-11W-A071-09		TCGA-BH-A0B3-01		TCGA-BH-A0B3-01A-11W-A071-09	TCGA-BH-A0B3-01	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01	TCGA-BH-A0B3-01A-11D-A059-01		TCGA-BH-A0B3-01A-11R-A056-07	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01A-11D-A059-01	TCGA-BH-A0B3-01
TCGA-BH-A0B3-11		53			1203			FEMALE									1203	0	Normal						followup			LIVING	0	TCGA-BH-A0B3-11	1203	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0B3	1203	0	days	1203	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0B3-F15418	TCGA-BH-A0B3			Negative		0			Negative	Other		NO			-19479			0	1203									Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy			Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2			No	M0	N1a	T2	Stage IIB		A0B3	TUMOR FREE										YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast		LIVING	2007	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437		bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437						TCGA-BH-A0B3-11B-21D-A10Q-05									TCGA-BH-A0B3-11	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	TCGA-BH-A0B3-11			TCGA-BH-A0B3-11B-21R-A089-07	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437		
TCGA-BH-A0B4-01	Stage IIIA	65	5	No_Conversion	1191		Positive	MALE	Positive	1	3	3	Negative	M0	Positive	N2	1191	0	LumA	Luminal A	Positive	ReacII	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B4-01	1191	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0B4	1191	0	days	1191	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left	Axillary lymph node dissection alone		TCGA-BH-A0B4-F15435	TCGA-BH-A0B4	TCGA-BH-A0B4-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-23980	995		0	1191							80-89%	2.0	Scheduled Follow-up Submission	2010-11-4	MALE					2+	40	5.65	2.83		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	340	NO	Equivocal	Positive		10	Negative																					4	6								NO	6		true	No	M0	N2	T2	Stage IIIA	TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2.pdf	A0B4	TUMOR FREE								50-59%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	bce6d618-4fdf-49fe-b3fe-87709bd79d75	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	bce6d618-4fdf-49fe-b3fe-87709bd79d75	TCGA-BH-A0B4-01A-21-A13C-20	TCGA-BH-A0B4-01A-11W-A019-09		TCGA-BH-A0B4-01			8406b2cf-e6f8-40ac-b0e9-f63535cc3574	TCGA-BH-A0B4-01	TCGA-BH-A0B4-01A-11W-A019-09	TCGA-BH-A0B4-01A-11D-A00Y-05	TCGA-BH-A0B4-01		TCGA-BH-A0B4-01A-11W-A019-09	TCGA-BH-A0B4-01	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	TCGA-BH-A0B4-01	TCGA-BH-A0B4-01A-11D-A011-01		TCGA-BH-A0B4-01A-11R-A00Z-07	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	TCGA-BH-A0B4-01A-11D-A011-01	TCGA-BH-A0B4-01
TCGA-BH-A0B5-01	Stage IIIA	40	2	Stage IIIA	1471		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N2	1471	0	LumA	Luminal B	Positive	ReacII	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0B5-01	2136	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-BH-A0B5	2136	0	days	2136	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left			TCGA-BH-A0B5-F59182	TCGA-BH-A0B5	TCGA-BH-A0B5-01A		Positive					Positive	Modified Radical Mastectomy					-14920	1008		0	2136					NO					2014-5-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	700	NO	Negative		NO	24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	7								NO	5		true	No	M0	N2a	T2	Stage IIIA	TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F.pdf	A0B5	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2007	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	78ff5370-519b-4bb9-ae5a-67f862038ff8	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	78ff5370-519b-4bb9-ae5a-67f862038ff8	TCGA-BH-A0B5-01A-21-A13C-20	TCGA-BH-A0B5-01A-11D-A12Q-09		TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11D-A12R-05		e6f7c6af-6c88-4305-a8f4-d8ea46f8b302	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11D-A12Q-09		TCGA-BH-A0B5-01	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11D-A12Q-09		4b964043-f6dd-4f19-ab4c-439ee68ce2b0		TCGA-BH-A0B5-01A-11D-A12N-01	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11R-A12P-07	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	TCGA-BH-A0B5-01A-11D-A12N-01	TCGA-BH-A0B5-01
TCGA-BH-A0B5-11		40			1471			FEMALE									1471	0	LumA						enrollment			LIVING	0	TCGA-BH-A0B5-11	2136	0	days		C3-BRCA/Luminal							mutation cluster 1	TCGA-BH-A0B5	2136	0	days	2136	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left			TCGA-BH-A0B5-F59182	TCGA-BH-A0B5	TCGA-BH-A0B5-11A		Positive					Positive	Modified Radical Mastectomy					-14920	1008		0	2136					NO					2014-5-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	600	NO	Negative		NO	24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	5		true	No	M0	N2a	T2	Stage IIIA		A0B5	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007	35429f42-252a-4a9d-8e99-125f26019418		35429f42-252a-4a9d-8e99-125f26019418																35429f42-252a-4a9d-8e99-125f26019418				TCGA-BH-A0B5-11A-23R-A12P-07	35429f42-252a-4a9d-8e99-125f26019418		
TCGA-BH-A0B6-01																													0	TCGA-BH-A0B6-01	2483	0	days	Squamous			BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 3			TCGA-BH-A0B6	2483	0	days	2483	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant			TCGA-BH-A0B6-F61943	TCGA-BH-A0B6			Positive					Positive	Other					-17346			0	2483					NO					2014-7-10	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Positive		NO	4	Negative																														NO	0			Yes	M0	N0	T1c	Stage I		A0B6	TUMOR FREE						NO	YES			YES	Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2006	b455387f-a8b4-43b8-b898-89628723d7da	aee8a3d7-7392-4e87-8315-b4fb849705fe	b455387f-a8b4-43b8-b898-89628723d7da	aee8a3d7-7392-4e87-8315-b4fb849705fe	TCGA-BH-A0B6-01A-21-A24A-20			TCGA-BH-A0B6-01	TCGA-BH-A0B6-01A-11D-A19Z-05		e7cb5207-9749-4bfb-9982-58a8efca7a8f	TCGA-BH-A0B6-01	TCGA-BH-A0B6-01A-11D-A19Y-09						b455387f-a8b4-43b8-b898-89628723d7da		TCGA-BH-A0B6-01A-11D-A19X-01			b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-11D-A19X-01	
TCGA-BH-A0B7-01	Stage IIB	42	3	Stage IIB	1733		Positive	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	1733	0	Her2	HER2-enriched	Positive	Her2	-11	-8	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0B7-01	2559	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A0B7	2559	0	days	2559	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right			TCGA-BH-A0B7-F58717	TCGA-BH-A0B7	TCGA-BH-A0B7-01A		Positive					Positive	Other					-15593	1391		0	2559					NO					2014-4-22	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Positive		NO	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C.pdf	A0B7	TUMOR FREE						YES	YES			YES	Primary Tumor	01	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH	Breast	A	LIVING	2006	2af2adfe-bd7b-4eb1-9971-182b11075159	08da84c6-2240-4884-be29-4f7c683f9e4e	2af2adfe-bd7b-4eb1-9971-182b11075159	08da84c6-2240-4884-be29-4f7c683f9e4e	TCGA-BH-A0B7-01A-21-A13B-20	TCGA-BH-A0B7-01A-12D-A10Y-09		TCGA-BH-A0B7-01			c759e411-0873-4535-8b6d-ed41dd2e6fba	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12D-A10Y-09	TCGA-BH-A0B7-01A-12D-A112-05	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12D-A10Y-09		2af2adfe-bd7b-4eb1-9971-182b11075159		TCGA-BH-A0B7-01A-12D-A111-01	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12R-A115-07	2af2adfe-bd7b-4eb1-9971-182b11075159	TCGA-BH-A0B7-01A-12D-A111-01	TCGA-BH-A0B7-01
TCGA-BH-A0B7-11		42			1733			FEMALE									1733	0	Normal						enrollment			LIVING	0	TCGA-BH-A0B7-11	2559	0	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0B7	2559	0	days	2559	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right			TCGA-BH-A0B7-F58717	TCGA-BH-A0B7	TCGA-BH-A0B7-11A		Positive					Positive	Other					-15593	1391		0	2559					NO					2014-4-22	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	930	NO	Positive		NO	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1a	T2	Stage IIB		A0B7	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH	Breast	A	LIVING	2006	30cee921-7fb5-4543-aeb6-ab3eaf669f84		30cee921-7fb5-4543-aeb6-ab3eaf669f84								A353AE14-6488-43F1-A9D1-BBD0C66D0814			TCGA-BH-A0B7-11A-34D-A112-05		TCGA-BH-A0B7-11			30cee921-7fb5-4543-aeb6-ab3eaf669f84			TCGA-BH-A0B7-11	TCGA-BH-A0B7-11A-34R-A115-07	30cee921-7fb5-4543-aeb6-ab3eaf669f84		
TCGA-BH-A0B8-01	Stage IB	64		Stage I	1569		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1569	0	LumA	Luminal A	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0B8-01	1569	0	days			cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-BH-A0B8	1569	0	days	1569	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B8-F15442	TCGA-BH-A0B8	TCGA-BH-A0B8-01A		Positive		3+			Positive	Lumpectomy		NO			-23380	1401		0	1569							90-99%		Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	7								NO	0		true	No	M0	N0 (i-)	T1b	Stage I	TCGA-BH-A0B8.11E1BCE2-F246-4930-A97C-A14B34BCF840.pdf	A0B8	TUMOR FREE								30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	79cc92c6-95f1-4a56-b064-d26a3d38b254	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	79cc92c6-95f1-4a56-b064-d26a3d38b254		TCGA-BH-A0B8-01A-21W-A071-09		TCGA-BH-A0B8-01	TCGA-BH-A0B8-01A-21D-A10P-05				TCGA-BH-A0B8-01A-21W-A071-09				TCGA-BH-A0B8-01A-21W-A071-09	TCGA-BH-A0B8-01	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	TCGA-BH-A0B8-01			TCGA-BH-A0B8-01A-21R-A056-07	de7eef02-1a8d-4a6a-9d87-e2b1430066e3		TCGA-BH-A0B8-01
TCGA-BH-A0B8-11		64			1569			FEMALE									1569	0	Normal						followup			LIVING	0	TCGA-BH-A0B8-11	1569	0	days									mutation c1uster 9	TCGA-BH-A0B8	1569	0	days	1569	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B8-F15442	TCGA-BH-A0B8	TCGA-BH-A0B8-11A		Positive		3+			Positive	Lumpectomy		NO			-23380	1401		0	1569							90-99%		Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	400	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0 (i-)	T1b	Stage I		A0B8	TUMOR FREE								30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23		61e357f3-e4e1-49b8-9e37-7e0ef5a29e23						TCGA-BH-A0B8-11A-41D-A093-05										61e357f3-e4e1-49b8-9e37-7e0ef5a29e23				TCGA-BH-A0B8-11A-41R-A089-07	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23		
TCGA-BH-A0B9-01	Stage IA	44	1	Stage I	1572		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1572	0		Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA-BH-A0B9-01	1572	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6		miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-BH-A0B9	1572	0	days	1572	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0B9-F15438	TCGA-BH-A0B9	TCGA-BH-A0B9-01A		Negative		0			Negative	Other		NO			-16310	1391		0	1572									Scheduled Follow-up Submission	2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	190	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5								NO	0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf	A0B9	TUMOR FREE										YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2006	d5c39754-79c3-432c-b496-34a394662e17	7fd0974b-7ac4-4bdd-904d-234af0722313	d5c39754-79c3-432c-b496-34a394662e17	7fd0974b-7ac4-4bdd-904d-234af0722313	TCGA-BH-A0B9-01A-21-A13C-20	TCGA-BH-A0B9-01A-11W-A071-09		TCGA-BH-A0B9-01	TCGA-BH-A0B9-01A-11D-A10P-05		99bf951a-a4c0-424e-bdf5-4308ec20f38d	TCGA-BH-A0B9-01	TCGA-BH-A0B9-01A-11W-A071-09		TCGA-BH-A0B9-01		TCGA-BH-A0B9-01A-11W-A071-09	TCGA-BH-A0B9-01	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01	TCGA-BH-A0B9-01A-11D-A059-01		TCGA-BH-A0B9-01A-11R-A056-07	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01A-11D-A059-01	TCGA-BH-A0B9-01
TCGA-BH-A0BA-01	Stage IIIC	51	3	No_Conversion	1132		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N3	1132	0	LumA	Luminal A	Positive	ReacI	-5	0	followup	T_Other	T3	LIVING	0	TCGA-BH-A0BA-01	1132	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0BA	1132	0	days	1132	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BA-F15461	TCGA-BH-A0BA	TCGA-BH-A0BA-01A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18839	1266		0	1132							80-89%		Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6								NO	27		true	No	M0	N3a	T3	Stage IIIC	TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB.pdf	A0BA	TUMOR FREE								40-49%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	c4a07ce3-f12a-4e73-b791-6dfa05f4b435	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	c4a07ce3-f12a-4e73-b791-6dfa05f4b435	TCGA-BH-A0BA-01A-21-A13C-20	TCGA-BH-A0BA-01A-11W-A071-09		TCGA-BH-A0BA-01	TCGA-BH-A0BA-01A-11D-A10P-05		348679c1-9edf-44d0-96e2-83602db6c2e7	TCGA-BH-A0BA-01	TCGA-BH-A0BA-01A-11W-A071-09		TCGA-BH-A0BA-01		TCGA-BH-A0BA-01A-11W-A071-09	TCGA-BH-A0BA-01	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01	TCGA-BH-A0BA-01A-11D-A059-01		TCGA-BH-A0BA-01A-11R-A056-07	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01A-11D-A059-01	TCGA-BH-A0BA-01
TCGA-BH-A0BA-11		51			1132			FEMALE									1132	0	Normal						followup			LIVING	0	TCGA-BH-A0BA-11	1132	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BA	1132	0	days	1132	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BA-F15461	TCGA-BH-A0BA	TCGA-BH-A0BA-11A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18839	1266		0	1132							80-89%		Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	220	NO	Negative			27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	27		true	No	M0	N3a	T3	Stage IIIC		A0BA	TUMOR FREE								40-49%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006	3bfd1811-bd2a-439d-8dde-237abcf855af		3bfd1811-bd2a-439d-8dde-237abcf855af						TCGA-BH-A0BA-11A-22D-A10Q-05										3bfd1811-bd2a-439d-8dde-237abcf855af				TCGA-BH-A0BA-11A-22R-A089-07	3bfd1811-bd2a-439d-8dde-237abcf855af		
TCGA-BH-A0BC-01	Stage IIIC	60	2	No_Conversion	974		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N3	974	0	LumA	Luminal A	Positive	ReacI	-4	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BC-01	974	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BC			days	974	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BC-F4487	TCGA-BH-A0BC	TCGA-BH-A0BC-01A		Positive		1+			Positive	Other		NO			-21949	1098		0	974							90-99%			2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4									12		true	No	M0	N3	T2	Stage IIIC	TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf	A0BC	TUMOR FREE								30-39%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	0ac2333e-89ba-4790-8104-87de2772833c	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	0ac2333e-89ba-4790-8104-87de2772833c	TCGA-BH-A0BC-01A-11-A13B-20	TCGA-BH-A0BC-01A-22D-A099-09		TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A10P-05		6b66ea4c-8556-4fc6-8014-f99e59727021	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A099-09		TCGA-BH-A0BC-01		TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A087-01		TCGA-BH-A0BC-01A-22R-A084-07	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-22D-A087-01	TCGA-BH-A0BC-01
TCGA-BH-A0BC-11		60			974			FEMALE									974	0	Normal						followup			LIVING	0	TCGA-BH-A0BC-11	974	0	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BC			days	974	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BC-F4487	TCGA-BH-A0BC	TCGA-BH-A0BC-11A		Positive		1+			Positive	Other		NO			-21949	1098		0	974							90-99%			2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														12		true	No	M0	N3	T2	Stage IIIC		A0BC	TUMOR FREE								30-39%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	32336250-dc07-4e96-9a6c-3c7094fd5342		32336250-dc07-4e96-9a6c-3c7094fd5342						TCGA-BH-A0BC-11A-22D-A093-05									TCGA-BH-A0BC-11	32336250-dc07-4e96-9a6c-3c7094fd5342	TCGA-BH-A0BC-11			TCGA-BH-A0BC-11A-22R-A089-07	32336250-dc07-4e96-9a6c-3c7094fd5342		
TCGA-BH-A0BD-01	Stage IIA	47	4	No_Conversion	554		Positive	FEMALE	Negative				Negative	M0	Positive	N1	554	0	LumB	Luminal B	Positive		0	0	followup	T1	T1	LIVING	0	TCGA-BH-A0BD-01	554	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0BD	554	0	days	554	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BD-F15423	TCGA-BH-A0BD	TCGA-BH-A0BD-01A		Positive					Positive	Other		NO			-17275	364		0	554						H-Score-190			Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	90	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	2		true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0BD.CE70DD1E-BCA4-4F89-AA5B-D90FE18A36FF.pdf	A0BD	TUMOR FREE	H-Score-230			H-Score	H-Score					YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH	Breast	A	LIVING	2009	bf23a402-18ab-47b7-8bca-a9b01eeaf605	14d1ebac-ab78-4daf-b4bf-158610be3948	bf23a402-18ab-47b7-8bca-a9b01eeaf605	14d1ebac-ab78-4daf-b4bf-158610be3948		TCGA-BH-A0BD-01A-11W-A050-09		TCGA-BH-A0BD-01				TCGA-BH-A0BD-01	TCGA-BH-A0BD-01A-11W-A050-09	TCGA-BH-A0BD-01A-11D-A032-05	TCGA-BH-A0BD-01		TCGA-BH-A0BD-01A-11W-A050-09	TCGA-BH-A0BD-01	bf23a402-18ab-47b7-8bca-a9b01eeaf605	TCGA-BH-A0BD-01	TCGA-BH-A0BD-01A-11D-A036-01		TCGA-BH-A0BD-01A-11R-A034-07	bf23a402-18ab-47b7-8bca-a9b01eeaf605	TCGA-BH-A0BD-01A-11D-A036-01	TCGA-BH-A0BD-01
TCGA-BH-A0BF-01	Stage IIB	56	2	Stage IIB	781		Positive	FEMALE	Negative	3	1	4	Negative	M0	Positive	N1	781	0	LumB	Luminal B	Positive	Basal	-2	-5	enrollment	T_Other	T2	LIVING	1	TCGA-BH-A0BF-01	1324	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BF	1324	0	days	1324	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Outer Quadrant			TCGA-BH-A0BF-F59142	TCGA-BH-A0BF	TCGA-BH-A0BF-01A		Positive					Positive	Other					-20691	413	1324	0	782					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	1		true	No	M0	N1mi	T2	Stage IIB	TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf	A0BF	TUMOR FREE						NO	YES			NO	Primary Tumor	01	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2009	3491d44a-675b-4510-8699-2ee83f960d02	ce3c088b-0131-49df-a2e7-f42a2712849c	3491d44a-675b-4510-8699-2ee83f960d02	ce3c088b-0131-49df-a2e7-f42a2712849c	TCGA-BH-A0BF-01A-11-A13C-20	TCGA-BH-A0BF-01A-21D-A12Q-09		TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21D-A12R-05		3d84a5c4-09f1-44f6-9ae6-dcb6a3c19b81	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21D-A12Q-09		TCGA-BH-A0BF-01	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21D-A12Q-09		3491d44a-675b-4510-8699-2ee83f960d02		TCGA-BH-A0BF-01A-21D-A12N-01	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21R-A12P-07	3491d44a-675b-4510-8699-2ee83f960d02	TCGA-BH-A0BF-01A-21D-A12N-01	TCGA-BH-A0BF-01
TCGA-BH-A0BF-11		56			781			FEMALE									781	0							enrollment			LIVING	1	TCGA-BH-A0BF-11	1324	1	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BF	1324	0	days	1324	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Outer Quadrant			TCGA-BH-A0BF-F59142	TCGA-BH-A0BF	TCGA-BH-A0BF-11A		Positive					Positive	Other					-20691	413	1324	0	782					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1mi	T2	Stage IIB		A0BF	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2009									TCGA-BH-A0BF-11A-31D-A12R-05																	
TCGA-BH-A0BG-01	Stage I	73	1	Stage I	756		Negative	FEMALE	Negative				Negative	M0	Negative	N0	756	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BG-01	1871	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA c1uster 9	cluster 4	mutation cluster 5	TCGA-BH-A0BG	1871	0	days	1871	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Lower Outer Quadrant			TCGA-BH-A0BG-F58615	TCGA-BH-A0BG	TCGA-BH-A0BG-01A		Negative					Negative	Other					-26988	798		0	1871					NO					2014-4-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	0		true	No	M0	N0	T1	Stage I	TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf	A0BG	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel axillary lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2008	70b29dd6-1688-4510-94dd-5fcb26a1a908	e0ad6225-f660-4276-9609-f8fc0889a61c	70b29dd6-1688-4510-94dd-5fcb26a1a908	e0ad6225-f660-4276-9609-f8fc0889a61c		TCGA-BH-A0BG-01A-11D-A10Y-09		TCGA-BH-A0BG-01				TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11D-A10Y-09	TCGA-BH-A0BG-01A-11D-A112-05	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11D-A10Y-09		70b29dd6-1688-4510-94dd-5fcb26a1a908		TCGA-BH-A0BG-01A-11D-A111-01	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11R-A115-07	70b29dd6-1688-4510-94dd-5fcb26a1a908	TCGA-BH-A0BG-01A-11D-A111-01	TCGA-BH-A0BG-01
TCGA-BH-A0BJ-01	Stage IIB	41	3	No_Conversion	660		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	660	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BJ-01	660	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation c1uster 9	TCGA-BH-A0BJ			days	660	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BJ-F4480	TCGA-BH-A0BJ	TCGA-BH-A0BJ-01A		Positive		3+			Positive	Other		NO			-15027	595		0	660						H-Score 300	90-99%			2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	7									2		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518.pdf	A0BJ	TUMOR FREE	H-Score 260			H-Score	H Score			70-79%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	224cbe13-ebf8-41eb-ab1c-1d6792a66774	e66a0d0b-c237-41dc-8411-beeee54998ec	224cbe13-ebf8-41eb-ab1c-1d6792a66774	e66a0d0b-c237-41dc-8411-beeee54998ec	TCGA-BH-A0BJ-01A-21-A13A-20	TCGA-BH-A0BJ-01A-11W-A071-09		TCGA-BH-A0BJ-01	TCGA-BH-A0BJ-01A-11D-A10P-05		188575e2-83fd-4463-8bd3-aed928b5acf0	TCGA-BH-A0BJ-01	TCGA-BH-A0BJ-01A-11W-A071-09		TCGA-BH-A0BJ-01		TCGA-BH-A0BJ-01A-11W-A071-09	TCGA-BH-A0BJ-01	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01	TCGA-BH-A0BJ-01A-11D-A059-01		TCGA-BH-A0BJ-01A-11R-A056-07	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01A-11D-A059-01	TCGA-BH-A0BJ-01
TCGA-BH-A0BJ-11		41			660			FEMALE									660	0	Normal						followup			LIVING	0	TCGA-BH-A0BJ-11	660	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0BJ			days	660	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BJ-F4480	TCGA-BH-A0BJ	TCGA-BH-A0BJ-11A		Positive		3+			Positive	Other		NO			-15027	595		0	660						H-Score 300	90-99%			2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														2		true	No	M0	N1a	T2	Stage IIB		A0BJ	TUMOR FREE	H-Score 260			H-Score	H Score			70-79%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	4317b197-dc43-44f2-8854-557832570098		4317b197-dc43-44f2-8854-557832570098						TCGA-BH-A0BJ-11A-23D-A10Q-05									TCGA-BH-A0BJ-11	4317b197-dc43-44f2-8854-557832570098	TCGA-BH-A0BJ-11			TCGA-BH-A0BJ-11A-23R-A089-07	4317b197-dc43-44f2-8854-557832570098		
TCGA-BH-A0BL-01	Stage I	35	3	Stage I	1339		Negative	FEMALE	Negative				Negative	M0	Negative	N0	1339	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BL-01	2278	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BL	2278	0	days	2278	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Outer Quadrant			TCGA-BH-A0BL-F59189	TCGA-BH-A0BL	TCGA-BH-A0BL-01A		Negative					Negative	Other					-12841	1135		0	2278					NO					2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	4								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf	A0BL	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	39ca8590-3733-4b61-9a46-4ec5e6e0501e	970819ce-f25d-4f05-98d7-7b3a22b92558	39ca8590-3733-4b61-9a46-4ec5e6e0501e	970819ce-f25d-4f05-98d7-7b3a22b92558		TCGA-BH-A0BL-01A-11D-A10Y-09		TCGA-BH-A0BL-01				TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11D-A10Y-09	TCGA-BH-A0BL-01A-11D-A112-05	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11D-A10Y-09		39ca8590-3733-4b61-9a46-4ec5e6e0501e		TCGA-BH-A0BL-01A-11D-A111-01	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11R-A115-07	39ca8590-3733-4b61-9a46-4ec5e6e0501e	TCGA-BH-A0BL-01A-11D-A111-01	TCGA-BH-A0BL-01
TCGA-BH-A0BL-11		35			1339			FEMALE									1339	0							enrollment			LIVING	0	TCGA-BH-A0BL-11	2278	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0BL	2278	0	days	2278	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Outer Quadrant			TCGA-BH-A0BL-F59189	TCGA-BH-A0BL	TCGA-BH-A0BL-11A		Negative					Negative	Other					-12841	1135		0	2278					NO					2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T1c	Stage I		A0BL	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007														TCGA-BH-A0BL-11A-12D-A112-05												
TCGA-BH-A0BM-01	Stage IIB	54	2	No_Conversion	1117		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1117	0	LumA	Luminal A	Negative	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0BM-01	1876	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0BM	1876	0	days	1876	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BM-F34064	TCGA-BH-A0BM	TCGA-BH-A0BM-01A		Positive		0			Negative	Lumpectomy		NO			-20049	1080		0	1876									Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	3		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21.pdf	A0BM	TUMOR FREE										NO	Primary Tumor	01		6th	YES	NO	YES	BH	Breast	A	LIVING	2007	986550fb-92db-4e9f-b79a-6c3023dd63a3	4570b87f-8116-48bf-86d3-b993536c88db	986550fb-92db-4e9f-b79a-6c3023dd63a3	4570b87f-8116-48bf-86d3-b993536c88db	TCGA-BH-A0BM-01A-21-A13B-20	TCGA-BH-A0BM-01A-11W-A071-09		TCGA-BH-A0BM-01	TCGA-BH-A0BM-01A-11D-A10P-05		f8cccdf6-fdf0-43a1-86f9-4897d845db8c	TCGA-BH-A0BM-01	TCGA-BH-A0BM-01A-11W-A071-09		TCGA-BH-A0BM-01		TCGA-BH-A0BM-01A-11W-A071-09	TCGA-BH-A0BM-01	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01	TCGA-BH-A0BM-01A-11D-A059-01		TCGA-BH-A0BM-01A-11R-A056-07	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01A-11D-A059-01	TCGA-BH-A0BM-01
TCGA-BH-A0BM-11		54			1117			FEMALE									1117	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BM-11	1876	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BM	1876	0	days	1876	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BM-F34064	TCGA-BH-A0BM	TCGA-BH-A0BM-11A		Positive		0			Negative	Lumpectomy		NO			-20049	1080		0	1876									Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3		true	No	M0	N1a	T2	Stage IIB		A0BM	TUMOR FREE										NO	Solid Tissue Normal	11		6th	YES	NO	YES	BH	Breast	A	LIVING	2007	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd		fe538d53-c7ce-455f-afe6-cb4fc3a63dbd						TCGA-BH-A0BM-11A-12D-A093-05										fe538d53-c7ce-455f-afe6-cb4fc3a63dbd				TCGA-BH-A0BM-11A-12R-A089-07	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd		
TCGA-BH-A0BO-01	Stage I	54	1	Stage I	1085		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	1085	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BO-01	2197	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A0BO	2197	0	days	2197	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant			TCGA-BH-A0BO-F61949	TCGA-BH-A0BO	TCGA-BH-A0BO-01A		Positive					Positive	Other					-19767	1162		0	2197					NO					2014-7-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Negative		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6								NO	0		true	No	M0	N0	T1b	Stage I	TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823.pdf	A0BO	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	54a230c7-e233-4b8b-81d9-7287b8f5d5e0	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	54a230c7-e233-4b8b-81d9-7287b8f5d5e0	TCGA-BH-A0BO-01A-11-A13B-20	TCGA-BH-A0BO-01A-23D-A12B-09		TCGA-BH-A0BO-01			6f30f209-57e0-4430-8132-4c36bcc0862c	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23D-A12B-09	TCGA-BH-A0BO-01A-23D-A12E-05	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23D-A12B-09		682a9c8d-8174-4435-9ec8-cb2d58bbe6d5		TCGA-BH-A0BO-01A-23D-A12A-01	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23R-A12D-07	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	TCGA-BH-A0BO-01A-23D-A12A-01	TCGA-BH-A0BO-01
TCGA-BH-A0BO-11		54			1085			FEMALE									1085	0							enrollment			LIVING	0	TCGA-BH-A0BO-11	2197	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BO	2197	0	days	2197	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant			TCGA-BH-A0BO-F61949	TCGA-BH-A0BO	TCGA-BH-A0BO-11A		Positive					Positive	Other					-19767	1162		0	2197					NO					2014-7-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T1b	Stage I		A0BO	TUMOR FREE						NO	YES			YES	Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007														TCGA-BH-A0BO-11A-11D-A12E-05												
TCGA-BH-A0BP-01	Stage I	76	2	Stage I	1481		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	1481	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	1	TCGA-BH-A0BP-01	2296	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BP	2296	0	days	2296	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant			TCGA-BH-A0BP-F59122	TCGA-BH-A0BP	TCGA-BH-A0BP-01A		Positive					Positive	Other					-27917	1217	2296	0	1481					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6.pdf	A0BP	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Segmental mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2006	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	33bfefcb-2e9c-4f68-a9e7-3a3ecf8d7e59	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	33bfefcb-2e9c-4f68-a9e7-3a3ecf8d7e59	TCGA-BH-A0BP-01A-21-A13C-20	TCGA-BH-A0BP-01A-11D-A10Y-09		TCGA-BH-A0BP-01			4ab91e5f-6fff-4de9-a249-9013a79f6a10	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11D-A10Y-09	TCGA-BH-A0BP-01A-11D-A112-05	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11D-A10Y-09		acbae442-ba6c-4d28-b3bc-58bb4dd93ece		TCGA-BH-A0BP-01A-11D-A111-01	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11R-A115-07	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	TCGA-BH-A0BP-01A-11D-A111-01	TCGA-BH-A0BP-01
TCGA-BH-A0BQ-01	Stage I	39	2	Stage I	826		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	826	0	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BQ-01	2255	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0BQ	1709	1	days	2255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left			TCGA-BH-A0BQ-F58695	TCGA-BH-A0BQ	TCGA-BH-A0BQ-01A		Positive					Positive	Other					-14494	1197		0	2255		1750	1709		NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6				Other, specify	Locoregional Recurrence	Dermis and epidermis	YES	YES	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037.pdf	A0BQ	TUMOR FREE						NO	YES			NO	Primary Tumor	01	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2007	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	cf180187-bd5a-468e-8560-da1e48441b52	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	cf180187-bd5a-468e-8560-da1e48441b52	TCGA-BH-A0BQ-01A-11-A13C-20	TCGA-BH-A0BQ-01A-21D-A10Y-09		TCGA-BH-A0BQ-01			f74f1027-b835-4e74-976c-8a884db74123	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21D-A10Y-09	TCGA-BH-A0BQ-01A-21D-A112-05	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21D-A10Y-09		2ada4fe0-57f2-4a54-9580-4e0ae45a2f65		TCGA-BH-A0BQ-01A-21D-A111-01	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21R-A115-07	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	TCGA-BH-A0BQ-01A-21D-A111-01	TCGA-BH-A0BQ-01
TCGA-BH-A0BQ-11		39			826			FEMALE									826	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BQ-11	2255	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0BQ	1709	1	days	2255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left			TCGA-BH-A0BQ-F58695	TCGA-BH-A0BQ	TCGA-BH-A0BQ-11A		Positive					Positive	Other					-14494	1197		0	2255		1750	1709		NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																									Other, specify	Locoregional Recurrence	Dermis and epidermis	YES	YES	0		true	No	M0	N0	T1c	Stage I		A0BQ	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2007	4096c8a6-5ead-4410-8da1-a20b0f37cce8		4096c8a6-5ead-4410-8da1-a20b0f37cce8											TCGA-BH-A0BQ-11A-33D-A112-05		TCGA-BH-A0BQ-11			4096c8a6-5ead-4410-8da1-a20b0f37cce8			TCGA-BH-A0BQ-11	TCGA-BH-A0BQ-11A-33R-A115-07	4096c8a6-5ead-4410-8da1-a20b0f37cce8		
TCGA-BH-A0BR-01	Stage I	59	1	Stage I	1632		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	1632	0	LumA	Luminal A	Positive	ReacI	-4	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BR-01	2330	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 3	TCGA-BH-A0BR	2330	0	days	2330	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Lower Inner Quadrant			TCGA-BH-A0BR-F61951	TCGA-BH-A0BR	TCGA-BH-A0BR-01A		Positive					Positive	Other					-21622	1170		0	2330					NO					2014-7-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8.pdf	A0BR	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	0ef20000-2c8e-47bb-86e5-ffa2814099a7	b8ff6277-3c53-4912-ae50-8e82a94f7244	0ef20000-2c8e-47bb-86e5-ffa2814099a7	b8ff6277-3c53-4912-ae50-8e82a94f7244	TCGA-BH-A0BR-01A-11-A13C-20	TCGA-BH-A0BR-01A-21W-A12T-09		TCGA-BH-A0BR-01			94b57709-97e9-4421-a146-e82570a42258	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21W-A12T-09	TCGA-BH-A0BR-01A-21D-A112-05	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21W-A12T-09		0ef20000-2c8e-47bb-86e5-ffa2814099a7		TCGA-BH-A0BR-01A-21D-A111-01	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21R-A115-07	0ef20000-2c8e-47bb-86e5-ffa2814099a7	TCGA-BH-A0BR-01A-21D-A111-01	TCGA-BH-A0BR-01
TCGA-BH-A0BS-01	Stage IIIA	55	2	Stage IIIA	1640		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1640	0	LumA	Luminal A	Positive	LumA/B	0	-2	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0BS-01	2612	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0BS	2612	0	days	2612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left			TCGA-BH-A0BS-F61955	TCGA-BH-A0BS	TCGA-BH-A0BS-01A		Positive					Positive	Simple Mastectomy					-20374	1164		0	2612					NO					2014-8-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO		Negative	NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7								NO	0		true	No	M0	N1c	T3	Stage IIIA	TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf	A0BS	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2007	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	59d70e3c-da53-46e9-9f46-177223c25d95	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	59d70e3c-da53-46e9-9f46-177223c25d95	TCGA-BH-A0BS-01A-21-A13A-20	TCGA-BH-A0BS-01A-11D-A12Q-09		TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11D-A12R-05		bc9af2fb-d022-40cc-9fca-685bd206e71b	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11D-A12Q-09		TCGA-BH-A0BS-01	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11D-A12Q-09		354c08e2-61d3-4cfa-9d26-76d74dcfe44f		TCGA-BH-A0BS-01A-11D-A12N-01	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11R-A12P-07	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	TCGA-BH-A0BS-01A-11D-A12N-01	TCGA-BH-A0BS-01
TCGA-BH-A0BS-11		55			1640			FEMALE									1640	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BS-11	2612	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BS	2612	0	days	2612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left			TCGA-BH-A0BS-F61955	TCGA-BH-A0BS	TCGA-BH-A0BS-11A		Positive					Positive	Simple Mastectomy					-20374	1164		0	2612					NO					2014-8-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO		Negative	NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N1c	T3	Stage IIIA		A0BS	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007	10d54893-647f-40a9-8aa7-602e04d55faf		10d54893-647f-40a9-8aa7-602e04d55faf						TCGA-BH-A0BS-11A-11D-A12R-05							TCGA-BH-A0BS-11			10d54893-647f-40a9-8aa7-602e04d55faf			TCGA-BH-A0BS-11	TCGA-BH-A0BS-11A-11R-A12P-07	10d54893-647f-40a9-8aa7-602e04d55faf		
TCGA-BH-A0BT-01	Stage IIA	56	4	Stage IIA	1386		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1386	0	LumA	Luminal A	Positive	ReacII	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BT-01	2365	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 6	mutation cluster 3	TCGA-BH-A0BT	2365	0	days	2365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Inner Quadrant			TCGA-BH-A0BT-F59143	TCGA-BH-A0BT	TCGA-BH-A0BT-01A		Positive					Positive	Other					-20625	1167		0	2365					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO		Negative																					2	6								NO			true	No	M0	N1mi	T1c	Stage IIA	TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019.pdf	A0BT	TUMOR FREE						YES				YES	Primary Tumor	01	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	fe8764cf-04ee-480d-96ce-09d0d388f4f6	6ca5a3d2-bc1c-4d8b-932b-0d156d1dbaa3	fe8764cf-04ee-480d-96ce-09d0d388f4f6	6ca5a3d2-bc1c-4d8b-932b-0d156d1dbaa3	TCGA-BH-A0BT-01A-21-A13C-20	TCGA-BH-A0BT-01A-11D-A12Q-09		TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11D-A12R-05		99e5ad3c-e46a-4d06-9feb-33f1b3819e6f	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11D-A12Q-09		TCGA-BH-A0BT-01	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11D-A12Q-09		fe8764cf-04ee-480d-96ce-09d0d388f4f6		TCGA-BH-A0BT-01A-11D-A12N-01	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11R-A12P-07	fe8764cf-04ee-480d-96ce-09d0d388f4f6	TCGA-BH-A0BT-01A-11D-A12N-01	TCGA-BH-A0BT-01
TCGA-BH-A0BT-11		56			1386			FEMALE									1386	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BT-11	2365	0	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0BT	2365	0	days	2365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Inner Quadrant			TCGA-BH-A0BT-F59143	TCGA-BH-A0BT	TCGA-BH-A0BT-11A		Positive					Positive	Other					-20625	1167		0	2365					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative		NO		Negative																														NO			true	No	M0	N1mi	T1c	Stage IIA		A0BT	TUMOR FREE						YES				YES	Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef		8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef						TCGA-BH-A0BT-11A-21D-A12R-05							TCGA-BH-A0BT-11			8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef			TCGA-BH-A0BT-11		8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef		
TCGA-BH-A0BV-01	Stage IIB	78	5	No_Conversion	1519		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	1519	0	LumA	Luminal A	Positive	LumA/B	0	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BV-01	1519	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 4	TCGA-BH-A0BV			days	1519	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BV-F4513	TCGA-BH-A0BV	TCGA-BH-A0BV-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-28699	1328		0	1519							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	450	NO	Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7									2		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf	A0BV	TUMOR FREE								50-59%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2006	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	800c72cb-4f3b-4ba0-bc8c-a1c62b0e943f	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	800c72cb-4f3b-4ba0-bc8c-a1c62b0e943f	TCGA-BH-A0BV-01A-21-A13B-20	TCGA-BH-A0BV-01A-11W-A019-09		TCGA-BH-A0BV-01			7815a57a-e2d9-42ae-93f3-6ddcf1f33ab2	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01A-11D-A00Y-05	TCGA-BH-A0BV-01		TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11D-A011-01		TCGA-BH-A0BV-01A-11R-A00Z-07	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01A-11D-A011-01	TCGA-BH-A0BV-01
TCGA-BH-A0BV-11		78			1519			FEMALE									1519	0	Normal						followup			LIVING	0	TCGA-BH-A0BV-11	1519	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0BV			days	1519	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0BV-F4513	TCGA-BH-A0BV	TCGA-BH-A0BV-11A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-28699	1328		0	1519							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														2		true	No	M0	N1a	T2	Stage IIB		A0BV	TUMOR FREE								50-59%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2006	452bf9da-c065-4d95-8272-adce3684a9e9		452bf9da-c065-4d95-8272-adce3684a9e9						TCGA-BH-A0BV-11A-31D-A10Q-05									TCGA-BH-A0BV-11	452bf9da-c065-4d95-8272-adce3684a9e9	TCGA-BH-A0BV-11			TCGA-BH-A0BV-11A-31R-A089-07	452bf9da-c065-4d95-8272-adce3684a9e9		
TCGA-BH-A0BW-01	Stage I	71	1	Stage I	355		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	355	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BW-01	2371	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0BW	2371	0	days	2371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Lower Outer Quadrant			TCGA-BH-A0BW-F59127	TCGA-BH-A0BW	TCGA-BH-A0BW-01A		Negative					Negative	Other					-25974	1344		0	2371					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf	A0BW	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Segmental mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2006	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	TCGA-BH-A0BW-01A-21-A13B-20	TCGA-BH-A0BW-01A-11D-A10Y-09		TCGA-BH-A0BW-01			a5fc2a17-0d67-4a6f-ae45-373d3cc91129	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11D-A10Y-09	TCGA-BH-A0BW-01A-11D-A112-05	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11D-A10Y-09		7e84df9f-1da5-4add-a5e8-a9d9d8af409c		TCGA-BH-A0BW-01A-11D-A111-01	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11R-A115-07	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	TCGA-BH-A0BW-01A-11D-A111-01	TCGA-BH-A0BW-01
TCGA-BH-A0BW-11		71			355			FEMALE									355	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BW-11	2371	0	days		C4-BRCA/Basal							mutation c1uster 9	TCGA-BH-A0BW	2371	0	days	2371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Lower Outer Quadrant			TCGA-BH-A0BW-F59127	TCGA-BH-A0BW			Negative					Negative	Other					-25974			0	2371					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			No	M0	N0	T1c	Stage I		A0BW	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Segmental mastectomy	6th		NO	YES	BH	Breast		LIVING	2006	ca5076dc-0fb2-444f-b34f-305c8479cba3		ca5076dc-0fb2-444f-b34f-305c8479cba3											TCGA-BH-A0BW-11A-12D-A112-05		TCGA-BH-A0BW-11			ca5076dc-0fb2-444f-b34f-305c8479cba3			TCGA-BH-A0BW-11	TCGA-BH-A0BW-11A-12R-A115-07	ca5076dc-0fb2-444f-b34f-305c8479cba3		
TCGA-BH-A0BZ-01	Stage IIIA	59	4	Stage IIIA	1492		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	1492	0	LumB	Luminal B	Positive	X	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0BZ-01	2255	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 10	TCGA-BH-A0BZ	2255	0	days	2255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left			TCGA-BH-A0BZ-F58683	TCGA-BH-A0BZ	TCGA-BH-A0BZ-01A		Positive					Positive	Modified Radical Mastectomy					-21856	1084		0	2255					NO					2014-4-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	830	NO	Negative		NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	1		true	No	M0	N1a	T3	Stage IIIA	TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf	A0BZ	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2007	317ffb84-f4a8-435b-907b-b05587d6515e	6eee21c1-5bc4-4eb7-bf40-151fc831d5b9	317ffb84-f4a8-435b-907b-b05587d6515e	6eee21c1-5bc4-4eb7-bf40-151fc831d5b9	TCGA-BH-A0BZ-01A-21-A13B-20	TCGA-BH-A0BZ-01A-31D-A12Q-09		TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31D-A12R-05		d2de5993-e58f-4d41-812b-2a355dd855ea	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31D-A12Q-09		TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31D-A12Q-09		317ffb84-f4a8-435b-907b-b05587d6515e		TCGA-BH-A0BZ-01A-31D-A12N-01	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31R-A12P-07	317ffb84-f4a8-435b-907b-b05587d6515e	TCGA-BH-A0BZ-01A-31D-A12N-01	TCGA-BH-A0BZ-01
TCGA-BH-A0BZ-11		59			1492			FEMALE									1492	0	Normal						enrollment			LIVING	0	TCGA-BH-A0BZ-11	2255	0	days		C3-BRCA/Luminal							mutation c1uster 10	TCGA-BH-A0BZ	2255	0	days	2255	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left			TCGA-BH-A0BZ-F58683	TCGA-BH-A0BZ	TCGA-BH-A0BZ-11A		Positive					Positive	Modified Radical Mastectomy					-21856	1084		0	2255					NO					2014-4-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	620	NO	Negative		NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1a	T3	Stage IIIA		A0BZ	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007	561e0da7-0e2c-430c-8a54-c9a3535a1679		561e0da7-0e2c-430c-8a54-c9a3535a1679						TCGA-BH-A0BZ-11A-61D-A12R-05		C3371B54-7D2D-4868-B8EF-E5C0466B0172					TCGA-BH-A0BZ-11			561e0da7-0e2c-430c-8a54-c9a3535a1679			TCGA-BH-A0BZ-11	TCGA-BH-A0BZ-11A-61R-A12P-07	561e0da7-0e2c-430c-8a54-c9a3535a1679		
TCGA-BH-A0C0-01	Stage IIA	62	3	No_Conversion	1270		Positive	FEMALE	Positive	1	1	4	Negative	M0	Positive	N1	1270	0	LumB	Luminal B	Positive	Basal	-2	-5	followup	T1	T1	LIVING	0	TCGA-BH-A0C0-01	1270	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0C0			days	1270	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0C0-F4518	TCGA-BH-A0C0			Positive					Positive	Other		NO			-23006			0	1270							90-99%	2.65		2010-11-16	FEMALE					2+	40	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Positive		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									1			No	M0	N1a	T1c	Stage IIA		A0C0	TUMOR FREE								60-69%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast		LIVING	2007	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	be4a4bb4-c86e-4dce-9c49-9f71eba44d32	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	be4a4bb4-c86e-4dce-9c49-9f71eba44d32	TCGA-BH-A0C0-01A-11-A13B-20	TCGA-BH-A0C0-01A-21W-A071-09		TCGA-BH-A0C0-01	TCGA-BH-A0C0-01A-21D-A10P-05		a4009327-f700-4c89-88fa-a560641ab193	TCGA-BH-A0C0-01	TCGA-BH-A0C0-01A-21W-A071-09		TCGA-BH-A0C0-01		TCGA-BH-A0C0-01A-21W-A071-09	TCGA-BH-A0C0-01	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01	TCGA-BH-A0C0-01A-21D-A059-01		TCGA-BH-A0C0-01A-21R-A056-07	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01A-21D-A059-01	TCGA-BH-A0C0-01
TCGA-BH-A0C0-11		62			1270			FEMALE									1270	0	Normal						followup			LIVING	0	TCGA-BH-A0C0-11	1270	0	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0C0			days	1270	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0C0-F4518	TCGA-BH-A0C0	TCGA-BH-A0C0-11A		Positive					Positive	Other		NO			-23006	1094		0	1270							90-99%	2.65		2010-11-16	FEMALE					2+	40	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	330	NO	Equivocal	Positive		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1		true	No	M0	N1a	T1c	Stage IIA		A0C0	TUMOR FREE								60-69%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	86c4b2fd-d034-469d-adfa-712055f30dc3		86c4b2fd-d034-469d-adfa-712055f30dc3						TCGA-BH-A0C0-11A-21D-A10Q-05									TCGA-BH-A0C0-11	86c4b2fd-d034-469d-adfa-712055f30dc3	TCGA-BH-A0C0-11			TCGA-BH-A0C0-11A-21R-A089-07	86c4b2fd-d034-469d-adfa-712055f30dc3		
TCGA-BH-A0C1-01	Stage IIIA	61	2	Stage IIIA	1338		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	1338	0	LumA	Luminal A	Positive	ReacII	-1	-1	enrollment	T_Other	T3	LIVING	1	TCGA-BH-A0C1-01	1411	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A0C1	1123	1	days	1411	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right			TCGA-BH-A0C1-F63399	TCGA-BH-A0C1	TCGA-BH-A0C1-01B		Positive					Positive	Modified Radical Mastectomy					-22377	1073	1411	0	1339			1123		YES					2014-8-7	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5				Bone	Distant Metastasis			YES	8		true	No	M0	N2a	T3	Stage IIIA	TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02.pdf	A0C1	WITH TUMOR						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	B	DECEASED	2007	73b732bb-f387-4618-a2a3-8c7db1c75fd8	d2046f6d-cec0-4e39-a437-8be0a260cfa4	73b732bb-f387-4618-a2a3-8c7db1c75fd8	d2046f6d-cec0-4e39-a437-8be0a260cfa4	TCGA-BH-A0C1-01B-21-A13D-20	TCGA-BH-A0C1-01B-11D-A12B-09		TCGA-BH-A0C1-01			dc364a19-d15e-4c8e-8d9b-cbd70b27d532	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11D-A12B-09	TCGA-BH-A0C1-01B-11D-A12E-05	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11D-A12B-09		73b732bb-f387-4618-a2a3-8c7db1c75fd8		TCGA-BH-A0C1-01B-11D-A12A-01	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11R-A12D-07	73b732bb-f387-4618-a2a3-8c7db1c75fd8	TCGA-BH-A0C1-01B-11D-A12A-01	TCGA-BH-A0C1-01
TCGA-BH-A0C3-01	Stage I	47	3	Stage I	1464		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	1464	0	LumB	Luminal B	Negative	Her2	-4	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A0C3-01	2709	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-BH-A0C3	2674	1	days	2709	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left			TCGA-BH-A0C3-F63533	TCGA-BH-A0C3	TCGA-BH-A0C3-01A		Positive					Negative	Other					-17221	1335		0	2709			2674		NO					2014-8-12	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	160	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6				Bone	Distant Metastasis			YES	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf	A0C3	WITH TUMOR						YES	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006	52a863fe-b210-456b-9c2d-545277362b65	40aac58d-9d3d-4cc3-ab4b-c02b28b8fc5f	52a863fe-b210-456b-9c2d-545277362b65	40aac58d-9d3d-4cc3-ab4b-c02b28b8fc5f	TCGA-BH-A0C3-01A-11-A13C-20	TCGA-BH-A0C3-01A-21D-A12Q-09		TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21D-A12R-05		42fa3207-2c4f-4499-99b8-fe5275232eed	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21D-A12Q-09		TCGA-BH-A0C3-01	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21D-A12Q-09		52a863fe-b210-456b-9c2d-545277362b65		TCGA-BH-A0C3-01A-21D-A12N-01	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21R-A12P-07	52a863fe-b210-456b-9c2d-545277362b65	TCGA-BH-A0C3-01A-21D-A12N-01	TCGA-BH-A0C3-01
TCGA-BH-A0C3-11		47			1464			FEMALE									1464	0	Normal						enrollment			LIVING	0	TCGA-BH-A0C3-11	2709	0	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0C3	2674	1	days	2709	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left			TCGA-BH-A0C3-F63533	TCGA-BH-A0C3	TCGA-BH-A0C3-11A		Positive					Negative	Other					-17221	1335		0	2709			2674		NO					2014-8-12	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																									Bone	Distant Metastasis			YES	0		true	No	M0	N0	T1c	Stage I		A0C3	WITH TUMOR						YES	YES			YES	Solid Tissue Normal	11	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2006	65923c68-2c86-4b4d-abe2-5320c08bb68f		65923c68-2c86-4b4d-abe2-5320c08bb68f						TCGA-BH-A0C3-11A-23D-A12R-05							TCGA-BH-A0C3-11			65923c68-2c86-4b4d-abe2-5320c08bb68f			TCGA-BH-A0C3-11	TCGA-BH-A0C3-11A-23R-A12P-07	65923c68-2c86-4b4d-abe2-5320c08bb68f		
TCGA-BH-A0C7-01	Stage IIB	48	5	Stage IIB	1305		Positive	FEMALE	Positive	1	3	4	Negative	M0	Positive	N1	1305	0	LumB	Luminal B	Negative	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0C7-01	2767	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0C7	2767	0	days	2767	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left			TCGA-BH-A0C7-F59178	TCGA-BH-A0C7	TCGA-BH-A0C7-01B		Positive					Negative	Simple Mastectomy					-17871	1520		0	2767					NO					2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO		Positive	NO	18	Negative	Peri (6-12 months since last menstrual period)																				4	4								NO	1		true	No	M0	N1mi	T2	Stage IIB	TCGA-BH-A0C7.880F3DC6-4342-4232-A04E-A128F1A8201D.pdf	A0C7	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	BH	Breast	B	LIVING	2006	e58a6cf4-a4ff-4179-9671-a5661f380a8d	84f33e36-25f6-47a9-9fe9-85f8d4247ef2	e58a6cf4-a4ff-4179-9671-a5661f380a8d	84f33e36-25f6-47a9-9fe9-85f8d4247ef2	TCGA-BH-A0C7-01B-21-A13D-20	TCGA-BH-A0C7-01B-11D-A10Y-09		TCGA-BH-A0C7-01			0846b423-a60b-4c54-9224-b9d129fb3278	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11D-A10Y-09	TCGA-BH-A0C7-01B-11D-A112-05	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11D-A10Y-09		e58a6cf4-a4ff-4179-9671-a5661f380a8d		TCGA-BH-A0C7-01B-11D-A111-01	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11R-A115-07	e58a6cf4-a4ff-4179-9671-a5661f380a8d	TCGA-BH-A0C7-01B-11D-A111-01	TCGA-BH-A0C7-01
TCGA-BH-A0DD-01	Stage IIB	58	3	Stage IIB	1393		Positive	MALE	Positive	1	3	4	Negative	M0	Positive	N1	1393	0	LumB	Luminal B	Positive	LumA/B	-6	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DD-01	2486	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0DD	2486	0	days	2486	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right			TCGA-BH-A0DD-F60386	TCGA-BH-A0DD	TCGA-BH-A0DD-01A		Positive					Positive	Modified Radical Mastectomy					-21386	1248		0	2486					NO					2014-6-9	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO	Positive	Positive	NO	22	Negative																					4	4								NO	0		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf	A0DD	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2006	e15ff180-38d3-4614-88ee-3645afaab54b	72f2a477-f43f-4ffe-a233-e09a3b66da3b	e15ff180-38d3-4614-88ee-3645afaab54b	72f2a477-f43f-4ffe-a233-e09a3b66da3b	TCGA-BH-A0DD-01A-21-A13B-20	TCGA-BH-A0DD-01A-31D-A12Q-09		TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31D-A12R-05		7ac181c9-6dba-4e27-a5fc-09cf02f735cf	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31D-A12Q-09		TCGA-BH-A0DD-01	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31D-A12Q-09		e15ff180-38d3-4614-88ee-3645afaab54b		TCGA-BH-A0DD-01A-31D-A12N-01	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31R-A12P-07	e15ff180-38d3-4614-88ee-3645afaab54b	TCGA-BH-A0DD-01A-31D-A12N-01	TCGA-BH-A0DD-01
TCGA-BH-A0DD-11		58			1393			MALE									1393	0	LumA						enrollment			LIVING	0	TCGA-BH-A0DD-11	2486	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DD	2486	0	days	2486	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right			TCGA-BH-A0DD-F60386	TCGA-BH-A0DD	TCGA-BH-A0DD-11A		Positive					Positive	Modified Radical Mastectomy					-21386	1248		0	2486					NO					2014-6-9	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	460	NO	Positive	Positive	NO	22	Negative																														NO	0		true	No	M0	N1a	T2	Stage IIB		A0DD	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2006	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5		c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5																c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5				TCGA-BH-A0DD-11A-23R-A12P-07	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5		
TCGA-BH-A0DE-01	Stage IIA	62	5	Stage IIA	948		Positive	FEMALE	Negative				Negative	M0	Negative	N0	948	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DE-01	2372	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-BH-A0DE	2372	0	days	2372	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant			TCGA-BH-A0DE-F63543	TCGA-BH-A0DE	TCGA-BH-A0DE-01A		Positive					Positive	Other					-22656	1130		0	2372					NO					2014-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A0DE.E8EA922D-A851-4D36-B70D-372DE9352548.pdf	A0DE	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	b9a1f505-713e-4044-b76e-57134a4802f1	358c7629-e5dc-4191-aece-4a0e0eb0d5da	b9a1f505-713e-4044-b76e-57134a4802f1	358c7629-e5dc-4191-aece-4a0e0eb0d5da		TCGA-BH-A0DE-01A-11D-A10Y-09		TCGA-BH-A0DE-01				TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11D-A10Y-09	TCGA-BH-A0DE-01A-11D-A112-05	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11D-A10Y-09		b9a1f505-713e-4044-b76e-57134a4802f1		TCGA-BH-A0DE-01A-11D-A111-01	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11R-A115-07	b9a1f505-713e-4044-b76e-57134a4802f1	TCGA-BH-A0DE-01A-11D-A111-01	TCGA-BH-A0DE-01
TCGA-BH-A0DE-11		62			948			FEMALE									948	0							enrollment			LIVING	0	TCGA-BH-A0DE-11	2372	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DE	2372	0	days	2372	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant			TCGA-BH-A0DE-F63543	TCGA-BH-A0DE	TCGA-BH-A0DE-11A		Positive					Positive	Other					-22656	1130		0	2372					NO					2014-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T2	Stage IIA		A0DE	TUMOR FREE						NO	YES			YES	Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007														TCGA-BH-A0DE-11A-23D-A112-05												
TCGA-BH-A0DG-01	Stage IIA	30	3	Stage IIA	713		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	713	0	LumA	Luminal A	Negative	ReacI	-4	-4	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DG-01	2041	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0DG	2041	0	days	2041	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					30	Right Upper Outer Quadrant			TCGA-BH-A0DG-F63658	TCGA-BH-A0DG	TCGA-BH-A0DG-01A		Positive					Negative	Other					-11204	972		0	2041					NO					2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1360	NO	Negative		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A0DG.46B16DD0-68E6-4A7A-919B-758219D1E85C.pdf	A0DG	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Total mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2007	a6b72c40-c921-4159-abad-b64e20619241	715f5846-1e11-4c15-ac61-927baf0b92d4	a6b72c40-c921-4159-abad-b64e20619241	715f5846-1e11-4c15-ac61-927baf0b92d4	TCGA-BH-A0DG-01A-11-A13B-20	TCGA-BH-A0DG-01A-21D-A12Q-09		TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21D-A12R-05		c74c7143-1584-4072-872f-405fd8e3bf0c	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21D-A12Q-09		TCGA-BH-A0DG-01	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21D-A12Q-09		a6b72c40-c921-4159-abad-b64e20619241		TCGA-BH-A0DG-01A-21D-A12N-01	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21R-A12P-07	a6b72c40-c921-4159-abad-b64e20619241	TCGA-BH-A0DG-01A-21D-A12N-01	TCGA-BH-A0DG-01
TCGA-BH-A0DG-11		30			713			FEMALE									713	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DG-11	2041	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DG	2041	0	days	2041	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					30	Right Upper Outer Quadrant			TCGA-BH-A0DG-F63658	TCGA-BH-A0DG	TCGA-BH-A0DG-11A		Positive					Negative	Other					-11204	972		0	2041					NO					2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470	NO	Negative		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T2	Stage IIA		A0DG	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Total mastectomy	6th		NO	YES	BH	Breast	A	LIVING	2007	61c8278b-4c06-4563-b1ac-97cceec76ca4		61c8278b-4c06-4563-b1ac-97cceec76ca4						TCGA-BH-A0DG-11A-43D-A12R-05							TCGA-BH-A0DG-11			61c8278b-4c06-4563-b1ac-97cceec76ca4			TCGA-BH-A0DG-11		61c8278b-4c06-4563-b1ac-97cceec76ca4		
TCGA-BH-A0DH-01	Stage IIB	63	2	No_Conversion	1156		Positive	FEMALE	Negative	5	3	3	Negative	M0	Positive	N1	1156	0	LumA	Luminal A	Positive	X	0	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DH-01	1156	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A0DH			days	1156	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0DH-F4529	TCGA-BH-A0DH	TCGA-BH-A0DH-01A	Negative	Positive		3+		Mastectomy NOS	Positive	Other		NO			-23366	968		0	1156							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	260	NO	Negative			28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1									3		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0DH.79B22278-2BA1-4904-BCA6-2B1368C77475.pdf	A0DH	TUMOR FREE								40-49%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	c643222a-e138-4b3c-a96d-02be24ccb0d0	3d2d8785-65ba-4b5e-a5b8-8ceed713b8f6	c643222a-e138-4b3c-a96d-02be24ccb0d0	3d2d8785-65ba-4b5e-a5b8-8ceed713b8f6	TCGA-BH-A0DH-01A-21-A13B-20	TCGA-BH-A0DH-01A-11D-A099-09		TCGA-BH-A0DH-01	TCGA-BH-A0DH-01A-11D-A10P-05		ce59142d-05cc-4392-92d4-806c8136465b	TCGA-BH-A0DH-01	TCGA-BH-A0DH-01A-11D-A099-09		TCGA-BH-A0DH-01		TCGA-BH-A0DH-01A-11D-A099-09	TCGA-BH-A0DH-01	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01	TCGA-BH-A0DH-01A-11D-A087-01		TCGA-BH-A0DH-01A-11R-A084-07	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01A-11D-A087-01	TCGA-BH-A0DH-01
TCGA-BH-A0DH-11		63			1156			FEMALE									1156	0	Normal						followup			LIVING	0	TCGA-BH-A0DH-11	1156	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DH			days	1156	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0DH-F4529	TCGA-BH-A0DH	TCGA-BH-A0DH-11A	Negative	Positive		3+		Mastectomy NOS	Positive	Other		NO			-23366	968		0	1156							90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	280	NO	Negative			28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														3		true	No	M0	N1a	T2	Stage IIB		A0DH	TUMOR FREE								40-49%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	4a8c96d9-b08d-4812-93ec-c8c9db8139aa		4a8c96d9-b08d-4812-93ec-c8c9db8139aa						TCGA-BH-A0DH-11A-31D-A10Q-05										4a8c96d9-b08d-4812-93ec-c8c9db8139aa				TCGA-BH-A0DH-11A-31R-A089-07	4a8c96d9-b08d-4812-93ec-c8c9db8139aa		
TCGA-BH-A0DI-01	Stage IIB	63	5	Stage IIB	673		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N1	673	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DI-01	912	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0DI	912	0	days	912	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right			TCGA-BH-A0DI-F58698	TCGA-BH-A0DI	TCGA-BH-A0DI-01A		Positive					Positive	Modified Radical Mastectomy					-23327	267		0	912					NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	3		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf	A0DI	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2009	91285ac6-c627-4101-b551-28f37b947276	dd174335-cc95-4d3d-a25b-9abaaaa432a2	91285ac6-c627-4101-b551-28f37b947276	dd174335-cc95-4d3d-a25b-9abaaaa432a2	TCGA-BH-A0DI-01A-11-A13B-20	TCGA-BH-A0DI-01A-21D-A12Q-09		TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21D-A12R-05		12b20a6c-5b0f-4014-85f5-b411c0ad5651	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21D-A12Q-09		TCGA-BH-A0DI-01	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21D-A12Q-09		91285ac6-c627-4101-b551-28f37b947276		TCGA-BH-A0DI-01A-21D-A12N-01	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21R-A12P-07	91285ac6-c627-4101-b551-28f37b947276	TCGA-BH-A0DI-01A-21D-A12N-01	TCGA-BH-A0DI-01
TCGA-BH-A0DI-11		63			673			FEMALE									673	0							enrollment			LIVING	0	TCGA-BH-A0DI-11	912	0	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A0DI	912	0	days	912	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right			TCGA-BH-A0DI-F58698	TCGA-BH-A0DI	TCGA-BH-A0DI-11A		Positive					Positive	Modified Radical Mastectomy					-23327	267		0	912					NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	640	NO	Negative		NO	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3		true	No	M0	N1a	T2	Stage IIB		A0DI	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2009									TCGA-BH-A0DI-11A-32D-A12R-05																	
TCGA-BH-A0DK-01	Stage IIA	49	2	Stage IIA	423		Positive	FEMALE	Negative	4	3	3	Negative	M0	Negative	N0	423	0	LumA	Luminal A	Positive	LumA/B	-4	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DK-01	423	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-BH-A0DK			days	423	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0DK-F4532	TCGA-BH-A0DK	TCGA-BH-A0DK-01A		Positive					Positive	Simple Mastectomy		NO			-18237	254		0	423						H-SCORE 260				2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	240	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	2									0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf	A0DK	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE					NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	fef221ff-634b-4188-92cf-5723b9a3c04d	b18d3669-3d80-4c66-b979-0d7e8541b509	fef221ff-634b-4188-92cf-5723b9a3c04d	b18d3669-3d80-4c66-b979-0d7e8541b509	TCGA-BH-A0DK-01A-11-A13B-20	TCGA-BH-A0DK-01A-21W-A071-09		TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21D-A10P-05		1ae8085b-99e9-4a9c-94a7-bcf4f903b95a	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21W-A071-09		TCGA-BH-A0DK-01		TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21D-A059-01		TCGA-BH-A0DK-01A-21R-A056-07	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-21D-A059-01	TCGA-BH-A0DK-01
TCGA-BH-A0DK-11		49			423			FEMALE									423	0	LumA						followup			LIVING	0	TCGA-BH-A0DK-11	423	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DK			days	423	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0DK-F4532	TCGA-BH-A0DK	TCGA-BH-A0DK-11A		Positive					Positive	Simple Mastectomy		NO			-18237	254		0	423						H-SCORE 260				2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	550	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														0		true	No	M0	N0 (i-)	T2	Stage IIA		A0DK	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE					NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009	4c1d73ba-31f8-4652-a83d-cc367dde9f43		4c1d73ba-31f8-4652-a83d-cc367dde9f43						TCGA-BH-A0DK-11A-13D-A10Q-05		F17E1810-1E54-4920-A1EA-A5B693205A55							TCGA-BH-A0DK-11	4c1d73ba-31f8-4652-a83d-cc367dde9f43	TCGA-BH-A0DK-11			TCGA-BH-A0DK-11A-13R-A089-07	4c1d73ba-31f8-4652-a83d-cc367dde9f43		
TCGA-BH-A0DL-01	Stage IIA	64	3	Stage IIA	1467		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1467	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DL-01	2381	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 11	cluster 4	mutation cluster 3	TCGA-BH-A0DL	2381	0	days	2381	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left			TCGA-BH-A0DL-F60389	TCGA-BH-A0DL	TCGA-BH-A0DL-01A		Positive					Negative	Other					-23628	1074		0	2381					NO					2014-6-9	FEMALE										Other, specify		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	350	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB.pdf	A0DL	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	1013446f-5beb-485d-809a-efe81a2138dd	298c4e12-a695-48f1-830a-ae66a78e3ee4	1013446f-5beb-485d-809a-efe81a2138dd	298c4e12-a695-48f1-830a-ae66a78e3ee4	TCGA-BH-A0DL-01A-21-A13B-20	TCGA-BH-A0DL-01A-11D-A10Y-09		TCGA-BH-A0DL-01			301ec456-dd25-42ff-9779-a4f7f86ff509	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11D-A10Y-09	TCGA-BH-A0DL-01A-11D-A112-05	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11D-A10Y-09		1013446f-5beb-485d-809a-efe81a2138dd		TCGA-BH-A0DL-01A-11D-A111-01	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11R-A115-07	1013446f-5beb-485d-809a-efe81a2138dd	TCGA-BH-A0DL-01A-11D-A111-01	TCGA-BH-A0DL-01
TCGA-BH-A0DL-11		64			1467			FEMALE									1467	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DL-11	2381	0	days		C4-BRCA/Basal							mutation cluster 3	TCGA-BH-A0DL	2381	0	days	2381	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left			TCGA-BH-A0DL-F60389	TCGA-BH-A0DL			Positive					Negative	Other					-23628			0	2381					NO					2014-6-9	FEMALE										Other, specify		No		C50.9	8575/3	C50.9		YES		Core needle biopsy			Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			No	M0	N0	T2	Stage IIA		A0DL	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2007	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d		f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d											TCGA-BH-A0DL-11A-13D-A112-05		TCGA-BH-A0DL-11			f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d			TCGA-BH-A0DL-11	TCGA-BH-A0DL-11A-13R-A115-07	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d		
TCGA-BH-A0DO-01	Stage I	78	2	Stage I	525		Positive	FEMALE	Negative				Negative	M0	Negative	N0	525	0	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DO-01	1644	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0DO	1644	0	days	1644	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Inner Quadrant			TCGA-BH-A0DO-F63671	TCGA-BH-A0DO	TCGA-BH-A0DO-01B		Positive					Positive	Simple Mastectomy					-28529	454		0	1644					NO					2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0		true	Yes	M0	N0	T1c	Stage I	TCGA-BH-A0DO.C75872B6-2260-41C3-9E21-91E4F52AD7EA.pdf	A0DO	TUMOR FREE						NO	YES			NO	Primary Tumor	01		6th		NO	YES	BH	Breast	B	LIVING	2009	46892fa4-f179-4991-99da-629d8cf936f6	579b5e2f-f3c6-48b6-8769-4950ac5c6abb	46892fa4-f179-4991-99da-629d8cf936f6	579b5e2f-f3c6-48b6-8769-4950ac5c6abb		TCGA-BH-A0DO-01B-11D-A12B-09		TCGA-BH-A0DO-01				TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11D-A12B-09	TCGA-BH-A0DO-01B-11D-A12E-05	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11D-A12B-09		46892fa4-f179-4991-99da-629d8cf936f6		TCGA-BH-A0DO-01B-11D-A12A-01	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11R-A12D-07	46892fa4-f179-4991-99da-629d8cf936f6	TCGA-BH-A0DO-01B-11D-A12A-01	TCGA-BH-A0DO-01
TCGA-BH-A0DO-11		78			525			FEMALE									525	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DO-11	1644	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DO	1644	0	days	1644	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Inner Quadrant			TCGA-BH-A0DO-F63671	TCGA-BH-A0DO			Positive					Positive	Simple Mastectomy					-28529			0	1644					NO					2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			Yes	M0	N0	T1c	Stage I		A0DO	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11		6th		NO	YES	BH	Breast		LIVING	2009	eb9e415f-0545-4e97-ad35-b56b0f3db79b		eb9e415f-0545-4e97-ad35-b56b0f3db79b											TCGA-BH-A0DO-11A-22D-A12E-05		TCGA-BH-A0DO-11			eb9e415f-0545-4e97-ad35-b56b0f3db79b			TCGA-BH-A0DO-11	TCGA-BH-A0DO-11A-22R-A12D-07	eb9e415f-0545-4e97-ad35-b56b0f3db79b		
TCGA-BH-A0DP-01	Stage IIB	60	2	Stage IIB	476		Positive	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	476	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-BH-A0DP-01	476	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation cluster 4	TCGA-BH-A0DP			days	476	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right	Sentinel node biopsy alone		TCGA-BH-A0DP-F4538	TCGA-BH-A0DP	TCGA-BH-A0DP-01A		Positive		3+			Positive	Simple Mastectomy		NO			-22199	293		0	476						H-SCORE 280	80-89%			2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	510	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2									0		true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-BH-A0DP.F04188AB-51CE-4AA1-B72C-399BE7863235.pdf	A0DP	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			80-89%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	72967b75-a711-425a-819d-dd673c5edc44	da040b34-361d-4d3c-9ea1-e9964b67f19b	72967b75-a711-425a-819d-dd673c5edc44	da040b34-361d-4d3c-9ea1-e9964b67f19b	TCGA-BH-A0DP-01A-11-A13B-20	TCGA-BH-A0DP-01A-21W-A071-09		TCGA-BH-A0DP-01	TCGA-BH-A0DP-01A-21D-A10P-05		2816036d-ed53-4c0d-b7fa-5a72f37da510	TCGA-BH-A0DP-01	TCGA-BH-A0DP-01A-21W-A071-09		TCGA-BH-A0DP-01		TCGA-BH-A0DP-01A-21W-A071-09	TCGA-BH-A0DP-01	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01	TCGA-BH-A0DP-01A-21D-A059-01		TCGA-BH-A0DP-01A-21R-A056-07	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01A-21D-A059-01	TCGA-BH-A0DP-01
TCGA-BH-A0DP-11		60			476			FEMALE									476	0	Normal						followup			LIVING	0	TCGA-BH-A0DP-11	476	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DP			days	476	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right	Sentinel node biopsy alone		TCGA-BH-A0DP-F4538	TCGA-BH-A0DP	TCGA-BH-A0DP-11A		Positive		3+			Positive	Simple Mastectomy		NO			-22199	293		0	476						H-SCORE 280	80-89%			2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	290	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0		true	No	M0	N0 (i-)	T3	Stage IIB		A0DP	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			80-89%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009	6ff2976a-2570-409b-afde-b7d2e7f2e4ea		6ff2976a-2570-409b-afde-b7d2e7f2e4ea						TCGA-BH-A0DP-11A-12D-A10Q-05		6B935910-61A6-4AC5-87EB-D3557C0777E4							TCGA-BH-A0DP-11	6ff2976a-2570-409b-afde-b7d2e7f2e4ea	TCGA-BH-A0DP-11			TCGA-BH-A0DP-11A-12R-A089-07	6ff2976a-2570-409b-afde-b7d2e7f2e4ea		
TCGA-BH-A0DQ-01	Stage IIB	42	5	No_Conversion	98		Positive	FEMALE	Negative				Negative	M0	Positive	N1	98	0	LumA	Luminal A	Positive		-5	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DQ-01	98	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0DQ			days	98	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DQ-F4560	TCGA-BH-A0DQ	TCGA-BH-A0DQ-01A		Positive		1+			Positive	Other		NO			-15533	190		0	98						H-SCORE 136	60-69%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	110	NO	Negative			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6									1		true	No	M0	N1	T2	Stage IIB	TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D.pdf	A0DQ	TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE			70-79%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	6022db68-1e06-4974-b657-cd65aed560c4	01bc5261-bf91-4f7b-a6b4-0e727c5e31d2	6022db68-1e06-4974-b657-cd65aed560c4	01bc5261-bf91-4f7b-a6b4-0e727c5e31d2		TCGA-BH-A0DQ-01A-11D-A099-09		TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01A-11D-A10P-05			TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01A-11D-A099-09		TCGA-BH-A0DQ-01		TCGA-BH-A0DQ-01A-11D-A099-09	TCGA-BH-A0DQ-01	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01A-11D-A087-01		TCGA-BH-A0DQ-01A-11R-A084-07	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01A-11D-A087-01	TCGA-BH-A0DQ-01
TCGA-BH-A0DQ-11		42			98			FEMALE									98	0	LumA						followup			LIVING	0	TCGA-BH-A0DQ-11	98	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0DQ			days	98	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DQ-F4560	TCGA-BH-A0DQ	TCGA-BH-A0DQ-11A		Positive		1+			Positive	Other		NO			-15533	190		0	98						H-SCORE 136	60-69%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100	NO	Negative			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1		true	No	M0	N1	T2	Stage IIB		A0DQ	TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE			70-79%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	2b11e565-01a8-4054-a200-03e06765bd5e		2b11e565-01a8-4054-a200-03e06765bd5e						TCGA-BH-A0DQ-11A-12D-A10Q-05									TCGA-BH-A0DQ-11	2b11e565-01a8-4054-a200-03e06765bd5e	TCGA-BH-A0DQ-11			TCGA-BH-A0DQ-11A-12R-A089-07	2b11e565-01a8-4054-a200-03e06765bd5e		
TCGA-BH-A0DS-01	Stage IIIA	71	3	No_Conversion	77		Positive	FEMALE	Negative	4	5	3	Negative	M0	Positive	N2	77	0	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DS-01	78	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A0DS			days	78	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DS-F4573	TCGA-BH-A0DS	TCGA-BH-A0DS-01A		Positive		2+			Positive	Other		NO			-25944	79		0	78						H-SCORE 190	70-79%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	6									8		true	No	M0	N2a	T2	Stage IIIA	TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf	A0DS	TUMOR FREE	H-SCORE 162			H-SCORE	H-SCORE			70-79%		YES	Primary Tumor	01	Segmental mastectomy	7th	YES	NO	YES	BH	Breast	A	LIVING	2010	00ee8acd-0841-4c85-a99a-8966a6828dd7	67942518-8522-4ba3-8458-cddcc98421c3	00ee8acd-0841-4c85-a99a-8966a6828dd7	67942518-8522-4ba3-8458-cddcc98421c3	TCGA-BH-A0DS-01A-21-A13B-20	TCGA-BH-A0DS-01A-11W-A071-09		TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11D-A10P-05		ad643947-edbf-4a15-a959-76ffd5589907	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11W-A071-09		TCGA-BH-A0DS-01		TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11D-A059-01		TCGA-BH-A0DS-01A-11R-A056-07	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-11D-A059-01	TCGA-BH-A0DS-01
TCGA-BH-A0DT-01	Stage IIA	41	2	Stage IIA	1170		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1170	0	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DT-01	2403	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-BH-A0DT	2403	0	days	2403	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Right			TCGA-BH-A0DT-F59149	TCGA-BH-A0DT			Positive					Positive	Other					-15078			0	2403					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6								NO	1			No	M0	N1a	T1c	Stage IIA		A0DT	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH	Breast		LIVING	2007	e88bcf68-e904-4511-92f6-01cbd0da62de	cc9ee06d-27bf-4038-bbcd-c95693b96321	e88bcf68-e904-4511-92f6-01cbd0da62de	cc9ee06d-27bf-4038-bbcd-c95693b96321	TCGA-BH-A0DT-01A-11-A13B-20	TCGA-BH-A0DT-01A-21D-A12B-09		TCGA-BH-A0DT-01			b170d872-08a7-4c4a-9e3f-e6525d8d5a88	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21D-A12B-09	TCGA-BH-A0DT-01A-21D-A12E-05	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21D-A12B-09		e88bcf68-e904-4511-92f6-01cbd0da62de		TCGA-BH-A0DT-01A-21D-A12A-01	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21R-A12D-07	e88bcf68-e904-4511-92f6-01cbd0da62de	TCGA-BH-A0DT-01A-21D-A12A-01	TCGA-BH-A0DT-01
TCGA-BH-A0DT-11		41			1170			FEMALE									1170	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DT-11	2403	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DT	2403	0	days	2403	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Right			TCGA-BH-A0DT-F59149	TCGA-BH-A0DT	TCGA-BH-A0DT-11A		Positive					Positive	Other					-15078	1044		0	2403					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative		NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1a	T1c	Stage IIA		A0DT	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2007	75ba5803-449e-4770-8105-b675af8e6907		75ba5803-449e-4770-8105-b675af8e6907											TCGA-BH-A0DT-11A-12D-A12E-05		TCGA-BH-A0DT-11			75ba5803-449e-4770-8105-b675af8e6907			TCGA-BH-A0DT-11	TCGA-BH-A0DT-11A-12R-A12D-07	75ba5803-449e-4770-8105-b675af8e6907		
TCGA-BH-A0DV-01	Stage IIIA	54	3	Stage IIIA	1374		Positive	FEMALE	Negative				Negative	M0	Positive	N2	1374	0	LumA		Positive	ReacII			enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DV-01	2064	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0DV	2064	0	days	2064	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left			TCGA-BH-A0DV-F63672	TCGA-BH-A0DV	TCGA-BH-A0DV-01A		Positive					Positive	Modified Radical Mastectomy					-19781	975		0	2064					NO					2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative		NO	9	Negative	Peri (6-12 months since last menstrual period)																				1	6								NO	9		true	No	M0	N2a	T2	Stage IIIA	TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf	A0DV	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	A	LIVING	2007	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	5b44486e-95e0-4505-9c39-bbd1515f155b	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	5b44486e-95e0-4505-9c39-bbd1515f155b	TCGA-BH-A0DV-01A-11-A13B-20	TCGA-BH-A0DV-01A-21D-A12Q-09		TCGA-BH-A0DV-01	TCGA-BH-A0DV-01A-21D-A12R-05		2ddc51b1-8ac4-4b9e-85d3-23c698917d5f	TCGA-BH-A0DV-01	TCGA-BH-A0DV-01A-21D-A12Q-09			TCGA-BH-A0DV-01	TCGA-BH-A0DV-01A-21D-A12Q-09		0d029d04-13cd-4870-a9e3-9d2e65c9b0b7		TCGA-BH-A0DV-01A-21D-A12N-01	TCGA-BH-A0DV-01		0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	TCGA-BH-A0DV-01A-21D-A12N-01	
TCGA-BH-A0DV-11		54			1374			FEMALE									1374	0	Normal						enrollment			LIVING	0	TCGA-BH-A0DV-11	2064	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0DV	2064	0	days	2064	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left			TCGA-BH-A0DV-F63672	TCGA-BH-A0DV	TCGA-BH-A0DV-11A		Positive					Positive	Modified Radical Mastectomy					-19781	975		0	2064					NO					2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	9	Negative	Peri (6-12 months since last menstrual period)																													NO	9		true	No	M0	N2a	T2	Stage IIIA		A0DV	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	LIVING	2007	09f570eb-a751-41db-9511-300be228f24e		09f570eb-a751-41db-9511-300be228f24e						TCGA-BH-A0DV-11A-22D-A12R-05							TCGA-BH-A0DV-11			09f570eb-a751-41db-9511-300be228f24e			TCGA-BH-A0DV-11	TCGA-BH-A0DV-11A-22R-A12P-07	09f570eb-a751-41db-9511-300be228f24e		
TCGA-BH-A0DX-01	Stage I	62	1	Stage I	1442		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1442	0	LumA	Luminal A	Positive		-4	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DX-01	2156	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-BH-A0DX	2156	0	days	2156	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Inner Quadrant			TCGA-BH-A0DX-F59135	TCGA-BH-A0DX			Positive					Positive	Other					-22833			0	2156					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0			No	M0	N0	T1b	Stage I		A0DX	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast		LIVING	2007	c791026a-9fda-47b4-86fd-9b5933325326	bb1546a4-5d30-48af-ae20-5955db13fadf	c791026a-9fda-47b4-86fd-9b5933325326	bb1546a4-5d30-48af-ae20-5955db13fadf		TCGA-BH-A0DX-01A-11D-A10Y-09		TCGA-BH-A0DX-01				TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11D-A10Y-09	TCGA-BH-A0DX-01A-11D-A112-05	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11D-A10Y-09		c791026a-9fda-47b4-86fd-9b5933325326		TCGA-BH-A0DX-01A-11D-A111-01	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11R-A115-07	c791026a-9fda-47b4-86fd-9b5933325326	TCGA-BH-A0DX-01A-11D-A111-01	TCGA-BH-A0DX-01
TCGA-BH-A0DZ-01	Stage IIB	43	5	No_Conversion	495		Positive	FEMALE	Positive				Negative	M0	Positive	N1	495	0	LumA	HER2-enriched	Positive		-2	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DZ-01	495	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-BH-A0DZ			days	495	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DZ-F4588	TCGA-BH-A0DZ	TCGA-BH-A0DZ-01A		Positive		2+			Positive	Simple Mastectomy		NO			-15980	308		0	495						H-SCORE 140	50-59%			2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	170	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4									1		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD.pdf	A0DZ	TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE			<10%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	4543cecd-6333-473b-b5ce-96d33ab47706	b17d5670-c08a-4863-9ceb-3af0ee4df007	4543cecd-6333-473b-b5ce-96d33ab47706	b17d5670-c08a-4863-9ceb-3af0ee4df007		TCGA-BH-A0DZ-01A-11W-A019-09		TCGA-BH-A0DZ-01				TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01A-11W-A019-09	TCGA-BH-A0DZ-01A-11D-A00Y-05	TCGA-BH-A0DZ-01		TCGA-BH-A0DZ-01A-11W-A019-09	TCGA-BH-A0DZ-01	4543cecd-6333-473b-b5ce-96d33ab47706	TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01A-11D-A011-01		TCGA-BH-A0DZ-01A-11R-A00Z-07	4543cecd-6333-473b-b5ce-96d33ab47706	TCGA-BH-A0DZ-01A-11D-A011-01	TCGA-BH-A0DZ-01
TCGA-BH-A0DZ-11		43			495			FEMALE									495	0							followup			LIVING	0	TCGA-BH-A0DZ-11	495	0	days		C3-BRCA/Luminal							mutation cluster 2	TCGA-BH-A0DZ			days	495	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0DZ-F4588	TCGA-BH-A0DZ			Positive		2+			Positive	Simple Mastectomy		NO			-15980			0	495						H-SCORE 140	50-59%			2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy			Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1			No	M0	N1a	T2	Stage IIB		A0DZ	TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE			<10%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast		LIVING	2009	f59f9272-412f-4884-9874-a6ff59ab1740		f59f9272-412f-4884-9874-a6ff59ab1740						TCGA-BH-A0DZ-11A-22D-A10Q-05									TCGA-BH-A0DZ-11	f59f9272-412f-4884-9874-a6ff59ab1740	TCGA-BH-A0DZ-11			TCGA-BH-A0DZ-11A-22R-A089-07	f59f9272-412f-4884-9874-a6ff59ab1740		
TCGA-BH-A0E0-01	Stage IIIC	38	1	No_Conversion	133		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N3	133	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	LIVING	0	TCGA-BH-A0E0-01	134	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-BH-A0E0			days	134	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E0-F4603	TCGA-BH-A0E0	TCGA-BH-A0E0-01A		Negative		0			Negative	Modified Radical Mastectomy		NO			-14175	136		0	134						H-SCORE 0				2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	620	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5									10		true	No	M0	N3a	T3	Stage IIIC	TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf	A0E0	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE					YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	fac9101c-a974-4415-9eac-d2d433d02b13	d0d4963f-0739-4d50-a631-119847fc08d7	fac9101c-a974-4415-9eac-d2d433d02b13	d0d4963f-0739-4d50-a631-119847fc08d7	TCGA-BH-A0E0-01A-21-A13B-20	TCGA-BH-A0E0-01A-11W-A071-09		TCGA-BH-A0E0-01	TCGA-BH-A0E0-01A-11D-A10P-05		9ccd25d1-e45d-469d-942d-0b514d4cb5a0	TCGA-BH-A0E0-01	TCGA-BH-A0E0-01A-11W-A071-09		TCGA-BH-A0E0-01		TCGA-BH-A0E0-01A-11W-A071-09	TCGA-BH-A0E0-01	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01	TCGA-BH-A0E0-01A-11D-A059-01		TCGA-BH-A0E0-01A-11R-A056-07	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01A-11D-A059-01	TCGA-BH-A0E0-01
TCGA-BH-A0E0-11		38			133			FEMALE									133	0	Normal						followup			LIVING	0	TCGA-BH-A0E0-11	134	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A0E0			days	134	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E0-F4603	TCGA-BH-A0E0	TCGA-BH-A0E0-11A		Negative		0			Negative	Modified Radical Mastectomy		NO			-14175	136		0	134						H-SCORE 0				2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	140	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														10		true	No	M0	N3a	T3	Stage IIIC		A0E0	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE					YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009	5cc82d2c-f960-40c3-9b37-59e087563dc1		5cc82d2c-f960-40c3-9b37-59e087563dc1						TCGA-BH-A0E0-11A-13D-A10Q-05										5cc82d2c-f960-40c3-9b37-59e087563dc1				TCGA-BH-A0E0-11A-13R-A089-07	5cc82d2c-f960-40c3-9b37-59e087563dc1		
TCGA-BH-A0E1-01	Stage IIB	52	2	No_Conversion	477		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	477	0	LumA	Luminal A	Positive	ReacII	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E1-01	477	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation c1uster 10	TCGA-BH-A0E1			days	477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0E1-F4631	TCGA-BH-A0E1	TCGA-BH-A0E1-01A		Positive		3+			Positive	Simple Mastectomy		NO			-19192	301		0	477						H-SCORE 180	70-79%	1.67		2010-11-16	FEMALE					2+	40	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	990	NO	Equivocal	Negative		17	Negative	Peri (6-12 months since last menstrual period)																				2	6									2		true	No	M0	N1	T2	Stage IIB	TCGA-BH-A0E1.891F4C63-8207-4CB8-AB59-A970CC6F1A1A.pdf	A0E1	TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE			50-59%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	9bf836ee-036e-40f2-88fb-cf903a40d9f5	a2a1f3e8-7484-4105-92b6-6a7d0b2d9ace	9bf836ee-036e-40f2-88fb-cf903a40d9f5	a2a1f3e8-7484-4105-92b6-6a7d0b2d9ace	TCGA-BH-A0E1-01A-21-A13B-20	TCGA-BH-A0E1-01A-11W-A071-09		TCGA-BH-A0E1-01	TCGA-BH-A0E1-01A-11D-A10P-05		e4fbf61f-e3f8-4722-b3fc-b5479c75ddae	TCGA-BH-A0E1-01	TCGA-BH-A0E1-01A-11W-A071-09		TCGA-BH-A0E1-01		TCGA-BH-A0E1-01A-11W-A071-09	TCGA-BH-A0E1-01	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01	TCGA-BH-A0E1-01A-11D-A059-01		TCGA-BH-A0E1-01A-11R-A056-07	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01A-11D-A059-01	TCGA-BH-A0E1-01
TCGA-BH-A0E1-11		52			477			FEMALE									477	0	Normal						followup			LIVING	0	TCGA-BH-A0E1-11	477	0	days		C3-BRCA/Luminal							mutation c1uster 10	TCGA-BH-A0E1			days	477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0E1-F4631	TCGA-BH-A0E1	TCGA-BH-A0E1-11A		Positive		3+			Positive	Simple Mastectomy		NO			-19192	301		0	477						H-SCORE 180	70-79%	1.67		2010-11-16	FEMALE					2+	40	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	500	NO	Equivocal	Negative		17	Negative	Peri (6-12 months since last menstrual period)																														2		true	No	M0	N1	T2	Stage IIB		A0E1	TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE			50-59%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2009	b6302c6b-2bab-40b1-b835-7f285719fff5		b6302c6b-2bab-40b1-b835-7f285719fff5						TCGA-BH-A0E1-11A-13D-A10Q-05		B5FC6749-9A17-4739-9144-FE17660801C3							TCGA-BH-A0E1-11	b6302c6b-2bab-40b1-b835-7f285719fff5	TCGA-BH-A0E1-11			TCGA-BH-A0E1-11A-13R-A089-07	b6302c6b-2bab-40b1-b835-7f285719fff5		
TCGA-BH-A0E2-01	Stage IIIA	49	2	No_Conversion	435		Positive	FEMALE	Negative				Negative	M0	Positive	N2	435	0	LumA	Luminal A	Positive	LumA/B	-8	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E2-01	435	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-BH-A0E2			days	435	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0E2-F4639	TCGA-BH-A0E2	TCGA-BH-A0E2-01A		Positive		1+			Positive	Modified Radical Mastectomy		NO			-18152	210		0	435						H-SCORE 300	90-99%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4										4		true	No	M0	N2a	T2	Stage IIIA	TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf	A0E2	TUMOR FREE	H-SCORE 1			H-SCORE	H-SCORE			<10%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	b605d803-523b-46e6-b656-7d9888d306cc	258d006c-a41d-49db-9bb4-e7e9a72eede1	b605d803-523b-46e6-b656-7d9888d306cc	258d006c-a41d-49db-9bb4-e7e9a72eede1	TCGA-BH-A0E2-01A-21-A13A-20	TCGA-BH-A0E2-01A-11W-A071-09		TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11D-A10P-05		98a8d468-efe1-41ff-a02a-615e09da0330	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11W-A071-09		TCGA-BH-A0E2-01	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11W-A071-09		b605d803-523b-46e6-b656-7d9888d306cc		TCGA-BH-A0E2-01A-11D-A059-01	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11R-A056-07	b605d803-523b-46e6-b656-7d9888d306cc	TCGA-BH-A0E2-01A-11D-A059-01	TCGA-BH-A0E2-01
TCGA-BH-A0E6-01	Stage IA	69	1	Stage I	292		Negative	FEMALE	Negative	1	4	3	Negative	M0	Negative	N0	292	0	Basal	Basal-like	Negative	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA-BH-A0E6-01	293	0	days	High	C4-BRCA/Basal	cluster 1	BRCA basal-like c8	OV-like c4	BRCA basal-like c8	miRNA cluster 12	cluster 4	mutation cluster 2	TCGA-BH-A0E6			days	293	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0E6-F4650	TCGA-BH-A0E6	TCGA-BH-A0E6-01A		Negative		0			Negative	Other		NO			-25408	134		0	293						H-SCORE 0		2.38		2010-11-16	FEMALE					2+	40	2.83	1.19		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	80	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf	A0E6	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE					YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	6bf094a5-1f62-406c-9b3a-e686bb4a074e	245f6917-4912-4707-9289-d4bc54345b81	6bf094a5-1f62-406c-9b3a-e686bb4a074e	245f6917-4912-4707-9289-d4bc54345b81	TCGA-BH-A0E6-01A-21-A13C-20	TCGA-BH-A0E6-01A-11W-A050-09		TCGA-BH-A0E6-01			1b1bb0d9-e8c0-4efa-bab4-73225525bd9c	TCGA-BH-A0E6-01	TCGA-BH-A0E6-01A-11W-A050-09	TCGA-BH-A0E6-01A-11D-A032-05	TCGA-BH-A0E6-01		TCGA-BH-A0E6-01A-11W-A050-09	TCGA-BH-A0E6-01	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA-BH-A0E6-01	TCGA-BH-A0E6-01A-11D-A036-01		TCGA-BH-A0E6-01A-11R-A034-07	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA-BH-A0E6-01A-11D-A036-01	TCGA-BH-A0E6-01
TCGA-BH-A0E7-01	Stage IIB	79	4	No_Conversion	1362		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1362	0	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E7-01	1363	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0E7			days	1363	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO	NO	79	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0E7-F4656	TCGA-BH-A0E7	TCGA-BH-A0E7-01A		Positive		3+			Positive	Other		NO			-29115	1259		0	1363							50-59%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Excisional Biopsy	140	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2									1		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0E7.CE32A294-10FC-4DBA-A779-FAEEBE677D38.pdf	A0E7	TUMOR FREE								60-69%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2006	3850a348-8e53-497d-8e06-680672b19557	36334043-4a27-4b60-945a-bef7a9adacbc	3850a348-8e53-497d-8e06-680672b19557	36334043-4a27-4b60-945a-bef7a9adacbc	TCGA-BH-A0E7-01A-21-A13C-20	TCGA-BH-A0E7-01A-11W-A050-09		TCGA-BH-A0E7-01			7c513473-0b7a-4cc6-9748-d0eaa83b6744	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01A-11W-A050-09	TCGA-BH-A0E7-01A-11D-A032-05	TCGA-BH-A0E7-01		TCGA-BH-A0E7-01A-11W-A050-09	TCGA-BH-A0E7-01	3850a348-8e53-497d-8e06-680672b19557	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01A-11D-A036-01		TCGA-BH-A0E7-01A-11R-A034-07	3850a348-8e53-497d-8e06-680672b19557	TCGA-BH-A0E7-01A-11D-A036-01	TCGA-BH-A0E7-01
TCGA-BH-A0E9-01	Stage IIB	53	3	Stage IIB	1405		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	1405	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0E9-01	2489	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-BH-A0E9	2489	0	days	2489	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right			TCGA-BH-A0E9-F59107	TCGA-BH-A0E9	TCGA-BH-A0E9-01B		Positive					Positive	Modified Radical Mastectomy					-19415	1357		0	2489					NO					2014-5-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	480	NO	Negative		NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	3		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0E9.8FDACA3D-C172-4198-9BBB-8F9E5A5FF0D6.pdf	A0E9	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	BH	Breast	B	LIVING	2006	bfc39e77-7a26-4699-a4a3-217d4ea9425b	dc318c7f-d583-49ae-978d-f298cef23098	bfc39e77-7a26-4699-a4a3-217d4ea9425b	dc318c7f-d583-49ae-978d-f298cef23098	TCGA-BH-A0E9-01B-21-A13A-20	TCGA-BH-A0E9-01B-11D-A10Y-09		TCGA-BH-A0E9-01			8eb64683-4ff3-4cc6-84ff-902fbb7a2bb1	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01B-11D-A112-05	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A10Y-09		bfc39e77-7a26-4699-a4a3-217d4ea9425b		TCGA-BH-A0E9-01B-11D-A111-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11R-A115-07	bfc39e77-7a26-4699-a4a3-217d4ea9425b	TCGA-BH-A0E9-01B-11D-A111-01	TCGA-BH-A0E9-01
TCGA-BH-A0EA-01	Stage IIA	72	2	Stage IIA	831	993	Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	993	1	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A0EA-01	991	1	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-BH-A0EA	991	0	days	991	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left			TCGA-BH-A0EA-F58566	TCGA-BH-A0EA	TCGA-BH-A0EA-01A		Positive					Positive	Other					-26548	567	991	0						NO					2014-4-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	2		true	Yes	M0	N1a	T1c	Stage IIA	TCGA-BH-A0EA.28231C7B-64EE-49AC-B7AB-9BADDDDCC17C.pdf	A0EA	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2008	ca71ca96-cbb7-4eab-9487-251dda34e107	97c64d6a-7dce-4d0f-9cb3-b3e4eb4719c5	ca71ca96-cbb7-4eab-9487-251dda34e107	97c64d6a-7dce-4d0f-9cb3-b3e4eb4719c5	TCGA-BH-A0EA-01A-21-A13C-20	TCGA-BH-A0EA-01A-11D-A10Y-09		TCGA-BH-A0EA-01			8629bf5a-cdaf-4f6a-90bb-27dd4a7565c5	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11D-A10Y-09	TCGA-BH-A0EA-01A-11D-A112-05	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11D-A10Y-09		ca71ca96-cbb7-4eab-9487-251dda34e107		TCGA-BH-A0EA-01A-11D-A111-01	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11R-A115-07	ca71ca96-cbb7-4eab-9487-251dda34e107	TCGA-BH-A0EA-01A-11D-A111-01	TCGA-BH-A0EA-01
TCGA-BH-A0EB-01	Stage IA	69	2	Stage I	745		Positive	FEMALE	Negative				Negative	M0	Negative	N0	745	0	LumA	Luminal A	Positive	LumA	-12	-4	followup	T1	T1	LIVING	0	TCGA-BH-A0EB-01	745	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 4	TCGA-BH-A0EB			days	745	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO	NO	69	Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0EB-F4662	TCGA-BH-A0EB	TCGA-BH-A0EB-01A		Positive		3+			Positive	Other		NO			-25259	552		0	745						H-SCORE 300	90-99%	2.13		2010-11-16	FEMALE					2+	40	2.65	1.25		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1										0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0EB.C6B0D463-9389-4BAE-93CA-3EE4717D20EC.pdf	A0EB	TUMOR FREE	H-SCORE 210			H-SCORE	H-SCORE			40-49%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	efb01993-cfe4-4f01-b628-ee34fceb4a5e	907f10f6-a879-43a8-9136-e943b896144d	efb01993-cfe4-4f01-b628-ee34fceb4a5e	907f10f6-a879-43a8-9136-e943b896144d	TCGA-BH-A0EB-01A-21-A13C-20	TCGA-BH-A0EB-01A-11W-A050-09		TCGA-BH-A0EB-01			ac9f49b6-6bc1-42c6-9722-0cee04e91fdd	TCGA-BH-A0EB-01	TCGA-BH-A0EB-01A-11W-A050-09	TCGA-BH-A0EB-01A-11D-A032-05	TCGA-BH-A0EB-01		TCGA-BH-A0EB-01A-11W-A050-09		efb01993-cfe4-4f01-b628-ee34fceb4a5e		TCGA-BH-A0EB-01A-11D-A036-01		TCGA-BH-A0EB-01A-11R-A034-07	efb01993-cfe4-4f01-b628-ee34fceb4a5e	TCGA-BH-A0EB-01A-11D-A036-01	TCGA-BH-A0EB-01
TCGA-BH-A0EE-01	Stage IIB	68	5	Stage IIB	943		Negative	FEMALE	Positive	2	3	1	Negative	M0	Negative	N0	943	0	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T_Other	T3	LIVING	0	TCGA-BH-A0EE-01	943	0	days	High	C3-BRCA/Luminal	cluster 1	Cluster 6	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0EE			days	943	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO	NO	68	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0EE-F4674	TCGA-BH-A0EE	TCGA-BH-A0EE-01A		Negative		0			Negative	Simple Mastectomy		NO			-24850	946		0	943										2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	890	NO	Positive			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	7									0		true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-BH-A0EE.B8664381-386A-44A2-AC3B-D69A4980A8EA.pdf	A0EE	TUMOR FREE										NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2007	24c0ef45-670d-4595-b623-87f81aeb92a7	de7f658d-2508-4621-afcd-c64ba3e554d2	24c0ef45-670d-4595-b623-87f81aeb92a7	de7f658d-2508-4621-afcd-c64ba3e554d2	TCGA-BH-A0EE-01A-21-A13C-20	TCGA-BH-A0EE-01A-11W-A050-09		TCGA-BH-A0EE-01			b92e55c0-b921-4817-9984-3f58c13f93b5	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01A-11W-A050-09	TCGA-BH-A0EE-01A-11D-A032-05	TCGA-BH-A0EE-01		TCGA-BH-A0EE-01A-11W-A050-09	TCGA-BH-A0EE-01	24c0ef45-670d-4595-b623-87f81aeb92a7	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01A-11D-A036-01		TCGA-BH-A0EE-01A-11R-A034-07	24c0ef45-670d-4595-b623-87f81aeb92a7	TCGA-BH-A0EE-01A-11D-A036-01	TCGA-BH-A0EE-01
TCGA-BH-A0EI-01	Stage IIA	51	5	Stage IIA	743		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	743	0	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0EI-01	1926	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0EI	1926	0	days	1926	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right			TCGA-BH-A0EI-F59115	TCGA-BH-A0EI	TCGA-BH-A0EI-01A		Positive					Positive	Other					-18741	541		0	1926					NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)																				4	4								NO	2		true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0EI.DFB21194-30C7-430E-A53C-C38345209B1F.pdf	A0EI	TUMOR FREE						NO	YES			YES	Primary Tumor	01	segmental mastectomy with right sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2008	c6929312-e22d-4d4e-830d-6f735184d9b2	690c778d-bca2-48c6-b084-3445f58cf216	c6929312-e22d-4d4e-830d-6f735184d9b2	690c778d-bca2-48c6-b084-3445f58cf216	TCGA-BH-A0EI-01A-21-A13B-20	TCGA-BH-A0EI-01A-11D-A10Y-09		TCGA-BH-A0EI-01			d2fe1d76-437a-4eec-b376-d17426760c2a	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11D-A10Y-09	TCGA-BH-A0EI-01A-11D-A112-05	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11D-A10Y-09		c6929312-e22d-4d4e-830d-6f735184d9b2		TCGA-BH-A0EI-01A-11D-A111-01	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11R-A115-07	c6929312-e22d-4d4e-830d-6f735184d9b2	TCGA-BH-A0EI-01A-11D-A111-01	TCGA-BH-A0EI-01
TCGA-BH-A0GY-01	Stage IIA	67	3	No_Conversion	923		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	923	0	LumA	Luminal A	Positive	ReacI	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0GY-01	923	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-BH-A0GY			days	923	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO	NO	67	Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0GY-F4695	TCGA-BH-A0GY	TCGA-BH-A0GY-01A		Positive		3+			Positive	Other		NO			-24493	745		0	923						H-Score 150	40-49%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200	NO	Negative			26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	5									3		true	No	M0	N1	T2	Stage IIA	TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62.pdf	A0GY	TUMOR FREE	H-Score 290			H-Score	H-Score			90-99%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	02275f5e-a3bf-4759-b481-d5ef710dff56	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	02275f5e-a3bf-4759-b481-d5ef710dff56	TCGA-BH-A0GY-01A-21-A13C-20	TCGA-BH-A0GY-01A-11W-A071-09		TCGA-BH-A0GY-01	TCGA-BH-A0GY-01A-11D-A10P-05		9a0ff086-5678-4a7d-953e-cd6be5d03183	TCGA-BH-A0GY-01	TCGA-BH-A0GY-01A-11W-A071-09		TCGA-BH-A0GY-01		TCGA-BH-A0GY-01A-11W-A071-09	TCGA-BH-A0GY-01	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01	TCGA-BH-A0GY-01A-11D-A059-01		TCGA-BH-A0GY-01A-11R-A056-07	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01A-11D-A059-01	TCGA-BH-A0GY-01
TCGA-BH-A0GZ-01	Stage IIA	62	3	No_Conversion	328		Positive	FEMALE	Negative				Negative	M0	Positive	N1	328	0	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0GZ-01	328	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0GZ			days	328	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO	NO	62	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0GZ-F4697	TCGA-BH-A0GZ	TCGA-BH-A0GZ-01A	Negative	Positive		3+			Positive	Other		NO			-22714	206		0	328						H-SCORE 300	90-99%	2.08		2010-11-16	FEMALE					2+	40	2.2	1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2									1		true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0GZ.C956B4B1-99E6-4823-886A-FA8FCD1E3E4D.pdf	A0GZ	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE			80-89%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	8ffcb765-094c-4623-b172-ea8400965f00	833793a9-9708-4363-ac40-ce7960a5e13d	8ffcb765-094c-4623-b172-ea8400965f00	833793a9-9708-4363-ac40-ce7960a5e13d		TCGA-BH-A0GZ-01A-11W-A071-09		TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01A-11D-A10P-05			TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01A-11W-A071-09		TCGA-BH-A0GZ-01		TCGA-BH-A0GZ-01A-11W-A071-09	TCGA-BH-A0GZ-01	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01A-11D-A059-01		TCGA-BH-A0GZ-01A-11R-A056-07	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01A-11D-A059-01	TCGA-BH-A0GZ-01
TCGA-BH-A0H0-01	Stage IA	69	2	Stage I	461		Positive	FEMALE	Negative				Negative	M0	Negative	N0	461	0	LumB	Luminal B	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H0-01	461	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-BH-A0H0			days	461	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H0-F4704	TCGA-BH-A0H0	TCGA-BH-A0H0-01A		Positive		2+			Positive	Other		NO			-25223	344		0	461						H-SCORE 190	50-59%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	70	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf	A0H0	TUMOR FREE	H-SCORE 7			H-SCORE	H-SCORE			<10%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	38e26122-c473-41c1-afb0-cd3b9096e9f4	e41ffe8d-8ad8-4ca1-9110-52c105f6f7ca	38e26122-c473-41c1-afb0-cd3b9096e9f4	e41ffe8d-8ad8-4ca1-9110-52c105f6f7ca		TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11D-A10P-05			TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01		TCGA-BH-A0H0-01A-11W-A071-09	TCGA-BH-A0H0-01	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11D-A059-01		TCGA-BH-A0H0-01A-11R-A056-07	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01A-11D-A059-01	TCGA-BH-A0H0-01
TCGA-BH-A0H3-01	Stage I	46	2	Stage I	1149		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1149	0	LumA	Luminal A	Positive		-2	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0H3-01	1928	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0H3	1928	0	days	1928	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Upper Outer Quadrant			TCGA-BH-A0H3-F58599	TCGA-BH-A0H3	TCGA-BH-A0H3-01A		Positive					Positive	Other					-17152	773		0	1928					NO					2014-4-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO		Negative	NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf	A0H3	TUMOR FREE						NO	YES			YES	Primary Tumor	01	Left segmental mastectomy with axillary lymph node dissection	6th		NO	YES	BH	Breast	A	LIVING	2008	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	836dd390-a9e4-416f-b0e1-a9fdb37155ab	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	836dd390-a9e4-416f-b0e1-a9fdb37155ab		TCGA-BH-A0H3-01A-11D-A12Q-09		TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11D-A12R-05			TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11D-A12Q-09		TCGA-BH-A0H3-01	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11D-A12Q-09		4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d		TCGA-BH-A0H3-01A-11D-A12N-01	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11R-A12P-07	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	TCGA-BH-A0H3-01A-11D-A12N-01	TCGA-BH-A0H3-01
TCGA-BH-A0H5-01	Stage I	45	1	Stage I	1080		Positive	FEMALE	Negative	2	2	1	Negative	M0	Negative	N0	1080	0	LumA	Luminal A	Positive	Basal	-2	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A0H5-01	1620	0	days	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0H5	1620	0	days	1620	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Outer Quadrant			TCGA-BH-A0H5-F58727	TCGA-BH-A0H5	TCGA-BH-A0H5-01A		Positive					Positive	Other					-16719	815		0	1620					NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	3								NO	0		true	No	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0H5.C350A3BE-1709-427D-8E1D-E0BBA480A56D.pdf	A0H5	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH	Breast	A	LIVING	2008	e5378cd0-4045-4afe-8157-7187b3d294ef	faaa02ff-b4f1-4f4d-be66-1254bd2c7403	e5378cd0-4045-4afe-8157-7187b3d294ef	faaa02ff-b4f1-4f4d-be66-1254bd2c7403	TCGA-BH-A0H5-01A-11-A13C-20	TCGA-BH-A0H5-01A-21D-A10Y-09		TCGA-BH-A0H5-01			3fd5b19e-218a-400d-85e7-23fb60737f41	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21D-A10Y-09	TCGA-BH-A0H5-01A-21D-A112-05	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21D-A10Y-09		e5378cd0-4045-4afe-8157-7187b3d294ef		TCGA-BH-A0H5-01A-21D-A111-01	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21R-A115-07	e5378cd0-4045-4afe-8157-7187b3d294ef	TCGA-BH-A0H5-01A-21D-A111-01	TCGA-BH-A0H5-01
TCGA-BH-A0H5-11		45			1080			FEMALE									1080	0	Normal						enrollment			LIVING	0	TCGA-BH-A0H5-11	1620	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0H5	1620	0	days	1620	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Outer Quadrant			TCGA-BH-A0H5-F58727	TCGA-BH-A0H5			Positive					Positive	Other					-16719			0	1620					NO					2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			No	M0	N0 (i-)	T1c	Stage I		A0H5	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH	Breast		LIVING	2008	fe1a74fd-c9b4-405b-86a7-61bcb75f825d		fe1a74fd-c9b4-405b-86a7-61bcb75f825d											TCGA-BH-A0H5-11A-62D-A112-05		TCGA-BH-A0H5-11			fe1a74fd-c9b4-405b-86a7-61bcb75f825d			TCGA-BH-A0H5-11	TCGA-BH-A0H5-11A-62R-A115-07	fe1a74fd-c9b4-405b-86a7-61bcb75f825d		
TCGA-BH-A0H6-01	Stage IA	82	4	No_Conversion	747		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	747	0	LumA	Luminal A	Positive	ReacI	-5	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H6-01	747	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0H6			days	747	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	No axillary staging		TCGA-BH-A0H6-F4711	TCGA-BH-A0H6	TCGA-BH-A0H6-01A		Positive		3+			Positive	Other		NO			-30125	583		0	747						H-SCORE 230	50-59%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	330	NO	Negative			0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2									0	0	true	No	M0	NX	T1b	Stage I	TCGA-BH-A0H6.93292768-8C20-4551-8CA8-44AE0FFB487E.pdf	A0H6	TUMOR FREE	H-SCORE 250			H-SCORE	H-SCORE			60-69%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	7cb2d031-fc42-48ac-b6f0-88fe60245c2e	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	7cb2d031-fc42-48ac-b6f0-88fe60245c2e	TCGA-BH-A0H6-01A-31-A13C-20	TCGA-BH-A0H6-01A-21W-A071-09		TCGA-BH-A0H6-01	TCGA-BH-A0H6-01A-21D-A10P-05		cc4de94d-e4e4-4e21-823c-005b9a846f19	TCGA-BH-A0H6-01	TCGA-BH-A0H6-01A-21W-A071-09		TCGA-BH-A0H6-01		TCGA-BH-A0H6-01A-21W-A071-09	TCGA-BH-A0H6-01	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01	TCGA-BH-A0H6-01A-21D-A059-01		TCGA-BH-A0H6-01A-21R-A056-07	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01A-21D-A059-01	TCGA-BH-A0H6-01
TCGA-BH-A0H7-01	Stage IIIA	65	3	No_Conversion	701		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N2	701	0	LumA	Luminal A	Positive	ReacII	-3	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H7-01	702	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-BH-A0H7			days	702	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0H7-F4737	TCGA-BH-A0H7	TCGA-BH-A0H7-01A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-23972	542		0	702						H-SCORE 255	70-79%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	440	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									6		true	No	M0	N2a	T1c	Stage IIIA	TCGA-BH-A0H7.CC7D1177-1638-4A80-A3AA-266ADC260EC9.pdf	A0H7	TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE			30-39%		YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	5969d3bb-19fb-4bda-9483-db4791257b95	be2892ed-6564-4c99-ad83-025414acbe76	5969d3bb-19fb-4bda-9483-db4791257b95	be2892ed-6564-4c99-ad83-025414acbe76	TCGA-BH-A0H7-01A-21-A13C-20	TCGA-BH-A0H7-01A-13W-A071-09		TCGA-BH-A0H7-01	TCGA-BH-A0H7-01A-13D-A10P-05		571ca6b7-118d-4261-a194-c0856e62b1d9	TCGA-BH-A0H7-01	TCGA-BH-A0H7-01A-13W-A071-09		TCGA-BH-A0H7-01		TCGA-BH-A0H7-01A-13W-A071-09	TCGA-BH-A0H7-01	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01	TCGA-BH-A0H7-01A-13D-A059-01		TCGA-BH-A0H7-01A-13R-A056-07	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01A-13D-A059-01	TCGA-BH-A0H7-01
TCGA-BH-A0H7-11		65			701			FEMALE									701	0	Normal						followup			LIVING	0	TCGA-BH-A0H7-11	702	0	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A0H7			days	702	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0H7-F4737	TCGA-BH-A0H7	TCGA-BH-A0H7-11A		Positive		2+			Positive	Modified Radical Mastectomy		NO			-23972	542		0	702						H-SCORE 255	70-79%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	380	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														6		true	No	M0	N2a	T1c	Stage IIIA		A0H7	TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE			30-39%		YES	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2008	6136a15e-6c8f-44bc-85c2-c7cbf675cab0		6136a15e-6c8f-44bc-85c2-c7cbf675cab0						TCGA-BH-A0H7-11A-13D-A10Q-05									TCGA-BH-A0H7-11	6136a15e-6c8f-44bc-85c2-c7cbf675cab0	TCGA-BH-A0H7-11			TCGA-BH-A0H7-11A-13R-A089-07	6136a15e-6c8f-44bc-85c2-c7cbf675cab0		
TCGA-BH-A0H9-01	Stage IIA	69	1	Stage IIA	1247		Positive	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	1247	0	LumA	Luminal A	Positive	LumA/B	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0H9-01	1247	0	days	Iq	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-BH-A0H9			days	1247	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H9-F4703	TCGA-BH-A0H9	TCGA-BH-A0H9-01A		Positive		1+			Positive	Other		NO			-25289	1088		0	1247							90-99%	2.98		2010-11-16	FEMALE					2+	40	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	120	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6									0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3.pdf	A0H9	TUMOR FREE								30-39%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	827431d3-e25a-45b6-9b0f-5732501e2a5b	2db50b93-b544-42c8-9c6b-39bcfe870324	827431d3-e25a-45b6-9b0f-5732501e2a5b	2db50b93-b544-42c8-9c6b-39bcfe870324	TCGA-BH-A0H9-01A-21-A13C-20	TCGA-BH-A0H9-01A-11W-A071-09		TCGA-BH-A0H9-01	TCGA-BH-A0H9-01A-11D-A10P-05		84ff2baf-9961-4324-91b6-e2e9a86128aa	TCGA-BH-A0H9-01	TCGA-BH-A0H9-01A-11W-A071-09		TCGA-BH-A0H9-01		TCGA-BH-A0H9-01A-11W-A071-09	TCGA-BH-A0H9-01	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01	TCGA-BH-A0H9-01A-11D-A059-01		TCGA-BH-A0H9-01A-11R-A056-07	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01A-11D-A059-01	TCGA-BH-A0H9-01
TCGA-BH-A0H9-11		69			1247			FEMALE									1247	0							followup			LIVING	0	TCGA-BH-A0H9-11	1247	0	days		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A0H9			days	1247	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0H9-F4703	TCGA-BH-A0H9	TCGA-BH-A0H9-11A		Positive		1+			Positive	Other		NO			-25289	1088		0	1247							90-99%	2.98		2010-11-16	FEMALE					2+	40	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	220	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0		true	No	M0	N0 (i-)	T2	Stage IIA		A0H9	TUMOR FREE								30-39%		YES	Solid Tissue Normal	11	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	27d4c881-e906-437f-921d-467eb107798a		27d4c881-e906-437f-921d-467eb107798a						TCGA-BH-A0H9-11A-22D-A093-05										27d4c881-e906-437f-921d-467eb107798a				TCGA-BH-A0H9-11A-22R-A089-07	27d4c881-e906-437f-921d-467eb107798a		
TCGA-BH-A0HA-01	Stage I	31	1	Stage I	856		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	856	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0HA-01	1611	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0HA	1611	0	days	1611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31	Right			TCGA-BH-A0HA-F43320	TCGA-BH-A0HA	TCGA-BH-A0HA-01A		Positive					Positive	Other					-11379	675		0	1611					NO				Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	0		true	No	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0HA.E6C20D27-63E5-4FFF-96BF-E8BD71296925.pdf	A0HA	TUMOR FREE						NO	YES			NO	Primary Tumor	01	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008	cffc0fe5-533f-46f8-a54a-2e09c392767d	9c593bef-cf0b-42a4-9cb1-02d9d13b16dd	cffc0fe5-533f-46f8-a54a-2e09c392767d	9c593bef-cf0b-42a4-9cb1-02d9d13b16dd	TCGA-BH-A0HA-01A-21-A13C-20	TCGA-BH-A0HA-01A-11D-A12Q-09		TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12R-05		f1a9fcd6-b351-4300-ab8c-e488c8d76cee	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12Q-09		TCGA-BH-A0HA-01	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12Q-09		cffc0fe5-533f-46f8-a54a-2e09c392767d		TCGA-BH-A0HA-01A-11D-A12N-01	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11R-A12P-07	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-11D-A12N-01	TCGA-BH-A0HA-01
TCGA-BH-A0HA-11		31			856			FEMALE									856	0	Normal						enrollment			LIVING	0	TCGA-BH-A0HA-11	1611	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A0HA	1611	0	days	1611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31	Right			TCGA-BH-A0HA-F43320	TCGA-BH-A0HA	TCGA-BH-A0HA-11A		Positive					Positive	Other					-11379	675		0	1611					NO				Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0 (i-)	T1c	Stage I		A0HA	TUMOR FREE						NO	YES			NO	Solid Tissue Normal	11	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008	a521a6fa-da2b-48ef-94e8-3307030427b6		a521a6fa-da2b-48ef-94e8-3307030427b6						TCGA-BH-A0HA-11A-31D-A12R-05		4DD09312-C6DE-4532-811D-242BAAE47F9D					TCGA-BH-A0HA-11			a521a6fa-da2b-48ef-94e8-3307030427b6			TCGA-BH-A0HA-11	TCGA-BH-A0HA-11A-31R-A12P-07	a521a6fa-da2b-48ef-94e8-3307030427b6		
TCGA-BH-A0HB-01	Stage IA	55	5	Stage I	806		Positive	FEMALE	Negative				Negative	M0	Negative	N0	806	0	LumA	Luminal A	Positive		-8	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HB-01	806	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-BH-A0HB			days	806	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HB-F4718	TCGA-BH-A0HB	TCGA-BH-A0HB-01A		Positive		1+			Positive	Other		NO			-20448	739		0	806						H-Score 300	90-99%	2.13		2010-11-16	FEMALE					2+	40	2.58	1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	70	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HB.C7476B2B-0040-4013-8D30-06935E3FB897.pdf	A0HB	TUMOR FREE	H-Score 70			H-Score	H-Score			30-39%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	67b214bc-ac5f-4993-9907-fe0e0398d4ed	f413a46e-2b09-429d-8463-286cbcdad0b6	67b214bc-ac5f-4993-9907-fe0e0398d4ed	f413a46e-2b09-429d-8463-286cbcdad0b6		TCGA-BH-A0HB-01A-11W-A071-09		TCGA-BH-A0HB-01	TCGA-BH-A0HB-01A-11D-A10P-05			TCGA-BH-A0HB-01	TCGA-BH-A0HB-01A-11W-A071-09		TCGA-BH-A0HB-01		TCGA-BH-A0HB-01A-11W-A071-09	TCGA-BH-A0HB-01	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01	TCGA-BH-A0HB-01A-11D-A059-01		TCGA-BH-A0HB-01A-11R-A056-07	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01A-11D-A059-01	TCGA-BH-A0HB-01
TCGA-BH-A0HF-01	Stage IA	77		Stage I	727		Positive	FEMALE	Negative				Negative	M0	Negative	N0	727	0	LumA	Luminal A	Positive		-5	-7	followup	T1	T1	LIVING	0	TCGA-BH-A0HF-01	727	0	days			cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-BH-A0HF			days	727	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HF-F4734	TCGA-BH-A0HF	TCGA-BH-A0HF-01A		Positive		1+			Positive	Other		NO			-28233	549		0	727						H-Score 295	90-99%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	40	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HF.71291A56-C2DB-4EB9-8223-DD7563CBBDC9.pdf	A0HF	TUMOR FREE	H-Score 15			H-Score	H-Score			<10%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	598d5706-eedb-4d5a-9048-4ac324573025	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	598d5706-eedb-4d5a-9048-4ac324573025				TCGA-BH-A0HF-01	TCGA-BH-A0HF-01A-11D-A10P-05				TCGA-BH-A0HF-01A-11W-A071-09					TCGA-BH-A0HF-01	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	TCGA-BH-A0HF-01			TCGA-BH-A0HF-01A-11R-A056-07	5b92fd62-9fec-4b18-b7c3-50c88fa0d464		TCGA-BH-A0HF-01
TCGA-BH-A0HI-01	Stage IA	78	2	Stage I	619		Positive	FEMALE	Negative				Negative	M0	Negative	N0	619	0	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HI-01	620	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0HI			days	620	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HI-F4756	TCGA-BH-A0HI	TCGA-BH-A0HI-01A		Positive		1+			Positive	Other		YES			-28644	554		0	620						H-Score 240	50-59%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7									0	0	true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf	A0HI	TUMOR FREE	H-Score 160			H-Score	H-Score			40-49%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2008	682942cb-589f-4348-abc2-3c7cc76fb34d	fab48d98-dc30-4a19-8108-48476a6362ee	682942cb-589f-4348-abc2-3c7cc76fb34d	fab48d98-dc30-4a19-8108-48476a6362ee		TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A10P-05			TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01		TCGA-BH-A0HI-01A-11D-A099-09	TCGA-BH-A0HI-01	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A087-01		TCGA-BH-A0HI-01A-11R-A084-07	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01A-11D-A087-01	TCGA-BH-A0HI-01
TCGA-BH-A0HK-01	Stage IIB	81	2	No_Conversion	178		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	178	0	LumA	Luminal A	Negative	LumA/B	0	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HK-01	178	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-BH-A0HK			days	178	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0HK-F4758	TCGA-BH-A0HK	TCGA-BH-A0HK-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-29751	35		0	178						H-SCORE 260	70-79%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	700	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	7									2		true	No	M0	N1	T2	Stage IIB	TCGA-BH-A0HK.575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09.pdf	A0HK	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			<10%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2010	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	6a9b5a0c-ce6c-4445-8316-0b25795d23d1	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	6a9b5a0c-ce6c-4445-8316-0b25795d23d1	TCGA-BH-A0HK-01A-21-A13C-20	TCGA-BH-A0HK-01A-11W-A071-09		TCGA-BH-A0HK-01	TCGA-BH-A0HK-01A-11D-A10P-05		c6d75d78-0a3e-4221-840e-b2c6099b8e72	TCGA-BH-A0HK-01	TCGA-BH-A0HK-01A-11W-A071-09		TCGA-BH-A0HK-01		TCGA-BH-A0HK-01A-11W-A071-09	TCGA-BH-A0HK-01	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01	TCGA-BH-A0HK-01A-11D-A059-01		TCGA-BH-A0HK-01A-11R-A056-07	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01A-11D-A059-01	TCGA-BH-A0HK-01
TCGA-BH-A0HK-11		81			178			FEMALE									178	0	Normal						followup			LIVING	0	TCGA-BH-A0HK-11	178	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A0HK			days	178	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone		TCGA-BH-A0HK-F4758	TCGA-BH-A0HK	TCGA-BH-A0HK-11A		Positive		0			Negative	Modified Radical Mastectomy		NO			-29751	35		0	178						H-SCORE 260	70-79%			2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	240	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														2		true	No	M0	N1	T2	Stage IIB		A0HK	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE			<10%		NO	Solid Tissue Normal	11			YES	NO	YES	BH	Breast	A	LIVING	2010	01163f75-8956-40a6-97a5-3c0478d904f8		01163f75-8956-40a6-97a5-3c0478d904f8						TCGA-BH-A0HK-11A-11D-A10Q-05		9959CAD8-B950-41C0-A0C7-3EF86F4DA9EC							TCGA-BH-A0HK-11	01163f75-8956-40a6-97a5-3c0478d904f8	TCGA-BH-A0HK-11			TCGA-BH-A0HK-11A-11R-A089-07	01163f75-8956-40a6-97a5-3c0478d904f8		
TCGA-BH-A0HL-01	Stage IIB	56		No_Conversion	72		Positive	FEMALE	Negative				Negative	M0	Positive	N1	72	0		Basal-like	Positive	LumA/B	-13	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HL-01	72	0	days			cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 11	cluster 4	mutation c1uster 9	TCGA-BH-A0HL			days	72	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0HL-F4792	TCGA-BH-A0HL	TCGA-BH-A0HL-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-20804	352		0	72						H-SCORE 295	90-99%	2.25		2010-11-16	FEMALE					2+	40	2.23	0.99		Infiltrating Ductal Carcinoma		No		C50.9	8503/3	C50.9	3+	YES		Core needle biopsy	250	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4									2		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0HL.79DAEAE5-A177-40E0-9BFC-54DC9F544764.pdf	A0HL	TUMOR FREE	H-SCORE 200			H-SCORE	H-SCORE			40-49%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	1ee60bda-48df-4288-90cb-480fbfbc5d50	53e67b89-52ff-4af2-a20f-378da3c2b9f4	1ee60bda-48df-4288-90cb-480fbfbc5d50	53e67b89-52ff-4af2-a20f-378da3c2b9f4	TCGA-BH-A0HL-01A-21-A13C-20	TCGA-BH-A0HL-01A-11W-A050-09		TCGA-BH-A0HL-01			2167df75-1057-4cb6-acea-3e737541d1ee		TCGA-BH-A0HL-01A-11W-A050-09	TCGA-BH-A0HL-01A-11D-A032-05		TCGA-BH-A0HL-01	TCGA-BH-A0HL-01A-11W-A050-09		1ee60bda-48df-4288-90cb-480fbfbc5d50			TCGA-BH-A0HL-01		1ee60bda-48df-4288-90cb-480fbfbc5d50		
TCGA-BH-A0HN-01	Stage IA	67		Stage I	516		Positive	FEMALE	Negative				Negative	M0	Negative	N0	516	0		Basal-like	Positive	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA-BH-A0HN-01	516	0	days			cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 11	cluster 6	mutation cluster 14	TCGA-BH-A0HN			days	516	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0HN-F4811	TCGA-BH-A0HN	TCGA-BH-A0HN-01A	Negative	Positive		3+		Mastectomy NOS	Positive	Other		NO			-24731	359		0	516						H-SCORE 300	90-99%	1.78		2010-11-16	FEMALE					2+	40	2.0	1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	130	NO	Equivocal	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HN.CA7E5555-5898-411A-8A5B-9BA2239A2B30.pdf	A0HN	TUMOR FREE	H-SCORE 290			H-SCORE	H-SCORE			90-99%		NO	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	6f0cf450-76f1-489d-9890-5093816c0680	4e118657-b2e3-491b-ba2d-e8d16e04be75	6f0cf450-76f1-489d-9890-5093816c0680	4e118657-b2e3-491b-ba2d-e8d16e04be75	TCGA-BH-A0HN-01A-21-A13C-20	TCGA-BH-A0HN-01A-11D-A099-09		TCGA-BH-A0HN-01	TCGA-BH-A0HN-01A-11D-A10P-05		b81e2777-d661-4576-b8dc-e95b03351e27		TCGA-BH-A0HN-01A-11D-A099-09			TCGA-BH-A0HN-01	TCGA-BH-A0HN-01A-11D-A099-09		6f0cf450-76f1-489d-9890-5093816c0680			TCGA-BH-A0HN-01		6f0cf450-76f1-489d-9890-5093816c0680		
TCGA-BH-A0HO-01	Stage IIA	48	2	No_Conversion	76		Positive	FEMALE	Negative				Negative	M0	Positive	N1	76	0	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HO-01	76	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 6	cluster 2	mutation c1uster 9	TCGA-BH-A0HO			days	76	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0HO-F4771	TCGA-BH-A0HO	TCGA-BH-A0HO-01A		Positive		3+			Positive	Other		YES			-17710	224		0	76						H-Score 200	90-99%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	110	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	2									1	1	true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2.pdf	A0HO	TUMOR FREE	H-Score 290			H-Score	H-Score			90-99%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	92f53e8e-abd5-4597-a6be-678be549315d	b4d2c0c0-92c9-407d-af6f-1f951e1096ae	92f53e8e-abd5-4597-a6be-678be549315d	b4d2c0c0-92c9-407d-af6f-1f951e1096ae		TCGA-BH-A0HO-01A-11W-A050-09		TCGA-BH-A0HO-01				TCGA-BH-A0HO-01	TCGA-BH-A0HO-01A-11W-A050-09	TCGA-BH-A0HO-01A-11D-A032-05	TCGA-BH-A0HO-01		TCGA-BH-A0HO-01A-11W-A050-09	TCGA-BH-A0HO-01	92f53e8e-abd5-4597-a6be-678be549315d	TCGA-BH-A0HO-01	TCGA-BH-A0HO-01A-11D-A036-01		TCGA-BH-A0HO-01A-11R-A034-07	92f53e8e-abd5-4597-a6be-678be549315d	TCGA-BH-A0HO-01A-11D-A036-01	TCGA-BH-A0HO-01
TCGA-BH-A0HP-01	Stage IIIA	65	2	No_Conversion	414		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N2	414	0	LumA	Luminal A	Negative	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-BH-A0HP-01	414	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-BH-A0HP			days	414	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-BH-A0HP-F4784	TCGA-BH-A0HP	TCGA-BH-A0HP-01A		Positive		0			Negative	Modified Radical Mastectomy		NO			-23883	346		0	414						H-Score 280	80-89%			2010-11-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	720	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Negative			1	6									8		true	No	M0	N2a	T3	Stage IIIA	TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf	A0HP	TUMOR FREE	H-Score 0			H-Score	H-Score					YES	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2009	f0c59856-0421-46e3-a2f9-e17f0f267930	f3f959ab-bf38-45eb-9422-ed83acae1244	f0c59856-0421-46e3-a2f9-e17f0f267930	f3f959ab-bf38-45eb-9422-ed83acae1244	TCGA-BH-A0HP-01A-21-A13C-20	TCGA-BH-A0HP-01A-12D-A099-09		TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A10P-05		189540a2-042e-4bac-99f0-b7b0feda0a23	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A099-09		TCGA-BH-A0HP-01		TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A087-01		TCGA-BH-A0HP-01A-12R-A084-07	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-12D-A087-01	TCGA-BH-A0HP-01
TCGA-BH-A0HQ-01	Stage IIA	56		Stage IIA	1121		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1121	0	LumA	Luminal A	Positive		-5	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HQ-01	1121	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0HQ			days	1121	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0HQ-F4795	TCGA-BH-A0HQ	TCGA-BH-A0HQ-01A		Positive		3+			Positive	Other		YES			-20719	962		0	1121							90-99%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2									0		true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-BH-A0HQ.A76A272F-675E-4E56-8761-96B71419A012.pdf	A0HQ	TUMOR FREE								90-99%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2007	856452d1-5480-4921-bf5b-4c6f625a99c0	e84b732c-f8a5-4f4c-933e-ea539fff5d48	856452d1-5480-4921-bf5b-4c6f625a99c0	e84b732c-f8a5-4f4c-933e-ea539fff5d48		TCGA-BH-A0HQ-01A-11W-A050-09		TCGA-BH-A0HQ-01				TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01A-11W-A050-09	TCGA-BH-A0HQ-01A-11D-A032-05	TCGA-BH-A0HQ-01		TCGA-BH-A0HQ-01A-11W-A050-09	TCGA-BH-A0HQ-01	856452d1-5480-4921-bf5b-4c6f625a99c0	TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01A-11D-A036-01		TCGA-BH-A0HQ-01A-11R-A034-07	856452d1-5480-4921-bf5b-4c6f625a99c0	TCGA-BH-A0HQ-01A-11D-A036-01	TCGA-BH-A0HQ-01
TCGA-BH-A0HU-01	Stage IA	52	2	Stage I	392		Positive	FEMALE	Negative	3	1	4	Negative	M0	Negative	N0	392	0	LumB	Luminal B	Positive	Her2	-2	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HU-01	392	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-BH-A0HU			days	392	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone		TCGA-BH-A0HU-F4813	TCGA-BH-A0HU	TCGA-BH-A0HU-01A		Positive		2+			Positive	Other		NO			-19216	394		0	392						H-Score 140	40-49%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																				2	4									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HU.1F35A542-2795-4B1F-A846-7097B442C2D9.pdf	A0HU	TUMOR FREE	H-Score 140			H-Score	H-Score			40-49%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2009	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	f5222559-bf86-457c-af8d-b14e676ae34c	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	f5222559-bf86-457c-af8d-b14e676ae34c	TCGA-BH-A0HU-01A-21-A13A-20	TCGA-BH-A0HU-01A-11W-A050-09		TCGA-BH-A0HU-01			1b5d1cb8-6b38-485a-aff3-24213e459637	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01A-11W-A050-09	TCGA-BH-A0HU-01A-11D-A032-05	TCGA-BH-A0HU-01		TCGA-BH-A0HU-01A-11W-A050-09	TCGA-BH-A0HU-01	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01A-11D-A036-01		TCGA-BH-A0HU-01A-11R-A034-07	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	TCGA-BH-A0HU-01A-11D-A036-01	TCGA-BH-A0HU-01
TCGA-BH-A0HW-01	Stage IA	62	4	Stage I	1560		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	1560	0	LumB	Luminal B	Negative	LumA/B	-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HW-01	1561	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0HW			days	1561	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0HW-F4827	TCGA-BH-A0HW	TCGA-BH-A0HW-01A		Positive		0			Negative	Other		NO			-22962	1591		0	1561							90-99%			2010-11-16	FEMALE					2+			1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2									0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-BH-A0HW.8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD.pdf	A0HW	TUMOR FREE								<10%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2006	0172d30c-287c-4f3e-b70c-5760c6dccb7c	6fa29a88-190a-4394-b84b-8eb6d12f5339	0172d30c-287c-4f3e-b70c-5760c6dccb7c	6fa29a88-190a-4394-b84b-8eb6d12f5339	TCGA-BH-A0HW-01A-21-A13B-20	TCGA-BH-A0HW-01A-11W-A050-09		TCGA-BH-A0HW-01			fe1d6a4b-4950-48e6-92fd-7ddc10953a83	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01A-11W-A050-09	TCGA-BH-A0HW-01A-11D-A032-05	TCGA-BH-A0HW-01		TCGA-BH-A0HW-01A-11W-A050-09	TCGA-BH-A0HW-01	0172d30c-287c-4f3e-b70c-5760c6dccb7c	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01A-11D-A036-01		TCGA-BH-A0HW-01A-11R-A034-07	0172d30c-287c-4f3e-b70c-5760c6dccb7c	TCGA-BH-A0HW-01A-11D-A036-01	TCGA-BH-A0HW-01
TCGA-BH-A0HX-01	Stage IIB	54	4	No_Conversion	829		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	829	0	LumA	Luminal A	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HX-01	829	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0HX			days	829	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0HX-F4838	TCGA-BH-A0HX	TCGA-BH-A0HX-01A		Positive		3+			Positive	Simple Mastectomy		YES			-19900	672		0	829						H-Score 270	80-89%			2010-11-16	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									2	2	true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A0HX.8C4FEB77-99B6-4C73-9751-508953A874DC.pdf	A0HX	TUMOR FREE	H-Score 190			H-Score	H-Score			50-59%		NO	Primary Tumor	01			YES	NO	YES	BH	Breast	A	LIVING	2008	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	c07a21d6-9aad-41c8-b3fc-ff846239c1fc	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	c07a21d6-9aad-41c8-b3fc-ff846239c1fc	TCGA-BH-A0HX-01A-11-A13B-20	TCGA-BH-A0HX-01A-21W-A071-09		TCGA-BH-A0HX-01	TCGA-BH-A0HX-01A-21D-A10P-05		a58fd02f-a169-42ee-ab9b-761d00d11179	TCGA-BH-A0HX-01	TCGA-BH-A0HX-01A-21W-A071-09		TCGA-BH-A0HX-01		TCGA-BH-A0HX-01A-21W-A071-09	TCGA-BH-A0HX-01	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01	TCGA-BH-A0HX-01A-21D-A059-01		TCGA-BH-A0HX-01A-21R-A056-07	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01A-21D-A059-01	TCGA-BH-A0HX-01
TCGA-BH-A0HY-01	Stage I	60		Stage I	867		Positive	FEMALE					Negative	M0	Negative	N0	867	0	LumB	HER2-enriched	Negative	ReacII	-1	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A0HY-01	1545	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0HY	1545	0	days	1545	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left			TCGA-BH-A0HY-F43316	TCGA-BH-A0HY	TCGA-BH-A0HY-01A		Positive					Negative	Other					-22179	470		0	1545					NO				Scheduled Follow-up Submission	2013-5-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Positive		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A0HY.E57B4989-102F-44FD-8FB2-0627143FA904.pdf	A0HY	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Total mastectomy with left sentinel lymph node biospy	6th	YES	NO	YES	BH	Breast	A	LIVING	2009	e074391d-348f-4f95-aad0-7f51c56b9696	4c85d947-2682-480c-bd54-947fa45c14f6	e074391d-348f-4f95-aad0-7f51c56b9696	4c85d947-2682-480c-bd54-947fa45c14f6	TCGA-BH-A0HY-01A-21-A13B-20	TCGA-BH-A0HY-01A-11W-A071-09		TCGA-BH-A0HY-01	TCGA-BH-A0HY-01A-11D-A10P-05		b5cba62d-f66e-40c7-88c8-0040d3d38607	TCGA-BH-A0HY-01	TCGA-BH-A0HY-01A-11W-A071-09		TCGA-BH-A0HY-01		TCGA-BH-A0HY-01A-11W-A071-09	TCGA-BH-A0HY-01	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01	TCGA-BH-A0HY-01A-11D-A059-01		TCGA-BH-A0HY-01A-11R-A056-07	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01A-11D-A059-01	TCGA-BH-A0HY-01
TCGA-BH-A0RX-01	Stage IIA	59	4	Stage IIA	170		Negative	FEMALE	Negative	3	2	2	Negative	M0	Negative	N0	170	0	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-BH-A0RX-01	170	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-BH-A0RX			days	170	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast		YES			59	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone		TCGA-BH-A0RX-F4875	TCGA-BH-A0RX	TCGA-BH-A0RX-01A		Negative		0			Negative	Other		NO			-21857	63		0	170						H-Score 0	<10%			2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	170	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4									0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0RX.57359A9F-7E5A-4599-918C-A95DCF0D9479.pdf	A0RX	TUMOR FREE	H-Score 0			H-Score	H-Score			<10%		YES	Primary Tumor	01	Segmental mastectomy		YES	NO	YES	BH	Breast	A	LIVING	2010	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	c73d082f-32bf-4c0f-ac42-1419b5d367be	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	c73d082f-32bf-4c0f-ac42-1419b5d367be	TCGA-BH-A0RX-01A-11-A13C-20	TCGA-BH-A0RX-01A-21D-A099-09		TCGA-BH-A0RX-01	TCGA-BH-A0RX-01A-21D-A10P-05		c8d587b3-a3d1-4375-bb94-7208c050421a	TCGA-BH-A0RX-01	TCGA-BH-A0RX-01A-21D-A099-09		TCGA-BH-A0RX-01		TCGA-BH-A0RX-01A-21D-A099-09	TCGA-BH-A0RX-01	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01	TCGA-BH-A0RX-01A-21D-A087-01		TCGA-BH-A0RX-01A-21R-A084-07	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01A-21D-A087-01	TCGA-BH-A0RX-01
TCGA-BH-A0W3-01	Stage IIA	58	2	No_Conversion	180		Positive	FEMALE	Negative				Negative	M0	Positive	N1	180	0	LumB	Luminal B	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W3-01	728	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BH-A0W3	728	0	days	728	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Inner Quadrant			TCGA-BH-A0W3-F34065	TCGA-BH-A0W3	TCGA-BH-A0W3-01A		Positive					Positive	Other					-21369	85		0	728									Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Equivocal	Negative		4		Indeterminate (neither Pre or Postmenopausal)																				2	5								NO	1	1	true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0W3.801A4E2F-E26E-424F-BF42-CD0D9CD62BCE.pdf	A0W3	TUMOR FREE										YES	Primary Tumor	01	Segmental mastectomy	7th	NO	NO	YES	BH	Breast	A	LIVING	2010	0def3ef8-7608-483c-b899-4d459f6d2e2d	6b6c28fb-84ba-407c-9317-3fad63e9e35d	0def3ef8-7608-483c-b899-4d459f6d2e2d	6b6c28fb-84ba-407c-9317-3fad63e9e35d		TCGA-BH-A0W3-01A-11D-A10G-09		TCGA-BH-A0W3-01	TCGA-BH-A0W3-01A-11D-A10A-05			TCGA-BH-A0W3-01	TCGA-BH-A0W3-01A-11D-A10G-09		TCGA-BH-A0W3-01		TCGA-BH-A0W3-01A-11D-A10G-09	TCGA-BH-A0W3-01	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01	TCGA-BH-A0W3-01A-11D-A107-01		TCGA-BH-A0W3-01A-11R-A109-07	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01A-11D-A107-01	TCGA-BH-A0W3-01
TCGA-BH-A0W4-01	Stage IIA	46	2	Stage IIA	175		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	175	0	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0W4-01	759	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0W4	759	0	days	759	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Upper Outer Quadrant			TCGA-BH-A0W4-F34069	TCGA-BH-A0W4	TCGA-BH-A0W4-01A		Positive					Positive	Other					-16911	119		0	759									Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			3																						2	4								NO			true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A0W4.0C158269-A420-4E71-9E59-8775FB26084B.pdf	A0W4	TUMOR FREE										NO	Primary Tumor	01	Total mastectomy	7th	NO	NO	YES	BH	Breast	A	LIVING	2010	750469b2-05c7-4647-b101-cdd94246d254	5256eab2-28f3-467a-a26d-9da6d612ed5b	750469b2-05c7-4647-b101-cdd94246d254	5256eab2-28f3-467a-a26d-9da6d612ed5b	TCGA-BH-A0W4-01A-21-A13D-20	TCGA-BH-A0W4-01A-11D-A10G-09		TCGA-BH-A0W4-01	TCGA-BH-A0W4-01A-11D-A10A-05		6a26c8ad-e0f9-44a9-9039-983f6771a989	TCGA-BH-A0W4-01	TCGA-BH-A0W4-01A-11D-A10G-09		TCGA-BH-A0W4-01		TCGA-BH-A0W4-01A-11D-A10G-09	TCGA-BH-A0W4-01	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01	TCGA-BH-A0W4-01A-11D-A107-01		TCGA-BH-A0W4-01A-11R-A109-07	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01A-11D-A107-01	TCGA-BH-A0W4-01
TCGA-BH-A0W5-01	Stage IIA	77	4	No_Conversion	543		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	543	0	LumA	Luminal A	Positive	LumA	-5	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W5-01	1288	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-BH-A0W5	1288	0	days	1288	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A0W5-F34070	TCGA-BH-A0W5	TCGA-BH-A0W5-01A		Positive					Positive	Other					-28304	906		0	1288									Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Equivocal	Equivocal		11	Negative																					1	4								NO	1	1	true	No	M0	N1a	T1c	Stage IIA	TCGA-BH-A0W5.60F59595-928B-43BB-978F-9E5B48539EFA.pdf	A0W5	TUMOR FREE										YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH	Breast	A	LIVING	2008	91e55e6f-b884-4112-8d3f-a9f8974dd63b	c2056ecb-78f2-4bc7-8954-030007e428dc	91e55e6f-b884-4112-8d3f-a9f8974dd63b	c2056ecb-78f2-4bc7-8954-030007e428dc	TCGA-BH-A0W5-01A-21-A13D-20	TCGA-BH-A0W5-01A-11D-A10G-09		TCGA-BH-A0W5-01	TCGA-BH-A0W5-01A-11D-A10A-05		ef0f5ff2-5b71-45fa-9036-b5dfc63510aa	TCGA-BH-A0W5-01	TCGA-BH-A0W5-01A-11D-A10G-09		TCGA-BH-A0W5-01		TCGA-BH-A0W5-01A-11D-A10G-09	TCGA-BH-A0W5-01	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01	TCGA-BH-A0W5-01A-11D-A107-01		TCGA-BH-A0W5-01A-11R-A109-07	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01A-11D-A107-01	TCGA-BH-A0W5-01
TCGA-BH-A0W7-01	Stage IA	49	4	Stage I	558		Positive	FEMALE	Negative				Negative	M0	Negative	N0	558	0	LumA	Luminal A	Positive		-4	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W7-01	1363	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0W7	1363	0	days	1363	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A0W7-F34073	TCGA-BH-A0W7			Positive					Positive	Other					-17996			0	1363									Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			2	Negative																					1	4								NO	0	0		No	M0	N0 (i-)	T1c	Stage I		A0W7	TUMOR FREE										YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH	Breast		LIVING	2008	afaeb45f-d795-4fe0-b4ee-5b90816e6427	a9266ff7-8563-45b1-914f-0855ecb4cddd	afaeb45f-d795-4fe0-b4ee-5b90816e6427	a9266ff7-8563-45b1-914f-0855ecb4cddd		TCGA-BH-A0W7-01A-11D-A10Y-09		TCGA-BH-A0W7-01				TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11D-A10Y-09	TCGA-BH-A0W7-01A-11D-A112-05	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11D-A10Y-09		afaeb45f-d795-4fe0-b4ee-5b90816e6427		TCGA-BH-A0W7-01A-11D-A111-01	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11R-A115-07	afaeb45f-d795-4fe0-b4ee-5b90816e6427	TCGA-BH-A0W7-01A-11D-A111-01	TCGA-BH-A0W7-01
TCGA-BH-A0WA-01	Stage IA	82	1	Stage I	372		Negative	FEMALE	Negative				Negative	M0	Negative	N0	372	0	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0WA-01	701	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-BH-A0WA	701	0	days	701	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-BH-A0WA-F34068	TCGA-BH-A0WA	TCGA-BH-A0WA-01A		Negative					Negative	Other					-30025	724		0	701									Scheduled Follow-up Submission	2012-7-29	FEMALE												No		C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative			3	Negative																					5	5								NO	0		true	No	M0	N0 (i-)	T1c	Stage I	TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf	A0WA	TUMOR FREE										NO	Primary Tumor	01	segmental mastectomy	6th	NO	NO	YES	BH	Breast	A	LIVING	2008	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	35001085-6428-46a2-a1c7-a45970cac84f	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	35001085-6428-46a2-a1c7-a45970cac84f		TCGA-BH-A0WA-01A-11D-A10G-09		TCGA-BH-A0WA-01	TCGA-BH-A0WA-01A-11D-A10A-05			TCGA-BH-A0WA-01	TCGA-BH-A0WA-01A-11D-A10G-09		TCGA-BH-A0WA-01		TCGA-BH-A0WA-01A-11D-A10G-09,TCGA-BH-A0WA-01A-11D-A128-09	TCGA-BH-A0WA-01	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01	TCGA-BH-A0WA-01A-11D-A107-01		TCGA-BH-A0WA-01A-11R-A109-07	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01A-11D-A107-01	TCGA-BH-A0WA-01
TCGA-BH-A18F-01	Stage IIA	50	2	Stage IIA	268		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	268	0	LumA	Luminal B	Positive	ReacI	-4	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A18F-01	1001	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation cluster 4	TCGA-BH-A18F	1001	0	days	1001	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A18F-F59193	TCGA-BH-A18F	TCGA-BH-A18F-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other					-18594	114		0	1001							70-79%			2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative		NO	1	Negative	Peri (6-12 months since last menstrual period)																				1	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728.pdf	A18F	TUMOR FREE						YES	YES	40-49%		YES	Primary Tumor	01	needle localized segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	eed6d177-6cec-493a-b811-1779bebae72a	df0ea333-0f5a-4da4-9242-f74a28e6a9ac	eed6d177-6cec-493a-b811-1779bebae72a	df0ea333-0f5a-4da4-9242-f74a28e6a9ac	TCGA-BH-A18F-01A-21-A13F-20	TCGA-BH-A18F-01A-11D-A12B-09		TCGA-BH-A18F-01			90367af6-b44b-46f1-9482-c1ddc1bc42e6	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11D-A12B-09	TCGA-BH-A18F-01A-11D-A12E-05	TCGA-BH-A18F-01	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11D-A12B-09		eed6d177-6cec-493a-b811-1779bebae72a		TCGA-BH-A18F-01A-11D-A12A-01	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11R-A12D-07	eed6d177-6cec-493a-b811-1779bebae72a	TCGA-BH-A18F-01A-11D-A12A-01	TCGA-BH-A18F-01
TCGA-BH-A18F-11		50			268			FEMALE									268	0							enrollment			LIVING	0	TCGA-BH-A18F-11	1001	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18F	1001	0	days	1001	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A18F-F59193	TCGA-BH-A18F	TCGA-BH-A18F-11A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other					-18594	114		0	1001							70-79%			2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative		NO	1	Negative	Peri (6-12 months since last menstrual period)																													NO	0		true	No	M0	N0	T2	Stage IIA		A18F	TUMOR FREE						YES	YES	40-49%		YES	Solid Tissue Normal	11	needle localized segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010														TCGA-BH-A18F-11A-22D-A12E-05												
TCGA-BH-A18G-01	Stage X	81	3	No_Conversion	61		Negative	FEMALE	Negative				Negative	M0	Negative	N0	61	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A18G-01	149	0	days	Iq	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 4		TCGA-BH-A18G	149	0	days	149	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A18G-F64216	TCGA-BH-A18G	TCGA-BH-A18G-01A		Negative					Negative	Other					-29820	78		0	149										2014-8-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.5	8500/3	C50.5		YES		Core needle biopsy	100	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf	A18G	TUMOR FREE						NO	YES			YES	Primary Tumor	01	right segmental mastectomy			NO	YES	BH	Breast	A	LIVING	2010	a8a7a335-8e21-4f24-b48b-8764caa21329	ee9101bf-b45d-41d3-bc63-16d9ca91e714	a8a7a335-8e21-4f24-b48b-8764caa21329	ee9101bf-b45d-41d3-bc63-16d9ca91e714	TCGA-BH-A18G-01A-21-A13F-20			TCGA-BH-A18G-01			7deb8368-b91a-4e0e-bd5c-5b6c93f12d8a	TCGA-BH-A18G-01	TCGA-BH-A18G-01A-11D-A12B-09	TCGA-BH-A18G-01A-11D-A12E-05	TCGA-BH-A18G-01	TCGA-BH-A18G-01			a8a7a335-8e21-4f24-b48b-8764caa21329		TCGA-BH-A18G-01A-11D-A12A-01	TCGA-BH-A18G-01	TCGA-BH-A18G-01A-11R-A12D-07	a8a7a335-8e21-4f24-b48b-8764caa21329	TCGA-BH-A18G-01A-11D-A12A-01	TCGA-BH-A18G-01
TCGA-BH-A18H-01	Stage IB	63	3	Stage I	0		Positive	FEMALE	Negative	3	1	3	Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	LumA/B	-2	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A18H-01	652	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-BH-A18H	652	0	days	652	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-BH-A18H-F59198	TCGA-BH-A18H	TCGA-BH-A18H-01A		Positive					Positive	Other		YES			-23065	16		0	652										2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Positive	Equivocal	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0		true	Yes	M0	N0	T1b	Stage IA	TCGA-BH-A18H.DF536409-601F-489B-9F8A-A2B372BF9999.pdf	A18H	TUMOR FREE						YES	YES			YES	Primary Tumor	01	segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	cdcbf3a0-b1eb-4a63-b669-f7a6438c6902	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	cdcbf3a0-b1eb-4a63-b669-f7a6438c6902	TCGA-BH-A18H-01A-21-A13F-20	TCGA-BH-A18H-01A-11D-A12B-09		TCGA-BH-A18H-01			d378a15a-1276-482a-b924-87df01d062f2	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11D-A12B-09	TCGA-BH-A18H-01A-11D-A12E-05	TCGA-BH-A18H-01	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11D-A12B-09		7bc7f99c-28d4-4b54-b9bd-53d5de00cab7		TCGA-BH-A18H-01A-11D-A12A-01	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11R-A12D-07	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	TCGA-BH-A18H-01A-11D-A12A-01	TCGA-BH-A18H-01
TCGA-BH-A18I-01	Stage IIA	53	4	Stage IIA	220		Positive	FEMALE	Negative				Negative	M0	Positive	N1	220	0	LumA	Luminal A	Positive		-5	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A18I-01	1093	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A18I	1093	0	days	1093	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A18I-F58710	TCGA-BH-A18I	TCGA-BH-A18I-01A	Negative	Positive				Modified radical mastectomy	Positive	Other					-19489	80		0	1093										2014-4-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.2	8500/3	C50.2		YES		Core needle biopsy	100	NO	Positive		NO	3	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	1	1	true	No	cM0 (i+)	N1a	T1c	Stage IIA	TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C.pdf	A18I	TUMOR FREE				H score	H score	YES	YES			NO	Primary Tumor	01	segmental mastectomy	7th		NO	YES	BH	Breast	A	LIVING	2010	844b3442-a740-4cb4-a1fb-b481c552cc88	aa8b87f4-9e6b-4da1-9942-1b2c86f3fcc0	844b3442-a740-4cb4-a1fb-b481c552cc88	aa8b87f4-9e6b-4da1-9942-1b2c86f3fcc0		TCGA-BH-A18I-01A-11D-A12B-09		TCGA-BH-A18I-01				TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11D-A12B-09	TCGA-BH-A18I-01A-11D-A12E-05	TCGA-BH-A18I-01	TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11D-A12B-09		844b3442-a740-4cb4-a1fb-b481c552cc88		TCGA-BH-A18I-01A-11D-A12A-01	TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11R-A12D-07	844b3442-a740-4cb4-a1fb-b481c552cc88	TCGA-BH-A18I-01A-11D-A12A-01	TCGA-BH-A18I-01
TCGA-BH-A18J-01	Stage IV	56	2	No_Conversion	611	611	Positive	FEMALE	Negative	3	3	4	Positive	M1	Positive	N2	611	1	LumA	Luminal B	Positive	ReacII	-1	-3	enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A18J-01	612	1	days	Squamous	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A18J			days	612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right				TCGA-BH-A18J	TCGA-BH-A18J-01A		Positive					Positive	Modified Radical Mastectomy					-20678	3948	612	0						YES		40-49%			2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			640	NO	Negative				Negative			Negative			Positive								Negative				Positive	Bone		1	4											true	No	M1	N2	T4b	Stage IV	TCGA-BH-A18J.589BC4DD-0079-4106-A2E6-9A48E9BD7DE2.pdf	A18J	WITH TUMOR								30-39%			Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2000	56d889ba-6484-4940-ae85-1373ce4255b9	eedb1e37-42d4-42d9-987f-e52dee3150e2	56d889ba-6484-4940-ae85-1373ce4255b9	eedb1e37-42d4-42d9-987f-e52dee3150e2	TCGA-BH-A18J-01A-21-A13E-20	TCGA-BH-A18J-01A-11D-A12B-09		TCGA-BH-A18J-01			dd4097f7-8330-42c3-aa6f-dd289837f65e	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11D-A12B-09	TCGA-BH-A18J-01A-11D-A12E-05	TCGA-BH-A18J-01	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11D-A12B-09		56d889ba-6484-4940-ae85-1373ce4255b9		TCGA-BH-A18J-01A-11D-A12A-01	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11R-A12D-07	56d889ba-6484-4940-ae85-1373ce4255b9	TCGA-BH-A18J-01A-11D-A12A-01	TCGA-BH-A18J-01
TCGA-BH-A18J-11		56			611	611		FEMALE									611	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18J-11	612	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18J			days	612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right				TCGA-BH-A18J	TCGA-BH-A18J-11A		Positive					Positive	Modified Radical Mastectomy					-20678	3948	612	0						YES		40-49%			2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			230	NO	Negative				Negative			Negative			Positive								Negative				Positive	Bone														true	No	M1	N2	T4b	Stage IV		A18J	WITH TUMOR								30-39%			Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2000	9fa440b0-6e8d-4c48-a425-50abc2682f6e		9fa440b0-6e8d-4c48-a425-50abc2682f6e											TCGA-BH-A18J-11A-31D-A12E-05		TCGA-BH-A18J-11			9fa440b0-6e8d-4c48-a425-50abc2682f6e			TCGA-BH-A18J-11	TCGA-BH-A18J-11A-31R-A12D-07	9fa440b0-6e8d-4c48-a425-50abc2682f6e		
TCGA-BH-A18K-01	Stage I	46	2	Stage I	2547	2762	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2762	1	LumA	Basal-like	Positive		-13	-12	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18K-01	2763	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 4	TCGA-BH-A18K			days	2763	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A18K	TCGA-BH-A18K-01A		Positive					Positive	Other					-16824	4011	2763	0						NO					2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			11	Negative																					2	5									0		true	No	M0	N0	T1	Stage I	TCGA-BH-A18K.EEB515A4-4AF3-475B-B6C0-A6134C96480A.pdf	A18K	WITH TUMOR							YES				Primary Tumor	01	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	78e00469-0dd6-490e-93f1-068b9a386839	c6914b68-40d4-4f98-ae22-92a713b29df3	78e00469-0dd6-490e-93f1-068b9a386839	c6914b68-40d4-4f98-ae22-92a713b29df3		TCGA-BH-A18K-01A-11D-A12B-09		TCGA-BH-A18K-01				TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11D-A12B-09	TCGA-BH-A18K-01A-11D-A12E-05	TCGA-BH-A18K-01	TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11D-A12B-09		78e00469-0dd6-490e-93f1-068b9a386839		TCGA-BH-A18K-01A-11D-A12A-01	TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11R-A12D-07	78e00469-0dd6-490e-93f1-068b9a386839	TCGA-BH-A18K-01A-11D-A12A-01	TCGA-BH-A18K-01
TCGA-BH-A18K-11		46			2547	2762		FEMALE									2762	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18K-11	2763	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18K			days	2763	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A18K			Positive					Positive	Other					-16824		2763	0						NO					2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			11	Negative																															0			No	M0	N0	T1	Stage I		A18K	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with axillary dissection	5th		NO	YES	BH	Breast		DECEASED	1999	dc55c016-0e33-46b0-ac5e-f854c667a378		dc55c016-0e33-46b0-ac5e-f854c667a378											TCGA-BH-A18K-11A-13D-A12E-05		TCGA-BH-A18K-11			dc55c016-0e33-46b0-ac5e-f854c667a378			TCGA-BH-A18K-11	TCGA-BH-A18K-11A-13R-A12D-07	dc55c016-0e33-46b0-ac5e-f854c667a378		
TCGA-BH-A18L-01	Stage IIB	50	5	Stage IIIA	372	811	Positive	FEMALE		1	1	4	Negative	M0	Positive	N1	811	1	LumB	Luminal B	Positive	ReacII	-10	-5	enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A18L-01	811	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A18L			days	811	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-BH-A18L			Positive					Positive	Other					-18519		811	0						NO					2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			3	Negative																					4	1									1	1		No	M0	N1mi	T3	Stage IIIA		A18L								YES				Primary Tumor	01	total mastectomy and sentinel node biopsy	6th		NO	YES	BH	Breast		DECEASED	2003	c3604281-d909-4819-a90e-a1081b1e9d7f	d814b694-f289-4784-bf97-2d21aef93e18	c3604281-d909-4819-a90e-a1081b1e9d7f	d814b694-f289-4784-bf97-2d21aef93e18	TCGA-BH-A18L-01A-21-A13F-20	TCGA-BH-A18L-01A-32D-A12B-09		TCGA-BH-A18L-01			ede8d4b2-4cfd-4f4f-a11f-3269c0ba7661	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32D-A12B-09	TCGA-BH-A18L-01A-32D-A12E-05	TCGA-BH-A18L-01	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32D-A12B-09		c3604281-d909-4819-a90e-a1081b1e9d7f		TCGA-BH-A18L-01A-32D-A12A-01	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32R-A12D-07	c3604281-d909-4819-a90e-a1081b1e9d7f	TCGA-BH-A18L-01A-32D-A12A-01	TCGA-BH-A18L-01
TCGA-BH-A18L-11		50			372	811		FEMALE									811	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18L-11	811	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18L			days	811	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-BH-A18L	TCGA-BH-A18L-11A		Positive					Positive	Other					-18519	2669	811	0						NO					2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative			3	Negative																															1	1	true	No	M0	N1mi	T3	Stage IIIA		A18L								YES				Solid Tissue Normal	11	total mastectomy and sentinel node biopsy	6th		NO	YES	BH	Breast	A	DECEASED	2003	0b937a20-66d4-4d05-bf50-4828cead9c92		0b937a20-66d4-4d05-bf50-4828cead9c92								AE6873BA-EA4A-4FE3-9D4F-B32FFC5BBF98			TCGA-BH-A18L-11A-42D-A12E-05		TCGA-BH-A18L-11			0b937a20-66d4-4d05-bf50-4828cead9c92			TCGA-BH-A18L-11	TCGA-BH-A18L-11A-42R-A12D-07	0b937a20-66d4-4d05-bf50-4828cead9c92		
TCGA-BH-A18M-01	Stage IIB	39	2	Stage IIIA	2207	2207	Positive	FEMALE	Positive	3	4	3	Negative	M0	Positive	N1	2207	1	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A18M-01	2207	1	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A18M			days	2207	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left Upper Inner Quadrant				TCGA-BH-A18M	TCGA-BH-A18M-01A		Positive					Positive	Modified Radical Mastectomy					-14532	3629	2207	0						NO					2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	360	NO	Positive	Positive		6	Negative																					1	6									4	4	true	No	M0	N1	T3	Stage IIIA	TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D.pdf	A18M								YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2001	4dfbdec6-1911-412c-9873-f6782ab8ff66	c642e766-98e7-4ea8-907a-8390e7425df2	4dfbdec6-1911-412c-9873-f6782ab8ff66	c642e766-98e7-4ea8-907a-8390e7425df2	TCGA-BH-A18M-01A-21-A13E-20	TCGA-BH-A18M-01A-11D-A12B-09		TCGA-BH-A18M-01			1d42bf05-8579-448e-bb82-e07aa1c93c97	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11D-A12B-09	TCGA-BH-A18M-01A-11D-A12E-05	TCGA-BH-A18M-01	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11D-A12B-09		4dfbdec6-1911-412c-9873-f6782ab8ff66		TCGA-BH-A18M-01A-11D-A12A-01	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11R-A12D-07	4dfbdec6-1911-412c-9873-f6782ab8ff66	TCGA-BH-A18M-01A-11D-A12A-01	TCGA-BH-A18M-01
TCGA-BH-A18M-11		39			2207	2207		FEMALE									2207	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18M-11	2207	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18M			days	2207	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left Upper Inner Quadrant				TCGA-BH-A18M	TCGA-BH-A18M-11A		Positive					Positive	Modified Radical Mastectomy					-14532	3629	2207	0						NO					2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	310	NO	Positive	Positive		6	Negative																															4	4	true	No	M0	N1	T3	Stage IIIA		A18M								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2001	2147e537-16f0-4bc3-a87f-572f8dcb9191		2147e537-16f0-4bc3-a87f-572f8dcb9191											TCGA-BH-A18M-11A-33D-A12E-05		TCGA-BH-A18M-11			2147e537-16f0-4bc3-a87f-572f8dcb9191			TCGA-BH-A18M-11	TCGA-BH-A18M-11A-33R-A12D-07	2147e537-16f0-4bc3-a87f-572f8dcb9191		
TCGA-BH-A18N-01	Stage IIA	88	3	No_Conversion	1148	1148	Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	1148	1	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18N-01	1148	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A18N			days	1148	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Left	Axillary lymph node dissection alone		TCGA-BH-A18N-F59153	TCGA-BH-A18N	TCGA-BH-A18N-01A		Positive					Positive	Modified Radical Mastectomy					-32404	3374	1148	0						NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Negative		NO	26	Negative																					2	6									2	2	true	No	M0	N1b	T2	Stage IIA	TCGA-BH-A18N.60E8A9CF-3E2D-4E36-947D-448BA27C6561.pdf	A18N							NO	YES			NO	Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	2001	a8884443-832f-45bb-96a0-dead699cc7e3	40ef83f0-cb32-4191-a440-3fcc76d1148f	a8884443-832f-45bb-96a0-dead699cc7e3	40ef83f0-cb32-4191-a440-3fcc76d1148f	TCGA-BH-A18N-01A-21-A13E-20	TCGA-BH-A18N-01A-11D-A12B-09		TCGA-BH-A18N-01			f3320803-e927-4d94-aafa-5bc8cef352f9	TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11D-A12B-09	TCGA-BH-A18N-01A-11D-A12E-05	TCGA-BH-A18N-01	TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11D-A12B-09		a8884443-832f-45bb-96a0-dead699cc7e3		TCGA-BH-A18N-01A-11D-A12A-01	TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11R-A12D-07	a8884443-832f-45bb-96a0-dead699cc7e3	TCGA-BH-A18N-01A-11D-A12A-01	TCGA-BH-A18N-01
TCGA-BH-A18N-11		88			1148	1148		FEMALE									1148	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18N-11	1148	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18N			days	1148	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Left	Axillary lymph node dissection alone		TCGA-BH-A18N-F59153	TCGA-BH-A18N	TCGA-BH-A18N-11A		Positive					Positive	Modified Radical Mastectomy					-32404	3374	1148	0						NO					2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative		NO	26	Negative																															2	2	true	No	M0	N1b	T2	Stage IIA		A18N							NO	YES			NO	Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6		d40f0f2c-4acf-4ea6-b344-1eca23f50fa6								3A6CFBA6-849B-416F-A652-F3540DEBEB02			TCGA-BH-A18N-11A-43D-A12E-05		TCGA-BH-A18N-11			d40f0f2c-4acf-4ea6-b344-1eca23f50fa6			TCGA-BH-A18N-11	TCGA-BH-A18N-11A-43R-A12D-07	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6		
TCGA-BH-A18P-01	Stage I	60	2	Stage I	921	921	Positive	FEMALE	Negative	1	3	1	Negative	M0	Negative	N0	921	1	Her2	HER2-enriched	Negative	X	-1	-1	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18P-01	921	1	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BH-A18P			days	921	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18P	TCGA-BH-A18P-01A		Positive					Negative	Simple Mastectomy					-22222	2639	921	0								<10%			2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	230	NO	Positive	Positive		2	Negative																					4	5									0		true	No	M0	N0	T1	Stage I	TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D.pdf	A18P	WITH TUMOR							YES				Primary Tumor	01		6th		NO	YES	BH	Breast	A	DECEASED	2003	3b48796b-8591-4d7a-a502-5c4293647156	f73ccb89-b952-40ab-ad9f-f817102cd1ca	3b48796b-8591-4d7a-a502-5c4293647156	f73ccb89-b952-40ab-ad9f-f817102cd1ca	TCGA-BH-A18P-01A-21-A13F-20	TCGA-BH-A18P-01A-11D-A12B-09		TCGA-BH-A18P-01			dc104da8-075e-46cb-b43b-d1c5bda730d3	TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11D-A12B-09	TCGA-BH-A18P-01A-11D-A12E-05	TCGA-BH-A18P-01	TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11D-A12B-09		3b48796b-8591-4d7a-a502-5c4293647156		TCGA-BH-A18P-01A-11D-A12A-01	TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11R-A12D-07	3b48796b-8591-4d7a-a502-5c4293647156	TCGA-BH-A18P-01A-11D-A12A-01	TCGA-BH-A18P-01
TCGA-BH-A18P-11		60			921	921		FEMALE									921	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18P-11	921	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A18P			days	921	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18P	TCGA-BH-A18P-11A		Positive					Negative	Simple Mastectomy					-22222	2639	921	0								<10%			2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	520	NO	Positive	Positive		2	Negative																															0		true	No	M0	N0	T1	Stage I		A18P	WITH TUMOR							YES				Solid Tissue Normal	11		6th		NO	YES	BH	Breast	A	DECEASED	2003	08236177-a046-4cfe-a11c-a24292a1f777		08236177-a046-4cfe-a11c-a24292a1f777								5C2F7AFD-3F6E-46BB-A17B-F10BE5E243FC			TCGA-BH-A18P-11A-43D-A12E-05		TCGA-BH-A18P-11			08236177-a046-4cfe-a11c-a24292a1f777			TCGA-BH-A18P-11	TCGA-BH-A18P-11A-43R-A12D-07	08236177-a046-4cfe-a11c-a24292a1f777		
TCGA-BH-A18Q-01	Stage IIB	56	1	No_Conversion	1692	1692	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1692	1	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18Q-01	1692	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-BH-A18Q			days	1692	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Axillary lymph node dissection alone			TCGA-BH-A18Q	TCGA-BH-A18Q-01A		Negative					Negative	Modified Radical Mastectomy					-20675	3417	1692	0											2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	130	NO	Positive	Negative		25	Negative																					5	5									2	2	true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf	A18Q								YES				Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	2001	2c75afc3-11b5-444d-b6e0-61d76b299f40	94a07da0-f029-444a-86d7-d9bc24e7e76d	2c75afc3-11b5-444d-b6e0-61d76b299f40	94a07da0-f029-444a-86d7-d9bc24e7e76d	TCGA-BH-A18Q-01A-21-A13E-20	TCGA-BH-A18Q-01A-12D-A12B-09		TCGA-BH-A18Q-01			44798c24-89d7-4d25-a4bc-3d2fab66b4e8	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12D-A12B-09	TCGA-BH-A18Q-01A-12D-A12E-05	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12D-A12B-09		2c75afc3-11b5-444d-b6e0-61d76b299f40		TCGA-BH-A18Q-01A-12D-A12A-01	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12R-A12D-07	2c75afc3-11b5-444d-b6e0-61d76b299f40	TCGA-BH-A18Q-01A-12D-A12A-01	TCGA-BH-A18Q-01
TCGA-BH-A18Q-11		56			1692	1692		FEMALE									1692	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18Q-11	1692	1	days		C4-BRCA/Basal							mutation cluster 13	TCGA-BH-A18Q			days	1692	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Axillary lymph node dissection alone			TCGA-BH-A18Q	TCGA-BH-A18Q-11A		Negative					Negative	Modified Radical Mastectomy					-20675	3417	1692	0											2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	510	NO	Positive	Negative		25	Negative																															2	2	true	No	M0	N1b	T2	Stage IIB		A18Q								YES				Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001	120bc298-f016-4c80-aa5f-a9006444942c		120bc298-f016-4c80-aa5f-a9006444942c								E36930F3-2442-4C58-B426-DC2C0CDCB79D			TCGA-BH-A18Q-11A-34D-A12E-05		TCGA-BH-A18Q-11			120bc298-f016-4c80-aa5f-a9006444942c			TCGA-BH-A18Q-11	TCGA-BH-A18Q-11A-34R-A12D-07	120bc298-f016-4c80-aa5f-a9006444942c		
TCGA-BH-A18R-01	Stage IB	50	3	No_Conversion	1099	1141	Indeterminate	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	1141	1	Her2	HER2-enriched	Negative	Her2	-2	0	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18R-01	1142	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A18R			days	1142	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Outer Quadrant				TCGA-BH-A18R	TCGA-BH-A18R-01A		Indeterminate					Negative	Modified Radical Mastectomy					-18524	3571	1142	0						NO		20-29%			2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	250	NO	Positive	Positive		15	Negative																					4	4									10		true	No	M0	N1	T2b	Stage IIA	TCGA-BH-A18R.46DE21ED-1E08-4095-9B68-88D10AC74673.pdf	A18R	TUMOR FREE							YES				Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	2001	b05828bc-eb75-4220-9972-6c6d62fa5303	01428281-1653-4839-b5cf-167bc62eb147	b05828bc-eb75-4220-9972-6c6d62fa5303	01428281-1653-4839-b5cf-167bc62eb147	TCGA-BH-A18R-01A-21-A13E-20	TCGA-BH-A18R-01A-11D-A12B-09		TCGA-BH-A18R-01			ae2a3335-136b-4a32-b247-5b160862fb22	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11D-A12B-09	TCGA-BH-A18R-01A-11D-A12E-05	TCGA-BH-A18R-01	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11D-A12B-09		b05828bc-eb75-4220-9972-6c6d62fa5303		TCGA-BH-A18R-01A-11D-A12A-01	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11R-A12D-07	b05828bc-eb75-4220-9972-6c6d62fa5303	TCGA-BH-A18R-01A-11D-A12A-01	TCGA-BH-A18R-01
TCGA-BH-A18R-11		50			1099	1141		FEMALE									1141	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18R-11	1142	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A18R			days	1142	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Outer Quadrant				TCGA-BH-A18R	TCGA-BH-A18R-11A		Indeterminate					Negative	Modified Radical Mastectomy					-18524	3571	1142	0						NO		20-29%			2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	350	NO	Positive	Positive		15	Negative																															10		true	No	M0	N1	T2b	Stage IIA		A18R	TUMOR FREE							YES				Solid Tissue Normal	11				NO	YES	BH	Breast	A	DECEASED	2001	5462aaff-d060-4ba7-9ab5-0e6977accb91		5462aaff-d060-4ba7-9ab5-0e6977accb91								0F909B7E-B7B3-4B79-B3E6-31BAAFFFA9C6			TCGA-BH-A18R-11A-42D-A12E-05		TCGA-BH-A18R-11			5462aaff-d060-4ba7-9ab5-0e6977accb91			TCGA-BH-A18R-11	TCGA-BH-A18R-11A-42R-A12D-07	5462aaff-d060-4ba7-9ab5-0e6977accb91		
TCGA-BH-A18S-01	Stage I	79	5	Stage I	2009	2009	Positive	FEMALE		3	3	3	Negative	M0	Negative	N0	2009	1	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18S-01	2009	1	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-BH-A18S			days	2009	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18S	TCGA-BH-A18S-01A		Positive					Positive	Other					-28974	2695	2009	0											2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy	320	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7									0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A18S.E89670CB-575A-4B67-AF79-1C730B9B86D4.pdf	A18S	TUMOR FREE							YES				Primary Tumor	01	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	cf00b389-d06b-4dd5-9b18-737b06ab9bed	037b8a48-b345-4971-9226-dc9199a29d82	cf00b389-d06b-4dd5-9b18-737b06ab9bed	037b8a48-b345-4971-9226-dc9199a29d82	TCGA-BH-A18S-01A-21-A13E-20	TCGA-BH-A18S-01A-11D-A12B-09		TCGA-BH-A18S-01			cd625353-3b48-44c0-9695-074db13850d9	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01A-11D-A12E-05	TCGA-BH-A18S-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12B-09		cf00b389-d06b-4dd5-9b18-737b06ab9bed		TCGA-BH-A18S-01A-11D-A12A-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11R-A12D-07	cf00b389-d06b-4dd5-9b18-737b06ab9bed	TCGA-BH-A18S-01A-11D-A12A-01	TCGA-BH-A18S-01
TCGA-BH-A18S-11		79			2009	2009		FEMALE									2009	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18S-11	2009	1	days		C3-BRCA/Luminal							mutation cluster 12	TCGA-BH-A18S			days	2009	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-BH-A18S			Positive					Positive	Other					-28974		2009	0											2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0			No	M0	N0	T1c	Stage I		A18S	TUMOR FREE							YES				Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH	Breast		DECEASED	2003	fa7bcdff-10e1-44f1-86ed-90fab26bc61f		fa7bcdff-10e1-44f1-86ed-90fab26bc61f											TCGA-BH-A18S-11A-43D-A12E-05		TCGA-BH-A18S-11			fa7bcdff-10e1-44f1-86ed-90fab26bc61f			TCGA-BH-A18S-11	TCGA-BH-A18S-11A-43R-A12D-07	fa7bcdff-10e1-44f1-86ed-90fab26bc61f		
TCGA-BH-A18T-01	Stage IIA	70	1	Stage IIA	224	224	Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	224	1	Basal	Luminal A	Negative	ReacII	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18T-01	224	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-BH-A18T			days	224	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-BH-A18T	TCGA-BH-A18T-01A		Negative					Negative	Other					-25674	2737	224	0											2011-7-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Positive	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	2											true	No	M0	N0	T2	Stage IIA	TCGA-BH-A18T.B8FF655E-47AB-4BB0-B119-1402A335126A.pdf	A18T	WITH TUMOR											Primary Tumor	01	segmental mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	733890d7-6557-454e-8697-fe9c619874e3	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	733890d7-6557-454e-8697-fe9c619874e3	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	TCGA-BH-A18T-01A-21-A13E-20	TCGA-BH-A18T-01A-11D-A12B-09		TCGA-BH-A18T-01			169f872a-65f6-40ae-8cd9-948822cc3a20	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11D-A12B-09	TCGA-BH-A18T-01A-11D-A12E-05	TCGA-BH-A18T-01	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11D-A12B-09		733890d7-6557-454e-8697-fe9c619874e3		TCGA-BH-A18T-01A-11D-A12A-01	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11R-A12D-07	733890d7-6557-454e-8697-fe9c619874e3	TCGA-BH-A18T-01A-11D-A12A-01	TCGA-BH-A18T-01
TCGA-BH-A18U-01	Stage IIIA	72	3	Stage IIIA	1317	1563	Positive	FEMALE	Positive	4	5	4	Negative	M0	Positive	N2	1563	1	LumB	Luminal B	Positive	ReacI	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18U-01	1563	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-BH-A18U			days	1563	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A18U	TCGA-BH-A18U-01A		Positive					Positive	Other					-26426	2697	1563	0											2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	530	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5									9		true	No	M0	N2a	T2	Stage IIIA	TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726.pdf	A18U	TUMOR FREE							YES				Primary Tumor	01	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	f6e76192-c4ed-485f-bb51-1b752bd7f544	cf285aaa-51f0-4eba-a92a-ae9ca8fd2198	f6e76192-c4ed-485f-bb51-1b752bd7f544	cf285aaa-51f0-4eba-a92a-ae9ca8fd2198	TCGA-BH-A18U-01A-31-A13E-20	TCGA-BH-A18U-01A-21D-A12B-09		TCGA-BH-A18U-01			12e8835a-7f82-4402-929a-bdce63fee8ed	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21D-A12B-09	TCGA-BH-A18U-01A-21D-A12E-05	TCGA-BH-A18U-01	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21D-A12B-09		f6e76192-c4ed-485f-bb51-1b752bd7f544		TCGA-BH-A18U-01A-21D-A12A-01	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21R-A12D-07	f6e76192-c4ed-485f-bb51-1b752bd7f544	TCGA-BH-A18U-01A-21D-A12A-01	TCGA-BH-A18U-01
TCGA-BH-A18U-11		72			1317	1563		FEMALE									1563	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18U-11	1563	1	days		C3-BRCA/Luminal							mutation cluster 13	TCGA-BH-A18U			days	1563	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A18U	TCGA-BH-A18U-11A		Positive					Positive	Other					-26426	2697	1563	0											2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	230	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														9		true	No	M0	N2a	T2	Stage IIIA		A18U	TUMOR FREE							YES				Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH	Breast	A	DECEASED	2003	02222fea-f3da-4328-8188-8ef24d1f55e4		02222fea-f3da-4328-8188-8ef24d1f55e4											TCGA-BH-A18U-11A-23D-A12E-05		TCGA-BH-A18U-11			02222fea-f3da-4328-8188-8ef24d1f55e4			TCGA-BH-A18U-11	TCGA-BH-A18U-11A-23R-A12D-07	02222fea-f3da-4328-8188-8ef24d1f55e4		
TCGA-BH-A18V-01	Stage IIB	48	1	No_Conversion	1555	1555	Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	1555	1	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18V-01	1556	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-BH-A18V			days	1556	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right	Axillary lymph node dissection alone			TCGA-BH-A18V	TCGA-BH-A18V-01A		Negative					Negative	Other					-17682	3621	1556	0						YES					2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	300	NO	Negative			25	Negative			Negative			Negative												Negative	Other, specify	axilaary node negative but intrammary node positive	5	5									0		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf	A18V								YES				Primary Tumor	01	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001	429b50eb-316f-459c-bc3a-0aca6e6dba46	12aa84c3-f49b-408a-a863-97f2254e442e	429b50eb-316f-459c-bc3a-0aca6e6dba46	12aa84c3-f49b-408a-a863-97f2254e442e		TCGA-BH-A18V-01A-11D-A12B-09		TCGA-BH-A18V-01			7bf9da92-5872-4f29-ba4d-f247ec7984f0	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12B-09	TCGA-BH-A18V-01A-11D-A12E-05	TCGA-BH-A18V-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12B-09		429b50eb-316f-459c-bc3a-0aca6e6dba46		TCGA-BH-A18V-01A-11D-A12A-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11R-A12D-07	429b50eb-316f-459c-bc3a-0aca6e6dba46	TCGA-BH-A18V-01A-11D-A12A-01	TCGA-BH-A18V-01
TCGA-BH-A18V-06		48			1555	1555		FEMALE									1555	1	Basal						enrollment			DECEASED	1	TCGA-BH-A18V-06	1556	1	days		C4-BRCA/Basal		BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 11		mutation cluster 2	TCGA-BH-A18V			days	1556	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right	Axillary lymph node dissection alone			TCGA-BH-A18V	TCGA-BH-A18V-06A		Negative					Negative	Other					-17682	3943	1556	0						YES					2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	1390	NO	Negative			25	Negative			Negative			Negative												Negative	Other, specify	axilaary node negative but intrammary node positive											0		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A18V.066F2FDC-3AE5-45F8-B827-620E24677A1E.pdf	A18V								YES				Metastatic	06	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001	ded1efed-b3b9-4d1a-b4c9-b595543fc461	3aa8422d-7f10-4aba-b6c6-80975f4850c5	ded1efed-b3b9-4d1a-b4c9-b595543fc461	3aa8422d-7f10-4aba-b6c6-80975f4850c5	TCGA-BH-A18V-06A-21-A24B-20				TCGA-BH-A18V-06A-11D-A212-05		f03d8a09-8fcf-4f2b-a5b3-ac6ffb2c0681		TCGA-BH-A18V-06A-11D-A20S-09			TCGA-BH-A18V-06			ded1efed-b3b9-4d1a-b4c9-b595543fc461			TCGA-BH-A18V-06		ded1efed-b3b9-4d1a-b4c9-b595543fc461		
TCGA-BH-A18V-11		48			1555	1555		FEMALE									1555	1	Normal						enrollment			DECEASED	1	TCGA-BH-A18V-11	1556	1	days		C4-BRCA/Basal							mutation cluster 2	TCGA-BH-A18V			days	1556	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right	Axillary lymph node dissection alone			TCGA-BH-A18V	TCGA-BH-A18V-11A		Negative					Negative	Other					-17682	3621	1556	0						YES					2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	450	NO	Negative			25	Negative			Negative			Negative												Negative	Other, specify	axilaary node negative but intrammary node positive											0		true	No	M0	N1b	T2	Stage IIB		A18V								YES				Solid Tissue Normal	11	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2001	288c81eb-4c43-406b-a5e5-fee452a95afb		288c81eb-4c43-406b-a5e5-fee452a95afb								1D76CB85-A291-45F8-88B0-29D72E04FA07			TCGA-BH-A18V-11A-52D-A12E-05					288c81eb-4c43-406b-a5e5-fee452a95afb				TCGA-BH-A18V-11A-52R-A12D-07	288c81eb-4c43-406b-a5e5-fee452a95afb		
TCGA-BH-A1EN-01	Stage IIA	78	3	Stage IIA		2052	Negative	FEMALE	Positive				Negative	M0	Negative	N0	2052	1	Her2		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EN-01	2127	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A1EN			days	2127	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right				TCGA-BH-A1EN	TCGA-BH-A1EN-01A		Negative					Negative	Other					-28724	4343	2127	0						NO					2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	140	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	3											true	No	M0	NX	T2	Stage IIA	TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf	A1EN	TUMOR FREE											Primary Tumor	01	right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999	a6db80e4-b161-412d-932a-fe2898a1722f	d47439d3-9c7a-4dea-838d-e9955842055b	a6db80e4-b161-412d-932a-fe2898a1722f	d47439d3-9c7a-4dea-838d-e9955842055b	TCGA-BH-A1EN-01A-21-A17I-20	TCGA-BH-A1EN-01A-11D-A17G-09		TCGA-BH-A1EN-01	TCGA-BH-A1EN-01A-11D-A13K-05		8de8ac77-d6ea-437d-9ca8-ef6f5480eb1b	TCGA-BH-A1EN-01	TCGA-BH-A1EN-01A-11D-A17G-09			TCGA-BH-A1EN-01	TCGA-BH-A1EN-01A-11D-A17G-09		a6db80e4-b161-412d-932a-fe2898a1722f		TCGA-BH-A1EN-01A-11D-A13J-01	TCGA-BH-A1EN-01		a6db80e4-b161-412d-932a-fe2898a1722f	TCGA-BH-A1EN-01A-11D-A13J-01	
TCGA-BH-A1EN-11		78				2052		FEMALE									2052	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1EN-11	2127	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EN			days	2127	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right				TCGA-BH-A1EN			Negative					Negative	Other					-28724		2127	0						NO					2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy			Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																																	No	M0	NX	T2	Stage IIA		A1EN	TUMOR FREE											Solid Tissue Normal	11	right segmental mastectomy	5th		NO	YES	BH	Breast		DECEASED	1999	c03683bd-2fe1-4ab2-9a16-796553be5467		c03683bd-2fe1-4ab2-9a16-796553be5467						TCGA-BH-A1EN-11A-23D-A13T-05							TCGA-BH-A1EN-11			c03683bd-2fe1-4ab2-9a16-796553be5467			TCGA-BH-A1EN-11		c03683bd-2fe1-4ab2-9a16-796553be5467		
TCGA-BH-A1EO-01	Stage IIA	68	3	Stage IIA		2798	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2798	1	LumA	Luminal A	Positive		-5	-3	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1EO-01	2798	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A1EO			days	2798	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right				TCGA-BH-A1EO	TCGA-BH-A1EO-01A		Positive					Positive	Other					-25136	4330	2798	0						NO					2011-9-6	FEMALE										Mixed Histology (please specify)	ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	100	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6									1		true	No	M0	N1	T1c	Stage IIA	TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf	A1EO	TUMOR FREE							YES				Primary Tumor	01	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	e6f1450a-6731-4593-82c3-28f839ebf148	7bed3841-5a16-43fc-8b2b-4e0aa0b89f1e	e6f1450a-6731-4593-82c3-28f839ebf148	7bed3841-5a16-43fc-8b2b-4e0aa0b89f1e	TCGA-BH-A1EO-01A-21-A17I-20	TCGA-BH-A1EO-01A-11D-A135-09		TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11D-A138-05		819bff28-56b5-455b-b86d-c803b081d75e	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11D-A135-09		TCGA-BH-A1EO-01	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11D-A135-09		e6f1450a-6731-4593-82c3-28f839ebf148		TCGA-BH-A1EO-01A-11D-A134-01	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11R-A137-07	e6f1450a-6731-4593-82c3-28f839ebf148	TCGA-BH-A1EO-01A-11D-A134-01	TCGA-BH-A1EO-01
TCGA-BH-A1EO-11		68				2798		FEMALE									2798	1	LumA						enrollment			DECEASED	1	TCGA-BH-A1EO-11	2798	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EO			days	2798	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right				TCGA-BH-A1EO	TCGA-BH-A1EO-11A		Positive					Positive	Other					-25136	4330	2798	0						NO					2011-9-6	FEMALE										Mixed Histology (please specify)	ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	250	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1		true	No	M0	N1	T1c	Stage IIA		A1EO	TUMOR FREE							YES				Solid Tissue Normal	11	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	71cc9cf0-2992-4ac6-8642-6fdb66958fca		71cc9cf0-2992-4ac6-8642-6fdb66958fca						TCGA-BH-A1EO-11A-31D-A138-05										71cc9cf0-2992-4ac6-8642-6fdb66958fca				TCGA-BH-A1EO-11A-31R-A137-07	71cc9cf0-2992-4ac6-8642-6fdb66958fca		
TCGA-BH-A1ES-01	Stage IIB	35	5	Stage IIB		3462	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3462	1	LumA	Luminal A	Positive		-9	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1ES-01	3462	1	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A1ES			days	3462	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Inner Quadrant				TCGA-BH-A1ES			Positive					Positive	Other					-13138		3462	0						NO					2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	5									1			No	M0	N1a	T2	Stage IIB		A1ES	WITH TUMOR							YES				Primary Tumor	01	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	Breast		DECEASED	1999	cbb45082-6d4e-4457-b023-52f9372ae053	c222b951-0d4d-42e1-8cf2-7011b4ba3b7d	cbb45082-6d4e-4457-b023-52f9372ae053	c222b951-0d4d-42e1-8cf2-7011b4ba3b7d		TCGA-BH-A1ES-01A-11D-A135-09		TCGA-BH-A1ES-01	TCGA-BH-A1ES-01A-11D-A138-05		e6c70136-ae35-4294-a16d-5673f0edbea5	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01A-11D-A135-09		TCGA-BH-A1ES-01	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01A-11D-A135-09		cbb45082-6d4e-4457-b023-52f9372ae053		TCGA-BH-A1ES-01A-11D-A134-01	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01A-11R-A137-07	cbb45082-6d4e-4457-b023-52f9372ae053	TCGA-BH-A1ES-01A-11D-A134-01	TCGA-BH-A1ES-01
TCGA-BH-A1ES-06		35				3462		FEMALE									3462	1							enrollment			DECEASED	1	TCGA-BH-A1ES-06	3462	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1ES			days	3462	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Inner Quadrant				TCGA-BH-A1ES	TCGA-BH-A1ES-06A		Positive					Positive	Other					-13138	4787	3462	0						NO					2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO	Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A1ES.7222C51A-3A1E-454B-A0E4-B8A0BBA042E4.pdf	A1ES	WITH TUMOR							YES				Metastatic	06	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	fc895598-73b9-4269-a250-52e4475c6be7	b6ada2ae-66de-49d0-9b83-685520858aaf	fc895598-73b9-4269-a250-52e4475c6be7	b6ada2ae-66de-49d0-9b83-685520858aaf	TCGA-BH-A1ES-06A-21-A24B-20				TCGA-BH-A1ES-06A-12D-A244-05		21ae0b23-d3aa-4b22-a3c7-3eb6d8e98a26		TCGA-BH-A1ES-06A-12D-A243-09			TCGA-BH-A1ES-06			fc895598-73b9-4269-a250-52e4475c6be7			TCGA-BH-A1ES-06		fc895598-73b9-4269-a250-52e4475c6be7		
TCGA-BH-A1ES-11		35				3462		FEMALE									3462	1							enrollment			DECEASED	1	TCGA-BH-A1ES-11	3462	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1ES			days	3462	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right Upper Inner Quadrant				TCGA-BH-A1ES	TCGA-BH-A1ES-11A		Positive					Positive	Other					-13138	4242	3462	0						NO					2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	340	NO	Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1		true	No	M0	N1a	T2	Stage IIB		A1ES	WITH TUMOR							YES				Solid Tissue Normal	11	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999									TCGA-BH-A1ES-11A-33D-A138-05																	
TCGA-BH-A1ET-01	Stage IIA	55	2	Stage I		2520	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2520	1	LumA	Luminal A	Positive		-12	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1ET-01	2520	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A1ET			days	2520	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left				TCGA-BH-A1ET			Positive					Positive	Other					-20425		2520	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			19																						2	6									1			No	M0	N0	T1	Stage I		A1ET	TUMOR FREE							YES				Primary Tumor	01	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH	Breast		DECEASED	1999	b0388c2e-0793-4084-bcc3-454c2ec88931	ff6c8bdf-a663-45fe-b48f-dcca255eb1d1	b0388c2e-0793-4084-bcc3-454c2ec88931	ff6c8bdf-a663-45fe-b48f-dcca255eb1d1	TCGA-BH-A1ET-01A-21-A17I-20	TCGA-BH-A1ET-01A-11D-A135-09		TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11D-A138-05		a8e7241b-076a-4fa3-83da-755694823091	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11D-A135-09		TCGA-BH-A1ET-01	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11D-A135-09		b0388c2e-0793-4084-bcc3-454c2ec88931		TCGA-BH-A1ET-01A-11D-A134-01	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11R-A137-07	b0388c2e-0793-4084-bcc3-454c2ec88931	TCGA-BH-A1ET-01A-11D-A134-01	TCGA-BH-A1ET-01
TCGA-BH-A1ET-11		55				2520		FEMALE									2520	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1ET-11	2520	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1ET			days	2520	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left				TCGA-BH-A1ET	TCGA-BH-A1ET-11B		Positive					Positive	Other					-20425	4137	2520	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	380	NO	Negative			19																																1		false	No	M0	N0	T1	Stage I		A1ET	TUMOR FREE							YES				Solid Tissue Normal	11	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be		ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be						TCGA-BH-A1ET-11B-23D-A138-05		48D344A0-2C10-412C-A51E-BB830474D9D5					TCGA-BH-A1ET-11			ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be			TCGA-BH-A1ET-11	TCGA-BH-A1ET-11B-23R-A137-07	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be		
TCGA-BH-A1EU-01	Stage I	83	1	Stage I		1286	Positive	FEMALE	Negative				Negative	M0	Negative	N0	1286	1	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1EU-01	1286	1	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A1EU			days	1286	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Right				TCGA-BH-A1EU	TCGA-BH-A1EU-01A		Positive					Positive						-30339	4106	1286	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	410	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6											true	No	M0	N0	T1	Stage I	TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf	A1EU	TUMOR FREE							NO				Primary Tumor	01	Right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999	bfeed1cc-e0f8-493f-a950-829ecb3acccc	784df7f1-e71f-4daa-bfda-0b1b1a69e0b6	bfeed1cc-e0f8-493f-a950-829ecb3acccc	784df7f1-e71f-4daa-bfda-0b1b1a69e0b6	TCGA-BH-A1EU-01A-21-A17I-20	TCGA-BH-A1EU-01A-11D-A135-09		TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11D-A138-05		73eb0467-0d24-4ef1-b0e6-ca457ad24f09	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11D-A135-09		TCGA-BH-A1EU-01	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11D-A135-09		bfeed1cc-e0f8-493f-a950-829ecb3acccc		TCGA-BH-A1EU-01A-11D-A134-01	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11R-A137-07	bfeed1cc-e0f8-493f-a950-829ecb3acccc	TCGA-BH-A1EU-01A-11D-A134-01	TCGA-BH-A1EU-01
TCGA-BH-A1EU-11		83				1286		FEMALE									1286	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1EU-11	1286	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1EU			days	1286	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					83	Right				TCGA-BH-A1EU	TCGA-BH-A1EU-11A		Positive					Positive						-30339	4106	1286	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																																true	No	M0	N0	T1	Stage I		A1EU	TUMOR FREE							NO				Solid Tissue Normal	11	Right segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1999	9e12314d-d1f0-44be-93f7-e50a56f86b46		9e12314d-d1f0-44be-93f7-e50a56f86b46						TCGA-BH-A1EU-11A-23D-A138-05							TCGA-BH-A1EU-11			9e12314d-d1f0-44be-93f7-e50a56f86b46			TCGA-BH-A1EU-11	TCGA-BH-A1EU-11A-23R-A137-07	9e12314d-d1f0-44be-93f7-e50a56f86b46		
TCGA-BH-A1EV-01		45	2			365	Positive	FEMALE									365	1	Her2	HER2-enriched	Positive		-1	-5	enrollment			DECEASED	1	TCGA-BH-A1EV-01	365	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 7	mutation cluster 5	TCGA-BH-A1EV	365	0	days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left			TCGA-BH-A1EV-F59154	TCGA-BH-A1EV	TCGA-BH-A1EV-01A		Positive					Positive	Modified Radical Mastectomy					-16504	4103	365	0											2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	600	NO	Positive		NO	10																						2	7								NO	3		true	No	M0	N1b	T3	Stage IIIA	TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf	A1EV	WITH TUMOR						NO	YES			YES	Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1999	4dac7a33-db46-4815-8c6c-fb326959c741	76537c73-9c3f-44db-bc92-10957f72d425	4dac7a33-db46-4815-8c6c-fb326959c741	76537c73-9c3f-44db-bc92-10957f72d425	TCGA-BH-A1EV-01A-21-A17I-20	TCGA-BH-A1EV-01A-11D-A135-09		TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11D-A138-05		59c3ce2b-d84e-4d4a-b6dc-ffdb9e3a34f5	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11D-A135-09		TCGA-BH-A1EV-01	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11D-A135-09		4dac7a33-db46-4815-8c6c-fb326959c741		TCGA-BH-A1EV-01A-11D-A134-01	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11R-A137-07	4dac7a33-db46-4815-8c6c-fb326959c741	TCGA-BH-A1EV-01A-11D-A134-01	TCGA-BH-A1EV-01
TCGA-BH-A1EV-11		45				365		FEMALE									365	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1EV-11	365	1	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1EV	365	0	days	365	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left			TCGA-BH-A1EV-F59154	TCGA-BH-A1EV	TCGA-BH-A1EV-11A		Positive					Positive	Modified Radical Mastectomy					-16504	4103	365	0											2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	580	NO	Positive		NO	10																															NO	3		true	No	M0	N1b	T3	Stage IIIA		A1EV	WITH TUMOR						NO	YES			YES	Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1999	7b234c36-729b-422d-8e2a-ebd42af74bce		7b234c36-729b-422d-8e2a-ebd42af74bce						TCGA-BH-A1EV-11A-24D-A138-05							TCGA-BH-A1EV-11			7b234c36-729b-422d-8e2a-ebd42af74bce			TCGA-BH-A1EV-11		7b234c36-729b-422d-8e2a-ebd42af74bce		
TCGA-BH-A1EW-01	Stage IIA	38	3	No_Conversion		1694	Negative	FEMALE	Negative				Negative	M0	Positive	N1	1694	1	LumA	Luminal B	Negative		-3	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EW-01	1694	1	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A1EW			days	1694	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant				TCGA-BH-A1EW	TCGA-BH-A1EW-01A		Negative					Negative	Other					-14090	4230	1694	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6									1		true	No	M0	N1b	T2	Stage IIA	TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf	A1EW	WITH TUMOR							YES				Primary Tumor	01	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	Breast	A	DECEASED	1999	59783c67-6446-44c1-b9b3-505470f54c82	aff7ebf5-e7ff-4932-972f-758e23aedf4b	59783c67-6446-44c1-b9b3-505470f54c82	aff7ebf5-e7ff-4932-972f-758e23aedf4b	TCGA-BH-A1EW-01A-21-A17I-20	TCGA-BH-A1EW-01A-11D-A135-09		TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11D-A138-05		fd676c7e-c137-4699-a8ea-57b72b10ff5b	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11D-A135-09		TCGA-BH-A1EW-01	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11D-A135-09		59783c67-6446-44c1-b9b3-505470f54c82		TCGA-BH-A1EW-01A-11D-A134-01	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11R-A137-07	59783c67-6446-44c1-b9b3-505470f54c82	TCGA-BH-A1EW-01A-11D-A134-01	TCGA-BH-A1EW-01
TCGA-BH-A1EW-11		38				1694		FEMALE									1694	1	LumA						enrollment			DECEASED	1	TCGA-BH-A1EW-11	1694	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1EW			days	1694	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left Upper Outer Quadrant				TCGA-BH-A1EW	TCGA-BH-A1EW-11B		Negative					Negative	Other					-14090	4230	1694	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1030	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																														1		false	No	M0	N1b	T2	Stage IIA		A1EW	WITH TUMOR							YES				Solid Tissue Normal	11	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	Breast	B	DECEASED	1999	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31		cf1027dc-9ba9-4e3c-80d9-4bb13021cc31						TCGA-BH-A1EW-11B-33D-A138-05		6AC30F47-7622-4DBF-94E9-4E6D93D8442F					TCGA-BH-A1EW-11			cf1027dc-9ba9-4e3c-80d9-4bb13021cc31			TCGA-BH-A1EW-11	TCGA-BH-A1EW-11B-33R-A137-07	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31		
TCGA-BH-A1EX-01	Stage IIB	67	3	Stage IIB		1508	Positive	FEMALE	Negative				Negative	M0	Positive	N1	1508	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EX-01	1508	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A1EX			days	1508	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Lower Inner Quadrant				TCGA-BH-A1EX	TCGA-BH-A1EX-01A		Positive					Positive	Other					-24544	3752	1508	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5									2		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A1EX.FA86A743-EA67-4554-ABA2-BB8C1DBDB0B1.pdf	A1EX	WITH TUMOR							YES				Primary Tumor	01	Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy	5th		NO	YES	BH	Breast	A	DECEASED	2000	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	936d1d83-4360-4be3-8de2-8ed7414c01dc	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	936d1d83-4360-4be3-8de2-8ed7414c01dc	TCGA-BH-A1EX-01A-21-A17I-20	TCGA-BH-A1EX-01A-11D-A13L-09		TCGA-BH-A1EX-01	TCGA-BH-A1EX-01A-11D-A13K-05		e4809caf-a1a9-4d9f-807f-530ae7c2e434	TCGA-BH-A1EX-01	TCGA-BH-A1EX-01A-11D-A13L-09			TCGA-BH-A1EX-01	TCGA-BH-A1EX-01A-11D-A13L-09		b5c8962b-15d5-45ba-9a5a-a75dfacbaad9		TCGA-BH-A1EX-01A-11D-A13J-01	TCGA-BH-A1EX-01		b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	TCGA-BH-A1EX-01A-11D-A13J-01	
TCGA-BH-A1EY-01	Stage IIA	79	2	Stage IIA		538	Positive	FEMALE	Negative				Negative	M0	Negative	N0	538	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EY-01	538	1	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-BH-A1EY	396	1	days	538	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant			TCGA-BH-A1EY-F59173	TCGA-BH-A1EY	TCGA-BH-A1EY-01A		Positive					Positive	Modified Radical Mastectomy					-28940	3840	538	0				396							2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Negative		NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1				Lung	Distant Metastasis	Liver		YES	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf	A1EY	WITH TUMOR						NO	YES			NO	Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2000	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	de9cbffc-addc-4ac0-bf95-0e1fd3ae7a00	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	de9cbffc-addc-4ac0-bf95-0e1fd3ae7a00	TCGA-BH-A1EY-01A-21-A17I-20	TCGA-BH-A1EY-01A-11D-A13L-09		TCGA-BH-A1EY-01	TCGA-BH-A1EY-01A-11D-A13K-05		7de680e0-63d0-41b4-ace3-82a8e80aaae3	TCGA-BH-A1EY-01	TCGA-BH-A1EY-01A-11D-A13L-09			TCGA-BH-A1EY-01	TCGA-BH-A1EY-01A-11D-A13L-09		4a6f7935-86f8-4c08-9d0e-9fe77878f2ce		TCGA-BH-A1EY-01A-11D-A13J-01	TCGA-BH-A1EY-01		4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-11D-A13J-01	
TCGA-BH-A1EY-11		79				538		FEMALE									538	1							enrollment			DECEASED	1	TCGA-BH-A1EY-11	538	1	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1EY	396	1	days	538	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant			TCGA-BH-A1EY-F59173	TCGA-BH-A1EY	TCGA-BH-A1EY-11B		Positive					Positive	Modified Radical Mastectomy					-28940	3840	538	0				396							2014-5-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Negative		NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis	Liver		YES	0		false	No	M0	N0	T2	Stage IIA		A1EY	WITH TUMOR						NO	YES			NO	Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	2000									TCGA-BH-A1EY-11B-21D-A13T-05		A5047A5B-665D-4C47-ADC8-1DFDF0180130															
TCGA-BH-A1F0-01	Stage IIA	80	1	Stage IIA		785	Negative	FEMALE	Negative				Negative	M0	Positive	N1	785	1	Basal	Basal-like	Indeterminate		-13	-12	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1F0-01	785	1	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 6	mutation cluster 5	TCGA-BH-A1F0			days	785	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left				TCGA-BH-A1F0	TCGA-BH-A1F0-01A		Negative					Indeterminate	Modified Radical Mastectomy					-29335	3879	785	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	180	NO	Negative			9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6									1		true	No	M0	N1c	T1a	Stage IIA	TCGA-BH-A1F0.E2EE2397-0F8A-4A71-9B3C-0007F7D00500.pdf	A1F0	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2000	d31b476c-c047-4e5f-a0cb-eff1065f0121	898c61fd-25f3-480d-864b-0902639e7ca8	d31b476c-c047-4e5f-a0cb-eff1065f0121	898c61fd-25f3-480d-864b-0902639e7ca8	TCGA-BH-A1F0-01A-21-A17I-20	TCGA-BH-A1F0-01A-11D-A135-09		TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11D-A138-05		a4bd17eb-0741-4d81-b457-158367d20ae9	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11D-A135-09		TCGA-BH-A1F0-01	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11D-A135-09		d31b476c-c047-4e5f-a0cb-eff1065f0121		TCGA-BH-A1F0-01A-11D-A134-01	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11R-A137-07	d31b476c-c047-4e5f-a0cb-eff1065f0121	TCGA-BH-A1F0-01A-11D-A134-01	TCGA-BH-A1F0-01
TCGA-BH-A1F0-11		80				785		FEMALE									785	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F0-11	785	1	days		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1F0			days	785	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left				TCGA-BH-A1F0	TCGA-BH-A1F0-11B		Negative					Indeterminate	Modified Radical Mastectomy					-29335	3879	785	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	180	NO	Negative			9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1		false	No	M0	N1c	T1a	Stage IIA		A1F0	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	2000	889f6f61-9b3a-406c-9af8-ddee74a8a19e		889f6f61-9b3a-406c-9af8-ddee74a8a19e						TCGA-BH-A1F0-11B-23D-A138-05							TCGA-BH-A1F0-11			889f6f61-9b3a-406c-9af8-ddee74a8a19e			TCGA-BH-A1F0-11	TCGA-BH-A1F0-11B-23R-A137-07	889f6f61-9b3a-406c-9af8-ddee74a8a19e		
TCGA-BH-A1F2-01	Stage IIIB	53	5	Stage		959	Positive	FEMALE	Positive				Negative	M0	Positive	N1	959	1	LumB		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1F2-01	959	1	days	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 14	TCGA-BH-A1F2			days	959	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left				TCGA-BH-A1F2	TCGA-BH-A1F2-01A		Positive					Positive	Modified Radical Mastectomy					-19701	4147	959	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	230	NO	Positive			19																						2	6									6		true	No	M0	N1b	T4b	Stage IIIB	TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf	A1F2	TUMOR FREE							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1999	dbba4276-4b85-4309-8f98-951313c3a3dc	684a637d-c0a0-471a-86d0-1e19aff9f17e	dbba4276-4b85-4309-8f98-951313c3a3dc	684a637d-c0a0-471a-86d0-1e19aff9f17e	TCGA-BH-A1F2-01A-21-A17I-20	TCGA-BH-A1F2-01A-31D-A13L-09		TCGA-BH-A1F2-01	TCGA-BH-A1F2-01A-31D-A13K-05		9c29c7e9-78b0-434d-a795-343fa6d8d937	TCGA-BH-A1F2-01	TCGA-BH-A1F2-01A-31D-A13L-09			TCGA-BH-A1F2-01	TCGA-BH-A1F2-01A-31D-A13L-09		dbba4276-4b85-4309-8f98-951313c3a3dc		TCGA-BH-A1F2-01A-31D-A13J-01	TCGA-BH-A1F2-01		dbba4276-4b85-4309-8f98-951313c3a3dc	TCGA-BH-A1F2-01A-31D-A13J-01	
TCGA-BH-A1F2-11		53				959		FEMALE									959	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F2-11	959	1	days		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A1F2			days	959	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left				TCGA-BH-A1F2	TCGA-BH-A1F2-11A		Positive					Positive	Modified Radical Mastectomy					-19701	4147	959	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	270	NO	Positive			19																																6		true	No	M0	N1b	T4b	Stage IIIB		A1F2	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1999	85e9922a-0ede-4fea-8338-ead05addef79		85e9922a-0ede-4fea-8338-ead05addef79						TCGA-BH-A1F2-11A-32D-A13T-05							TCGA-BH-A1F2-11			85e9922a-0ede-4fea-8338-ead05addef79			TCGA-BH-A1F2-11		85e9922a-0ede-4fea-8338-ead05addef79		
TCGA-BH-A1F5-01		62				2712	Positive	FEMALE									2712	1	LumA		Positive				enrollment			DECEASED	1	TCGA-BH-A1F5-01	2712	1	days	Kirc+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-BH-A1F5			days	2712	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right				TCGA-BH-A1F5	TCGA-BH-A1F5-01A		Positive					Positive						-22842	3091	2712	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4																																1		true	Yes	M0	N1a	T1c	Stage IIA	TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf	A1F5	TUMOR FREE							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	2002	07c52f68-8ece-4702-8573-9b21f32df787	7fedf65f-1c06-4ad9-b979-a88a75c9288c	07c52f68-8ece-4702-8573-9b21f32df787	7fedf65f-1c06-4ad9-b979-a88a75c9288c	TCGA-BH-A1F5-01A-21-A17I-20	TCGA-BH-A1F5-01A-12D-A13L-09		TCGA-BH-A1F5-01	TCGA-BH-A1F5-01A-12D-A13K-05		07dd3a1f-05f8-488d-9b80-4fe5b94923c4	TCGA-BH-A1F5-01	TCGA-BH-A1F5-01A-12D-A13L-09			TCGA-BH-A1F5-01	TCGA-BH-A1F5-01A-12D-A13L-09		07c52f68-8ece-4702-8573-9b21f32df787		TCGA-BH-A1F5-01A-12D-A13J-01	TCGA-BH-A1F5-01		07c52f68-8ece-4702-8573-9b21f32df787	TCGA-BH-A1F5-01A-12D-A13J-01	
TCGA-BH-A1F5-11		62				2712		FEMALE									2712	1							enrollment			DECEASED	1	TCGA-BH-A1F5-11	2712	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1F5			days	2712	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right				TCGA-BH-A1F5	TCGA-BH-A1F5-11A		Positive					Positive						-22842	3091	2712	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative			4																																1		true	Yes	M0	N1a	T1c	Stage IIA		A1F5	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	2002									TCGA-BH-A1F5-11A-43D-A13T-05																	
TCGA-BH-A1F6-01		51				2965	Negative	FEMALE									2965	1	Basal		Negative				enrollment			DECEASED	1	TCGA-BH-A1F6-01	2965	1	days	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12		mutation cluster 5	TCGA-BH-A1F6			days	2965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left				TCGA-BH-A1F6	TCGA-BH-A1F6-01A		Negative					Negative	Modified Radical Mastectomy					-18691	5230	2965	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			6																																6		true	No	MX	N2a	T4d		TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf	A1F6								YES				Primary Tumor	01				NO	YES	BH	Breast	A	DECEASED	1996	5f5a884c-ffbd-401a-8689-baded1bdbe50	9221bace-db00-4adc-ac61-aa064672c1ad	5f5a884c-ffbd-401a-8689-baded1bdbe50	9221bace-db00-4adc-ac61-aa064672c1ad	TCGA-BH-A1F6-01A-21-A17I-20	TCGA-BH-A1F6-01A-11D-A13L-09		TCGA-BH-A1F6-01	TCGA-BH-A1F6-01A-11D-A13K-05		9e1df13d-422b-46a6-8dd0-0f3d943c301b	TCGA-BH-A1F6-01	TCGA-BH-A1F6-01A-11D-A13L-09			TCGA-BH-A1F6-01	TCGA-BH-A1F6-01A-11D-A13L-09		5f5a884c-ffbd-401a-8689-baded1bdbe50		TCGA-BH-A1F6-01A-11D-A13J-01	TCGA-BH-A1F6-01		5f5a884c-ffbd-401a-8689-baded1bdbe50	TCGA-BH-A1F6-01A-11D-A13J-01	
TCGA-BH-A1F6-11		51				2965		FEMALE									2965	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F6-11	2965	1	days		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1F6			days	2965	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left				TCGA-BH-A1F6			Negative					Negative	Modified Radical Mastectomy					-18691		2965	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			6																																6			No	MX	N2a	T4d			A1F6								YES				Solid Tissue Normal	11				NO	YES	BH	Breast		DECEASED	1996	a248476b-7c40-42c6-905b-b9c3ba6b2aed		a248476b-7c40-42c6-905b-b9c3ba6b2aed						TCGA-BH-A1F6-11B-94D-A13T-05							TCGA-BH-A1F6-11			a248476b-7c40-42c6-905b-b9c3ba6b2aed			TCGA-BH-A1F6-11		a248476b-7c40-42c6-905b-b9c3ba6b2aed		
TCGA-BH-A1F8-01	Stage IIIB	90	1	Stage IIIC		749	Positive	FEMALE	Negative				Negative	M0	Positive	N2	749	1	LumB		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1F8-01	763	1	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4	mutation cluster 4	TCGA-BH-A1F8			days	763	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Left				TCGA-BH-A1F8			Positive					Positive	Modified Radical Mastectomy					-32871		763	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Positive			13		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4									12			No	M0	N2	T4b	Stage IIIB		A1F8	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast		DECEASED	1999	ca39657a-073d-4b89-a3da-900f7c9f1012	e1551e9a-dffe-4810-9836-3567199c4092	ca39657a-073d-4b89-a3da-900f7c9f1012	e1551e9a-dffe-4810-9836-3567199c4092	TCGA-BH-A1F8-01A-21-A17I-20	TCGA-BH-A1F8-01A-11D-A13L-09		TCGA-BH-A1F8-01	TCGA-BH-A1F8-01A-11D-A13K-05		bcc978dd-e7cd-4cff-be13-d6f0926dfc9d	TCGA-BH-A1F8-01	TCGA-BH-A1F8-01A-11D-A13L-09			TCGA-BH-A1F8-01	TCGA-BH-A1F8-01A-11D-A13L-09		ca39657a-073d-4b89-a3da-900f7c9f1012		TCGA-BH-A1F8-01A-11D-A13J-01	TCGA-BH-A1F8-01		ca39657a-073d-4b89-a3da-900f7c9f1012	TCGA-BH-A1F8-01A-11D-A13J-01	
TCGA-BH-A1F8-11		90				749		FEMALE									749	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1F8-11	763	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A1F8			days	763	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Left				TCGA-BH-A1F8	TCGA-BH-A1F8-11B		Positive					Positive	Modified Radical Mastectomy					-32871	4301	763	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Positive			13		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														12		false	No	M0	N2	T4b	Stage IIIB		A1F8	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1999	c6cc7496-98d2-4181-8517-fbd875fd5623		c6cc7496-98d2-4181-8517-fbd875fd5623						TCGA-BH-A1F8-11B-21D-A13T-05		80FD1099-D66E-4A9A-AA9E-CB7D0178D612					TCGA-BH-A1F8-11			c6cc7496-98d2-4181-8517-fbd875fd5623			TCGA-BH-A1F8-11		c6cc7496-98d2-4181-8517-fbd875fd5623		
TCGA-BH-A1FB-01	Stage IIB	60	4	Stage IIB		3669	Positive	FEMALE	Negative				Negative	M0	Positive	N1	3669	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FB-01	3669	1	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6		TCGA-BH-A1FB			days	3669	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right				TCGA-BH-A1FB	TCGA-BH-A1FB-01A		Positive					Positive						-21933	3871	3669	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6									0		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A.pdf	A1FB	WITH TUMOR							YES				Primary Tumor	01	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	2000	5b262ec0-72f2-4c54-820e-a39afad67212	ed5f14b2-ffc0-4eb6-bbb0-576c2c102128	5b262ec0-72f2-4c54-820e-a39afad67212	ed5f14b2-ffc0-4eb6-bbb0-576c2c102128	TCGA-BH-A1FB-01A-21-A17I-20			TCGA-BH-A1FB-01	TCGA-BH-A1FB-01A-11D-A13K-05		ee88f81e-c7f3-41b4-a115-751d02d07fd0	TCGA-BH-A1FB-01				TCGA-BH-A1FB-01			5b262ec0-72f2-4c54-820e-a39afad67212		TCGA-BH-A1FB-01A-11D-A13J-01	TCGA-BH-A1FB-01		5b262ec0-72f2-4c54-820e-a39afad67212	TCGA-BH-A1FB-01A-11D-A13J-01	
TCGA-BH-A1FB-11		60				3669		FEMALE									3669	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FB-11	3669	1	days		C3-BRCA/Luminal								TCGA-BH-A1FB			days	3669	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right				TCGA-BH-A1FB	TCGA-BH-A1FB-11A		Positive					Positive						-21933	3871	3669	0											2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0		true	No	M0	N1b	T2	Stage IIB		A1FB	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	2000	71899388-d223-4774-a1ce-3be260240b2c		71899388-d223-4774-a1ce-3be260240b2c						TCGA-BH-A1FB-11A-33D-A13T-05							TCGA-BH-A1FB-11			71899388-d223-4774-a1ce-3be260240b2c			TCGA-BH-A1FB-11		71899388-d223-4774-a1ce-3be260240b2c		
TCGA-BH-A1FC-01	Stage IIA	78	4	Stage IIA		3471	Negative	FEMALE	Negative				Negative	M0	Positive	N1	3471	1	Basal		Negative				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FC-01	3472	1	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A1FC			days	3472	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Outer Quadrant				TCGA-BH-A1FC	TCGA-BH-A1FC-01A		Negative					Negative	Other					-28706	4456	3472	0											2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	90	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3									1		true	No	M0	N1b	T1c	Stage IIA	TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf	A1FC	TUMOR FREE							YES				Primary Tumor	01	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	42e2160c-07b5-4be6-a989-1e3474926d2a	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	42e2160c-07b5-4be6-a989-1e3474926d2a	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	TCGA-BH-A1FC-01A-21-A17I-20	TCGA-BH-A1FC-01A-11D-A13L-09		TCGA-BH-A1FC-01	TCGA-BH-A1FC-01A-11D-A13K-05		9ce04c0d-97f2-4acd-a985-c9b162221210	TCGA-BH-A1FC-01	TCGA-BH-A1FC-01A-11D-A13L-09			TCGA-BH-A1FC-01	TCGA-BH-A1FC-01A-11D-A13L-09		42e2160c-07b5-4be6-a989-1e3474926d2a		TCGA-BH-A1FC-01A-11D-A13J-01	TCGA-BH-A1FC-01		42e2160c-07b5-4be6-a989-1e3474926d2a	TCGA-BH-A1FC-01A-11D-A13J-01	
TCGA-BH-A1FC-11		78				3471		FEMALE									3471	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FC-11	3472	1	days		C4-BRCA/Basal							mutation cluster 5	TCGA-BH-A1FC			days	3472	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Upper Outer Quadrant				TCGA-BH-A1FC	TCGA-BH-A1FC-11A		Negative					Negative	Other					-28706	4456	3472	0											2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														1		true	No	M0	N1b	T1c	Stage IIA		A1FC	TUMOR FREE							YES				Solid Tissue Normal	11	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	58e94be5-2da2-4a96-944a-060f20216572		58e94be5-2da2-4a96-944a-060f20216572						TCGA-BH-A1FC-11A-32D-A13T-05							TCGA-BH-A1FC-11			58e94be5-2da2-4a96-944a-060f20216572			TCGA-BH-A1FC-11		58e94be5-2da2-4a96-944a-060f20216572		
TCGA-BH-A1FD-01	Stage I	68	4	Stage I		1008	Positive	FEMALE	Negative				Negative	M0	Negative	N0	1008	1	LumB		Positive				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FD-01	1009	1	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 3	TCGA-BH-A1FD			days	1009	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left				TCGA-BH-A1FD	TCGA-BH-A1FD-01A		Positive					Positive						-24940	4420	1009	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3										0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A1FD.9F838476-4DF1-44D6-989F-33A1D490424B.pdf	A1FD	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	744ed141-8809-4bc9-90e6-74098383914e	e8763755-1460-48c9-b60a-5a5b9ed61da5	744ed141-8809-4bc9-90e6-74098383914e	e8763755-1460-48c9-b60a-5a5b9ed61da5	TCGA-BH-A1FD-01A-21-A17I-20	TCGA-BH-A1FD-01A-11W-A14Q-09		TCGA-BH-A1FD-01	TCGA-BH-A1FD-01A-11D-A13K-05		7c4d6492-831a-4535-b46f-7fdcafd3dcdf	TCGA-BH-A1FD-01	TCGA-BH-A1FD-01A-11W-A14Q-09				TCGA-BH-A1FD-01A-11W-A14Q-09		744ed141-8809-4bc9-90e6-74098383914e		TCGA-BH-A1FD-01A-11D-A13J-01			744ed141-8809-4bc9-90e6-74098383914e	TCGA-BH-A1FD-01A-11D-A13J-01	
TCGA-BH-A1FD-11		68				1008		FEMALE									1008	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FD-11	1009	1	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1FD			days	1009	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left				TCGA-BH-A1FD	TCGA-BH-A1FD-11B		Positive					Positive						-24940	4420	1009	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440	NO	Negative			19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0		false	No	M0	N0	T1c	Stage I		A1FD	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998	e0ed3e93-0ead-4fc0-a82d-79807c7d5162		e0ed3e93-0ead-4fc0-a82d-79807c7d5162						TCGA-BH-A1FD-11B-21D-A13T-05		81425ECA-DA4A-428C-BAAE-E3B55821C356					TCGA-BH-A1FD-11			e0ed3e93-0ead-4fc0-a82d-79807c7d5162			TCGA-BH-A1FD-11		e0ed3e93-0ead-4fc0-a82d-79807c7d5162		
TCGA-BH-A1FE-01	Stage IIB	31	2	Stage IIB		2273	Positive	FEMALE	Negative				Negative	M0	Positive	N1	2273	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FE-01	2273	1	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-BH-A1FE			days	2273	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31	Left				TCGA-BH-A1FE	TCGA-BH-A1FE-01A		Positive					Positive	Modified Radical Mastectomy					-11650	4456	2273	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO				12																						4	6									1		true	No	M0	N1	T2	Stage IIB	TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf	A1FE	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	2cb3a793-6e37-42fd-a544-65aa2d939d50	1427907e-73c9-42c0-ab7b-64cd9b64d874	2cb3a793-6e37-42fd-a544-65aa2d939d50	1427907e-73c9-42c0-ab7b-64cd9b64d874		TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01	TCGA-BH-A1FE-01A-11D-A13K-05		8e3a6a91-27f1-497a-84dc-76ab2ee74185	TCGA-BH-A1FE-01	TCGA-BH-A1FE-01A-11D-A13L-09			TCGA-BH-A1FE-01	TCGA-BH-A1FE-01A-11D-A13L-09		2cb3a793-6e37-42fd-a544-65aa2d939d50		TCGA-BH-A1FE-01A-11D-A13J-01	TCGA-BH-A1FE-01		2cb3a793-6e37-42fd-a544-65aa2d939d50	TCGA-BH-A1FE-01A-11D-A13J-01	
TCGA-BH-A1FE-06		31				2273		FEMALE									2273	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FE-06	2273	1	days		C3-BRCA/Luminal		Low purity c2		GBM-like c6	miRNA cluster 5		mutation cluster 3	TCGA-BH-A1FE			days	2273	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31	Left				TCGA-BH-A1FE	TCGA-BH-A1FE-06A		Positive					Positive	Modified Radical Mastectomy					-11650	4742	2273	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	900	NO				12																																1		true	No	M0	N1	T2	Stage IIB	TCGA-BH-A1FE.3F499CDC-18A3-44A7-B796-71716F2A2BD2.pdf	A1FE	WITH TUMOR							YES				Metastatic	06		5th		NO	YES	BH	Breast	A	DECEASED	1998	aad871a8-1a52-4e96-8b13-444d08289236	9817a432-9c60-42d5-928e-531e3fd480dd	aad871a8-1a52-4e96-8b13-444d08289236	9817a432-9c60-42d5-928e-531e3fd480dd	TCGA-BH-A1FE-06A-21-A24B-20				TCGA-BH-A1FE-06A-11D-A212-05		ee4151b6-cf2c-43e9-b3ed-9407e9e83282					TCGA-BH-A1FE-06	TCGA-BH-A1FE-06A-11D-A20S-09		aad871a8-1a52-4e96-8b13-444d08289236			TCGA-BH-A1FE-06		aad871a8-1a52-4e96-8b13-444d08289236		
TCGA-BH-A1FE-11		31				2273		FEMALE									2273	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FE-11	2273	1	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-BH-A1FE			days	2273	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					31	Left				TCGA-BH-A1FE	TCGA-BH-A1FE-11B		Positive					Positive	Modified Radical Mastectomy					-11650	4456	2273	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520	NO				12																																1		true	No	M0	N1	T2	Stage IIB		A1FE	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998	64f3f52d-a484-49c6-9048-6eadedd2c2c5		64f3f52d-a484-49c6-9048-6eadedd2c2c5						TCGA-BH-A1FE-11B-14D-A13T-05		160198A9-3024-40DF-9887-E20F9371AC0A					TCGA-BH-A1FE-11			64f3f52d-a484-49c6-9048-6eadedd2c2c5			TCGA-BH-A1FE-11		64f3f52d-a484-49c6-9048-6eadedd2c2c5		
TCGA-BH-A1FG-01	Stage I	88	4	Stage I		3738	Positive	FEMALE					Negative	M0	Negative	N0	3738	1	LumA		Positive				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FG-01	3736	1	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A1FG			days	3736	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Left				TCGA-BH-A1FG	TCGA-BH-A1FG-01A		Positive					Positive	Other					-32295	4460	3736	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	120	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2											true	No	M0	NX	T1c	Stage I	TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf	A1FG												Primary Tumor	01	segmental mastectomy	5th		NO	YES	BH	Breast	A	DECEASED	1998	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	16ab0981-23d8-4602-ac15-898caa502ff4	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	16ab0981-23d8-4602-ac15-898caa502ff4	TCGA-BH-A1FG-01A-21-A17I-20	TCGA-BH-A1FG-01A-11D-A13L-09		TCGA-BH-A1FG-01	TCGA-BH-A1FG-01A-11D-A13K-05		590744af-fc53-40ec-957f-ca5ca31d76c5	TCGA-BH-A1FG-01	TCGA-BH-A1FG-01A-11D-A13L-09			TCGA-BH-A1FG-01	TCGA-BH-A1FG-01A-11D-A13L-09		39fe5d50-f454-4f7b-b07b-1a59b5c828f9		TCGA-BH-A1FG-01A-11D-A13J-01	TCGA-BH-A1FG-01		39fe5d50-f454-4f7b-b07b-1a59b5c828f9	TCGA-BH-A1FG-01A-11D-A13J-01	
TCGA-BH-A1FG-11		88				3738		FEMALE									3738	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FG-11	3736	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FG			days	3736	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Left				TCGA-BH-A1FG			Positive					Positive	Other					-32295		3736	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy			Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																																	No	M0	NX	T1c	Stage I		A1FG												Solid Tissue Normal	11	segmental mastectomy	5th		NO	YES	BH	Breast		DECEASED	1998	ea037776-3759-425c-a7f4-35e8a5571025		ea037776-3759-425c-a7f4-35e8a5571025						TCGA-BH-A1FG-11B-12D-A13T-05							TCGA-BH-A1FG-11			ea037776-3759-425c-a7f4-35e8a5571025			TCGA-BH-A1FG-11		ea037776-3759-425c-a7f4-35e8a5571025		
TCGA-BH-A1FH-01	Stage IV	47	4	No_Conversion		1123	Positive	FEMALE	Negative				Positive	M1	Positive	N1	1123	1	LumA		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FH-01	1034	1	days	Kirc+	C3-BRCA/Luminal	cluster 1	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A1FH			days	1034	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant				TCGA-BH-A1FH	TCGA-BH-A1FH-01A		Positive					Negative	Modified Radical Mastectomy					-17172	4670	1034	0						YES					2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO				13																				Bone		1	6									8		true	No	M1	N1b	T2	Stage IV	TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf	A1FH	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	693a3c69-75bd-435d-874e-f3b90b7ed180	8dedb075-afa7-4699-b486-178cdaba1e9e	693a3c69-75bd-435d-874e-f3b90b7ed180	8dedb075-afa7-4699-b486-178cdaba1e9e	TCGA-BH-A1FH-01A-21-A17I-20	TCGA-BH-A1FH-01A-12D-A13L-09		TCGA-BH-A1FH-01	TCGA-BH-A1FH-01A-12D-A13K-05		c2f9d1f7-4fea-4868-a3ec-58f863b4e449	TCGA-BH-A1FH-01	TCGA-BH-A1FH-01A-12D-A13L-09			TCGA-BH-A1FH-01	TCGA-BH-A1FH-01A-12D-A13L-09		693a3c69-75bd-435d-874e-f3b90b7ed180		TCGA-BH-A1FH-01A-12D-A13J-01	TCGA-BH-A1FH-01		693a3c69-75bd-435d-874e-f3b90b7ed180	TCGA-BH-A1FH-01A-12D-A13J-01	
TCGA-BH-A1FH-11		47				1123		FEMALE									1123	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FH-11	1034	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FH			days	1034	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant				TCGA-BH-A1FH	TCGA-BH-A1FH-11B		Positive					Negative	Modified Radical Mastectomy					-17172	4670	1034	0						YES					2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO				13																				Bone												8		false	No	M1	N1b	T2	Stage IV		A1FH	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998	1b831e2d-c265-4eac-aee0-248493a14218		1b831e2d-c265-4eac-aee0-248493a14218						TCGA-BH-A1FH-11B-42D-A13T-05							TCGA-BH-A1FH-11			1b831e2d-c265-4eac-aee0-248493a14218			TCGA-BH-A1FH-11		1b831e2d-c265-4eac-aee0-248493a14218		
TCGA-BH-A1FJ-01	Stage IIIA	66	3	Stage IIIA		1927	Negative	FEMALE	Negative				Negative	M0	Positive	N1	1927	1	LumB		Positive				enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A1FJ-01	1927	1	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-BH-A1FJ			days	1927	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant				TCGA-BH-A1FJ	TCGA-BH-A1FJ-01A		Negative					Positive	Modified Radical Mastectomy					-24262	4574	1927	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO				35																						4	2									6		true	No	M0	N1b	T3	Stage IIIA	TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf	A1FJ								YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	28bc840d-296e-436e-93b8-9c28c0eaf47a	98f36ce5-e678-4356-a0e9-f2daf679f1f1	28bc840d-296e-436e-93b8-9c28c0eaf47a	98f36ce5-e678-4356-a0e9-f2daf679f1f1	TCGA-BH-A1FJ-01A-21-A17I-20	TCGA-BH-A1FJ-01A-11D-A13L-09		TCGA-BH-A1FJ-01	TCGA-BH-A1FJ-01A-11D-A13K-05		1efab28c-3820-4638-b688-f34d0daa58d3	TCGA-BH-A1FJ-01	TCGA-BH-A1FJ-01A-11D-A13L-09			TCGA-BH-A1FJ-01	TCGA-BH-A1FJ-01A-11D-A13L-09		28bc840d-296e-436e-93b8-9c28c0eaf47a		TCGA-BH-A1FJ-01A-11D-A13J-01	TCGA-BH-A1FJ-01		28bc840d-296e-436e-93b8-9c28c0eaf47a	TCGA-BH-A1FJ-01A-11D-A13J-01	
TCGA-BH-A1FJ-11		66				1927		FEMALE									1927	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FJ-11	1927	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FJ			days	1927	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Upper Outer Quadrant				TCGA-BH-A1FJ	TCGA-BH-A1FJ-11B		Negative					Positive	Modified Radical Mastectomy					-24262	4574	1927	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO				35																																6		false	No	M0	N1b	T3	Stage IIIA		A1FJ								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998	3078c384-b624-4f5a-ae36-fc896212e616		3078c384-b624-4f5a-ae36-fc896212e616						TCGA-BH-A1FJ-11B-42D-A13T-05							TCGA-BH-A1FJ-11			3078c384-b624-4f5a-ae36-fc896212e616			TCGA-BH-A1FJ-11		3078c384-b624-4f5a-ae36-fc896212e616		
TCGA-BH-A1FL-01	Stage IIB	69	2	Stage IIIA		1673	Positive	FEMALE	Negative				Negative	M0	Positive	N1	1673	1	LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FL-01	1673	1	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A1FL			days	1673	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Outer Quadrant				TCGA-BH-A1FL	TCGA-BH-A1FL-01A		Positive					Positive	Other					-25558	4572	1673	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	100	NO				22																						4	6									4		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf	A1FL	WITH TUMOR							YES				Primary Tumor	01	needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1998	0858a026-142c-4428-b05d-fdc22080afd3	f4aa579c-fa0c-4313-a4a1-ca88a367d71f	0858a026-142c-4428-b05d-fdc22080afd3	f4aa579c-fa0c-4313-a4a1-ca88a367d71f	TCGA-BH-A1FL-01A-21-A17I-20	TCGA-BH-A1FL-01A-11D-A13L-09		TCGA-BH-A1FL-01	TCGA-BH-A1FL-01A-11D-A13K-05		dcfae1dd-7e5f-49d7-b3b8-171c97913d1a	TCGA-BH-A1FL-01	TCGA-BH-A1FL-01A-11D-A13L-09			TCGA-BH-A1FL-01	TCGA-BH-A1FL-01A-11D-A13L-09		0858a026-142c-4428-b05d-fdc22080afd3		TCGA-BH-A1FL-01A-11D-A13J-01	TCGA-BH-A1FL-01		0858a026-142c-4428-b05d-fdc22080afd3	TCGA-BH-A1FL-01A-11D-A13J-01	
TCGA-BH-A1FM-01	Stage IIIA	44	1	Stage IIIA		1388	Positive	FEMALE	Negative				Negative	M0	Positive	N2	1388	1	LumB		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FM-01	1388	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A1FM			days	1388	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant				TCGA-BH-A1FM	TCGA-BH-A1FM-01A		Positive					Negative	Modified Radical Mastectomy					-16289	4753	1388	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO				10																						3	4									8		true	No	M0	N2	T2	Stage IIIA	TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf	A1FM								YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1998	99157b66-ae2a-4ba2-8b28-5653803063a9	c1636423-5fa8-4d4c-bba1-b9dd369e3830	99157b66-ae2a-4ba2-8b28-5653803063a9	c1636423-5fa8-4d4c-bba1-b9dd369e3830	TCGA-BH-A1FM-01A-21-A17I-20	TCGA-BH-A1FM-01A-11D-A13L-09		TCGA-BH-A1FM-01	TCGA-BH-A1FM-01A-11D-A13K-05		25b0f619-ad2b-437a-bf44-e03cce5ff63f	TCGA-BH-A1FM-01	TCGA-BH-A1FM-01A-11D-A13L-09			TCGA-BH-A1FM-01	TCGA-BH-A1FM-01A-11D-A13L-09		99157b66-ae2a-4ba2-8b28-5653803063a9		TCGA-BH-A1FM-01A-11D-A13J-01	TCGA-BH-A1FM-01		99157b66-ae2a-4ba2-8b28-5653803063a9	TCGA-BH-A1FM-01A-11D-A13J-01	
TCGA-BH-A1FM-11		44				1388		FEMALE									1388	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FM-11	1388	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FM			days	1388	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant				TCGA-BH-A1FM	TCGA-BH-A1FM-11B		Positive					Negative	Modified Radical Mastectomy					-16289	4753	1388	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO				10																																8		false	No	M0	N2	T2	Stage IIIA		A1FM								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	B	DECEASED	1998	39ec3623-c15f-4af6-b2df-5413eec21bec		39ec3623-c15f-4af6-b2df-5413eec21bec						TCGA-BH-A1FM-11B-23D-A13T-05							TCGA-BH-A1FM-11			39ec3623-c15f-4af6-b2df-5413eec21bec			TCGA-BH-A1FM-11		39ec3623-c15f-4af6-b2df-5413eec21bec		
TCGA-BH-A1FN-01	Stage IIA	34	1	Stage IIA		2192	Positive	FEMALE	Negative				Negative	M0	Negative	N0	2192	1	LumB		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FN-01	2192	1	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A1FN			days	2192	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Right Upper Outer Quadrant				TCGA-BH-A1FN	TCGA-BH-A1FN-01A		Positive					Positive	Other					-12525	4838	2192	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	80	NO				29																						5	4									0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26.pdf	A1FN	WITH TUMOR							YES				Primary Tumor	01	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997	c870e04b-c3b7-495c-8465-7ef2a00fadc7	ce3297a5-e5d6-4abb-a771-4a5d8c4da516	c870e04b-c3b7-495c-8465-7ef2a00fadc7	ce3297a5-e5d6-4abb-a771-4a5d8c4da516	TCGA-BH-A1FN-01A-21-A17I-20	TCGA-BH-A1FN-01A-11D-A13L-09		TCGA-BH-A1FN-01	TCGA-BH-A1FN-01A-11D-A13K-05		3d0671e6-de93-4023-b91c-66a2e311fed6	TCGA-BH-A1FN-01	TCGA-BH-A1FN-01A-11D-A13L-09			TCGA-BH-A1FN-01	TCGA-BH-A1FN-01A-11D-A13L-09		c870e04b-c3b7-495c-8465-7ef2a00fadc7		TCGA-BH-A1FN-01A-11D-A13J-01	TCGA-BH-A1FN-01		c870e04b-c3b7-495c-8465-7ef2a00fadc7	TCGA-BH-A1FN-01A-11D-A13J-01	
TCGA-BH-A1FN-11		34				2192		FEMALE									2192	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FN-11	2192	1	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1FN			days	2192	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Right Upper Outer Quadrant				TCGA-BH-A1FN	TCGA-BH-A1FN-11A		Positive					Positive	Other					-12525	4838	2192	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy		NO				29																																0		true	No	M0	N0	T2	Stage IIA		A1FN	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997	48353101-484c-4d47-ae60-239d710ec00a		48353101-484c-4d47-ae60-239d710ec00a						TCGA-BH-A1FN-11A-34D-A13T-05		BAC42747-AC16-4A8B-A673-236A4F3F0568					TCGA-BH-A1FN-11			48353101-484c-4d47-ae60-239d710ec00a			TCGA-BH-A1FN-11		48353101-484c-4d47-ae60-239d710ec00a		
TCGA-BH-A1FR-01	Stage IIIB	73	1	No_Conversion		4398	Positive	FEMALE	Negative				Negative	M0	Positive	N1	4398	1	LumA		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1FR-01	1642	1	days	Quiet	C3-BRCA/Luminal	cluster 2	KIRC-like c17	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A1FR			days	1642	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Right Upper Inner Quadrant				TCGA-BH-A1FR	TCGA-BH-A1FR-01A		Positive					Positive	Other					-26684	4876	1642	0											2011-9-8	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Core needle biopsy	110	NO				10																						2	1									4		true	No	M0	N1a	T4b	Stage IIIB	TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf	A1FR	WITH TUMOR							YES				Primary Tumor	01	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH	Breast	A	DECEASED	1997	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	8e5ce7fa-08f9-4610-bb85-dd59c335ebbd	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	8e5ce7fa-08f9-4610-bb85-dd59c335ebbd	TCGA-BH-A1FR-01A-21-A17I-20	TCGA-BH-A1FR-01A-11D-A13L-09		TCGA-BH-A1FR-01	TCGA-BH-A1FR-01A-11D-A13K-05		a20031de-1d1e-4019-8d09-d8810bea4462	TCGA-BH-A1FR-01	TCGA-BH-A1FR-01A-11D-A13L-09			TCGA-BH-A1FR-01	TCGA-BH-A1FR-01A-11D-A13L-09		56d5aac4-62b4-43e4-b0e4-f40b19a5893f		TCGA-BH-A1FR-01A-11D-A13J-01	TCGA-BH-A1FR-01		56d5aac4-62b4-43e4-b0e4-f40b19a5893f	TCGA-BH-A1FR-01A-11D-A13J-01	
TCGA-BH-A1FR-11		73				4398		FEMALE									4398	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FR-11	1642	1	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-BH-A1FR			days	1642	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Right Upper Inner Quadrant				TCGA-BH-A1FR			Positive					Positive	Other					-26684		1642	0											2011-9-8	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES		Core needle biopsy						10																																4			No	M0	N1a	T4b	Stage IIIB		A1FR	WITH TUMOR							YES				Solid Tissue Normal	11	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH	Breast		DECEASED	1997	c2db17b1-c288-4f73-8e22-22929d846678		c2db17b1-c288-4f73-8e22-22929d846678						TCGA-BH-A1FR-11B-42D-A13T-05							TCGA-BH-A1FR-11			c2db17b1-c288-4f73-8e22-22929d846678			TCGA-BH-A1FR-11		c2db17b1-c288-4f73-8e22-22929d846678		
TCGA-BH-A1FU-01	Stage IA	44	4	Stage I		2192	Negative	FEMALE	Positive				Negative	M0	Negative	N0	2192	1	Normal		Negative				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FU-01	1688	1	days	Kirc+	C3-BRCA/Luminal	cluster 1	Cluster 5		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-BH-A1FU			days	1688	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant				TCGA-BH-A1FU	TCGA-BH-A1FU-01A		Negative					Negative	Modified Radical Mastectomy					-16174	5041	1688	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110	NO				5																						1	6									0		true	No	M0	N0	T1c	Stage IA	TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf	A1FU	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1997	05a4f4ff-cdfd-4332-8146-066657a4c3cc	7a83fa45-d75d-40c9-a35a-2f6b5e1e70ee	05a4f4ff-cdfd-4332-8146-066657a4c3cc	7a83fa45-d75d-40c9-a35a-2f6b5e1e70ee		TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01	TCGA-BH-A1FU-01A-11D-A14H-05			TCGA-BH-A1FU-01	TCGA-BH-A1FU-01A-11D-A14G-09			TCGA-BH-A1FU-01	TCGA-BH-A1FU-01A-11D-A14G-09		05a4f4ff-cdfd-4332-8146-066657a4c3cc		TCGA-BH-A1FU-01A-11D-A14F-01	TCGA-BH-A1FU-01		05a4f4ff-cdfd-4332-8146-066657a4c3cc	TCGA-BH-A1FU-01A-11D-A14F-01	
TCGA-BH-A1FU-11		44				2192		FEMALE									2192	1	Normal						enrollment			DECEASED	1	TCGA-BH-A1FU-11	1688	1	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-BH-A1FU			days	1688	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant				TCGA-BH-A1FU			Negative					Negative	Modified Radical Mastectomy					-16174		1688	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy						5																																0			No	M0	N0	T1c	Stage IA		A1FU	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast		DECEASED	1997	df661ba2-098b-49e0-884c-27cf2ecd87f2		df661ba2-098b-49e0-884c-27cf2ecd87f2													TCGA-BH-A1FU-11			df661ba2-098b-49e0-884c-27cf2ecd87f2			TCGA-BH-A1FU-11		df661ba2-098b-49e0-884c-27cf2ecd87f2		
TCGA-BH-A201-01		64	5		209		Positive	FEMALE									209	0	LumA		Positive				enrollment			LIVING	0	TCGA-BH-A201-01	856	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation c1uster 9	TCGA-BH-A201	856	0	days	856	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left			TCGA-BH-A201-F64222	TCGA-BH-A201	TCGA-BH-A201-01A		Positive					Positive	Other					-23423	86		0	856										2014-8-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0		true	No	M0	N0	T1	Stage IA	TCGA-BH-A201.6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8.pdf	A201	TUMOR FREE						NO	YES			YES	Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy and wire localization	7th		NO	YES	BH	Breast	A	LIVING	2011	a7050752-eefd-4576-a304-c79dc6fa30e7	f4e002a0-1f2f-4ffd-bff9-8020c931d51b	a7050752-eefd-4576-a304-c79dc6fa30e7	f4e002a0-1f2f-4ffd-bff9-8020c931d51b	TCGA-BH-A201-01A-21-A17I-20	TCGA-BH-A201-01A-11D-A14K-09		TCGA-BH-A201-01	TCGA-BH-A201-01A-11D-A14N-05		27773791-0c8a-421a-9469-3e9b93ce80d2	TCGA-BH-A201-01	TCGA-BH-A201-01A-11D-A14K-09			TCGA-BH-A201-01	TCGA-BH-A201-01A-11D-A14K-09		a7050752-eefd-4576-a304-c79dc6fa30e7		TCGA-BH-A201-01A-11D-A14J-01	TCGA-BH-A201-01		a7050752-eefd-4576-a304-c79dc6fa30e7	TCGA-BH-A201-01A-11D-A14J-01	
TCGA-BH-A202-01		60	2		22		Positive	FEMALE									22	0	LumB		Positive				enrollment			LIVING	0	TCGA-BH-A202-01	795	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-BH-A202	795	0	days	795	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left			TCGA-BH-A202-F64226	TCGA-BH-A202	TCGA-BH-A202-01A		Positive					Positive	Other					-22052	62		0	795										2014-8-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive		NO	4		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0		true	No	M0	N0	T2	Stage II	TCGA-BH-A202.57323AE5-3EFE-4492-8522-D9A6DB3F1BE0.pdf	A202	TUMOR FREE						YES	YES			YES	Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	Breast	A	LIVING	2011	d3169d74-dd69-4c6b-8232-6e15ac2920b9	6a4af154-27d5-4a5d-9d88-1f4db2dc70d8	d3169d74-dd69-4c6b-8232-6e15ac2920b9	6a4af154-27d5-4a5d-9d88-1f4db2dc70d8	TCGA-BH-A202-01A-21-A17K-20	TCGA-BH-A202-01A-11D-A14K-09		TCGA-BH-A202-01	TCGA-BH-A202-01A-11D-A14N-05		c393111f-c4f6-473b-a396-05dd90d531e1	TCGA-BH-A202-01	TCGA-BH-A202-01A-11D-A14K-09			TCGA-BH-A202-01	TCGA-BH-A202-01A-11D-A14K-09		d3169d74-dd69-4c6b-8232-6e15ac2920b9		TCGA-BH-A202-01A-11D-A14J-01	TCGA-BH-A202-01		d3169d74-dd69-4c6b-8232-6e15ac2920b9	TCGA-BH-A202-01A-11D-A14J-01	
TCGA-BH-A203-01		78	3			1174		FEMALE									1174	1	Her2						enrollment			DECEASED	1	TCGA-BH-A203-01	1174	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-BH-A203			days	1174	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right				TCGA-BH-A203	TCGA-BH-A203-01A								Lumpectomy					-28609	5418	1174	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			340	NO				39		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3										35		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A203.3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB.pdf	A203	WITH TUMOR							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1996	ff6fb75e-aefc-44e3-accd-c4f690a51cca	ee9ecf8c-e528-40b6-a196-eb1f2689a397	ff6fb75e-aefc-44e3-accd-c4f690a51cca	ee9ecf8c-e528-40b6-a196-eb1f2689a397	TCGA-BH-A203-01A-21-A17K-20	TCGA-BH-A203-01A-12D-A167-09		TCGA-BH-A203-01	TCGA-BH-A203-01A-12D-A16A-05		570d0406-4cbb-471f-bf26-b07dd4f927cf	TCGA-BH-A203-01	TCGA-BH-A203-01A-12D-A167-09			TCGA-BH-A203-01	TCGA-BH-A203-01A-12D-A167-09		ff6fb75e-aefc-44e3-accd-c4f690a51cca		TCGA-BH-A203-01A-12D-A166-01	TCGA-BH-A203-01		ff6fb75e-aefc-44e3-accd-c4f690a51cca	TCGA-BH-A203-01A-12D-A166-01	
TCGA-BH-A203-11		78				1174		FEMALE									1174	1	Normal						enrollment			DECEASED	1	TCGA-BH-A203-11	1174	1	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-BH-A203			days	1174	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right				TCGA-BH-A203	TCGA-BH-A203-11A								Lumpectomy					-28609	5418	1174	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			480	NO				39		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														35		false	No	M0	N1b	T2	Stage IIB		A203	WITH TUMOR							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996	6e5015d8-55e8-448a-9663-7b8625f170ae		6e5015d8-55e8-448a-9663-7b8625f170ae						TCGA-BH-A203-11A-42D-A16A-05		87EB8632-D2C0-4E37-A707-66410942D9A1					TCGA-BH-A203-11			6e5015d8-55e8-448a-9663-7b8625f170ae			TCGA-BH-A203-11		6e5015d8-55e8-448a-9663-7b8625f170ae		
TCGA-BH-A204-01		80	4			2534		FEMALE									2534	1	LumB						enrollment			DECEASED	1	TCGA-BH-A204-01	2534	1	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 14	TCGA-BH-A204			days	2534	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left				TCGA-BH-A204	TCGA-BH-A204-01A								Modified Radical Mastectomy					-29529	5538	2534	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	420	NO				16		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3										2		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf	A204								YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1996	19c3c4c7-d34c-47d5-b09f-c5671f49b858	88bb74ad-b634-48d4-a342-83850d37069a	19c3c4c7-d34c-47d5-b09f-c5671f49b858	88bb74ad-b634-48d4-a342-83850d37069a	TCGA-BH-A204-01A-21-A17K-20	TCGA-BH-A204-01A-11D-A159-09		TCGA-BH-A204-01	TCGA-BH-A204-01A-11D-A161-05		6bf2c85b-1783-4017-9305-e1f18c0e7645	TCGA-BH-A204-01	TCGA-BH-A204-01A-11D-A159-09			TCGA-BH-A204-01	TCGA-BH-A204-01A-11D-A159-09		19c3c4c7-d34c-47d5-b09f-c5671f49b858		TCGA-BH-A204-01A-11D-A160-01	TCGA-BH-A204-01		19c3c4c7-d34c-47d5-b09f-c5671f49b858	TCGA-BH-A204-01A-11D-A160-01	
TCGA-BH-A204-11		80				2534		FEMALE									2534	1	Normal						enrollment			DECEASED	1	TCGA-BH-A204-11	2534	1	days		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A204			days	2534	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left				TCGA-BH-A204	TCGA-BH-A204-11A								Modified Radical Mastectomy					-29529	5538	2534	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	450	NO				16		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														2		false	No	M0	N1b	T2	Stage IIB		A204								YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996	6b52803e-274b-4a1b-910f-2d307932bbb2		6b52803e-274b-4a1b-910f-2d307932bbb2						TCGA-BH-A204-11A-53D-A161-05							TCGA-BH-A204-11			6b52803e-274b-4a1b-910f-2d307932bbb2			TCGA-BH-A204-11		6b52803e-274b-4a1b-910f-2d307932bbb2		
TCGA-BH-A208-01		48	3			1759		FEMALE									1759	1	Normal						enrollment			DECEASED	1	TCGA-BH-A208-01	1759	1	days	High	C3-BRCA/Luminal	cluster 5	OV-like c1	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 11		mutation cluster 8	TCGA-BH-A208			days	1759	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left				TCGA-BH-A208	TCGA-BH-A208-01A								Lumpectomy					-17715	5893	1759	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	620	NO				15																						5										3		true	No	M0	N1b	T2	Stage IIB	TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf	A208	TUMOR FREE							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1995	7a276d04-8f45-4c07-9c24-8b1f50a1202d	c2ab364e-16f8-47de-a506-35ec95fcd29d	7a276d04-8f45-4c07-9c24-8b1f50a1202d	c2ab364e-16f8-47de-a506-35ec95fcd29d	TCGA-BH-A208-01A-21-A17K-20	TCGA-BH-A208-01A-11D-A159-09		TCGA-BH-A208-01	TCGA-BH-A208-01A-11D-A161-05		20175b85-f502-4712-aa9d-f3a96c5921f8	TCGA-BH-A208-01	TCGA-BH-A208-01A-11D-A159-09			TCGA-BH-A208-01	TCGA-BH-A208-01A-11D-A159-09		7a276d04-8f45-4c07-9c24-8b1f50a1202d		TCGA-BH-A208-01A-11D-A160-01	TCGA-BH-A208-01		7a276d04-8f45-4c07-9c24-8b1f50a1202d	TCGA-BH-A208-01A-11D-A160-01	
TCGA-BH-A208-11		48				1759		FEMALE									1759	1	Normal						enrollment			DECEASED	1	TCGA-BH-A208-11	1759	1	days		C3-BRCA/Luminal							mutation cluster 8	TCGA-BH-A208			days	1759	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left				TCGA-BH-A208	TCGA-BH-A208-11A								Lumpectomy					-17715	5893	1759	0											2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	920	NO				15																																3		false	No	M0	N1b	T2	Stage IIB		A208	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1995	a0ac3d9f-7700-4319-929a-fb51d85c9d49		a0ac3d9f-7700-4319-929a-fb51d85c9d49						TCGA-BH-A208-11A-51D-A161-05		CE2C9C0F-7CD7-4C05-AF2F-85D4552F8183					TCGA-BH-A208-11			a0ac3d9f-7700-4319-929a-fb51d85c9d49			TCGA-BH-A208-11		a0ac3d9f-7700-4319-929a-fb51d85c9d49		
TCGA-BH-A209-01		77	4			3959	Positive	FEMALE									3959	1	LumB		Positive				enrollment			DECEASED	1	TCGA-BH-A209-01	3959	1	days	High	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 14	TCGA-BH-A209			days	3959	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left Upper Outer Quadrant				TCGA-BH-A209	TCGA-BH-A209-01A		Positive					Positive	Lumpectomy					-28403	5392	3959	0											2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	390	NO				12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3										0		true	No	M0	N0	T1c	Stage I	TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf	A209	TUMOR FREE							YES				Primary Tumor	01		5th		NO	YES	BH	Breast	A	DECEASED	1996	9073fc5c-a281-4ed2-a66e-5235a5a55098	7e96d825-cf43-4caa-b6be-9a972e9295f3	9073fc5c-a281-4ed2-a66e-5235a5a55098	7e96d825-cf43-4caa-b6be-9a972e9295f3	TCGA-BH-A209-01A-21-A17K-20	TCGA-BH-A209-01A-11D-A17G-09		TCGA-BH-A209-01	TCGA-BH-A209-01A-11D-A161-05		f89486f5-6292-40bd-a4af-ff27eae691aa	TCGA-BH-A209-01	TCGA-BH-A209-01A-11D-A17G-09			TCGA-BH-A209-01	TCGA-BH-A209-01A-11D-A17G-09		9073fc5c-a281-4ed2-a66e-5235a5a55098		TCGA-BH-A209-01A-11D-A160-01	TCGA-BH-A209-01		9073fc5c-a281-4ed2-a66e-5235a5a55098	TCGA-BH-A209-01A-11D-A160-01	
TCGA-BH-A209-11		77				3959		FEMALE									3959	1	Normal						enrollment			DECEASED	1	TCGA-BH-A209-11	3959	1	days		C3-BRCA/Luminal							mutation cluster 14	TCGA-BH-A209			days	3959	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left Upper Outer Quadrant				TCGA-BH-A209	TCGA-BH-A209-11A		Positive					Positive	Lumpectomy					-28403	5392	3959	0											2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	400	NO				12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														0		false	No	M0	N0	T1c	Stage I		A209	TUMOR FREE							YES				Solid Tissue Normal	11		5th		NO	YES	BH	Breast	A	DECEASED	1996	7a4e994d-ed10-45e7-9107-51dc02068963		7a4e994d-ed10-45e7-9107-51dc02068963						TCGA-BH-A209-11A-42D-A161-05							TCGA-BH-A209-11			7a4e994d-ed10-45e7-9107-51dc02068963			TCGA-BH-A209-11		7a4e994d-ed10-45e7-9107-51dc02068963		
TCGA-BH-A28O-01																													0	TCGA-BH-A28O-01	1120	0	days	Quiet			Low purity c2			miRNA cluster 4			TCGA-BH-A28O	1120	0	days	1120	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A28O-F64237	TCGA-BH-A28O	TCGA-BH-A28O-01A		Positive					Positive	Other		NO			-18501	163		0	1120					NO					2014-8-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative		NO	14	Negative																														NO	14		true	No	M0	N3	T3a	Stage IIIC	TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf	A28O	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Segmental mastectomy	7th		YES	NO	BH	Breast	A	LIVING	2010	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	1ffca953-dced-4469-959f-307bb3670a56	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	1ffca953-dced-4469-959f-307bb3670a56				TCGA-BH-A28O-01	TCGA-BH-A28O-01A-11D-A22B-05			TCGA-BH-A28O-01	TCGA-BH-A28O-01A-11D-A228-09			TCGA-BH-A28O-01			7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b		TCGA-BH-A28O-01A-11D-A227-01	TCGA-BH-A28O-01		7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	TCGA-BH-A28O-01A-11D-A227-01	
TCGA-BH-A28Q-01		46	2		196		Positive	FEMALE									196	0	LumA		Positive				enrollment			LIVING	0	TCGA-BH-A28Q-01	1119	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3		mutation c1uster 9	TCGA-BH-A28Q	1119	0	days	1119	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right			TCGA-BH-A28Q-F64272	TCGA-BH-A28Q	TCGA-BH-A28Q-01A		Positive					Positive	Modified Radical Mastectomy					-16882	223		0	1119										2014-8-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	400	NO	Negative	Indeterminate	NO	18		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf	A28Q	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		NO	YES	BH	Breast	A	LIVING	2010	5427eb83-38f3-4258-b241-25efae8fa70a	f40a7b59-1b58-45d6-940b-3b33b6ca261a	5427eb83-38f3-4258-b241-25efae8fa70a	f40a7b59-1b58-45d6-940b-3b33b6ca261a	TCGA-BH-A28Q-01A-21-A17K-20	TCGA-BH-A28Q-01A-11D-A16D-09		TCGA-BH-A28Q-01	TCGA-BH-A28Q-01A-11D-A16G-05		45d40b9a-e057-4d32-b7f5-46d9d4e89d89	TCGA-BH-A28Q-01	TCGA-BH-A28Q-01A-11D-A16D-09			TCGA-BH-A28Q-01	TCGA-BH-A28Q-01A-11D-A16D-09		5427eb83-38f3-4258-b241-25efae8fa70a		TCGA-BH-A28Q-01A-11D-A16C-01	TCGA-BH-A28Q-01		5427eb83-38f3-4258-b241-25efae8fa70a	TCGA-BH-A28Q-01A-11D-A16C-01	
TCGA-BH-A2L8-01																			LumA										0	TCGA-BH-A2L8-01	612	0	days	Kirc+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-BH-A2L8	612	0	days	612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A2L8-F39616	TCGA-BH-A2L8	TCGA-BH-A2L8-01A		Positive					Positive	Other		NO			-16658	86		0	612					NO		70-79%			2013-1-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO	Negative	Negative	NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-BH-A2L8.B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD.pdf	A2L8	TUMOR FREE				Oncotype Dx test	Oncotype Dx test	YES	YES	80-89%		NO	Primary Tumor	01	TOTAL MASTECTOMY	7th		YES	NO	BH	Breast	A	LIVING	2011	c55bb0b8-3417-4142-97f8-c43f1ec56496	cf4b7782-45d9-4dfc-b36d-af59befa7c03	c55bb0b8-3417-4142-97f8-c43f1ec56496	cf4b7782-45d9-4dfc-b36d-af59befa7c03	TCGA-BH-A2L8-01A-21-A24A-20			TCGA-BH-A2L8-01	TCGA-BH-A2L8-01A-11D-A18O-05		0c505acf-0d07-4d38-a4cb-ad0311c255b3	TCGA-BH-A2L8-01	TCGA-BH-A2L8-01A-11D-A18P-09			TCGA-BH-A2L8-01			c55bb0b8-3417-4142-97f8-c43f1ec56496		TCGA-BH-A2L8-01A-11D-A18N-01	TCGA-BH-A2L8-01		c55bb0b8-3417-4142-97f8-c43f1ec56496	TCGA-BH-A2L8-01A-11D-A18N-01	
TCGA-BH-A42T-01																													1	TCGA-BH-A42T-01	320	1	days										TCGA-BH-A42T	320	0	days	320	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left	Sentinel node biopsy alone		TCGA-BH-A42T-F61922	TCGA-BH-A42T	TCGA-BH-A42T-01A		Positive					Positive	Simple Mastectomy					-27731	80	320	0	30										2014-7-10	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO	Positive	Equivocal	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO		1	true	No	M0	N0 (i+)	T2	Stage IIA	TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf	A42T	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	DECEASED	2012	59b2f0cb-4789-4642-9aa6-605a1ebb0e32	a91f1e9c-3bb5-4b46-b62c-ae39f70f183f	59b2f0cb-4789-4642-9aa6-605a1ebb0e32	a91f1e9c-3bb5-4b46-b62c-ae39f70f183f				TCGA-BH-A42T-01	TCGA-BH-A42T-01A-11D-A244-05		be2031ff-59ba-4ee0-aa0e-9831692a949f	TCGA-BH-A42T-01	TCGA-BH-A42T-01A-11D-A243-09			TCGA-BH-A42T-01			59b2f0cb-4789-4642-9aa6-605a1ebb0e32		TCGA-BH-A42T-01A-11D-A242-01	TCGA-BH-A42T-01		59b2f0cb-4789-4642-9aa6-605a1ebb0e32	TCGA-BH-A42T-01A-11D-A242-01	
TCGA-BH-A42U-01																													0	TCGA-BH-A42U-01	3364	0	days										TCGA-BH-A42U	3364	0	days	3364	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right			TCGA-BH-A42U-F61923	TCGA-BH-A42U	TCGA-BH-A42U-01A		Negative					Negative	Simple Mastectomy					-29330	3080		0	3364										2014-7-10	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	290	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			true	No	M0	N0	T2	Stage IIA	TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf	A42U	TUMOR FREE						NO	YES			NO	Primary Tumor	01		6th		YES	NO	BH	Breast	A	LIVING	2004	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	ede65d88-d290-4017-b9d7-9be40d87e6b0	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	ede65d88-d290-4017-b9d7-9be40d87e6b0				TCGA-BH-A42U-01	TCGA-BH-A42U-01A-12D-A244-05		6bab8423-84c9-41ec-88f7-5efcfcc1ab30	TCGA-BH-A42U-01	TCGA-BH-A42U-01A-12D-A243-09			TCGA-BH-A42U-01			b3ce7ee4-fc5e-445c-b1ca-5f324b33678a		TCGA-BH-A42U-01A-12D-A242-01	TCGA-BH-A42U-01		b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	TCGA-BH-A42U-01A-12D-A242-01	
TCGA-BH-A42V-01																													0	TCGA-BH-A42V-01	635	0	days										TCGA-BH-A42V	635	0	days	635	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-BH-A42V-F61941	TCGA-BH-A42V	TCGA-BH-A42V-01A	Negative	Positive				Other	Positive	Modified Radical Mastectomy	Reexcision of segmental mastectomy				-15158	197		0	635										2014-7-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	3	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1mi	T1c	Stage IB	TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf	A42V	TUMOR FREE						NO	YES			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	2fa59be9-ecde-49b2-b109-7000d5180847	6803e7ad-1c44-43ac-999a-05ec8bc5138e	2fa59be9-ecde-49b2-b109-7000d5180847	6803e7ad-1c44-43ac-999a-05ec8bc5138e				TCGA-BH-A42V-01	TCGA-BH-A42V-01A-11D-A244-05		719aaf42-d96b-466f-b6ac-40439aec2138	TCGA-BH-A42V-01	TCGA-BH-A42V-01A-11D-A243-09			TCGA-BH-A42V-01			2fa59be9-ecde-49b2-b109-7000d5180847		TCGA-BH-A42V-01A-11D-A242-01	TCGA-BH-A42V-01		2fa59be9-ecde-49b2-b109-7000d5180847	TCGA-BH-A42V-01A-11D-A242-01	
TCGA-BH-A5IZ-01																													0	TCGA-BH-A5IZ-01	567	0	days										TCGA-BH-A5IZ	567	0	days	567	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left			TCGA-BH-A5IZ-F63663	TCGA-BH-A5IZ	TCGA-BH-A5IZ-01A		Positive					Negative	Lumpectomy					-18927	140		0	567										2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	cM0 (i+)	N1a	T2	Stage IIB	TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf	A5IZ	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	39033a17-79c9-4723-9fa7-fa82f67f5344	368b8969-b847-4f91-8054-231f26eb565d	39033a17-79c9-4723-9fa7-fa82f67f5344	368b8969-b847-4f91-8054-231f26eb565d				TCGA-BH-A5IZ-01	TCGA-BH-A5IZ-01A-11D-A27Y-05			TCGA-BH-A5IZ-01	TCGA-BH-A5IZ-01A-11D-A27P-09			TCGA-BH-A5IZ-01			39033a17-79c9-4723-9fa7-fa82f67f5344		TCGA-BH-A5IZ-01A-11D-A27O-01	TCGA-BH-A5IZ-01		39033a17-79c9-4723-9fa7-fa82f67f5344	TCGA-BH-A5IZ-01A-11D-A27O-01	
TCGA-BH-A5J0-01																													0	TCGA-BH-A5J0-01	715	0	days										TCGA-BH-A5J0	715	0	days	715	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left			TCGA-BH-A5J0-F63664	TCGA-BH-A5J0	TCGA-BH-A5J0-01A		Positive					Positive	Simple Mastectomy					-23072	184		0	715										2014-8-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-BH-A5J0.80DA141E-2752-4464-8D23-06DC7E9B05FE.pdf	A5J0	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	57be94f9-39e9-4dbd-982c-78fc7cb9bdda	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	57be94f9-39e9-4dbd-982c-78fc7cb9bdda				TCGA-BH-A5J0-01	TCGA-BH-A5J0-01A-11D-A27Y-05			TCGA-BH-A5J0-01	TCGA-BH-A5J0-01A-11D-A27P-09			TCGA-BH-A5J0-01			a5f14d53-fe35-494e-b6b1-bc5c8484e4a9		TCGA-BH-A5J0-01A-11D-A27O-01	TCGA-BH-A5J0-01		a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	TCGA-BH-A5J0-01A-11D-A27O-01	
TCGA-BH-A6R8-01																													0	TCGA-BH-A6R8-01	293	0	days										TCGA-BH-A6R8	293	0	days	293	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left			TCGA-BH-A6R8-F63677	TCGA-BH-A6R8	TCGA-BH-A6R8-01A		Positive					Positive	Lumpectomy					-16829	260		0	293										2014-8-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative	NO	4	Negative																														NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf	A6R8	TUMOR FREE						NO	YES			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	2bea5d05-bcad-4a2e-8954-462b589a8aa4	7304a16f-da9e-4769-90e7-8bf1439fbfb1	2bea5d05-bcad-4a2e-8954-462b589a8aa4	7304a16f-da9e-4769-90e7-8bf1439fbfb1				TCGA-BH-A6R8-01	TCGA-BH-A6R8-01A-21D-A33F-05		C23EA212-403F-44F3-B3BC-8F07229D7006	TCGA-BH-A6R8-01				TCGA-BH-A6R8-01			2bea5d05-bcad-4a2e-8954-462b589a8aa4		TCGA-BH-A6R8-01A-21D-A33D-01	TCGA-BH-A6R8-01		2bea5d05-bcad-4a2e-8954-462b589a8aa4	TCGA-BH-A6R8-01A-21D-A33D-01	
TCGA-BH-A6R9-01																													0	TCGA-BH-A6R9-01	160	0	days										TCGA-BH-A6R9	160	0	days	160	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left			TCGA-BH-A6R9-F63678	TCGA-BH-A6R9	TCGA-BH-A6R9-01A		Negative					Positive	Modified Radical Mastectomy					-22325	237		0	160										2014-8-15	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	220	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			true	No	M0	N0	T2	Stage IIA	TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf	A6R9	TUMOR FREE						NO				NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	11010d89-eaee-41ba-b77b-cf1ac4f893a8	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	11010d89-eaee-41ba-b77b-cf1ac4f893a8				TCGA-BH-A6R9-01	TCGA-BH-A6R9-01A-21D-A32T-05		8C499FE0-D3D8-41FD-9E45-679C3403942C	TCGA-BH-A6R9-01				TCGA-BH-A6R9-01			7c73dae6-4478-4cbc-aee1-0b18e730f7a2		TCGA-BH-A6R9-01A-21D-A32H-01	TCGA-BH-A6R9-01		7c73dae6-4478-4cbc-aee1-0b18e730f7a2	TCGA-BH-A6R9-01A-21D-A32H-01	
TCGA-BH-A8FY-01																													1	TCGA-BH-A8FY-01	295	1	days										TCGA-BH-A8FY	295	0	days	295	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					87	Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant				TCGA-BH-A8FY	TCGA-BH-A8FY-01A		Positive					Positive	Simple Mastectomy					-31932	477	295	0											2014-3-25	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			200	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	Yes	M0	N0 (i+)	T1c	Stage IA	TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf	A8FY	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	DECEASED	2012	f037b9d3-819b-429d-8e2d-fa8b27008e70	4ef71edc-9943-4036-a5e7-64d996970137	f037b9d3-819b-429d-8e2d-fa8b27008e70	4ef71edc-9943-4036-a5e7-64d996970137				TCGA-BH-A8FY-01	TCGA-BH-A8FY-01A-11D-A36K-05		12726541-C142-46CD-8AE1-763DAC0943B7	TCGA-BH-A8FY-01				TCGA-BH-A8FY-01			f037b9d3-819b-429d-8e2d-fa8b27008e70		TCGA-BH-A8FY-01A-11D-A36I-01	TCGA-BH-A8FY-01		f037b9d3-819b-429d-8e2d-fa8b27008e70	TCGA-BH-A8FY-01A-11D-A36I-01	
TCGA-BH-A8FZ-01																													0	TCGA-BH-A8FZ-01	574	0	days										TCGA-BH-A8FZ	574	0	days	574	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left			TCGA-BH-A8FZ-F63679	TCGA-BH-A8FZ	TCGA-BH-A8FZ-01A		Positive					Positive	Simple Mastectomy					-21343	468		0	574										2014-8-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal		NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T1b	Stage IA	TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf	A8FZ	TUMOR FREE						NO	YES			YES	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	2281c64c-9394-44f6-a4e7-87c7cce08c13	4a98eb15-a60d-4e8b-8aab-31ca9286549a	2281c64c-9394-44f6-a4e7-87c7cce08c13	4a98eb15-a60d-4e8b-8aab-31ca9286549a				TCGA-BH-A8FZ-01	TCGA-BH-A8FZ-01A-11D-A357-05		2B0ED842-B3E6-42E2-9A1E-7D4F96EF2E9D	TCGA-BH-A8FZ-01				TCGA-BH-A8FZ-01			2281c64c-9394-44f6-a4e7-87c7cce08c13		TCGA-BH-A8FZ-01A-11D-A350-01	TCGA-BH-A8FZ-01		2281c64c-9394-44f6-a4e7-87c7cce08c13	TCGA-BH-A8FZ-01A-11D-A350-01	
TCGA-BH-A8G0-01																													0	TCGA-BH-A8G0-01	662	0	days										TCGA-BH-A8G0	662	0	days	662	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left			TCGA-BH-A8G0-F64200	TCGA-BH-A8G0	TCGA-BH-A8G0-01A		Positive					Positive	Simple Mastectomy					-19975	436		0	662										2014-8-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	3	Negative	Peri (6-12 months since last menstrual period)																													NO	3		true	No	M0	N1a	T2	Stage IIB	TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf	A8G0	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2012	8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	4cd7d2c1-0d36-493c-8b3b-7c4148899fdc	8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	4cd7d2c1-0d36-493c-8b3b-7c4148899fdc				TCGA-BH-A8G0-01	TCGA-BH-A8G0-01A-11D-A357-05		A05330AE-C933-4E90-941C-2063295F9A7A	TCGA-BH-A8G0-01				TCGA-BH-A8G0-01			8e9f7a7a-3115-4687-9fce-a97e4c3c9cde		TCGA-BH-A8G0-01A-11D-A350-01	TCGA-BH-A8G0-01		8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	TCGA-BH-A8G0-01A-11D-A350-01	
TCGA-BH-AB28-01																													0	TCGA-BH-AB28-01	287	0	days										TCGA-BH-AB28	287	0	days	287	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left			TCGA-BH-AB28-F64209	TCGA-BH-AB28	TCGA-BH-AB28-01A		Positive					Positive	Modified Radical Mastectomy					-19570	105		0	287										2015-2-25	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	440	NO	Negative	Indeterminate	NO	20	Negative																														NO	3		true	No	M0	N1a	T3	Stage IIIA	TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf	AB28	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	BH	Breast	A	LIVING	2013	3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	0edc855f-8b77-4822-980f-61d2547a588a	3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	0edc855f-8b77-4822-980f-61d2547a588a				TCGA-BH-AB28-01	TCGA-BH-AB28-01A-31D-A41Q-05			TCGA-BH-AB28-01				TCGA-BH-AB28-01			3cf4fddd-7fb5-4bb6-bca8-412019df4e2d		TCGA-BH-AB28-01A-31D-A41E-01	TCGA-BH-AB28-01		3cf4fddd-7fb5-4bb6-bca8-412019df4e2d	TCGA-BH-AB28-01A-31D-A41E-01	
TCGA-C8-A12K-01	Stage IIB	80	1	No_Conversion	0			FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	0	0	Basal	Basal-like		Basal	-13	-12	enrollment	T_Other	T2	LIVING		TCGA-C8-A12K-01			days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 3	mutation cluster 8	TCGA-C8-A12K			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Upper Inner Quadrant	Other (specify)	Pateys surgery		TCGA-C8-A12K	TCGA-C8-A12K-01A								Other		NO			-29463	57		0	0										2011-4-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	970	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3									1		true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf	A12K	TUMOR FREE											Primary Tumor	01	Pateys surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	cab482fe-e5e3-438a-8ece-322111d17c4b	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	cab482fe-e5e3-438a-8ece-322111d17c4b	TCGA-C8-A12K-01A-11-A13D-20	TCGA-C8-A12K-01A-21D-A10Y-09		TCGA-C8-A12K-01			5daae9b4-734a-479f-a414-50e0629a8598	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21D-A10Y-09	TCGA-C8-A12K-01A-21D-A112-05	TCGA-C8-A12K-01	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21D-A10Y-09		0ef00203-8a0a-4d04-aa1e-c1164958d8ec		TCGA-C8-A12K-01A-21D-A111-01	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21R-A115-07	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	TCGA-C8-A12K-01A-21D-A111-01	TCGA-C8-A12K-01
TCGA-C8-A12L-01	Stage IIA	67	1	Stage IIA	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Negative	Her2	-11	-9	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12L-01	363	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A12L	363	0	days	363	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Axillary lymph node dissection alone		TCGA-C8-A12L-F20258	TCGA-C8-A12L	TCGA-C8-A12L-01A		Negative					Negative	Other					-24710	62		0	363									Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Suregery	Other method, specify:	460	NO	Equivocal			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO			true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12L.150DD5CB-1CA0-4110-95A7-6476B5B6FC24.pdf	A12L	TUMOR FREE										NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	0a5a7511-4e7b-4fe4-b323-c354acffab57	3cd311fc-51df-4b20-9c27-fabb68bc3e2c	0a5a7511-4e7b-4fe4-b323-c354acffab57	3cd311fc-51df-4b20-9c27-fabb68bc3e2c	TCGA-C8-A12L-01A-21-A13D-20	TCGA-C8-A12L-01A-11D-A10Y-09		TCGA-C8-A12L-01			f9312b49-d0bf-45d8-b6b1-96b3752475e7	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11D-A10Y-09	TCGA-C8-A12L-01A-11D-A112-05	TCGA-C8-A12L-01	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11D-A10Y-09		0a5a7511-4e7b-4fe4-b323-c354acffab57		TCGA-C8-A12L-01A-11D-A111-01	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11R-A115-07	0a5a7511-4e7b-4fe4-b323-c354acffab57	TCGA-C8-A12L-01A-11D-A111-01	TCGA-C8-A12L-01
TCGA-C8-A12M-01	Stage IIA	70	5	Stage IIA	0		Positive	FEMALE		4	1	4	Negative	M0	Negative	N0	0	0	LumB	Luminal B	Negative	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12M-01	358	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-C8-A12M	358	0	days	358	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left	Axillary lymph node dissection alone		TCGA-C8-A12M-F19093	TCGA-C8-A12M	TCGA-C8-A12M-01A		Positive					Negative	Other					-25811	57		0	358									Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	510	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO			true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12M.76F67AA2-4E17-48F5-810B-E4F4338902DC.pdf	A12M	TUMOR FREE					Allred Score 8					NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	8f007e7a-6260-4ecc-baff-f68665b760cb	29a000d7-43d4-4f30-b63b-35836f20384a	8f007e7a-6260-4ecc-baff-f68665b760cb	29a000d7-43d4-4f30-b63b-35836f20384a	TCGA-C8-A12M-01A-21-A13D-20	TCGA-C8-A12M-01A-11D-A135-09		TCGA-C8-A12M-01			abdef80c-32bb-4620-95d2-16d985cd20f0	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11D-A135-09	TCGA-C8-A12M-01A-11D-A112-05	TCGA-C8-A12M-01	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11D-A135-09		8f007e7a-6260-4ecc-baff-f68665b760cb		TCGA-C8-A12M-01A-11D-A111-01	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11R-A115-07	8f007e7a-6260-4ecc-baff-f68665b760cb	TCGA-C8-A12M-01A-11D-A111-01	TCGA-C8-A12M-01
TCGA-C8-A12N-01	Stage IIA	58	4	Stage IIA	0		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	ReacI	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12N-01	358	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-C8-A12N	358	0	days	358	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right	Axillary lymph node dissection alone		TCGA-C8-A12N-F20264	TCGA-C8-A12N	TCGA-C8-A12N-01A		Positive					Positive	Other					-21428	57		0	358									Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	290	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO			true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12N.A845013D-BF15-42FB-8BFE-FCE206E943FE.pdf	A12N	TUMOR FREE				Allread Score 8	Allred Score 8					NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	48becee8-1c71-4320-b0e8-72e345797daf	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	48becee8-1c71-4320-b0e8-72e345797daf	TCGA-C8-A12N-01A-21-A13D-20	TCGA-C8-A12N-01A-11D-A10Y-09		TCGA-C8-A12N-01			8e2ac007-601d-45c4-a94c-3cefb96b8f99	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11D-A10Y-09	TCGA-C8-A12N-01A-11D-A112-05	TCGA-C8-A12N-01	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11D-A10Y-09		9eb3306d-6c84-4bc1-be42-4bd00ef46cbb		TCGA-C8-A12N-01A-11D-A111-01	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11R-A115-07	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	TCGA-C8-A12N-01A-11D-A111-01	TCGA-C8-A12N-01
TCGA-C8-A12O-01	Stage IIA	50		Stage IIA	0		Positive	FEMALE					Negative	M0	Negative	N0	0	0	LumA	Luminal A	Positive	Her2	-2	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12O-01	385	0	days		C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A12O	385	0	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left	Axillary lymph node dissection alone		TCGA-C8-A12O-F20261	TCGA-C8-A12O	TCGA-C8-A12O-01A		Positive					Positive	Other					-18506	57		0	385									Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	650	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO			true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-C8-A12O.273152AA-7B4C-4AE5-9231-1A3160058C74.pdf	A12O	TUMOR FREE				Allred Score 7	Allred Score 7					NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	5efabaa8-f296-4c9c-9632-559ef7f6dd44	0c86eab9-cfc8-4a03-823b-4331c43d2038	5efabaa8-f296-4c9c-9632-559ef7f6dd44	0c86eab9-cfc8-4a03-823b-4331c43d2038	TCGA-C8-A12O-01A-21-A13D-20	TCGA-C8-A12O-01A-11D-A10Y-09		TCGA-C8-A12O-01			834cc759-8dcd-4d51-9570-aef1622b90e1	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11D-A10Y-09	TCGA-C8-A12O-01A-11D-A112-05	TCGA-C8-A12O-01	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11D-A10Y-09		5efabaa8-f296-4c9c-9632-559ef7f6dd44		TCGA-C8-A12O-01A-11D-A111-01	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11R-A115-07	5efabaa8-f296-4c9c-9632-559ef7f6dd44	TCGA-C8-A12O-01A-11D-A111-01	TCGA-C8-A12O-01
TCGA-C8-A12P-01	Stage IIB	55	3	No_Conversion	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	0	0	Her2	HER2-enriched	Negative	Her2	-11	-10	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12P-01	358	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12P	358	0	days	358	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left			TCGA-C8-A12P-F20267	TCGA-C8-A12P	TCGA-C8-A12P-01A		Negative					Negative	Other					-20332	57		0	358									Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	380	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12P.F04324BB-F0B1-4948-9189-7833646029F1.pdf	A12P	TUMOR FREE										NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	9e30b9ee-391d-40d9-8eba-de47656f3629	cf2aac8b-1f32-4f0c-91f6-4b80c38d4419	9e30b9ee-391d-40d9-8eba-de47656f3629	cf2aac8b-1f32-4f0c-91f6-4b80c38d4419	TCGA-C8-A12P-01A-21-A13D-20	TCGA-C8-A12P-01A-11D-A10Y-09		TCGA-C8-A12P-01			a3b71b2e-5bb6-4585-95e7-6a2ddbf99659	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11D-A10Y-09	TCGA-C8-A12P-01A-11D-A112-05	TCGA-C8-A12P-01	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11D-A10Y-09		9e30b9ee-391d-40d9-8eba-de47656f3629		TCGA-C8-A12P-01A-11D-A111-01	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11R-A115-07	9e30b9ee-391d-40d9-8eba-de47656f3629	TCGA-C8-A12P-01A-11D-A111-01	TCGA-C8-A12P-01
TCGA-C8-A12Q-01	Stage IIIA	78	5	No_Conversion	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N2	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T1	T1	LIVING	1	TCGA-C8-A12Q-01	385	1	days	High	C3-BRCA/Luminal	cluster 2	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12Q			days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		78	Left	Axillary lymph node dissection alone		TCGA-C8-A12Q-F20253	TCGA-C8-A12Q	TCGA-C8-A12Q-01A		Negative					Negative	Other					-28733	57	385	0	2									Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	810	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4				Liver	Distant Metastasis			YES			true	No	M0	N2	T1	Stage IIIA	TCGA-C8-A12Q.90AF32F0-5684-4D5B-B619-2B12DA3823C6.pdf	A12Q	WITH TUMOR										NO	Primary Tumor	01	Pateys Surgery		NO	YES	NO	C8	Breast	A	DECEASED	2010	e042ea6d-3204-41a7-9811-25f4ac0c3558	586f3601-cf46-45d6-9efd-a80482519e58	e042ea6d-3204-41a7-9811-25f4ac0c3558	586f3601-cf46-45d6-9efd-a80482519e58	TCGA-C8-A12Q-01A-21-A13D-20	TCGA-C8-A12Q-01A-11D-A10Y-09		TCGA-C8-A12Q-01			588f723a-3e25-4cdc-91f6-36d00bb179e5	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01A-11D-A112-05	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A10Y-09		e042ea6d-3204-41a7-9811-25f4ac0c3558		TCGA-C8-A12Q-01A-11D-A111-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11R-A115-07	e042ea6d-3204-41a7-9811-25f4ac0c3558	TCGA-C8-A12Q-01A-11D-A111-01	TCGA-C8-A12Q-01
TCGA-C8-A12T-01	Stage IIA	43	4	Stage IIA	0		Positive	FEMALE	Positive	1	1	1	Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Positive	ReacII	-2	-1	enrollment	T_Other	T2	LIVING		TCGA-C8-A12T-01			days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-C8-A12T			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left	Axillary lymph node dissection alone			TCGA-C8-A12T	TCGA-C8-A12T-01A		Positive					Positive	Other		NO				51		0	0					NO					2011-4-11	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	540	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4									0		true	No	M0	N0	T2	Stage IIA	TCGA-C8-A12T.4D751232-CD64-468E-AEBF-46F94FB6281F.pdf	A12T	TUMOR FREE				Allred Score 8	Allred Score 6		YES				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	c13962b2-674a-4edc-a7c8-c077ab86d198	f4b9a452-bbf8-4130-850b-1c9b503ef0e5	c13962b2-674a-4edc-a7c8-c077ab86d198	f4b9a452-bbf8-4130-850b-1c9b503ef0e5	TCGA-C8-A12T-01A-21-A13D-20	TCGA-C8-A12T-01A-11D-A10Y-09		TCGA-C8-A12T-01			08bd259e-9a37-4dd1-b97c-c67f288f833e	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11D-A10Y-09	TCGA-C8-A12T-01A-11D-A112-05	TCGA-C8-A12T-01	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11D-A10Y-09		c13962b2-674a-4edc-a7c8-c077ab86d198		TCGA-C8-A12T-01A-11D-A111-01	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11R-A115-07	c13962b2-674a-4edc-a7c8-c077ab86d198	TCGA-C8-A12T-01A-11D-A111-01	TCGA-C8-A12T-01
TCGA-C8-A12U-01	Stage IB	46	5	Stage IIB	0		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	0	0	LumB	Luminal B	Positive	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12U-01	385	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 4	TCGA-C8-A12U	385	0	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right	Axillary lymph node dissection alone		TCGA-C8-A12U-F20249	TCGA-C8-A12U	TCGA-C8-A12U-01A		Positive					Positive	Other					-17045	57		0	385					NO				Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	580	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	5								NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12U.B6428344-2D68-404B-AD9F-CA6E0B0552B2.pdf	A12U	TUMOR FREE				Allred Score 3	Allred Score 5		YES			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	803bb42f-e0f2-44b6-aebb-8f956646ecc7	ad305034-cc87-4557-9031-a50710646810	803bb42f-e0f2-44b6-aebb-8f956646ecc7	ad305034-cc87-4557-9031-a50710646810	TCGA-C8-A12U-01A-21-A13D-20	TCGA-C8-A12U-01A-11D-A10Y-09		TCGA-C8-A12U-01			671835d4-23bb-4945-a62a-26d5f9094325	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11D-A10Y-09	TCGA-C8-A12U-01A-11D-A112-05	TCGA-C8-A12U-01	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11D-A10Y-09		803bb42f-e0f2-44b6-aebb-8f956646ecc7		TCGA-C8-A12U-01A-11D-A111-01	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11R-A115-07	803bb42f-e0f2-44b6-aebb-8f956646ecc7	TCGA-C8-A12U-01A-11D-A111-01	TCGA-C8-A12U-01
TCGA-C8-A12V-01	Stage IIA	55	1	Stage IIA	0		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12V-01	385	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-C8-A12V	385	0	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right	Axillary lymph node dissection alone		TCGA-C8-A12V-F19095	TCGA-C8-A12V	TCGA-C8-A12V-01A		Negative					Negative	Other					-20346	57		0	385					NO				Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	540	NO	Negative			5		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-C8-A12V.8ED8A37B-C885-4333-AC5D-EA73A5A81173.pdf	A12V	TUMOR FREE							YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	b12c9095-55c7-4add-9e22-3d65eeef2040	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	b12c9095-55c7-4add-9e22-3d65eeef2040	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	TCGA-C8-A12V-01A-21-A13D-20	TCGA-C8-A12V-01A-11D-A10Y-09		TCGA-C8-A12V-01			46c61ec3-e651-474c-8ce2-0cbced7cbca5	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11D-A10Y-09	TCGA-C8-A12V-01A-11D-A112-05	TCGA-C8-A12V-01	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11D-A10Y-09		b12c9095-55c7-4add-9e22-3d65eeef2040		TCGA-C8-A12V-01A-11D-A111-01	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11R-A115-07	b12c9095-55c7-4add-9e22-3d65eeef2040	TCGA-C8-A12V-01A-11D-A111-01	TCGA-C8-A12V-01
TCGA-C8-A12W-01	Stage IIIB	49	3	Stage IIIB	0		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	0	0	LumB	Luminal B	Positive	ReacII	-2	-5	enrollment	T_Other	T4	LIVING	0	TCGA-C8-A12W-01	385	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12W	385	0	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left	Axillary lymph node dissection alone		TCGA-C8-A12W-F20244	TCGA-C8-A12W	TCGA-C8-A12W-01A		Positive					Positive	Other					-18140	57		0	385									Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	890	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO			true	No	M0	N1	T4	Stage IIIB	TCGA-C8-A12W.8A64D890-ABEF-4AF2-8915-D17DA89B8FC5.pdf	A12W	TUMOR FREE				Allred Score 6	Allred Score 7		YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	b24caa7b-337e-43d0-9908-2815f24dd7b5	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	b24caa7b-337e-43d0-9908-2815f24dd7b5	TCGA-C8-A12W-01A-21-A13D-20	TCGA-C8-A12W-01A-11D-A10Y-09		TCGA-C8-A12W-01			ee4be56e-b6c6-421f-ae10-fd129c8028df	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11D-A10Y-09	TCGA-C8-A12W-01A-11D-A112-05	TCGA-C8-A12W-01	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11D-A10Y-09		24e6e8f5-3caa-46f0-8915-7bd09f0736f9		TCGA-C8-A12W-01A-11D-A111-01	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11R-A115-07	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	TCGA-C8-A12W-01A-11D-A111-01	TCGA-C8-A12W-01
TCGA-C8-A12X-01	Stage IIB	62	4	Stage IIB	0		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	0	0	LumA	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12X-01	385	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-C8-A12X	385	0	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left	Axillary lymph node dissection alone		TCGA-C8-A12X-F19102	TCGA-C8-A12X	TCGA-C8-A12X-01A		Positive					Positive	Other					-22889	57		0	385					NO				Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES	Pateys Surgery	Other method, specify:	410	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12X.B3FCE052-931C-4798-A188-F04A2178A5F6.pdf	A12X	TUMOR FREE				Allred Score 7	Allred Score 8		YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	a32074a1-de53-4200-a933-540029a37372	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	a32074a1-de53-4200-a933-540029a37372	TCGA-C8-A12X-01A-21-A13D-20	TCGA-C8-A12X-01A-11D-A10Y-09		TCGA-C8-A12X-01			b91a61e2-4b2e-4a9c-b79d-07570ae50cc3	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11D-A10Y-09	TCGA-C8-A12X-01A-11D-A112-05	TCGA-C8-A12X-01	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11D-A10Y-09		2efa4fd0-1c0b-49c8-a11f-606d8618ec97		TCGA-C8-A12X-01A-11D-A111-01	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11R-A115-07	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	TCGA-C8-A12X-01A-11D-A111-01	TCGA-C8-A12X-01
TCGA-C8-A12Y-01	Stage IIB	44	2	Stage IIB	0			FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	0	0	LumA	Luminal A		LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12Y-01	1476	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-C8-A12Y	1476	0	days	1476	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left	Axillary lymph node dissection alone		TCGA-C8-A12Y-F70839	TCGA-C8-A12Y	TCGA-C8-A12Y-01A								Other						57		0	1476					NO					2015-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	380	NO			NO	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12Y.28E368DA-56B9-4BB1-99C3-7FF2CEC964CF.pdf	A12Y	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	635288ea-41cf-4d68-9295-19044e6c8fda	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	635288ea-41cf-4d68-9295-19044e6c8fda	TCGA-C8-A12Y-01A-21-A13D-20	TCGA-C8-A12Y-01A-11D-A12B-09		TCGA-C8-A12Y-01			1e9b9f3a-3fb5-4404-94e5-d22d4702391e	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11D-A12B-09	TCGA-C8-A12Y-01A-11D-A12E-05	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11D-A12B-09		ef42155a-112e-48fe-b52a-a99ebcd5f7f5		TCGA-C8-A12Y-01A-11D-A12A-01	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11R-A12D-07	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	TCGA-C8-A12Y-01A-11D-A12A-01	TCGA-C8-A12Y-01
TCGA-C8-A12Z-01	Stage II	45	2	Stage IIB	0		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12Z-01	382	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A12Z	382	0	days	382	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right	Axillary lymph node dissection alone		TCGA-C8-A12Z-F70810	TCGA-C8-A12Z	TCGA-C8-A12Z-01A	Negative	Negative					Negative	Other					-16508	69		0	382					NO					2015-3-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Positive		NO	2	Negative	Peri (6-12 months since last menstrual period)																				4	4								NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-C8-A12Z.89B312D1-9FDD-4756-9C15-5442B428F75A.pdf	A12Z	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	4018d26c-0ce0-4c5a-9ce4-200bb4273349	6d730c4d-2c62-4214-aa35-f40126e65560	4018d26c-0ce0-4c5a-9ce4-200bb4273349	6d730c4d-2c62-4214-aa35-f40126e65560	TCGA-C8-A12Z-01A-21-A13D-20	TCGA-C8-A12Z-01A-11D-A10Y-09		TCGA-C8-A12Z-01			76306f2d-c820-4442-966f-b79872d69025	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11D-A10Y-09	TCGA-C8-A12Z-01A-11D-A112-05	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11D-A10Y-09		4018d26c-0ce0-4c5a-9ce4-200bb4273349		TCGA-C8-A12Z-01A-11D-A111-01	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11R-A115-07	4018d26c-0ce0-4c5a-9ce4-200bb4273349	TCGA-C8-A12Z-01A-11D-A111-01	TCGA-C8-A12Z-01
TCGA-C8-A130-01	Stage IIIA	52	1	Stage IIIA	0		Positive	FEMALE	Equivocal	1	1	1	Negative	M0	Positive	N2	0	0	LumB	HER2-enriched	Positive	Her2	-2	0	enrollment	T_Other	T3	LIVING	0	TCGA-C8-A130-01	370	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A130	370	0	days	370	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left	Axillary lymph node dissection alone		TCGA-C8-A130-F70814	TCGA-C8-A130	TCGA-C8-A130-01A		Positive					Positive	Other					-19117	89		0	370					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Equivocal		NO	8	Negative	Peri (6-12 months since last menstrual period)																				2	4								NO			true	No	M0	N2	T3	Stage IIIA	TCGA-C8-A130.3E24D3A0-9741-4635-89DB-EED4BA3F6AAA.pdf	A130	TUMOR FREE				Allred Score 7	Allred Score 7	[Discrepancy]	YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	b3b38912-25f6-45ca-9ee5-a5a4a299b5ce	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	b3b38912-25f6-45ca-9ee5-a5a4a299b5ce	TCGA-C8-A130-01A-21-A13D-20	TCGA-C8-A130-01A-31D-A10Y-09		TCGA-C8-A130-01			62caa696-e8a5-46f6-b4c1-1baf5ae62bd4	TCGA-C8-A130-01	TCGA-C8-A130-01A-31D-A10Y-09	TCGA-C8-A130-01A-31D-A112-05	TCGA-C8-A130-01	TCGA-C8-A130-01	TCGA-C8-A130-01A-31D-A10Y-09		697dfcbf-0c6b-4cae-b851-d46dd6be42c9		TCGA-C8-A130-01A-31D-A111-01	TCGA-C8-A130-01	TCGA-C8-A130-01A-31R-A115-07	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	TCGA-C8-A130-01A-31D-A111-01	TCGA-C8-A130-01
TCGA-C8-A131-01	Stage III	82	1	Stage IIIA	0		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N2	0	0	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A131-01	411	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	OV-like c4	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-C8-A131	411	0	days	411	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Left	Axillary lymph node dissection alone		TCGA-C8-A131-F70827	TCGA-C8-A131	TCGA-C8-A131-01A		Negative					Negative	Other					-29966	163		0	411					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	460	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	5								NO	4		true	No	M0	N2	T2	Stage IIIA	TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf	A131	TUMOR FREE						YES	YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	5162ef6d-6978-4ff7-b385-a59325cefe17	8451e6fa-790e-4ea7-9068-520299fad8a1	5162ef6d-6978-4ff7-b385-a59325cefe17	8451e6fa-790e-4ea7-9068-520299fad8a1	TCGA-C8-A131-01A-21-A13D-20	TCGA-C8-A131-01A-11D-A10Y-09		TCGA-C8-A131-01			4a1fa1ef-67ab-4ea7-a650-5276030b04ee	TCGA-C8-A131-01	TCGA-C8-A131-01A-11D-A10Y-09	TCGA-C8-A131-01A-11D-A112-05	TCGA-C8-A131-01	TCGA-C8-A131-01	TCGA-C8-A131-01A-11D-A10Y-09		5162ef6d-6978-4ff7-b385-a59325cefe17		TCGA-C8-A131-01A-11D-A111-01	TCGA-C8-A131-01	TCGA-C8-A131-01A-11R-A115-07	5162ef6d-6978-4ff7-b385-a59325cefe17	TCGA-C8-A131-01A-11D-A111-01	TCGA-C8-A131-01
TCGA-C8-A132-01	Stage II	56	5	Stage IIB	0		Positive	FEMALE	Positive	2	3	3	Negative	M0	Positive	N1	0	0	LumA	Luminal A	Positive	Her2	-2	-4	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A132-01	383	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 5	mutation c1uster 9	TCGA-C8-A132	383	0	days	383	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Axillary lymph node dissection alone		TCGA-C8-A132-F70826	TCGA-C8-A132	TCGA-C8-A132-01A		Positive					Positive	Other					-20471	162		0	383					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO			NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	5								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-C8-A132.175224E6-3A06-4799-B695-704C254A847C.pdf	A132	TUMOR FREE				Allred Score 7	Allred Score 8	[Discrepancy]	YES			NO	Primary Tumor	01	Modified Radical Masectomy	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	143e8620-56cc-4b65-a2aa-d793543f6854	f52bfd4d-965c-4f12-9e71-7842ed116268	143e8620-56cc-4b65-a2aa-d793543f6854	f52bfd4d-965c-4f12-9e71-7842ed116268	TCGA-C8-A132-01A-41-A13D-20	TCGA-C8-A132-01A-31D-A10Y-09		TCGA-C8-A132-01			4b907222-06fc-47d4-b425-b116df8162aa	TCGA-C8-A132-01	TCGA-C8-A132-01A-31D-A10Y-09	TCGA-C8-A132-01A-31D-A112-05	TCGA-C8-A132-01	TCGA-C8-A132-01	TCGA-C8-A132-01A-31D-A10Y-09		143e8620-56cc-4b65-a2aa-d793543f6854		TCGA-C8-A132-01A-31D-A111-01	TCGA-C8-A132-01	TCGA-C8-A132-01A-31R-A115-07	143e8620-56cc-4b65-a2aa-d793543f6854	TCGA-C8-A132-01A-31D-A111-01	TCGA-C8-A132-01
TCGA-C8-A133-01	Stage IIIA	65	1	Stage IIIA	0		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	0	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T3	LIVING		TCGA-C8-A133-01			days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-C8-A133			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right	Axillary lymph node dissection alone			TCGA-C8-A133	TCGA-C8-A133-01A		Positive					Positive	Modified Radical Mastectomy					-23922	119		0	0										2011-4-15	FEMALE										Other, specify		No		C50.9	8523/3	C50.9		YES	Modified Radical Masectomy	Other method, specify:	480	NO				26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1											true	No	M0	N1	T3	Stage IIIA	TCGA-C8-A133.C47488B4-0E7E-46FB-91C6-0BEA58695974.pdf	A133	TUMOR FREE				Allred Score 8	Allred Score 8		YES				Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	3028d15d-698a-4a23-8a09-a79221e28a62	de88f4c3-0824-4ce2-8d1c-c6155db0f967	3028d15d-698a-4a23-8a09-a79221e28a62	de88f4c3-0824-4ce2-8d1c-c6155db0f967	TCGA-C8-A133-01A-21-A13D-20	TCGA-C8-A133-01A-32D-A12B-09		TCGA-C8-A133-01			a4236581-7665-4520-84c9-16fb6fa8fd22	TCGA-C8-A133-01	TCGA-C8-A133-01A-32D-A12B-09	TCGA-C8-A133-01A-32D-A12E-05	TCGA-C8-A133-01	TCGA-C8-A133-01	TCGA-C8-A133-01A-32D-A12B-09		3028d15d-698a-4a23-8a09-a79221e28a62		TCGA-C8-A133-01A-32D-A12A-01	TCGA-C8-A133-01	TCGA-C8-A133-01A-32R-A12D-07	3028d15d-698a-4a23-8a09-a79221e28a62	TCGA-C8-A133-01A-32D-A12A-01	TCGA-C8-A133-01
TCGA-C8-A134-01	Stage IIA	52	1	No_Conversion	0		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A134-01	383	0	days	BRCA-LUAD+	C8-BLCA	cluster 4	Cluster 6	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-C8-A134	383	0	days	383	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left	Axillary lymph node dissection alone		TCGA-C8-A134-F70822	TCGA-C8-A134			Negative					Negative	Other					-19010			0	383									Scheduled Follow-up Submission	2015-3-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal		NO	7	Negative	Peri (6-12 months since last menstrual period)																				4	6								NO				No	M0	N0	T2	Stage IIA		A134	TUMOR FREE						YES				NO	Primary Tumor	01	Modified Radical Masectomy	6th	YES	YES	NO	C8	Breast		LIVING	2010	d96863aa-33a8-43bf-a9b5-589de1e9cf44	aad64468-8c93-47ce-bc77-829f4fb8b2d6	d96863aa-33a8-43bf-a9b5-589de1e9cf44	aad64468-8c93-47ce-bc77-829f4fb8b2d6	TCGA-C8-A134-01A-21-A13D-20	TCGA-C8-A134-01A-11D-A10Y-09		TCGA-C8-A134-01			ec21c134-e0b1-44e4-be21-ff70c20ee979	TCGA-C8-A134-01	TCGA-C8-A134-01A-11D-A10Y-09	TCGA-C8-A134-01A-11D-A112-05	TCGA-C8-A134-01	TCGA-C8-A134-01	TCGA-C8-A134-01A-11D-A10Y-09		d96863aa-33a8-43bf-a9b5-589de1e9cf44		TCGA-C8-A134-01A-11D-A111-01	TCGA-C8-A134-01	TCGA-C8-A134-01A-11R-A115-07	d96863aa-33a8-43bf-a9b5-589de1e9cf44	TCGA-C8-A134-01A-11D-A111-01	TCGA-C8-A134-01
TCGA-C8-A135-01	Stage II	64	1	Stage IIB	0		Negative	FEMALE	Positive	2	2	1	Negative	M0	Positive	N1	0	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A135-01	393	0	days	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 7	mutation cluster 3	TCGA-C8-A135	393	0	days	393	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left	Axillary lymph node dissection alone		TCGA-C8-A135-F70817	TCGA-C8-A135	TCGA-C8-A135-01A		Negative					Negative	Modified Radical Mastectomy					-23667	162		0	393					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	760	NO	Positive		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	7								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-C8-A135.7045ECC9-72B3-4AD3-A6C6-4F8C6914EAA1.pdf	A135	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th	NO	YES	NO	C8	Breast	A	LIVING	2010	306818e8-2e51-4dee-b27c-53ee9cea8d03	dc5b229b-a3c1-4e91-a28a-809ce6035c0c	306818e8-2e51-4dee-b27c-53ee9cea8d03	dc5b229b-a3c1-4e91-a28a-809ce6035c0c	TCGA-C8-A135-01A-21-A13D-20	TCGA-C8-A135-01A-11D-A10Y-09		TCGA-C8-A135-01			bded0f4f-068a-4577-a130-66b59f0bce47	TCGA-C8-A135-01	TCGA-C8-A135-01A-11D-A10Y-09	TCGA-C8-A135-01A-11D-A112-05	TCGA-C8-A135-01	TCGA-C8-A135-01	TCGA-C8-A135-01A-11D-A10Y-09		306818e8-2e51-4dee-b27c-53ee9cea8d03		TCGA-C8-A135-01A-11D-A111-01	TCGA-C8-A135-01	TCGA-C8-A135-01A-11R-A115-07	306818e8-2e51-4dee-b27c-53ee9cea8d03	TCGA-C8-A135-01A-11D-A111-01	TCGA-C8-A135-01
TCGA-C8-A137-01	Stage II	34	5	Stage IIB	3		Negative	FEMALE	Positive				Negative	M0	Positive	N1	3	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A137-01	379	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7			mutation c1uster 9	TCGA-C8-A137	136	1	days	379	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			34	Left	Axillary lymph node dissection alone		TCGA-C8-A137-F70815	TCGA-C8-A137	TCGA-C8-A137-01A		Negative					Negative	Modified Radical Mastectomy					-12729	102		0	379			136		NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	610	NO	Positive		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4						Locoregional Recurrence		NO	YES			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A137.140F8918-739F-498A-9A17-B307E40E6060.pdf	A137	WITH TUMOR						[Discrepancy]	YES			NO	Primary Tumor	01		6th	YES	YES	NO	C8	Breast	A	LIVING	2010	2c829af4-a6a7-48b1-9e48-a88be0564752	21cd18a4-1c4a-4df0-953c-2f20ab4318f1	2c829af4-a6a7-48b1-9e48-a88be0564752	21cd18a4-1c4a-4df0-953c-2f20ab4318f1	TCGA-C8-A137-01A-21-A13D-20	TCGA-C8-A137-01A-11D-A10Y-09		TCGA-C8-A137-01			b7d481d8-71b8-473b-802b-0457592d7054	TCGA-C8-A137-01	TCGA-C8-A137-01A-11D-A10Y-09	TCGA-C8-A137-01A-11D-A112-05	TCGA-C8-A137-01	TCGA-C8-A137-01	TCGA-C8-A137-01A-11D-A10Y-09		2c829af4-a6a7-48b1-9e48-a88be0564752		TCGA-C8-A137-01A-11D-A111-01	TCGA-C8-A137-01	TCGA-C8-A137-01A-11R-A115-07	2c829af4-a6a7-48b1-9e48-a88be0564752	TCGA-C8-A137-01A-11D-A111-01	TCGA-C8-A137-01
TCGA-C8-A138-01	Stage III	54	2	Stage IIIA	7		Positive	FEMALE	Positive	3	2	1	Negative	M0	Positive	N2	7	0	Her2	HER2-enriched	Negative	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A138-01	380	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-C8-A138	380	0	days	380	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left	Axillary lymph node dissection alone		TCGA-C8-A138-F71893	TCGA-C8-A138	TCGA-C8-A138-01A		Positive					Negative	Modified Radical Mastectomy					-20053	93		0	380					NO				Scheduled Follow-up Submission	2015-3-31	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO			true	No	M0	N2	T2	Stage IIIA	TCGA-C8-A138.3584F6CE-F9ED-441C-8714-BDF67C141CD6.pdf	A138	TUMOR FREE					Allred Score 5	YES	YES			NO	Primary Tumor	01		6th	NO	YES	NO	C8	Breast	A	LIVING	2010	f543c792-d997-420a-8bf1-c45456b62a8b	d8e8db6d-4f38-4ef6-a77a-d3ea769cc78f	f543c792-d997-420a-8bf1-c45456b62a8b	d8e8db6d-4f38-4ef6-a77a-d3ea769cc78f	TCGA-C8-A138-01A-21-A13D-20	TCGA-C8-A138-01A-11D-A10Y-09		TCGA-C8-A138-01			5fa600b0-7ba1-45bf-be7d-8d60925dce68	TCGA-C8-A138-01	TCGA-C8-A138-01A-11D-A10Y-09	TCGA-C8-A138-01A-11D-A112-05	TCGA-C8-A138-01	TCGA-C8-A138-01	TCGA-C8-A138-01A-11D-A10Y-09		f543c792-d997-420a-8bf1-c45456b62a8b		TCGA-C8-A138-01A-11D-A111-01	TCGA-C8-A138-01	TCGA-C8-A138-01A-11R-A115-07	f543c792-d997-420a-8bf1-c45456b62a8b	TCGA-C8-A138-01A-11D-A111-01	TCGA-C8-A138-01
TCGA-C8-A1HE-01	Stage IIA	59	2	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HE-01	375	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-C8-A1HE	375	0	days	375	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right	Axillary lymph node dissection alone		TCGA-C8-A1HE-F20269	TCGA-C8-A1HE	TCGA-C8-A1HE-01A		Positive					Positive	Other		NO				109		0	375					NO				Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	280	NO	Equivocal			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A1HE.DDB31719-1D2F-4502-B80E-544B684DC16F.pdf	A1HE	TUMOR FREE				Allred Score 4	Allred Score 7		YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	2f506a7d-668f-4b51-87b5-74b260663de6	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	2f506a7d-668f-4b51-87b5-74b260663de6	TCGA-C8-A1HE-01A-21-A17J-20	TCGA-C8-A1HE-01A-11D-A188-09		TCGA-C8-A1HE-01	TCGA-C8-A1HE-01A-11D-A13K-05		f1bdea64-1ae0-442f-83cd-00ae1531f9fb	TCGA-C8-A1HE-01	TCGA-C8-A1HE-01A-11D-A188-09			TCGA-C8-A1HE-01	TCGA-C8-A1HE-01A-11D-A188-09		b5f56bfb-6fc1-448f-8c2b-4753084aaa00		TCGA-C8-A1HE-01A-11D-A13J-01	TCGA-C8-A1HE-01		b5f56bfb-6fc1-448f-8c2b-4753084aaa00	TCGA-C8-A1HE-01A-11D-A13J-01	
TCGA-C8-A1HF-01	Stage IIA	48	2	Stage IIA	0		Negative	FEMALE	Positive				Negative	M0	Negative	N0	0	0	Her2	HER2-enriched	Positive		-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HF-01	332	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-C8-A1HF	332	0	days	332	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left	Axillary lymph node dissection alone		TCGA-C8-A1HF-F19092	TCGA-C8-A1HF	TCGA-C8-A1HF-01A		Negative					Positive	Other		NO				109		0	332					NO				Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	460	NO	Positive			12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf	A1HF	TUMOR FREE				Allred Score 3			YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	62b06301-531d-4fc1-bb00-ede8e507e8f4	d5447c87-4ee0-4566-a933-997ad63e6009	62b06301-531d-4fc1-bb00-ede8e507e8f4	d5447c87-4ee0-4566-a933-997ad63e6009	TCGA-C8-A1HF-01A-21-A17J-20	TCGA-C8-A1HF-01A-11D-A135-09		TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11D-A138-05		c95c9a7c-4192-4100-9452-5def84184e9c	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11D-A135-09		TCGA-C8-A1HF-01	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11D-A135-09		62b06301-531d-4fc1-bb00-ede8e507e8f4		TCGA-C8-A1HF-01A-11D-A134-01	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11R-A137-07	62b06301-531d-4fc1-bb00-ede8e507e8f4	TCGA-C8-A1HF-01A-11D-A134-01	TCGA-C8-A1HF-01
TCGA-C8-A1HG-01	Stage IIA	50	4	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HG-01	345	0	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-C8-A1HG	345	0	days	345	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right	Axillary lymph node dissection alone		TCGA-C8-A1HG-F19096	TCGA-C8-A1HG	TCGA-C8-A1HG-01A		Positive					Positive	Other		NO				122		0	345					NO				Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	300	NO	Negative				Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf	A1HG	TUMOR FREE				Allred Score 7	Allred Score 8		NO			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	094076d0-97e4-460d-b48c-7ee2371db99d	1580dd65-d698-4a80-8345-ad50e16709d1	094076d0-97e4-460d-b48c-7ee2371db99d	1580dd65-d698-4a80-8345-ad50e16709d1	TCGA-C8-A1HG-01A-21-A17J-20	TCGA-C8-A1HG-01A-11D-A135-09		TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11D-A138-05		3ba46266-c84a-482f-abc7-8756831856e6	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11D-A135-09		TCGA-C8-A1HG-01	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11D-A135-09		094076d0-97e4-460d-b48c-7ee2371db99d		TCGA-C8-A1HG-01A-11D-A134-01	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11R-A137-07	094076d0-97e4-460d-b48c-7ee2371db99d	TCGA-C8-A1HG-01A-11D-A134-01	TCGA-C8-A1HG-01
TCGA-C8-A1HI-01	Stage IIIA	40	2	Stage IIIA	2		Positive	FEMALE	Negative				Negative	M0	Positive	N2	2	0	LumA	Luminal A	Positive		-5	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HI-01	343	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-C8-A1HI	343	0	days	343	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Axillary lymph node dissection alone		TCGA-C8-A1HI-F19099	TCGA-C8-A1HI	TCGA-C8-A1HI-01A		Positive					Positive	Other						120		0	343					NO				Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	490	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO			true	No	M0	N2	T2	Stage IIIA	TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf	A1HI	TUMOR FREE				Allred Score 6	Allred Score 8		YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	d8c894f8-3423-401d-9656-65dfd0383fd7	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	d8c894f8-3423-401d-9656-65dfd0383fd7	TCGA-C8-A1HI-01A-21-A17J-20	TCGA-C8-A1HI-01A-11D-A135-09		TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11D-A138-05		8e8a6562-23a5-48a7-a06e-efc30fab8f15	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11D-A135-09		TCGA-C8-A1HI-01	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11D-A135-09		994c96ec-ea0a-4741-8fef-53cdbfe28cfa		TCGA-C8-A1HI-01A-11D-A134-01	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11R-A137-07	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	TCGA-C8-A1HI-01A-11D-A134-01	TCGA-C8-A1HI-01
TCGA-C8-A1HJ-01	Stage II	53	1	Stage IIA	5		Negative	FEMALE	Negative				Negative	M0	Negative	N0	5	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HJ-01	5	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-C8-A1HJ			days	5	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right	Axillary lymph node dissection alone			TCGA-C8-A1HJ	TCGA-C8-A1HJ-01A		Negative					Negative	Other					-19629	121		0	5					NO					2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	1070	NO	Negative			10	Negative	Peri (6-12 months since last menstrual period)																				5	5											true	No	M0	N0	T2	Stage IIA	TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf	A1HJ	TUMOR FREE							YES				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	TCGA-C8-A1HJ-01A-21-A17J-20	TCGA-C8-A1HJ-01A-11D-A13L-09		TCGA-C8-A1HJ-01	TCGA-C8-A1HJ-01A-11D-A13K-05		6528f6b1-d0f5-413c-a304-0fa218a132ac	TCGA-C8-A1HJ-01	TCGA-C8-A1HJ-01A-11D-A13L-09			TCGA-C8-A1HJ-01	TCGA-C8-A1HJ-01A-11D-A13L-09		c0dd6c33-008d-44e8-b20c-8089bc3e29a3		TCGA-C8-A1HJ-01A-11D-A13J-01	TCGA-C8-A1HJ-01		c0dd6c33-008d-44e8-b20c-8089bc3e29a3	TCGA-C8-A1HJ-01A-11D-A13J-01	
TCGA-C8-A1HK-01	Stage IIB	53	5	Stage IIB	7		Negative	FEMALE	Positive				Negative	M0	Positive	N1	7	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HK-01	366	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-C8-A1HK	366	0	days	366	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right	Axillary lymph node dissection alone		TCGA-C8-A1HK-F19100	TCGA-C8-A1HK	TCGA-C8-A1HK-01A		Negative					Negative	Other						116		0	366					NO				Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	460	NO	Positive			8	Negative	Peri (6-12 months since last menstrual period)																				4	1								NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf	A1HK	TUMOR FREE							YES			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	74864fc6-1cd0-46b0-9a71-65f73444f7ee	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	74864fc6-1cd0-46b0-9a71-65f73444f7ee	TCGA-C8-A1HK-01A-11-A17J-20	TCGA-C8-A1HK-01A-21D-A13L-09		TCGA-C8-A1HK-01	TCGA-C8-A1HK-01A-21D-A13K-05		5f7c521f-28b4-46ba-9d1e-a6bf55885d28	TCGA-C8-A1HK-01	TCGA-C8-A1HK-01A-21D-A13L-09			TCGA-C8-A1HK-01	TCGA-C8-A1HK-01A-21D-A13L-09		83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c		TCGA-C8-A1HK-01A-21D-A13J-01	TCGA-C8-A1HK-01		83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	TCGA-C8-A1HK-01A-21D-A13J-01	
TCGA-C8-A1HL-01	Stage IIIA	38	5	Stage IIIA	2		Positive	FEMALE	Positive				Negative	M0	Positive	N1	2	0	LumB	Luminal B	Negative		-2	-3	enrollment	T_Other	T3	LIVING	0	TCGA-C8-A1HL-01	317	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-C8-A1HL	317	0	days	317	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Left	Axillary lymph node dissection alone		TCGA-C8-A1HL-F20266	TCGA-C8-A1HL	TCGA-C8-A1HL-01A		Positive					Negative	Other						94		0	317					NO				Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Other, specify		No		C50.9	8480/3	C50.9		YES	Pateys Surgery	Other method, specify:	980	NO	Equivocal			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO			true	Yes	M0	N1	T3	Stage IIIA	TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf	A1HL	TUMOR FREE					Allred Score 8		YES			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	9d80ba46-b65f-4338-99bc-370f8eaefe4e	5b7b0e6b-b247-4478-8dd3-a9b749e32efe	9d80ba46-b65f-4338-99bc-370f8eaefe4e	5b7b0e6b-b247-4478-8dd3-a9b749e32efe	TCGA-C8-A1HL-01A-21-A17J-20	TCGA-C8-A1HL-01A-11D-A135-09		TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11D-A138-05		d026ab37-87a8-4486-a09d-0aabeba2dd89	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11D-A135-09		TCGA-C8-A1HL-01	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11D-A135-09		9d80ba46-b65f-4338-99bc-370f8eaefe4e		TCGA-C8-A1HL-01A-11D-A134-01	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11R-A137-07	9d80ba46-b65f-4338-99bc-370f8eaefe4e	TCGA-C8-A1HL-01A-11D-A134-01	TCGA-C8-A1HL-01
TCGA-C8-A1HM-01	Stage II	74	3	Stage IIA	6		Positive	FEMALE	Negative				Negative	M0	Negative	N0	6	0	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HM-01	375	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A1HM	375	0	days	375	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left	Axillary lymph node dissection alone		TCGA-C8-A1HM-F70806	TCGA-C8-A1HM			Positive					Positive	Modified Radical Mastectomy					-27063			0	375					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO				No	M0	N0	T2	Stage IIA		A1HM	TUMOR FREE				Allred Score 5	Allred Score 8	YES	NO			NO	Primary Tumor	01		6th	YES	YES	NO	C8	Breast		LIVING	2010	eb908a6f-d6f2-40ef-90da-97438cd2281e	b3696964-30e2-4342-914d-d7c2f5c88322	eb908a6f-d6f2-40ef-90da-97438cd2281e	b3696964-30e2-4342-914d-d7c2f5c88322	TCGA-C8-A1HM-01A-21-A17J-20	TCGA-C8-A1HM-01A-12D-A135-09		TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A138-05		e15bb106-69e3-4af4-bd2f-9c9098aa34e3	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A135-09		TCGA-C8-A1HM-01	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A135-09		eb908a6f-d6f2-40ef-90da-97438cd2281e		TCGA-C8-A1HM-01A-12D-A134-01	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12R-A137-07	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-12D-A134-01	TCGA-C8-A1HM-01
TCGA-C8-A1HN-01	Stage II	56		Stage IIA	2		Positive	FEMALE	Equivocal				Negative	M0	Negative	N0	2	0	LumB	Luminal B	Positive		-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HN-01	394	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-C8-A1HN	394	0	days	394	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Axillary lymph node dissection alone		TCGA-C8-A1HN-F71885	TCGA-C8-A1HN	TCGA-C8-A1HN-01A		Positive					Positive	Modified Radical Mastectomy					-20712	88		0	394					NO				Scheduled Follow-up Submission	2015-3-31	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7								NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf	A1HN	TUMOR FREE				Allred Score 3	Allred Score 8	YES	NO			NO	Primary Tumor	01		6th	YES	YES	NO	C8	Breast	A	LIVING	2010	4795628e-50d8-41e0-b3c6-00fe4600dc5d	65261a78-78b6-4276-be43-f7e7ef91829d	4795628e-50d8-41e0-b3c6-00fe4600dc5d	65261a78-78b6-4276-be43-f7e7ef91829d	TCGA-C8-A1HN-01A-21-A17J-20	TCGA-C8-A1HN-01A-11D-A135-09		TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11D-A138-05		4090fc73-565b-4fa8-96c9-958fcb8eda09	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11D-A135-09		TCGA-C8-A1HN-01	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11D-A135-09		4795628e-50d8-41e0-b3c6-00fe4600dc5d		TCGA-C8-A1HN-01A-11D-A134-01	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11R-A137-07	4795628e-50d8-41e0-b3c6-00fe4600dc5d	TCGA-C8-A1HN-01A-11D-A134-01	TCGA-C8-A1HN-01
TCGA-C8-A1HO-01	Stage III	34	5	Stage IIIC	0		Positive	FEMALE	Negative				Negative	M0	Positive	N3	0	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A1HO-01	375	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-C8-A1HO	375	0	days	375	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Left Upper Inner Quadrant			TCGA-C8-A1HO-F70802	TCGA-C8-A1HO	TCGA-C8-A1HO-01A		Positive					Positive	[Discrepancy]					-12715	52		0	375										2015-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	380	NO	Negative		NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	5								NO			true	No	M0	N3	T3	Stage IIIC	TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf	A1HO	TUMOR FREE				Allred Score 5	Allred Score 7	YES	NO			NO	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	8cd0933f-c93e-4265-a6c4-6892f407ced9	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	8cd0933f-c93e-4265-a6c4-6892f407ced9	TCGA-C8-A1HO-01A-21-A17J-20	TCGA-C8-A1HO-01A-11D-A13L-09		TCGA-C8-A1HO-01	TCGA-C8-A1HO-01A-11D-A13K-05		654028c2-038a-4cfb-95c6-13ad5000346d	TCGA-C8-A1HO-01	TCGA-C8-A1HO-01A-11D-A13L-09			TCGA-C8-A1HO-01	TCGA-C8-A1HO-01A-11D-A13L-09		1d8ecbae-6996-4d9d-bff8-ac761a8309ea		TCGA-C8-A1HO-01A-11D-A13J-01	TCGA-C8-A1HO-01		1d8ecbae-6996-4d9d-bff8-ac761a8309ea	TCGA-C8-A1HO-01A-11D-A13J-01	
TCGA-C8-A26V-01	Stage III	47	1	Stage IIIA	9		Positive	FEMALE	Negative				Negative	M0	Positive	N2	9	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A26V-01	616	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12		mutation cluster 8	TCGA-C8-A26V	616	0	days	616	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right			TCGA-C8-A26V-F70799	TCGA-C8-A26V	TCGA-C8-A26V-01A		Positive					Positive	Modified Radical Mastectomy					-17468	143		0	616										2015-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Modified Radical Masectomy	Other method, specify:	310	NO	Negative		NO		Negative	Peri (6-12 months since last menstrual period)																				4									NO			true	No	M0	N2	T3	Stage IIIA	TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf	A26V	TUMOR FREE				Allred Score 8	Allred Score 8	YES	NO			YES	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	67a58c72-fa64-4c63-b568-bec834626edf	cdb4d8c0-f68c-4b40-a1b4-7b3b8324d9e1	67a58c72-fa64-4c63-b568-bec834626edf	cdb4d8c0-f68c-4b40-a1b4-7b3b8324d9e1	TCGA-C8-A26V-01A-21-A17K-20	TCGA-C8-A26V-01A-11D-A16D-09		TCGA-C8-A26V-01	TCGA-C8-A26V-01A-11D-A16G-05		a8d7929f-263f-4277-be5e-f01eadc08bc3	TCGA-C8-A26V-01	TCGA-C8-A26V-01A-11D-A16D-09			TCGA-C8-A26V-01	TCGA-C8-A26V-01A-11D-A16D-09		67a58c72-fa64-4c63-b568-bec834626edf		TCGA-C8-A26V-01A-11D-A16C-01	TCGA-C8-A26V-01		67a58c72-fa64-4c63-b568-bec834626edf	TCGA-C8-A26V-01A-11D-A16C-01	
TCGA-C8-A26W-01	Stage II	58	1	Stage IIB	7		Positive	FEMALE	Positive				Negative	M0	Positive	N1	7	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26W-01	381	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12		mutation cluster 8	TCGA-C8-A26W	381	0	days	381	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant			TCGA-C8-A26W-F70796	TCGA-C8-A26W	TCGA-C8-A26W-01A		Positive					Positive	Modified Radical Mastectomy					-21391	142		0	381										2015-3-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO	Equivocal		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf	A26W	TUMOR FREE				Allred Score 8	Allred Score 8	YES	NO			NO	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	bd304a35-2d0c-4b11-bd62-3db480c1e730	6311b4c7-cb03-4c2a-a3d0-039d362c4d4d	bd304a35-2d0c-4b11-bd62-3db480c1e730	6311b4c7-cb03-4c2a-a3d0-039d362c4d4d	TCGA-C8-A26W-01A-21-A17K-20	TCGA-C8-A26W-01A-11D-A16D-09		TCGA-C8-A26W-01	TCGA-C8-A26W-01A-11D-A16G-05		4c5440c5-3eb7-4bfc-a5e7-51e1a55aa219	TCGA-C8-A26W-01	TCGA-C8-A26W-01A-11D-A16D-09			TCGA-C8-A26W-01	TCGA-C8-A26W-01A-11D-A16D-09		bd304a35-2d0c-4b11-bd62-3db480c1e730		TCGA-C8-A26W-01A-11D-A16C-01	TCGA-C8-A26W-01		bd304a35-2d0c-4b11-bd62-3db480c1e730	TCGA-C8-A26W-01A-11D-A16C-01	
TCGA-C8-A26X-01	Stage II	58	4	Stage IIA	11		Negative	FEMALE	Negative				Negative	M0	Positive	N1	11	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-C8-A26X-01	376	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 3	TCGA-C8-A26X	376	0	days	376	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant			TCGA-C8-A26X-F70792	TCGA-C8-A26X	TCGA-C8-A26X-01A		Negative					Negative	Modified Radical Mastectomy					-21463	136		0	376										2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO			true	No	M0	N1	T1	Stage IIA	TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf	A26X	TUMOR FREE						YES	NO			NO	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	5213da80-35ac-4172-b2e8-de686e73a498	95c7e7dd-400b-4864-8593-40f348078b3a	5213da80-35ac-4172-b2e8-de686e73a498	95c7e7dd-400b-4864-8593-40f348078b3a	TCGA-C8-A26X-01A-41-A17K-20	TCGA-C8-A26X-01A-31D-A16D-09		TCGA-C8-A26X-01	TCGA-C8-A26X-01A-31D-A16G-05		6a344715-e7bd-49b5-9ca7-0e1060a19710	TCGA-C8-A26X-01	TCGA-C8-A26X-01A-31D-A16D-09			TCGA-C8-A26X-01	TCGA-C8-A26X-01A-31D-A16D-09		5213da80-35ac-4172-b2e8-de686e73a498		TCGA-C8-A26X-01A-31D-A16C-01	TCGA-C8-A26X-01		5213da80-35ac-4172-b2e8-de686e73a498	TCGA-C8-A26X-01A-31D-A16C-01	
TCGA-C8-A26Y-01	Stage II	90	2	Stage IIA	13		Negative	FEMALE	Negative				Negative	M0	Negative	N0	13	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26Y-01	394	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-C8-A26Y	394	0	days	394	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Left Upper Outer Quadrant			TCGA-C8-A26Y-F70791	TCGA-C8-A26Y	TCGA-C8-A26Y-01A		Negative					Negative	Modified Radical Mastectomy					-32872	134		0	394										2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf	A26Y	TUMOR FREE						NO	NO			NO	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	afad9647-befe-4493-8386-475d0097c716	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	afad9647-befe-4493-8386-475d0097c716	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	TCGA-C8-A26Y-01A-21-A17K-20			TCGA-C8-A26Y-01	TCGA-C8-A26Y-01A-11D-A16G-05		4cf610ef-12f6-4149-ab0b-d0211e9642a6	TCGA-C8-A26Y-01	TCGA-C8-A26Y-01A-11D-A16D-09			TCGA-C8-A26Y-01			afad9647-befe-4493-8386-475d0097c716		TCGA-C8-A26Y-01A-11D-A16C-01	TCGA-C8-A26Y-01		afad9647-befe-4493-8386-475d0097c716	TCGA-C8-A26Y-01A-11D-A16C-01	
TCGA-C8-A26Z-01	Stage IIA	59	3	Stage IIA	4		Positive	FEMALE	Negative				Negative	M0	Negative	N0	4	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26Z-01	470	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-C8-A26Z	470	0	days	470	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right Upper Inner Quadrant			TCGA-C8-A26Z-F70835	TCGA-C8-A26Z	TCGA-C8-A26Z-01A		Positive					Positive	Other						125		0	470					NO				Scheduled Follow-up Submission	2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	470	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf	A26Z	TUMOR FREE				Allred Score 4	Allred Score 8	YES	NO			NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	Breast	A	LIVING	2010	8213eb8c-db23-4f92-b3d3-07b45eeec76a	22d25b42-1b1e-4758-a192-6e3702414cc8	8213eb8c-db23-4f92-b3d3-07b45eeec76a	22d25b42-1b1e-4758-a192-6e3702414cc8	TCGA-C8-A26Z-01A-21-A17K-20	TCGA-C8-A26Z-01A-11D-A16D-09		TCGA-C8-A26Z-01	TCGA-C8-A26Z-01A-11D-A16G-05		fb0eeacf-e38d-42f7-85b5-215ceed54e69	TCGA-C8-A26Z-01	TCGA-C8-A26Z-01A-11D-A16D-09			TCGA-C8-A26Z-01	TCGA-C8-A26Z-01A-11D-A16D-09		8213eb8c-db23-4f92-b3d3-07b45eeec76a		TCGA-C8-A26Z-01A-11D-A16C-01	TCGA-C8-A26Z-01		8213eb8c-db23-4f92-b3d3-07b45eeec76a	TCGA-C8-A26Z-01A-11D-A16C-01	
TCGA-C8-A273-01	Stage IIB	29	3	Stage IIB	6		Positive	FEMALE	Negative				Negative	M0	Positive	N1	6	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A273-01	513	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-C8-A273	513	0	days	513	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-C8-A273-F70833	TCGA-C8-A273	TCGA-C8-A273-01A		Positive					Positive	Other						168		0	513									Scheduled Follow-up Submission	2015-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	590	NO	Negative		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf	A273	TUMOR FREE				Allred Score 5	Allred Score 8	YES	YES			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	fb139187-1f6a-4354-8e25-279dc4960116	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	fb139187-1f6a-4354-8e25-279dc4960116	TCGA-C8-A273-01A-21-A17K-20	TCGA-C8-A273-01A-11D-A16D-09		TCGA-C8-A273-01	TCGA-C8-A273-01A-11D-A16G-05		67662a35-222b-4c66-a105-86e9332fc019	TCGA-C8-A273-01	TCGA-C8-A273-01A-11D-A16D-09			TCGA-C8-A273-01	TCGA-C8-A273-01A-11D-A16D-09		c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa		TCGA-C8-A273-01A-11D-A16C-01	TCGA-C8-A273-01		c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	TCGA-C8-A273-01A-11D-A16C-01	
TCGA-C8-A274-01	Stage IIA	63	2	Stage IIA	1		Positive	FEMALE	Negative				Negative	M0	Negative	N0	1	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A274-01	508	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 1	TCGA-C8-A274	508	0	days	508	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right			TCGA-C8-A274-F70831	TCGA-C8-A274	TCGA-C8-A274-01A		Positive					Positive	Other					-23337	163		0	508									Scheduled Follow-up Submission	2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	470	NO	Negative		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO			true	No	M0	N0	T2	Stage IIA	TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf	A274	TUMOR FREE				Allred Score 7	Allred Score 8	YES	NO			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	f9521be2-aaaf-414c-a906-3ba53a060614	a6343496-02a8-41be-ba50-25df086b21f7	f9521be2-aaaf-414c-a906-3ba53a060614	a6343496-02a8-41be-ba50-25df086b21f7	TCGA-C8-A274-01A-21-A17K-20	TCGA-C8-A274-01A-11D-A16D-09		TCGA-C8-A274-01	TCGA-C8-A274-01A-11D-A16G-05		99762a09-75aa-4d91-8911-2f259e4f4f40	TCGA-C8-A274-01	TCGA-C8-A274-01A-11D-A16D-09			TCGA-C8-A274-01	TCGA-C8-A274-01A-11D-A16D-09		f9521be2-aaaf-414c-a906-3ba53a060614		TCGA-C8-A274-01A-11D-A16C-01	TCGA-C8-A274-01		f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-11D-A16C-01	
TCGA-C8-A275-01	Stage IIA	56	3	Stage IIA	1			FEMALE	Positive				Negative	M0	Positive	N1	1	0	Her2						enrollment	T1	T1	LIVING	0	TCGA-C8-A275-01	1	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-C8-A275			days	1	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant				TCGA-C8-A275	TCGA-C8-A275-01A								Other					-20774	169		0	1										2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO					Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4												true	No	M0	N1	T1	Stage IIA	TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf	A275	TUMOR FREE							NO				Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	Breast	A	LIVING	2010	59c6ed76-762c-4caa-98c1-0886b6d9651c	c65dfc5d-a66d-4a43-ae04-4bd8edd88962	59c6ed76-762c-4caa-98c1-0886b6d9651c	c65dfc5d-a66d-4a43-ae04-4bd8edd88962	TCGA-C8-A275-01A-11-A17K-20	TCGA-C8-A275-01A-21D-A16D-09		TCGA-C8-A275-01	TCGA-C8-A275-01A-21D-A16G-05		46fbe024-54ed-49b2-9492-98b4f59c8f51	TCGA-C8-A275-01	TCGA-C8-A275-01A-21D-A16D-09			TCGA-C8-A275-01	TCGA-C8-A275-01A-21D-A16D-09		59c6ed76-762c-4caa-98c1-0886b6d9651c		TCGA-C8-A275-01A-21D-A16C-01	TCGA-C8-A275-01		59c6ed76-762c-4caa-98c1-0886b6d9651c	TCGA-C8-A275-01A-21D-A16C-01	
TCGA-C8-A278-01	Stage IIIA	61	4	Stage IIIA	1		Negative	FEMALE	Positive				Negative	M0	Positive	N2	1	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A278-01	297	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7		mutation cluster 3	TCGA-C8-A278	297	0	days	297	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left			TCGA-C8-A278-F20278	TCGA-C8-A278	TCGA-C8-A278-01A		Negative					Negative	Other					-22598	163		0	297									Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	630	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO			true	No	M0	N2	T2	Stage IIIA	TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf	A278	TUMOR FREE							NO			NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	Breast	A	LIVING	2010	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	666a8f56-7f29-4dba-8bdf-f2fccbe78bbd	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	666a8f56-7f29-4dba-8bdf-f2fccbe78bbd	TCGA-C8-A278-01A-21-A17K-20	TCGA-C8-A278-01A-11D-A167-09		TCGA-C8-A278-01	TCGA-C8-A278-01A-11D-A16A-05		0b7b4dce-2a48-489f-aa4d-68af0d749a17	TCGA-C8-A278-01	TCGA-C8-A278-01A-11D-A167-09			TCGA-C8-A278-01	TCGA-C8-A278-01A-11D-A167-09		8cdae811-9f3f-4c8b-9fe5-e542d30d40f2		TCGA-C8-A278-01A-11D-A166-01	TCGA-C8-A278-01		8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	TCGA-C8-A278-01A-11D-A166-01	
TCGA-C8-A27A-01	Stage IIB	48	4	Stage IIB	371		Positive	FEMALE	Negative				Negative	M0	Positive	N1	371	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A27A-01	747	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-C8-A27A	747	0	days	747	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant			TCGA-C8-A27A-F70786	TCGA-C8-A27A	TCGA-C8-A27A-01A		Positive					Positive	Modified Radical Mastectomy					-17779	435		0	747										2015-3-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Negative		NO		Negative	Peri (6-12 months since last menstrual period)																				3	5								NO			true	No	M0	N1	T2	Stage IIB	TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf	A27A	TUMOR FREE					Allred Score 7	YES	NO			NO	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2010	520a6569-bf3a-495f-9460-7f65e4f59687	2fb480d8-ea3c-40a7-aff7-c98eb38f0059	520a6569-bf3a-495f-9460-7f65e4f59687	2fb480d8-ea3c-40a7-aff7-c98eb38f0059	TCGA-C8-A27A-01A-21-A17K-20	TCGA-C8-A27A-01A-11D-A167-09		TCGA-C8-A27A-01	TCGA-C8-A27A-01A-11D-A16A-05		6e6b5e9d-fbb0-480b-9300-d9ecdbbde2b7	TCGA-C8-A27A-01	TCGA-C8-A27A-01A-11D-A167-09			TCGA-C8-A27A-01	TCGA-C8-A27A-01A-11D-A167-09		520a6569-bf3a-495f-9460-7f65e4f59687		TCGA-C8-A27A-01A-11D-A166-01	TCGA-C8-A27A-01		520a6569-bf3a-495f-9460-7f65e4f59687	TCGA-C8-A27A-01A-11D-A166-01	
TCGA-C8-A27B-01	Stage IIB	48	1	Stage IIB	30		Negative	FEMALE	Negative				Negative	M0	Negative	N0	30	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A27B-01	439	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-C8-A27B	439	0	days	439	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left			TCGA-C8-A27B-F70781	TCGA-C8-A27B	TCGA-C8-A27B-01A		Negative					Negative	Modified Radical Mastectomy					-17763	93		0	439										2015-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	240	NO	Negative		NO		Negative	Peri (6-12 months since last menstrual period)																				5	5								NO			true	No	M0	N0	T3	Stage IIB	TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf	A27B	TUMOR FREE						YES	NO			NO	Primary Tumor	01		6th		YES	NO	C8	Breast	A	LIVING	2011	fb03a31f-6611-4343-816d-37a332147eac	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	fb03a31f-6611-4343-816d-37a332147eac	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	TCGA-C8-A27B-01A-21-A17K-20	TCGA-C8-A27B-01A-11D-A167-09		TCGA-C8-A27B-01	TCGA-C8-A27B-01A-11D-A16A-05		14732205-f21b-44fc-9e31-7d8f9dde67df	TCGA-C8-A27B-01	TCGA-C8-A27B-01A-11D-A167-09			TCGA-C8-A27B-01	TCGA-C8-A27B-01A-11D-A167-09		fb03a31f-6611-4343-816d-37a332147eac		TCGA-C8-A27B-01A-11D-A166-01	TCGA-C8-A27B-01		fb03a31f-6611-4343-816d-37a332147eac	TCGA-C8-A27B-01A-11D-A166-01	
TCGA-C8-A3M7-01																			LumA										1	TCGA-C8-A3M7-01	1034	1	days	Iq	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-C8-A3M7	1034	1	days	1034	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			60	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-C8-A3M7-F70838	TCGA-C8-A3M7			Negative					Negative	Modified Radical Mastectomy		NO			-22096		1034	0	1			1034		NO					2015-3-9	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																										Locoregional Recurrence		NO	YES	0			No	M0	N0	T4b	Stage IIIB		A3M7	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th		YES	NO	C8	Breast		DECEASED	2010	b55b6630-7cf5-4bca-b76f-e135271018e4	fa8586a0-46be-45b5-9dd0-54f20b4c673c	b55b6630-7cf5-4bca-b76f-e135271018e4	fa8586a0-46be-45b5-9dd0-54f20b4c673c	TCGA-C8-A3M7-01A-21-A24A-20			TCGA-C8-A3M7-01	TCGA-C8-A3M7-01A-12D-A21R-05		c07c21cd-c286-4fd3-b98a-886e161a6ead	TCGA-C8-A3M7-01	TCGA-C8-A3M7-01A-12D-A21Q-09			TCGA-C8-A3M7-01			b55b6630-7cf5-4bca-b76f-e135271018e4		TCGA-C8-A3M7-01A-12D-A21P-01	TCGA-C8-A3M7-01		b55b6630-7cf5-4bca-b76f-e135271018e4	TCGA-C8-A3M7-01A-12D-A21P-01	
TCGA-C8-A3M8-01																			LumB										0	TCGA-C8-A3M8-01	394	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-C8-A3M8	394	0	days	394	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-C8-A3M8-F70779	TCGA-C8-A3M8	TCGA-C8-A3M8-01A		Positive					Positive	Modified Radical Mastectomy		NO			-24877	264		0	394					NO					2015-3-9	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	280	NO	Positive		NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			true	No	M0	N0	T1c	Stage IA	TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf	A3M8	TUMOR FREE		Dako		Allred	Allred	YES	YES			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2011	a04ad65d-6d83-4e84-8bd8-3cab2a195642	315dad75-6b4f-456f-be6e-77b9d066beb4	a04ad65d-6d83-4e84-8bd8-3cab2a195642	315dad75-6b4f-456f-be6e-77b9d066beb4	TCGA-C8-A3M8-01A-21-A24A-20			TCGA-C8-A3M8-01	TCGA-C8-A3M8-01A-11D-A212-05		45db31fd-5919-4580-8641-31aec5565486	TCGA-C8-A3M8-01	TCGA-C8-A3M8-01A-11D-A20S-09			TCGA-C8-A3M8-01			a04ad65d-6d83-4e84-8bd8-3cab2a195642		TCGA-C8-A3M8-01A-11D-A20R-01	TCGA-C8-A3M8-01		a04ad65d-6d83-4e84-8bd8-3cab2a195642	TCGA-C8-A3M8-01A-11D-A20R-01	
TCGA-C8-A8HP-01																													0	TCGA-C8-A8HP-01	396	0	days										TCGA-C8-A8HP	396	0	days	396	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-C8-A8HP-F69610	TCGA-C8-A8HP	TCGA-C8-A8HP-01A		Negative					Negative	Modified Radical Mastectomy					-21613	231		0	396										2015-1-15	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Core needle biopsy	240	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	6		true	No	M0	N2	T2	Stage IIIA	TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf	A8HP	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013	02cf1db9-55c0-4ece-b230-966b30cd0b94	03fd168b-3ada-472c-89a9-33dae1531fc3	02cf1db9-55c0-4ece-b230-966b30cd0b94	03fd168b-3ada-472c-89a9-33dae1531fc3				TCGA-C8-A8HP-01	TCGA-C8-A8HP-01A-11D-A36K-05		0D8764CE-08F0-4612-886E-07065119924F	TCGA-C8-A8HP-01				TCGA-C8-A8HP-01			02cf1db9-55c0-4ece-b230-966b30cd0b94		TCGA-C8-A8HP-01A-11D-A36I-01	TCGA-C8-A8HP-01		02cf1db9-55c0-4ece-b230-966b30cd0b94	TCGA-C8-A8HP-01A-11D-A36I-01	
TCGA-C8-A8HQ-01																													0	TCGA-C8-A8HQ-01	380	0	days										TCGA-C8-A8HQ	380	0	days	380	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left	Axillary lymph node dissection alone		TCGA-C8-A8HQ-F69879	TCGA-C8-A8HQ	TCGA-C8-A8HQ-01A		Positive					Positive	Modified Radical Mastectomy		NO			-19432	185		0	380										2015-1-22	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3	4	true	No	M0	N1	T2	Stage IIB	TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf	A8HQ	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013	7f8c9d62-0803-44d6-9375-b4e71612a0b1	a90a8770-3fdd-4afd-8f39-8c3b410ae8f1	7f8c9d62-0803-44d6-9375-b4e71612a0b1	a90a8770-3fdd-4afd-8f39-8c3b410ae8f1				TCGA-C8-A8HQ-01	TCGA-C8-A8HQ-01A-11D-A36K-05		39E9AC4D-F0C1-4629-9C69-09C72747A2E8	TCGA-C8-A8HQ-01				TCGA-C8-A8HQ-01			7f8c9d62-0803-44d6-9375-b4e71612a0b1		TCGA-C8-A8HQ-01A-11D-A36I-01	TCGA-C8-A8HQ-01		7f8c9d62-0803-44d6-9375-b4e71612a0b1	TCGA-C8-A8HQ-01A-11D-A36I-01	
TCGA-C8-A8HR-01																													0	TCGA-C8-A8HR-01	408	0	days										TCGA-C8-A8HR	408	0	days	408	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right	Axillary lymph node dissection alone		TCGA-C8-A8HR-F69796	TCGA-C8-A8HR	TCGA-C8-A8HR-01A								Modified Radical Mastectomy		NO			-17921	162		0	408										2015-1-20	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	420	NO			NO	8	Negative	Peri (6-12 months since last menstrual period)																													NO	5		true	No	M0	N2	T3	Stage IIIA	TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf	A8HR	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013	d817dcee-1322-4949-a6e9-138447e6fc56	77c63c3d-458d-4e59-bb39-3394cda8ba21	d817dcee-1322-4949-a6e9-138447e6fc56	77c63c3d-458d-4e59-bb39-3394cda8ba21				TCGA-C8-A8HR-01	TCGA-C8-A8HR-01A-11D-A36K-05		D888CD95-8F1F-48DE-8DDC-70C9AD64579F	TCGA-C8-A8HR-01				TCGA-C8-A8HR-01			d817dcee-1322-4949-a6e9-138447e6fc56		TCGA-C8-A8HR-01A-11D-A36I-01	TCGA-C8-A8HR-01		d817dcee-1322-4949-a6e9-138447e6fc56	TCGA-C8-A8HR-01A-11D-A36I-01	
TCGA-C8-A9FZ-01																													0	TCGA-C8-A9FZ-01	592	0	days										TCGA-C8-A9FZ	592	0	days	592	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left	Axillary lymph node dissection alone		TCGA-C8-A9FZ-F69966	TCGA-C8-A9FZ	TCGA-C8-A9FZ-01A								Modified Radical Mastectomy		NO			-18038	191		0	592										2015-1-23	FEMALE										Mixed Histology (please specify)	Infiltrating Tubulo-Lobular Carcinoma	No		C50.9	8524/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3		true	No	M0	N1	T2	Stage IIB	TCGA-C8-A9FZ.23B3BAED-E281-4A1D-AB78-51D8D62466FF.pdf	A9FZ	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	C8	Breast	A	LIVING	2013		158677fe-9918-45b1-b1b4-62288491d4a1		158677fe-9918-45b1-b1b4-62288491d4a1					TCGA-C8-A9FZ-01A-11D-A41Q-05		7E0EFE5A-8C0A-4B7F-950D-9F0CFFB57F01					TCGA-C8-A9FZ-01					TCGA-C8-A9FZ-01A-11D-A41E-01	TCGA-C8-A9FZ-01			TCGA-C8-A9FZ-01A-11D-A41E-01	
TCGA-D8-A13Y-01	Stage IA	52	5	No_Conversion	362		Positive	FEMALE	Negative	3	2	4	Negative	M0	Negative	N0	362	0	LumB	Luminal B	Positive	Basal	-2	-6	followup	T1	T1	LIVING	0	TCGA-D8-A13Y-01	1728	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	GBM-like c6	miRNA cluster 6	cluster 1	mutation cluster 2	TCGA-D8-A13Y	1728	0	days	1728	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A13Y-F72210	TCGA-D8-A13Y	TCGA-D8-A13Y-01A		Positive					Positive	Modified Radical Mastectomy		NO			-19028	184		0	1728						manual counting	70-79%		Scheduled Follow-up Submission	2015-4-29	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO	Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181.pdf	A13Y	TUMOR FREE	manual counting			10-75%	10-75%	YES		70-79%		NO	Primary Tumor	01			YES	YES	NO	D8	Breast	A	LIVING	2010	9a92e20a-2a43-4917-981d-c93179770050	7d1b722a-15e9-4ba8-846c-94fb949345ed	9a92e20a-2a43-4917-981d-c93179770050	7d1b722a-15e9-4ba8-846c-94fb949345ed	TCGA-D8-A13Y-01A-21-A13D-20	TCGA-D8-A13Y-01A-11D-A10Y-09		TCGA-D8-A13Y-01			664694fa-7bea-4f87-b6ff-4df52540d15b	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11D-A10Y-09	TCGA-D8-A13Y-01A-11D-A112-05	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11D-A10Y-09		9a92e20a-2a43-4917-981d-c93179770050		TCGA-D8-A13Y-01A-11D-A111-01	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11R-A115-07	9a92e20a-2a43-4917-981d-c93179770050	TCGA-D8-A13Y-01A-11D-A111-01	TCGA-D8-A13Y-01
TCGA-D8-A13Z-01	Stage X	51	1	Stage IIIA	210		Negative	FEMALE	Negative	2	2	1	Negative	M0	Positive	N2	210	0	Her2	HER2-enriched	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-D8-A13Z-01	635	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A13Z	635	0	days	635	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A13Z-F20731	TCGA-D8-A13Z	TCGA-D8-A13Z-01A		Negative					Negative	Modified Radical Mastectomy					-18942	214		0	635									Scheduled Follow-up Submission	2012-1-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	9		false	No	M0	N2a	T2		TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf	A13Z	TUMOR FREE		Hercep Test  TM Dako					YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	TCGA-D8-A13Z-01A-21-A13D-20	TCGA-D8-A13Z-01A-11D-A10Y-09		TCGA-D8-A13Z-01			ecffe473-31aa-41e3-a964-ca96147a8023	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11D-A10Y-09	TCGA-D8-A13Z-01A-11D-A112-05	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11D-A10Y-09		624ac458-8ff1-441c-a8c5-aaf4a08a4b84		TCGA-D8-A13Z-01A-11D-A111-01	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11R-A115-07	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	TCGA-D8-A13Z-01A-11D-A111-01	TCGA-D8-A13Z-01
TCGA-D8-A140-01	Stage IIB	62		Stage IIB	403		Positive	FEMALE	Positive				Negative	M0	Positive	N1	403	0	LumA	Luminal B	Positive	LumA/B	-10	-5	followup	T_Other	T2	LIVING	0	TCGA-D8-A140-01	403	0	days		C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-D8-A140	403	0	days	403	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-D8-A140-F13808	TCGA-D8-A140	TCGA-D8-A140-01A		Positive					Positive	Modified Radical Mastectomy		NO			-22900	204		0	403						manual counting			Scheduled Follow-up Submission	2011-6-20	FEMALE		Hercep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Positive			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	6								NO	1		false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A140.D78476E6-799F-4DED-A219-CBFE2DE3C77B.pdf	A140	TUMOR FREE	manual counting			<10%	>75%		YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	3551b6ac-c340-4640-9bbf-fe1181e1c773	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	3551b6ac-c340-4640-9bbf-fe1181e1c773	TCGA-D8-A140-01A-21-A13D-20	TCGA-D8-A140-01A-11D-A10Y-09		TCGA-D8-A140-01			ce3b8c9f-acd7-4ba7-8042-3a3de6225cde	TCGA-D8-A140-01	TCGA-D8-A140-01A-11D-A10Y-09	TCGA-D8-A140-01A-11D-A112-05	TCGA-D8-A140-01	TCGA-D8-A140-01	TCGA-D8-A140-01A-11D-A10Y-09		116f1b9d-8c0c-4b29-b9b2-06ea186f4480		TCGA-D8-A140-01A-11D-A111-01	TCGA-D8-A140-01	TCGA-D8-A140-01A-11R-A115-07	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	TCGA-D8-A140-01A-11D-A111-01	TCGA-D8-A140-01
TCGA-D8-A141-01	Stage X	40	2	Stage IIA	113		Positive	FEMALE	Negative				Negative	M0	Positive	N1	113	0	LumA	Luminal A	Positive		-5	-4	enrollment	T1	T1	LIVING	0	TCGA-D8-A141-01	626	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A141	626	0	days	626	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Axillary lymph node dissection alone		TCGA-D8-A141-F20734	TCGA-D8-A141			Positive					Positive	Modified Radical Mastectomy					-14626			0	626						manual counting			Scheduled Follow-up Submission	2012-1-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			15	Negative	Indeterminate (neither Pre or Postmenopausal)																				1	4								NO	1			No	M0	N1	T1c			A141	TUMOR FREE	manual counting	Hercep Test  TM Dako		>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	b96324a1-55fb-4b3a-b813-0305e6bd31c2	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	b96324a1-55fb-4b3a-b813-0305e6bd31c2		TCGA-D8-A141-01A-11D-A10Y-09		TCGA-D8-A141-01				TCGA-D8-A141-01	TCGA-D8-A141-01A-11D-A10Y-09	TCGA-D8-A141-01A-11D-A112-05	TCGA-D8-A141-01	TCGA-D8-A141-01	TCGA-D8-A141-01A-11D-A10Y-09		cb6c668a-ff24-4ebe-99f7-0c24fcf17c32		TCGA-D8-A141-01A-11D-A111-01	TCGA-D8-A141-01	TCGA-D8-A141-01A-11R-A115-07	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	TCGA-D8-A141-01A-11D-A111-01	TCGA-D8-A141-01
TCGA-D8-A142-01	Stage IIB	74	1	Stage IIB	425		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	425	0	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	LIVING	0	TCGA-D8-A142-01	425	0	days	High	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9	cluster 3	mutation cluster 5	TCGA-D8-A142	425	0	days	425	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone		TCGA-D8-A142-F13813	TCGA-D8-A142	TCGA-D8-A142-01A		Negative					Negative	Modified Radical Mastectomy		NO			-27313	212		0	425									Scheduled Follow-up Submission	2011-6-20	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0		false	No	M0	N0	T3	Stage IIB	TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf	A142	TUMOR FREE		FISH					YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	336577b1-b012-4346-936b-0502d0f8a597	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	336577b1-b012-4346-936b-0502d0f8a597	TCGA-D8-A142-01A-21-A13D-20	TCGA-D8-A142-01A-11D-A10Y-09		TCGA-D8-A142-01			d434b104-6d07-417e-9a84-c729c071cf14	TCGA-D8-A142-01	TCGA-D8-A142-01A-11D-A10Y-09	TCGA-D8-A142-01A-11D-A112-05	TCGA-D8-A142-01	TCGA-D8-A142-01	TCGA-D8-A142-01A-11D-A10Y-09		9f440cd6-d55f-4cb6-a433-637ef1f9d38f		TCGA-D8-A142-01A-11D-A111-01	TCGA-D8-A142-01	TCGA-D8-A142-01A-11R-A115-07	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	TCGA-D8-A142-01A-11D-A111-01	TCGA-D8-A142-01
TCGA-D8-A143-01	Stage IIA	51	3	Stage IIA	431		Negative	FEMALE	Negative				Negative	M0	Negative	N0	431	0	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-D8-A143-01	431	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7			mutation cluster 3	TCGA-D8-A143	431	0	days	431	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A143-F13817	TCGA-D8-A143	TCGA-D8-A143-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18984	211		0	431									Scheduled Follow-up Submission	2011-7-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf	A143	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	TCGA-D8-A143-01A-21-A13D-20	TCGA-D8-A143-01A-11D-A10Y-09		TCGA-D8-A143-01			e9cd47fb-4a8f-44c9-af6a-f931387d14a7	TCGA-D8-A143-01	TCGA-D8-A143-01A-11D-A10Y-09	TCGA-D8-A143-01A-11D-A112-05	TCGA-D8-A143-01	TCGA-D8-A143-01	TCGA-D8-A143-01A-11D-A10Y-09		4bf5f56d-448a-426a-8edc-f1bdbf6a8d55		TCGA-D8-A143-01A-11D-A111-01	TCGA-D8-A143-01	TCGA-D8-A143-01A-11R-A115-07	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	TCGA-D8-A143-01A-11D-A111-01	TCGA-D8-A143-01
TCGA-D8-A145-01	Stage IIA	80	1	Stage IIA	410		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	410	0	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-D8-A145-01	410	0	days	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-D8-A145	410	0	days	410	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A145-F13811	TCGA-D8-A145	TCGA-D8-A145-01A		Positive					Positive	Simple Mastectomy		NO			-29280	191		0	410						manual counting			Scheduled Follow-up Submission	2011-7-4	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	1		false	No	M0	N1a	T1c	Stage IIA	TCGA-D8-A145.1D26CB97-536A-4D10-A593-73C3A846BB13.pdf	A145	TUMOR FREE	manual counting				>75%		YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	6223244a-ed38-46b5-8e65-cc8e4926c809	6afb99b2-188d-4de2-9d42-821be341609d	6223244a-ed38-46b5-8e65-cc8e4926c809	6afb99b2-188d-4de2-9d42-821be341609d	TCGA-D8-A145-01A-21-A13D-20	TCGA-D8-A145-01A-11D-A10Y-09		TCGA-D8-A145-01			c734c71e-bd11-4c7c-862a-1d578d1951b1	TCGA-D8-A145-01	TCGA-D8-A145-01A-11D-A10Y-09	TCGA-D8-A145-01A-11D-A112-05	TCGA-D8-A145-01	TCGA-D8-A145-01	TCGA-D8-A145-01A-11D-A10Y-09		6223244a-ed38-46b5-8e65-cc8e4926c809		TCGA-D8-A145-01A-11D-A111-01	TCGA-D8-A145-01	TCGA-D8-A145-01A-11R-A115-07	6223244a-ed38-46b5-8e65-cc8e4926c809	TCGA-D8-A145-01A-11D-A111-01	TCGA-D8-A145-01
TCGA-D8-A146-01	Stage IIA	57		Stage IIA	344		Positive	FEMALE	Negative				Negative	M0	Negative	N0	344	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A146-01	643	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-D8-A146	643	0	days	643	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone		TCGA-D8-A146-F20750	TCGA-D8-A146	TCGA-D8-A146-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20861	221		0	643					NO	manual counting			Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKO Hercep Test TM			1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	Yes	MX	N0	T2	Stage IIA	TCGA-D8-A146.79749F5D-329A-400D-8511-C4CF479C1FCC.pdf	A146	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	69f535c7-8f70-4efc-98bc-7f99924d7db1	136bb2dd-32dc-434d-978c-310c93fa1dd8	69f535c7-8f70-4efc-98bc-7f99924d7db1	136bb2dd-32dc-434d-978c-310c93fa1dd8	TCGA-D8-A146-01A-21-A13D-20	TCGA-D8-A146-01A-31D-A10Y-09		TCGA-D8-A146-01			9953ddb6-cba3-4fd0-9917-42071efaabdb	TCGA-D8-A146-01	TCGA-D8-A146-01A-31D-A10Y-09	TCGA-D8-A146-01A-31D-A112-05	TCGA-D8-A146-01		TCGA-D8-A146-01A-31D-A10Y-09		69f535c7-8f70-4efc-98bc-7f99924d7db1		TCGA-D8-A146-01A-31D-A111-01		TCGA-D8-A146-01A-31R-A115-07	69f535c7-8f70-4efc-98bc-7f99924d7db1	TCGA-D8-A146-01A-31D-A111-01	TCGA-D8-A146-01
TCGA-D8-A147-01	Stage X	45	1	Stage IIA	2		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	2	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-D8-A147-01	584	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-D8-A147	584	0	days	584	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A147-F20737	TCGA-D8-A147	TCGA-D8-A147-01A		Negative					Negative	Lumpectomy					-16736	163		0	584									Scheduled Follow-up Submission	2012-1-14	FEMALE		Hercep Test  TM Dako								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			1	Negative	Indeterminate (neither Pre or Postmenopausal)																				5	5								NO	0		false	No	M0	N0	T2		TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf	A147	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	4d28bcbc-dbdd-46f8-9329-49f359480a97	92830f47-3f32-4b74-bef4-4536963be38f	4d28bcbc-dbdd-46f8-9329-49f359480a97	92830f47-3f32-4b74-bef4-4536963be38f	TCGA-D8-A147-01A-21-A13D-20	TCGA-D8-A147-01A-11D-A10Y-09		TCGA-D8-A147-01			a8d9009e-ecf1-420f-a3b7-faab805210de	TCGA-D8-A147-01	TCGA-D8-A147-01A-11D-A10Y-09	TCGA-D8-A147-01A-11D-A112-05	TCGA-D8-A147-01	TCGA-D8-A147-01	TCGA-D8-A147-01A-11D-A10Y-09		4d28bcbc-dbdd-46f8-9329-49f359480a97		TCGA-D8-A147-01A-11D-A111-01	TCGA-D8-A147-01	TCGA-D8-A147-01A-11R-A115-07	4d28bcbc-dbdd-46f8-9329-49f359480a97	TCGA-D8-A147-01A-11D-A111-01	TCGA-D8-A147-01
TCGA-D8-A1J8-01	Stage IIB	77	2	Stage IIB	256		Positive	FEMALE	Negative				Negative	M0	Positive	N1	256	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1J8-01	431	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-D8-A1J8	431	0	days	431	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1J8-F14040	TCGA-D8-A1J8	TCGA-D8-A1J8-01A		Positive					Positive	Modified Radical Mastectomy					-28444	272		0	431							70-79%		Scheduled Follow-up Submission	2011-7-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	3		false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1J8.E8E799F8-158D-4AEC-8F86-D40F132C071C.pdf	A1J8	TUMOR FREE								70-79%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	809e26fd-e8ab-4ad2-aaac-25fbfe767682	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	809e26fd-e8ab-4ad2-aaac-25fbfe767682	TCGA-D8-A1J8-01A-21-A17J-20			TCGA-D8-A1J8-01	TCGA-D8-A1J8-01A-11D-A13K-05		f1a4f40a-6d0d-49a8-ab70-d275856a8996	TCGA-D8-A1J8-01	TCGA-D8-A1J8-01A-11D-A13L-09			TCGA-D8-A1J8-01			ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef		TCGA-D8-A1J8-01A-11D-A13J-01	TCGA-D8-A1J8-01		ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-11D-A13J-01	
TCGA-D8-A1J9-01	Stage IA	48	2	Stage I	248		Positive	FEMALE	Positive				Negative	M0	Negative	N0	248	0	LumB		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1J9-01	532	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-D8-A1J9	532	0	days	532	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1J9-F20944	TCGA-D8-A1J9	TCGA-D8-A1J9-01A		Positive					Negative	Modified Radical Mastectomy					-17879	211		0	532						manual counting			Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Positive			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf	A1J9	TUMOR FREE	manual counting			0%	10-75%					NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	6570866d-4604-4a9d-a672-516cb1168f6c	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	6570866d-4604-4a9d-a672-516cb1168f6c	TCGA-D8-A1J9-01A-21-A17J-20	TCGA-D8-A1J9-01A-11D-A13L-09		TCGA-D8-A1J9-01	TCGA-D8-A1J9-01A-11D-A13K-05		07d51184-85a3-4ba7-9cc2-badcb3ccfa23	TCGA-D8-A1J9-01	TCGA-D8-A1J9-01A-11D-A13L-09			TCGA-D8-A1J9-01	TCGA-D8-A1J9-01A-11D-A13L-09		ff7159e7-e9f2-4cc8-ab89-f4167d19672c		TCGA-D8-A1J9-01A-11D-A13J-01	TCGA-D8-A1J9-01		ff7159e7-e9f2-4cc8-ab89-f4167d19672c	TCGA-D8-A1J9-01A-11D-A13J-01	
TCGA-D8-A1JA-01	Stage X	60	1	Stage IIIB	18		Negative	FEMALE	Positive				Negative	M0	Negative	N0	18	0	Her2		Negative				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A1JA-01	502	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5		TCGA-D8-A1JA	431	1	days	502	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES	NO		60	Left Upper Outer Quadrant	No axillary staging		TCGA-D8-A1JA-F20941	TCGA-D8-A1JA	TCGA-D8-A1JA-01A		Negative					Negative	Modified Radical Mastectomy		NO			-21918	194		0	502			431			manual counting	<10%		Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	310	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5					Locoregional Disease			YES			false	No	M0	NX	T4b		TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf	A1JA	WITH TUMOR	manual counting			0%			NO			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	ae81378c-ada3-43cb-9855-941467fd856c	05cd681e-6864-4296-88d3-f3848bdaaf58	ae81378c-ada3-43cb-9855-941467fd856c	05cd681e-6864-4296-88d3-f3848bdaaf58	TCGA-D8-A1JA-01A-21-A17J-20			TCGA-D8-A1JA-01	TCGA-D8-A1JA-01A-11D-A13K-05		62f05450-0574-4a36-aaae-6a2d2078950e	TCGA-D8-A1JA-01	TCGA-D8-A1JA-01A-11D-A13L-09			TCGA-D8-A1JA-01			ae81378c-ada3-43cb-9855-941467fd856c		TCGA-D8-A1JA-01A-11D-A13J-01	TCGA-D8-A1JA-01		ae81378c-ada3-43cb-9855-941467fd856c	TCGA-D8-A1JA-01A-11D-A13J-01	
TCGA-D8-A1JB-01	Stage IIB	54	3	Stage IIB	0		Positive	FEMALE	Positive				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JB-01	1688	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-D8-A1JB	1688	0	days	1688	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JB-F72209	TCGA-D8-A1JB	TCGA-D8-A1JB-01A		Positive					Positive	Modified Radical Mastectomy		NO			-19822	232		0	1688						manual counting			Scheduled Follow-up Submission	2015-4-29	FEMALE		Hecep Test TM DAKO		Path Vysion HER2 D Probe Kit	2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Equivocal	Positive	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	1		false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf	A1JB	TUMOR FREE	manual counting			10-75%	>75%	YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	ba751e6e-5336-423f-81a4-5ec3109ae4e7	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	ba751e6e-5336-423f-81a4-5ec3109ae4e7	TCGA-D8-A1JB-01A-21-A17J-20	TCGA-D8-A1JB-01A-11D-A13L-09		TCGA-D8-A1JB-01	TCGA-D8-A1JB-01A-11D-A13K-05		6c49abf3-08bb-47a4-be2c-6957bf1de2eb	TCGA-D8-A1JB-01	TCGA-D8-A1JB-01A-11D-A13L-09			TCGA-D8-A1JB-01	TCGA-D8-A1JB-01A-11D-A13L-09		45fe02d2-5d68-43c4-9cea-7da6e16a55a2		TCGA-D8-A1JB-01A-11D-A13J-01	TCGA-D8-A1JB-01		45fe02d2-5d68-43c4-9cea-7da6e16a55a2	TCGA-D8-A1JB-01A-11D-A13J-01	
TCGA-D8-A1JC-01	Stage IIIA	59	5	Stage IIIA	178		Positive	FEMALE	Negative				Negative	M0	Positive	N2	178	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JC-01	480	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-D8-A1JC	480	0	days	480	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JC-F20847	TCGA-D8-A1JC	TCGA-D8-A1JC-01A		Positive					Positive	Modified Radical Mastectomy		NO			-21898	201		0	480									Scheduled Follow-up Submission	2012-1-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	180	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	4		false	No	M0	N2a	T2	Stage IIIA	TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf	A1JC	TUMOR FREE				>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	d7bb6fff-6305-4980-ab29-0bb9757b7687	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	d7bb6fff-6305-4980-ab29-0bb9757b7687	TCGA-D8-A1JC-01A-21-A17J-20	TCGA-D8-A1JC-01A-11D-A13L-09		TCGA-D8-A1JC-01	TCGA-D8-A1JC-01A-11D-A13K-05		57323434-3660-45b6-90fd-6183e75a5b54	TCGA-D8-A1JC-01	TCGA-D8-A1JC-01A-11D-A13L-09			TCGA-D8-A1JC-01	TCGA-D8-A1JC-01A-11D-A13L-09		d69c60ae-d21b-4e6e-89c5-ef0750a31c71		TCGA-D8-A1JC-01A-11D-A13J-01	TCGA-D8-A1JC-01		d69c60ae-d21b-4e6e-89c5-ef0750a31c71	TCGA-D8-A1JC-01A-11D-A13J-01	
TCGA-D8-A1JD-01	Stage IIB	41	5	Stage IIB	273		Positive	FEMALE	Negative				Negative	M0	Positive	N1	273	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JD-01	552	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1JD	552	0	days	552	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JD-F20844	TCGA-D8-A1JD	TCGA-D8-A1JD-01A		Positive					Positive	Modified Radical Mastectomy					-15166	230		0	552						manual counting			Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO	3	0	false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf	A1JD	TUMOR FREE	manual counting			10-75%	>75%					YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	f2ee7101-b51e-4f75-95fa-555b5b79af74	907cd6bb-05fd-4557-b21d-d8d8d16fb8a3	f2ee7101-b51e-4f75-95fa-555b5b79af74	907cd6bb-05fd-4557-b21d-d8d8d16fb8a3	TCGA-D8-A1JD-01A-21-A17J-20	TCGA-D8-A1JD-01A-11D-A13L-09		TCGA-D8-A1JD-01	TCGA-D8-A1JD-01A-11D-A13K-05		7788922c-5c28-46e3-9ee9-6fb8aab752d4	TCGA-D8-A1JD-01	TCGA-D8-A1JD-01A-11D-A13L-09			TCGA-D8-A1JD-01	TCGA-D8-A1JD-01A-11D-A13L-09		f2ee7101-b51e-4f75-95fa-555b5b79af74		TCGA-D8-A1JD-01A-11D-A13J-01	TCGA-D8-A1JD-01		f2ee7101-b51e-4f75-95fa-555b5b79af74	TCGA-D8-A1JD-01A-11D-A13J-01	
TCGA-D8-A1JE-01	Stage IIA	62	2	Stage IIA	57		Positive	FEMALE	Negative				Negative	M0	Positive	N1	57	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JE-01	575	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1JE	575	0	days	575	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JE-F20759	TCGA-D8-A1JE			Positive					Positive	Modified Radical Mastectomy		NO			-22683			0	575						manual counting			Scheduled Follow-up Submission	2012-1-8	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	3			No	M0	N1a	T1c	Stage IIA		A1JE	TUMOR FREE	manual counting			10-75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	c7139402-146f-4c49-bcd0-f2a6a378911e	ff8bc49a-9c34-45ab-864b-0e052fd6e594	c7139402-146f-4c49-bcd0-f2a6a378911e	ff8bc49a-9c34-45ab-864b-0e052fd6e594	TCGA-D8-A1JE-01A-21-A17J-20	TCGA-D8-A1JE-01A-11D-A13L-09		TCGA-D8-A1JE-01	TCGA-D8-A1JE-01A-11D-A13K-05		ad15f06b-4988-4132-9b8c-1c04e14fa98e	TCGA-D8-A1JE-01	TCGA-D8-A1JE-01A-11D-A13L-09			TCGA-D8-A1JE-01	TCGA-D8-A1JE-01A-11D-A13L-09		c7139402-146f-4c49-bcd0-f2a6a378911e		TCGA-D8-A1JE-01A-11D-A13J-01	TCGA-D8-A1JE-01		c7139402-146f-4c49-bcd0-f2a6a378911e	TCGA-D8-A1JE-01A-11D-A13J-01	
TCGA-D8-A1JF-01	Stage IIIA	79	3	Stage IIIA	96		Negative	FEMALE	Negative				Negative	M0	Positive	N2	96	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JF-01	366	0	days	COAD-READ	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-D8-A1JF	366	0	days	366	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JF-F14058	TCGA-D8-A1JF			Negative					Negative	Modified Radical Mastectomy		NO			-29199			0	366									Scheduled Follow-up Submission	2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	3								NO	8			No	M0	N2a	T1c	Stage IIIA		A1JF	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2010	a74b20ca-06f9-47ec-8888-cb01e0ba3257	b93cb7b4-ce63-4f54-864e-f271f86c0781	a74b20ca-06f9-47ec-8888-cb01e0ba3257	b93cb7b4-ce63-4f54-864e-f271f86c0781	TCGA-D8-A1JF-01A-21-A17J-20	TCGA-D8-A1JF-01A-11D-A13L-09		TCGA-D8-A1JF-01	TCGA-D8-A1JF-01A-11D-A13K-05		c9bf8bae-3cf7-4b3f-8fb4-51e9bd4e83a8	TCGA-D8-A1JF-01	TCGA-D8-A1JF-01A-11D-A13L-09			TCGA-D8-A1JF-01	TCGA-D8-A1JF-01A-11D-A13L-09		a74b20ca-06f9-47ec-8888-cb01e0ba3257		TCGA-D8-A1JF-01A-11D-A13J-01	TCGA-D8-A1JF-01		a74b20ca-06f9-47ec-8888-cb01e0ba3257	TCGA-D8-A1JF-01A-11D-A13J-01	
TCGA-D8-A1JG-01	Stage IIA	62	1	Stage IIA	187		Negative	FEMALE	Negative				Negative	M0	Negative	N0	187	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JG-01	1612	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1JG	1612	0	days	1612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JG-F72208	TCGA-D8-A1JG	TCGA-D8-A1JG-01B		Negative					Negative	Lumpectomy		NO			-22878	215		0	1612									Scheduled Follow-up Submission	2015-4-29	FEMALE					2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	250	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JG.E1907A10-207B-41F1-8B8B-24D5B551BD05.pdf	A1JG	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	B	LIVING	2010	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	TCGA-D8-A1JG-01B-21-A17J-20	TCGA-D8-A1JG-01B-11D-A13L-09		TCGA-D8-A1JG-01	TCGA-D8-A1JG-01B-11D-A13K-05		dc251841-a624-484b-b4ce-b149651d3b57	TCGA-D8-A1JG-01	TCGA-D8-A1JG-01B-11D-A13L-09			TCGA-D8-A1JG-01	TCGA-D8-A1JG-01B-11D-A13L-09		ee8b563d-11bb-4d84-ac53-e2acc8d0275d		TCGA-D8-A1JG-01B-11D-A13J-01	TCGA-D8-A1JG-01		ee8b563d-11bb-4d84-ac53-e2acc8d0275d	TCGA-D8-A1JG-01B-11D-A13J-01	
TCGA-D8-A1JH-01	Stage IA	56	1	Stage I	426		Positive	FEMALE	Negative				Negative	M0	Negative	N0	426	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JH-01	426	0	days	Quiet	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-D8-A1JH	426	0	days	426	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JH-F14055	TCGA-D8-A1JH	TCGA-D8-A1JH-01A		Positive					Positive	Modified Radical Mastectomy					-20497	263		0	426						manual counting			Scheduled Follow-up Submission	2011-7-18	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO			false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf	A1JH	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	fb59b402-77cf-4eac-aaf8-4ebaf715acbb	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	fb59b402-77cf-4eac-aaf8-4ebaf715acbb	TCGA-D8-A1JH-01A-21-A17J-20	TCGA-D8-A1JH-01A-11D-A188-09		TCGA-D8-A1JH-01	TCGA-D8-A1JH-01A-11D-A13K-05		16c99b80-d0de-4a1e-b8f8-d119431fc8db	TCGA-D8-A1JH-01	TCGA-D8-A1JH-01A-11D-A188-09			TCGA-D8-A1JH-01	TCGA-D8-A1JH-01A-11D-A188-09		00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8		TCGA-D8-A1JH-01A-11D-A13J-01	TCGA-D8-A1JH-01		00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	TCGA-D8-A1JH-01A-11D-A13J-01	
TCGA-D8-A1JI-01	Stage IIA	54	2	Stage IIA	21		Positive	FEMALE	Negative				Negative	M0	Positive	N1	21	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JI-01	577	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1JI	577	0	days	577	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JI-F20757	TCGA-D8-A1JI	TCGA-D8-A1JI-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20072	226		0	577						manual counting			Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO	2		false	No	MX	N1a	T1c	Stage IIA	TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf	A1JI	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	27706c21-96cb-48e9-88ec-1c52769bfe45	06007408-83ae-42dd-b7ea-bd017e97669f	27706c21-96cb-48e9-88ec-1c52769bfe45	06007408-83ae-42dd-b7ea-bd017e97669f	TCGA-D8-A1JI-01A-21-A17J-20	TCGA-D8-A1JI-01A-11D-A13L-09		TCGA-D8-A1JI-01	TCGA-D8-A1JI-01A-11D-A13K-05		621f10de-1603-49a6-ab27-8cfc9c4fd621	TCGA-D8-A1JI-01	TCGA-D8-A1JI-01A-11D-A13L-09			TCGA-D8-A1JI-01	TCGA-D8-A1JI-01A-11D-A13L-09		27706c21-96cb-48e9-88ec-1c52769bfe45		TCGA-D8-A1JI-01A-11D-A13J-01	TCGA-D8-A1JI-01		27706c21-96cb-48e9-88ec-1c52769bfe45	TCGA-D8-A1JI-01A-11D-A13J-01	
TCGA-D8-A1JJ-01	Stage IIA	54	1	Stage IIA	274		Positive	FEMALE	Negative				Negative	M0	Negative	N0	274	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JJ-01	611	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 3	TCGA-D8-A1JJ	611	0	days	611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JJ-F20754	TCGA-D8-A1JJ	TCGA-D8-A1JJ-01A		Positive					Positive	Other					-19966	260		0	611						manual counting			Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf	A1JJ	TUMOR FREE	manual counting	10-75%		10-75%	>75%		YES			YES	Primary Tumor	01	breast conserving therapy	7th	YES	YES	NO	D8	Breast	A	LIVING	2010	091cb252-dd08-4e9c-939c-749f595713f6	d52157a2-cf02-470c-b912-78697cb75086	091cb252-dd08-4e9c-939c-749f595713f6	d52157a2-cf02-470c-b912-78697cb75086	TCGA-D8-A1JJ-01A-11-A17J-20	TCGA-D8-A1JJ-01A-31D-A14K-09		TCGA-D8-A1JJ-01	TCGA-D8-A1JJ-01A-31D-A14N-05		f1275b85-f44d-447b-8def-00e4f4c9b2c0	TCGA-D8-A1JJ-01	TCGA-D8-A1JJ-01A-31D-A14K-09			TCGA-D8-A1JJ-01	TCGA-D8-A1JJ-01A-31D-A14K-09		091cb252-dd08-4e9c-939c-749f595713f6		TCGA-D8-A1JJ-01A-31D-A14J-01	TCGA-D8-A1JJ-01		091cb252-dd08-4e9c-939c-749f595713f6	TCGA-D8-A1JJ-01A-31D-A14J-01	
TCGA-D8-A1JK-01	Stage IIA	90	1	Stage IIA	109		Negative	FEMALE	Negative				Negative	M0	Negative	N0	109	0	Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JK-01	612	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 4	mutation cluster 3	TCGA-D8-A1JK	612	0	days	612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JK-F20751	TCGA-D8-A1JK	TCGA-D8-A1JK-01A		Negative					Positive	Modified Radical Mastectomy					-32872	261		0	612						manual counting			Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	270	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf	A1JK	TUMOR FREE	manual counting				0%		YES	<10%		NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	7013da0d-5e90-4f8d-a489-8077b55309b0	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	7013da0d-5e90-4f8d-a489-8077b55309b0	TCGA-D8-A1JK-01A-21-A17J-20	TCGA-D8-A1JK-01A-11D-A13L-09		TCGA-D8-A1JK-01	TCGA-D8-A1JK-01A-11D-A13K-05		0f3becf1-2a76-4401-950b-6809dfd90276	TCGA-D8-A1JK-01	TCGA-D8-A1JK-01A-11D-A13L-09			TCGA-D8-A1JK-01	TCGA-D8-A1JK-01A-11D-A13L-09		f7dd2e6b-a87e-467b-890a-3c422ae3dea7		TCGA-D8-A1JK-01A-11D-A13J-01	TCGA-D8-A1JK-01		f7dd2e6b-a87e-467b-890a-3c422ae3dea7	TCGA-D8-A1JK-01A-11D-A13J-01	
TCGA-D8-A1JL-01	Stage IIA	72	3	Stage IIA	265		Negative	FEMALE	Negative				Negative	M0	Negative	N0	265	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JL-01	611	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1JL	611	0	days	611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JL-F20747	TCGA-D8-A1JL	TCGA-D8-A1JL-01A		Negative					Negative	Modified Radical Mastectomy					-26484	264		0	611						manual counting			Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	2								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JL.156DF753-DB3A-4934-9618-1E18CE46C845.pdf	A1JL	TUMOR FREE	manual counting			0%	0%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	b4673313-fa18-43e8-a01b-5cdb3cf5425e	8f111081-c896-403e-b965-65d3e3a9ba62	b4673313-fa18-43e8-a01b-5cdb3cf5425e	8f111081-c896-403e-b965-65d3e3a9ba62	TCGA-D8-A1JL-01A-21-A17J-20	TCGA-D8-A1JL-01A-11D-A13L-09		TCGA-D8-A1JL-01	TCGA-D8-A1JL-01A-11D-A13K-05		c5c33030-617d-46a1-89a5-fa6ddd7d06fc	TCGA-D8-A1JL-01	TCGA-D8-A1JL-01A-11D-A13L-09			TCGA-D8-A1JL-01	TCGA-D8-A1JL-01A-11D-A13L-09		b4673313-fa18-43e8-a01b-5cdb3cf5425e		TCGA-D8-A1JL-01A-11D-A13J-01	TCGA-D8-A1JL-01		b4673313-fa18-43e8-a01b-5cdb3cf5425e	TCGA-D8-A1JL-01A-11D-A13J-01	
TCGA-D8-A1JM-01	Stage IIB	59	1	Stage IIB	238		Positive	FEMALE	Negative				Negative	M0	Positive	N1	238	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JM-01	590	0	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-D8-A1JM	590	0	days	590	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JM-F20742	TCGA-D8-A1JM	TCGA-D8-A1JM-01A		Positive					Negative	Modified Radical Mastectomy					-21602	243		0	590						manual counting	<10%		Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	3		false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1JM.947954F1-4CBA-42D3-99B2-6BE6E44E5239.pdf	A1JM	TUMOR FREE	manual counting			0%			YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	d2f50599-788e-4f91-9b11-ec882d5b7736	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	d2f50599-788e-4f91-9b11-ec882d5b7736	TCGA-D8-A1JM-01A-21-A17J-20	TCGA-D8-A1JM-01A-11D-A13L-09		TCGA-D8-A1JM-01	TCGA-D8-A1JM-01A-11D-A13K-05		8d31dc1e-928f-4d15-9ebc-cdab6a5e3527	TCGA-D8-A1JM-01	TCGA-D8-A1JM-01A-11D-A13L-09				TCGA-D8-A1JM-01A-11D-A13L-09		ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525		TCGA-D8-A1JM-01A-11D-A13J-01			ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-11D-A13J-01	
TCGA-D8-A1JN-01	Stage IIIC	80	2	Stage IIIC	217		Positive	FEMALE	Negative				Negative	M0	Positive	N3	217	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1JN-01	620	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-D8-A1JN	620	0	days	620	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left	Axillary lymph node dissection alone		TCGA-D8-A1JN-F20745	TCGA-D8-A1JN	TCGA-D8-A1JN-01A		Positive					Positive	Modified Radical Mastectomy					-29331	273		0	620						manual counting			Scheduled Follow-up Submission	2012-1-15	FEMALE	HER2 amplification - negative	DAKOHercepTest TM		PathVision HER2 D Probe Kit						Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	180	NO	Indeterminate	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	3								NO	11		false	No	MX	N3a	T3	Stage IIIC	TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf	A1JN	TUMOR FREE	manual counting				>75%		YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	874de789-c1c4-4fd3-b45c-e885f62aaeab	501e2d9b-703f-4ca0-95f6-bcf0267d1a32	874de789-c1c4-4fd3-b45c-e885f62aaeab	501e2d9b-703f-4ca0-95f6-bcf0267d1a32	TCGA-D8-A1JN-01A-21-A17J-20	TCGA-D8-A1JN-01A-11D-A13L-09		TCGA-D8-A1JN-01	TCGA-D8-A1JN-01A-11D-A13K-05		42e89a13-3aee-4749-861a-947fc66091bc	TCGA-D8-A1JN-01	TCGA-D8-A1JN-01A-11D-A13L-09			TCGA-D8-A1JN-01	TCGA-D8-A1JN-01A-11D-A13L-09		874de789-c1c4-4fd3-b45c-e885f62aaeab		TCGA-D8-A1JN-01A-11D-A13J-01	TCGA-D8-A1JN-01		874de789-c1c4-4fd3-b45c-e885f62aaeab	TCGA-D8-A1JN-01A-11D-A13J-01	
TCGA-D8-A1JP-01	Stage IA	73	1	Stage I	167		Positive	FEMALE	Negative				Negative	M0	Negative	N0	167	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JP-01	639	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1JP	639	0	days	639	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JP-F20740	TCGA-D8-A1JP	TCGA-D8-A1JP-01A	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy					-26862	292		0	639						manual counting			Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO			false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1JP.1B61F1C1-8B19-4D9C-B6B9-87EEE350A472.pdf	A1JP	TUMOR FREE	manual counting				>75%		YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	1dd196c1-6198-4edf-b8a1-66fed90a68b3	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	1dd196c1-6198-4edf-b8a1-66fed90a68b3	TCGA-D8-A1JP-01A-21-A17J-20	TCGA-D8-A1JP-01A-11D-A13L-09		TCGA-D8-A1JP-01	TCGA-D8-A1JP-01A-11D-A13K-05		f51d8572-21b5-4b6f-99dd-00ca06c53b6f	TCGA-D8-A1JP-01	TCGA-D8-A1JP-01A-11D-A13L-09			TCGA-D8-A1JP-01	TCGA-D8-A1JP-01A-11D-A13L-09		f7461164-08b5-4a5c-ae74-cb4332f5ff7a		TCGA-D8-A1JP-01A-11D-A13J-01	TCGA-D8-A1JP-01		f7461164-08b5-4a5c-ae74-cb4332f5ff7a	TCGA-D8-A1JP-01A-11D-A13J-01	
TCGA-D8-A1JS-01	Stage IA	77	2	Stage I	371		Positive	FEMALE	Negative				Negative	M0	Negative	N0	371	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JS-01	371	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-D8-A1JS	371	0	days	371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JS-F14051	TCGA-D8-A1JS	TCGA-D8-A1JS-01A		Positive					Positive	Lumpectomy		NO			-28178	212		0	371						manual counting			Scheduled Follow-up Submission	2011-7-18	FEMALE		Hecep Test TM DAKO			1+					Other, specify		No		C50.9	8503/3	C50.9		YES	intraoperative examination	Other method, specify:	190	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3								NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf	A1JS	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	dce7b4c5-15a6-4201-8bbf-8cec0c229720	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	dce7b4c5-15a6-4201-8bbf-8cec0c229720	TCGA-D8-A1JS-01A-21-A17J-20	TCGA-D8-A1JS-01A-11D-A13L-09		TCGA-D8-A1JS-01	TCGA-D8-A1JS-01A-11D-A13K-05		7ec4164a-68b4-4bbd-a560-b754876e5d33	TCGA-D8-A1JS-01	TCGA-D8-A1JS-01A-11D-A13L-09			TCGA-D8-A1JS-01	TCGA-D8-A1JS-01A-11D-A13L-09		b347056d-3ae3-43c7-9e3b-f48cee1bfbb2		TCGA-D8-A1JS-01A-11D-A13J-01	TCGA-D8-A1JS-01		b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	TCGA-D8-A1JS-01A-11D-A13J-01	
TCGA-D8-A1JT-01	Stage IIA	70	4	Stage IIA	405		Positive	FEMALE	Negative				Negative	M0	Negative	N0	405	0	LumB		Positive				followup	T_Other	T2	LIVING	0	TCGA-D8-A1JT-01	405	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-D8-A1JT	405	0	days	405	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1JT-F14048	TCGA-D8-A1JT	TCGA-D8-A1JT-01A		Positive					Positive	Modified Radical Mastectomy		NO			-25677	250		0	405							70-79%		Scheduled Follow-up Submission	2011-7-18	FEMALE					2+		not amplified			Other, specify		No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	250	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf	A1JT	TUMOR FREE							YES	70-79%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	33600bf2-ec43-49d2-93dd-4985feb500aa	3de70cd5-875b-483a-9051-fe3e78038172	33600bf2-ec43-49d2-93dd-4985feb500aa	3de70cd5-875b-483a-9051-fe3e78038172	TCGA-D8-A1JT-01A-41-A17J-20	TCGA-D8-A1JT-01A-31D-A13L-09		TCGA-D8-A1JT-01	TCGA-D8-A1JT-01A-31D-A13K-05		fd766efd-b1bc-4000-97bf-a8f88aea66a7	TCGA-D8-A1JT-01	TCGA-D8-A1JT-01A-31D-A13L-09			TCGA-D8-A1JT-01	TCGA-D8-A1JT-01A-31D-A13L-09		33600bf2-ec43-49d2-93dd-4985feb500aa		TCGA-D8-A1JT-01A-31D-A13J-01	TCGA-D8-A1JT-01		33600bf2-ec43-49d2-93dd-4985feb500aa	TCGA-D8-A1JT-01A-31D-A13J-01	
TCGA-D8-A1JU-01	Stage IA	51	2	Stage I	447		Positive	FEMALE	Negative				Negative	M0	Negative	N0	447	0	LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JU-01	447	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1JU	447	0	days	447	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1JU-F14045	TCGA-D8-A1JU	TCGA-D8-A1JU-01A		Positive					Positive	Simple Mastectomy					-18733	295		0	447						manual counting			Scheduled Follow-up Submission	2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf	A1JU	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	5cfd5649-03c6-4919-b469-522684b6ceef	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	5cfd5649-03c6-4919-b469-522684b6ceef	TCGA-D8-A1JU-01A-21-A17J-20	TCGA-D8-A1JU-01A-11D-A13L-09		TCGA-D8-A1JU-01	TCGA-D8-A1JU-01A-11D-A13K-05		226a87df-e0cb-4c94-80ab-9d1bed969e0f	TCGA-D8-A1JU-01	TCGA-D8-A1JU-01A-11D-A13L-09			TCGA-D8-A1JU-01	TCGA-D8-A1JU-01A-11D-A13L-09		8e10b30e-5789-4ad4-a70b-c7a86927ac6b		TCGA-D8-A1JU-01A-11D-A13J-01	TCGA-D8-A1JU-01		8e10b30e-5789-4ad4-a70b-c7a86927ac6b	TCGA-D8-A1JU-01A-11D-A13J-01	
TCGA-D8-A1X5-01	Stage IIIC	81	5	Stage IIIC	171		Positive	FEMALE	Positive				Negative	M0	Positive	N3	171	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X5-01	565	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	squamous c3	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-D8-A1X5	565	0	days	565	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X5-F29934	TCGA-D8-A1X5	TCGA-D8-A1X5-01A		Positive					Positive	Modified Radical Mastectomy					-29734	197		0	565					NO	manual counting			Scheduled Follow-up Submission	2012-3-30	FEMALE		Hercep Test  TM Dako			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5								NO	14		false	No	MX	N3a	T2	Stage IIIC	TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf	A1X5	TUMOR FREE	manual counting			10-75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	95a12af8-5704-4745-b0a0-960f67af8cec	778e70fe-3515-4314-8035-c97e1970bf69	95a12af8-5704-4745-b0a0-960f67af8cec	778e70fe-3515-4314-8035-c97e1970bf69	TCGA-D8-A1X5-01A-21-A17K-20	TCGA-D8-A1X5-01A-11D-A14G-09		TCGA-D8-A1X5-01	TCGA-D8-A1X5-01A-11D-A14H-05		8e7e66c1-ecb2-47e7-a590-56fd4b0cb3b5	TCGA-D8-A1X5-01	TCGA-D8-A1X5-01A-11D-A14G-09			TCGA-D8-A1X5-01	TCGA-D8-A1X5-01A-11D-A14G-09		95a12af8-5704-4745-b0a0-960f67af8cec		TCGA-D8-A1X5-01A-11D-A14F-01	TCGA-D8-A1X5-01		95a12af8-5704-4745-b0a0-960f67af8cec	TCGA-D8-A1X5-01A-11D-A14F-01	
TCGA-D8-A1X6-01	Stage IIIA	80	4	Stage IIIA	236		Positive	FEMALE	Negative				Negative	M0	Positive	N2	236	0	LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1X6-01	541	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-D8-A1X6	541	0	days	541	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X6-F29980	TCGA-D8-A1X6	TCGA-D8-A1X6-01A		Positive					Positive	Modified Radical Mastectomy					-29256	173		0	541					NO	manual counting			Scheduled Follow-up Submission	2012-3-31	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	550	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	5		false	No	MX	N2a	T3	Stage IIIA	TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf	A1X6	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	ac361cbe-2302-4115-8c0f-40845c0ccec9	ed8ece0b-e4c8-4789-be92-e5ef0f0e6af2	ac361cbe-2302-4115-8c0f-40845c0ccec9	ed8ece0b-e4c8-4789-be92-e5ef0f0e6af2	TCGA-D8-A1X6-01A-21-A17K-20	TCGA-D8-A1X6-01A-11D-A14K-09		TCGA-D8-A1X6-01	TCGA-D8-A1X6-01A-11D-A14N-05		45aa8d7f-2fd6-4413-8191-52872f8d31d7	TCGA-D8-A1X6-01	TCGA-D8-A1X6-01A-11D-A14K-09			TCGA-D8-A1X6-01	TCGA-D8-A1X6-01A-11D-A14K-09		ac361cbe-2302-4115-8c0f-40845c0ccec9		TCGA-D8-A1X6-01A-11D-A14J-01	TCGA-D8-A1X6-01		ac361cbe-2302-4115-8c0f-40845c0ccec9	TCGA-D8-A1X6-01A-11D-A14J-01	
TCGA-D8-A1X7-01	Stage IIA	40	3	Stage IIA	85		Positive	FEMALE	Negative				Negative	M0	Negative	N0	85	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X7-01	509	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-D8-A1X7	509	0	days	509	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X7-F29985	TCGA-D8-A1X7	TCGA-D8-A1X7-01A		Positive					Positive	Simple Mastectomy					-14858	141		0	509					NO	manual counting			Scheduled Follow-up Submission	2012-3-31	FEMALE										Other, specify		No		C50.9	8503/3	C50.9		YES		Fine needle aspiration biopsy	170	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6								NO	0		false	No	MX	N0	T2	Stage IIA	TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf	A1X7	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	2f0ceb78-d089-4bda-8cd7-a9998b3ef37c	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	2f0ceb78-d089-4bda-8cd7-a9998b3ef37c	TCGA-D8-A1X7-01A-21-A17K-20	TCGA-D8-A1X7-01A-11D-A14K-09		TCGA-D8-A1X7-01	TCGA-D8-A1X7-01A-11D-A14N-05		436728e0-24a5-4033-86d5-2d24f669ea72	TCGA-D8-A1X7-01	TCGA-D8-A1X7-01A-11D-A14K-09			TCGA-D8-A1X7-01	TCGA-D8-A1X7-01A-11D-A14K-09		6b2497ef-abe8-4f6f-9225-1d700f55ad1c		TCGA-D8-A1X7-01A-11D-A14J-01	TCGA-D8-A1X7-01		6b2497ef-abe8-4f6f-9225-1d700f55ad1c	TCGA-D8-A1X7-01A-11D-A14J-01	
TCGA-D8-A1X8-01	Stage IIA	62	2	Stage IIIA	272		Positive	FEMALE	Negative				Negative	M0	Positive	N2	272	0	LumA		Indeterminate				enrollment	T1	T1	LIVING	0	TCGA-D8-A1X8-01	783	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-D8-A1X8	783	0	days	783	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X8-F29428	TCGA-D8-A1X8	TCGA-D8-A1X8-01A		Positive		2+	4 Point Scale		Indeterminate	Modified Radical Mastectomy		NO			-22995	225		0	783					NO	% IHC			Scheduled Follow-up Submission	2012-10-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	360	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	1								NO	9	0	false	No	M0	N2a	T1c	Stage IIIA	TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf	A1X8	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	f65fbe35-608e-406e-bc17-881ce2cb6c23	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	f65fbe35-608e-406e-bc17-881ce2cb6c23	TCGA-D8-A1X8-01A-21-A17K-20	TCGA-D8-A1X8-01A-11D-A14K-09		TCGA-D8-A1X8-01	TCGA-D8-A1X8-01A-11D-A14N-05		9bd7faf1-8b85-4e46-b968-35a1a5cc2cb5	TCGA-D8-A1X8-01	TCGA-D8-A1X8-01A-11D-A14K-09			TCGA-D8-A1X8-01	TCGA-D8-A1X8-01A-11D-A14K-09		cbc8608e-ffe1-41d5-93c5-66dd665c9bf0		TCGA-D8-A1X8-01A-11D-A14J-01	TCGA-D8-A1X8-01		cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-11D-A14J-01	
TCGA-D8-A1X9-01	Stage IIA	66	5	Stage IIB	380		Positive	FEMALE	Negative				Negative	M0	Positive	N1	380	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X9-01	727	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 14	TCGA-D8-A1X9	727	0	days	727	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1X9-F29431	TCGA-D8-A1X9	TCGA-D8-A1X9-01A		Positive					Positive	Modified Radical Mastectomy		NO			-24417	399		0	727					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE							not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Indeterminate	Negative		23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	3	0	false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf	A1X9	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	87fe6581-eab6-4755-8837-75771304741f	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	87fe6581-eab6-4755-8837-75771304741f	TCGA-D8-A1X9-01A-21-A17K-20	TCGA-D8-A1X9-01A-12D-A159-09		TCGA-D8-A1X9-01	TCGA-D8-A1X9-01A-12D-A161-05		4672d6c4-b826-4143-887c-464ab4020a6d	TCGA-D8-A1X9-01	TCGA-D8-A1X9-01A-12D-A159-09			TCGA-D8-A1X9-01	TCGA-D8-A1X9-01A-12D-A159-09		2b3d596a-68ca-4c60-bb16-8c0cbd8fb190		TCGA-D8-A1X9-01A-12D-A160-01	TCGA-D8-A1X9-01		2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	TCGA-D8-A1X9-01A-12D-A160-01	
TCGA-D8-A1XA-01	Stage IA	64	1	Stage I	274		Positive	FEMALE	Negative				Negative	M0	Negative	N0	274	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XA-01	839	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1XA	839	0	days	839	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XA-F29434	TCGA-D8-A1XA	TCGA-D8-A1XA-01A		Positive					Positive	Lumpectomy		NO			-23387	218		0	839					NO	% IHC			Scheduled Follow-up Submission	2012-12-3	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	140	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0	0	false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf	A1XA	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	79d0e02e-b518-4dce-8c20-00073d04e399	a6a18a90-cdd5-4a5f-a8a2-6480bc1742c2	79d0e02e-b518-4dce-8c20-00073d04e399	a6a18a90-cdd5-4a5f-a8a2-6480bc1742c2	TCGA-D8-A1XA-01A-21-A17K-20	TCGA-D8-A1XA-01A-11D-A14G-09		TCGA-D8-A1XA-01	TCGA-D8-A1XA-01A-11D-A14H-05		b480ba7d-ad4f-41f6-87a4-ad062ced62ae	TCGA-D8-A1XA-01	TCGA-D8-A1XA-01A-11D-A14G-09			TCGA-D8-A1XA-01	TCGA-D8-A1XA-01A-11D-A14G-09		79d0e02e-b518-4dce-8c20-00073d04e399		TCGA-D8-A1XA-01A-11D-A14F-01	TCGA-D8-A1XA-01		79d0e02e-b518-4dce-8c20-00073d04e399	TCGA-D8-A1XA-01A-11D-A14F-01	
TCGA-D8-A1XB-01	Stage IIB	62	4	Stage IIB	201		Positive	FEMALE	Negative				Negative	M0	Positive	N1	201	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XB-01	552	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XB	552	0	days	552	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XB-F29436	TCGA-D8-A1XB	TCGA-D8-A1XB-01A		Positive					Positive	Modified Radical Mastectomy		NO			-22976	251		0	552					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	1	0	false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf	A1XB	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	8a2adff0-2527-43fa-ad17-a3081e22f846	0eae4d42-893c-48ff-b1a3-52ae7d1220ce	8a2adff0-2527-43fa-ad17-a3081e22f846	0eae4d42-893c-48ff-b1a3-52ae7d1220ce	TCGA-D8-A1XB-01A-21-A17K-20	TCGA-D8-A1XB-01A-11D-A14G-09		TCGA-D8-A1XB-01	TCGA-D8-A1XB-01A-11D-A14H-05		7badd356-a8c5-4c61-a520-27a25695f71e	TCGA-D8-A1XB-01	TCGA-D8-A1XB-01A-11D-A14G-09			TCGA-D8-A1XB-01	TCGA-D8-A1XB-01A-11D-A14G-09		8a2adff0-2527-43fa-ad17-a3081e22f846		TCGA-D8-A1XB-01A-11D-A14F-01	TCGA-D8-A1XB-01		8a2adff0-2527-43fa-ad17-a3081e22f846	TCGA-D8-A1XB-01A-11D-A14F-01	
TCGA-D8-A1XC-01	Stage IIIB	85	3	Stage IIIB	81		Positive	FEMALE	Negative				Negative	M0	Positive	N1	81	0	LumA		Positive				enrollment	T_Other	T4	LIVING	1	TCGA-D8-A1XC-01	377	1	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-D8-A1XC			days	377	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		85	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XC-F29439	TCGA-D8-A1XC	TCGA-D8-A1XC-01A		Positive					Positive	Modified Radical Mastectomy		NO			-31220	215	377	0	81			[Discrepancy]		NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES	intraoperative examination	Other method, specify:	260	NO	Negative			20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	7				Bone	Distant Metastasis			YES	1	0	false	No	M0	N1a	T4b	Stage IIIB	TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf	A1XC	WITH TUMOR	%IHC			>75%	>75%		YES			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	DECEASED	2010	4328ae51-6063-4296-b266-a70bc5dda94f	21024980-32e1-4b97-8f04-3d2dc520b86d	4328ae51-6063-4296-b266-a70bc5dda94f	21024980-32e1-4b97-8f04-3d2dc520b86d	TCGA-D8-A1XC-01A-21-A17K-20	TCGA-D8-A1XC-01A-11D-A14G-09		TCGA-D8-A1XC-01	TCGA-D8-A1XC-01A-11D-A14H-05		d91c5cb0-55c9-4cf9-814c-d26df5d0a971	TCGA-D8-A1XC-01	TCGA-D8-A1XC-01A-11D-A14G-09			TCGA-D8-A1XC-01	TCGA-D8-A1XC-01A-11D-A14G-09		4328ae51-6063-4296-b266-a70bc5dda94f		TCGA-D8-A1XC-01A-11D-A14F-01	TCGA-D8-A1XC-01		4328ae51-6063-4296-b266-a70bc5dda94f	TCGA-D8-A1XC-01A-11D-A14F-01	
TCGA-D8-A1XD-01	Stage IIIA	36	4	Stage IIIA	155		Positive	FEMALE	Negative				Negative	M0	Positive	N2	155	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XD-01	522	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5		TCGA-D8-A1XD	522	0	days	522	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XD-F29440	TCGA-D8-A1XD	TCGA-D8-A1XD-01A		Positive					Positive	Modified Radical Mastectomy		NO			-13510	188		0	522					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		[Discrepancy]	210	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	5								NO	6		false	No	M0	N2a	T1c	Stage IIIA	TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf	A1XD	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	af520d74-dc8a-4d36-bd2c-80bc23e6d029	39b1e20d-51f1-4c8b-9689-a0e054354aa3	af520d74-dc8a-4d36-bd2c-80bc23e6d029	39b1e20d-51f1-4c8b-9689-a0e054354aa3	TCGA-D8-A1XD-01A-21-A17K-20			TCGA-D8-A1XD-01	TCGA-D8-A1XD-01A-11D-A14H-05		71a3ddcc-c443-445f-b3c6-e0d36183ac53	TCGA-D8-A1XD-01				TCGA-D8-A1XD-01			af520d74-dc8a-4d36-bd2c-80bc23e6d029		TCGA-D8-A1XD-01A-11D-A14F-01	TCGA-D8-A1XD-01		af520d74-dc8a-4d36-bd2c-80bc23e6d029	TCGA-D8-A1XD-01A-11D-A14F-01	
TCGA-D8-A1XF-01	Stage IIA	45	3	Stage IIA	197		Positive	FEMALE	Negative				Negative	M0	Negative	N0	197	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XF-01	463	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-D8-A1XF	463	0	days	463	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XF-F29442	TCGA-D8-A1XF	TCGA-D8-A1XF-01A		Positive					Positive	Modified Radical Mastectomy		NO			-16787	170		0	463					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	180	NO	Negative			8		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	5								NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf	A1XF	TUMOR FREE	%IHC			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	80562b20-3e3e-4f77-8ca2-958f8636d720	2084c32d-ed1a-43a7-adbb-ff2338363e11	80562b20-3e3e-4f77-8ca2-958f8636d720	2084c32d-ed1a-43a7-adbb-ff2338363e11	TCGA-D8-A1XF-01A-21-A17K-20	TCGA-D8-A1XF-01A-11D-A14G-09		TCGA-D8-A1XF-01	TCGA-D8-A1XF-01A-11D-A14H-05		83d58431-912e-4861-90cb-1dffc7d4a8b0	TCGA-D8-A1XF-01	TCGA-D8-A1XF-01A-11D-A14G-09			TCGA-D8-A1XF-01	TCGA-D8-A1XF-01A-11D-A14G-09		80562b20-3e3e-4f77-8ca2-958f8636d720		TCGA-D8-A1XF-01A-11D-A14F-01	TCGA-D8-A1XF-01		80562b20-3e3e-4f77-8ca2-958f8636d720	TCGA-D8-A1XF-01A-11D-A14F-01	
TCGA-D8-A1XG-01	Stage IIIB	86	3	Stage IIIB	196		Positive	FEMALE	Negative				Negative	M0	Positive	N1	196	0	LumA		Negative				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A1XG-01	448	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1XG	448	0	days	448	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					86	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XG-F29444	TCGA-D8-A1XG	TCGA-D8-A1XG-01A		Positive					Negative	Modified Radical Mastectomy		YES			-31748	169		0	448					NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	590	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO	2	0	false	No	M0	N1a	T4b	Stage IIIB	TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf	A1XG	TUMOR FREE					10-75%		YES			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	56bc2076-bafe-47aa-8255-9f03d438cb00	f2ca4584-cab5-49ef-b6b2-f2311785e403	56bc2076-bafe-47aa-8255-9f03d438cb00	f2ca4584-cab5-49ef-b6b2-f2311785e403	TCGA-D8-A1XG-01A-21-A17K-20	TCGA-D8-A1XG-01A-11D-A14G-09		TCGA-D8-A1XG-01	TCGA-D8-A1XG-01A-11D-A14H-05		c51c59e6-0a2c-4597-88df-59166bf2c096	TCGA-D8-A1XG-01	TCGA-D8-A1XG-01A-11D-A14G-09			TCGA-D8-A1XG-01	TCGA-D8-A1XG-01A-11D-A14G-09		56bc2076-bafe-47aa-8255-9f03d438cb00		TCGA-D8-A1XG-01A-11D-A14F-01	TCGA-D8-A1XG-01		56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-11D-A14F-01	
TCGA-D8-A1XJ-01	Stage IIIA	76	1	Stage IIIA	352		Positive	FEMALE	Positive				Negative	M0	Positive	N1	352	0	Her2		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1XJ-01	663	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 5	TCGA-D8-A1XJ	663	0	days	663	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XJ-F30111	TCGA-D8-A1XJ	TCGA-D8-A1XJ-01A		Positive					Positive	Modified Radical Mastectomy					-27967	295		0	663					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE		Hercep Test  TM Dako			3+					Other, specify		No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	440	NO	Positive			43	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	7								NO	2		false	No	MX	N1a	T3	Stage IIIA	TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf	A1XJ	TUMOR FREE	manual counting			10-75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	ef91ee42-e50f-44f7-967a-48698e920d12	42e694ab-fa1a-4613-8066-745b28a6ea9a	ef91ee42-e50f-44f7-967a-48698e920d12	42e694ab-fa1a-4613-8066-745b28a6ea9a	TCGA-D8-A1XJ-01A-21-A17K-20	TCGA-D8-A1XJ-01A-11D-A14K-09		TCGA-D8-A1XJ-01	TCGA-D8-A1XJ-01A-11D-A14N-05		9dcb0e51-ac2f-4954-ac24-a1c9e20e7c8a	TCGA-D8-A1XJ-01	TCGA-D8-A1XJ-01A-11D-A14K-09			TCGA-D8-A1XJ-01	TCGA-D8-A1XJ-01A-11D-A14K-09		ef91ee42-e50f-44f7-967a-48698e920d12		TCGA-D8-A1XJ-01A-11D-A14J-01	TCGA-D8-A1XJ-01		ef91ee42-e50f-44f7-967a-48698e920d12	TCGA-D8-A1XJ-01A-11D-A14J-01	
TCGA-D8-A1XK-01	Stage IB	55	1	Stage IIB	326		Negative	FEMALE	Negative				Negative	M0	Positive	N1	326	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XK-01	441	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 14	cluster 5		TCGA-D8-A1XK	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XK-F30074	TCGA-D8-A1XK	TCGA-D8-A1XK-01A		Negative					Negative	Modified Radical Mastectomy					-20092	275		0	441					NO				Scheduled Follow-up Submission	2012-2-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	3		false	No	MX	N1a	T2	Stage IIB	TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf	A1XK	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	e4edbc10-8939-4bbf-befa-ee44229e4394	97f9770c-3539-4578-84f4-bb63a7463900	e4edbc10-8939-4bbf-befa-ee44229e4394	97f9770c-3539-4578-84f4-bb63a7463900	TCGA-D8-A1XK-01A-11-A17K-20			TCGA-D8-A1XK-01	TCGA-D8-A1XK-01A-21D-A14N-05		567f0c52-eb40-43cc-a34c-a7e1714b420a	TCGA-D8-A1XK-01	TCGA-D8-A1XK-01A-21D-A14K-09			TCGA-D8-A1XK-01			e4edbc10-8939-4bbf-befa-ee44229e4394		TCGA-D8-A1XK-01A-21D-A14J-01	TCGA-D8-A1XK-01		e4edbc10-8939-4bbf-befa-ee44229e4394	TCGA-D8-A1XK-01A-21D-A14J-01	
TCGA-D8-A1XL-01	Stage IIB	34	1	Stage IIB	319		Positive	FEMALE	Negative				Negative	M0	Positive	N1	319	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XL-01	606	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 3	TCGA-D8-A1XL	606	0	days	606	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XL-F29990	TCGA-D8-A1XL	TCGA-D8-A1XL-01A		Positive					Positive	Lumpectomy					-12668	282		0	606					NO	manual counting			Scheduled Follow-up Submission	2012-3-31	FEMALE		HercepTest TM Dako			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Equivocal	Negative		13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	7								NO	2		false	No	MX	N1a	T2	Stage IIB	TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf	A1XL	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	26f5aec2-a2d8-4151-b975-33d7518e36d0	c50f9ab3-c448-4289-b6b1-36ddcbd9efb9	26f5aec2-a2d8-4151-b975-33d7518e36d0	c50f9ab3-c448-4289-b6b1-36ddcbd9efb9	TCGA-D8-A1XL-01A-21-A17K-20	TCGA-D8-A1XL-01A-11D-A14K-09		TCGA-D8-A1XL-01	TCGA-D8-A1XL-01A-11D-A14N-05		2505f3cc-34a7-448a-9935-97126fec7c57	TCGA-D8-A1XL-01	TCGA-D8-A1XL-01A-11D-A14K-09			TCGA-D8-A1XL-01	TCGA-D8-A1XL-01A-11D-A14K-09		26f5aec2-a2d8-4151-b975-33d7518e36d0		TCGA-D8-A1XL-01A-11D-A14J-01	TCGA-D8-A1XL-01		26f5aec2-a2d8-4151-b975-33d7518e36d0	TCGA-D8-A1XL-01A-11D-A14J-01	
TCGA-D8-A1XM-01	Stage IA	57	3	Stage I	218		Positive	FEMALE	Negative				Negative	M0	Negative	N0	218	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XM-01	538	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XM	538	0	days	538	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XM-F29445	TCGA-D8-A1XM	TCGA-D8-A1XM-01A		Positive					Positive	Lumpectomy		NO			-21056	189		0	538					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0	0	false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf	A1XM	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	3049e9ab-8e65-4264-865a-b7a14e27aae1	9f9702c2-7a67-48fd-aacf-93531102e1f7	3049e9ab-8e65-4264-865a-b7a14e27aae1	9f9702c2-7a67-48fd-aacf-93531102e1f7	TCGA-D8-A1XM-01A-11-A17K-20	TCGA-D8-A1XM-01A-21D-A14K-09		TCGA-D8-A1XM-01	TCGA-D8-A1XM-01A-21D-A14N-05		6885966b-8453-46b3-8f90-6dfc1117e87b	TCGA-D8-A1XM-01	TCGA-D8-A1XM-01A-21D-A14K-09			TCGA-D8-A1XM-01	TCGA-D8-A1XM-01A-21D-A14K-09		3049e9ab-8e65-4264-865a-b7a14e27aae1		TCGA-D8-A1XM-01A-21D-A14J-01	TCGA-D8-A1XM-01		3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-21D-A14J-01	
TCGA-D8-A1XO-01	Stage IIB	56	2	Stage IIB	242		Positive	FEMALE	Negative				Negative	M0	Positive	N1	242	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XO-01	1682	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 7	mutation cluster 4	TCGA-D8-A1XO	1682	0	days	1682	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XO-F72206	TCGA-D8-A1XO	TCGA-D8-A1XO-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20606	193		0	1682					NO	% IHC			Scheduled Follow-up Submission	2015-4-29	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	360	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	7								NO	1	0	false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1XO.9AAB53EC-89A0-4878-BB9D-D96BC56B54C4.pdf	A1XO	TUMOR FREE	%IHC			>75%	>75%	YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	eddd285e-a946-4e4e-a21d-6e84ed397594	0323e53c-a64f-426b-9f8e-f76b6bdf6118	eddd285e-a946-4e4e-a21d-6e84ed397594	0323e53c-a64f-426b-9f8e-f76b6bdf6118	TCGA-D8-A1XO-01A-21-A17K-20	TCGA-D8-A1XO-01A-11D-A14K-09		TCGA-D8-A1XO-01	TCGA-D8-A1XO-01A-11D-A14N-05		f75c4694-aa3e-4855-8b51-bfb5de5373fc	TCGA-D8-A1XO-01	TCGA-D8-A1XO-01A-11D-A14K-09			TCGA-D8-A1XO-01	TCGA-D8-A1XO-01A-11D-A14K-09		eddd285e-a946-4e4e-a21d-6e84ed397594		TCGA-D8-A1XO-01A-11D-A14J-01	TCGA-D8-A1XO-01		eddd285e-a946-4e4e-a21d-6e84ed397594	TCGA-D8-A1XO-01A-11D-A14J-01	
TCGA-D8-A1XQ-01	Stage IIA	69	1	Stage IIA	177		Negative	FEMALE	Negative				Negative	M0	Negative	N0	177	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XQ-01	499	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3		TCGA-D8-A1XQ	499	0	days	499	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XQ-F29449	TCGA-D8-A1XQ	TCGA-D8-A1XQ-01A		Negative					Negative	Modified Radical Mastectomy		NO			-25345	158		0	499					NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf	A1XQ	TUMOR FREE					0%		YES	<10%		NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	0c7fc003-950b-4138-8390-036c072b640e	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	0c7fc003-950b-4138-8390-036c072b640e	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	TCGA-D8-A1XQ-01A-21-A17K-20			TCGA-D8-A1XQ-01	TCGA-D8-A1XQ-01A-11D-A14N-05		43fa736b-5235-4357-8ae7-2b0029efecfc	TCGA-D8-A1XQ-01	TCGA-D8-A1XQ-01A-11D-A14K-09			TCGA-D8-A1XQ-01			0c7fc003-950b-4138-8390-036c072b640e		TCGA-D8-A1XQ-01A-11D-A14J-01	TCGA-D8-A1XQ-01		0c7fc003-950b-4138-8390-036c072b640e	TCGA-D8-A1XQ-01A-11D-A14J-01	
TCGA-D8-A1XR-01	Stage IIB	56	2	Stage IIB	168		Positive	FEMALE	Negative				Negative	M0	Positive	N1	168	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XR-01	482	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-D8-A1XR	482	0	days	482	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XR-F29451	TCGA-D8-A1XR	TCGA-D8-A1XR-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20488	162		0	482					NO	% IHC			Scheduled Follow-up Submission	2012-3-6	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	3								NO	2	0	false	No	M0	N1a	T2	Stage IIB	TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf	A1XR	TUMOR FREE	%IHC			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	9c55164e-fb87-46b5-87ce-cc277ba378f5	c668fd1c-a18a-4f11-89bb-5e5384da30d6	9c55164e-fb87-46b5-87ce-cc277ba378f5	c668fd1c-a18a-4f11-89bb-5e5384da30d6	TCGA-D8-A1XR-01A-21-A17K-20	TCGA-D8-A1XR-01A-11D-A14K-09		TCGA-D8-A1XR-01	TCGA-D8-A1XR-01A-11D-A14N-05		f97f91f5-8d8b-494d-847c-848251489758	TCGA-D8-A1XR-01	TCGA-D8-A1XR-01A-11D-A14K-09			TCGA-D8-A1XR-01	TCGA-D8-A1XR-01A-11D-A14K-09		9c55164e-fb87-46b5-87ce-cc277ba378f5		TCGA-D8-A1XR-01A-11D-A14J-01	TCGA-D8-A1XR-01		9c55164e-fb87-46b5-87ce-cc277ba378f5	TCGA-D8-A1XR-01A-11D-A14J-01	
TCGA-D8-A1XS-01	Stage IIIC	48	3	Stage IIIC	18		Positive	MALE	Positive				Negative	M0	Positive	N3	18	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XS-01	496	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XS	496	0	days	496	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XS-F12133	TCGA-D8-A1XS	TCGA-D8-A1XS-01A		Positive					Positive	Modified Radical Mastectomy		NO			-17708	164		0	496					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	MALE					3+					Other, specify		No		C50.9	8507/3	C50.9		YES		Core needle biopsy	340	NO	Positive			28	Negative																					2	4								NO	25	0	false	No	M0	N3a	T2	Stage IIIC	TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf	A1XS	TUMOR FREE	%IHC			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	11b43261-66e4-4c28-8d24-6e38b4295f34	58be3d70-17bf-423e-86af-fd13b6b792a2	11b43261-66e4-4c28-8d24-6e38b4295f34	58be3d70-17bf-423e-86af-fd13b6b792a2	TCGA-D8-A1XS-01A-21-A17K-20	TCGA-D8-A1XS-01A-11D-A14K-09		TCGA-D8-A1XS-01	TCGA-D8-A1XS-01A-11D-A14N-05		22edabb4-30a0-4d5d-95f2-3ee9c3883fd1	TCGA-D8-A1XS-01	TCGA-D8-A1XS-01A-11D-A14K-09			TCGA-D8-A1XS-01	TCGA-D8-A1XS-01A-11D-A14K-09		11b43261-66e4-4c28-8d24-6e38b4295f34		TCGA-D8-A1XS-01A-11D-A14J-01	TCGA-D8-A1XS-01		11b43261-66e4-4c28-8d24-6e38b4295f34	TCGA-D8-A1XS-01A-11D-A14J-01	
TCGA-D8-A1XT-01	Stage IIA	61	1	Stage IIA	193		Negative	FEMALE	Positive				Negative	M0	Positive	N1	193	0	Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XT-01	506	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A1XT	506	0	days	506	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XT-F29454	TCGA-D8-A1XT	TCGA-D8-A1XT-01A		Negative					Negative	Modified Radical Mastectomy		NO			-22448	144		0	506					NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	3	0	false	No	M0	N1a	T1c	Stage IIA	TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf	A1XT	TUMOR FREE	%IHC			0%	0%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	47901dff-8acf-4afa-9e42-851d98777085	43781f58-a738-48c1-a251-d4dc5f3fe062	47901dff-8acf-4afa-9e42-851d98777085	43781f58-a738-48c1-a251-d4dc5f3fe062	TCGA-D8-A1XT-01A-21-A17K-20	TCGA-D8-A1XT-01A-11D-A14K-09		TCGA-D8-A1XT-01	TCGA-D8-A1XT-01A-11D-A14N-05		0321074c-bcf8-42f7-9212-b2673201860d	TCGA-D8-A1XT-01	TCGA-D8-A1XT-01A-11D-A14K-09			TCGA-D8-A1XT-01	TCGA-D8-A1XT-01A-11D-A14K-09		47901dff-8acf-4afa-9e42-851d98777085		TCGA-D8-A1XT-01A-11D-A14J-01	TCGA-D8-A1XT-01		47901dff-8acf-4afa-9e42-851d98777085	TCGA-D8-A1XT-01A-11D-A14J-01	
TCGA-D8-A1XU-01	Stage IA	56		Stage I	149		Positive	FEMALE	Negative				Negative	M0	Negative	N0	149	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XU-01	395	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1XU	395	0	days	395	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XU-F29456	TCGA-D8-A1XU	TCGA-D8-A1XU-01A	Negative	Positive					Positive	Modified Radical Mastectomy		NO			-20715	102		0	395					NO	% IHC			Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	6								NO	0	0	false	No	M0	N0	T1c	Stage IA	TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf	A1XU	TUMOR FREE	%IHC			10-75%	>75%		YES			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	0718af55-25eb-45b7-9e76-5d663a00dca5	062f01fb-85b6-4c22-bb39-1ebaeca09d82	0718af55-25eb-45b7-9e76-5d663a00dca5	062f01fb-85b6-4c22-bb39-1ebaeca09d82	TCGA-D8-A1XU-01A-21-A17K-20	TCGA-D8-A1XU-01A-11D-A14K-09		TCGA-D8-A1XU-01	TCGA-D8-A1XU-01A-11D-A14N-05		d4978f30-9304-47e3-a4a7-1c5b32f6ddde	TCGA-D8-A1XU-01	TCGA-D8-A1XU-01A-11D-A14K-09			TCGA-D8-A1XU-01	TCGA-D8-A1XU-01A-11D-A14K-09		0718af55-25eb-45b7-9e76-5d663a00dca5		TCGA-D8-A1XU-01A-11D-A14J-01	TCGA-D8-A1XU-01		0718af55-25eb-45b7-9e76-5d663a00dca5	TCGA-D8-A1XU-01A-11D-A14J-01	
TCGA-D8-A1XV-01	Stage IIA	84	3	Stage IIA	146		Positive	FEMALE	Negative				Negative	M0	Negative	N0	146	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XV-01	461	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 7	mutation c1uster 9	TCGA-D8-A1XV	461	0	days	461	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A1XV-F29457	TCGA-D8-A1XV	TCGA-D8-A1XV-01A		Positive					Positive	Modified Radical Mastectomy		NO			-30830	103		0	461					NO	% IHC			Scheduled Follow-up Submission	2012-3-19	FEMALE					2+		not amplified			Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	420	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	7								NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf	A1XV	TUMOR FREE	%IHC			>75%	>75%		YES			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	1fa10a5d-7fc9-4a26-9251-bade7c2cbf13	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	1fa10a5d-7fc9-4a26-9251-bade7c2cbf13	TCGA-D8-A1XV-01A-21-A17K-20	TCGA-D8-A1XV-01A-11D-A14K-09		TCGA-D8-A1XV-01	TCGA-D8-A1XV-01A-11D-A14N-05		fc4169c4-863c-42b2-9b67-2682355d343d	TCGA-D8-A1XV-01	TCGA-D8-A1XV-01A-11D-A14K-09			TCGA-D8-A1XV-01	TCGA-D8-A1XV-01A-11D-A14K-09		5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6		TCGA-D8-A1XV-01A-11D-A14J-01	TCGA-D8-A1XV-01		5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	TCGA-D8-A1XV-01A-11D-A14J-01	
TCGA-D8-A1XW-01	Stage IIA	53	3	Stage IIA	117		Negative	FEMALE	Negative				Negative	M0	Negative	N0	117	0	Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XW-01	1309	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1XW	1309	0	days	1309	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A1XW-F72205	TCGA-D8-A1XW	TCGA-D8-A1XW-01A		Negative					Positive	Modified Radical Mastectomy		NO			-19478	76		0	1309					NO	% IHC			Scheduled Follow-up Submission	2015-4-29	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	310	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf	A1XW	TUMOR FREE					0%	YES	YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	8e24b2f8-459c-4861-9d31-d171e8d1a08b	64573c1d-c2ff-4490-b7b6-b4b587b47ccb	8e24b2f8-459c-4861-9d31-d171e8d1a08b	64573c1d-c2ff-4490-b7b6-b4b587b47ccb	TCGA-D8-A1XW-01A-21-A17K-20	TCGA-D8-A1XW-01A-11D-A14K-09		TCGA-D8-A1XW-01	TCGA-D8-A1XW-01A-11D-A14N-05		645dc9bf-f601-46eb-84e0-cb5df8d9981b	TCGA-D8-A1XW-01	TCGA-D8-A1XW-01A-11D-A14K-09			TCGA-D8-A1XW-01	TCGA-D8-A1XW-01A-11D-A14K-09		8e24b2f8-459c-4861-9d31-d171e8d1a08b		TCGA-D8-A1XW-01A-11D-A14J-01	TCGA-D8-A1XW-01		8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-11D-A14J-01	
TCGA-D8-A1XY-01	Stage IIA	74		Stage IIA	81		Positive	FEMALE	Positive				Negative	M0	Negative	N0	81	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XY-01	503	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XY	503	0	days	503	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XY-F29994	TCGA-D8-A1XY	TCGA-D8-A1XY-01A		Positive					Positive	Simple Mastectomy					-27106	135		0	503					NO	manual counting			Scheduled Follow-up Submission	2012-3-31	FEMALE		HerceptTest TM Dako			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Positive			3		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	0		false	No	MX	N0	T2	Stage IIA	TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf	A1XY	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	5b233291-8984-4925-8be4-3911f541a15f	05936306-3484-48d1-9305-f4596aed82f3	5b233291-8984-4925-8be4-3911f541a15f	05936306-3484-48d1-9305-f4596aed82f3	TCGA-D8-A1XY-01A-21-A17K-20	TCGA-D8-A1XY-01A-11D-A14K-09		TCGA-D8-A1XY-01	TCGA-D8-A1XY-01A-11D-A14N-05		68b05ccb-ae51-4690-9b4d-e18bc9b4e9ea	TCGA-D8-A1XY-01	TCGA-D8-A1XY-01A-11D-A14K-09			TCGA-D8-A1XY-01	TCGA-D8-A1XY-01A-11D-A14K-09		5b233291-8984-4925-8be4-3911f541a15f		TCGA-D8-A1XY-01A-11D-A14J-01	TCGA-D8-A1XY-01		5b233291-8984-4925-8be4-3911f541a15f	TCGA-D8-A1XY-01A-11D-A14J-01	
TCGA-D8-A1XZ-01	Stage IIIA	81	1	Stage IIIA	120		Positive	FEMALE	Negative				Negative	M0	Positive	N2	120	0	LumB		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XZ-01	466	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-D8-A1XZ	466	0	days	466	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					81	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1XZ-F30077	TCGA-D8-A1XZ	TCGA-D8-A1XZ-01A		Positive					Negative	Modified Radical Mastectomy					-29916	98		0	466					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	6		false	No	MX	N2a	T1c	Stage IIIA	TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf	A1XZ	TUMOR FREE					>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	8b592b3b-47b5-45fa-98eb-01bf75096605	6eb5b047-3e90-4a41-8082-46a74c008a90	8b592b3b-47b5-45fa-98eb-01bf75096605	6eb5b047-3e90-4a41-8082-46a74c008a90	TCGA-D8-A1XZ-01A-21-A17K-20	TCGA-D8-A1XZ-01A-11D-A14K-09		TCGA-D8-A1XZ-01	TCGA-D8-A1XZ-01A-11D-A14N-05		6de7dbf5-0fdb-4871-a5ba-5909cd85f6e1	TCGA-D8-A1XZ-01	TCGA-D8-A1XZ-01A-11D-A14K-09			TCGA-D8-A1XZ-01	TCGA-D8-A1XZ-01A-11D-A14K-09		8b592b3b-47b5-45fa-98eb-01bf75096605		TCGA-D8-A1XZ-01A-11D-A14J-01	TCGA-D8-A1XZ-01		8b592b3b-47b5-45fa-98eb-01bf75096605	TCGA-D8-A1XZ-01A-11D-A14J-01	
TCGA-D8-A1Y0-01	Stage IIIA	65	5	Stage IIIA	166		Positive	FEMALE	Negative				Negative	M0	Positive	N2	166	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1Y0-01	472	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-D8-A1Y0	472	0	days	472	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left	Axillary lymph node dissection alone		TCGA-D8-A1Y0-F30080	TCGA-D8-A1Y0	TCGA-D8-A1Y0-01A		Positive					Positive	Modified Radical Mastectomy					-24083	104		0	472					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	190	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	9		false	No	MX	N2a	T1c	Stage IIIA	TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf	A1Y0	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	8dd30d68-86d0-456f-814c-ae59a5c0a071	8d743d31-2f7b-4281-ae5b-424e9adc15fe	8dd30d68-86d0-456f-814c-ae59a5c0a071	8d743d31-2f7b-4281-ae5b-424e9adc15fe	TCGA-D8-A1Y0-01A-21-A17K-20	TCGA-D8-A1Y0-01A-11D-A14K-09		TCGA-D8-A1Y0-01	TCGA-D8-A1Y0-01A-11D-A14N-05		afa6d295-e75a-41fa-a678-2b0d4d82cbc2	TCGA-D8-A1Y0-01	TCGA-D8-A1Y0-01A-11D-A14K-09			TCGA-D8-A1Y0-01	TCGA-D8-A1Y0-01A-11D-A14K-09		8dd30d68-86d0-456f-814c-ae59a5c0a071		TCGA-D8-A1Y0-01A-11D-A14J-01	TCGA-D8-A1Y0-01		8dd30d68-86d0-456f-814c-ae59a5c0a071	TCGA-D8-A1Y0-01A-11D-A14J-01	
TCGA-D8-A1Y1-01	Stage IIIA	80	2	Stage IIIA	115		Positive	FEMALE	Negative				Negative	M0	Positive	N1	115	0	LumB		Positive				enrollment	T_Other	T3	LIVING	1	TCGA-D8-A1Y1-01	302	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-D8-A1Y1	302	0	days	302	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1Y1-F30084	TCGA-D8-A1Y1	TCGA-D8-A1Y1-01A		Positive					Positive	Modified Radical Mastectomy					-29474	93	302	0	116					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO	Negative			22		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	1		false	No	MX	N1a	T3	Stage IIIA	TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf	A1Y1	WITH TUMOR	manual counting			>75%	10-75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	DECEASED	2010	2d49cea0-0d08-4203-afa0-a1252cbf739a	a20f3655-2ba9-4af6-b683-490b69c54070	2d49cea0-0d08-4203-afa0-a1252cbf739a	a20f3655-2ba9-4af6-b683-490b69c54070	TCGA-D8-A1Y1-01A-11-A17K-20	TCGA-D8-A1Y1-01A-21D-A14K-09		TCGA-D8-A1Y1-01	TCGA-D8-A1Y1-01A-21D-A14N-05		2a4e381f-db2d-4b2e-828c-9264d218439c	TCGA-D8-A1Y1-01	TCGA-D8-A1Y1-01A-21D-A14K-09			TCGA-D8-A1Y1-01	TCGA-D8-A1Y1-01A-21D-A14K-09		2d49cea0-0d08-4203-afa0-a1252cbf739a		TCGA-D8-A1Y1-01A-21D-A14J-01	TCGA-D8-A1Y1-01		2d49cea0-0d08-4203-afa0-a1252cbf739a	TCGA-D8-A1Y1-01A-21D-A14J-01	
TCGA-D8-A1Y2-01	Stage IIA	71	4	Stage IIA	72		Positive	FEMALE	Negative				Negative	M0	Negative	N0	72	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1Y2-01	433	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation cluster 4	TCGA-D8-A1Y2	433	0	days	433	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1Y2-F30086	TCGA-D8-A1Y2	TCGA-D8-A1Y2-01A		Positive					Positive	Modified Radical Mastectomy					-26021	65		0	433					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Indeterminate	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	0		false	No	MX	N0	T2	Stage IIA	TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf	A1Y2	TUMOR FREE	manual counting				>75%		YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	4d184421-3a3d-499a-bdb5-230f45e6d16f	cbe5aea9-00bc-40c4-9e9d-bbf285a2b8df	4d184421-3a3d-499a-bdb5-230f45e6d16f	cbe5aea9-00bc-40c4-9e9d-bbf285a2b8df	TCGA-D8-A1Y2-01A-21-A17K-20	TCGA-D8-A1Y2-01A-11D-A159-09		TCGA-D8-A1Y2-01	TCGA-D8-A1Y2-01A-11D-A161-05		4a0da6ed-16e6-4f14-8f18-0df68e63d002	TCGA-D8-A1Y2-01	TCGA-D8-A1Y2-01A-11D-A159-09			TCGA-D8-A1Y2-01	TCGA-D8-A1Y2-01A-11D-A159-09		4d184421-3a3d-499a-bdb5-230f45e6d16f		TCGA-D8-A1Y2-01A-11D-A160-01	TCGA-D8-A1Y2-01		4d184421-3a3d-499a-bdb5-230f45e6d16f	TCGA-D8-A1Y2-01A-11D-A160-01	
TCGA-D8-A1Y3-01	Stage IIIA	61	4	Stage IIIA	124		Positive	FEMALE	Negative				Negative	M0	Positive	N2	124	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1Y3-01	430	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10		mutation cluster 5	TCGA-D8-A1Y3	430	0	days	430	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A1Y3-F30088	TCGA-D8-A1Y3	TCGA-D8-A1Y3-01A		Positive					Positive	Modified Radical Mastectomy					-22317	62		0	430					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	300	NO	Indeterminate	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	5		false	No	MX	N2a	T2	Stage IIIA	TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf	A1Y3	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	0da7828c-fa60-464e-bf84-43de16003663	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	0da7828c-fa60-464e-bf84-43de16003663	TCGA-D8-A1Y3-01A-21-A17K-20	TCGA-D8-A1Y3-01A-11D-A159-09		TCGA-D8-A1Y3-01	TCGA-D8-A1Y3-01A-11D-A161-05		98a25723-ede5-43a7-988d-5a753c500649	TCGA-D8-A1Y3-01	TCGA-D8-A1Y3-01A-11D-A159-09			TCGA-D8-A1Y3-01	TCGA-D8-A1Y3-01A-11D-A159-09		e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9		TCGA-D8-A1Y3-01A-11D-A160-01	TCGA-D8-A1Y3-01		e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	TCGA-D8-A1Y3-01A-11D-A160-01	
TCGA-D8-A27E-01	Stage IA	66		Stage I	182		Positive	FEMALE	Negative				Negative	M0	Negative	N0	182	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27E-01	530	0	days	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-D8-A27E	530	0	days	530	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A27E-F30112	TCGA-D8-A27E	TCGA-D8-A27E-01A		Positive					Positive	[Discrepancy]		NO			-24315	204		0	530					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE		Hercep Test  TM Dako			1+					Other, specify		No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	110	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf	A27E	TUMOR FREE					>75%		YES	<10%		YES	Primary Tumor	01	quadrantectomy	7th	YES	YES	NO	D8	Breast	A	LIVING	2010	5e32f7e7-6022-4ce2-aa79-4c6671493406	62b607cb-63e1-4619-993e-94a5d696b1a7	5e32f7e7-6022-4ce2-aa79-4c6671493406	62b607cb-63e1-4619-993e-94a5d696b1a7	TCGA-D8-A27E-01A-21-A17K-20	TCGA-D8-A27E-01A-11D-A16D-09		TCGA-D8-A27E-01	TCGA-D8-A27E-01A-11D-A16G-05		bac504b5-18a0-4fdb-aea0-4b6e76e8eeb9	TCGA-D8-A27E-01	TCGA-D8-A27E-01A-11D-A16D-09			TCGA-D8-A27E-01	TCGA-D8-A27E-01A-11D-A16D-09		5e32f7e7-6022-4ce2-aa79-4c6671493406		TCGA-D8-A27E-01A-11D-A16C-01	TCGA-D8-A27E-01		5e32f7e7-6022-4ce2-aa79-4c6671493406	TCGA-D8-A27E-01A-11D-A16C-01	
TCGA-D8-A27F-01	Stage IIA	40	1	Stage IIA	227		Negative	FEMALE	Negative				Negative	M0	Negative	N0	227	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27F-01	488	0	days	BRCA-LUAD+	C1-LUAD-enriched	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 12		mutation cluster 12	TCGA-D8-A27F	488	0	days	488	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27F-F29515	TCGA-D8-A27F	TCGA-D8-A27F-01A		Negative					Negative	Modified Radical Mastectomy		NO			-14731	166		0	488					NO				Scheduled Follow-up Submission	2012-3-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	320	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5									NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf	A27F	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	0a69935d-9552-4792-9b2e-1a630114691e	96972bfb-01a7-4731-aca8-43dc346feb10	0a69935d-9552-4792-9b2e-1a630114691e	96972bfb-01a7-4731-aca8-43dc346feb10	TCGA-D8-A27F-01A-21-A17K-20	TCGA-D8-A27F-01A-11D-A16D-09		TCGA-D8-A27F-01	TCGA-D8-A27F-01A-11D-A16G-05		7ce10802-b13b-47af-abe3-b8deaf2c64f4	TCGA-D8-A27F-01	TCGA-D8-A27F-01A-11D-A16D-09			TCGA-D8-A27F-01	TCGA-D8-A27F-01A-11D-A16D-09		0a69935d-9552-4792-9b2e-1a630114691e		TCGA-D8-A27F-01A-11D-A16C-01	TCGA-D8-A27F-01		0a69935d-9552-4792-9b2e-1a630114691e	TCGA-D8-A27F-01A-11D-A16C-01	
TCGA-D8-A27G-01	Stage IIA	75	2	Stage IIA	209		Positive	FEMALE	Negative				Negative	M0	Negative	N0	209	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27G-01	409	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-D8-A27G	409	0	days	409	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27G-F29519	TCGA-D8-A27G	TCGA-D8-A27G-01A		Positive					Positive	Modified Radical Mastectomy		NO			-27521	156		0	409					NO	manual counting			Scheduled Follow-up Submission	2012-3-21	FEMALE					2+		not amplified			Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		31	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf	A27G	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2010	2ba9072c-39b9-438d-9a2c-0726dc3dc659	38f3fe40-a4aa-4f30-94a1-91e54c11c99b	2ba9072c-39b9-438d-9a2c-0726dc3dc659	38f3fe40-a4aa-4f30-94a1-91e54c11c99b	TCGA-D8-A27G-01A-21-A17K-20			TCGA-D8-A27G-01	TCGA-D8-A27G-01A-11D-A16G-05		10a00b30-4059-4d67-90a5-6fc691cb676e	TCGA-D8-A27G-01	TCGA-D8-A27G-01A-11D-A16D-09			TCGA-D8-A27G-01			2ba9072c-39b9-438d-9a2c-0726dc3dc659		TCGA-D8-A27G-01A-11D-A16C-01	TCGA-D8-A27G-01		2ba9072c-39b9-438d-9a2c-0726dc3dc659	TCGA-D8-A27G-01A-11D-A16C-01	
TCGA-D8-A27H-01	Stage IIA	72	1	Stage IIA	140		Negative	FEMALE	Negative				Negative	M0	Negative	N0	140	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27H-01	397	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 3		mutation cluster 2	TCGA-D8-A27H	397	0	days	397	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Upper Outer Quadrant	No axillary staging		TCGA-D8-A27H-F29536	TCGA-D8-A27H	TCGA-D8-A27H-01A		Negative					Negative	Modified Radical Mastectomy		NO			-26588	84		0	397					NO				Scheduled Follow-up Submission	2012-3-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	170	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO			false	No	M0	N0	T2	Stage IIA	TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf	A27H	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	123725b8-4f66-4b97-9726-e0c70300d38e	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	123725b8-4f66-4b97-9726-e0c70300d38e	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	TCGA-D8-A27H-01A-21-A17K-20	TCGA-D8-A27H-01A-11D-A16D-09		TCGA-D8-A27H-01	TCGA-D8-A27H-01A-11D-A16G-05		54304e23-2f82-43d6-9ace-f054d7a0f410	TCGA-D8-A27H-01	TCGA-D8-A27H-01A-11D-A16D-09			TCGA-D8-A27H-01	TCGA-D8-A27H-01A-11D-A16D-09		123725b8-4f66-4b97-9726-e0c70300d38e		TCGA-D8-A27H-01A-11D-A16C-01	TCGA-D8-A27H-01		123725b8-4f66-4b97-9726-e0c70300d38e	TCGA-D8-A27H-01A-11D-A16C-01	
TCGA-D8-A27I-01	Stage IIIA	58	3	Stage IIIA	185		Positive	FEMALE	Negative				Negative	M0	Positive	N2	185	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27I-01	439	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27I	439	0	days	439	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27I-F29521	TCGA-D8-A27I	TCGA-D8-A27I-01A		Positive					Positive	Modified Radical Mastectomy		NO			-21327	132		0	439					NO	manual counting			Scheduled Follow-up Submission	2012-3-21	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	900	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	4	0	false	No	M0	N2a	T1c	Stage IIIA	TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf	A27I	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2010	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	764e1076-1148-442b-ade8-a9463b88e89e	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	764e1076-1148-442b-ade8-a9463b88e89e	TCGA-D8-A27I-01A-21-A17L-20	TCGA-D8-A27I-01A-11D-A16D-09		TCGA-D8-A27I-01	TCGA-D8-A27I-01A-11D-A16G-05		19440cd1-daa0-4103-9be8-b878a9c59988	TCGA-D8-A27I-01	TCGA-D8-A27I-01A-11D-A16D-09			TCGA-D8-A27I-01	TCGA-D8-A27I-01A-11D-A16D-09		6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1		TCGA-D8-A27I-01A-11D-A16C-01	TCGA-D8-A27I-01		6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	TCGA-D8-A27I-01A-11D-A16C-01	
TCGA-D8-A27K-01	Stage IIB	47	2	Stage IIB	118		Positive	FEMALE	Negative				Negative	M0	Positive	N1	118	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27K-01	1461	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3		mutation cluster 4	TCGA-D8-A27K	1461	0	days	1461	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27K-F72201	TCGA-D8-A27K			Positive					Positive	Modified Radical Mastectomy		NO			-17426			0	1461					NO	manual counting			Scheduled Follow-up Submission	2015-4-29	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative		NO	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	2			No	M0	N1a	T2	Stage IIB		A27K	TUMOR FREE	manual counting			>75%	>75%	YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast		LIVING	2011	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	a602eac1-ebad-4c44-90de-62ae59208059	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	a602eac1-ebad-4c44-90de-62ae59208059	TCGA-D8-A27K-01A-21-A17L-20	TCGA-D8-A27K-01A-11D-A16D-09		TCGA-D8-A27K-01	TCGA-D8-A27K-01A-11D-A16G-05		d8b985f8-cbad-42bb-995c-42d7f8221ea4	TCGA-D8-A27K-01	TCGA-D8-A27K-01A-11D-A16D-09			TCGA-D8-A27K-01	TCGA-D8-A27K-01A-11D-A16D-09		c0ecd31a-9cce-45d2-9d04-89c465f9b55d		TCGA-D8-A27K-01A-11D-A16C-01	TCGA-D8-A27K-01		c0ecd31a-9cce-45d2-9d04-89c465f9b55d	TCGA-D8-A27K-01A-11D-A16C-01	
TCGA-D8-A27L-01	Stage IIB	49	4	Stage IIIA	125		Positive	FEMALE	Negative				Negative	M0	Positive	N2	125	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27L-01	499	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 14	TCGA-D8-A27L	499	0	days	499	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A27L-F29590	TCGA-D8-A27L	TCGA-D8-A27L-01A		Positive					Positive	Modified Radical Mastectomy		NO			-18025	84		0	499					NO	manual counting			Scheduled Follow-up Submission	2012-6-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	2		false	No	M0	N2a	T1c	Stage IIIA	TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf	A27L	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	de27ab29-90b0-4d13-8102-1c2bebc4c29a	2c270f48-b696-471a-9804-3d7427b0ba73	de27ab29-90b0-4d13-8102-1c2bebc4c29a	2c270f48-b696-471a-9804-3d7427b0ba73	TCGA-D8-A27L-01A-21-A17L-20	TCGA-D8-A27L-01A-11D-A16D-09		TCGA-D8-A27L-01	TCGA-D8-A27L-01A-11D-A16G-05		5f8e2312-38bd-45f9-b2e3-4b51674613c6	TCGA-D8-A27L-01	TCGA-D8-A27L-01A-11D-A16D-09			TCGA-D8-A27L-01	TCGA-D8-A27L-01A-11D-A16D-09		de27ab29-90b0-4d13-8102-1c2bebc4c29a		TCGA-D8-A27L-01A-11D-A16C-01	TCGA-D8-A27L-01		de27ab29-90b0-4d13-8102-1c2bebc4c29a	TCGA-D8-A27L-01A-11D-A16C-01	
TCGA-D8-A27M-01	Stage IIA	59	1	Stage I	144		Negative	FEMALE	Negative				Negative	M0	Negative	N0	144	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A27M-01	410	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5		mutation cluster 5	TCGA-D8-A27M	410	0	days	410	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A27M-F29592	TCGA-D8-A27M	TCGA-D8-A27M-01A		Negative					Negative	Modified Radical Mastectomy		NO			-21910	83		0	410					NO				Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO			false	No	M0	N0	T1c	Stage IA	TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf	A27M	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	20486352-7d5f-4065-ab10-7a3f792ec1e1	e44bc46c-7def-4fec-8865-38842dd349d1	20486352-7d5f-4065-ab10-7a3f792ec1e1	e44bc46c-7def-4fec-8865-38842dd349d1	TCGA-D8-A27M-01A-21-A17L-20	TCGA-D8-A27M-01A-11D-A16D-09		TCGA-D8-A27M-01	TCGA-D8-A27M-01A-11D-A16G-05		1d3de8e5-df7a-4e6c-a929-e03f23ddf78b	TCGA-D8-A27M-01	TCGA-D8-A27M-01A-11D-A16D-09			TCGA-D8-A27M-01	TCGA-D8-A27M-01A-11D-A16D-09		20486352-7d5f-4065-ab10-7a3f792ec1e1		TCGA-D8-A27M-01A-11D-A16C-01	TCGA-D8-A27M-01		20486352-7d5f-4065-ab10-7a3f792ec1e1	TCGA-D8-A27M-01A-11D-A16C-01	
TCGA-D8-A27N-01	Stage IIIA	36	5	Stage IIIA	145		Positive	FEMALE	Positive				Negative	M0	Positive	N2	145	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27N-01	519	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-D8-A27N	519	0	days	519	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27N-F29594	TCGA-D8-A27N	TCGA-D8-A27N-01A		Positive					Positive	Modified Radical Mastectomy		NO			-13243	75		0	519					NO	manual counting			Scheduled Follow-up Submission	2012-3-26	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Positive			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	4	0	false	No	M0	N2a	T2	Stage IIIA	TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf	A27N	TUMOR FREE	manual counting			10-75%	>75%		YES			NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	50808f98-d10b-4190-aff7-428f56abb0f9	17105ff5-33f1-4bfc-b21c-477135667919	50808f98-d10b-4190-aff7-428f56abb0f9	17105ff5-33f1-4bfc-b21c-477135667919	TCGA-D8-A27N-01A-21-A17L-20	TCGA-D8-A27N-01A-11D-A16D-09		TCGA-D8-A27N-01	TCGA-D8-A27N-01A-11D-A16G-05		40a0ee09-0c09-4320-8895-74c68841c341	TCGA-D8-A27N-01	TCGA-D8-A27N-01A-11D-A16D-09			TCGA-D8-A27N-01	TCGA-D8-A27N-01A-11D-A16D-09		50808f98-d10b-4190-aff7-428f56abb0f9		TCGA-D8-A27N-01A-11D-A16C-01	TCGA-D8-A27N-01		50808f98-d10b-4190-aff7-428f56abb0f9	TCGA-D8-A27N-01A-11D-A16C-01	
TCGA-D8-A27P-01	Stage IIA	64	2	Stage I	22		Positive	FEMALE	Negative				Negative	M0	Negative	N0	22	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27P-01	49	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3		mutation cluster 4	TCGA-D8-A27P	49	0	days	49	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-D8-A27P-F29596	TCGA-D8-A27P	TCGA-D8-A27P-01A		Positive					Positive	Modified Radical Mastectomy		NO			-23576	37		0	49					NO	manual counting			Scheduled Follow-up Submission	2012-10-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	100	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2									NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf	A27P	TUMOR FREE	manual counting			>75%	>75%		YES			NO	Primary Tumor	01		7th	NO	YES	NO	D8	Breast	A	LIVING	2011	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	2b37e86a-a7a9-445f-afec-7393f19360ff	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	2b37e86a-a7a9-445f-afec-7393f19360ff	TCGA-D8-A27P-01A-21-A17L-20	TCGA-D8-A27P-01A-11D-A16D-09		TCGA-D8-A27P-01	TCGA-D8-A27P-01A-11D-A16G-05		ead322fe-b46f-4cc6-a367-5e7681a6f494	TCGA-D8-A27P-01	TCGA-D8-A27P-01A-11D-A16D-09			TCGA-D8-A27P-01	TCGA-D8-A27P-01A-11D-A16D-09		189c7b41-4d4e-422e-85a2-1f575b5c8b5c		TCGA-D8-A27P-01A-11D-A16C-01	TCGA-D8-A27P-01		189c7b41-4d4e-422e-85a2-1f575b5c8b5c	TCGA-D8-A27P-01A-11D-A16C-01	
TCGA-D8-A27R-01	Stage IIIC	41	5	Stage IIIC	90		Positive	FEMALE	Negative				Negative	M0	Positive	N3	90	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27R-01	29	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27R			days	29	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A27R-F29701	TCGA-D8-A27R	TCGA-D8-A27R-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15122	50		0	29					NO	manual counting		polisomy	Scheduled Follow-up Submission	2012-4-28	FEMALE					2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440	NO	Equivocal	Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1										11		false	No	M0	N3a	T2	Stage IIIC	TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf	A27R	TUMOR FREE	manual counting			>75%	>75%		YES				Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2011	70546486-80a3-452c-8722-1bd7b14d5ac4	da7c504e-b884-40e3-8c4b-6c7936a68a5c	70546486-80a3-452c-8722-1bd7b14d5ac4	da7c504e-b884-40e3-8c4b-6c7936a68a5c	TCGA-D8-A27R-01A-21-A17L-20	TCGA-D8-A27R-01A-11D-A16D-09		TCGA-D8-A27R-01	TCGA-D8-A27R-01A-11D-A16G-05		a5eef620-ca1e-4125-9143-286bada198cf	TCGA-D8-A27R-01	TCGA-D8-A27R-01A-11D-A16D-09			TCGA-D8-A27R-01	TCGA-D8-A27R-01A-11D-A16D-09		70546486-80a3-452c-8722-1bd7b14d5ac4		TCGA-D8-A27R-01A-11D-A16C-01	TCGA-D8-A27R-01		70546486-80a3-452c-8722-1bd7b14d5ac4	TCGA-D8-A27R-01A-11D-A16C-01	
TCGA-D8-A27T-01	Stage IIIC	53	2	Stage IIIC	135		Positive	FEMALE	Negative				Negative	M0	Positive	N3	135	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27T-01	398	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12		mutation cluster 4	TCGA-D8-A27T	398	0	days	398	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A27T-F30096	TCGA-D8-A27T	TCGA-D8-A27T-01A		Positive					Positive	Simple Mastectomy		NO			-19591	68		0	398					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	12		false	No	M0	N3a	T2	Stage IIIC	TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf	A27T	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	090d6483-72df-4a55-84ef-5e196d1982cf	e7e113cc-1203-4bd9-9411-1f8dfacb7968	090d6483-72df-4a55-84ef-5e196d1982cf	e7e113cc-1203-4bd9-9411-1f8dfacb7968	TCGA-D8-A27T-01A-21-A17L-20	TCGA-D8-A27T-01A-11D-A16D-09		TCGA-D8-A27T-01	TCGA-D8-A27T-01A-11D-A16G-05		bc97c384-d3a4-400b-b9f7-cbca9e5356d8	TCGA-D8-A27T-01	TCGA-D8-A27T-01A-11D-A16D-09			TCGA-D8-A27T-01	TCGA-D8-A27T-01A-11D-A16D-09		090d6483-72df-4a55-84ef-5e196d1982cf		TCGA-D8-A27T-01A-11D-A16C-01	TCGA-D8-A27T-01		090d6483-72df-4a55-84ef-5e196d1982cf	TCGA-D8-A27T-01A-11D-A16C-01	
TCGA-D8-A27V-01	Stage IIA	62	2	Stage IIA	73		Positive	FEMALE	Negative				Negative	M0	Negative	N0	73	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27V-01	381	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-D8-A27V	381	0	days	381	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A27V-F30105	TCGA-D8-A27V	TCGA-D8-A27V-01A		Positive					Positive	Simple Mastectomy		NO			-22958	51		0	381					NO	manual counting			Scheduled Follow-up Submission	2012-3-29	FEMALE		Venten			1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-D8-A27V.E5011BD1-E1DE-4A47-BF3C-66BA1E0B84DC.pdf	A27V	TUMOR FREE					>75%		YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	a4c963fd-c8a6-4dcb-8b6e-159591e61d49	12f03a32-be3d-40c0-b380-b104d972a3f1	a4c963fd-c8a6-4dcb-8b6e-159591e61d49	12f03a32-be3d-40c0-b380-b104d972a3f1	TCGA-D8-A27V-01A-21-A24A-20			TCGA-D8-A27V-01	TCGA-D8-A27V-01A-12D-A17F-05		afa1063a-d82c-4277-a7af-552dd7df54b5	TCGA-D8-A27V-01	TCGA-D8-A27V-01A-12D-A17D-09			TCGA-D8-A27V-01			a4c963fd-c8a6-4dcb-8b6e-159591e61d49		TCGA-D8-A27V-01A-12D-A17C-01	TCGA-D8-A27V-01		a4c963fd-c8a6-4dcb-8b6e-159591e61d49	TCGA-D8-A27V-01A-12D-A17C-01	
TCGA-D8-A27W-01	Stage IIIB	55	3	Stage IIIB	15		Positive	FEMALE	Positive				Negative	M0	Negative	N0	15	0	LumB		Positive				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A27W-01	373	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27W	373	0	days	373	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right	Axillary lymph node dissection alone		TCGA-D8-A27W-F30107	TCGA-D8-A27W	TCGA-D8-A27W-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20173	43		0	373					NO	manual counting			Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten		Path Vysion HER2 D Probe Kit	2+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Equivocal	Positive		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	0		false	No	M0	N0	T4b	Stage IIIB	TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf	A27W	TUMOR FREE	manual counting			>75%	>75%		YES			YES	Primary Tumor	01		7th	YES	YES	NO	D8	Breast	A	LIVING	2011	65843fe1-4da2-4165-8926-a0d6f878a7f8	4a98e514-5c43-4d64-a7e6-8a8d59b89f25	65843fe1-4da2-4165-8926-a0d6f878a7f8	4a98e514-5c43-4d64-a7e6-8a8d59b89f25	TCGA-D8-A27W-01A-21-A17L-20	TCGA-D8-A27W-01A-11D-A16D-09		TCGA-D8-A27W-01	TCGA-D8-A27W-01A-11D-A16G-05		14737f59-b01c-4ed7-a08b-3a05926f8d87	TCGA-D8-A27W-01	TCGA-D8-A27W-01A-11D-A16D-09			TCGA-D8-A27W-01	TCGA-D8-A27W-01A-11D-A16D-09		65843fe1-4da2-4165-8926-a0d6f878a7f8		TCGA-D8-A27W-01A-11D-A16C-01	TCGA-D8-A27W-01		65843fe1-4da2-4165-8926-a0d6f878a7f8	TCGA-D8-A27W-01A-11D-A16C-01	
TCGA-D8-A3Z5-01																													0	TCGA-D8-A3Z5-01	1015	0	days										TCGA-D8-A3Z5	1015	0	days	1015	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right	Other (specify)	mastectomy with TLND	TCGA-D8-A3Z5-F57869	TCGA-D8-A3Z5	TCGA-D8-A3Z5-01A		Positive					Positive	Simple Mastectomy		NO			-19846	418		0	1015					NO					2014-3-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	320	NO	Negative		NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	19		false	No	M0	N3a	T2	Stage IIIC	TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf	A3Z5	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2011	f47007db-f16a-4721-aac4-c7fb6e9ca868	b43507b1-4ade-4f26-abee-1391e9433a57	f47007db-f16a-4721-aac4-c7fb6e9ca868	b43507b1-4ade-4f26-abee-1391e9433a57				TCGA-D8-A3Z5-01	TCGA-D8-A3Z5-01A-41D-A244-05		4d39d2a1-a65b-4845-8938-cf37bb0ac0ea	TCGA-D8-A3Z5-01	TCGA-D8-A3Z5-01A-41D-A243-09			TCGA-D8-A3Z5-01			f47007db-f16a-4721-aac4-c7fb6e9ca868		TCGA-D8-A3Z5-01A-41D-A242-01	TCGA-D8-A3Z5-01		f47007db-f16a-4721-aac4-c7fb6e9ca868	TCGA-D8-A3Z5-01A-41D-A242-01	
TCGA-D8-A3Z6-01																													0	TCGA-D8-A3Z6-01	563	0	days										TCGA-D8-A3Z6	563	0	days	563	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left	Other (specify)	mastectomy with TLND	TCGA-D8-A3Z6-F51367	TCGA-D8-A3Z6	TCGA-D8-A3Z6-01A		Positive					Positive	Modified Radical Mastectomy		NO			-20629	160		0	563					NO					2013-11-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	19		false	No	M0	N3a	T3	Stage IIIC	TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf	A3Z6	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2011	0593faf5-8fcc-4aba-a926-c06c70cef7a8	b5370ac3-c55f-464c-bb98-6baa05d8b6b8	0593faf5-8fcc-4aba-a926-c06c70cef7a8	b5370ac3-c55f-464c-bb98-6baa05d8b6b8				TCGA-D8-A3Z6-01	TCGA-D8-A3Z6-01A-11D-A23D-05			TCGA-D8-A3Z6-01	TCGA-D8-A3Z6-01A-11D-A23C-09			TCGA-D8-A3Z6-01			0593faf5-8fcc-4aba-a926-c06c70cef7a8		TCGA-D8-A3Z6-01A-11D-A238-01	TCGA-D8-A3Z6-01		0593faf5-8fcc-4aba-a926-c06c70cef7a8	TCGA-D8-A3Z6-01A-11D-A238-01	
TCGA-D8-A4Z1-01																													0	TCGA-D8-A4Z1-01	659	0	days										TCGA-D8-A4Z1	659	0	days	659	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Right|Right Upper Inner Quadrant	No axillary staging		TCGA-D8-A4Z1-F58485	TCGA-D8-A4Z1			Positive					Positive	Simple Mastectomy		NO			-25097			0	659							70-79%			2014-4-11	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			No	M0	N0	T1c	Stage IA		A4Z1	TUMOR FREE						YES	YES	10-19%		NO	Primary Tumor	01		7th		YES	NO	D8	Breast		LIVING	2012	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	f552a80d-3e4c-4c0b-b827-806305e48a35	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	f552a80d-3e4c-4c0b-b827-806305e48a35				TCGA-D8-A4Z1-01	TCGA-D8-A4Z1-01A-21D-A268-05			TCGA-D8-A4Z1-01	TCGA-D8-A4Z1-01A-21D-A25Q-09			TCGA-D8-A4Z1-01			e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72		TCGA-D8-A4Z1-01A-21D-A25N-01	TCGA-D8-A4Z1-01		e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	TCGA-D8-A4Z1-01A-21D-A25N-01	
TCGA-D8-A73U-01																													0	TCGA-D8-A73U-01	492	0	days										TCGA-D8-A73U	492	0	days	492	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					88	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-D8-A73U-F57871	TCGA-D8-A73U	TCGA-D8-A73U-01A		Positive					Positive	Simple Mastectomy		NO			-32208	285		0	492							70-79%			2014-3-28	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	90	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	No	M0	N0	T2	Stage IIA	TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf	A73U	WITH TUMOR						YES	NO	70-79%		NO	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2012	57728a07-cb68-45d9-ac86-eba57e674e1d	a527543f-fdc1-44a9-a00e-bfb45cbb15b8	57728a07-cb68-45d9-ac86-eba57e674e1d	a527543f-fdc1-44a9-a00e-bfb45cbb15b8				TCGA-D8-A73U-01	TCGA-D8-A73U-01A-11D-A33F-05		B493DB95-AFD7-42BC-A00E-B703F9FB9D1F	TCGA-D8-A73U-01				TCGA-D8-A73U-01			57728a07-cb68-45d9-ac86-eba57e674e1d		TCGA-D8-A73U-01A-11D-A33D-01	TCGA-D8-A73U-01		57728a07-cb68-45d9-ac86-eba57e674e1d	TCGA-D8-A73U-01A-11D-A33D-01	
TCGA-D8-A73W-01																													1	TCGA-D8-A73W-01	385	1	days										TCGA-D8-A73W	21	1	days	385	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			79	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-D8-A73W-F72197	TCGA-D8-A73W	TCGA-D8-A73W-01A		Positive					Negative	Simple Mastectomy		NO			-29125	191	385	0	244			21				70-79%			2015-4-29	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Tumor resection	230	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Lung|Bone							Lung	Distant Metastasis		NO	YES	1		false	No	MX	N1a	T3	Stage IIIA	TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf	A73W	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th		YES	NO	D8	Breast	A	DECEASED	2013	ae442e30-9756-46a8-825b-3e5b7ad394d5	5974f930-a7aa-432e-a3a5-281350781fd0	ae442e30-9756-46a8-825b-3e5b7ad394d5	5974f930-a7aa-432e-a3a5-281350781fd0				TCGA-D8-A73W-01	TCGA-D8-A73W-01A-22D-A357-05		411140F2-9383-4269-B52B-D48CC374DBDE	TCGA-D8-A73W-01				TCGA-D8-A73W-01			ae442e30-9756-46a8-825b-3e5b7ad394d5		TCGA-D8-A73W-01A-22D-A350-01	TCGA-D8-A73W-01		ae442e30-9756-46a8-825b-3e5b7ad394d5	TCGA-D8-A73W-01A-22D-A350-01	
TCGA-D8-A73X-01																													0	TCGA-D8-A73X-01	767	0	days										TCGA-D8-A73X	767	0	days	767	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-D8-A73X-F72193	TCGA-D8-A73X	TCGA-D8-A73X-01A		Positive					Positive	Simple Mastectomy		NO			-19607	140		0	767							70-79%			2015-4-29	FEMALE					1+					Other, specify		No		C50.9	8211/3	C50.9		YES		Core needle biopsy	140	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	No	M0	N0	T2	Stage IIA	TCGA-D8-A73X.9B227A4E-6237-4C95-B640-E64AFF0CC5F4.pdf	A73X	TUMOR FREE						YES	NO	70-79%		YES	Primary Tumor	01		7th		YES	NO	D8	Breast	A	LIVING	2013	a982e795-5256-439a-ae7b-9c250eefea53	e831ad69-0f96-4d82-a435-6b754e44122f	a982e795-5256-439a-ae7b-9c250eefea53	e831ad69-0f96-4d82-a435-6b754e44122f				TCGA-D8-A73X-01	TCGA-D8-A73X-01A-11D-A32T-05		062D46A5-FB34-4EF7-86A8-C56A88FC5119	TCGA-D8-A73X-01				TCGA-D8-A73X-01			a982e795-5256-439a-ae7b-9c250eefea53		TCGA-D8-A73X-01A-11D-A32H-01	TCGA-D8-A73X-01		a982e795-5256-439a-ae7b-9c250eefea53	TCGA-D8-A73X-01A-11D-A32H-01	
TCGA-E2-A105-01	Stage IIA	79	5	Stage IIA	1163		Positive	FEMALE	Equivocal				Negative	M0	Negative	N0	1163	0	LumA	Luminal A	Positive		-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A105-01	1308	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-E2-A105	1308	0	days	1308	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A105-F17431	TCGA-E2-A105	TCGA-E2-A105-01A		Positive					Positive	Lumpectomy		NO			-28855	1171		0	1308						Allred score 3 + 2 = 5			Scheduled Follow-up Submission	2011-9-9	FEMALE			70-79%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO	0		false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E2-A105.252A2D12-EC16-459E-8486-7814FF39E6C2.pdf	A105	TUMOR FREE	Allred score 3 + 2 = 5			Allred score 5	Allred score 5					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	b9bb3fb2-5692-4e7b-9353-45db1d58843f	1a387c5a-10d0-4a4b-9e5d-23184f15d70c	b9bb3fb2-5692-4e7b-9353-45db1d58843f	1a387c5a-10d0-4a4b-9e5d-23184f15d70c		TCGA-E2-A105-01A-11D-A10M-09		TCGA-E2-A105-01	TCGA-E2-A105-01A-11D-A10N-05			TCGA-E2-A105-01	TCGA-E2-A105-01A-11D-A10M-09		TCGA-E2-A105-01		TCGA-E2-A105-01A-11D-A10M-09	TCGA-E2-A105-01	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01	TCGA-E2-A105-01A-11D-A10L-01		TCGA-E2-A105-01A-11R-A10J-07	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01A-11D-A10L-01	TCGA-E2-A105-01
TCGA-E2-A106-01	Stage IB	34	4	No_Conversion	1807		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1807	0	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-E2-A106-01	2541	0	days	Kirc+		cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-E2-A106	2541	0	days	2541	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A106-F70397	TCGA-E2-A106		Negative	Positive				Other	Positive	Simple Mastectomy	inner-upper margin re-excision	NO			-12528			0	2541							90-99%		Scheduled Follow-up Submission	2015-3-17	FEMALE			10-19%		2+			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	16	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	1			No	M0	N1mi	T1c	Stage IB		A106	TUMOR FREE						YES		80-89%		NO	Primary Tumor	01			YES	NO	YES	E2	Breast		LIVING	2006	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2		cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2					TCGA-E2-A106-01	TCGA-E2-A106-01A-11D-A10N-05									TCGA-E2-A106-01	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	TCGA-E2-A106-01			TCGA-E2-A106-01A-11R-A10J-07	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2		TCGA-E2-A106-01
TCGA-E2-A107-01	Stage IIIA	54	2	No_Conversion	1046		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N2	1046	0		Luminal B	Negative	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-E2-A107-01	1047	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A107	1047	0	days	1047	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A107-F17173	TCGA-E2-A107	TCGA-E2-A107-01A		Positive					Negative	Simple Mastectomy		NO			-20065	715		0	1047						Allred score 5+3=8			Scheduled Follow-up Submission	2011-9-28	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	4		false	No	M0	N2a	T3	Stage IIIA	TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf	A107	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	254c611f-7808-4745-9155-f2d578b29df2	66b6796c-a14a-4bef-ac6b-aee438e04563	254c611f-7808-4745-9155-f2d578b29df2	66b6796c-a14a-4bef-ac6b-aee438e04563	TCGA-E2-A107-01A-21-A13D-20	TCGA-E2-A107-01A-11D-A10M-09		TCGA-E2-A107-01	TCGA-E2-A107-01A-11D-A10N-05		ea9612ed-23f6-44e6-92f4-7cc7d3cef266	TCGA-E2-A107-01	TCGA-E2-A107-01A-11D-A10M-09		TCGA-E2-A107-01		TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01	TCGA-E2-A107-01A-11D-A10L-01		TCGA-E2-A107-01A-11R-A10J-07	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-11D-A10L-01	TCGA-E2-A107-01
TCGA-E2-A108-01	Stage IIIA	64	4	No_Conversion	837		Positive	FEMALE	Negative	1	4	3	Negative	M0	Positive	N2	837	0	Normal	Normal-like	Positive	ReacI	-5	-8	followup	T_Other	T2	LIVING	0	TCGA-E2-A108-01	837	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A108	837	0	days	837	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant			TCGA-E2-A108-F17423	TCGA-E2-A108	TCGA-E2-A108-01A		Positive					Positive	Lumpectomy					-23530	596		0	837						Allred score 7 (outside facility)			Scheduled Follow-up Submission	2011-9-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	4		false	No	M0	N2a	T2	Stage IIIA	TCGA-E2-A108.DDBEE56C-F8E8-4A7D-8CF6-E0D63EE53FC4.pdf	A108	WITH TUMOR	Allred score 7 per outside facility report			Allred score 7 per outside facility report	Allred score 7 (per outside facility)					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	48188b57-1f05-43dc-b8d4-a422c4f443a9	6c84b94a-ae86-4265-9620-0d66bb6cfacc	48188b57-1f05-43dc-b8d4-a422c4f443a9	6c84b94a-ae86-4265-9620-0d66bb6cfacc	TCGA-E2-A108-01A-21-A13D-20	TCGA-E2-A108-01A-13D-A10M-09		TCGA-E2-A108-01	TCGA-E2-A108-01A-13D-A10N-05		0e4168e1-0fd3-4a3b-b878-d4c88ced0311	TCGA-E2-A108-01	TCGA-E2-A108-01A-13D-A10M-09		TCGA-E2-A108-01		TCGA-E2-A108-01A-13D-A10M-09	TCGA-E2-A108-01	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01	TCGA-E2-A108-01A-13D-A10L-01		TCGA-E2-A108-01A-13R-A10J-07	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01A-13D-A10L-01	TCGA-E2-A108-01
TCGA-E2-A109-01	Stage IIA	64	5	Stage IIA	1417		Positive	FEMALE	Negative	4	1	4	Negative	M0	Negative	N0	1417	0	LumB	Luminal B	Negative	LumA/B	-10	-5	followup	T_Other	T2	LIVING	0	TCGA-E2-A109-01	1417	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 6	mutation cluster 5	TCGA-E2-A109	1417	0	days	1417	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A109-F17418	TCGA-E2-A109	TCGA-E2-A109-01A		Positive					Negative	Simple Mastectomy		NO			-23521	1155		0	1417						Allred score 5+3=8			Scheduled Follow-up Submission	2011-9-9	FEMALE			50-59%		2+			1.46		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	6								NO	0		false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E2-A109.089E0FB9-6B45-4E3E-843E-EC98D39863F6.pdf	A109	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8					NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	818dbfb5-8c4a-44d1-a44d-6cb138dadca6	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	818dbfb5-8c4a-44d1-a44d-6cb138dadca6	TCGA-E2-A109-01A-21-A13D-20	TCGA-E2-A109-01A-11D-A10M-09		TCGA-E2-A109-01	TCGA-E2-A109-01A-11D-A10N-05		a2cbc0c2-b14e-460f-bc12-5aa350950e00	TCGA-E2-A109-01	TCGA-E2-A109-01A-11D-A10M-09		TCGA-E2-A109-01		TCGA-E2-A109-01A-11D-A10M-09	TCGA-E2-A109-01	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01	TCGA-E2-A109-01A-11D-A10L-01		TCGA-E2-A109-01A-11R-A10J-07	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01A-11D-A10L-01	TCGA-E2-A109-01
TCGA-E2-A10A-01	Stage IIB	41	2	Stage IIB	1229		Positive	FEMALE	Negative	3	3	4	Negative	M0	Negative	N0	1229	0	LumA	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-E2-A10A-01	1229	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E2-A10A	92	1	days	1229	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	NO		41	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A10A-F17522	TCGA-E2-A10A	TCGA-E2-A10A-01A		Positive					Positive	Simple Mastectomy		NO			-15085	1096		0	1229			92			Allred score 4+3=7			Scheduled Follow-up Submission	2011-10-12	FEMALE			40-49%		2+			1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Positive	Negative		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	1				Brain	Distant Metastasis			YES	0	0	false	No	M0	N0 (i-)	T3	Stage IIB	TCGA-E2-A10A.AA1BACC4-0B3D-4E2E-865E-24B570DA4E74.pdf	A10A	WITH TUMOR	Allred score 5+3=8			Allred score 8	Allred score 7					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	104213ad-3ec6-4a24-9760-72333b6c2c22	d01c9656-e545-4261-aceb-135ef42825ce	104213ad-3ec6-4a24-9760-72333b6c2c22	d01c9656-e545-4261-aceb-135ef42825ce	TCGA-E2-A10A-01A-11-A13D-20	TCGA-E2-A10A-01A-21D-A10Y-09		TCGA-E2-A10A-01			18a5dc5d-47d6-495a-a3d5-e19cd79678f4	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21D-A10Y-09	TCGA-E2-A10A-01A-21D-A112-05	TCGA-E2-A10A-01	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21D-A10Y-09		104213ad-3ec6-4a24-9760-72333b6c2c22		TCGA-E2-A10A-01A-21D-A111-01	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21R-A115-07	104213ad-3ec6-4a24-9760-72333b6c2c22	TCGA-E2-A10A-01A-21D-A111-01	TCGA-E2-A10A-01
TCGA-E2-A10B-01	Stage IIB	67	3	No_Conversion	1141		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	1141	0	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-E2-A10B-01	1141	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A10B	195	1	days	1141	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES	YES		67	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A10B-F17370	TCGA-E2-A10B	TCGA-E2-A10B-01A		Positive					Positive	Lumpectomy		NO		195	-24577	1065		0	1141			195			Allred score 5+3= 8			Scheduled Follow-up Submission	2011-9-19	FEMALE			10-19%		2+			1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		28	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Negative												Negative			4	4				Lung	New Primary Tumor			YES	2	0	false	No	M0	N1a	T2	Stage IIB	TCGA-E2-A10B.5DAC95DD-5DA6-475B-AC14-5C79FC2F30A6.pdf	A10B	TUMOR FREE	Allred score 5+3= 8			Allred score 8	Allred score 8					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	3b72a173-8ce4-444e-aeeb-39be3f3eb558	b451d230-d158-40cb-91a9-bf25a4da50e6	3b72a173-8ce4-444e-aeeb-39be3f3eb558	b451d230-d158-40cb-91a9-bf25a4da50e6	TCGA-E2-A10B-01A-21-A13D-20	TCGA-E2-A10B-01A-11D-A10M-09		TCGA-E2-A10B-01	TCGA-E2-A10B-01A-11D-A10N-05		f0d6030f-5893-4ff7-8072-b4ecafb7a860	TCGA-E2-A10B-01	TCGA-E2-A10B-01A-11D-A10M-09		TCGA-E2-A10B-01		TCGA-E2-A10B-01A-11D-A10M-09	TCGA-E2-A10B-01	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01	TCGA-E2-A10B-01A-11D-A10L-01		TCGA-E2-A10B-01A-11R-A10J-07	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01A-11D-A10L-01	TCGA-E2-A10B-01
TCGA-E2-A10C-01	Stage IIB	54	3	No_Conversion	1219		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N1	1219	0	LumB	Luminal B	Positive	ReacI	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-E2-A10C-01	1220	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 3	TCGA-E2-A10C	1220	0	days	1220	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A10C-F17357	TCGA-E2-A10C	TCGA-E2-A10C-01A		Positive					Positive	Lumpectomy		NO			-19849	995		0	1220						Allred score 5+3=8			Scheduled Follow-up Submission	2011-9-26	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	1		false	No	M0	N1a	T2	Stage IIB	TCGA-E2-A10C.E8A61AAC-BFF5-4341-B051-EDD87515ECDC.pdf	A10C	TUMOR FREE	Allred score 3+3=6			Allred score 6	Allred score 8					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	47ba6d6f-734a-4e33-af3e-eef3783cc26b	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	47ba6d6f-734a-4e33-af3e-eef3783cc26b	TCGA-E2-A10C-01A-11-A13D-20	TCGA-E2-A10C-01A-21D-A10M-09		TCGA-E2-A10C-01	TCGA-E2-A10C-01A-21D-A10N-05		a000b0bf-7241-4898-8bc9-1d130065cc5d	TCGA-E2-A10C-01	TCGA-E2-A10C-01A-21D-A10M-09		TCGA-E2-A10C-01		TCGA-E2-A10C-01A-21D-A10M-09	TCGA-E2-A10C-01	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01	TCGA-E2-A10C-01A-21D-A10L-01		TCGA-E2-A10C-01A-21R-A10J-07	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01A-21D-A10L-01	TCGA-E2-A10C-01
TCGA-E2-A10E-01	Stage IIA	64	2	No_Conversion	865		Positive	FEMALE	Negative	1	3	3	Negative	M0	Positive	N1	865	0	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T1	T1	LIVING	0	TCGA-E2-A10E-01	865	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A10E	865	0	days	865	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A10E-F17248	TCGA-E2-A10E	TCGA-E2-A10E-01A		Positive					Positive	Simple Mastectomy		NO			-23684	869		0	865						Allred score 5+3=8			Scheduled Follow-up Submission	2011-9-26	FEMALE			40-49%		2+			1.07		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Equivocal	Negative		21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	2		false	No	M0	N1a	T1c	Stage IIA	TCGA-E2-A10E.CFB8EE09-41D3-4A39-A4AE-4CDEC84BB9BC.pdf	A10E	TUMOR FREE	Allred score 3+2=5			Allred score 5	Allred score 8					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	0e932148-a592-42e2-b1df-4fd599db21e9	828071d6-b83c-4040-8012-8a25ef18261a	0e932148-a592-42e2-b1df-4fd599db21e9	828071d6-b83c-4040-8012-8a25ef18261a	TCGA-E2-A10E-01A-11-A13D-20	TCGA-E2-A10E-01A-21D-A10M-09		TCGA-E2-A10E-01	TCGA-E2-A10E-01A-21D-A10N-05		3511ab99-23f6-45bb-b2f9-28e547200841	TCGA-E2-A10E-01	TCGA-E2-A10E-01A-21D-A10M-09		TCGA-E2-A10E-01		TCGA-E2-A10E-01A-21D-A10M-09	TCGA-E2-A10E-01	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01	TCGA-E2-A10E-01A-21D-A10L-01		TCGA-E2-A10E-01A-21R-A10J-07	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01A-21D-A10L-01	TCGA-E2-A10E-01
TCGA-E2-A10F-01	Stage IIA	47	2	Stage IIA	878		Positive	FEMALE	Negative				Negative	M0	Negative	N0	878	0	LumA	Luminal A	Positive		-5	-4	followup	T_Other	T2	LIVING	0	TCGA-E2-A10F-01	878	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A10F	878	0	days	878	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A10F-F17187	TCGA-E2-A10F	TCGA-E2-A10F-01A		Positive					Positive	Lumpectomy		NO			-17257	801		0	878						Allred score 5+3=8			Scheduled Follow-up Submission	2011-9-27	FEMALE			20-29%		2+			1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	0		false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E2-A10F.71C82089-E070-4C7B-B15B-0492DECCB3BF.pdf	A10F	TUMOR FREE	Allred score 5+3=8			Allred score 8	Allred score 8					YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	05918561-a713-464b-9b5c-4f7c9258a827	49d20029-a697-4499-8ef4-e87c04dfa2dc	05918561-a713-464b-9b5c-4f7c9258a827	49d20029-a697-4499-8ef4-e87c04dfa2dc		TCGA-E2-A10F-01A-11D-A10M-09		TCGA-E2-A10F-01	TCGA-E2-A10F-01A-11D-A10N-05			TCGA-E2-A10F-01	TCGA-E2-A10F-01A-11D-A10M-09		TCGA-E2-A10F-01		TCGA-E2-A10F-01A-11D-A10M-09	TCGA-E2-A10F-01	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01	TCGA-E2-A10F-01A-11D-A10L-01		TCGA-E2-A10F-01A-11R-A10J-07	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01A-11D-A10L-01	TCGA-E2-A10F-01
TCGA-E2-A14N-01	Stage IIB	37	4	Stage IIB	1350		Negative	FEMALE	Negative				Negative	M0	Positive	N1	1350	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14N-01	1434	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-E2-A14N	1434	0	days	1434	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14N-F19154	TCGA-E2-A14N	TCGA-E2-A14N-01A		Negative					Negative	Simple Mastectomy		NO			-13743	1240		0	1434					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-17	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	440	NO	Negative			38	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	6								NO	1		false	No	M0	N1	T2	Stage IIB	TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf	A14N	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	6e45dd01-225d-4871-9a3a-f591808ad234	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	6e45dd01-225d-4871-9a3a-f591808ad234	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	TCGA-E2-A14N-01A-21-A17I-20	TCGA-E2-A14N-01A-31D-A135-09		TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31D-A138-05		df24b18e-26f0-494d-a7bc-4672b1a0314b	TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31D-A135-09		TCGA-E2-A14N-01	TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31D-A135-09		6e45dd01-225d-4871-9a3a-f591808ad234		TCGA-E2-A14N-01A-31D-A134-01	TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31R-A137-07	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA-E2-A14N-01A-31D-A134-01	TCGA-E2-A14N-01
TCGA-E2-A14O-01	Stage IIIA	76	2	Stage IIIA	1172		Positive	FEMALE	Negative	1	3	4	Negative	M0	Positive	N1	1172	0	LumB	Luminal B	Positive	LumA/B	0	-3	enrollment	T_Other	T3	LIVING	0	TCGA-E2-A14O-01	1359	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A14O	1359	0	days	1359	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14O-F18521	TCGA-E2-A14O	TCGA-E2-A14O-01A		Positive					Positive	Modified Radical Mastectomy		NO			-27837	1064		0	1359					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-10-19	FEMALE			50-59%		2+			1.65		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Equivocal	Negative		18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	2		false	No	M0	N1a	T3	Stage IIIA	TCGA-E2-A14O.42E9A561-B052-412E-B0FD-563DC097C3C5.pdf	A14O	TUMOR FREE	Allred score 5+2 = 7			Allred score = 7	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	2791089c-f659-41e8-8e18-57fc6a079e6b	2def89d4-9863-4170-880b-4fec28a1465b	2791089c-f659-41e8-8e18-57fc6a079e6b	2def89d4-9863-4170-880b-4fec28a1465b	TCGA-E2-A14O-01A-21-A13E-20	TCGA-E2-A14O-01A-31D-A10Y-09		TCGA-E2-A14O-01			1b57149c-21de-43c8-8f92-f6adbd5623c3	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31D-A10Y-09	TCGA-E2-A14O-01A-31D-A112-05	TCGA-E2-A14O-01	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31D-A10Y-09		2791089c-f659-41e8-8e18-57fc6a079e6b		TCGA-E2-A14O-01A-31D-A111-01	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31R-A115-07	2791089c-f659-41e8-8e18-57fc6a079e6b	TCGA-E2-A14O-01A-31D-A111-01	TCGA-E2-A14O-01
TCGA-E2-A14P-01	Stage IIIC	79	3	Stage IIIC	487		Negative	FEMALE	Positive	1	1	1	Negative	M0	Positive	N3	487	0	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14P-01	1246	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A14P	1246	0	days	1246	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A14P-F18846	TCGA-E2-A14P	TCGA-E2-A14P-01A		Negative					Negative	Lumpectomy		NO			-28923	965		0	1246					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-10-20	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Positive			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	10		false	No	M0	N3	T2	Stage IIIC	TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C.pdf	A14P	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	NO	NO	YES	E2	Breast	A	LIVING	2008	a4cb04f5-91b3-40ba-8005-b1df46d6b555	32d3f1cd-077f-43bf-843e-1fe9f0ec0cba	a4cb04f5-91b3-40ba-8005-b1df46d6b555	32d3f1cd-077f-43bf-843e-1fe9f0ec0cba	TCGA-E2-A14P-01A-21-A13E-20	TCGA-E2-A14P-01A-31D-A12B-09		TCGA-E2-A14P-01			3a9dace0-ee3c-42bc-8c9a-30998aae35f0	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31D-A12B-09	TCGA-E2-A14P-01A-31D-A12E-05	TCGA-E2-A14P-01	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31D-A12B-09		a4cb04f5-91b3-40ba-8005-b1df46d6b555		TCGA-E2-A14P-01A-31D-A12A-01	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31R-A12D-07	a4cb04f5-91b3-40ba-8005-b1df46d6b555	TCGA-E2-A14P-01A-31D-A12A-01	TCGA-E2-A14P-01
TCGA-E2-A14Q-01	Stage IIA	50	2	Stage IIB	974		Positive	FEMALE	Negative	3	4	3	Negative	M0	Positive	N1	974	0	LumA	Luminal A	Positive	LumA	0	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14Q-01	1163	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A14Q	1163	0	days	1163	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14Q-F18800	TCGA-E2-A14Q	TCGA-E2-A14Q-01A		Positive					Positive	Lumpectomy		NO			-18507	960		0	1163					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-10-20	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	2								NO	1		false	No	M0	N1mi	T2	Stage IIB	TCGA-E2-A14Q.42A1A073-69B4-4A66-A998-BE4366E0C89C.pdf	A14Q	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	48d70a9a-b6ae-4ed6-80da-999a919f8da9	d897dae1-1649-463c-aba4-e93fae68c5e8	48d70a9a-b6ae-4ed6-80da-999a919f8da9	d897dae1-1649-463c-aba4-e93fae68c5e8	TCGA-E2-A14Q-01A-21-A13E-20	TCGA-E2-A14Q-01A-11D-A12B-09		TCGA-E2-A14Q-01			9ebd7a3c-5f75-479b-a6a3-b4f00221955f	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11D-A12B-09	TCGA-E2-A14Q-01A-11D-A12E-05	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11D-A12B-09		48d70a9a-b6ae-4ed6-80da-999a919f8da9		TCGA-E2-A14Q-01A-11D-A12A-01	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11R-A12D-07	48d70a9a-b6ae-4ed6-80da-999a919f8da9	TCGA-E2-A14Q-01A-11D-A12A-01	TCGA-E2-A14Q-01
TCGA-E2-A14R-01	Stage IIA	62	1	Stage IIA	845		Negative	FEMALE	Negative				Negative	M0	Negative	N0	845	0	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14R-01	1174	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A14R	971	1	days	1174	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES	YES		62	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14R-F18838	TCGA-E2-A14R	TCGA-E2-A14R-01A		Negative					Negative	Lumpectomy		NO		971	-22686	910		0	1174			971		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-10-24	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5				Other, specify	New Primary Tumor	Endometrial		YES	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf	A14R	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	76a625e9-22b3-42b8-8813-27c133d0b248	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d	76a625e9-22b3-42b8-8813-27c133d0b248	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d		TCGA-E2-A14R-01A-11D-A10Y-09		TCGA-E2-A14R-01				TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11D-A10Y-09	TCGA-E2-A14R-01A-11D-A112-05	TCGA-E2-A14R-01	TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11D-A10Y-09		76a625e9-22b3-42b8-8813-27c133d0b248		TCGA-E2-A14R-01A-11D-A111-01	TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11R-A115-07	76a625e9-22b3-42b8-8813-27c133d0b248	TCGA-E2-A14R-01A-11D-A111-01	TCGA-E2-A14R-01
TCGA-E2-A14S-01	Stage I	65	4	Stage I	834		Positive	FEMALE	Negative	1	3	4	Negative	M0	Negative	N0	834	0	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A14S-01	1009	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A14S	1009	0	days	1009	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A14S-F18831	TCGA-E2-A14S	TCGA-E2-A14S-01A		Positive					Positive	Lumpectomy		NO			-23878	827		0	1009					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-3	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A14S.810B3936-DFF0-420C-BD6C-8D4990B8F536.pdf	A14S	TUMOR FREE	Allred score 4+3 = 7			Allred score = 7	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	5aaf8edc-5d66-4099-824b-f4e06827ad12	48a87c28-38ea-4e10-b545-b3b55caf3225	5aaf8edc-5d66-4099-824b-f4e06827ad12	48a87c28-38ea-4e10-b545-b3b55caf3225	TCGA-E2-A14S-01A-21-A13E-20	TCGA-E2-A14S-01A-11D-A12B-09		TCGA-E2-A14S-01			010a31fc-4218-4110-b2d0-4791ca77d417	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11D-A12B-09	TCGA-E2-A14S-01A-11D-A12E-05	TCGA-E2-A14S-01	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11D-A12B-09		5aaf8edc-5d66-4099-824b-f4e06827ad12		TCGA-E2-A14S-01A-11D-A12A-01	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11R-A12D-07	5aaf8edc-5d66-4099-824b-f4e06827ad12	TCGA-E2-A14S-01A-11D-A12A-01	TCGA-E2-A14S-01
TCGA-E2-A14T-01	Stage IIA	52		Stage IIA	890		Positive	FEMALE	Negative				Negative	M0	Negative	N0	890	0	LumA	Luminal A	Positive	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14T-01	2311	0	days		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E2-A14T	2311	0	days	2311	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A14T-F70396	TCGA-E2-A14T	TCGA-E2-A14T-01A		Positive					Positive	Simple Mastectomy		NO			-19237	792		0	2311					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2015-3-17	FEMALE					1+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative	Negative	NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	1								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A14T.6C8B56C1-330B-4116-8B60-7A81A1983277.pdf	A14T	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8	YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	7aa46530-2311-41ed-a452-9ca06f38c0c1	e0629d66-17b1-4abb-beff-7b459b373089	7aa46530-2311-41ed-a452-9ca06f38c0c1	e0629d66-17b1-4abb-beff-7b459b373089	TCGA-E2-A14T-01A-21-A13E-20	TCGA-E2-A14T-01A-11D-A10Y-09		TCGA-E2-A14T-01			356382a7-c34b-4e96-aaf2-9901ccc6d72c	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11D-A10Y-09	TCGA-E2-A14T-01A-11D-A112-05	TCGA-E2-A14T-01	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11D-A10Y-09		7aa46530-2311-41ed-a452-9ca06f38c0c1		TCGA-E2-A14T-01A-11D-A111-01	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11R-A115-07	7aa46530-2311-41ed-a452-9ca06f38c0c1	TCGA-E2-A14T-01A-11D-A111-01	TCGA-E2-A14T-01
TCGA-E2-A14U-01																													0	TCGA-E2-A14U-01	1318	0	days	Quiet			BRCA non-CIMP c9			miRNA cluster 5			TCGA-E2-A14U	1318	0	days	1318	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Right Upper Outer Quadrant	Other (specify)	Sentinel lymph node dissection	TCGA-E2-A14U-F33622	TCGA-E2-A14U	TCGA-E2-A14U-01A		Positive					Positive	Lumpectomy		NO			-27389	796		0	1318					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2012-7-11	FEMALE			40-49%		2+			1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf	A14U	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	20d25e27-b509-45eb-a734-9b8d6a40c632	a20a0a7b-90ff-4427-91f6-72ebf8c7b61e	20d25e27-b509-45eb-a734-9b8d6a40c632	a20a0a7b-90ff-4427-91f6-72ebf8c7b61e				TCGA-E2-A14U-01	TCGA-E2-A14U-01A-11D-A22B-05			TCGA-E2-A14U-01	TCGA-E2-A14U-01A-11D-A228-09			TCGA-E2-A14U-01			20d25e27-b509-45eb-a734-9b8d6a40c632		TCGA-E2-A14U-01A-11D-A227-01	TCGA-E2-A14U-01		20d25e27-b509-45eb-a734-9b8d6a40c632	TCGA-E2-A14U-01A-11D-A227-01	
TCGA-E2-A14V-01	Stage IIB	53	5	Stage IIB	748		Positive	FEMALE	Positive	1	1	1	Negative	M0	Positive	N1	748	0	Her2	HER2-enriched	Positive	Her2	-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14V-01	1042	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A14V	1042	0	days	1042	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14V-F18870	TCGA-E2-A14V	TCGA-E2-A14V-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-19643	722		0	1042					NO				Scheduled Follow-up Submission	2011-11-4	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Positive			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	3		false	No	M0	N1	T2	Stage IIB	TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf	A14V	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	83803fb6-49a3-46a2-a927-657c4733337a	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	83803fb6-49a3-46a2-a927-657c4733337a	TCGA-E2-A14V-01A-21-A13E-20	TCGA-E2-A14V-01A-11D-A12B-09		TCGA-E2-A14V-01			40a19899-83c4-44c1-8e91-c4b4339d7ea8	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01A-11D-A12E-05	TCGA-E2-A14V-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12B-09		d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf		TCGA-E2-A14V-01A-11D-A12A-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11R-A12D-07	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	TCGA-E2-A14V-01A-11D-A12A-01	TCGA-E2-A14V-01
TCGA-E2-A14W-01	Stage IIA	78	5	Stage IIA	833		Positive	FEMALE	Positive	3	3	4	Negative	M0	Negative	N0	833	0	LumB	Luminal B	Positive	Her2	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14W-01	974	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation cluster 12	TCGA-E2-A14W	974	0	days	974	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A14W-F18803	TCGA-E2-A14W	TCGA-E2-A14W-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-28664	716		0	974					NO				Scheduled Follow-up Submission	2011-11-4	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	150	NO		Positive		5	Negative																					2	7								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A14W.9ECD3DA1-25A4-4325-9B3B-6D7C12283C37.pdf	A14W	TUMOR FREE							YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	f898f44d-a728-41cf-b1ac-20b1995a86b9	77d07305-dbcf-4795-9f23-e69fc65b04b1	f898f44d-a728-41cf-b1ac-20b1995a86b9	77d07305-dbcf-4795-9f23-e69fc65b04b1	TCGA-E2-A14W-01A-21-A13E-20	TCGA-E2-A14W-01A-11D-A12B-09		TCGA-E2-A14W-01			de3f269f-cfa8-4ff2-bd60-14ffe2a45d83	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11D-A12B-09	TCGA-E2-A14W-01A-11D-A12E-05	TCGA-E2-A14W-01	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11D-A12B-09		f898f44d-a728-41cf-b1ac-20b1995a86b9		TCGA-E2-A14W-01A-11D-A12A-01	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11R-A12D-07	f898f44d-a728-41cf-b1ac-20b1995a86b9	TCGA-E2-A14W-01A-11D-A12A-01	TCGA-E2-A14W-01
TCGA-E2-A14X-01	Stage IIIA	55	4	Stage IIIA	692		Negative	FEMALE	Negative	3	2	2	Negative	M0	Positive	N2	692	0	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14X-01	972	0	days	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A14X	972	0	days	972	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A14X-F18857	TCGA-E2-A14X	TCGA-E2-A14X-01A		Negative					Negative	Lumpectomy		NO			-20105	652		0	972					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-4	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	5		false	No	M0	N2	T2	Stage IIIA	TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146.pdf	A14X	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	d9f827bb-2498-49b0-aa85-71cb554eb926	83255030-c4f5-48ed-829b-3b06dd57adbb	d9f827bb-2498-49b0-aa85-71cb554eb926	83255030-c4f5-48ed-829b-3b06dd57adbb	TCGA-E2-A14X-01A-21-A13E-20	TCGA-E2-A14X-01A-11D-A10Y-09		TCGA-E2-A14X-01			29a42295-97db-4c28-885f-801d655b5b0f	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11D-A10Y-09	TCGA-E2-A14X-01A-11D-A112-05	TCGA-E2-A14X-01	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11D-A10Y-09		d9f827bb-2498-49b0-aa85-71cb554eb926		TCGA-E2-A14X-01A-11D-A111-01	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11R-A115-07	d9f827bb-2498-49b0-aa85-71cb554eb926	TCGA-E2-A14X-01A-11D-A111-01	TCGA-E2-A14X-01
TCGA-E2-A14Y-01	Stage IIA	35	2	Stage IIA	688		Positive	FEMALE	Positive	3	3	3	Negative	M0	Negative	N0	688	0	Basal	Basal-like	Positive	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14Y-01	2109	0	days	Iq	C4-BRCA/Basal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 3	TCGA-E2-A14Y	2109	0	days	2109	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right	Sentinel node biopsy alone		TCGA-E2-A14Y-F70401	TCGA-E2-A14Y	TCGA-E2-A14Y-01A		Positive					Positive	Simple Mastectomy		NO			-13004	597		0	2109					NO				Scheduled Follow-up Submission	2015-3-17	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Equivocal	Positive	NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	5								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A14Y.957AC7B0-D613-4F97-BBBC-930EB95EE2E4.pdf	A14Y	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	3ea70053-af2a-4fec-9416-d18b6156f516	4f21ba10-b578-4a5a-a941-399c4cc65329	3ea70053-af2a-4fec-9416-d18b6156f516	4f21ba10-b578-4a5a-a941-399c4cc65329	TCGA-E2-A14Y-01A-11-A13E-20	TCGA-E2-A14Y-01A-21D-A12B-09		TCGA-E2-A14Y-01			173f9cd2-092c-479a-b9f2-f58ebd0ffa69	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21D-A12B-09	TCGA-E2-A14Y-01A-21D-A12E-05	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21D-A12B-09		3ea70053-af2a-4fec-9416-d18b6156f516		TCGA-E2-A14Y-01A-21D-A12A-01	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21R-A12D-07	3ea70053-af2a-4fec-9416-d18b6156f516	TCGA-E2-A14Y-01A-21D-A12A-01	TCGA-E2-A14Y-01
TCGA-E2-A14Y-11		35			688			FEMALE									688	0							enrollment			LIVING	0	TCGA-E2-A14Y-11	2109	0	days		C4-BRCA/Basal							mutation cluster 3	TCGA-E2-A14Y	2109	0	days	2109	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Right	Sentinel node biopsy alone		TCGA-E2-A14Y-F70401	TCGA-E2-A14Y	TCGA-E2-A14Y-11A		Positive					Positive	Simple Mastectomy		NO			-13004	597		0	2109					NO				Scheduled Follow-up Submission	2015-3-17	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Equivocal	Positive	NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		false	No	M0	N0	T2	Stage IIA		A14Y	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009														TCGA-E2-A14Y-11A-33D-A12E-05												
TCGA-E2-A14Z-01	Stage I	64	1	Stage I	518		Positive	FEMALE	Negative	3	2	3	Negative	M0	Negative	N0	518	0	LumA	Luminal A	Positive	LumA	0	-2	enrollment	T1	T1	LIVING	1	TCGA-E2-A14Z-01	563	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-E2-A14Z	188	1	days	563	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		64	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A14Z-F18792	TCGA-E2-A14Z	TCGA-E2-A14Z-01A		Positive					Positive	Lumpectomy		NO			-23682	519	563	0	518			188		NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-28	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6				Liver	Distant Metastasis			YES	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A14Z.750D4149-BD70-4D7C-B915-9694BD1EC760.pdf	A14Z	WITH TUMOR	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	DECEASED	2009	bcf768ee-138c-42a4-a3bf-b8d509c644d9	04dac9e1-f867-481c-aa21-5c17336af1fd	bcf768ee-138c-42a4-a3bf-b8d509c644d9	04dac9e1-f867-481c-aa21-5c17336af1fd	TCGA-E2-A14Z-01A-21-A13E-20	TCGA-E2-A14Z-01A-11D-A10Y-09		TCGA-E2-A14Z-01			5a68a63e-17ae-4bd8-ab5d-0451e8ae8cc1	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11D-A10Y-09	TCGA-E2-A14Z-01A-11D-A112-05	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11D-A10Y-09		bcf768ee-138c-42a4-a3bf-b8d509c644d9		TCGA-E2-A14Z-01A-11D-A111-01	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11R-A115-07	bcf768ee-138c-42a4-a3bf-b8d509c644d9	TCGA-E2-A14Z-01A-11D-A111-01	TCGA-E2-A14Z-01
TCGA-E2-A150-01	Stage IIA	48	1	Stage IIA	591		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	591	0	Basal	Basal-like	Negative	X	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A150-01	1935	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	squamous c3	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A150	1935	0	days	1935	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A150-F71066	TCGA-E2-A150	TCGA-E2-A150-01A		Negative					Negative	Lumpectomy		NO			-17580	506		0	1935					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-3-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf	A150	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	46262a6c-8a11-4bb9-8851-8b6e44c95288	752855b4-0b2c-4e89-b11f-f4e52d40c45f	46262a6c-8a11-4bb9-8851-8b6e44c95288	752855b4-0b2c-4e89-b11f-f4e52d40c45f	TCGA-E2-A150-01A-21-A13E-20	TCGA-E2-A150-01A-11D-A12B-09		TCGA-E2-A150-01			c44ec1a9-cea5-46a0-b2c5-1686127fd1eb	TCGA-E2-A150-01	TCGA-E2-A150-01A-11D-A12B-09	TCGA-E2-A150-01A-11D-A12E-05	TCGA-E2-A150-01	TCGA-E2-A150-01	TCGA-E2-A150-01A-11D-A12B-09		46262a6c-8a11-4bb9-8851-8b6e44c95288		TCGA-E2-A150-01A-11D-A12A-01	TCGA-E2-A150-01	TCGA-E2-A150-01A-11R-A12D-07	46262a6c-8a11-4bb9-8851-8b6e44c95288	TCGA-E2-A150-01A-11D-A12A-01	TCGA-E2-A150-01
TCGA-E2-A152-01	Stage I	56	1	Stage I	588		Positive	FEMALE	Positive	2	2	1	Negative	M0	Negative	N0	588	0	Her2	HER2-enriched	Negative	Her2	-1	-5	enrollment	T1	T1	LIVING	0	TCGA-E2-A152-01	2128	0	days	High	C3-BRCA/Luminal	cluster 1	Cluster 5	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-E2-A152	966	1	days	2128	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		56	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A152-F72471	TCGA-E2-A152	TCGA-E2-A152-01A		Positive					Negative	Lumpectomy		NO			-20705	484		0	2128		1044	966		NO				Scheduled Follow-up Submission	2015-6-23	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Positive		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Positive	3+		Negative												Negative			1	5				Other, specify	Locoregional Recurrence	Breast	YES	YES	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A152.46EE72F9-2F59-413F-8278-7A073760F095.pdf	A152	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	be8c1926-064b-4a2f-9345-e34f0dc78bff	01a1e8a0-51e3-400b-81dc-581a93199892	be8c1926-064b-4a2f-9345-e34f0dc78bff	01a1e8a0-51e3-400b-81dc-581a93199892	TCGA-E2-A152-01A-21-A13E-20	TCGA-E2-A152-01A-11D-A12B-09		TCGA-E2-A152-01			f726d427-03ec-4234-b1e1-fec426bb46ac	TCGA-E2-A152-01	TCGA-E2-A152-01A-11D-A12B-09	TCGA-E2-A152-01A-11D-A12E-05	TCGA-E2-A152-01	TCGA-E2-A152-01	TCGA-E2-A152-01A-11D-A12B-09		be8c1926-064b-4a2f-9345-e34f0dc78bff		TCGA-E2-A152-01A-11D-A12A-01	TCGA-E2-A152-01	TCGA-E2-A152-01A-11R-A12D-07	be8c1926-064b-4a2f-9345-e34f0dc78bff	TCGA-E2-A152-01A-11D-A12A-01	TCGA-E2-A152-01
TCGA-E2-A153-01	Stage IIB	51	2	Stage IIA	586		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N1	586	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A153-01	707	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A153	707	0	days	707	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A153-F18945	TCGA-E2-A153	TCGA-E2-A153-01A		Positive					Positive	Modified Radical Mastectomy		NO			-18875	475		0	707					NO				Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	270	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	3		false	No	M0	N1a	T2	Stage IIB	TCGA-E2-A153.06D417E8-68C2-408C-8ABC-B3042566C976.pdf	A153	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	be4b0243-555a-4e4b-94fb-af6ba60058d0	4fe0a5b3-cc20-4dc4-8d8a-6417866e392b	be4b0243-555a-4e4b-94fb-af6ba60058d0	4fe0a5b3-cc20-4dc4-8d8a-6417866e392b	TCGA-E2-A153-01A-21-A13E-20	TCGA-E2-A153-01A-12D-A12B-09		TCGA-E2-A153-01			e93fc765-47be-401c-bbbb-8b3e16ae7c65	TCGA-E2-A153-01	TCGA-E2-A153-01A-12D-A12B-09	TCGA-E2-A153-01A-12D-A12E-05	TCGA-E2-A153-01	TCGA-E2-A153-01	TCGA-E2-A153-01A-12D-A12B-09		be4b0243-555a-4e4b-94fb-af6ba60058d0		TCGA-E2-A153-01A-12D-A12A-01	TCGA-E2-A153-01	TCGA-E2-A153-01A-12R-A12D-07	be4b0243-555a-4e4b-94fb-af6ba60058d0	TCGA-E2-A153-01A-12D-A12A-01	TCGA-E2-A153-01
TCGA-E2-A153-11		51			586			FEMALE									586	0	Normal						enrollment			LIVING	0	TCGA-E2-A153-11	707	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A153	707	0	days	707	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A153-F18945	TCGA-E2-A153			Positive					Positive	Modified Radical Mastectomy		NO			-18875			0	707					NO				Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3			No	M0	N1a	T2	Stage IIB		A153	TUMOR FREE							YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast		LIVING	2009	b5ab3b76-36f6-45a7-acad-77288da0d13c		b5ab3b76-36f6-45a7-acad-77288da0d13c											TCGA-E2-A153-11A-31D-A12E-05		TCGA-E2-A153-11			b5ab3b76-36f6-45a7-acad-77288da0d13c			TCGA-E2-A153-11	TCGA-E2-A153-11A-31R-A12D-07	b5ab3b76-36f6-45a7-acad-77288da0d13c		
TCGA-E2-A154-01	Stage I	68	2	Stage I	325		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	325	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A154-01	591	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-E2-A154	591	0	days	591	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A154-F18940	TCGA-E2-A154	TCGA-E2-A154-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-24999	461		0	591					NO		90-99%		Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A154.8F8DCA87-B27A-429C-952A-186F8D4502AE.pdf	A154	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	81589acc-5dae-4cad-9f97-88b81fa53f92	38971878-2e49-4de3-be7c-e1ce5f1317b6	81589acc-5dae-4cad-9f97-88b81fa53f92	38971878-2e49-4de3-be7c-e1ce5f1317b6	TCGA-E2-A154-01A-21-A13E-20	TCGA-E2-A154-01A-11D-A10Y-09		TCGA-E2-A154-01			9f67c05d-d95e-4932-bace-78ee0cfbf304	TCGA-E2-A154-01	TCGA-E2-A154-01A-11D-A10Y-09	TCGA-E2-A154-01A-11D-A112-05	TCGA-E2-A154-01	TCGA-E2-A154-01	TCGA-E2-A154-01A-11D-A10Y-09		81589acc-5dae-4cad-9f97-88b81fa53f92		TCGA-E2-A154-01A-11D-A111-01	TCGA-E2-A154-01	TCGA-E2-A154-01A-11R-A115-07	81589acc-5dae-4cad-9f97-88b81fa53f92	TCGA-E2-A154-01A-11D-A111-01	TCGA-E2-A154-01
TCGA-E2-A155-01	Stage IIB	58	1	Stage IIB	553		Positive	FEMALE	Negative	4	3	4	Negative	M0	Positive	N1	553	0	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A155-01	640	0	days	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-E2-A155	640	0	days	640	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E2-A155-F18942	TCGA-E2-A155	TCGA-E2-A155-01A		Positive					Negative	Modified Radical Mastectomy		NO			-21348	457		0	640					NO				Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5								NO	2		false	No	M0	N1a	T2	Stage IIB	TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77.pdf	A155	TUMOR FREE							YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	6a345a9e-8173-4c9e-972d-df0b154c97b0	e5ab2046-c8a8-4636-865c-c92d6b3da823	6a345a9e-8173-4c9e-972d-df0b154c97b0	e5ab2046-c8a8-4636-865c-c92d6b3da823	TCGA-E2-A155-01A-21-A13E-20	TCGA-E2-A155-01A-11D-A12B-09		TCGA-E2-A155-01			89f9e8d3-6526-4680-a393-c6b3b997599d	TCGA-E2-A155-01	TCGA-E2-A155-01A-11D-A12B-09	TCGA-E2-A155-01A-11D-A12E-05	TCGA-E2-A155-01	TCGA-E2-A155-01	TCGA-E2-A155-01A-11D-A12B-09		6a345a9e-8173-4c9e-972d-df0b154c97b0		TCGA-E2-A155-01A-11D-A12A-01	TCGA-E2-A155-01	TCGA-E2-A155-01A-11R-A12D-07	6a345a9e-8173-4c9e-972d-df0b154c97b0	TCGA-E2-A155-01A-11D-A12A-01	TCGA-E2-A155-01
TCGA-E2-A156-01	Stage I	61	2	Stage I	481		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	481	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A156-01	726	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A156	726	0	days	726	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left	Sentinel node biopsy alone		TCGA-E2-A156-F18786	TCGA-E2-A156			Positive					Positive	Lumpectomy		NO			-22422			0	726					NO				Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0			No	M0	N0	T1c	Stage I		A156	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2009	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	f0443dd8-df97-44bb-bc63-5667adfe093c	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	f0443dd8-df97-44bb-bc63-5667adfe093c	TCGA-E2-A156-01A-21-A13E-20	TCGA-E2-A156-01A-11D-A12B-09		TCGA-E2-A156-01			eafe692c-6651-466b-a92c-1ed965eba047	TCGA-E2-A156-01	TCGA-E2-A156-01A-11D-A12B-09	TCGA-E2-A156-01A-11D-A12E-05	TCGA-E2-A156-01	TCGA-E2-A156-01	TCGA-E2-A156-01A-11D-A12B-09		b6ed3dfa-4d81-4e5c-9c1a-166894f92752		TCGA-E2-A156-01A-11D-A12A-01	TCGA-E2-A156-01	TCGA-E2-A156-01A-11R-A12D-07	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	TCGA-E2-A156-01A-11D-A12A-01	TCGA-E2-A156-01
TCGA-E2-A158-01	Stage IIA	43	1	Stage IIA	450		Negative	FEMALE	Negative	2	2	2	Negative	M0	Positive	N1	450	0	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA-E2-A158-01	450	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A158	450	0	days	450	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A158-F18956	TCGA-E2-A158	TCGA-E2-A158-01A		Negative					Negative	Simple Mastectomy		NO			-15903	436		0	450					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	200	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5								NO	1		false	Yes	M0	N1mi	T1c	Stage IIA	TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf	A158	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	43326f71-c61c-410b-af4b-c71a054e27c9	c75325af-6b3b-40b9-88a2-79754c120cae	43326f71-c61c-410b-af4b-c71a054e27c9	c75325af-6b3b-40b9-88a2-79754c120cae	TCGA-E2-A158-01A-21-A13E-20	TCGA-E2-A158-01A-11D-A12B-09		TCGA-E2-A158-01			cc34e050-b748-413b-a5ec-064c216e98c3	TCGA-E2-A158-01	TCGA-E2-A158-01A-11D-A12B-09	TCGA-E2-A158-01A-11D-A12E-05	TCGA-E2-A158-01	TCGA-E2-A158-01	TCGA-E2-A158-01A-11D-A12B-09		43326f71-c61c-410b-af4b-c71a054e27c9		TCGA-E2-A158-01A-11D-A12A-01	TCGA-E2-A158-01	TCGA-E2-A158-01A-11R-A12D-07	43326f71-c61c-410b-af4b-c71a054e27c9	TCGA-E2-A158-01A-11D-A12A-01	TCGA-E2-A158-01
TCGA-E2-A158-11		43			450			FEMALE									450	0	Normal						enrollment			LIVING	0	TCGA-E2-A158-11	450	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A158	450	0	days	450	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A158-F18956	TCGA-E2-A158	TCGA-E2-A158-11A		Negative					Negative	Simple Mastectomy		NO			-15903	436		0	450					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		false	Yes	M0	N1mi	T1c	Stage IIA		A158	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	5ba99650-56d2-4951-aa24-3d2fea3d1921		5ba99650-56d2-4951-aa24-3d2fea3d1921											TCGA-E2-A158-11A-22D-A12E-05					5ba99650-56d2-4951-aa24-3d2fea3d1921				TCGA-E2-A158-11A-22R-A12D-07	5ba99650-56d2-4951-aa24-3d2fea3d1921		
TCGA-E2-A159-01	Stage IIA	50	1	Stage IIA	515		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	515	0	Basal	Basal-like	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A159-01	762	0	days	High	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A159	762	0	days	762	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A159-F19115	TCGA-E2-A159	TCGA-E2-A159-01A		Negative					Negative	Lumpectomy		NO			-18621	434		0	762					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	240	NO		Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	3								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf	A159	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	95c7abfa-a417-4d81-96c2-a952a081d997	c14c922b-4900-455a-8bf9-36021ff843aa	95c7abfa-a417-4d81-96c2-a952a081d997	c14c922b-4900-455a-8bf9-36021ff843aa	TCGA-E2-A159-01A-21-A13E-20	TCGA-E2-A159-01A-11D-A10Y-09		TCGA-E2-A159-01			c9662a04-c4e9-42c3-989f-cade253340dc	TCGA-E2-A159-01	TCGA-E2-A159-01A-11D-A10Y-09	TCGA-E2-A159-01A-11D-A112-05	TCGA-E2-A159-01	TCGA-E2-A159-01	TCGA-E2-A159-01A-11D-A10Y-09		95c7abfa-a417-4d81-96c2-a952a081d997		TCGA-E2-A159-01A-11D-A111-01	TCGA-E2-A159-01	TCGA-E2-A159-01A-11R-A115-07	95c7abfa-a417-4d81-96c2-a952a081d997	TCGA-E2-A159-01A-11D-A111-01	TCGA-E2-A159-01
TCGA-E2-A15A-01	Stage IIIC	45	4	Stage IIIC	502		Positive	FEMALE	Negative	1	1	4	Negative	M0	Positive	N3	502	0	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15A-01	710	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15A	710	0	days	710	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15A-F18926	TCGA-E2-A15A	TCGA-E2-A15A-01A		Positive					Positive	Simple Mastectomy		NO			-16750	426		0	710					NO				Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	13		false	No	M0	N3a	T2	Stage IIIC	TCGA-E2-A15A.744919EA-D97A-41A1-B1F3-70A2F972D9A7.pdf	A15A	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	a4754430-f713-4aeb-998c-0f470a5549d1	42063455-e17c-42aa-a825-71b32c84437f	a4754430-f713-4aeb-998c-0f470a5549d1	42063455-e17c-42aa-a825-71b32c84437f		TCGA-E2-A15A-01A-11D-A12B-09		TCGA-E2-A15A-01			eee0fe49-2254-4347-b328-49a69bea7619	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11D-A12B-09	TCGA-E2-A15A-01A-11D-A12E-05	TCGA-E2-A15A-01	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11D-A12B-09		a4754430-f713-4aeb-998c-0f470a5549d1		TCGA-E2-A15A-01A-11D-A12A-01	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11R-A12D-07	a4754430-f713-4aeb-998c-0f470a5549d1	TCGA-E2-A15A-01A-11D-A12A-01	TCGA-E2-A15A-01
TCGA-E2-A15A-06		45			502			FEMALE									502	0	LumB						enrollment			LIVING	0	TCGA-E2-A15A-06	710	0	days		C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15A	710	0	days	710	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15A-F18926	TCGA-E2-A15A	TCGA-E2-A15A-06A		Positive					Positive	Simple Mastectomy		NO			-16750	426		0	710					NO				Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	13		false	No	M0	N3a	T2	Stage IIIC	TCGA-E2-A15A.3687AF42-4BB3-46E2-8091-E0C5C84F15E6.pdf	A15A	TUMOR FREE							YES			YES	Metastatic	06		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	e55bc0c9-ee0f-4efb-8024-3baed3c24080	8444c824-a5d8-4d12-a94e-10875f0bbc4e	e55bc0c9-ee0f-4efb-8024-3baed3c24080	8444c824-a5d8-4d12-a94e-10875f0bbc4e	TCGA-E2-A15A-06A-21-A24B-20						234a8293-3dd6-4625-9f76-fa9e144aee3e		TCGA-E2-A15A-06A-11D-A12B-09	TCGA-E2-A15A-06A-11D-A12E-05		TCGA-E2-A15A-06	TCGA-E2-A15A-06A-11D-A12B-09		e55bc0c9-ee0f-4efb-8024-3baed3c24080			TCGA-E2-A15A-06	TCGA-E2-A15A-06A-11R-A12D-07	e55bc0c9-ee0f-4efb-8024-3baed3c24080		
TCGA-E2-A15C-01	Stage I	61	4	Stage I	496		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	496	0	LumA	Luminal A	Positive	ReacI	-5	-4	enrollment	T1	T1	LIVING	0	TCGA-E2-A15C-01	694	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A15C	694	0	days	694	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15C-F18935	TCGA-E2-A15C	TCGA-E2-A15C-01A		Positive					Positive	Lumpectomy		NO			-22583	393		0	694					NO				Scheduled Follow-up Submission	2011-11-9	FEMALE			20-29%		2+			1.02		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	200	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510.pdf	A15C	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	1a77082d-f130-436b-9028-23c8dd9dc565	42eb6aaf-02b1-4f22-b5d2-7c871ca4d516	1a77082d-f130-436b-9028-23c8dd9dc565	42eb6aaf-02b1-4f22-b5d2-7c871ca4d516	TCGA-E2-A15C-01A-21-A13E-20	TCGA-E2-A15C-01A-31D-A12B-09		TCGA-E2-A15C-01			b003e078-2c0b-42bc-ad2e-adb171765c57	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31D-A12B-09	TCGA-E2-A15C-01A-31D-A12E-05	TCGA-E2-A15C-01	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31D-A12B-09		1a77082d-f130-436b-9028-23c8dd9dc565		TCGA-E2-A15C-01A-31D-A12A-01	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31R-A12D-07	1a77082d-f130-436b-9028-23c8dd9dc565	TCGA-E2-A15C-01A-31D-A12A-01	TCGA-E2-A15C-01
TCGA-E2-A15D-01	Stage IIA	47		Stage IIA	315		Positive	FEMALE	Negative				Negative	M0	Negative	N0	315	0	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15D-01	526	0	days		C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15D	526	0	days	526	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right	Sentinel node biopsy alone		TCGA-E2-A15D-F18783	TCGA-E2-A15D	TCGA-E2-A15D-01A		Positive					Positive	Lumpectomy		NO			-17224	393		0	526					NO				Scheduled Follow-up Submission	2011-11-9	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4.pdf	A15D	TUMOR FREE				Allred score = 8	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	b58514d7-7785-497d-ba94-165ee0a1b941	7266b08c-75d0-4307-9852-73fc482f5644	b58514d7-7785-497d-ba94-165ee0a1b941	7266b08c-75d0-4307-9852-73fc482f5644	TCGA-E2-A15D-01A-21-A13E-20	TCGA-E2-A15D-01A-11D-A10Y-09		TCGA-E2-A15D-01			0a257700-c228-4e46-9b2d-af39db001515	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11D-A10Y-09	TCGA-E2-A15D-01A-11D-A112-05	TCGA-E2-A15D-01	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11D-A10Y-09		b58514d7-7785-497d-ba94-165ee0a1b941		TCGA-E2-A15D-01A-11D-A111-01	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11R-A115-07	b58514d7-7785-497d-ba94-165ee0a1b941	TCGA-E2-A15D-01A-11D-A111-01	TCGA-E2-A15D-01
TCGA-E2-A15E-01	Stage IIA	40	4	Stage IIA	517		Positive	FEMALE	Positive	3	4	3	Negative	M0	Positive	N1	517	0	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A15E-01	630	0	days	Squamous	C3-BRCA/Luminal	cluster 2	Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-E2-A15E	630	0	days	630	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15E-F18919	TCGA-E2-A15E	TCGA-E2-A15E-01A		Positive					Positive	Lumpectomy		NO			-14894	387		0	630					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	520	NO		Positive		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	1		false	No	M0	N1a	T1c	Stage IIA	TCGA-E2-A15E.514D4C2E-8215-4770-9FC1-25F988232A85.pdf	A15E	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	1c91adc5-4b1d-49e0-b2d3-eb6191a80f8f	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	1c91adc5-4b1d-49e0-b2d3-eb6191a80f8f	TCGA-E2-A15E-01A-21-A13E-20	TCGA-E2-A15E-01A-11D-A12B-09		TCGA-E2-A15E-01			d0c1fe33-e7c4-4705-9a97-1520151d4ffb	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11D-A12B-09	TCGA-E2-A15E-01A-11D-A12E-05	TCGA-E2-A15E-01	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11D-A12B-09		42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3		TCGA-E2-A15E-01A-11D-A12A-01	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11R-A12D-07	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	TCGA-E2-A15E-01A-11D-A12A-01	TCGA-E2-A15E-01
TCGA-E2-A15E-06		40			517			FEMALE									517	0	LumA						enrollment			LIVING	0	TCGA-E2-A15E-06	630	0	days		C3-BRCA/Luminal	cluster 2	Low purity c2		BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-E2-A15E	630	0	days	630	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15E-F18919	TCGA-E2-A15E	TCGA-E2-A15E-06A		Positive					Positive	Lumpectomy		NO			-14894	387		0	630					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	60	NO		Positive		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		false	No	M0	N1a	T1c	Stage IIA	TCGA-E2-A15E.57341F00-74F5-4015-B6D4-7BDED33F35A7.pdf	A15E	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			YES	Metastatic	06		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	8131b824-c3db-4c83-99b9-aa0c60747c5d	6c2fdfa7-33a8-462e-9d27-8ed7079938d7	8131b824-c3db-4c83-99b9-aa0c60747c5d	6c2fdfa7-33a8-462e-9d27-8ed7079938d7									TCGA-E2-A15E-06A-11D-A12B-09	TCGA-E2-A15E-06A-11D-A12E-05		TCGA-E2-A15E-06	TCGA-E2-A15E-06A-11D-A12B-09		8131b824-c3db-4c83-99b9-aa0c60747c5d			TCGA-E2-A15E-06	TCGA-E2-A15E-06A-11R-A12D-07	8131b824-c3db-4c83-99b9-aa0c60747c5d		
TCGA-E2-A15F-01	Stage I	64		Stage IIA	468		Positive	FEMALE	Negative				Negative	M0	Negative	N0	468	0		Luminal A	Positive	ReacI	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15F-01	658	0	days			cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15F	658	0	days	658	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15F-F18906	TCGA-E2-A15F	TCGA-E2-A15F-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-23660	360		0	658					NO		90-99%		Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	190	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E.pdf	A15F	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	2e41bc6a-bece-4b6d-a646-be9b98707bba	4df297a3-8822-4df2-b0ef-77279e053b32	2e41bc6a-bece-4b6d-a646-be9b98707bba	4df297a3-8822-4df2-b0ef-77279e053b32	TCGA-E2-A15F-01A-21-A13E-20	TCGA-E2-A15F-01A-11D-A10Y-09		TCGA-E2-A15F-01			3d2f1976-cf0a-4cab-817a-92301b6d9275	TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11D-A10Y-09	TCGA-E2-A15F-01A-11D-A112-05	TCGA-E2-A15F-01	TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11D-A10Y-09		2e41bc6a-bece-4b6d-a646-be9b98707bba		TCGA-E2-A15F-01A-11D-A111-01	TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11R-A115-07	2e41bc6a-bece-4b6d-a646-be9b98707bba	TCGA-E2-A15F-01A-11D-A111-01	TCGA-E2-A15F-01
TCGA-E2-A15G-01	Stage IIA	76	2	Stage IIA	315		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	315	0	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15G-01	554	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-E2-A15G	554	0	days	554	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					76	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15G-F18901	TCGA-E2-A15G	TCGA-E2-A15G-01A		Positive					Positive	Lumpectomy		NO			-28013	358		0	554					NO				Scheduled Follow-up Submission	2011-11-14	FEMALE					1+					Mixed Histology (please specify)	Invasive ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	110	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	1								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A15G.DD9FDF3B-29CA-4D11-8615-E2EEB5D601D1.pdf	A15G	TUMOR FREE				Allred score = 8	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	a88e6892-93fe-451f-9b7e-f6fe260ba9af	d0f71973-7cb2-4541-a0df-6e608af68899	a88e6892-93fe-451f-9b7e-f6fe260ba9af	d0f71973-7cb2-4541-a0df-6e608af68899	TCGA-E2-A15G-01A-21-A13E-20	TCGA-E2-A15G-01A-11D-A12B-09		TCGA-E2-A15G-01			1af0a946-026d-4dbb-b52d-db12449e4c31	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11D-A12B-09	TCGA-E2-A15G-01A-11D-A12E-05	TCGA-E2-A15G-01	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11D-A12B-09		a88e6892-93fe-451f-9b7e-f6fe260ba9af		TCGA-E2-A15G-01A-11D-A12A-01	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11R-A12D-07	a88e6892-93fe-451f-9b7e-f6fe260ba9af	TCGA-E2-A15G-01A-11D-A12A-01	TCGA-E2-A15G-01
TCGA-E2-A15H-01	Stage IIA	38	2	Stage IIA	42		Positive	FEMALE	Positive	3	1	3	Negative	M0	Positive	N1	42	0	LumA	Luminal A	Positive	Her2	0	0	enrollment	T1	T1	LIVING	0	TCGA-E2-A15H-01	393	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15H	393	0	days	393	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15H-F18916	TCGA-E2-A15H	TCGA-E2-A15H-01A		Positive					Positive	Lumpectomy		NO			-13985	357		0	393					NO				Scheduled Follow-up Submission	2011-11-14	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	90	NO	Equivocal	Positive		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	4								NO	1		false	No	M0	N1mi	T1c	Stage IIA	TCGA-E2-A15H.E4D1A7DC-62B1-44D8-A747-5A19842C6F69.pdf	A15H	TUMOR FREE				Allred score = 8	Allred Score = 7		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	b23312bc-ad6f-4e38-83e3-c7459ceaf7bc	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	b23312bc-ad6f-4e38-83e3-c7459ceaf7bc	TCGA-E2-A15H-01A-21-A13E-20	TCGA-E2-A15H-01A-11D-A12B-09		TCGA-E2-A15H-01			f381f799-7861-47be-b54f-26a1e5236887	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11D-A12B-09	TCGA-E2-A15H-01A-11D-A12E-05	TCGA-E2-A15H-01	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11D-A12B-09		75b2227e-0279-4dfb-a1a1-e64c53b48d7a		TCGA-E2-A15H-01A-11D-A12A-01	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11R-A12D-07	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	TCGA-E2-A15H-01A-11D-A12A-01	TCGA-E2-A15H-01
TCGA-E2-A15I-01	Stage IIA	44	2	Stage IIA	411		Positive	FEMALE	Negative				Negative	M0	Negative	N0	411	0	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15I-01	1692	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-E2-A15I	1692	0	days	1692	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15I-F70023	TCGA-E2-A15I	TCGA-E2-A15I-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16163	344		0	1692					NO		90-99%		Scheduled Follow-up Submission	2015-2-9	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Equivocal	Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	7								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf	A15I	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	db6a187b-083a-4f71-9d8b-f08b5f208d7e	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	db6a187b-083a-4f71-9d8b-f08b5f208d7e	TCGA-E2-A15I-01A-11-A17I-20	TCGA-E2-A15I-01A-21D-A135-09		TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21D-A138-05		6be5e02d-4e5b-4b24-b603-4512dff0f17c	TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21D-A135-09		TCGA-E2-A15I-01	TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21D-A135-09		4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c		TCGA-E2-A15I-01A-21D-A134-01	TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21R-A137-07	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	TCGA-E2-A15I-01A-21D-A134-01	TCGA-E2-A15I-01
TCGA-E2-A15I-11		44			411			FEMALE									411	0	Normal						enrollment			LIVING	0	TCGA-E2-A15I-11	1692	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15I	1692	0	days	1692	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15I-F70023	TCGA-E2-A15I			Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16163			0	1692					NO		90-99%		Scheduled Follow-up Submission	2015-2-9	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Equivocal	Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0			No	M0	N0	T2	Stage IIA		A15I	TUMOR FREE						YES	YES	90-99%		NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast		LIVING	2009	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9		f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9						TCGA-E2-A15I-11A-32D-A138-05							TCGA-E2-A15I-11			f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9			TCGA-E2-A15I-11	TCGA-E2-A15I-11A-32R-A137-07	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9		
TCGA-E2-A15J-01	Stage I	51	2	Stage I	463		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	463	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A15J-01	1640	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15J	1640	0	days	1640	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15J-F70020	TCGA-E2-A15J	TCGA-E2-A15J-01A		Positive					Positive	Simple Mastectomy		NO			-18771	344		0	1640					NO				Scheduled Follow-up Submission	2015-2-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Equivocal	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A15J.352BF6A2-974B-440E-BB0B-DCD79874DAC3.pdf	A15J	TUMOR FREE				Allred score = 8	Allred score = 7	YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	376c13fa-ba3e-4f2e-a8bc-87fb70541239	61104111-09d5-417b-9ca6-d53fb28bafec	376c13fa-ba3e-4f2e-a8bc-87fb70541239	61104111-09d5-417b-9ca6-d53fb28bafec	TCGA-E2-A15J-01A-21-A13E-20	TCGA-E2-A15J-01A-11D-A12Q-09		TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11D-A12R-05		ffe06b3a-f290-463c-bb0e-994c0679f8be	TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11D-A12Q-09		TCGA-E2-A15J-01	TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11D-A12Q-09		376c13fa-ba3e-4f2e-a8bc-87fb70541239		TCGA-E2-A15J-01A-11D-A12N-01	TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11R-A12P-07	376c13fa-ba3e-4f2e-a8bc-87fb70541239	TCGA-E2-A15J-01A-11D-A12N-01	TCGA-E2-A15J-01
TCGA-E2-A15K-01	Stage IIA	58	2	Stage IIB	34		Positive	FEMALE	Negative	3	3	4	Negative	M0	Positive	N1	34	0	LumB	Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15K-01	275	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A15K	275	0	days	275	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869	TCGA-E2-A15K	TCGA-E2-A15K-01A		Positive					Positive	Lumpectomy		NO			-21514	309		0	275					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	2		false	No	M0	N1a	T2	Stage IIB	TCGA-E2-A15K.2BAC50DA-016F-4B5C-B8D1-DE75377EF0C7.pdf	A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	141e15ac-1537-4182-9db5-ba2115cd93d6	b41bd6ce-5113-4a6f-86d8-17c45406b1ac	141e15ac-1537-4182-9db5-ba2115cd93d6	b41bd6ce-5113-4a6f-86d8-17c45406b1ac		TCGA-E2-A15K-01A-11D-A12Q-09		TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11D-A12R-05		1afef343-eb28-46d1-ba40-2475188b33c5	TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11D-A12Q-09		TCGA-E2-A15K-01	TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11D-A12Q-09		141e15ac-1537-4182-9db5-ba2115cd93d6		TCGA-E2-A15K-01A-11D-A12N-01	TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11R-A12P-07	141e15ac-1537-4182-9db5-ba2115cd93d6	TCGA-E2-A15K-01A-11D-A12N-01	TCGA-E2-A15K-01
TCGA-E2-A15K-06		58			34			FEMALE									34	0	LumB						enrollment			LIVING	0	TCGA-E2-A15K-06	275	0	days		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-E2-A15K	275	0	days	275	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869	TCGA-E2-A15K	TCGA-E2-A15K-06A		Positive					Positive	Lumpectomy		NO			-21514	309		0	275					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	No	M0	N1a	T2	Stage IIB	TCGA-E2-A15K.72FE0659-6B7E-4129-B61D-C376C59C428F.pdf	A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES			YES	Metastatic	06		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	69f0bc59-c026-40e2-a3b6-88fcde091a82	7513e337-00ae-48cc-8be4-a62fa39602b9	69f0bc59-c026-40e2-a3b6-88fcde091a82	7513e337-00ae-48cc-8be4-a62fa39602b9	TCGA-E2-A15K-06A-21-A24B-20				TCGA-E2-A15K-06A-11D-A12R-05		7e1db33b-2235-49f6-8f01-5d8ab274ce14		TCGA-E2-A15K-06A-11D-A12Q-09			TCGA-E2-A15K-06	TCGA-E2-A15K-06A-11D-A12Q-09		69f0bc59-c026-40e2-a3b6-88fcde091a82			TCGA-E2-A15K-06	TCGA-E2-A15K-06A-11R-A12P-07	69f0bc59-c026-40e2-a3b6-88fcde091a82		
TCGA-E2-A15K-11		58			34			FEMALE									34	0							enrollment			LIVING	0	TCGA-E2-A15K-11	275	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15K	275	0	days	275	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A15K-F18869	TCGA-E2-A15K	TCGA-E2-A15K-11A		Positive					Positive	Lumpectomy		NO			-21514	309		0	275					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	No	M0	N1a	T2	Stage IIB		A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	49a33b4d-4b1e-4b30-b0ba-a7c7d594db41		49a33b4d-4b1e-4b30-b0ba-a7c7d594db41						TCGA-E2-A15K-11A-13D-A12R-05							TCGA-E2-A15K-11			49a33b4d-4b1e-4b30-b0ba-a7c7d594db41			TCGA-E2-A15K-11		49a33b4d-4b1e-4b30-b0ba-a7c7d594db41		
TCGA-E2-A15L-01	Stage IIA	65	2	Stage IIA	331		Positive	FEMALE	Negative				Negative	M0	Negative	N0	331	0	LumA	Luminal B	Positive	ReacI	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15L-01	626	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 4	TCGA-E2-A15L	626	0	days	626	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right	Sentinel node biopsy alone		TCGA-E2-A15L-F18885	TCGA-E2-A15L	TCGA-E2-A15L-01A		Positive					Positive	Simple Mastectomy		NO			-23845	289		0	626					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-15	FEMALE			30-39%		2+			0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	240	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2									NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A15L.C04B3267-9833-44D6-8C3D-45D7F829C38C.pdf	A15L	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	68a4bd03-2b97-4387-926f-c9d25fac8d29	e96765f9-45a3-446f-924a-45202dd4b7db	68a4bd03-2b97-4387-926f-c9d25fac8d29	e96765f9-45a3-446f-924a-45202dd4b7db	TCGA-E2-A15L-01A-21-A13E-20	TCGA-E2-A15L-01A-11D-A12B-09		TCGA-E2-A15L-01			bf925eb7-7a5b-44b2-9ace-627782f168c3	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11D-A12B-09	TCGA-E2-A15L-01A-11D-A12E-05	TCGA-E2-A15L-01	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11D-A12B-09		68a4bd03-2b97-4387-926f-c9d25fac8d29		TCGA-E2-A15L-01A-11D-A12A-01	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11R-A12D-07	68a4bd03-2b97-4387-926f-c9d25fac8d29	TCGA-E2-A15L-01A-11D-A12A-01	TCGA-E2-A15L-01
TCGA-E2-A15L-11		65			331			FEMALE									331	0							enrollment			LIVING	0	TCGA-E2-A15L-11	626	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A15L	626	0	days	626	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right	Sentinel node biopsy alone		TCGA-E2-A15L-F18885	TCGA-E2-A15L	TCGA-E2-A15L-11A		Positive					Positive	Simple Mastectomy		NO			-23845	289		0	626					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-15	FEMALE			30-39%		2+			0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	210	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA		A15L	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010														TCGA-E2-A15L-11A-31D-A12E-05												
TCGA-E2-A15M-01	Stage IIA	66	3	Stage IIA	234		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	234	0	LumA	Luminal B	Positive	ReacI	-4	-4	enrollment	T_Other	T2	LIVING	1	TCGA-E2-A15M-01	336	1	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-E2-A15M	336	0	days	336	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15M-F18852	TCGA-E2-A15M	TCGA-E2-A15M-01A		Positive					Positive	Lumpectomy		NO			-24266	287	336	0	235					NO				Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	270	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A15M.51601F8B-BA50-42C4-B0C9-B3581F80CD2C.pdf	A15M	TUMOR FREE				Allred score = 8	Allred score = 8		YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	DECEASED	2010	e596b149-e807-4d29-b0fa-685f07efb9d6	597cc060-51ba-447d-b17e-a454e38cf00b	e596b149-e807-4d29-b0fa-685f07efb9d6	597cc060-51ba-447d-b17e-a454e38cf00b	TCGA-E2-A15M-01A-21-A13E-20	TCGA-E2-A15M-01A-11D-A12B-09		TCGA-E2-A15M-01			52e4ab39-3d51-4623-a65a-09a99017e96b	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11D-A12B-09	TCGA-E2-A15M-01A-11D-A12E-05	TCGA-E2-A15M-01	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11D-A12B-09		e596b149-e807-4d29-b0fa-685f07efb9d6		TCGA-E2-A15M-01A-11D-A12A-01	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11R-A12D-07	e596b149-e807-4d29-b0fa-685f07efb9d6	TCGA-E2-A15M-01A-11D-A12A-01	TCGA-E2-A15M-01
TCGA-E2-A15M-11		66			234			FEMALE									234	0	Normal						enrollment			LIVING	1	TCGA-E2-A15M-11	336	1	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-E2-A15M	336	0	days	336	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15M-F18852	TCGA-E2-A15M			Positive					Positive	Lumpectomy		NO			-24266		336	0	235					NO				Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			No	M0	N0	T2	Stage IIA		A15M	TUMOR FREE				Allred score = 8	Allred score = 8		YES			YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast		DECEASED	2010	f75e5efb-056f-40bf-afed-33d971478ca4		f75e5efb-056f-40bf-afed-33d971478ca4											TCGA-E2-A15M-11A-22D-A12E-05		TCGA-E2-A15M-11			f75e5efb-056f-40bf-afed-33d971478ca4			TCGA-E2-A15M-11	TCGA-E2-A15M-11A-22R-A12D-07	f75e5efb-056f-40bf-afed-33d971478ca4		
TCGA-E2-A15O-01	Stage I	89	4	Stage IIA	395		Positive	FEMALE	Negative	1	3	3	Negative	M0	Negative	N0	395	0	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15O-01	1545	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E2-A15O	1210	1	days	1545	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			89	Left Upper Inner Quadrant	No axillary staging		TCGA-E2-A15O-F70024	TCGA-E2-A15O	TCGA-E2-A15O-01A		Positive					Positive	Lumpectomy		NO			-32583	273		0	1545		1230	1210		NO	Allred score 5+2 = 7			Scheduled Follow-up Submission	2015-3-16	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Equivocal	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive					3 Point Scale	3+	3+					Positive			4	2			3 Point Scale		Locoregional Recurrence		YES	YES			false	Yes	M0	NX	T1c	Stage I	TCGA-E2-A15O.AA4B6E2D-7503-4E51-BEA4-632CC994770A.pdf	A15O	TUMOR FREE	Allred score 4+3 = 7			Allred score = 7	Allred score = 7	YES	NO			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	4a28ecf3-c70e-42d0-918b-866d11804c13	61a71ac8-5aad-4b2d-b931-57d347210540	4a28ecf3-c70e-42d0-918b-866d11804c13	61a71ac8-5aad-4b2d-b931-57d347210540	TCGA-E2-A15O-01A-21-A13E-20	TCGA-E2-A15O-01A-11D-A10Y-09		TCGA-E2-A15O-01			538d33c5-6bc8-4cda-950b-93c16e500d48	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11D-A10Y-09	TCGA-E2-A15O-01A-11D-A112-05	TCGA-E2-A15O-01	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11D-A10Y-09		4a28ecf3-c70e-42d0-918b-866d11804c13		TCGA-E2-A15O-01A-11D-A111-01	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11R-A115-07	4a28ecf3-c70e-42d0-918b-866d11804c13	TCGA-E2-A15O-01A-11D-A111-01	TCGA-E2-A15O-01
TCGA-E2-A15P-01	Stage IA	61	2	Stage I	315		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	315	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A15P-01	595	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A15P	595	0	days	595	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15P-F19144	TCGA-E2-A15P	TCGA-E2-A15P-01A		Positive					Positive	Lumpectomy		NO			-22524	269		0	595					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-E2-A15P.8C7442C0-540C-4023-BBFA-8482935259A7.pdf	A15P	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	61c279ee-777a-4c05-bc38-e1a9183faaff	2bdfaad7-f202-4d89-a8f6-a55789594e2a	61c279ee-777a-4c05-bc38-e1a9183faaff	2bdfaad7-f202-4d89-a8f6-a55789594e2a	TCGA-E2-A15P-01A-21-A13E-20	TCGA-E2-A15P-01A-11D-A10Y-09		TCGA-E2-A15P-01			776d3800-9f60-4eb4-930c-8bb036607730	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11D-A10Y-09	TCGA-E2-A15P-01A-11D-A112-05	TCGA-E2-A15P-01	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11D-A10Y-09		61c279ee-777a-4c05-bc38-e1a9183faaff		TCGA-E2-A15P-01A-11D-A111-01	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11R-A115-07	61c279ee-777a-4c05-bc38-e1a9183faaff	TCGA-E2-A15P-01A-11D-A111-01	TCGA-E2-A15P-01
TCGA-E2-A15R-01	Stage IIIA	64	4	Stage IIA	330		Positive	FEMALE	Negative	4	3	3	Negative	M0	Positive	N1	330	0	LumA	Luminal A	Positive	LumA/B	-10	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A15R-01	1732	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-E2-A15R	1732	0	days	1732	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15R-F70011	TCGA-E2-A15R	TCGA-E2-A15R-01A		Positive					Positive	Lumpectomy		NO			-23570	247		0	1732					NO	Allred score 5+3 = 8		1.9	Scheduled Follow-up Submission	2015-2-9	FEMALE					2+		2.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	5								NO	3		false	No	M0	N1a	T1c	Stage IIA	TCGA-E2-A15R.0F708C6E-0262-46EE-8ED2-67E791D5C379.pdf	A15R	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8	YES	YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	8f90121d-5f9a-4702-a2ae-2a9b34a99171	37d17072-0bcc-41ed-a80e-87a27ea956d4	8f90121d-5f9a-4702-a2ae-2a9b34a99171	37d17072-0bcc-41ed-a80e-87a27ea956d4	TCGA-E2-A15R-01A-21-A13E-20	TCGA-E2-A15R-01A-11D-A10Y-09		TCGA-E2-A15R-01			7bec7525-d926-443f-a521-09334b963a89	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11D-A10Y-09	TCGA-E2-A15R-01A-11D-A112-05	TCGA-E2-A15R-01	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11D-A10Y-09		8f90121d-5f9a-4702-a2ae-2a9b34a99171		TCGA-E2-A15R-01A-11D-A111-01	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11R-A115-07	8f90121d-5f9a-4702-a2ae-2a9b34a99171	TCGA-E2-A15R-01A-11D-A111-01	TCGA-E2-A15R-01
TCGA-E2-A15S-01	Stage IIB	34		Stage IIB	274		Positive	FEMALE	Negative				Negative	M0	Positive	N1	274	0	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15S-01	428	0	days		C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 6	mutation c1uster 9	TCGA-E2-A15S	428	0	days	428	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A15S-F19135	TCGA-E2-A15S	TCGA-E2-A15S-01A		Positive					Negative	Simple Mastectomy		NO			-12671	247		0	428					NO				Scheduled Follow-up Submission	2011-11-16	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	560	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	1		false	No	M0	N1	T2	Stage IIB	TCGA-E2-A15S.AF740239-D3E2-4C74-844E-0F5AD1A905ED.pdf	A15S	TUMOR FREE				Allred score = 2	Allred score = 7		YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	754fd66b-f39a-4308-a57c-05de251f9014	888a41e1-bc82-44a2-b2c1-05b7590ab22a	754fd66b-f39a-4308-a57c-05de251f9014	888a41e1-bc82-44a2-b2c1-05b7590ab22a	TCGA-E2-A15S-01A-21-A13E-20	TCGA-E2-A15S-01A-11D-A10Y-09		TCGA-E2-A15S-01			19e14655-2099-4ebc-91eb-d95db082bbc7	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11D-A10Y-09	TCGA-E2-A15S-01A-11D-A112-05	TCGA-E2-A15S-01	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11D-A10Y-09		754fd66b-f39a-4308-a57c-05de251f9014		TCGA-E2-A15S-01A-11D-A111-01	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11R-A115-07	754fd66b-f39a-4308-a57c-05de251f9014	TCGA-E2-A15S-01A-11D-A111-01	TCGA-E2-A15S-01
TCGA-E2-A15T-01	Stage IIA	65		Stage IIA	267		Positive	FEMALE	Negative				Negative	M0	Negative	N0	267	0		Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15T-01	1563	0	days			cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E2-A15T	1563	0	days	1563	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A15T-F70019	TCGA-E2-A15T	TCGA-E2-A15T-01A		Positive					Positive	Simple Mastectomy		NO			-24054	162		0	1563					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2015-2-9	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	360	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0		false	No	M0	N0	T2	Stage IIA	TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A.pdf	A15T	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8	YES	YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	5db1c37a-2329-4bd3-baf2-89d26a8959fa	93d6d838-9563-4daa-ab69-5ba0073c9d1d	5db1c37a-2329-4bd3-baf2-89d26a8959fa	93d6d838-9563-4daa-ab69-5ba0073c9d1d	TCGA-E2-A15T-01A-21-A13E-20	TCGA-E2-A15T-01A-11D-A10Y-09		TCGA-E2-A15T-01			e8fe1a3f-ec8a-49a8-a932-01341de67004	TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11D-A10Y-09	TCGA-E2-A15T-01A-11D-A112-05	TCGA-E2-A15T-01	TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11D-A10Y-09		5db1c37a-2329-4bd3-baf2-89d26a8959fa		TCGA-E2-A15T-01A-11D-A111-01	TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11R-A115-07	5db1c37a-2329-4bd3-baf2-89d26a8959fa	TCGA-E2-A15T-01A-11D-A111-01	TCGA-E2-A15T-01
TCGA-E2-A1AZ-01	Stage IIB	63	4	Stage IIB	1964		Negative	FEMALE	Negative				Negative	M0	Positive	N1	1964	0	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1AZ-01	2329	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8			mutation c1uster 9	TCGA-E2-A1AZ	2329	0	days	2329	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1AZ-F19462	TCGA-E2-A1AZ	TCGA-E2-A1AZ-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-23230	2527		0	2329					NO				Scheduled Follow-up Submission	2011-12-6	FEMALE								0.42		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	250	NO	Indeterminate	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf	A1AZ	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2004	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	TCGA-E2-A1AZ-01A-21-A13E-20	TCGA-E2-A1AZ-01A-11D-A12Q-09		TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11D-A12R-05		187a4af6-1941-419e-a58d-d3fb18510b65	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11D-A12Q-09		TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11D-A12Q-09		fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c		TCGA-E2-A1AZ-01A-11D-A12N-01	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11R-A12P-07	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA-E2-A1AZ-01A-11D-A12N-01	TCGA-E2-A1AZ-01
TCGA-E2-A1B0-01	Stage IIIA	50	3	Stage IIIA	1271		Negative	FEMALE	Positive	1	2	2	Negative	M0	Positive	N2	1271	0	Her2	HER2-enriched	Negative	ReacI	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B0-01	1631	0	days	High	C3-BRCA/Luminal	cluster 5	Cluster 5	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A1B0	1631	0	days	1631	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1B0-F19460	TCGA-E2-A1B0	TCGA-E2-A1B0-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18346	1315		0	1631					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-12-7	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Positive			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	6		true	No	M0	N2	T2	Stage IIIA	TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf	A1B0	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	8bb3543b-5c83-41c6-b81c-b20935c38d72	fd63fcef-ebac-4386-beb6-29d42bdae2d9	8bb3543b-5c83-41c6-b81c-b20935c38d72	fd63fcef-ebac-4386-beb6-29d42bdae2d9	TCGA-E2-A1B0-01A-21-A13E-20	TCGA-E2-A1B0-01A-11D-A12Q-09		TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11D-A12R-05		2eae7190-37af-4257-9a9e-29a8c937a513	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11D-A12Q-09		TCGA-E2-A1B0-01	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11D-A12Q-09		8bb3543b-5c83-41c6-b81c-b20935c38d72		TCGA-E2-A1B0-01A-11D-A12N-01	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11R-A12P-07	8bb3543b-5c83-41c6-b81c-b20935c38d72	TCGA-E2-A1B0-01A-11D-A12N-01	TCGA-E2-A1B0-01
TCGA-E2-A1B1-01	Stage IIB	45	3	Stage IIB	1361		Positive	FEMALE	Positive	1	2	3	Negative	M0	Positive	N1	1361	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B1-01	2653	0	days	Kirc+	C5-KIRC	cluster 5	Low purity c2	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A1B1	2653	0	days	2653	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1B1-F70009	TCGA-E2-A1B1	TCGA-E2-A1B1-01A		Positive					Positive	Lumpectomy		NO			-16603	1268		0	2653					NO	Allred score 3+2 = 5			Scheduled Follow-up Submission	2015-2-9	FEMALE			70-79%		2+			15.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO	Equivocal	Positive	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	4								NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf	A1B1	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 5	YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	2aa34033-a6f5-45a8-833b-b433352e58ba	f4171ca1-a9b6-4e8a-8e80-a259329ac696	2aa34033-a6f5-45a8-833b-b433352e58ba	f4171ca1-a9b6-4e8a-8e80-a259329ac696	TCGA-E2-A1B1-01A-11-A13E-20	TCGA-E2-A1B1-01A-21D-A12Q-09		TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21D-A12R-05		c476545a-0d56-4d49-9180-bb707d02a1c9	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21D-A12Q-09		TCGA-E2-A1B1-01	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21D-A12Q-09		2aa34033-a6f5-45a8-833b-b433352e58ba		TCGA-E2-A1B1-01A-21D-A12N-01	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21R-A12P-07	2aa34033-a6f5-45a8-833b-b433352e58ba	TCGA-E2-A1B1-01A-21D-A12N-01	TCGA-E2-A1B1-01
TCGA-E2-A1B4-01	Stage IIIA	74	2	Stage IIIA	911		Positive	FEMALE	Negative	3	3	3	Negative	M0	Positive	N2	911	0	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	LIVING	1	TCGA-E2-A1B4-01	1004	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-E2-A1B4	1004	0	days	1004	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1B4-F19443	TCGA-E2-A1B4	TCGA-E2-A1B4-01A		Positive					Positive	Lumpectomy		NO			-27241	798	1004	0	911					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	3		true	No	M0	N2a	T1c	Stage IIIA	TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf	A1B4	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	DECEASED	2008	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	f64a244c-40c8-4689-bd55-3263bb01f9fa	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	f64a244c-40c8-4689-bd55-3263bb01f9fa	TCGA-E2-A1B4-01A-21-A13E-20	TCGA-E2-A1B4-01A-11D-A12Q-09		TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11D-A12R-05		4b198843-12fe-41e0-af18-0638dd948c6a	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11D-A12Q-09		TCGA-E2-A1B4-01	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11D-A12Q-09		2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6		TCGA-E2-A1B4-01A-11D-A12N-01	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11R-A12P-07	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	TCGA-E2-A1B4-01A-11D-A12N-01	TCGA-E2-A1B4-01
TCGA-E2-A1B5-01	Stage IIA	46	3	Stage IIA	774		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	774	0	LumA	Basal-like	Positive	ReacI	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B5-01	984	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-E2-A1B5	984	0	days	984	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left	Sentinel node biopsy alone		TCGA-E2-A1B5-F19393	TCGA-E2-A1B5	TCGA-E2-A1B5-01A		Positive					Positive	Lumpectomy		NO			-17039	783		0	984					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-12-8	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf	A1B5	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	4fd5a826-8410-4572-9403-960947308df7	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	4fd5a826-8410-4572-9403-960947308df7	TCGA-E2-A1B5-01A-31-A13E-20	TCGA-E2-A1B5-01A-21D-A12Q-09		TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21D-A12R-05		96c90192-0896-42a2-bc87-ae6bf8bb5c9f	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21D-A12Q-09		TCGA-E2-A1B5-01	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21D-A12Q-09		a2c80f8e-f08d-4574-90a0-f0651c0a9b1b		TCGA-E2-A1B5-01A-21D-A12N-01	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21R-A12P-07	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	TCGA-E2-A1B5-01A-21D-A12N-01	TCGA-E2-A1B5-01
TCGA-E2-A1B5-11		46			774			FEMALE									774	0							enrollment			LIVING	0	TCGA-E2-A1B5-11	984	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1B5	984	0	days	984	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left	Sentinel node biopsy alone		TCGA-E2-A1B5-F19393	TCGA-E2-A1B5	TCGA-E2-A1B5-11A		Positive					Positive	Lumpectomy		NO			-17039	783		0	984					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2011-12-8	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T2	Stage IIA		A1B5	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008									TCGA-E2-A1B5-11A-23D-A12R-05																	
TCGA-E2-A1B6-01	Stage IIA	44	1	Stage IIA	338		Negative	FEMALE	Negative	2	2	2	Negative	M0	Negative	N0	338	0		Luminal A	Negative	Basal	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B6-01	867	0	days	Quiet	C13-AML	cluster 5	Low purity c2	BRCA basal-like c6		miRNA cluster 15	cluster 6	mutation cluster 5	TCGA-E2-A1B6	867	0	days	867	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left	Sentinel node biopsy alone		TCGA-E2-A1B6-F19389	TCGA-E2-A1B6	TCGA-E2-A1B6-01A		Negative					Negative	Simple Mastectomy		NO			-16370	729		0	867					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		2+			1.03		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E2-A1B6.539FF792-534D-401D-87A6-B3B7C2BC2EFC.pdf	A1B6	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	eb398b00-8669-4c22-8285-03cdf76436f3	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	eb398b00-8669-4c22-8285-03cdf76436f3	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	TCGA-E2-A1B6-01A-21-A13E-20	TCGA-E2-A1B6-01A-31D-A12Q-09		TCGA-E2-A1B6-01	TCGA-E2-A1B6-01A-31D-A12R-05		dc503863-7967-469b-b966-69dcea2dfb86	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01A-31D-A12Q-09		TCGA-E2-A1B6-01	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01A-31D-A12Q-09		eb398b00-8669-4c22-8285-03cdf76436f3		TCGA-E2-A1B6-01A-31D-A12N-01	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01A-31R-A12P-07	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA-E2-A1B6-01A-31D-A12N-01	TCGA-E2-A1B6-01
TCGA-E2-A1BC-01	Stage IA	63	2	Stage I	297		Positive	FEMALE	Negative	3	4	3	Negative	M0	Negative	N0	297	0	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A1BC-01	501	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1BC	501	0	days	501	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Sentinel node biopsy alone		TCGA-E2-A1BC-F19427	TCGA-E2-A1BC	TCGA-E2-A1BC-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-23168	275		0	501					NO				Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.9		YES		Tumor resection	100	NO	Negative			4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	0		true	Yes	M0	N0	T1c	Stage IA	TCGA-E2-A1BC.817D4725-01FE-4148-A8FC-3431F28D5CD8.pdf	A1BC	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	a2cf164c-5b26-43eb-9de9-d1d457a5de06	1085f98f-9f84-4d1e-9c07-f6b43cc571b7	a2cf164c-5b26-43eb-9de9-d1d457a5de06	1085f98f-9f84-4d1e-9c07-f6b43cc571b7	TCGA-E2-A1BC-01A-21-A13E-20	TCGA-E2-A1BC-01A-11D-A14G-09		TCGA-E2-A1BC-01	TCGA-E2-A1BC-01A-11D-A12R-05		8d3961ff-444a-4808-a697-c21898446648	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01A-11D-A14G-09		TCGA-E2-A1BC-01	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01A-11D-A14G-09		a2cf164c-5b26-43eb-9de9-d1d457a5de06		TCGA-E2-A1BC-01A-11D-A12N-01	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01A-11R-A12P-07	a2cf164c-5b26-43eb-9de9-d1d457a5de06	TCGA-E2-A1BC-01A-11D-A12N-01	TCGA-E2-A1BC-01
TCGA-E2-A1BC-11		63			297			FEMALE									297	0							enrollment			LIVING	0	TCGA-E2-A1BC-11	501	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E2-A1BC	501	0	days	501	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Sentinel node biopsy alone		TCGA-E2-A1BC-F19427	TCGA-E2-A1BC			Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-23168			0	501					NO				Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.9		YES		Tumor resection			Negative			4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			Yes	M0	N0	T1c	Stage IA		A1BC	TUMOR FREE							YES			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast		LIVING	2010	afe373b9-f1c1-412d-9506-091749d47534		afe373b9-f1c1-412d-9506-091749d47534						TCGA-E2-A1BC-11A-32D-A12R-05							TCGA-E2-A1BC-11			afe373b9-f1c1-412d-9506-091749d47534			TCGA-E2-A1BC-11	TCGA-E2-A1BC-11A-32R-A12P-07	afe373b9-f1c1-412d-9506-091749d47534		
TCGA-E2-A1BD-01	Stage IIA	53	2	Stage IIA	317		Positive	FEMALE	Negative	3	3	3	Negative	M0	Negative	N0	317	0	LumA	Luminal A	Positive	LumA	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1BD-01	1133	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1BD	1133	0	days	1133	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1BD-F70021	TCGA-E2-A1BD	TCGA-E2-A1BD-01A		Positive					Positive	Lumpectomy		NO			-19627	260		0	1133					NO	Allred score 5+3 = 8			Scheduled Follow-up Submission	2015-2-9	FEMALE			10-19%		2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf	A1BD	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8	YES	YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	58138777-4be6-498c-9b6c-4dab28541ec7	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	58138777-4be6-498c-9b6c-4dab28541ec7	TCGA-E2-A1BD-01A-21-A13E-20	TCGA-E2-A1BD-01A-11D-A12Q-09		TCGA-E2-A1BD-01	TCGA-E2-A1BD-01A-11D-A12R-05		139a9795-35ff-4c82-9530-fb103ea5ca8c	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01A-11D-A12Q-09		TCGA-E2-A1BD-01	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01A-11D-A12Q-09		fa1917b0-c3e1-412d-b063-e74b5cafb8dc		TCGA-E2-A1BD-01A-11D-A12N-01	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01A-11R-A12P-07	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	TCGA-E2-A1BD-01A-11D-A12N-01	TCGA-E2-A1BD-01
TCGA-E2-A1IE-01	Stage IIB	61	5	Stage IIB	983		Positive	FEMALE	Negative				Negative	M0	Positive	N1	983	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IE-01	2362	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-E2-A1IE	1810	1	days	2362	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			61	Right	Sentinel node biopsy alone		TCGA-E2-A1IE-F70297	TCGA-E2-A1IE			Positive					Positive	Lumpectomy		NO			-22510			0	2362			1810		NO	allred score 5 + 3 = 8			Scheduled Follow-up Submission	2015-3-16	FEMALE			20-29%		2+			1.05	2.1	Infiltrating Ductal Carcinoma		No	200	C50.9	8500/3	C50.9		YES		Tumor resection			Equivocal	Negative	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive				1.0	3 Point Scale	3+	3+	Negative				Positive			3	6	2.2		3 Point Scale	Liver	Distant Metastasis		NO	YES	1			No	M0	N1	T2	Stage IIB		A1IE	WITH TUMOR	allred score 3 + 3 = 6			allred score = 6	allred score = 8	YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2008	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	e3703f32-e1f2-4f3a-9861-6e25fdbd8144	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	e3703f32-e1f2-4f3a-9861-6e25fdbd8144		TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01	TCGA-E2-A1IE-01A-11D-A13K-05			TCGA-E2-A1IE-01	TCGA-E2-A1IE-01A-11D-A188-09			TCGA-E2-A1IE-01	TCGA-E2-A1IE-01A-11D-A188-09		ec6f69db-ff0b-491c-8b70-d53d0e7ad65f		TCGA-E2-A1IE-01A-11D-A13J-01	TCGA-E2-A1IE-01		ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	TCGA-E2-A1IE-01A-11D-A13J-01	
TCGA-E2-A1IF-01	Stage I	74	2	Stage I	956		Positive	FEMALE	Negative				Negative	M0	Negative	N0	956	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IF-01	1138	0	days	Iq	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 1	TCGA-E2-A1IF	1138	0	days	1138	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IF-F19962	TCGA-E2-A1IF	TCGA-E2-A1IF-01A		Positive					Positive	Lumpectomy		NO			-27341	932		0	1138					NO	allred score 5+3=8			Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	6								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf	A1IF	TUMOR FREE	allred score 4+2=6			allred score = 6	allred scrore = 8		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	98d263ad-3cc6-4846-916c-17de953a89a0	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	98d263ad-3cc6-4846-916c-17de953a89a0		TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01	TCGA-E2-A1IF-01A-11D-A145-05			TCGA-E2-A1IF-01	TCGA-E2-A1IF-01A-11D-A142-09			TCGA-E2-A1IF-01	TCGA-E2-A1IF-01A-11D-A142-09		34a8b02b-01a2-4f2d-8e8e-c3358d43665a		TCGA-E2-A1IF-01A-11D-A141-01	TCGA-E2-A1IF-01		34a8b02b-01a2-4f2d-8e8e-c3358d43665a	TCGA-E2-A1IF-01A-11D-A141-01	
TCGA-E2-A1IF-11		74			956			FEMALE									956	0							enrollment			LIVING	0	TCGA-E2-A1IF-11	1138	0	days		C3-BRCA/Luminal							mutation cluster 1	TCGA-E2-A1IF	1138	0	days	1138	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IF-F19962	TCGA-E2-A1IF	TCGA-E2-A1IF-11A		Positive					Positive	Lumpectomy		NO			-27341	932		0	1138					NO	allred score 5+3=8			Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T1c	Stage I		A1IF	TUMOR FREE	allred score 4+2=6			allred score = 6	allred scrore = 8		YES			NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008									TCGA-E2-A1IF-11A-22D-A145-05																	
TCGA-E2-A1IG-01	Stage IIB	45	5	Stage IIB	755		Positive	FEMALE					Negative	M0	Positive	N1	755	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IG-01	2140	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-E2-A1IG	2140	0	days	2140	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IG-F70394	TCGA-E2-A1IG			Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16757			0	2140					NO				Scheduled Follow-up Submission	2015-3-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	4								NO	1			No	M0	N1mi	T2	Stage IIB		A1IG	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2009	d0705a73-e6d0-4282-82b1-76d44bda242f	e3df00a4-ca76-4515-b652-ba5903b82f99	d0705a73-e6d0-4282-82b1-76d44bda242f	e3df00a4-ca76-4515-b652-ba5903b82f99	TCGA-E2-A1IG-01A-21-A17J-20	TCGA-E2-A1IG-01A-11D-A142-09		TCGA-E2-A1IG-01	TCGA-E2-A1IG-01A-11D-A145-05		e1a96343-ccc9-4e16-a96d-749528da4dfb	TCGA-E2-A1IG-01	TCGA-E2-A1IG-01A-11D-A142-09			TCGA-E2-A1IG-01	TCGA-E2-A1IG-01A-11D-A142-09		d0705a73-e6d0-4282-82b1-76d44bda242f		TCGA-E2-A1IG-01A-11D-A141-01	TCGA-E2-A1IG-01		d0705a73-e6d0-4282-82b1-76d44bda242f	TCGA-E2-A1IG-01A-11D-A141-01	
TCGA-E2-A1IG-11		45			755			FEMALE									755	0	Normal						enrollment			LIVING	0	TCGA-E2-A1IG-11	2140	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1IG	2140	0	days	2140	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IG-F70394	TCGA-E2-A1IG	TCGA-E2-A1IG-11A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-16757	679		0	2140					NO				Scheduled Follow-up Submission	2015-3-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative		NO	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		false	No	M0	N1mi	T2	Stage IIB		A1IG	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	1e55cf08-da43-471d-813c-9d37c7abc730		1e55cf08-da43-471d-813c-9d37c7abc730													TCGA-E2-A1IG-11			1e55cf08-da43-471d-813c-9d37c7abc730			TCGA-E2-A1IG-11		1e55cf08-da43-471d-813c-9d37c7abc730		
TCGA-E2-A1IH-01	Stage I	80	2	Stage I	658		Positive	FEMALE	Negative				Negative	M0	Negative	N0	658	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IH-01	1026	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation c1uster 10	TCGA-E2-A1IH	1026	0	days	1026	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IH-F19960	TCGA-E2-A1IH	TCGA-E2-A1IH-01A		Positive					Positive	Lumpectomy		NO			-29444	883		0	1026					NO	allred score 5+3=8			Scheduled Follow-up Submission	2011-12-21	FEMALE			20-29%		2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	80	NO	Equivocal			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf	A1IH	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	2d06908f-3332-4b77-b88c-145dc5c4828f	ebd32da6-da68-4130-bd91-b15c230f5cdb	2d06908f-3332-4b77-b88c-145dc5c4828f	ebd32da6-da68-4130-bd91-b15c230f5cdb		TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01	TCGA-E2-A1IH-01A-11D-A13K-05			TCGA-E2-A1IH-01	TCGA-E2-A1IH-01A-11D-A188-09			TCGA-E2-A1IH-01	TCGA-E2-A1IH-01A-11D-A188-09		2d06908f-3332-4b77-b88c-145dc5c4828f		TCGA-E2-A1IH-01A-11D-A13J-01	TCGA-E2-A1IH-01		2d06908f-3332-4b77-b88c-145dc5c4828f	TCGA-E2-A1IH-01A-11D-A13J-01	
TCGA-E2-A1II-01	Stage I	51	2	Stage I	850		Negative	FEMALE	Negative				Negative	M0	Negative	N0	850	0	Basal		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1II-01	1025	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A1II	1025	0	days	1025	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left	Sentinel node biopsy alone		TCGA-E2-A1II-F19954	TCGA-E2-A1II			Negative					Positive	Lumpectomy		NO			-18788			0	1025					NO	allred score 0 + 0 = 0			Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	0			No	M0	N0	T1c	Stage I		A1II	TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast		LIVING	2008	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	bb949708-34dc-48db-94db-c438ce611f57	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	bb949708-34dc-48db-94db-c438ce611f57		TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01	TCGA-E2-A1II-01A-11D-A145-05			TCGA-E2-A1II-01	TCGA-E2-A1II-01A-11D-A142-09			TCGA-E2-A1II-01	TCGA-E2-A1II-01A-11D-A142-09		f7a5cfcb-623c-4858-ba32-e6ca63c75d2a		TCGA-E2-A1II-01A-11D-A141-01	TCGA-E2-A1II-01		f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	TCGA-E2-A1II-01A-11D-A141-01	
TCGA-E2-A1II-11		51			850			FEMALE									850	0							enrollment			LIVING	0	TCGA-E2-A1II-11	1025	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A1II	1025	0	days	1025	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left	Sentinel node biopsy alone		TCGA-E2-A1II-F19954	TCGA-E2-A1II	TCGA-E2-A1II-11A		Negative					Positive	Lumpectomy		NO			-18788	854		0	1025					NO	allred score 0 + 0 = 0			Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T1c	Stage I		A1II	TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2008									TCGA-E2-A1II-11A-21D-A145-05																	
TCGA-E2-A1IJ-01	Stage I	57	3	Stage I	725		Positive	FEMALE	Negative				Negative	M0	Negative	N0	725	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IJ-01	865	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A1IJ	865	0	days	865	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IJ-F19950	TCGA-E2-A1IJ	TCGA-E2-A1IJ-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-20956	707		0	865					NO		90-99%		Scheduled Follow-up Submission	2011-12-21	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf	A1IJ	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	ccbdba80-fcd1-44ca-9265-4f0c5818dd60	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	ccbdba80-fcd1-44ca-9265-4f0c5818dd60		TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01	TCGA-E2-A1IJ-01A-11D-A145-05			TCGA-E2-A1IJ-01	TCGA-E2-A1IJ-01A-11D-A142-09			TCGA-E2-A1IJ-01	TCGA-E2-A1IJ-01A-11D-A142-09		14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2		TCGA-E2-A1IJ-01A-11D-A141-01	TCGA-E2-A1IJ-01		14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	TCGA-E2-A1IJ-01A-11D-A141-01	
TCGA-E2-A1IK-01	Stage IIA	71	1	Stage IIA	518		Positive	FEMALE	Negative				Negative	M0	Positive	N1	518	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IK-01	1800	0	days	Quiet	C5-KIRC	cluster 1	Low purity c2		BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-E2-A1IK	1800	0	days	1800	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left	Sentinel node biopsy alone		TCGA-E2-A1IK-F70395	TCGA-E2-A1IK	TCGA-E2-A1IK-01A		Positive					Positive	Lumpectomy		NO			-26052	423		0	1800					NO				Scheduled Follow-up Submission	2015-3-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	7								NO	1		false	No	M0	N1mi	T1c	Stage IIA	TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf	A1IK	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	96a11934-f6cd-4892-a808-672433f84429	41e6ce80-5607-4d63-aba4-fdf657eb0227	96a11934-f6cd-4892-a808-672433f84429	41e6ce80-5607-4d63-aba4-fdf657eb0227		TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01	TCGA-E2-A1IK-01A-11D-A145-05			TCGA-E2-A1IK-01	TCGA-E2-A1IK-01A-11D-A17G-09			TCGA-E2-A1IK-01	TCGA-E2-A1IK-01A-11D-A17G-09		96a11934-f6cd-4892-a808-672433f84429		TCGA-E2-A1IK-01A-11D-A141-01	TCGA-E2-A1IK-01		96a11934-f6cd-4892-a808-672433f84429	TCGA-E2-A1IK-01A-11D-A141-01	
TCGA-E2-A1IL-01	Stage IIA	78	2	Stage IIA	14		Positive	FEMALE	Negative				Negative	M0	Positive	N1	14	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IL-01	118	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-E2-A1IL	118	0	days	118	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IL-F20276	TCGA-E2-A1IL	TCGA-E2-A1IL-01A		Positive					Positive	Lumpectomy		NO			-28495	417		0	118					NO	allred score 5+3=8			Scheduled Follow-up Submission	2012-1-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	6								NO	1		false	No	M0	N1a	T1c	Stage IIA	TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf	A1IL	TUMOR FREE	allred score 4 + 3 = 7			allred score = 7	allred score = 8		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	efbd26b2-9623-45f3-a4c6-aea7266bb688	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	efbd26b2-9623-45f3-a4c6-aea7266bb688	TCGA-E2-A1IL-01A-21-A17J-20	TCGA-E2-A1IL-01A-11D-A14G-09		TCGA-E2-A1IL-01	TCGA-E2-A1IL-01A-11D-A14H-05		dbdb0a12-88ea-4a7b-a215-e7e83adc666f	TCGA-E2-A1IL-01	TCGA-E2-A1IL-01A-11D-A14G-09			TCGA-E2-A1IL-01	TCGA-E2-A1IL-01A-11D-A14G-09		5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d		TCGA-E2-A1IL-01A-11D-A14F-01	TCGA-E2-A1IL-01		5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	TCGA-E2-A1IL-01A-11D-A14F-01	
TCGA-E2-A1IN-01	Stage I	60	4	Stage I	392		Positive	FEMALE	Negative				Negative	M0	Negative	N0	392	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IN-01	675	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E2-A1IN	675	0	days	675	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right	Sentinel node biopsy alone		TCGA-E2-A1IN-F20323	TCGA-E2-A1IN	TCGA-E2-A1IN-01A		Positive					Positive	Lumpectomy		NO			-22199	368		0	675					NO	allred score 5+3=8			Scheduled Follow-up Submission	2012-1-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	20	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A1IN.CC0B1145-B242-45BD-A946-B14BA5A9E923.pdf	A1IN	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	dde1d3ab-ad71-4526-bc98-058b6049edcf	08e895e6-2f45-436c-9b33-9768b66dc33b	dde1d3ab-ad71-4526-bc98-058b6049edcf	08e895e6-2f45-436c-9b33-9768b66dc33b		TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01	TCGA-E2-A1IN-01A-11D-A13K-05			TCGA-E2-A1IN-01	TCGA-E2-A1IN-01A-11D-A13L-09			TCGA-E2-A1IN-01	TCGA-E2-A1IN-01A-11D-A13L-09		dde1d3ab-ad71-4526-bc98-058b6049edcf		TCGA-E2-A1IN-01A-11D-A13J-01	TCGA-E2-A1IN-01		dde1d3ab-ad71-4526-bc98-058b6049edcf	TCGA-E2-A1IN-01A-11D-A13J-01	
TCGA-E2-A1IO-01	Stage I	37	1	Stage I	448		Positive	FEMALE	Negative				Negative	M0	Negative	N0	448	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IO-01	1855	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-E2-A1IO	1855	0	days	1855	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right	Sentinel node biopsy alone		TCGA-E2-A1IO-F70391	TCGA-E2-A1IO	TCGA-E2-A1IO-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-13671	416		0	1855					NO				Scheduled Follow-up Submission	2015-3-16	FEMALE			30-39%		2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Equivocal	Negative	NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf	A1IO	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	72611671-51cc-4662-b992-6701eb1df987	1123e3e5-8125-432d-9246-195e8114be97	72611671-51cc-4662-b992-6701eb1df987	1123e3e5-8125-432d-9246-195e8114be97		TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01	TCGA-E2-A1IO-01A-11D-A145-05			TCGA-E2-A1IO-01	TCGA-E2-A1IO-01A-11D-A142-09			TCGA-E2-A1IO-01	TCGA-E2-A1IO-01A-11D-A142-09		72611671-51cc-4662-b992-6701eb1df987		TCGA-E2-A1IO-01A-11D-A141-01	TCGA-E2-A1IO-01		72611671-51cc-4662-b992-6701eb1df987	TCGA-E2-A1IO-01A-11D-A141-01	
TCGA-E2-A1IO-11		37			448			FEMALE									448	0							enrollment			LIVING	0	TCGA-E2-A1IO-11	1855	0	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-E2-A1IO	1855	0	days	1855	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right	Sentinel node biopsy alone		TCGA-E2-A1IO-F70391	TCGA-E2-A1IO	TCGA-E2-A1IO-11A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-13671	416		0	1855					NO				Scheduled Follow-up Submission	2015-3-16	FEMALE			30-39%		2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		false	No	M0	N0	T1c	Stage I		A1IO	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009									TCGA-E2-A1IO-11A-21D-A145-05																	
TCGA-E2-A1IP-01	Stage IIB	42		Stage IIB	427		Positive	FEMALE	Negative				Negative	M0	Positive	N1	427	0	Basal		Negative				enrollment	T_Other	T2	LIVING		TCGA-E2-A1IP-01			days										TCGA-E2-A1IP			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast											TCGA-E2-A1IP-01A														359																																			80	NO																																						false						TCGA-E2-A1IP.021D6868-16EA-4D55-9784-46A0F85C50C8.pdf													Primary Tumor	01								A			dfd81aa5-5be4-4cf3-877f-0f52e01beb60	2d0dc4e5-c1ad-4f80-b428-0b164d2803fd	dfd81aa5-5be4-4cf3-877f-0f52e01beb60	2d0dc4e5-c1ad-4f80-b428-0b164d2803fd					TCGA-E2-A1IP-01A-11D-A14H-05										dfd81aa5-5be4-4cf3-877f-0f52e01beb60					dfd81aa5-5be4-4cf3-877f-0f52e01beb60		
TCGA-E2-A1IU-01	Stage IA	60	2	Stage I	127		Positive	FEMALE	Negative				Negative	M0	Negative	N0	127	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IU-01	337	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-E2-A1IU	337	0	days	337	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1IU-F19974	TCGA-E2-A1IU	TCGA-E2-A1IU-01A		Positive					Positive	Simple Mastectomy		NO			-22279	136		0	337					NO				Scheduled Follow-up Submission	2012-1-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	270	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	2								NO	0		false	No	M0	N0 (mol+)	T1c	Stage IA	TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf	A1IU	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	53c8bbbd-16cd-4790-a99b-f45b0f958157	34a6f1be-b1db-4659-b620-6e21e0f73b2b	53c8bbbd-16cd-4790-a99b-f45b0f958157	34a6f1be-b1db-4659-b620-6e21e0f73b2b	TCGA-E2-A1IU-01A-21-A17J-20	TCGA-E2-A1IU-01A-11D-A14G-09		TCGA-E2-A1IU-01	TCGA-E2-A1IU-01A-11D-A14H-05		19429156-19ad-44f5-a671-1fef7a6e693c	TCGA-E2-A1IU-01	TCGA-E2-A1IU-01A-11D-A14G-09			TCGA-E2-A1IU-01	TCGA-E2-A1IU-01A-11D-A14G-09		53c8bbbd-16cd-4790-a99b-f45b0f958157		TCGA-E2-A1IU-01A-11D-A14F-01	TCGA-E2-A1IU-01		53c8bbbd-16cd-4790-a99b-f45b0f958157	TCGA-E2-A1IU-01A-11D-A14F-01	
TCGA-E2-A1L6-01	Stage IIA	44	2	Stage IIA	1312		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1312	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1L6-01	1648	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 7	mutation cluster 4	TCGA-E2-A1L6	1648	0	days	1648	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1L6-F20570	TCGA-E2-A1L6	TCGA-E2-A1L6-01A		Positive					Positive	Simple Mastectomy		NO			-16403	1325		0	1648					NO	allred score 5 + 3 = 8			Scheduled Follow-up Submission	2012-1-10	FEMALE			40-49%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	7								NO	1		false	No	M0	N1mi	T1c	Stage IIA	TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf	A1L6	TUMOR FREE	allred score 5 + 3 = 8			allred score =  8	allred score = 8		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2007	4142c779-86ab-44f5-9371-539bbaa363d2	bed7e88d-b9ca-480b-b4c5-43c3403c7990	4142c779-86ab-44f5-9371-539bbaa363d2	bed7e88d-b9ca-480b-b4c5-43c3403c7990	TCGA-E2-A1L6-01A-21-A17J-20	TCGA-E2-A1L6-01A-11D-A13L-09		TCGA-E2-A1L6-01	TCGA-E2-A1L6-01A-11D-A13K-05		bca87047-7257-4983-9e8c-e6811b33a10e	TCGA-E2-A1L6-01	TCGA-E2-A1L6-01A-11D-A13L-09			TCGA-E2-A1L6-01	TCGA-E2-A1L6-01A-11D-A13L-09		4142c779-86ab-44f5-9371-539bbaa363d2		TCGA-E2-A1L6-01A-11D-A13J-01	TCGA-E2-A1L6-01		4142c779-86ab-44f5-9371-539bbaa363d2	TCGA-E2-A1L6-01A-11D-A13J-01	
TCGA-E2-A1L7-01	Stage IIIA	40	1	Stage IIIA	633		Negative	FEMALE	Negative				Negative	M0	Positive	N2	633	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1L7-01	1836	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-E2-A1L7	1619	1	days	1836	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1L7-F70298	TCGA-E2-A1L7	TCGA-E2-A1L7-01A		Negative					Negative	Modified Radical Mastectomy		NO			-14854	548		0	1836		1662	1619		NO	Allred score 1+1 = 2			Scheduled Follow-up Submission	2015-3-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	150	NO	Negative		NO	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Negative												Negative			2	5				Other, specify	New Primary Tumor	left breast	YES	YES	7		false	No	M0	N2	T2	Stage IIIA	TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf	A1L7	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2	YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	ec38c31b-def8-41cc-8656-57ce98f3faa7	11491d25-c862-49e4-8e23-ebbed8e1d87b	ec38c31b-def8-41cc-8656-57ce98f3faa7	11491d25-c862-49e4-8e23-ebbed8e1d87b	TCGA-E2-A1L7-01A-21-A17J-20	TCGA-E2-A1L7-01A-11D-A142-09		TCGA-E2-A1L7-01	TCGA-E2-A1L7-01A-11D-A145-05		9a9baaf4-427c-48cd-ae41-25fd84ae612f	TCGA-E2-A1L7-01	TCGA-E2-A1L7-01A-11D-A142-09			TCGA-E2-A1L7-01	TCGA-E2-A1L7-01A-11D-A142-09		ec38c31b-def8-41cc-8656-57ce98f3faa7		TCGA-E2-A1L7-01A-11D-A141-01	TCGA-E2-A1L7-01		ec38c31b-def8-41cc-8656-57ce98f3faa7	TCGA-E2-A1L7-01A-11D-A141-01	
TCGA-E2-A1L7-11		40			633			FEMALE									633	0	Normal						enrollment			LIVING	0	TCGA-E2-A1L7-11	1836	0	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-E2-A1L7	1619	1	days	1836	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	YES			40	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1L7-F70298	TCGA-E2-A1L7	TCGA-E2-A1L7-11A		Negative					Negative	Modified Radical Mastectomy		NO			-14854	548		0	1836		1662	1619		NO	Allred score 1+1 = 2			Scheduled Follow-up Submission	2015-3-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Negative		NO	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)					Negative												Negative								Other, specify	New Primary Tumor	left breast	YES	YES	7		false	No	M0	N2	T2	Stage IIIA		A1L7	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2	YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	53e9749e-5554-443b-b41e-5efade6fce7a		53e9749e-5554-443b-b41e-5efade6fce7a						TCGA-E2-A1L7-11A-33D-A145-05							TCGA-E2-A1L7-11			53e9749e-5554-443b-b41e-5efade6fce7a			TCGA-E2-A1L7-11		53e9749e-5554-443b-b41e-5efade6fce7a		
TCGA-E2-A1L8-01	Stage IIA	52	2	Stage IIB	1015		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1015	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1L8-01	2240	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-E2-A1L8	2240	0	days	2240	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1L8-F70018	TCGA-E2-A1L8	TCGA-E2-A1L8-01A		Positive					Positive	Simple Mastectomy		NO			-19187	912		0	2240					NO	allred score 5 + 3 = 8			Scheduled Follow-up Submission	2015-2-9	FEMALE			40-49%		2+			1.10		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	180	NO	Equivocal	Negative	NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	6								NO	2		false	Yes	M0	N1a	T2	Stage IIB	TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf	A1L8	TUMOR FREE	allred score 4 + 3 = 7			allred score = 7	allred score = 8	YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	a18c840d-01e1-4827-a756-46e677b5def8	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	a18c840d-01e1-4827-a756-46e677b5def8	TCGA-E2-A1L8-01A-21-A17J-20	TCGA-E2-A1L8-01A-11D-A13L-09		TCGA-E2-A1L8-01	TCGA-E2-A1L8-01A-11D-A13K-05		da720181-484f-4eff-8f96-b7e4298c751b	TCGA-E2-A1L8-01	TCGA-E2-A1L8-01A-11D-A13L-09			TCGA-E2-A1L8-01	TCGA-E2-A1L8-01A-11D-A13L-09		68c8e567-1ac0-40f1-a3a7-a79d77a4ae12		TCGA-E2-A1L8-01A-11D-A13J-01	TCGA-E2-A1L8-01		68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	TCGA-E2-A1L8-01A-11D-A13J-01	
TCGA-E2-A1L9-01	Stage IIB	40	3	Stage IIA	388		Positive	FEMALE	Negative				Negative	M0	Positive	N1	388	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1L9-01	598	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1L9	598	0	days	598	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right	Sentinel node biopsy alone		TCGA-E2-A1L9-F20597	TCGA-E2-A1L9	TCGA-E2-A1L9-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-14868	465		0	598					NO		80-89%		Scheduled Follow-up Submission	2012-1-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	40	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6								NO	1		false	No	M0	N1mi	T1c	Stage IIA	TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf	A1L9	TUMOR FREE				allred score = 7	allred score = 7		YES	80-89%		YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	05329e4e-6623-4044-9abf-46f3ed4ccfd8	e466e6b6-de5c-402e-9123-66a98b6579cb	05329e4e-6623-4044-9abf-46f3ed4ccfd8	e466e6b6-de5c-402e-9123-66a98b6579cb		TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01	TCGA-E2-A1L9-01A-11D-A13K-05			TCGA-E2-A1L9-01	TCGA-E2-A1L9-01A-11D-A13L-09			TCGA-E2-A1L9-01	TCGA-E2-A1L9-01A-11D-A13L-09		05329e4e-6623-4044-9abf-46f3ed4ccfd8		TCGA-E2-A1L9-01A-11D-A13J-01	TCGA-E2-A1L9-01		05329e4e-6623-4044-9abf-46f3ed4ccfd8	TCGA-E2-A1L9-01A-11D-A13J-01	
TCGA-E2-A1LA-01	Stage IIA	59	5	Stage IIA	463		Positive	FEMALE	Negative				Negative	M0	Positive	N1	463	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LA-01	748	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 12	TCGA-E2-A1LA	748	0	days	748	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1LA-F20586	TCGA-E2-A1LA	TCGA-E2-A1LA-01A		Positive					Positive	Simple Mastectomy		NO			-21773	581		0	748					NO	allred score 5 + 3 = 8			Scheduled Follow-up Submission	2012-1-12	FEMALE					2+			1.15		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	40	NO	Equivocal	Negative		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	1		false	No	M0	N1a	T1c	Stage IIA	TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf	A1LA	TUMOR FREE	allred score 5 +3 = 8			allred score = 8	allred score = 8		YES			NO	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2009	9a56eb8b-99fa-4671-99dc-29776dca4cd6	0c31423d-3359-4d38-889a-8156d35472f3	9a56eb8b-99fa-4671-99dc-29776dca4cd6	0c31423d-3359-4d38-889a-8156d35472f3		TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01	TCGA-E2-A1LA-01A-11D-A145-05			TCGA-E2-A1LA-01	TCGA-E2-A1LA-01A-11D-A142-09			TCGA-E2-A1LA-01	TCGA-E2-A1LA-01A-11D-A142-09		9a56eb8b-99fa-4671-99dc-29776dca4cd6		TCGA-E2-A1LA-01A-11D-A141-01	TCGA-E2-A1LA-01		9a56eb8b-99fa-4671-99dc-29776dca4cd6	TCGA-E2-A1LA-01A-11D-A141-01	
TCGA-E2-A1LB-01	Stage IIB	41	1	Stage IIB	972		Negative	FEMALE	Positive				Negative	M0	Positive	N1	972	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LB-01	2306	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-E2-A1LB	2306	0	days	2306	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LB-F70015	TCGA-E2-A1LB	TCGA-E2-A1LB-01A		Negative					Negative	Lumpectomy		NO			-15283	909		0	2306					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Positive		NO	25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	3								NO	2		false	No	M0	N1	T2	Stage IIB	TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf	A1LB	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	acf1ec71-46a5-4e7b-84b1-55203bca29d8	b690db1d-6560-4c02-a3b9-3abc43d39c03	acf1ec71-46a5-4e7b-84b1-55203bca29d8	b690db1d-6560-4c02-a3b9-3abc43d39c03	TCGA-E2-A1LB-01A-21-A17J-20	TCGA-E2-A1LB-01A-11D-A142-09		TCGA-E2-A1LB-01	TCGA-E2-A1LB-01A-11D-A145-05		82c21aa1-4547-4da6-aaf4-ca207c327ea1	TCGA-E2-A1LB-01	TCGA-E2-A1LB-01A-11D-A142-09			TCGA-E2-A1LB-01	TCGA-E2-A1LB-01A-11D-A142-09		acf1ec71-46a5-4e7b-84b1-55203bca29d8		TCGA-E2-A1LB-01A-11D-A141-01	TCGA-E2-A1LB-01		acf1ec71-46a5-4e7b-84b1-55203bca29d8	TCGA-E2-A1LB-01A-11D-A141-01	
TCGA-E2-A1LB-11		41			972			FEMALE									972	0	Normal						enrollment			LIVING	0	TCGA-E2-A1LB-11	2306	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E2-A1LB	2306	0	days	2306	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LB-F70015	TCGA-E2-A1LB			Negative					Negative	Lumpectomy		NO			-15283			0	2306					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive		NO	25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	2			No	M0	N1	T2	Stage IIB		A1LB	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast		LIVING	2008	b34ad5ac-c581-4747-88db-e2d52fa7e463		b34ad5ac-c581-4747-88db-e2d52fa7e463						TCGA-E2-A1LB-11A-22D-A145-05							TCGA-E2-A1LB-11			b34ad5ac-c581-4747-88db-e2d52fa7e463			TCGA-E2-A1LB-11		b34ad5ac-c581-4747-88db-e2d52fa7e463		
TCGA-E2-A1LE-01																													1	TCGA-E2-A1LE-01	879	1	days	Squamous			BRCA CIMP c7	BRCA basal-like c6		miRNA cluster 7			TCGA-E2-A1LE	361	1	days	879	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		71	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A1LE-F20657	TCGA-E2-A1LE	TCGA-E2-A1LE-01A		Negative					Negative	Simple Mastectomy		NO			-26239	986	879	0				361		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2012-1-18	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	600	NO	Positive			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis			YES	27		false	No	M0	N3a	T2	Stage IIIC	TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf	A1LE	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	DECEASED	2008	776c18b3-4e53-41d6-8838-70a6029c07dd	0f1195ba-3464-497c-9c2f-9555f7af44b7	776c18b3-4e53-41d6-8838-70a6029c07dd	0f1195ba-3464-497c-9c2f-9555f7af44b7	TCGA-E2-A1LE-01A-21-A24A-20			TCGA-E2-A1LE-01	TCGA-E2-A1LE-01A-12D-A19Z-05		fc80abcf-e8e0-4354-8646-d9ea84d87f7d	TCGA-E2-A1LE-01	TCGA-E2-A1LE-01A-12D-A19Y-09			TCGA-E2-A1LE-01			776c18b3-4e53-41d6-8838-70a6029c07dd		TCGA-E2-A1LE-01A-12D-A19X-01	TCGA-E2-A1LE-01		776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-12D-A19X-01	
TCGA-E2-A1LG-01	Stage IIA	50	2	Stage IIA	350		Negative	FEMALE	Negative				Negative	M0	Negative	N0	350	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LG-01	1523	0	days	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	KIRC-like c1	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LG	1523	0	days	1523	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LG-F70390	TCGA-E2-A1LG	TCGA-E2-A1LG-01A		Negative					Negative	Modified Radical Mastectomy		NO			-18492	252		0	1523					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-3-16	FEMALE			60-69%		2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	310	NO	Equivocal	Negative	NO	19	Negative	Peri (6-12 months since last menstrual period)																				5	5								NO	0		false	Yes	M0	N0	T2	Stage IIA	TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf	A1LG	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	b2cc4c34-e90b-4377-b50b-222e507cffcc	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	b2cc4c34-e90b-4377-b50b-222e507cffcc	TCGA-E2-A1LG-01A-41-A17J-20	TCGA-E2-A1LG-01A-21D-A14K-09		TCGA-E2-A1LG-01	TCGA-E2-A1LG-01A-21D-A14N-05		ed36c1d5-f0b6-4ff7-bb8b-34a94cf24075	TCGA-E2-A1LG-01	TCGA-E2-A1LG-01A-21D-A14K-09			TCGA-E2-A1LG-01	TCGA-E2-A1LG-01A-21D-A14K-09		94d92cd8-21cf-495d-b4fe-8f8c6067fe9e		TCGA-E2-A1LG-01A-21D-A14J-01	TCGA-E2-A1LG-01		94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	TCGA-E2-A1LG-01A-21D-A14J-01	
TCGA-E2-A1LH-01	Stage I	59	3	Stage I	2875		Negative	FEMALE	Negative				Negative	M0	Negative	N0	2875	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LH-01	3247	0	days	High	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8			mutation cluster 2	TCGA-E2-A1LH	3247	0	days	3247	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right	Sentinel node biopsy alone		TCGA-E2-A1LH-F20649	TCGA-E2-A1LH	TCGA-E2-A1LH-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21628	2998		0	3247					NO				Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	0		false	No	M0	N0	T1c	Stage I	TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf	A1LH	TUMOR FREE		ACIS					YES			YES	Primary Tumor	01		5th	YES	NO	YES	E2	Breast	A	LIVING	2002	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	8bab6eb6-da3c-49d9-b786-d078f8ebda09	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	8bab6eb6-da3c-49d9-b786-d078f8ebda09		TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01	TCGA-E2-A1LH-01A-11D-A14H-05			TCGA-E2-A1LH-01	TCGA-E2-A1LH-01A-11D-A14G-09			TCGA-E2-A1LH-01	TCGA-E2-A1LH-01A-11D-A14G-09		66f3892f-f4ec-412c-9c56-a9e9b56a15ee		TCGA-E2-A1LH-01A-11D-A14F-01	TCGA-E2-A1LH-01		66f3892f-f4ec-412c-9c56-a9e9b56a15ee	TCGA-E2-A1LH-01A-11D-A14F-01	
TCGA-E2-A1LH-11		59			2875			FEMALE									2875	0	Normal						enrollment			LIVING	0	TCGA-E2-A1LH-11	3247	0	days		C4-BRCA/Basal							mutation cluster 2	TCGA-E2-A1LH	3247	0	days	3247	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right	Sentinel node biopsy alone		TCGA-E2-A1LH-F20649	TCGA-E2-A1LH			Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21628			0	3247					NO				Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0			No	M0	N0	T1c	Stage I		A1LH	TUMOR FREE		ACIS					YES			YES	Solid Tissue Normal	11		5th	YES	NO	YES	E2	Breast		LIVING	2002	c0c2059a-2931-4834-84a7-bfacf137c182		c0c2059a-2931-4834-84a7-bfacf137c182													TCGA-E2-A1LH-11			c0c2059a-2931-4834-84a7-bfacf137c182			TCGA-E2-A1LH-11		c0c2059a-2931-4834-84a7-bfacf137c182		
TCGA-E2-A1LI-01	Stage IIB	57	3	Stage IIB	2750		Negative	FEMALE	Negative				Negative	M0	Positive	N1	2750	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LI-01	3121	0	days	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 7		mutation c1uster 9	TCGA-E2-A1LI	3121	0	days	3121	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LI-F20623	TCGA-E2-A1LI	TCGA-E2-A1LI-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21064	2815		0	3121					NO				Scheduled Follow-up Submission	2012-1-12	FEMALE								1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	80	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	0		false	No	M0	N1	T2	Stage IIB	TCGA-E2-A1LI.B3A319BE-2230-43E2-91E5-A3B3C76B85BA.pdf	A1LI	TUMOR FREE		ACIS					YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2003	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	178e0166-9a9b-4495-896e-4a08f661c49a	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	178e0166-9a9b-4495-896e-4a08f661c49a		TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01	TCGA-E2-A1LI-01A-12D-A161-05			TCGA-E2-A1LI-01	TCGA-E2-A1LI-01A-12D-A159-09			TCGA-E2-A1LI-01	TCGA-E2-A1LI-01A-12D-A159-09		fa643dcc-4f4c-44d0-9f4d-199de04f8d2b		TCGA-E2-A1LI-01A-12D-A160-01	TCGA-E2-A1LI-01		fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	TCGA-E2-A1LI-01A-12D-A160-01	
TCGA-E2-A1LI-11		57			2750			FEMALE									2750	0							enrollment			LIVING	0	TCGA-E2-A1LI-11	3121	0	days		C4-BRCA/Basal							mutation c1uster 9	TCGA-E2-A1LI	3121	0	days	3121	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LI-F20623	TCGA-E2-A1LI	TCGA-E2-A1LI-11A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21064	2815		0	3121					NO				Scheduled Follow-up Submission	2012-1-12	FEMALE								1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N1	T2	Stage IIB		A1LI	TUMOR FREE		ACIS					YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2	Breast	A	LIVING	2003									TCGA-E2-A1LI-11A-23D-A161-05																	
TCGA-E2-A1LK-01	Stage IIIC	84	4	Stage IIIA		266	Negative	FEMALE	Negative				Negative	M0	Positive	N1	266	1	Basal		Negative				enrollment	T_Other	T3	DECEASED	1	TCGA-E2-A1LK-01	266	1	days	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LK	155	1	days	266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		84	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LK-F20620	TCGA-E2-A1LK	TCGA-E2-A1LK-01A		Negative					Negative	Modified Radical Mastectomy		NO		200	-30757	1051	266	0				155		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2012-1-12	FEMALE			80-89%		2+			1.41		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Allred Score = 0	Equivocal	2+	Allred score 0+0 = 0	Negative			30-39%	0.95				Negative			Allred score 0+0 = 0	Negative			3	5				Other, specify	Locoregional Disease	Left axilla		YES	11		false	No	M0	N3a	T4b	Stage IIIC	TCGA-E2-A1LK.6CC4E6EF-6664-448E-933E-FFA9117C7ABF.pdf	A1LK	WITH TUMOR	Allred score 0+0 = 0		Allred score = 0	Allred score = 0	Allred score = 0		YES			NO	Primary Tumor	01		6th	NO	NO	YES	E2	Breast	A	DECEASED	2008	d6301614-9ba7-4632-bdca-ac1b11e8e811	0efeb3b3-219b-452f-bc62-148b1b2d909b	d6301614-9ba7-4632-bdca-ac1b11e8e811	0efeb3b3-219b-452f-bc62-148b1b2d909b	TCGA-E2-A1LK-01A-11-A17K-20	TCGA-E2-A1LK-01A-21D-A14G-09		TCGA-E2-A1LK-01	TCGA-E2-A1LK-01A-21D-A14H-05		f5fd203d-214a-42f1-aaf9-c9ee9b12c4fc	TCGA-E2-A1LK-01	TCGA-E2-A1LK-01A-21D-A14G-09			TCGA-E2-A1LK-01	TCGA-E2-A1LK-01A-21D-A14G-09		d6301614-9ba7-4632-bdca-ac1b11e8e811		TCGA-E2-A1LK-01A-21D-A14F-01	TCGA-E2-A1LK-01		d6301614-9ba7-4632-bdca-ac1b11e8e811	TCGA-E2-A1LK-01A-21D-A14F-01	
TCGA-E2-A1LL-01	Stage IIIA	73	1	Stage IIIA	1014		Negative	FEMALE	Negative				Negative	M0	Positive	N2	1014	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-E2-A1LL-01	1309	0	days	Squamous	C2-Squamous-like	cluster 1	BRCA CIMP c7	KIRC-like c1	squamous-like c4	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A1LL	1303	1	days	1309	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	NO		73	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A1LL-F20616	TCGA-E2-A1LL	TCGA-E2-A1LL-01A		Negative					Negative	Simple Mastectomy		NO			-27028	988		0	1309			1303		NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2012-1-17	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4				Liver	Distant Metastasis			YES	5		false	No	MX	N2a	T3	Stage IIIA	TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf	A1LL	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		YES			YES	Primary Tumor	01		6th	YES	NO	YES	E2	Breast	A	LIVING	2008	526c9170-0f25-4374-9287-1fc40acb6555	d64ae769-0555-42d9-ab57-abbb6f292d82	526c9170-0f25-4374-9287-1fc40acb6555	d64ae769-0555-42d9-ab57-abbb6f292d82	TCGA-E2-A1LL-01A-21-A17J-20	TCGA-E2-A1LL-01A-11D-A142-09		TCGA-E2-A1LL-01	TCGA-E2-A1LL-01A-11D-A145-05		fdf3231f-d485-4a5e-b10b-43d9ab536a66	TCGA-E2-A1LL-01	TCGA-E2-A1LL-01A-11D-A142-09			TCGA-E2-A1LL-01	TCGA-E2-A1LL-01A-11D-A142-09		526c9170-0f25-4374-9287-1fc40acb6555		TCGA-E2-A1LL-01A-11D-A141-01	TCGA-E2-A1LL-01		526c9170-0f25-4374-9287-1fc40acb6555	TCGA-E2-A1LL-01A-11D-A141-01	
TCGA-E2-A1LS-01	Stage IA	46		Stage I	239		Negative	FEMALE	Negative				Negative	M0	Negative	N0	239	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LS-01	1604	0	days		C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14		mutation cluster 5	TCGA-E2-A1LS	1604	0	days	1604	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LS-F70016	TCGA-E2-A1LS	TCGA-E2-A1LS-01A		Negative					Negative	Simple Mastectomy		NO			-16887	176		0	1604					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3									NO	0		false	No	M0	N0	T1c	Stage IA	TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf	A1LS	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	81239059-614b-46b7-a21e-224ec62e2939		81239059-614b-46b7-a21e-224ec62e2939		TCGA-E2-A1LS-01A-21-A17J-20	TCGA-E2-A1LS-01A-12D-A159-09		TCGA-E2-A1LS-01	TCGA-E2-A1LS-01A-12D-A161-05		9e7e3f34-faa6-4a3d-a0cb-d733c45b9b65		TCGA-E2-A1LS-01A-12D-A159-09			TCGA-E2-A1LS-01	TCGA-E2-A1LS-01A-12D-A159-09		81239059-614b-46b7-a21e-224ec62e2939			TCGA-E2-A1LS-01		81239059-614b-46b7-a21e-224ec62e2939		
TCGA-E2-A1LS-11		46			239			FEMALE									239	0	Normal						enrollment			LIVING	0	TCGA-E2-A1LS-11	1604	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-E2-A1LS	1604	0	days	1604	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A1LS-F70016	TCGA-E2-A1LS	TCGA-E2-A1LS-11A		Negative					Negative	Simple Mastectomy		NO			-16887	176		0	1604					NO	Allred score 0+0 = 0			Scheduled Follow-up Submission	2015-2-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Negative		NO	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		false	No	M0	N0	T1c	Stage IA		A1LS	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0	YES	YES			NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2	Breast	A	LIVING	2010	a2c2973d-0af5-4065-a5b0-1dd73abdc581		a2c2973d-0af5-4065-a5b0-1dd73abdc581						TCGA-E2-A1LS-11A-32D-A161-05										a2c2973d-0af5-4065-a5b0-1dd73abdc581					a2c2973d-0af5-4065-a5b0-1dd73abdc581		
TCGA-E2-A2P5-01																													1	TCGA-E2-A2P5-01	821	1	days	High			BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 5			TCGA-E2-A2P5	597	1	days	821	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			78	Left	Axillary lymph node dissection alone		TCGA-E2-A2P5-F68575	TCGA-E2-A2P5	TCGA-E2-A2P5-01A		Positive					Positive	Modified Radical Mastectomy		NO			-28621	219	821	0	515			597		NO	Allred score = 8			Scheduled Follow-up Submission	2014-11-26	FEMALE								1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	260	NO		Negative	NO	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Distant Metastasis		NO	YES	21		true	Yes	M0	N3	T2	Stage IIIC	TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf	A2P5	WITH TUMOR	Allred score = 8			Allred score = 8	Allred score = 8	YES	YES			YES	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	DECEASED	2011	90d04601-4a15-44fc-bf1b-e0859310e644	5a5c03bd-ebac-4ee3-b6dd-d5d488bb5611	90d04601-4a15-44fc-bf1b-e0859310e644	5a5c03bd-ebac-4ee3-b6dd-d5d488bb5611	TCGA-E2-A2P5-01A-21-A24A-20			TCGA-E2-A2P5-01	TCGA-E2-A2P5-01A-11D-A19Z-05		b4da5ffb-397d-4760-8e01-a67791dd37fc	TCGA-E2-A2P5-01	TCGA-E2-A2P5-01A-11D-A19Y-09			TCGA-E2-A2P5-01			90d04601-4a15-44fc-bf1b-e0859310e644		TCGA-E2-A2P5-01A-11D-A19X-01	TCGA-E2-A2P5-01		90d04601-4a15-44fc-bf1b-e0859310e644	TCGA-E2-A2P5-01A-11D-A19X-01	
TCGA-E2-A2P6-01																													0	TCGA-E2-A2P6-01	1051	0	days	Iq			BRCA CIMP c7			miRNA cluster 14			TCGA-E2-A2P6	1051	0	days	1051	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A2P6-F68574	TCGA-E2-A2P6	TCGA-E2-A2P6-01A	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		NO			-28411	174		0	1051					NO	Allread score 5+3 = 8			Scheduled Follow-up Submission	2014-11-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative	NO	5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-E2-A2P6.E6A21CE6-841D-4D9B-A563-80B9BAF6E682.pdf	A2P6	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8	YES	YES			NO	Primary Tumor	01		7th	YES	NO	YES	E2	Breast	A	LIVING	2011	bc94874b-f73a-44c8-bc6f-9ec50972c9b2	7d50bbff-dd79-407c-8701-a42c332c404f	bc94874b-f73a-44c8-bc6f-9ec50972c9b2	7d50bbff-dd79-407c-8701-a42c332c404f				TCGA-E2-A2P6-01	TCGA-E2-A2P6-01A-11D-A19Z-05			TCGA-E2-A2P6-01	TCGA-E2-A2P6-01A-11D-A19Y-09			TCGA-E2-A2P6-01			bc94874b-f73a-44c8-bc6f-9ec50972c9b2		TCGA-E2-A2P6-01A-11D-A19X-01	TCGA-E2-A2P6-01		bc94874b-f73a-44c8-bc6f-9ec50972c9b2	TCGA-E2-A2P6-01A-11D-A19X-01	
TCGA-E2-A3DX-01																			LumA										0	TCGA-E2-A3DX-01	1325	0	days	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-E2-A3DX	1325	0	days	1325	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right	Axillary lymph node dissection alone		TCGA-E2-A3DX-F70017	TCGA-E2-A3DX	TCGA-E2-A3DX-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15969	142		0	1325					NO					2015-2-9	FEMALE								7.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	180	NO		Positive	NO	36	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	25		false	No	M0	N3	T2	Stage IIIC	TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf	A3DX	TUMOR FREE				Allred score = 8	Allred score = 7	YES	YES			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011	2424c058-78c6-41dd-86e9-efcd61b72add	cba10c3b-fd66-4fe2-8a2e-1f7066481c51	2424c058-78c6-41dd-86e9-efcd61b72add	cba10c3b-fd66-4fe2-8a2e-1f7066481c51	TCGA-E2-A3DX-01A-11-A24A-20			TCGA-E2-A3DX-01	TCGA-E2-A3DX-01A-21D-A212-05		8439f41b-dd33-46a5-bf4a-f10a23d65b36	TCGA-E2-A3DX-01	TCGA-E2-A3DX-01A-21D-A20S-09			TCGA-E2-A3DX-01			2424c058-78c6-41dd-86e9-efcd61b72add		TCGA-E2-A3DX-01A-21D-A20R-01	TCGA-E2-A3DX-01		2424c058-78c6-41dd-86e9-efcd61b72add	TCGA-E2-A3DX-01A-21D-A20R-01	
TCGA-E2-A56Z-01																													0	TCGA-E2-A56Z-01	252	0	days										TCGA-E2-A56Z	252	0	days	252	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-E2-A56Z-F67584	TCGA-E2-A56Z	TCGA-E2-A56Z-01A		Positive					Positive	Lumpectomy		NO			-25282	254		0	252						Allred 8 = 5+3	10-19%	2.2		2014-11-6	FEMALE			10-19%		2+	200	3.2	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf	A56Z	TUMOR FREE	Allred 5 = 2+3			Allred Score	Allred Score	YES	YES	<10%		YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2012	96af7552-6f51-4abe-8394-b9e966a70228	f6d13af1-9daf-4ede-92d7-986820f4e3cd	96af7552-6f51-4abe-8394-b9e966a70228	f6d13af1-9daf-4ede-92d7-986820f4e3cd				TCGA-E2-A56Z-01	TCGA-E2-A56Z-01A-12D-A29O-05		dc92e37a-e9dd-4055-acaf-bb63ec1d901b	TCGA-E2-A56Z-01	TCGA-E2-A56Z-01A-12D-A29N-09			TCGA-E2-A56Z-01			96af7552-6f51-4abe-8394-b9e966a70228		TCGA-E2-A56Z-01A-12D-A29M-01	TCGA-E2-A56Z-01		96af7552-6f51-4abe-8394-b9e966a70228	TCGA-E2-A56Z-01A-12D-A29M-01	
TCGA-E2-A570-01																													0	TCGA-E2-A570-01	931	0	days										TCGA-E2-A570	931	0	days	931	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-E2-A570-F61335	TCGA-E2-A570	TCGA-E2-A570-01A		Positive					Positive	Simple Mastectomy		NO			-17456	416		0	931						Allred 7 = 5+2		2.0		2014-6-27	FEMALE			10-19%		2+	200	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Equivocal	Negative	NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1		true	No	M0	N1mi	T1c	Stage IB	TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf	A570	TUMOR FREE	Allred 8 = 5+3			Allred Score	Allred Score	YES	YES			NO	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011	635a7c2c-7731-48c1-948d-4d7ecf05c472	b3068552-cd69-4e1f-942d-346a779fefcb	635a7c2c-7731-48c1-948d-4d7ecf05c472	b3068552-cd69-4e1f-942d-346a779fefcb				TCGA-E2-A570-01	TCGA-E2-A570-01A-11D-A29O-05			TCGA-E2-A570-01	TCGA-E2-A570-01A-11D-A29N-09			TCGA-E2-A570-01			635a7c2c-7731-48c1-948d-4d7ecf05c472		TCGA-E2-A570-01A-11D-A29M-01	TCGA-E2-A570-01		635a7c2c-7731-48c1-948d-4d7ecf05c472	TCGA-E2-A570-01A-11D-A29M-01	
TCGA-E2-A572-01																													0	TCGA-E2-A572-01	1208	0	days										TCGA-E2-A572	1208	0	days	1208	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left	Axillary lymph node dissection alone		TCGA-E2-A572-F65007	TCGA-E2-A572	TCGA-E2-A572-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-26399	560		0	1208										2014-9-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	8	true	Yes	M0	N2	T2	Stage IIIA	TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf	A572	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011	43a88718-f528-4d0b-88e6-f2ade6854c53	bdeb88bb-5ce8-4221-988e-1386605e693f	43a88718-f528-4d0b-88e6-f2ade6854c53	bdeb88bb-5ce8-4221-988e-1386605e693f				TCGA-E2-A572-01	TCGA-E2-A572-01A-13D-A31V-05		7b3b60fa-cd2e-4340-98f8-085f61b2148d					TCGA-E2-A572-01			43a88718-f528-4d0b-88e6-f2ade6854c53			TCGA-E2-A572-01		43a88718-f528-4d0b-88e6-f2ade6854c53		
TCGA-E2-A573-01																													0	TCGA-E2-A573-01	1062	0	days										TCGA-E2-A573	1062	0	days	1062	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A573-F61338	TCGA-E2-A573	TCGA-E2-A573-01A		Negative					Negative	Other		NO			-17689	595		0	1062						Allred 0 = 0+0		1.8		2014-6-27	FEMALE			10-19%		2+	200	2.3	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Equivocal	Negative	NO	4	Negative	Peri (6-12 months since last menstrual period)																													NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-E2-A573.14EB270E-0AAB-4C12-8D71-ED79076C2E93.pdf	A573	TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES	YES			YES	Primary Tumor	01	Partial Mastectomy	7th		NO	YES	E2	Breast	A	LIVING	2011	be17bc7b-550a-461b-9f7b-2a5845cc12b2	150d0521-0135-44b1-b5c5-635050b30973	be17bc7b-550a-461b-9f7b-2a5845cc12b2	150d0521-0135-44b1-b5c5-635050b30973				TCGA-E2-A573-01	TCGA-E2-A573-01A-11D-A29O-05			TCGA-E2-A573-01	TCGA-E2-A573-01A-11D-A29N-09			TCGA-E2-A573-01			be17bc7b-550a-461b-9f7b-2a5845cc12b2		TCGA-E2-A573-01A-11D-A29M-01	TCGA-E2-A573-01		be17bc7b-550a-461b-9f7b-2a5845cc12b2	TCGA-E2-A573-01A-11D-A29M-01	
TCGA-E2-A574-01																													0	TCGA-E2-A574-01	1179	0	days										TCGA-E2-A574	1179	0	days	1179	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left	Sentinel node biopsy alone		TCGA-E2-A574-F70296	TCGA-E2-A574	TCGA-E2-A574-01A		Negative					Negative	Lumpectomy		NO			-16195	429		0	1179						Allred 0 = 0+0		2.8		2015-2-9	FEMALE			10-19%		2+	200	2.8	1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf	A574	TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES	YES			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011	fec9b75b-9a91-4979-9056-ecdd852429d8	2df2ecf5-359b-4a32-a24f-e93f64828f7e	fec9b75b-9a91-4979-9056-ecdd852429d8	2df2ecf5-359b-4a32-a24f-e93f64828f7e				TCGA-E2-A574-01	TCGA-E2-A574-01A-11D-A29O-05		19a7926b-5288-4e60-b0a3-ebdb0ff58b1a	TCGA-E2-A574-01	TCGA-E2-A574-01A-11D-A29N-09			TCGA-E2-A574-01			fec9b75b-9a91-4979-9056-ecdd852429d8		TCGA-E2-A574-01A-11D-A29M-01	TCGA-E2-A574-01		fec9b75b-9a91-4979-9056-ecdd852429d8	TCGA-E2-A574-01A-11D-A29M-01	
TCGA-E2-A576-01																													0	TCGA-E2-A576-01	1043	0	days										TCGA-E2-A576	1043	0	days	1043	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-E2-A576-F67575	TCGA-E2-A576	TCGA-E2-A576-01A		Positive					Positive	Lumpectomy		YES			-25350	343		0	1043										2014-11-6	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Equivocal	Negative	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	MX	N0	T1c	Stage IA	TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf	A576	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2011	1323e58e-5e3f-459a-99ff-e7a6748d3d77	67328c5c-3165-45cc-b5ca-09eabe931a2c	1323e58e-5e3f-459a-99ff-e7a6748d3d77	67328c5c-3165-45cc-b5ca-09eabe931a2c				TCGA-E2-A576-01	TCGA-E2-A576-01A-11D-A31V-05			TCGA-E2-A576-01				TCGA-E2-A576-01			1323e58e-5e3f-459a-99ff-e7a6748d3d77		TCGA-E2-A576-01A-11D-A31T-01	TCGA-E2-A576-01		1323e58e-5e3f-459a-99ff-e7a6748d3d77	TCGA-E2-A576-01A-11D-A31T-01	
TCGA-E2-A9RU-01																													0	TCGA-E2-A9RU-01	538	0	days										TCGA-E2-A9RU	538	0	days	538	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E2-A9RU-F70313	TCGA-E2-A9RU	TCGA-E2-A9RU-01A		Positive					Negative	Lumpectomy		YES			-32873	188		0	538							70-79%			2015-2-9	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Equivocal	Negative	NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	12		true	No	MX	N3a	T2	Stage IIIC	TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf	A9RU	TUMOR FREE					Allred Score 6	YES	YES			YES	Primary Tumor	01		7th		NO	YES	E2	Breast	A	LIVING	2013	12037b1a-ef64-4ea7-99c8-703132eb2d1e	7f4d75ed-36ef-4cca-a38b-3f4b3f65fb75	12037b1a-ef64-4ea7-99c8-703132eb2d1e	7f4d75ed-36ef-4cca-a38b-3f4b3f65fb75				TCGA-E2-A9RU-01	TCGA-E2-A9RU-01A-11D-A41Q-05		5492E47A-045A-4CB8-A83D-D30F7E68CCF0	TCGA-E2-A9RU-01				TCGA-E2-A9RU-01			12037b1a-ef64-4ea7-99c8-703132eb2d1e		TCGA-E2-A9RU-01A-11D-A41E-01	TCGA-E2-A9RU-01		12037b1a-ef64-4ea7-99c8-703132eb2d1e	TCGA-E2-A9RU-01A-11D-A41E-01	
TCGA-E9-A1N3-01	Stage IIIA	70	1	Stage IIIA	0			FEMALE	Negative				Negative	M0	Positive	N2	0	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1N3-01	1059	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7		mutation c1uster 9	TCGA-E9-A1N3	1059	0	days	1059	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N3-F62627	TCGA-E9-A1N3	TCGA-E9-A1N3-01A								Modified Radical Mastectomy		NO			-25714	65		0	1059					NO				Scheduled Follow-up Submission	2014-7-22	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	230	NO			NO	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	7		true	No	M0	N2	T1c	Stage IIIA	TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf	A1N3	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	aaddb80d-7710-4aab-8efc-e84da79f9c68	80b0ec2b-db01-42de-a4c5-c699754d5053	aaddb80d-7710-4aab-8efc-e84da79f9c68	80b0ec2b-db01-42de-a4c5-c699754d5053	TCGA-E9-A1N3-01A-21-A17J-20	TCGA-E9-A1N3-01A-12D-A159-09		TCGA-E9-A1N3-01	TCGA-E9-A1N3-01A-12D-A161-05		167bccdb-afaa-49f7-b3af-6d5bd49e7422	TCGA-E9-A1N3-01	TCGA-E9-A1N3-01A-12D-A159-09			TCGA-E9-A1N3-01	TCGA-E9-A1N3-01A-12D-A159-09		aaddb80d-7710-4aab-8efc-e84da79f9c68		TCGA-E9-A1N3-01A-12D-A160-01	TCGA-E9-A1N3-01		aaddb80d-7710-4aab-8efc-e84da79f9c68	TCGA-E9-A1N3-01A-12D-A160-01	
TCGA-E9-A1N4-01	Stage IIIA	41	2	Stage IIIA	0		Positive	FEMALE	Negative				Negative	M0	Positive	N2	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N4-01	1000	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-E9-A1N4	1000	0	days	1000	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N4-F39767	TCGA-E9-A1N4	TCGA-E9-A1N4-01A		Positive					Positive			NO			-15055	65		0	1000					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	310	NO	Positive		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	7								NO	4	0	true	No	M0	N2	T2	Stage IIIA	TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf	A1N4	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	0ad8db08-453f-4b99-9bff-4c463648a8f6	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	0ad8db08-453f-4b99-9bff-4c463648a8f6	TCGA-E9-A1N4-01A-21-A17K-20	TCGA-E9-A1N4-01A-11D-A14K-09		TCGA-E9-A1N4-01	TCGA-E9-A1N4-01A-11D-A14N-05		e593a9f8-484a-4693-9d6c-75ddc09dea59	TCGA-E9-A1N4-01	TCGA-E9-A1N4-01A-11D-A14K-09			TCGA-E9-A1N4-01	TCGA-E9-A1N4-01A-11D-A14K-09		55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a		TCGA-E9-A1N4-01A-11D-A14J-01	TCGA-E9-A1N4-01		55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	TCGA-E9-A1N4-01A-11D-A14J-01	
TCGA-E9-A1N4-11		41			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N4-11	1000	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1N4	1000	0	days	1000	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N4-F39767	TCGA-E9-A1N4	TCGA-E9-A1N4-11A		Positive					Positive			NO			-15055	65		0	1000					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	340	NO	Positive		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	4	0	true	No	M0	N2	T2	Stage IIIA		A1N4	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	922b7051-1447-4e8d-9343-c5521ee45346		922b7051-1447-4e8d-9343-c5521ee45346						TCGA-E9-A1N4-11A-33D-A14N-05							TCGA-E9-A1N4-11			922b7051-1447-4e8d-9343-c5521ee45346			TCGA-E9-A1N4-11		922b7051-1447-4e8d-9343-c5521ee45346		
TCGA-E9-A1N5-01	Stage IIB	45	5	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N5-01	1120	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E9-A1N5	1120	0	days	1120	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N5-F39765	TCGA-E9-A1N5	TCGA-E9-A1N5-01A		Positive					Positive			NO			-16736	63		0	1120					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	190	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	2	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf	A1N5	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	1adf0e70-b1fb-4862-8a01-6454b09636f4	2dedc4aa-78bc-48c6-b280-c0b56e56beca	1adf0e70-b1fb-4862-8a01-6454b09636f4	2dedc4aa-78bc-48c6-b280-c0b56e56beca	TCGA-E9-A1N5-01A-21-A17J-20	TCGA-E9-A1N5-01A-11D-A14G-09		TCGA-E9-A1N5-01	TCGA-E9-A1N5-01A-11D-A14H-05		1efeb02c-7e68-449e-9f4f-8b8f985ab01e	TCGA-E9-A1N5-01	TCGA-E9-A1N5-01A-11D-A14G-09			TCGA-E9-A1N5-01	TCGA-E9-A1N5-01A-11D-A14G-09		1adf0e70-b1fb-4862-8a01-6454b09636f4		TCGA-E9-A1N5-01A-11D-A14F-01	TCGA-E9-A1N5-01		1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-11D-A14F-01	
TCGA-E9-A1N5-11		45			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N5-11	1120	0	days		C3-BRCA/Luminal							mutation cluster 3	TCGA-E9-A1N5	1120	0	days	1120	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N5-F39765	TCGA-E9-A1N5	TCGA-E9-A1N5-11A		Positive					Positive			NO			-16736	63		0	1120					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection		NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2	0	true	No	M0	N1	T2	Stage IIB		A1N5	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7		8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7						TCGA-E9-A1N5-11A-41D-A14H-05		0D7A5303-6F45-4910-8BC5-F08E8FC11463					TCGA-E9-A1N5-11			8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7			TCGA-E9-A1N5-11		8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7		
TCGA-E9-A1N6-01	Stage IIB	52	5	Stage IIB	0		Positive	FEMALE	Positive				Negative	M0	Positive	N1	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1N6-01	678	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9	cluster 4		TCGA-E9-A1N6	443	1	days	678	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			52	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N6-F63536	TCGA-E9-A1N6	TCGA-E9-A1N6-01A		Positive					Positive			NO			-19327	63	678	0	410			443		NO				Scheduled Follow-up Submission	2014-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	220	NO	Positive		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4				Bone	Distant Metastasis		NO	YES	2	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf	A1N6	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2010	05b5084f-5e4f-43a3-9819-456a4f24ad82	e52f1f1f-dfed-49b5-a7f2-f81e0af3c810	05b5084f-5e4f-43a3-9819-456a4f24ad82	e52f1f1f-dfed-49b5-a7f2-f81e0af3c810	TCGA-E9-A1N6-01A-21-A17K-20			TCGA-E9-A1N6-01	TCGA-E9-A1N6-01A-11D-A145-05		4a7c1f26-54e8-40e4-a966-b01498c98782	TCGA-E9-A1N6-01				TCGA-E9-A1N6-01			05b5084f-5e4f-43a3-9819-456a4f24ad82		TCGA-E9-A1N6-01A-11D-A141-01	TCGA-E9-A1N6-01		05b5084f-5e4f-43a3-9819-456a4f24ad82	TCGA-E9-A1N6-01A-11D-A141-01	
TCGA-E9-A1N6-11		52			0			FEMALE									0	0	Normal						enrollment			LIVING	1	TCGA-E9-A1N6-11	678	1	days		C3-BRCA/Luminal								TCGA-E9-A1N6	443	1	days	678	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			52	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N6-F63536	TCGA-E9-A1N6	TCGA-E9-A1N6-11A		Positive					Positive			NO			-19327	63	678	0	410			443		NO				Scheduled Follow-up Submission	2014-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	670	NO	Positive		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Distant Metastasis		NO	YES	2	0	true	No	M0	N1	T2	Stage IIB		A1N6	WITH TUMOR						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2010	0f263a65-a664-4e23-bd9c-91e955f3bf21		0f263a65-a664-4e23-bd9c-91e955f3bf21						TCGA-E9-A1N6-11A-32D-A145-05		F251633F-A6B6-4238-93A8-6C32EFCA1607					TCGA-E9-A1N6-11			0f263a65-a664-4e23-bd9c-91e955f3bf21			TCGA-E9-A1N6-11		0f263a65-a664-4e23-bd9c-91e955f3bf21		
TCGA-E9-A1N8-01	Stage IIA	48	1	Stage IIA	0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	0	0	Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N8-01	1039	0	days	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N8	1039	0	days	1039	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N8-F53518	TCGA-E9-A1N8	TCGA-E9-A1N8-01A		Negative								NO			-17652	66		0	1039					NO				Scheduled Follow-up Submission	2013-12-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	680	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf	A1N8	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	7d6b6a17-5f1e-4586-9316-195c0e96925c	0179d350-8a90-4269-8eee-a0b971d23cb8	7d6b6a17-5f1e-4586-9316-195c0e96925c	0179d350-8a90-4269-8eee-a0b971d23cb8	TCGA-E9-A1N8-01A-21-A17K-20	TCGA-E9-A1N8-01A-11D-A142-09		TCGA-E9-A1N8-01	TCGA-E9-A1N8-01A-11D-A145-05		8ea109e3-1e03-468c-b117-43cbd5c7571d	TCGA-E9-A1N8-01	TCGA-E9-A1N8-01A-11D-A142-09			TCGA-E9-A1N8-01	TCGA-E9-A1N8-01A-11D-A142-09		7d6b6a17-5f1e-4586-9316-195c0e96925c		TCGA-E9-A1N8-01A-11D-A141-01	TCGA-E9-A1N8-01		7d6b6a17-5f1e-4586-9316-195c0e96925c	TCGA-E9-A1N8-01A-11D-A141-01	
TCGA-E9-A1N8-11		48			0			FEMALE									0	0							enrollment			LIVING	0	TCGA-E9-A1N8-11	1039	0	days		C4-BRCA/Basal							mutation cluster 5	TCGA-E9-A1N8	1039	0	days	1039	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N8-F53518	TCGA-E9-A1N8	TCGA-E9-A1N8-11A		Negative								NO			-17652	66		0	1039					NO				Scheduled Follow-up Submission	2013-12-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	510	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA		A1N8	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2010									TCGA-E9-A1N8-11A-42D-A145-05		EFBC87A0-993F-4C1E-9D9A-32C76BCCC13A															
TCGA-E9-A1N9-01	Stage IIA	58	4	Stage IIA	0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	0	0	Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N9-01	1101	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N9	1101	0	days	1101	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N9-F58373	TCGA-E9-A1N9	TCGA-E9-A1N9-01A		Negative					Positive			YES			-21228	44		0	1101					NO				Scheduled Follow-up Submission	2014-4-8	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	230	NO	Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	5								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1N9.39D6D1DE-2CAE-470F-836B-926242F46E67.pdf	A1N9	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	cdada0b1-f90d-40bc-9257-6377987b7baa	5ae97b02-7893-4ef8-83aa-585b87983f37	cdada0b1-f90d-40bc-9257-6377987b7baa	5ae97b02-7893-4ef8-83aa-585b87983f37	TCGA-E9-A1N9-01A-21-A17K-20	TCGA-E9-A1N9-01A-11D-A14G-09		TCGA-E9-A1N9-01	TCGA-E9-A1N9-01A-11D-A14H-05		f211c550-de9f-47f6-a1c2-546f560ac335	TCGA-E9-A1N9-01	TCGA-E9-A1N9-01A-11D-A14G-09			TCGA-E9-A1N9-01	TCGA-E9-A1N9-01A-11D-A14G-09		cdada0b1-f90d-40bc-9257-6377987b7baa		TCGA-E9-A1N9-01A-11D-A14F-01	TCGA-E9-A1N9-01		cdada0b1-f90d-40bc-9257-6377987b7baa	TCGA-E9-A1N9-01A-11D-A14F-01	
TCGA-E9-A1N9-11		58			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1N9-11	1101	0	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-E9-A1N9	1101	0	days	1101	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1N9-F58373	TCGA-E9-A1N9	TCGA-E9-A1N9-11A		Negative					Positive			YES			-21228	44		0	1101					NO				Scheduled Follow-up Submission	2014-4-8	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1190	NO	Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA		A1N9	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	f6e8424b-338c-4f9a-bdc7-f7d8de0c5634		f6e8424b-338c-4f9a-bdc7-f7d8de0c5634								39636744-785B-4D93-8EE5-40D075AEAB71					TCGA-E9-A1N9-11			f6e8424b-338c-4f9a-bdc7-f7d8de0c5634			TCGA-E9-A1N9-11		f6e8424b-338c-4f9a-bdc7-f7d8de0c5634		
TCGA-E9-A1NA-01	Stage IIA	58	5	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NA-01	1112	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E9-A1NA	1112	0	days	1112	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1-F39782	TCGA-E9-A1	TCGA-E9-A1-01A		Positive					Positive			YES			-21397	42		0	1112					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	110	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf	A1	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	7edc6614-6c8b-43ec-87dd-7720961bd174	06885aa5-33ae-4eab-ae31-f5f9c9b16480	7edc6614-6c8b-43ec-87dd-7720961bd174	06885aa5-33ae-4eab-ae31-f5f9c9b16480	TCGA-E9-A1NA-01A-21-A17K-20	TCGA-E9-A1NA-01A-11D-A142-09		TCGA-E9-A1NA-01	TCGA-E9-A1NA-01A-11D-A145-05		693f43fc-0cb7-44e8-90c4-7c1bc12d7da6	TCGA-E9-A1NA-01	TCGA-E9-A1NA-01A-11D-A142-09			TCGA-E9-A1NA-01	TCGA-E9-A1NA-01A-11D-A142-09		7edc6614-6c8b-43ec-87dd-7720961bd174		TCGA-E9-A1NA-01A-11D-A141-01	TCGA-E9-A1NA-01		7edc6614-6c8b-43ec-87dd-7720961bd174	TCGA-E9-A1NA-01A-11D-A141-01	
TCGA-E9-A1NA-11		58			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1NA-11	1112	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1NA	1112	0	days	1112	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1-F39782	TCGA-E9-A1	TCGA-E9-A1-11A		Positive					Positive			YES			-21397	42		0	1112					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	330	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA		A1	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	7b9569bc-f513-4b64-9a7c-7bb53b9be79b		7b9569bc-f513-4b64-9a7c-7bb53b9be79b						TCGA-E9-A1NA-11A-33D-A145-05							TCGA-E9-A1NA-11			7b9569bc-f513-4b64-9a7c-7bb53b9be79b			TCGA-E9-A1NA-11		7b9569bc-f513-4b64-9a7c-7bb53b9be79b		
TCGA-E9-A1NC-01	Stage IIB	61	1	Stage IIB	0		Negative	FEMALE	Negative				Negative	M0	Positive	N1	0	0			Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NC-01	1203	0	days	Squamous		cluster 5	Low purity c2			miRNA cluster 13		mutation c1uster 9	TCGA-E9-A1NC	1203	0	days	1203	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NC-F40639	TCGA-E9-A1NC	TCGA-E9-A1NC-01A		Negative					Positive			YES			-22355	38		0	1203					NO				Scheduled Follow-up Submission	2013-2-26	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	200	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	1	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1NC.AA1B707B-4DE8-4E0D-87CA-601760F4A6CF.pdf	A1NC	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	7145e63d-79f8-4a72-8571-9065d51c8f8e	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	7145e63d-79f8-4a72-8571-9065d51c8f8e		TCGA-E9-A1NC-01A-12W-A16L-09		TCGA-E9-A1NC-01	TCGA-E9-A1NC-01A-12D-A161-05			TCGA-E9-A1NC-01	TCGA-E9-A1NC-01A-12W-A16L-09				TCGA-E9-A1NC-01A-12W-A16L-09		50f23d00-f6fd-4b3d-aed2-0705f7ae6a17		TCGA-E9-A1NC-01A-12D-A160-01			50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	TCGA-E9-A1NC-01A-12D-A160-01	
TCGA-E9-A1ND-01	Stage IIB	75	1	Stage IIB	0		Negative	FEMALE	Negative				Negative	M0	Positive	N1	0	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1ND-01	1266	0	days	Squamous	C4-BRCA/Basal	cluster 5	Cluster 5	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-E9-A1ND	1266	0	days	1266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1ND-F62586	TCGA-E9-A1ND	TCGA-E9-A1ND-01A		Negative					Negative			YES			-27400	37		0	1266					NO				Scheduled Follow-up Submission	2014-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	420	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	1	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf	A1ND	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	526da11e-9125-4fcd-98d7-02994c9783d1	20428d6b-edda-4596-af5d-2ae057ba9bbd	526da11e-9125-4fcd-98d7-02994c9783d1	20428d6b-edda-4596-af5d-2ae057ba9bbd	TCGA-E9-A1ND-01A-21-A17J-20	TCGA-E9-A1ND-01A-11D-A142-09		TCGA-E9-A1ND-01	TCGA-E9-A1ND-01A-11D-A145-05		c323e6ab-8ba2-4347-a5d0-931a5d9754a1	TCGA-E9-A1ND-01	TCGA-E9-A1ND-01A-11D-A142-09			TCGA-E9-A1ND-01	TCGA-E9-A1ND-01A-11D-A142-09		526da11e-9125-4fcd-98d7-02994c9783d1		TCGA-E9-A1ND-01A-11D-A141-01	TCGA-E9-A1ND-01		526da11e-9125-4fcd-98d7-02994c9783d1	TCGA-E9-A1ND-01A-11D-A141-01	
TCGA-E9-A1ND-11		75			0			FEMALE									0	0	Normal						enrollment			LIVING	0	TCGA-E9-A1ND-11	1266	0	days		C4-BRCA/Basal							mutation cluster 2	TCGA-E9-A1ND	1266	0	days	1266	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1ND-F62586	TCGA-E9-A1ND	TCGA-E9-A1ND-11A		Negative					Negative			YES			-27400	37		0	1266					NO				Scheduled Follow-up Submission	2014-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	1070	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	0	true	No	M0	N1	T2	Stage IIB		A1ND	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	ef84a69f-37bc-46fa-98ac-b3976212e11d		ef84a69f-37bc-46fa-98ac-b3976212e11d						TCGA-E9-A1ND-11A-43D-A145-05		1DFA3ABA-51BC-48FA-B854-39ED4F94E701					TCGA-E9-A1ND-11			ef84a69f-37bc-46fa-98ac-b3976212e11d			TCGA-E9-A1ND-11		ef84a69f-37bc-46fa-98ac-b3976212e11d		
TCGA-E9-A1NE-01	Stage IIB	28	1	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NE-01	1088	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-E9-A1NE	1088	0	days	1088	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					28	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NE-F39781	TCGA-E9-A1NE	TCGA-E9-A1NE-01A		Positive					Positive			YES			-10564	31		0	1088					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Tumor resection	280	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	6								NO	1	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf	A1NE	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	f7aa01e5-56c8-4c23-94f5-c028f5b8057c	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	f7aa01e5-56c8-4c23-94f5-c028f5b8057c	TCGA-E9-A1NE-01A-11-A17K-20	TCGA-E9-A1NE-01A-21D-A14K-09		TCGA-E9-A1NE-01	TCGA-E9-A1NE-01A-21D-A14N-05		8eb2885b-f9c7-4fcc-a9fe-a7673af9a3ec	TCGA-E9-A1NE-01	TCGA-E9-A1NE-01A-21D-A14K-09			TCGA-E9-A1NE-01	TCGA-E9-A1NE-01A-21D-A14K-09		92691eb7-5df9-4da9-8bd0-c4f4de528bdc		TCGA-E9-A1NE-01A-21D-A14J-01	TCGA-E9-A1NE-01		92691eb7-5df9-4da9-8bd0-c4f4de528bdc	TCGA-E9-A1NE-01A-21D-A14J-01	
TCGA-E9-A1NE-11		28			0			FEMALE									0	0							enrollment			LIVING	0	TCGA-E9-A1NE-11	1088	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1NE	1088	0	days	1088	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					28	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NE-F39781	TCGA-E9-A1NE	TCGA-E9-A1NE-11A		Positive					Positive			YES			-10564	31		0	1088					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Tumor resection	830	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1	0	true	No	M0	N1	T2	Stage IIB		A1NE	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011									TCGA-E9-A1NE-11A-43D-A14N-05		233FE7AC-4003-4A6C-80A1-101B561B6842															
TCGA-E9-A1NF-01	Stage IIA	60	5	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1NF-01	1072	1	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-E9-A1NF	1072	0	days	1072	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES		NO		60	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NF-F39778	TCGA-E9-A1NF	TCGA-E9-A1NF-01A		Positive					Positive			YES			-21981	31	1072	0	610			90		NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	240	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4				Lung	Distant Metastasis			NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf	A1NF	WITH TUMOR						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	69e0026c-c87c-4987-8e46-f94d21f6bfb6	2c3d8b4c-f188-43e2-8b4b-246ad2e392a2	69e0026c-c87c-4987-8e46-f94d21f6bfb6	2c3d8b4c-f188-43e2-8b4b-246ad2e392a2	TCGA-E9-A1NF-01A-21-A17K-20	TCGA-E9-A1NF-01A-11D-A14G-09		TCGA-E9-A1NF-01	TCGA-E9-A1NF-01A-11D-A14H-05		710e4246-7a43-4a0a-b6e2-0dddc3420c59	TCGA-E9-A1NF-01	TCGA-E9-A1NF-01A-11D-A14G-09			TCGA-E9-A1NF-01	TCGA-E9-A1NF-01A-11D-A14G-09		69e0026c-c87c-4987-8e46-f94d21f6bfb6		TCGA-E9-A1NF-01A-11D-A14F-01	TCGA-E9-A1NF-01		69e0026c-c87c-4987-8e46-f94d21f6bfb6	TCGA-E9-A1NF-01A-11D-A14F-01	
TCGA-E9-A1NF-11		60			0			FEMALE									0	0	LumA						enrollment			LIVING	1	TCGA-E9-A1NF-11	1072	1	days		C3-BRCA/Luminal							mutation cluster 13	TCGA-E9-A1NF	1072	0	days	1072	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES		NO		60	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NF-F39778	TCGA-E9-A1NF	TCGA-E9-A1NF-11A		Positive					Positive			YES			-21981	31	1072	0	610			90		NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1520	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Lung	Distant Metastasis			NO	0	0	true	No	M0	N0	T2	Stage IIA		A1NF	WITH TUMOR						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	39f6a4d4-650f-4caf-a778-4a24af4f11ba		39f6a4d4-650f-4caf-a778-4a24af4f11ba						TCGA-E9-A1NF-11A-73D-A14H-05		DF5927EA-DE81-492A-B1AD-03A0E533A338								39f6a4d4-650f-4caf-a778-4a24af4f11ba					39f6a4d4-650f-4caf-a778-4a24af4f11ba		
TCGA-E9-A1NG-01	Stage IIA	62	1	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1NG-01	786	1	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 1	TCGA-E9-A1NG	786	0	days	786	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NG-F39774	TCGA-E9-A1NG	TCGA-E9-A1NG-01A		Positive					Positive			YES			-22896	30	786	0	656					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	380	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf	A1NG	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	e4df045b-7b42-4c67-8671-cab204450719	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	e4df045b-7b42-4c67-8671-cab204450719	TCGA-E9-A1NG-01A-11-A17K-20	TCGA-E9-A1NG-01A-21D-A14K-09		TCGA-E9-A1NG-01	TCGA-E9-A1NG-01A-21D-A14N-05		38b632fe-cdcb-4b5d-9687-86977604c842	TCGA-E9-A1NG-01	TCGA-E9-A1NG-01A-21D-A14K-09			TCGA-E9-A1NG-01	TCGA-E9-A1NG-01A-21D-A14K-09		91918c5e-3c5c-4674-9a7f-1e93d9cf9949		TCGA-E9-A1NG-01A-21D-A14J-01	TCGA-E9-A1NG-01		91918c5e-3c5c-4674-9a7f-1e93d9cf9949	TCGA-E9-A1NG-01A-21D-A14J-01	
TCGA-E9-A1NG-11		62			0			FEMALE									0	0	Normal						enrollment			LIVING	1	TCGA-E9-A1NG-11	786	1	days		C3-BRCA/Luminal							mutation cluster 1	TCGA-E9-A1NG	786	0	days	786	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NG-F39774	TCGA-E9-A1NG	TCGA-E9-A1NG-11A		Positive					Positive			YES			-22896	30	786	0	656					NO				Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA		A1NG	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	a4172e12-2a82-436e-8cb9-a532dc0e9ec4		a4172e12-2a82-436e-8cb9-a532dc0e9ec4						TCGA-E9-A1NG-11A-52D-A14N-05		89FE3D24-088B-4F16-82A2-534DB14FF98D					TCGA-E9-A1NG-11			a4172e12-2a82-436e-8cb9-a532dc0e9ec4			TCGA-E9-A1NG-11		a4172e12-2a82-436e-8cb9-a532dc0e9ec4		
TCGA-E9-A1NH-01	Stage IIB	71	2	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NH-01	576	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-E9-A1NH	576	0	days	576	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NH-F35049	TCGA-E9-A1NH	TCGA-E9-A1NH-01A		Positive					Positive	Modified Radical Mastectomy		YES			-26221	30		0	576					NO					2012-9-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	3	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf	A1NH	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	a01c0857-1760-45dc-b426-082a9b59fe90	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	a01c0857-1760-45dc-b426-082a9b59fe90	TCGA-E9-A1NH-01A-21-A17K-20	TCGA-E9-A1NH-01A-11D-A14G-09		TCGA-E9-A1NH-01	TCGA-E9-A1NH-01A-11D-A14H-05		14a33bcb-ec41-48da-9c49-cfbcc3fab7de	TCGA-E9-A1NH-01	TCGA-E9-A1NH-01A-11D-A14G-09			TCGA-E9-A1NH-01	TCGA-E9-A1NH-01A-11D-A14G-09		0eb9c5a5-1e4e-4808-882e-858b4d0ed396		TCGA-E9-A1NH-01A-11D-A14F-01	TCGA-E9-A1NH-01		0eb9c5a5-1e4e-4808-882e-858b4d0ed396	TCGA-E9-A1NH-01A-11D-A14F-01	
TCGA-E9-A1NH-11		71			0			FEMALE									0	0							enrollment			LIVING	0	TCGA-E9-A1NH-11	576	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1NH	576	0	days	576	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NH-F35049	TCGA-E9-A1NH	TCGA-E9-A1NH-11A		Positive					Positive	Modified Radical Mastectomy		YES			-26221	30		0	576					NO					2012-9-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	730	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3	0	true	No	M0	N1	T2	Stage IIB		A1NH	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th		YES	NO	E9	Breast	A	LIVING	2011											A6417AA5-7E20-4D27-AFCC-306B837B095F															
TCGA-E9-A1NI-01	Stage IIA	51	2	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NI-01	300	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1NI	300	0	days	300	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1NI-F52056	TCGA-E9-A1NI	TCGA-E9-A1NI-01A		Positive					Positive			YES			-18985	21		0	300					NO				Scheduled Follow-up Submission	2013-11-27	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	280	NO	Negative		YES	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf	A1NI	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	07ac0536-240f-46be-9909-a8af1a22e2b8	f532e691-9f2f-4535-b6ab-00ff42e14176	07ac0536-240f-46be-9909-a8af1a22e2b8	f532e691-9f2f-4535-b6ab-00ff42e14176	TCGA-E9-A1NI-01A-21-A17K-20	TCGA-E9-A1NI-01A-11W-A16H-09		TCGA-E9-A1NI-01	TCGA-E9-A1NI-01A-11D-A14H-05		e1eda531-b715-4139-9c80-c91ffc100fc2	TCGA-E9-A1NI-01	TCGA-E9-A1NI-01A-11W-A16H-09			TCGA-E9-A1NI-01	TCGA-E9-A1NI-01A-11W-A16H-09		07ac0536-240f-46be-9909-a8af1a22e2b8		TCGA-E9-A1NI-01A-11D-A14F-01	TCGA-E9-A1NI-01		07ac0536-240f-46be-9909-a8af1a22e2b8	TCGA-E9-A1NI-01A-11D-A14F-01	
TCGA-E9-A1QZ-01	Stage IIA	61	3	Stage IIA	0			FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1QZ-01	755	0	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation c1uster 9	TCGA-E9-A1QZ	755	0	days	755	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1QZ-F66270	TCGA-E9-A1QZ	TCGA-E9-A1QZ-01A													-22397	58		0	755					NO				Scheduled Follow-up Submission	2014-10-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	590	NO			NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1									NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf	A1QZ	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th	NO	YES	NO	E9	Breast	A	LIVING	2011	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	6ff0d34a-027a-46be-a93f-ba6ed2686157	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	6ff0d34a-027a-46be-a93f-ba6ed2686157	TCGA-E9-A1QZ-01A-41-A17J-20	TCGA-E9-A1QZ-01A-21D-A167-09		TCGA-E9-A1QZ-01	TCGA-E9-A1QZ-01A-21D-A16A-05		0794c219-5e82-4c62-9e40-091a0c71c6b4	TCGA-E9-A1QZ-01	TCGA-E9-A1QZ-01A-21D-A167-09			TCGA-E9-A1QZ-01	TCGA-E9-A1QZ-01A-21D-A167-09		64897f59-3a93-4ac3-82d5-66e9f4dc7ac6		TCGA-E9-A1QZ-01A-21D-A166-01	TCGA-E9-A1QZ-01		64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	TCGA-E9-A1QZ-01A-21D-A166-01	
TCGA-E9-A1R0-01	Stage IIA	58	2	Stage IIA	0			FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R0-01	860	0	days	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5		mutation cluster 4	TCGA-E9-A1R0	860	0	days	860	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R0-F41214	TCGA-E9-A1R0	TCGA-E9-A1R0-01A													-21394	44		0	860					NO				Scheduled Follow-up Submission	2013-3-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO			NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	1		true	No	M0	N1	T1c	Stage IIA	TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf	A1R0	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	ef16eca9-6bfa-4db1-860a-adccb484d2b3	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	ef16eca9-6bfa-4db1-860a-adccb484d2b3	TCGA-E9-A1R0-01A-11-A17J-20	TCGA-E9-A1R0-01A-22D-A16D-09		TCGA-E9-A1R0-01	TCGA-E9-A1R0-01A-22D-A16G-05		79bdc020-426c-41df-8b45-be0425815405	TCGA-E9-A1R0-01	TCGA-E9-A1R0-01A-22D-A16D-09			TCGA-E9-A1R0-01	TCGA-E9-A1R0-01A-22D-A16D-09		4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3		TCGA-E9-A1R0-01A-22D-A16C-01	TCGA-E9-A1R0-01		4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	TCGA-E9-A1R0-01A-22D-A16C-01	
TCGA-E9-A1R2-01	Stage IIIC	51	5	Stage IIIC	19		Positive	FEMALE	Negative				Negative	M0	Positive	N3	19	0	LumA		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R2-01	1063	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-E9-A1R2	1063	0	days	1063	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R2-F57941	TCGA-E9-A1R2	TCGA-E9-A1R2-01A		Positive					Negative	Lumpectomy		NO			-18936	64		0	1063					NO		90-99%	74	Scheduled Follow-up Submission	2014-3-31	FEMALE			90-99%				114			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	160	NO	Equivocal	Negative	YES	19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	17		true	No	MX	N3	T2	Stage IIIC	TCGA-E9-A1R2.5B9C0E4A-3958-4ECF-B8B2-E758E04E7722.pdf	A1R2	TUMOR FREE				Two-tier	Two-tier		YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	e24bfd9d-87b2-44a7-bddc-7b7f60461252	2e6cebd3-ce33-4553-a190-ac2dd9bcf91a	e24bfd9d-87b2-44a7-bddc-7b7f60461252	2e6cebd3-ce33-4553-a190-ac2dd9bcf91a	TCGA-E9-A1R2-01A-21-A17J-20	TCGA-E9-A1R2-01A-11D-A14G-09		TCGA-E9-A1R2-01	TCGA-E9-A1R2-01A-11D-A14H-05		e2a04b43-75e6-4ede-8536-d3cfe5eb9113	TCGA-E9-A1R2-01	TCGA-E9-A1R2-01A-11D-A14G-09			TCGA-E9-A1R2-01	TCGA-E9-A1R2-01A-11D-A14G-09		e24bfd9d-87b2-44a7-bddc-7b7f60461252		TCGA-E9-A1R2-01A-11D-A14F-01	TCGA-E9-A1R2-01		e24bfd9d-87b2-44a7-bddc-7b7f60461252	TCGA-E9-A1R2-01A-11D-A14F-01	
TCGA-E9-A1R3-01	Stage IIIC	70	2	Stage IIIC	64			FEMALE	Negative				Negative	M0	Positive	N3	64	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R3-01	78	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1R3	78	0	days	78	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R3-F48697	TCGA-E9-A1R3	TCGA-E9-A1R3-01A								Modified Radical Mastectomy		NO			-25693	80		0	78					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	10		true	No	M0	N3	T2	Stage IIIC	TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf	A1R3	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	678ba111-3b01-49b7-83d9-165ef0288a34	b48037f7-5060-4cd6-b8b1-07d77bd8c858	678ba111-3b01-49b7-83d9-165ef0288a34	b48037f7-5060-4cd6-b8b1-07d77bd8c858	TCGA-E9-A1R3-01A-41-A17J-20	TCGA-E9-A1R3-01A-31D-A14K-09		TCGA-E9-A1R3-01	TCGA-E9-A1R3-01A-31D-A14N-05		fa7047e6-5a4e-4979-a1ee-ecac9434f163	TCGA-E9-A1R3-01	TCGA-E9-A1R3-01A-31D-A14K-09			TCGA-E9-A1R3-01	TCGA-E9-A1R3-01A-31D-A14K-09		678ba111-3b01-49b7-83d9-165ef0288a34		TCGA-E9-A1R3-01A-31D-A14J-01	TCGA-E9-A1R3-01		678ba111-3b01-49b7-83d9-165ef0288a34	TCGA-E9-A1R3-01A-31D-A14J-01	
TCGA-E9-A1R4-01	Stage IA	66	1	Stage I	29			FEMALE	Negative				Negative	M0	Negative	N0	29	0	LumB						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R4-01	186	0	days	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 4	mutation cluster 4	TCGA-E9-A1R4	186	0	days	186	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R4-F48699	TCGA-E9-A1R4	TCGA-E9-A1R4-01A										NO			-24181	45		0	186					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	430	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf	A1R4	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	11353ea3-2ff0-4658-b528-6aa922dbb665	fcd41d63-c0f1-4f8e-ad1f-ea398203a3a4	11353ea3-2ff0-4658-b528-6aa922dbb665	fcd41d63-c0f1-4f8e-ad1f-ea398203a3a4	TCGA-E9-A1R4-01A-11-A17J-20	TCGA-E9-A1R4-01A-21D-A14G-09		TCGA-E9-A1R4-01	TCGA-E9-A1R4-01A-21D-A14H-05		146230f2-2e64-46d7-84da-719567028426	TCGA-E9-A1R4-01	TCGA-E9-A1R4-01A-21D-A14G-09			TCGA-E9-A1R4-01	TCGA-E9-A1R4-01A-21D-A14G-09		11353ea3-2ff0-4658-b528-6aa922dbb665		TCGA-E9-A1R4-01A-21D-A14F-01	TCGA-E9-A1R4-01		11353ea3-2ff0-4658-b528-6aa922dbb665	TCGA-E9-A1R4-01A-21D-A14F-01	
TCGA-E9-A1R5-01	Stage IA	63	2	Stage I	42			FEMALE	Negative				Negative	M0	Negative	N0	42	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R5-01	92	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1R5	92	0	days	92	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R5-F48700	TCGA-E9-A1R5	TCGA-E9-A1R5-01A								Lumpectomy		NO			-23116	58		0	92					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	370	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf	A1R5	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	7b06a333-ba77-41dd-bfd1-4824fe43d06f	07e28d9a-a162-4def-b3db-1ad0ce9827f3	7b06a333-ba77-41dd-bfd1-4824fe43d06f	07e28d9a-a162-4def-b3db-1ad0ce9827f3	TCGA-E9-A1R5-01A-21-A17J-20	TCGA-E9-A1R5-01A-11D-A14K-09		TCGA-E9-A1R5-01	TCGA-E9-A1R5-01A-11D-A14N-05		95daa854-64b7-48d2-a82b-bacbfea25944	TCGA-E9-A1R5-01	TCGA-E9-A1R5-01A-11D-A14K-09			TCGA-E9-A1R5-01	TCGA-E9-A1R5-01A-11D-A14K-09		7b06a333-ba77-41dd-bfd1-4824fe43d06f		TCGA-E9-A1R5-01A-11D-A14J-01	TCGA-E9-A1R5-01		7b06a333-ba77-41dd-bfd1-4824fe43d06f	TCGA-E9-A1R5-01A-11D-A14J-01	
TCGA-E9-A1R6-01	Stage IIA	63	4	Stage IIA	84			FEMALE	Negative				Negative	M0	Negative	N0	84	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R6-01	339	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E9-A1R6	339	0	days	339	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R6-F39520	TCGA-E9-A1R6	TCGA-E9-A1R6-01A								Lumpectomy		NO			-23347	100		0	339					NO				Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	730	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	2								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf	A1R6	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2010	2b022043-a976-40a7-929e-664b9549c411	c6e7c59d-708f-497e-b6e6-ed91ba294943	2b022043-a976-40a7-929e-664b9549c411	c6e7c59d-708f-497e-b6e6-ed91ba294943	TCGA-E9-A1R6-01A-21-A17J-20	TCGA-E9-A1R6-01A-11D-A14G-09		TCGA-E9-A1R6-01	TCGA-E9-A1R6-01A-11D-A14H-05		e3b3d877-30e8-48f5-bc12-87618c1dbb34	TCGA-E9-A1R6-01	TCGA-E9-A1R6-01A-11D-A14G-09			TCGA-E9-A1R6-01	TCGA-E9-A1R6-01A-11D-A14G-09		2b022043-a976-40a7-929e-664b9549c411		TCGA-E9-A1R6-01A-11D-A14F-01	TCGA-E9-A1R6-01		2b022043-a976-40a7-929e-664b9549c411	TCGA-E9-A1R6-01A-11D-A14F-01	
TCGA-E9-A1R7-01	Stage IIA	64	5	Stage IIA	34			FEMALE	Negative				Negative	M0	Negative	N0	34	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R7-01	1467	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E9-A1R7	1467	0	days	1467	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R7-F71424	TCGA-E9-A1R7	TCGA-E9-A1R7-01A								Lumpectomy		NO			-23397	51		0	1467					NO				Scheduled Follow-up Submission	2015-3-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	400	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	1								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf	A1R7	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	5ac273e2-3a3f-48a6-8782-956587bab667	23c38a57-6a93-4845-8c80-53d2fb835d37	5ac273e2-3a3f-48a6-8782-956587bab667	23c38a57-6a93-4845-8c80-53d2fb835d37	TCGA-E9-A1R7-01A-21-A17J-20	TCGA-E9-A1R7-01A-11D-A14K-09		TCGA-E9-A1R7-01	TCGA-E9-A1R7-01A-11D-A14N-05		95f3d6af-2e61-4df8-b5bd-ce495b3b8b69	TCGA-E9-A1R7-01	TCGA-E9-A1R7-01A-11D-A14K-09			TCGA-E9-A1R7-01	TCGA-E9-A1R7-01A-11D-A14K-09		5ac273e2-3a3f-48a6-8782-956587bab667		TCGA-E9-A1R7-01A-11D-A14J-01	TCGA-E9-A1R7-01		5ac273e2-3a3f-48a6-8782-956587bab667	TCGA-E9-A1R7-01A-11D-A14J-01	
TCGA-E9-A1R7-11		64			34			FEMALE									34	0	Normal						enrollment			LIVING	0	TCGA-E9-A1R7-11	1467	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1R7	1467	0	days	1467	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1R7-F71424	TCGA-E9-A1R7	TCGA-E9-A1R7-11A								Lumpectomy		NO			-23397	51		0	1467					NO				Scheduled Follow-up Submission	2015-3-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	440	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA		A1R7	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	1457ae2c-4b9b-448a-b455-432a7121beb4		1457ae2c-4b9b-448a-b455-432a7121beb4						TCGA-E9-A1R7-11A-42D-A14N-05							TCGA-E9-A1R7-11			1457ae2c-4b9b-448a-b455-432a7121beb4			TCGA-E9-A1R7-11		1457ae2c-4b9b-448a-b455-432a7121beb4		
TCGA-E9-A1RA-01	Stage IA	48	3	Stage I	29			FEMALE	Negative				Negative	M0	Negative	N0	29	0							enrollment	T1	T1	LIVING	0	TCGA-E9-A1RA-01	1369	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8		miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E9-A1RA	1369	0	days	1369	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RA-F68493	TCGA-E9-A1RA	TCGA-E9-A1RA-01A										NO			-17699	45		0	1369					NO				Scheduled Follow-up Submission	2014-11-20	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	200	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	6								NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-E9-A1RA.26140CA5-AF22-47DD-BE48-C3C7DE07E5DB.pdf	A1RA	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	29f0d297-d89f-41a2-8d31-51f9194996f0	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	29f0d297-d89f-41a2-8d31-51f9194996f0	TCGA-E9-A1RA-01A-21-A17J-20	TCGA-E9-A1RA-01A-11D-A14G-09		TCGA-E9-A1RA-01	TCGA-E9-A1RA-01A-11D-A14H-05		e20d43c8-401d-4975-ac2a-b355dd5bd528	TCGA-E9-A1RA-01	TCGA-E9-A1RA-01A-11D-A14G-09			TCGA-E9-A1RA-01	TCGA-E9-A1RA-01A-11D-A14G-09		da9bcd8c-7f5b-41f4-bff8-7129a88caf22		TCGA-E9-A1RA-01A-11D-A14F-01	TCGA-E9-A1RA-01		da9bcd8c-7f5b-41f4-bff8-7129a88caf22	TCGA-E9-A1RA-01A-11D-A14F-01	
TCGA-E9-A1RB-01	Stage IIA	40	4	Stage IIA	21			FEMALE	Negative				Negative	M0	Negative	N0	21	0	LumB						enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1RB-01	976	1	days	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 5	TCGA-E9-A1RB	976	0	days	976	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RB-F39530	TCGA-E9-A1RB	TCGA-E9-A1RB-01A								Modified Radical Mastectomy		NO			-14755	39	976	0	633					NO				Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1									NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf	A1RB	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	7e2a8676-10a4-4abf-b153-2255e06bcb40	458805a0-64c5-4e9a-958e-537047e41a86	7e2a8676-10a4-4abf-b153-2255e06bcb40	458805a0-64c5-4e9a-958e-537047e41a86	TCGA-E9-A1RB-01A-21-A17J-20	TCGA-E9-A1RB-01A-11D-A17G-09		TCGA-E9-A1RB-01	TCGA-E9-A1RB-01A-11D-A161-05		d0e45995-93b2-4247-85b7-bc7071578e1f	TCGA-E9-A1RB-01	TCGA-E9-A1RB-01A-11D-A17G-09			TCGA-E9-A1RB-01	TCGA-E9-A1RB-01A-11D-A17G-09		7e2a8676-10a4-4abf-b153-2255e06bcb40		TCGA-E9-A1RB-01A-11D-A160-01	TCGA-E9-A1RB-01		7e2a8676-10a4-4abf-b153-2255e06bcb40	TCGA-E9-A1RB-01A-11D-A160-01	
TCGA-E9-A1RB-11		40			21			FEMALE									21	0	Normal						enrollment			LIVING	1	TCGA-E9-A1RB-11	976	1	days		C3-BRCA/Luminal							mutation cluster 5	TCGA-E9-A1RB	976	0	days	976	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RB-F39530	TCGA-E9-A1RB	TCGA-E9-A1RB-11A								Modified Radical Mastectomy		NO			-14755	39	976	0	633					NO				Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	false	No	M0	N0	T2	Stage IIA		A1RB	TUMOR FREE						YES	YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	b8499b28-1746-4ffd-a183-a765e6d290e3		b8499b28-1746-4ffd-a183-a765e6d290e3						TCGA-E9-A1RB-11A-33D-A161-05		0EFB66E0-3439-4FAE-9B6A-C5D085876AAF					TCGA-E9-A1RB-11			b8499b28-1746-4ffd-a183-a765e6d290e3			TCGA-E9-A1RB-11		b8499b28-1746-4ffd-a183-a765e6d290e3		
TCGA-E9-A1RC-01	Stage IIIC	56	3	Stage IIIC	1228			FEMALE	Negative				Negative	M0	Positive	N3	1228	0	LumA						enrollment	T_Other	T4	LIVING	0	TCGA-E9-A1RC-01	1224	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation cluster 4	TCGA-E9-A1RC	1224	0	days	1224	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RC-F48701	TCGA-E9-A1RC	TCGA-E9-A1RC-01A								Modified Radical Mastectomy		NO			-20795	1246		0	1224					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	620	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	10	0	true	No	M0	N3	T4b	Stage IIIC	TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf	A1RC	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2007	00168e86-d23a-48ae-8c60-36d970051907	8805f2a1-b210-4663-b5c6-f2f9baca280a	00168e86-d23a-48ae-8c60-36d970051907	8805f2a1-b210-4663-b5c6-f2f9baca280a	TCGA-E9-A1RC-01A-21-A17J-20	TCGA-E9-A1RC-01A-11D-A159-09		TCGA-E9-A1RC-01	TCGA-E9-A1RC-01A-11D-A161-05		9243e0b1-b98d-4d50-817a-b2fed305e841	TCGA-E9-A1RC-01	TCGA-E9-A1RC-01A-11D-A159-09			TCGA-E9-A1RC-01	TCGA-E9-A1RC-01A-11D-A159-09		00168e86-d23a-48ae-8c60-36d970051907		TCGA-E9-A1RC-01A-11D-A160-01	TCGA-E9-A1RC-01		00168e86-d23a-48ae-8c60-36d970051907	TCGA-E9-A1RC-01A-11D-A160-01	
TCGA-E9-A1RC-11		56			1228			FEMALE									1228	0	LumA						enrollment			LIVING	0	TCGA-E9-A1RC-11	1224	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RC	1224	0	days	1224	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RC-F48701	TCGA-E9-A1RC	TCGA-E9-A1RC-11A								Modified Radical Mastectomy		NO			-20795	1246		0	1224					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1040	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	10	0	false	No	M0	N3	T4b	Stage IIIC		A1RC	TUMOR FREE							YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2007	81769714-1765-4b76-8a3a-18f79e314852		81769714-1765-4b76-8a3a-18f79e314852						TCGA-E9-A1RC-11A-33D-A161-05		68A3D687-0B01-4BDD-B650-D8D204E65559								81769714-1765-4b76-8a3a-18f79e314852					81769714-1765-4b76-8a3a-18f79e314852		
TCGA-E9-A1RD-01	Stage IIA	67	2	Stage IIA	20			FEMALE	Negative				Negative	M0	Negative	N0	20	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RD-01	34	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13		mutation cluster 4	TCGA-E9-A1RD	34	0	days	34	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RD-F48702	TCGA-E9-A1RD	TCGA-E9-A1RD-01A								Modified Radical Mastectomy		NO			-24719	38		0	34					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	340	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1RD.EDDEB48B-B712-40B0-9DE5-9F5B5791AF4D.pdf	A1RD	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	709852ad-ac59-48af-ba05-2d7a80326afa	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	709852ad-ac59-48af-ba05-2d7a80326afa	TCGA-E9-A1RD-01A-21-A17J-20	TCGA-E9-A1RD-01A-11D-A159-09		TCGA-E9-A1RD-01	TCGA-E9-A1RD-01A-11D-A161-05		ef7d073e-90b6-4d14-bcad-a6d9759122dc	TCGA-E9-A1RD-01	TCGA-E9-A1RD-01A-11D-A159-09			TCGA-E9-A1RD-01	TCGA-E9-A1RD-01A-11D-A159-09		eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16		TCGA-E9-A1RD-01A-11D-A160-01	TCGA-E9-A1RD-01		eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-11D-A160-01	
TCGA-E9-A1RD-11		67			20			FEMALE									20	0	Normal						enrollment			LIVING	0	TCGA-E9-A1RD-11	34	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RD	34	0	days	34	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RD-F48702	TCGA-E9-A1RD	TCGA-E9-A1RD-11A								Modified Radical Mastectomy		NO			-24719	38		0	34					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA		A1RD	TUMOR FREE							YES			NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	000d877f-8d03-44bc-8607-27b5ba84b5fe		000d877f-8d03-44bc-8607-27b5ba84b5fe						TCGA-E9-A1RD-11A-33D-A161-05		738328DA-0CBE-4801-A523-667D56E6A73E					TCGA-E9-A1RD-11			000d877f-8d03-44bc-8607-27b5ba84b5fe			TCGA-E9-A1RD-11		000d877f-8d03-44bc-8607-27b5ba84b5fe		
TCGA-E9-A1RE-01	Stage IIIA	74	4	Stage IIIA	47			FEMALE	Negative				Negative	M0	Positive	N2	47	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RE-01	1419	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation cluster 4	TCGA-E9-A1RE	1419	0	days	1419	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RE-F68732	TCGA-E9-A1RE	TCGA-E9-A1RE-01A								Modified Radical Mastectomy		NO			-27392	65		0	1419					NO				Scheduled Follow-up Submission	2014-12-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	730	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	9		true	No	M0	N2	T2	Stage IIIA	TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf	A1RE	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	dce9e705-2d4f-4786-ad68-fb47615c7f3f	09a7d8d3-0973-405b-96e0-01b579b331b4	dce9e705-2d4f-4786-ad68-fb47615c7f3f	09a7d8d3-0973-405b-96e0-01b579b331b4	TCGA-E9-A1RE-01A-21-A17J-20	TCGA-E9-A1RE-01A-11D-A159-09		TCGA-E9-A1RE-01	TCGA-E9-A1RE-01A-11D-A161-05		347208e2-3e3d-4b02-8fc0-1092a95f9bcf	TCGA-E9-A1RE-01	TCGA-E9-A1RE-01A-11D-A159-09			TCGA-E9-A1RE-01	TCGA-E9-A1RE-01A-11D-A159-09		dce9e705-2d4f-4786-ad68-fb47615c7f3f		TCGA-E9-A1RE-01A-11D-A160-01	TCGA-E9-A1RE-01		dce9e705-2d4f-4786-ad68-fb47615c7f3f	TCGA-E9-A1RE-01A-11D-A160-01	
TCGA-E9-A1RF-01	Stage IIIA	68	5	Stage IIIA	38			FEMALE	Negative				Negative	M0	Positive	N2	38	0	LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RF-01	200	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A1RF	200	0	days	200	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RF-F48703	TCGA-E9-A1RF	TCGA-E9-A1RF-01A								Modified Radical Mastectomy		NO			-25119	56		0	200					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	330	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	5		true	No	M0	N2	T2	Stage IIIA	TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf	A1RF	TUMOR FREE							YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	502939cc-3381-4bc2-9ae6-332846cf836b	cec10976-a9f7-47cf-b7b4-a9e04ef7d6c9	502939cc-3381-4bc2-9ae6-332846cf836b	cec10976-a9f7-47cf-b7b4-a9e04ef7d6c9	TCGA-E9-A1RF-01A-21-A17J-20	TCGA-E9-A1RF-01A-11D-A159-09		TCGA-E9-A1RF-01	TCGA-E9-A1RF-01A-11D-A161-05		97534d53-162f-4e78-bf68-a227f1c2ae36	TCGA-E9-A1RF-01	TCGA-E9-A1RF-01A-11D-A159-09			TCGA-E9-A1RF-01	TCGA-E9-A1RF-01A-11D-A159-09		502939cc-3381-4bc2-9ae6-332846cf836b		TCGA-E9-A1RF-01A-11D-A160-01	TCGA-E9-A1RF-01		502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-11D-A160-01	
TCGA-E9-A1RF-11		68			38			FEMALE									38	0	LumA						enrollment			LIVING	0	TCGA-E9-A1RF-11	200	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-E9-A1RF	200	0	days	200	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RF-F48703	TCGA-E9-A1RF	TCGA-E9-A1RF-11A								Modified Radical Mastectomy		NO			-25119	56		0	200					NO				Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1050	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5		false	No	M0	N2	T2	Stage IIIA		A1RF	TUMOR FREE							YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	da13db3f-cde6-4e25-9596-009147aa3fa9		da13db3f-cde6-4e25-9596-009147aa3fa9						TCGA-E9-A1RF-11A-32D-A161-05		97627951-60EF-4283-940A-9550114962F1								da13db3f-cde6-4e25-9596-009147aa3fa9					da13db3f-cde6-4e25-9596-009147aa3fa9		
TCGA-E9-A1RG-01	Stage IIIA	62	2	Stage IIIA	35			FEMALE	Negative				Negative	M0	Positive	N2	35	0							enrollment	T1	T1	LIVING	0	TCGA-E9-A1RG-01	647	0	days	High	C1-LUAD-enriched	cluster 2	Cluster 5	BRCA nonbasal-like c8		miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-E9-A1RG	647	0	days	647	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RG-F39534	TCGA-E9-A1RG	TCGA-E9-A1RG-01A								Lumpectomy		NO			-22788	53		0	647					NO				Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	540	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	5								NO	4		true	No	M0	N2	T1c	Stage IIIA	TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf	A1RG	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	dbf09347-4e3e-490e-977f-97d826143634	5cc785cc-8845-4b90-95eb-097896412250	dbf09347-4e3e-490e-977f-97d826143634	5cc785cc-8845-4b90-95eb-097896412250	TCGA-E9-A1RG-01A-21-A17J-20	TCGA-E9-A1RG-01A-11D-A14G-09		TCGA-E9-A1RG-01	TCGA-E9-A1RG-01A-11D-A14H-05		4c16616e-47cf-474c-b8c3-f681f390493f	TCGA-E9-A1RG-01	TCGA-E9-A1RG-01A-11D-A14G-09			TCGA-E9-A1RG-01	TCGA-E9-A1RG-01A-11D-A14G-09		dbf09347-4e3e-490e-977f-97d826143634		TCGA-E9-A1RG-01A-11D-A14F-01	TCGA-E9-A1RG-01		dbf09347-4e3e-490e-977f-97d826143634	TCGA-E9-A1RG-01A-11D-A14F-01	
TCGA-E9-A1RH-01	Stage IIA	63	4	Stage IIA	14			FEMALE	Negative				Negative	M0	Negative	N0	14	0	Her2						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RH-01	1417	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RH	1417	0	days	1417	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RH-F70141	TCGA-E9-A1RH	TCGA-E9-A1RH-01A								Lumpectomy		NO			-23224	32		0	1417					NO				Scheduled Follow-up Submission	2015-1-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	410	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf	A1RH	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	422a4277-12f1-42ae-9f94-88d37517b9b0	f1b4f790-083e-44f0-b924-06dc7c167a20	422a4277-12f1-42ae-9f94-88d37517b9b0	f1b4f790-083e-44f0-b924-06dc7c167a20	TCGA-E9-A1RH-01A-11-A17J-20	TCGA-E9-A1RH-01A-21D-A167-09		TCGA-E9-A1RH-01	TCGA-E9-A1RH-01A-21D-A16A-05		7daa20aa-d253-4dc4-a90b-c68c6535d837	TCGA-E9-A1RH-01	TCGA-E9-A1RH-01A-21D-A167-09			TCGA-E9-A1RH-01	TCGA-E9-A1RH-01A-21D-A167-09		422a4277-12f1-42ae-9f94-88d37517b9b0		TCGA-E9-A1RH-01A-21D-A166-01	TCGA-E9-A1RH-01		422a4277-12f1-42ae-9f94-88d37517b9b0	TCGA-E9-A1RH-01A-21D-A166-01	
TCGA-E9-A1RH-11		63			14			FEMALE									14	0	Normal						enrollment			LIVING	0	TCGA-E9-A1RH-11	1417	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RH	1417	0	days	1417	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RH-F70141	TCGA-E9-A1RH	TCGA-E9-A1RH-11A								Lumpectomy		NO			-23224	32		0	1417					NO				Scheduled Follow-up Submission	2015-1-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	720	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	M0	N0	T2	Stage IIA		A1RH	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	6574e15e-7e1f-4dca-899e-56e911f27848		6574e15e-7e1f-4dca-899e-56e911f27848						TCGA-E9-A1RH-11A-34D-A16A-05		ABDD9B9C-278F-4077-BB4F-5B890D7E58C7					TCGA-E9-A1RH-11			6574e15e-7e1f-4dca-899e-56e911f27848			TCGA-E9-A1RH-11		6574e15e-7e1f-4dca-899e-56e911f27848		
TCGA-E9-A1RI-01	Stage IIIA	43	2	Stage IIIA	48			FEMALE					Negative	M0	Positive	N2	48	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1RI-01	1449	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RI	1449	0	days	1449	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RI-F70144	TCGA-E9-A1RI	TCGA-E9-A1RI-01A								Modified Radical Mastectomy		NO			-15942	64		0	1449					NO				Scheduled Follow-up Submission	2015-1-28	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	290	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	5		true	No	M0	N2	T1c	Stage IIIA	TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf	A1RI	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	1c77a00e-8cea-48ae-b9b5-193cdecf3604	815c2a7a-a33b-4899-a2aa-df187eccf1bd	1c77a00e-8cea-48ae-b9b5-193cdecf3604	815c2a7a-a33b-4899-a2aa-df187eccf1bd	TCGA-E9-A1RI-01A-21-A17J-20	TCGA-E9-A1RI-01A-11D-A167-09		TCGA-E9-A1RI-01	TCGA-E9-A1RI-01A-11D-A16A-05		fde109be-d1bb-48df-af59-0bee2ca9ed1e	TCGA-E9-A1RI-01	TCGA-E9-A1RI-01A-11D-A167-09			TCGA-E9-A1RI-01	TCGA-E9-A1RI-01A-11D-A167-09		1c77a00e-8cea-48ae-b9b5-193cdecf3604		TCGA-E9-A1RI-01A-11D-A166-01	TCGA-E9-A1RI-01		1c77a00e-8cea-48ae-b9b5-193cdecf3604	TCGA-E9-A1RI-01A-11D-A166-01	
TCGA-E9-A1RI-11		43			48			FEMALE									48	0	LumA						enrollment			LIVING	0	TCGA-E9-A1RI-11	1449	0	days		C3-BRCA/Luminal							mutation cluster 4	TCGA-E9-A1RI	1449	0	days	1449	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A1RI-F70144	TCGA-E9-A1RI	TCGA-E9-A1RI-11A								Modified Radical Mastectomy		NO			-15942	64		0	1449					NO				Scheduled Follow-up Submission	2015-1-28	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	800	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	5		false	No	M0	N2	T1c	Stage IIIA		A1RI	TUMOR FREE						YES	YES			YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	7391b882-0be5-45b0-aa01-43c3381a476d		7391b882-0be5-45b0-aa01-43c3381a476d						TCGA-E9-A1RI-11A-41D-A16A-05		21E8CC9D-962D-4FA5-9814-8134FFA59C51								7391b882-0be5-45b0-aa01-43c3381a476d					7391b882-0be5-45b0-aa01-43c3381a476d		
TCGA-E9-A226-01	Stage IIIA	45	2	Stage IIIA	16			FEMALE	Negative				Negative	M0	Positive	N2	16	0	LumB						enrollment	T_Other	T2	LIVING	1	TCGA-E9-A226-01	1048	1	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 3	TCGA-E9-A226	1048	0	days	1048	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			45	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A226-F39536	TCGA-E9-A226	TCGA-E9-A226-01A								Modified Radical Mastectomy		NO			-16511	48	1048	0	628			790		NO				Scheduled Follow-up Submission	2015-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	510	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3					Bone	Distant Metastasis		NO	NO	6		true	No	M0	N2	T2	Stage IIIA	TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf	A226	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	2f11f003-9c39-46ba-990f-10d326953f1b	dbfe507d-f859-4ca8-9da1-18bfe3e89a68	2f11f003-9c39-46ba-990f-10d326953f1b	dbfe507d-f859-4ca8-9da1-18bfe3e89a68	TCGA-E9-A226-01A-11-A17K-20	TCGA-E9-A226-01A-21D-A159-09		TCGA-E9-A226-01	TCGA-E9-A226-01A-21D-A161-05		67837600-8189-44bd-af2f-1cb30522bc65	TCGA-E9-A226-01	TCGA-E9-A226-01A-21D-A159-09			TCGA-E9-A226-01	TCGA-E9-A226-01A-21D-A159-09		2f11f003-9c39-46ba-990f-10d326953f1b		TCGA-E9-A226-01A-21D-A160-01	TCGA-E9-A226-01		2f11f003-9c39-46ba-990f-10d326953f1b	TCGA-E9-A226-01A-21D-A160-01	
TCGA-E9-A227-01	Stage IIB	42	2	Stage IIB	24		Positive	FEMALE	Negative				Negative	M0	Positive	N1	24	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A227-01	975	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation cluster 1	TCGA-E9-A227	975	0	days	975	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-E9-A227-F58571	TCGA-E9-A227	TCGA-E9-A227-01A	Negative	Positive		4+		Other	Positive	Lumpectomy	Re-excision of original lumpectomy site	NO			-15602	66		0	975					NO		90-99%		Scheduled Follow-up Submission	2014-4-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	180	NO	Negative		YES	17	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1									NO	1		true	No	M0	N1	T2	Stage IIB	TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf	A227	TUMOR FREE				Two-tier	Two-tier		YES	80-89%		YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	2f315234-dee1-4f36-b7dc-72280c219a1c	3e648342-a21d-4c25-8e1f-1c1dda9b543f	2f315234-dee1-4f36-b7dc-72280c219a1c	3e648342-a21d-4c25-8e1f-1c1dda9b543f	TCGA-E9-A227-01A-21-A17K-20	TCGA-E9-A227-01A-11D-A159-09		TCGA-E9-A227-01	TCGA-E9-A227-01A-11D-A161-05		ad8672fa-20e1-4624-ac65-10e1d4f057ed	TCGA-E9-A227-01	TCGA-E9-A227-01A-11D-A159-09			TCGA-E9-A227-01	TCGA-E9-A227-01A-11D-A159-09		2f315234-dee1-4f36-b7dc-72280c219a1c		TCGA-E9-A227-01A-11D-A160-01	TCGA-E9-A227-01		2f315234-dee1-4f36-b7dc-72280c219a1c	TCGA-E9-A227-01A-11D-A160-01	
TCGA-E9-A228-01	Stage IIB	58	5	Stage IIB	0			FEMALE	Positive				Negative	M0	Positive	N1	0	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A228-01	1285	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14		mutation c1uster 9	TCGA-E9-A228	1285	0	days	1285	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A228-F65804	TCGA-E9-A228	TCGA-E9-A228-01A													-21294	42		0	1285					NO				Scheduled Follow-up Submission	2014-9-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740	NO			NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf	A228	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	5903d969-2fd6-4952-b475-a79e6c241efd	6e3c544e-9a1d-431d-8775-cbbd41de89c2	5903d969-2fd6-4952-b475-a79e6c241efd	6e3c544e-9a1d-431d-8775-cbbd41de89c2	TCGA-E9-A228-01A-41-A17K-20	TCGA-E9-A228-01A-31D-A159-09		TCGA-E9-A228-01	TCGA-E9-A228-01A-31D-A161-05		edcb326a-16d2-4ac1-a8da-de4ffcaca34a	TCGA-E9-A228-01	TCGA-E9-A228-01A-31D-A159-09			TCGA-E9-A228-01	TCGA-E9-A228-01A-31D-A159-09		5903d969-2fd6-4952-b475-a79e6c241efd		TCGA-E9-A228-01A-31D-A160-01	TCGA-E9-A228-01		5903d969-2fd6-4952-b475-a79e6c241efd	TCGA-E9-A228-01A-31D-A160-01	
TCGA-E9-A229-01	Stage IA	37	5	Stage I	0			FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A229-01	1148	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation cluster 4	TCGA-E9-A229	1148	0	days	1148	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					37	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A229-F65803	TCGA-E9-A229	TCGA-E9-A229-01A													-13817	56		0	1148					NO				Scheduled Follow-up Submission	2014-9-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO			NO	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1									NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf	A229	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	b56e8eb4-5efb-4f29-bee6-da6e61aa44a2	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	b56e8eb4-5efb-4f29-bee6-da6e61aa44a2	TCGA-E9-A229-01A-21-A17K-20	TCGA-E9-A229-01A-31D-A17G-09		TCGA-E9-A229-01	TCGA-E9-A229-01A-31D-A161-05		9ff7a9ee-7e6e-4f4d-95f8-d2f6e1e88cc3	TCGA-E9-A229-01	TCGA-E9-A229-01A-31D-A17G-09			TCGA-E9-A229-01	TCGA-E9-A229-01A-31D-A17G-09		b956a823-b7d5-4a9e-a9d1-c66f0faf544a		TCGA-E9-A229-01A-31D-A160-01	TCGA-E9-A229-01		b956a823-b7d5-4a9e-a9d1-c66f0faf544a	TCGA-E9-A229-01A-31D-A160-01	
TCGA-E9-A22A-01	Stage IIA	74	1	Stage IIA	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22A-01	1189	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22A	1189	0	days	1189	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22A-F39785	TCGA-E9-A22A	TCGA-E9-A22A-01A		Positive					Negative			YES			-27288	59		0	1189					NO		10-19%		Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	340	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf	A22A	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	3b807901-2667-4023-8210-20c0ebb5d189	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	3b807901-2667-4023-8210-20c0ebb5d189	TCGA-E9-A22A-01A-21-A17K-20	TCGA-E9-A22A-01A-11D-A159-09		TCGA-E9-A22A-01	TCGA-E9-A22A-01A-11D-A161-05		31514349-7cce-4d67-8dd4-4fb5f7fea530	TCGA-E9-A22A-01	TCGA-E9-A22A-01A-11D-A159-09			TCGA-E9-A22A-01	TCGA-E9-A22A-01A-11D-A159-09		2513da31-4ee0-49cd-85de-d2bc8e71e2e5		TCGA-E9-A22A-01A-11D-A160-01	TCGA-E9-A22A-01		2513da31-4ee0-49cd-85de-d2bc8e71e2e5	TCGA-E9-A22A-01A-11D-A160-01	
TCGA-E9-A22B-01	Stage IA	71	5	Stage I	0		Positive	FEMALE	Negative				Negative	M0	Negative	N0	0	0	LumA		Negative				enrollment	T1	T1	LIVING	0	TCGA-E9-A22B-01	1167	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22B	1167	0	days	1167	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22B-F64425	TCGA-E9-A22B	TCGA-E9-A22B-01A		Positive					Negative			YES			-26278	59		0	1167					NO		10-19%		Scheduled Follow-up Submission	2014-9-2	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	250	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0	0	true	No	M0	N0	T1c	Stage IA	TCGA-E9-A22B.FC896EB8-1CEC-46A0-82E1-E3FBFAAB69F1.pdf	A22B	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	f563bc24-00d1-4637-a073-87744ed7311a	260ee6fb-7c05-41d7-93c4-8c5c5e40f5ff	f563bc24-00d1-4637-a073-87744ed7311a	260ee6fb-7c05-41d7-93c4-8c5c5e40f5ff	TCGA-E9-A22B-01A-21-A17K-20	TCGA-E9-A22B-01A-11D-A159-09		TCGA-E9-A22B-01	TCGA-E9-A22B-01A-11D-A161-05		be719b89-4746-465d-9b38-1f32c86a2914	TCGA-E9-A22B-01	TCGA-E9-A22B-01A-11D-A159-09			TCGA-E9-A22B-01	TCGA-E9-A22B-01A-11D-A159-09		f563bc24-00d1-4637-a073-87744ed7311a		TCGA-E9-A22B-01A-11D-A160-01	TCGA-E9-A22B-01		f563bc24-00d1-4637-a073-87744ed7311a	TCGA-E9-A22B-01A-11D-A160-01	
TCGA-E9-A22D-01	Stage IIA	38	5	Stage IIA	0		Positive	FEMALE	Positive				Negative	M0	Negative	N0	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22D-01	1248	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A22D	1248	0	days	1248	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22D-F39787	TCGA-E9-A22D	TCGA-E9-A22D-01A		Positive					Positive	Modified Radical Mastectomy		YES			-14115	52		0	1248							10-19%		Scheduled Follow-up Submission	2013-2-1	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	620	NO	Positive		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3									NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf	A22D	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	1fdac226-ed6b-41a8-9575-67117b4cf035	1b0a7689-323d-487b-8e4f-9e5742f24438	1fdac226-ed6b-41a8-9575-67117b4cf035	1b0a7689-323d-487b-8e4f-9e5742f24438	TCGA-E9-A22D-01A-21-A17K-20	TCGA-E9-A22D-01A-11D-A159-09		TCGA-E9-A22D-01	TCGA-E9-A22D-01A-11D-A161-05		4691c2b1-8da2-48b4-9510-badea3a8353f	TCGA-E9-A22D-01	TCGA-E9-A22D-01A-11D-A159-09			TCGA-E9-A22D-01	TCGA-E9-A22D-01A-11D-A159-09		1fdac226-ed6b-41a8-9575-67117b4cf035		TCGA-E9-A22D-01A-11D-A160-01	TCGA-E9-A22D-01		1fdac226-ed6b-41a8-9575-67117b4cf035	TCGA-E9-A22D-01A-11D-A160-01	
TCGA-E9-A22E-01	Stage IIIA	56	1	Stage IIIA	0		Positive	FEMALE	Negative				Negative	M0	Positive	N2	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22E-01	1269	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22E	1269	0	days	1269	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22E-F63565	TCGA-E9-A22E	TCGA-E9-A22E-01A		Positive					Positive			YES			-20574	52		0	1269					NO		10-19%		Scheduled Follow-up Submission	2014-8-13	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	620	NO	Positive		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	4	0	true	No	M0	N2	T2	Stage IIIA	TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf	A22E	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	2ea69f1e-ccd7-4691-a0c1-f6cb6f5f343c	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	2ea69f1e-ccd7-4691-a0c1-f6cb6f5f343c	TCGA-E9-A22E-01A-21-A17K-20	TCGA-E9-A22E-01A-11D-A159-09		TCGA-E9-A22E-01	TCGA-E9-A22E-01A-11D-A161-05		30d1b1ed-e4da-4758-b523-271f2bc19e6c	TCGA-E9-A22E-01	TCGA-E9-A22E-01A-11D-A159-09			TCGA-E9-A22E-01	TCGA-E9-A22E-01A-11D-A159-09		e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b		TCGA-E9-A22E-01A-11D-A160-01	TCGA-E9-A22E-01		e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	TCGA-E9-A22E-01A-11D-A160-01	
TCGA-E9-A22G-01	Stage IIIA	47	1	Stage IIA	0		Negative	FEMALE	Negative				Negative	M0	Negative	N0	0	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22G-01	1239	0	days	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 1		mutation cluster 5	TCGA-E9-A22G	1239	0	days	1239	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22G-F62594	TCGA-E9-A22G	TCGA-E9-A22G-01A		Negative					Negative			YES			-17300	45		0	1239					NO				Scheduled Follow-up Submission	2014-7-21	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	650	NO	Positive		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf	A22G	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	88d93dca-ffae-4d57-9a60-346aec436543	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	88d93dca-ffae-4d57-9a60-346aec436543	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	TCGA-E9-A22G-01A-21-A17K-20	TCGA-E9-A22G-01A-11D-A159-09		TCGA-E9-A22G-01	TCGA-E9-A22G-01A-11D-A161-05		62d5983b-ccc1-4700-9cb9-e97ff4bb1277	TCGA-E9-A22G-01	TCGA-E9-A22G-01A-11D-A159-09			TCGA-E9-A22G-01	TCGA-E9-A22G-01A-11D-A159-09		88d93dca-ffae-4d57-9a60-346aec436543		TCGA-E9-A22G-01A-11D-A160-01	TCGA-E9-A22G-01		88d93dca-ffae-4d57-9a60-346aec436543	TCGA-E9-A22G-01A-11D-A160-01	
TCGA-E9-A22H-01	Stage IIB	42	2	Stage IIB	0		Positive	FEMALE	Negative				Negative	M0	Positive	N1	0	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22H-01	1232	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 4	TCGA-E9-A22H	1232	0	days	1232	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					42	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A22H-F63224	TCGA-E9-A22H	TCGA-E9-A22H-01A		Positive					Positive	Modified Radical Mastectomy		YES			-15504	38		0	1232					NO		<10%		Scheduled Follow-up Submission	2014-8-4	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	500	NO	Positive		NO	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1									NO	1	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf	A22H	TUMOR FREE						YES	YES	10-19%		YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	c388d3be-37d9-4377-8c85-f6124b2ad436	80737d22-494c-491b-82de-4e3ab2f693ef	c388d3be-37d9-4377-8c85-f6124b2ad436	80737d22-494c-491b-82de-4e3ab2f693ef	TCGA-E9-A22H-01A-21-A17K-20	TCGA-E9-A22H-01A-11D-A159-09		TCGA-E9-A22H-01	TCGA-E9-A22H-01A-11D-A161-05		25eba4f9-cda1-4925-8504-5291fd135b5f	TCGA-E9-A22H-01	TCGA-E9-A22H-01A-11D-A159-09			TCGA-E9-A22H-01	TCGA-E9-A22H-01A-11D-A159-09		c388d3be-37d9-4377-8c85-f6124b2ad436		TCGA-E9-A22H-01A-11D-A160-01	TCGA-E9-A22H-01		c388d3be-37d9-4377-8c85-f6124b2ad436	TCGA-E9-A22H-01A-11D-A160-01	
TCGA-E9-A243-01	Stage IIA	52	3	Stage IIA	43			FEMALE	Negative				Negative	M0	Negative	N0	43	0	Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A243-01	612	0	days	High	C4-BRCA/Basal	cluster 5	OV-like c1	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E9-A243	305	1	days	612	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		52	Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A243-F56656	TCGA-E9-A243	TCGA-E9-A243-01A								Lumpectomy		NO		305	-19035	94		0	612			305		NO				Scheduled Follow-up Submission	2014-2-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	270	NO			YES	10	Negative	Peri (6-12 months since last menstrual period)		Negative			Negative												Negative			5	3				Bone	Distant Metastasis			YES	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf	A243	WITH TUMOR							YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	2a67b3a1-4ab0-43ee-9630-8532d0f56b5d	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	2a67b3a1-4ab0-43ee-9630-8532d0f56b5d	TCGA-E9-A243-01A-11-A17K-20	TCGA-E9-A243-01A-21D-A167-09		TCGA-E9-A243-01	TCGA-E9-A243-01A-21D-A16A-05		a1b3b8fa-af81-479c-a27b-485bc4557e82	TCGA-E9-A243-01	TCGA-E9-A243-01A-21D-A167-09			TCGA-E9-A243-01	TCGA-E9-A243-01A-21D-A167-09		619ffb2b-a591-4f3b-aa48-b0c44f4ee36a		TCGA-E9-A243-01A-21D-A166-01	TCGA-E9-A243-01		619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	TCGA-E9-A243-01A-21D-A166-01	
TCGA-E9-A244-01	Stage IIA	54	1	Stage IIA	20			FEMALE	Negative				Negative	M0	Negative	N0	20	0	Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A244-01	21	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA c1uster 9		mutation cluster 5	TCGA-E9-A244	21	0	days	21	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A244-F31164	TCGA-E9-A244	TCGA-E9-A244-01A								Lumpectomy		NO			-19778	58		0	21					NO				Scheduled Follow-up Submission	2012-4-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	310	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf	A244	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	4695c0f4-4d30-4604-84b3-81407bf980e8	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	4695c0f4-4d30-4604-84b3-81407bf980e8	TCGA-E9-A244-01A-21-A17K-20	TCGA-E9-A244-01A-11D-A167-09		TCGA-E9-A244-01	TCGA-E9-A244-01A-11D-A16A-05		a6266eec-b341-4642-aed5-9c6cd44f14df	TCGA-E9-A244-01	TCGA-E9-A244-01A-11D-A167-09			TCGA-E9-A244-01	TCGA-E9-A244-01A-11D-A167-09		147d6ebb-7359-449a-9e6a-6c8443ebaa2e		TCGA-E9-A244-01A-11D-A166-01	TCGA-E9-A244-01		147d6ebb-7359-449a-9e6a-6c8443ebaa2e	TCGA-E9-A244-01A-11D-A166-01	
TCGA-E9-A245-01	Stage IIB	47	3	Stage IIB	25			FEMALE	Negative				Negative	M0	Positive	N1	25	0	LumA						enrollment	T_Other	T2	LIVING		TCGA-E9-A245-01			days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-E9-A245			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A245-F31169	TCGA-E9-A245	TCGA-E9-A245-01A								Lumpectomy		NO			-17363	62		0	26					NO				Scheduled Follow-up Submission	2012-4-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO				10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2									NO	3		true	No	M0	N1	T2	Stage IIB	TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf	A245	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	c45b38c4-d7ce-4f8d-ba2f-c42ff0794ecc	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	c45b38c4-d7ce-4f8d-ba2f-c42ff0794ecc	TCGA-E9-A245-01A-11-A17K-20	TCGA-E9-A245-01A-22D-A16D-09		TCGA-E9-A245-01	TCGA-E9-A245-01A-22D-A16G-05		7a2a6276-0ac6-40a8-b678-d53877fe07fb	TCGA-E9-A245-01	TCGA-E9-A245-01A-22D-A16D-09			TCGA-E9-A245-01	TCGA-E9-A245-01A-22D-A16D-09		538ab6dc-6dff-49e2-ae6a-b91ee6619bce		TCGA-E9-A245-01A-22D-A16C-01	TCGA-E9-A245-01		538ab6dc-6dff-49e2-ae6a-b91ee6619bce	TCGA-E9-A245-01A-22D-A16C-01	
TCGA-E9-A247-01	Stage IB	59	4	Stage I	12			FEMALE	Negative				Negative	M0	Negative	N0	12	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A247-01	1186	0	days	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation c1uster 9	TCGA-E9-A247	1186	0	days	1186	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A247-F61874	TCGA-E9-A247	TCGA-E9-A247-01A													-21562	49		0	1186					NO				Scheduled Follow-up Submission	2014-7-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	370	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3									NO	0		true	No	M0	N0 (i-)	T1c	Stage IA	TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf	A247	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	37240e3a-9340-4509-a5e9-c7877ed93f52	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	37240e3a-9340-4509-a5e9-c7877ed93f52	TCGA-E9-A247-01A-21-A17K-20	TCGA-E9-A247-01A-11D-A167-09		TCGA-E9-A247-01	TCGA-E9-A247-01A-11D-A16A-05		572eb344-87fb-46f5-9d4b-81756d946892	TCGA-E9-A247-01	TCGA-E9-A247-01A-11D-A167-09			TCGA-E9-A247-01	TCGA-E9-A247-01A-11D-A167-09		3c38c1fe-9f57-4523-9654-c4bc6b02e84f		TCGA-E9-A247-01A-11D-A166-01	TCGA-E9-A247-01		3c38c1fe-9f57-4523-9654-c4bc6b02e84f	TCGA-E9-A247-01A-11D-A166-01	
TCGA-E9-A248-01	Stage IIA	51	4	Stage IIA	21			FEMALE	Negative				Negative	M0	Negative	N0	21	0	Her2						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A248-01	59	0	days	Squamous	C3-BRCA/Luminal	cluster 1	OV-like c1	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-E9-A248	59	0	days	59	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A248-F31211	TCGA-E9-A248	TCGA-E9-A248-01A								Lumpectomy		NO			-18684	52		0	59					NO				Scheduled Follow-up Submission	2012-4-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	540	NO				10	Negative	Peri (6-12 months since last menstrual period)																				1	3								NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf	A248	TUMOR FREE							YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	0a9215ea-d5d2-41ad-a00d-bd7722f41229	091f70c0-586a-49e8-a0e5-0b60caa72c1b	0a9215ea-d5d2-41ad-a00d-bd7722f41229	091f70c0-586a-49e8-a0e5-0b60caa72c1b	TCGA-E9-A248-01A-21-A17K-20	TCGA-E9-A248-01A-11D-A167-09		TCGA-E9-A248-01	TCGA-E9-A248-01A-11D-A16A-05		1b143b9f-74db-42c6-903c-b446834bd9f2	TCGA-E9-A248-01	TCGA-E9-A248-01A-11D-A167-09			TCGA-E9-A248-01	TCGA-E9-A248-01A-11D-A167-09		0a9215ea-d5d2-41ad-a00d-bd7722f41229		TCGA-E9-A248-01A-11D-A166-01	TCGA-E9-A248-01		0a9215ea-d5d2-41ad-a00d-bd7722f41229	TCGA-E9-A248-01A-11D-A166-01	
TCGA-E9-A249-01	Stage IIA	45	2	Stage IIA	28			FEMALE	Negative				Negative	M0	Negative	N0	28	0	LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A249-01	217	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-E9-A249	217	0	days	217	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A249-F49108	TCGA-E9-A249	TCGA-E9-A249-01A								Lumpectomy		NO			-16689	59		0	217					NO				Scheduled Follow-up Submission	2013-9-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	470	NO			YES	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4	3								NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf	A249	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	2e3fb75f-065e-4db0-bddf-8bcc6c7ace38	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	2e3fb75f-065e-4db0-bddf-8bcc6c7ace38	TCGA-E9-A249-01A-21-A17K-20	TCGA-E9-A249-01A-11D-A167-09		TCGA-E9-A249-01	TCGA-E9-A249-01A-11D-A16A-05		8917880a-d278-410b-974b-440741ceb6de	TCGA-E9-A249-01	TCGA-E9-A249-01A-11D-A167-09			TCGA-E9-A249-01	TCGA-E9-A249-01A-11D-A167-09		5285c747-0cb2-4f6a-83d8-40e45f8e4f6e		TCGA-E9-A249-01A-11D-A166-01	TCGA-E9-A249-01		5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	TCGA-E9-A249-01A-11D-A166-01	
TCGA-E9-A24A-01	Stage IIA	69	2	Stage IIA	10			FEMALE	Negative				Negative	M0	Positive	N1	10	0	LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A24A-01	747	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E9-A24A	747	0	days	747	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A24A-F39541	TCGA-E9-A24A	TCGA-E9-A24A-01A										NO			-25370	41		0	747					NO				Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	390	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	1		true	No	M0	N1	T1c	Stage IIA	TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf	A24A	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	a2bec98a-d946-40d2-b4d9-6495d815de9a	646a5d15-e48b-4183-b437-98280a5821c3	a2bec98a-d946-40d2-b4d9-6495d815de9a	646a5d15-e48b-4183-b437-98280a5821c3	TCGA-E9-A24A-01A-21-A17K-20	TCGA-E9-A24A-01A-11D-A167-09		TCGA-E9-A24A-01	TCGA-E9-A24A-01A-11D-A16A-05		8d96bc5d-6af2-4f5b-82d2-2b8f20848870	TCGA-E9-A24A-01	TCGA-E9-A24A-01A-11D-A167-09			TCGA-E9-A24A-01	TCGA-E9-A24A-01A-11D-A167-09		a2bec98a-d946-40d2-b4d9-6495d815de9a		TCGA-E9-A24A-01A-11D-A166-01	TCGA-E9-A24A-01		a2bec98a-d946-40d2-b4d9-6495d815de9a	TCGA-E9-A24A-01A-11D-A166-01	
TCGA-E9-A295-01			3																LumA										0	TCGA-E9-A295-01	375	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6		mutation cluster 4	TCGA-E9-A295	375	0	days	375	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A295-F35355	TCGA-E9-A295	TCGA-E9-A295-01A		Positive					Positive	Modified Radical Mastectomy		YES			-25957	63		0	375							80-89%			2012-9-25	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	670	NO	Positive		YES	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf	A295	TUMOR FREE				7	7	YES	YES	80-89%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	28ad8481-78a8-4103-b501-5cfd23ae3e81	17b870b5-a1e1-4cd3-8120-da9c6e95747f	28ad8481-78a8-4103-b501-5cfd23ae3e81	17b870b5-a1e1-4cd3-8120-da9c6e95747f	TCGA-E9-A295-01A-21-A17K-20	TCGA-E9-A295-01A-11D-A16D-09		TCGA-E9-A295-01	TCGA-E9-A295-01A-11D-A16G-05		21dc7633-3a7e-407d-ae43-88edfef05091	TCGA-E9-A295-01	TCGA-E9-A295-01A-11D-A16D-09			TCGA-E9-A295-01	TCGA-E9-A295-01A-11D-A16D-09		28ad8481-78a8-4103-b501-5cfd23ae3e81		TCGA-E9-A295-01A-11D-A16C-01	TCGA-E9-A295-01		28ad8481-78a8-4103-b501-5cfd23ae3e81	TCGA-E9-A295-01A-11D-A16C-01	
TCGA-E9-A2JS-01																			LumB										1	TCGA-E9-A2JS-01	904	1	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-E9-A2JS	524	1	days	904	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	NO		72	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A2JS-F40293	TCGA-E9-A2JS	TCGA-E9-A2JS-01A								Lumpectomy		NO			-26407	79	904	0	540			524						Scheduled Follow-up Submission	2013-2-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	420	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Distant Metastasis	Liver	NO	YES	1		true	No	M0	N1	T2	Stage IIB	TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf	A2JS	WITH TUMOR						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	DECEASED	2011	4fe55069-e1b6-4d85-a51a-03a10c6116e2	93e94458-a4e5-4de6-b4f0-13eb5e558d74	4fe55069-e1b6-4d85-a51a-03a10c6116e2	93e94458-a4e5-4de6-b4f0-13eb5e558d74	TCGA-E9-A2JS-01A-21-A24B-20			TCGA-E9-A2JS-01	TCGA-E9-A2JS-01A-11D-A17Z-05		e26e41fb-223b-484b-8463-a20e34844050	TCGA-E9-A2JS-01	TCGA-E9-A2JS-01A-11D-A17W-09			TCGA-E9-A2JS-01			4fe55069-e1b6-4d85-a51a-03a10c6116e2		TCGA-E9-A2JS-01A-11D-A17U-01	TCGA-E9-A2JS-01		4fe55069-e1b6-4d85-a51a-03a10c6116e2	TCGA-E9-A2JS-01A-11D-A17U-01	
TCGA-E9-A2JT-01																			LumA										0	TCGA-E9-A2JT-01	288	0	days	Kirc+	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-E9-A2JT	288	0	days	288	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A2JT-F40292	TCGA-E9-A2JT	TCGA-E9-A2JT-01A								Lumpectomy		NO			-23318	94		0	288									Scheduled Follow-up Submission	2013-2-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	260	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf	A2JT	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th	YES	YES	NO	E9	Breast	A	LIVING	2011	95b5e301-f942-43bb-8211-d992948e8136	27145418-15bb-49d6-bc77-80194079b46d	95b5e301-f942-43bb-8211-d992948e8136	27145418-15bb-49d6-bc77-80194079b46d	TCGA-E9-A2JT-01A-11-A24A-20			TCGA-E9-A2JT-01	TCGA-E9-A2JT-01A-22D-A18O-05		013e6c9f-a4fb-4588-9159-562bd6f2721c	TCGA-E9-A2JT-01	TCGA-E9-A2JT-01A-22D-A18P-09			TCGA-E9-A2JT-01			95b5e301-f942-43bb-8211-d992948e8136		TCGA-E9-A2JT-01A-22D-A18N-01	TCGA-E9-A2JT-01		95b5e301-f942-43bb-8211-d992948e8136	TCGA-E9-A2JT-01A-22D-A18N-01	
TCGA-E9-A3HO-01																			LumB										0	TCGA-E9-A3HO-01	1158	0	days	Iq	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7				TCGA-E9-A3HO	1158	0	days	1158	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3HO-F61875	TCGA-E9-A3HO									Modified Radical Mastectomy		NO			-18046			0	1158					NO				Scheduled Follow-up Submission	2014-7-9	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)					NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0			No	M0	N0 (i-)	T2	Stage IIA		A3HO	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th	YES	YES	NO	E9	Breast		LIVING	2011	d151b46a-1e20-455a-bab3-9c698cee312d	ce888acf-cb20-43f6-936b-be22ed0f817e	d151b46a-1e20-455a-bab3-9c698cee312d	ce888acf-cb20-43f6-936b-be22ed0f817e	TCGA-E9-A3HO-01A-21-A24A-20			TCGA-E9-A3HO-01	TCGA-E9-A3HO-01A-11D-A212-05		c6f8e3fb-8702-4064-b325-1f85c2d9815b	TCGA-E9-A3HO-01	TCGA-E9-A3HO-01A-11D-A20S-09						d151b46a-1e20-455a-bab3-9c698cee312d		TCGA-E9-A3HO-01A-11D-A20R-01			d151b46a-1e20-455a-bab3-9c698cee312d	TCGA-E9-A3HO-01A-11D-A20R-01	
TCGA-E9-A3Q9-01																			LumA										0	TCGA-E9-A3Q9-01	1001	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-E9-A3Q9	1001	0	days	1001	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					78	Right Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3Q9-F59741	TCGA-E9-A3Q9	TCGA-E9-A3Q9-01A		Positive					Positive			YES			-28715	198		0	1001					NO		40-49%			2014-5-20	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	580	NO	Indeterminate		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	22	0	true	No	M0	N3	T3	Stage IIIC	TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf	A3Q9	TUMOR FREE				8	8	YES	YES	40-49%		NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	941748e8-5690-4e98-a5f4-d79b0e033ba1	31afcf05-454e-40db-99db-c2ad7828d87f	941748e8-5690-4e98-a5f4-d79b0e033ba1	31afcf05-454e-40db-99db-c2ad7828d87f	TCGA-E9-A3Q9-01A-21-A24A-20			TCGA-E9-A3Q9-01	TCGA-E9-A3Q9-01A-11D-A21R-05		acbb7029-4851-48e2-8517-9c69b0f9aaf4	TCGA-E9-A3Q9-01	TCGA-E9-A3Q9-01A-11D-A21Q-09			TCGA-E9-A3Q9-01			941748e8-5690-4e98-a5f4-d79b0e033ba1		TCGA-E9-A3Q9-01A-11D-A21P-01	TCGA-E9-A3Q9-01		941748e8-5690-4e98-a5f4-d79b0e033ba1	TCGA-E9-A3Q9-01A-11D-A21P-01	
TCGA-E9-A3QA-01																													0	TCGA-E9-A3QA-01	918	0	days	High			Low purity c2	BRCA basal-like c6		miRNA cluster 4			TCGA-E9-A3QA	918	0	days	918	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					33	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3QA-F66100	TCGA-E9-A3QA	TCGA-E9-A3QA-01A													-12142	282		0	918					NO					2014-10-2	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Tumor resection	750	NO			NO	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf	A3QA	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	8a7e272c-39f2-42e6-b1d5-7225cf12fceb	d8a0163f-045f-415c-a456-4ae0cf0e307e	8a7e272c-39f2-42e6-b1d5-7225cf12fceb	d8a0163f-045f-415c-a456-4ae0cf0e307e	TCGA-E9-A3QA-01A-71-A24A-20			TCGA-E9-A3QA-01	TCGA-E9-A3QA-01A-61D-A22B-05		ed7f6269-7805-4032-870a-0f105960bfbc	TCGA-E9-A3QA-01	TCGA-E9-A3QA-01A-61D-A228-09			TCGA-E9-A3QA-01			8a7e272c-39f2-42e6-b1d5-7225cf12fceb		TCGA-E9-A3QA-01A-61D-A227-01	TCGA-E9-A3QA-01		8a7e272c-39f2-42e6-b1d5-7225cf12fceb	TCGA-E9-A3QA-01A-61D-A227-01	
TCGA-E9-A3X8-01																													0	TCGA-E9-A3X8-01	926	0	days					BRCA nonbasal-like c8					TCGA-E9-A3X8	926	0	days	926	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A3X8-F59742	TCGA-E9-A3X8	TCGA-E9-A3X8-01A		Positive					Positive	Modified Radical Mastectomy		YES			-17588	233		0	926					NO		20-29%			2014-5-20	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	4	0	true	No	M0	N1	T2	Stage IIB	TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf	A3X8	TUMOR FREE				8	8	YES	YES	20-29%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2011	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	e753e2a7-4812-4ba1-8e21-7b4dff099d40	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	e753e2a7-4812-4ba1-8e21-7b4dff099d40	TCGA-E9-A3X8-01A-21-A24A-20			TCGA-E9-A3X8-01	TCGA-E9-A3X8-01A-31D-A230-05		1ba9391b-4d20-4637-8c2a-6765cd37beb4	TCGA-E9-A3X8-01	TCGA-E9-A3X8-01A-31D-A22X-09			TCGA-E9-A3X8-01			b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9		TCGA-E9-A3X8-01A-31D-A22W-01	TCGA-E9-A3X8-01		b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	TCGA-E9-A3X8-01A-31D-A22W-01	
TCGA-E9-A54X-01																													0	TCGA-E9-A54X-01	727	0	days										TCGA-E9-A54X	727	0	days	727	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					85	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A54X-F66449	TCGA-E9-A54X	TCGA-E9-A54X-01A		Positive		3+			Positive	Lumpectomy		NO			-31173	78		0	727							90-99%			2014-10-15	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Core needle biopsy	220	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0 (i-)	T1b	Stage IA	TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf	A54X	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012	fc36b662-fabd-4caa-81f7-00fe0a3164a6	65112812-773c-4bcc-b32d-fcef869d0e4f	fc36b662-fabd-4caa-81f7-00fe0a3164a6	65112812-773c-4bcc-b32d-fcef869d0e4f				TCGA-E9-A54X-01	TCGA-E9-A54X-01A-11D-A268-05		4168faaa-8df8-48b5-a9cb-86932b2a0ffe	TCGA-E9-A54X-01	TCGA-E9-A54X-01A-11D-A25Q-09			TCGA-E9-A54X-01			fc36b662-fabd-4caa-81f7-00fe0a3164a6		TCGA-E9-A54X-01A-11D-A25N-01	TCGA-E9-A54X-01		fc36b662-fabd-4caa-81f7-00fe0a3164a6	TCGA-E9-A54X-01A-11D-A25N-01	
TCGA-E9-A54Y-01																													0	TCGA-E9-A54Y-01	725	0	days										TCGA-E9-A54Y	725	0	days	725	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Axillary lymph node dissection alone		TCGA-E9-A54Y-F66450	TCGA-E9-A54Y	TCGA-E9-A54Y-01A		Positive		3+			Positive	Modified Radical Mastectomy		NO			-23057	76		0	725							90-99%			2014-10-15	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Fine needle aspiration biopsy	370	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	8		true	No	M0	N2	T2	Stage IIIA	TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf	A54Y	TUMOR FREE						NO	YES	50-59%		NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012	c11ffcd0-8e82-4815-b30b-2d08945ce0bc	fc728459-51da-4bed-8f19-89c724e2139f	c11ffcd0-8e82-4815-b30b-2d08945ce0bc	fc728459-51da-4bed-8f19-89c724e2139f				TCGA-E9-A54Y-01	TCGA-E9-A54Y-01A-11D-A268-05		190643c9-d8a9-4e20-ac54-de58928ddfaf	TCGA-E9-A54Y-01	TCGA-E9-A54Y-01A-11D-A25Q-09			TCGA-E9-A54Y-01			c11ffcd0-8e82-4815-b30b-2d08945ce0bc		TCGA-E9-A54Y-01A-11D-A25N-01	TCGA-E9-A54Y-01		c11ffcd0-8e82-4815-b30b-2d08945ce0bc	TCGA-E9-A54Y-01A-11D-A25N-01	
TCGA-E9-A5FK-01																													0	TCGA-E9-A5FK-01	812	0	days										TCGA-E9-A5FK	812	0	days	812	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5FK-F70209	TCGA-E9-A5FK	TCGA-E9-A5FK-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-22199	77		0	812							80-89%			2015-1-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	10		true	No	M0	N3	T2	Stage IIIC	TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf	A5FK	TUMOR FREE						YES	YES	70-79%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012	6cdd2900-2b84-44d4-a9b3-bf75b12946b9	daaa223b-f768-4c89-8426-1c4f00bf9d0c	6cdd2900-2b84-44d4-a9b3-bf75b12946b9	daaa223b-f768-4c89-8426-1c4f00bf9d0c				TCGA-E9-A5FK-01	TCGA-E9-A5FK-01A-11D-A27Y-05		4dc0a26f-8214-4458-a74d-309dcd10c6a1	TCGA-E9-A5FK-01	TCGA-E9-A5FK-01A-11D-A27P-09			TCGA-E9-A5FK-01			6cdd2900-2b84-44d4-a9b3-bf75b12946b9		TCGA-E9-A5FK-01A-11D-A27O-01	TCGA-E9-A5FK-01		6cdd2900-2b84-44d4-a9b3-bf75b12946b9	TCGA-E9-A5FK-01A-11D-A27O-01	
TCGA-E9-A5FL-01																													0	TCGA-E9-A5FL-01	24	0	days										TCGA-E9-A5FL	24	0	days	24	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5FL-F56061	TCGA-E9-A5FL	TCGA-E9-A5FL-01A		Negative					Negative	Modified Radical Mastectomy		NO			-24053	73		0	24										2014-1-24	FEMALE										Metaplastic Carcinoma		No		C50.9	8575/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	590	NO	Negative		YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T3	Stage IIB	TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf	A5FL	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012	7810122d-fa8b-483d-9398-aa26fc7fedc5	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a	7810122d-fa8b-483d-9398-aa26fc7fedc5	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a				TCGA-E9-A5FL-01	TCGA-E9-A5FL-01A-11D-A27Y-05		dca0a85a-e2c5-4dcf-bc19-4b0374669de4	TCGA-E9-A5FL-01	TCGA-E9-A5FL-01A-11D-A27P-09			TCGA-E9-A5FL-01			7810122d-fa8b-483d-9398-aa26fc7fedc5		TCGA-E9-A5FL-01A-11D-A27O-01	TCGA-E9-A5FL-01		7810122d-fa8b-483d-9398-aa26fc7fedc5	TCGA-E9-A5FL-01A-11D-A27O-01	
TCGA-E9-A5UO-01																													0	TCGA-E9-A5UO-01	785	0	days										TCGA-E9-A5UO	785	0	days	785	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5UO-F70210	TCGA-E9-A5UO	TCGA-E9-A5UO-01A								Other		NO			-15050	98		0	785										2015-1-30	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	400	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf	A5UO	TUMOR FREE						NO	YES			NO	Primary Tumor	01	Partial mastectomy	7th		YES	NO	E9	Breast	A	LIVING	2012	4d601c2f-824f-461e-9270-42db0ab9138e	c70418fa-6b66-401e-b1c4-330100fe60a0	4d601c2f-824f-461e-9270-42db0ab9138e	c70418fa-6b66-401e-b1c4-330100fe60a0				TCGA-E9-A5UO-01	TCGA-E9-A5UO-01A-11D-A28C-05		9efb2dc7-5c0d-459f-9819-f1ca46df5bb0	TCGA-E9-A5UO-01	TCGA-E9-A5UO-01A-11D-A28B-09			TCGA-E9-A5UO-01			4d601c2f-824f-461e-9270-42db0ab9138e		TCGA-E9-A5UO-01A-11D-A28A-01	TCGA-E9-A5UO-01		4d601c2f-824f-461e-9270-42db0ab9138e	TCGA-E9-A5UO-01A-11D-A28A-01	
TCGA-E9-A5UP-01																													0	TCGA-E9-A5UP-01	803	0	days										TCGA-E9-A5UP	803	0	days	803	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-E9-A5UP-F71525	TCGA-E9-A5UP	TCGA-E9-A5UP-01A										NO			-23371	85		0	803										2015-3-26	FEMALE										Other, specify		No		C50.9	8503/3	C50.9		YES		Tumor resection	140	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf	A5UP	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012	0a9af348-b2a7-4fad-b939-7eda53e4f5a0	4bc204b6-5ec6-4786-9504-209305c82371	0a9af348-b2a7-4fad-b939-7eda53e4f5a0	4bc204b6-5ec6-4786-9504-209305c82371				TCGA-E9-A5UP-01	TCGA-E9-A5UP-01A-11D-A28C-05		7ba6fce9-3ad3-4659-9756-a6642af820e1	TCGA-E9-A5UP-01	TCGA-E9-A5UP-01A-11D-A28B-09			TCGA-E9-A5UP-01			0a9af348-b2a7-4fad-b939-7eda53e4f5a0		TCGA-E9-A5UP-01A-11D-A28A-01	TCGA-E9-A5UP-01		0a9af348-b2a7-4fad-b939-7eda53e4f5a0	TCGA-E9-A5UP-01A-11D-A28A-01	
TCGA-E9-A6HE-01																													0	TCGA-E9-A6HE-01	847	0	days										TCGA-E9-A6HE	847	0	days	847	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					45	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-E9-A6HE-F70947	TCGA-E9-A6HE	TCGA-E9-A6HE-01A		Positive					Positive	Simple Mastectomy		NO			-16697	203		0	847							90-99%	1.7		2015-3-10	FEMALE			<10%		1+	30	1.8	1.08		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	580	NO	Negative	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	12		true	No	MX	N3	T3	Stage IIIC	TCGA-E9-A6HE.649E6215-36F9-4BEB-9EE9-683E4FC75C42.pdf	A6HE	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	E9	Breast	A	LIVING	2012	ce48b228-7e2a-46e9-beca-ab990b5c2b3e	4d7aae97-ae34-43e0-97a4-bfb15e3543b4	ce48b228-7e2a-46e9-beca-ab990b5c2b3e	4d7aae97-ae34-43e0-97a4-bfb15e3543b4				TCGA-E9-A6HE-01	TCGA-E9-A6HE-01A-11D-A31V-05		a828df39-aa87-48a0-936a-7fd28c031dcf	TCGA-E9-A6HE-01				TCGA-E9-A6HE-01			ce48b228-7e2a-46e9-beca-ab990b5c2b3e		TCGA-E9-A6HE-01A-11D-A31T-01	TCGA-E9-A6HE-01		ce48b228-7e2a-46e9-beca-ab990b5c2b3e	TCGA-E9-A6HE-01A-11D-A31T-01	
TCGA-EW-A1IW-01	Stage IIB	80	2	Stage IIB	252		Positive	FEMALE	Positive				Negative	M0	Positive	N1	252	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1IW-01	371	0	days	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-EW-A1IW	371	0	days	371	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1IW-F21380	TCGA-EW-A1IW	TCGA-EW-A1IW-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-29529	213		0	371					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE		+ or -	90-99%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	90	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				3	4								NO	2	0	true	No	MX	N1a	T2	Stage IIB	TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf	A1IW	TUMOR FREE		CISH					YES	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	11707654-03d2-4f5b-988d-7d5f5b17386b	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	11707654-03d2-4f5b-988d-7d5f5b17386b		TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01	TCGA-EW-A1IW-01A-11D-A13K-05			TCGA-EW-A1IW-01	TCGA-EW-A1IW-01A-11D-A13L-09			TCGA-EW-A1IW-01	TCGA-EW-A1IW-01A-11D-A13L-09		7ddad1e7-783e-4095-87e0-48dbf5c5aa39		TCGA-EW-A1IW-01A-11D-A13J-01	TCGA-EW-A1IW-01		7ddad1e7-783e-4095-87e0-48dbf5c5aa39	TCGA-EW-A1IW-01A-11D-A13J-01	
TCGA-EW-A1IX-01	Stage IIA	48	4	Stage IIA	1082		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1082	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1IX-01	1208	0	days	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-EW-A1IX	1208	0	days	1208	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1IX-F21542	TCGA-EW-A1IX	TCGA-EW-A1IX-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-17597	1030		0	1208					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Other, specify		No		C50.9	8524/3	C50.9	3+	YES		Core needle biopsy	130	NO	Negative			27	Negative	Peri (6-12 months since last menstrual period)																				1	4								NO	1	1	true	No	MX	N1a	T1b	Stage IIA	TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf	A1IX	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01	total mastectomy	6th	YES	NO	YES	EW	Breast	A	LIVING	2008	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	1f0fc4e8-c27e-40dd-b531-4315a15be5af	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	1f0fc4e8-c27e-40dd-b531-4315a15be5af	TCGA-EW-A1IX-01A-21-A17J-20	TCGA-EW-A1IX-01A-12D-A142-09		TCGA-EW-A1IX-01	TCGA-EW-A1IX-01A-12D-A145-05		9b8d5601-180a-45df-a639-787f257c2e95	TCGA-EW-A1IX-01	TCGA-EW-A1IX-01A-12D-A142-09			TCGA-EW-A1IX-01	TCGA-EW-A1IX-01A-12D-A142-09		b908cd1b-b274-4b23-9cd5-b59d93a7a6c2		TCGA-EW-A1IX-01A-12D-A141-01	TCGA-EW-A1IX-01		b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	TCGA-EW-A1IX-01A-12D-A141-01	
TCGA-EW-A1IY-01	Stage I	38	2	Stage I	258		Positive	FEMALE	Negative				Negative	M0	Negative	N0	258	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1IY-01	258	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 12	cluster 7	mutation cluster 4	TCGA-EW-A1IY	258	0	days	258	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Right Upper Inner Quadrant	Other (specify)	sentinel LN and one non sentinel LN	TCGA-EW-A1IY-F29084	TCGA-EW-A1IY	TCGA-EW-A1IY-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-14122	590		0	258					NO		90-99%		Scheduled Follow-up Submission	2012-3-5	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	50	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	7								NO	0	0	true	No	MX	N0	T1c	Stage I	TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf	A1IY	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	8bdd50df-ff86-4ba2-ba6c-0b1ee39ceb25	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	8bdd50df-ff86-4ba2-ba6c-0b1ee39ceb25		TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01	TCGA-EW-A1IY-01A-11D-A13K-05			TCGA-EW-A1IY-01	TCGA-EW-A1IY-01A-11D-A188-09			TCGA-EW-A1IY-01	TCGA-EW-A1IY-01A-11D-A188-09		9b605e4f-fb75-4b02-a827-a6acfeb3c1b2		TCGA-EW-A1IY-01A-11D-A13J-01	TCGA-EW-A1IY-01		9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	TCGA-EW-A1IY-01A-11D-A13J-01	
TCGA-EW-A1IZ-01	Stage IIIA	53	1	Stage IIIA	260		Positive	FEMALE	Negative				Negative	M0	Positive	N2	260	0			Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1IZ-01	554	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8		miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-EW-A1IZ	554	0	days	554	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1IZ-F21543	TCGA-EW-A1IZ	TCGA-EW-A1IZ-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-19706	194		0	554					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES	stereotactic biopsy	Other method, specify:	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	3								NO	5		true	No	MX	N2a	T2	Stage IIIA	TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf	A1IZ	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	f5c72291-4c3f-456f-97a3-d93878744b54	8e008f46-3426-4b3f-b9bd-57f4b0ae24c6	f5c72291-4c3f-456f-97a3-d93878744b54	8e008f46-3426-4b3f-b9bd-57f4b0ae24c6	TCGA-EW-A1IZ-01A-21-A17J-20	TCGA-EW-A1IZ-01A-11D-A188-09		TCGA-EW-A1IZ-01	TCGA-EW-A1IZ-01A-11D-A13K-05		401f0a1d-c38e-463b-8195-8eba9ea21869	TCGA-EW-A1IZ-01	TCGA-EW-A1IZ-01A-11D-A188-09			TCGA-EW-A1IZ-01	TCGA-EW-A1IZ-01A-11D-A188-09		f5c72291-4c3f-456f-97a3-d93878744b54		TCGA-EW-A1IZ-01A-11D-A13J-01	TCGA-EW-A1IZ-01		f5c72291-4c3f-456f-97a3-d93878744b54	TCGA-EW-A1IZ-01A-11D-A13J-01	
TCGA-EW-A1J1-01	Stage IIB	38	2	Stage IIB	282		Positive	FEMALE	Negative				Negative	M0	Positive	N1	282	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1J1-01	575	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1J1	575	0	days	575	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					38	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1J1-F21181	TCGA-EW-A1J1	TCGA-EW-A1J1-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-14122	214		0	575					NO		90-99%		Scheduled Follow-up Submission	2012-2-3	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	170	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	5								NO	1	0	true	No	M0	N1a	T2	Stage IIB	TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf	A1J1	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	a9358498-02cf-4073-89bd-7c6add6e4120	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	a9358498-02cf-4073-89bd-7c6add6e4120	TCGA-EW-A1J1-01A-21-A17J-20	TCGA-EW-A1J1-01A-11D-A188-09		TCGA-EW-A1J1-01	TCGA-EW-A1J1-01A-11D-A13K-05		e87551f0-94b3-418c-b313-7cea4e66f70d	TCGA-EW-A1J1-01	TCGA-EW-A1J1-01A-11D-A188-09			TCGA-EW-A1J1-01	TCGA-EW-A1J1-01A-11D-A188-09		9d64aa0c-84a6-4e48-b28b-12aaf04813b6		TCGA-EW-A1J1-01A-11D-A13J-01	TCGA-EW-A1J1-01		9d64aa0c-84a6-4e48-b28b-12aaf04813b6	TCGA-EW-A1J1-01A-11D-A13J-01	
TCGA-EW-A1J2-01	Stage IIB	50	2	Stage IIA	139		Positive	FEMALE	Negative				Negative	M0	Positive	N1	139	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J2-01	403	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-EW-A1J2	403	0	days	403	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1J2-F21544	TCGA-EW-A1J2	TCGA-EW-A1J2-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-18558	51		0	403					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				2	6								NO	1	1	true	No	MX	N1mi	T1c	[Discrepancy]	TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf	A1J2	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	5a6b6013-11d0-498d-a014-3ea8e14c61d5	92172c25-66d6-497f-b9cf-03945ba27acd	5a6b6013-11d0-498d-a014-3ea8e14c61d5	92172c25-66d6-497f-b9cf-03945ba27acd	TCGA-EW-A1J2-01A-11-A17J-20	TCGA-EW-A1J2-01A-21D-A13L-09		TCGA-EW-A1J2-01	TCGA-EW-A1J2-01A-21D-A13K-05		ff844a9f-6c79-4252-bbb3-b5bbf5c3cf6f	TCGA-EW-A1J2-01	TCGA-EW-A1J2-01A-21D-A13L-09			TCGA-EW-A1J2-01	TCGA-EW-A1J2-01A-21D-A13L-09		5a6b6013-11d0-498d-a014-3ea8e14c61d5		TCGA-EW-A1J2-01A-21D-A13J-01	TCGA-EW-A1J2-01		5a6b6013-11d0-498d-a014-3ea8e14c61d5	TCGA-EW-A1J2-01A-21D-A13J-01	
TCGA-EW-A1J3-01	Stage IA	61	2	Stage I	252		Positive	FEMALE	Positive				Negative	M0	Negative	N0	252	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J3-01	504	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1J3	504	0	days	504	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1J3-F21351	TCGA-EW-A1J3	TCGA-EW-A1J3-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-22332	155		0	504					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE			90-99%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	80	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	2								NO	0	0	true	No	M0	N0	T1c	Stage IA	TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf	A1J3	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01	TOTAL MASTECTOMY	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	6e757a91-de03-4c2d-9088-22235e4b745a	f2f5bfd3-c9a3-4f3a-a7c9-ea412c46c589	6e757a91-de03-4c2d-9088-22235e4b745a	f2f5bfd3-c9a3-4f3a-a7c9-ea412c46c589	TCGA-EW-A1J3-01A-21-A17J-20	TCGA-EW-A1J3-01A-11D-A13L-09		TCGA-EW-A1J3-01	TCGA-EW-A1J3-01A-11D-A13K-05		01473e37-dbc5-42f9-b5e1-332a9b47c175	TCGA-EW-A1J3-01	TCGA-EW-A1J3-01A-11D-A13L-09			TCGA-EW-A1J3-01	TCGA-EW-A1J3-01A-11D-A13L-09		6e757a91-de03-4c2d-9088-22235e4b745a		TCGA-EW-A1J3-01A-11D-A13J-01	TCGA-EW-A1J3-01		6e757a91-de03-4c2d-9088-22235e4b745a	TCGA-EW-A1J3-01A-11D-A13J-01	
TCGA-EW-A1J5-01	Stage IIB	59	5	Stage IIB	227		Positive	FEMALE	Negative				Negative	M0	Negative	N0	227	0	LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-EW-A1J5-01	477	0	days	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-EW-A1J5	477	0	days	477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left	Sentinel node biopsy alone		TCGA-EW-A1J5-F21353	TCGA-EW-A1J5	TCGA-EW-A1J5-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-21559	123		0	477					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	180	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	7								NO	0	0	true	No	M0	N0 (i-)	T3	Stage IIB	TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf	A1J5	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast	A	LIVING	2010	b1c4af00-f395-47ac-93c7-b32a293ca060	8069f916-9d52-4a2c-b30d-3f10e520e1e1	b1c4af00-f395-47ac-93c7-b32a293ca060	8069f916-9d52-4a2c-b30d-3f10e520e1e1	TCGA-EW-A1J5-01A-21-A17J-20	TCGA-EW-A1J5-01A-11D-A13L-09		TCGA-EW-A1J5-01	TCGA-EW-A1J5-01A-11D-A13K-05		7470a7db-5af2-4e9e-92f6-d9f8ca74e15d	TCGA-EW-A1J5-01	TCGA-EW-A1J5-01A-11D-A13L-09			TCGA-EW-A1J5-01	TCGA-EW-A1J5-01A-11D-A13L-09		b1c4af00-f395-47ac-93c7-b32a293ca060		TCGA-EW-A1J5-01A-11D-A13J-01	TCGA-EW-A1J5-01		b1c4af00-f395-47ac-93c7-b32a293ca060	TCGA-EW-A1J5-01A-11D-A13J-01	
TCGA-EW-A1J6-01	Stage I	70	4	Stage I	595		Positive	FEMALE	Negative				Negative	M0	Negative	N0	595	0	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J6-01	875	0	days	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1J6	875	0	days	875	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-EW-A1J6-F21347	TCGA-EW-A1J6	TCGA-EW-A1J6-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-25830	528		0	875					NO		90-99%		Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	80	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	2								NO	0	0	true	No	M0	N0 (i-)	T1c	Stage I	TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf	A1J6	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	7051836f-e1d4-49dd-8118-4541c0bdde57	64cc469d-eaf1-4a4e-853e-612c931c28b6	7051836f-e1d4-49dd-8118-4541c0bdde57	64cc469d-eaf1-4a4e-853e-612c931c28b6		TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01	TCGA-EW-A1J6-01A-11D-A13K-05			TCGA-EW-A1J6-01	TCGA-EW-A1J6-01A-11D-A188-09			TCGA-EW-A1J6-01	TCGA-EW-A1J6-01A-11D-A188-09		7051836f-e1d4-49dd-8118-4541c0bdde57		TCGA-EW-A1J6-01A-11D-A13J-01	TCGA-EW-A1J6-01		7051836f-e1d4-49dd-8118-4541c0bdde57	TCGA-EW-A1J6-01A-11D-A13J-01	
TCGA-EW-A1OV-01	Stage IIB	56	1	Stage IIB	522		Negative	FEMALE	Negative				Negative	M0	Positive	N1	522	0	Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OV-01	789	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1OV	789	0	days	789	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1OV-F29119	TCGA-EW-A1OV	TCGA-EW-A1OV-01A	Negative	Negative	3 Point Scale		3 Point Scale	Modified radical mastectomy	Negative	Lumpectomy		YES			-20764	469		0	789					NO		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%					1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative	Negative		6	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	5								NO	0	1	true	No	MX	N1mi	T2	Stage IIB	TCGA-EW-A1OV.88E39E13-8ADC-481A-992E-610B3BEBCBD4.pdf	A1OV	TUMOR FREE							YES	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	b21367b5-91a3-4546-ba89-e33c462cb75b	5ffeb466-cd09-441c-a635-9feea1d71ff4	b21367b5-91a3-4546-ba89-e33c462cb75b	5ffeb466-cd09-441c-a635-9feea1d71ff4	TCGA-EW-A1OV-01A-21-A17J-20	TCGA-EW-A1OV-01A-11D-A142-09		TCGA-EW-A1OV-01	TCGA-EW-A1OV-01A-11D-A145-05		c9e8a21c-2cd8-404b-a8dc-7958940df71a	TCGA-EW-A1OV-01	TCGA-EW-A1OV-01A-11D-A142-09			TCGA-EW-A1OV-01	TCGA-EW-A1OV-01A-11D-A142-09		b21367b5-91a3-4546-ba89-e33c462cb75b		TCGA-EW-A1OV-01A-11D-A141-01	TCGA-EW-A1OV-01		b21367b5-91a3-4546-ba89-e33c462cb75b	TCGA-EW-A1OV-01A-11D-A141-01	
TCGA-EW-A1OW-01	Stage IIA	58	1	Stage IIA	463		Negative	FEMALE	Negative				Negative	M0	Negative	N0	463	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OW-01	694	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8				TCGA-EW-A1OW	694	0	days	694	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1OW-F29117	TCGA-EW-A1OW	TCGA-EW-A1OW-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-21465	444		0	694					NO		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8090/3	C50.9		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5									NO	0	0	true	No	MX	N0	T2	Stage IIA	TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf	A1OW	TUMOR FREE							YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	21cc5775-0987-4088-b19c-86bf43f09bb2	0941a978-c8aa-467b-8464-9f979d1f0418	21cc5775-0987-4088-b19c-86bf43f09bb2	0941a978-c8aa-467b-8464-9f979d1f0418	TCGA-EW-A1OW-01A-11-A17J-20			TCGA-EW-A1OW-01	TCGA-EW-A1OW-01A-21D-A145-05		a4d72446-5d9b-4b8d-af59-9add055da84e	TCGA-EW-A1OW-01				TCGA-EW-A1OW-01			21cc5775-0987-4088-b19c-86bf43f09bb2		TCGA-EW-A1OW-01A-21D-A141-01	TCGA-EW-A1OW-01		21cc5775-0987-4088-b19c-86bf43f09bb2	TCGA-EW-A1OW-01A-21D-A141-01	
TCGA-EW-A1OX-01	Stage IIA	43	3	Stage IIA	562		Positive	FEMALE	Negative				Negative	M0	Negative	N0	562	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OX-01	911	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-EW-A1OX	911	0	days	911	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right Upper Inner Quadrant	Other (specify)	sentinel + non sentinel	TCGA-EW-A1OX-F29099	TCGA-EW-A1OX	TCGA-EW-A1OX-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-15837	550		0	911					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Mucinous Carcinoma		No		C50.9	8523/3	C50.9	3+	YES		Core needle biopsy	140	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				3	1								NO	0	0	true	No	MX	N0	T2	Stage IIA	TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf	A1OX	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	9b5d680e-5662-442c-a8ab-5fd16551b23e	d6e0a8bc-62cf-476a-8528-9a6e7b98871f	9b5d680e-5662-442c-a8ab-5fd16551b23e	d6e0a8bc-62cf-476a-8528-9a6e7b98871f	TCGA-EW-A1OX-01A-21-A17J-20	TCGA-EW-A1OX-01A-11D-A142-09		TCGA-EW-A1OX-01	TCGA-EW-A1OX-01A-11D-A145-05		7cf0f94c-e8fc-4237-8cbf-164c073c26b0	TCGA-EW-A1OX-01	TCGA-EW-A1OX-01A-11D-A142-09			TCGA-EW-A1OX-01	TCGA-EW-A1OX-01A-11D-A142-09		9b5d680e-5662-442c-a8ab-5fd16551b23e		TCGA-EW-A1OX-01A-11D-A141-01	TCGA-EW-A1OX-01		9b5d680e-5662-442c-a8ab-5fd16551b23e	TCGA-EW-A1OX-01A-11D-A141-01	
TCGA-EW-A1OY-01	Stage IIA	63	5	Stage IIA	593		Positive	FEMALE	Negative				Negative	M0	Negative	N0	593	0	LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OY-01	908	0	days	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-EW-A1OY	908	0	days	908	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left	Sentinel node biopsy alone		TCGA-EW-A1OY-F30950	TCGA-EW-A1OY	TCGA-EW-A1OY-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-23266	526		0	908					NO		90-99%		Scheduled Follow-up Submission	2012-3-23	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	4								NO	0	0	true	No	MX	N0	T2	Stage IIA	TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf	A1OY	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	0c3f0857-32d7-4ef6-b303-6e452ee04516	5c54e392-615a-4904-b3a4-d50ed00a8f73	0c3f0857-32d7-4ef6-b303-6e452ee04516	5c54e392-615a-4904-b3a4-d50ed00a8f73	TCGA-EW-A1OY-01A-21-A17J-20	TCGA-EW-A1OY-01A-11D-A142-09		TCGA-EW-A1OY-01	TCGA-EW-A1OY-01A-11D-A145-05		5355fa5f-6aba-4f01-9799-7f1a83eadc2a	TCGA-EW-A1OY-01	TCGA-EW-A1OY-01A-11D-A142-09			TCGA-EW-A1OY-01	TCGA-EW-A1OY-01A-11D-A142-09		0c3f0857-32d7-4ef6-b303-6e452ee04516		TCGA-EW-A1OY-01A-11D-A141-01	TCGA-EW-A1OY-01		0c3f0857-32d7-4ef6-b303-6e452ee04516	TCGA-EW-A1OY-01A-11D-A141-01	
TCGA-EW-A1OZ-01	Stage IIA	56	5	Stage IIA	941		Positive	FEMALE	Positive				Negative	M0	Negative	N0	941	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OZ-01	1229	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation cluster 8	TCGA-EW-A1OZ	1229	0	days	1229	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1OZ-F29098	TCGA-EW-A1OZ	TCGA-EW-A1OZ-01A		Positive	3 Point Scale		3 Point Scale		Negative	Other		YES			-20664	928		0	1229					NO		90-99%	2	Scheduled Follow-up Submission	2012-3-8	FEMALE			20-29%		2+	40		2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	210	NO	Equivocal	Positive		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	4								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf	A1OZ	TUMOR FREE							YES	<10%		NO	Primary Tumor	01	total mastectomy	6th	YES	NO	YES	EW	Breast	A	LIVING	2008	73f6a579-eab4-4fbf-bb17-41f1a6614ace	d71a4ddd-13bd-4c7d-86c4-dd64b25450ac	73f6a579-eab4-4fbf-bb17-41f1a6614ace	d71a4ddd-13bd-4c7d-86c4-dd64b25450ac	TCGA-EW-A1OZ-01A-21-A17J-20	TCGA-EW-A1OZ-01A-11D-A142-09		TCGA-EW-A1OZ-01	TCGA-EW-A1OZ-01A-11D-A145-05		ec87ecc1-dbdd-478f-aea6-a982f92222e8	TCGA-EW-A1OZ-01	TCGA-EW-A1OZ-01A-11D-A142-09			TCGA-EW-A1OZ-01	TCGA-EW-A1OZ-01A-11D-A142-09		73f6a579-eab4-4fbf-bb17-41f1a6614ace		TCGA-EW-A1OZ-01A-11D-A141-01	TCGA-EW-A1OZ-01		73f6a579-eab4-4fbf-bb17-41f1a6614ace	TCGA-EW-A1OZ-01A-11D-A141-01	
TCGA-EW-A1P0-01	Stage IIB	55	4	Stage IIB	1121		Positive	FEMALE	Negative				Negative	M0	Positive	N1	1121	0	LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P0-01	1251	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-EW-A1P0	1094	1	days	1251	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		55	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1P0-F29105	TCGA-EW-A1P0	TCGA-EW-A1P0-01A		Positive	3 Point Scale		3 Point Scale		Negative	Modified Radical Mastectomy		NO		1105	-20107	1142		0	1251			1094		YES		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Other, specify		No		C50.9	8523/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%		<10%			3+	1+			<10%		Negative			5	7				Other, specify	Distant Metastasis	mediastinal lymph node		YES	1		true	No	MX	N1b	T2	Stage IIB	TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf	A1P0	TUMOR FREE							YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	16fcbaec-f629-4d04-ab61-3f9b782e710d	c5e3d0a9-e703-4c1c-92eb-3dcc093d14e2	16fcbaec-f629-4d04-ab61-3f9b782e710d	c5e3d0a9-e703-4c1c-92eb-3dcc093d14e2	TCGA-EW-A1P0-01A-21-A17J-20	TCGA-EW-A1P0-01A-11D-A142-09		TCGA-EW-A1P0-01	TCGA-EW-A1P0-01A-11D-A145-05		d39ecd5c-5a18-46dc-b6e6-356c239d7ec3	TCGA-EW-A1P0-01	TCGA-EW-A1P0-01A-11D-A142-09			TCGA-EW-A1P0-01	TCGA-EW-A1P0-01A-11D-A142-09		16fcbaec-f629-4d04-ab61-3f9b782e710d		TCGA-EW-A1P0-01A-11D-A141-01	TCGA-EW-A1P0-01		16fcbaec-f629-4d04-ab61-3f9b782e710d	TCGA-EW-A1P0-01A-11D-A141-01	
TCGA-EW-A1P1-01	Stage IIIC	68	1	Stage IIIC	919		Negative	FEMALE	Negative				Negative	M0	Positive	N3	919	0			Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P1-01	1210	0	days	Kirc+	C5-KIRC	cluster 1	Low purity c2	KIRC-like c1		miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-EW-A1P1	1014	1	days	1210	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO	YES		68	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P1-F29115	TCGA-EW-A1P1	TCGA-EW-A1P1-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO		1200	-24923	850		0	1210			1014		YES		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	1+		Negative	<10%		<10%							<10%		Negative	Lung		1	6				Lung	Distant Metastasis			YES	11		true	No	MX	N3b	T2	Stage IIIC	TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf	A1P1	TUMOR FREE							YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	8a430d45-6511-4900-954e-fd01106d0f22	cceccfe3-7764-4959-89ee-978af184c489	8a430d45-6511-4900-954e-fd01106d0f22	cceccfe3-7764-4959-89ee-978af184c489	TCGA-EW-A1P1-01A-21-A17J-20	TCGA-EW-A1P1-01A-31D-A14G-09		TCGA-EW-A1P1-01	TCGA-EW-A1P1-01A-31D-A14H-05		3d649ce7-95df-442d-a4bb-88e71c4f5b10	TCGA-EW-A1P1-01	TCGA-EW-A1P1-01A-31D-A14G-09			TCGA-EW-A1P1-01	TCGA-EW-A1P1-01A-31D-A14G-09		8a430d45-6511-4900-954e-fd01106d0f22		TCGA-EW-A1P1-01A-31D-A14F-01	TCGA-EW-A1P1-01		8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-31D-A14F-01	
TCGA-EW-A1P3-01	Stage IIA	48	2	Stage IIA	987		Positive	FEMALE	Negative				Negative	M0	Negative	N0	987	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P3-01	1611	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-EW-A1P3	1611	0	days	1611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right Lower Outer Quadrant	Other (specify)	SN+1 non sentinel node	TCGA-EW-A1P3-F41142	TCGA-EW-A1P3	TCGA-EW-A1P3-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-17637	919		0	1611					NO		90-99%		Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				1	4								NO	0	0	true	Yes	MX	N0	T2	Stage IIA	TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf	A1P3	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	43c8eaea-f686-4e28-ba9c-360fea61b3ca	85ca025c-dd6b-413d-8994-e2d3e91d040f	43c8eaea-f686-4e28-ba9c-360fea61b3ca	85ca025c-dd6b-413d-8994-e2d3e91d040f	TCGA-EW-A1P3-01A-21-A17J-20	TCGA-EW-A1P3-01A-11D-A142-09		TCGA-EW-A1P3-01	TCGA-EW-A1P3-01A-11D-A145-05		d1b203a1-19d6-4504-a925-2cf22b888095	TCGA-EW-A1P3-01	TCGA-EW-A1P3-01A-11D-A142-09			TCGA-EW-A1P3-01	TCGA-EW-A1P3-01A-11D-A142-09		43c8eaea-f686-4e28-ba9c-360fea61b3ca		TCGA-EW-A1P3-01A-11D-A141-01	TCGA-EW-A1P3-01		43c8eaea-f686-4e28-ba9c-360fea61b3ca	TCGA-EW-A1P3-01A-11D-A141-01	
TCGA-EW-A1P4-01	Stage IIA	43	1	Stage IIA	501		Negative	FEMALE	Negative				Negative	M0	Negative	N0	501	0	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P4-01	907	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-EW-A1P4	907	0	days	907	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1P4-F29684	TCGA-EW-A1P4	TCGA-EW-A1P4-01A		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		YES			-15989	525		0	907					NO		<10%		Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%							Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Core needle biopsy	290	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				5	5								NO	0	0	true	No	M0	N0 (i-)	T2	Stage IIA	TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf	A1P4	TUMOR FREE							YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2009	91a5b906-6a04-4f0d-8710-172311e84789	260e860c-9034-4c71-bc77-db7f25ae2baf	91a5b906-6a04-4f0d-8710-172311e84789	260e860c-9034-4c71-bc77-db7f25ae2baf	TCGA-EW-A1P4-01A-11-A17J-20	TCGA-EW-A1P4-01A-21D-A142-09		TCGA-EW-A1P4-01	TCGA-EW-A1P4-01A-21D-A145-05		b7cf8b60-fd76-4c2c-aa8e-cc0d0c89009a	TCGA-EW-A1P4-01	TCGA-EW-A1P4-01A-21D-A142-09			TCGA-EW-A1P4-01	TCGA-EW-A1P4-01A-21D-A142-09		91a5b906-6a04-4f0d-8710-172311e84789		TCGA-EW-A1P4-01A-21D-A141-01	TCGA-EW-A1P4-01		91a5b906-6a04-4f0d-8710-172311e84789	TCGA-EW-A1P4-01A-21D-A141-01	
TCGA-EW-A1P5-01	Stage IIB	77	3	Stage IIB	365		Positive	FEMALE	Negative				Negative	M0	Positive	N1	365	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P5-01	703	0	days	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6	cluster 3	mutation cluster 4	TCGA-EW-A1P5	703	0	days	703	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P5-F32249	TCGA-EW-A1P5	TCGA-EW-A1P5-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-28177	325		0	703					NO		90-99%		Scheduled Follow-up Submission	2012-5-15	FEMALE			<10%					1.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative	Negative		40	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4	3								NO	3	0	true	No	M0	N1a	T2	Stage IIB	TCGA-EW-A1P5.82771A56-81CA-4414-949F-EFBCAE1C98D4.pdf	A1P5	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	e9d4f9c8-7355-44c4-9b18-923db7bae832	9e80cde3-cb84-4a55-a77d-15eb2d799d10	e9d4f9c8-7355-44c4-9b18-923db7bae832	9e80cde3-cb84-4a55-a77d-15eb2d799d10	TCGA-EW-A1P5-01A-21-A17J-20	TCGA-EW-A1P5-01A-11D-A142-09		TCGA-EW-A1P5-01	TCGA-EW-A1P5-01A-11D-A145-05		ef44d5ee-0e6f-4ec3-8db0-b0c426708430	TCGA-EW-A1P5-01	TCGA-EW-A1P5-01A-11D-A142-09			TCGA-EW-A1P5-01	TCGA-EW-A1P5-01A-11D-A142-09		e9d4f9c8-7355-44c4-9b18-923db7bae832		TCGA-EW-A1P5-01A-11D-A141-01	TCGA-EW-A1P5-01		e9d4f9c8-7355-44c4-9b18-923db7bae832	TCGA-EW-A1P5-01A-11D-A141-01	
TCGA-EW-A1P6-01	Stage IIB	64	4	Stage IIB	312		Positive	FEMALE	Negative				Negative	M0	Positive	N1	312	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P6-01	562	0	days	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1P6	562	0	days	562	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P6-F29114	TCGA-EW-A1P6	TCGA-EW-A1P6-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-23485	249		0	562					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	50	NO	Negative			25	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2	2								NO	2	0	true	No	M0	N1a	T2	Stage IIB	TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf	A1P6	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	9dddaf60-64ed-4d41-a546-79e86db1101e	b6a2cace-5fb3-440b-8647-08548b388755	9dddaf60-64ed-4d41-a546-79e86db1101e	b6a2cace-5fb3-440b-8647-08548b388755		TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01	TCGA-EW-A1P6-01A-11D-A145-05			TCGA-EW-A1P6-01	TCGA-EW-A1P6-01A-11D-A142-09			TCGA-EW-A1P6-01	TCGA-EW-A1P6-01A-11D-A142-09		9dddaf60-64ed-4d41-a546-79e86db1101e		TCGA-EW-A1P6-01A-11D-A141-01	TCGA-EW-A1P6-01		9dddaf60-64ed-4d41-a546-79e86db1101e	TCGA-EW-A1P6-01A-11D-A141-01	
TCGA-EW-A1P7-01	Stage IIA	59	1	Stage IIA	635		Negative	FEMALE	Negative				Negative	M0	Negative	N0	635	0	Normal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P7-01	915	0	days	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2		BRCA basal-like c8	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-EW-A1P7	729	1	days	915	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO	YES		59	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A1P7-F29118	TCGA-EW-A1P7			Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES		793	-21750			0	915			729		NO		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	3				Other, specify	Distant Metastasis	mediastinal lymph nodes		YES	0	0		No	M0	N0 (i-)	T2	Stage IIA		A1P7	WITH TUMOR							YES	<10%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast		LIVING	2009	e11a1fd3-d409-4e09-a8ab-5d0afb455263	f179bb91-8b60-4eaf-aea1-5161b0c96719	e11a1fd3-d409-4e09-a8ab-5d0afb455263	f179bb91-8b60-4eaf-aea1-5161b0c96719		TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01	TCGA-EW-A1P7-01A-21D-A145-05			TCGA-EW-A1P7-01	TCGA-EW-A1P7-01A-21D-A142-09			TCGA-EW-A1P7-01	TCGA-EW-A1P7-01A-21D-A142-09		e11a1fd3-d409-4e09-a8ab-5d0afb455263		TCGA-EW-A1P7-01A-21D-A141-01	TCGA-EW-A1P7-01		e11a1fd3-d409-4e09-a8ab-5d0afb455263	TCGA-EW-A1P7-01A-21D-A141-01	
TCGA-EW-A1P8-01	Stage IIIC	58	3	Stage IIIC	239	239	Negative	FEMALE	Negative				Negative	M0	Positive	N3	239	1	Basal		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-EW-A1P8-01	239	1	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 12	TCGA-EW-A1P8	207	1	days	239	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast			NO		58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1P8-F29121	TCGA-EW-A1P8	TCGA-EW-A1P8-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		NO			-21501	224	239	0				207		YES		<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	160	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative	<10%		<10%							<10%		Negative	Lung|Bone|Liver|Other, specify	skin	5	5				Lung	Distant Metastasis			YES	14		true	No	M0	N3b	T2	Stage IIIC	TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf	A1P8	WITH TUMOR							YES	<10%		NO	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	DECEASED	2010	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	1dce5c12-1c51-4544-b148-7d313826a491	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	1dce5c12-1c51-4544-b148-7d313826a491	TCGA-EW-A1P8-01A-21-A17J-20	TCGA-EW-A1P8-01A-11D-A142-09		TCGA-EW-A1P8-01	TCGA-EW-A1P8-01A-11D-A145-05		9729bae9-2494-4ef3-9382-a564fa2a1363	TCGA-EW-A1P8-01	TCGA-EW-A1P8-01A-11D-A142-09			TCGA-EW-A1P8-01	TCGA-EW-A1P8-01A-11D-A142-09		d763ccd4-4a11-4e84-b0a6-1b42da020ce4		TCGA-EW-A1P8-01A-11D-A141-01	TCGA-EW-A1P8-01		d763ccd4-4a11-4e84-b0a6-1b42da020ce4	TCGA-EW-A1P8-01A-11D-A141-01	
TCGA-EW-A1PA-01	Stage IIB	59	1	Stage IIB	267		Positive	FEMALE	Negative				Negative	M0	Positive	N1	267	0	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1PA-01	575	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7			mutation cluster 5	TCGA-EW-A1PA	575	0	days	575	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1PA-F30937	TCGA-EW-A1PA	TCGA-EW-A1PA-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-21837	220		0	575					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				4									NO	1		true	No	M0	N1a	T2	Stage IIB	TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf	A1PA	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	8c0b7027-f371-4a72-9152-2d00fc54e086	80450b0c-0c95-4b4a-9575-4d5a07de3821	8c0b7027-f371-4a72-9152-2d00fc54e086	80450b0c-0c95-4b4a-9575-4d5a07de3821	TCGA-EW-A1PA-01A-21-A17K-20	TCGA-EW-A1PA-01A-11D-A142-09		TCGA-EW-A1PA-01	TCGA-EW-A1PA-01A-11D-A145-05		281ecf6a-bcfa-485e-bec7-694899bf33ba	TCGA-EW-A1PA-01	TCGA-EW-A1PA-01A-11D-A142-09			TCGA-EW-A1PA-01	TCGA-EW-A1PA-01A-11D-A142-09		8c0b7027-f371-4a72-9152-2d00fc54e086		TCGA-EW-A1PA-01A-11D-A141-01	TCGA-EW-A1PA-01		8c0b7027-f371-4a72-9152-2d00fc54e086	TCGA-EW-A1PA-01A-11D-A141-01	
TCGA-EW-A1PB-01	Stage IIIA	70	3	Stage IIIA	608		Negative	FEMALE	Negative				Negative	M0	Positive	N1	608	0	Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-EW-A1PB-01	608	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-EW-A1PB	608	0	days	608	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1PB-F29107	TCGA-EW-A1PB	TCGA-EW-A1PB-01A		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		NO			-25770	569		0	608							<10%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	2								NO	2		true	No	MX	N1a	T3	Stage IIIA	TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf	A1PB	TUMOR FREE							YES	<10%		NO	Primary Tumor	01		6th	NO	NO	YES	EW	Breast	A	LIVING	2009	50674dde-30c1-4530-a164-381d5326e29c	e50f848e-a469-41c1-b44b-4dbc283fd0a6	50674dde-30c1-4530-a164-381d5326e29c	e50f848e-a469-41c1-b44b-4dbc283fd0a6	TCGA-EW-A1PB-01A-21-A17J-20	TCGA-EW-A1PB-01A-11D-A142-09		TCGA-EW-A1PB-01	TCGA-EW-A1PB-01A-11D-A145-05		0bdf178b-3488-411a-bda6-2b7ee3beb0fd	TCGA-EW-A1PB-01	TCGA-EW-A1PB-01A-11D-A142-09			TCGA-EW-A1PB-01	TCGA-EW-A1PB-01A-11D-A142-09		50674dde-30c1-4530-a164-381d5326e29c		TCGA-EW-A1PB-01A-11D-A141-01	TCGA-EW-A1PB-01		50674dde-30c1-4530-a164-381d5326e29c	TCGA-EW-A1PB-01A-11D-A141-01	
TCGA-EW-A1PC-01																			LumB										0	TCGA-EW-A1PC-01	187	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A1PC	187	0	days	187	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left	Sentinel node biopsy alone		TCGA-EW-A1PC-F29681	TCGA-EW-A1PC	TCGA-EW-A1PC-01B		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-24434	146		0	187					NO		90-99%		Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	MX	N0 (i-)	T3	Stage IIB	TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf	A1PC	TUMOR FREE							YES	50-59%		NO	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	B	LIVING	2011	3960601b-c341-45fb-8a8c-ec244ee719ac	21b60917-e609-4abf-ae06-cb5da81971a2	3960601b-c341-45fb-8a8c-ec244ee719ac	21b60917-e609-4abf-ae06-cb5da81971a2	TCGA-EW-A1PC-01B-21-A24A-20			TCGA-EW-A1PC-01	TCGA-EW-A1PC-01B-11D-A21R-05		ea4d6b89-3adf-4eb2-a91c-88e799d79af3	TCGA-EW-A1PC-01	TCGA-EW-A1PC-01B-11D-A21Q-09			TCGA-EW-A1PC-01			3960601b-c341-45fb-8a8c-ec244ee719ac		TCGA-EW-A1PC-01B-11D-A21P-01	TCGA-EW-A1PC-01		3960601b-c341-45fb-8a8c-ec244ee719ac	TCGA-EW-A1PC-01B-11D-A21P-01	
TCGA-EW-A1PD-01	Stage IIA	61	5	Stage IIA	174		Positive	MALE	Positive				Negative	M0	Positive	N1	174	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PD-01	424	0	days	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 14	cluster 4	mutation c1uster 9	TCGA-EW-A1PD	424	0	days	424	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1PD-F29106	TCGA-EW-A1PD	TCGA-EW-A1PD-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-22536	112		0	424					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	MALE			20-29%		2+		>6.0	2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	120	NO	Equivocal	Positive		7	Negative																					2	4								NO	2		true	No	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf	A1PD	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	69971d5c-5be4-4886-bf7c-753de9593a1e	954517bf-4fed-4279-9e69-f036b0a48858	69971d5c-5be4-4886-bf7c-753de9593a1e	954517bf-4fed-4279-9e69-f036b0a48858	TCGA-EW-A1PD-01A-21-A17J-20	TCGA-EW-A1PD-01A-11D-A142-09		TCGA-EW-A1PD-01	TCGA-EW-A1PD-01A-11D-A145-05		1dab2beb-b0c7-4eee-bc45-71997f6077e9	TCGA-EW-A1PD-01	TCGA-EW-A1PD-01A-11D-A142-09			TCGA-EW-A1PD-01	TCGA-EW-A1PD-01A-11D-A142-09		69971d5c-5be4-4886-bf7c-753de9593a1e		TCGA-EW-A1PD-01A-11D-A141-01	TCGA-EW-A1PD-01		69971d5c-5be4-4886-bf7c-753de9593a1e	TCGA-EW-A1PD-01A-11D-A141-01	
TCGA-EW-A1PE-01	Stage IIA	56	2	Stage IIA	139		Positive	FEMALE	Negative				Negative	M0	Positive	N1	139	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PE-01	320	0	days	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-EW-A1PE	320	0	days	320	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A1PE-F29108	TCGA-EW-A1PE	TCGA-EW-A1PE-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-20694	44		0	320					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8507/3	C50.9	3+	YES		[Discrepancy]	150	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	3								NO	1		true	No	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf	A1PE	TUMOR FREE							YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2011	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	edb71760-a163-45eb-9e5a-671cdebc2539	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	edb71760-a163-45eb-9e5a-671cdebc2539	TCGA-EW-A1PE-01A-21-A17J-20	TCGA-EW-A1PE-01A-11D-A142-09		TCGA-EW-A1PE-01	TCGA-EW-A1PE-01A-11D-A145-05		f5581422-7c21-4ccb-8006-b976b1b49459	TCGA-EW-A1PE-01	TCGA-EW-A1PE-01A-11D-A142-09			TCGA-EW-A1PE-01	TCGA-EW-A1PE-01A-11D-A142-09		4a21d42c-b231-4ffc-8c15-4bd73bf610b4		TCGA-EW-A1PE-01A-11D-A141-01	TCGA-EW-A1PE-01		4a21d42c-b231-4ffc-8c15-4bd73bf610b4	TCGA-EW-A1PE-01A-11D-A141-01	
TCGA-EW-A1PF-01	Stage IA	50	5	Stage I	139		Positive	FEMALE	Negative				Negative	M0	Negative	N0	139	0	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PF-01	439	0	days	Kirc+		cluster 1	BRCA CIMP c7		BRCA nonbasal-like c7	miRNA cluster 4	cluster 4		TCGA-EW-A1PF	439	0	days	439	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right Upper Outer Quadrant	Other (specify)	sentinel + 2 non-sentinel LN	TCGA-EW-A1PF-F29109	TCGA-EW-A1PF			Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-18384			0	439					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	4								NO	0	0		No	M0	N0	T1c	Stage IA		A1PF	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	Breast		LIVING	2010	faa3383f-6f9f-43d8-b61d-4a1522a71444	c8b29059-d76b-4b62-9a59-31f7dc9bc3a1	faa3383f-6f9f-43d8-b61d-4a1522a71444	c8b29059-d76b-4b62-9a59-31f7dc9bc3a1				TCGA-EW-A1PF-01	TCGA-EW-A1PF-01A-11D-A145-05			TCGA-EW-A1PF-01				TCGA-EW-A1PF-01			faa3383f-6f9f-43d8-b61d-4a1522a71444		TCGA-EW-A1PF-01A-11D-A141-01	TCGA-EW-A1PF-01		faa3383f-6f9f-43d8-b61d-4a1522a71444	TCGA-EW-A1PF-01A-11D-A141-01	
TCGA-EW-A1PG-01	Stage IIB	53	1	Stage IIB	875		Positive	FEMALE	Negative				Negative	M0	Positive	N1	875	0	Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1PG-01	1051	0	days	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-EW-A1PG	1051	0	days	1051	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1PG-F29103	TCGA-EW-A1PG	TCGA-EW-A1PG-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-19464	829		0	1051					NO		90-99%		Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+		<4.0	1.8		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	210	NO	Equivocal	Negative		25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				1	6								NO	1	1	true	No	MX	N1a	T2	Stage IIB	TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf	A1PG	TUMOR FREE							YES	90-99%		NO	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	1205dc3c-e766-4a25-b485-c66e301e3b6d	ae1d6f65-aca6-4e15-86e3-f9a6db8a726b	1205dc3c-e766-4a25-b485-c66e301e3b6d	ae1d6f65-aca6-4e15-86e3-f9a6db8a726b	TCGA-EW-A1PG-01A-21-A17J-20	TCGA-EW-A1PG-01A-11D-A142-09		TCGA-EW-A1PG-01	TCGA-EW-A1PG-01A-11D-A145-05		6621baf4-3dc5-4905-99b2-f40d75886fa0	TCGA-EW-A1PG-01	TCGA-EW-A1PG-01A-11D-A142-09			TCGA-EW-A1PG-01	TCGA-EW-A1PG-01A-11D-A142-09		1205dc3c-e766-4a25-b485-c66e301e3b6d		TCGA-EW-A1PG-01A-11D-A141-01	TCGA-EW-A1PG-01		1205dc3c-e766-4a25-b485-c66e301e3b6d	TCGA-EW-A1PG-01A-11D-A141-01	
TCGA-EW-A1PH-01	Stage IIA	52	1	Stage IIA	139		Negative	FEMALE					Negative	M0	Positive	N1	139	0	Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PH-01	607	0	days	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-EW-A1PH	607	0	days	607	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A1PH-F41145	TCGA-EW-A1PH	TCGA-EW-A1PH-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-19073	77		0	607					NO		<10%		Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				5	5								NO	1	0	true	No	M0	N1a	T1c	Stage IIA	TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf	A1PH	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2010	39413018-090f-46ca-b6df-244124f098c3	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba	39413018-090f-46ca-b6df-244124f098c3	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba		TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01	TCGA-EW-A1PH-01A-11D-A14N-05			TCGA-EW-A1PH-01	TCGA-EW-A1PH-01A-11D-A14K-09			TCGA-EW-A1PH-01	TCGA-EW-A1PH-01A-11D-A14K-09		39413018-090f-46ca-b6df-244124f098c3		TCGA-EW-A1PH-01A-11D-A14J-01	TCGA-EW-A1PH-01		39413018-090f-46ca-b6df-244124f098c3	TCGA-EW-A1PH-01A-11D-A14J-01	
TCGA-EW-A2FR-01																			Her2										0	TCGA-EW-A2FR-01	1673	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A2FR	1673	0	days	1673	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-EW-A2FR-F42056	TCGA-EW-A2FR	TCGA-EW-A2FR-01A		Negative	3 Point Scale	1+	3 Point Scale		Negative	Lumpectomy		NO			-21628	1015		0	1673					NO		<10%	2	Scheduled Follow-up Submission	2013-4-10	FEMALE			10-19%	ratio > 2.2 is positive	2+	40	>6	3.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100	NO	Equivocal	Positive	NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	19		true	No	MX	N3a	T1b	Stage IIIC	TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf	A2FR	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	2bd1673c-b5c0-425b-9e62-c501bf29616b	e7f50845-3225-4f28-88ce-4a11cdd598b3	2bd1673c-b5c0-425b-9e62-c501bf29616b	e7f50845-3225-4f28-88ce-4a11cdd598b3	TCGA-EW-A2FR-01A-21-A24A-20			TCGA-EW-A2FR-01	TCGA-EW-A2FR-01A-11D-A21R-05		977e315e-d1c6-4ef2-a078-178b88ff0ee5	TCGA-EW-A2FR-01	TCGA-EW-A2FR-01A-11D-A21Q-09			TCGA-EW-A2FR-01			2bd1673c-b5c0-425b-9e62-c501bf29616b		TCGA-EW-A2FR-01A-11D-A21P-01	TCGA-EW-A2FR-01		2bd1673c-b5c0-425b-9e62-c501bf29616b	TCGA-EW-A2FR-01A-11D-A21P-01	
TCGA-EW-A2FS-01		41	5		1173		Positive	FEMALE									1173	0	LumA		Negative				enrollment			LIVING	0	TCGA-EW-A2FS-01	1604	0	days	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A2FS	1604	0	days	1604	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A2FS-F42061	TCGA-EW-A2FS	TCGA-EW-A2FS-01A		Positive	3 Point Scale	1+	3 Point Scale		Negative	Lumpectomy		YES			-15302	1074		0	1604					NO		90-99%		Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative		NO	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	1		true	No	MX	N1mi	T2	Stage IIB	TCGA-EW-A2FS.F273B11F-D3CE-4619-BEC2-15C110567503.pdf	A2FS	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	EW	Breast	A	LIVING	2008	c0f29396-d239-4f0d-a95a-0838770eb24a	21baef37-e289-498a-b523-a283df5485af	c0f29396-d239-4f0d-a95a-0838770eb24a	21baef37-e289-498a-b523-a283df5485af	TCGA-EW-A2FS-01A-21-A24A-20			TCGA-EW-A2FS-01	TCGA-EW-A2FS-01A-11D-A17F-05		f5d09917-197f-4ba1-b19d-437841854522	TCGA-EW-A2FS-01	TCGA-EW-A2FS-01A-11D-A17D-09			TCGA-EW-A2FS-01			c0f29396-d239-4f0d-a95a-0838770eb24a		TCGA-EW-A2FS-01A-11D-A17C-01	TCGA-EW-A2FS-01		c0f29396-d239-4f0d-a95a-0838770eb24a	TCGA-EW-A2FS-01A-11D-A17C-01	
TCGA-EW-A2FV-01		39	3		238		Positive	FEMALE									238	0	LumA		Positive				enrollment			LIVING	0	TCGA-EW-A2FV-01	788	0	days	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-EW-A2FV	788	0	days	788	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Left Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-EW-A2FV-F42065	TCGA-EW-A2FV	TCGA-EW-A2FV-01A	Negative	Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-14316	133		0	788					NO		90-99%		Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Other, specify		No		C50.9	8507/3	C50.9	3+	YES		Excisional Biopsy	80	NO	Negative		NO	32	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																				4									NO	29		true	No	MX	N3a	T3	Stage IIIC	TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf	A2FV	TUMOR FREE						YES		90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2011	d60bfd82-87f0-4f13-8e90-6766beb84e9a	6c8f4fa1-9a13-4038-9ec1-a6b75b369488	d60bfd82-87f0-4f13-8e90-6766beb84e9a	6c8f4fa1-9a13-4038-9ec1-a6b75b369488	TCGA-EW-A2FV-01A-21-A24A-20			TCGA-EW-A2FV-01	TCGA-EW-A2FV-01A-11D-A17F-05		65bf3e8b-5558-49a2-a59e-6066ce8f38b5	TCGA-EW-A2FV-01	TCGA-EW-A2FV-01A-11D-A17D-09			TCGA-EW-A2FV-01			d60bfd82-87f0-4f13-8e90-6766beb84e9a		TCGA-EW-A2FV-01A-11D-A17C-01	TCGA-EW-A2FV-01		d60bfd82-87f0-4f13-8e90-6766beb84e9a	TCGA-EW-A2FV-01A-11D-A17C-01	
TCGA-EW-A2FW-01		52	3		190		Positive	FEMALE									190	0	LumB		Positive				enrollment			LIVING	0	TCGA-EW-A2FW-01	672	0	days	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-EW-A2FW	672	0	days	672	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A2FW-F42062	TCGA-EW-A2FW	TCGA-EW-A2FW-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-19085	99		0	672					NO		90-99%		Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Other, specify		No		C50.9	8503/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																				2									NO	0	0	true	No	MX	N0 (i-)	T2	Stage IIA	TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf	A2FW	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th	YES	NO	YES	EW	Breast	A	LIVING	2011	743f2962-126c-4b28-92fa-250b1170b825	0a9860d2-bf4a-4951-8bec-e9106594a1e8	743f2962-126c-4b28-92fa-250b1170b825	0a9860d2-bf4a-4951-8bec-e9106594a1e8	TCGA-EW-A2FW-01A-21-A24A-20			TCGA-EW-A2FW-01	TCGA-EW-A2FW-01A-11D-A17F-05		a4c623f3-e037-4a14-9be5-665cfc6a0c65	TCGA-EW-A2FW-01	TCGA-EW-A2FW-01A-11D-A17D-09			TCGA-EW-A2FW-01			743f2962-126c-4b28-92fa-250b1170b825		TCGA-EW-A2FW-01A-11D-A17C-01	TCGA-EW-A2FW-01		743f2962-126c-4b28-92fa-250b1170b825	TCGA-EW-A2FW-01A-11D-A17C-01	
TCGA-EW-A3E8-01																													0	TCGA-EW-A3E8-01	1035	0	days										TCGA-EW-A3E8	1035	0	days	1035	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A3E8-F57617	TCGA-EW-A3E8	TCGA-EW-A3E8-01B		Positive					Negative	Simple Mastectomy					-21922	505		0	1035										2014-3-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	50	NO	Negative		NO	2	Negative																														NO	0		true	No	MX	N0	T3	Stage IIB	TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf	A3E8	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	EW	Breast	B	LIVING	2011	37cb523b-c33a-4980-9b06-6e91389ce70e	6102c7a1-159c-4b8a-8725-6f0cd54959f7	37cb523b-c33a-4980-9b06-6e91389ce70e	6102c7a1-159c-4b8a-8725-6f0cd54959f7				TCGA-EW-A3E8-01	TCGA-EW-A3E8-01B-11D-A244-05			TCGA-EW-A3E8-01	TCGA-EW-A3E8-01B-11D-A243-09			TCGA-EW-A3E8-01			37cb523b-c33a-4980-9b06-6e91389ce70e		TCGA-EW-A3E8-01B-11D-A242-01	TCGA-EW-A3E8-01		37cb523b-c33a-4980-9b06-6e91389ce70e	TCGA-EW-A3E8-01B-11D-A242-01	
TCGA-EW-A3U0-01																													0	TCGA-EW-A3U0-01	532	0	days	High			Low purity c2	BRCA basal-like c6		miRNA cluster 4			TCGA-EW-A3U0	532	0	days	532	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left	Sentinel lymph node biopsy plus axillary dissection		TCGA-EW-A3U0-F42032	TCGA-EW-A3U0	TCGA-EW-A3U0-01A		Negative					Negative	Other		NO			-22520	182		0	532					NO					2013-4-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	M0	N1a	T3	Stage IIIA	TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf	A3U0	TUMOR FREE						YES	YES			YES	Primary Tumor	01	partial left mastectomy	7th		YES	NO	EW	Breast	A	LIVING	2011	4763b4dd-1eef-4503-9381-4baa57cc690f	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	4763b4dd-1eef-4503-9381-4baa57cc690f	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	TCGA-EW-A3U0-01A-21-A24A-20			TCGA-EW-A3U0-01	TCGA-EW-A3U0-01A-11D-A22B-05		0c52f4b2-07d9-4591-a6b7-e4700f8d476d	TCGA-EW-A3U0-01	TCGA-EW-A3U0-01A-11D-A228-09			TCGA-EW-A3U0-01			4763b4dd-1eef-4503-9381-4baa57cc690f		TCGA-EW-A3U0-01A-11D-A227-01	TCGA-EW-A3U0-01		4763b4dd-1eef-4503-9381-4baa57cc690f	TCGA-EW-A3U0-01A-11D-A227-01	
TCGA-EW-A423-01																													0	TCGA-EW-A423-01	533	0	days										TCGA-EW-A423	533	0	days	533	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-EW-A423-F42558	TCGA-EW-A423	TCGA-EW-A423-01A		Positive					Positive	Lumpectomy		NO			-27627	161		0	533							50-59%			2014-3-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO	Negative		YES	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	MX	N0	T2	Stage IIA	TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf	A423	TUMOR FREE						[Discrepancy]	YES	<10%		[Discrepancy]	Primary Tumor	01		7th		YES	NO	EW	Breast	A	LIVING	2012	994c8287-b6e2-4743-80bb-fe8d0076ae44	c338d9aa-93a4-48d4-9774-e9c5b1a5b589	994c8287-b6e2-4743-80bb-fe8d0076ae44	c338d9aa-93a4-48d4-9774-e9c5b1a5b589				TCGA-EW-A423-01	TCGA-EW-A423-01A-11D-A244-05		9632bb77-ebd1-4a10-86ba-86f090839a31	TCGA-EW-A423-01	TCGA-EW-A423-01A-11D-A243-09			TCGA-EW-A423-01			994c8287-b6e2-4743-80bb-fe8d0076ae44		TCGA-EW-A423-01A-11D-A242-01	TCGA-EW-A423-01		994c8287-b6e2-4743-80bb-fe8d0076ae44	TCGA-EW-A423-01A-11D-A242-01	
TCGA-EW-A424-01																													0	TCGA-EW-A424-01	715	0	days										TCGA-EW-A424	715	0	days	715	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right	Sentinel node biopsy alone		TCGA-EW-A424-F57612	TCGA-EW-A424	TCGA-EW-A424-01A		Positive					Positive	Simple Mastectomy		YES			-18850	141		0	715							50-59%			2014-3-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Positive		NO	1	Negative																														NO	0	1	true	No	MX	N1	T3	Stage IIIA	TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf	A424	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	EW	Breast	A	LIVING	2012	1a571942-1f4c-4f93-8ad3-ea84dad7edaa	0ef9295c-2b43-455b-9cba-68eb70dd27d3	1a571942-1f4c-4f93-8ad3-ea84dad7edaa	0ef9295c-2b43-455b-9cba-68eb70dd27d3				TCGA-EW-A424-01	TCGA-EW-A424-01A-11D-A244-05		f3c98936-9cae-4e6c-8ff3-0af1a45b4a24	TCGA-EW-A424-01				TCGA-EW-A424-01			1a571942-1f4c-4f93-8ad3-ea84dad7edaa		TCGA-EW-A424-01A-11D-A242-01	TCGA-EW-A424-01		1a571942-1f4c-4f93-8ad3-ea84dad7edaa	TCGA-EW-A424-01A-11D-A242-01	
TCGA-EW-A6S9-01																													0	TCGA-EW-A6S9-01	463	0	days										TCGA-EW-A6S9	463	0	days	463	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					34	Right|Right Upper Outer Quadrant			TCGA-EW-A6S9-F71706	TCGA-EW-A6S9	TCGA-EW-A6S9-01A		Positive					Positive	Lumpectomy					-12755	139		0	463							50-59%			2015-3-30	FEMALE			50-59%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Positive		NO	3																															NO	1	1	true	No	M0	N1	T1c	Stage IIA	TCGA-EW-A6S9.4FC32F17-7A4D-4FF6-A710-FFFBC610CB56.pdf	A6S9	TUMOR FREE						NO	YES			NO	Primary Tumor	01		7th				EW	Breast	A	LIVING	2013	692abecd-9c2a-48ec-8794-7e84a5317c46	0a049359-6f7d-44c2-8a8a-3867fb4d87e1	692abecd-9c2a-48ec-8794-7e84a5317c46	0a049359-6f7d-44c2-8a8a-3867fb4d87e1				TCGA-EW-A6S9-01	TCGA-EW-A6S9-01A-22D-A33F-05		58744A3B-FEB8-4ADD-8B01-36397505D052	TCGA-EW-A6S9-01				TCGA-EW-A6S9-01			692abecd-9c2a-48ec-8794-7e84a5317c46		TCGA-EW-A6S9-01A-22D-A33D-01	TCGA-EW-A6S9-01		692abecd-9c2a-48ec-8794-7e84a5317c46	TCGA-EW-A6S9-01A-22D-A33D-01	
TCGA-EW-A6SA-01																													0	TCGA-EW-A6SA-01	510	0	days										TCGA-EW-A6SA	510	0	days	510	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left|Left Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-EW-A6SA	TCGA-EW-A6SA-01A		Positive					Negative	Simple Mastectomy		YES			-21623	152		0	510							50-59%			2015-2-27	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Negative			4	Negative																														NO		1	true	No	MX	N0 (i+)	T2	Stage II	TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf	A6SA	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	EW	Breast	A	LIVING	2013	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	6631aa60-6bc2-4604-98ab-0c7d5187fc7f	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	6631aa60-6bc2-4604-98ab-0c7d5187fc7f				TCGA-EW-A6SA-01	TCGA-EW-A6SA-01A-21D-A32T-05		3C4C4A1F-544E-4CB5-A1E8-50534496B737	TCGA-EW-A6SA-01				TCGA-EW-A6SA-01			2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168		TCGA-EW-A6SA-01A-21D-A32H-01	TCGA-EW-A6SA-01		2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	TCGA-EW-A6SA-01A-21D-A32H-01	
TCGA-EW-A6SB-01																													0	TCGA-EW-A6SB-01	760	0	days										TCGA-EW-A6SB	760	0	days	760	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left|Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-EW-A6SB	TCGA-EW-A6SB-01A		Negative					Negative	Modified Radical Mastectomy		YES			-22844	244		0	760										2015-3-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			8	Negative																														NO	0	0	true	No	M0	N0	T2	Stage II	TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf	A6SB	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th				EW	Breast	A	LIVING	2012	5cb6b038-fe0b-48db-af0b-2a25beb8d79b	d9b9b065-fec4-4abf-b818-6f832d64ead4	5cb6b038-fe0b-48db-af0b-2a25beb8d79b	d9b9b065-fec4-4abf-b818-6f832d64ead4				TCGA-EW-A6SB-01	TCGA-EW-A6SB-01A-12D-A32T-05		85666B68-022F-4583-83BB-7CD199387E0F	TCGA-EW-A6SB-01				TCGA-EW-A6SB-01			5cb6b038-fe0b-48db-af0b-2a25beb8d79b		TCGA-EW-A6SB-01A-12D-A32H-01	TCGA-EW-A6SB-01		5cb6b038-fe0b-48db-af0b-2a25beb8d79b	TCGA-EW-A6SB-01A-12D-A32H-01	
TCGA-EW-A6SC-01																													0	TCGA-EW-A6SC-01	952	0	days										TCGA-EW-A6SC	952	0	days	952	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					60	Left|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-EW-A6SC-F71017	TCGA-EW-A6SC	TCGA-EW-A6SC-01A		Positive					Positive	Lumpectomy		YES			-21918	350		0	952							50-59%			2015-3-12	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Negative		NO	2	Negative																														NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf	A6SC	TUMOR FREE						YES	YES	40-49%		YES	Primary Tumor	01		7th				EW	Breast	A	LIVING	2012	3b7ae466-954f-42aa-8e01-9908ef1c8123	71796d70-39a8-4fa4-894e-2e19953dd94d	3b7ae466-954f-42aa-8e01-9908ef1c8123	71796d70-39a8-4fa4-894e-2e19953dd94d				TCGA-EW-A6SC-01	TCGA-EW-A6SC-01A-12D-A32T-05		79418E7F-949D-489B-B953-B4942BC4C027	TCGA-EW-A6SC-01				TCGA-EW-A6SC-01			3b7ae466-954f-42aa-8e01-9908ef1c8123		TCGA-EW-A6SC-01A-12D-A32H-01	TCGA-EW-A6SC-01		3b7ae466-954f-42aa-8e01-9908ef1c8123	TCGA-EW-A6SC-01A-12D-A32H-01	
TCGA-EW-A6SD-01																													0	TCGA-EW-A6SD-01	1010	0	days										TCGA-EW-A6SD	1010	0	days	1010	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					32	Left|Left Upper Outer Quadrant				TCGA-EW-A6SD	TCGA-EW-A6SD-01A		Negative					Negative	Lumpectomy					-12006	441		0	1010							<10%			2015-3-14	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO				31	Negative																														NO	2	0	true	No	M0	N1a	T2	Stage IIB	TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf	A6SD	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	EW	Breast	A	LIVING	2012	54d166b6-fb32-4003-b944-8d0f23cfa125	58cceccb-40f5-4907-9e65-2e6b51f62a0a	54d166b6-fb32-4003-b944-8d0f23cfa125	58cceccb-40f5-4907-9e65-2e6b51f62a0a				TCGA-EW-A6SD-01	TCGA-EW-A6SD-01A-12D-A33F-05		9085B5BF-0B41-4E31-940F-BE8AF05ED3EC	TCGA-EW-A6SD-01				TCGA-EW-A6SD-01			54d166b6-fb32-4003-b944-8d0f23cfa125		TCGA-EW-A6SD-01A-12D-A33D-01	TCGA-EW-A6SD-01		54d166b6-fb32-4003-b944-8d0f23cfa125	TCGA-EW-A6SD-01A-12D-A33D-01	
TCGA-GI-A2C8-01			3																LumA										0	TCGA-GI-A2C8-01	225	0	days	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4		mutation c1uster 9	TCGA-GI-A2C8	225	0	days	225	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Sentinel node biopsy alone		TCGA-GI-A2C8-F21661	TCGA-GI-A2C8	TCGA-GI-A2C8-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-23103	2429		0	225					NO		90-99%		Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100	NO	Negative	Negative		10	Negative																					3									NO	0		false	No	MX	N0	T4b	Stage IIIB	TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf	A2C8								YES	<10%		YES	Primary Tumor	01		6th	YES	NO	YES	GI	Breast	A	LIVING	2004	21531069-76ec-4e0f-b915-51c00b2c42f1	d986386e-b0cc-46f5-a9dc-8e0c58178f4a	21531069-76ec-4e0f-b915-51c00b2c42f1	d986386e-b0cc-46f5-a9dc-8e0c58178f4a	TCGA-GI-A2C8-01A-21-A17K-20	TCGA-GI-A2C8-01A-11D-A16D-09		TCGA-GI-A2C8-01	TCGA-GI-A2C8-01A-11D-A16G-05		b9f3060c-ac00-4181-acde-92e45a2ae5a8	TCGA-GI-A2C8-01	TCGA-GI-A2C8-01A-11D-A16D-09			TCGA-GI-A2C8-01	TCGA-GI-A2C8-01A-11D-A16D-09		21531069-76ec-4e0f-b915-51c00b2c42f1		TCGA-GI-A2C8-01A-11D-A16C-01	TCGA-GI-A2C8-01		21531069-76ec-4e0f-b915-51c00b2c42f1	TCGA-GI-A2C8-01A-11D-A16C-01	
TCGA-GI-A2C8-11																			LumA										0	TCGA-GI-A2C8-11	225	0	days		C3-BRCA/Luminal							mutation c1uster 9	TCGA-GI-A2C8	225	0	days	225	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Sentinel node biopsy alone		TCGA-GI-A2C8-F21661	TCGA-GI-A2C8	TCGA-GI-A2C8-11A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-23103	2429		0	225					NO		90-99%		Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100	NO	Negative	Negative		10	Negative																														NO	0		false	No	MX	N0	T4b	Stage IIIB		A2C8								YES	<10%		YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI	Breast	A	LIVING	2004	6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7		6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7																6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7					6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7		
TCGA-GI-A2C9-01																			Basal										0	TCGA-GI-A2C9-01	3342	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	BRCA basal-like c6	BRCA basal-like c8	miRNA cluster 4			TCGA-GI-A2C9	3342	0	days	3342	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-GI-A2C9-F21663	TCGA-GI-A2C9	TCGA-GI-A2C9-01A		Negative					Negative	Lumpectomy		YES			-21534	2979		0	3342					NO				Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T3	Stage IIB	TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf	A2C9	TUMOR FREE							YES			YES	Primary Tumor	01		6th	YES	NO	YES	GI	Breast	A	LIVING	2003	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	49f9eae1-6d7c-45a8-bcf1-b321f980a581	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	49f9eae1-6d7c-45a8-bcf1-b321f980a581	TCGA-GI-A2C9-01A-21-A24A-20			TCGA-GI-A2C9-01	TCGA-GI-A2C9-01A-11D-A21R-05		179ce5cd-da63-4c2e-bf72-253129faf128	TCGA-GI-A2C9-01	TCGA-GI-A2C9-01A-11D-A21Q-09			TCGA-GI-A2C9-01			b5b8fdd8-c4df-4f79-aed5-23ac41f75f18		TCGA-GI-A2C9-01A-11D-A21P-01	TCGA-GI-A2C9-01		b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	TCGA-GI-A2C9-01A-11D-A21P-01	
TCGA-GI-A2C9-11																			Normal										0	TCGA-GI-A2C9-11	3342	0	days		C4-BRCA/Basal								TCGA-GI-A2C9	3342	0	days	3342	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-GI-A2C9-F21663	TCGA-GI-A2C9	TCGA-GI-A2C9-11A		Negative					Negative	Lumpectomy		YES			-21534	2979		0	3342					NO				Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T3	Stage IIB		A2C9	TUMOR FREE							YES			YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI	Breast	A	LIVING	2003	69a8b5fd-7ca6-49d7-b16a-2beba16e40b1		69a8b5fd-7ca6-49d7-b16a-2beba16e40b1													TCGA-GI-A2C9-11			69a8b5fd-7ca6-49d7-b16a-2beba16e40b1			TCGA-GI-A2C9-11		69a8b5fd-7ca6-49d7-b16a-2beba16e40b1		
TCGA-GM-A2D9-01		69				1812	Positive	FEMALE									1812	1	LumA		Positive				enrollment			DECEASED	1	TCGA-GM-A2D9-01	1812	1	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3			TCGA-GM-A2D9	536	1	days	1812	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			69	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-GM-A2D9-F47033	TCGA-GM-A2D9	TCGA-GM-A2D9-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		YES			-25490	1910	1812	0			536	536		YES		90-99%	1.93		2013-8-21	FEMALE						60	2.23	1.16		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	130	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive	90-99%												Bone							Bone	Distant Metastasis		YES	YES	0	0	false	No	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf	A2D9	WITH TUMOR						YES	YES	40-49%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	DECEASED	2006	4ffff9ea-3386-47d5-8974-722037f31849	1fcd4cc6-e594-415c-956a-a65c309fa105	4ffff9ea-3386-47d5-8974-722037f31849	1fcd4cc6-e594-415c-956a-a65c309fa105	TCGA-GM-A2D9-01A-21-A24A-20			TCGA-GM-A2D9-01	TCGA-GM-A2D9-01A-11D-A18O-05		3a04c178-dd57-499e-959e-ba106a878397	TCGA-GM-A2D9-01	TCGA-GM-A2D9-01A-11D-A18P-09			TCGA-GM-A2D9-01			4ffff9ea-3386-47d5-8974-722037f31849		TCGA-GM-A2D9-01A-11D-A18N-01	TCGA-GM-A2D9-01		4ffff9ea-3386-47d5-8974-722037f31849	TCGA-GM-A2D9-01A-11D-A18N-01	
TCGA-GM-A2DA-01		46			5909		Positive	FEMALE									5909	0	LumA		Positive				enrollment			LIVING	1	TCGA-GM-A2DA-01	6593	1	days	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DA	3014	1	days	6593	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			46	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A2DA-F47040	TCGA-GM-A2DA	TCGA-GM-A2DA-01A		Positive					Positive	Modified Radical Mastectomy		NO			-16854	6583	6593	0	5909			3014		YES		90-99%	3.70		2013-8-21	FEMALE			90-99%		2+	60	15	4.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	50	NO	Equivocal	Positive	NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Distant Metastasis		NO	YES	2	0	false	No	M0	N1b	T2	Stage IIB	TCGA-GM-A2DA.F3CD8E6E-B02F-4D5D-B895-6DF063F61603.pdf	A2DA	WITH TUMOR						YES	YES	50-59%		YES	Primary Tumor	01		4th		NO	YES	GM	Breast	A	DECEASED	1993	df5061ca-929b-4e23-89fb-6d05c1a9ffa4	9bd1f34e-2bf1-45d9-8553-9abc40c3c175	df5061ca-929b-4e23-89fb-6d05c1a9ffa4	9bd1f34e-2bf1-45d9-8553-9abc40c3c175				TCGA-GM-A2DA-01	TCGA-GM-A2DA-01A-11D-A18O-05			TCGA-GM-A2DA-01	TCGA-GM-A2DA-01A-11D-A18P-09			TCGA-GM-A2DA-01			df5061ca-929b-4e23-89fb-6d05c1a9ffa4		TCGA-GM-A2DA-01A-11D-A18N-01	TCGA-GM-A2DA-01		df5061ca-929b-4e23-89fb-6d05c1a9ffa4	TCGA-GM-A2DA-01A-11D-A18N-01	
TCGA-GM-A2DB-01		62			1615		Negative	FEMALE									1615	0	Her2		Negative				enrollment			LIVING	0	TCGA-GM-A2DB-01	2406	0	days	Squamous	C3-BRCA/Luminal		BRCA CIMP c7	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DB	2406	0	days	2406	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DB-F47156	TCGA-GM-A2DB	TCGA-GM-A2DB-01A		Negative					Negative	Lumpectomy		YES			-22883	1644		0	2406					NO		<10%	1.50		2013-8-22	FEMALE					1+	60	1.67	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf	A2DB	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2006	e5aeb7a3-1454-4605-a924-d4b1ed082e87	49a7d88b-449d-4070-82b3-d81ee76c7757	e5aeb7a3-1454-4605-a924-d4b1ed082e87	49a7d88b-449d-4070-82b3-d81ee76c7757	TCGA-GM-A2DB-01A-21-A24A-20			TCGA-GM-A2DB-01	TCGA-GM-A2DB-01A-31D-A18O-05		06141302-8b54-448e-811d-c6b69434ec4a	TCGA-GM-A2DB-01	TCGA-GM-A2DB-01A-31D-A19Y-09			TCGA-GM-A2DB-01			e5aeb7a3-1454-4605-a924-d4b1ed082e87		TCGA-GM-A2DB-01A-31D-A18N-01	TCGA-GM-A2DB-01		e5aeb7a3-1454-4605-a924-d4b1ed082e87	TCGA-GM-A2DB-01A-31D-A18N-01	
TCGA-GM-A2DC-01		57			1628		Positive	FEMALE									1628	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DC-01	2535	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DC	2535	0	days	2535	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A2DC-F47061	TCGA-GM-A2DC			Positive					Positive	Lumpectomy		NO			-21122			0	2535					NO		90-99%	4.43		2013-8-22	FEMALE						60	4.70	1.06		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative	NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	0		No	M0	N1a	T1c	Stage IIA		A2DC	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast		LIVING	2006	beb2f2cc-8893-4db2-a527-50a7a40d6d4f	b567c843-1143-4bbf-842d-42ece6a80242	beb2f2cc-8893-4db2-a527-50a7a40d6d4f	b567c843-1143-4bbf-842d-42ece6a80242	TCGA-GM-A2DC-01A-21-A24A-20			TCGA-GM-A2DC-01	TCGA-GM-A2DC-01A-11D-A18O-05		efd14d4d-750d-43ac-ae08-7e75a25ec143	TCGA-GM-A2DC-01	TCGA-GM-A2DC-01A-11D-A18P-09			TCGA-GM-A2DC-01			beb2f2cc-8893-4db2-a527-50a7a40d6d4f		TCGA-GM-A2DC-01A-11D-A18N-01	TCGA-GM-A2DC-01		beb2f2cc-8893-4db2-a527-50a7a40d6d4f	TCGA-GM-A2DC-01A-11D-A18N-01	
TCGA-GM-A2DD-01		53			1309		Negative	FEMALE									1309	0	Normal		Negative				enrollment			LIVING	0	TCGA-GM-A2DD-01	2282	0	days	High	C3-BRCA/Luminal		BRCA CIMP c7	KIRC-like c1	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DD	2282	0	days	2282	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Right	Sentinel node biopsy alone		TCGA-GM-A2DD-F47070	TCGA-GM-A2DD			Negative					Negative	Simple Mastectomy		YES			-19415			0	2282					NO		<10%	1.45		2013-8-22	FEMALE			<10%		2+	60	1.62	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0		Yes	M0	N0 (i-)	T1c	Stage I		A2DD	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast		LIVING	2007	ddc6e148-34b7-4466-b692-3bb227004e2b	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	ddc6e148-34b7-4466-b692-3bb227004e2b	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	TCGA-GM-A2DD-01A-21-A24A-20			TCGA-GM-A2DD-01	TCGA-GM-A2DD-01A-11D-A17Z-05		cf5d72b5-6d47-450b-90e3-8ffe9e291e75	TCGA-GM-A2DD-01	TCGA-GM-A2DD-01A-11D-A17W-09			TCGA-GM-A2DD-01			ddc6e148-34b7-4466-b692-3bb227004e2b		TCGA-GM-A2DD-01A-11D-A17U-01	TCGA-GM-A2DD-01		ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-11D-A17U-01	
TCGA-GM-A2DF-01		53			1299		Negative	FEMALE									1299	0	Basal		Negative				enrollment			LIVING	0	TCGA-GM-A2DF-01	2155	0	days	High	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 5			TCGA-GM-A2DF	2155	0	days	2155	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					53	Left Lower Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A2DF-F47074	TCGA-GM-A2DF	TCGA-GM-A2DF-01A		Negative					Negative	Lumpectomy		NO			-19614	1372		0	2155					NO		<10%	1.40		2013-8-22	FEMALE					1+	60	1.57	1.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative	Negative	NO	32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	0	false	No	M0	N1a	T1c	Stage IIA	TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf	A2DF	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	1fdda772-80cf-45f4-ae85-79ebf4000fb7	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	1fdda772-80cf-45f4-ae85-79ebf4000fb7	TCGA-GM-A2DF-01A-21-A24A-20			TCGA-GM-A2DF-01	TCGA-GM-A2DF-01A-11D-A17Z-05		1af97bf7-a99d-48f9-9ed1-69612327c1f9	TCGA-GM-A2DF-01	TCGA-GM-A2DF-01A-11D-A17W-09			TCGA-GM-A2DF-01			83f8c292-5ae0-4c58-9f08-e58ce391f4f4		TCGA-GM-A2DF-01A-11D-A17U-01	TCGA-GM-A2DF-01		83f8c292-5ae0-4c58-9f08-e58ce391f4f4	TCGA-GM-A2DF-01A-11D-A17U-01	
TCGA-GM-A2DH-01		58			1286		Negative	FEMALE									1286	0	Her2		Negative				enrollment			LIVING	0	TCGA-GM-A2DH-01	2193	0	days	High	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA basal-like c6	BRCA nonbasal-like c7	miRNA c1uster 10			TCGA-GM-A2DH	2193	0	days	2193	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DH-F47081	TCGA-GM-A2DH	TCGA-GM-A2DH-01A		Negative					Negative	Simple Mastectomy		YES			-21344	1464		0	2193					NO		<10%	2.80		2013-8-22	FEMALE					1+	60	2.80	1.00		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	1	false	No	M0	N0 (i+)	T1c	Stage I	TCGA-GM-A2DH.C3243207-2190-4435-9AA9-39E3B913E316.pdf	A2DH	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007	ec2ac902-f5ca-45a5-a72a-1b266360410a	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	ec2ac902-f5ca-45a5-a72a-1b266360410a	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	TCGA-GM-A2DH-01A-21-A24A-20			TCGA-GM-A2DH-01	TCGA-GM-A2DH-01A-11D-A17Z-05		d2a00ef2-dd0f-4bd7-91e5-21e80e8b7e9e	TCGA-GM-A2DH-01	TCGA-GM-A2DH-01A-11D-A17W-09			TCGA-GM-A2DH-01			ec2ac902-f5ca-45a5-a72a-1b266360410a		TCGA-GM-A2DH-01A-11D-A17U-01	TCGA-GM-A2DH-01		ec2ac902-f5ca-45a5-a72a-1b266360410a	TCGA-GM-A2DH-01A-11D-A17U-01	
TCGA-GM-A2DI-01		52			1883		Negative	FEMALE									1883	0	LumA		Negative				enrollment			LIVING	0	TCGA-GM-A2DI-01	2590	0	days	Squamous	C3-BRCA/Luminal		Low purity c2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 3			TCGA-GM-A2DI	2590	0	days	2590	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DI-F47089	TCGA-GM-A2DI	TCGA-GM-A2DI-01A		Negative					Negative	Simple Mastectomy		YES			-19030	2144		0	2590					NO		<10%	3.33		2013-8-22	FEMALE						60	3.53	1.06		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO		Negative	NO	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	1	false	No	M0	N0 (i+)	T1c	Stage I	TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf	A2DI	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2005	c50e1f9f-6059-4609-876d-938efb8a784e	82f1dfdc-1d68-4dd2-b933-80961316de23	c50e1f9f-6059-4609-876d-938efb8a784e	82f1dfdc-1d68-4dd2-b933-80961316de23	TCGA-GM-A2DI-01A-21-A24A-20			TCGA-GM-A2DI-01	TCGA-GM-A2DI-01A-31D-A18O-05		88140136-0e0a-44e3-84ac-ae2e2724a95f	TCGA-GM-A2DI-01	TCGA-GM-A2DI-01A-31D-A18P-09			TCGA-GM-A2DI-01			c50e1f9f-6059-4609-876d-938efb8a784e		TCGA-GM-A2DI-01A-31D-A18N-01	TCGA-GM-A2DI-01		c50e1f9f-6059-4609-876d-938efb8a784e	TCGA-GM-A2DI-01A-31D-A18N-01	
TCGA-GM-A2DK-01		58			1896		Positive	FEMALE									1896	0	LumA		Negative				enrollment			LIVING	0	TCGA-GM-A2DK-01	2645	0	days	COAD-READ	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DK	2645	0	days	2645	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DK-F47094	TCGA-GM-A2DK	TCGA-GM-A2DK-01A		Positive					Negative	Lumpectomy		YES			-21198	2109		0	2645					NO		90-99%			2013-8-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf	A2DK	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2005	52df7d5d-7236-464f-9394-7c20f8726280	d7061bf4-68ed-452b-93d0-46005a916bd6	52df7d5d-7236-464f-9394-7c20f8726280	d7061bf4-68ed-452b-93d0-46005a916bd6	TCGA-GM-A2DK-01A-11-A24A-20			TCGA-GM-A2DK-01	TCGA-GM-A2DK-01A-21D-A17Z-05		7f74c5f0-6c1f-4b93-a192-ee7d9c492c67	TCGA-GM-A2DK-01	TCGA-GM-A2DK-01A-21D-A17W-09			TCGA-GM-A2DK-01			52df7d5d-7236-464f-9394-7c20f8726280		TCGA-GM-A2DK-01A-21D-A17U-01	TCGA-GM-A2DK-01		52df7d5d-7236-464f-9394-7c20f8726280	TCGA-GM-A2DK-01A-21D-A17U-01	
TCGA-GM-A2DL-01		50			2762		Positive	FEMALE									2762	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DL-01	3519	0	days	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DL	3519	0	days	3519	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DL-F47098	TCGA-GM-A2DL	TCGA-GM-A2DL-01A		Positive					Positive	Lumpectomy		YES			-18475	2723		0	3519					NO		90-99%			2013-8-22	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative		NO	2	Negative	Peri (6-12 months since last menstrual period)																													NO	0	0	false	No	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf	A2DL	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2003	8955404a-c756-4116-9613-dea06077a056	2cd3acc2-31e5-41b3-9db4-baad97c03990	8955404a-c756-4116-9613-dea06077a056	2cd3acc2-31e5-41b3-9db4-baad97c03990	TCGA-GM-A2DL-01A-21-A24A-20			TCGA-GM-A2DL-01	TCGA-GM-A2DL-01A-11D-A18O-05		eba15eee-e233-45cc-b24d-fd3d99aa7e00	TCGA-GM-A2DL-01	TCGA-GM-A2DL-01A-11D-A18P-09			TCGA-GM-A2DL-01			8955404a-c756-4116-9613-dea06077a056		TCGA-GM-A2DL-01A-11D-A18N-01	TCGA-GM-A2DL-01		8955404a-c756-4116-9613-dea06077a056	TCGA-GM-A2DL-01A-11D-A18N-01	
TCGA-GM-A2DM-01		57			2331		Positive	FEMALE									2331	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DM-01	3226	0	days	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-GM-A2DM	3226	0	days	3226	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DM-F47104	TCGA-GM-A2DM	TCGA-GM-A2DM-01A		Positive					Positive	Lumpectomy		YES			-21160	2464		0	3226					NO		40-49%			2013-8-22	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf	A2DM	TUMOR FREE						YES	YES	30-39%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2004	8d8fed5e-4b27-472a-93fa-2dba57098576	4b642fb4-cae4-42d6-99d4-f07470b4fe3f	8d8fed5e-4b27-472a-93fa-2dba57098576	4b642fb4-cae4-42d6-99d4-f07470b4fe3f	TCGA-GM-A2DM-01A-21-A24A-20			TCGA-GM-A2DM-01	TCGA-GM-A2DM-01A-11D-A17Z-05		0f5e7aba-bcea-43bb-b280-ad49450691dd	TCGA-GM-A2DM-01	TCGA-GM-A2DM-01A-11D-A17W-09			TCGA-GM-A2DM-01			8d8fed5e-4b27-472a-93fa-2dba57098576		TCGA-GM-A2DM-01A-11D-A17U-01	TCGA-GM-A2DM-01		8d8fed5e-4b27-472a-93fa-2dba57098576	TCGA-GM-A2DM-01A-11D-A17U-01	
TCGA-GM-A2DN-01		58			2352		Positive	FEMALE									2352	0	LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DN-01	3091	0	days	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 5			TCGA-GM-A2DN	3091	0	days	3091	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A2DN-F47124	TCGA-GM-A2DN	TCGA-GM-A2DN-01A		Positive					Positive	Modified Radical Mastectomy		YES			-21288	2436		0	3091					NO		90-99%			2013-8-22	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf	A2DN	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2004	0872770d-ed18-47c4-8190-212b7250f7cf	8ca7be4e-bcbe-444f-a2d3-c4ffdcb8ca5e	0872770d-ed18-47c4-8190-212b7250f7cf	8ca7be4e-bcbe-444f-a2d3-c4ffdcb8ca5e	TCGA-GM-A2DN-01A-21-A24A-20			TCGA-GM-A2DN-01	TCGA-GM-A2DN-01A-11D-A17Z-05		cbb6932d-84f3-4a8f-9518-d8135db77eb2	TCGA-GM-A2DN-01	TCGA-GM-A2DN-01A-11D-A17W-09			TCGA-GM-A2DN-01			0872770d-ed18-47c4-8190-212b7250f7cf		TCGA-GM-A2DN-01A-11D-A17U-01	TCGA-GM-A2DN-01		0872770d-ed18-47c4-8190-212b7250f7cf	TCGA-GM-A2DN-01A-11D-A17U-01	
TCGA-GM-A2DO-01		54			1622		Positive	FEMALE									1622	0	LumB		Positive				enrollment			LIVING	0	TCGA-GM-A2DO-01	2596	0	days	Kirc+	C3-BRCA/Luminal		Cluster 5	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 4			TCGA-GM-A2DO	2596	0	days	2596	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A2DO-F47151	TCGA-GM-A2DO	TCGA-GM-A2DO-01A		Positive					Positive	Lumpectomy		YES			-19842	1932		0	2596					NO		90-99%			2013-8-22	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T1c	Stage I	TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf	A2DO	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2006	9827d98e-4e2e-44cb-b0a5-f51b74ec0675	5ac03fe2-dfd1-4fad-aad6-bd1b04be6298	9827d98e-4e2e-44cb-b0a5-f51b74ec0675	5ac03fe2-dfd1-4fad-aad6-bd1b04be6298	TCGA-GM-A2DO-01A-21-A24A-20			TCGA-GM-A2DO-01	TCGA-GM-A2DO-01A-11D-A18O-05		0db11312-24bd-4df2-9bb6-f271db3a0d30	TCGA-GM-A2DO-01	TCGA-GM-A2DO-01A-11D-A19Y-09			TCGA-GM-A2DO-01			9827d98e-4e2e-44cb-b0a5-f51b74ec0675		TCGA-GM-A2DO-01A-11D-A18N-01	TCGA-GM-A2DO-01		9827d98e-4e2e-44cb-b0a5-f51b74ec0675	TCGA-GM-A2DO-01A-11D-A18N-01	
TCGA-GM-A3NW-01																													0	TCGA-GM-A3NW-01	3361	0	days	BRCA-LUAD+			BRCA CIMP c7			miRNA cluster 14			TCGA-GM-A3NW	3361	0	days	3361	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-GM-A3NW-F40398	TCGA-GM-A3NW	TCGA-GM-A3NW-01A		Negative					Positive	Simple Mastectomy		YES			-23041	3110		0	3361					NO			1.57		2013-2-18	FEMALE			30-39%		1+	60	1.80	1.15		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A3NW.00C6FB2B-A1C9-4310-B178-740313565A32.pdf	A3NW	TUMOR FREE						YES	YES	20-29%		NO	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2003	e996b750-d0d3-43c8-860a-17da2f607b15	35b6fe5d-68fc-4d0d-916c-f66d18eae97e	e996b750-d0d3-43c8-860a-17da2f607b15	35b6fe5d-68fc-4d0d-916c-f66d18eae97e				TCGA-GM-A3NW-01	TCGA-GM-A3NW-01A-21D-A22B-05			TCGA-GM-A3NW-01	TCGA-GM-A3NW-01A-21D-A228-09			TCGA-GM-A3NW-01			e996b750-d0d3-43c8-860a-17da2f607b15		TCGA-GM-A3NW-01A-21D-A227-01	TCGA-GM-A3NW-01		e996b750-d0d3-43c8-860a-17da2f607b15	TCGA-GM-A3NW-01A-21D-A227-01	
TCGA-GM-A3NY-01																			LumA										0	TCGA-GM-A3NY-01	1162	0	days	Iq	C3-BRCA/Luminal		BRCA CIMP c7	BRCA nonbasal-like c8	BRCA nonbasal-like c7	miRNA cluster 6			TCGA-GM-A3NY	1162	0	days	1162	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-GM-A3NY-F40403	TCGA-GM-A3NY	TCGA-GM-A3NY-01A		Positive					Positive	Lumpectomy		NO			-26642	778		0	1162					NO		90-99%			2013-2-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	0	false	No	M0	N1a	T2	Stage IIB	TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf	A3NY	TUMOR FREE						YES	YES	20-29%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2009	85c4a097-4567-4bdf-879c-96c9a4f48052	5c02b684-a187-4b98-8e99-3b8234ac9161	85c4a097-4567-4bdf-879c-96c9a4f48052	5c02b684-a187-4b98-8e99-3b8234ac9161	TCGA-GM-A3NY-01A-21-A24A-20			TCGA-GM-A3NY-01	TCGA-GM-A3NY-01A-11D-A21R-05		b6420819-1738-4d07-9a22-c3a38f0755d4	TCGA-GM-A3NY-01	TCGA-GM-A3NY-01A-11D-A21Q-09			TCGA-GM-A3NY-01			85c4a097-4567-4bdf-879c-96c9a4f48052		TCGA-GM-A3NY-01A-11D-A21P-01	TCGA-GM-A3NY-01		85c4a097-4567-4bdf-879c-96c9a4f48052	TCGA-GM-A3NY-01A-11D-A21P-01	
TCGA-GM-A3XG-01																													0	TCGA-GM-A3XG-01	1330	0	days										TCGA-GM-A3XG	1330	0	days	1330	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A3XG-F46963	TCGA-GM-A3XG	TCGA-GM-A3XG-01A		Positive					Positive	Modified Radical Mastectomy		YES			-16948	899		0	1330							90-99%	1.67		2013-8-20	FEMALE					1+	60	1.73	1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	270	NO	Negative	Negative	NO	26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3	0	false	No	M0	N1a	T3	Stage IIIA	TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf	A3XG	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2009	718c3d2a-517e-4e32-a96b-ef17848d56d8	b02fe819-aeca-4af8-9057-856dbebce2fc	718c3d2a-517e-4e32-a96b-ef17848d56d8	b02fe819-aeca-4af8-9057-856dbebce2fc				TCGA-GM-A3XG-01	TCGA-GM-A3XG-01A-31D-A244-05		fef9a497-d85c-46eb-9ebf-6a9645462a4a	TCGA-GM-A3XG-01	TCGA-GM-A3XG-01A-31D-A243-09			TCGA-GM-A3XG-01			718c3d2a-517e-4e32-a96b-ef17848d56d8		TCGA-GM-A3XG-01A-31D-A242-01	TCGA-GM-A3XG-01		718c3d2a-517e-4e32-a96b-ef17848d56d8	TCGA-GM-A3XG-01A-31D-A242-01	
TCGA-GM-A3XL-01																													0	TCGA-GM-A3XL-01	2108	0	days					BRCA basal-like c6		miRNA cluster 4			TCGA-GM-A3XL	2108	0	days	2108	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right|Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-GM-A3XL-F41970	TCGA-GM-A3XL	TCGA-GM-A3XL-01A		Negative					Negative	Lumpectomy		YES			-18171	1779		0	2108							<10%			2013-4-8	FEMALE								0.99		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO		Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf	A3XL	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007	29c98197-249e-45c9-96dc-34dfb4ac1430	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	29c98197-249e-45c9-96dc-34dfb4ac1430	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	TCGA-GM-A3XL-01A-21-A24A-20			TCGA-GM-A3XL-01	TCGA-GM-A3XL-01A-11D-A230-05		01083b39-09ef-40dd-86c0-5cb8a2a5a646	TCGA-GM-A3XL-01	TCGA-GM-A3XL-01A-11D-A22X-09			TCGA-GM-A3XL-01			29c98197-249e-45c9-96dc-34dfb4ac1430		TCGA-GM-A3XL-01A-11D-A22W-01	TCGA-GM-A3XL-01		29c98197-249e-45c9-96dc-34dfb4ac1430	TCGA-GM-A3XL-01A-11D-A22W-01	
TCGA-GM-A3XN-01																													0	TCGA-GM-A3XN-01	2019	0	days					BRCA nonbasal-like c8		miRNA cluster 4			TCGA-GM-A3XN	2019	0	days	2019	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A3XN-F46967	TCGA-GM-A3XN	TCGA-GM-A3XN-01A		Positive					Positive	Lumpectomy		NO			-16109	1627		0	2019							80-89%	1.73		2013-8-20	FEMALE					1+	60	1.85	1.07		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	100	NO	Negative	Negative	NO	34	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5	0	false	No	M0	N2a	T1c	Stage IIIA	TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf	A3XN	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007	740c53d0-b037-4475-82b3-044b2f879aac	de3f72da-05ed-4aeb-a82e-ca2263907159	740c53d0-b037-4475-82b3-044b2f879aac	de3f72da-05ed-4aeb-a82e-ca2263907159	TCGA-GM-A3XN-01A-21-A24A-20			TCGA-GM-A3XN-01	TCGA-GM-A3XN-01A-12D-A230-05		dc2ec9a1-7c3d-4265-be91-132bb9456eff	TCGA-GM-A3XN-01	TCGA-GM-A3XN-01A-12D-A22X-09			TCGA-GM-A3XN-01			740c53d0-b037-4475-82b3-044b2f879aac		TCGA-GM-A3XN-01A-12D-A22W-01	TCGA-GM-A3XN-01		740c53d0-b037-4475-82b3-044b2f879aac	TCGA-GM-A3XN-01A-12D-A22W-01	
TCGA-GM-A4E0-01																													0	TCGA-GM-A4E0-01	2191	0	days										TCGA-GM-A4E0	2191	0	days	2191	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-GM-A4E0-F47030	TCGA-GM-A4E0	TCGA-GM-A4E0-01A		Positive					Positive	Modified Radical Mastectomy		YES			-24788	1871		0	2191							90-99%			2013-8-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO		Negative	NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	10	1	false	No	M0	N3a	T3	Stage IIIC	TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf	A4E0	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	GM	Breast	A	LIVING	2007	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	323df895-a6a9-4fd1-9aab-6ae770381071	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	323df895-a6a9-4fd1-9aab-6ae770381071				TCGA-GM-A4E0-01	TCGA-GM-A4E0-01A-12D-A268-05		016da2b9-36c0-4cde-bf58-e0a46e381af9	TCGA-GM-A4E0-01	TCGA-GM-A4E0-01A-12D-A25Q-09			TCGA-GM-A4E0-01			da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0		TCGA-GM-A4E0-01A-12D-A25N-01	TCGA-GM-A4E0-01		da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	TCGA-GM-A4E0-01A-12D-A25N-01	
TCGA-GM-A5PV-01																													0	TCGA-GM-A5PV-01	412	0	days										TCGA-GM-A5PV	412	0	days	412	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-GM-A5PV	TCGA-GM-A5PV-01A		Positive					Positive	Modified Radical Mastectomy		NO			-23215	499		0	412							90-99%	2.70		2013-4-12	FEMALE						40	3.65	1.35		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	190	NO		Negative		24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	No	M0	N1a	T2	Stage IIB	TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf	A5PV	TUMOR FREE						YES	YES	30-39%		NO	Primary Tumor	01		7th		NO	YES	GM	Breast	A	LIVING	2011	96c1cfef-0507-46f5-a007-d0f7369cced5	0e4a3b1c-9795-4261-8a01-3e604d04422e	96c1cfef-0507-46f5-a007-d0f7369cced5	0e4a3b1c-9795-4261-8a01-3e604d04422e				TCGA-GM-A5PV-01	TCGA-GM-A5PV-01A-11D-A28C-05		a099aed3-9597-47e9-afd2-58e19aba2018	TCGA-GM-A5PV-01	TCGA-GM-A5PV-01A-11D-A28B-09			TCGA-GM-A5PV-01			96c1cfef-0507-46f5-a007-d0f7369cced5		TCGA-GM-A5PV-01A-11D-A28A-01	TCGA-GM-A5PV-01		96c1cfef-0507-46f5-a007-d0f7369cced5	TCGA-GM-A5PV-01A-11D-A28A-01	
TCGA-GM-A5PX-01																													0	TCGA-GM-A5PX-01	551	0	days										TCGA-GM-A5PX	551	0	days	551	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-GM-A5PX	TCGA-GM-A5PX-01A		Positive					Positive	Simple Mastectomy		YES			-23753	616		0	551							90-99%	1.78		2013-4-12	FEMALE			30-39%		1+	60	1.98			Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	2	false	No	M0	N1mi	T2	Stage IIB	TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf	A5PX	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		7th		NO	YES	GM	Breast	A	LIVING	2011	76f171dd-1980-4504-8dc2-d8c8264458c9	10c8c344-12f5-4c1d-860c-10ba59d82ce3	76f171dd-1980-4504-8dc2-d8c8264458c9	10c8c344-12f5-4c1d-860c-10ba59d82ce3				TCGA-GM-A5PX-01	TCGA-GM-A5PX-01A-12D-A28C-05		e0413f7a-1629-4323-84d0-53d7819eea0e	TCGA-GM-A5PX-01	TCGA-GM-A5PX-01A-12D-A28B-09			TCGA-GM-A5PX-01			76f171dd-1980-4504-8dc2-d8c8264458c9		TCGA-GM-A5PX-01A-12D-A28A-01	TCGA-GM-A5PX-01		76f171dd-1980-4504-8dc2-d8c8264458c9	TCGA-GM-A5PX-01A-12D-A28A-01	
TCGA-HN-A2NL-01																			Basal										0	TCGA-HN-A2NL-01	79	0	days	Squamous	C4-BRCA/Basal		BRCA basal-like c8	KIRC-like c1	BRCA basal-like c8	miRNA cluster 1			TCGA-HN-A2NL	79	0	days	79	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-HN-A2NL-F60149	TCGA-HN-A2NL	TCGA-HN-A2NL-01A		Negative					Negative	Simple Mastectomy		YES			-20483			0	79										2014-5-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	170	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf	A2NL	TUMOR FREE						YES	YES				Primary Tumor	01		6th		NO	YES	HN	Breast	A	LIVING		6593576c-a4a8-4284-8591-321f980f2e58	a5327c43-f90e-42b7-b76e-13602f606844	6593576c-a4a8-4284-8591-321f980f2e58	a5327c43-f90e-42b7-b76e-13602f606844	TCGA-HN-A2NL-01A-21-A24A-20			TCGA-HN-A2NL-01	TCGA-HN-A2NL-01A-11D-A18O-05		826ef0de-68ba-4771-a305-97f27770407a	TCGA-HN-A2NL-01	TCGA-HN-A2NL-01A-11D-A18P-09			TCGA-HN-A2NL-01			6593576c-a4a8-4284-8591-321f980f2e58		TCGA-HN-A2NL-01A-11D-A18N-01	TCGA-HN-A2NL-01		6593576c-a4a8-4284-8591-321f980f2e58	TCGA-HN-A2NL-01A-11D-A18N-01	
TCGA-HN-A2OB-01																													1	TCGA-HN-A2OB-01	1900	1	days										TCGA-HN-A2OB	1552	1	days	1900	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	NO			45	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-HN-A2OB-F71891	TCGA-HN-A2OB	TCGA-HN-A2OB-01A		Positive					Positive	Simple Mastectomy		NO			-16672		1900	0	1849			1552					1.7		2015-4-1	FEMALE						60	2.0	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	320	NO	Negative	Negative	NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Positive					3 Point Scale	3+	2+					Positive							3 Point Scale	Bone	Distant Metastasis		NO	YES	2		false	No	M0	N1	T2	Stage IIB	TCGA-HN-A2OB.32AE5A1A-703B-43C3-948A-719A90DDACC5.pdf	A2OB	WITH TUMOR						YES	YES			YES	Primary Tumor	01		6th		NO	YES	HN	Breast	A	DECEASED		f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	b6a8307b-66fe-4aa1-aa5c-9cd0822c6d3f	f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	b6a8307b-66fe-4aa1-aa5c-9cd0822c6d3f				TCGA-HN-A2OB-01	TCGA-HN-A2OB-01A-21D-A27Y-05		27e8a52c-a4b2-4773-afde-1e2dba0e5822	TCGA-HN-A2OB-01	TCGA-HN-A2OB-01A-21D-A27P-09			TCGA-HN-A2OB-01			f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e		TCGA-HN-A2OB-01A-21D-A27O-01	TCGA-HN-A2OB-01		f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	TCGA-HN-A2OB-01A-21D-A27O-01	
TCGA-JL-A3YW-01																													0	TCGA-JL-A3YW-01	360	0	days					BRCA basal-like c6					TCGA-JL-A3YW	360	0	days	360	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left	Axillary lymph node dissection alone			TCGA-JL-A3YW	TCGA-JL-A3YW-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy						312		0	360							30-39%			2012-11-8	FEMALE			30-39%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	400	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3	0	false	No	M0	N1	T2	Stage IIB	TCGA-JL-A3YW.476488A9-3708-4B11-854A-C91B583C7804.pdf	A3YW							NO	YES	30-39%		NO	Primary Tumor	01		7th		YES	NO	JL	Breast	A	LIVING	2011	a550da17-2d06-49ac-96dc-a2204298ddfb	0d134d64-ce0b-4b15-a56a-550830ab02e6	a550da17-2d06-49ac-96dc-a2204298ddfb	0d134d64-ce0b-4b15-a56a-550830ab02e6	TCGA-JL-A3YW-01A-21-A24B-20			TCGA-JL-A3YW-01	TCGA-JL-A3YW-01A-12D-A23D-05		c2d6cdae-b8a7-4d4b-a4ee-b4ff66bd1b38	TCGA-JL-A3YW-01	TCGA-JL-A3YW-01A-12D-A23C-09			TCGA-JL-A3YW-01			a550da17-2d06-49ac-96dc-a2204298ddfb		TCGA-JL-A3YW-01A-12D-A238-01	TCGA-JL-A3YW-01		a550da17-2d06-49ac-96dc-a2204298ddfb	TCGA-JL-A3YW-01A-12D-A238-01	
TCGA-JL-A3YX-01																													0	TCGA-JL-A3YX-01	352	0	days					KIRC-like c1		miRNA cluster 4			TCGA-JL-A3YX	352	0	days	352	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left	Axillary lymph node dissection alone			TCGA-JL-A3YX	TCGA-JL-A3YX-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy						306		0	352							30-39%			2012-11-8	FEMALE			30-39%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Tumor resection	900	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf	A3YX							NO	YES	30-39%		NO	Primary Tumor	01		7th		YES	NO	JL	Breast	A	LIVING	2011	b2b92b23-3f2a-4305-8c6c-27c91c67c072	bd5865c1-e787-42c6-94d7-456b97b866e8	b2b92b23-3f2a-4305-8c6c-27c91c67c072	bd5865c1-e787-42c6-94d7-456b97b866e8	TCGA-JL-A3YX-01A-21-A24B-20			TCGA-JL-A3YX-01	TCGA-JL-A3YX-01A-11D-A230-05		28195fde-9084-494d-9b76-a65c7fe11ba9	TCGA-JL-A3YX-01	TCGA-JL-A3YX-01A-11D-A22X-09			TCGA-JL-A3YX-01			b2b92b23-3f2a-4305-8c6c-27c91c67c072		TCGA-JL-A3YX-01A-11D-A22W-01	TCGA-JL-A3YX-01		b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-11D-A22W-01	
TCGA-LD-A66U-01																													0	TCGA-LD-A66U-01	646	0	days										TCGA-LD-A66U	646	0	days	646	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LD-A66U-F63067	TCGA-LD-A66U			Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-16101			0	646							90-99%			2014-7-30	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative		NO	15	Negative																														NO	2			No	MX	N1mi	T2	Stage IIB		A66U	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	LD	Breast		LIVING	2012	d37ab528-22b6-4b9e-b838-4d90f6d8bc14	f0f7b361-1498-4cff-8929-cf600a350ce8	d37ab528-22b6-4b9e-b838-4d90f6d8bc14	f0f7b361-1498-4cff-8929-cf600a350ce8				TCGA-LD-A66U-01	TCGA-LD-A66U-01A-11D-A31V-05		c65aac48-9f36-4802-8509-a1bff8136db3	TCGA-LD-A66U-01				TCGA-LD-A66U-01			d37ab528-22b6-4b9e-b838-4d90f6d8bc14		TCGA-LD-A66U-01A-11D-A31T-01	TCGA-LD-A66U-01		d37ab528-22b6-4b9e-b838-4d90f6d8bc14	TCGA-LD-A66U-01A-11D-A31T-01	
TCGA-LD-A74U-01																													0	TCGA-LD-A74U-01	402	0	days										TCGA-LD-A74U	402	0	days	402	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					79	Right	Axillary lymph node dissection alone		TCGA-LD-A74U-F69186	TCGA-LD-A74U	TCGA-LD-A74U-01A		Positive	3 Point Scale		3 Point Scale		Negative	Lumpectomy					-28981	59		0	402							<10%			2014-12-30	FEMALE										Other, specify		No		C50.9	8524/3	C50.9	3+	YES		Core needle biopsy	210	NO	Negative		NO	12	Negative																														NO	11		true	Yes	M0	N3a	T3	Stage IIIC	TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf	A74U	WITH TUMOR						YES	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	LD	Breast	A	LIVING	2013	11782f87-4d58-4897-9a61-7a4605c05eca	a7e1a7ba-762d-45b0-b084-118c6ed9690b	11782f87-4d58-4897-9a61-7a4605c05eca	a7e1a7ba-762d-45b0-b084-118c6ed9690b				TCGA-LD-A74U-01	TCGA-LD-A74U-01A-13D-A33F-05		F4F6B174-8640-46C3-9913-5F5043856ADA	TCGA-LD-A74U-01				TCGA-LD-A74U-01			11782f87-4d58-4897-9a61-7a4605c05eca		TCGA-LD-A74U-01A-13D-A33D-01	TCGA-LD-A74U-01		11782f87-4d58-4897-9a61-7a4605c05eca	TCGA-LD-A74U-01A-13D-A33D-01	
TCGA-LD-A7W5-01																													0	TCGA-LD-A7W5-01	216	0	days										TCGA-LD-A7W5	216	0	days	216	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LD-A7W5-F69184	TCGA-LD-A7W5	TCGA-LD-A7W5-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		NO			-19169	83		0	216							90-99%			2014-12-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative		NO	23	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	23		true	No	M0	N3a	T2	Stage IIIC	TCGA-LD-A7W5.ADBA741B-AABF-4A33-A61F-C10EE555D175.pdf	A7W5	WITH TUMOR						YES	YES			NO	Primary Tumor	01		7th		YES	NO	LD	Breast	A	LIVING	2013	c83d9436-3f08-4197-9392-ff33fe4c632e	ac9fab7a-b830-4ebe-bd2c-939c812d7826	c83d9436-3f08-4197-9392-ff33fe4c632e	ac9fab7a-b830-4ebe-bd2c-939c812d7826				TCGA-LD-A7W5-01	TCGA-LD-A7W5-01A-22D-A357-05		7DEB3148-9179-4E71-98E3-81DE903CE3E5	TCGA-LD-A7W5-01				TCGA-LD-A7W5-01			c83d9436-3f08-4197-9392-ff33fe4c632e		TCGA-LD-A7W5-01A-22D-A350-01	TCGA-LD-A7W5-01		c83d9436-3f08-4197-9392-ff33fe4c632e	TCGA-LD-A7W5-01A-22D-A350-01	
TCGA-LD-A7W6-01																													0	TCGA-LD-A7W6-01	404	0	days										TCGA-LD-A7W6	404	0	days	404	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right|Right Upper Inner Quadrant	Axillary lymph node dissection alone		TCGA-LD-A7W6-F69193	TCGA-LD-A7W6	TCGA-LD-A7W6-01A		Positive	3 Point Scale		3 Point Scale		Positive	Modified Radical Mastectomy		NO			-20077	91		0	404							90-99%			2014-12-30	FEMALE										Other, specify		No		C50.2	8524/3	C50.2	3+	YES		Core needle biopsy	630	NO	Negative		NO	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		true	No	M0	N1a	T2	Stage IIB	TCGA-LD-A7W6.859561F6-3113-45C8-8FBE-718BF860B582.pdf	A7W6	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	LD	Breast	A	LIVING	2013	da8e08c7-6006-4e66-ae0f-7047177ca02a	b52a570c-9511-40f3-911e-de079cdbb1ec	da8e08c7-6006-4e66-ae0f-7047177ca02a	b52a570c-9511-40f3-911e-de079cdbb1ec				TCGA-LD-A7W6-01	TCGA-LD-A7W6-01A-81D-A357-05		4F831753-0FF7-4B6E-987C-CCC50799E73D	TCGA-LD-A7W6-01				TCGA-LD-A7W6-01			da8e08c7-6006-4e66-ae0f-7047177ca02a		TCGA-LD-A7W6-01A-81D-A350-01	TCGA-LD-A7W6-01		da8e08c7-6006-4e66-ae0f-7047177ca02a	TCGA-LD-A7W6-01A-81D-A350-01	
TCGA-LD-A9QF-01																													0	TCGA-LD-A9QF-01	323	0	days										TCGA-LD-A9QF	323	0	days	323	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Left	Sentinel node biopsy alone		TCGA-LD-A9QF-F69216	TCGA-LD-A9QF	TCGA-LD-A9QF-01A		Negative					Negative	Simple Mastectomy		YES			-26869	85		0	323										2014-12-30	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Positive		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T1c	Stage IA	TCGA-LD-A9QF.E8601979-AE05-4E4D-BB39-6B9C5E67D050.pdf	A9QF	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	LD	Breast	A	LIVING	2013	c2df60f6-40d5-4fe0-88f8-d168feb0d921	fccb2cd3-cb95-47ec-a684-91e3ba16faa9	c2df60f6-40d5-4fe0-88f8-d168feb0d921	fccb2cd3-cb95-47ec-a684-91e3ba16faa9				TCGA-LD-A9QF-01	TCGA-LD-A9QF-01A-32D-A41Q-05		1D404A66-9E4B-4AA3-9ADA-A5A789ECF185	TCGA-LD-A9QF-01				TCGA-LD-A9QF-01			c2df60f6-40d5-4fe0-88f8-d168feb0d921		TCGA-LD-A9QF-01A-32D-A41E-01	TCGA-LD-A9QF-01		c2df60f6-40d5-4fe0-88f8-d168feb0d921	TCGA-LD-A9QF-01A-32D-A41E-01	
TCGA-LL-A440-01																													0	TCGA-LL-A440-01	759	0	days										TCGA-LL-A440	759	0	days	759	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A440-F46387	TCGA-LL-A440	TCGA-LL-A440-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-22497	32		0	759							90-99%	46		2013-8-7	FEMALE					2+	20	79	1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	Yes	MX	N0 (i-)	T1c	Stage IA	TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf	A440	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012	f34965fe-e7d5-48bd-b0a0-575cbd895c5a	c8bb9247-4dc5-487a-beba-19d8fa955c47	f34965fe-e7d5-48bd-b0a0-575cbd895c5a	c8bb9247-4dc5-487a-beba-19d8fa955c47				TCGA-LL-A440-01	TCGA-LL-A440-01A-11D-A244-05		4bc983f8-0b5f-456c-88be-f1a7e901255b	TCGA-LL-A440-01	TCGA-LL-A440-01A-11D-A243-09			TCGA-LL-A440-01			f34965fe-e7d5-48bd-b0a0-575cbd895c5a		TCGA-LL-A440-01A-11D-A242-01	TCGA-LL-A440-01		f34965fe-e7d5-48bd-b0a0-575cbd895c5a	TCGA-LL-A440-01A-11D-A242-01	
TCGA-LL-A441-01																													0	TCGA-LL-A441-01	996	0	days										TCGA-LL-A441	996	0	days	996	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LL-A441-F46386	TCGA-LL-A441	TCGA-LL-A441-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-22772	37		0	996										2013-8-7	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T1c	Stage IA	TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf	A441	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	4588244d-e5f9-4cad-9915-1c6f4c0f887c	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	4588244d-e5f9-4cad-9915-1c6f4c0f887c				TCGA-LL-A441-01	TCGA-LL-A441-01A-11D-A244-05		76fc75d8-5131-4ccf-9c99-be1dac58876d	TCGA-LL-A441-01	TCGA-LL-A441-01A-11D-A243-09			TCGA-LL-A441-01			8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662		TCGA-LL-A441-01A-11D-A242-01	TCGA-LL-A441-01		8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	TCGA-LL-A441-01A-11D-A242-01	
TCGA-LL-A442-01																													0	TCGA-LL-A442-01	889	0	days										TCGA-LL-A442	889	0	days	889	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					56	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A442-F46384	TCGA-LL-A442	TCGA-LL-A442-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		YES			-20495	60		0	889							90-99%	35		2013-8-7	FEMALE					2+	20	60	1.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	Yes	MX	N0 (i-)	T2	Stage IIA	TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf	A442	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012	7c355987-c70f-43f1-94cc-f4d12afe0132	765cb9f5-7c66-49fb-840b-7a85c9b7c64e	7c355987-c70f-43f1-94cc-f4d12afe0132	765cb9f5-7c66-49fb-840b-7a85c9b7c64e				TCGA-LL-A442-01	TCGA-LL-A442-01A-11D-A244-05		068153fa-935a-429c-9719-84aebe91f185	TCGA-LL-A442-01				TCGA-LL-A442-01			7c355987-c70f-43f1-94cc-f4d12afe0132		TCGA-LL-A442-01A-11D-A242-01	TCGA-LL-A442-01		7c355987-c70f-43f1-94cc-f4d12afe0132	TCGA-LL-A442-01A-11D-A242-01	
TCGA-LL-A50Y-01																													0	TCGA-LL-A50Y-01	762	0	days										TCGA-LL-A50Y	762	0	days	762	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					84	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A50Y-F50406	TCGA-LL-A50Y	TCGA-LL-A50Y-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-30934	91		0	762							90-99%	2.5		2013-10-23	FEMALE					2+	167	2.6	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO	Equivocal	Negative	NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	Yes	MX	N0	T2	Stage IIA	TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf	A50Y	TUMOR FREE						YES	YES	90-99%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012	02a65cb0-158c-478b-b72e-d6bae04429c7	1cfb1bb1-082b-4fda-a30a-ad5189c7602b	02a65cb0-158c-478b-b72e-d6bae04429c7	1cfb1bb1-082b-4fda-a30a-ad5189c7602b				TCGA-LL-A50Y-01	TCGA-LL-A50Y-01A-11D-A268-05		acabe392-7b49-4967-90b5-81ac53cfec8e	TCGA-LL-A50Y-01	TCGA-LL-A50Y-01A-11D-A25Q-09			TCGA-LL-A50Y-01			02a65cb0-158c-478b-b72e-d6bae04429c7		TCGA-LL-A50Y-01A-11D-A25N-01	TCGA-LL-A50Y-01		02a65cb0-158c-478b-b72e-d6bae04429c7	TCGA-LL-A50Y-01A-11D-A25N-01	
TCGA-LL-A5YL-01																													0	TCGA-LL-A5YL-01	519	0	days										TCGA-LL-A5YL	519	0	days	519	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right|Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LL-A5YL-F59650	TCGA-LL-A5YL	TCGA-LL-A5YL-01A		Positive	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy					-23395	84		0	519							90-99%	2.9		2014-5-19	FEMALE					3+	65	2.6	0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	570	NO	Positive	Negative	NO	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	3	0	false	No	MX	N1a	T2	Stage IIB	TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf	A5YL							YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012	979d9841-337c-47a3-acaf-77d45e276589	59f1a99c-e061-4ef5-97be-6edaa58239d9	979d9841-337c-47a3-acaf-77d45e276589	59f1a99c-e061-4ef5-97be-6edaa58239d9				TCGA-LL-A5YL-01	TCGA-LL-A5YL-01A-12D-A29O-05		daaf11f9-0595-4ad7-9f96-7a3a0a82513e	TCGA-LL-A5YL-01	TCGA-LL-A5YL-01A-12D-A29N-09			TCGA-LL-A5YL-01			979d9841-337c-47a3-acaf-77d45e276589		TCGA-LL-A5YL-01A-12D-A29M-01	TCGA-LL-A5YL-01		979d9841-337c-47a3-acaf-77d45e276589	TCGA-LL-A5YL-01A-12D-A29M-01	
TCGA-LL-A5YM-01																													0	TCGA-LL-A5YM-01	466	0	days										TCGA-LL-A5YM	258	1	days	466	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			88	Left|Left Upper Inner Quadrant	No axillary staging		TCGA-LL-A5YM-F57541	TCGA-LL-A5YM	TCGA-LL-A5YM-01A	Negative	Positive	3 Point Scale	3+	3 Point Scale	Mastectomy NOS	Positive	Other					-32478	131		0	466		258	258				90-99%	54		2014-3-14	FEMALE					2+	20	172	3.2		Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9	3+	YES		Core needle biopsy	280	NO	Equivocal	Positive	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Other, specify	Locoregional Recurrence	Skin left chest wall	YES	YES			false	No	M0	NX	T4b	Stage IIIB	TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf	A5YM	WITH TUMOR						NO	NO	90-99%		NO	Primary Tumor	01	partial mastectomy	7th		YES	NO	LL	Breast	A	LIVING	2012	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	7de0d9d1-8ff8-4bc3-a4b0-a10092804380	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	7de0d9d1-8ff8-4bc3-a4b0-a10092804380				TCGA-LL-A5YM-01	TCGA-LL-A5YM-01A-11D-A28C-05		38350a57-ff95-4cd4-bf2c-44c934606d80	TCGA-LL-A5YM-01	TCGA-LL-A5YM-01A-11D-A28B-09			TCGA-LL-A5YM-01			02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6		TCGA-LL-A5YM-01A-11D-A28A-01	TCGA-LL-A5YM-01		02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	TCGA-LL-A5YM-01A-11D-A28A-01	
TCGA-LL-A5YN-01																													0	TCGA-LL-A5YN-01	447	0	days										TCGA-LL-A5YN	447	0	days	447	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A5YN-F59362	TCGA-LL-A5YN	TCGA-LL-A5YN-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		NO			-16884	41		0	447							90-99%	54		2014-5-9	FEMALE					2+	20	172	3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	230	NO	Equivocal	Positive	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0 (i-)	T2	Stage IIA	TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf	A5YN	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	844d9d2c-4467-415f-b66d-a4c35c818310	75bea157-67fe-4ded-a3a5-d8c1b05aee78	844d9d2c-4467-415f-b66d-a4c35c818310	75bea157-67fe-4ded-a3a5-d8c1b05aee78				TCGA-LL-A5YN-01	TCGA-LL-A5YN-01A-11D-A28C-05		297362a8-ec87-42d7-b56a-25a29b04b91d	TCGA-LL-A5YN-01	TCGA-LL-A5YN-01A-11D-A28B-09			TCGA-LL-A5YN-01			844d9d2c-4467-415f-b66d-a4c35c818310		TCGA-LL-A5YN-01A-11D-A28A-01	TCGA-LL-A5YN-01		844d9d2c-4467-415f-b66d-a4c35c818310	TCGA-LL-A5YN-01A-11D-A28A-01	
TCGA-LL-A5YO-01																													0	TCGA-LL-A5YO-01	440	0	days										TCGA-LL-A5YO	440	0	days	440	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A5YO-F58638	TCGA-LL-A5YO	TCGA-LL-A5YO-01A		Negative					Negative	Lumpectomy		YES			-18354	47		0	440										2014-4-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	false	No	MX	N0	T1b	Stage IA	TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf	A5YO	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	51c263b0-32eb-49fe-b7ed-7de6b0a94c33	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	51c263b0-32eb-49fe-b7ed-7de6b0a94c33				TCGA-LL-A5YO-01	TCGA-LL-A5YO-01A-21D-A28C-05		62e25802-1209-470d-8fe1-6c17c1c28b71	TCGA-LL-A5YO-01	TCGA-LL-A5YO-01A-21D-A28B-09			TCGA-LL-A5YO-01			4b5b44ea-8589-4aea-a69f-b5d5041b1acd		TCGA-LL-A5YO-01A-21D-A28A-01	TCGA-LL-A5YO-01		4b5b44ea-8589-4aea-a69f-b5d5041b1acd	TCGA-LL-A5YO-01A-21D-A28A-01	
TCGA-LL-A5YP-01																													0	TCGA-LL-A5YP-01	450	0	days										TCGA-LL-A5YP	450	0	days	450	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right|Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LL-A5YP-F59323	TCGA-LL-A5YP	TCGA-LL-A5YP-01A		Positive	3 Point Scale		3 Point Scale		Negative	Modified Radical Mastectomy		NO			-18041	29		0	450							<10%	35		2014-5-8	FEMALE			<10%		1+	20	118	3.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	490	NO	Negative	Positive	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		false	Yes	M0	N1a	T2	Stage IIB	TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf	A5YP							YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	de637c67-c60e-4b6f-99cf-0bcef33204cc	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	de637c67-c60e-4b6f-99cf-0bcef33204cc				TCGA-LL-A5YP-01	TCGA-LL-A5YP-01A-21D-A28C-05		e0457a11-2e43-40f1-a33b-f7cae98e4073	TCGA-LL-A5YP-01	TCGA-LL-A5YP-01A-21D-A28B-09			TCGA-LL-A5YP-01			5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c		TCGA-LL-A5YP-01A-21D-A28A-01	TCGA-LL-A5YP-01		5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	TCGA-LL-A5YP-01A-21D-A28A-01	
TCGA-LL-A6FP-01																													0	TCGA-LL-A6FP-01	677	0	days										TCGA-LL-A6FP	677	0	days	677	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					90	Right Upper Outer Quadrant	No axillary staging		TCGA-LL-A6FP-F64050	TCGA-LL-A6FP	TCGA-LL-A6FP-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		NO			-32873	259		0	677							90-99%	3.1		2014-8-25	FEMALE					2+	549	2.6	0.9		Infiltrating Lobular Carcinoma		Yes		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	500	NO	Equivocal	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			false	No	MX	NX	T2	Stage IIA	TCGA-LL-A6FP.D318A0F0-38B2-4DFA-8326-E362603AAC5E.pdf	A6FP	TUMOR FREE						YES	NO	20-29%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2012	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	23353deb-8af1-474e-8654-70d444529e5e	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	23353deb-8af1-474e-8654-70d444529e5e				TCGA-LL-A6FP-01	TCGA-LL-A6FP-01A-11D-A31V-05		abc6d9bf-6269-4601-8200-f1e6758789fb	TCGA-LL-A6FP-01				TCGA-LL-A6FP-01			b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1		TCGA-LL-A6FP-01A-11D-A31T-01	TCGA-LL-A6FP-01		b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	TCGA-LL-A6FP-01A-11D-A31T-01	
TCGA-LL-A6FQ-01																													0	TCGA-LL-A6FQ-01	80	0	days										TCGA-LL-A6FQ			days	80	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A6FQ-F58204	TCGA-LL-A6FQ	TCGA-LL-A6FQ-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-28375	128		0	80							90-99%			2014-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	250	NO	Negative		YES	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														7	0	false	No	MX	N2a	T2	Stage IIIA	TCGA-LL-A6FQ.5C3D9179-7434-4776-A2FF-68CEA0149C68.pdf	A6FQ							NO	YES	80-89%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	d490ceb7-e3b2-44ee-8c46-923cbd4374dd	ae249200-498e-4044-9aa2-fa9b8c3daa7e	d490ceb7-e3b2-44ee-8c46-923cbd4374dd	ae249200-498e-4044-9aa2-fa9b8c3daa7e				TCGA-LL-A6FQ-01	TCGA-LL-A6FQ-01A-11D-A31V-05		349f287a-7f9a-4b55-a3ad-0f8527b84b94	TCGA-LL-A6FQ-01				TCGA-LL-A6FQ-01			d490ceb7-e3b2-44ee-8c46-923cbd4374dd		TCGA-LL-A6FQ-01A-11D-A31T-01	TCGA-LL-A6FQ-01		d490ceb7-e3b2-44ee-8c46-923cbd4374dd	TCGA-LL-A6FQ-01A-11D-A31T-01	
TCGA-LL-A6FR-01																													0	TCGA-LL-A6FR-01	489	0	days										TCGA-LL-A6FR	489	0	days	489	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					50	Right|Right Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A6FR-F64045	TCGA-LL-A6FR	TCGA-LL-A6FR-01A		Negative		1+	3 Point Scale		Positive	Lumpectomy		YES			-18520	30		0	489										2014-8-25	FEMALE					2+	20		2.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Equivocal	Positive	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf	A6FR	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	1cefed42-1e09-4bff-b323-55faeaee18e1	380ab3e1-4711-4b6b-9914-8e826c2d58c0	1cefed42-1e09-4bff-b323-55faeaee18e1	380ab3e1-4711-4b6b-9914-8e826c2d58c0				TCGA-LL-A6FR-01	TCGA-LL-A6FR-01A-12D-A31V-05		dda737e9-f03b-4125-9b62-3a8fa1e2da16	TCGA-LL-A6FR-01				TCGA-LL-A6FR-01			1cefed42-1e09-4bff-b323-55faeaee18e1		TCGA-LL-A6FR-01A-12D-A31T-01	TCGA-LL-A6FR-01		1cefed42-1e09-4bff-b323-55faeaee18e1	TCGA-LL-A6FR-01A-12D-A31T-01	
TCGA-LL-A73Y-01																													0	TCGA-LL-A73Y-01	477	0	days										TCGA-LL-A73Y	477	0	days	477	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A73Y-F67099	TCGA-LL-A73Y	TCGA-LL-A73Y-01A		Negative	3 Point Scale	3+	3 Point Scale		Negative	Simple Mastectomy		NO			-24647	55		0	477										2014-10-30	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0	T1c	Stage IA	TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf	A73Y	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	535ab8cf-47a9-4541-b3ef-223bba76a13e	8e13bd29-de53-4cb0-991f-7ae7460cb548	535ab8cf-47a9-4541-b3ef-223bba76a13e	8e13bd29-de53-4cb0-991f-7ae7460cb548				TCGA-LL-A73Y-01	TCGA-LL-A73Y-01A-11D-A33F-05			TCGA-LL-A73Y-01				TCGA-LL-A73Y-01			535ab8cf-47a9-4541-b3ef-223bba76a13e		TCGA-LL-A73Y-01A-11D-A33D-01	TCGA-LL-A73Y-01		535ab8cf-47a9-4541-b3ef-223bba76a13e	TCGA-LL-A73Y-01A-11D-A33D-01	
TCGA-LL-A73Z-01																													1	TCGA-LL-A73Z-01	227	1	days										TCGA-LL-A73Z	192	1	days	227	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	NO	NO			55	Left|Left Lower Inner Quadrant	No axillary staging		TCGA-LL-A73Z-F64983	TCGA-LL-A73Z	TCGA-LL-A73Z-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Lumpectomy		NO			-20118	40	227	0	137			192				10-19%	2.2		2014-9-16	FEMALE					2+	243	2.5	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Excisional Biopsy	240	NO	Equivocal	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Other, specify	skin						Brain	Distant Metastasis		NO	YES			false	No	M1	NX	T1c	Stage IV	TCGA-LL-A73Z.D9FE314C-61F4-4E4D-BB29-4B681C2A8A10.pdf	A73Z	WITH TUMOR						YES	NO	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	DECEASED	2013	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	5e1d2320-02a9-4d5b-89b6-d5a95eb774b8	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	5e1d2320-02a9-4d5b-89b6-d5a95eb774b8				TCGA-LL-A73Z-01	TCGA-LL-A73Z-01A-11D-A32T-05		31B0CE66-3E66-4210-ABBC-82C85BB9902C	TCGA-LL-A73Z-01				TCGA-LL-A73Z-01			9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126		TCGA-LL-A73Z-01A-11D-A32H-01	TCGA-LL-A73Z-01		9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	TCGA-LL-A73Z-01A-11D-A32H-01	
TCGA-LL-A740-01																													0	TCGA-LL-A740-01	441	0	days										TCGA-LL-A740	441	0	days	441	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-LL-A740-F65059	TCGA-LL-A740	TCGA-LL-A740-01A		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-22416	37		0	441								2.9		2014-9-18	FEMALE					2+	113	3.3	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T1c	Stage IA	TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf	A740	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	02600c52-6742-4d06-b417-16694f0c026b	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	02600c52-6742-4d06-b417-16694f0c026b				TCGA-LL-A740-01	TCGA-LL-A740-01A-21D-A32T-05		A13762BD-83CD-4DBC-94FE-1879E3A4B5A4	TCGA-LL-A740-01				TCGA-LL-A740-01			9014d9c4-ab6b-4318-9b07-c00266d9f5a9		TCGA-LL-A740-01A-21D-A32H-01	TCGA-LL-A740-01		9014d9c4-ab6b-4318-9b07-c00266d9f5a9	TCGA-LL-A740-01A-21D-A32H-01	
TCGA-LL-A7SZ-01																													0	TCGA-LL-A7SZ-01	594	0	days										TCGA-LL-A7SZ	594	0	days	594	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A7SZ-F66973	TCGA-LL-A7SZ	TCGA-LL-A7SZ-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Other		YES			-18161	63		0	594							90-99%			2014-10-29	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	240	NO	Negative		NO	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	2	0	false	No	MX	N1a	T2	Stage IIB	TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf	A7SZ	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01	SKIN SPARING RADICAL MASTECTOMY	7th		YES	NO	LL	Breast	A	LIVING	2013	e256282c-da2c-4272-a94b-14cf44da6178	9dca3383-62e0-4375-a816-2e4f257f714e	e256282c-da2c-4272-a94b-14cf44da6178	9dca3383-62e0-4375-a816-2e4f257f714e				TCGA-LL-A7SZ-01	TCGA-LL-A7SZ-01A-32D-A357-05		C972C687-4BA1-4F38-A073-4A2AB182F8B0	TCGA-LL-A7SZ-01				TCGA-LL-A7SZ-01			e256282c-da2c-4272-a94b-14cf44da6178		TCGA-LL-A7SZ-01A-32D-A350-01	TCGA-LL-A7SZ-01		e256282c-da2c-4272-a94b-14cf44da6178	TCGA-LL-A7SZ-01A-32D-A350-01	
TCGA-LL-A7T0-01																													0	TCGA-LL-A7T0-01	376	0	days										TCGA-LL-A7T0	376	0	days	376	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left Lower Inner Quadrant	Axillary lymph node dissection alone		TCGA-LL-A7T0-F64970	TCGA-LL-A7T0	TCGA-LL-A7T0-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		NO			-25867	70		0	376							90-99%			2014-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	380	NO	Positive		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	No	M0	N1a	T2	Stage IIB	TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf	A7T0	TUMOR FREE						NO	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	67e967d6-be17-4fe1-a1fb-197655fad18d	9432254f-7c2d-4b93-adc6-8c360c0e2e20	67e967d6-be17-4fe1-a1fb-197655fad18d	9432254f-7c2d-4b93-adc6-8c360c0e2e20				TCGA-LL-A7T0-01	TCGA-LL-A7T0-01A-31D-A357-05			TCGA-LL-A7T0-01				TCGA-LL-A7T0-01			67e967d6-be17-4fe1-a1fb-197655fad18d		TCGA-LL-A7T0-01A-31D-A350-01	TCGA-LL-A7T0-01		67e967d6-be17-4fe1-a1fb-197655fad18d	TCGA-LL-A7T0-01A-31D-A350-01	
TCGA-LL-A8F5-01																													0	TCGA-LL-A8F5-01	596	0	days										TCGA-LL-A8F5	596	0	days	596	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right|Right Upper Inner Quadrant	Sentinel node biopsy alone		TCGA-LL-A8F5-F66965	TCGA-LL-A8F5	TCGA-LL-A8F5-01A		Positive	3 Point Scale		3 Point Scale		Negative	Lumpectomy		YES			-22544	78		0	596							20-29%			2014-10-29	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	230	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	MX	N0 (i-)	T2	Stage IIA	TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf	A8F5	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	3cc7e12e-2bc8-494c-b74a-de071d711410	b9fdf03c-d0d2-4b11-bbe6-f6996d403e90	3cc7e12e-2bc8-494c-b74a-de071d711410	b9fdf03c-d0d2-4b11-bbe6-f6996d403e90				TCGA-LL-A8F5-01	TCGA-LL-A8F5-01A-11D-A36K-05		FBB89BA4-95C2-4EEE-8248-B344B94C696F	TCGA-LL-A8F5-01				TCGA-LL-A8F5-01			3cc7e12e-2bc8-494c-b74a-de071d711410		TCGA-LL-A8F5-01A-11D-A36I-01	TCGA-LL-A8F5-01		3cc7e12e-2bc8-494c-b74a-de071d711410	TCGA-LL-A8F5-01A-11D-A36I-01	
TCGA-LL-A9Q3-01																													0	TCGA-LL-A9Q3-01	532	0	days										TCGA-LL-A9Q3	532	0	days	532	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					69	Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-LL-A9Q3-F67103	TCGA-LL-A9Q3	TCGA-LL-A9Q3-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-25477	80		0	532							90-99%			2014-10-30	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	610	NO	Positive		NO	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	28	0	false	No	MX	N3a	T3	Stage IIIC	TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf	A9Q3	TUMOR FREE						YES	YES	<10%		YES	Primary Tumor	01		7th		YES	NO	LL	Breast	A	LIVING	2013	0aad6d2a-1699-4403-8d45-f0b315ec89c7	56fb1d49-78c7-4965-9a17-a90a2c1a9b95	0aad6d2a-1699-4403-8d45-f0b315ec89c7	56fb1d49-78c7-4965-9a17-a90a2c1a9b95				TCGA-LL-A9Q3-01	TCGA-LL-A9Q3-01A-11D-A41Q-05		A26726B7-5B72-4AC3-9EDF-F3F13C2E471F	TCGA-LL-A9Q3-01				TCGA-LL-A9Q3-01			0aad6d2a-1699-4403-8d45-f0b315ec89c7		TCGA-LL-A9Q3-01A-11D-A41E-01	TCGA-LL-A9Q3-01		0aad6d2a-1699-4403-8d45-f0b315ec89c7	TCGA-LL-A9Q3-01A-11D-A41E-01	
TCGA-LQ-A4E4-01																													0	TCGA-LQ-A4E4-01	849	0	days										TCGA-LQ-A4E4	681	1	days	849	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast	YES	YES			73	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-LQ-A4E4-F52290	TCGA-LQ-A4E4	TCGA-LQ-A4E4-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		NO			-26883	414		0	849			681				90-99%	1.1		2013-12-2	FEMALE						60	1.1	1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	200	NO		Negative	NO	26	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Negative								Bone	Distant Metastasis		NO	YES	3	0	true	No	MX	N1a	T3	Stage IIIA	TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf	A4E4	WITH TUMOR						YES	YES	90-99%		YES	Primary Tumor	01		7th		NO	YES	LQ	Breast	A	LIVING	2011	5965fc49-0ee5-41d8-b673-9ade5c70db71	77cf9295-680b-433c-98b6-022747c28474	5965fc49-0ee5-41d8-b673-9ade5c70db71	77cf9295-680b-433c-98b6-022747c28474				TCGA-LQ-A4E4-01	TCGA-LQ-A4E4-01A-11D-A268-05		610e443b-3ef2-4a65-80f9-6d300736ba70	TCGA-LQ-A4E4-01	TCGA-LQ-A4E4-01A-11D-A25Q-09			TCGA-LQ-A4E4-01			5965fc49-0ee5-41d8-b673-9ade5c70db71		TCGA-LQ-A4E4-01A-11D-A25N-01	TCGA-LQ-A4E4-01		5965fc49-0ee5-41d8-b673-9ade5c70db71	TCGA-LQ-A4E4-01A-11D-A25N-01	
TCGA-MS-A51U-01																													0	TCGA-MS-A51U-01	681	0	days										TCGA-MS-A51U	681	0	days	681	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					44	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left			TCGA-MS-A51U-F59818	TCGA-MS-A51U	TCGA-MS-A51U-01A		Positive					Positive	Modified Radical Mastectomy					-16213	129		0	681					NO		90-99%			2014-6-4	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			190	NO	Negative	Negative	NO	18	Negative																														NO	2		true	No	M0	N1	T2	Stage IIB	TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf	A51U	TUMOR FREE						YES	YES	20-29%		YES	Primary Tumor	01		7th		YES	NO	MS	Breast	A	LIVING	2012	b41dfa6b-a221-4e03-95d7-428781787067	d220df14-d382-4b98-9c10-1df8c28808e1	b41dfa6b-a221-4e03-95d7-428781787067	d220df14-d382-4b98-9c10-1df8c28808e1				TCGA-MS-A51U-01	TCGA-MS-A51U-01A-31D-A268-05		8eb29e3b-4e9b-481e-9bb2-564d1ee1a5dc	TCGA-MS-A51U-01	TCGA-MS-A51U-01A-31D-A25Q-09			TCGA-MS-A51U-01			b41dfa6b-a221-4e03-95d7-428781787067		TCGA-MS-A51U-01A-31D-A25N-01	TCGA-MS-A51U-01		b41dfa6b-a221-4e03-95d7-428781787067	TCGA-MS-A51U-01A-31D-A25N-01	
TCGA-OK-A5Q2-01																													0	TCGA-OK-A5Q2-01	64	0	days										TCGA-OK-A5Q2	64	0	days	64	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Right	Axillary lymph node dissection alone			TCGA-OK-A5Q2	TCGA-OK-A5Q2-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-21555	149		0	64							90-99%			2013-1-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES			20	NO	Negative			13	Negative																														NO	2	2	false	No	MX	N1a	T2	Stage II	TCGA-OK-A5Q2.8F2F2141-EC62-4321-B799-054D32FEBA87.pdf	A5Q2								YES	20-29%			Primary Tumor	01		7th		YES	NO	OK	Breast	A	LIVING	2012	b835c127-4f06-4870-a0a4-7f95be0260a4	8141d561-b148-446e-b500-566f1a2cd075	b835c127-4f06-4870-a0a4-7f95be0260a4	8141d561-b148-446e-b500-566f1a2cd075				TCGA-OK-A5Q2-01	TCGA-OK-A5Q2-01A-11D-A27Y-05			TCGA-OK-A5Q2-01	TCGA-OK-A5Q2-01A-11D-A27P-09			TCGA-OK-A5Q2-01			b835c127-4f06-4870-a0a4-7f95be0260a4		TCGA-OK-A5Q2-01A-11D-A27O-01	TCGA-OK-A5Q2-01		b835c127-4f06-4870-a0a4-7f95be0260a4	TCGA-OK-A5Q2-01A-11D-A27O-01	
TCGA-OL-A5D6-01																													1	TCGA-OL-A5D6-01	1104	1	days										TCGA-OL-A5D6	1104	0	days	1104	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5D6-F55437	TCGA-OL-A5D6	TCGA-OL-A5D6-01A		Negative					Negative	Simple Mastectomy					-26052	1378	1104	0	385										2014-1-10	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO		0	true	No	MX	N0	T2	Stage IIA	TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf	A5D6	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	OL	Breast	A	DECEASED	2009	5657c6b6-ba04-4dd8-8623-2a3834820f7d	5e5b667c-4179-45ba-882c-21d35684ae1a	5657c6b6-ba04-4dd8-8623-2a3834820f7d	5e5b667c-4179-45ba-882c-21d35684ae1a				TCGA-OL-A5D6-01	TCGA-OL-A5D6-01A-21D-A27Y-05			TCGA-OL-A5D6-01	TCGA-OL-A5D6-01A-21D-A27P-09			TCGA-OL-A5D6-01			5657c6b6-ba04-4dd8-8623-2a3834820f7d		TCGA-OL-A5D6-01A-21D-A27O-01	TCGA-OL-A5D6-01		5657c6b6-ba04-4dd8-8623-2a3834820f7d	TCGA-OL-A5D6-01A-21D-A27O-01	
TCGA-OL-A5D7-01																													0	TCGA-OL-A5D7-01	1780	0	days										TCGA-OL-A5D7	1780	0	days	1780	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					70	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5D7-F55439	TCGA-OL-A5D7	TCGA-OL-A5D7-01A		Negative					Negative	Lumpectomy					-25643	1415		0	1780										2014-1-10	FEMALE								1.36		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO		0	true	No	MX	N0	T2	Stage IIA	TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf	A5D7	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2009	a9f404db-e7fa-49bf-acca-fccd676f2e7c	589febe7-e680-4541-b582-d8eeade0625d	a9f404db-e7fa-49bf-acca-fccd676f2e7c	589febe7-e680-4541-b582-d8eeade0625d				TCGA-OL-A5D7-01	TCGA-OL-A5D7-01A-11D-A27Y-05		2cdb08fa-d13c-496e-8f53-9852a8a165ef	TCGA-OL-A5D7-01	TCGA-OL-A5D7-01A-11D-A27P-09			TCGA-OL-A5D7-01			a9f404db-e7fa-49bf-acca-fccd676f2e7c		TCGA-OL-A5D7-01A-11D-A27O-01	TCGA-OL-A5D7-01		a9f404db-e7fa-49bf-acca-fccd676f2e7c	TCGA-OL-A5D7-01A-11D-A27O-01	
TCGA-OL-A5D8-01																													0	TCGA-OL-A5D8-01	973	0	days										TCGA-OL-A5D8	973	0	days	973	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Left Lower Outer Quadrant	Other (specify)	axillary ultrasound	TCGA-OL-A5D8-F55438	TCGA-OL-A5D8	TCGA-OL-A5D8-01A		Positive					Positive	Simple Mastectomy		NO			-14853	1357		0	973							90-99%	2.25		2014-1-10	FEMALE						20	2	0.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative	NO	2		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO			true	No	MX	N0	T3	Stage IIB	TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C.pdf	A5D8	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2009	8c435d42-a76a-4078-a593-6a41a2bb6f5e	666c158e-0a58-493a-8f2d-39f81778957f	8c435d42-a76a-4078-a593-6a41a2bb6f5e	666c158e-0a58-493a-8f2d-39f81778957f				TCGA-OL-A5D8-01	TCGA-OL-A5D8-01A-11D-A27Y-05		321a0511-ed95-4937-92b2-5a77c86e1f48	TCGA-OL-A5D8-01	TCGA-OL-A5D8-01A-11D-A27P-09			TCGA-OL-A5D8-01			8c435d42-a76a-4078-a593-6a41a2bb6f5e		TCGA-OL-A5D8-01A-11D-A27O-01	TCGA-OL-A5D8-01		8c435d42-a76a-4078-a593-6a41a2bb6f5e	TCGA-OL-A5D8-01A-11D-A27O-01	
TCGA-OL-A5DA-01																													0	TCGA-OL-A5DA-01	1783	0	days										TCGA-OL-A5DA	1783	0	days	1783	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5DA-F55440	TCGA-OL-A5DA	TCGA-OL-A5DA-01A		Positive					Positive	Other					-22411	1407		0	1783							60-69%			2014-1-10	FEMALE	1									Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES	Ultrasound-guided mammotome biopsy	Other method, specify:	240	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO		0	true	No	MX	N0	T2	Stage IIA	TCGA-OL-A5DA.5049C91E-F4BB-4AA7-BE64-837168189379.pdf	A5DA	TUMOR FREE						NO	YES	60-69%		NO	Primary Tumor	01	partial mastectomy	6th		NO	YES	OL	Breast	A	LIVING	2009	b881706f-5ee8-43da-a691-53c036d94494	f1dacc81-2040-4772-94d3-0bc349ab567c	b881706f-5ee8-43da-a691-53c036d94494	f1dacc81-2040-4772-94d3-0bc349ab567c				TCGA-OL-A5DA-01	TCGA-OL-A5DA-01A-11D-A27Y-05		1e062952-e6da-43a7-ad52-e2eff10461da	TCGA-OL-A5DA-01	TCGA-OL-A5DA-01A-11D-A27P-09			TCGA-OL-A5DA-01			b881706f-5ee8-43da-a691-53c036d94494		TCGA-OL-A5DA-01A-11D-A27O-01	TCGA-OL-A5DA-01		b881706f-5ee8-43da-a691-53c036d94494	TCGA-OL-A5DA-01A-11D-A27O-01	
TCGA-OL-A5RU-01																													0	TCGA-OL-A5RU-01	1219	0	days										TCGA-OL-A5RU	1219	0	days	1219	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5RU-F56569	TCGA-OL-A5RU	TCGA-OL-A5RU-01A		Positive					Positive	Modified Radical Mastectomy					-23108	826		0	1219							90-99%			2014-2-14	FEMALE								1.02		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO		Negative	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	MX	N1	T1c	Stage IIA	TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf	A5RU	TUMOR FREE						YES	YES	80-89%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2010	02873204-1097-45ea-b143-a97f3e047537	fbdb3e72-fa98-48f6-be78-a112b93de1d4	02873204-1097-45ea-b143-a97f3e047537	fbdb3e72-fa98-48f6-be78-a112b93de1d4				TCGA-OL-A5RU-01	TCGA-OL-A5RU-01A-11D-A28C-05		63002326-8f58-4457-b841-9d0773e65587	TCGA-OL-A5RU-01	TCGA-OL-A5RU-01A-11D-A28B-09			TCGA-OL-A5RU-01			02873204-1097-45ea-b143-a97f3e047537		TCGA-OL-A5RU-01A-11D-A28A-01	TCGA-OL-A5RU-01		02873204-1097-45ea-b143-a97f3e047537	TCGA-OL-A5RU-01A-11D-A28A-01	
TCGA-OL-A5RV-01																													0	TCGA-OL-A5RV-01	1062	0	days										TCGA-OL-A5RV	1062	0	days	1062	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-OL-A5RV-F56564	TCGA-OL-A5RV	TCGA-OL-A5RV-01A		Positive					Positive	Modified Radical Mastectomy		NO			-15820	755		0	1062							90-99%			2014-2-14	FEMALE								1.00		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative	NO	29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	20		true	No	MX	N3	T2	Stage IIIC	TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf	A5RV	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011	2dca31d2-af60-4529-afac-e8838a7ee67c	974a292a-7fcd-424c-8cf3-28991184425b	2dca31d2-af60-4529-afac-e8838a7ee67c	974a292a-7fcd-424c-8cf3-28991184425b				TCGA-OL-A5RV-01	TCGA-OL-A5RV-01A-12D-A28C-05		ec9c3ed3-1246-42ab-9120-6a027f56d494	TCGA-OL-A5RV-01	TCGA-OL-A5RV-01A-12D-A28B-09			TCGA-OL-A5RV-01			2dca31d2-af60-4529-afac-e8838a7ee67c		TCGA-OL-A5RV-01A-12D-A28A-01	TCGA-OL-A5RV-01		2dca31d2-af60-4529-afac-e8838a7ee67c	TCGA-OL-A5RV-01A-12D-A28A-01	
TCGA-OL-A5RW-01																													0	TCGA-OL-A5RW-01	1106	0	days										TCGA-OL-A5RW	1106	0	days	1106	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					40	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-OL-A5RW-F56568	TCGA-OL-A5RW			Negative					Negative	Lumpectomy					-14638			0	1106										2014-2-14	FEMALE								1.91		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy				Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	1			No	MX	N1	T1c	Stage IIA		A5RW	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	OL	Breast		LIVING	2010	c5a7673a-c45e-4789-a2c8-32889f39c102	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee	c5a7673a-c45e-4789-a2c8-32889f39c102	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee				TCGA-OL-A5RW-01	TCGA-OL-A5RW-01A-11D-A28C-05		e1d1d1cd-4b4d-4cfe-86b8-7dfe9ca08c75	TCGA-OL-A5RW-01	TCGA-OL-A5RW-01A-11D-A28B-09			TCGA-OL-A5RW-01			c5a7673a-c45e-4789-a2c8-32889f39c102		TCGA-OL-A5RW-01A-11D-A28A-01	TCGA-OL-A5RW-01		c5a7673a-c45e-4789-a2c8-32889f39c102	TCGA-OL-A5RW-01A-11D-A28A-01	
TCGA-OL-A5RX-01																													0	TCGA-OL-A5RX-01	878	0	days										TCGA-OL-A5RX	878	0	days	878	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A5RX-F56570	TCGA-OL-A5RX	TCGA-OL-A5RX-01A		Positive					Positive	Simple Mastectomy					-18942	561		0	878							90-99%			2014-2-14	FEMALE								1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO			true	No	MX	N0	T1c	Stage IA	TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf	A5RX	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011	650c0c98-4432-4e9a-9e83-4ad8a7a0d628	0b486cb1-bb48-4a49-b96f-ed9468831195	650c0c98-4432-4e9a-9e83-4ad8a7a0d628	0b486cb1-bb48-4a49-b96f-ed9468831195				TCGA-OL-A5RX-01	TCGA-OL-A5RX-01A-11D-A28C-05		7f3a5deb-3015-4ca7-aa12-f46870a5da8e	TCGA-OL-A5RX-01	TCGA-OL-A5RX-01A-11D-A28B-09			TCGA-OL-A5RX-01			650c0c98-4432-4e9a-9e83-4ad8a7a0d628		TCGA-OL-A5RX-01A-11D-A28A-01	TCGA-OL-A5RX-01		650c0c98-4432-4e9a-9e83-4ad8a7a0d628	TCGA-OL-A5RX-01A-11D-A28A-01	
TCGA-OL-A5RY-01																													0	TCGA-OL-A5RY-01	752	0	days										TCGA-OL-A5RY	752	0	days	752	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					52	Right	Sentinel node biopsy alone		TCGA-OL-A5RY-F56565	TCGA-OL-A5RY	TCGA-OL-A5RY-01A	Negative	Positive				Mastectomy NOS	Negative	Lumpectomy					-19216	421		0	752							10-19%			2014-2-14	FEMALE								7.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Ultrasound-guided biopsy	Other method, specify:	300	NO		Positive	NO	25	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		true	No	MX	N1	T1c	Stage IIA	TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf	A5RY	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011	2407816a-86e7-4094-a028-e81c0cda5448	3fd01fad-79d8-461d-9aec-a2bf42474827	2407816a-86e7-4094-a028-e81c0cda5448	3fd01fad-79d8-461d-9aec-a2bf42474827				TCGA-OL-A5RY-01	TCGA-OL-A5RY-01A-21D-A28C-05		7bd9aba2-054f-48ac-ab14-ee53896d353d	TCGA-OL-A5RY-01	TCGA-OL-A5RY-01A-21D-A28B-09			TCGA-OL-A5RY-01			2407816a-86e7-4094-a028-e81c0cda5448		TCGA-OL-A5RY-01A-21D-A28A-01	TCGA-OL-A5RY-01		2407816a-86e7-4094-a028-e81c0cda5448	TCGA-OL-A5RY-01A-21D-A28A-01	
TCGA-OL-A5RZ-01																													0	TCGA-OL-A5RZ-01	679	0	days										TCGA-OL-A5RZ	679	0	days	679	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					57	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-OL-A5RZ-F56571	TCGA-OL-A5RZ			Positive					Negative	Simple Mastectomy					-21038			0	679							30-39%	2.0		2014-2-14	FEMALE							21.0	10.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Positive	NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO				No	MX	N0	T1b	Stage IA		A5RZ	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast		LIVING	2012	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	a7893e2d-7629-4815-9913-712291d8f693	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	a7893e2d-7629-4815-9913-712291d8f693				TCGA-OL-A5RZ-01	TCGA-OL-A5RZ-01A-11D-A28C-05		aae8eb5d-0797-424c-a2a1-6b8d08c7463e	TCGA-OL-A5RZ-01	TCGA-OL-A5RZ-01A-11D-A28B-09			TCGA-OL-A5RZ-01			fc8c0c74-cd1b-4bc7-ab1d-568d302c5719		TCGA-OL-A5RZ-01A-11D-A28A-01	TCGA-OL-A5RZ-01		fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	TCGA-OL-A5RZ-01A-11D-A28A-01	
TCGA-OL-A5S0-01																													0	TCGA-OL-A5S0-01	620	0	days										TCGA-OL-A5S0	620	0	days	620	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Right	Axillary lymph node dissection alone		TCGA-OL-A5S0-F56567	TCGA-OL-A5S0	TCGA-OL-A5S0-01A		Positive					Negative	Modified Radical Mastectomy					-24139	279		0	620							30-39%			2014-2-14	FEMALE								3.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO		Positive	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2		true	No	MX	N1a	T2	Stage IIB	TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB.pdf	A5S0	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012	f6e02767-7522-4895-bc70-c7de6b1796ab	a03329fe-b674-48be-9ef6-0c4d4f439830	f6e02767-7522-4895-bc70-c7de6b1796ab	a03329fe-b674-48be-9ef6-0c4d4f439830				TCGA-OL-A5S0-01	TCGA-OL-A5S0-01A-11D-A28C-05		07817555-b5eb-4502-9229-236a38430974	TCGA-OL-A5S0-01	TCGA-OL-A5S0-01A-11D-A28B-09			TCGA-OL-A5S0-01			f6e02767-7522-4895-bc70-c7de6b1796ab		TCGA-OL-A5S0-01A-11D-A28A-01	TCGA-OL-A5S0-01		f6e02767-7522-4895-bc70-c7de6b1796ab	TCGA-OL-A5S0-01A-11D-A28A-01	
TCGA-OL-A66H-01																													0	TCGA-OL-A66H-01	812	0	days										TCGA-OL-A66H	812	0	days	812	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					74	Right			TCGA-OL-A66H-F58492	TCGA-OL-A66H	TCGA-OL-A66H-01A		Positive					Positive	Lumpectomy					-27280	441		0	812							90-99%	1.7		2014-4-11	FEMALE							1.8	1.03		Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	80	NO		Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			true	No	MX	N1mi	T1c	Stage IB	TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf	A66H	TUMOR FREE						NO	YES	80-89%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012	428ca7a1-6f08-4426-8f2d-28939166df70	ce6abca6-47d8-4404-82d3-2209e450c709	428ca7a1-6f08-4426-8f2d-28939166df70	ce6abca6-47d8-4404-82d3-2209e450c709				TCGA-OL-A66H-01	TCGA-OL-A66H-01A-11D-A29O-05			TCGA-OL-A66H-01	TCGA-OL-A66H-01A-11D-A29N-09			TCGA-OL-A66H-01			428ca7a1-6f08-4426-8f2d-28939166df70		TCGA-OL-A66H-01A-11D-A29M-01	TCGA-OL-A66H-01		428ca7a1-6f08-4426-8f2d-28939166df70	TCGA-OL-A66H-01A-11D-A29M-01	
TCGA-OL-A66I-01																													0	TCGA-OL-A66I-01	714	0	days										TCGA-OL-A66I	714	0	days	714	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					36	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66I-F58496	TCGA-OL-A66I	TCGA-OL-A66I-01A		Negative					Negative	Lumpectomy					-13458	1715		0	714										2014-4-11	FEMALE								1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO		Negative	YES	13	Negative																														NO	0		true	No	MX	N1mi	T1c	Stage IIA	TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf	A66I	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2008	d92ddf45-68b6-42da-9497-8faabcc50be0	a9914a13-282b-42c9-ae86-ad7241f462a9	d92ddf45-68b6-42da-9497-8faabcc50be0	a9914a13-282b-42c9-ae86-ad7241f462a9				TCGA-OL-A66I-01	TCGA-OL-A66I-01A-21D-A29O-05		3e69923d-a657-4a7f-b605-bd2b9222c94f	TCGA-OL-A66I-01	TCGA-OL-A66I-01A-21D-A29N-09			TCGA-OL-A66I-01			d92ddf45-68b6-42da-9497-8faabcc50be0		TCGA-OL-A66I-01A-21D-A29M-01	TCGA-OL-A66I-01		d92ddf45-68b6-42da-9497-8faabcc50be0	TCGA-OL-A66I-01A-21D-A29M-01	
TCGA-OL-A66J-01																													0	TCGA-OL-A66J-01	1996	0	days										TCGA-OL-A66J	1996	0	days	1996	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					80	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66J-F58495	TCGA-OL-A66J	TCGA-OL-A66J-01A		Positive					Positive	Lumpectomy					-29345	1645		0	1996							90-99%			2014-4-11	FEMALE								1.50		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO		Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	MX	N0	T1c	Stage I	TCGA-OL-A66J.D5DE4BB3-81AC-44CB-9336-060F324C7A2F.pdf	A66J	TUMOR FREE						NO	YES	50-59%		YES	Primary Tumor	01		6th		NO	YES	OL	Breast	A	LIVING	2008	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	415eb849-be66-47d3-a813-100c1eed8345	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	415eb849-be66-47d3-a813-100c1eed8345				TCGA-OL-A66J-01	TCGA-OL-A66J-01A-11D-A29O-05		cffbe18d-d8c9-4bb3-8916-634e6ad7ab8a	TCGA-OL-A66J-01	TCGA-OL-A66J-01A-11D-A29N-09			TCGA-OL-A66J-01			fc8cb6a7-c7ed-4037-8fb9-7530cdebc705		TCGA-OL-A66J-01A-11D-A29M-01	TCGA-OL-A66J-01		fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	TCGA-OL-A66J-01A-11D-A29M-01	
TCGA-OL-A66K-01																													1	TCGA-OL-A66K-01	1275	1	days										TCGA-OL-A66K	1275	0	days	1275	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66K-F58498	TCGA-OL-A66K	TCGA-OL-A66K-01A		Positive					Positive	Simple Mastectomy					-26299	981	1275	0	1021							70-79%			2014-4-11	FEMALE					2+			1.23		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			true	No	MX	N0	T2	Stage IIA	TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf	A66K	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	DECEASED	2010	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	04ca65ff-5024-4c58-9c7e-5f03691f3c6d	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	04ca65ff-5024-4c58-9c7e-5f03691f3c6d				TCGA-OL-A66K-01	TCGA-OL-A66K-01A-11D-A29O-05		97c6fb8d-f158-4f4c-8139-6a886bf38f99	TCGA-OL-A66K-01	TCGA-OL-A66K-01A-11D-A29N-09			TCGA-OL-A66K-01			7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf		TCGA-OL-A66K-01A-11D-A29M-01	TCGA-OL-A66K-01		7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	TCGA-OL-A66K-01A-11D-A29M-01	
TCGA-OL-A66L-01																													0	TCGA-OL-A66L-01	1301	0	days										TCGA-OL-A66L	1301	0	days	1301	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Right Lower Inner Quadrant			TCGA-OL-A66L-F58493	TCGA-OL-A66L	TCGA-OL-A66L-01A		Positive					Positive	Lumpectomy					-26186	952		0	1301							90-99%			2014-4-11	FEMALE								1.10		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO			true	No	MX	N0	T1c	Stage IA	TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf	A66L	TUMOR FREE						NO	YES	90-99%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2010	0df01f96-a14b-4bd9-bddb-1dab47491d2d	83411c5a-3bb9-45dd-9ed2-f0e27eb3e7c5	0df01f96-a14b-4bd9-bddb-1dab47491d2d	83411c5a-3bb9-45dd-9ed2-f0e27eb3e7c5				TCGA-OL-A66L-01	TCGA-OL-A66L-01A-12D-A31V-05			TCGA-OL-A66L-01				TCGA-OL-A66L-01			0df01f96-a14b-4bd9-bddb-1dab47491d2d		TCGA-OL-A66L-01A-12D-A31T-01	TCGA-OL-A66L-01		0df01f96-a14b-4bd9-bddb-1dab47491d2d	TCGA-OL-A66L-01A-12D-A31T-01	
TCGA-OL-A66N-01																													0	TCGA-OL-A66N-01	792	0	days										TCGA-OL-A66N	792	0	days	792	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					59	Left	Sentinel node biopsy alone		TCGA-OL-A66N-F58500	TCGA-OL-A66N	TCGA-OL-A66N-01A		Positive					Negative	Modified Radical Mastectomy					-21608	505		0	792							80-89%			2014-4-11	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	310	NO		Negative	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	13		true	No	MX	N3	T3	Stage IIIC	TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf	A66N	TUMOR FREE						NO	YES			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011	43cde130-82ef-43ca-ba81-8ab14588069c	dfedbd6d-63f7-4b3f-8ba2-5f56ba2712ce	43cde130-82ef-43ca-ba81-8ab14588069c	dfedbd6d-63f7-4b3f-8ba2-5f56ba2712ce				TCGA-OL-A66N-01	TCGA-OL-A66N-01A-12D-A31V-05		3acac7e1-22c1-4a61-847d-bda89e3a10c1	TCGA-OL-A66N-01				TCGA-OL-A66N-01			43cde130-82ef-43ca-ba81-8ab14588069c		TCGA-OL-A66N-01A-12D-A31T-01	TCGA-OL-A66N-01		43cde130-82ef-43ca-ba81-8ab14588069c	TCGA-OL-A66N-01A-12D-A31T-01	
TCGA-OL-A66O-01																													0	TCGA-OL-A66O-01	528	0	days										TCGA-OL-A66O	528	0	days	528	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					39	Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A66O-F58497	TCGA-OL-A66O	TCGA-OL-A66O-01A		Positive					Positive	Modified Radical Mastectomy					-14272	170		0	528							90-99%			2014-4-11	FEMALE								1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO		Negative	NO	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	3		true	No	MX	N1a	T2	Stage IIB	TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf	A66O	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012	c7f57147-b774-4209-8b7f-2666f59543d8	67db47cd-e3f4-48f3-bf1e-e0c9e5b862b0	c7f57147-b774-4209-8b7f-2666f59543d8	67db47cd-e3f4-48f3-bf1e-e0c9e5b862b0				TCGA-OL-A66O-01	TCGA-OL-A66O-01A-11D-A31V-05		024e8275-694b-4942-832d-3137b1c5303a	TCGA-OL-A66O-01				TCGA-OL-A66O-01			c7f57147-b774-4209-8b7f-2666f59543d8		TCGA-OL-A66O-01A-11D-A31T-01	TCGA-OL-A66O-01		c7f57147-b774-4209-8b7f-2666f59543d8	TCGA-OL-A66O-01A-11D-A31T-01	
TCGA-OL-A66P-01																													0	TCGA-OL-A66P-01	428	0	days										TCGA-OL-A66P	428	0	days	428	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right	Sentinel node biopsy alone		TCGA-OL-A66P-F58494	TCGA-OL-A66P	TCGA-OL-A66P-01A		Negative					Negative	Simple Mastectomy					-27489	98		0	428										2014-4-11	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO		Negative	NO	2	Negative																														NO			true	No	MX	N0	T2	Stage IIA	TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf	A66P	TUMOR FREE						YES	YES			NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2013	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228				TCGA-OL-A66P-01	TCGA-OL-A66P-01A-11D-A31V-05		737f4dca-ab51-4053-ad90-6654f312ca6d	TCGA-OL-A66P-01				TCGA-OL-A66P-01			bbd01868-6fc1-42e7-b375-f0ac1a54a43c		TCGA-OL-A66P-01A-11D-A31T-01	TCGA-OL-A66P-01		bbd01868-6fc1-42e7-b375-f0ac1a54a43c	TCGA-OL-A66P-01A-11D-A31T-01	
TCGA-OL-A6VO-01																													0	TCGA-OL-A6VO-01	858	0	days										TCGA-OL-A6VO	858	0	days	858	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					43	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-OL-A6VO-F59365	TCGA-OL-A6VO	TCGA-OL-A6VO-01A		Negative					Negative	Lumpectomy					-15780	507		0	858										2014-5-10	FEMALE								1.23		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative	Negative	NO	7	Negative																														NO	0		true	No	MX	N0	T1c	Stage IA	TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf	A6VO	TUMOR FREE						YES	YES			YES	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012	5cb12edf-25a1-40f6-831a-5fb1f56676e1	98c2fa71-63aa-4bfe-b49e-41aa4abdb391	5cb12edf-25a1-40f6-831a-5fb1f56676e1	98c2fa71-63aa-4bfe-b49e-41aa4abdb391				TCGA-OL-A6VO-01	TCGA-OL-A6VO-01A-12D-A33F-05		79E2C9D4-0FF5-43E0-B7CE-EF665A49853D	TCGA-OL-A6VO-01				TCGA-OL-A6VO-01			5cb12edf-25a1-40f6-831a-5fb1f56676e1		TCGA-OL-A6VO-01A-12D-A33D-01	TCGA-OL-A6VO-01		5cb12edf-25a1-40f6-831a-5fb1f56676e1	TCGA-OL-A6VO-01A-12D-A33D-01	
TCGA-OL-A6VQ-01																													0	TCGA-OL-A6VQ-01	600	0	days										TCGA-OL-A6VQ	600	0	days	600	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					49	Right			TCGA-OL-A6VQ-F59366	TCGA-OL-A6VQ	TCGA-OL-A6VQ-01A	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy					-18151	278		0	600							90-99%			2014-5-10	FEMALE								1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			110	NO		Negative	NO	1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	MX	N0	T2	Stage IIA	TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf	A6VQ	TUMOR FREE						NO	YES	10-19%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2012	10fbe91f-3570-4cc4-9a86-ea660a86a806	95aa9717-87dc-42e6-8149-251e9b743de8	10fbe91f-3570-4cc4-9a86-ea660a86a806	95aa9717-87dc-42e6-8149-251e9b743de8				TCGA-OL-A6VQ-01	TCGA-OL-A6VQ-01A-12D-A41Q-05		EF77266B-ED91-4FDA-AA99-CCCFAA90E687	TCGA-OL-A6VQ-01				TCGA-OL-A6VQ-01			10fbe91f-3570-4cc4-9a86-ea660a86a806		TCGA-OL-A6VQ-01A-12D-A41E-01	TCGA-OL-A6VQ-01		10fbe91f-3570-4cc4-9a86-ea660a86a806	TCGA-OL-A6VQ-01A-12D-A41E-01	
TCGA-OL-A6VR-01																													0	TCGA-OL-A6VR-01	1220	0	days										TCGA-OL-A6VR	1220	0	days	1220	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					48	Right	Sentinel lymph node biopsy plus axillary dissection		TCGA-OL-A6VR-F59367	TCGA-OL-A6VR	TCGA-OL-A6VR-01A		Positive					Positive	Simple Mastectomy					-17702	869		0	1220							30-39%			2014-5-10	FEMALE								1.23		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative	Negative	NO	2	Negative																														NO	0		true	No	MX	N0	T1b	Stage IA	TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf	A6VR	TUMOR FREE						NO	YES	90-99%		NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2011	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	15e01f89-f689-4b8f-92dd-1037cc87626b	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	15e01f89-f689-4b8f-92dd-1037cc87626b				TCGA-OL-A6VR-01	TCGA-OL-A6VR-01A-32D-A33F-05			TCGA-OL-A6VR-01				TCGA-OL-A6VR-01			19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4		TCGA-OL-A6VR-01A-32D-A33D-01	TCGA-OL-A6VR-01		19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	TCGA-OL-A6VR-01A-32D-A33D-01	
TCGA-OL-A97C-01																													0	TCGA-OL-A97C-01	271	0	days										TCGA-OL-A97C	271	0	days	271	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Left			TCGA-OL-A97C-F66330	TCGA-OL-A97C	TCGA-OL-A97C-01A		Negative					Negative	Simple Mastectomy					-24735	216		0	271										2014-10-31	FEMALE										Other, specify		No		C50.9	9020/3	C50.9		YES		Fine needle aspiration biopsy	410	NO		Negative	NO	6		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T3	Stage IIB	TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf	A97C	TUMOR FREE							YES			NO	Primary Tumor	01		7th		NO	YES	OL	Breast	A	LIVING	2013	590ae2bc-c076-4547-97dc-e2c8a0d396a6	9eb5ef11-18df-40b8-8c58-0236102b90e0	590ae2bc-c076-4547-97dc-e2c8a0d396a6	9eb5ef11-18df-40b8-8c58-0236102b90e0				TCGA-OL-A97C-01	TCGA-OL-A97C-01A-32D-A41Q-05			TCGA-OL-A97C-01				TCGA-OL-A97C-01			590ae2bc-c076-4547-97dc-e2c8a0d396a6		TCGA-OL-A97C-01A-32D-A41E-01	TCGA-OL-A97C-01		590ae2bc-c076-4547-97dc-e2c8a0d396a6	TCGA-OL-A97C-01A-32D-A41E-01	
TCGA-PE-A5DC-01																													1	TCGA-PE-A5DC-01	1430	1	days										TCGA-PE-A5DC	1430	0	days	1430	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					72	Right Upper Inner Quadrant				TCGA-PE-A5DC	TCGA-PE-A5DC-01A		Positive					Positive						-26514	2858	1430	0											2013-4-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			350	NO	Positive			31		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5		true	No	M0	N2a	T2	Stage IIIA	TCGA-PE-A5DC.8693580D-FCB3-4943-9C2F-5F3DABFB5AF0.pdf	A5DC	TUMOR FREE						YES	YES			YES	Primary Tumor	01		6th		NO	YES	PE	Breast	A	DECEASED	2005	05a8e240-5384-4a03-abeb-7ef3697c946d	c5b1d103-453a-4fe5-aef2-63683a56d262	05a8e240-5384-4a03-abeb-7ef3697c946d	c5b1d103-453a-4fe5-aef2-63683a56d262				TCGA-PE-A5DC-01	TCGA-PE-A5DC-01A-12D-A27Y-05		bf2669ec-ff95-4bbd-9d78-451fd90ba389	TCGA-PE-A5DC-01	TCGA-PE-A5DC-01A-12D-A27P-09			TCGA-PE-A5DC-01			05a8e240-5384-4a03-abeb-7ef3697c946d		TCGA-PE-A5DC-01A-12D-A27O-01	TCGA-PE-A5DC-01		05a8e240-5384-4a03-abeb-7ef3697c946d	TCGA-PE-A5DC-01A-12D-A27O-01	
TCGA-PE-A5DD-01																													0	TCGA-PE-A5DD-01	1953	0	days										TCGA-PE-A5DD	1953	0	days	1953	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right Lower Inner Quadrant			TCGA-PE-A5DD-F66361	TCGA-PE-A5DD	TCGA-PE-A5DD-01A		Positive					Negative	Other					-23686	2411		0	1953										2014-10-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	270	NO	Positive	Positive	YES	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf	A5DD	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Reexc of biopsy site for gross/micro residual disease	6th		NO	YES	PE	Breast	A	LIVING	2006	38adc5a4-bf82-4a06-a179-e84dd42593da	51c041dc-88a3-4619-82f3-29995e05c5db	38adc5a4-bf82-4a06-a179-e84dd42593da	51c041dc-88a3-4619-82f3-29995e05c5db				TCGA-PE-A5DD-01	TCGA-PE-A5DD-01A-12D-A27Y-05		9e583b42-e1d2-4055-bf6d-eb6122474edf	TCGA-PE-A5DD-01	TCGA-PE-A5DD-01A-12D-A27P-09			TCGA-PE-A5DD-01			38adc5a4-bf82-4a06-a179-e84dd42593da		TCGA-PE-A5DD-01A-12D-A27O-01	TCGA-PE-A5DD-01		38adc5a4-bf82-4a06-a179-e84dd42593da	TCGA-PE-A5DD-01A-12D-A27O-01	
TCGA-PE-A5DE-01																													0	TCGA-PE-A5DE-01	2645	0	days										TCGA-PE-A5DE	2645	0	days	2645	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					41	Left			TCGA-PE-A5DE-F66373	TCGA-PE-A5DE	TCGA-PE-A5DE-01A		Positive					Positive	Other					-15216	2066		0	2645										2014-10-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	190	NO	Negative		NO	1		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF.pdf	A5DE	TUMOR FREE						YES	YES			YES	Primary Tumor	01	Partial Mastectomy	6th		NO	YES	PE	Breast	A	LIVING	2007	041c71a0-06d5-44a5-8930-7f1dd2a638d1	303dc766-ae5f-4f9d-b840-8609cc453153	041c71a0-06d5-44a5-8930-7f1dd2a638d1	303dc766-ae5f-4f9d-b840-8609cc453153				TCGA-PE-A5DE-01	TCGA-PE-A5DE-01A-11D-A27Y-05		9a364ab7-d541-4771-bf12-11b8628cd9f1	TCGA-PE-A5DE-01	TCGA-PE-A5DE-01A-11D-A27P-09			TCGA-PE-A5DE-01			041c71a0-06d5-44a5-8930-7f1dd2a638d1		TCGA-PE-A5DE-01A-11D-A27O-01	TCGA-PE-A5DE-01		041c71a0-06d5-44a5-8930-7f1dd2a638d1	TCGA-PE-A5DE-01A-11D-A27O-01	
TCGA-PL-A8LV-01																														TCGA-PL-A8LV-01			days										TCGA-PL-A8LV			days		days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					54	Right|Right Upper Outer Quadrant	No axillary staging		TCGA-PL-A8LV-F64849	TCGA-PL-A8LV	TCGA-PL-A8LV-01A													-19746	240		0	-7										2014-10-17	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Excisional Biopsy	840	NO			YES																																			false	No	M0	N0	T4	Stage IIIB	TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf	A8LV	WITH TUMOR							NO			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013	34f3d207-0bfe-4699-b01b-d145942ba488	22f1be3b-bde1-4466-9f54-316c0924a835	34f3d207-0bfe-4699-b01b-d145942ba488	22f1be3b-bde1-4466-9f54-316c0924a835				TCGA-PL-A8LV-01	TCGA-PL-A8LV-01A-21D-A41Q-05		E260A9A0-230C-482C-A3E6-9A4DB6ECD90F	TCGA-PL-A8LV-01				TCGA-PL-A8LV-01			34f3d207-0bfe-4699-b01b-d145942ba488		TCGA-PL-A8LV-01A-21D-A41E-01	TCGA-PL-A8LV-01		34f3d207-0bfe-4699-b01b-d145942ba488	TCGA-PL-A8LV-01A-21D-A41E-01	
TCGA-PL-A8LX-01																													0	TCGA-PL-A8LX-01	5	0	days										TCGA-PL-A8LX			days	5	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					35	Left|Left Upper Outer Quadrant			TCGA-PL-A8LX-F64852	TCGA-PL-A8LX	TCGA-PL-A8LX-01A													-12840	74		0	5										2014-10-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	540	NO			YES			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		Bone|Liver														false	No	M1	N1a	T4	Stage IV	TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B.pdf	A8LX	WITH TUMOR						NO	YES			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013	19cadb60-b213-4fd3-b5ad-d2b49000b6a3	e28bac01-5bd3-4b66-83f7-2c778be9a0d5	19cadb60-b213-4fd3-b5ad-d2b49000b6a3	e28bac01-5bd3-4b66-83f7-2c778be9a0d5				TCGA-PL-A8LX-01	TCGA-PL-A8LX-01A-11D-A41Q-05		22B100C7-397E-4940-8A06-94FA7D3F46DC	TCGA-PL-A8LX-01				TCGA-PL-A8LX-01			19cadb60-b213-4fd3-b5ad-d2b49000b6a3		TCGA-PL-A8LX-01A-11D-A41E-01	TCGA-PL-A8LX-01		19cadb60-b213-4fd3-b5ad-d2b49000b6a3	TCGA-PL-A8LX-01A-11D-A41E-01	
TCGA-PL-A8LY-01																													0	TCGA-PL-A8LY-01	8	0	days										TCGA-PL-A8LY	8	0	days	8	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					30	Right|Right Upper Outer Quadrant			TCGA-PL-A8LY-F64851	TCGA-PL-A8LY	TCGA-PL-A8LY-01A													-11199	129		0	8										2014-10-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	350	NO			YES			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO			false	No	M0	N0	T3	Stage IIB	TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA.pdf	A8LY	WITH TUMOR						NO	NO			NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013	2ca5942e-dcbf-46f1-8427-1ea7216dc559	9a1bfc69-79f4-442d-b7f5-b451e22cf143	2ca5942e-dcbf-46f1-8427-1ea7216dc559	9a1bfc69-79f4-442d-b7f5-b451e22cf143				TCGA-PL-A8LY-01	TCGA-PL-A8LY-01A-11D-A41Q-05		1133DAAA-33B9-4DA6-B84C-F1C7B576AB64	TCGA-PL-A8LY-01				TCGA-PL-A8LY-01			2ca5942e-dcbf-46f1-8427-1ea7216dc559		TCGA-PL-A8LY-01A-11D-A41E-01	TCGA-PL-A8LY-01		2ca5942e-dcbf-46f1-8427-1ea7216dc559	TCGA-PL-A8LY-01A-11D-A41E-01	
TCGA-PL-A8LZ-01																													0	TCGA-PL-A8LZ-01	302	0	days										TCGA-PL-A8LZ	302	0	days	302	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left|Left Upper Outer Quadrant			TCGA-PL-A8LZ-F64850	TCGA-PL-A8LZ	TCGA-PL-A8LZ-01A													-10869	157		0	302										2014-9-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	830	NO			NO			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO			false	No	M0	N2	T4b	Stage IIIB	TCGA-PL-A8LZ.436F3280-98C7-4FA9-BD6F-1B02CAF1D262.pdf	A8LZ	TUMOR FREE						YES				NO	Primary Tumor	01		7th		YES	NO	PL	Breast	A	LIVING	2013	de01d9b6-e29d-495e-815a-c7d2a7c15af3	0e185d4c-d0cd-4098-a9ce-0a0ead6ab508	de01d9b6-e29d-495e-815a-c7d2a7c15af3	0e185d4c-d0cd-4098-a9ce-0a0ead6ab508				TCGA-PL-A8LZ-01	TCGA-PL-A8LZ-01A-31D-A36K-05			TCGA-PL-A8LZ-01				TCGA-PL-A8LZ-01			de01d9b6-e29d-495e-815a-c7d2a7c15af3		TCGA-PL-A8LZ-01A-31D-A36I-01	TCGA-PL-A8LZ-01		de01d9b6-e29d-495e-815a-c7d2a7c15af3	TCGA-PL-A8LZ-01A-31D-A36I-01	
TCGA-S3-A6ZF-01																													0	TCGA-S3-A6ZF-01	572	0	days										TCGA-S3-A6ZF	572	0	days	572	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right|Right Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-A6ZF-F67764	TCGA-S3-A6ZF	TCGA-S3-A6ZF-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		YES			-23650	107		0	572						CAP scoring guideline 2010	90-99%	39		2014-11-11	FEMALE		CAP scoring guideline 2010	50-59%		2+	20	60	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	1350	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	No	M0	N0	T2	Stage IIA	TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf	A6ZF	TUMOR FREE	CAP scoring guideline 2010			moderate	Moderate	YES	YES	40-49%		NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	4d464cde-4885-4b17-9e02-23be26be0540	48198b9b-450c-40fd-a50b-fb804e663cb0	4d464cde-4885-4b17-9e02-23be26be0540	48198b9b-450c-40fd-a50b-fb804e663cb0				TCGA-S3-A6ZF-01	TCGA-S3-A6ZF-01A-32D-A32T-05			TCGA-S3-A6ZF-01				TCGA-S3-A6ZF-01			4d464cde-4885-4b17-9e02-23be26be0540		TCGA-S3-A6ZF-01A-32D-A32H-01	TCGA-S3-A6ZF-01		4d464cde-4885-4b17-9e02-23be26be0540	TCGA-S3-A6ZF-01A-32D-A32H-01	
TCGA-S3-A6ZG-01																													0	TCGA-S3-A6ZG-01	562	0	days										TCGA-S3-A6ZG	562	0	days	562	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					71	Left|Left Upper Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-A6ZG-F70438	TCGA-S3-A6ZG	TCGA-S3-A6ZG-01A		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		YES			-26141	102		0	562						CAP scoring guideline 2010	90-99%			2015-2-26	FEMALE		CAP scoring guidelines 2010	<10%							Mixed Histology (please specify)	Invasive mixed ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	980	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1	0	false	No	M0	N1	T2	Stage IIB	TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf	A6ZG	TUMOR FREE	CAP scoring guideline 2010			Moderate	Moderate	YES	YES	80-89%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	0967df37-66ae-4ab3-a1fd-e196d4bc9995	e18e9c74-60c6-4687-93e5-6d216c131587	0967df37-66ae-4ab3-a1fd-e196d4bc9995	e18e9c74-60c6-4687-93e5-6d216c131587				TCGA-S3-A6ZG-01	TCGA-S3-A6ZG-01A-22D-A32T-05		CA211F7F-3EF6-4AC7-9C51-321C035AA4AF	TCGA-S3-A6ZG-01				TCGA-S3-A6ZG-01			0967df37-66ae-4ab3-a1fd-e196d4bc9995		TCGA-S3-A6ZG-01A-22D-A32H-01	TCGA-S3-A6ZG-01		0967df37-66ae-4ab3-a1fd-e196d4bc9995	TCGA-S3-A6ZG-01A-22D-A32H-01	
TCGA-S3-A6ZH-01																													0	TCGA-S3-A6ZH-01	641	0	days										TCGA-S3-A6ZH	641	0	days	641	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					29	Left|Left Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-S3-A6ZH-F68306	TCGA-S3-A6ZH	TCGA-S3-A6ZH-01A		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		NO			-10832	158		0	641							90-99%	69		2014-11-14	FEMALE		CAP scoring guideline 2010		CAP scoring guideline 2010	2+	20	79	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	580	NO	Equivocal	Negative	NO	21	Negative																														NO	14	0	false	No	MX	N3a	T3	Stage IIIC	TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf	A6ZH	TUMOR FREE	CAP scoring guideline 2010			Strong	Strong	YES	YES	80-89%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	4cb51871-a26f-467e-8742-bb7c09b26ed2	889e93b1-b471-4cd4-ad09-398ddc375719	4cb51871-a26f-467e-8742-bb7c09b26ed2	889e93b1-b471-4cd4-ad09-398ddc375719				TCGA-S3-A6ZH-01	TCGA-S3-A6ZH-01A-22D-A32T-05		45E0455A-5D80-4D40-ACE5-F70316204288	TCGA-S3-A6ZH-01				TCGA-S3-A6ZH-01			4cb51871-a26f-467e-8742-bb7c09b26ed2		TCGA-S3-A6ZH-01A-22D-A32H-01	TCGA-S3-A6ZH-01		4cb51871-a26f-467e-8742-bb7c09b26ed2	TCGA-S3-A6ZH-01A-22D-A32H-01	
TCGA-S3-AA0Z-01																													0	TCGA-S3-AA0Z-01	629	0	days										TCGA-S3-AA0Z	629	0	days	629	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Left|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-S3-AA0Z-F70168	TCGA-S3-AA0Z	TCGA-S3-AA0Z-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		YES			-23314	204		0	629						CAP scoring guideline 2010	90-99%	33		2015-2-26	FEMALE		CAP scoring guideline 2010	10-19%	CAP scoring guideline 2010	1+	20	42	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	330	NO	Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2	0	true	No	M0	N1a	T2	Stage IIB	TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf	AA0Z	TUMOR FREE	CAP scoring guideline 2010				moderate	YES	YES	<10%		NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	cfe44709-9e63-4dd4-9778-80176be7fbd9	406831ad-971a-438b-843b-b2e2912e8b29	cfe44709-9e63-4dd4-9778-80176be7fbd9	406831ad-971a-438b-843b-b2e2912e8b29				TCGA-S3-AA0Z-01	TCGA-S3-AA0Z-01A-11D-A41Q-05		A46027BA-DFAC-427A-89E3-51088763C0A0	TCGA-S3-AA0Z-01				TCGA-S3-AA0Z-01			cfe44709-9e63-4dd4-9778-80176be7fbd9		TCGA-S3-AA0Z-01A-11D-A41E-01	TCGA-S3-AA0Z-01		cfe44709-9e63-4dd4-9778-80176be7fbd9	TCGA-S3-AA0Z-01A-11D-A41E-01	
TCGA-S3-AA10-01																													0	TCGA-S3-AA10-01	586	0	days										TCGA-S3-AA10	586	0	days	586	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					65	Right|Right Upper Outer Quadrant	Axillary lymph node dissection alone		TCGA-S3-AA10-F70441	TCGA-S3-AA10	TCGA-S3-AA10-01A		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		NO			-24075	168		0	586						CAP scoring guideline 2010				2015-2-26	FEMALE		CAP scoring guideline 2010			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	410	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		true	No	M0	N0	T2	Stage IIA	TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf	AA10	TUMOR FREE	CAP scoring guideline 2010					YES	YES			NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	4c80c4a1-7e99-4f9e-b32c-898ae20206c5	7779cc82-d022-43c2-83be-e23303797ce0	4c80c4a1-7e99-4f9e-b32c-898ae20206c5	7779cc82-d022-43c2-83be-e23303797ce0				TCGA-S3-AA10-01	TCGA-S3-AA10-01A-21D-A41Q-05		F3DF6E4D-CA53-4DEA-B48D-652306B60C77	TCGA-S3-AA10-01				TCGA-S3-AA10-01			4c80c4a1-7e99-4f9e-b32c-898ae20206c5		TCGA-S3-AA10-01A-21D-A41E-01	TCGA-S3-AA10-01		4c80c4a1-7e99-4f9e-b32c-898ae20206c5	TCGA-S3-AA10-01A-21D-A41E-01	
TCGA-S3-AA11-01																													0	TCGA-S3-AA11-01	421	0	days										TCGA-S3-AA11	421	0	days	421	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					67	Right	Sentinel node biopsy alone		TCGA-S3-AA11-F67563	TCGA-S3-AA11	TCGA-S3-AA11-01A		Positive	4 Point Scale	2+	3 Point Scale		Positive	Lumpectomy		YES			-24813	148		0	421						CAP scoring guideline 2010	90-99%	40		2014-11-7	FEMALE		CAP scoring guideline 2010	<10%	CAP scoring guideline 2010	2+	20	59	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	280	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	true	No	M0	N0	T2	Stage IIA	TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf	AA11	TUMOR FREE	CAP scoring guideline 2010					YES	YES	60-69%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	0a50d096-f517-485c-9b61-5ab097ce7d8d	11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	0a50d096-f517-485c-9b61-5ab097ce7d8d				TCGA-S3-AA11-01	TCGA-S3-AA11-01A-31D-A41Q-05		424E9C41-A1FA-4342-AFA8-01DA15FD41E7	TCGA-S3-AA11-01				TCGA-S3-AA11-01			11785b0e-04c6-4cf5-80c6-2c4ffcb206f6		TCGA-S3-AA11-01A-31D-A41E-01	TCGA-S3-AA11-01		11785b0e-04c6-4cf5-80c6-2c4ffcb206f6	TCGA-S3-AA11-01A-31D-A41E-01	
TCGA-S3-AA12-01																													0	TCGA-S3-AA12-01	574	0	days										TCGA-S3-AA12	574	0	days	574	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					82	Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-S3-AA12-F70442	TCGA-S3-AA12	TCGA-S3-AA12-01A		Positive	3 Point Scale	2+	3 Point Scale		Negative	Simple Mastectomy		NO			-30101	156		0	574						CAP SCORING GUIDELINE 2010	90-99%			2015-2-26	FEMALE		CAP SCORING GUIDELINE 2010		CAP SCORING GUIDELINE 2007	1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	2190	NO	Negative	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Lung|Other, specify	left adrenal gland										NO	2	0	true	Yes	MX	N1a	T3	Stage IIIA	TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf	AA12	TUMOR FREE	CAP SCORING GUIDELINE 2010			MODERATE	MODERATE	YES	YES			NO	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	a18a4d65-5383-4c29-ac03-959f8b9cb37d	2113ca5c-95af-4433-a3d9-e589b4a04a57	a18a4d65-5383-4c29-ac03-959f8b9cb37d	2113ca5c-95af-4433-a3d9-e589b4a04a57				TCGA-S3-AA12-01	TCGA-S3-AA12-01A-11D-A41Q-05		3761BFE6-9A5D-41AB-AA78-DFF11DA7B9B3	TCGA-S3-AA12-01				TCGA-S3-AA12-01			a18a4d65-5383-4c29-ac03-959f8b9cb37d		TCGA-S3-AA12-01A-11D-A41E-01	TCGA-S3-AA12-01		a18a4d65-5383-4c29-ac03-959f8b9cb37d	TCGA-S3-AA12-01A-11D-A41E-01	
TCGA-S3-AA14-01																													0	TCGA-S3-AA14-01	529	0	days										TCGA-S3-AA14	529	0	days	529	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					47	Right	Sentinel node biopsy alone		TCGA-S3-AA14-F70444	TCGA-S3-AA14	TCGA-S3-AA14-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		YES			-17352	127		0	529						CAP SCORING GUIDELINE 2010	70-79%			2015-2-26	FEMALE		CAP SCORING GUIDELINE 2010	70-79%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	290	NO	Positive		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	3	true	No	cM0 (i+)	N0 (i+)	T1	Stage I	TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf	AA14	TUMOR FREE	CAP SCORING GUIDELINE 2010					YES	YES	70-79%		YES	Primary Tumor	01	EXCISION WITH NEEDLE WIRE LOCALIZATION	7th		YES	NO	S3	Breast	A	LIVING	2013	eb8b259a-b2b3-4fb1-b9d3-b41480642da7	54351c40-70e3-4afb-aa2a-6349a0b843ec	eb8b259a-b2b3-4fb1-b9d3-b41480642da7	54351c40-70e3-4afb-aa2a-6349a0b843ec				TCGA-S3-AA14-01	TCGA-S3-AA14-01A-11D-A41Q-05		0F0662DF-E193-4F71-B2A3-FBE544DA5869	TCGA-S3-AA14-01				TCGA-S3-AA14-01			eb8b259a-b2b3-4fb1-b9d3-b41480642da7		TCGA-S3-AA14-01A-11D-A41E-01	TCGA-S3-AA14-01		eb8b259a-b2b3-4fb1-b9d3-b41480642da7	TCGA-S3-AA14-01A-11D-A41E-01	
TCGA-S3-AA15-01																													0	TCGA-S3-AA15-01	525	0	days										TCGA-S3-AA15	525	0	days	525	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					51	Right|Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-S3-AA15-F72098	TCGA-S3-AA15	TCGA-S3-AA15-01A		Negative			3 Point Scale		Negative	Simple Mastectomy		YES			-18659	93		0	525						CAP SCORING GUIDELINE 2010				2015-4-10	FEMALE		CAP SCORING GUIDELINE 2010								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	990	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	2	0	true	No	cM0 (i+)	N1a	T2	Stage IIB	TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf	AA15	TUMOR FREE	CAP SCORING GUIDELINE 2010					YES	YES			YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	181e9c9f-7dbd-4f3a-8298-12797c717e1f	51ab9b17-4565-4792-826e-4ea1e86ddaba	181e9c9f-7dbd-4f3a-8298-12797c717e1f	51ab9b17-4565-4792-826e-4ea1e86ddaba				TCGA-S3-AA15-01	TCGA-S3-AA15-01A-11D-A41Q-05		A6D6E30B-1F8A-4B8B-B81C-5E016CBC4561	TCGA-S3-AA15-01				TCGA-S3-AA15-01			181e9c9f-7dbd-4f3a-8298-12797c717e1f		TCGA-S3-AA15-01A-11D-A41E-01	TCGA-S3-AA15-01		181e9c9f-7dbd-4f3a-8298-12797c717e1f	TCGA-S3-AA15-01A-11D-A41E-01	
TCGA-S3-AA17-01																													0	TCGA-S3-AA17-01	424	0	days										TCGA-S3-AA17	424	0	days	424	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					64	Right|Right Lower Outer Quadrant	Sentinel node biopsy alone		TCGA-S3-AA17-F67708	TCGA-S3-AA17	TCGA-S3-AA17-01A		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		YES			-23642	92		0	424						CAP SCORING GUIDELINE 2010	90-99%	35		2014-11-11	FEMALE		CAP SCORING GUIDELINE 2010		CAP SCORING GUIDELINE 2010	2+	20	61	1.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	520	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	1	true	Yes	cM0 (i+)	N1mi	T2	Stage IIB	TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf	AA17	TUMOR FREE	CAP SCORING GUIDELINE 2010			MODERATE	STRONG	YES	YES	70-79%		YES	Primary Tumor	01		7th		YES	NO	S3	Breast	A	LIVING	2013	5e032694-2d7f-4e11-8800-0451ff71e5fe	41e8549a-9aed-42bb-9955-cf8b7aff0203	5e032694-2d7f-4e11-8800-0451ff71e5fe	41e8549a-9aed-42bb-9955-cf8b7aff0203				TCGA-S3-AA17-01	TCGA-S3-AA17-01A-11D-A41Q-05		6D0969F0-27F9-4FF0-B943-F4F4510F917D	TCGA-S3-AA17-01				TCGA-S3-AA17-01			5e032694-2d7f-4e11-8800-0451ff71e5fe		TCGA-S3-AA17-01A-11D-A41E-01	TCGA-S3-AA17-01		5e032694-2d7f-4e11-8800-0451ff71e5fe	TCGA-S3-AA17-01A-11D-A41E-01	
TCGA-UL-AAZ6-01																													0	TCGA-UL-AAZ6-01	518	0	days										TCGA-UL-AAZ6	518	0	days	518	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					73	Right			TCGA-UL-AAZ6-F69329	TCGA-UL-AAZ6	TCGA-UL-AAZ6-01A		Positive	3 Point Scale				Positive						-26999	187		0	518							90-99%			2015-1-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES			170	NO	Positive		NO			Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Positive	3+		Positive	90-99%		50-59%		3 Point Scale	3+	1+			<10%		Negative							3 Point Scale					NO			true	No	MX	N0	T2	Stage IIA	TCGA-UL-AAZ6.1AD1E3C4-0D7C-447B-B330-0245F9159FCC.pdf	AAZ6	TUMOR FREE						YES		<10%		NO	Primary Tumor	01		7th		YES	NO	UL	Breast	A	LIVING	2013	5a6b1292-431d-4057-912f-6c8b8f12aed8	d1990a4b-9db1-4f6f-9564-eed89ccc47f0	5a6b1292-431d-4057-912f-6c8b8f12aed8	d1990a4b-9db1-4f6f-9564-eed89ccc47f0				TCGA-UL-AAZ6-01	TCGA-UL-AAZ6-01A-11D-A41Q-05		2102D1F5-40E4-41EA-A564-27AABF047BF9	TCGA-UL-AAZ6-01				TCGA-UL-AAZ6-01			5a6b1292-431d-4057-912f-6c8b8f12aed8		TCGA-UL-AAZ6-01A-11D-A41E-01	TCGA-UL-AAZ6-01		5a6b1292-431d-4057-912f-6c8b8f12aed8	TCGA-UL-AAZ6-01A-11D-A41E-01	
TCGA-UU-A93S-01																													1	TCGA-UU-A93S-01	116	1	days										TCGA-UU-A93S	116	0	days	116	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					63	Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant	No axillary staging			TCGA-UU-A93S	TCGA-UU-A93S-01A		Negative					Negative	Modified Radical Mastectomy		YES			-23278	22	116	0											2014-11-11	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	980	NO	Positive				Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		Bone|Liver											NO			true	No	M1	N3b	T4d	Stage IV	TCGA-UU-A93S.821ED144-DF12-4E49-ADC7-27FA5E422B83.pdf	A93S	WITH TUMOR						NO	NO			NO	Primary Tumor	01		7th		YES	NO	UU	Breast	A	DECEASED	2013	24ef9702-a1e5-4276-abb2-87088861d471	8f2c56aa-6e4e-4b56-90bf-e70cfc9206f3	24ef9702-a1e5-4276-abb2-87088861d471	8f2c56aa-6e4e-4b56-90bf-e70cfc9206f3				TCGA-UU-A93S-01	TCGA-UU-A93S-01A-21D-A41Q-05		49836FDA-BD22-48FC-A520-BC9CA5757C04	TCGA-UU-A93S-01				TCGA-UU-A93S-01			24ef9702-a1e5-4276-abb2-87088861d471		TCGA-UU-A93S-01A-21D-A41E-01	TCGA-UU-A93S-01		24ef9702-a1e5-4276-abb2-87088861d471	TCGA-UU-A93S-01A-21D-A41E-01	
TCGA-V7-A7HQ-01																													0	TCGA-V7-A7HQ-01	2033	0	days										TCGA-V7-A7HQ	2033	0	days	2033	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					75	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-V7-A7HQ-F71970	TCGA-V7-A7HQ	TCGA-V7-A7HQ-01A	Negative	Positive	3 Point Scale	3+	3 Point Scale	Other	Positive	Modified Radical Mastectomy	Additional resection/ margins (taken after first margin positive)	NO			-27684	1493		0	2033							60-69%	1.0		2015-3-31	FEMALE						20	1.1	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	50	NO		Negative	NO	18	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5		false	No	M0	N2a	T1c	Stage IIIA	TCGA-V7-A7HQ.82B46073-10CE-4D05-9421-6308E3FAD1AD.pdf	A7HQ	TUMOR FREE					Moderate to strong	YES	YES	80-89%		YES	Primary Tumor	01		6th		NO	YES	V7	Breast	A	LIVING	2009	d42c079f-31a6-42cd-b02a-ea951b8d15a9	00d8d966-3b07-4ecc-aa3e-3adf967de41c	d42c079f-31a6-42cd-b02a-ea951b8d15a9	00d8d966-3b07-4ecc-aa3e-3adf967de41c				TCGA-V7-A7HQ-01	TCGA-V7-A7HQ-01A-11D-A33F-05			TCGA-V7-A7HQ-01				TCGA-V7-A7HQ-01			d42c079f-31a6-42cd-b02a-ea951b8d15a9		TCGA-V7-A7HQ-01A-11D-A33D-01	TCGA-V7-A7HQ-01		d42c079f-31a6-42cd-b02a-ea951b8d15a9	TCGA-V7-A7HQ-01A-11D-A33D-01	
TCGA-W8-A86G-01																													0	TCGA-W8-A86G-01	347	0	days										TCGA-W8-A86G	347	0	days	347	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					66	Left|Left Lower Inner Quadrant	Sentinel node biopsy alone		TCGA-W8-A86G-F65574	TCGA-W8-A86G	TCGA-W8-A86G-01A	Negative	Positive	3 Point Scale	1+	3 Point Scale	Other	Positive	Lumpectomy	Mastectomy	YES			-24125	126		0	347							90-99%			2014-9-25	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	210	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0	0	false	Yes	MX	N0 (i-)	T2a	Stage IIA	TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf	A86G	TUMOR FREE						YES	YES	70-79%		NO	Primary Tumor	01		7th		YES	NO	W8	Breast	A	LIVING	2013	37106eb9-90ee-4468-aded-0709fa4bba47	b88956ed-4bc5-44f9-9995-2cef9c30391f	37106eb9-90ee-4468-aded-0709fa4bba47	b88956ed-4bc5-44f9-9995-2cef9c30391f				TCGA-W8-A86G-01	TCGA-W8-A86G-01A-21D-A36K-05		3927BD5E-5BB3-45A3-886F-639895BA69F8	TCGA-W8-A86G-01				TCGA-W8-A86G-01			37106eb9-90ee-4468-aded-0709fa4bba47		TCGA-W8-A86G-01A-21D-A36I-01	TCGA-W8-A86G-01		37106eb9-90ee-4468-aded-0709fa4bba47	TCGA-W8-A86G-01A-21D-A36I-01	
TCGA-WT-AB41-01																													0	TCGA-WT-AB41-01	1611	0	days										TCGA-WT-AB41	1611	0	days	1611	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					55	Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	No axillary staging		TCGA-WT-AB41-F66639	TCGA-WT-AB41	TCGA-WT-AB41-01A		Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy						1415		0	1611							90-99%			2014-10-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	1		false	Yes	MX	N1mi	T2	Stage IIB	TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf	AB41	TUMOR FREE						YES	YES	<10%		NO	Primary Tumor	01		7th		NO	YES	WT	Breast	A	LIVING	2010	a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	64a77049-5d0c-4cc6-ba17-014e39eb7711	a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	64a77049-5d0c-4cc6-ba17-014e39eb7711				TCGA-WT-AB41-01	TCGA-WT-AB41-01A-11D-A41Q-05		3A31AEBF-2CC3-4604-8AF6-84DB45550587	TCGA-WT-AB41-01				TCGA-WT-AB41-01			a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa		TCGA-WT-AB41-01A-11D-A41E-01	TCGA-WT-AB41-01		a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa	TCGA-WT-AB41-01A-11D-A41E-01	
TCGA-WT-AB44-01																													0	TCGA-WT-AB44-01	883	0	days										TCGA-WT-AB44	883	0	days	883	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					77	Left	No axillary staging		TCGA-WT-AB44-F66640	TCGA-WT-AB44	TCGA-WT-AB44-01A		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy						656		0	883							90-99%			2014-10-21	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	MX	N0 (i-)	T1c	Stage IA	TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf	AB44	TUMOR FREE						YES	YES	90-99%		YES	Primary Tumor	01		7th		NO	YES	WT	Breast	A	LIVING	2012	77ea5b95-f8df-4fae-b271-182680c4a62a	5b7aacc0-7bc9-4318-b439-e5b15e61cdfc	77ea5b95-f8df-4fae-b271-182680c4a62a	5b7aacc0-7bc9-4318-b439-e5b15e61cdfc				TCGA-WT-AB44-01	TCGA-WT-AB44-01A-11D-A41Q-05			TCGA-WT-AB44-01				TCGA-WT-AB44-01			77ea5b95-f8df-4fae-b271-182680c4a62a		TCGA-WT-AB44-01A-11D-A41E-01	TCGA-WT-AB44-01		77ea5b95-f8df-4fae-b271-182680c4a62a	TCGA-WT-AB44-01A-11D-A41E-01	
TCGA-XX-A899-01																													0	TCGA-XX-A899-01	467	0	days										TCGA-XX-A899	467	0	days	467	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-XX-A899-F67626	TCGA-XX-A899	TCGA-XX-A899-01A		Positive					Positive	Modified Radical Mastectomy		NO			-17022	181		0	467							90-99%			2014-11-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	260	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5	0	false	No	MX	N2a	T1c	Stage IIIA	TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf	A899	TUMOR FREE				strong	strong	YES	YES	70-79%		YES	Primary Tumor	01		7th		NO	YES	XX	Breast	A	LIVING	2013	8e339298-3e3c-4b31-96a9-a842e973e583	31fad9a6-80ba-4ed8-862a-d8e17816c645	8e339298-3e3c-4b31-96a9-a842e973e583	31fad9a6-80ba-4ed8-862a-d8e17816c645				TCGA-XX-A899-01	TCGA-XX-A899-01A-11D-A36K-05		1D814A7B-DA34-4E53-B6C5-23A22F6B5F10	TCGA-XX-A899-01				TCGA-XX-A899-01			8e339298-3e3c-4b31-96a9-a842e973e583		TCGA-XX-A899-01A-11D-A36I-01	TCGA-XX-A899-01		8e339298-3e3c-4b31-96a9-a842e973e583	TCGA-XX-A899-01A-11D-A36I-01	
TCGA-XX-A899-11																													0	TCGA-XX-A899-11	467	0	days										TCGA-XX-A899	467	0	days	467	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-XX-A899-F67626	TCGA-XX-A899	TCGA-XX-A899-11A		Positive					Positive	Modified Radical Mastectomy		NO			-17022	181		0	467							90-99%			2014-11-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	5	0	false	No	MX	N2a	T1c	Stage IIIA		A899	TUMOR FREE				strong	strong	YES	YES	70-79%		YES	Solid Tissue Normal	11		7th		NO	YES	XX	Breast	A	LIVING	2013											A8CECAA2-9F67-4079-8D69-3EA987F4BF69															
TCGA-XX-A89A-01																													0	TCGA-XX-A89A-01	488	0	days										TCGA-XX-A89A	488	0	days	488	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					68	Left Upper Outer Quadrant			TCGA-XX-A89A-F67425	TCGA-XX-A89A	TCGA-XX-A89A-01A		Positive					Positive	Simple Mastectomy					-25000	174		0	488							70-79%			2014-11-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Negative		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																													NO	0		false	No	MX	N0	T3	Stage IIB	TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf	A89A	TUMOR FREE				moderately to strongly	moderately to strongly	NO	YES	70-79%		YES	Primary Tumor	01		7th		NO	YES	XX	Breast	A	LIVING	2013	501a70d8-3932-49c0-aa13-774756fb89e3	e6031cb7-3b18-4a8e-a40a-c1c86066b9a1	501a70d8-3932-49c0-aa13-774756fb89e3	e6031cb7-3b18-4a8e-a40a-c1c86066b9a1				TCGA-XX-A89A-01	TCGA-XX-A89A-01A-11D-A36K-05			TCGA-XX-A89A-01				TCGA-XX-A89A-01			501a70d8-3932-49c0-aa13-774756fb89e3		TCGA-XX-A89A-01A-11D-A36I-01	TCGA-XX-A89A-01		501a70d8-3932-49c0-aa13-774756fb89e3	TCGA-XX-A89A-01A-11D-A36I-01	
TCGA-Z7-A8R5-01																													0	TCGA-Z7-A8R5-01	3287	0	days										TCGA-Z7-A8R5	3287	1	days	3287	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					61	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-Z7-A8R5-F58763	TCGA-Z7-A8R5	TCGA-Z7-A8R5-01A		Positive	4 Point Scale	1+	4 Point Scale		Positive	Other		YES			-22280	2928		0	3287			3287							2014-7-9	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	450	NO	Negative		NO	5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																									Bone	Locoregional Recurrence			YES	3	3	true	Yes	MX	N1a	T3	Stage IIIA	TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf	A8R5	WITH TUMOR						YES	YES			NO	Primary Tumor	01	Segmental Mastectomy	6th		NO	YES	Z7	Breast	A	LIVING	2005	43c6d23b-2fcd-499e-82ef-10f15d8ede90	54a35393-ebdf-4d7c-a8fe-a89b9a0f6cb6	43c6d23b-2fcd-499e-82ef-10f15d8ede90	54a35393-ebdf-4d7c-a8fe-a89b9a0f6cb6				TCGA-Z7-A8R5-01	TCGA-Z7-A8R5-01A-42D-A41Q-05		049AE25E-31B6-4E0D-B67F-08B7034BF093	TCGA-Z7-A8R5-01				TCGA-Z7-A8R5-01			43c6d23b-2fcd-499e-82ef-10f15d8ede90		TCGA-Z7-A8R5-01A-42D-A41E-01	TCGA-Z7-A8R5-01		43c6d23b-2fcd-499e-82ef-10f15d8ede90	TCGA-Z7-A8R5-01A-42D-A41E-01	
TCGA-Z7-A8R6-01																													0	TCGA-Z7-A8R6-01	3256	0	days										TCGA-Z7-A8R6	3256	0	days	3256	days	TCGA Breast Cancer (BRCA)	breast invasive carcinoma	Breast					46	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection		TCGA-Z7-A8R6-F58752	TCGA-Z7-A8R6	TCGA-Z7-A8R6-01A		Positive	4 Point Scale	2+	4 Point Scale		Positive	Lumpectomy		YES			-16955	3020		0	3256										2014-7-9	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.8	8022/3	C50.8	2+	YES		Tumor resection	520	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																													NO	0	0	true	No	M0	N0	T1c	Stage I	TCGA-Z7-A8R6.9A5C8EDF-9243-4F55-9036-A400CF3F4CC1.pdf	A8R6	TUMOR FREE						YES	YES			NO	Primary Tumor	01		6th		NO	YES	Z7	Breast	A	LIVING	2005	d8a45ca6-8f09-4949-8d55-13259b4826d2	bb3b3be9-0e57-4a9f-b80f-2d9240999803	d8a45ca6-8f09-4949-8d55-13259b4826d2	bb3b3be9-0e57-4a9f-b80f-2d9240999803				TCGA-Z7-A8R6-01	TCGA-Z7-A8R6-01A-11D-A41Q-05		DEEEA4DC-9DF5-4D60-92BF-01AEA22171DD	TCGA-Z7-A8R6-01				TCGA-Z7-A8R6-01			d8a45ca6-8f09-4949-8d55-13259b4826d2		TCGA-Z7-A8R6-01A-11D-A41E-01	TCGA-Z7-A8R6-01		d8a45ca6-8f09-4949-8d55-13259b4826d2	TCGA-Z7-A8R6-01A-11D-A41E-01